Citrus Sinensis ID: 019628

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------34
Protein Sequence
MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL
Secondary Structure (PSIPRED)
cccEEEEEEEcccccEEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEcccccccccccccccccccccccccccHHcccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHccccEEEEEccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEccccccEEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEcccccccEEEEEcccccEcccccccccccccHccccHHHHccccccccEEEEEHHHHHHHHHHHcccccccccccHHHHHHHHHHHcccEEccccccccHHHHHHHHHHHcccHcccccHHHHHccHHHHccccHHHccccccccccccccccHHHHHHHHHHHHccccccHHHHHHHccccccccccccHHHHHHccccccEEEcc
Coil and Loop (DISEMBL)
MERYEIVKDigsgnfgvAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMnhrslkhpnivrfkevlltpTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISgvsychsmqiCHRDLKLentlldgstaprvkicdfgyskssvlhsqpkstvgtpayiapevltkkeydgkiadvWSCGVTLYVMLVgaypfedpedpknfrKTIGRILSVHYSFPDYVRVSLECKHLLSRIFvansekritipeiknhpwflrnlpielteggswqshdvnnpsqSLEEVLSLIHEAtkpleaprvgghllgssmelddldadadledtetsgdfvcpl
Flexible Loop (DISEMBL)
meryeivkdigsgnfgvaklvrDKWTRELLAVKFiergqkidEHVQREImnhrslkhpnivrFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKssvlhsqpkstvgtpayiapevlTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIfvansekritipeiknhpwfLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMELDDLDADADLEdtetsgdfvcpl
Low Complexity Region (SEG)
MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMelddldadadledtetSGDFVCPL
Disordered region (IsUnstruct)
****EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH*****TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSW****************************************************************
Disordered Region (DISOPRED)
*ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELT***************************************LLGSSMELDDLDADADLEDTETSGDFVCPL
Disordered Region (DISEMBL)
MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL
Disordered Region (DISPRO)
MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVC**
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	338	2.2.26 [Sep-21-2011]
A2YNT8	339	Serine/threonine-protein	N/A	no	0.994	0.991	0.803	1e-159
Q0D4J7	339	Serine/threonine-protein	yes	no	0.994	0.991	0.800	1e-158
Q75LR7	342	Serine/threonine-protein	no	no	0.994	0.982	0.787	1e-156
Q02066	332	Abscisic acid-inducible p	N/A	no	0.967	0.984	0.789	1e-149
Q9M9E9	343	Serine/threonine-protein	yes	no	0.875	0.862	0.830	1e-147
Q940H6	362	Serine/threonine-protein	no	no	0.937	0.875	0.755	1e-145
Q75H77	362	Serine/threonine-protein	no	no	0.881	0.823	0.776	1e-141
Q75V57	361	Serine/threonine-protein	no	no	0.881	0.825	0.766	1e-141
P0C5D6	334	Serine/threonine-protein	no	no	0.967	0.979	0.716	1e-140
A2ZAB5	334	Serine/threonine-protein	N/A	no	0.967	0.979	0.716	1e-140

>sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2

 Score =  560 bits (1443), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 274/341 (80%), Positives = 302/341 (88%), Gaps = 5/341 (1%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYE++KDIGSGNFGVAKLVRD  T+EL AVKFIERGQKIDE+VQREIMNHRSL+HPNI
Sbjct: 1   MERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VRFKEV+LTPTHLAIVMEYAAGGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQIC
Sbjct: 61  VRFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+
Sbjct: 121 HRDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKV 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDP++P+NFRKTI RILSV Y  PDYVRVS+EC+HLLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEATK 298
           FVAN E+RITIPEIKNHPWFL+NLPIE+T+    S Q +D+N PSQ LEE++++I EA K
Sbjct: 241 FVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARK 300

Query: 299 PLEAPRVGGHLLG-SSMELDDLDADADLEDTETSGDFVCPL 338
           P +  +  G + G  SMEL   D D D  D E SGDFVC L
Sbjct: 301 PGDGSKFSGQIPGLGSMEL--DDIDTDDIDVEDSGDFVCAL 339

May play a role in signal transduction of hyperosmotic response.
Oryza sativa subsp. indica (taxid: 39946)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1

 Score =  557 bits (1436), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 273/341 (80%), Positives = 302/341 (88%), Gaps = 5/341 (1%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYE++KDIGSGNFGVAKLVRD  T+EL AVKFIERGQKIDE+VQREIMNHRSL+HPNI
Sbjct: 1   MERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VRFKEV+LTPTHLAIVMEYAAGGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQIC
Sbjct: 61  VRFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGS APR+KICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGK+
Sbjct: 121 HRDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKV 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDP++P+NFRKTI RILSV Y  PDYVRVS+EC+HLLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEATK 298
           FVAN E+RITIPEIKNHPWFL+NLPIE+T+    S Q +D+N PSQ LEE++++I EA K
Sbjct: 241 FVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARK 300

Query: 299 PLEAPRVGGHLLG-SSMELDDLDADADLEDTETSGDFVCPL 338
           P +  +  G + G  SMEL   D D D  D E SGDFVC L
Sbjct: 301 PGDGSKFSGQIPGLGSMEL--DDVDTDDIDVEDSGDFVCAL 339

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1

 Score =  552 bits (1422), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 271/344 (78%), Positives = 296/344 (86%), Gaps = 8/344 (2%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYE+++DIGSGNFGVAKLVRD  T  L AVKFIERG KIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MERYEVMRDIGSGNFGVAKLVRDVATNHLFAVKFIERGLKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +RFKEV+LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ+C
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGS  PR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL++KEYDGK+
Sbjct: 121 HRDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKV 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTI RILSV YS PDYVRVS +C+HLLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEATK 298
           FV N E+RITIPEIKNHPWFL+NLPIE+T+    S Q  D+N PSQSLEEV+++I EA K
Sbjct: 241 FVGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQLADMNTPSQSLEEVMAIIQEARK 300

Query: 299 PLEAPRVGG----HLLGSSMELDDLDADADLEDTETSGDFVCPL 338
           P +A ++ G      LGS         D D  D E SGDFVC L
Sbjct: 301 PGDAMKLAGAGQVACLGSMDLD--DIDDIDDIDIENSGDFVCAL 342

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q02066|AAIP_WHEAT Abscisic acid-inducible protein kinase (Fragment) OS=Triticum aestivum PE=2 SV=1

 Score =  526 bits (1356), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 263/333 (78%), Positives = 294/333 (88%), Gaps = 6/333 (1%)

Query: 11  GSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP 70
           GSGNFGVAKLVRD  T+E  AVKFIERG KIDEHVQREIMNHRSLKHPNI+RFKEV+LTP
Sbjct: 1   GSGNFGVAKLVRDVRTKEHFAVKFIERGHKIDEHVQREIMNHRSLKHPNIIRFKEVVLTP 60

Query: 71  THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL 130
           THLAIVMEYA+GGELF+RICNAGRFSEDE RFFFQQLISGVSYCHSMQ+CHRDLKLENTL
Sbjct: 61  THLAIVMEYASGGELFQRICNAGRFSEDEGRFFFQQLISGVSYCHSMQVCHRDLKLENTL 120

Query: 131 LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 190
           LDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL+++EYDGK+ADVWSCGVTL
Sbjct: 121 LDGSVAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRREYDGKVADVWSCGVTL 180

Query: 191 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT 250
           YVMLVGAYPFEDP++P+NFRKTI RILSV YS PDYVRVS++C HLLSRIFV N ++RIT
Sbjct: 181 YVMLVGAYPFEDPDEPRNFRKTITRILSVQYSVPDYVRVSMDCIHLLSRIFVGNPQQRIT 240

Query: 251 IPEIKNHPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEATKPLE-APRVGG 307
           IPEIKNHPWFL+ LP+E+T+    S Q  D+N PSQSLEE +++I EA KP + A  V G
Sbjct: 241 IPEIKNHPWFLKRLPVEMTDEYQRSMQLADMNTPSQSLEEAMAIIQEAQKPGDNALGVAG 300

Query: 308 HL--LGSSMELDDLDADADLEDTETSGDFVCPL 338
            +  LG SM+LDD+D D D  D E+SGDFVCPL
Sbjct: 301 QVACLG-SMDLDDIDFDIDDIDVESSGDFVCPL 332

Involved in water-stress responses.

Triticum aestivum (taxid: 4565)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M9E9|SRK2C_ARATH Serine/threonine-protein kinase SRK2C OS=Arabidopsis thaliana GN=SRK2C PE=1 SV=1

 Score =  520 bits (1340), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 250/301 (83%), Positives = 273/301 (90%), Gaps = 5/301 (1%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYEIVKDIGSGNFGVAKLVRDK+++EL AVKFIERGQKIDEHVQREIMNHRSL HPNI
Sbjct: 1   MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +RFKEVLLT THLA+VMEYAAGGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+QIC
Sbjct: 61  IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGS APRVKICDFGYSKS VLHSQPK+TVGTPAYIAPEVL+ KEYDGKI
Sbjct: 121 HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDP DPK+FRKTIGRIL   Y+ PDYVRVS EC+HLLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPS-QSLEEVLSLIHEATKP 299
           FVAN EKRITI EIKNH WFL+NLP+E+ EG    S  +N PS Q++EE++ +I EA KP
Sbjct: 241 FVANPEKRITIEEIKNHSWFLKNLPVEMYEG----SLMMNGPSTQTVEEIVWIIEEARKP 296

Query: 300 L 300
           +
Sbjct: 297 I 297

Involved in gene regulation and confers tolerance to drought and osmotic stress.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1

 Score =  515 bits (1326), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 241/319 (75%), Positives = 281/319 (88%), Gaps = 2/319 (0%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RYE+VKDIGSGNFGVA+L+RDK + EL+AVK+IERG+KIDE+V+REI+NHRSL+HPNIV
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258

Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKP 299
           VA+  KRI+IPEI+NH WFL+NLP +L    +   Q  + + P QS+EE++ +I EAT P
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318

Query: 300 LEAPRVGGHLLGSSMELDD 318
               +   H L  S+++DD
Sbjct: 319 PAGTQNLNHYLTGSLDIDD 337

Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1

 Score =  501 bits (1291), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 233/300 (77%), Positives = 268/300 (89%), Gaps = 2/300 (0%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RYE+V+DIGSGNFGVA+L+R +   +L+AVK+IERG KIDE+VQREI+NHRSL+HPNI+
Sbjct: 21  DRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKIDENVQREIINHRSLRHPNII 80

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 81  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGSTAPR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGKIA
Sbjct: 141 RDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDP++PKNFRKTI RIL V YS PDYV +S EC+ L++RIF
Sbjct: 201 DVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGVQYSIPDYVHISPECRDLIARIF 260

Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATKP 299
           VAN   RI+IPEI+NHPWFL+NLP +L +    S Q  +   P QS++E++ ++ EAT P
Sbjct: 261 VANPATRISIPEIRNHPWFLKNLPADLMDDSKMSSQYEEPEQPMQSMDEIMQILAEATIP 320

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1

 Score =  501 bits (1291), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 230/300 (76%), Positives = 271/300 (90%), Gaps = 2/300 (0%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RYE+VK+IGSGNFGVA+L+R++ + +L+AVK+I+RG+KIDE+VQREI+NHRSL+HPNI+
Sbjct: 20  DRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEKIDENVQREIINHRSLRHPNII 79

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 80  RFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQVCH 139

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGSTAPR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGKIA
Sbjct: 140 RDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 199

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI +IL V YS PDYV +S EC+ L++RIF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQYSIPDYVHISPECRDLITRIF 259

Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATKP 299
           V N   RIT+PEIKNHPWF++N+P +L + G  S Q  + + P Q++ E++ ++ EAT P
Sbjct: 260 VGNPASRITMPEIKNHPWFMKNIPADLMDDGMVSNQYEEPDQPMQNMNEIMQILAEATIP 319

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1

 Score =  499 bits (1286), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 237/331 (71%), Positives = 280/331 (84%), Gaps = 4/331 (1%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           ERYE +K++G+GNFGVA+LVRDK ++EL+AVK+IERG+KIDE+VQREI+NHRSL+HPNI+
Sbjct: 3   ERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV LTPTHLAIVMEYAAGGELFE+IC AGRFSEDEAR+FFQQLISGVSYCHS++ICH
Sbjct: 63  RFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEICH 122

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS  PRVKICDFGYSKS++LHS+PKSTVGTPAYIAPEVL++KEYDGK+A
Sbjct: 123 RDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGKVA 182

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVG+YPFEDP DP+NFRKTI RIL V YS PDYVRVS +C+ LLS+IF
Sbjct: 183 DVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQIF 242

Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELT--EGGSWQSHDVNNPSQSLEEVLSLIHEATKP 299
           VA+  KRITIPEIK H WFL+NLP E++  E   ++  D   P+Q++EE++ +I EA  P
Sbjct: 243 VADPSKRITIPEIKKHTWFLKNLPKEISEREKADYKDTDAAPPTQAVEEIMRIIQEAKVP 302

Query: 300 LEAPRVGGHLLGSSMEL--DDLDADADLEDT 328
            +       LL    EL  DD +  AD  DT
Sbjct: 303 GDMAAADPALLAELAELKSDDEEEAADEYDT 333

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2ZAB5|SAPK3_ORYSI Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. indica GN=SAPK3 PE=1 SV=2

 Score =  499 bits (1286), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 237/331 (71%), Positives = 280/331 (84%), Gaps = 4/331 (1%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           ERYE +K++G+GNFGVA+LVRDK ++EL+AVK+IERG+KIDE+VQREI+NHRSL+HPNI+
Sbjct: 3   ERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV LTPTHLAIVMEYAAGGELFE+IC AGRFSEDEAR+FFQQLISGVSYCHS++ICH
Sbjct: 63  RFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEICH 122

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS  PRVKICDFGYSKS++LHS+PKSTVGTPAYIAPEVL++KEYDGK+A
Sbjct: 123 RDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGKVA 182

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVG+YPFEDP DP+NFRKTI RIL V YS PDYVRVS +C+ LLS+IF
Sbjct: 183 DVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQIF 242

Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELT--EGGSWQSHDVNNPSQSLEEVLSLIHEATKP 299
           VA+  KRITIPEIK H WFL+NLP E++  E   ++  D   P+Q++EE++ +I EA  P
Sbjct: 243 VADPSKRITIPEIKKHTWFLKNLPKEISEREKADYKDTDAAPPTQAVEEIMRIIQEAKVP 302

Query: 300 LEAPRVGGHLLGSSMEL--DDLDADADLEDT 328
            +       LL    EL  DD +  AD  DT
Sbjct: 303 GDMAAADPALLAELAELKSDDEEEAADEYDT 333

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	338
255545790	338	Serine/threonine-protein kinase SAPK1, p	1.0	1.0	0.884	1e-172
224066977	337	predicted protein [Populus trichocarpa]	0.997	1.0	0.896	1e-172
357489739	339	Serine-threonine protein kinase [Medicag	0.997	0.994	0.854	1e-171
356500711	338	PREDICTED: serine/threonine-protein kina	1.0	1.0	0.878	1e-171
356500713	346	PREDICTED: serine/threonine-protein kina	1.0	0.976	0.858	1e-169
356552912	338	PREDICTED: serine/threonine-protein kina	1.0	1.0	0.869	1e-168
224082109	343	predicted protein [Populus trichocarpa]	1.0	0.985	0.862	1e-166
359492886	335	PREDICTED: serine/threonine-protein kina	0.991	1.0	0.840	1e-165
359480471	338	PREDICTED: serine/threonine-protein kina	0.994	0.994	0.85	1e-164
359497246	338	PREDICTED: serine/threonine-protein kina	0.994	0.994	0.85	1e-164

>gi|255545790|ref|XP_002513955.1| Serine/threonine-protein kinase SAPK1, putative [Ricinus communis] gi|223547041|gb|EEF48538.1| Serine/threonine-protein kinase SAPK1, putative [Ricinus communis]

 Score =  610 bits (1572), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 299/338 (88%), Positives = 318/338 (94%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYEI+KDIGSGNFGVAKLVRD+WT+EL AVKFIERGQKIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MERYEILKDIGSGNFGVAKLVRDRWTKELFAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VRFKEV LTPTHLAIVMEYAAGGELFERI NAGRFSEDEARFFFQQLISGVSYCHSMQIC
Sbjct: 61  VRFKEVRLTPTHLAIVMEYAAGGELFERISNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGSTAPRVKICDFGYSKS+VLHSQPKSTVGTPAYIAPEVL+KKEYDGKI
Sbjct: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSTVLHSQPKSTVGTPAYIAPEVLSKKEYDGKI 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVML+GAYPFEDP+DPKNFRKTIGRILSVHYS PDYVRVS+ECKHLLSRI
Sbjct: 181 ADVWSCGVTLYVMLIGAYPFEDPDDPKNFRKTIGRILSVHYSIPDYVRVSIECKHLLSRI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPL 300
           FV N EKRI+IPEIK+HPWFL+NLPIEL EGGS QSHDVNNPSQ++EEV+S+I EA K +
Sbjct: 241 FVVNPEKRISIPEIKDHPWFLKNLPIELMEGGSCQSHDVNNPSQNIEEVVSIIQEARKAV 300

Query: 301 EAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL 338
             P+ G +LL  SM+LDD DADAD ED ETSGDFVCPL
Sbjct: 301 VLPKSGNNLLEGSMDLDDADADADCEDIETSGDFVCPL 338

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224066977|ref|XP_002302308.1| predicted protein [Populus trichocarpa] gi|222844034|gb|EEE81581.1| predicted protein [Populus trichocarpa]

 Score =  609 bits (1570), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 302/337 (89%), Positives = 318/337 (94%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYEI+KDIGSGNFGVAKLVRDKWT+E  AVKFIERGQKIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MERYEIIKDIGSGNFGVAKLVRDKWTKEFFAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR FFQQLISGVSYCHSMQIC
Sbjct: 61  VKFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARIFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGSTAPRVKICDFGYSKS+VLHSQPKSTVGTPAYIAPEVL KKEYDGKI
Sbjct: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSAVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           +DVWSCGVTLYVMLVGAYPFEDP+DPKNFRKTIGRILSV+YS PDY+RVS+EC HLLSRI
Sbjct: 181 SDVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRILSVNYSIPDYIRVSVECNHLLSRI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPL 300
           FVAN EKRITIPEIKNHPWFL+NLPIEL EG SWQS DVNN SQS+EEVLS+I EA+KP+
Sbjct: 241 FVANPEKRITIPEIKNHPWFLKNLPIELMEGQSWQSIDVNNLSQSIEEVLSIIQEASKPV 300

Query: 301 EAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCP 337
              +  GHLLG SM+LDDLDADADLED ETSGDFVCP
Sbjct: 301 SLSKAVGHLLGGSMDLDDLDADADLEDIETSGDFVCP 337

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357489739|ref|XP_003615157.1| Serine-threonine protein kinase [Medicago truncatula] gi|355516492|gb|AES98115.1| Serine-threonine protein kinase [Medicago truncatula]

 Score =  608 bits (1567), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 288/337 (85%), Positives = 312/337 (92%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           M+RYE+VKDIGSGNF VAKLVRD +T+EL AVKFIERGQKID++VQREIMNHRSLKHPNI
Sbjct: 1   MDRYEVVKDIGSGNFAVAKLVRDIFTKELFAVKFIERGQKIDDNVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VRFKEVLLTPTHLAIVMEYAAGGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSM IC
Sbjct: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMLIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI
Sbjct: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDP DPK+F+KTI +ILSV Y  PD+VRVS EC +LLS+I
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPADPKDFKKTISKILSVQYKVPDFVRVSPECINLLSQI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPL 300
           FVAN EKRITIPEIKNHPWFLRNLP+EL EGGSWQS+DVNNPSQS++EVLS++ EA KPL
Sbjct: 241 FVANPEKRITIPEIKNHPWFLRNLPVELMEGGSWQSNDVNNPSQSVDEVLSILQEARKPL 300

Query: 301 EAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCP 337
             P++GG L   SM+LD+ D DADLED ET GDF+CP
Sbjct: 301 NNPKIGGLLSVGSMDLDEFDLDADLEDIETFGDFMCP 337

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500711|ref|XP_003519175.1| PREDICTED: serine/threonine-protein kinase SAPK2-like isoform 1 [Glycine max]

 Score =  607 bits (1564), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 297/338 (87%), Positives = 318/338 (94%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYEI+KDIGSGNF VAKLVRD +T EL AVKFIERGQKIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MERYEILKDIGSGNFAVAKLVRDNYTNELFAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +RFKEVLLTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVLLTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT+KEYDGKI
Sbjct: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTRKEYDGKI 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDP DP+NF+KTIG+ILSV YS PDYVRVS+EC+HLLS+I
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPADPRNFKKTIGKILSVQYSVPDYVRVSMECRHLLSQI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPL 300
           FVA+ EKRITIPEIKNHPWFLRNLP+ELTEGGSWQ +DVNNPSQ++EEVLS+I EA K L
Sbjct: 241 FVASPEKRITIPEIKNHPWFLRNLPMELTEGGSWQMNDVNNPSQNVEEVLSIIQEARKSL 300

Query: 301 EAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL 338
             P+VGG L G SM+LDD DAD DLED ETSG+FVCP+
Sbjct: 301 NVPKVGGLLTGGSMDLDDFDADEDLEDLETSGEFVCPI 338

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500713|ref|XP_003519176.1| PREDICTED: serine/threonine-protein kinase SAPK2-like isoform 2 [Glycine max]

 Score =  600 bits (1546), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 297/346 (85%), Positives = 318/346 (91%), Gaps = 8/346 (2%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYEI+KDIGSGNF VAKLVRD +T EL AVKFIERGQKIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MERYEILKDIGSGNFAVAKLVRDNYTNELFAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--------ARFFFQQLISGVS 112
           +RFKEVLLTPTHLAIVMEYA+GGELFERICNAGRFSEDE        ARFFFQQLISGVS
Sbjct: 61  IRFKEVLLTPTHLAIVMEYASGGELFERICNAGRFSEDEVILVTFHQARFFFQQLISGVS 120

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT
Sbjct: 121 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 180

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +KEYDGKIADVWSCGVTLYVMLVGAYPFEDP DP+NF+KTIG+ILSV YS PDYVRVS+E
Sbjct: 181 RKEYDGKIADVWSCGVTLYVMLVGAYPFEDPADPRNFKKTIGKILSVQYSVPDYVRVSME 240

Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSL 292
           C+HLLS+IFVA+ EKRITIPEIKNHPWFLRNLP+ELTEGGSWQ +DVNNPSQ++EEVLS+
Sbjct: 241 CRHLLSQIFVASPEKRITIPEIKNHPWFLRNLPMELTEGGSWQMNDVNNPSQNVEEVLSI 300

Query: 293 IHEATKPLEAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL 338
           I EA K L  P+VGG L G SM+LDD DAD DLED ETSG+FVCP+
Sbjct: 301 IQEARKSLNVPKVGGLLTGGSMDLDDFDADEDLEDLETSGEFVCPI 346

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552912|ref|XP_003544806.1| PREDICTED: serine/threonine-protein kinase SAPK2-like isoform 1 [Glycine max]

 Score =  598 bits (1542), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 294/338 (86%), Positives = 316/338 (93%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           ME YEI+KDIGSGNF VAKLVRD  T EL AVKFIERGQKIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MEGYEILKDIGSGNFAVAKLVRDNCTNELFAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +RFKEVLLTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQL+SGVSYCHSMQIC
Sbjct: 61  IRFKEVLLTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLVSGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT+KEYDGK+
Sbjct: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTRKEYDGKV 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDPEDP+NF+KTIG+ILSV YS PDYVRVS+EC+HLLS+I
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPRNFKKTIGKILSVQYSVPDYVRVSMECRHLLSQI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPL 300
           FVA+ EKRI IPEIKNHPWFLRNLPIE  EGGSWQ +DVNNPSQS+EEVLS+I EA K L
Sbjct: 241 FVASPEKRIKIPEIKNHPWFLRNLPIEQMEGGSWQMNDVNNPSQSVEEVLSIIQEARKSL 300

Query: 301 EAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL 338
             P+VGG L+G SM+LDDLDAD DLED +TSG+FVCP+
Sbjct: 301 NVPKVGGLLIGGSMDLDDLDADEDLEDLQTSGEFVCPI 338

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082109|ref|XP_002306567.1| predicted protein [Populus trichocarpa] gi|222856016|gb|EEE93563.1| predicted protein [Populus trichocarpa]

 Score =  591 bits (1523), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 296/343 (86%), Positives = 319/343 (93%), Gaps = 5/343 (1%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           M+RYEI+K+IGSGNFGV KLVRD+ T+E  AVKF ERG+KIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MDRYEIMKNIGSGNFGVTKLVRDRCTKEFFAVKFFERGEKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--- 117
           VRFKEVLLTPTHLAIVMEYAAGGELFERIC+AG+FSEDEARFFFQQLISGVSYCHSM   
Sbjct: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICSAGKFSEDEARFFFQQLISGVSYCHSMIFM 120

Query: 118 --QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
             QICHRDLKLENTLLDG+T PRVKICDFGYSKS+VLHSQPKS VGTPAYIAPEVL+KKE
Sbjct: 121 LQQICHRDLKLENTLLDGNTVPRVKICDFGYSKSAVLHSQPKSAVGTPAYIAPEVLSKKE 180

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           YDGKIADVWSCGVTLYVMLVGAYPFEDP+ PKNFRKTIGRILSVHYS PDYVRVS+ECKH
Sbjct: 181 YDGKIADVWSCGVTLYVMLVGAYPFEDPDGPKNFRKTIGRILSVHYSIPDYVRVSIECKH 240

Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHE 295
           LL+RIFVA+ EKRITIPEIKNHPWFL+NLPIEL EGGSWQS+DVNNPSQS+EEVLS+I E
Sbjct: 241 LLTRIFVADPEKRITIPEIKNHPWFLKNLPIELMEGGSWQSNDVNNPSQSVEEVLSIIQE 300

Query: 296 ATKPLEAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL 338
           A+KP+   +   HLLGSSM+LDDLDADADLED ETSGDFVCPL
Sbjct: 301 ASKPVFLSKGEEHLLGSSMDLDDLDADADLEDIETSGDFVCPL 343

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359492886|ref|XP_003634478.1| PREDICTED: serine/threonine-protein kinase SAPK2 [Vitis vinifera] gi|302141990|emb|CBI19193.3| unnamed protein product [Vitis vinifera]

 Score =  586 bits (1510), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 284/338 (84%), Positives = 307/338 (90%), Gaps = 3/338 (0%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYEI+KDIGSGNFGVA+LV DK TREL AVKFIERGQKIDEHVQREIMNHRSL HPNI
Sbjct: 1   MERYEIIKDIGSGNFGVARLVSDKRTRELFAVKFIERGQKIDEHVQREIMNHRSLMHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VRFKEVLLTPTHLAIVMEYAAGGELF RICNAGRFSEDEARFFFQQLISGVSYCHSM+IC
Sbjct: 61  VRFKEVLLTPTHLAIVMEYAAGGELFGRICNAGRFSEDEARFFFQQLISGVSYCHSMRIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL++KEYDGK+
Sbjct: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           +DVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTIGRILSVHYS PDYVRVS+EC+HLLSR+
Sbjct: 181 SDVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTIGRILSVHYSIPDYVRVSIECRHLLSRV 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPL 300
           FVAN +KRITIPEIK HPWFL+NLPIE+ +GGSWQ +DVNNPSQS+EE+LS+I EA K  
Sbjct: 241 FVANPDKRITIPEIKTHPWFLKNLPIEMMDGGSWQKNDVNNPSQSVEEILSIIQEARKTT 300

Query: 301 EAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL 338
              + GG  +  SM+   LD     ED ETSGDFVCPL
Sbjct: 301 GVRKAGGPFMEGSMD---LDDIDADEDIETSGDFVCPL 335

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359480471|ref|XP_003632469.1| PREDICTED: serine/threonine-protein kinase SAPK2-like [Vitis vinifera] gi|297741826|emb|CBI33139.3| unnamed protein product [Vitis vinifera]

 Score =  584 bits (1505), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 289/340 (85%), Positives = 315/340 (92%), Gaps = 4/340 (1%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYEI+KDIGSGNFGVAKLVRDKW+ EL AVK+IERGQKIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MERYEILKDIGSGNFGVAKLVRDKWSGELYAVKYIERGQKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR+FFQQLISGVSYCHSMQIC
Sbjct: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL++KEYDGKI
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKI 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTI RILSVHYS PDYVRVS+ECKHLLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTIARILSVHYSIPDYVRVSMECKHLLSRI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATK 298
           FVAN EKRITIPEI+NHPWF+RNLPIE  +GG  S Q+  VN+PSQS+++++ +I EA  
Sbjct: 241 FVANPEKRITIPEIQNHPWFIRNLPIEFMQGGEASAQTDYVNDPSQSIDDIVKIIQEAR- 299

Query: 299 PLEAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL 338
            +E P+VGGH  G+SM+LDDLD DADL+D E SGDFVC L
Sbjct: 300 -IEGPKVGGHFFGASMDLDDLDEDADLDDIEASGDFVCAL 338

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497246|ref|XP_002262731.2| PREDICTED: serine/threonine-protein kinase SAPK2-like [Vitis vinifera] gi|296088948|emb|CBI38514.3| unnamed protein product [Vitis vinifera]

 Score =  583 bits (1503), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 289/340 (85%), Positives = 315/340 (92%), Gaps = 4/340 (1%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           MERYEI+KDIGSGNFGVAKLVRDKW+ EL AVK+IERGQKIDEHVQREIMNHRSLKHPNI
Sbjct: 1   MERYEILKDIGSGNFGVAKLVRDKWSGELHAVKYIERGQKIDEHVQREIMNHRSLKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR+FFQQLISGVSYCHSMQIC
Sbjct: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL++KEYDGKI
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKI 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTI RILSVHYS PDYVRVS+ECKHLLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTIARILSVHYSIPDYVRVSMECKHLLSRI 240

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATK 298
           FVAN EKRITIPEI+NHPWF+RNLPIE  +GG  S Q+  VN+PSQS+++++ +I EA  
Sbjct: 241 FVANPEKRITIPEIQNHPWFIRNLPIEFMQGGEASAQTDYVNDPSQSIDDIVKIIQEAR- 299

Query: 299 PLEAPRVGGHLLGSSMELDDLDADADLEDTETSGDFVCPL 338
            +E P+VGGH  G+SM+LDDLD DADL+D E SGDFVC L
Sbjct: 300 -IEGPKVGGHFFGASMDLDDLDEDADLDDIEASGDFVCAL 338

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	338
TAIR|locus:2032075	343	SNRK2-8 "SNF1-RELATED PROTEIN	0.875	0.862	0.830	3.8e-133
TAIR|locus:2118929	362	OST1 "OPEN STOMATA 1" [Arabido	0.926	0.864	0.758	1.7e-130
TAIR|locus:2174999	361	SNRK2.3 "sucrose nonfermenting	0.878	0.822	0.774	6.1e-126
TAIR|locus:2206046	361	SNRK2.10 "SNF1-related protein	0.899	0.842	0.742	2.4e-124
TAIR|locus:2159597	353	SNRK2.1 "SNF1-related protein	0.884	0.847	0.737	1.3e-123
TAIR|locus:2140104	350	SNRK2.7 "SNF1-related protein	1.0	0.965	0.677	3.5e-123
TAIR|locus:2160559	360	SNRK2.5 "SNF1-related protein	0.884	0.830	0.735	3.5e-123
TAIR|locus:2045319	339	SNRK2.9 "SNF1-related protein	0.896	0.893	0.693	3.6e-112
TAIR|locus:2102132	535	KIN10 "AT3G01090" [Arabidopsis	0.760	0.480	0.438	6.3e-53
DICTYBASE|DDB_G0277905	727	snfA "AMP-activated protein ki	0.863	0.401	0.405	8e-53

TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1305 (464.4 bits), Expect = 3.8e-133, P = 3.8e-133
 Identities = 250/301 (83%), Positives = 273/301 (90%)

Query:     1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
             MERYEIVKDIGSGNFGVAKLVRDK+++EL AVKFIERGQKIDEHVQREIMNHRSL HPNI
Sbjct:     1 MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 60

Query:    61 VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
             +RFKEVLLT THLA+VMEYAAGGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+QIC
Sbjct:    61 IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
             HRDLKLENTLLDGS APRVKICDFGYSKS VLHSQPK+TVGTPAYIAPEVL+ KEYDGKI
Sbjct:   121 HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
             ADVWSCGVTLYVMLVGAYPFEDP DPK+FRKTIGRIL   Y+ PDYVRVS EC+HLLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRI 240

Query:   241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPS-QSLEEVLSLIHEATKP 299
             FVAN EKRITI EIKNH WFL+NLP+E+ EG    S  +N PS Q++EE++ +I EA KP
Sbjct:   241 FVANPEKRITIEEIKNHSWFLKNLPVEMYEG----SLMMNGPSTQTVEEIVWIIEEARKP 296

Query:   300 L 300
             +
Sbjct:   297 I 297

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0080167 "response to karrikin" evidence=IEP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IGI

TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1280 (455.6 bits), Expect = 1.7e-130, P = 1.7e-130
 Identities = 239/315 (75%), Positives = 277/315 (87%)

Query:     2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
             +RYE+VKDIGSGNFGVA+L+RDK + EL+AVK+IERG+KIDE+V+REI+NHRSL+HPNIV
Sbjct:    19 DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query:    62 RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
             RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct:    79 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query:   122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
             RDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGK+A
Sbjct:   139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

Query:   182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
             DVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIF
Sbjct:   199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258

Query:   242 VANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKP 299
             VA+  KRI+IPEI+NH WFL+NLP +L    +   Q  + + P QS+EE++ +I EAT P
Sbjct:   259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318

Query:   300 LEAPRVGGHLLGSSM 314
                 +   H L  S+
Sbjct:   319 PAGTQNLNHYLTGSL 333

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=IGI;IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IDA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0009931 "calcium-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:2000377 "regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005985 "sucrose metabolic process" evidence=IMP

GO:0006636 "unsaturated fatty acid biosynthetic process" evidence=IMP

GO:0019432 "triglyceride biosynthetic process" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0042744 "hydrogen peroxide catabolic process" evidence=RCA

TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1237 (440.5 bits), Expect = 6.1e-126, P = 6.1e-126
 Identities = 233/301 (77%), Positives = 268/301 (89%)

Query:     2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
             +RY+ VKDIGSGNFGVA+L+RDK T+EL+AVK+IERG KIDE+VQREI+NHRSL+HPNIV
Sbjct:    20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query:    62 RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
             RFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEARFFFQQL+SGVSYCHSMQICH
Sbjct:    80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query:   122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
             RDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL ++EYDGKIA
Sbjct:   140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199

Query:   182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
             DVWSCGVTLYVMLVGAYPFEDPE+P+++RKTI RILSV YS PD +R+S EC HL+SRIF
Sbjct:   200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259

Query:   242 VANSEKRITIPEIKNHPWFLRNLPIEL---TEGGSWQSHDVNNPSQSLEEVLSLIHEATK 298
             VA+   RI+IPEIK H WFL+NLP +L   +  GS Q  +   P QSL+ ++ +I EAT 
Sbjct:   260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGS-QFQEPEQPMQSLDTIMQIISEATI 318

Query:   299 P 299
             P
Sbjct:   319 P 319

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IGI

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0009739 "response to gibberellin stimulus" evidence=IGI

GO:0010029 "regulation of seed germination" evidence=IGI;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009414 "response to water deprivation" evidence=IGI

TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1222 (435.2 bits), Expect = 2.4e-124, P = 2.4e-124
 Identities = 228/307 (74%), Positives = 266/307 (86%)

Query:     1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
             M++YE+VKDIG+GNFGVA+L+R K ++EL+A+K+IERG KIDE+V REI+NHRSL+HPNI
Sbjct:     1 MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query:    61 VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
             +RFKEV+LTPTH+AI MEYAAGGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQIC
Sbjct:    61 IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query:   121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
             HRDLKLENTLLDGS APR+KICDFGYSKSS+LHS PKSTVGTPAYIAPEVL++ EYDGK+
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
             ADVWSCGVTLYVMLVGAYPFED EDPKNF+KTI RI++V Y  PDYV +S +CKHLLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRI 240

Query:   241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPS---QSLEEVLSLIHEAT 297
             FV NS KRITI +IK HPWFL+NLP ELTE          NP+   QS+EE++ ++ EA 
Sbjct:   241 FVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAK 300

Query:   298 KPLEAPR 304
              P    R
Sbjct:   301 TPARVSR 307

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0048527 "lateral root development" evidence=IMP

GO:0070300 "phosphatidic acid binding" evidence=IDA

TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1215 (432.8 bits), Expect = 1.3e-123, P = 1.3e-123
 Identities = 222/301 (73%), Positives = 264/301 (87%)

Query:     1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
             M++Y++VKD+G+GNFGVA+L+R K T+EL+A+K+IERG+KIDE+V REI+NHRSLKHPNI
Sbjct:     1 MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query:    61 VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
             +RFKEV+LTPTHLAIVMEYA+GGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
             HRDLKLENTLLDGS AP +KICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL+++EYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
             ADVWSCGVTLYVMLVGAYPFEDP DPKNFRKTI RI++V Y  PDYV +S ECKHLLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRI 240

Query:   241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGG--SWQSHDVNNPSQSLEEVLSLIHEATK 298
             FV NS KRIT+ EIKNHPW+L+NLP EL E    ++   D +   QS+E+++ ++ EA  
Sbjct:   241 FVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDTSFSLQSVEDIMKIVGEARN 300

Query:   299 P 299
             P
Sbjct:   301 P 301

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
 Identities = 237/350 (67%), Positives = 275/350 (78%)

Query:     1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
             MERY+I++D+GSGNFGVAKLVR+K   E  AVK+IERG KIDEHVQREI+NHR LKHPNI
Sbjct:     1 MERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNI 60

Query:    61 VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
             +RFKEV +TPTHLAIVMEYAAGGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQIC
Sbjct:    61 IRFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQIC 120

Query:   121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
             HRDLKLENTLLDGS +  +KICDFGYSKSSVLHSQPKSTVGTPAY+APEVL++KEY+GKI
Sbjct:   121 HRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKI 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
             ADVWSCGVTLYVMLVGAYPFEDPEDP+N R TI RILSVHY+ PDYVR+S ECKHLLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRI 240

Query:   241 FVANSEKRITIPEIKNHPWFLRN---LPIE---LTEGGSWQSHDVNNPSQSLEEVLSLIH 294
             FVA+ +KRIT+PEI+ HPWFL+    +P E      G   +  +     QS+EE++ +I 
Sbjct:   241 FVADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKIIE 300

Query:   295 EATKPLEAP-RVGG-HLLGSSMXXXXXXXXXXXXXXXX----SGDFVCPL 338
             EA K +      GG  L+  S+                    +GDFVC L
Sbjct:   301 EARKGVNGTDNNGGLGLIDGSIDLDDIDDADIYDDVDDDEERNGDFVCAL 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
 Identities = 222/302 (73%), Positives = 264/302 (87%)

Query:     1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
             M++YE+VKD+G+GNFGVA+L+R K T+EL+A+K+IERG+KIDE+V REI+NHRSL+HPNI
Sbjct:     1 MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query:    61 VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
             +RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSE EAR+FFQQLI GV YCHS+QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
             HRDLKLENTLLDGS AP +KICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL+++EYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
             ADVWSCGVTLYVMLVG YPFEDP+DP+NFRKTI RI++V Y  PDYV +S EC+HLLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRI 240

Query:   241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPS---QSLEEVLSLIHEAT 297
             FV NS KRIT+ EIK HPW+L+NLP ELTE      +    PS   QS+E+++ ++ EA 
Sbjct:   241 FVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKIVGEAR 300

Query:   298 KP 299
              P
Sbjct:   301 NP 302

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
 Identities = 215/310 (69%), Positives = 254/310 (81%)

Query:     1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
             ME+YE+VKD+G GNFG+A+L+R+K T EL+AVKFI+RG KIDE+V REI+NHR+L HPNI
Sbjct:     1 MEKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNI 60

Query:    61 VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
             VRFKEV+LTPTHL IVMEYAAGGELFERI + GRFSE EAR+FFQQLI GV Y H++QIC
Sbjct:    61 VRFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQIC 120

Query:   121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
             HRDLKLENTLLDGS APR+KICDFGYSKSSVLHS PKSTVGTPAYIAPEV  + EYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKS 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
              DVWSCGV LYVMLVGAYPFEDP+DP+NFRKT+ +I++V+Y  P YV +S +C+ LLSRI
Sbjct:   181 VDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRI 240

Query:   241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGS--WQSHDVN--NPS-QSLEEVLSLIHE 295
             FVAN   R T+ EIK+H WFL+NLP EL E     +   +VN  N S Q +EE++ ++ E
Sbjct:   241 FVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGE 300

Query:   296 A-TKP-LEAP 303
             A T P L  P
Sbjct:   301 ARTIPNLSRP 310

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=IGI

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 6.3e-53, P = 6.3e-53
 Identities = 118/269 (43%), Positives = 158/269 (58%)

Query:     1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER----GQKIDEHVQREIMNHRSLK 56
             +  Y++ + +G G+FG  K+     T   +A+K + R      +++E V+REI   R   
Sbjct:    39 LPNYKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 98

Query:    57 HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
             HP+I+R  EV+ TPT + +VMEY   GELF+ I   GR  EDEAR FFQQ+ISGV YCH 
Sbjct:    99 HPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR 158

Query:   117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
               + HRDLK EN LLD      VKI DFG S         K++ G+P Y APEV++ K Y
Sbjct:   159 NMVVHRDLKPENLLLDSKC--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 216

Query:   177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
              G   DVWSCGV LY +L G  PF+D   P  F+K  G I    Y+ P ++  S   + L
Sbjct:   217 AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPSHL--SPGARDL 270

Query:   237 LSRIFVANSEKRITIPEIKNHPWFLRNLP 265
             + R+ V +  KR+TIPEI+ HPWF  +LP
Sbjct:   271 IPRMLVVDPMKRVTIPEIRQHPWFQAHLP 299

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000152 "nuclear ubiquitin ligase complex" evidence=IPI

GO:0003006 "developmental process involved in reproduction" evidence=IMP

GO:0010050 "vegetative phase change" evidence=IMP

GO:0010260 "organ senescence" evidence=IMP

GO:0080022 "primary root development" evidence=IMP

GO:0009594 "detection of nutrient" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0010182 "sugar mediated signaling pathway" evidence=IMP

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006486 "protein glycosylation" evidence=RCA

DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)]

 Score = 547 (197.6 bits), Expect = 8.0e-53, P = 8.0e-53
 Identities = 124/306 (40%), Positives = 173/306 (56%)

Query:     4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPN 59
             Y + K +G G+FG  KL     T   +A+K + R +    K+DE ++REI N +  +HP+
Sbjct:    31 YRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIRREIQNMKLFRHPH 90

Query:    60 IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
             I++  EV+ T T + +VMEY  GGELFE I   G+  EDE+R  FQQ+ISGV YCH   +
Sbjct:    91 IIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQMISGVDYCHHHMV 150

Query:   120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
              HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV++ K Y G 
Sbjct:   151 VHRDLKPENLLLDPINKC-IKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAGP 209

Query:   180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
               DVWSCGV LY  L    PF+D   P  F+K    I    +S PD+V  S  C  L+ +
Sbjct:   210 EVDVWSCGVILYAFLCAKLPFDDESIPMLFKK----IREGVFSIPDFVSPS--CADLIKK 263

Query:   240 IFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKP 299
             + V +  KRITI EI+NHPWF   LP  L+   ++ S  +   + S   +L+ + +   P
Sbjct:   264 MLVVDPVKRITIHEIRNHPWFQVKLPKYLSSPHTFLSKSIQTINNS---ILNEMVQVYAP 320

Query:   300 LEAPRV 305
             ++  R+
Sbjct:   321 IDRERI 326

GO:0046956 "positive phototaxis" evidence=IMP

GO:0008283 "cell proliferation" evidence=IMP

GO:0007005 "mitochondrion organization" evidence=IMP

GO:0006754 "ATP biosynthetic process" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007165 "signal transduction" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9C958	SRK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.7387	0.9082	0.8504	no	no
Q9FFP9	SRK2H_ARATH	2, ., 7, ., 1, 1, ., 1	0.7350	0.8846	0.8305	no	no
A2ZAB5	SAPK3_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7160	0.9674	0.9790	N/A	no
P0C5D6	SAPK3_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7160	0.9674	0.9790	no	no
Q0D4J7	SAPK2_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8005	0.9940	0.9911	yes	no
Q5N942	SAPK4_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7138	0.9053	0.85	no	no
Q02066	AAIP_WHEAT	2, ., 7, ., 1, 1, ., 1	0.7897	0.9674	0.9849	N/A	no
Q9M9E9	SRK2C_ARATH	2, ., 7, ., 1, 1, ., 1	0.8305	0.8757	0.8629	yes	no
Q7XQP4	SAPK7_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7125	0.9437	0.8885	no	no
Q75LR7	SAPK1_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7877	0.9940	0.9824	no	no
P43292	SRK2G_ARATH	2, ., 7, ., 1, 1, ., 1	0.7375	0.8846	0.8470	no	no
P43291	SRK2A_ARATH	2, ., 7, ., 1, 1, ., 1	0.7450	0.8846	0.8236	no	no
Q39193	SRK2I_ARATH	2, ., 7, ., 1, 1, ., 1	0.7740	0.8786	0.8227	no	no
Q39192	SRK2D_ARATH	2, ., 7, ., 1, 1, ., 1	0.7466	0.8816	0.8232	no	no
Q940H6	SRK2E_ARATH	2, ., 7, ., 1, 1, ., 1	0.7554	0.9378	0.8756	no	no
Q75H77	SAPKA_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7766	0.8816	0.8232	no	no
A2YNT8	SAPK2_ORYSI	2, ., 7, ., 1, 1, ., 1	0.8035	0.9940	0.9911	N/A	no
Q6ZI44	SAPK6_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7302	0.8846	0.8191	no	no
Q7Y0B9	SAPK8_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7361	0.9023	0.8221	no	no
Q75V57	SAPK9_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7666	0.8816	0.8254	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	fgenesh4_pg.C_LG_II000922	hypothetical protein (337 aa)
		(Populus trichocarpa)
Predicted Functional Partners:
	gw1.II.888.1	hypothetical protein (295 aa)			•						0.436
	fgenesh4_pg.C_scaffold_762000005	hypothetical protein (313 aa)			•						0.429
	fgenesh4_pg.C_scaffold_201000030	hypothetical protein (313 aa)			•						0.427

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	338
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-100
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-87
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-67
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-65
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-64
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-60
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-58
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-57
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-54
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-53
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-48
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-47
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-47
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-46
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-45
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-44
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-43
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-43
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-43
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-42
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-42
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-42
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-41
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-41
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-40
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-40
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-40
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-39
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-39
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-39
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-38
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-38
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-38
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-38
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-38
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-38
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-38
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-37
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-37
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-37
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-37
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-37
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-36
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-36
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-36
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-36
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-35
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-35
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-35
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-35
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-35
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-35
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-35
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-35
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-35
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-35
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-34
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-34
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-34
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-34
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-34
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-34
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-34
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-34
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-34
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-33
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-33
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-33
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-33
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-33
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-33
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-33
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-33
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-32
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-32
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-32
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-32
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-30
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-30
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-30
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-29
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-29
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-29
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-29
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-29
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-29
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-29
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-28
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-28
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-27
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-27
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-27
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-27
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-27
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-27
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-27
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-26
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-26
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-26
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-26
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-26
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-26
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-26
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-25
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-25
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-25
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-25
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-25
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-25
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-24
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-24
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-24
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-24
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-24
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-24
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-24
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-24
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-24
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-24
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-24
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-23
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-23
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-23
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-23
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-23
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-23
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-23
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-23
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-23
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-22
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-22
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-22
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-22
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-21
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-21
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-21
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-20
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-20
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-20
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-20
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-20
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-20
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-19
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-19
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-19
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-19
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-19
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-18
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-17
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-17
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-17
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-16
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-15
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-11
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  295 bits (759), Expect = e-100
 Identities = 108/260 (41%), Positives = 149/260 (57%), Gaps = 9/260 (3%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIV 61
           YEI++ +G G+FG   L RDK T +L+A+K I  ++ +K  E + REI   + LKHPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           R  +V      L +VMEY  GG+LF+ +   GR SEDEARF+ +Q++S + Y HS  I H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLK EN LLD      VK+ DFG ++      +  + VGTP Y+APEVL  K Y   + 
Sbjct: 121 RDLKPENILLDEDG--HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DYVRVSLECKHLLSRI 240
           D+WS GV LY +L G  PF   +      +   +I      FP     +S E K L+ ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 241 FVANSEKRITIPEIKNHPWF 260
            V + EKR+T  E   HP+F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  262 bits (673), Expect = 2e-87
 Identities = 108/263 (41%), Positives = 144/263 (54%), Gaps = 9/263 (3%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKHPNI 60
           YE+++ +GSG+FG     + K T +++AVK +       K D+  +REI   R L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VR  +      HL +VMEY  GG+LF+ +   G  SEDEA+    Q++ G+ Y HS  I 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGK 179
           HRDLK EN LLD +    VKI DFG +K  +  S   +T VGTP Y+APEVL      G 
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDYVRVSLECKHLL 237
             DVWS GV LY +L G  PF   E+  +  + I RIL   + +  P +   S E K L+
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 238 SRIFVANSEKRITIPEIKNHPWF 260
            +    +  KR T  EI  HPWF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  208 bits (532), Expect = 9e-67
 Identities = 93/253 (36%), Positives = 122/253 (48%), Gaps = 42/253 (16%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIVRFKEVL 67
           +G G FG   L RDK T + +A+K I  E    + E + REI   + L HPNIV+   V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 68  LTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKL 126
               HL +VMEY  GG L + +  N G+ SEDE      Q++ G+ Y HS  I HRDLK 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 127 ENTLLDGSTAPRVKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
           EN LLD     +VK+ DFG SK  +   S  K+ VGTPAY+APEVL  K Y  + +D+WS
Sbjct: 121 ENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANS 245
            GV LY +                                      E K L+ ++   + 
Sbjct: 180 LGVILYEL-------------------------------------PELKDLIRKMLQKDP 202

Query: 246 EKRITIPEIKNHP 258
           EKR +  EI  H 
Sbjct: 203 EKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  207 bits (529), Expect = 1e-65
 Identities = 93/262 (35%), Positives = 140/262 (53%), Gaps = 20/262 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKHPN 59
           +YEI+K IG G+FG   LVR K   +L  +K I      +K  E    E+   + L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 115
           I+++ E       L IVMEYA GG+L ++I    +    F E++   +F QL   + Y H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLT 172
           S +I HRD+K +N  L   +   VK+ DFG SK   S+V  +  K+ VGTP Y++PE+  
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
            K Y+ K +D+WS G  LY +    +PFE     +N  +   +IL   Y  P   + S E
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQYP-PIPSQYSSE 230

Query: 233 CKHLLSRIFVANSEKRITIPEI 254
            ++L+S +   + E+R +I +I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  204 bits (521), Expect = 1e-64
 Identities = 100/259 (38%), Positives = 139/259 (53%), Gaps = 17/259 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLKHPNIVRFKE 65
           +G G+FG   LVR K T +L A+K +++ + I     EH   E      + HP IV+   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              T   L +V+EYA GGELF  +   GRFSE+ ARF+  +++  + Y HS+ I +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVW 184
            EN LLD      +K+ DFG +K      S+  +  GTP Y+APEVL  K Y GK  D W
Sbjct: 121 PENILLDADG--HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177

Query: 185 SCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVAN 244
           S GV LY ML G  PF   +  + + K    IL     FP++  +S E + L+S +   +
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEK----ILKDPLRFPEF--LSPEARDLISGLLQKD 231

Query: 245 SEKRIT---IPEIKNHPWF 260
             KR+      EIK HP+F
Sbjct: 232 PTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  193 bits (493), Expect = 9e-60
 Identities = 97/272 (35%), Positives = 148/272 (54%), Gaps = 32/272 (11%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLKHPN 59
           +E +K +G+G+FG   LVR K + +  A+K + + + +     EHV  E    +S++HP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 60  IVR----FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           +V     F++     ++L +VMEY  GGELF  +  +GRF E  ARF+  Q++  + Y H
Sbjct: 63  LVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 116 SMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
           S+ I +RDLK EN LLD  G     +KI DFG++K   +  +  +  GTP Y+APE++  
Sbjct: 119 SLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILS 172

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           K Y GK  D W+ G+ +Y ML G  PF D    + + K    IL     FP +   S + 
Sbjct: 173 KGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK----ILEGKVRFPSF--FSPDA 225

Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           K L+  +   +  KR+      + +IKNHPWF
Sbjct: 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  189 bits (482), Expect = 1e-58
 Identities = 89/266 (33%), Positives = 131/266 (49%), Gaps = 14/266 (5%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKHPN 59
            +   + +G G+FG   L  DK T EL+AVK +E     +E +   +REI    SL+HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 60  IVRFK--EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           IVR+   E       L I +EY +GG L   +   G+  E   R + +Q++ G++Y HS 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKK 174
            I HRD+K  N L+D      VK+ DFG +K            S  GTP ++APEV+  +
Sbjct: 121 GIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           EY    AD+WS G T+  M  G  P+ +  +P      IG         P++  +S E K
Sbjct: 179 EYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE-IPEH--LSEEAK 234

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWF 260
             L +    + +KR T  E+  HP+ 
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  184 bits (470), Expect = 6e-57
 Identities = 86/261 (32%), Positives = 131/261 (50%), Gaps = 14/261 (5%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-ERGQKIDEHVQREIMNHRSLKHPNIVR 62
           +EI++ IG G FG     R K T + +A+K I    ++  E +  EI   +  KHPNIV+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICH 121
           +    L    L IVME+ +GG L + + +  +  +E +  +  ++L+ G+ Y HS  I H
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 122 RDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
           RD+K  N LL  DG     VK+ DFG S          + VGTP ++APEV+  K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-SVHYSFPDYVRVSLECKHLLS 238
            AD+WS G+T   +  G  P+ +        K + +I  +      +  + S E K  L 
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232

Query: 239 RIFVANSEKRITIPEIKNHPW 259
           +    N EKR T  ++  HP+
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  178 bits (454), Expect = 2e-54
 Identities = 89/267 (33%), Positives = 135/267 (50%), Gaps = 23/267 (8%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR----SLKHPNIVRFKE 65
           I  G +G   L + K T ++ A+K I++   I ++   +++  R      + P +V+   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
                 +L +VMEY  GG+L   + N G   ED AR +  +++  + Y HS  I HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 126 LENTLLDGSTAPRVKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            +N L+D +    +K+ DFG SK          +    + K  VGTP YIAPEV+  + +
Sbjct: 121 PDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
             K  D WS G  LY  LVG  PF      +   +    IL+    +P+ V VS E   L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG----ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233

Query: 237 LSRIFVANSEKRI---TIPEIKNHPWF 260
           +S++ V + EKR+   +I EIKNHP+F
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  176 bits (449), Expect = 2e-53
 Identities = 87/292 (29%), Positives = 139/292 (47%), Gaps = 49/292 (16%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVK-----FIERGQKIDE-HVQREIMNHRSLKH 57
           ++  K IG G+F    L ++K T +  A+K      + + +K+    +++E++  R   H
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61

Query: 58  PNIVR----FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           P I++    F++      +L  V+EYA  GEL + I   G   E   RF+  +++  + Y
Sbjct: 62  PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---------------------SSVL 152
            HS  I HRDLK EN LLD      +KI DFG +K                         
Sbjct: 118 LHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT 212
             +  S VGT  Y++PE+L +K   GK +D+W+ G  +Y ML G  PF    +   F+K 
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK- 233

Query: 213 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI----PEIKNHPWF 260
              IL + YSFP       + K L+ ++ V + + R+ +     E+K HP+F
Sbjct: 234 ---ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  163 bits (414), Expect = 2e-48
 Identities = 88/263 (33%), Positives = 129/263 (49%), Gaps = 20/263 (7%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKE 65
           +G G FG  +LV+ K      A+K +++         EH+  E        HP IV+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
                 ++ ++MEY  GGEL+  + + G F E  ARF+   ++    Y H+  I +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            EN LLD  +   VK+ DFG++K      +  +  GTP Y+APE++  K YD    D WS
Sbjct: 121 PENLLLD--SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177

Query: 186 CGVTLYVMLVGAYPF-EDPEDPKNFRKTIGRILSV--HYSFPDYVRVSLECKHLLSRIFV 242
            G+ LY +L G  PF ED EDP    +    IL       FP+Y  +    K L+ ++  
Sbjct: 178 LGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKAAKDLIKQLLR 232

Query: 243 ANSEKRI-----TIPEIKNHPWF 260
            N E+R+      I +IK H WF
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  165 bits (417), Expect = 7e-48
 Identities = 92/281 (32%), Positives = 136/281 (48%), Gaps = 28/281 (9%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHP- 58
           Y I++ +G G+FG   L RD+   +L+A+K + +      K  E   REI    SL HP 
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 115
           NIV+  +       L +VMEY  GG L + +      G  SE EA F   Q++S + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 168
           S  I HRD+K EN LLD      VK+ DFG +K       +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLDRDG-RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 169 EVL--TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-------KNFRKTIGRILSV 219
           EVL      Y    +D+WS G+TLY +L G  PFE  ++        K   +     L+ 
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             S  +   +S     LL ++   + + R++     +H   
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  162 bits (411), Expect = 2e-47
 Identities = 90/296 (30%), Positives = 132/296 (44%), Gaps = 43/296 (14%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKHP 58
            ++ +K +G G+ G   LVR K T +L A+K +++ + I       V  E     +L HP
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHS 116
            +        T T+L +VM+Y  GGELF   +       SE+ ARF+  +++  + Y H 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 117 MQICHRDLKLENTLLDGS-----------------TAPRVKICDFGYSKSSVLHSQP--- 156
           + I +RDLK EN LL  S                   P  K    G  +SSV        
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 157 --------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN 208
                    S VGT  YIAPEV++   +   + D W+ G+ LY ML G  PF+      N
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG----SN 236

Query: 209 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI----TIPEIKNHPWF 260
             +T   IL    +FP    VS   + L+ ++ V +  KR+       EIK HP+F
Sbjct: 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  162 bits (411), Expect = 4e-47
 Identities = 97/302 (32%), Positives = 138/302 (45%), Gaps = 57/302 (18%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQREIMNHRSL 55
           + +E++K IG G FG   LVRDK T ++ A+K       I+R Q      +R+I+     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD--A 58

Query: 56  KHPNIVR----FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
             P IV+    F++      HL +VMEY  GG+L   +     F E+ ARF+  +L+  +
Sbjct: 59  DSPWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLAL 114

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----------------------- 148
              H +   HRD+K +N L+D      +K+ DFG  K                       
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 149 ---SSVLHSQPK----STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
                  H Q +    STVGTP YIAPEVL    Y  +  D WS GV LY ML G  PF 
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFY 231

Query: 202 DPEDPKNFRKTIGRILS--VHYSFPDYVRVSLECKHLLSRIFVANSEKRIT-IPEIKNHP 258
                   ++T  +I++      FP    VS E   L+ R  + + E R+    EIK+HP
Sbjct: 232 SD----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHP 286

Query: 259 WF 260
           +F
Sbjct: 287 FF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 3e-46
 Identities = 90/268 (33%), Positives = 138/268 (51%), Gaps = 20/268 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLKH 57
           +  E +K +G+G FG   LVRD+ +    A+K +   + I     +HV  E    + + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P I+R          L ++MEY  GGELF  + N+GRFS     F+  +++  + Y HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           +I +RDLK EN LLD      +K+ DFG++K   L  +  +  GTP Y+APEV+  K + 
Sbjct: 121 EIVYRDLKPENILLDKEG--HIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K  D W+ G+ +Y MLVG  PF D     N      +IL+    FP +  + L  K L+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPRH--LDLYAKDLI 229

Query: 238 SRIFVANSEKRI-----TIPEIKNHPWF 260
            ++ V +  +R+        ++KNH WF
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  154 bits (391), Expect = 5e-45
 Identities = 88/270 (32%), Positives = 138/270 (51%), Gaps = 20/270 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQ-KIDEHVQREIMNHRSLKHPN 59
           R++    IG G FG      +  T EL+AVK I  +    K  + +  E+     LKHPN
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSM 117
           +V++  V +    + I MEY +GG L E +   GR   DE   R +  QL+ G++Y HS 
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLT 172
            I HRD+K  N  LD +    +K+ DFG +      ++ +  + +S  GTPAY+APEV+T
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 173 KKEYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRV 229
             +  G    AD+WS G  +  M  G  P+ + ++   F + +  + + H    PD +++
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EF-QIMFHVGAGHKPPIPDSLQL 233

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           S E K  L R   ++ +KR T  E+  HP+
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  154 bits (392), Expect = 1e-44
 Identities = 94/262 (35%), Positives = 132/262 (50%), Gaps = 20/262 (7%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHPNIVRFK 64
           +G G+FG   L   K T EL AVK +++   + +      M  + +     KHP + +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I  +GRF E  ARF+  +++ G+ + H   I +RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N LLD      +KI DFG  K  +L     ST  GTP YIAPE+L+ + Y G   D 
Sbjct: 123 KLDNVLLDSEG--HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179

Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           W+ GV LY ML G  PFE  ++ + F+     IL     +P +  +S E K +L      
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQS----ILEDEVRYPRW--LSKEAKSILKSFLTK 233

Query: 244 NSEKRITIP-----EIKNHPWF 260
           N EKR+        +IK HP+F
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFF 255

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  149 bits (378), Expect = 4e-43
 Identities = 83/271 (30%), Positives = 129/271 (47%), Gaps = 25/271 (9%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPN 59
           YE+++ IG G+FG  + VR K   ++L  K I+ G  + E  ++++++     R LKHPN
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60

Query: 60  IVRF--KEVLLTPTHLAIVMEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSY 113
           IVR+  + +  +   L IVMEY  GG+L + I           E+       QL+  +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 114 CH-----SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIA 167
           CH        + HRDLK  N  LD +    VK+ DFG +K     S    T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDAN--NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 227
           PE L    YD K +D+WS G  +Y +   + PF      +N  +   +I    +    Y 
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT----ARNQLQLASKIKEGKFRRIPY- 232

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
           R S E   ++  +   + +KR +  E+   P
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  150 bits (380), Expect = 7e-43
 Identities = 91/264 (34%), Positives = 133/264 (50%), Gaps = 19/264 (7%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRS-----LKHPNIVR 62
           K IG G+FG   L + K   +  AVK +++   + +  Q+ IM  R+     +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLK EN LLD  +   V + DFG  K  + HS+  ST  GTP Y+APEVL K+ YD +  
Sbjct: 121 DLKPENILLD--SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           D W  G  LY ML G  PF   +  + +   + + L +  +      +S+  +HLL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHLLEGLL 231

Query: 242 VANSEKRI----TIPEIKNHPWFL 261
             +  KR+       EIKNH +F 
Sbjct: 232 QKDRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  149 bits (379), Expect = 9e-43
 Identities = 94/264 (35%), Positives = 131/264 (49%), Gaps = 19/264 (7%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSLK---HPNIVRF 63
           K +G G FG   LVR+K T +  A+K +++   I  + V   +   R L+   HP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
           K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS  + +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIAD 182
           LKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL   +Y G+  D
Sbjct: 121 LKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 183 VWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV 242
            W  GV +Y M+ G  PF + +  K F      IL     FP    +S E K LL+ +  
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLSPEAKSLLAGLLK 231

Query: 243 ANSEKRI-----TIPEIKNHPWFL 261
            + ++R+        EI  H +F 
Sbjct: 232 KDPKQRLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  148 bits (375), Expect = 1e-42
 Identities = 76/269 (28%), Positives = 134/269 (49%), Gaps = 24/269 (8%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR----SLKHPN 59
           +E+++ IG G FG   +V+ + T+++ A+K++ + + +++   R ++N R     L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           +V          ++ +V++   GG+L   +    +FSE++ +F+  +++  + Y HS  I
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            HRD+K +N LLD      V I DF  +      +   ST GTP Y+APEVL ++ Y   
Sbjct: 122 IHRDIKPDNILLDEQG--HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL------SVHYSFPDYVRVSLEC 233
             D WS GVT Y  L G  P+       + R    +I        V Y        S E 
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATW----STEA 229

Query: 234 KHLLSRIFVANSEKRI--TIPEIKNHPWF 260
              ++++   + +KR+   + ++KNHP+F
Sbjct: 230 IDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 2e-42
 Identities = 86/266 (32%), Positives = 130/266 (48%), Gaps = 20/266 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHP 58
            Y++   IG G FGV     +  T + +A+K I   +KI E   + IM      ++LKHP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISL-EKIKEEALKSIMQEIDLLKNLKHP 59

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIV++   + T   L I++EYA  G L + I   G F E     +  Q++ G++Y H   
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 119 ICHRDLKLENTLL--DGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           + HRD+K  N L   DG     VK+ DFG + K + +     S VGTP ++APEV+    
Sbjct: 120 VIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECK 234
                +D+WS G T+  +L G  P+ D  +P      + RI+   H   P+   +S E K
Sbjct: 176 ASTA-SDIWSLGCTVIELLTGNPPYYD-LNPMA---ALFRIVQDDHPPLPE--GISPELK 228

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWF 260
             L + F  +   R T  ++  HPW 
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  146 bits (372), Expect = 5e-42
 Identities = 90/296 (30%), Positives = 130/296 (43%), Gaps = 53/296 (17%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLKHPN 59
           YE ++ +G G +GV    RDK T E++A+K I R    +E +     REI   + LKHPN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 118
           IV+  +V+ T   L +V EY    +L + +    G  S +  +    QL+ G++YCHS +
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLTK- 173
           I HRDLK +N L++      +K+ DFG +++      P  T    V T  Y APE+L   
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE------------------DPEDPKNFRKTIGR 215
           K Y   + D+WS G     M+ G   F                     E      K    
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK---- 228

Query: 216 ILSVHYS--FPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                Y   FP +    L         E   LLS++   N  KRI+  E   HP+F
Sbjct: 229 --LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  147 bits (372), Expect = 2e-41
 Identities = 89/269 (33%), Positives = 139/269 (51%), Gaps = 23/269 (8%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSL----KH 57
           ++I+  +G G +G   L + K T E++A+K +++    K++E   R ++  R +    K 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDILTTTKS 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
             +V+         +L + MEY  GG+    + N G  SED ARF+  ++   V   H +
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
              HRDLK EN L+D S    +K+ DFG SK  V  +   S VG+P Y+APEVL  K YD
Sbjct: 121 GYIHRDLKPENFLIDASG--HIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYD 176

Query: 178 GKIADVWSCGVTLYVMLVGAYPF------EDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
             + D WS G  LY  L G  PF      E  E+ K +++T+ R     Y  P +  +S 
Sbjct: 177 FTV-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR---PVYDDPRF-NLSD 231

Query: 232 ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           E   L++++    S +  ++ +IKNHP+F
Sbjct: 232 EAWDLITKLINDPSRRFGSLEDIKNHPFF 260

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  146 bits (369), Expect = 4e-41
 Identities = 89/266 (33%), Positives = 140/266 (52%), Gaps = 20/266 (7%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPN 59
           +E+ + +G+G+FG  ++ + K T E  A+K +++ +    K  +HV +E      L HP 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           IV           +  ++E+  GGELF  +  AGRF  D A+F+  +L+    Y HS  I
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            +RDLK EN LLD      VK+ DFG++K   +  +  +  GTP Y+APEV+  K + GK
Sbjct: 140 IYRDLKPENLLLDNKG--HVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GK 194

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             D W+ GV LY  + G  PF D + P  FR    +IL+    FP++       + L+  
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNW--FDGRARDLVKG 248

Query: 240 IFVANSEKRI-TIP----EIKNHPWF 260
           +   +  KR+ T+     ++KNHP+F
Sbjct: 249 LLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  144 bits (365), Expect = 6e-41
 Identities = 87/265 (32%), Positives = 138/265 (52%), Gaps = 15/265 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E Y+ ++ IG G  G      D+ T + +A+K +   ++  E +  EI+  +  KHPNIV
Sbjct: 19  ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
            + +  L    L +VMEY  GG L + I  N  R +E +  +  ++++ G+ Y HS  + 
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           HRD+K +N LL  DGS    VK+ DFG++ + +   S+  S VGTP ++APEV+ +K+Y 
Sbjct: 139 HRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 178 GKIADVWSCGVTLYVMLVGAYP-FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
            K+ D+WS G+    M  G  P   +P  P      I     +     +  + S E K  
Sbjct: 195 PKV-DIWSLGIMCIEMAEGEPPYLREP--PLRALFLI-TTKGIP-PLKNPEKWSPEFKDF 249

Query: 237 LSRIFVANSEKRITIPEIKNHPWFL 261
           L++  V + EKR +  E+  HP FL
Sbjct: 250 LNKCLVKDPEKRPSAEELLQHP-FL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  143 bits (363), Expect = 3e-40
 Identities = 83/273 (30%), Positives = 137/273 (50%), Gaps = 25/273 (9%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHV-----QREIMNHRSLKH 57
           +++   +G G+FG  ++VR+K T ++ A+K +++   +  E V     +R+I++  +   
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--S 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 116
           P I + +       +L +VMEY  GG+L   +     +F ED A+F+  +L+  +   H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKK 174
           M   HRD+K EN L+D +    +K+ DFG +   ++      K  VGTP YIAPEVLT  
Sbjct: 121 MGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 175 EYDGKIA-----DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYV 227
             DGK       D WS GV  Y M+ G  PF   E      KT   I++      FP+  
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH--EG--TSAKTYNNIMNFQRFLKFPEDP 234

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           +VS +   L+  + +   ++R+    +  HP+F
Sbjct: 235 KVSSDFLDLIQSL-LCGQKERLGYEGLCCHPFF 266

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 3e-40
 Identities = 92/311 (29%), Positives = 140/311 (45%), Gaps = 68/311 (21%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQREIMNHRSLKH 57
           +E +K IG G FG  +LV+ K T  + A+K       +E+ Q      +R+I+      +
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA--EADN 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P +V+         +L ++MEY  GG++   +     F+E+E RF+  + I  +   H +
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK---------------------SSVLHSQP 156
              HRD+K +N LLD      +K+ DFG                             S+P
Sbjct: 121 GYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 157 K------------------STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAY 198
                              STVGTP YIAPEV  +  Y  K  D WS GV +Y MLVG  
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYP 237

Query: 199 PF--EDPEDP----KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 252
           PF  ++P++      N+++T+         FPD V +S E K L+ R     +E+R+   
Sbjct: 238 PFCSDNPQETYRKIINWKETL--------QFPDEVPLSPEAKDLIKR-LCCEAERRLGNN 288

Query: 253 ---EIKNHPWF 260
              EIK+HP+F
Sbjct: 289 GVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  143 bits (362), Expect = 3e-40
 Identities = 95/260 (36%), Positives = 140/260 (53%), Gaps = 16/260 (6%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSL----KHPNIVR 62
           K +G G+FG   L   K T E  A+K +++     D+ V+  ++  R L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T  HL  VMEY  GG+L   I ++GRF E  ARF+  ++I G+ + H   I +R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLKL+N LLD      +KI DFG  K ++      ST  GTP YIAPE+L  ++Y+  + 
Sbjct: 121 DLKLDNVLLDKDG--HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV- 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           D WS GV LY ML+G  PF   ++ + F      IL+    FP +  +S E K  LS++F
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDS----ILNDRPHFPRW--ISKEAKDCLSKLF 231

Query: 242 VANSEKRITIP-EIKNHPWF 260
             +  KR+ +  +I+ HP+F
Sbjct: 232 ERDPTKRLGVDGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  141 bits (358), Expect = 4e-40
 Identities = 79/259 (30%), Positives = 124/259 (47%), Gaps = 8/259 (3%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVR 62
           E VK +G G+ GV   VR K T ++ A+K I      +   Q  RE+   RS + P +V+
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICH 121
                     ++IV+EY  GG L + +   G+  E    +  +Q++ G+ Y H+   I H
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKI 180
           RD+K  N L+  ++   VKI DFG SK         +T VGT  Y++PE + + E     
Sbjct: 124 RDIKPSNLLI--NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGESYSYA 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           AD+WS G+TL    +G +PF  P  P +F + +  I             S E +  +S  
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239

Query: 241 FVANSEKRITIPEIKNHPW 259
              + +KR +  E+  HP+
Sbjct: 240 LQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 2e-39
 Identities = 87/259 (33%), Positives = 124/259 (47%), Gaps = 17/259 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----KHPNIVRFKE 65
           IG G+FG    VR + T+ + A+K I +   +        +  R++      P IV  K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              +P  L +V+ +  GGELF  +   GRF    ARF+  +L+  +   H   + +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVW 184
            EN LLD      + +CDFG  K ++      +T  GTP Y+APE+L    Y  K  D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177

Query: 185 SCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVAN 244
           + GV LY ML G  PF D    + +RK    IL     FPD      + K LL  +   +
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPDGFDR--DAKDLLIGLLSRD 231

Query: 245 SEKRITI---PEIKNHPWF 260
             +R+      EIKNHP+F
Sbjct: 232 PTRRLGYNGAQEIKNHPFF 250

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  139 bits (351), Expect = 3e-39
 Identities = 88/261 (33%), Positives = 128/261 (49%), Gaps = 12/261 (4%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH---VQREIMNHRSLKHPN 59
           +YE ++ +G G FG+  L R K  ++L+ +K I   Q   +     Q E    + L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 117
           I+ + E  L    L IVMEYA GG L E I         ED    FF Q++  + + H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
            I HRDLK +N LLD      VKI DFG SK     S+  + VGTP YI+PE+   K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K +D+W+ G  LY +      FE      N    + +I+S  ++ P   R S + + L+
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFE----AANLPALVLKIMSGTFA-PISDRYSPDLRQLI 233

Query: 238 SRIFVANSEKRITIPEIKNHP 258
             +   +  KR  + +I   P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  138 bits (350), Expect = 4e-39
 Identities = 83/265 (31%), Positives = 140/265 (52%), Gaps = 20/265 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKHPN 59
           +Y  VK IG G+FG A LV+ K   +   +K I   +   K  E  ++E+    ++KHPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 116
           IV+++E      +L IVM+Y  GG+L+++I NA R   F ED+   +F Q+   + + H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTK 173
            +I HRD+K +N  L       +K+ DFG ++  VL+S     ++ +GTP Y++PE+   
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + Y+ K +D+W+ G  LY M    + FE      N +  + +I+   Y  P     S + 
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAFE----AGNMKNLVLKIIRGSYP-PVSSHYSYDL 229

Query: 234 KHLLSRIFVANSEKRITIPEIKNHP 258
           ++L+S++F  N   R ++  I    
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  140 bits (354), Expect = 1e-38
 Identities = 92/280 (32%), Positives = 143/280 (51%), Gaps = 30/280 (10%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH------VQREIMNHRSL 55
           E ++++K IG G FG  +LVR K ++++ A+K + + + I          +R+IM H + 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN- 101

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
               IV+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H
Sbjct: 102 -SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVL 171
           SM   HRD+K +N LLD S    +K+ DFG       + ++     + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEVL 215

Query: 172 TKKEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS--FPDY 226
             +  D   G+  D WS GV LY MLVG  PF       +   T  +I+    S  FPD 
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMDHKNSLTFPDD 271

Query: 227 VRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLRN 263
           + +S + K L+   F+ + E R+    + EIK+HP+F  +
Sbjct: 272 IEISKQAKDLI-CAFLTDREVRLGRNGVDEIKSHPFFKND 310

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 1e-38
 Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 25/273 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHPN 59
           E + +++ IG G+FG      DK T +++A+K I+  +  D  E +Q+EI      + P 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           I ++    L  + L I+MEY  GG   + +   G+  E    F  ++++ G+ Y H    
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
            HRD+K  N LL  S    VK+ DFG S   +   S+  + VGTP ++APEV+ +  YD 
Sbjct: 120 IHRDIKAANILL--SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177

Query: 179 KIADVWSCGVTLYVMLVGAYPFED--P-----EDPKNFRKTI-GRILSVHYSFPDYVRVS 230
           K AD+WS G+T   +  G  P  D  P       PKN   ++ G   S    F D+V + 
Sbjct: 178 K-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFS--KPFKDFVSLC 234

Query: 231 LE--------CKHLLSRIFVANSEKRITIPEIK 255
           L          K LL   F+  ++K   +  + 
Sbjct: 235 LNKDPKERPSAKELLKHKFIKKAKKTSYLTLLI 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  137 bits (348), Expect = 2e-38
 Identities = 81/295 (27%), Positives = 129/295 (43%), Gaps = 47/295 (15%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKHPN 59
           RY+I+  IG G  G+    +D+ T E +A+K +        I     REI   ++ +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 118
           +V+  +V    +   +VMEY     L E + +  R   E + + + + L+ GV+Y H+  
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 119 ICHRDLKLENTLL--DGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVL-TK 173
           I HRDLK  N L+  DG     +KI DFG ++  S          V T  Y APE+L   
Sbjct: 120 IMHRDLKPANLLISADGV----LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-----------HYS 222
           ++YD  + D+W+ G     +L G+ P    E   N  + +  +                S
Sbjct: 176 RKYDPGV-DLWAVGCIFAELLNGS-PLFPGE---NDIEQLAIVFRTLGTPNEETWPGLTS 230

Query: 223 FPDYVRVSL-ECK----------------HLLSRIFVANSEKRITIPEIKNHPWF 260
            PDY +++  E K                 LL  + V +  KR++  E   HP+F
Sbjct: 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  137 bits (346), Expect = 2e-38
 Identities = 87/267 (32%), Positives = 128/267 (47%), Gaps = 25/267 (9%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE----------RGQKIDEHVQREIMNHRSLKHPN 59
           IGSG+FG   L  +  + EL+AVK +E          R + + + + REI   + L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           IV++    L   HL I +EY  GG +   + N G F E   R F +Q++ G++Y H+  I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLT 172
            HRD+K  N L+D      +KI DFG SK       S+  +    S  G+  ++APEV+ 
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +  Y  K AD+WS G  +  ML G +PF D    +   K            P    +S E
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP---EIPS--NISSE 239

Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
               L + F  +  KR T  E+  HP+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  137 bits (346), Expect = 3e-38
 Identities = 83/274 (30%), Positives = 136/274 (49%), Gaps = 23/274 (8%)

Query: 4   YEIVKDIGSGNFGVAKLVRD---KWTRELLAVKFIERG-----QKIDEHV--QREIMNHR 53
           +E+++ +G+G +G   LVR        +L A+K +++       K  EH   +R+++   
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
             + P +V       T T L ++++Y  GGELF  +     F+E E R +  +++  + +
Sbjct: 62  R-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD      V + DFG SK  +   + +  S  GT  Y+APEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 172 TKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG-RILSVHYSFPDYVRV 229
                   K  D WS GV  + +L GA PF   +  +N +  I  RIL     FP    +
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK--TM 235

Query: 230 SLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
           S E +  + ++   + +KR+      EIKNHP+F
Sbjct: 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  137 bits (347), Expect = 4e-38
 Identities = 90/261 (34%), Positives = 140/261 (53%), Gaps = 18/261 (6%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHPNIVR 62
           K +G G+FG   L   K T +  A+K +++   + D+ V+  ++  R L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T  +L  VMEY  GG+L   I +  +F    A F+  ++I G+ + HS  I +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLKL+N LLD  T   +KI DFG  K ++L      T  GTP YIAPE+L  ++Y+  + 
Sbjct: 121 DLKLDNILLD--TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV- 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRI 240
           D WS GV LY ML+G  PF   ++ + F+       S+    P Y R ++ E K +L ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREAKDILVKL 230

Query: 241 FVANSEKRITIP-EIKNHPWF 260
           FV   E+R+ +  +I+ HP+F
Sbjct: 231 FVREPERRLGVKGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  137 bits (347), Expect = 5e-38
 Identities = 89/261 (34%), Positives = 134/261 (51%), Gaps = 18/261 (6%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSL----KHPNIVR 62
           K +G G+FG   L   K   E  AVK +++    ID+ V+  ++  R L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T  HL  VME+  GG+L   I + GRF    A F+  +++ G+ + HS  I +R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLKL+N +LD      +KI DFG  K +V      ST  GTP YIAPE+L   +Y   + 
Sbjct: 121 DLKLDNVMLDRDG--HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRI 240
           D WS GV LY ML+G  PF   ++ + F        S+    P Y R ++ E K +L ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKL 230

Query: 241 FVANSEKRITIP-EIKNHPWF 260
           F  +  +R+ +   I+ HP+F
Sbjct: 231 FERDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 1e-37
 Identities = 87/266 (32%), Positives = 129/266 (48%), Gaps = 23/266 (8%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE---HVQR---EIMNHRSLKHPNIV 61
           K +G G FG   L  D  T   LAVK +       E    V     EI   ++L+H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           ++   L     L+I MEY  GG + +++   G  +E   R + +Q++ GV Y HS  I H
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLTKKEYD 177
           RD+K  N L D  +A  VK+ DFG SK    + S     KS  GTP +++PEV++ + Y 
Sbjct: 128 RDIKGANILRD--SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY- 184

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV---RVSLECK 234
           G+ ADVWS G T+  ML    P+ + E        +  I  +     +      VS + +
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFE-------AMAAIFKIATQPTNPQLPSHVSPDAR 237

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWF 260
           + L R FV N++KR +  E+  H + 
Sbjct: 238 NFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  136 bits (344), Expect = 2e-37
 Identities = 92/266 (34%), Positives = 133/266 (50%), Gaps = 27/266 (10%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR-------SLKHPNIVR 62
           +G G+FG   L   K T EL A+K +++G  I       +M  +       S +HP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T  H+  VMEYAAGG+L   I +   FSE  A F+   ++ G+ Y H  +I +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLKL+N LLD  T   VKI DFG  K  +      ST  GTP ++APEVLT+  Y  +  
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182

Query: 182 DVWSCGVTLYVMLVGAYPF--EDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
           D W  GV +Y MLVG  PF  +D E+          I++    +P +  +S E   ++ R
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDEVRYPRF--LSREAISIMRR 234

Query: 240 IFVANSEKRI-----TIPEIKNHPWF 260
           +   N E+R+        ++K  P+F
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  136 bits (343), Expect = 2e-37
 Identities = 94/263 (35%), Positives = 132/263 (50%), Gaps = 19/263 (7%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSLK---HPNIVRF 63
           K +G G FG   LVR+K + +  A+K +++   I  + V   +   R LK   HP +   
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
           K    T   L  VMEY  GGELF  +     FSED  RF+  +++S + Y HS +I +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIAD 182
           LKLEN +LD      +KI DFG  K  +  +   K+  GTP Y+APEVL   +Y G+  D
Sbjct: 121 LKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 183 VWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV 242
            W  GV +Y M+ G  PF + +  K F      IL     FP    +S + K LLS + +
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPR--TLSADAKSLLSGLLI 231

Query: 243 ANSEKRI-----TIPEIKNHPWF 260
            +  KR+        EI  H +F
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (343), Expect = 2e-37
 Identities = 89/264 (33%), Positives = 135/264 (51%), Gaps = 21/264 (7%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIER----GQKIDEHV--QREIMNHRSLKH-PNIVR 62
           IG G FG    VR K TR + A+K + +     +K   H   +R I+    L   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
            K    T + L +V +Y +GGELF  +   GRFSED A+F+  +L+  + + H   I +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLK EN LLD +    + +CDFG SK+++  ++  +T  GT  Y+APEVL  ++   K  
Sbjct: 121 DLKPENILLDATG--HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRK-TIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           D WS GV ++ M  G  PF   +  + +R    G++      FP  V +S E +  +  +
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-----RFPKNV-LSDEGRQFVKGL 232

Query: 241 FVANSEKRI----TIPEIKNHPWF 260
              N + R+       E+K HP+F
Sbjct: 233 LNRNPQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  133 bits (336), Expect = 5e-37
 Identities = 82/255 (32%), Positives = 121/255 (47%), Gaps = 12/255 (4%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVK---FIERGQKIDEHVQ---REIMNHRSLKHPNIVRF 63
           +GSG+FG      +    +  AVK     + GQ   E V+   +EI     L+HPNIV++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
                   +L I +E   GG L + +   G F E   R + +Q++ G+ Y H     HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADV 183
           +K  N L+D +    VK+ DFG +K  V  S  KS  G+P ++APEV+ ++   G  AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS G T+  M  G  P+   E      K IGR        PD+  +S E K  + +    
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRS-KELPPIPDH--LSDEAKDFILKCLQR 241

Query: 244 NSEKRITIPEIKNHP 258
           +   R T  E+  HP
Sbjct: 242 DPSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  134 bits (338), Expect = 1e-36
 Identities = 90/264 (34%), Positives = 132/264 (50%), Gaps = 19/264 (7%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---KHPNIVRF 63
           K +G G FG   LVR+K T    A+K + +   I  + V   +   R L   +HP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
           K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS  + +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIAD 182
           +KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y G+  D
Sbjct: 121 IKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 183 VWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV 242
            W  GV +Y M+ G  PF + +  + F      IL     FP    +S E K LL+ +  
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKSLLAGLLK 231

Query: 243 ANSEKRI-----TIPEIKNHPWFL 261
            + ++R+        E+  H +FL
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFFL 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  134 bits (338), Expect = 1e-36
 Identities = 87/268 (32%), Positives = 144/268 (53%), Gaps = 25/268 (9%)

Query: 7   VKDIGSGNFGVAKLVRDKWTRE---LLAVKFIERGQ-KIDEHV----QREIMNHRSLKHP 58
           +K +G G+FG   LVR     +   L A+K +++   K+ + V    +R+I+    + HP
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHP 58

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
            IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + HS+ 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKEYD 177
           I +RDLK EN LLD      +K+ DFG SK S+ H  +  S  GT  Y+APEV+ ++ + 
Sbjct: 119 IIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            + AD WS GV ++ ML G+ PF+     K+ ++T+  IL      P +  +S E + LL
Sbjct: 177 -QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLL 229

Query: 238 SRIFVANSEKRI-----TIPEIKNHPWF 260
             +F  N   R+      + EIK HP+F
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  133 bits (335), Expect = 4e-36
 Identities = 88/275 (32%), Positives = 142/275 (51%), Gaps = 24/275 (8%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKW---TRELLAVKFIERG-----QKIDEHV--QREIMNHR 53
           +E++K +G+G +G   LVR      T +L A+K +++       K  EH   +R ++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
             + P +V       T   L ++++Y +GGE+F  +     FSEDE RF+  ++I  + +
Sbjct: 62  R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD  +   V + DFG SK  +   + +  S  GT  Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLD--SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG-RILSVHYSFPDYVRVS 230
             K   GK  D WS G+ ++ +L GA PF   E  +N +  +  RIL     FP    + 
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFPS--FIG 235

Query: 231 LECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            E + LL ++   + +KR+        EIK HP+F
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  132 bits (333), Expect = 5e-36
 Identities = 78/199 (39%), Positives = 102/199 (51%), Gaps = 9/199 (4%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR-----SLKHPNIVR 62
           K IG G+FG   L + K      AVK +++   + +  Q  IM  R     +LKHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLK EN LLD  +   V + DFG  K  V   +  ST  GTP Y+APEVL K+ YD +  
Sbjct: 121 DLKPENILLD--SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177

Query: 182 DVWSCGVTLYVMLVGAYPF 200
           D W  G  LY ML G  PF
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  131 bits (331), Expect = 1e-35
 Identities = 89/263 (33%), Positives = 133/263 (50%), Gaps = 19/263 (7%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHPNIVR 62
           K IG G+FG   L R K   +  AVK +++   + +  ++ IM+ R++     KHP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ I +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLK EN LLD  +   + + DFG  K ++ H+   ST  GTP Y+APEVL K+ YD +  
Sbjct: 121 DLKPENILLD--SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           D W  G  LY ML G  PF      + +   + + L +    P+   ++   +HLL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSARHLLEGLL 231

Query: 242 VANSEKRI----TIPEIKNHPWF 260
             +  KR+       EIKNH +F
Sbjct: 232 QKDRTKRLGAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  129 bits (327), Expect = 1e-35
 Identities = 89/267 (33%), Positives = 124/267 (46%), Gaps = 21/267 (7%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQR----------EIMNHRSLKHP 58
           IG G +G   L  +  T E++AVK +E    I   H  R          EI   + L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIV++     T  +L+I +EY  GG +   +   GRF E   RFF +Q++ G++Y HS  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LTK 173
           I HRDLK +N L+D       KI DFG SK S     + Q  S  G+  ++APEV     
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV-RVSLE 232
           + Y  K+ D+WS G  +  M  G  P+ D E      K +G   S     PD    +S  
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-LGNKRSAPPIPPDVSMNLSPV 244

Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
               L+  F  N + R T  E+  HP+
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  130 bits (329), Expect = 2e-35
 Identities = 91/288 (31%), Positives = 140/288 (48%), Gaps = 39/288 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQREIMNHRSL 55
           E +E +K I +G +G   LVR K TR+  A+K       I R Q     V+R+I+     
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-- 58

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           ++P +V       T  HL +VMEY  GG+    + N G    D AR +F + +  + Y H
Sbjct: 59  ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS----------------QPKST 159
           +  I HRDLK +N L+  ++   +K+ DFG SK  ++                    K  
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEDPKNFRKTIGRIL 217
            GTP YIAPEV+ ++ Y GK  D W+ G+ LY  LVG  PF  + PE+        G+++
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVI 229

Query: 218 SVHYSFPDYVR-VSLECKHLLSRIFVANSEKRITIP---EIKNHPWFL 261
           S    +P+    +  + + L+SR+   N  +R+      E+K H +FL
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  130 bits (328), Expect = 3e-35
 Identities = 90/267 (33%), Positives = 137/267 (51%), Gaps = 26/267 (9%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHPNIVRFK 64
           +G G+FG   L   K T EL A+K +++   I D+ V+  ++  R L    K P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   G+F E  A F+  ++  G+ + HS  I +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N +LD      +KI DFG  K ++   +   T  GTP YIAPE++  + Y GK  D 
Sbjct: 128 KLDNVMLDAEG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR---VSLECKHLLSRI 240
           W+ GV LY ML G  PF+  ++ + F+     I+  + S+P  +    VS+ CK LL++ 
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPKSLSKEAVSI-CKGLLTK- 238

Query: 241 FVANSEKRITI-----PEIKNHPWFLR 262
              +  KR+        +I+ H +F R
Sbjct: 239 ---HPAKRLGCGPTGERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 3e-35
 Identities = 81/265 (30%), Positives = 125/265 (47%), Gaps = 22/265 (8%)

Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQREIMNHRSLKHPNI 60
           +K I  G FG   L + + T +  A+K       I + Q  +   +R IM  +    P +
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES-PYV 59

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
            +      +  +L +VMEY  GG+    I   G   ED A+ +  +++ GV   H   I 
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRD+K EN L+D      +K+ DFG S++ +     K  VGTP Y+APE +     D K+
Sbjct: 120 HRDIKPENLLID--QTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKM 173

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL--ECKHLLS 238
           +D WS G  ++  L G  PF   E P         ILS   ++P+ V+     E   L++
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFH-AETPD---AVFDNILSRRINWPEEVKEFCSPEAVDLIN 229

Query: 239 RIFVANSEKRI---TIPEIKNHPWF 260
           R+   +  KR+      EIK+HP+F
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 4e-35
 Identities = 75/200 (37%), Positives = 108/200 (54%), Gaps = 19/200 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           E YE+++ IGSG +G     RD  T EL+A+K I  E G   +  +Q+EI   +  +HPN
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           IV +    L    L IVMEY  GG L +      G  SE +  +  ++ + G++Y H   
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121

Query: 119 ICHRDLKLENTLL--DGSTAPRVKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 171
             HRD+K  N LL  DG     VK+ DFG S    +++  ++ KS +GTP ++APEV   
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175

Query: 172 -TKKEYDGKIADVWSCGVTL 190
             K  YDGK  D+W+ G+T 
Sbjct: 176 ERKGGYDGK-CDIWALGITA 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  128 bits (324), Expect = 4e-35
 Identities = 76/270 (28%), Positives = 133/270 (49%), Gaps = 23/270 (8%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIM-----NHRSLKHPN 59
           E + ++G+GN GV   V  + T +++AVK I     I+E +Q++I+      H+    P 
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS- 116
           IV F         ++I MEY  GG L    +    GR  E         ++ G++Y H  
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            +I HRD+K  N L++  +  ++K+CDFG S   V +S  K+ VGT +Y+APE +   +Y
Sbjct: 120 HKIIHRDVKPSNILVN--SRGQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RVSLE 232
             K +D+WS G++L  +  G +P+    DP +    I  +L    + P       + S +
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEPPPRLPSGKFSPD 232

Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
            +  ++   + +  +R +  E+  HP+  +
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 5e-35
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 38/289 (13%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y+ +  IG G +GV    RDK T E++A+K I+   + +   +   REI   + L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQI 119
           ++  +V      L +V E+    +L++ I +  R   E   + +  QL+ G+++CHS  I
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVL-TKKE 175
            HRDLK EN L++      +K+ DFG ++S    S  +     V T  Y APE+L   K 
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 176 YDGKIADVWSCGVTLYVMLVGA--YPFEDPED-------------PKNFRKTIGRILSVH 220
           Y   + D+WS G     +L     +P +   D             P+ + K      +  
Sbjct: 176 YSTPV-DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234

Query: 221 YSFPDYVRVSLE---------CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           +SFP    + L             LLS++   +  KRIT  +   HP+F
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  127 bits (322), Expect = 5e-35
 Identities = 85/266 (31%), Positives = 119/266 (44%), Gaps = 22/266 (8%)

Query: 3   RYEIVKDIGSGNFGVAKLVR---DKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN 59
            ++++K +G G++G    V+   D     L  V      QK  E    EI    S+ HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 115
           I+ +KE  L    L IVMEYA  G+L + I    +      E E    F QL+ G+   H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLTKK 174
             +I HRDLK  N LL       VKI D G SK  VL     K+ +GTP Y+APEV   +
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFE--DPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
            Y  K +D+WS G  LY M   A PFE    +D +       ++    Y  P     S +
Sbjct: 177 PYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRY------KVQRGKYP-PIPPIYSQD 228

Query: 233 CKHLLSRIFVANSEKRITIPEIKNHP 258
            ++ +  +     + R    +I   P
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  129 bits (325), Expect = 7e-35
 Identities = 88/267 (32%), Positives = 127/267 (47%), Gaps = 24/267 (8%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHPNIVR 62
           K +G G+FG   L   K T E+ A+K +++   + D+ V   +   R L    KHP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T   L  VMEY  GG+L  +I  + +F E  +RF+  ++   + + H   + +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLKL+N LLD       K+ DFG  K  +L+    +T  GTP YIAPE+L + EY   + 
Sbjct: 121 DLKLDNILLDAEG--HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV- 177

Query: 182 DVWSCGVTLYVMLVGAYPFE-DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           D W+ GV +Y M+ G  PFE D ED          IL     +P  V +S E   +L   
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDVLYP--VWLSKEAVSILKAF 230

Query: 241 FVANSEKRI-------TIPEIKNHPWF 260
              N  KR+           IK HP+F
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFF 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  127 bits (320), Expect = 1e-34
 Identities = 86/267 (32%), Positives = 133/267 (49%), Gaps = 19/267 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVK---FIERGQKIDEHVQREIMNHRSLKHPN 59
           RYEI+K IG G+FG   L + K   E   +K     +   K  E  ++E++    +KHPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 116
           IV F         L IVMEY  GG+L +RI N  R   FSED+   +F Q+  G+ + H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTK 173
            +I HRD+K +N  L        K+ DFG ++   L+       + VGTP Y++PE+   
Sbjct: 120 RKILHRDIKSQNIFLS-KNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + Y+ K  D+WS G  LY +    +PFE      N  + + +I   +++ P     S + 
Sbjct: 177 RPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSRDL 230

Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWF 260
           + L+S++F  +   R +I  I   P+ 
Sbjct: 231 RSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  128 bits (323), Expect = 1e-34
 Identities = 93/264 (35%), Positives = 133/264 (50%), Gaps = 20/264 (7%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---KHPNIVRF 63
           K +G G FG   LV++K T    A+K +++   +  + V   +  +R L   +HP +   
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHR 122
           K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS   + +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           DLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y G+  
Sbjct: 121 DLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           D W  GV +Y M+ G  PF + +  K F      IL     FP    +S E K LLS + 
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLSPEAKSLLSGLL 231

Query: 242 VANSEKRI-----TIPEIKNHPWF 260
             + ++R+        EI  H +F
Sbjct: 232 KKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  127 bits (320), Expect = 2e-34
 Identities = 93/296 (31%), Positives = 137/296 (46%), Gaps = 45/296 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK-FIERGQKIDEHV----QREIMNHRSLK 56
            +YE++  +G G +GV    R+K T E++A+K F E     DE V     RE+   R L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLR 58

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           H NIV  KE       L +V EY      EL E   + G    D  R +  QL+  ++YC
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 170
           HS  I HRD+K EN L+  S    +K+CDFG++++  L ++P S     V T  Y APE+
Sbjct: 117 HSHNIIHRDIKPENILVSESGV--LKLCDFGFARA--LRARPASPLTDYVATRWYRAPEL 172

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF---RKTIGRILSVHYS----- 222
           L      GK  DVW+ G  +  +L G   F    D       +K +G +   H       
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232

Query: 223 -------FPD-YVRVSLECKH--LLSRI---FVANS-----EKRITIPEIKNHPWF 260
                  FP+     SLE ++   +S     F+        ++R+T  E+  HP+F
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  127 bits (320), Expect = 4e-34
 Identities = 91/268 (33%), Positives = 132/268 (49%), Gaps = 23/268 (8%)

Query: 7   VKDIGSGNFGVAKLVR---DKWTRELLAVKF-----IERGQKIDEHVQREIMNHRSLKHP 58
           +K +G G +G    VR      T ++ A+K      I R QK   H + E     ++KHP
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
            IV       T   L +++EY +GGELF  +   G F ED A F+  ++   + + H   
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYD 177
           I +RDLK EN LLD      VK+ DFG  K S+       T  GT  Y+APE+L +  + 
Sbjct: 121 IIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH- 177

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
           GK  D WS G  +Y ML GA PF      +N +KTI +IL    + P Y  ++ E + LL
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFT----AENRKKTIDKILKGKLNLPPY--LTPEARDLL 231

Query: 238 SRIFVANSEKRI-----TIPEIKNHPWF 260
            ++   N   R+        E+++HP+F
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  126 bits (317), Expect = 5e-34
 Identities = 85/258 (32%), Positives = 134/258 (51%), Gaps = 14/258 (5%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +  DK T   +AVK ++ R Q+  E +  E++  R  +HPNIV      L
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S+ H+  + HRD+K ++
Sbjct: 87  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145

Query: 129 TLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            LL  DG    RVK+ DFG+ ++ S    + KS VGTP ++APEV+++  Y G   D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200

Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANS 245
            G+ +  M+ G  P+ + E P    K I   L       +  +VS   +  L R+ V + 
Sbjct: 201 LGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK--LKNLHKVSPRLRSFLDRMLVRDP 257

Query: 246 EKRITIPEIKNHPWFLRN 263
            +R T  E+ NHP FL  
Sbjct: 258 AQRATAAELLNHP-FLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  125 bits (315), Expect = 5e-34
 Identities = 81/265 (30%), Positives = 129/265 (48%), Gaps = 20/265 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRS----LKHP 58
            Y  ++ +G G FG A L R      L+  K +    ++ E  +R+ +N       L+HP
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNL-TRLSEKERRDALNEIVILSLLQHP 59

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+ +    +    L I MEYA GG L+++I       F E+   ++  Q++S VSY H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTK 173
             I HRD+K  N  L  + A  +K+ DFG SK   S    ++  + VGTP Y++PE+   
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
            +Y+ K +D+W+ G  LY +L     F    D  N    + +I+  +Y+ P     S E 
Sbjct: 176 VKYNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYT-PVVSVYSSEL 229

Query: 234 KHLLSRIFVANSEKRITIPEIKNHP 258
             L+  +   + EKR T  E+ + P
Sbjct: 230 ISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  125 bits (315), Expect = 5e-34
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 8/204 (3%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E ++I++ +G G++G       K T +++A+K +   + + E + +EI   +    P IV
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE-IIKEISILKQCDSPYIV 61

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           ++       T L IVMEY   G + +  +I N    +E+E      Q + G+ Y HS + 
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKK 120

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
            HRD+K  N LL+     + K+ DFG S + +   ++  + +GTP ++APEV+ +  Y+ 
Sbjct: 121 IHRDIKAGNILLN--EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 179 KIADVWSCGVTLYVMLVGAYPFED 202
           K AD+WS G+T   M  G  P+ D
Sbjct: 179 K-ADIWSLGITAIEMAEGKPPYSD 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  127 bits (319), Expect = 6e-34
 Identities = 87/271 (32%), Positives = 139/271 (51%), Gaps = 25/271 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDK-WTRELLAVKFIERG----QKIDEHV--QREIMNHRS 54
           E +  ++ +G+G+FG   L   K      +A+K  E+     QK  +HV  +R+I+N+  
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-- 87

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           + HP  V         ++L +V+E+  GGE F  +    RF  D   F+  Q++    Y 
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
            S+ I +RDLK EN LLD      +K+ DFG++K  V+ ++  +  GTP YIAPE+L   
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNV 203

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            + GK AD W+ G+ +Y +LVG  PF   E    ++K +  I+     FP ++  +  CK
Sbjct: 204 GH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----YFPKFLDNN--CK 256

Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           HL+ ++   +  KR          +K HPWF
Sbjct: 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  127 bits (321), Expect = 9e-34
 Identities = 91/310 (29%), Positives = 131/310 (42%), Gaps = 61/310 (19%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HV--QREIMNHRSLKH 57
           +  +K IG G FG   LVR   T  L A+K + +   +      HV  +R+I+      +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
             +V+         +L  VM+Y  GG++   +   G F ED ARF+  +L   +   H M
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFG-------------YSK---------------S 149
              HRD+K +N L+D      +K+ DFG             Y K               S
Sbjct: 121 GFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 150 SVLHSQPK----------------STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 193
            +   + K                S VGTP YIAPEVL +  Y  ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237

Query: 194 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---T 250
           LVG  PF      +   K I    ++H   P   ++S E   L+ R+    +E R+    
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLH--IPSQAKLSREASDLILRL-CCGAEDRLGKNG 294

Query: 251 IPEIKNHPWF 260
             EIK HP+F
Sbjct: 295 ADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  126 bits (318), Expect = 1e-33
 Identities = 85/300 (28%), Positives = 132/300 (44%), Gaps = 50/300 (16%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ------REIMNHRSLK 56
           RYE++K IGSG +GV     DK T   +A+K I     + + +       REI   R L+
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHLR 57

Query: 57  HPNIVRFKEVLLTPT-----HLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISG 110
           H NI+   ++L  P+      + IV E     +L  ++  + +  ++D  ++F  Q++ G
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELM-ETDL-HKVIKSPQPLTDDHIQYFLYQILRG 115

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPAYI 166
           + Y HS  + HRDLK  N L++ +    +KICDFG ++        K      V T  Y 
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 167 APEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PKNFRK 211
           APE+ L+   Y   I D+WS G     +L     +P  D  D             +   K
Sbjct: 174 APELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232

Query: 212 TIGRILSVHY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            I    + +Y  S P   +  L         E   LL ++ V + +KRIT  E   HP+ 
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  126 bits (317), Expect = 1e-33
 Identities = 89/268 (33%), Positives = 135/268 (50%), Gaps = 20/268 (7%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHP 58
           +  +  +G G+FG   L   K T EL A+K +++   I D+ V+  ++  R L    K P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
            + +      T   L  VMEY  GG+L  +I   GRF E  A F+  ++  G+ + HS  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLTKKEYD 177
           I +RDLKL+N +LD      +KI DFG  K ++      K+  GTP YIAPE++  + Y 
Sbjct: 122 IIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY- 178

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
           GK  D W+ GV LY ML G  PFE  ++ + F+     I+  + ++P    +S E   + 
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPK--SMSKEAVAIC 232

Query: 238 SRIFVANSEKRITI-PE----IKNHPWF 260
             +   +  KR+   PE    IK H +F
Sbjct: 233 KGLMTKHPGKRLGCGPEGERDIKEHAFF 260

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  125 bits (315), Expect = 2e-33
 Identities = 84/263 (31%), Positives = 128/263 (48%), Gaps = 19/263 (7%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHPNIVR 62
           K IG G+FG   L + K   +  AVK +++   ++   Q+ IM  R++     KHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 T   L  V+++  GGELF  +     F E  ARF+  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIA 181
           DLK EN LLD  +   V + DFG  K  +  S   +T  GTP Y+APEV+ K+ YD  + 
Sbjct: 121 DLKPENILLD--SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV- 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           D W  G  LY ML G  PF   +  + +   + + L +          SL    +L  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG------ASLTAWSILEELL 231

Query: 242 VANSEKRI----TIPEIKNHPWF 260
             + ++R+       EI+ HP+F
Sbjct: 232 EKDRQRRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  125 bits (315), Expect = 4e-33
 Identities = 96/275 (34%), Positives = 141/275 (51%), Gaps = 26/275 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH------VQREIMNHRSL 55
           E YE+VK IG G FG  +LVR K TR++ A+K + + + I          +R+IM   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN- 101

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
             P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H
Sbjct: 102 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIH 159

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVL 171
           SM   HRD+K +N LLD S    +K+ DFG     +K  ++     + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVL 215

Query: 172 TKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
             +    Y G+  D WS GV LY MLVG  PF        + K +    S+  +FPD   
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--TFPDDND 273

Query: 229 VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
           +S E K+L+   F+ + E R+    + EIK H +F
Sbjct: 274 ISKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 4e-33
 Identities = 90/293 (30%), Positives = 134/293 (45%), Gaps = 46/293 (15%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVK-FIERGQKIDEHVQ-REIMNHRSLK-HPNI 60
           Y+++K +G G FG   L R+K T EL+A+K   ++    +E +  RE+ + R L  HPNI
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           V+ KEV      L  V EY   G L++ +       FSE   R    Q++ G+++ H   
Sbjct: 61  VKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTK-KE 175
             HRDLK EN L+ G     VKI DFG ++   + S+P  T  V T  Y APE+L +   
Sbjct: 120 FFHRDLKPENLLVSGPE--VVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 176 YDGKIADVWSCG---VTLYVM------------------LVGAYPFED--PEDPK----- 207
           Y   + D+W+ G     LY +                  ++G  P +   PE  K     
Sbjct: 176 YSSPV-DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT-PTKQDWPEGYKLASKL 233

Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            FR       S+H   P+    S E   L+  +   + +KR T  +   HP+F
Sbjct: 234 GFRFPQFAPTSLHQLIPN---ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  124 bits (312), Expect = 5e-33
 Identities = 90/267 (33%), Positives = 138/267 (51%), Gaps = 26/267 (9%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHPNIVRFK 64
           +G G+FG   L   K T EL A+K +++   I D+ V+  ++  R L    K P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   G+F E +A F+  ++  G+ + H   I +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N +LD  +   +KI DFG  K  ++      T  GTP YIAPE++  + Y GK  D 
Sbjct: 128 KLDNVMLD--SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR---VSLECKHLLSRI 240
           W+ GV LY ML G  PF+  ++ + F+     I+  + S+P  +    VS+ CK L+++ 
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPKSLSKEAVSI-CKGLMTK- 238

Query: 241 FVANSEKRITI-PE----IKNHPWFLR 262
              +  KR+   PE    I+ H +F R
Sbjct: 239 ---HPSKRLGCGPEGERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  122 bits (309), Expect = 6e-33
 Identities = 81/264 (30%), Positives = 120/264 (45%), Gaps = 20/264 (7%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE------RGQKIDEHVQREIMNHRSLKHPNIVRF 63
           +G G FG     + K T ++ A K ++      R  +     +++I+   S     IV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS--SRFIVSL 58

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICH 121
                T   L +VM    GG+L   I N G   F E  A F+  Q+I G+ + H  +I +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLK EN LLD      V+I D G +       + K   GTP Y+APEVL  + YD    
Sbjct: 119 RDLKPENVLLDDHG--NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           D ++ G TLY M+ G  PF   ++     +   R L +   +PD  + S E K L   + 
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALL 233

Query: 242 VANSEKRI-----TIPEIKNHPWF 260
             + EKR+     +  E++ HP F
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 8e-33
 Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 14/209 (6%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE--HVQREIMNHRSLKH--- 57
           R E+   IG G +G     +   T  ++A+K I      D+   +QRE+     L+    
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI ++    L    L I+MEYA GG +   +  AG  +E       ++++  + Y H +
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTK-KE 175
            + HRD+K  N L+  +    VK+CDFG +     +S  +ST VGTP ++APEV+T+ K 
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPE 204
           YD K AD+WS G+T+Y M  G  P+ D +
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVD 206

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  121 bits (305), Expect = 1e-32
 Identities = 74/207 (35%), Positives = 110/207 (53%), Gaps = 15/207 (7%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPN 59
           +EI+  IG G+FGV   V  K  + + A+K I+   K++   + E ++       L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSM 117
           I+R+ E  L    L IVMEYA  G+L + +    GR   ED+   FF Q++ G+++ HS 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKK 174
           +I HRD+K  N  LD      VKI D G +K  +L        + VGTP Y++PE+   K
Sbjct: 121 KILHRDIKSLNLFLDAYD--NVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFE 201
            Y+ K +DVW+ GV LY    G +PF+
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  122 bits (308), Expect = 2e-32
 Identities = 75/198 (37%), Positives = 104/198 (52%), Gaps = 9/198 (4%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHPNIVRFK 64
           +G G+FG   L R K +  L AVK +++   + D+ V+  +   R L     HP + +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               TP  L  VME+  GG+L   I  + RF E  ARF+  ++ S + + H   I +RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N LLD       K+ DFG  K  + + +  ST  GTP YIAPE+L +  Y G   D 
Sbjct: 123 KLDNVLLDHEG--HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179

Query: 184 WSCGVTLYVMLVGAYPFE 201
           W+ GV LY ML G  PFE
Sbjct: 180 WAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  120 bits (303), Expect = 2e-32
 Identities = 82/254 (32%), Positives = 131/254 (51%), Gaps = 19/254 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           +Y +++ +G G+FG A LV+   + +  A+K I   +     E  ++E +    +KHPNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQ 118
           V FKE      HL IVMEY  GG+L ++I    G+ F ED    +F Q+  GV + H  +
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLTKK 174
           + HRD+K +N  L  +   +VK+ DFG   S+ L + P +     VGTP Y+ PE+    
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            Y+ K +D+WS G  LY +    +PF+      +++  I ++    Y  P     S E +
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPFQ----ANSWKNLILKVCQGSYK-PLPSHYSYELR 229

Query: 235 HLLSRIFVANSEKR 248
            L+ ++F  N   R
Sbjct: 230 SLIKQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 5e-32
 Identities = 78/304 (25%), Positives = 124/304 (40%), Gaps = 64/304 (21%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---------REIMNHRS 54
           YE +  IG G +G     R+K T EL+A+K      KI    +         REI   + 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK------KIRMENEKEGFPITAIREIKLLQK 54

Query: 55  LKHPNIVRFKEVLLTPTHLAI--VMEYA----AGGELFERICNAGRFSEDEARFFFQQLI 108
           L+HPNIVR KE++ +    +I  V EY      G  L +      +F+E + + + +QL+
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLL 110

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYI 166
            G+ Y HS  I HRD+K  N L++      +K+ DFG ++     +    T  V T  Y 
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSADYTNRVITLWYR 168

Query: 167 APEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPF------------------------- 200
            PE+L     Y  ++ D+WS G  L  + +G   F                         
Sbjct: 169 PPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227

Query: 201 --EDPEDPKNFR--KTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 256
                   +N +  K   R L   +       +      LL ++   + +KRI+  +   
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKH----LIDPSALDLLDKLLTLDPKKRISADQALQ 283

Query: 257 HPWF 260
           H +F
Sbjct: 284 HEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  121 bits (305), Expect = 1e-31
 Identities = 89/275 (32%), Positives = 142/275 (51%), Gaps = 26/275 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH------VQREIMNHRSL 55
           E Y++VK IG G FG  +LVR K ++++ A+K + + + I          +R+IM   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN- 101

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
             P +V+         +L +VMEY  GG+L   + N     E  A+F+  +++  +   H
Sbjct: 102 -SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIH 159

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVL 171
           SM + HRD+K +N LLD      +K+ DFG      ++ ++     + VGTP YI+PEVL
Sbjct: 160 SMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVL 215

Query: 172 TKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
             +    Y G+  D WS GV L+ MLVG  PF        + K +    S+  +FP+ V 
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL--NFPEDVE 273

Query: 229 VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
           +S   K+L+   F+ + E R+    + EIK HP+F
Sbjct: 274 ISKHAKNLIC-AFLTDREVRLGRNGVEEIKQHPFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  115 bits (290), Expect = 2e-30
 Identities = 73/267 (27%), Positives = 112/267 (41%), Gaps = 30/267 (11%)

Query: 5   EIVKDIGSGNFGV---AKLV-RDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKH 57
            + K +G G FG     KL  +    +  +AVK + +    ++ ++   RE    R L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 116
           PN+V+   V      L IVMEY  GG+L   +  N  + S  +   F  Q+  G+ Y  S
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 171
               HRDL   N L+  +    VKI DFG     Y          K  +    ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
            + ++  K +DVWS GV L+ +       YP    E+   + K   R+       P+   
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYD 234

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIK 255
           + L+C       +  + E R T  E+ 
Sbjct: 235 LMLQC-------WAEDPEDRPTFSELV 254

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  115 bits (290), Expect = 3e-30
 Identities = 80/259 (30%), Positives = 130/259 (50%), Gaps = 16/259 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           +G G +G+    RD  T+  +A+K I   ++   +VQ    EI  H  LKH NIV++   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 67  LLTPTHLAIVMEYAAGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
                   I ME   GG L           + +E    F+ +Q++ G+ Y H  QI HRD
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK--KEYDGKI 180
           +K +N L++ + +  VKI DFG SK  + ++   ++  GT  Y+APEV+ K  + Y G  
Sbjct: 134 IKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAP 191

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           AD+WS G T+  M  G  PF +  +P+     +G +  +H   P+   +S E K+ + R 
Sbjct: 192 ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-MFKIHPEIPE--SLSAEAKNFILRC 248

Query: 241 FVANSEKRITIPEIKNHPW 259
           F  + +KR +  ++   P+
Sbjct: 249 FEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 9e-30
 Identities = 85/279 (30%), Positives = 132/279 (47%), Gaps = 30/279 (10%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHP 58
           + +EI+ ++G G FG     + K T    A K I+     +  D  V+ +I++    KHP
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 117
           NIV   E       L I++E+  GG L   +    R  +E + R+  +Q++  +++ HS 
Sbjct: 63  NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 118 QICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL--- 171
           ++ HRDLK  N LL  DG     VK+ DFG S  +    Q + T +GTP ++APEV+   
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 172 TKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV-- 227
           T K+  YD K AD+WS G+TL  +       E P    N  + + +IL    S P  +  
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIELAQM----EPPHHELNPMRVLLKILK---SEPPTLDQ 230

Query: 228 --RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 264
             + S      L    V + + R T  E+  HP+     
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (286), Expect = 9e-30
 Identities = 72/267 (26%), Positives = 109/267 (40%), Gaps = 31/267 (11%)

Query: 5   EIVKDIGSGNFGV---AKLV-RDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKH 57
            + K +G G FG      L  +       +AVK + +    ++ ++   RE    R L H
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNIV+   V      L IVMEY  GG+L  + R       S  +   F  Q+  G+ Y  
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEV 170
           S    HRDL   N L+  +    VKI DFG     Y          K  +    ++APE 
Sbjct: 121 SKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEDPKNFRKTIGRILSVHYSFPDYV 227
           L + ++  K +DVWS GV L+ +       YP     +   + K   R+       P+  
Sbjct: 176 LKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELY 234

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEI 254
           ++ L+C       +  + E R T  E+
Sbjct: 235 KLMLQC-------WAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  114 bits (287), Expect = 1e-29
 Identities = 82/276 (29%), Positives = 139/276 (50%), Gaps = 25/276 (9%)

Query: 4   YEIVKDIGSGNFGVAKLVRD---KWTRELLAVKFIERGQ-----KIDEHV--QREIMNHR 53
           +E++K +G+G +G   LVR      + +L A+K +++       K  EH   +R+++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
             + P +V       T T L ++++Y  GGELF  +    RF E E + +  +++  + +
Sbjct: 62  R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD +    V + DFG SK        +  S  GT  Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 172 TKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 229
              +  +D K  D WS GV +Y +L GA PF    +  +  +   RIL     +P    +
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 235

Query: 230 SLECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           S   K ++ R+ + + +KR+        EIK HP+F
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  114 bits (286), Expect = 1e-29
 Identities = 81/267 (30%), Positives = 127/267 (47%), Gaps = 23/267 (8%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQ-------KIDEHVQREIMNHRSLKHPNIVR 62
           +G+G F      RD  T  L+AVK +   +       ++ E +++EI     L HP+I+R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                   +H  + +E+ AGG +   +   G F E     + +QL+ G+SY H  QI HR
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLTKKE 175
           D+K  N L+D ST  R++I DFG   ++ L ++           +GT A++APEVL  ++
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SFPDYVRVSLEC 233
           Y G+  DVWS G  +  M     P+ + E   N    I +I S     S P+++   L  
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPGL-- 240

Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWF 260
           + +  R      E R    E+  HP F
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  114 bits (288), Expect = 1e-29
 Identities = 94/305 (30%), Positives = 132/305 (43%), Gaps = 62/305 (20%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ-------REIMNHRS 54
           + YE +  I  G +GV    RDK T E++A+K +    K+++  +       REI     
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60

Query: 55  LKHPNIVRFKEVLL--TPTHLAIVMEYAAGGE-----LFERICNAGRFSEDEARFFFQQL 107
           L+HPNIV  KEV++      + +VMEY    E     L E +     F + E +    QL
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAY 165
           +SGV++ H   I HRDLK  N LL  +    +KICDFG ++   S L    +  V T  Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172

Query: 166 IAPEVLT-KKEYDGKIADVWSCG------VTLYVMLVGA--------------YPFED-- 202
            APE+L   KEY   I D+WS G      +T   +  G                P E   
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 203 PE-------DPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 255
           P          K F K     L     FP    +S     LL+R+   +  KRI+  +  
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKK--FPAL-SLSDNGFDLLNRLLTYDPAKRISAEDAL 288

Query: 256 NHPWF 260
            HP+F
Sbjct: 289 KHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  113 bits (285), Expect = 2e-29
 Identities = 82/272 (30%), Positives = 119/272 (43%), Gaps = 30/272 (11%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFKEVL 67
           +G G  G     R K T  + A+K I      D   Q  RE+  ++S K P IV++    
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 68  LTP--THLAIVMEYAAGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           L    + + I MEY  GG L + I        GR  E       + ++ G+SY HS +I 
Sbjct: 69  LDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKII 127

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRD+K  N LL      +VK+CDFG S   V  S   +  GT  Y+APE +  K Y    
Sbjct: 128 HRDIKPSNILLT--RKGQVKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGKPYSIT- 183

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY---SFP--------DYVRV 229
           +DVWS G+TL  +    +PF  PE        +G I  + Y              + ++ 
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFP-PEGEPP----LGPIELLSYIVNMPNPELKDEPGNGIKW 238

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
           S E K  + +    +  +R T  ++  HPW  
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  113 bits (284), Expect = 3e-29
 Identities = 85/265 (32%), Positives = 133/265 (50%), Gaps = 14/265 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A+K +  + Q   E +  EI+  R  KHPNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVI 137

Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYD 177
           HRD+K +N LL  DGS    VK+ DFG+          +ST VGTP ++APEV+T+K Y 
Sbjct: 138 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  ++S   +  L
Sbjct: 194 PKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 249

Query: 238 SRIFVANSEKRITIPEIKNHPWFLR 262
           +R    + EKR +  E+  HP FL+
Sbjct: 250 NRCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  114 bits (286), Expect = 5e-29
 Identities = 86/283 (30%), Positives = 129/283 (45%), Gaps = 33/283 (11%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIVR 62
           E V  IGSG  G    V  + T  L A+K I       +   + REI   R + HPN+V+
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
             ++      + +++E+  GG L        +F  D AR    Q++SG++Y H   I HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LTKKEYD 177
           D+K  N L++  +A  VKI DFG S+       P  S+VGT AY++PE     L    YD
Sbjct: 193 DIKPSNLLIN--SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR-------ILSVHYSFPDY--VR 228
           G   D+WS GV++    +G +PF            +GR       + ++  S P      
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPF-----------GVGRQGDWASLMCAICMSQPPEAPAT 299

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEG 271
            S E +H +S        KR +  ++  HP+ LR  P +   G
Sbjct: 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGG 342

Length = 353

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  113 bits (284), Expect = 5e-29
 Identities = 85/300 (28%), Positives = 126/300 (42%), Gaps = 48/300 (16%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK------IDEHVQREIMNHRSLK 56
           RYE  K +G G + V    RDK T  ++A+K I+ G++      I+    REI   + LK
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 114
           HPNI+   +V    +++ +V E+       E++        +  + + +    + G+ Y 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118

Query: 115 HSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPK----STVGTPAYIAP 168
           HS  I HRDLK  N L+  DG     +K+ DFG ++S      P       V T  Y AP
Sbjct: 119 HSNWILHRDLKPNNLLIASDG----VLKLADFGLARS---FGSPNRKMTHQVVTRWYRAP 171

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------VH 220
           E+L    + G   D+WS G     +L+   PF   +   +    I   L           
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGV 230

Query: 221 YSFPDYVRV---------------SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
            S PDYV                 S +   LL R+   N  KRIT  +   HP+F  N P
Sbjct: 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF-SNDP 289

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  111 bits (280), Expect = 9e-29
 Identities = 81/270 (30%), Positives = 123/270 (45%), Gaps = 18/270 (6%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIV 61
           YE+++ IG G   V          E +A+K I  E+ Q   + +++E+       HPN+V
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           ++    +    L +VM Y +GG L +        G   E       ++++ G+ Y HS  
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122

Query: 119 ICHRDLKLENTLL--DGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVL 171
             HRD+K  N LL  DGS    VKI DFG S S            K+ VGTP ++APEV+
Sbjct: 123 QIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 172 TKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 230
            +   YD K AD+WS G+T   +  GA P+      K    T+        +  DY + S
Sbjct: 179 EQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237

Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPWF 260
              + ++S     +  KR T  E+  H +F
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  113 bits (284), Expect = 1e-28
 Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 49/300 (16%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----KHPN 59
           +E +K IG G FG  +LV+ K T  + A+K + +   +++     I   R +        
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           +V+         +L ++ME+  GG++   +      SE+  +F+  + +  +   H +  
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKS-----------SVLHSQPK----------- 157
            HRD+K +N LLD      VK+ DFG               ++ H+ P            
Sbjct: 123 IHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 158 --------------STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 203
                         STVGTP YIAPEV  +  Y+ K+ D WS GV +Y ML+G  PF   
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 204 EDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
              + +RK +    ++   FP  V +S + K L+ R F  +SE RI    + EIK+HP+F
Sbjct: 240 TPQETYRKVMNWKETL--VFPPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 4e-28
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 49/288 (17%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNI 60
             +E+V+ IG G +G     R K T +L+A+K ++  +  +E ++ E    R    HPNI
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 61  VRFKEVLLTPTH------LAIVMEYAAGG---ELFERICNAG-RFSEDEARFFFQQLISG 110
             F    +          L +VME   GG   +L + +   G R  E+   +  ++ + G
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTP 163
           ++Y H  ++ HRD+K +N LL  +    VK+ DFG S      +Q  ST       +GTP
Sbjct: 126 LAYLHENKVIHRDIKGQNILL--TKNAEVKLVDFGVS------AQLDSTLGRRNTFIGTP 177

Query: 164 AYIAPEVLTKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED--PED-----PKNFRK 211
            ++APEV+   E     YD + +DVWS G+T   +  G  P  D  P       P+N   
Sbjct: 178 YWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236

Query: 212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           T+    +    F D++   L            N E+R  + E+  HP+
Sbjct: 237 TLKSPENWSKKFNDFISECLI----------KNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  108 bits (270), Expect = 1e-27
 Identities = 85/269 (31%), Positives = 128/269 (47%), Gaps = 22/269 (8%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTR---ELLAVKFIERGQ-KIDEHVQ--REIMNHRSLK 56
           RY + + +G G+FG   LV+DK       L  +K I  G+   +E VQ  +E      L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI----CNAGRFSEDEARFFFQQLISGVS 112
           HP IV+F    L      I+ EY  G +L  ++          SE++   +F QL+ GV 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 171
           Y H  +I HRDLK +N  L  +    +KI DFG S+  +      +T  GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVS 230
             + YD K +D+WS G  LY M   A+ FE     +NF   + RI+     S P+    S
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE--TYS 230

Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPW 259
            +   ++  +   +   R +  EI  +P+
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  108 bits (273), Expect = 3e-27
 Identities = 80/299 (26%), Positives = 124/299 (41%), Gaps = 46/299 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ-----REIMNHRSLK 56
            RY+ +++IGSG +GV     D  + + +A+K I      D         RE+   R  K
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILRHFK 62

Query: 57  HPNIVRFKEVLLTP----THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           H NI+  +++L  P      + +VM+     +L   I +    +E+  R+F  QL+ G+ 
Sbjct: 63  HDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQ-PKSTVGTPAYIA 167
           Y HS  + HRDLK  N L++      ++I DFG     S S   H       V T  Y A
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 168 PEVL-TKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PKNFRKT 212
           PE+L +  EY   I D+WS G     ML     +P ++                +     
Sbjct: 180 PELLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 213 IGRILSVHY--SFPDYVRVSLE----CKH-----LLSRIFVANSEKRITIPEIKNHPWF 260
           IG      Y  + P    V               LLS++   + E+RIT+ +   HP+ 
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  107 bits (270), Expect = 3e-27
 Identities = 92/296 (31%), Positives = 145/296 (48%), Gaps = 45/296 (15%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           M++YE V+ IG G +GV    RD+ T E +A+K I   Q+ DE V     REI   + ++
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ 59

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQQLISGVSYC 114
           H NIVR ++V+ +   L +V EY    +L + + ++  F+++    + +  Q++ G++YC
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 170
           HS ++ HRDLK +N L+D  T   +K+ DFG +++  +   P  T    V T  Y APE+
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEI 174

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEDPKNFRKTIGRILSVHY------- 221
           L    +     D+WS G  ++  +V   P    D E  + F+  I RIL           
Sbjct: 175 LLGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGV 231

Query: 222 -SFPDY--------------VRVSLECK--HLLSRIFVANSEKRITIPEIKNHPWF 260
            S PDY              V  +LE     LLS++   +  KRIT      H +F
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 4e-27
 Identities = 85/293 (29%), Positives = 122/293 (41%), Gaps = 42/293 (14%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-----ERGQKIDEHVQREIMNHRSLK-- 56
           YE + +IG G +G     RD  T   +A+K +     E G  I     REI   + L+  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58

Query: 57  -HPNIVRFKEVLLTP-----THLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLIS 109
            HPNIVR  +V   P       L +V E+       +   C       +  +   +QL+ 
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 169
           GV + HS +I HRDLK +N L+  ++  +VKI DFG ++         S V T  Y APE
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176

Query: 170 VLTKKEYDGKIADVWSCGVTLYVM--LVGAYPFEDPEDP--KNFRKTIGR---------I 216
           VL +  Y   + D+WS G     +      +      D   K F   IG          +
Sbjct: 177 VLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV-IGLPSEEEWPRNV 234

Query: 217 LSVHYSFPDYVRVSLE------CK---HLLSRIFVANSEKRITIPEIKNHPWF 260
                SFP Y   S +      C+    LL ++   N  KRI+  E   HP+F
Sbjct: 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  107 bits (270), Expect = 6e-27
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 11/199 (5%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH----VQRE--IMNHRSLKHPNIVRF 63
           IG G++    LV  K TR + A+K I++    D+     VQ E  +    S  HP +V  
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGL 61

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
                T + L  V+E+ +GG+L   +    +  E+ ARF+  ++   +++ H   I +RD
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIAD 182
           LKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L  ++Y   + D
Sbjct: 122 LKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV-D 178

Query: 183 VWSCGVTLYVMLVGAYPFE 201
            W+ GV ++ M+ G  PF+
Sbjct: 179 WWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  107 bits (267), Expect = 7e-27
 Identities = 82/269 (30%), Positives = 133/269 (49%), Gaps = 13/269 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A+K +  + Q   E +  EI+  R  K+PNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVI 137

Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYD 177
           HRD+K +N LL  DGS    VK+ DFG+          +ST VGTP ++APEV+T+K Y 
Sbjct: 138 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  R+S   +  L
Sbjct: 194 PKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--RLSAVFRDFL 249

Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLPI 266
           +R    + ++R +  E+  HP+     P+
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFLKLAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  106 bits (266), Expect = 7e-27
 Identities = 80/269 (29%), Positives = 126/269 (46%), Gaps = 21/269 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           E +E+++ IGSG +G     R+  T EL A+K I  E G+     VQ+EI+  +  KH N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSN 67

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           IV +    L    L I ME+  GG L +     G  SE +  +  ++ + G+ Y HS   
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
            HRD+K  N LL  +    VK+ DFG S   +   ++ KS +GTP ++APEV   +   G
Sbjct: 128 MHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 179 --KIADVWSCGVTLYVMLVGAYPFEDPEDPK-NFRKTIGRILSVHYSF-----PDYVRVS 230
             ++ D+W+ G+T       A    + + P  +        L    +F      D ++ S
Sbjct: 186 YNQLCDIWAVGIT-------AIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238

Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPW 259
               H +      N +KR T  ++  HP+
Sbjct: 239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 1e-26
 Identities = 89/322 (27%), Positives = 147/322 (45%), Gaps = 77/322 (23%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDE--HV--QREIMNHRSL 55
           E +  VK IG G FG  +LV+ K T ++ A+K + + +  K D+  HV  +R+++     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
             P +V          +L ++ME+  GG+L   +     FSED  RF+  + +  +   H
Sbjct: 60  -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG-------------YSK-------------- 148
            +   HRD+K +N L+D      +K+ DFG             Y K              
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 149 --------SSVLHSQPK-------------STVGTPAYIAPEVLTKKEYDGKIADVWSCG 187
                   +  + S+ +             STVGTP YIAPE+  ++ Y G+  D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235

Query: 188 VTLYVMLVGAYPF--EDPEDPK----NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
             ++  L+G  PF  E+  +      N+R+T+         FPD + +S+E + L+ R+ 
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKIINWRETL--------YFPDDIHLSVEAEDLIRRL- 286

Query: 242 VANSEKRI---TIPEIKNHPWF 260
           + N+E R+      EIK+HP+F
Sbjct: 287 ITNAENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  106 bits (266), Expect = 1e-26
 Identities = 86/271 (31%), Positives = 136/271 (50%), Gaps = 17/271 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A+K I  + Q   E +  EI+  + LK+PNI
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQ 118
           V F +  L    L +VMEY AGG L + +        DEA+     ++ +  + + H+ Q
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ 135

Query: 119 ICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKE 175
           + HRD+K +N LL  DGS    VK+ DFG+          +ST VGTP ++APEV+T+K 
Sbjct: 136 VIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y  K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  ++S   + 
Sbjct: 192 YGPKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSPIFRD 247

Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNLPI 266
            L+R    + EKR +  E+  HP+     P+
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 1e-26
 Identities = 87/283 (30%), Positives = 139/283 (49%), Gaps = 38/283 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQREIMNHRSL 55
           + +EI+K IG G FG   +V+ K T ++ A+K       ++R +      +R+++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 114
           +   I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST------VGTPAYIAP 168
           H +   HRD+K +N LLD      +++ DFG    S L      T      VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLD--KNGHIRLADFG----SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 169 EVLTKKEYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HY 221
           E+L   E DGK       D WS GV +Y ML G  PF      ++  +T G+I++   H+
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHKEHF 227

Query: 222 SFPDYVR-VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
            FP  V  VS E K L+ R+ + + E R+    + + K+HP+F
Sbjct: 228 QFPPDVTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  105 bits (264), Expect = 2e-26
 Identities = 76/266 (28%), Positives = 117/266 (43%), Gaps = 22/266 (8%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREIMNHRSLKHPN 59
           ++I K IG G F V           ++A+K ++       K  +   +EI   + L HPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 115
           ++++    +    L IV+E A  G+L   I +  +      E     +F QL S + + H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 170
           S +I HRD+K  N  +  +    VK+ D G      SK++  HS     VGTP Y++PE 
Sbjct: 124 SKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSPER 177

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 230
           + +  Y+ K +D+WS G  LY M     PF    D  N      +I    Y        S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYS 234

Query: 231 LECKHLLSRIFVANSEKRITIPEIKN 256
            E + L+SR    + EKR  I  +  
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 2e-26
 Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 25/215 (11%)

Query: 8   KDIGSGNFGV---AKLVRDKWTRELLAVK----FIERGQKIDEHVQREIMNHRSLKHPNI 60
           K +G G FG     KL         +AVK         ++ D    +E    + L HPN+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD--FLKEARVMKKLGHPNV 58

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 111
           VR   V      L +V+EY  GG+L  + R       S +++    + L+S       G+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 168
            Y  S +  HRDL   N L+       VKI DFG S+        +   G    I   AP
Sbjct: 119 EYLASKKFVHRDLAARNCLVG--EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 169 EVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           E L    +  K +DVWS GV L+ +  +GA P+  
Sbjct: 177 ESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 2e-26
 Identities = 90/269 (33%), Positives = 133/269 (49%), Gaps = 20/269 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK---FIERGQKIDEHVQR---EIMNHRSL 55
             + + K +G G FG   L  D  T   LAVK   F    Q+  + V     EI   ++L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 56  KHPNIVRFKEVLLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           +H  IV++   L  P    L+I +EY  GG + +++   G  +E+  R + +Q++ GVSY
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPE 169
            HS  I HRD+K  N L D  +A  VK+ DFG SK   ++  S    KS  GTP +++PE
Sbjct: 122 LHSNMIVHRDIKGANILRD--SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 229
           V++ + Y G+ ADVWS   T+  ML    P+ + E      K   +        PD   V
Sbjct: 180 VISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTKPMLPD--GV 234

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHP 258
           S  C+  L +IFV   ++R T   +  HP
Sbjct: 235 SDACRDFLKQIFV-EEKRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  107 bits (267), Expect = 2e-26
 Identities = 87/312 (27%), Positives = 147/312 (47%), Gaps = 46/312 (14%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE------HVQREIMNHRSL 55
           + +EI+K IG G FG   +V+ K T  + A+K + + + +          +R ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 114
           +   I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLT 172
           H +   HRD+K +N LLD +    +++ DFG           +S+  VGTP YI+PE+L 
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 173 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDY 226
             E      G   D WS GV +Y ML G  PF      ++  +T G+I++    + FP +
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHEERFQFPSH 232

Query: 227 VR-VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLRNLPIELTEGGSWQS------ 276
           +  VS E K L+ R+ + + E+R+    I + K H +F         EG  W++      
Sbjct: 233 ITDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFF---------EGIDWENIRNLEA 282

Query: 277 ---HDVNNPSQS 285
               DV++PS +
Sbjct: 283 PYIPDVSSPSDT 294

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  105 bits (264), Expect = 2e-26
 Identities = 75/257 (29%), Positives = 136/257 (52%), Gaps = 13/257 (5%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  + R+K +   +AVK ++ R Q+  E +  E++  R  +H N+V   +  L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L ++ME+  GG L + I +  R +E++     + ++  + Y HS  + HRD+K ++
Sbjct: 89  VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147

Query: 129 TL--LDGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            L  LDG    RVK+ DFG+ ++ S    + KS VGTP ++APEV+++  Y  ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202

Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANS 245
            G+ +  M+ G  P+   + P    K +    S      +  ++S   +  L R+     
Sbjct: 203 LGIMVIEMVDGEPPYFS-DSPVQAMKRLRD--SPPPKLKNAHKISPVLRDFLERMLTREP 259

Query: 246 EKRITIPEIKNHPWFLR 262
           ++R T  E+ +HP+ L+
Sbjct: 260 QERATAQELLDHPFLLQ 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  105 bits (263), Expect = 3e-26
 Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 44/292 (15%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ-------REIMNHRSLK 56
           ++ V+ IG G +GV    R+K T E++A+K I    ++D   +       REI   + L 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKELN 57

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           HPNIV+  +V+ T   L +V E+     + F              + +  QL+ G+++CH
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 171
           S ++ HRDLK +N L++   A  +K+ DFG +++  +   P  T    V T  Y APE+L
Sbjct: 118 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEIL 172

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY------- 221
              +Y     D+WS G     M+     F  D E  + FR  +T+G    V +       
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 222 ----SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
               SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  109 bits (272), Expect = 4e-26
 Identities = 85/249 (34%), Positives = 119/249 (47%), Gaps = 37/249 (14%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQR--EIMNHRSLKH 57
           +  YE++K IG+G FG   LV+ K T+E    K I  RG K  E  Q   E+   R LKH
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 58  PNIVRFKEVLLTPTH--LAIVMEYAAGGELFERICNA----GRFSEDEARFFFQQLISGV 111
            NIVR+ +  L   +  L I+ME+   G+L   I       G+  E       +QL+  +
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 112 SYCHSMQ-------ICHRDLKLENTLLDGS-------TA--------PRVKICDFGYSKS 149
           +YCH+++       + HRDLK +N  L          TA        P  KI DFG SK+
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 150 SVLHSQPKSTVGTPAYIAPEVL--TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK 207
             + S   S VGTP Y +PE+L    K YD K +D+W+ G  +Y +  G  PF       
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPF---HKAN 247

Query: 208 NFRKTIGRI 216
           NF + I  +
Sbjct: 248 NFSQLISEL 256

Length = 1021

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  104 bits (261), Expect = 6e-26
 Identities = 82/291 (28%), Positives = 133/291 (45%), Gaps = 40/291 (13%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLKHP 58
           +YE ++ IG G +G     +++ T E++A+K + R    DE V     REI   + LKH 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS 116
           NIVR  +VL +   L +V EY    +  ++  ++  G    +  + F  QL+ G+++CHS
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYC--DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLT-KK 174
             + HRDLK +N L++ +    +K+ DFG +++  +      + V T  Y  P+VL   K
Sbjct: 118 HNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL---------SVHYSFPD 225
            Y   I D+WS G     +     P     D  +  K I R+L          V    PD
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS-KLPD 233

Query: 226 YV----------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           Y                 +++   + LL  + V N  +RI+  E   HP+F
Sbjct: 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  103 bits (259), Expect = 9e-26
 Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 20/212 (9%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELL-AVKFIERGQKIDEHVQ--REIMNHRSLKHP 58
           E+ K +G G FG      L  D    E   AVK ++ G   +E  +   E    + L HP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NIVR   V      L IV EY  GG+L  F R  +  + +  +      Q+  G+ Y  S
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 171
               HRDL   N L+  +    VKI DFG S+   ++            +     APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 172 TKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
              ++  K +DVWS GV L+ +  +G  P+  
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPG 207

Length = 258

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  103 bits (258), Expect = 1e-25
 Identities = 73/215 (33%), Positives = 102/215 (47%), Gaps = 21/215 (9%)

Query: 4   YEIVKDIGSGNFGVAKLVRDK-WTRELLAVKFI------------ERGQKIDEHVQREIM 50
           Y +++ +GSG FG    VR K   + LLA+K I            ER + I + V    +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN----AGRFSEDEARFFFQQ 106
               L+HPNIVR+ +  L    L IVM+   G  L E   +      RF+E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 107 LISGVSYCH-SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY 165
           ++  + Y H   +I HRDL   N +L      +V I DFG +K     S+  S VGT  Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
             PE++  + Y G+ ADVW+ G  LY M     PF
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  104 bits (259), Expect = 1e-25
 Identities = 88/301 (29%), Positives = 146/301 (48%), Gaps = 30/301 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A++ +  + Q   E +  EI+  R  K+PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           HRD+K +N LL  DGS    VK+ DFG+ ++ +   S+  + VGTP ++APEV+T+K Y 
Sbjct: 139 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  ++S   +  L
Sbjct: 195 PKV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 250

Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEAT 297
           +R    + EKR +  E+  H  FL+                +  P  SL  +++   EAT
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQ-FLK----------------IAKPLSSLTPLIAAAKEAT 293

Query: 298 K 298
           K
Sbjct: 294 K 294

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  104 bits (261), Expect = 2e-25
 Identities = 88/308 (28%), Positives = 139/308 (45%), Gaps = 61/308 (19%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----KH 57
           E +E +K IG G FG  +LV+ K T  + A+K + +   +++     I   R +      
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
             +V+         +L ++ME+  GG++   +      +E+E +F+  + +  +   H +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKS-----------SVLHSQPK--------- 157
              HRD+K +N LLD  +   VK+ DFG               ++ HS P          
Sbjct: 121 GFIHRDIKPDNLLLD--SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 158 ----------------STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF- 200
                           STVGTP YIAPEV  +  Y+ K+ D WS GV +Y ML+G  PF 
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237

Query: 201 -EDPEDP----KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP--- 252
            E P++      N+++T+         FP  V +S + K L+ R F    E RI  P   
Sbjct: 238 SETPQETYKKVMNWKETL--------IFPPEVPISEKAKDLILR-FCCEWEHRIGAPGVE 288

Query: 253 EIKNHPWF 260
           EIK +P+F
Sbjct: 289 EIKTNPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  102 bits (257), Expect = 3e-25
 Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 17/197 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQ---REIMNHRSLKH 57
           + +  +++IG G+FG     RD  T E++A+K +   G++ +E  Q   +E+   + L+H
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PN + +K   L      +VMEY  G   ++ E   +     E E        + G++Y H
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV---LT 172
           S +  HRD+K  N LL  +    VK+ DFG   S+ L S   S VGTP ++APEV   + 
Sbjct: 133 SHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMD 187

Query: 173 KKEYDGKIADVWSCGVT 189
           + +YDGK  DVWS G+T
Sbjct: 188 EGQYDGK-VDVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  101 bits (252), Expect = 6e-25
 Identities = 85/266 (31%), Positives = 133/266 (50%), Gaps = 20/266 (7%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR------EIMNHRSLKH 57
           + + K +G G FG   L  D  T   LAVK ++   +  E  +       EI   ++L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 58  PNIVRFKEVLLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
             IV++   L  P    L+I ME+  GG + +++ + G  +E+  R + +Q++ GVSY H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVL 171
           S  I HRD+K  N L D  +   VK+ DFG SK      +  +  KS  GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRD--SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
           + + Y G+ AD+WS G T+  ML    P+ + E      K   +    +   P +  VS 
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLPPH--VSD 236

Query: 232 ECKHLLSRIFVANSEKRITIPEIKNH 257
            C+  L RIFV  ++ R +  E+  H
Sbjct: 237 HCRDFLKRIFV-EAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  102 bits (255), Expect = 7e-25
 Identities = 82/279 (29%), Positives = 138/279 (49%), Gaps = 30/279 (10%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE------HVQREIMNHRSL 55
           E +EI+K IG G FG   +V+ K   ++ A+K + + + +          +R+++ +   
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 114
           +   I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  QW--ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLT 172
           H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L 
Sbjct: 119 HQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 173 KKEYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPD 225
             E DGK       D WS GV +Y ML G  PF      ++  +T G+I++    + FP 
Sbjct: 177 AME-DGKGKYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHKERFQFPA 231

Query: 226 YVR-VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
            V  VS + K L+ R+ + + E R+    I + K HP+F
Sbjct: 232 QVTDVSEDAKDLIRRL-ICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  101 bits (253), Expect = 8e-25
 Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 41/290 (14%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVK-FIERGQKIDEHVQ-REIMNHRSLK-HPNI 60
           Y+I+  IG G F      + + T +  A+K   +  + +++    REI   R L  HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 61  VRFKEVLLTPTH--LAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 117
           +R  EVL       LA+V E      L+E I    R   E   + +  QL+  + + H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKE 175
            I HRD+K EN L+       +K+ DFG  +   ++S+P  T  + T  Y APE L    
Sbjct: 120 GIFHRDIKPENILIKDDI---LKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 176 YDGKIADVWSCGVTLYVM--LVGAYPFED--------------PEDPKNFRKTIGRILSV 219
           Y G   D+W+ G   + +  L   +P  +              P+     +    R ++ 
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN- 233

Query: 220 HYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            Y+FP              S E   LL ++   + ++RIT  +   HP+F
Sbjct: 234 -YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  101 bits (252), Expect = 9e-25
 Identities = 80/265 (30%), Positives = 124/265 (46%), Gaps = 19/265 (7%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPN---IVRFKE 65
           +G G FG     + + T +L A K + + + K  +  +  ++  R L   +   IV    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICH 121
              T T L +VM    GG+L   I N       F E  A F+  Q+ISG+ + H  +I +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           RDLK EN LLD      V+I D G + +     S+ K   GTP ++APE+L  +EYD  +
Sbjct: 121 RDLKPENVLLD--NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            D ++ GVTLY M+    PF    +    ++   RIL+   ++PD  + S   K     +
Sbjct: 179 -DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEAL 235

Query: 241 FVANSEKRI-----TIPEIKNHPWF 260
              + EKR+         ++ HP F
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLF 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 1e-24
 Identities = 90/292 (30%), Positives = 133/292 (45%), Gaps = 44/292 (15%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLKHPN 59
           Y+ V+ IG G +GV    RDK T E++A+K I R +  DE V     REI   + L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 117
           IVR  +V+ +   L +V E+    +L + + ++     D      +  QL+ G++YCHS 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLTK 173
           ++ HRDLK +N L+D      +K+ DFG +++      P  T    V T  Y APE+L  
Sbjct: 119 RVLHRDLKPQNLLID--REGALKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 173

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFRKTIGRILSV------------- 219
                   D+WS G     M+     F  D E  + FR  I R L               
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTSLP 231

Query: 220 --HYSFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
               +FP + R  L         +   LLS++ V +  KRI+      HP+F
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  100 bits (250), Expect = 1e-24
 Identities = 66/190 (34%), Positives = 103/190 (54%), Gaps = 6/190 (3%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNIVR 62
           YE+++ +GSG +G     R+  T EL AVK I+     D   +Q+EI   +  KH NIV 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
           +    L+   L I MEY  GG L +     G  SE +  +  ++ + G++Y HS    HR
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Query: 123 DLKLENTLLDGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG--K 179
           D+K  N LL  +    VK+ DFG  +K +   ++ KS +GTP ++APEV   ++  G  +
Sbjct: 131 DIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188

Query: 180 IADVWSCGVT 189
           + D+W+ G+T
Sbjct: 189 LCDIWAVGIT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  100 bits (251), Expect = 1e-24
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 12/195 (6%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKHPN 59
           ++E++  +G G +GV    R K T+E++A+K     E  +++ E   RE+   R+LK  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           IV  KE       L +V EY      EL E + N      ++ R +  QLI  + +CH  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKN 119

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKE 175
            I HRD+K EN L+  S    +K+CDFG++++    S    T  V T  Y +PE+L    
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 176 YDGKIADVWSCGVTL 190
           Y GK  D+WS G  L
Sbjct: 178 Y-GKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  101 bits (252), Expect = 2e-24
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 23/278 (8%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIER-----GQKIDEHVQREIMNHRSLKHPNIVRFK 64
           IG G++    LVR K T  + A+K +++      + ID     + +  ++  HP +V   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N LLD  +   +K+ D+G  K  +      ST  GTP YIAPE+L  ++Y G   D 
Sbjct: 123 KLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179

Query: 184 WSCGVTLYVMLVGAYPFE-----DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 238
           W+ GV ++ M+ G  PF+     D  D          IL      P    +S++   +L 
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLK 237

Query: 239 RIFVANSEKRI-TIPE-----IKNHPWFLRNLPIELTE 270
                + ++R+   P+     I+ HP+F RN+  +L E
Sbjct: 238 SFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDLME 274

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  100 bits (250), Expect = 2e-24
 Identities = 80/260 (30%), Positives = 133/260 (51%), Gaps = 13/260 (5%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +   K + +L+AVK ++ R Q+  E +  E++  R  +H N+V      L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146

Query: 129 TLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            LL  DG    RVK+ DFG+ ++ S    + KS VGTP ++APE++++  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201

Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANS 245
            G+ +  M+ G  P+ + E P    K I   L       +  +VS   K  L R+ V + 
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPP--KLKNLHKVSPSLKGFLDRLLVRDP 258

Query: 246 EKRITIPEIKNHPWFLRNLP 265
            +R T  E+  HP+  +  P
Sbjct: 259 AQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  100 bits (249), Expect = 2e-24
 Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 9/205 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE--HVQREIMNHRSLKHPN 59
           E +  ++ IG G+FG      D  T++++A+K I+  +  DE   +Q+EI        P 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +  AG F E +     ++++ G+ Y HS + 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLTKKEYD 177
            HRD+K  N LL  S    VK+ DFG +   +  +Q K  + VGTP ++APEV+ +  YD
Sbjct: 123 IHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179

Query: 178 GKIADVWSCGVTLYVMLVGAYPFED 202
            K AD+WS G+T   +  G  P  D
Sbjct: 180 SK-ADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  100 bits (251), Expect = 2e-24
 Identities = 86/311 (27%), Positives = 131/311 (42%), Gaps = 65/311 (20%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE---HVQREIMNHRSLKHPNI 60
           +E +  IG G +G+    RD  + E++A+K +    + D       REI    +L+HPNI
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 61  VRFKEVLLTPTHLA---IVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           V  KEV+    HL    +VMEY       L + +     FSE + +    QL+ G+ Y H
Sbjct: 69  VELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLH 125

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLT-K 173
              I HRDLK+ N LL       +KI DFG +++  L ++P +  V T  Y APE+L   
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183

Query: 174 KEYDGKIADVWSCG---------------------VTLYVMLVGA-----YP-------- 199
             Y   I D+W+ G                     + L + L+G      +P        
Sbjct: 184 TTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242

Query: 200 --FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
             F  P+ P N        L   + +     +S     LL+ + + + +KR T  E    
Sbjct: 243 GKFTLPKQPYNN-------LKHKFPW-----LSEAGLRLLNFLLMYDPKKRATAEEALES 290

Query: 258 PWFLRN-LPIE 267
            +F    LP E
Sbjct: 291 SYFKEKPLPCE 301

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 99.4 bits (247), Expect = 3e-24
 Identities = 86/264 (32%), Positives = 130/264 (49%), Gaps = 20/264 (7%)

Query: 8   KDIGSGNFGVAKLVRDKWT-RELLA--VKFIERGQKIDEHVQR---EIMNHRSLKHPNIV 61
           K +G G FG   L  D  T REL A  V+F     +  + V     EI   ++L+H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 62  RFKEVLLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           ++   L       L I MEY  GG + +++   G  +E   R + +Q++ G+SY HS  I
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLTKKE 175
            HRD+K  N L D  +A  VK+ DFG SK   ++  S    +S  GTP +++PEV++ + 
Sbjct: 128 VHRDIKGANILRD--SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G+ ADVWS G T+  ML    P+ + E        I +I +   +      +S   + 
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHARD 240

Query: 236 LLSRIFVANSEKRITIPEIKNHPW 259
            L  IFV  +  R +  E+  HP+
Sbjct: 241 FLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 99.5 bits (248), Expect = 3e-24
 Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 42/291 (14%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH------VQREIMNHRSLKH 57
           ++ ++ +G G +      R++ T E++A+K I     +D          REI   + LKH
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI----HLDAEEGTPSTAIREISLMKELKH 57

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            NIVR  +V+ T   L +V EY      +  +     G    +  + F  QL+ G+++CH
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLT-K 173
             ++ HRDLK +N L++      +K+ DFG +++  +  +   + V T  Y AP+VL   
Sbjct: 118 ENRVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--------YSFPD 225
           + Y   I D+WS G  +  M+ G   F    +     K I RI+              P+
Sbjct: 176 RTYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLK-IFRIMGTPTESTWPGISQLPE 233

Query: 226 YVRVSLECKH----------------LLSRIFVANSEKRITIPEIKNHPWF 260
           Y                         LL R+   N E RI+  +   HPWF
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 99.3 bits (247), Expect = 4e-24
 Identities = 88/272 (32%), Positives = 133/272 (48%), Gaps = 26/272 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           E +EI+ ++G G FG     ++K T  L A K I+ + ++  E    EI    S  HPNI
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQI 119
           V+  +      +L I++E+ AGG +   +    R  +E + R   +Q +  ++Y H  +I
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124

Query: 120 CHRDLKLENTL--LDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVL---TK 173
            HRDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV+   T 
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 174 KE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV---- 227
           K+  YD K ADVWS G+TL  M          E P +    +  +L +  S P  +    
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM-------AQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           R S E K  L +    N + R T  ++  HP+
Sbjct: 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 98.8 bits (247), Expect = 5e-24
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 4   YEIVKDIGS--GNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR-EIMNHRSLK-HPN 59
            EIVK +    G FG   +++ K T++L   K I+      ++    E M H+ +K +PN
Sbjct: 16  CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIK-----AKNFNAIEPMVHQLMKDNPN 70

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
            ++    + T     ++M+Y   G+LF+ +   G+ SE E +   +QL+  ++  H   I
Sbjct: 71  FIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNI 130

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            H D+KLEN L D +   R+ +CD+G  K       P    GT  Y +PE +    YD  
Sbjct: 131 IHNDIKLENVLYDRAK-DRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNYDVS 186

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPED 205
             D W+ GV  Y +L G +PF++ ED
Sbjct: 187 F-DWWAVGVLTYELLTGKHPFKEDED 211

Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 99.5 bits (248), Expect = 7e-24
 Identities = 78/288 (27%), Positives = 133/288 (46%), Gaps = 37/288 (12%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHP 58
            RY  ++ +G G FG+    RD+ T + +A+K I +      + +   RE+   + L+H 
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 59  NIVRFKEVLLTP-THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           NI+   ++ ++P   +  V E    G    R+  +    +   ++F  Q++ G+ Y HS 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV-LTKKEY 176
            + HRDLK  N L++ +    +KICDFG ++  +   Q    V T  Y APE+ LT ++Y
Sbjct: 128 GVVHRDLKPSNILINENC--DLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 177 DGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PKNFRKTIGRILSVHY- 221
           D ++ D+WS G     ML G   +P +D  +            P +   TI    ++ + 
Sbjct: 184 DVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242

Query: 222 -SFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKNHPW 259
            S P    V    K          LL ++ V + +KRI+  E   HP+
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.6 bits (246), Expect = 7e-24
 Identities = 70/222 (31%), Positives = 104/222 (46%), Gaps = 20/222 (9%)

Query: 7   VKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKHPN 59
           +K +G G+FG  +L R       T E +AVK +    + ++H    +REI   R+L H N
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-EQHRSDFEREIEILRTLDHEN 67

Query: 60  IVRFKEVLLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 116
           IV++K V   P    L ++MEY   G L + +  +  + +      F  Q+  G+ Y  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLT 172
            +  HRDL   N L++      VKI DFG +K           K    +P  + APE L 
Sbjct: 128 QRYIHRDLAARNILVESED--LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
             ++    +DVWS GVTLY +     P + P  P  F + IG
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMIG 224

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 98.2 bits (244), Expect = 1e-23
 Identities = 68/196 (34%), Positives = 99/196 (50%), Gaps = 7/196 (3%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE--HVQREIMNHRSLKHPNIVRFKEVL 67
           IG G+FG      D  T+E++A+K I+  +  DE   +Q+EI        P I R+    
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 68  LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLE 127
           L  T L I+MEY  GG   + +   G   E       ++++ G+ Y HS +  HRD+K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130

Query: 128 NTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSC 186
           N LL  S    VK+ DFG +         ++T VGTP ++APEV+ +  YD K AD+WS 
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187

Query: 187 GVTLYVMLVGAYPFED 202
           G+T   +  G  P  D
Sbjct: 188 GITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 20/266 (7%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIER-----GQKIDEHVQREIMNHRSLKHPNIVRFK 64
           IG G++    LVR K   ++ A+K +++      + ID     + +  ++  +P +V   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               T + L +V+EY  GG+L   +    +  E+ ARF+  ++   +++ H   I +RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L  +EY G   D 
Sbjct: 123 KLDNVLLDADG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179

Query: 184 WSCGVTLYVMLVGAYPFE---DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           W+ GV ++ M+ G  PF+   D  D          IL      P +  +S++  H+L   
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGF 237

Query: 241 FVANSEKRI------TIPEIKNHPWF 260
              + ++R+         +IK+H +F
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFF 263

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 97.5 bits (242), Expect = 2e-23
 Identities = 80/273 (29%), Positives = 124/273 (45%), Gaps = 28/273 (10%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE--HVQREIMNHRSLKHPN 59
           E +  ++ IG G+FG      D  T++++A+K I+  +  DE   +Q+EI        P 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD 177
            HRD+K  N LL  S    VK+ DFG +   +  +Q K    VGTP ++APEV+ +  YD
Sbjct: 123 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRILSVHYSFPDYVRVS 230
            K AD+WS G+T   +  G  P  +          PKN   T    L  +YS P      
Sbjct: 180 SK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP------ 228

Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
              K  +          R T  E+  H + +R 
Sbjct: 229 --LKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 97.3 bits (242), Expect = 2e-23
 Identities = 80/269 (29%), Positives = 123/269 (45%), Gaps = 30/269 (11%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-------PNIVR 62
           IG G FG     R   T ++ A+K +++ +   +  +   +N R +         P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 TP  L+ +++   GG+L   +   G FSE E RF+  ++I G+ + H+  + +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 123 DLKLENTLLDGSTAPRVK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK-EYD 177
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL K   YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR-ILSVHYSFPDYVRVSLECKHL 236
              AD +S G  L+ +L G  PF   +     +  I R  L++    PD    S E + L
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPD--SFSPELRSL 229

Query: 237 LSRIFVANSEKRITI-----PEIKNHPWF 260
           L  +   +  +R+        E+K HP+F
Sbjct: 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 20/271 (7%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVR 62
           +EI++ IG G +G    V +K    L AVK ++    +DE ++ E    +SL  HPN+V+
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83

Query: 63  FKEVLLTPTHLA-----IVMEYAAGG---ELFERICNAG-RFSEDEARFFFQQLISGVSY 113
           F  +      L      +V+E   GG   EL + +   G R  E    +     + G+ +
Sbjct: 84  FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLT 172
            H+ +I HRD+K  N LL  +T   VK+ DFG S   +    +  ++VGTP ++APEV+ 
Sbjct: 144 LHNNRIIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201

Query: 173 -KKEYDGKI---ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
            +++YD       DVWS G+T   +  G  P  D    K   K I R        P+  +
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPPPTLLHPE--K 258

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
                 H +S+  + + E R ++  +  HP+
Sbjct: 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 85/301 (28%), Positives = 123/301 (40%), Gaps = 54/301 (17%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPN 59
            RY+ +  IG G +G+      K T   +A+K I     Q   +   REI   R  KH N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCH 115
           I+   +++  P       +     EL E    ++      S D  ++F  Q++ G+ Y H
Sbjct: 65  IIGILDII-RPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV- 170
           S  + HRDLK  N LL+  T   +KICDFG ++ +             V T  Y APE+ 
Sbjct: 124 SANVLHRDLKPSNLLLN--TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYSFP----- 224
           L  K Y   I D+WS G  L  ML     F     P K++   +  IL V  + P     
Sbjct: 182 LNSKGYTKAI-DIWSVGCILAEMLSNRPLF-----PGKDYLHQLNLILGVLGT-PSQEDL 234

Query: 225 ---------DYVRVSLECK-----------------HLLSRIFVANSEKRITIPEIKNHP 258
                    +Y++ SL  K                  LL ++   N  KRIT+ E   HP
Sbjct: 235 NCIISLRARNYIK-SLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293

Query: 259 W 259
           +
Sbjct: 294 Y 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 96.3 bits (240), Expect = 6e-23
 Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 16/204 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK-FIERGQKIDEHVQ----REIMNHRSLK 56
           E+YE +  +G G++G+    + K T +++A+K F+E     D+ V+    REI   + L+
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 114
           H N+V   EV      L +V E+     L   E+  N     E   R +  Q++ G+ +C
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLT 172
           HS  I HRD+K EN L+  S +  VK+CDFG+++ ++       T  V T  Y APE+L 
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173

Query: 173 KKEYDGKIADVWSCGVTLYVMLVG 196
                G+  D+W+ G  +  ML G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 96.3 bits (239), Expect = 6e-23
 Identities = 74/257 (28%), Positives = 130/257 (50%), Gaps = 17/257 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +  +K T + +AVK ++ R Q+  E +  E++  R   H N+V      L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +SY H+  + HRD+K ++
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148

Query: 129 TLLDGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCG 187
            LL  ++  R+K+ DFG+ ++ S    + KS VGTP ++APEV+++  Y G   D+WS G
Sbjct: 149 ILL--TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLG 205

Query: 188 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP----DYVRVSLECKHLLSRIFVA 243
           + +  M+ G  P+ +    +  R+       +  + P    D  +VS   +  L  + V 
Sbjct: 206 IMVIEMIDGEPPYFNEPPLQAMRR-------IRDNLPPRVKDSHKVSSVLRGFLDLMLVR 258

Query: 244 NSEKRITIPEIKNHPWF 260
              +R T  E+  HP+ 
Sbjct: 259 EPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 95.9 bits (239), Expect = 7e-23
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 14/203 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK-FIERGQKIDEHVQ----REIMNHRSLK 56
           E+YE +  IG G++GV    R++ T +++A+K F+E     D  ++    REI   + LK
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLK 58

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN+V   EV      L +V EY     L E   N     E   +    Q +  V++CH 
Sbjct: 59  HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLTK 173
               HRD+K EN L+  +   ++K+CDFG+++  +L          V T  Y APE+L  
Sbjct: 119 HNCIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 174 KEYDGKIADVWSCGVTLYVMLVG 196
               G   DVW+ G     +L G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 96.7 bits (240), Expect = 7e-23
 Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 8/217 (3%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V+ K +  ++A K I  E    I   + RE+        P 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  A R  E+        ++ G++Y     Q
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 125 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 181

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR 215
           + +D+WS G++L  + +G YP   P D K      GR
Sbjct: 182 Q-SDIWSMGLSLVELAIGRYPIP-PPDAKELEAIFGR 216

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 95.9 bits (238), Expect = 8e-23
 Identities = 84/272 (30%), Positives = 132/272 (48%), Gaps = 26/272 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           E +EI+ ++G G FG     ++K T  L A K IE + ++  E    EI    +  HP I
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQI 119
           V+          L I++E+  GG +   +    R  +E + +   +Q++  + Y HSM+I
Sbjct: 72  VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131

Query: 120 CHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVL---TK 173
            HRDLK  N LL  DG     +K+ DFG S  +V   Q + S +GTP ++APEV+   T 
Sbjct: 132 IHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 174 KE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV---- 227
           K+  YD K AD+WS G+TL  M          E P +    +  +L +  S P  +    
Sbjct: 188 KDTPYDYK-ADIWSLGITLIEM-------AQIEPPHHELNPMRVLLKIAKSEPPTLSQPS 239

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           + S+E +  L      + E R +  ++  HP+
Sbjct: 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.0 bits (236), Expect = 1e-22
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 18/205 (8%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-------RGQKIDEHVQREIMNHRSLKHPNIVR 62
           +G G +G           +L+AVK +E         +K  E +Q E+   +SLKH NIV+
Sbjct: 8   LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
           +    L    ++I ME+  GG +   +   G   E     + +Q++ GV+Y H+  + HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLTKKE 175
           D+K  N +L  +    +K+ DFG ++          HS   KS  GTP ++APEV+ +  
Sbjct: 127 DIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPF 200
           Y G+ +D+WS G T++ M  G  P 
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 95.2 bits (237), Expect = 1e-22
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 11/206 (5%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----PNI 60
           E + D+G+GN G    V+   T  ++A K +  G K    V+++I+    + H    P I
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYI 65

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QI 119
           V F    L   ++ + ME+   G L       G    +        ++ G++Y +++ +I
Sbjct: 66  VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI 125

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            HRD+K  N L++     ++K+CDFG S   +++S   + VGT  Y++PE +   +Y  K
Sbjct: 126 MHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPED 205
            +DVWS G+++  + +G +PF     
Sbjct: 183 -SDVWSLGISIIELALGKFPFAFSNI 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 87/303 (28%), Positives = 129/303 (42%), Gaps = 59/303 (19%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ-----REIMNHRSLKH 57
           +Y  +K IG G +G+    ++  T E +A+K I      D  +      REI   R L H
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRHLDH 63

Query: 58  PNIVRFKEVLLTPTH------LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
            N++  K+++  P H      + IV E     +L + I ++   S+D  ++F  QL+ G+
Sbjct: 64  ENVIAIKDIM-PPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEV 170
            Y HS  + HRDLK  N LL+ +    +KICDFG ++ +S         V T  Y APE+
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 171 -LTKKEYDGKIADVWSCG---------------------VTLYVMLVGAYPFEDPE--DP 206
            L   EY   I DVWS G                     + L   L+G+   ED      
Sbjct: 180 LLNCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238

Query: 207 KNFRKTIGRILSVHYSFPDYVRVSLECKH---------LLSRIFVANSEKRITIPEIKNH 257
           +  R+ I        S P   R S              LL ++ V +  KRIT+ E   H
Sbjct: 239 EKARRYI-------RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291

Query: 258 PWF 260
           P+ 
Sbjct: 292 PYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 94.1 bits (234), Expect = 4e-22
 Identities = 73/285 (25%), Positives = 129/285 (45%), Gaps = 30/285 (10%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----PNI 60
           E++ ++G GN+G    V  + T   +A+K I    ++DE    +I+    + H    P I
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYI 61

Query: 61  VRFKEVLLTPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC-HS 116
           V F         + + MEY   G   +L+          ED  R     ++ G+ +    
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             I HRD+K  N L++G+   +VK+CDFG S  +++ S  K+ +G  +Y+APE +     
Sbjct: 122 HNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGP 178

Query: 177 DGKI-----ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP----DYV 227
           +        +DVWS G+++  M +G YP+  PE   N    +  I  V    P     Y 
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYP-PETYANIFAQLSAI--VDGDPPTLPSGY- 234

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL--RNLPIELTE 270
             S + +  +++       +R T  ++  HPW +  +N  +++ E
Sbjct: 235 --SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAE 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 69/191 (36%), Positives = 101/191 (52%), Gaps = 19/191 (9%)

Query: 9   DIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQ---REIMNHRSLKHPNIVRFK 64
           +IG G+FG      +  T E++AVK +   G++ +E  Q   +E+   + LKHPN + +K
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 65  EVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              L      +VMEY  G   +L E   +     E E        + G++Y HS  + HR
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 123 DLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV---LTKKEYDG 178
           D+K  N LL   T P +VK+ DFG   S+   S   S VGTP ++APEV   + + +YDG
Sbjct: 146 DIKAGNILL---TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYDG 199

Query: 179 KIADVWSCGVT 189
           K+ DVWS G+T
Sbjct: 200 KV-DVWSLGIT 209

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 95.5 bits (237), Expect = 4e-22
 Identities = 86/310 (27%), Positives = 128/310 (41%), Gaps = 63/310 (20%)

Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQREIMNHRSLKHPNI 60
           +K +G G FG   L     T  L A+K       + R Q      +R+I+      +  +
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+         +L  VM+Y  GG++   +     F E  ARF+  +L   +   H M   
Sbjct: 64  VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123

Query: 121 HRDLKLENTLLDGSTAPRVKICDFG-------------YSKSSVLHS---QPK------- 157
           HRD+K +N L+D      +K+ DFG             Y K S +     +P        
Sbjct: 124 HRDIKPDNILID--LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 158 -------------------------STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV 192
                                    S VGTP YIAPEVL +K Y  ++ D WS GV L+ 
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240

Query: 193 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK--RIT 250
           MLVG  PF  P   +   K I    ++H   P  V++S E   L++++  +  E+  R  
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKLCCSAEERLGRNG 298

Query: 251 IPEIKNHPWF 260
             +IK HP+F
Sbjct: 299 ADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 93.5 bits (232), Expect = 5e-22
 Identities = 80/268 (29%), Positives = 121/268 (45%), Gaps = 28/268 (10%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-------PNIVR 62
           IG G FG     R   T ++ A+K +++ +   +  +   +N R +         P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
                 TP  L  +++   GG+L   +   G FSE E RF+  ++I G+ + H+  + +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 123 DLKLENTLLDGSTAPRVK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL K     
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDYVRVSLECKHLL 237
             AD +S G  L+ +L G  PF   +     +  I R+ L+V+   PD    S E K LL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTVNVELPD--SFSPELKSLL 230

Query: 238 SRIFVANSEKRITI-----PEIKNHPWF 260
             +   +  KR+        E+K H +F
Sbjct: 231 EGLLQRDVSKRLGCLGRGAQEVKEHVFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 7e-22
 Identities = 80/318 (25%), Positives = 119/318 (37%), Gaps = 62/318 (19%)

Query: 3   RYEIVKDIGSGNFG-VAKLVRDKWTR-ELLAVKFIE----RGQKIDEHVQREIMNHRSLK 56
           +YEI   IG G +G V K  R      +  A+K  +    +   I +   REI   R LK
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 57  HPNIVRFKEVLLTPTHLAIVM--EYAAGGEL----FERICNAGRFSEDEARFFFQQLISG 110
           H N+V   EV L     ++ +  +YA         F R            +    Q+++G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 111 VSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKS------TVGT 162
           V Y HS  + HRDLK  N L+  +G     VKI D G ++  + ++  K        V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178

Query: 163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKN---FRKT-IGRIL 217
             Y APE+L    +  K  D+W+ G     +L     F+      K    F++  + RI 
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238

Query: 218 SV-----------------------HYSFPDYVRVSL------------ECKHLLSRIFV 242
            V                        +    Y   SL            +   LL ++  
Sbjct: 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298

Query: 243 ANSEKRITIPEIKNHPWF 260
            +  KRIT  E   HP+F
Sbjct: 299 YDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 94.0 bits (233), Expect = 7e-22
 Identities = 69/193 (35%), Positives = 105/193 (54%), Gaps = 19/193 (9%)

Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQ---REIMNHRSLKHPNIVR 62
           +++IG G+FG     RD  T E++A+K +   G++ +E  Q   +E+   + +KHPN + 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 63  FKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +K   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 121 HRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV---LTKKEY 176
           HRD+K  N LL   T P +VK+ DFG   S+ + S   S VGTP ++APEV   + + +Y
Sbjct: 148 HRDIKAGNILL---TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQY 201

Query: 177 DGKIADVWSCGVT 189
           DGK+ DVWS G+T
Sbjct: 202 DGKV-DVWSLGIT 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 84/305 (27%), Positives = 124/305 (40%), Gaps = 57/305 (18%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---------REIMN 51
           + +YEI++ +G G +G+     D+ T+E++A+K      KI +  +         REIM 
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREIMF 59

Query: 52  HRSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQ 106
            + L  HPNIV+   V+       I + +    E  E     +  A    +   R+   Q
Sbjct: 60  LQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQ 115

Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST------V 160
           L+  + Y HS  + HRDLK  N LL+     RVK+ DFG ++S     +          V
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDC--RVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK---TIGR-- 215
            T  Y APE+L       K  D+WS G  L  ML+G   F          K    IG   
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233

Query: 216 ---ILSVHYSFPDYVRVSLECKH-----------------LLSRIFVANSEKRITIPEIK 255
              I S+   F   +  SL  +                  LL ++ V N  KR+T  E  
Sbjct: 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293

Query: 256 NHPWF 260
            HP+ 
Sbjct: 294 EHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 64/193 (33%), Positives = 103/193 (53%), Gaps = 19/193 (9%)

Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQ---REIMNHRSLKHPNIVR 62
           +++IG G+FG     RD    E++A+K +   G++ +E  Q   +E+   + L+HPN ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 63  FKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           ++   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 121 HRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV---LTKKEY 176
           HRD+K  N LL   + P  VK+ DFG   S+ + +     VGTP ++APEV   + + +Y
Sbjct: 138 HRDVKAGNILL---SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQY 191

Query: 177 DGKIADVWSCGVT 189
           DGK+ DVWS G+T
Sbjct: 192 DGKV-DVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 91.1 bits (226), Expect = 4e-21
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 24/207 (11%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----PNIVRFKE 65
           +G GN G         TR +LAVK I     I   +Q++IM+   + +    P I+ F  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP--LDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 66  VLLTPTHLAIVMEYAAGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICH 121
                  ++I  E+  GG L  + +I     GR +          ++ G++Y  S++I H
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RD+K  N L++  T  +VK+CDFG S   V +S  K+ VGT AY+APE ++ ++Y G  +
Sbjct: 119 RDVKPSNMLVN--TRGQVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174

Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKN 208
           DVWS G++   + +G +P+  P+  KN
Sbjct: 175 DVWSLGISFMELALGRFPY--PQIQKN 199

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 82/297 (27%), Positives = 129/297 (43%), Gaps = 41/297 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  + +  ++A K I  E    I   + RE+        P 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQ 118
           IV F     +   ++I ME+  GG L + +  AGR  E+        ++ G++Y     +
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 121 IMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYTV 177

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS----------VHYSFPDYVR 228
           + +D+WS G++L  M +G YP   P D K      GR +S          V    PD  R
Sbjct: 178 Q-SDIWSLGLSLVEMAIGRYPIP-PPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235

Query: 229 -----------VSLECKHLLSRIF------------VANSEKRITIPEIKNHPWFLR 262
                      V+     L S  F              N ++R  + E+  HP+  R
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 92.8 bits (230), Expect = 4e-21
 Identities = 85/311 (27%), Positives = 124/311 (39%), Gaps = 59/311 (18%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE------RGQKIDEHVQREIMNHRSLKH 57
           +  +K +G G FG   L R   T+ L A+K +       R Q      +R+I+      +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
             +VR         +L  VM+Y  GG++   +   G F ED ARF+  +L   V   H M
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120

Query: 118 QICHRDLKLENTLLD--------------------------GSTAPRVKICDFGYS---- 147
              HRD+K +N L+D                               R    DF       
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 148 --------------KSSVLHSQ--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 191
                         +++  H +    S VGTP YIAPEVL +  Y  ++ D WS GV LY
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239

Query: 192 VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK--RI 249
            MLVG  PF      +   K I    S+H   P   ++S E   L+ ++     ++  + 
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLH--IPPQAKLSPEASDLIIKLCRGPEDRLGKN 297

Query: 250 TIPEIKNHPWF 260
              EIK HP+F
Sbjct: 298 GADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 91.6 bits (227), Expect = 5e-21
 Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 8/214 (3%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIV 61
           +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P IV
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QIC 120
            F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +I 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  + 
Sbjct: 127 HRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQ- 182

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
           +D+WS G++L  M +G YP   P D K      G
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIP-PPDAKELELMFG 215

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 90.0 bits (223), Expect = 6e-21
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 21/266 (7%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKHPNI 60
           Y  V+ +G G++G   LVR +   +   +K +      ++  +  ++E      LKHPNI
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 61  VRFKEVLL-TPTHLAIVMEYAAGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHSM 117
           V ++E        L IVM +  GG+L+ ++    G+   E++   +F Q+   + Y H  
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKK 174
            I HRDLK +N  L  +    +K+ D G ++  VL +Q     + +GTP Y++PE+ + K
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLEC 233
            Y+ K +DVW+ G  +Y M    + F    + K+    + RI  +    P   +  S E 
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDYSPEL 230

Query: 234 KHLLSRIFVANSEKRITIPEIKNHPW 259
             L++ +     EKR ++  I   P+
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 90.6 bits (225), Expect = 7e-21
 Identities = 84/310 (27%), Positives = 125/310 (40%), Gaps = 65/310 (20%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ-------REIMNHR 53
           +++++I+  IG G +G     RDK T EL+A+K +    ++D   +       REI   R
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV----RLDNEKEGFPITAIREIKILR 61

Query: 54  SLKHPNIVRFKEVLLTPTH----------LAIVMEYAAG---GELFERICNAGRFSEDEA 100
            L H NIV  KE++                 +V EY      G L   + +   FSED  
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHI 118

Query: 101 RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST- 159
           + F +QL+ G++YCH     HRD+K  N LL+     ++K+ DFG ++          T 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEESRPYTN 176

Query: 160 -VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------------- 204
            V T  Y  PE+L  +E  G   DVWSCG  L  +      F+  +              
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236

Query: 205 -DPKNF--------------RKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 249
             P  +              +K   R L   +SF     +      LL  +   +  KR 
Sbjct: 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF-----IPTPALDLLDHMLTLDPSKRC 291

Query: 250 TIPEIKNHPW 259
           T  E  N PW
Sbjct: 292 TAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 80/290 (27%), Positives = 137/290 (47%), Gaps = 39/290 (13%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLKHPN 59
           Y  ++ IG G +GV    R+K T +++A+K I R +  +E V     REI   + L+HPN
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           IV  ++VL+  + L ++ E+ +    +  + +        +  + +  Q++ G+ +CHS 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLTKKEY 176
           ++ HRDLK +N L+D      +K+ DFG +++  +  +  +  V T  Y APEVL     
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178

Query: 177 DGKIADVWSCGVTLYVMLVGAYPF--EDPEDPKNFRKTIGRILSV--------------- 219
                D+WS G T++  +    P    D E  + FR  I RIL                 
Sbjct: 179 YSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVTSLPDY 235

Query: 220 HYSFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKNHPWF 260
             +FP + + SL             LL ++ + +  KRI+  +  NHP+F
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 83/290 (28%), Positives = 126/290 (43%), Gaps = 35/290 (12%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHP 58
           +E Y  +  +G G +      R K T  L+A+K I  E  +       RE+   ++LKH 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSM 117
           NIV   +++ T   L +V EY    +L + + N G   S    + F  QL+ G+SYCH  
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT-KKE 175
           +I HRDLK +N L++      +K+ DFG +++  + ++  S  V T  Y  P+VL    E
Sbjct: 123 KILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------- 219
           Y   I D+W  G  LY M  G  P       K     I R+L                  
Sbjct: 181 YSTPI-DMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238

Query: 220 HYSFPDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            Y FP Y          R+  +   LLS + +  ++ RI+      H +F
Sbjct: 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 74/227 (32%), Positives = 112/227 (49%), Gaps = 21/227 (9%)

Query: 2   ERY-EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIER--GQKIDEHVQREIMNHRS 54
           +RY + ++ +G G+FG   L      +  T E++AVK ++R  GQ+     ++EI   ++
Sbjct: 3   KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT 62

Query: 55  LKHPNIVRFKEVLLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           L H NIV++K          L ++MEY   G L + +    + +  +   F QQ+  G++
Sbjct: 63  LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMA 121

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGTPAY-IAP 168
           Y HS    HRDL   N LLD      VKI DFG +K+      + + +    +P +  A 
Sbjct: 122 YLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 169 EVLTKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
           E L  KE     A DVWS GVTLY +L      + P  PK F + IG
Sbjct: 180 ECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMIG 222

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ------REIMNHRSLK 56
           RY+I + IG G++GV     D  T E +A+K I     + EHV       REI   R L+
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57

Query: 57  HPNIVRFKEVLLTPTH-----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
           HP+IV  K ++L P+      + +V E     +L + I      + +  +FF  QL+  +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK----STVGTPAYIA 167
            Y H+  + HRDLK +N L +     ++KICDFG ++ +   +         V T  Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 168 PEVLTK--KEYDGKIADVWSCGVTLYVMLVG 196
           PE+      +Y   I D+WS G     +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 69/207 (33%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGV 111
            H  IV+  +   +   L ++MEY +GG+L ++I    +    F E E    F Q++  +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGTPAYIAP 168
              HS ++ HRDLK  N  L  +    +K+ DFG+SK    SV      S  GTP Y+AP
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FPDYV 227
           E+  +K Y  K AD+WS GV LY +L    PF+ P      R+ + ++L   Y  FP   
Sbjct: 241 ELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYDPFP--C 293

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEI 254
            VS   K LL  +   N   R T  ++
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQL 320

Length = 478

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 15/204 (7%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y ++K +  G+ G   +       + + +K  ++G  +      E M  +++ HP+++R 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL-----IEAMLLQNVNHPSVIRM 122

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
           K+ L++     +V+ + +  +L+  +   +     D+A    +Q++ G+ Y H+ +I HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIAD 182
           D+K EN  ++     +V I D G ++  V+        GT    APEVL + +Y+ K AD
Sbjct: 182 DVKTENIFIN--DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-AD 238

Query: 183 VWSCGVTLYVMLVGAYP---FEDP 203
           +WS G+ L+ ML  AYP   FEDP
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDP 260

Length = 357

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 88.2 bits (219), Expect = 5e-20
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 19/209 (9%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR--SLKH--PNI 60
           E + +IGSG  G    +R K T  ++AVK + R    +E+ +R +M+       H  P I
Sbjct: 18  ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSHDCPYI 76

Query: 61  VRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYC-HSM 117
           V+     +T + + I ME  +    +L +RI   G   ED        ++  + Y     
Sbjct: 77  VKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH 134

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLT---- 172
            + HRD+K  N LLD S    VK+CDFG S   V  S+ K+ + G  AY+APE +     
Sbjct: 135 GVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERIDPPDP 191

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
             +YD + ADVWS G++L  +  G +P++
Sbjct: 192 NPKYDIR-ADVWSLGISLVELATGQFPYK 219

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 87.7 bits (217), Expect = 7e-20
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 16/258 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIER-------GQKIDEHVQREIMNHRSLKHPNIVR 62
           +G G FG    V+ K T ++ A K +++       G+K+   +++EI+    +  P IV 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQIC 120
                 + THL +VM    GG+L   I N G    +  R   +  Q+  G+ + HSM I 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           +RD+K EN LLD     R  + D G +             GT  Y+APE+L ++ Y   +
Sbjct: 118 YRDMKPENVLLDDQGNCR--LSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            D ++ G ++Y M+ G  PF+D ++     +   R L     F ++   + E K +    
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233

Query: 241 FVANSEKRITIPEIKNHP 258
                E R+   E  + P
Sbjct: 234 LAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.9 bits (215), Expect = 8e-20
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)

Query: 6   IVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            +K++G+G FGV K    KW  +  +A+K I+ G   ++    E      L H  +V+  
Sbjct: 8   FLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLY 65

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 117
            V      + IV EY + G      C      E   RF   QL+        G++Y  S 
Sbjct: 66  GVCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKK 174
           Q  HRDL   N L+D      VK+ DFG S+  VL  +  S+VG+     +  PEVL   
Sbjct: 120 QFIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYS 176

Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  K +DVW+ GV ++ V  +G  P+E
Sbjct: 177 KFSSK-SDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 89.5 bits (222), Expect = 8e-20
 Identities = 80/279 (28%), Positives = 134/279 (48%), Gaps = 34/279 (12%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSL 55
           ++Y I + +GSG  G    AK V D       AVK ++     +    R   E+    + 
Sbjct: 32  KKYWISRVLGSGATGTVLCAKRVSDGEP---FAVKVVDMEGMSEADKNRAQAEVCCLLNC 88

Query: 56  KHPNIVRFKEVLLTP--------THLAIVMEYAAGGELFERICN---AGR-FSEDEARFF 103
              +IV+  E               +A+V++YA  G+L + I +     R F E EA   
Sbjct: 89  DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLL 148

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTV 160
           F Q++  V + HS  + HRD+K  N LL   +   VK+ DFG+SK   ++V     ++  
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILL--CSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206

Query: 161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH 220
           GTP Y+APE+  +K Y  K AD++S GV LY +L    PF    D +N  + + + L+  
Sbjct: 207 GTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPF----DGENMEEVMHKTLAGR 261

Query: 221 YS-FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
           Y   P    +S E + +++ +  ++ ++R +  ++ N P
Sbjct: 262 YDPLPP--SISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 87.0 bits (215), Expect = 9e-20
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           +  ++I K IG G F           R+ +A+K ++  + +D   +    +EI   + L 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVS 112
           HPN++++ +  +    L IV+E A  G+L + I    +      E     +F QL S V 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIA 167
           + HS ++ HRD+K  N  +  +    VK+ D G      SK++  H    S VGTP Y++
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 174

Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
           PE + +  Y+ K +D+WS G  LY M     PF
Sbjct: 175 PERIHENGYNFK-SDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 18/214 (8%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-MNHRSLKHPNIVR 62
           +E+V+ +G+G +G     R   T +L A+K ++  +  +E ++ EI M  +   H NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 63  FKEVLLT---PTH---LAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 114
           +    +    P H   L +VME+   G + + + N       ED   +  ++++ G+++ 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTK 173
           H+ ++ HRD+K +N LL  +    VK+ DFG S         ++T +GTP ++APEV+  
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 174 KE-----YDGKIADVWSCGVTLYVMLVGAYPFED 202
            E     YD + +D+WS G+T   M  GA P  D
Sbjct: 196 DENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 33/290 (11%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHP 58
           +E Y  +  +G G +      R K T  L+A+K I  E  +       RE+   + LKH 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 117
           NIV   +++ T   L +V EY    +L + + + G   +    + F  QL+ G++YCH  
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT-KKE 175
           ++ HRDLK +N L++      +K+ DFG +++  + ++  S  V T  Y  P++L    +
Sbjct: 124 KVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 176 YDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNF---------RKTIGRILS----VH 220
           Y  +I D+W  G   Y M  G   +P    E+  +F          +T   ILS      
Sbjct: 182 YSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240

Query: 221 YSFPDY---------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
           Y++P Y          R+  +   LLS++      KRI+  E   HP+F 
Sbjct: 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 39/292 (13%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHP 58
           ME Y  ++ +G G +      R K T  L+A+K I  E  +       RE+   + LKH 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 117
           NIV   +++ T   L +V EY    +L + + + G   S    + F  Q++ G++YCH  
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT-KKE 175
           ++ HRDLK +N L++      +K+ DFG +++  + ++  S  V T  Y  P+VL    E
Sbjct: 124 KVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 176 YDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV-------------- 219
           Y  +I D+W  G   + M  G   +P    ED  +    I R+L                
Sbjct: 182 YSTQI-DMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDE 237

Query: 220 --HYSFPDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             +Y+FP Y          R+  E   LL++     S+KRI+  E   H +F
Sbjct: 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 65/213 (30%), Positives = 89/213 (41%), Gaps = 22/213 (10%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNIV 61
           RY  ++ +G G+ G+     D    + +AVK I        +H  REI   R L H NIV
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 62  RFKEVLLT-----------PTHLA---IVMEYAAGGELFERICNAGRFSEDEARFFFQQL 107
           +  EVL              T L    IV EY         +   G  SE+ AR F  QL
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQL 123

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS----TVGTP 163
           + G+ Y HS  + HRDLK  N  ++      +KI DFG ++    H   K      + T 
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 196
            Y +P +L       K  D+W+ G     ML G
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 3e-19
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 23/201 (11%)

Query: 8   KDIGSGNFGVAKLVRDKWTREL-----LAVKFIERG--QKIDEHVQREIMNHRSLKHPNI 60
           K +G G+FGV +  R +W+        +AVK ++      I +   +E     SL H N+
Sbjct: 1   KKLGDGSFGVVR--RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQ 118
           +R   V+LT   L +V E A  G L +R+  +A G F       +  Q+ +G+ Y  S +
Sbjct: 59  IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLT 172
             HRDL   N LL  ++  +VKI DFG  ++   +      +    V  P A+ APE L 
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173

Query: 173 KKEYDGKIADVWSCGVTLYVM 193
            + +    +DVW  GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 85.8 bits (212), Expect = 3e-19
 Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 38/280 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNI 60
           + +EI++ IG G +G    V +K      AVK ++    IDE ++ E    ++L  HPN+
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 61  VRF-----KEVLLTPTHLAIVMEYAAGG---ELFERICNAG-RFSEDEARFFFQQLISGV 111
           V+F     K+ +     L +V+E   GG   +L +     G R  E    +   + + G+
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 169
            + H  +  HRD+K  N LL  +T   VK+ DFG S   +S    +  ++VGTP ++APE
Sbjct: 138 QHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAPE 194

Query: 170 VLTKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRIL 217
           V+  ++     YD +  DVWS G+T   +  G  P  D          P+N   T+ +  
Sbjct: 195 VIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253

Query: 218 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
                F D++R          +    + EKR T+ ++  H
Sbjct: 254 LWSNEFNDFIR----------KCLTKDYEKRPTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 56/301 (18%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
           +RY+ +  +GSG +G      D  T   +A+K + R  +   H +   RE+   + + H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 59  NIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           N++   +V    + L       +V     G +L   I    + S+D  +F   Q++ G+ 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGLK 132

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE+
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 186

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV--------- 219
           +    +  +  D+WS G  +  +L G   +P  D  D       + RI+++         
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID------QLKRIMNLVGTPDEELL 240

Query: 220 ---------HY--SFPDYVR---------VSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
                    +Y  S P   +          +     LL ++ V + +KRIT  E   HP+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Query: 260 F 260
            
Sbjct: 301 L 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 9e-19
 Identities = 83/294 (28%), Positives = 127/294 (43%), Gaps = 40/294 (13%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           +E Y+ +  +G G++      R K T +L+A+K I      +E       RE    + LK
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLK 61

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCH 115
           H NIV   +++ T   L +V EY    +L + + + G   S    R F  QL+ G++YCH
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT-K 173
             ++ HRDLK +N L+  S    +K+ DFG +++  + S+  S  V T  Y  P+VL   
Sbjct: 121 QRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS 178

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------------- 218
            EY   + D+W  G   Y M  G   F    D ++    I R+L                
Sbjct: 179 TEYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237

Query: 219 -VHYSFPDYVRVSL-----------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
              YSFP Y    L             + L  +      +KRI+  E   HP+F
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 17/284 (5%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRS-LKHPN---IVRFKE 65
           +G G FG     + + T ++ A K +E+ +      +   +N +  L+  N   +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I N G   F E+ A F+  +++ G+   H     +RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADV 183
           LK EN LLD      ++I D G +         +  VGT  Y+APEVL  + Y     D 
Sbjct: 128 LKPENILLDDYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDY 184

Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           W  G  +Y M+ G  PF   ++     +   R+L     +    + S E K +   +   
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTK 242

Query: 244 NSEKRITIP-----EIKNHPWFLRNLPIELTEGGSWQSHDVNNP 282
           + ++R+        E+K HP F RN+  +  E G      V +P
Sbjct: 243 DPKQRLGCQEEGAGEVKRHP-FFRNMNFKRLEAGMLDPPFVPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 71/209 (33%), Positives = 105/209 (50%), Gaps = 28/209 (13%)

Query: 2   ERYEI-VKDIGSGNFGVAKLVR-----DKWTRELLAVKFIERGQKIDEHV---QREIMNH 52
           ER+   ++ +G GNFG  +L R     D  T E++AVK ++      EH+   +REI   
Sbjct: 3   ERHLKFIQQLGKGNFGSVELCRYDPLQDN-TGEVVAVKKLQHSTA--EHLRDFEREIEIL 59

Query: 53  RSLKHPNIVRFKEVLLTP--THLAIVMEYAAGGELFER-ICNAGRFSEDEARFFFQQLIS 109
           +SL+H NIV++K V  +    +L +VMEY   G L +    +  R    +   +  Q+  
Sbjct: 60  KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS--TVGTPA--- 164
           G+ Y  S +  HRDL   N L++     RVKI DFG +K   +  Q K    V  P    
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTK---VLPQDKEYYKVREPGESP 174

Query: 165 --YIAPEVLTKKEYDGKIADVWSCGVTLY 191
             + APE LT+ ++    +DVWS GV LY
Sbjct: 175 IFWYAPESLTESKFS-VASDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 82/330 (24%), Positives = 134/330 (40%), Gaps = 44/330 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKHP 58
           +RY  +K +GSG +G      D+ T   +A+K + R  + +   +   RE+   + +KH 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 59  NIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           N++   +V      L       +VM +   G    ++    + SED  +F   Q++ G+ 
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           Y H+  I HRDLK  N  ++      +KI DFG ++ +   S+    V T  Y APEV+ 
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFE--------------------------DPEDP 206
              +  +  D+WS G  +  ML G   F+                            ED 
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248

Query: 207 KNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           KN+ K + R       F   +   +    ++L ++ V ++E RIT  E   HP+F     
Sbjct: 249 KNYVKKLPRFRK--KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306

Query: 266 IELTEGGSWQSHDVNNPSQSLEEVLSLIHE 295
            E            +   QSLEE   L   
Sbjct: 307 PEDETEAPPYDDSFDEVDQSLEEWKRLTFT 336

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 83.4 bits (206), Expect = 4e-18
 Identities = 84/337 (24%), Positives = 146/337 (43%), Gaps = 53/337 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHP 58
           ERY  +K +GSG +G      DK T E +A+K + R    +   +   RE+   + ++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 59  NIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           N++   +V  +           +VM Y       ++I      SED+ ++   Q++ G+ 
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLK 131

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           Y HS  I HRDLK  N  ++      +KI DFG ++ +   ++    V T  Y APEV+ 
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHA--DAEMTGYVVTRWYRAPEVIL 187

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFE--------------------------DPEDP 206
              +  +  D+WS G  +  ML G   F+                          + +  
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247

Query: 207 KNFRKTIGRILSVHYS--FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF--LR 262
           K++ K++ +     +S  FP   + S +   LL ++   + +KR+T  E   HP+F   R
Sbjct: 248 KSYIKSLPKYPRKDFSTLFP---KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304

Query: 263 NLPIELTEGGSW-QSHDVNNPSQSLEEVLSLIHEATK 298
           +   E TE   +  S +  N   S++E    I++  K
Sbjct: 305 D-ADEETEQQPYDDSLE--NEKLSVDEWKKHIYKEVK 338

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 82.1 bits (202), Expect = 5e-18
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 18/214 (8%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-MNHRSLKHPNIVR 62
           +E+V+ +G+G +G     R   T +L A+K ++     +E +++EI M  +   H NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 63  FKEVLLTPT------HLAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 114
           +    +          L +VME+   G + + I N       E+   +  ++++ G+S+ 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTK 173
           H  ++ HRD+K +N LL  +    VK+ DFG S         ++T +GTP ++APEV+  
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 174 KE-----YDGKIADVWSCGVTLYVMLVGAYPFED 202
            E     YD K +D+WS G+T   M  GA P  D
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 66/311 (21%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-----ERGQKIDEHVQREIMNHRSLKH 57
           +YE +  IG G FG     R K T++++A+K +     + G  I     REI   + LKH
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT--ALREIKILQLLKH 70

Query: 58  PNIVRFKEVLLTPT--------HLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLI 108
            N+V   E+  T             +V E+    +L   + N   +F+  E +   + L+
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTP 163
           +G+ Y H  +I HRD+K  N L+       +K+ DFG +++  L    K       V T 
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 164 AYIAPEVLTKKEYDGKIADVWSCG---------------------VTLYVMLVGA----- 197
            Y  PE+L  +   G   D+W  G                     +TL   L G+     
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247

Query: 198 YP-------FEDPEDPKN-FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 249
           +P       F+  E P+   RK   R+         YV+       L+ ++ V +  KRI
Sbjct: 248 WPGVDKLELFKKMELPQGQKRKVKERLKP-------YVK-DPHALDLIDKLLVLDPAKRI 299

Query: 250 TIPEIKNHPWF 260
                 NH +F
Sbjct: 300 DADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 82.4 bits (203), Expect = 9e-18
 Identities = 82/326 (25%), Positives = 138/326 (42%), Gaps = 36/326 (11%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D   R+ +AVK + R  +   H +R   E+   + +KH 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 59  NIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           N++   +V    T +     + +     G     I    + S++  +F   QL+ G+ Y 
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N  ++      ++I DFG ++ +    +    V T  Y APE++   
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLNW 190

Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDP-KNFRKTIG--------RILSVH--- 220
            +  +  D+WS G  +  +L G   +P  D  D  K   + +G        +I S H   
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250

Query: 221 --YSFPDYVRVSLE---------CKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
              S P   +  L+            LL ++ V +S+KRI+  E   HP+F +    E  
Sbjct: 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE 310

Query: 270 EGGSWQSHDVNNPSQSLEEVLSLIHE 295
                      N  +++EE   L +E
Sbjct: 311 PEAEPYDESPENKERTIEEWKELTYE 336

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 77/270 (28%), Positives = 121/270 (44%), Gaps = 32/270 (11%)

Query: 7   VKDIGSGNFGVAKLVR-----DKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           ++D+G G+FG  +L R     D  T E +AVK +  E G      +++EI   R+L H N
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67

Query: 60  IVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 116
           IV++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  S
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLT 172
            Q  HRDL   N L++     +VKI DFG +K+     +    K  + +P +  APE L 
Sbjct: 128 RQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG------------RILSVH 220
           + ++    +DVWS GVTLY +L   Y   +      F K IG            R+L   
Sbjct: 186 QSKF-YIASDVWSFGVTLYELL--TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242

Query: 221 YSFPDYVRVSLECKHLLSRIFVANSEKRIT 250
              P       E   L+ + +     KR T
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 81.4 bits (201), Expect = 1e-17
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 18/263 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----KHPNIVRFKE 65
           +G G FG     + + T ++ A K +E+ +      +   +N + +        +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I N G   F E+ A F+  ++  G+   H  +I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIAD 182
           LK EN LLD      ++I D G +   +   +  +  VGT  Y+APEV+  + Y     D
Sbjct: 128 LKPENILLDDYG--HIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPD 183

Query: 183 VWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV 242
            W  G  +Y M+ G  PF   ++     +   R+      + +  + S   + +  ++  
Sbjct: 184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSICRQLLT 241

Query: 243 ANSEKRI-----TIPEIKNHPWF 260
            +   R+        E+K HP+F
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 71/261 (27%), Positives = 113/261 (43%), Gaps = 22/261 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           +  + I K IG G F              +A+K ++    +D   +    +EI   + L 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVS 112
           HPN++++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIA 167
           + HS ++ HRD+K  N  +  +    VK+ D G      SK++  H    S VGTP Y++
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 174

Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 227
           PE + +  Y+ K +D+WS G  LY M     PF    D  N      +I    Y      
Sbjct: 175 PERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSD 231

Query: 228 RVSLECKHLLSRIFVANSEKR 248
             S E + L++     + EKR
Sbjct: 232 HYSEELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 74/272 (27%), Positives = 129/272 (47%), Gaps = 27/272 (9%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIM----NHRSLKHPNI 60
           E+++++G G +GV   +R   T  ++AVK I R     +  +R +M    + RS+  P  
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYT 62

Query: 61  VRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDE--ARFFFQQLISGVSYCHS 116
           V F   L     + I ME       + ++++ + G    ++   +     ++  + Y HS
Sbjct: 63  VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALEYLHS 121

Query: 117 -MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPE----V 170
            + + HRD+K  N L++     +VK+CDFG S   V  S  K+   G   Y+APE     
Sbjct: 122 KLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPE 178

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--R 228
           L +K YD K +DVWS G+T+  +  G +P++  + P    K +     V    P     +
Sbjct: 179 LNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-----VEEPSPQLPAEK 232

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            S E +  +++    N ++R   PE+  HP+F
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 10  IGSGNFG--VAKLVRDKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKHPNIVRFK 64
           IG       +  L + K T  L+AVK I       E +   Q+EI+  R L+HPNI+ + 
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 65  EVLLTPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
              +  + L +V    A G   +L +     G   E    F  + +++ + Y HS    H
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIH 124

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYS--------KSSVLHSQPKSTVGTPAYIAPEVLTK 173
           R +K  + LL G    +V +    YS        +  V+H  PKS+V    +++PEVL +
Sbjct: 125 RSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 174 --KEYDGKIADVWSCGVTLYVMLVGAYPFED 202
             + Y+ K  D++S G+T   +  G  PF+D
Sbjct: 183 NLQGYNEKS-DIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 73/301 (24%), Positives = 127/301 (42%), Gaps = 45/301 (14%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +AVK + R  +   H +R   E++  + + H
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C       D  R  +   Q++ G+ + 
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 139

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++  +      V T  Y APEV+   
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 197

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI------------------ 216
            Y   + D+WS G  +  ++ G+  F+  +    + K I ++                  
Sbjct: 198 GYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256

Query: 217 ---------LSVHYSFPDYVRVS---------LECKHLLSRIFVANSEKRITIPEIKNHP 258
                    +S    FPD++  S          + + LLS++ V + +KRI++ E   HP
Sbjct: 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316

Query: 259 W 259
           +
Sbjct: 317 Y 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 79.4 bits (196), Expect = 4e-17
 Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 12/201 (5%)

Query: 7   VKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKE 65
           +K++GSG FGV  L   KW  ++ +A+K I  G   ++    E      L HPN+V+   
Sbjct: 9   LKELGSGQFGVVHL--GKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 66  VLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
           V      + IV EY A G L   +    G+   +        +   + Y  S    HRDL
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEYDGKIA 181
              N L+ G     VK+ DFG ++  VL  Q  S+ GT   +    PEV     +  K +
Sbjct: 127 AARNCLV-GEDNV-VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182

Query: 182 DVWSCGVTLY-VMLVGAYPFE 201
           DVWS GV ++ V   G  P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 6/152 (3%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----K 56
           +E + IVK I  G FG   L R K   +L AVK +++   I++++  ++   R      K
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P IV     L +  ++ +VMEY  GG++   +   G F E+ A  +  ++   + Y H 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK 148
             I HRDLK +N L+  S    +K+ DFG SK
Sbjct: 123 HGIIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.7 bits (194), Expect = 8e-17
 Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 7   VKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKE 65
           +K++GSG FGV  L   KW  ++ +A+K I  G   +E    E      L HP +V+   
Sbjct: 9   MKELGSGQFGVVHL--GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 66  VLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
           V      L IV E+   G L   +    G+ S+D      Q +  G+ Y       HRDL
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKIA 181
              N L+  S+   VK+ DFG ++  VL  +  S+ G      +  PEV    +Y  K +
Sbjct: 127 AARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-S 182

Query: 182 DVWSCGVTLY-VMLVGAYPFE 201
           DVWS GV ++ V   G  PFE
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 78/324 (24%), Positives = 121/324 (37%), Gaps = 83/324 (25%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHV---------QREIMN 51
           +  YEI+  +G G FG     R   T  ++A+K      KI  H           REI  
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALK------KILMHNEKDGFPITALREIKI 60

Query: 52  HRSLKHPNIVRF--------KEVLLTPTHLAIVMEYA----AGGELFE--RICNAGRFSE 97
            + LKHPN+V           +       + +V  Y     +G  L E   +    + +E
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTE 114

Query: 98  DEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK 157
            + + +  QL+ G++Y H   I HRD+K  N L+D      +KI DFG ++       P 
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPP 170

Query: 158 --------------STVGTPAYIAPE-VLTKKEYDGKIADVWSCGVTLYVM------LVG 196
                         + V T  Y  PE +L ++ Y   + D+W  G     M      L G
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQG 229

Query: 197 AYPFE------------DPEDPKNFRKTIGRILSVHYSFPDYVR--------VSLECKHL 236
               +              E    +R   G      +SF +Y R        +  E   L
Sbjct: 230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPG--CEGVHSFTNYPRTLEERFGKLGPEGLDL 287

Query: 237 LSRIFVANSEKRITIPEIKNHPWF 260
           LS++   +  KR+T  +   HP+F
Sbjct: 288 LSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 55/185 (29%), Positives = 84/185 (45%), Gaps = 11/185 (5%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           IG G FG   L    +  + +AVK ++      +    E     +L+HPN+V+   V+L 
Sbjct: 14  IGKGEFGDVML--GDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 70  PTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLE 127
              L IV EY A G L + + + GR   +  +   F   +  G+ Y       HRDL   
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131

Query: 128 NTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSC 186
           N L+        K+ DFG +K +       K  V    + APE L +K++  K +DVWS 
Sbjct: 132 NVLVSEDLV--AKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTK-SDVWSF 185

Query: 187 GVTLY 191
           G+ L+
Sbjct: 186 GILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 79/305 (25%), Positives = 126/305 (41%), Gaps = 59/305 (19%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTR--ELLAVKFIER--GQKI-DEHVQREIMNHRSLK- 56
           RYE++K++G G +G+    R+  T   E +A+K I     +KI  +   RE+   R  + 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 57  HPNIV-----------RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQ 105
           H NI             F E+ L       +ME     +L + I +    ++   + F  
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAHFQSFIY 112

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH--SQPKST--V 160
           Q++ G+ Y HS  + HRDLK  N L++      +KICDFG ++  S     +    T  V
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADC--ELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED--------------- 205
            T  Y APE++   +   K  DVWS G  L   L+G  P    +D               
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPVFKGKDYVDQLNQILQVLGTP 229

Query: 206 PKNFRKTIGRILSVHY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEI 254
            +     IG   + +Y  S P+  +                LL ++   +  KRI++ E 
Sbjct: 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289

Query: 255 KNHPW 259
             HP+
Sbjct: 290 LEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGA--YPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249

Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 250 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308

Query: 263 --NLPIELTEGGSWQSHDVNN---PSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 309 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 344

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.6 bits (189), Expect = 5e-16
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVRFKE 65
           IG G FG    +  K +  ++AVK I R    ++  +R +M+     RS   P IV+F  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 66  VLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYC---------H 115
            L       I ME      + F +        E       ++++  ++            
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL- 171
            ++I HRD+K  N LLD +    +K+CDFG S     S+  ++     G   Y+APE + 
Sbjct: 126 ELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTR---DAGCRPYMAPERID 180

Query: 172 --TKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
              +  YD + +DVWS G+TLY +  G +P+
Sbjct: 181 PSARDGYDVR-SDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 70/318 (22%), Positives = 120/318 (37%), Gaps = 68/318 (21%)

Query: 2   ERYEIV-KDIGSGNFGVAKLVRDKWTRELLAVK----------FIERGQKIDE---H--V 45
           ERY      +G G +G  +   D  T +++A+K            +  Q +     H   
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 46  QREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQ 105
            RE+     +KH NI+   +V +    + +VM+  A  +L + +    R +E + +    
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILL 126

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-----------HS 154
           Q+++G++  H     HRDL   N  ++  +    KI DFG ++                 
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN--SKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 155 QPK----STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKN 208
           Q +    S V T  Y APE+L   E      D+WS G     +L G   +P E+  D   
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID--- 241

Query: 209 FRKTIGRILSV-----HYSFPDYVRVSLECKH---------------------LLSRIFV 242
               +GRI  +       ++P   ++ L  +                      LL  +  
Sbjct: 242 ---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298

Query: 243 ANSEKRITIPEIKNHPWF 260
            N  +RI+  E   H +F
Sbjct: 299 LNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 10/201 (4%)

Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEV 66
           V++IGSG FG+  L      R++ A+K I  G   +E    E      L HP +V+   V
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
               + + +V E+   G L + +    G+FS++        +  G++Y  S  + HRDL 
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127

Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKIAD 182
             N L+  +    VK+ DFG ++  VL  Q  S+ GT     + +PEV +  +Y  K +D
Sbjct: 128 ARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK-SD 183

Query: 183 VWSCGVTLY-VMLVGAYPFED 202
           VWS GV ++ V   G  P+E+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 9/209 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI----ERGQKIDEHVQREIMNHRSLKH 57
           + YE ++ +G G++      + K   +L+A+K I    E G        RE    + LKH
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKH 62

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
            NIV   +++ T   L +V EY           + G    +  + F  QL+ G+SY H  
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEY 176
            I HRDLK +N L+  S    +K+ DFG +++  + S   S  V T  Y  P+VL     
Sbjct: 123 YILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPED 205
                D+W  G     M+ G   F   +D
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 1e-15
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 8   KDIGSGNFG--VAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRS----LKHPNI 60
           K++G GNFG  V  +   K  +E+ +AVK +++        ++E +   S    L HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG--KKEFLREASVMAQLDHPCI 58

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VR   V      L +VME A  G L + +         + +    Q+  G++Y  S    
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLTKKEY 176
           HRDL   N LL      + KI DFG S++        ++T     P  + APE +   ++
Sbjct: 118 HRDLAARNVLL--VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 177 DGKIADVWSCGVTLYVML-VGAYPFED 202
             K +DVWS GVTL+     GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 80/307 (26%), Positives = 130/307 (42%), Gaps = 57/307 (18%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 58  PNIVRFKEVLLTPTH-------LAIVMEYAAGGELFERICNAGRFSEDEAR--FFFQQLI 108
            NI+    V  TP         + IVME      +   +C   +   D  R  +   Q++
Sbjct: 83  KNIIGLLNVF-TPQKSLEEFQDVYIVMEL-----MDANLCQVIQMELDHERMSYLLYQML 136

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAP 168
            G+ + HS  I HRDLK  N ++       +KI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFR 210
           EV+    Y   + D+WS G  +  M+ G   +P  D                PE  K  +
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

Query: 211 KTI-----GRILSVHYS----FPDYV---------RVSLECKHLLSRIFVANSEKRITIP 252
            T+      R     YS    FPD +           + + + LLS++ V ++ KRI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313

Query: 253 EIKNHPW 259
           E   HP+
Sbjct: 314 EALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 21/207 (10%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-----ERGQKIDEHVQREIMNHRSLK- 56
           +YE V +IG G +G     RD  +   +A+K +     E G  +     RE+   + L+ 
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS--TVREVALLKRLEA 58

Query: 57  --HPNIVRFKEVLLT-----PTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQL 107
             HPNIVR  +V  T      T + +V E+         +++   G    +  +   +Q 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
           + G+ + H+  I HRDLK EN L+  ++  +VK+ DFG ++           V T  Y A
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVML 194
           PEVL +  Y   + D+WS G     M 
Sbjct: 176 PEVLLQSTYATPV-DMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 21/216 (9%)

Query: 1   MERYEIVKDIGSGNFG-VAKLVRDKWTREL------LAVKFI--ERGQKIDEHVQREIMN 51
               E +K +GSG FG V K V   W  E       +A+K +  E   K ++ +  E   
Sbjct: 6   ETELEKIKVLGSGAFGTVYKGV---WIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62

Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISG 110
             S+ HP++VR   + L+     ++ +    G L + +  +           +  Q+  G
Sbjct: 63  MASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVG-TP-AYIA 167
           +SY    ++ HRDL   N L+   T   VKI DFG +K   V   +  +  G  P  ++A
Sbjct: 122 MSYLEEKRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            E +  + Y  K +DVWS GVT++ +M  GA P+E 
Sbjct: 180 LESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 77/292 (26%), Positives = 120/292 (41%), Gaps = 41/292 (14%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG-QKI--DEHVQREIMNHRSLKHPNIV 61
           E  + IG G FGV   V D    + +A+K +    Q +   + V RE+      KH N++
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFER-----ICNAGRFSEDEARFFFQQLISGVSYCHS 116
              ++L  P H+    E     EL +      I +    S D  + F  Q++ G+ Y HS
Sbjct: 63  SALDILQPP-HIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLT-K 173
             I HRD+K  N L++ +    +KICDFG ++          T  V T  Y APE+L   
Sbjct: 122 AGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE----------------DP--EDPKNFRK-TIG 214
           + Y   + D+WS G     +L     F+                 P  E  ++  +    
Sbjct: 180 RHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238

Query: 215 RILSVHYSFPDYVRVSL-------ECKHLLSRIFVANSEKRITIPEIKNHPW 259
            IL   +  P    +         E  HLL R+ V + +KRI+  +   HP+
Sbjct: 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 73.7 bits (181), Expect = 7e-15
 Identities = 79/300 (26%), Positives = 121/300 (40%), Gaps = 47/300 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLKH 57
           + YE ++ IG G +G     RDK T +L+A+K   R +  +E +     REI   + L  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK-KTRLEMDEEGIPPTALREISLLQMLSE 59

Query: 58  -PNIVRFKEVLLTPTH-----LAIVMEYAAGGELFERICNAGR-----FSEDEARFFFQQ 106
              IVR  +V           L +V EY    +L + + + GR           + F  Q
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAY 165
           L+ GV++CH   + HRDLK +N L+D      +KI D G  ++ S+        + T  Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177

Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIG-------- 214
            APEVL    +     D+WS G     M      F  D E  +     K +G        
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237

Query: 215 --------------RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                         +   +  + PD   +S E   LL ++   +  KRI+      HP+F
Sbjct: 238 GVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 70/263 (26%), Positives = 116/263 (44%), Gaps = 18/263 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL- 68
           +G G FG     + + T ++ A K +E+ +      +   +N + +      RF   L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 69  ---TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I + G   F E  A F+  ++  G+   H  +I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADV 183
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+  + Y     D 
Sbjct: 128 LKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 184

Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-SVHYSFPDYVRVSLECKHLLSRIFV 242
           W+ G  LY M+ G  PF+     K  R+ + R++  V   + +  + S + + L   +  
Sbjct: 185 WALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYSE--KFSPDARSLCKMLLC 241

Query: 243 ANSEKRI-----TIPEIKNHPWF 260
            + ++R+        E+K HP F
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 23/235 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E  E  + + S N G  K  R       L  K ++ G +    ++ EI+    L H NI+
Sbjct: 174 EEAEARRGVNSTNQGKPKCER-------LIAKRVKAGSRAAIQLENEILALGRLNHENIL 226

Query: 62  RFKEVLLTPTH-LAIVMEYAAGGELFERICNAGRFSED-----EARFFFQQLISGVSYCH 115
           + +E+L +  +   I  +Y    +L+  + +     +D     + R   +QL+  V Y H
Sbjct: 227 KIEEILRSEANTYMITQKYDF--DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTK 173
             ++ HRD+KLEN  L+     ++ + DFG +       +      VGT A  +PE+L  
Sbjct: 285 DKKLIHRDIKLENIFLNCDG--KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAY-PFED-PEDP-KNFRKTIGRILSVHYSFPD 225
             Y  +I D+WSCG+ L  ML   + P  D    P K   K I  +      FPD
Sbjct: 343 DGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD 396

Length = 501

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 67/262 (25%), Positives = 111/262 (42%), Gaps = 16/262 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPN---IVRFKE 65
           +G G FG     + + T ++ A K +E+ +      +   +N  R L+  N   +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I N G   F E  A F+  +L  G+      +I +RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127

Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADV 183
           LK EN LLD      ++I D G +         +  VGT  Y+APEV+  ++Y     D 
Sbjct: 128 LKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PDW 184

Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           W  G  +Y M+ G  PF   ++     +   R+      + +  + S + K +   +   
Sbjct: 185 WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSICRMLLTK 242

Query: 244 NSEKRITI-----PEIKNHPWF 260
           N ++R+         +K HP F
Sbjct: 243 NPKERLGCRGNGAAGVKQHPIF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y++   IG+G+FGV        T E +A+K + +     ++  RE++  ++L H NI+  
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFL 124

Query: 64  KEVLLTPT--------HLAIVMEYAAGG-----ELFERICNAGRFSEDEARFFFQQLISG 110
           K+   T           L +VME+         + + R  N         + +  QL   
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRA 182

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           ++Y HS  ICHRDLK +N L+D +T   +K+CDFG +K+ +   +  S + +  Y APE+
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHT-LKLCDFGSAKNLLAGQRSVSYICSRFYRAPEL 241

Query: 171 -LTKKEYDGKIADVWSCGVTLYVMLVGAYP 199
            L    Y   I D+WS G  +  M++G YP
Sbjct: 242 MLGATNYTTHI-DLWSLGCIIAEMILG-YP 269

Length = 440

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 45/301 (14%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ E   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312

Query: 259 W 259
           +
Sbjct: 313 Y 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 59/179 (32%), Positives = 84/179 (46%), Gaps = 11/179 (6%)

Query: 28  ELLAVKFIERGQKIDEHVQ----REIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG 83
           +L+A+K I    K +E V     RE    + LKH NIV   +++ T   L  V EY    
Sbjct: 31  QLVALKVIS--MKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88

Query: 84  ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD 143
                I + G       R F  QL+ G++Y H   I HRDLK +N L+  S    +K+ D
Sbjct: 89  LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLAD 146

Query: 144 FGYSKSSVLHSQPKST-VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPF 200
           FG +++  + SQ  S+ V T  Y  P+VL    +Y   + D+W  G     ML G   F
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRD-KWTRELLAVKFI-----ERGQKIDEHVQREIMNH-RS 54
           ++YE V +IG G +G     RD K     +A+K +     E G  +    +  ++ H  +
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 55  LKHPNIVRFKEVLLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQL 107
            +HPN+VR  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 119

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
           + G+ + HS ++ HRDLK +N L+  +++ ++K+ DFG ++         S V T  Y A
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 177

Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVML 194
           PEVL +  Y   + D+WS G     M 
Sbjct: 178 PEVLLQSSYATPV-DLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 39/220 (17%)

Query: 6   IVKDIGSGNFG-VAK--LVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHP 58
           I K IG G FG V +  L         +A+K ++ G    Q++D   +  IM      HP
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD--HP 65

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLI-------S 109
           NI+R + V+     + I+ EY   G L  F R        E++ +F   QL+       S
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIAS 117

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT-----PA 164
           G+ Y   M   HRDL   N L++ +     K+ DFG S+   L    ++T  T     P 
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSR--RLED-SEATYTTKGGKIPI 172

Query: 165 -YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            + APE +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 173 RWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 24/216 (11%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERG----QKIDEHVQREIMNHRSL 55
             +I K IG+G FG     R K    RE+ +A+K ++ G    Q+ D   +  IM     
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQ--F 62

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSY 113
            HPNI+  + V+     + IV EY   G L  F R  + G+F+  +     + + SG+ Y
Sbjct: 63  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKY 121

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIA 167
              M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + A
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTA 177

Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           PE +  +++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 178 PEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 8   KDIGSGNFG-VAK-LVRDKWTREL-LAVKFIERG----QKIDEHVQREIMNHRSLKHPNI 60
           K IG+G FG V + +++    +E+ +A+K ++ G    Q+ D   +  IM   S  H NI
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS--HHNI 68

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           +R + V+       I+ EY   G L + +  + G FS  +     + + +G+ Y   M  
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLTK 173
            HRDL   N L++ +     K+ DFG S+  VL   P+ T  T        + APE +  
Sbjct: 129 VHRDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 185 RKFTSA-SDVWSFGIVMWEVMSFGERPYWD 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 77/311 (24%), Positives = 126/311 (40%), Gaps = 62/311 (19%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHPN 59
           RY+ +K IGSG  G+     D  T + +A+K + R  +   H +R   E++  + + H N
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76

Query: 60  IVRFKEVLLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEAR--FFFQQLISG 110
           I+    V  TP         + +VME      +   +C   +   D  R  +   Q++ G
Sbjct: 77  IIGLLNVF-TPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQMLCG 130

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           + + HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PKNFRKTIG-- 214
           +    Y   + D+WS G  +  M+ G   +P  D  D               F   +   
Sbjct: 189 ILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247

Query: 215 -----------RILSVHYSFPDYV----------RVSLECKHLLSRIFVANSEKRITIPE 253
                         S    FPD +            + + + LLS++ V + EKRI++ +
Sbjct: 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307

Query: 254 IKNHP----WF 260
              HP    W+
Sbjct: 308 ALQHPYINVWY 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 34/226 (15%)

Query: 1   MERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRS- 54
            E+  +++++G G+FG     +AK V        +A+K +     + E  + E +N  S 
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE--RIEFLNEASV 62

Query: 55  ---LKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARF------- 102
                  ++VR   V+ T     +VME  A G+L  + R     R   +           
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQ 119

Query: 103 -FFQ---QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS 158
            F Q   ++  G++Y  + +  HRDL   N ++       VKI DFG ++        + 
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRK 177

Query: 159 TVGT--PA-YIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPF 200
                 P  ++APE L    +  K +DVWS GV L+ M  +   P+
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 17/209 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQKID-EHVQREIMNHRSLKHPN 59
           E + + + +GSG FG  ++    W  R  +A+K ++    +  +  Q+E+   + L+H +
Sbjct: 6   EEFTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKH 63

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 117
           ++    V      + I+ E    G L   + +        A       Q+  G++Y    
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLTK 173
              HRDL   N L+        K+ DFG +   K  V L S  K       + APE  + 
Sbjct: 124 NSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASH 178

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
             +  K +DVWS G+ LY +   G  P+ 
Sbjct: 179 GTFSTK-SDVWSFGILLYEMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 64/241 (26%), Positives = 96/241 (39%), Gaps = 41/241 (17%)

Query: 2   ERYEIVKDIGSGNFGVAKL--------------VRDKWTRE--LLAVKFIERGQKID--E 43
           +    V+ +G G FG   L                +       L+AVK +      +  E
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64

Query: 44  HVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FER---------ICNA 92
              +E+     L  PNI R   V      L ++MEY   G+L  F +          CN+
Sbjct: 65  DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124

Query: 93  GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL 152
              S     +   Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S++  L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY--TIKIADFGMSRN--L 180

Query: 153 HSQPKSTVG--TPAYI---APEVLTKKEYDGKIADVWSCGVTLY--VMLVGAYPFEDPED 205
           +S     V    P  I   A E +   ++  K +DVW+ GVTL+  + L    P+E   D
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTD 239

Query: 206 P 206
            
Sbjct: 240 Q 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 10  IGSGNFGVAKLVRDKWT--REL-LAVKFIERGQKIDEHVQREIMNHRSL----KHPNIVR 62
           IG+G FG     R K    RE+ +A+K ++ G    E  +R+ ++  S+     HPNI+ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIH 69

Query: 63  FKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
            + V+     + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLT 172
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE + 
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 46/160 (28%), Positives = 65/160 (40%), Gaps = 14/160 (8%)

Query: 26  TRELLAVKFIERGQKIDEH----VQREIMNHRSLKHPNIVRFKEVLLTPTHLAI-VMEYA 80
           T   +A+K +      +EH     +RE      L HPNIV   +    P  L   V EY 
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 81  AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRV 139
            G  L E +   G     E      Q++  ++  H+  I HRDLK +N ++  +   P  
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 140 KICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 171
           K+ DFG             +    T   +GTP Y APE L
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.9 bits (155), Expect = 9e-12
 Identities = 60/199 (30%), Positives = 84/199 (42%), Gaps = 12/199 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK---HPNIVRFKEV 66
           IG GNFG     R +     +AVK   R     +   + +   R LK   HPNIVR   V
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 67  LLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
                 + IVME   GG+    +   G R    E     +   +G+ Y  S    HRDL 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 126 LENTLLDGSTAPRVKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLTKKEYDGKIAD 182
             N L+       +KI DFG S+     +++        P  + APE L    Y  + +D
Sbjct: 122 ARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-SD 178

Query: 183 VWSCGVTLY-VMLVGAYPF 200
           VWS G+ L+    +GA P+
Sbjct: 179 VWSFGILLWEAFSLGAVPY 197

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 71/247 (28%), Positives = 106/247 (42%), Gaps = 32/247 (12%)

Query: 4   YEIVKDIGSGNFGVAKLVR--DKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           YE  K +G G +G     +  D    +  A+K IE G  I     REI   R LKHPN++
Sbjct: 4   YEGCK-VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVI 61

Query: 62  RFKEVLLTPT--HLAIVMEYAAGGEL----FERICNAGR----FSEDEARFFFQQLISGV 111
             ++V L+ +   + ++ +YA         F R   A +          +    Q++ G+
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 112 SYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQP-------KSTVGT 162
            Y H+  + HRDLK  N L+  +G    RVKI D G+++   L + P          V T
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVT 178

Query: 163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEDPKNF-RKTIGRIL 217
             Y APE+L    +  K  D+W+ G     +L     F    ED +    F    + RI 
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238

Query: 218 SVHYSFP 224
           SV   FP
Sbjct: 239 SV-MGFP 244

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 28/219 (12%)

Query: 5   EIVKDIGSG--NFGVAKLVRDKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKHPN 59
           E++  IG G  +     L R K T E + V+ I      +E V   Q E+   +   HPN
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 117
           IV ++   +    L +V  + A G   + IC       SE    +  Q ++  + Y H M
Sbjct: 61  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120

Query: 118 QICHRDLKLENTL--LDGSTAPRVKICDFGY----------SKSSVLHSQPKSTVGTPAY 165
              HR +K  + L  +DG      K+   G            +  V+H  PK +V    +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174

Query: 166 IAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 202
           ++PEVL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 74/302 (24%), Positives = 106/302 (35%), Gaps = 100/302 (33%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHV-QREIMNHRSLK--- 56
           M+RY+I++ IG G  G   L  D      +A+K      KI E + +  ++  R L+   
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALK------KIREDLSENPLLKKRFLREAK 54

Query: 57  ------HPNIV-------------------------------RFKEVLLTPTHLAIVMEY 79
                 HP IV                                 KE L     LA     
Sbjct: 55  IAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSV 112

Query: 80  AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV 139
            A   +F +IC                  + + Y HS  + HRDLK +N LL       V
Sbjct: 113 GAFLSIFHKIC------------------ATIEYVHSKGVLHRDLKPDNILL--GLFGEV 152

Query: 140 KICDFG----------------YSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKI 180
            I D+G                  + ++ +S    P   VGTP Y+APE L         
Sbjct: 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES- 211

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVRVSLECKHLLS 238
            D+++ GV LY ML  ++P         +R+  GR +S       P  V    E    LS
Sbjct: 212 TDIYALGVILYQMLTLSFP---------YRRKKGRKISYRDVILSPIEVAPYREIPPFLS 262

Query: 239 RI 240
           +I
Sbjct: 263 QI 264

Length = 932

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 63/198 (31%), Positives = 90/198 (45%), Gaps = 20/198 (10%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IG G FG   +++ ++T + +AVK I    K D   Q    E      L H N+VR   V
Sbjct: 14  IGEGEFG--AVLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 67  LLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQICHRDL 124
           +L    L IVME  + G L   +   GR      +   F   +  G+ Y  S ++ HRDL
Sbjct: 68  ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLTKKEYDGKIADV 183
              N L+  S     K+ DFG ++   + S        P  + APE L  K++  K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180

Query: 184 WSCGVTLY-VMLVGAYPF 200
           WS GV L+ V   G  P+
Sbjct: 181 WSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 13/195 (6%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           M+  ++++ IG G FG   L   +  +  +AVK I+        +  E      L+H N+
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLA-EASVMTQLRHSNL 61

Query: 61  VRFKEVLLTP-THLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 117
           V+   V++     L IV EY A G L + + + GR     D    F   +   + Y  + 
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLTKKEY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L +K++
Sbjct: 122 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 176

Query: 177 DGKIADVWSCGVTLY 191
             K +DVWS G+ L+
Sbjct: 177 STK-SDVWSFGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.9 bits (150), Expect = 4e-11
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 15/194 (7%)

Query: 8   KDIGSGNFGVAK--LVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIV 61
            ++GSGNFG  K  + + K + + +AVK I +    D  ++ E++      + L +P IV
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           R   +        +VME A  G L + +      +E        Q+  G+ Y       H
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           RDL   N LL   T    KI DFG SK   +   + + K+    P  + APE +   ++ 
Sbjct: 119 RDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 177 SK-SDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 85/319 (26%), Positives = 127/319 (39%), Gaps = 67/319 (21%)

Query: 4   YEIVKDIGSGNFG-VAKLVR-DKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           YE  K +G G +G V K  R D       A+K IE G  I     REI   R LKHPN++
Sbjct: 4   YEGCK-VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVI 61

Query: 62  RFKEVLLTPT--HLAIVMEYAAGGEL----FERICNAGR----FSEDEARFFFQQLISGV 111
             ++V L+     + ++ +YA         F R   A +          +    Q++ G+
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 112 SYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQP-------KSTVGT 162
            Y H+  + HRDLK  N L+  +G    RVKI D G+++   L + P          V T
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVT 178

Query: 163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVML---------------------------- 194
             Y APE+L    +  K  D+W+ G     +L                            
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238

Query: 195 -VGAYP----FED----PEDP---KNFRK-TIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
            V  +P    +ED    PE     K+FR+ T      + Y     V+   +  HLL ++ 
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298

Query: 242 VANSEKRITIPEIKNHPWF 260
             +  KRIT  +    P+F
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 61.8 bits (150), Expect = 6e-11
 Identities = 65/236 (27%), Positives = 101/236 (42%), Gaps = 35/236 (14%)

Query: 10  IGSGNFG-----VAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHPN 59
           +GSG FG      A  +    +  + +AVK + +G    E  ++E +    L     HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 112
           IV+   V L      I+ME   GG+L   + +A            ++L+        G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 113 YCHSMQICHRDLKLENTLLD--GSTAPR-VKICDFGYSK---SSVLHSQPKSTVGTPAYI 166
           Y   M   HRDL   N L+   G  A R VKI DFG ++    S  + +    +    ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 167 APEVLTKKEYDGKI---ADVWSCGVTLY-VMLVG--AYPFEDPEDPKNFRKTIGRI 216
           APE L     DGK    +DVWS GV ++ ++ +G   YP  + ++        GR+
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 27/210 (12%)

Query: 6   IVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
           + + +G+G FG V     +  T+  +AVK ++ G    E   +E    + L+H  +V+  
Sbjct: 10  LERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHS 116
            V      + IV EY + G L + +         E +     QL+        G++Y  S
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLT 172
               HRDL   N L+  +     KI DFG ++  ++       +     P  + APE   
Sbjct: 122 RNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAAN 177

Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
              +  K +DVWS G+ L  ++  G  P+ 
Sbjct: 178 YGRFTIK-SDVWSFGILLTEIVTYGRVPYP 206

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 49/217 (22%)

Query: 10  IGSGNFGVAKLVRDKW-----TRELLAVKFIERGQKIDEHVQREIMNHRSLK---HPNIV 61
           IG GNFG      D +         +AVK   R     +  ++ +     LK   HPNIV
Sbjct: 3   IGKGNFG------DVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYC 114
           +   V +    + IVME   GG L   +       + + R   ++L+       +G+ Y 
Sbjct: 56  KLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYL 109

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFG---------YSKSSVLHSQP-KSTVGTPA 164
            S    HRDL   N L+  +    +KI DFG         Y+ S  L   P K T     
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT----- 162

Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             APE L    Y  + +DVWS G+ L+    +G  P+
Sbjct: 163 --APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)

Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRE--LLAVKFI-ERGQKIDEHVQREIMNHRSL 55
           MER +I     +G G +G  ++    W +    +AVK + E   +++E + +E    + +
Sbjct: 3   MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEI 59

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQ--QLISGVSY 113
           KHPN+V+   V        I+ E+   G L + +    R   +     +   Q+ S + Y
Sbjct: 60  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAP 168
                  HRDL   N L+       VK+ DFG S+     +   H+  K  +    + AP
Sbjct: 120 LEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAP 174

Query: 169 EVLTKKEYDGKIADVWSCGVTLY 191
           E L   ++  K +DVW+ GV L+
Sbjct: 175 ESLAYNKFSIK-SDVWAFGVLLW 196

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 17/224 (7%)

Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKF----IERGQKIDEHVQREIMNHRSLK 56
           E   + + IG G FG V + V      E +AV            + E   +E    R   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 115
           HP+IV+   V+ T   + IVME A  GEL   +  N           +  QL + ++Y  
Sbjct: 66  HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLTK 173
           S +  HRD+   N L+  S+   VK+ DFG S+     S  K++ G  P  ++APE +  
Sbjct: 125 SKRFVHRDIAARNVLV--SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRI 216
           + +    +DVW  GV ++ ++++G  PF+  ++       IGRI
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRI 221

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.9 bits (142), Expect = 5e-10
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++VK +G+G FG V     +  T+  +AVK ++ G    +    E    ++L+H  +
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+     + I+ EY A G L  F +    G+    +   F  Q+  G++Y     
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  S +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 124 YIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  K +DVWS G+ LY ++  G  P+
Sbjct: 181 FTIK-SDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 49/186 (26%), Positives = 72/186 (38%), Gaps = 32/186 (17%)

Query: 48  EIMNHRSLKHPNIVRFKEVLLTPTHLAI--------VMEYAAGGEL--FERIC------N 91
           E      L H NI       L   H+ I        +  Y   G L  F + C      N
Sbjct: 58  ESCLLYGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN 110

Query: 92  AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-- 149
               S  +      Q+  G+SY H   + H+D+   N ++D     +VKI D   S+   
Sbjct: 111 PQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNALSRDLF 168

Query: 150 -SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPED 205
               H    +      ++A E L  KEY    +DVWS GV L+ +M +G  P+   DP +
Sbjct: 169 PMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE 227

Query: 206 PKNFRK 211
              + K
Sbjct: 228 MAAYLK 233

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 18/164 (10%)

Query: 47  REIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL------------FERICNAGR 94
           +EI     LK+PNI+R   V ++   L ++ EY   G+L            F    N   
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125

Query: 95  FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSV 151
            S     +   Q+ SG+ Y  S+   HRDL   N L+       +KI DFG S+   S  
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGD 183

Query: 152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV 195
            +      V    ++A E +   ++    +DVW+ GVTL+ M  
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 21/225 (9%)

Query: 8   KDIGSGNFGVAKL--VRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRF 63
            +IG+G FG   L       ++  + VK +      DE +   +E+  +R L HPN+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 64  KEVLLTPTHLAIVMEYAAGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
               +      +V+E+   G+L       R   A    +D  +    ++ SG+ + H   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVLTKKE 175
             H DL L N  L    +  VKI D+G    +    +   K     P  ++APE++  + 
Sbjct: 121 FIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 176 YDGKIAD------VWSCGVTLYVML-VGAYPFEDPEDPKNFRKTI 213
            D    D      +WS GVT++ +      P+ D  D +  ++ +
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 9   DIGSGNFG-VAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKH----PNIVR 62
           ++GSGNFG V K V     +++ +A+K ++     ++ V+ E+M    + H    P IVR
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
              V      L +VME A+GG L + +       +         Q+  G+ Y       H
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLTKKEYD 177
           RDL   N LL        KI DFG SK+      + + +S    P  + APE +  +++ 
Sbjct: 119 RDLAARNVLL--VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 178 GKIADVWSCGVTLYVML-VGAYPFEDPEDPK 207
            + +DVWS G+T++     G  P++  + P+
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 5   EIVKDIGSGNFG------VAKLVRDKWTRELLAVKFIERGQKIDEHV--QREIMNHRSLK 56
           E V+DIG G FG         L+  +    ++AVK ++     D     QRE        
Sbjct: 8   EYVRDIGQGAFGRVFQARAPGLLPYE-PFTMVAVKMLKEEASADMQADFQREAALMAEFD 66

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--------------------RICNAGR-- 94
           HPNIV+   V      + ++ EY A G+L E                    R C      
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 95  FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSV 151
            S  E     +Q+ +G++Y    +  HRDL   N L+  +    VKI DFG S+   S+ 
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSAD 184

Query: 152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY 191
            +   ++      ++ PE +    Y  + +DVW+ GV L+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 70/244 (28%), Positives = 104/244 (42%), Gaps = 24/244 (9%)

Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDE--HVQREIMNHRSLKHPNIVRFK 64
           IG G+FG      L+     +   AVK + R   ++E     +E +  +   HPN++   
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 65  EVLLTPTHLA-IVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L       +V+ Y   G+L   I +     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122

Query: 123 DLKLENTLLDGSTAPRVKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLTKK 174
           DL   N +LD S    VK+ DFG     Y K   S   H+  K  V    ++A E L  +
Sbjct: 123 DLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQTQ 177

Query: 175 EYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
           ++  K +DVWS GV L+ +M  GA  YP  D  D   +     R+L   Y       V L
Sbjct: 178 KFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML 236

Query: 232 ECKH 235
            C H
Sbjct: 237 SCWH 240

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 32/227 (14%)

Query: 1   MERYEIV--KDIGSGNFGVAKLVR-----DKWTRELLAVKFIERGQ---KIDEHVQREIM 50
           ++R+ IV  +++G G FG   L        +  + L+AVK ++      + D H + E++
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-------------RFSE 97
              +L+H +IV+F  V +    L +V EY   G+L + +   G               ++
Sbjct: 62  T--NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119

Query: 98  DEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHS 154
            +     QQ+ +G+ Y  S    HRDL   N L+  +    VKI DFG S+   S+  + 
Sbjct: 120 SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYR 177

Query: 155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
               T+    ++ PE +  +++  + +DVWS GV L+ +   G  P+
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 61/201 (30%), Positives = 89/201 (44%), Gaps = 37/201 (18%)

Query: 10  IGSGNFG-VAK-LVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKE 65
           +G GNFG V K  ++DK     +AVK  +    Q++      E    +   HPNIV+   
Sbjct: 3   LGKGNFGEVFKGTLKDKTP---VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 118
           V      + IVME   GG+    +    R  +DE +   +QL+       +G++Y  S  
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESKN 113

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEV 170
             HRDL   N L+  +    +KI DFG S+        SS L   P        + APE 
Sbjct: 114 CIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEA 165

Query: 171 LTKKEYDGKIADVWSCGVTLY 191
           L    Y  + +DVWS G+ L+
Sbjct: 166 LNYGRYSSE-SDVWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 33/217 (15%)

Query: 10  IGSGNFG--VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHPNIVR 62
           IG GNFG  +  +++    +   A+K ++     ++H  R+      +      HPNI+ 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKLGHHPNIIN 67

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEA---------RFFFQQLI----- 108
                    +L I +EYA  G L + +  +     D A             QQL+     
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 109 --SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT-PA- 164
             +G+ Y    Q  HRDL   N L+  + A   KI DFG S+   ++   K T+G  P  
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183

Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           ++A E L    Y  K +DVWS GV L+ ++ +G  P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 35/220 (15%)

Query: 8   KDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQREI-------MNHRSLKH 57
           K +G G FG     +L +D  ++  +AVK +    K+D H   EI          +   H
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 58  PNIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLI--- 108
           PN+++   V    + L       +++ +   G+L   +    R      +   Q L+   
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFM 119

Query: 109 ----SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVG 161
                G+ Y  +    HRDL   N +L       V + DFG SK   S   + Q +    
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              +IA E L  + Y  K +DVW+ GVT++ +   G  P+
Sbjct: 178 PVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 25/182 (13%)

Query: 40  KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE------RICNAG 93
           K+ +  ++E      L+HPNIV    V        ++ EY A G+L E         + G
Sbjct: 50  KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVG 109

Query: 94  RFSED-------EARFFFQ---QLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKIC 142
             S D       +   F     Q+ +G+ Y  S    HRDL   N L+ +G T   VKI 
Sbjct: 110 AESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKIS 166

Query: 143 DFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAY 198
           DFG S+   S+  +     ++    ++ PE +   ++  + +D+WS GV L+ +   G  
Sbjct: 167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQ 225

Query: 199 PF 200
           P+
Sbjct: 226 PY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)

Query: 10  IGSGNFG--VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHPNIVR 62
           IG GNFG  +   ++    R   A+K ++     D+H  R+      +      HPNI+ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 106
                    +L + +EYA  G L +     R+             A   S  +   F   
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT-PA- 164
           +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176

Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 41/139 (29%), Positives = 69/139 (49%), Gaps = 14/139 (10%)

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 161
           Q+  G+ +  S +  HRDL   N LL  +    VKICDFG ++   ++  P    K +  
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARD--IYKDPDYVRKGSAR 237

Query: 162 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTI---GRI 216
            P  ++APE +  K Y  + +DVWS GV L+ +  +GA P+   +  + F + +    R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296

Query: 217 LSVHYSFPDYVRVSLECKH 235
            +   + P+  R+ L C  
Sbjct: 297 RAPENATPEIYRIMLACWQ 315

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 54/249 (21%)

Query: 8   KDIGSGNFGVAKLVRDKWTR-------ELLAVKFIERGQKIDEHVQREIMNH----RSLK 56
           K +G G FG  K+V+    R         +AVK ++      E   R++++     + + 
Sbjct: 6   KTLGEGEFG--KVVKATAFRLKGRAGYTTVAVKMLKENASSSEL--RDLLSEFNLLKQVN 61

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERIC---------------NAGRFSEDE 99
           HP++++          L +++EYA  G L  F R                 ++   + DE
Sbjct: 62  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 100 ARFFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---- 148
                  LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+    
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYE 179

Query: 149 --SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDP 203
             S V  S+ +  V    ++A E L    Y  + +DVWS GV L+ ++ +G   YP   P
Sbjct: 180 EDSYVKRSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAP 235

Query: 204 EDPKNFRKT 212
           E   N  KT
Sbjct: 236 ERLFNLLKT 244

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 43/279 (15%)

Query: 6   IVKDIGSGNFG------VAKLVRDKWTRELLAVKFIERGQKIDEH--VQREIMNHRSLKH 57
           + +++G G FG         L  +   +EL+AVK ++     D     +RE     + +H
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPEN-DKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERI--------------CNAGRFSEDEARFF 103
            NIV+F  V        +V EY   G+L + +                 G  +  +    
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP 163
             Q+ SG+ Y  S    HRDL   N L+       VKI DFG S+   +++     VG  
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGH 183

Query: 164 A-----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYP-FEDPEDPKNFRKTIGRI 216
                 ++ PE +  +++  + +DVWS GV L+ +   G  P +    +      T GR+
Sbjct: 184 TMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242

Query: 217 LSVHYSFPDYV-RVSLECKHLLSRIFVANSEKRITIPEI 254
           L    + P  V  + L C       +  + ++RI I +I
Sbjct: 243 LQRPRTCPSEVYDIMLGC-------WKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 67/302 (22%), Positives = 120/302 (39%), Gaps = 50/302 (16%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKW---TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN 59
           +Y I+  +  G+ G    V  K     R+ + VK +  G+       REI   +++ H  
Sbjct: 93  QYNILSSLTPGSEGEV-FVCTKHGDEQRKKVIVKAVTGGKTPG----REIDILKTISHRA 147

Query: 60  IVRFKEVLLTPTHLAIVM-EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           I+         + + +VM +Y    +LF  +  +G    ++A    ++L+  ++Y H   
Sbjct: 148 IINLIHAYRWKSTVCMVMPKYKC--DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG 205

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLTKKE 175
           I HRD+K EN  LD        + DFG +     H   P+     GT    +PE+L    
Sbjct: 206 IIHRDVKTENIFLDEPE--NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPF---EDPEDPKNFRKTIGRILSVH------------ 220
           Y  K  D+WS G+ L+ M V        +        R  I R + VH            
Sbjct: 264 YCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEFPQNGSTNL 321

Query: 221 --------------YSFPDYVR---VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
                         Y+ P  +R   + ++ ++L++++   + E R +  +I + P F + 
Sbjct: 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381

Query: 264 LP 265
             
Sbjct: 382 PI 383

Length = 392

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 19/163 (11%)

Query: 47  REIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-----------NAGRF 95
           +EI     LK PNI+R   V +T   L ++ EY   G+L + +            +    
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 96  SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 155
           S     F   Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S++  L+S 
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN--LYSG 183

Query: 156 PKSTVGTPAYIAPEVLTKKE-YDGKI---ADVWSCGVTLYVML 194
               +   A +    ++ +    GK    +DVW+ GVTL+ +L
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 15/197 (7%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE-HVQREIMNHRSLKHPNIVR 62
           + I++    G  G A    D  T E + +K  +RG    E H+ R      ++ HP+I++
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILR------AINHPSIIQ 147

Query: 63  FKEVLLTPTHLAIVM-EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
            K          +++  Y    +L+  +      +  +     + ++  + Y H  +I H
Sbjct: 148 LKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIH 205

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLTKKEYDGK 179
           RD+K EN  ++      V + DFG +   V  +  K     GT A  APE+L +  Y G 
Sbjct: 206 RDIKAENIFINHPG--DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GP 262

Query: 180 IADVWSCGVTLYVMLVG 196
             D+WS G+ L+ M   
Sbjct: 263 AVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 38/112 (33%), Positives = 51/112 (45%), Gaps = 17/112 (15%)

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC--DFGY------SKSSVLHSQP 156
           +QL+S + Y H   I HRD+K EN L++G       IC  DFG       S S+  H   
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322

Query: 157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
             TV T    APEVL    Y   + D+WS G+ ++   V  A  F      +
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDE 370

Length = 461

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 7   VKDIGSGNFGVAKLVRDKWTRE------LLAVKFIER--GQKIDEHVQREIMNHRSLKHP 58
           VK +GSG FG   + +  W  E       +A+K +    G K +     E +   S+ HP
Sbjct: 12  VKVLGSGAFGT--VYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 117
           ++VR   V L+PT + +V +    G L + +  +           +  Q+  G+ Y    
Sbjct: 70  HLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLT 172
           ++ HRDL   N L+   +   VKI DFG ++  +L    K            ++A E + 
Sbjct: 129 RLVHRDLAARNVLV--KSPNHVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            +++  + +DVWS GVT++ +M  G  P++
Sbjct: 185 YRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 35/220 (15%)

Query: 1   MERYEIVK--DIGSGNFG------VAKLVRDKWTRELLAVKFI-ERGQKIDEHVQREIMN 51
           ++R +IV   ++G G FG         L+ ++  + L+AVK + E  +   +  QRE   
Sbjct: 2   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQ-DKMLVAVKALKEASESARQDFQREAEL 60

Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FER-------------ICNAGRFS 96
              L+H +IVRF  V      L +V EY   G+L  F R                 G+ +
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 97  EDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 156
             +      Q+ SG+ Y  S+   HRDL   N L+       VKI DFG S+   ++S  
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTD 176

Query: 157 KSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY 191
              VG        ++ PE +  +++  + +D+WS GV L+
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 31/222 (13%)

Query: 8   KDIGSGNFGVAKL--VRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRF 63
           K+IG+G FG   L  V   +T   + VK +     + E ++   E   +RSL+H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 64  KEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHSMQ 118
                  T   +VME+   G+L  + R C        +     +   ++  G+ + H   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 170
             H DL L N LL       VKI D+G S     H++ K               +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 171 LTKKEYDGKIAD------VWSCGVTLYVML-VGAYPFEDPED 205
           + +   +  + D      VWS GVT++ +  +G+ P+    D
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 21/161 (13%)

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 161
           Q+  G+ +  S +  HRDL   N LL  +    VKICDFG ++   ++  P    K    
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARD--IYKDPDYVRKGDAR 242

Query: 162 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNF---RKTIGRI 216
            P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F    K   R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301

Query: 217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 302 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 17/261 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E  ++VK +G+G FG   +       ++ A+K +++G    E    E    + L+HP +V
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64

Query: 62  RFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           R   V+ T   + I+ EY   G L  F +     + + ++      Q+  G+++      
Sbjct: 65  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEY 176
            HRDL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +
Sbjct: 124 IHRDLRAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
             K +DVWS G+ L  ++  G  P+    +P+  +      L   Y  P       E   
Sbjct: 181 TIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-----LERGYRMPRPDNCPEELYE 234

Query: 236 LLSRIFVANSEKRITIPEIKN 256
           L+   +    E+R T   +++
Sbjct: 235 LMRLCWKEKPEERPTFEYLRS 255

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 44/140 (31%), Positives = 70/140 (50%), Gaps = 16/140 (11%)

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 161
           Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++  P    K    
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236

Query: 162 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE----DPEDPKNFRKTIGR 215
            P  ++APE +  K Y  + +DVWS GV L+ +  +GA P+     D E  +  ++   R
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-R 294

Query: 216 ILSVHYSFPDYVRVSLECKH 235
           + +  Y+ P+   + L+C H
Sbjct: 295 MRAPEYATPEIYSIMLDCWH 314

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 60/246 (24%), Positives = 107/246 (43%), Gaps = 24/246 (9%)

Query: 20  LVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY 79
           LV D  T++   +K + +  +     +  I+ H     PN+V   + +++   + +V+++
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYSR-ERLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66

Query: 80  AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV 139
           A GG+L+  I       E+  + +  +++  +   H   I  RDL   N LLD      +
Sbjct: 67  AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD--DRGHI 124

Query: 140 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP 199
           ++  F    S V  S     V    Y APEV    E + +  D WS G  L+ +L G   
Sbjct: 125 QLTYFS-RWSEVEDSCDGEAVEN-MYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181

Query: 200 FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI-----TIPEI 254
            E      N   T+        + P++  VS E + LL ++   N  +R+      + +I
Sbjct: 182 VECHPSGINTHTTL--------NIPEW--VSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231

Query: 255 KNHPWF 260
           K+HP+F
Sbjct: 232 KSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           ++++ +G+G FG  ++    W     +AVK ++ G    +    E    + L+HP +++ 
Sbjct: 9   QLLRKLGAGQFG--EVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL 66

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHS 116
             V      + IV E    G L E +                QLI       SG++Y  +
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTK 173
               HRDL   N L+  +     K+ DFG ++  +     ++  G    I   APE    
Sbjct: 122 QNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALY 178

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             +  K +DVWS G+ L  ++  G  P+
Sbjct: 179 NRFSIK-SDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)

Query: 10  IGSGNFG--VAKLVRDKWTRELLAVKFIERGQKIDEHV----QREIMNHRSLKHPNIVRF 63
           IG GNFG  +   ++    R   A+K ++     D+H     + E++  +   HPNI+  
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNIINL 73

Query: 64  KEVLLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDEARFFFQQL 107
                   +L + +EYA  G L + +                  A   S  +   F   +
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT-PA-Y 165
             G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  +
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYV--KKTMGRLPVRW 189

Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 190 MAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 16/213 (7%)

Query: 5   EIVKDIGSG--NFGVAKLVRDKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKHPN 59
           E+  +IG G  N     L R   T  L+ V+  +     +EH+   Q E++     +HPN
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60

Query: 60  IVRFKEVLLTPTHLAIV---MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           I+    V  T + L ++   M Y +   L +     G  SE          + G++Y H 
Sbjct: 61  IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEV 170
               HR++K  + L+ G     +      YS      K+ V++  P+ +     +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 171 LTKKEYDGKI-ADVWSCGVTLYVMLVGAYPFED 202
           L +  Y   + +D++S G+T   +  G  PF+D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 25/166 (15%)

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEAR-----FFFQ 105
           KH NI+           L +++EYA+ G L E +  A R     +S D AR       F+
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFK 137

Query: 106 QLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQP 156
            L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++ + + 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKK 195

Query: 157 KSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            +    P  ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 7   VKDIGSGNFGVAKLVRDKWTRE------LLAVKFIE--RGQKIDEHVQREIMNHRSLKHP 58
           +K +GSG FG     +  W  E       +A+K I+   G++  + +   ++   SL H 
Sbjct: 12  LKLLGSGVFGTVH--KGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 117
            IVR   +    + L +V + +  G L + +  +           +  Q+  G+ Y    
Sbjct: 70  YIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK----STVGTP-AYIAPEVLT 172
           ++ HR+L   N LL   +   V+I DFG +   +L+   K    S   TP  ++A E + 
Sbjct: 129 RMVHRNLAARNILLKSDS--IVQIADFGVA--DLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 173 KKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
              Y  + +DVWS GVT++ M+  GA P+
Sbjct: 185 FGRYTHQ-SDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 37/231 (16%)

Query: 1   MERYEIV--KDIGSGNFGVAKL--------VRDKWTRELLAVKFIERGQ-KIDEHVQREI 49
           ++R +IV  +++G G FG   L         +DK    L+AVK ++       +  QRE 
Sbjct: 2   IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKM---LVAVKALKDPTLAARKDFQREA 58

Query: 50  MNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FER--------------ICNAG 93
               +L+H +IV+F  V      L +V EY   G+L  F R                  G
Sbjct: 59  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118

Query: 94  RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SS 150
                +      Q+ SG+ Y  S    HRDL   N L+  +    VKI DFG S+   S+
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYST 176

Query: 151 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             +     T+    ++ PE +  +++  + +DVWS GV L+ +   G  P+
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 28/221 (12%)

Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLKHPNI 60
           K +G G FG   ++  +  ++   +K   +  KI        E    E +  +   HPN+
Sbjct: 5   KTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 61  VRFKEVLLTPTHL------AIVMEYAAGGEL-----FERICNAGRFSEDEARF-FFQQLI 108
           +R   V L            +++ +   G+L     + R+ +  ++   +    F   + 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAY 165
           SG+ Y  S    HRDL   N +L+ +    V + DFG SK   +   + Q +       +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPED 205
           IA E L  + Y  K +DVWS GVT++ +   G  P+   E+
Sbjct: 181 IAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVEN 220

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 6/102 (5%)

Query: 160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
           +GTP Y+APE+L  K + G   D W+ GV L+  L G  PF D E P+   +    IL+ 
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND-ETPQ---QVFQNILNR 595

Query: 220 HYSFPD-YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
              +P+   ++S+  ++ +  +   +  KR  + E+K HP F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 19/170 (11%)

Query: 33  KFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL-----FE 87
           K +    +              L H ++V+   V +   ++ +V EY   G L      E
Sbjct: 36  KVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHRE 94

Query: 88  RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-----DGSTAPRVKIC 142
           +   +  +  D A    +QL S + Y    ++ H ++  +N L+     +    P +K+ 
Sbjct: 95  KNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150

Query: 143 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA-DVWSCGVTLY 191
           D G   + +   +    +    +IAPE +   +    IA D WS G TL 
Sbjct: 151 DPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTLL 197

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 18/218 (8%)

Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++ K +G+G FG V     +K T+  +AVK ++ G    E    E    ++L+H  +
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 63

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           V+   V+ T   + I+ E+ A G L  F +     +    +   F  Q+  G+++     
Sbjct: 64  VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLTK 173
             HRDL+  N L+  S +   KI DFG ++             K  +    + APE +  
Sbjct: 123 YIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINF 177

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFR 210
             +  K +DVWS G+ L  ++  G  P+    +P+  R
Sbjct: 178 GSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 45/234 (19%)

Query: 2   ERYEIVKDIGSGNFGVAKLVR------DKWTREL-LAVKFI--ERGQK--IDEHVQREIM 50
           +R  + K +G G FG  ++V+      D       +AVK +  +  +K   D   + E+M
Sbjct: 12  DRLTLGKPLGEGAFG--QVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF-------- 102
                KH NI+    V      L +V+EYAA G L + +  A R   + A          
Sbjct: 70  K-MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPEE 127

Query: 103 ---------FFQQLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVL 152
                    F  Q+  G+ +  S +  HRDL   N L+ +      +KI DFG ++   +
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV---MKIADFGLARD--I 182

Query: 153 HSQP---KSTVG-TPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           H      K+T G  P  ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 15/154 (9%)

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 114
           H NIVR + V+     + IV EY + G L  F R  + G+    +       L SG+ Y 
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYL 123

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFG---YSKSSVLHS--QPKSTVGTPAYIAPE 169
             M   H+ L     L++       KI  F      KS  +++    KS V    + APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAAPE 178

Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +    +    +DVWS G+ ++ VM  G  P+ D
Sbjct: 179 AIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 37/246 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI--DEHVQREIMNHRSLKHPN 59
           +R++I+  +G G FG      D+  +E  AVK +    K   D  ++ + M       P 
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188

Query: 60  ----IVRFKEVLLTPT-HLAIVM-EYAAGGELFERICNAGRFSEDE-ARFFFQQLISGVS 112
               +++ +      T H+ IVM +Y  G  L + I   G FS    A+  FQ   +GV+
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQ---TGVA 243

Query: 113 --YCHS-MQICHRDLKLENTLLDGS-----------TAP---RVKICDFGYSKSSVLHSQ 155
             Y H+ + + H DLK EN L++ S             P   RV+ICD G       HS+
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR 302

Query: 156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF---RKT 212
             + V T  Y +PEV+    +     D+WS G  +Y +  G   ++  ++ ++     KT
Sbjct: 303 -TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360

Query: 213 IGRILS 218
           +GR+ S
Sbjct: 361 LGRLPS 366

Length = 467

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE------LLAVKFIERGQ--KIDEHVQREIMNHRSL 55
           ++ +K +GSG FG   + +  W  E       +A+K +      K ++ +  E     S+
Sbjct: 9   FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            +P++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y 
Sbjct: 67  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
              ++ HRDL   N L+   T   VKI DFG +K  +L +  K            ++A E
Sbjct: 126 EERRLVHRDLAARNVLV--KTPQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALE 181

Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 182 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 13/156 (8%)

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERIC--NAGRFSE---DEARFFFQQLIS 109
           H NIVR   V        I++E  AGG+L  F R       R S     +  F  + +  
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRV-KICDFGYSKS---SVLHSQPKSTVGTPAY 165
           G  Y       HRD+   N LL      RV KI DFG ++    +  + +    +    +
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           + PE      +  K  DVWS GV L+ +  +G  P+
Sbjct: 188 MPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 7   VKDIGSGNFGVAKLVRDKW------TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHP 58
           VK +GSG FG   + +  W       +  +A+K +      K ++ +  E      +  P
Sbjct: 12  VKVLGSGAFGT--VYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 117
            + R   + LT T + +V +    G L + +  N  R    +   +  Q+  G+SY   +
Sbjct: 70  YVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLTKK 174
           ++ HRDL   N L+       VKI DFG ++   +        G      ++A E +  +
Sbjct: 129 RLVHRDLAARNVLVKSPN--HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            +  + +DVWS GVT++ +M  GA P++
Sbjct: 187 RFTHQ-SDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 25/166 (15%)

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSED-----EARFFFQ 105
           KH NI+           L +++EYA+ G L E +  A R     +S D     E +  F+
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 106 QLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPK 157
            L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKK 192

Query: 158 STVGT-PA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +T G  P  ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 32/220 (14%)

Query: 10  IGSGNFG---VAKL--VRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLKHPNI 60
           +G G FG   +AK   + ++    L+ VK ++  +  DE++Q    RE+   R L H N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 111
           VR   +        +++EY   G+L  F R   +            +Q ++       G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKI-----CDFGYSKSSVLHSQPKSTVGTPAYI 166
            +  + +  HRDL   N L+  S+   VK+         Y+            +    ++
Sbjct: 131 DHLSNARFVHRDLAARNCLV--SSQREVKVSLLSLSKDVYNSEYYKLRNALIPL---RWL 185

Query: 167 APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPED 205
           APE + + ++  K +DVWS GV ++ V   G  PF    D
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSD 224

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 9/110 (8%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKST 159
           F  Q+ +G+ +  S    HRDL   N L+       VKICDFG ++  +  S      ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
                ++APE +    Y   ++DVWS G+ L+ +  +G  P+  PE P N
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMN 348

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 29/229 (12%)

Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKF----IERGQKIDEHVQREIMNHRSLKHPNIVR 62
           +G G FG    A+L  +  + + +AVK     I     I+E + RE    +   HPN+++
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFL-REAACMKEFDHPNVIK 65

Query: 63  FKEVLL---TPTHLAIVM---EYAAGGELFERICNAGRFSEDEARFFFQQLI-------S 109
              V L       L I M    +   G+L   +    R  E+      Q L+       S
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYI 166
           G+ Y  S    HRDL   N +L+ +    V + DFG SK   S   + Q  ++     ++
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 167 APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIG 214
           A E L    Y    +DVW+ GVT++ +M  G  P+   E+ + +   I 
Sbjct: 183 ALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 25/166 (15%)

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSED-----EARFFFQ 105
           KH NI+    V      L +++EYAA G L E +  A R     ++ D     E +  F+
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFK 134

Query: 106 QLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS--SVLHSQP 156
            L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    + + + 
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKK 192

Query: 157 KSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            S    P  ++APE L  + Y  + +DVWS G+ ++ +  +G  P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.9 bits (111), Expect = 4e-06
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 26/212 (12%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  +++K +G+G FG  ++    W     +AVK ++ G    E    E    + L+H  +
Sbjct: 6   ESLQLIKKLGNGQFG--EVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 114
           V+   V+ +   + IV EY + G L + + +  GR  +     D A     Q+ +G++Y 
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
             M   HRDL+  N L+        KI DFG ++   L    + T    A     + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173

Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
                 +  K +DVWS G+ L  ++  G  P+
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 68/271 (25%), Positives = 111/271 (40%), Gaps = 29/271 (10%)

Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRE----LLAVKFIERGQKIDEH----VQREIMNH 52
                 K +G+G FG V +      ++      +AVK ++      E      + +IM+H
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 53  RSLKHPNIVRFKEVLLTPTH---LAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQL 107
               H NIV    +L   T    + ++ EY   G+L  F R       + ++   F  Q+
Sbjct: 95  LG-NHENIV---NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKSTVGTPA- 164
             G+++  S    HRDL   N LL  +    VKICDFG ++  +  S    K     P  
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF 223
           ++APE +    Y  + +DVWS G+ L+ +  +G+ P+        F K I       Y  
Sbjct: 209 WMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRM 263

Query: 224 PDYVRVSLECKHLLSRIFVANSEKRITIPEI 254
                   E   ++   + A+  KR T  +I
Sbjct: 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT 162
           F  Q+  G+ +  S    HRDL   N LL  +    VKICDFG ++  ++H     + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298

Query: 163 P----AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
                 ++APE +    Y   ++DVWS G+ L+ +  +G  P+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 21/191 (10%)

Query: 10  IGSGNFGVAKLVRDKWT-RELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           +G G FG  ++    W     +A+K ++ G    E   +E    + L+H  +V+   V+ 
Sbjct: 14  LGQGCFG--EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 70

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSE----DEARFFFQQLISGVSYCHSMQICHRDL 124
           +   + IV EY + G L + +   G   +     +      Q+ SG++Y   M   HRDL
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128

Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLTKKEYDGK 179
           +  N L+  +     K+ DFG ++   L    + T    A     + APE      +  K
Sbjct: 129 RAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 180 IADVWSCGVTL 190
            +DVWS G+ L
Sbjct: 184 -SDVWSFGILL 193

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 23/178 (12%)

Query: 43  EHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERIC------NAGRFS 96
           E  + E M    L+HPNIV    V+     L+++  Y +  +L E +       + G   
Sbjct: 53  EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112

Query: 97  EDE--------ARFF--FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 146
           +D+        A F     Q+ +G+ +  S  + H+DL   N L+       VKI D G 
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--VKISDLGL 170

Query: 147 SK---SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            +   ++  +    +++    +++PE +   ++    +D+WS GV L+ V   G  P+
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 20/170 (11%)

Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQ----QL 107
           +R L+HPNI++     +      +V EY   G+L   +        +      Q    ++
Sbjct: 49  YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI 108

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS----KSSVLHSQPKSTVGTP 163
            +GV++ H     H DL L N  L       VK+ D+G      K   + ++    V   
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL- 165

Query: 164 AYIAPEVLTKKEYDG-------KIADVWSCGVTLYVML-VGAYPFEDPED 205
            ++APE++ +    G       K ++VW+ GVTL+ +    A P+    D
Sbjct: 166 RWLAPELVGEFH-GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 23/165 (13%)

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +  +     E +  F+ 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 199

Query: 159 TVGT-PA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G  P  ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 33/178 (18%)

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR------------- 101
           LK PNI+R   V +    L ++ EY   G+L  +  ++    + E               
Sbjct: 76  LKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPAHCLPA 134

Query: 102 -------FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S++  L++
Sbjct: 135 ISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRN--LYA 190

Query: 155 QPKSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY--VMLVGAYPFEDPED 205
                +   A     ++A E +   ++    +DVW+ GVTL+  +ML    P+ +  D
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGELTD 247

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 45/140 (32%), Positives = 66/140 (47%), Gaps = 14/140 (10%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV-KICDFGYSKSSVLHSQ--PKST 159
           F  Q+  G+S+  S    HRDL   N LL   T  R+ KICDFG ++     S    K  
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSNYVVKGN 275

Query: 160 VGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFED-PEDPKNFRKTIG-- 214
              P  ++APE +    Y  + +DVWS G+ L+ +  +G+ P+   P D K F K I   
Sbjct: 276 ARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKEG 333

Query: 215 -RILSVHYSFPDYVRVSLEC 233
            R+LS   +  +   +   C
Sbjct: 334 YRMLSPECAPSEMYDIMKSC 353

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 43.5 bits (102), Expect = 7e-05
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 26/177 (14%)

Query: 46  QREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI----------CNAG-- 93
           Q+E      L HPNIV    V+     + ++ EY   G+L E +          C++   
Sbjct: 55  QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114

Query: 94  ---RFSEDEARFFFQ--QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 148
              + S D   F     Q+ +G+ Y  S    H+DL   N L+       VKI D G S+
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL--HVKISDLGLSR 172

Query: 149 ----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
               +     QPKS +    ++ PE +   ++    +D+WS GV L+ +   G  P+
Sbjct: 173 EIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 10/109 (9%)

Query: 97  EDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQ 155
           +D  RF  Q +  G+ +  S    HRD+   N LL DG  A   KICDFG ++  +  S 
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267

Query: 156 --PKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPF 200
              K     P  ++APE +    Y  + +DVWS G+ L+ +  +G  P+
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.5 bits (90), Expect = 0.002
 Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)

Query: 114 CHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
             +++  HR  K  N LL  DG           G    SV    P+ +   P ++APEV+
Sbjct: 27  LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76

Query: 172 TKKEYDGKIADVWSCGVTLYVML 194
             + Y  K AD++S G+TLY  L
Sbjct: 77  QGQSYTEK-ADIYSLGITLYEAL 98

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 20/68 (29%), Positives = 32/68 (47%), Gaps = 3/68 (4%)

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS--SVLHSQPKSTVG 161
            +Q++  +   HS  I HRD+K +N +    +    KI D G +      ++  PK  + 
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAAADLRVGINYIPKEFLL 319

Query: 162 TPAYIAPE 169
            P Y APE
Sbjct: 320 DPRYAAPE 327

Length = 566

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 33/215 (15%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK 56
           E+  +++++G G+FG      A+ +        +AVK +     + E +  E +N  S+ 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63

Query: 57  HP----NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERIC------NAGRFSE--DEARF 102
                 ++VR   V+       +VME  A G+L  + R        N GR      E   
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKST 159
              ++  G++Y ++ +  HRDL   N ++       VKI DFG ++    +  + +    
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181

Query: 160 VGTPAYIAPEVLTKKEYDGKI---ADVWSCGVTLY 191
           +    ++APE L     DG     +D+WS GV L+
Sbjct: 182 LLPVRWMAPESLK----DGVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	338
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.95
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
PRK10345	210	hypothetical protein; Provisional	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
smart00090	237	RIO RIO-like kinase.	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.58
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
KOG1243	690	consensus Protein kinase [General function predict	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.45
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.42
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.4
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.22
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.05
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.96
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.95
COG4248	637	Uncharacterized protein with protein kinase and he	98.91
PRK09902	216	hypothetical protein; Provisional	98.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.86
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.77
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
PF01636	239	APH: Phosphotransferase enzyme family This family	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
PLN02876	822	acyl-CoA dehydrogenase	98.57
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.56
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.5
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.45
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.29
PRK10593	297	hypothetical protein; Provisional	98.29
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.26
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.25
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.23
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.16
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.06
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.06
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.05
KOG2270	520	consensus Serine/threonine protein kinase involved	97.99
PRK05231	319	homoserine kinase; Provisional	97.92
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.87
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.84
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.71
PLN02236	344	choline kinase	97.51
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.39
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.34
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.33
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.31
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.3
PLN02756	418	S-methyl-5-thioribose kinase	97.27
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.99
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.97
PRK12396	409	5-methylribose kinase; Reviewed	96.94
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.84
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.54
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.46
PRK06148	1013	hypothetical protein; Provisional	96.45
PTZ00384	383	choline kinase; Provisional	96.4
COG2334	331	Putative homoserine kinase type II (protein kinase	96.38
PRK11768	325	serine/threonine protein kinase; Provisional	96.38
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.27
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.09
PTZ00296	442	choline kinase; Provisional	95.53

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-66  Score=455.85  Aligned_cols=258  Identities=39%  Similarity=0.632  Sum_probs=229.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~   73 (338)
                      +.|.+.+.||+|+||.|.+|..+.+|+.||||++.+...        ....+++|+++|++|+|||||+++++|..+++.
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            568999999999999999999999999999999987421        123467999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCccccc
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~  152 (338)
                      |+||||++||+|++.+..++.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ....+||+|||+|+....
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~  331 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE  331 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999755 334899999999998877


Q ss_pred             CCCCCCccccCcccccccccCCc--cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCccc
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVR  228 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  228 (338)
                      ...+.+.||||.|.|||++.+..  ++..++|+|||||++|-+++|.+||.+......   ...+|..+.|.+  +.|..
T Consensus       332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHHHHhcCcccccChhhhh
Confidence            78889999999999999998754  344458999999999999999999987554432   234466666654  56889


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ++.++++||.+||+.||++|||+.|+|+||||+-
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence            9999999999999999999999999999999963

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-63  Score=458.02  Aligned_cols=253  Identities=39%  Similarity=0.637  Sum_probs=234.9

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeec----CccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER----GQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +|+..+.||+|+|+.||.+++..+|+.||+|++.+    .....+++.+||++.++|+|||||+++++|++.+++|+|.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            69999999999999999999999999999999988    44556789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~  157 (338)
                      +|..++|..+++.+++++|.+++++++||+.||.|||+++|+|||||..|+|++++.  ++||+|||+|+..... +...
T Consensus        99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~--~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM--NVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC--cEEecccceeeeecCcccccc
Confidence            999999999999999999999999999999999999999999999999999998776  7999999999977644 6778


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      +.||||.|.|||++...+.+.. +||||+||+||.||+|++||..    ..+..+..+|....+.+|.  .+|.++++||
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dLI  249 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDLI  249 (592)
T ss_pred             eecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHHH
Confidence            8999999999999998887666 8999999999999999999986    4456677778889999999  8999999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccCC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      .+||+.+|.+|||++++|.|+||++..
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            999999999999999999999995443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-62  Score=425.45  Aligned_cols=257  Identities=30%  Similarity=0.473  Sum_probs=228.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeec--CccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-eEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-HLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-~~~iv~e~   79 (338)
                      +.+.++.||+|..|+||+|+|+.+++.+|+|++..  .....+++.+|+++++.++|||||++|++|..+. .++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            56678899999999999999999999999999943  4455678999999999999999999999999999 49999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |++|+|..+++..+.++|..+..++.+|++||.|||. ++||||||||+|||++..  |.|||||||.++..... ...+
T Consensus       160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk--GeVKicDFGVS~~lvnS-~a~t  236 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK--GEVKICDFGVSGILVNS-IANT  236 (364)
T ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC--CCEEeccccccHHhhhh-hccc
Confidence            9999999999988999999999999999999999995 899999999999999654  48999999999876555 7788


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCC-CChHHHHHHHhhHhh-ccccCCCcccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EDPKNFRKTIGRILS-VHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  236 (338)
                      ++||..|||||.+.+..|+.+ +||||||++++||++|+.||... .........+..|.. ..+.+|.. .+|+++++|
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~F  314 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSF  314 (364)
T ss_pred             ccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHH
Confidence            999999999999999999777 89999999999999999999875 223344555566665 44556663 599999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      |.+||++||.+|||+.|+++|||+++..
T Consensus       315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  315 VSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            9999999999999999999999998654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-61  Score=420.89  Aligned_cols=254  Identities=37%  Similarity=0.611  Sum_probs=225.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+|++|+.+.+++.||+|++++..    ...+....|..+|..++||+||+++..|++++.+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            68999999999999999999999999999999998853    34467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc-ccCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLHSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~-~~~~~~  156 (338)
                      ||++||+|+..|++.+.++|..++.++..|+.||.|||++|||||||||+|||+|.++  +++|+|||+|+.. ..+...
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G--Hi~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG--HIKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC--cEEEeccccchhcccCCCcc
Confidence            9999999999999999999999999999999999999999999999999999997655  9999999999854 344566


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      .+.|||+.|||||++.+..|+.. +|+||||+++|+|++|.+||...+.    .++...+.......+. ..++.++++|
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~~~k~~~~p-~~ls~~ardl  256 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKILKGKLPLPP-GYLSEEARDL  256 (357)
T ss_pred             ccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHhcCcCCCCC-ccCCHHHHHH
Confidence            67899999999999999988655 9999999999999999999998654    3444455555533332 1489999999


Q ss_pred             HHHhcccCCCcCC----ChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRI----TIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~----s~~ell~hp~~~~~  263 (338)
                      ++++|..+|.+|.    ++.++.+||||...
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            9999999999996    78999999999654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-60  Score=433.16  Aligned_cols=252  Identities=33%  Similarity=0.570  Sum_probs=225.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      .+|++++.||+|+|++|++|+.+.+++.||||++.+.    +...+-+.+|-..|.+| .||+|++++-.|+++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            5799999999999999999999999999999999774    23345577888899999 899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      +||+++|+|.++|++.+.+++...+.++.||+.||+|||++|||||||||+|||+|.+.  ++||+|||.|+....... 
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm--hikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG--HIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC--cEEEeeccccccCChhhcc
Confidence            99999999999999999999999999999999999999999999999999999997655  999999999975432211 


Q ss_pred             -------------CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc
Q 019628          156 -------------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS  222 (338)
Q Consensus       156 -------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (338)
                                   ..+++||..|.+||++..+..+ +.+|+|+||||+|+|+.|++||.+.++.    .++++|....+.
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~Ney----liFqkI~~l~y~  305 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEY----LIFQKIQALDYE  305 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHH----HHHHHHHHhccc
Confidence                         1458899999999999877664 5599999999999999999999987764    455667888999


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ||.  .+++.+++||+++|..||++|+|+.||.+||||..
T Consensus       306 fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  306 FPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             CCC--CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            998  78999999999999999999999999999999954

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-59  Score=431.41  Aligned_cols=255  Identities=49%  Similarity=0.845  Sum_probs=233.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----c--cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----Q--KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~--~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~   74 (338)
                      .+|++.+.||+|+||+|+++.+..++..||+|++.+.    .  ...+.+.+|+.+++++. ||||+++++++.....+|
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            4899999999999999999999999999999987664    1  23467789999999999 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc-ccC
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLH  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~-~~~  153 (338)
                      +||||+.||+|+++|...++++|..++.+++||+.||+|||++||+||||||+|||++.+. +++||+|||++... ...
T Consensus        97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~  175 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGED  175 (370)
T ss_pred             EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCC
Confidence            9999999999999999989999999999999999999999999999999999999998773 48999999999977 456


Q ss_pred             CCCCCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ....+.+||+.|+|||++.+.. |+++++||||+|++||.|++|+.||...+..    .+...+....+.+|.+.. |++
T Consensus       176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~l~~ki~~~~~~~p~~~~-S~~  250 (370)
T KOG0583|consen  176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----NLYRKIRKGEFKIPSYLL-SPE  250 (370)
T ss_pred             CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----HHHHHHhcCCccCCCCcC-CHH
Confidence            6778899999999999999988 9989999999999999999999999985443    344447888899999655 999


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +++|+++||..+|.+|+|+.++++||||+.
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999987

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-60  Score=401.50  Aligned_cols=250  Identities=37%  Similarity=0.674  Sum_probs=228.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||.|+||.|.+++++.+|..||+|++.+.+.    ..++..+|..+|+.+.||+++++++.|.+.+++|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            4789999999999999999999999999999999988653    335678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||++||.|+.++++.+++++..++.++.||+.||+|||+++|++|||||+|||+|.++  ++||+|||+|+....  .+
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G--~iKitDFGFAK~v~~--rT  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG--HIKITDFGFAKRVSG--RT  198 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC--cEEEEeccceEEecC--cE
Confidence            99999999999999999999999999999999999999999999999999999998666  899999999996543  36


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      .+.||||.|+|||++....|+ +++|+|||||++|||+.|.+||...+.    ..+...|....+.||.  .+++++++|
T Consensus       199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~--~fs~~~kdL  271 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPS--YFSSDAKDL  271 (355)
T ss_pred             EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCc--ccCHHHHHH
Confidence            778999999999999998885 559999999999999999999998766    4455667888999998  699999999


Q ss_pred             HHHhcccCCCcCC-----ChhHHhcCcccc
Q 019628          237 LSRIFVANSEKRI-----TIPEIKNHPWFL  261 (338)
Q Consensus       237 i~~~L~~dp~~R~-----s~~ell~hp~~~  261 (338)
                      |+++|+.|-.+|.     ...++..||||.
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence            9999999999994     568999999996

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-60  Score=436.91  Aligned_cols=255  Identities=38%  Similarity=0.720  Sum_probs=239.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      =|++++.||.|+-|.|-+|++..||+.+|||++.+.    +.....+.+||.+|+.+.||||+++|++|..+.++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            389999999999999999999999999999999875    3344679999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |++||.|++++..++++++.+++++++||+.|+.|||..+|+||||||+|+|+|..+  +|||+|||+|.....+....+
T Consensus        93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~--nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN--NIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc--CEeeeccceeecccCCccccc
Confidence            999999999999999999999999999999999999999999999999999998776  599999999998888888899


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      .||+|.|.|||++.+..|++.++||||+|||||.||||+.||.+    ++....+..+..+.|.+|.  .+|+++++||+
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLLr  244 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLLR  244 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHHH
Confidence            99999999999999999999999999999999999999999985    4556777788899999997  79999999999


Q ss_pred             HhcccCCCcCCChhHHhcCcccccCCC
Q 019628          239 RIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      +||..||++|+|.+||+.|||+.....
T Consensus       245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HHhccCccccccHHHHhhCchhhcCCC
Confidence            999999999999999999999976554

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.5e-59  Score=423.64  Aligned_cols=257  Identities=35%  Similarity=0.588  Sum_probs=226.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||+|+||.||+|+.+.||+.||+|+++++..    ..+.+..|-.+|....+|+||++|..|++..++|+|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            4789999999999999999999999999999999998653    336788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc----
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL----  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~----  152 (338)
                      |||++||++..+|...+.|+++.++.++.+++.|++-||+.|+|||||||+|+|||..+  ++||+|||||+....    
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G--HiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG--HIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC--CEeeccccccchhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999997665  999999999862111    


Q ss_pred             ------------------CCCC--------------------------CCccccCcccccccccCCccCCCcchHHHHHH
Q 019628          153 ------------------HSQP--------------------------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGV  188 (338)
Q Consensus       153 ------------------~~~~--------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~  188 (338)
                                        ....                          .+.+|||.|||||++.+..|... +|+|||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG~  376 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLGC  376 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHHH
Confidence                              0000                          12459999999999999997544 99999999


Q ss_pred             HHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCC---ChhHHhcCcccccC
Q 019628          189 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLRN  263 (338)
Q Consensus       189 il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~~  263 (338)
                      |+||||.|.+||...+....+.+++..  ...+.+|....++++++|||.+||. ||.+|.   ++.||.+||||..-
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            999999999999998877776666543  3346788888999999999999999 999998   58999999999754

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-60  Score=426.04  Aligned_cols=262  Identities=29%  Similarity=0.475  Sum_probs=229.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccH--HHHHHHHHHhcCC-CCCcceeEEEEEcCC-eEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE--HVQREIMNHRSLK-HPNIVRFKEVLLTPT-HLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~-~~~iv   76 (338)
                      |+||.++++||.|+||.||+|+.+.+|..||||.+++.....+  .-.||+..|++|+ |||||++.+++.+++ .+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            6899999999999999999999999999999999987643333  3468999999999 999999999999988 99999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ||||+ .+|+++++.+ +.+++..++.|++||++||+|+|.+|+.|||+||||||+..+.  .|||+|||+|+.......
T Consensus        89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~--~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND--VIKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc--eeEecccccccccccCCC
Confidence            99994 6999999865 4599999999999999999999999999999999999996443  799999999998888888


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------cc
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VH  220 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------~~  220 (338)
                      .+.++.|.||+|||++....+++.+.|||++|||++|+.+-++.|.+.++.+++.++...+..               ..
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            889999999999999988887777799999999999999999999999988887777543322               23


Q ss_pred             ccCCCc---------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          221 YSFPDY---------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       221 ~~~~~~---------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      +.+|..         ...++++.++|.+||.+||++||||.|+|+||||+....
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            334432         237899999999999999999999999999999975443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.4e-60  Score=403.34  Aligned_cols=258  Identities=26%  Similarity=0.476  Sum_probs=224.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      |++|+.+.++|+|+||+|++|+++.||+.||||++.-++.   ..+-..|||++|++++|+|+|.++++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            8999999999999999999999999999999999976543   3456789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCC
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~  155 (338)
                      |||+. ++.+-+.. ...++++.++.+++|++.|+.|||++++|||||||+||||..++  .+||||||+|+... ++..
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g--vvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG--VVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC--cEEeccchhhHhhcCCcch
Confidence            99976 55555544 44699999999999999999999999999999999999997665  89999999999766 5666


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc---------------
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---------------  220 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~---------------  220 (338)
                      .+.++.|.||+|||.+.+...+++++||||+||++.||++|.+.|.+.++.+++..+...+....               
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            78899999999999999966667779999999999999999999999999888776654332211               


Q ss_pred             ccCCC----------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          221 YSFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       221 ~~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      ..+|.          +..++..+.||+++||..||.+|+|.+|+|.||||.
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence            12222          334677899999999999999999999999999994

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-59  Score=411.71  Aligned_cols=258  Identities=36%  Similarity=0.574  Sum_probs=227.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .+|.+.+.||+|+||+||+++++.++..||||++.+..   +..+.+..|+.+|+.++|||||++++++..++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            58999999999999999999999999999999998753   344567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CC---CcEEEeecCCCcccccCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TA---PRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~---~~ikL~Dfg~a~~~~~~~  154 (338)
                      ||+||+|..+|+..+.++|..++.++.||+.||++||+++||||||||.|||++.. ..   ..+||+|||+|+......
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~  169 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS  169 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence            99999999999999999999999999999999999999999999999999999754 22   479999999999888888


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC-cccCCHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-YVRVSLEC  233 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  233 (338)
                      ...+.||+|.|||||++....|+.+ +|+||+|+|+|+|++|++||...+..+-+.    .+.......|. ....+..+
T Consensus       170 ~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~~s~~~  244 (429)
T KOG0595|consen  170 MAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAELSNPL  244 (429)
T ss_pred             HHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhhccCch
Confidence            8888999999999999999999878 899999999999999999999766543332    33333322222 12466778


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      .+|+...|+.+|..|.+..+-+.|+++..+.
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            8999999999999999999999999997655

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-58  Score=400.78  Aligned_cols=297  Identities=27%  Similarity=0.387  Sum_probs=240.0

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeec---CccccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THLA   74 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~~   74 (338)
                      +|..++.||+|+||.|+.+.++.+|+.||||++..   .....++..||+++|+.++|+||+.+++++..+     +.+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            56678999999999999999999999999999974   334567889999999999999999999999762     4699


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc--
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL--  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~--  152 (338)
                      +|+|+| +.+|.+.|+.++.+++..++.+++||++||+|+|+.||+||||||.|+|++.+.  .+||+|||+|+....  
T Consensus       103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c--~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC--DLKICDFGLARYLDKFF  179 (359)
T ss_pred             EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC--CEEeccccceeeccccC
Confidence            999999 569999999888899999999999999999999999999999999999996655  799999999997653  


Q ss_pred             -CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-------------
Q 019628          153 -HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------  218 (338)
Q Consensus       153 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------------  218 (338)
                       ....+.++.|.+|+|||++....-++++.||||+|||+.||++|++.|.+.+...++..++..+..             
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             444577899999999999987666677799999999999999999999987766655444321110             


Q ss_pred             ------ccccCC------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCCCCCH
Q 019628          219 ------VHYSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSL  286 (338)
Q Consensus       219 ------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (338)
                            .....|      .+...++.+.+|+.+||..||.+|+|++|+|+|||+......+............... .+.
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~~~~~-~~~  338 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDSFEHE-LTE  338 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcccccc-ccH
Confidence                  000111      1235889999999999999999999999999999997655433222111111112233 778


Q ss_pred             HHHHHHhHhhCCCCCCC
Q 019628          287 EEVLSLIHEATKPLEAP  303 (338)
Q Consensus       287 ~~~~~~~~~~~~~~~~~  303 (338)
                      +++++++.++...+.+.
T Consensus       339 ~~~r~~i~~e~~~~~~~  355 (359)
T KOG0660|consen  339 EELRELIYKEILDFHPD  355 (359)
T ss_pred             HHHHHHHHHHHHhhCcc
Confidence            99999999886555443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.5e-57  Score=377.71  Aligned_cols=261  Identities=30%  Similarity=0.452  Sum_probs=225.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++||...+.||+|.||+||+|++..+|+.||||+++.++..   .....|||+.|+.++|+||+.++++|...+.+.+|+
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            57999999999999999999999999999999999876433   467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CC
Q 019628           78 EYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~  155 (338)
                      ||++. +|...|+.+. .++...++.|+.++++||+|||++.|+||||||+|+|+++++  .+||+|||+|+..... ..
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g--~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG--QLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC--cEEeecccchhccCCCCcc
Confidence            99965 9999997544 589999999999999999999999999999999999996554  8999999999965433 33


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCCCc--------
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDY--------  226 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~--------  226 (338)
                      .+..+.|.+|+|||.+.+...++..+||||.|||+.||+-|.+-|.+.++.+++..++..+..... .+|+.        
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            344589999999999998776677799999999999999999999999998888777765433211 12221        


Q ss_pred             -------------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          227 -------------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       227 -------------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                                   ...+.++.||+.+||.+||.+|+|+.|+|+|+||...+
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                         13578899999999999999999999999999998643

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3e-59  Score=387.66  Aligned_cols=256  Identities=36%  Similarity=0.640  Sum_probs=227.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +.|++.+.||+|.|++|+++.+..+|+.+|+|++...   ....+.+.+|+++-+.|+|||||++++.+......|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            5799999999999999999999999999999998643   3345789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ++.|++|..-|..+..++|..+..+++||+.||.|||.+||||||+||+|+++-+.. ..-+||+|||+|.....+....
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~  170 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH  170 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence            999999999888877789999999999999999999999999999999999995433 3369999999998777666667


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (338)
                      ...|||.|||||++...+|+.+ +|||+.|+|||-|+.|.+||.+.+....+    ++|..+.+.+  |.|..+++++++
T Consensus       171 G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rly----e~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  171 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLY----EQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHH----HHHhccccCCCCcccCcCCHHHHH
Confidence            7899999999999999888655 89999999999999999999985554444    4455555554  468899999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      |+++||..||.+|+|+.|+|+|||+.+
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcc
Confidence            999999999999999999999999965

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.1e-57  Score=411.82  Aligned_cols=254  Identities=34%  Similarity=0.616  Sum_probs=230.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      |++|.+.+.||+|+||.||+++.+.+.+.||||++.+..+   ..+.+.+|+++++.++|||||.++++|++..++++|.
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            8999999999999999999999999999999999987543   3456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      |||.| +|+.++...+.++|+.++.++.|++.||.|||+++|+|||+||.|||++.++  ++|+||||+|+...... ..
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~--~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG--TLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC--ceeechhhhhhhcccCceee
Confidence            99976 9999999999999999999999999999999999999999999999996544  89999999999665443 34


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ++..|||.|||||++.+..|+.. +|+||||||+|||++|++||..    ..+...++.|...+..+|.  .+|..++.|
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~nf  230 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVNF  230 (808)
T ss_pred             eeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHHH
Confidence            55679999999999998888777 8999999999999999999975    4456667777877777777  799999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +..+|.+||.+|+|+.+++.|||++...
T Consensus       231 l~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             HHHHhhcChhhcccHHHHhcChHHhhhh
Confidence            9999999999999999999999997643

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-56  Score=394.96  Aligned_cols=257  Identities=35%  Similarity=0.501  Sum_probs=214.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeEEEEEcCC--eEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSLKHPNIVRFKEVLLTPT--HLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~iv~e~   79 (338)
                      +|...+.||+|+||+||++.+..+|..+|||.+...... .+.+.+|+.+|++++|||||++++......  .++++|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            578899999999999999999999999999998765221 456899999999999999999999754444  69999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc----CC
Q 019628           80 AAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL----HS  154 (338)
Q Consensus        80 ~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~----~~  154 (338)
                      +++|+|.+++...+ ++++..++.+.+||++||.|||++|||||||||+|||++.. ++.+||+|||+++....    ..
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-~~~~KlaDFG~a~~~~~~~~~~~  176 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-NGDVKLADFGLAKKLESKGTKSD  176 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-CCeEEeccCcccccccccccccc
Confidence            99999999999877 79999999999999999999999999999999999999863 23799999999886543    22


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc--cccCCCcccCCHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVRVSLE  232 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  232 (338)
                      ......||+.|||||++..+....+++|||||||++.||+||.+||........  .. -.+...  .+.+|.  .+|++
T Consensus       177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~--~~-~~ig~~~~~P~ip~--~ls~~  251 (313)
T KOG0198|consen  177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE--AL-LLIGREDSLPEIPD--SLSDE  251 (313)
T ss_pred             ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH--HH-HHHhccCCCCCCCc--ccCHH
Confidence            344678999999999998644444469999999999999999999987411111  11 112222  234455  59999


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      +++||++||..+|++||||.++|+|||..++..
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            999999999999999999999999999976543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-56  Score=398.00  Aligned_cols=261  Identities=38%  Similarity=0.625  Sum_probs=223.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------------ccHHHHHHHHHHhcCCCCCcceeEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------------IDEHVQREIMNHRSLKHPNIVRFKE   65 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~Iv~~~~   65 (338)
                      +++|++++.||+|.||.|.+|++..+++.||||++.+.+.               ..+++.+||.+|+++.|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            5799999999999999999999999999999999976321               1247899999999999999999999


Q ss_pred             EEEcC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEee
Q 019628           66 VLLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD  143 (338)
Q Consensus        66 ~~~~~--~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~D  143 (338)
                      +..++  +.+|+|+|||..|.+...=.....+++.+++.|++.++.||+|||.+|||||||||+|+|+++.  |++||+|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~--g~VKIsD  253 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD--GTVKISD  253 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC--CcEEeec
Confidence            98775  5799999999998875433332239999999999999999999999999999999999999655  5999999


Q ss_pred             cCCCcccccC------CCCCCccccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh
Q 019628          144 FGYSKSSVLH------SQPKSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG  214 (338)
Q Consensus       144 fg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~  214 (338)
                      ||.+......      .......|||.|+|||.+.+   ..+.+.+.||||+||+||.|+.|+.||-+..    ...+..
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----~~~l~~  329 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----ELELFD  329 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----HHHHHH
Confidence            9998744222      12234689999999999987   4567788999999999999999999998744    355566


Q ss_pred             hHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcc
Q 019628          215 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIE  267 (338)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~  267 (338)
                      .|.+....||....+.++++|||.+||.+||++|+++.++..|||..+.....
T Consensus       330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            77888889999888999999999999999999999999999999998764433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-55  Score=397.83  Aligned_cols=258  Identities=26%  Similarity=0.440  Sum_probs=222.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~iv   76 (338)
                      +.|+.+++||+|+||.||+|++..+|+.||+|++....   .......|||.+|++|.||||+++.++....  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            46889999999999999999999999999999998754   3335678999999999999999999998876  689999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           77 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      +|||+. +|..++.. .-.+++.+++.+++||+.||+|||++||+|||||.+|||||+++  .+||+|||+|+...... 
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G--~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG--VLKIADFGLARFYTPSGS  273 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC--CEEeccccceeeccCCCC
Confidence            999965 89888875 34699999999999999999999999999999999999997655  89999999999654433 


Q ss_pred             -CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc------cCCC--
Q 019628          155 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY------SFPD--  225 (338)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~--  225 (338)
                       ..++.+.|.||+|||++.+..-++.++|+||+||||.||++|++.|.+.++.+++.++++.......      .+|.  
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence             4678889999999999999776677799999999999999999999999998888777653322111      1111  


Q ss_pred             ---------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          226 ---------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       226 ---------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                                     ...+++.+.+|+..||..||.+|.||.++|+|+||..
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                           1236888999999999999999999999999999943

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-56  Score=366.17  Aligned_cols=253  Identities=34%  Similarity=0.644  Sum_probs=230.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++.+.||+|.||.||+++.+.++-.||+|++.+++    ....++.+|+++...|+||||+++|++|.+...+|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            578999999999999999999999999999999998865    2346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           77 MEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +||..+|+|+..+.  ...++++...+.+++|++.||.|||.++||||||||+|+|++..+  .+||+|||.+.... ..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--~lkiAdfGwsV~~p-~~  177 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAP-SN  177 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC--CeeccCCCceeecC-CC
Confidence            99999999999998  666799999999999999999999999999999999999996554  89999999987554 55


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...+.|||..|.+||.+.+..++.. +|+|++|++.||++.|.+||....    .....++|...++.+|.  .++.++.
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI~k~~~~~p~--~is~~a~  250 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQS----HSETYKRIRKVDLKFPS--TISGGAA  250 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHHHHccccCCc--ccChhHH
Confidence            6778999999999999999988777 899999999999999999998755    35566678888888886  7999999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |||.+||..+|.+|++..|++.|||+..+
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            99999999999999999999999999643

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-57  Score=379.87  Aligned_cols=242  Identities=32%  Similarity=0.498  Sum_probs=209.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEE-EEEcCCe-EEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKE-VLLTPTH-LAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~-~~~~~~~-~~iv   76 (338)
                      ..|++.++||+|+||+||+|.+..+|..+|.|.+.-..   +..+....|+.+|++|+|||||++++ .|..++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            35999999999999999999999999999999997543   33456789999999999999999998 5555544 9999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhh--cC--ceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           77 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~--~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      ||+|.+|+|...|+.    .+.++|..+++++.|++.||.+||+  ..  |+||||||.||+++.++  .+||+|||+++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g--vvKLGDfGL~r  176 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG--VVKLGDFGLGR  176 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC--ceeeccchhHh
Confidence            999999999999974    3459999999999999999999999  44  99999999999997655  89999999999


Q ss_pred             ccccCC-CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc-CCCc
Q 019628          149 SSVLHS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FPDY  226 (338)
Q Consensus       149 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  226 (338)
                      ...... ...+.+|||.||+||++...+|+.+ |||||+||++|||+..++||.+.    ++....+.|..+++. .|+ 
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~-  250 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPD-  250 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcH-
Confidence            665433 3457899999999999999999877 89999999999999999999985    455566667777664 442 


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCCh
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITI  251 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~  251 (338)
                      ..+|.++..||..|+..||..||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            3689999999999999999999986

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-54  Score=394.87  Aligned_cols=256  Identities=37%  Similarity=0.633  Sum_probs=229.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|.||.||+|+++.+|+.+|+|++++...    ....+.+|+.+|++++ |||||.++++|.+...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            479999999999999999999999999999999987543    2358999999999999 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC--CcEEEeecCCCcccccCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~--~~ikL~Dfg~a~~~~~~~  154 (338)
                      ||+|.||+|++.|... .+++..+..+++|++.|++|||+.||+||||||+|+|+.....  +.+|++|||+|.......
T Consensus       115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~  193 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE  193 (382)
T ss_pred             EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence            9999999999999877 5999999999999999999999999999999999999965543  479999999999776666


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--cCCCcccCCHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SFPDYVRVSLE  232 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  232 (338)
                      .....+||+.|+|||++....|... +||||+|+++|.|++|.+||.+.+....+.    .+....+  ..+.|..++..
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             eEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcCCCCCCCCCccccCHH
Confidence            6778899999999999988888655 899999999999999999999877655554    3444444  44568889999


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +++||++||..||.+|+|+.++|+|||+...
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999999754

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-55  Score=386.89  Aligned_cols=250  Identities=38%  Similarity=0.691  Sum_probs=231.7

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ||++.++||+|.||.|.+|.....|+.||||.|+++....    -++.+||++|..|+||||+.+|++|...+.+.||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            7999999999999999999999999999999998864322    368899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |..+|.|+++|...+.|++.+++++++||+.|+.|||+++++|||||.+|||+|.++  ++||+|||++..........+
T Consensus       134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~--NiKIADFGLSNly~~~kfLqT  211 (668)
T KOG0611|consen  134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN--NIKIADFGLSNLYADKKFLQT  211 (668)
T ss_pred             ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC--CeeeeccchhhhhccccHHHH
Confidence            999999999999999999999999999999999999999999999999999998777  799999999998777777889


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      +||+|.|.+||++++..|.++.+|.||||++||.|..|..||.+.+    ...++.+|..+.|.-|.   .+.++.-||+
T Consensus       212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~GaYrEP~---~PSdA~gLIR  284 (668)
T KOG0611|consen  212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGAYREPE---TPSDASGLIR  284 (668)
T ss_pred             hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhcccccCCC---CCchHHHHHH
Confidence            9999999999999999999999999999999999999999999854    45667778888887775   6778999999


Q ss_pred             HhcccCCCcCCChhHHhcCcccc
Q 019628          239 RIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      .||..+|++|.|+.++-.|=|..
T Consensus       285 wmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  285 WMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHhcCcccchhHHHHhhhheee
Confidence            99999999999999999998874

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-54  Score=379.48  Aligned_cols=254  Identities=31%  Similarity=0.518  Sum_probs=222.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +.|++++.||.|.-|+||+|....++..+|+|++.+..    +...+++.|.+||..++||.++.+|..|+.++..|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            56889999999999999999999999999999998853    33456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc---
Q 019628           78 EYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---  152 (338)
Q Consensus        78 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~---  152 (338)
                      |||+||+|..+.+++  +.+++..++.++..++.||+|||-.|||+|||||+||||.++  |+|.|+||.++.....   
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred--GHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED--GHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC--CcEEeeeccccccCCCCCe
Confidence            999999999988754  359999999999999999999999999999999999999554  4999999998742100   


Q ss_pred             ------------------------------C-C-----------------------CCCCccccCcccccccccCCccCC
Q 019628          153 ------------------------------H-S-----------------------QPKSTVGTPAYIAPEVLTKKEYDG  178 (338)
Q Consensus       153 ------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~  178 (338)
                                                    . .                       ..++++||-.|.|||++.+.+...
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0 0                       113456999999999999988755


Q ss_pred             CcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCC----hhHH
Q 019628          179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT----IPEI  254 (338)
Q Consensus       179 ~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s----~~el  254 (338)
                      . +|+|+|||++|||+.|..||.+.+....+    ..+......||....++..++|||+++|.+||.+|+.    |.||
T Consensus       315 A-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl----~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  315 A-VDWWTFGIFLYEMLYGTTPFKGSNNKETL----RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             h-hhHHHHHHHHHHHHhCCCCcCCCCchhhH----HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            5 89999999999999999999998875544    4566678889988889999999999999999999998    9999


Q ss_pred             hcCccccc
Q 019628          255 KNHPWFLR  262 (338)
Q Consensus       255 l~hp~~~~  262 (338)
                      .+||||..
T Consensus       390 K~HpFF~g  397 (459)
T KOG0610|consen  390 KRHPFFEG  397 (459)
T ss_pred             hcCccccC
Confidence            99999964

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-55  Score=369.32  Aligned_cols=255  Identities=33%  Similarity=0.558  Sum_probs=224.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-----ccc----HHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----KID----EHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~----~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      +.|.-.+.||.|..++|-++.++.+|+.+|+|++....     ...    +.-.+|+.+|+++ .||+|+++.++|+++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            46777889999999999999999999999999996421     111    3456799999998 5999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           72 HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      .+++|+|.|+.|.|++++...-.+||...+.|++|++.|+.|||.++||||||||+|||++++.  ++||+|||+|+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~--~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM--NIKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc--ceEEeccceeeccC
Confidence            9999999999999999999988999999999999999999999999999999999999998777  79999999999998


Q ss_pred             cCCCCCCccccCcccccccccCCcc-----CCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc--CC
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS--FP  224 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~  224 (338)
                      .+...+..||||+|.|||.+....+     +++.+|+|++|+|||.|+.|.+||-...    ...++..|..+.+.  .|
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----QmlMLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----QMLMLRMIMEGKYQFRSP  250 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----HHHHHHHHHhcccccCCc
Confidence            8989999999999999999865322     2455899999999999999999998633    23445556666655  57


Q ss_pred             CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .|.++|...++||++||+.||.+|+|++|+|.||||.+
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            89999999999999999999999999999999999943

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-54  Score=399.81  Aligned_cols=253  Identities=35%  Similarity=0.591  Sum_probs=223.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|.+++.||+|+||+|+++..+.+++.||||++++..    ...+....|.+++.... ||+++.++.+|++++++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            578999999999999999999999999999999999864    34466778888887775 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~  154 (338)
                      ||||+.||++. .+...+.+++..++.|++.|+.||+|||++||||||||.+|||+|..+  ++||+|||+++..- .+.
T Consensus       447 vmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG--h~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  447 VMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG--HVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC--cEEecccccccccCCCCC
Confidence            99999999944 444556899999999999999999999999999999999999997555  99999999998544 455


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .+.++||||.|||||++.+..|+.. +|+|||||+|||||.|+.||.+.+..+    .+..|...++.+|.  .+|.++.
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee----~FdsI~~d~~~yP~--~ls~ea~  596 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEE----VFDSIVNDEVRYPR--FLSKEAI  596 (694)
T ss_pred             ccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCCCCCC--cccHHHH
Confidence            6778999999999999999998644 899999999999999999999876644    44557777888888  5899999


Q ss_pred             HHHHHhcccCCCcCCC-----hhHHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRIT-----IPEIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s-----~~ell~hp~~~~~  263 (338)
                      ++++++|.++|++|..     +.+|..||||+.-
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            9999999999999995     5889999999643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.3e-54  Score=370.06  Aligned_cols=260  Identities=28%  Similarity=0.376  Sum_probs=219.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~iv   76 (338)
                      +.|+.+..|++|+||+||+|+++.+++.||+|+++....   ..-...|||.+|.+++|||||.+.++....  +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            568999999999999999999999999999999987542   123567999999999999999999987654  579999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-C
Q 019628           77 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~  154 (338)
                      ||||+. +|..++...+ ++++.+++-++.|+++||+|||++.|+||||||+|+|++..  |.+||+|||+|+..... .
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~--G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK--GILKIADFGLAREYGSPLK  232 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC--CcEEecccchhhhhcCCcc
Confidence            999965 8999997655 79999999999999999999999999999999999999544  48999999999965433 3


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc--------------
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--------------  220 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--------------  220 (338)
                      ..+..+.|.||+|||.+.+...++.+.|+||+|||+.||+++++.|.+....+++.++++.+....              
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence            456778999999999999877666669999999999999999999999998888877765432210              


Q ss_pred             -ccCCCc-----------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          221 -YSFPDY-----------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       221 -~~~~~~-----------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                       ..++..           ..++....+|+..+|.+||.+|.||.|+|+|+||...+
T Consensus       313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence             111110           01568899999999999999999999999999997643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-53  Score=372.61  Aligned_cols=260  Identities=28%  Similarity=0.413  Sum_probs=220.1

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCC-cceeEEEEEcCC-----
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPN-IVRFKEVLLTPT-----   71 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~-----   71 (338)
                      |..|..+++||+|+||+||+|+++.+|+.||+|++.....   ......+|+.+++.++|+| ||++++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3568888999999999999999999999999999987644   4467889999999999999 999999999887     


Q ss_pred             -eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           72 -HLAIVMEYAAGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        72 -~~~iv~e~~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                       .+++||||++ .+|..++....    .++...++.+++||+.||+|||+++|+||||||+||||+.  .|.+||+|||+
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~--~G~lKlaDFGl  166 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS--SGVLKLADFGL  166 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC--CCcEeeeccch
Confidence             8999999995 59999997654    5888999999999999999999999999999999999976  44899999999


Q ss_pred             Ccccc-cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc------
Q 019628          147 SKSSV-LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------  219 (338)
Q Consensus       147 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~------  219 (338)
                      |+... .....+..++|.+|+|||++.+...++...||||+|||++||+++++.|.+..+.++...++..+...      
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            98544 34446778999999999999988555555899999999999999999999988877766665433221      


Q ss_pred             --------cccCCCcc----------cCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          220 --------HYSFPDYV----------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       220 --------~~~~~~~~----------~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                              ...++.+.          ..+.+..+++.+||+++|.+|+|++.+|+||||...
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence                    11222221          123578999999999999999999999999999754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-54  Score=392.20  Aligned_cols=253  Identities=31%  Similarity=0.509  Sum_probs=220.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcccc-HHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .+|...++||+|+-|.||.+....+++.||||.+....... +-+.+|+.+|+..+|+|||.+++.|...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            46888899999999999999999999999999998755433 55789999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      +||+|.+.+... .++|.+++.|++.+++||+|||.+||+|||||.+|||++.++  .+||+|||++....... ...+.
T Consensus       353 ~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g--~vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  353 EGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG--SVKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             CCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC--cEEEeeeeeeeccccccCccccc
Confidence            999999988654 599999999999999999999999999999999999996555  79999999998665544 56778


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      +|||.|||||++....|..+ .||||||++++||+-|++||-..+. -.....+  ..++.+.+.....+|+.+++|+.+
T Consensus       430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~P-lrAlyLI--a~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENP-LRALYLI--ATNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCCh-HHHHHHH--hhcCCCCcCCccccCHHHHHHHHH
Confidence            99999999999999999766 8999999999999999999986333 2222222  234445555555899999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccc
Q 019628          240 IFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      ||+.|+.+|+||.|||+||||+
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhh
Confidence            9999999999999999999995

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-53  Score=385.23  Aligned_cols=254  Identities=35%  Similarity=0.671  Sum_probs=233.5

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      |.+-+.||+|.|++|.+|++..+|..||||++.+.+   ....++.+|++.|+.++|||||++|++......+|+|+|+-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            778899999999999999999999999999998754   33457889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           81 AGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      .+|+|+++|.+. ..+.|+.+++|+.||+.|+.|||+..+|||||||+|+.+-+. .|-+||+|||++....++...++.
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~kL~Ts  178 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKKLTTS  178 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcchhhcc
Confidence            999999999754 469999999999999999999999999999999999988644 348999999999999899999999


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      ||+..|.|||++.+..|+.+++||||||||||.|.+|++||...++.+.    +..|+...|+.|.  .+|.+|++||..
T Consensus       179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----LTmImDCKYtvPs--hvS~eCrdLI~s  252 (864)
T KOG4717|consen  179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----LTMIMDCKYTVPS--HVSKECRDLIQS  252 (864)
T ss_pred             cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----hhhhhcccccCch--hhhHHHHHHHHH
Confidence            9999999999999999999999999999999999999999999887654    4457788899888  799999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccCC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ||+.||.+|.|+++|..|+|++...
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCCC
Confidence            9999999999999999999997543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-52  Score=379.14  Aligned_cols=250  Identities=35%  Similarity=0.625  Sum_probs=217.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            58999999999999999999999999999999987543    22356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....  ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Ccc
Confidence            9999999999999888899999999999999999999999999999999999997544  899999999875432  233


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+    ..+......+|.  .++..+++||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~li  229 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIY----EKILAGKLEFPR--HLDLYAKDLI  229 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCcCCCc--cCCHHHHHHH
Confidence            4679999999999988777544 89999999999999999999875543322    334444555555  5689999999


Q ss_pred             HHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          238 SRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       238 ~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      ++||+.||.+||+     +.++++||||..
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            9999999999995     999999999963

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-52  Score=384.38  Aligned_cols=251  Identities=33%  Similarity=0.591  Sum_probs=218.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.++++++||||+++++++..++.+|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            468999999999999999999999999999999997642    2235678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||+++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....  ..
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~--~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG--HVKVTDFGFAKKVPD--RT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC--CEEEeeccCceEcCC--Cc
Confidence            99999999999999888899999999999999999999999999999999999997554  899999999875432  23


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......    ....+......+|.  .++..+++|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  245 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFR----IYEKILAGRLKFPN--WFDGRARDL  245 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCcCCCC--CCCHHHHHH
Confidence            35679999999999988777544 899999999999999999998654322    23334455555665  478999999


Q ss_pred             HHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          237 LSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      |++||+.||.+||+     +.++++||||..
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            99999999999997     799999999975

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.7e-52  Score=385.73  Aligned_cols=256  Identities=30%  Similarity=0.501  Sum_probs=214.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..    .....+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999997632    22346788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++  ++||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999997654  89999999987432110   


Q ss_pred             ---------------------------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCC
Q 019628          155 ---------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE  201 (338)
Q Consensus       155 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~  201 (338)
                                                       .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence                                             0124579999999999988877655 899999999999999999998


Q ss_pred             CCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCc---CCChhHHhcCcccccC
Q 019628          202 DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK---RITIPEIKNHPWFLRN  263 (338)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~---R~s~~ell~hp~~~~~  263 (338)
                      .......+......  .....+|....+++++++||.+|+. +|.+   ||+++|+++||||...
T Consensus       238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         238 SETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            76544333332211  1234566656789999999999775 4554   5899999999999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-53  Score=371.03  Aligned_cols=256  Identities=32%  Similarity=0.502  Sum_probs=219.7

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcC--C---eEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--T---HLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~---~~~iv~   77 (338)
                      .|+-.+.+|.|+||+||+++...+++.||||++.......   .+|+.+|+.++|||||++..+|...  +   ++.+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            4788899999999999999999999999999987665433   3799999999999999998888653  2   467999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           78 EYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      ||++. +|...++.    +..++.-.++-++.||++||.|||+.||+||||||.|+|+|... |.+||||||.|+....+
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccC
Confidence            99975 99999974    56899999999999999999999999999999999999998654 48999999999999888


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh--------c-----c
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------V-----H  220 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--------~-----~  220 (338)
                      +...+++.|..|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+..+++..+++.+..        .     .
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            88999999999999999998776666699999999999999999999998877777666543211        1     1


Q ss_pred             ccCCC----------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          221 YSFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       221 ~~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..+|.          ....++++.+|+.++|+++|.+|.|+.|++.||||..-
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence            12222          12478999999999999999999999999999999643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-51  Score=372.07  Aligned_cols=257  Identities=28%  Similarity=0.462  Sum_probs=210.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      |++|++++.||+|+||+||++.+..+++.||+|+++...  .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            689999999999999999999999999999999987543  233567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           79 YAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      |+++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ...
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEECcCcceeeccCCCccc
Confidence            9975 8998887544 479999999999999999999999999999999999997554  8999999998753322 223


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------ccc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VHY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (338)
                      ....||+.|+|||++.+....+.++||||+||++|+|++|++||...+..+...........               ..+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            44678999999999876443345599999999999999999999876554443333221110               001


Q ss_pred             cCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          222 SFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       222 ~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+|.         ...++.++++||++||++||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            1111         12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.3e-52  Score=379.97  Aligned_cols=247  Identities=36%  Similarity=0.597  Sum_probs=212.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      +.||+|+||.||+|.+..+|+.||||++++..    .....+.+|+.++++++||||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997642    22345778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCcccc
Q 019628           84 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVGT  162 (338)
Q Consensus        84 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~gt  162 (338)
                      +|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.... .......+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--CEEEeeCCCCcccccCCCcccceecC
Confidence            9999998888899999999999999999999999999999999999997554  799999999874322 2334456799


Q ss_pred             CcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcc
Q 019628          163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV  242 (338)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (338)
                      +.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..    .....+......+|.  .++.++.+||++||.
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (323)
T cd05571         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFPR--TLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHHHHHcc
Confidence            99999999988777655 89999999999999999999865432    222334444555555  689999999999999


Q ss_pred             cCCCcCC-----ChhHHhcCcccccC
Q 019628          243 ANSEKRI-----TIPEIKNHPWFLRN  263 (338)
Q Consensus       243 ~dp~~R~-----s~~ell~hp~~~~~  263 (338)
                      .||++||     ++.++++||||...
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999     89999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.4e-52  Score=372.43  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=215.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .|++.+.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3889999999999999999999999999999987542    122356789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           79 YAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |+++|+|...+...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++  .++|+|||++.........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG--HIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeCCCcEEcCCCCee
Confidence            99999998887543  3589999999999999999999999999999999999997554  7999999999865433344


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+......++.  .++.++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~l  235 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSI  235 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc--cCCHHHHHH
Confidence            55679999999999988887655 899999999999999999998765433333333333333333333  688999999


Q ss_pred             HHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          237 LSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      |++||+.+|.+|||     ++++++||||..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            99999999999997     899999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.1e-51  Score=372.65  Aligned_cols=259  Identities=25%  Similarity=0.415  Sum_probs=208.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            689999999999999999999999999999999875432  234677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCC
Q 019628           80 AAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~  157 (338)
                      +. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.... .....
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECCCCcceeccCCCccCC
Confidence            95 5788777653 5689999999999999999999999999999999999997554  799999999874322 22234


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-----------------
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-----------------  220 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-----------------  220 (338)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||....+.......+.......                 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            567899999999987654444558999999999999999999987654332222111111000                 


Q ss_pred             -cc--CC-------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          221 -YS--FP-------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       221 -~~--~~-------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                       +.  .+       .....+.++++|+++||+.||.+|||+.|+++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence             00  00       001245789999999999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-52  Score=384.94  Aligned_cols=255  Identities=35%  Similarity=0.591  Sum_probs=215.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..    .....+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            58999999999999999999999999999999997642    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      ||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .++|+|||+++......   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEeecccceecccccccc
Confidence            9999999999998888899999999999999999999999999999999999997655  89999999986432111   


Q ss_pred             ------------------------------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCC
Q 019628          155 ------------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAY  198 (338)
Q Consensus       155 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~  198 (338)
                                                          ...+.+||+.|+|||++.+..++.+ +|||||||++|+|++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence                                                0113469999999999988777655 899999999999999999


Q ss_pred             CCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCC---hhHHhcCccccc
Q 019628          199 PFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT---IPEIKNHPWFLR  262 (338)
Q Consensus       199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~  262 (338)
                      ||...............  .....+|....+++++++||.+||. +|.+|++   +.++++||||..
T Consensus       238 Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         238 PFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            99876543333222211  1233455555789999999999997 9999998   999999999965

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-53  Score=361.24  Aligned_cols=258  Identities=36%  Similarity=0.563  Sum_probs=226.5

Q ss_pred             CCceEe-eeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEc----CCeEEE
Q 019628            2 ERYEIV-KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLT----PTHLAI   75 (338)
Q Consensus         2 ~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~----~~~~~i   75 (338)
                      ++|.+- +.||-|-.|.|-.+.++.+|+.+|+|++..+    .+.++|+++.... .|||||.++++|..    ...+.+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            456554 5799999999999999999999999988655    5677888876655 69999999999865    357899


Q ss_pred             EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCccccc
Q 019628           76 VMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||.|+||+|+..|+.++.  ++|.++..|++||+.|+.|||+.+|.||||||+|+|...+ .+..+||+|||+|+....
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999999999998765  9999999999999999999999999999999999999533 445799999999998776


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCC
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVS  230 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  230 (338)
                      .....+.|.||.|.|||++....|+ +.+|+||+||++|-|++|.+||.........-.+..+|..+.|.||  +|..+|
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS  295 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS  295 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence            7778889999999999999888875 5599999999999999999999877665555566678888888887  588999


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ++++++|+++|..+|.+|+|+.++++|||+.+..
T Consensus       296 e~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  296 EAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             HHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            9999999999999999999999999999997654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=368.13  Aligned_cols=258  Identities=29%  Similarity=0.436  Sum_probs=217.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +.|++...||.|.-++||+|+...++..||||++...+  .....+++|+..|+.++||||++++.+|..+..+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            57999999999999999999999999999999997643  3357899999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--
Q 019628           80 AAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--  155 (338)
Q Consensus        80 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--  155 (338)
                      |.+|++.++++..-  .++|..++.|++++++||.|||.+|.||||||+.||||+.++  .|||+|||.+........  
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG--~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG--TVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC--cEEEcCceeeeeecccCcee
Confidence            99999999998643  499999999999999999999999999999999999997555  899999998754322211  


Q ss_pred             --C-CCccccCcccccccccC--CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-------cC
Q 019628          156 --P-KSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-------SF  223 (338)
Q Consensus       156 --~-~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~  223 (338)
                        . +..+||++|||||++..  .+|+.+ +||||||++..||.+|+.||.....-..+...   +.+..+       ..
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t---Lqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLT---LQNDPPTLLTSGLDK  259 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHH---hcCCCCCcccccCCh
Confidence              1 55689999999999533  456666 89999999999999999999887654433333   222222       11


Q ss_pred             CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      .....++..++.+|..||++||.+|||++++|.|+||++...
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            223457788999999999999999999999999999976544

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-51  Score=379.42  Aligned_cols=251  Identities=32%  Similarity=0.544  Sum_probs=215.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCC-cEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTR-ELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++.+.||+|+||.||+|.+..++ ..||+|++.+..    .....+.+|+.+++.++||||+++++++..++.+|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            368999999999999999999876554 689999987532    233567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...  ..
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~~~~--~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAKVVD--TR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCeecC--CC
Confidence            999999999999999888999999999999999999999999999999999999997544  89999999987543  22


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|.+||...+....+    ..+......+|.  .+++.+.+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~  257 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIY----QKILEGIIYFPK--FLDNNCKH  257 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHHH----HHHhcCCCCCCC--CCCHHHHH
Confidence            345679999999999987776544 89999999999999999999875543322    334444455555  57899999


Q ss_pred             HHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      +|++||+.+|.+|+     |++++++||||.+
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            99999999999995     8999999999964

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.1e-51  Score=382.50  Aligned_cols=255  Identities=33%  Similarity=0.518  Sum_probs=214.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      .+|++++.||+|+||+||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            37999999999999999999999999999999997643    22356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC----
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH----  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~----  153 (338)
                      ||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.....    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g--~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEeECCCCcccccccccc
Confidence            9999999999998888899999999999999999999999999999999999997554  8999999997521100    


Q ss_pred             --------------------------------------------CCCCCccccCcccccccccCCccCCCcchHHHHHHH
Q 019628          154 --------------------------------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT  189 (338)
Q Consensus       154 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i  189 (338)
                                                                  ....+.+||+.|+|||++.+..++.. +|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi  237 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence                                                        00123579999999999988887655 899999999


Q ss_pred             HHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCC---hhHHhcCccccc
Q 019628          190 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT---IPEIKNHPWFLR  262 (338)
Q Consensus       190 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~  262 (338)
                      +|+|++|++||...+..........  ......+|....+++++.++|.+|+. +|.+|++   +.++++||||..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCC
Confidence            9999999999987654333322221  12234455556789999999999874 9999997   999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-51  Score=384.52  Aligned_cols=255  Identities=33%  Similarity=0.549  Sum_probs=214.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||++.+..+++.||||++.+..    .....+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            58999999999999999999999999999999987642    22356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEEeecccccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999997544  89999999986221100   


Q ss_pred             ---------------------------------------------CCCCccccCcccccccccCCccCCCcchHHHHHHH
Q 019628          155 ---------------------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVT  189 (338)
Q Consensus       155 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i  189 (338)
                                                                   ...+.+||+.|+|||++.+..++.+ +|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence                                                         0013569999999999988777655 899999999


Q ss_pred             HHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcC---CChhHHhcCccccc
Q 019628          190 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR---ITIPEIKNHPWFLR  262 (338)
Q Consensus       190 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~s~~ell~hp~~~~  262 (338)
                      +|+|++|.+||........+......  .....+|....++.++++||.+||. +|.+|   +|+.++++||||..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            99999999999876543333332211  2234456666789999999999998 67765   59999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.4e-51  Score=380.22  Aligned_cols=255  Identities=31%  Similarity=0.477  Sum_probs=213.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .|++++.||+|+||+||+|.+..+++.||||++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6999999999999999999999999999999997643    223567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-----
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-----  153 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-----  153 (338)
                      |++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccccccccc
Confidence            999999999998888899999999999999999999999999999999999997544  8999999987532100     


Q ss_pred             -------------------------------------------CCCCCccccCcccccccccCCccCCCcchHHHHHHHH
Q 019628          154 -------------------------------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL  190 (338)
Q Consensus       154 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  190 (338)
                                                                 ....+.+||+.|+|||++.+..++.+ +|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHH
Confidence                                                       00124579999999999988777655 8999999999


Q ss_pred             HHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcc--cCCCcCCChhHHhcCccccc
Q 019628          191 YVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV--ANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       191 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dp~~R~s~~ell~hp~~~~  262 (338)
                      |+|++|..||..............  ......+|....+++++++||.+||.  .+|..|+|+.++++||||..
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            999999999987654333322221  12234556666789999999999654  45556999999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-53  Score=376.23  Aligned_cols=251  Identities=30%  Similarity=0.447  Sum_probs=219.0

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .|..++.||+|+||.||++.+..+++.||||++....  ...+.+++|+.++.+++++||.++|+.|.....++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            5788899999999999999999999999999998754  33468999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      .||++.+.++....+.+..+..++++++.||.|||..+.+|||||+.|||+..+  |.+||+|||++....... ...++
T Consensus        94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~--g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES--GDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc--CcEEEEecceeeeeechhhccccc
Confidence            999999999887777999999999999999999999999999999999999655  589999999987554332 34788


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  238 (338)
                      +|||.|||||++.+..|+.+ +||||||++.|||++|.+||.......    .+..|.+. .+.+..  .+|+.+++|+.
T Consensus       172 vGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmr----vlflIpk~~PP~L~~--~~S~~~kEFV~  244 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMR----VLFLIPKSAPPRLDG--DFSPPFKEFVE  244 (467)
T ss_pred             cccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcce----EEEeccCCCCCcccc--ccCHHHHHHHH
Confidence            99999999999998889888 899999999999999999998766521    11112222 222222  68999999999


Q ss_pred             HhcccCCCcCCChhHHhcCccccc
Q 019628          239 RIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .||.++|+.||||.++|.|+|+++
T Consensus       245 ~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             HHhhcCcccCcCHHHHhhhHHHHh
Confidence            999999999999999999999975

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.8e-51  Score=366.56  Aligned_cols=256  Identities=28%  Similarity=0.420  Sum_probs=209.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++.+.||+|+||+||++++..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            58999999999999999999999999999999987642   234567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~  156 (338)
                      |++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++  .+||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND--VLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccCcccccccccccc
Confidence            999877766555556799999999999999999999999999999999999997554  89999999998543222  22


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------ccc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VHY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (338)
                      ....||+.|+|||++.+..++.+ +||||+||++|+|++|++||......+...........               ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            34579999999999988777554 89999999999999999999876543332221111000               000


Q ss_pred             cCCCc-----------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          222 SFPDY-----------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       222 ~~~~~-----------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+|..           ..+|.++.+||++||++||++|||++++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            11111           1367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.8e-52  Score=386.85  Aligned_cols=257  Identities=29%  Similarity=0.404  Sum_probs=219.4

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-C-----CCcceeEEEEEcCCeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-H-----PNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h-----~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ||++.+.||+|+||.|-+|.+..|++.||||++++......+...|+++|..|+ |     -|+|+++++|...+++|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            799999999999999999999999999999999998888888899999999997 3     3899999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           77 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +|++ +.+|+++|+.++  +++...++.++.||+.||.+||+.||||+||||||||+.+.....|||+|||.|.....  
T Consensus       267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q--  343 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ--  343 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC--
Confidence            9999 569999998764  58999999999999999999999999999999999999766666899999999985432  


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh----------------
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS----------------  218 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----------------  218 (338)
                      ..-+++.+..|+|||++.+.+|+.. .||||||||++||++|.+.|.+.+..+++..++..+..                
T Consensus       344 ~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff  422 (586)
T KOG0667|consen  344 RVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF  422 (586)
T ss_pred             cceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence            2338899999999999999999877 89999999999999999999988877776655432100                


Q ss_pred             --------------------------------ccccCC-Ccc--------cCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          219 --------------------------------VHYSFP-DYV--------RVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       219 --------------------------------~~~~~~-~~~--------~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                                                      .....| ...        .-...+.+||++||++||.+|+|+.|+|+|
T Consensus       423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                                            000011 000        012347899999999999999999999999


Q ss_pred             cccccC
Q 019628          258 PWFLRN  263 (338)
Q Consensus       258 p~~~~~  263 (338)
                      |||...
T Consensus       503 pfl~~~  508 (586)
T KOG0667|consen  503 PFLTGT  508 (586)
T ss_pred             cccccc
Confidence            999743

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-51  Score=376.00  Aligned_cols=254  Identities=33%  Similarity=0.512  Sum_probs=216.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||+|.+..+++.||||++++..    .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997642    22356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.....  ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG--HIKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEEEeCcCCccccc--ccC
Confidence            9999999999998888899999999999999999999999999999999999997554  899999999875432  345


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCc----ccCCHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY----VRVSLEC  233 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  233 (338)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+.......  .....|..    ..++.++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCccccccCHHH
Confidence            6789999999999988877655 899999999999999999998765443333222111  11112222    2568999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+||.+||..+|.+|||+.++++||||..
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            99999999999999999999999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.4e-51  Score=372.41  Aligned_cols=247  Identities=35%  Similarity=0.593  Sum_probs=211.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      +.||+|+||.||++.+..+|+.||+|++.+..    .....+.+|+.+++.++||||++++++|...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999997642    22345678999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCcccc
Q 019628           84 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVGT  162 (338)
Q Consensus        84 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~gt  162 (338)
                      +|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... ........||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC--CEEecccHHhccccCCCCccccccCC
Confidence            9999998888899999999999999999999999999999999999997554  899999999874322 2223456799


Q ss_pred             CcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcc
Q 019628          163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV  242 (338)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (338)
                      +.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|.  .+++++.+||.+||.
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (323)
T cd05595         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFPR--TLSPEAKSLLAGLLK  231 (323)
T ss_pred             cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence            99999999988777555 8999999999999999999986544322    2233344445555  689999999999999


Q ss_pred             cCCCcCC-----ChhHHhcCcccccC
Q 019628          243 ANSEKRI-----TIPEIKNHPWFLRN  263 (338)
Q Consensus       243 ~dp~~R~-----s~~ell~hp~~~~~  263 (338)
                      .+|.+|+     ++.++++||||...
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            9999998     89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-51  Score=376.81  Aligned_cols=255  Identities=36%  Similarity=0.586  Sum_probs=219.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..    .....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            58999999999999999999999999999999997642    23356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      ||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEeecCCCCccCcccCccc
Confidence            9999999999998888899999999999999999999999999999999999997554  89999999987543322   


Q ss_pred             ---------------------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChH
Q 019628          155 ---------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK  207 (338)
Q Consensus       155 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~  207 (338)
                                                 ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                       2334579999999999988877655 899999999999999999998766443


Q ss_pred             HHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCC-hhHHhcCccccc
Q 019628          208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT-IPEIKNHPWFLR  262 (338)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~ell~hp~~~~  262 (338)
                      ........  .....+|....+++++.+||.+||. +|.+||+ +.++++||||..
T Consensus       238 ~~~~i~~~--~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         238 TYNKIINW--KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHHHhcc--CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            33332221  1334556555689999999999997 9999999 999999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-50  Score=377.22  Aligned_cols=256  Identities=33%  Similarity=0.537  Sum_probs=215.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999997532    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--Q  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~  155 (338)
                      ||++||+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.......  .
T Consensus       123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC--CEEEEeccceeeccCCCccc
Confidence            99999999998865 4689999999999999999999999999999999999997554  89999999987543322  2


Q ss_pred             CCCccccCcccccccccCCc---cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ....+||+.|+|||++.+..   ..+.++|||||||++|+|++|.+||........+......  .....+|....+|.+
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~  277 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQ  277 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCHH
Confidence            23567999999999986532   2345599999999999999999999876654443333221  123456766678999


Q ss_pred             HHHHHHHhcccCCCc--CCChhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEK--RITIPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~--R~s~~ell~hp~~~~  262 (338)
                      +++||++||+.+|.+  |+|+.++++||||..
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            999999999999988  999999999999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.7e-51  Score=374.48  Aligned_cols=257  Identities=33%  Similarity=0.566  Sum_probs=214.3

Q ss_pred             CceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ-----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      +|++++.||+|+||+||++.+.   .+++.||+|++.+..     ...+.+.+|+.+++.+ .||||+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5999999999999999999874   478999999987532     2234677899999999 589999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+||||+++|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~--~~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC--CEEEeeCcCCcccccc
Confidence            99999999999999998888899999999999999999999999999999999999997554  8999999998754322


Q ss_pred             C--CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          154 S--QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       154 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      .  .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||...............+......++.  .++.
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  236 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS--FIGP  236 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCH
Confidence            2  23346799999999999875544555899999999999999999997544333333333344444444444  6889


Q ss_pred             HHHHHHHHhcccCCCcCC-----ChhHHhcCcccccC
Q 019628          232 ECKHLLSRIFVANSEKRI-----TIPEIKNHPWFLRN  263 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~~  263 (338)
                      .+.+||.+||+.||++||     ++.++++||||...
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999999     88899999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-51  Score=372.46  Aligned_cols=245  Identities=34%  Similarity=0.583  Sum_probs=210.7

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.++++++||||+++++++..++.+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999987532    2335677899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccccCc
Q 019628           86 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVGTPA  164 (338)
Q Consensus        86 ~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~gt~~  164 (338)
                      .+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG--HIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC--cEEEEECcccccCccCCCccccccCCcc
Confidence            99998888899999999999999999999999999999999999997554  899999999875322 223345679999


Q ss_pred             ccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccC
Q 019628          165 YIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVAN  244 (338)
Q Consensus       165 y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  244 (338)
                      |+|||++.+..++.+ +||||+||++|+|++|+.||.......    ....+......+|.  .+++++++||.+||..|
T Consensus       159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~d  231 (312)
T cd05585         159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQEPLRFPD--GFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCC
Confidence            999999988777655 899999999999999999998754433    33344445555555  68899999999999999


Q ss_pred             CCcCC---ChhHHhcCcccccC
Q 019628          245 SEKRI---TIPEIKNHPWFLRN  263 (338)
Q Consensus       245 p~~R~---s~~ell~hp~~~~~  263 (338)
                      |.+||   ++.+++.||||.+.
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCC
Confidence            99997   57999999999753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.8e-51  Score=372.65  Aligned_cols=246  Identities=36%  Similarity=0.610  Sum_probs=211.1

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      +.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997642    22356778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCcccc
Q 019628           84 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVGT  162 (338)
Q Consensus        84 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~gt  162 (338)
                      +|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC--cEEEecCcCCccCCCcccccccccCC
Confidence            9999998888899999999999999999999999999999999999997554  899999999875322 2223456799


Q ss_pred             CcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcc
Q 019628          163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV  242 (338)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (338)
                      +.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+......+|.  .++.++.+||++||.
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (328)
T cd05593         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEDIKFPR--TLSADAKSLLSGLLI  231 (328)
T ss_pred             cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHH----HHHHhccCCccCCC--CCCHHHHHHHHHHcC
Confidence            99999999988777555 899999999999999999998654322    22333444455555  689999999999999


Q ss_pred             cCCCcCC-----ChhHHhcCccccc
Q 019628          243 ANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       243 ~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      .+|++|+     ++.++++||||..
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999997     8999999999964

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.5e-51  Score=380.89  Aligned_cols=255  Identities=33%  Similarity=0.531  Sum_probs=214.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      .+|++++.||+|+||.||+|.+..+++.||||++.+..    .....+.+|+.+++.++||||+++++.|..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999987532    23356789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC----
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH----  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~----  153 (338)
                      ||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|......    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC--CEEEEeCCCCcccccccccc
Confidence            9999999999998888899999999999999999999999999999999999997554  8999999997421100    


Q ss_pred             ----------------------------------------CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHH
Q 019628          154 ----------------------------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM  193 (338)
Q Consensus       154 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l  193 (338)
                                                              ......+||+.|+|||++.+..++.+ +|||||||++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence                                                    00123579999999999988777655 8999999999999


Q ss_pred             HcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCC---ChhHHhcCccccc
Q 019628          194 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLR  262 (338)
Q Consensus       194 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~  262 (338)
                      ++|+.||..............  ......+|....+++++.+||.+|+ .+|.+|+   |+.++++||||..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            999999987654333322211  1123344555578999999999987 5999999   9999999999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-50  Score=385.48  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=208.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcC--------CeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--------THL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--------~~~   73 (338)
                      .+|++++.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.++||||++++++|...        ..+
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            47999999999999999999999999999999886542   3345799999999999999999887532        257


Q ss_pred             EEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           74 AIVMEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      ++||||+++ +|..++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ +.+||+|||+|+.
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~  220 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-Cceeeeccccchh
Confidence            899999975 7777664    345799999999999999999999999999999999999997543 2699999999986


Q ss_pred             cccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-----------
Q 019628          150 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-----------  218 (338)
Q Consensus       150 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-----------  218 (338)
                      ...........||+.|+|||++.+....+.++|||||||++|+|++|.+||.+....+.+...+..+..           
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~  300 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP  300 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence            655555566789999999999876543345599999999999999999999887665554444332111           


Q ss_pred             --ccccCCCc----------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          219 --VHYSFPDY----------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       219 --~~~~~~~~----------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                        ....+|..          ...+.++++||.+||+++|.+|||+.|+|+||||...
T Consensus       301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence              01111211          1367899999999999999999999999999999653

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7e-51  Score=378.02  Aligned_cols=255  Identities=32%  Similarity=0.543  Sum_probs=215.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999997532    23356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      ||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++  +++|+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccccccccc
Confidence            9999999999998888899999999999999999999999999999999999997544  89999999986432110   


Q ss_pred             ---------------------------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCC
Q 019628          155 ---------------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE  201 (338)
Q Consensus       155 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~  201 (338)
                                                       .....+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence                                             0123579999999999988887655 899999999999999999998


Q ss_pred             CCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCC---ChhHHhcCccccc
Q 019628          202 DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLR  262 (338)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~  262 (338)
                      .......+......  .....+|....+++++++||.+|+. +|.+|+   ++.++++||||..
T Consensus       238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         238 SETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence            76554433332211  2234456555689999999999885 999998   4799999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.8e-50  Score=374.85  Aligned_cols=256  Identities=32%  Similarity=0.522  Sum_probs=213.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++..++.+|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999987532    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--Q  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~  155 (338)
                      ||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|.......  .
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~--~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEEecccceecccCCcee
Confidence            999999999998654 689999999999999999999999999999999999997554  89999999987543222  2


Q ss_pred             CCCccccCcccccccccCCc---cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ....+||+.|+|||++.+..   +.+.++||||+||++|+|++|+.||........+.....  ....+.+|....++..
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~  277 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD--HKNSLNFPEDVEISKH  277 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCcccCCCCcccCCHH
Confidence            24567999999999987543   234559999999999999999999987654443333221  1123456666678999


Q ss_pred             HHHHHHHhcccCCCc--CCChhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEK--RITIPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~--R~s~~ell~hp~~~~  262 (338)
                      +++++.+||..++.+  |+|+.|+++||||..
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            999999999865544  889999999999964

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6e-50  Score=367.61  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=213.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||.||++.+..++..+|+|.+....  .....+.+|+.+++.++||||+++++++...+.+++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            68999999999999999999999999999999987642  2345788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      +++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++  .+||+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~-~~~~~  161 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SMANS  161 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC--cEEEccCcccccccc-ccccc
Confidence            99999999998888899999999999999999999986 699999999999997554  899999999875422 23345


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh------------------------
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG------------------------  214 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~------------------------  214 (338)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .+...+.                        
T Consensus       162 ~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCccccccccc
Confidence            679999999999988777655 89999999999999999999754332 1111111                        


Q ss_pred             -------------------hHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          215 -------------------RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       215 -------------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                         .+............+++++++||.+||+.||++|||+.++++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                               0111000000112468899999999999999999999999999999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-52  Score=376.35  Aligned_cols=256  Identities=33%  Similarity=0.494  Sum_probs=225.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe-EEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH-LAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-~~iv   76 (338)
                      |++|+.++.+|+|+||.+++++++..++.|++|.+....   .......+|+.+++++.|||||.+.+.|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            689999999999999999999999999999999997643   233467899999999999999999999999888 9999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           77 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      |+||+||+|.+.|...+  .++++.+..|+.|++.||+|||+++|+|||||+.|||+..+.  .|||+|||+|+......
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~--~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK--KVKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC--ceeecchhhhhhcCCch
Confidence            99999999999998654  489999999999999999999999999999999999996554  78999999999877766


Q ss_pred             -CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          155 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                       ...+.+||+.||+||++.+..|..+ +|||||||++|||++-+++|...+......++    .... ..|....++.++
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki----~~~~-~~Plp~~ys~el  234 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKI----NRGL-YSPLPSMYSSEL  234 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHH----hhcc-CCCCCccccHHH
Confidence             6778899999999999999999777 89999999999999999999986654444433    3333 234445799999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +.+|+.||..+|..||++.++|.+|.++...
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            9999999999999999999999999886543

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.8e-51  Score=374.14  Aligned_cols=255  Identities=30%  Similarity=0.539  Sum_probs=215.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||+||++.+..+++.||+|++++...    ....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            579999999999999999999999999999999986432    3356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           78 EYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      ||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++........ 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC--CEEeccCCCCeECCCCCce
Confidence            999999999999876 6799999999999999999999999999999999999997554  899999999975433222 


Q ss_pred             -CCCccccCcccccccccC------CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          156 -PKSTVGTPAYIAPEVLTK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                       .....||+.|+|||++..      ..+ +.++|||||||++|+|++|..||........+......  .....+|....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~  235 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPK  235 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCC
Confidence             233579999999999863      334 34489999999999999999999876654443333221  12234566557


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ++.++.+||.+||. +|.+|||+.++++||||..
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            89999999999998 9999999999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.5e-50  Score=365.90  Aligned_cols=251  Identities=31%  Similarity=0.541  Sum_probs=213.8

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCC-CcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHP-NIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~-~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +|++++.||+|+||.||+|.+..+++.||||++.+..    .....+..|+.+++.++|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999997632    2335677889999999765 5888999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~~  156 (338)
                      ||+++|+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.... .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC--CEEEeecCcceecCCCCCce
Confidence            9999999999998888899999999999999999999999999999999999997554  89999999987432 22233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........    ...+......+|.  .++.++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~l  231 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQSIMEHNVSYPK--SLSKEAVSI  231 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHH
Confidence            45679999999999988777555 8999999999999999999987554332    2334444455554  688999999


Q ss_pred             HHHhcccCCCcCCCh-----hHHhcCccccc
Q 019628          237 LSRIFVANSEKRITI-----PEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s~-----~ell~hp~~~~  262 (338)
                      +++||..+|.+|+++     .++++||||..
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999999999999987     89999999964

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=352.00  Aligned_cols=261  Identities=31%  Similarity=0.517  Sum_probs=225.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      +.||+|+|+.|--+.+..++..||||++.+.. ....++.||++++.++ .|+||++++++|+++..+|+|||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            57999999999999999999999999998864 3457899999999888 599999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEec-CCCCCcEEEeecCCCcccccC--------CCC
Q 019628           86 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSTAPRVKICDFGYSKSSVLH--------SQP  156 (338)
Q Consensus        86 ~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~-~~~~~~ikL~Dfg~a~~~~~~--------~~~  156 (338)
                      ...|.+++.++|.++..+++.|+.||++||.+||.||||||+|||.. .+.-.-+|||||.+.......        ...
T Consensus       164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L  243 (463)
T KOG0607|consen  164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL  243 (463)
T ss_pred             HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence            99999999999999999999999999999999999999999999984 223336899999987643221        122


Q ss_pred             CCccccCccccccccc----CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC-----------hHHHHHHHhhHhhccc
Q 019628          157 KSTVGTPAYIAPEVLT----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-----------PKNFRKTIGRILSVHY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-----------~~~~~~~~~~~~~~~~  221 (338)
                      .+.+|+..|||||++.    ...++.+.+|.||||+|+|-||+|++||.+...           ..-.++.+..|..+.|
T Consensus       244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY  323 (463)
T KOG0607|consen  244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY  323 (463)
T ss_pred             cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC
Confidence            4568999999999863    344556779999999999999999999975443           2345677888999999


Q ss_pred             cCCC--cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCccc
Q 019628          222 SFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIEL  268 (338)
Q Consensus       222 ~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~  268 (338)
                      .||+  |..+|.++++|++.+|..++..|.++.++++|||++...+...
T Consensus       324 eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka  372 (463)
T KOG0607|consen  324 EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA  372 (463)
T ss_pred             cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence            9995  8899999999999999999999999999999999987765543

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-50  Score=366.22  Aligned_cols=248  Identities=33%  Similarity=0.544  Sum_probs=210.6

Q ss_pred             eeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ-----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++.||+|+||.||+|++.   .+++.||+|++++..     .....+.+|+.+++.++||||++++++|..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999874   478899999987532     223456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~  157 (338)
                      |+++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccCCCccc
Confidence            999999999998888899999999999999999999999999999999999997554  899999999874322 22334


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+......+|.  .+++++.+||
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~li  231 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGKLNLPP--YLTPEARDLL  231 (323)
T ss_pred             ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHH
Confidence            5679999999999988776544 899999999999999999998755433    23334444555554  5789999999


Q ss_pred             HHhcccCCCcCC-----ChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRI-----TIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~-----s~~ell~hp~~~~~  263 (338)
                      .+||+.+|++||     ++.++++||||...
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.2e-50  Score=367.69  Aligned_cols=246  Identities=33%  Similarity=0.535  Sum_probs=209.4

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||+||+|.++.+++.||||++.+..    .....+.+|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532    2234566788888766 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      |+|...+.....+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++.... ........|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~--~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--cEEEeeCCCCeecCcCCCccccccc
Confidence            99999998888899999999999999999999999999999999999997554  899999999874322 223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|.  .++.++.+||++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~L  231 (320)
T cd05590         159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPT--WLSQDAVDILKAFM  231 (320)
T ss_pred             CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988777555 8999999999999999999987654332    3334444555555  57899999999999


Q ss_pred             ccCCCcCCCh------hHHhcCccccc
Q 019628          242 VANSEKRITI------PEIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~s~------~ell~hp~~~~  262 (338)
                      +.||.+||++      +++++||||..
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            9999999998      99999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-50  Score=369.03  Aligned_cols=250  Identities=29%  Similarity=0.510  Sum_probs=209.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||++.+..+++.||+|++++..    .....+.+|+.+++.+ +||||++++++|...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998642    2234577899999888 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~~~~~~g  161 (338)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++... ........+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEECcCccccccccCCCccccccC
Confidence            99999998888899999999999999999999999999999999999997554  89999999987432 2233445689


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----NFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      |+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.......     ......+.+......+|.  .++.++.+|
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l  235 (329)
T cd05588         159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSV  235 (329)
T ss_pred             CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence            999999999988777655 899999999999999999996422111     111223334444555565  578999999


Q ss_pred             HHHhcccCCCcCCC------hhHHhcCccccc
Q 019628          237 LSRIFVANSEKRIT------IPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s------~~ell~hp~~~~  262 (338)
                      |++||+.+|.+|+|      +.++++||||..
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            99999999999997      789999999954

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.7e-50  Score=367.92  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=206.0

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THLA   74 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~~   74 (338)
                      ||++.+.||+|+||.||++.+..+++.||||++....   .....+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            7999999999999999999999999999999987532   2234678999999999999999999988643     3589


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEccCcccccccccc
Confidence            9999995 68999998888899999999999999999999999999999999999997554  89999999987432221


Q ss_pred             ----CCCCccccCcccccccccC--CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh--------------
Q 019628          155 ----QPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG--------------  214 (338)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~--------------  214 (338)
                          ......||+.|+|||++.+  ..++ .++|||||||++|+|++|++||..............              
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence                1234579999999999865  4454 448999999999999999999977554322211100              


Q ss_pred             ---------hHhhcc-ccC-CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          215 ---------RILSVH-YSF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       215 ---------~~~~~~-~~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                               .+.... ..+ ......++++.++|.+||+.+|++|||+.|+++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                     000000 000 1123467889999999999999999999999999999653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-50  Score=373.89  Aligned_cols=253  Identities=20%  Similarity=0.296  Sum_probs=205.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .+|++++.||+|+||.||+|.+..+++.||+|+...     ..+.+|+.++++++||||++++++|..+...+++||++.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            579999999999999999999999999999997542     356789999999999999999999999999999999995


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC--CCCCCc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--SQPKST  159 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~--~~~~~~  159 (338)
                       ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++..+  .+||+|||+|+.....  ......
T Consensus       167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~--~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG--DVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC--CEEEEeCCcccccccccccccccc
Confidence             68999998888899999999999999999999999999999999999997554  7999999998643221  223356


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC-------hHHHHHHHhhHh---------------
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRIL---------------  217 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-------~~~~~~~~~~~~---------------  217 (338)
                      +||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....       ...+...+....               
T Consensus       244 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        244 AGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             cCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            79999999999988777554 8999999999999999988753221       111111111100               


Q ss_pred             -------hccc----cCCC---cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          218 -------SVHY----SFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       218 -------~~~~----~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                             ....    ..+.   ...++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                   0000    0111   11356789999999999999999999999999999753

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-49  Score=364.32  Aligned_cols=251  Identities=32%  Similarity=0.538  Sum_probs=213.4

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +|++++.||+|+||.||++.+..+++.||+|++.+...    .......|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999876421    223456677777776 5899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~  156 (338)
                      ||+++|+|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC--cEEEccCCCceecCCCCCcc
Confidence            9999999999998888899999999999999999999999999999999999997655  899999999874322 2233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........    ...+......+|.  .++.++.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~l  231 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPK--SMSKEAVAI  231 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--cCCHHHHHH
Confidence            45679999999999988887655 8999999999999999999987554332    3334445555565  689999999


Q ss_pred             HHHhcccCCCcCCCh-----hHHhcCccccc
Q 019628          237 LSRIFVANSEKRITI-----PEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s~-----~ell~hp~~~~  262 (338)
                      +.+||+.+|.+|++.     .++++||||..
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            999999999999985     89999999964

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-50  Score=358.97  Aligned_cols=255  Identities=24%  Similarity=0.397  Sum_probs=215.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999875321    22446789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           79 YAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |+++++|...+...  ..+++..+..++.|++.||.|||++|++||||||+||++++++  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCCcc
Confidence            99999999888643  3589999999999999999999999999999999999997554  8999999998865444444


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+|++.|+|||++.+..++.+ +||||+||++|+|++|+.||...............+......++.  .++..+.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  235 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSI  235 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc--ccCHHHHHH
Confidence            55689999999999987777655 899999999999999999998765443333333333333333333  588999999


Q ss_pred             HHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          237 LSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      |.+||..||++||     ++.++++||||..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            9999999999999     8999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.7e-50  Score=368.06  Aligned_cols=247  Identities=36%  Similarity=0.590  Sum_probs=210.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      +.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++..++.+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997632    22345678999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           84 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        84 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      +|...+.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++  .+||+|||+++.... ........|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC--CEEEecCCCCeecCCCCcccccccC
Confidence            999999888889999999999999999999997 7999999999999997554  899999999874322 223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.......    ....+......+|.  .+++++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~li~~~L  231 (325)
T cd05594         159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIRFPR--TLSPEAKSLLSGLL  231 (325)
T ss_pred             CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHH----HHHHHhcCCCCCCC--CCCHHHHHHHHHHh
Confidence            999999999988777655 899999999999999999998654422    22333444455555  58899999999999


Q ss_pred             ccCCCcCC-----ChhHHhcCcccccC
Q 019628          242 VANSEKRI-----TIPEIKNHPWFLRN  263 (338)
Q Consensus       242 ~~dp~~R~-----s~~ell~hp~~~~~  263 (338)
                      +.||++|+     ++.++++||||...
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            99999997     99999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-49  Score=369.40  Aligned_cols=257  Identities=27%  Similarity=0.448  Sum_probs=207.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------   71 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------   71 (338)
                      +++|++.+.||+|+||.||++.+..+|+.||+|++.+..   .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999999999999999987532   23456778999999999999999999986543      


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           72 HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      .+|+||||+++ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~--~~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEecCCCccccc
Confidence            57999999965 6776664  3589999999999999999999999999999999999997554  89999999998654


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH---------------
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI---------------  216 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~---------------  216 (338)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+.......               
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            4444556789999999999988877665 899999999999999999998765433332222111               


Q ss_pred             ---hhcccc---------CCCc---------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          217 ---LSVHYS---------FPDY---------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       217 ---~~~~~~---------~~~~---------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                         ......         ++.+         ...++++++||.+||..||++|||+.|+|+||||...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence               000000         1111         1246789999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-49  Score=363.92  Aligned_cols=250  Identities=35%  Similarity=0.583  Sum_probs=210.4

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHH---hcCCCCCcceeEEEEEcCCeEEEE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNH---RSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l---~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      |++++.||+|+||.||++.+..+++.||||++++..    ...+.+.+|+.++   +.++||||+++++++...+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999997642    2234566666554   567899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~  155 (338)
                      |||+++++|...+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++.... ...
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG--FVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--cEEeCcccCCccCCCCCCc
Confidence            999999999988854 5799999999999999999999999999999999999997655  899999999874322 223


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+    ..+......+|.  .++..+.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~  230 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVF----DSIVNDEVRYPR--FLSREAIS  230 (324)
T ss_pred             ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCC--CCCHHHHH
Confidence            345679999999999988777555 89999999999999999999875543322    334444445554  57899999


Q ss_pred             HHHHhcccCCCcCC-----ChhHHhcCcccccC
Q 019628          236 LLSRIFVANSEKRI-----TIPEIKNHPWFLRN  263 (338)
Q Consensus       236 li~~~L~~dp~~R~-----s~~ell~hp~~~~~  263 (338)
                      ||.+||+.||.+||     ++.++++||||...
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            99999999999999     79999999999653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-49  Score=368.18  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=208.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC------C
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------T   71 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~   71 (338)
                      +++|++.+.||+|+||.||++.+..+++.||||++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            478999999999999999999999999999999987532   2335678899999999999999999988654      3


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           72 HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      .+|+||||+++ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~  177 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAG  177 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC--cEEEEeCCCccccC
Confidence            57999999965 77777753  588999999999999999999999999999999999997554  89999999998654


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-------------
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------  218 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------------  218 (338)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+...+..+..             
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            4444456789999999999988777655 89999999999999999999876654444443321110             


Q ss_pred             -----cccc---------CCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          219 -----VHYS---------FPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       219 -----~~~~---------~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                           ....         ++.         ....+.++++||.+||+.||.+|||+.++|+||||..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                 0000         000         0113567899999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=353.77  Aligned_cols=253  Identities=38%  Similarity=0.622  Sum_probs=225.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      |++|..++.||+|.||.|.+|+.+.+++.||||++++.-    ....+-.-|-++|+..+||++..+...|+..+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            788999999999999999999999999999999998743    2334566788999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc-ccCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~-~~~~~  155 (338)
                      |||++||.|+..+.....+++...+.+-..|+.||.|||+++||.||||.+|+|+|.++  +|||+|||+++.. .....
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG--HIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG--HIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC--ceEeeecccchhcccccce
Confidence            99999999999999888999999999999999999999999999999999999997554  9999999999843 34556


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ..++||||.|.|||++....|. .++|+|.+||++|||++|+.||...+..    +.+.-|.-....||.  .++++++.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~----kLFeLIl~ed~kFPr--~ls~eAkt  397 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHE----KLFELILMEDLKFPR--TLSPEAKT  397 (516)
T ss_pred             eccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchh----HHHHHHHhhhccCCc--cCCHHHHH
Confidence            7789999999999999988885 4489999999999999999999875543    344456667788888  79999999


Q ss_pred             HHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      |+..+|.+||.+|.     .+.|+.+|+||..
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            99999999999998     5799999999964

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.6e-49  Score=368.57  Aligned_cols=256  Identities=35%  Similarity=0.528  Sum_probs=212.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++..++.+|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999987532    22345678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--Q  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~  155 (338)
                      ||++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++......  .
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~--~ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--CEEEEeCCceeEcCcCCccc
Confidence            999999999998654 689999999999999999999999999999999999997554  89999999987543322  2


Q ss_pred             CCCccccCcccccccccCCc---cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ....+||+.|+|||++.+..   ..+.++|||||||++|+|++|.+||...+....+......  .....+|....++..
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~  277 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDISKE  277 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCCHH
Confidence            23567999999999987543   2345599999999999999999999876544333332221  123456666679999


Q ss_pred             HHHHHHHhcccCCCc--CCChhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEK--RITIPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~--R~s~~ell~hp~~~~  262 (338)
                      +++||.+||..++.+  |+++.++++||||.+
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            999999999844433  789999999999964

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8e-50  Score=366.44  Aligned_cols=250  Identities=29%  Similarity=0.514  Sum_probs=208.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||++.+..+++.||+|++++..    .....+.+|+.++.++ +||||+++++++..++.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998642    2234567888888766 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~~~~~~g  161 (338)
                      ++|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++... .........|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~--~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--CEEEeeCCccccccCCCCccccccC
Confidence            99999998888899999999999999999999999999999999999997554  89999999987432 2223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC-----hHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-----PKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.....     ..........+......+|.  .++..+.+|
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~l  235 (329)
T cd05618         159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV  235 (329)
T ss_pred             CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHH
Confidence            999999999988777655 8999999999999999999953211     11112223334444555665  688999999


Q ss_pred             HHHhcccCCCcCCC------hhHHhcCccccc
Q 019628          237 LSRIFVANSEKRIT------IPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s------~~ell~hp~~~~  262 (338)
                      |++||+.||.+|||      +.++++||||..
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            99999999999998      479999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-49  Score=357.25  Aligned_cols=255  Identities=29%  Similarity=0.425  Sum_probs=204.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-CCcEEEEEEeecCc---cccHHHHHHHHHHhcC---CCCCcceeEEEEEc-----
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQ---KIDEHVQREIMNHRSL---KHPNIVRFKEVLLT-----   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~-----   69 (338)
                      ++|++++.||+|+||+||+|.+.. +++.||+|++....   .......+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            589999999999999999999854 46889999887532   2224566777777665   69999999998852     


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           70 PTHLAIVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ...+++||||++ ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~--~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC--CEEEccccce
Confidence            456999999996 5899988653  3589999999999999999999999999999999999997554  8999999999


Q ss_pred             cccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCC-
Q 019628          148 KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPD-  225 (338)
Q Consensus       148 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~-  225 (338)
                      +............||+.|+|||++.+..++.+ +|||||||++|+|++|.+||........+.......... ...++. 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            76544444456679999999999988777655 899999999999999999999876655544443221100 000100 


Q ss_pred             -------------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          226 -------------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       226 -------------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                                         ...++..+++|+.+||+.+|++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                               12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-49  Score=380.96  Aligned_cols=260  Identities=24%  Similarity=0.387  Sum_probs=204.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC------CCcceeEEEEEcC-CeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH------PNIVRFKEVLLTP-THLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h------~~Iv~~~~~~~~~-~~~~   74 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||+++...........|+.+++.+.|      .++++++++|..+ .++|
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            57999999999999999999999999999999997654444556677777777654      4588999988765 5799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCC--------------CcE
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTA--------------PRV  139 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~--------------~~i  139 (338)
                      +||+++ |++|.+++...+.+++..++.++.||+.||.|||+ .|||||||||+|||++..+.              ..+
T Consensus       209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v  287 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV  287 (467)
T ss_pred             EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence            999998 77999999888889999999999999999999998 59999999999999975432              249


Q ss_pred             EEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc
Q 019628          140 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV  219 (338)
Q Consensus       140 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  219 (338)
                      ||+|||.+...  .......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||........+..+...+...
T Consensus       288 kl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        288 RICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             EECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence            99999987632  223456789999999999988887655 899999999999999999998765543332221111000


Q ss_pred             ccc--------------------CCC----------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          220 HYS--------------------FPD----------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       220 ~~~--------------------~~~----------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ...                    .+.                .....+.+.+||.+||++||.+|||+.|+|+||||.+.
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            000                    000                00123567899999999999999999999999999765


Q ss_pred             CC
Q 019628          264 LP  265 (338)
Q Consensus       264 ~~  265 (338)
                      .+
T Consensus       445 ~~  446 (467)
T PTZ00284        445 YP  446 (467)
T ss_pred             CC
Confidence            43

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-49  Score=364.57  Aligned_cols=246  Identities=33%  Similarity=0.528  Sum_probs=209.5

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||+|.+..+++.||+|++.+..    .....+..|..+++.+ +||||++++++|..++.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999987642    2234566788888765 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++..... ........|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeecccceecccCCcccccccc
Confidence            99999998888899999999999999999999999999999999999997654  899999999874322 223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~ll~~~L  231 (321)
T cd05591         159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDL----FESILHDDVLYPV--WLSKEAVSILKAFM  231 (321)
T ss_pred             CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence            999999999988777655 8999999999999999999987654333    3334444555555  47899999999999


Q ss_pred             ccCCCcCC-------ChhHHhcCccccc
Q 019628          242 VANSEKRI-------TIPEIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~-------s~~ell~hp~~~~  262 (338)
                      +.+|++||       ++.++++||||..
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            99999999       9999999999954

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.4e-49  Score=359.16  Aligned_cols=259  Identities=27%  Similarity=0.449  Sum_probs=210.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      |++|++++.||+|+||.||++.+..+++.||+|+++...  .....+.+|+.++++++||||+++++++..++..|+|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            689999999999999999999999999999999987542  223467789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      |+++ +|...+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++..... ...
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECccccceecCCCcccc
Confidence            9975 888887654 3489999999999999999999999999999999999997554  8999999998743222 223


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------ccc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VHY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (338)
                      ....+|+.|+|||++.+....+.++|||||||++|+|+||++||...+..+...........               ...
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            34578999999999876543445599999999999999999999876654443333221110               001


Q ss_pred             cCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          222 SFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       222 ~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .++.         ...++.++++||.+||..||.+|||+.|+++||||..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence            1111         1246889999999999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-49  Score=362.75  Aligned_cols=257  Identities=30%  Similarity=0.533  Sum_probs=208.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||++.+..+++.||+|++.+..    ...+.+.+|+.+++.++|+||++++++|..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999997532    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      ||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||++........ 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC--CEEEEECCceeecCCCCCc
Confidence            99999999999976 45799999999999999999999999999999999999996554  899999999875433222 


Q ss_pred             -CCCccccCcccccccccC----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC-cccC
Q 019628          156 -PKSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-YVRV  229 (338)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  229 (338)
                       .....||+.|+|||++..    ....+.++||||+||++|+|++|+.||........+......  ...+.++. ...+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~  236 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDV  236 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCC
Confidence             223469999999999863    222344589999999999999999999875543333332211  11122322 2357


Q ss_pred             CHHHHHHHHHhcccCCCc--CCChhHHhcCccccc
Q 019628          230 SLECKHLLSRIFVANSEK--RITIPEIKNHPWFLR  262 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~  262 (338)
                      +.++++||++||..++++  |+++.++++||||..
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            999999999999764444  789999999999964

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.5e-49  Score=362.61  Aligned_cols=247  Identities=33%  Similarity=0.550  Sum_probs=207.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhc-CCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRS-LKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||++.+..+|+.||+|++++..    ........|..++.. ++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999997642    223456677777765 4899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      ++|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++  .++|+|||+++.... .......+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEeCccCCCeecccCCCceeccCC
Confidence            99999998888899999999999999999999999999999999999997654  899999999874322 223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.......    ....+......+|.  .++.++++||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05620         159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDE----LFESIRVDTPHYPR--WITKESKDILEKLF  231 (316)
T ss_pred             CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988777655 899999999999999999998655432    22333333444554  47899999999999


Q ss_pred             ccCCCcCCCh-hHHhcCcccccC
Q 019628          242 VANSEKRITI-PEIKNHPWFLRN  263 (338)
Q Consensus       242 ~~dp~~R~s~-~ell~hp~~~~~  263 (338)
                      ..||++||++ .++++||||...
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCC
Confidence            9999999998 589999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-49  Score=366.99  Aligned_cols=254  Identities=30%  Similarity=0.469  Sum_probs=206.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||.||++.+..+++.||||++....  .....+.+|+.+++.++|+||+++++++...+.+|+||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            56889999999999999999999999999999986543  2345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  158 (338)
                      +++++|...    ...++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... .....
T Consensus       154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK--NVKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEcccccceecccccccccc
Confidence            999988542    3467888999999999999999999999999999999997554  8999999998754322 22345


Q ss_pred             ccccCcccccccccC----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh-hccccCCCcccCCHHH
Q 019628          159 TVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-SVHYSFPDYVRVSLEC  233 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (338)
                      ..||..|+|||++..    ..+.+.++|||||||++|+|++|+.||...... .+......+. ......  ...++.++
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~l  304 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICMSQPPEA--PATASREF  304 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhccCCCCC--CCccCHHH
Confidence            679999999999853    234445689999999999999999999843322 2222222221 111122  23678999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ++||.+||..+|++|||+.|+++||||....
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999997653

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.8e-49  Score=356.03  Aligned_cols=248  Identities=32%  Similarity=0.458  Sum_probs=206.8

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ||+|+||+||++.+..+++.||+|++.+...    ....+..|+.+++.++||||+++.+++..+..+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999875422    224567899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCcc
Q 019628           86 FERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTV  160 (338)
Q Consensus        86 ~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~  160 (338)
                      ...+..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++  .++|+|||++...... .......
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCccceecCCCCccccccC
Confidence            887742    34689999999999999999999999999999999999997554  7999999998754332 2233467


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHh
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI  240 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (338)
                      ||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...............+......++.  .++.++.+++.+|
T Consensus       159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~  235 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEAL  235 (280)
T ss_pred             CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc--cCCHHHHHHHHHH
Confidence            9999999999988877655 899999999999999999998654433323333333333333443  5889999999999


Q ss_pred             cccCCCcCC-----ChhHHhcCccccc
Q 019628          241 FVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       241 L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      |+.+|++||     |++++++||||+.
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            999999999     8899999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-49  Score=366.56  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=206.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC------Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~   72 (338)
                      ++|++++.||+|+||+||++.+..+++.||+|++.+..   .....+.+|+.+++.++||||++++++|...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            68999999999999999999999999999999987642   2234577899999999999999999988643      35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|++++++ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++....
T Consensus        95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~--~~kl~Dfg~~~~~~~  170 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQADD  170 (343)
T ss_pred             EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC--CEEEcCCccceecCC
Confidence            79999998 779988775 45799999999999999999999999999999999999997554  899999999985432


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------  219 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (338)
                        ......||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..........             
T Consensus       171 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             --CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence              34456799999999999774444555999999999999999999998755433332222111000             


Q ss_pred             ------cccCCC------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          220 ------HYSFPD------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       220 ------~~~~~~------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                            ....+.      ....++.+.+||.+||..||.+|||+.|+|+||||.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                  000010      123567789999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-49  Score=362.48  Aligned_cols=246  Identities=37%  Similarity=0.606  Sum_probs=209.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||+||+|.+..+++.||||++++..    .....+.+|+.+++.+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998642    2234567888888877 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      ++|...+.....+++..+..++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG--HIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC--cEEecccCCCeecCcCCCcccceec
Confidence            99999998888899999999999999999999999999999999999997655  899999999874322 223344679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||........    ...+......+|.  .++.++.+||++||
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (318)
T cd05570         159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDEVRYPR--WLSKEAKSILKSFL  231 (318)
T ss_pred             CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCCC--cCCHHHHHHHHHHc
Confidence            999999999988877655 8999999999999999999986553322    2333444445554  57899999999999


Q ss_pred             ccCCCcCCCh-----hHHhcCccccc
Q 019628          242 VANSEKRITI-----PEIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~s~-----~ell~hp~~~~  262 (338)
                      ..||++|||+     .++++||||..
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999999999     99999999965

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-51  Score=396.13  Aligned_cols=255  Identities=36%  Similarity=0.549  Sum_probs=220.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|+|++.||+|+||.|.+++++.+++.||+|++.+-    .....-|..|-.+|..-+.+-|+.++..|.++.++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            5899999999999999999999999999999999872    223345777888888889999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--Q  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~  155 (338)
                      |||+||+|..++.+..++|+..+++|+..|+.||.-||+.|+|||||||+|||+|-.+  +|||+|||.+-......  .
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhcCCCCcEE
Confidence            9999999999999988999999999999999999999999999999999999997555  99999999887655333  2


Q ss_pred             CCCccccCcccccccccC---C-ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc--cccCCCcccC
Q 019628          156 PKSTVGTPAYIAPEVLTK---K-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVRV  229 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~---~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  229 (338)
                      ....+|||.|.+||++..   + ..+++.+|+||+||++|||+.|..||....    +..+...|.+-  .+.||....+
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHHHhchhhhcCCCccccc
Confidence            456789999999999853   2 344666999999999999999999998744    44444555543  7788977789


Q ss_pred             CHHHHHHHHHhcccCCCcCCC---hhHHhcCcccccC
Q 019628          230 SLECKHLLSRIFVANSEKRIT---IPEIKNHPWFLRN  263 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~~  263 (338)
                      |.++++||++++. +|+.|..   ++++..||||.+.
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            9999999999976 7899998   9999999999643

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.2e-49  Score=364.27  Aligned_cols=257  Identities=26%  Similarity=0.416  Sum_probs=208.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC------C
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------T   71 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~   71 (338)
                      +++|++++.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            478999999999999999999999999999999987542   2235677899999999999999999998654      3


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           72 HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      .+|+||||+++ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~--~~kl~Dfg~~~~~~  170 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAG  170 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC--CEEEeeCcccccCC
Confidence            57999999965 67777653  589999999999999999999999999999999999997554  89999999998654


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-------------
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------  218 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------------  218 (338)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........+...+.....             
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            4444556789999999999988777655 89999999999999999999876544443332221110             


Q ss_pred             -----cc-----ccCC----C---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          219 -----VH-----YSFP----D---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       219 -----~~-----~~~~----~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                           ..     ..++    .         ....+.++++||.+||..||++|||+.|+|+||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                 00     0000    0         11235678999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.6e-49  Score=366.81  Aligned_cols=258  Identities=28%  Similarity=0.392  Sum_probs=210.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-----eEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-----HLA   74 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~~   74 (338)
                      +|++++.||+|+||.||++.+..+++.||||++....   ...+.+.+|+.+++.++||||+++++++..++     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5889999999999999999999999999999986532   22356889999999999999999999998876     799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-  153 (338)
                      +||||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC--CEEeccccceeecccCc
Confidence            9999996 58999888888899999999999999999999999999999999999997554  8999999998754322 


Q ss_pred             -CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhh-----------------
Q 019628          154 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR-----------------  215 (338)
Q Consensus       154 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~-----------------  215 (338)
                       .......+|+.|+|||++.+....+.++||||+||++|+|++|+.||...+...........                 
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence             22334578999999999987554455589999999999999999999876554333322111                 


Q ss_pred             --HhhccccCC-------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          216 --ILSVHYSFP-------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       216 --~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                        +.......+       .....++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence              011111111       112457889999999999999999999999999999763

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-49  Score=360.37  Aligned_cols=247  Identities=34%  Similarity=0.569  Sum_probs=207.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhc-CCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRS-LKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||+||+|.+..+++.||||++++..    ........|..+++. ++||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999997642    223455667777765 5899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      |+|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++.... ........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG--HIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--CEEEccCCcceECCCCCCceeeecC
Confidence            99999998877899999999999999999999999999999999999997654  899999999874322 223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +||||+||++|+|++|..||...+....    ...+......+|.  .++.++++||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05619         159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSIRMDNPCYPR--WLTREAKDILVKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHHHHHHHh
Confidence            999999999988777655 8999999999999999999987554322    2223333344454  47899999999999


Q ss_pred             ccCCCcCCChh-HHhcCcccccC
Q 019628          242 VANSEKRITIP-EIKNHPWFLRN  263 (338)
Q Consensus       242 ~~dp~~R~s~~-ell~hp~~~~~  263 (338)
                      +.+|++||++. ++++||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCC
Confidence            99999999996 89999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.5e-49  Score=360.27  Aligned_cols=246  Identities=37%  Similarity=0.619  Sum_probs=205.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhc-CCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRS-LKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||+||+|.+..+++.||+|++++..    ........|..++.. .+||||+++++++..++.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997642    222344556666654 4899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      |+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG--HIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC--CEEEccCcCCeECCCCCCccccccC
Confidence            99999998888899999999999999999999999999999999999997554  899999999875322 223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+    ..+......+|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~ll~~~l  231 (316)
T cd05592         159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELF----DSILNDRPHFPR--WISKEAKDCLSKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988777655 89999999999999999999876543322    233333444444  57899999999999


Q ss_pred             ccCCCcCCChh-HHhcCccccc
Q 019628          242 VANSEKRITIP-EIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~s~~-ell~hp~~~~  262 (338)
                      +.+|.+||++. ++++||||..
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCC
Confidence            99999999874 8889999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.4e-49  Score=360.67  Aligned_cols=247  Identities=35%  Similarity=0.575  Sum_probs=206.1

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHH-HHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIM-NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||+||++.+..+|+.||||++.+..    .....+.+|.. +++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999997642    12233444544 56789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--cEEEeccCCCcccccCCCccccccC
Confidence            99999998888899999999999999999999999999999999999997554  899999999874322 223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......+.  .++..+.++|++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEM----YDNILNKPLRLKP--NISVSARHLLEGLL  231 (323)
T ss_pred             ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence            999999999988777655 8999999999999999999987544332    2233333333333  57899999999999


Q ss_pred             ccCCCcCCCh----hHHhcCcccccC
Q 019628          242 VANSEKRITI----PEIKNHPWFLRN  263 (338)
Q Consensus       242 ~~dp~~R~s~----~ell~hp~~~~~  263 (338)
                      +.+|.+||++    .++++||||...
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            9999999998    599999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.4e-49  Score=360.62  Aligned_cols=256  Identities=28%  Similarity=0.482  Sum_probs=211.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.++||+|+||.||++.+..++..+|+|++....  .....+.+|+.+++.++||||++++++|...+.+|+||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            68999999999999999999999999999999887642  2335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      +++++|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++  .+||+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~-~~~~~  161 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SMANS  161 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC--CEEEeeCCcchhhhh-hcccc
Confidence            99999999998888899999999999999999999985 799999999999997554  799999999874422 23345


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh------------------------
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG------------------------  214 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~------------------------  214 (338)
                      ..||..|+|||++.+..++.+ +|+|||||++|+|++|+.||....... ....+.                        
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         162 FVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKE-LELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             CCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhH-HHHHhcCcccCCccccccCcccCCccchhh
Confidence            679999999999987776555 899999999999999999997543311 111110                        


Q ss_pred             -----------------hHhhc-cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          215 -----------------RILSV-HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       215 -----------------~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                       .+... ...++ ....+.++++||.+||+.||++|||+.|++.||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                             00000 00111 11357889999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1e-48  Score=358.21  Aligned_cols=251  Identities=31%  Similarity=0.547  Sum_probs=212.4

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.+..    ...+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4889999999999999999999999999999987632    22345677888888876 577888999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      ||+++|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ...
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~--~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeccccccccCCCCccc
Confidence            9999999999998888899999999999999999999999999999999999997654  8999999998743222 223


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||+.|+|||++.+..++.+ +||||+||++|+|++|.+||.......    ....+......+|.  .++.++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  231 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHNVSYPK--SLSKEAVSI  231 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHHHH
Confidence            45679999999999988777555 899999999999999999998755432    23334444555555  578999999


Q ss_pred             HHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          237 LSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      +.+||+.+|.+|++     ..++++||||..
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence            99999999999997     478999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.8e-49  Score=352.15  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=204.9

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcC---CCCCcceeEEEEEc-----CC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSL---KHPNIVRFKEVLLT-----PT   71 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~-----~~   71 (338)
                      +|++++.||+|+||+||+|.+..+++.||+|.++...   .......+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            6999999999999999999999999999999987532   2224566777777665   79999999998864     34


Q ss_pred             eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           72 HLAIVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      .++++||++.+ +|..++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--QVKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccCcccc
Confidence            68999999974 898888653  3489999999999999999999999999999999999997554  899999999986


Q ss_pred             cccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCC----
Q 019628          150 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFP----  224 (338)
Q Consensus       150 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~----  224 (338)
                      ...........||+.|+|||++.+..++.+ +||||+||++|+|++|.+||..........+........ ...++    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            544444455678999999999988777555 899999999999999999998766554444433221100 00000    


Q ss_pred             ----------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          225 ----------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       225 ----------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                                      ....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                            012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-49  Score=360.23  Aligned_cols=245  Identities=31%  Similarity=0.463  Sum_probs=205.8

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcE-EEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeEEEEEcCC-eEEEEEe
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKI---DEHVQREIMNHRSLKHPNIVRFKEVLLTPT-HLAIVME   78 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~-vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-~~~iv~e   78 (338)
                      ..+.+.||.|+||+||++...  |.. ||+|++......   .+.+.+|+.+|++++|||||++++++..+. .+++|||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            345667999999999999885  666 999999865422   458999999999999999999999999887 7999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcC-ceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-C
Q 019628           79 YAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~-iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~  154 (338)
                      |+++|+|..++..  ...++...+..++.||++|++|||+++ ||||||||+|||++... .++||+|||+++..... .
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKT  199 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccc
Confidence            9999999999987  578999999999999999999999999 99999999999997653 38999999999865543 3


Q ss_pred             CCCCccccCccccccccc--CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          155 QPKSTVGTPAYIAPEVLT--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ..+...||+.|||||++.  +..|+.+ +||||+|+++|||+||..||.............  .......+|.  ..++.
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~--~~~~Rp~~p~--~~~~~  274 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV--VGGLRPPIPK--ECPPH  274 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hcCCCCCCCc--cCCHH
Confidence            445578999999999999  5577666 999999999999999999999876522221111  1223334444  48899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +..|+.+|+..||.+||+..+++.
T Consensus       275 l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  275 LSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999999875

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=360.52  Aligned_cols=257  Identities=30%  Similarity=0.465  Sum_probs=230.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++.|..-+.||+|+||.||-+.-..||+.||+|++.+..    .......+|-.+|.+++.++||.+-..|++++.+|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356788899999999999999999999999999987642    3335577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           77 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +..|+||+|.-.|.+.+  .+++..++.++.+|+.||++||..+||.|||||+|||+|+.+  +++|+|+|+|.......
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G--hvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG--HVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC--CeEeeccceEEecCCCC
Confidence            99999999999888766  799999999999999999999999999999999999998665  99999999999887777


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ..+..+||.+|||||++.+..|+.. .|+|||||++|+|+.|+.||............-+++......+++  .+|++++
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eak  418 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAK  418 (591)
T ss_pred             ccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHH
Confidence            7788899999999999999998766 799999999999999999999877666555666667777777776  7999999


Q ss_pred             HHHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          235 HLLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      +|.+.+|.+||++|.     ++.++.+||||+.
T Consensus       419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            999999999999998     5789999999964

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.7e-49  Score=359.38  Aligned_cols=247  Identities=33%  Similarity=0.553  Sum_probs=206.1

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHH-HHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIM-NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||++.+..+|+.||+|++.+..    .....+.+|.. +++.++||||+++++++..++.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999987642    22234445544 56789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      |+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEeecCCcccCCCCCCCcccccC
Confidence            99999998888899999999999999999999999999999999999997655  899999999874322 233445679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+.    .+......++.  ..+..+.++|++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~ll~~ll  231 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYD----NILHKPLVLRP--GASLTAWSILEELL  231 (325)
T ss_pred             ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHH----HHHcCCccCCC--CCCHHHHHHHHHHh
Confidence            999999999988877655 899999999999999999998755433332    23333333332  57899999999999


Q ss_pred             ccCCCcCCCh----hHHhcCcccccC
Q 019628          242 VANSEKRITI----PEIKNHPWFLRN  263 (338)
Q Consensus       242 ~~dp~~R~s~----~ell~hp~~~~~  263 (338)
                      +.+|.+||++    .++++||||...
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            9999999987    589999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.9e-49  Score=360.98  Aligned_cols=250  Identities=29%  Similarity=0.503  Sum_probs=209.2

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||+|.+..+++.||+|++++..    .....+.+|+.++.++ .||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998642    2234577899888888 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~~~~~~g  161 (338)
                      ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++... ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG--HIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC--CEEEeccccceeccCCCCceecccC
Confidence            99999998888899999999999999999999999999999999999997655  79999999987432 2233445679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---KNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||......   .........+......+|.  .++..+.++|.
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~  235 (327)
T cd05617         159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLK  235 (327)
T ss_pred             CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence            999999999988777655 89999999999999999999643211   1112223334444445555  58899999999


Q ss_pred             HhcccCCCcCCCh------hHHhcCccccc
Q 019628          239 RIFVANSEKRITI------PEIKNHPWFLR  262 (338)
Q Consensus       239 ~~L~~dp~~R~s~------~ell~hp~~~~  262 (338)
                      +||+.||.+|+++      .++++||||..
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            9999999999984      69999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.9e-49  Score=358.31  Aligned_cols=246  Identities=35%  Similarity=0.566  Sum_probs=205.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHH-HHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREI-MNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~-~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||+|++..+++.||+|++.+..    .....+.+|. .+++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532    1223444554 467889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~~~~~~g  161 (338)
                      ++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++... ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEccCCCCccCCCCCCccccccC
Confidence            99999998888899999999999999999999999999999999999997554  89999999987432 2223345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+...    ....+......+|.  ..+.++.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNILHKPLQLPG--GKTVAACDLLVGLL  231 (321)
T ss_pred             CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHH----HHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988777655 899999999999999999998754322    22334444444444  57889999999999


Q ss_pred             ccCCCcCCCh----hHHhcCccccc
Q 019628          242 VANSEKRITI----PEIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~s~----~ell~hp~~~~  262 (338)
                      +.+|.+||++    .++++|+||..
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            9999999976    49999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-49  Score=362.96  Aligned_cols=248  Identities=33%  Similarity=0.571  Sum_probs=209.9

Q ss_pred             eeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            7 VKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++.||+|+||.||++++.   .+|+.||+|++.+..   .....+.+|+.++++++||||+++++++..++.+|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            367999999999999873   578999999997643   22345678999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  159 (338)
                      ++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ......
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC--cEEEeeccCCcccCCCCCceecc
Confidence            9999999998888899999999999999999999999999999999999997554  7999999998754333 233456


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|.  .+++++.+||++
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~  231 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKET----MTMILKAKLGMPQ--FLSPEAQSLLRA  231 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHH
Confidence            79999999999987776545 8999999999999999999987554332    2333444445554  578999999999


Q ss_pred             hcccCCCcCCC-----hhHHhcCcccccC
Q 019628          240 IFVANSEKRIT-----IPEIKNHPWFLRN  263 (338)
Q Consensus       240 ~L~~dp~~R~s-----~~ell~hp~~~~~  263 (338)
                      ||+.||.+|||     +.+++.||||...
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            99999999999     6779999999653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-48  Score=350.52  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=210.8

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.++++++|++|+.+++.+...+.+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            48899999999999999999999999999999875422    12346789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           79 YAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |+++++|.+.+...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++  .++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeccceeecCCCccc
Confidence            99999999988643  3589999999999999999999999999999999999997554  7999999998754433333


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||..|+|||++.+..++.+ +||||+||++|+|++|+.||......................++.  .+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  235 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE--KFSPDARSL  235 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCc--cCCHHHHHH
Confidence            45679999999999988777655 899999999999999999998654322111111111111122232  578899999


Q ss_pred             HHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          237 LSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      +.+||+.+|++|||     +.|+++||||.+
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            99999999999999     899999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.4e-49  Score=347.55  Aligned_cols=253  Identities=37%  Similarity=0.602  Sum_probs=210.1

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccH---HHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE---HVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      |++++.||+|+||+||++++..+++.||+|++........   ...+|+.++++++||||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            8999999999999999999999999999999987654332   3356999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc-ccCCCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLHSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~-~~~~~~~~~  159 (338)
                      ++++|.+++.....+++..+..++.||+.||.+||++|++|+||||+||+++.++  .++|+|||.+... .........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG--EVKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS--EEEESSGTTTEESTSTTSEBSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence            9999999998788899999999999999999999999999999999999997444  8999999998742 223344567


Q ss_pred             cccCccccccccc-CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--cCCCcccCCHHHHHH
Q 019628          160 VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SFPDYVRVSLECKHL  236 (338)
Q Consensus       160 ~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  236 (338)
                      .+|..|+|||++. +..+ +.++||||||+++|+|++|..||........ ...+........  ........+..+.++
T Consensus       159 ~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             cccccccccccccccccc-cccccccccccccccccccccccccccchhh-hhhhhhcccccccccccccchhHHHHHHH
Confidence            7999999999998 4555 4559999999999999999999997632222 222222222111  122212234889999


Q ss_pred             HHHhcccCCCcCCChhHHhcCccc
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      |.+||+.+|++|||+.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-49  Score=361.48  Aligned_cols=246  Identities=34%  Similarity=0.533  Sum_probs=204.3

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC---CCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSL---KHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      ||+|+||+||++.+..+++.||+|++.+...    .......|..++..+   .||||+++++++...+.+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999875321    122344566666555   699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      |+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .++|+|||+++.... .......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEecCCcCcCCCCCCCCccCccC
Confidence            99999998888899999999999999999999999999999999999997554  899999999875322 233445679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+....+.++|||||||++|+|++|..||......    .....+......+|.. .+++++.+||++||
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L  233 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYRNIAFGKVRFPKN-VLSDEGRQFVKGLL  233 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----HHHHHHHcCCCCCCCc-cCCHHHHHHHHHHc
Confidence            999999999876543345599999999999999999999875432    2233344444455542 47899999999999


Q ss_pred             ccCCCcCC----ChhHHhcCccccc
Q 019628          242 VANSEKRI----TIPEIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~----s~~ell~hp~~~~  262 (338)
                      ..+|.+||    ++.++++||||..
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcCccccC
Confidence            99999998    7899999999965

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-48  Score=348.10  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=205.2

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ||+|+||.||++.+..+|+.||+|++.....    ....+..|+.+++.++||||+++++++..+..+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999865321    223456799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccC
Q 019628           86 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP  163 (338)
Q Consensus        86 ~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~  163 (338)
                      ...+....  .+++..+..++.|++.||+|||++||+||||||+||+++.+.  .++|+|||++.............||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG--NCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC--CEEEeeceeeeecCCCceeeccCCCC
Confidence            98886433  588999999999999999999999999999999999997654  79999999987554433344567999


Q ss_pred             cccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhccc
Q 019628          164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA  243 (338)
Q Consensus       164 ~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  243 (338)
                      .|+|||++.+..++.+ +||||+||++|+|++|+.||......................++ ...+++++++|+++||+.
T Consensus       159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence            9999999988776555 89999999999999999999865443222233333333232222 235789999999999999


Q ss_pred             CCCcCCCh----hHHhcCccccc
Q 019628          244 NSEKRITI----PEIKNHPWFLR  262 (338)
Q Consensus       244 dp~~R~s~----~ell~hp~~~~  262 (338)
                      +|.+||++    .+++.||||+.
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcC
Confidence            99999999    67889999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-48  Score=358.32  Aligned_cols=246  Identities=35%  Similarity=0.589  Sum_probs=204.8

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHH-HHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREI-MNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~-~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||+||+|.+..+++.||+|++.+..    .....+.+|. .+++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999997632    1122334443 456889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  161 (338)
                      ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCCcccccC
Confidence            99999998888899999999999999999999999999999999999997554  899999999874322 223445679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|.+||...+....+.    .+......++.  .++..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~li~~~l  231 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLKP--NITNSARHLLEGLL  231 (325)
T ss_pred             CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHH----HHHhCCcCCCC--CCCHHHHHHHHHHc
Confidence            999999999988777655 899999999999999999998755433322    23333333332  68899999999999


Q ss_pred             ccCCCcCCChh----HHhcCccccc
Q 019628          242 VANSEKRITIP----EIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~s~~----ell~hp~~~~  262 (338)
                      +.+|.+|+++.    ++++|+||..
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCC
Confidence            99999999886    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.6e-48  Score=347.21  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=215.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .|+..+.||+|+||+||++.+..+++.+|+|++.....    ....+.+|+.+++.++|+||+.+++++..++.+|++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            48899999999999999999999999999999875431    22346789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           79 YAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |+++++|...+...  ..+++..+..++.|++.||.|||++||+||||||+||+++.+.  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCCcc
Confidence            99999999888643  3699999999999999999999999999999999999997654  7999999998754433344


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....|+..|+|||++.+..++.+ +|+||+||++|+|++|..||...............+......++.  .++.++.+|
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  235 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA--KFSEEAKSI  235 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc--cCCHHHHHH
Confidence            55679999999999988777655 899999999999999999998765433333333333333333333  578899999


Q ss_pred             HHHhcccCCCcCCC-----hhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRIT-----IPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s-----~~ell~hp~~~~~  263 (338)
                      +.+||+.+|.+|||     +.+++.|+||...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            99999999999999     8899999999643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.4e-48  Score=349.41  Aligned_cols=258  Identities=26%  Similarity=0.462  Sum_probs=209.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +++|++++.||+|+||.||++.+..+++.||+|.++...  .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            578999999999999999999999999999999987542  223467789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      |++ ++|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||++....... ..
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC--cEEECcCcchhccCCCCCcc
Confidence            996 5898888653 4689999999999999999999999999999999999997654  89999999987533222 22


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------ccc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VHY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (338)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|++||...+..............               ...
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            34567899999999876554455589999999999999999999876543332222111100               001


Q ss_pred             cCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          222 SFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       222 ~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      .+|.         ...+++++++||.+||..||.+|||+.|+++||||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            1111         124688899999999999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.3e-48  Score=355.45  Aligned_cols=256  Identities=29%  Similarity=0.536  Sum_probs=209.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||++.+..+++.+|+|++.+..    .....+.+|+.++..++|+||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999986532    22234778899999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      ||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~--~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEeecchheecccCCcc
Confidence            99999999999976 45789999999999999999999999999999999999997554  899999999874322221 


Q ss_pred             -CCCccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC-ccc
Q 019628          156 -PKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-YVR  228 (338)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  228 (338)
                       ....+||+.|+|||++.+     ..+ +.++|||||||++|+|++|+.||........+......  .....+|. ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~  235 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KERFQFPAQVTD  235 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCC-CCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC--CccccCCCcccc
Confidence             234579999999999863     234 44589999999999999999999876544443333221  11223333 235


Q ss_pred             CCHHHHHHHHHhcccCCCc--CCChhHHhcCccccc
Q 019628          229 VSLECKHLLSRIFVANSEK--RITIPEIKNHPWFLR  262 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~  262 (338)
                      ++.++++||++||..++.+  |+++.++++||||..
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            7999999999999765554  689999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-47  Score=339.34  Aligned_cols=252  Identities=33%  Similarity=0.478  Sum_probs=212.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +.|++.+.||+|++|.||++.+..+++.+|+|.+.....      ....+.+|+.++++++||||+++++++..+..+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999999875421      22467889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ++||+++++|.+.+...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++  .++|+|||+++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~--~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecccccc
Confidence            999999999999998888899999999999999999999999999999999999997554  899999999875432211


Q ss_pred             C----CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          156 P----KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       156 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      .    ....|+..|+|||.+.+..++.+ +|||||||++|+|++|+.||...+..........  ......+|.  .++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~  234 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPQLPS--HVSP  234 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc--cCCCCCCCc--cCCH
Confidence            1    34568889999999988776544 8999999999999999999987554333222111  111222333  6789


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+.++|++||..+|.+|||+.++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-48  Score=357.72  Aligned_cols=252  Identities=26%  Similarity=0.457  Sum_probs=200.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .+|++++.||+|+||.||+|.+..+++.||+|+..+.     ....|+.++++++||||+++++++......|+|||++.
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            3699999999999999999999999999999975433     23569999999999999999999999999999999995


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCcc
Q 019628           82 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV  160 (338)
Q Consensus        82 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  160 (338)
                       ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++...  .+||+|||+++............
T Consensus       141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEecCccccccccCccccccc
Confidence             588888764 45689999999999999999999999999999999999997555  79999999987544333445567


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCC-CCCCCCCh---------HHHHHHHhhHhhccccCC------
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEDP---------KNFRKTIGRILSVHYSFP------  224 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~-pf~~~~~~---------~~~~~~~~~~~~~~~~~~------  224 (338)
                      ||+.|+|||++.+..++.+ +|||||||++|+|+++.. +|......         ..+...+.........++      
T Consensus       218 gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        218 GTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             ccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            9999999999988887655 899999999999998544 44432211         011111111110011111      


Q ss_pred             ----------------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          225 ----------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       225 ----------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                                            ....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                  11245677889999999999999999999999999964

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.8e-48  Score=355.64  Aligned_cols=256  Identities=29%  Similarity=0.515  Sum_probs=209.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999987532    22244778899999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      ||++||+|..++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++  .+||+|||++........ 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC--CEEEEeccceeeccCCCce
Confidence            99999999999976 46799999999999999999999999999999999999997554  899999999875432221 


Q ss_pred             -CCCccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC-ccc
Q 019628          156 -PKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-YVR  228 (338)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  228 (338)
                       .....||+.|+|||++.+     ..++ .++||||+||++|+|++|+.||........+......  ...+.+|. ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~  235 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITD  235 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCcccc
Confidence             123579999999999865     3343 4489999999999999999999875543333322211  11223333 235


Q ss_pred             CCHHHHHHHHHhcccCCCc--CCChhHHhcCccccc
Q 019628          229 VSLECKHLLSRIFVANSEK--RITIPEIKNHPWFLR  262 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~  262 (338)
                      +++++++||.+||..++.+  |++++++++||||..
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            7899999999999876654  469999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-49  Score=363.85  Aligned_cols=254  Identities=41%  Similarity=0.670  Sum_probs=230.6

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      -|.+.++||+|.|++|.++++.-++..||||.+.+....   ..++.+|+.+|+.++|||||+++.+...+..+|+||||
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey  136 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY  136 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence            589999999999999999999999999999999886533   24578999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      +.+|.+++++.+.+.+.+..++.++.|+++|++|||+++|||||||.+|||++.+.  ++||+|||++..........++
T Consensus       137 a~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m--nikIaDfgfS~~~~~~~~lqt~  214 (596)
T KOG0586|consen  137 ASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM--NIKIADFGFSTFFDYGLMLQTF  214 (596)
T ss_pred             ccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc--ceeeeccccceeeccccccccc
Confidence            99999999999999999999999999999999999999999999999999998766  6999999999988888888999


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      ||++.|.|||++.+..|++..+|+||+|+++|.|+.|.+||.+..-.    ..-.+.....+..|.  .++.++.++|++
T Consensus       215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk----~Lr~rvl~gk~rIp~--~ms~dce~lLrk  288 (596)
T KOG0586|consen  215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK----ELRPRVLRGKYRIPF--YMSCDCEDLLRK  288 (596)
T ss_pred             CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----cccchheeeeecccc--eeechhHHHHHH
Confidence            99999999999999999999999999999999999999999975432    222344555666666  588999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccCC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +|..+|.+|++.+++..|.|.....
T Consensus       289 ~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             hhccCccccCCHHHhhhhcccchhh
Confidence            9999999999999999999985443

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.6e-48  Score=350.99  Aligned_cols=252  Identities=26%  Similarity=0.389  Sum_probs=193.7

Q ss_pred             eeeeccCCceEEEEEEEc--CCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeEEEEEeccCC
Q 019628            7 VKDIGSGNFGVAKLVRDK--WTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHLAIVMEYAAG   82 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~iv~e~~~~   82 (338)
                      .++||+|+||+||+|.++  .+++.||+|.+.... ....+.+|+.++++++||||+++++++..  ...+|++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999975  467899999886543 33567899999999999999999999864  457899999995 


Q ss_pred             CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC--CCCcEEEeecCCCcccc
Q 019628           83 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--TAPRVKICDFGYSKSSV  151 (338)
Q Consensus        83 ~~L~~~i~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~--~~~~ikL~Dfg~a~~~~  151 (338)
                      ++|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+...  ..+.+||+|||+++...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            5888877532         248999999999999999999999999999999999999532  33479999999997543


Q ss_pred             cCC----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh---------HHHHHHHhhHh-
Q 019628          152 LHS----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---------KNFRKTIGRIL-  217 (338)
Q Consensus       152 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~~~~~~~-  217 (338)
                      ...    ......||+.|+|||++.+....+.++||||+||++|+|++|++||......         ..+........ 
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF  243 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence            221    2235678999999999987554455599999999999999999999754321         11111111000 


Q ss_pred             -----------------------hccccC--------CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          218 -----------------------SVHYSF--------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       218 -----------------------~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                                             ......        ......+..+.+||++||+.||.+|||++|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                   000000        0011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-47  Score=360.01  Aligned_cols=255  Identities=23%  Similarity=0.349  Sum_probs=206.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEc--CCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK--WTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      .+|++++.||+|+||.||++...  .++..||+|.+...    ....+|+.+++.++||||+++++++.....+|++||+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            36999999999999999999764  35678999987654    3456899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC---C
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---P  156 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~---~  156 (338)
                      +. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++..+  .++|+|||+++.......   .
T Consensus       168 ~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~--~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        168 YK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--NAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             cC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEccCccccccCcccccccc
Confidence            95 68999997777899999999999999999999999999999999999997554  899999999875433222   2


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhhHhhccc------------
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---KNFRKTIGRILSVHY------------  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~~~~~~~~~~~------------  221 (338)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....   ..+..++..+.....            
T Consensus       245 ~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        245 YGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             cccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence            34679999999999988777655 89999999999999999999764432   122222211111111            


Q ss_pred             -------------cCCC---cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          222 -------------SFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       222 -------------~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                                   ..|.   ...++.++.+||++||..+|++|||+.|+|.||||.+..
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                         1111   113567899999999999999999999999999997643

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.9e-47  Score=342.44  Aligned_cols=250  Identities=38%  Similarity=0.660  Sum_probs=215.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.+..    .....+.+|+.++++++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            57999999999999999999999999999999987643    23356888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||+++++|.+++.....+++..+..++.||+.||.|||++|++|+||+|.||+++.++  .+||+|||++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEeeCCCccccCCC--CC
Confidence            9999999999998888899999999999999999999999999999999999997654  7999999998854333  34


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ...|++.|+|||.+.+...+ .++|+||||+++|+|++|..||......    .....+......+|.  .++..++++|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~--~~~~~l~~li  229 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKILEGKVRFPS--FFSPDAKDLI  229 (290)
T ss_pred             CCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCccCCc--cCCHHHHHHH
Confidence            55789999999999776654 4489999999999999999999865532    222233344444554  5689999999


Q ss_pred             HHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          238 SRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       238 ~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      .+||..+|.+|+     +++++++||||..
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCccccc
Confidence            999999999999     9999999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-47  Score=367.25  Aligned_cols=252  Identities=29%  Similarity=0.421  Sum_probs=210.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCC-CcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWT-RELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .|.+.+.||+|+||.||+|.+..+ +..||+|.+..... ....+.+|+.+++.++||||++++++|..++.+|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            499999999999999999998877 78899997755432 2345778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--
Q 019628           81 AGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--  154 (338)
Q Consensus        81 ~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--  154 (338)
                      +||+|.+.+..    ..++++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......  
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~--~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG--IIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC--cEEEEeCcCceecCCcccc
Confidence            99999987753    34689999999999999999999999999999999999997554  89999999998543221  


Q ss_pred             -CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          155 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                       .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........+    ..+...... +....++.++
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~----~~~~~~~~~-~~~~~~s~~~  299 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIM----QQVLYGKYD-PFPCPVSSGM  299 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCC-CCCccCCHHH
Confidence             2345679999999999988777555 89999999999999999999865443322    222222222 1223688999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+||.+||..+|++|||+.+++.|||+..
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999853

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.2e-47  Score=340.91  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=210.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++....   ...+.+.+|+.++++++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            58999999999999999999999999999999886543   223567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~  157 (338)
                      |+++++|..++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++  .++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccccc
Confidence            999988888877767799999999999999999999999999999999999997554  89999999987554332 233


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc---------------ccc
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------HYS  222 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  222 (338)
                      ...++..|+|||.+.+....+.++||||+||++|+|++|..||......+............               ...
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            45688999999998764433455899999999999999999998765543332222111000               000


Q ss_pred             CCC----------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          223 FPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       223 ~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .|.          ...++..+.+|+.+||..+|++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            111          12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.9e-47  Score=341.10  Aligned_cols=255  Identities=27%  Similarity=0.446  Sum_probs=206.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++++.||+|++|.||++.+..++..||+|++....   .....+.+|+.++++++||||+++++++..+..+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5899999999999999999999999999999986532   2235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CC
Q 019628           80 AAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ  155 (338)
Q Consensus        80 ~~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~  155 (338)
                      ++ ++|.+++...   ..+++..++.++.||+.||.|||++|++||||||+||+++.++  .++|+|||++...... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG--VIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC--cEEECcccceeecCCCccc
Confidence            97 5888887642   4689999999999999999999999999999999999997554  8999999998743222 12


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh--------------hccc
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL--------------SVHY  221 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~--------------~~~~  221 (338)
                      .....+++.|+|||++.+....+.++|||||||++|+|+||++||.................              ....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            23456789999999987654434559999999999999999999987654333322211110              0000


Q ss_pred             cCC---------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          222 SFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       222 ~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .++         ....+++++++||++||..||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            011         122478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=345.70  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=219.4

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      |.++++||+|+||.||++.++.+|+.+|||.++.... .+.+..||.+++++++|+||++|+.+.....++||||||..|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            5678899999999999999999999999999886543 467788999999999999999999999999999999999999


Q ss_pred             ChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCCCCCccc
Q 019628           84 ELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQPKSTVG  161 (338)
Q Consensus        84 ~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~~~~~~g  161 (338)
                      ++.+.++ +++++++.++..+++.-++||+|||...-||||||..|||+  +..|+.||+|||.|.... .....++.+|
T Consensus       114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL--NT~G~AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T KOG0574|consen  114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL--NTDGIAKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T ss_pred             cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE--cccchhhhhhccccchhhhhHHhhCcccc
Confidence            9999987 46679999999999999999999999999999999999999  566699999999987543 2334567899


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      ||.|||||++..-.|++. +||||||++..||.-|++||.....-   +.++-...+..++|......|+++.||+++||
T Consensus       192 TPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  192 TPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             CcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            999999999999899888 89999999999999999999865432   11111122334445444568999999999999


Q ss_pred             ccCCCcCCChhHHhcCcccccCCC
Q 019628          242 VANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       242 ~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      .+.|++|-|+.++++|||+++...
T Consensus       268 iK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  268 IKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             cCCHHHHHHHHHHhhhhhhcCCCc
Confidence            999999999999999999976543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.1e-47  Score=380.65  Aligned_cols=258  Identities=29%  Similarity=0.472  Sum_probs=211.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~i   75 (338)
                      +++|++++.||+|+||+||+|.+..++..||+|++....   .....+.+|+.+++.++|||||+++++|..  ...+|+
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            478999999999999999999999999999999987532   234568899999999999999999999865  457999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhc-------CceecCCCCCcEEecCC----------
Q 019628           76 VMEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QICHRDLKLENTLLDGS----------  134 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~-------~iiH~Dlkp~NIl~~~~----------  134 (338)
                      ||||+++++|..+|..    ...+++..++.|+.||+.||.|||+.       +||||||||+|||++..          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999999865    25699999999999999999999984       49999999999999642          


Q ss_pred             -----CCCcEEEeecCCCcccccCCCCCCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHH
Q 019628          135 -----TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN  208 (338)
Q Consensus       135 -----~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~  208 (338)
                           ..+.+||+|||++.............||+.|+|||++.+.. ..+.++||||||||+|+|+||..||........
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence                 23358999999998654444445668999999999986432 223458999999999999999999987655433


Q ss_pred             HHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          209 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +...   +... ..+|. ...+.++.+||.+||..+|.+|||+.|+|.|||+...
T Consensus       252 li~~---lk~~-p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        252 LISE---LKRG-PDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHH---HhcC-CCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            3222   2221 22221 2468999999999999999999999999999999654

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.7e-47  Score=366.69  Aligned_cols=252  Identities=29%  Similarity=0.452  Sum_probs=209.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-------   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-------   71 (338)
                      ++|.+.+.||+|+||+||++.+..+++.||||++....   .....+.+|+..+..++|+||+++++.+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            58999999999999999999999999999999987643   22346778999999999999999988775432       


Q ss_pred             -eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           72 -HLAIVMEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        72 -~~~iv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                       .+++||||+++|+|.+.+...    ..+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC--CEEEEeccc
Confidence             378999999999999988643    4689999999999999999999999999999999999997654  899999999


Q ss_pred             Cccccc---CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-c
Q 019628          147 SKSSVL---HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-S  222 (338)
Q Consensus       147 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~  222 (338)
                      ++....   .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........+.    .+....+ .
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~----~~~~~~~~~  264 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMH----KTLAGRYDP  264 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHhcCCCCC
Confidence            875332   122345679999999999988777655 899999999999999999998754333222    2222222 2


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +|  ..+++++.+|+.+||..+|.+|||+.++++|||++.
T Consensus       265 ~~--~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        265 LP--PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CC--CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            23  368899999999999999999999999999999864

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.9e-47  Score=342.86  Aligned_cols=256  Identities=29%  Similarity=0.500  Sum_probs=210.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....  .....+.+|++++++++||||++++++|..++.+|++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            57999999999999999999999999999999886542  2235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      +++++|.+++...+.+++..++.++.|++.||.|||+ .+++||||||+|||++.++  .++|+|||++..... .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC--cEEEccCCCcccccc-ccccc
Confidence            9999999999888889999999999999999999998 5999999999999997554  799999999874422 23345


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH----------------------
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI----------------------  216 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~----------------------  216 (338)
                      ..|++.|+|||.+.+..++.+ +|+||+||++|+|++|..||..... ..........                      
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            678999999999877666544 8999999999999999999965432 1111111100                      


Q ss_pred             -----------h-hccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          217 -----------L-SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       217 -----------~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                 . ......|. ..++.++++|+.+||..+|++|||+.++++||||.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                       0 00011111 1367889999999999999999999999999999653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8e-47  Score=338.58  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=207.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|.+....  .....+.+|+.++++++||||+++++++...+..+++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            57999999999999999999999999999999987642  2235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      +++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+||+++.++  .++|+|||++..... ......
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~--~~~l~dfg~~~~~~~-~~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLVN-SIAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC--CEEEeeCCcceeccc-ccccCC
Confidence            999988644    3578999999999999999999999999999999999997654  899999999875432 233456


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHH---HHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN---FRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      .||..|+|||++.+..++.+ +|+|||||++|+|++|..||........   .......+.............++++.+|
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            89999999999988777555 8999999999999999999965332111   1111111121111111123478899999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +.+||+.+|.+||++.++++||||...
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.3e-47  Score=341.56  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=204.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||+|+||.||++.+..+|+.+|+|.++...   .....+.+|+.++++++||||+++++++.+.+.+|+++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            6999999999999999999999999999999987532   2235677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCC
Q 019628           80 AAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~  157 (338)
                      ++ ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||+++..... ....
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC--cEEECccchhhccCCCCCCcC
Confidence            96 578887764 56799999999999999999999999999999999999997554  8999999998754322 2223


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChH-HHHHHHhhHhh-------------ccccC
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-NFRKTIGRILS-------------VHYSF  223 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~-------------~~~~~  223 (338)
                      ...+++.|+|||++.+....+.++|||||||++|+|++|..||....... .+.........             ....+
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            45688999999998775544455999999999999999988864433322 22221111100             00000


Q ss_pred             C----------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          224 P----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       224 ~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +          ....+++++++||.+||..+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0          012468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-49  Score=355.72  Aligned_cols=248  Identities=35%  Similarity=0.635  Sum_probs=219.1

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      +.||.|.||+||-++++++|+.||||+|.+-   .+....+++|+.+|+++.||+||.+.-.|++++.+++|||-+.| +
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence            6799999999999999999999999999763   34457899999999999999999999999999999999999965 5


Q ss_pred             hHHHHH--hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCcccccCCCCCCccc
Q 019628           85 LFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHSQPKSTVG  161 (338)
Q Consensus        85 L~~~i~--~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~~~~~~~~~g  161 (338)
                      +...|-  ..+++++...+.++.||+.||+|||.+||+|+||||+|||+.+. .-+.+||||||+|+......-.++.+|
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence            555553  45679999999999999999999999999999999999999543 345899999999998887778889999


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCCHHHHHHHHH
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHLLSR  239 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~  239 (338)
                      ||.|.|||++.++.|+.. -|+||+|+|+|--++|..||...++...      +|.+..+-+|  .|..++.++.|||..
T Consensus       729 TPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdInd------QIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDIND------QIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             CccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccchhH------HhhccccccCCCchhhcCHHHHHHHHH
Confidence            999999999999999766 7999999999999999999987665332      3455555555  478999999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +|+..=.+|.|+++.|.|||++..
T Consensus       802 LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  802 LLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHhcchHhhccchhhhcc
Confidence            999999999999999999999754

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-46  Score=334.30  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=212.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||.|+||+||++....++..+|+|++....  .....+.+|+..++.++|+||+++++.+...+.+|++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            58999999999999999999998899999999986543  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           80 AAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        80 ~~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      +++++|.+++...   ..+++..++.++.|++.||.|||++|++||||||+||++++++  .++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~--~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccchHHHhccCccc
Confidence            9999999999764   3589999999999999999999999999999999999997654  799999999864433221 


Q ss_pred             ----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC---ccc
Q 019628          156 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD---YVR  228 (338)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  228 (338)
                          .....|+..|+|||.+......+.++|+|||||++|+|++|+.||........+......   ....++.   +..
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKK  235 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccccc
Confidence                233468999999999877633345589999999999999999999876554433333222   1112222   236


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +++.+.+++.+||..+|++|||+.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            78999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-46  Score=334.32  Aligned_cols=250  Identities=34%  Similarity=0.511  Sum_probs=210.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc----------cHHHHHHHHHHhcCCCCCcceeEEEEEcCCe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----------DEHVQREIMNHRSLKHPNIVRFKEVLLTPTH   72 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~   72 (338)
                      +|.+.+.||+|++|.||+|.+..+++.+|+|.+......          .+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            688999999999999999999989999999988653221          2457789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      .+++|||+++++|..++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.+.  .++|+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~--~~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG--GIKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC--CEEecccCCCccccc
Confidence            999999999999999998888899999999999999999999999999999999999997554  799999999875432


Q ss_pred             CC-------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC
Q 019628          153 HS-------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD  225 (338)
Q Consensus       153 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (338)
                      ..       ......|+..|+|||.+.+..++.. +|+||+||++|+|++|+.||.............   ......++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~  234 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---ENASPEIPS  234 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh---ccCCCcCCc
Confidence            11       1123458899999999988777555 899999999999999999998754433222211   111222333


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                        .++..+.++|++||+.+|.+||++.++++||||
T Consensus       235 --~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         235 --NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             --ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence              578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-48  Score=324.30  Aligned_cols=252  Identities=28%  Similarity=0.420  Sum_probs=208.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-----eEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-----HLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~~i   75 (338)
                      +||.|.+.||+|+|+.||++++..+++.||+|++.... ...+...+|+...++++||||++++++...+.     ..|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            58999999999999999999999999999999998765 45577899999999999999999988765443     4999


Q ss_pred             EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           76 VMEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      +++|...|+|.+.|...    ..++|.++..|+.+|++||++||+..  ++||||||.|||+.++  +.++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~--~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS--GLPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC--CceEEEeccCccc
Confidence            99999999999998642    25899999999999999999999998  9999999999999654  4899999999875


Q ss_pred             cccCCCC----------CCccccCcccccccccCCccC--CCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh
Q 019628          150 SVLHSQP----------KSTVGTPAYIAPEVLTKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL  217 (338)
Q Consensus       150 ~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  217 (338)
                      ....-..          .....|..|+|||.+.-....  +.++|||||||++|.|+.|..||...-..-.  -..-.+.
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--SlaLAv~  256 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--SLALAVQ  256 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--eEEEeee
Confidence            4322111          223588999999998654332  3448999999999999999999964211000  0011345


Q ss_pred             hccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          218 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +..+.+|....+|+.+.+||+.||+.||.+||++.+++.+
T Consensus       257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            6678899888899999999999999999999999999874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.1e-47  Score=348.53  Aligned_cols=248  Identities=23%  Similarity=0.381  Sum_probs=198.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcC-Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTP-TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-~~   72 (338)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+|+.+++.+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            68999999999999999999752     345689999987543  2235688999999999 899999999988764 46


Q ss_pred             EEEEEeccCCCChHHHHHhc------------------------------------------------------------
Q 019628           73 LAIVMEYAAGGELFERICNA------------------------------------------------------------   92 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~------------------------------------------------------------   92 (338)
                      ++++|||+++|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            89999999999999998642                                                            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---CCCCccccCcccc
Q 019628           93 --GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIA  167 (338)
Q Consensus        93 --~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~a  167 (338)
                        .++++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++......   ......+++.|+|
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccC
Confidence              2477888999999999999999999999999999999997554  89999999997542221   1223446678999


Q ss_pred             cccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCC
Q 019628          168 PEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE  246 (338)
Q Consensus       168 PE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  246 (338)
                      ||++.+..++.+ +|||||||++|+|++ |..||........+...+..  ......|  ...++++.+|+.+||..+|.
T Consensus       245 PE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         245 PESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--GTRMRAP--ENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc--CCCCCCC--CCCCHHHHHHHHHHccCChh
Confidence            999988777655 899999999999997 99999875543333222211  1112223  36788999999999999999


Q ss_pred             cCCChhHHhc
Q 019628          247 KRITIPEIKN  256 (338)
Q Consensus       247 ~R~s~~ell~  256 (338)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1e-46  Score=336.15  Aligned_cols=252  Identities=26%  Similarity=0.418  Sum_probs=207.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcC------CeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTP------THLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~------~~~~   74 (338)
                      .+|++.+.||+|+||.||++....+++.||+|++.........+.+|+.+++++ +||||+++++++...      ..+|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            368999999999999999999999999999999987665567788999999998 699999999998753      4689


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.+.  .++|+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~--~~~l~Dfg~~~~~~~  163 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC--CEEEccCCCceeccc
Confidence            999999999999998763  3589999999999999999999999999999999999997655  799999999875432


Q ss_pred             C-CCCCCccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCc
Q 019628          153 H-SQPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY  226 (338)
Q Consensus       153 ~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (338)
                      . .......|++.|+|||++.+     ..++. ++||||+||++|+|++|..||............    ..........
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~  238 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNPAPRLKS  238 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCc-hhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----hcCCCCCCCC
Confidence            2 23345679999999999863     23444 489999999999999999999765433222211    1111111222


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ..++.++.+|+.+||..+|.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            3578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-46  Score=342.05  Aligned_cols=254  Identities=34%  Similarity=0.556  Sum_probs=215.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||+||+|.+..+++.||+|.+.+...    ..+.+.+|+.+++.++||||+++++.+......|++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            589999999999999999999999999999999976532    2356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           78 EYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      ||+.+++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||++....... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC--CEEEeecchhhccccccc
Confidence            999999999998754  4689999999999999999999999999999999999997654  89999999886432211 


Q ss_pred             -----------------------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC
Q 019628          155 -----------------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED  205 (338)
Q Consensus       155 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~  205 (338)
                                                   ......||..|+|||++.+..++. ++|||||||++|+|++|..||...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                         111346889999999998777654 48999999999999999999987665


Q ss_pred             hHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCC----hhHHhcCccccc
Q 019628          206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT----IPEIKNHPWFLR  262 (338)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s----~~ell~hp~~~~  262 (338)
                      ...+..    +......++....++..+.++|.+||..+|++|||    +.++|.||||+.
T Consensus       238 ~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         238 DETFSN----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HHHHHH----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            444333    23334445554457999999999999999999999    999999999964

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-49  Score=362.10  Aligned_cols=257  Identities=28%  Similarity=0.410  Sum_probs=217.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC-ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG-QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +-|+|+..||.|+||.||+|.++.++-..|-|+|... ....+.+.-||.||..++||+||++++.|..++.++|+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            3478999999999999999999999999999998753 445577888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCCCCC
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~~~~  158 (338)
                      .||-....+.. ...|++.+++.+++|++.||.|||+++|||||||..|||+...+  .|+|+|||.+.... ......+
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG--dirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG--DIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC--cEeeecccccccchhHHhhhcc
Confidence            99998887754 44699999999999999999999999999999999999996544  89999999876432 2334567


Q ss_pred             ccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          159 TVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ++|||+|||||++.+     .+|+.+ +||||||++|.+|.-+.+|....+.   ...+++.....++++-....++..+
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccch---HHHHHHHhhcCCCcccCcchhhhHH
Confidence            899999999999753     456666 8999999999999999999876544   2333333344445554555789999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      .||+.+||..+|..||++.++|+||||++..
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            9999999999999999999999999997543

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6e-47  Score=336.86  Aligned_cols=251  Identities=31%  Similarity=0.469  Sum_probs=208.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++.... ....+.+|+.+++.++||||+++++++...+.+|++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            478999999999999999999999999999999876432 2345788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  159 (338)
                      ++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++  .++|+|||++...... ......
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG--HVKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECcceeeeEccCcccccccc
Confidence            9999999998888999999999999999999999999999999999999997554  7999999998643322 223456


Q ss_pred             cccCccccccccc---CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc---CCCcccCCHHH
Q 019628          160 VGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS---FPDYVRVSLEC  233 (338)
Q Consensus       160 ~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (338)
                      .|+..|+|||++.   ...++ .++|+|||||++|+|++|..||............    ......   +.....++..+
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----TKSNFQPPKLKDKMKWSNSF  241 (267)
T ss_pred             cCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----hccCCCCCcccccCCCCHHH
Confidence            7999999999974   33344 4589999999999999999999764432222111    111111   12223577889


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                      .++|.+||..+|++|||+.++++|||
T Consensus       242 ~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         242 HHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-46  Score=357.20  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=201.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .+|.+.+.||+|+||.||++.+..+++.||||....     ..+.+|+.++++++|+|||++++++...+..++|||++.
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~  243 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR  243 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence            369999999999999999999999999999996432     345789999999999999999999999999999999995


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---CCC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPK  157 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---~~~  157 (338)
                       ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++......   ...
T Consensus       244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC--CEEEcccCCceeccccccccccc
Confidence             6888888654 4699999999999999999999999999999999999997554  79999999987543221   122


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC-------hHHHHHHHhhHhhcc----------
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRILSVH----------  220 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-------~~~~~~~~~~~~~~~----------  220 (338)
                      ...||+.|+|||++.+..++.+ +|||||||++|||++|..|+.....       ...+.+++.......          
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            4569999999999988777655 8999999999999998765432211       112222222111000          


Q ss_pred             ----------------cc---CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          221 ----------------YS---FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       221 ----------------~~---~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                                      ..   +..+..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                            00   1112245678999999999999999999999999999963

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.1e-47  Score=335.12  Aligned_cols=252  Identities=29%  Similarity=0.514  Sum_probs=215.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +|++.+.||.|+||.||++.+..+++.||+|++.+..    ...+.+.+|+.++++++||||+++++++..+..+|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5999999999999999999999999999999997643    234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |+.|++|...+....++++..+..++.||+.||.|||++|++|+||+|+||++++++  .++|+|||++...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG--HVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC--CEEEeecccccccCCCccccc
Confidence            999999999998877899999999999999999999999999999999999997654  899999999876544434455


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      ..|+..|+|||.+.+..++.+ +|+||||+++|+|++|..||...... ...............+|.  .++.++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~  234 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYPA--TWSTEAIDAIN  234 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccCcc--cCcHHHHHHHH
Confidence            678999999999987776555 89999999999999999999876542 111222222222333343  57899999999


Q ss_pred             HhcccCCCcCCCh--hHHhcCccc
Q 019628          239 RIFVANSEKRITI--PEIKNHPWF  260 (338)
Q Consensus       239 ~~L~~dp~~R~s~--~ell~hp~~  260 (338)
                      +||..+|.+||++  .|+++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.8e-47  Score=338.93  Aligned_cols=256  Identities=25%  Similarity=0.440  Sum_probs=211.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|.+....  .....+.+|+.++++++||||+++++++..++.+|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            58999999999999999999999999999999887532  2235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           80 AAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        80 ~~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      +++++|..++...   ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++  .++|+|||++..... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-Cc
Confidence            9999999888763   368999999999999999999997 5999999999999997644  899999999875422 23


Q ss_pred             CCCccccCcccccccccCCcc-----CCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-ccccCCCcccC
Q 019628          156 PKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDYVRV  229 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  229 (338)
                      .....+++.|+|||.+.+...     .+.++|+|||||++|+|++|..||........+.. +..+.. .....+.  .+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~--~~  234 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIVDGDPPTLPS--GY  234 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHhhcCCCCCCc--cc
Confidence            344568889999999865432     23458999999999999999999976544333222 222222 2223333  48


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +.++.+||.+||+.+|++||++.++++||||...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            8999999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-46  Score=336.63  Aligned_cols=256  Identities=28%  Similarity=0.455  Sum_probs=211.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++....   .....+.+|+.++++++||||+++++++.....+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            6999999999999999999999899999999987643   2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CC
Q 019628           80 AAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QP  156 (338)
Q Consensus        80 ~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~  156 (338)
                      + +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++  .++|+|||++.......  ..
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCCCCCcc
Confidence            9 9999999864 45689999999999999999999999999999999999997644  89999999987554332  13


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc---------------cc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------HY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------------~~  221 (338)
                      ....|+..|+|||.+.+....+.++||||+||++|+|++|.+||........+..........               ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            345789999999998765544556999999999999999998887766544443333221110               00


Q ss_pred             cCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          222 SFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       222 ~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      .++.         ....+..+.+||.+||..+|.+|||++++++||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            0110         124578899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.9e-47  Score=346.31  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=200.7

Q ss_pred             eEeeeeccC--CceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            5 EIVKDIGSG--NFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         5 ~~~~~LG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++++.||+|  +||+||++.++.+|+.||+|.+....   .....+.+|+.+++.++||||++++++|..++..|+||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            367889999  78899999999999999999987642   2335677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           80 AAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        80 ~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      +++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++  .++++||+.+.......   
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~--~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC--cEEEcccchhhccccccccc
Confidence            9999999999653  4589999999999999999999999999999999999997554  79999998654221111   


Q ss_pred             -----CCCCccccCcccccccccCC--ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc--------
Q 019628          155 -----QPKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------  219 (338)
Q Consensus       155 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--------  219 (338)
                           ......++..|+|||++.+.  .++ .++||||+||++|+|++|+.||...................        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                 11223567789999999763  354 44899999999999999999997654332222211100000        


Q ss_pred             --c------------------------------ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          220 --H------------------------------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       220 --~------------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                        .                              ...+....+++.+.+||++||+.||++|||+.|+++||||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence              0                              000111235678999999999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-46  Score=335.17  Aligned_cols=251  Identities=29%  Similarity=0.439  Sum_probs=207.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            57999999999999999999999999999999987543 23346788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      ++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++  .++|+|||++....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06646          89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEECcCccceeecccccccCcc
Confidence            9999999998888899999999999999999999999999999999999997554  79999999987543222 23445


Q ss_pred             cccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc---CCCcccCCHHH
Q 019628          160 VGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS---FPDYVRVSLEC  233 (338)
Q Consensus       160 ~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (338)
                      .|++.|+|||.+..   ..++ .++|+||+||++|+|++|+.||..........    .+....+.   ++....++..+
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALF----LMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             ccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhhe----eeecCCCCCCCCccccccCHHH
Confidence            78999999999853   3343 45899999999999999999996543221111    11111111   12223578899


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                      .+||++||..+|++|||++++++|+|
T Consensus       242 ~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         242 HNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.3e-48  Score=331.07  Aligned_cols=264  Identities=28%  Similarity=0.395  Sum_probs=210.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCc----EEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc-CCe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT-PTH   72 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~   72 (338)
                      +..|++++.||+|.||.||+|..+.++.    .+|||+++...   -.....-||+.+++.++||||+.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3579999999999999999997665543    78999987643   334678899999999999999999999988 788


Q ss_pred             EEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC--CCCcEEEeecC
Q 019628           73 LAIVMEYAAGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--TAPRVKICDFG  145 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~--~~~~ikL~Dfg  145 (338)
                      +++++||++. +|...|+.     .+.++...++.|+.||+.|+.|||++=|+||||||.|||+-..  ..|.+||+|||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999999975 99999963     2358999999999999999999999999999999999999433  34699999999


Q ss_pred             CCcccccCC----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC---------hHHHHHH
Q 019628          146 YSKSSVLHS----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED---------PKNFRKT  212 (338)
Q Consensus       146 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---------~~~~~~~  212 (338)
                      +++.....-    .....+.|.+|+|||.+.+...++++.|||++|||+.||+|..+.|.+.+.         .+++.++
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            998643321    234567899999999999988888889999999999999999999976442         1222222


Q ss_pred             HhhHhh-ccccC------CCc------------------------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          213 IGRILS-VHYSF------PDY------------------------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       213 ~~~~~~-~~~~~------~~~------------------------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      +.-+.. ....+      |++                        ..-++.+.+|+.+||++||.+|+|++++|+|+||.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            211110 00011      111                        01244588999999999999999999999999998


Q ss_pred             cCCC
Q 019628          262 RNLP  265 (338)
Q Consensus       262 ~~~~  265 (338)
                      ...-
T Consensus       342 ~d~l  345 (438)
T KOG0666|consen  342 EDPL  345 (438)
T ss_pred             cCCC
Confidence            7643

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-46  Score=338.38  Aligned_cols=259  Identities=29%  Similarity=0.423  Sum_probs=211.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +|++.+.||+|+||.||++.+..+++.||||.+.....      ....+..|+.+++.++|+||+++++++...+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            69999999999999999999998999999999976432      234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-C
Q 019628           77 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~  154 (338)
                      |||+ +++|..++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++  .++|+|||+++..... .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC--CEEEccceeeeeccCCCc
Confidence            9999 889999998765 799999999999999999999999999999999999997554  8999999998754332 2


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCC---------
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFP---------  224 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~---------  224 (338)
                      ......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||........+.+.......... .++         
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            2334467889999999866444455699999999999999998888876654443333221100000 000         


Q ss_pred             ------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          225 ------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       225 ------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                                  .....+..+.+||.+||..+|++|||+.|+++||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                        0123578899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.6e-46  Score=329.18  Aligned_cols=253  Identities=32%  Similarity=0.488  Sum_probs=214.6

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ||++.+.||+|+||.||++.+..+++.||+|.++....   ....+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            79999999999999999999998999999999876543   446788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC---
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---  156 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~---  156 (338)
                      +++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||++++++  .+||+|||++.........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCCCCcccc
Confidence            99999999998877799999999999999999999999999999999999997644  8999999998754333221   


Q ss_pred             --CCccccCcccccccccCCc---cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          157 --KSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       157 --~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                        ....+++.|+|||.+.+..   +. .++||||+|+++|+|++|+.||..........  ..........+|....++.
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~-~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  235 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHG-RAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHVGAGHKPPIPDSLQLSP  235 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCC-cccchHHHHHHHHHHHhCCCCccCCcchHHHH--HHHhcCCCCCCCcccccCH
Confidence              1346788999999997655   44 44899999999999999999997654322211  1111233445666666789


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+.+||.+||+.+|.+|||+.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-46  Score=335.60  Aligned_cols=248  Identities=32%  Similarity=0.487  Sum_probs=207.7

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ||+|+||+||+|.+..+|+.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999987532    2234567899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccC
Q 019628           86 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP  163 (338)
Q Consensus        86 ~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~  163 (338)
                      .+++....  .+++..+..++.|++.||.|||++|++||||+|+||+++.++  .++|+|||++.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG--NVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEccCcchhhhccCCccccccCCC
Confidence            99997765  699999999999999999999999999999999999997654  79999999987554333444567888


Q ss_pred             cccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhccc
Q 019628          164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA  243 (338)
Q Consensus       164 ~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  243 (338)
                      .|+|||.+.+..++.+ +||||+||++|+|++|+.||...............+.......+.  .+++.+.++|.+||+.
T Consensus       159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~  235 (277)
T cd05577         159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQK  235 (277)
T ss_pred             CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc--cCCHHHHHHHHHHccC
Confidence            9999999987776545 899999999999999999997755432323333333333333333  5789999999999999


Q ss_pred             CCCcCC-----ChhHHhcCccccc
Q 019628          244 NSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       244 dp~~R~-----s~~ell~hp~~~~  262 (338)
                      +|.+||     ++.++++||||.+
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhc
Confidence            999999     8888999999963

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-46  Score=335.46  Aligned_cols=257  Identities=30%  Similarity=0.493  Sum_probs=204.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +++|++.+.||.|++|.||++.+..+++.||||.+.....  ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999999998999999999875432  23456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      |+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||+++..... ...
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG--ELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC--CEEECccccccccCCCCccc
Confidence            9975 899988653 4689999999999999999999999999999999999997655  7999999998743221 122


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc----------------c
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------H  220 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~----------------~  220 (338)
                      ....++..|+|||++.+....+.++||||+||++|+|++|+.||............+......                .
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            234578899999998764433455899999999999999999997655322221111110000                0


Q ss_pred             ccCC---------CcccCC--HHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          221 YSFP---------DYVRVS--LECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       221 ~~~~---------~~~~~~--~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ..++         ....++  .++.+++.+||..+|.+|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000         001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-46  Score=334.30  Aligned_cols=253  Identities=29%  Similarity=0.460  Sum_probs=213.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||.|++|.||++.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++..+..+|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            58999999999999999999999999999999987643  2235678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  158 (338)
                      +++++|.+++... ++++..++.++.|++.||.|||+++++||||+|+||+++.++  .++|+|||+++..... .....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEcccccceeeccccccccc
Confidence            9999999999765 899999999999999999999999999999999999997654  7999999998755433 23345


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  237 (338)
                      ..+++.|+|||.+.+..++.+ +|||||||++|+|++|+.||.........    ..+... ....+. ..++.++.+++
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~l  231 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVL----FLIPKNNPPSLEG-NKFSKPFKDFV  231 (274)
T ss_pred             ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHH----HHhhhcCCCCCcc-cccCHHHHHHH
Confidence            678899999999988776555 99999999999999999999765432221    112222 222222 12788999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+||..+|++|||++++++||||.+.
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCC
Confidence            99999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-47  Score=348.16  Aligned_cols=251  Identities=29%  Similarity=0.413  Sum_probs=201.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeec---CccccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .|+++++||+||.+.||+|.....+ .||+|++..   .......+.+|+..|.+|+ |.+||+++++=..++.+|+|||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            5999999999999999999997544 456655543   2334467899999999995 8999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           79 YAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l-~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      += ..+|.++|++.... +.-.++.|..||+.|+.++|..||||.||||.|+|+-   .|.+||+|||.|.......   
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeechhcccCccccce
Confidence            75 57999999877654 3358999999999999999999999999999999994   4489999999998554332   


Q ss_pred             CCCCccccCcccccccccCCccC----------CCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc--ccc
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYS  222 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~~  222 (338)
                      ...+.+||+.||+||.+....++          +.++||||||||||+|+.|++||....   +....+..|...  ...
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDPNHEIE  593 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCCCcccc
Confidence            23467899999999998643332          334899999999999999999998532   233333444443  346


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ||.... ..++.++++.||.+||++|||+.++|+|||++.
T Consensus       594 fp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  594 FPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            666432 233999999999999999999999999999864

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4e-46  Score=333.87  Aligned_cols=253  Identities=29%  Similarity=0.458  Sum_probs=205.1

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCcceeEEEEEcC--CeEEEEEe
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLK-HPNIVRFKEVLLTP--THLAIVME   78 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~--~~~~iv~e   78 (338)
                      |++++.||+|+||.||++.+..+++.||+|++++...  ......+|+..++++. |+||+++++++.++  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            7899999999999999999999999999999876422  2233457888888885 99999999999987  88999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |++ ++|.+.+... ..+++..++.++.|++.||.|||++|++||||||+||+++.   +.+||+|||+++.........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcC
Confidence            996 5888888753 46899999999999999999999999999999999999986   589999999998654444445


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh--------------hccccC
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL--------------SVHYSF  223 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~--------------~~~~~~  223 (338)
                      ...++..|+|||.+.+....+.++||||+||++|+|++|.+||...+..+.+........              ...+.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            567899999999876555445569999999999999999999987654433322221110              011122


Q ss_pred             CC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          224 PD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       224 ~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      |.         ...++.++.+||.+||+++|++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            21         12467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-46  Score=332.78  Aligned_cols=254  Identities=30%  Similarity=0.464  Sum_probs=210.9

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-------cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-------KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +|+..+.||+|+||.||++.+..+++.+|+|++....       .....+.+|+.++++++|+||+++++++...+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5889999999999999999999999999999987532       123568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      ||||+++++|.+++...+++++..++.++.||+.||.|||++|++|+||+|+||+++.++ ..++|+|||++....... 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~-~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG-QRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEcccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999996543 269999999987543221 


Q ss_pred             ----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc--cccCCCccc
Q 019628          155 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVR  228 (338)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  228 (338)
                          ......|+..|+|||.+.+..++.+ +|+||+||++|+|++|..||........... +..+...  ....|.  .
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~  235 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASATTAPSIPE--H  235 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccCCCCCCch--h
Confidence                1223468899999999987776555 8999999999999999999975443222222 2122111  122222  5


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      ++.++.+++.+||..+|++|||+.++++||||.
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            788999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=356.67  Aligned_cols=251  Identities=30%  Similarity=0.485  Sum_probs=213.4

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecC-ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCChHH
Q 019628            9 DIGSGNFGVAKLVRDKWTRELLAVKFIERG-QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE   87 (338)
Q Consensus         9 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~   87 (338)
                      .||+|.||+||.+++..++...|||.++.. ....+-+..||.+.++|+|.|||++++++..++.+-|.||-++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999999999999999998753 3344568899999999999999999999999999999999999999999


Q ss_pred             HHHh-cCCC--CHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCccccC
Q 019628           88 RICN-AGRF--SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTP  163 (338)
Q Consensus        88 ~i~~-~~~l--~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~gt~  163 (338)
                      ++.. -+++  .|..+..+.+||++||+|||++.|||||||-+|+||+. -.|.+||+|||-+++...- ..+.++.||.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCccccccccch
Confidence            9975 4566  88999999999999999999999999999999999963 3458999999998865443 3455788999


Q ss_pred             cccccccccCC-ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcc
Q 019628          164 AYIAPEVLTKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV  242 (338)
Q Consensus       164 ~y~aPE~~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (338)
                      .|||||++-.+ .-+++++|||||||++.||.||++||.....+....-.+ ...+..+..|.  .+|.+++.||.+|+.
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyKvHP~iPe--elsaeak~FilrcFe  817 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYKVHPPIPE--ELSAEAKNFILRCFE  817 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cceecCCCCcH--HHHHHHHHHHHHHcC
Confidence            99999999654 345777999999999999999999999877654321111 12233334444  789999999999999


Q ss_pred             cCCCcCCChhHHhcCcccccC
Q 019628          243 ANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       243 ~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ++|.+||||.++|+.||++.+
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccHHHhccCcccccC
Confidence            999999999999999999765

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.7e-46  Score=330.76  Aligned_cols=251  Identities=26%  Similarity=0.421  Sum_probs=208.0

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +|++.+.||+|+||.||++... +++.+|+|.+.....       ....+.+|+.+++.++|+||+++++++...+.+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            6899999999999999999874 788999998865321       12457889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc---
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---  152 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~---  152 (338)
                      +|||+++++|.+++....++++..++.++.|++.||.|||+.||+|+||+|+||+++.++  .++|+|||++.....   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC--eEEeccchhhHhhhhccc
Confidence            999999999999998878899999999999999999999999999999999999997554  899999998864321   


Q ss_pred             ----CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          153 ----HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       153 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                          ........|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||...+........ ..........+  ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~--~~  233 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-GAHRGLMPRLP--DS  233 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHh-hhccCCCCCCC--CC
Confidence                112234568999999999988776555 89999999999999999999865443322111 11111111223  25


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ++.++.++|++||..+|.+|||+.++++||||
T Consensus       234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            88999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-46  Score=343.57  Aligned_cols=293  Identities=27%  Similarity=0.388  Sum_probs=221.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~   73 (338)
                      ++|++.+.||+|+||+||++.+..+++.||||.+...   ......+.+|+.+++.++|+||+++++++...     ..+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            5899999999999999999999999999999998753   22335677899999999999999999988654     358


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |++|||+. ++|.+++...+.+++..++.++.|++.||.|||+++++||||||+||+++.++  .+||+|||++......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECcCccccccCCC
Confidence            99999995 68999998888899999999999999999999999999999999999997554  8999999998754332


Q ss_pred             -CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH----------------
Q 019628          154 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI----------------  216 (338)
Q Consensus       154 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~----------------  216 (338)
                       .......++..|+|||.+.+....+.++|||||||++|+|++|++||...+............                
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence             223455789999999998654333455999999999999999999997654322211111000                


Q ss_pred             -------hhc-cccC-CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccC-CCcccCCCCCCCCCH
Q 019628          217 -------LSV-HYSF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEG-GSWQSHDVNNPSQSL  286 (338)
Q Consensus       217 -------~~~-~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  286 (338)
                             ... ...+ .....++.++.+||++||+.+|++|||+.++++||||........... ......++....-+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTE  321 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhcCH
Confidence                   000 0000 012357889999999999999999999999999999965322211111 111122333444556


Q ss_pred             HHHHHHhHhhC
Q 019628          287 EEVLSLIHEAT  297 (338)
Q Consensus       287 ~~~~~~~~~~~  297 (338)
                      +++.+++..+.
T Consensus       322 ~~~~~~~~~~~  332 (337)
T cd07858         322 EDIKELIYNEM  332 (337)
T ss_pred             HHHHHHHHHHH
Confidence            66776666543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.9e-46  Score=345.31  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=206.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC------Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~   72 (338)
                      ++|++++.||+|+||.||++.+..+++.||||++.+..   .....+.+|+.++++++||||++++++|...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            68999999999999999999999999999999986532   2234677899999999999999999998654      35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      .|+||||+. ++|...+...  +++..+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||+++....
T Consensus        96 ~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~  170 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGT  170 (353)
T ss_pred             EEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCccceeCCC
Confidence            799999995 5888887654  89999999999999999999999999999999999997654  799999999986544


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh--------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------------  218 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--------------  218 (338)
                      ........+++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+....+.........              
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            444455678999999999988777655 89999999999999999999876543333332211100              


Q ss_pred             ----ccc--------------cCCC-----cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          219 ----VHY--------------SFPD-----YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       219 ----~~~--------------~~~~-----~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                          ...              .++.     ....++.+++||.+||+.||++|||+.|+|+||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                000              0000     11246678999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1e-45  Score=326.52  Aligned_cols=251  Identities=35%  Similarity=0.518  Sum_probs=211.9

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....   .....+.+|+.++++++||||+++++.+...+.+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            6999999999999999999999999999999987643   2345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           80 AAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      +++++|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.+. +.++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK-MVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEccCCCceecCCCcccc
Confidence            9999999999764  3489999999999999999999999999999999999997543 368999999998654444444


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ...|+..|+|||.+.+..++.+ +||||+|+++|+|++|..||...+.........   .......+.  .++.++.+++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~l~~li  233 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIM---SGTFAPISD--RYSPDLRQLI  233 (256)
T ss_pred             ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHH---hcCCCCCCC--CcCHHHHHHH
Confidence            5678999999999987766544 899999999999999999998755433222221   111222333  5789999999


Q ss_pred             HHhcccCCCcCCChhHHhcCccc
Q 019628          238 SRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+||..+|++|||+.|+++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.5e-46  Score=334.11  Aligned_cols=255  Identities=28%  Similarity=0.438  Sum_probs=208.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcC-----CeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTP-----THLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-----~~~~i   75 (338)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++++ +||||+++++++...     ..+|+
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l  101 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL  101 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence            579999999999999999999999999999999876655556788899999998 899999999998754     36899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           76 VMEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      ||||+++++|.+++..    ...+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||++....
T Consensus       102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~--~~kl~dfg~~~~~~  179 (291)
T cd06639         102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG--GVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--CEEEeecccchhcc
Confidence            9999999999998853    35689999999999999999999999999999999999997554  79999999987543


Q ss_pred             cCC-CCCCccccCcccccccccCCcc----CCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCc
Q 019628          152 LHS-QPKSTVGTPAYIAPEVLTKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY  226 (338)
Q Consensus       152 ~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (338)
                      ... ......|+..|+|||.+.....    .+.++||||+||++|+|++|++||..............   .........
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~  256 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTLLHP  256 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCCCcc
Confidence            322 2234568999999999865331    23458999999999999999999987654333322211   111122222


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      ...+..+.+||.+||+.+|++|||+.++++||||+
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            25678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-46  Score=335.11  Aligned_cols=257  Identities=24%  Similarity=0.434  Sum_probs=213.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||+||++.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.....+|+||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57999999999999999999999999999999887543  3346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      +++++|..++...+.+++..++.++.|++.||.|||+ .+++||||||+||+++.++  .++|+|||++..... .....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~-~~~~~  161 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN-SIADT  161 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh-hccCc
Confidence            9999999999888889999999999999999999997 5999999999999997554  899999999864322 22334


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh-------HHHHHHHhhHhhcc-ccCCCcccCC
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-------KNFRKTIGRILSVH-YSFPDYVRVS  230 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~  230 (338)
                      ..|+..|+|||++.+..++.+ +|+||+||++|+|++|..||......       .........+.... ..++. ..++
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  239 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS-SDFP  239 (284)
T ss_pred             cccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc-hhcC
Confidence            678999999999987776555 89999999999999999999864432       11112222222211 12222 2377


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .++.+|+.+||+.+|++|||+.|+++|+||.+.
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            889999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-46  Score=329.65  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=211.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||++....+++.+|+|.+..... .+.+.+|+.+++.++||||+++++++.....+|+++||++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            689999999999999999999998899999999876543 5788999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           82 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        82 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      +++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|.||+++.++  .++|+|||++....... .....
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG--QAKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC--cEEEcccccchhcccCccccccc
Confidence            9999999875 45689999999999999999999999999999999999997654  79999999987543332 23345


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .|+..|+|||.+.+..++.+ +||||+||++|+|++|+.||............ ..  .....+.....++..+.++|.+
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-PN--KPPPTLSDPEKWSPEFNDFVKK  235 (256)
T ss_pred             cCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-cc--CCCCCCCchhhcCHHHHHHHHH
Confidence            58899999999988777555 89999999999999999999865432221111 11  1111122223577899999999


Q ss_pred             hcccCCCcCCChhHHhcCccc
Q 019628          240 IFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ||+.+|++|||+.++++||||
T Consensus       236 ~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         236 CLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-45  Score=326.41  Aligned_cols=249  Identities=27%  Similarity=0.483  Sum_probs=207.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc-CCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT-PTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~iv~e   78 (338)
                      +|++++.||+|++|.||++.+..+++.||+|++....   ...+.+.+|+.++++++|+|++++++.+.. ...+|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5999999999999999999999999999999987543   233567889999999999999999998864 446899999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CC
Q 019628           79 YAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ  155 (338)
Q Consensus        79 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~  155 (338)
                      |+++++|.+.+...  ..+++..++.++.|++.||.+||++|++||||||+||+++.+.  .++|+|||++...... ..
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN--IIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC--cEEEecccceEEecccCCc
Confidence            99999999999753  3589999999999999999999999999999999999997554  8999999998754322 22


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCCCcccCCHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLECK  234 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (338)
                      .....+++.|+|||++.+..++.+ +|+||+||++|+|++|+.||...+......    .+..... ..+  ..+++.+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~  231 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVY----RIIEGKLPPMP--KDYSPELG  231 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHhcCCCCCc--cccCHHHH
Confidence            334568999999999988777655 899999999999999999998654322222    2222221 222  35889999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCccc
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +|+.+||+.+|++|||+.+++.||||
T Consensus       232 ~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         232 ELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.5e-46  Score=337.95  Aligned_cols=259  Identities=29%  Similarity=0.427  Sum_probs=207.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~i   75 (338)
                      +++|++.+.||+|+||.||++.+..+|+.||+|++.....   ......+|+.++++++|+||+++++++...  +.+++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4789999999999999999999999999999999875432   223566899999999999999999998765  56899


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-
Q 019628           76 VMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-  153 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-  153 (338)
                      ||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++  .+||+|||++...... 
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCcc
Confidence            9999964 88888765 35689999999999999999999999999999999999997554  8999999998754332 


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------  218 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------  218 (338)
                      .......+++.|+|||++.+....+.++|||||||++|+|++|++||...+....+.........               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            22233456888999999876544445599999999999999999999876655444333321110               


Q ss_pred             ccccCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          219 VHYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       219 ~~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..+..+.         ....++.+.+||++||+.||++|||+.++++||||..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            0001110         1125788999999999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-46  Score=327.99  Aligned_cols=254  Identities=31%  Similarity=0.457  Sum_probs=210.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||.|+||.||++.+..+++.+|+|++..... ..+.+.+|+.++++++||||+++++++...+.+|++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            689999999999999999999998999999999876532 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCC
Q 019628           81 AGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  158 (338)
                      ++++|..++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++  .++|+|||++....... ....
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC--CEEECccccchhhhhhhhcccc
Confidence            999999998766 6899999999999999999999999999999999999997554  79999999987543322 2344


Q ss_pred             ccccCcccccccccCC---ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          159 TVGTPAYIAPEVLTKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ..++..|+|||.+.+.   .++.. +|+||+||++|+|++|.+||................. ..........++.++.+
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFHD  238 (262)
T ss_pred             ccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHHH
Confidence            5788999999998766   56544 8999999999999999999987554332222111100 01111112246788999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                      |+++||..+|.+|||+.+++.|+|
T Consensus       239 li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         239 FIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-45  Score=334.10  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=213.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .+|++++.||.|+||.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.....+|+|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            479999999999999999999999999999999875432 3456788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      ++++|..++... .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++....... .....
T Consensus        99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655          99 AGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             CCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccchhcccccccCCCc
Confidence            999999988654 689999999999999999999999999999999999997544  89999999987543322 22345


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .++..|+|||.+.+..++.+ +|+|||||++|+|++|..||.............   ......+.....++..+.+||++
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHHHHH
Confidence            78999999999987777555 899999999999999999998765433222211   11122222334688999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||..+|.+|||+.+++.||||...
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhc
Confidence            999999999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.1e-46  Score=335.00  Aligned_cols=255  Identities=28%  Similarity=0.441  Sum_probs=212.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .+|++++.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++.|......|+||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            589999999999999999999999999999999876432 3456888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      ++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++  .++|+|||++....... .....
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEECccccchhccccccccCcc
Confidence            99999998864 4689999999999999999999999999999999999997554  79999999887543222 22345


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .|++.|+|||.+.+..++.+ +||||+||++|+|++|+.||............   ........+....++..+.+|+.+
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             cCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHHHHHH
Confidence            78999999999987776555 89999999999999999999765432222211   111112222233578899999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||..+|++|||+.++++||||...
T Consensus       253 ~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         253 CLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HCcCCcccCcCHHHHhhChhhhcc
Confidence            999999999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.7e-46  Score=332.55  Aligned_cols=255  Identities=31%  Similarity=0.432  Sum_probs=209.4

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      -|++.+.||.|+||.||++.+..++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            4788999999999999999999999999999986543 334567889999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCc
Q 019628           82 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKST  159 (338)
Q Consensus        82 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  159 (338)
                      +++|...+.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++  .++|+|||++...... ......
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--CEEEccccccccccccccccccc
Confidence            9999887764 45799999999999999999999999999999999999997654  7999999998753322 223445


Q ss_pred             cccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          160 VGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       160 ~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .+++.|+|||++..     ..++ .++||||+||++|+|++|++||.............   .......+....++.++.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  239 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLAQPSRWSSEFK  239 (282)
T ss_pred             cccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh---hcCCCCCCCccccCHHHH
Confidence            78999999999842     2343 44899999999999999999998755433222221   111122222335789999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +||.+||..+|.+|||+.++++||||...
T Consensus       240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         240 DFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            99999999999999999999999999743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.6e-46  Score=331.04  Aligned_cols=254  Identities=32%  Similarity=0.453  Sum_probs=208.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-----------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-----------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPT   71 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~   71 (338)
                      +|.+.+.||.|+||.||++.+..+++.+|+|.++....           ..+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68999999999999999999998999999998864211           1235778999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           72 HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      .+++||||+++++|.+++.....+++..++.++.|++.||.|||++|++||||+|+||+++.++  .++|+|||+++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG--ICKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC--eEEEeecccccccc
Confidence            9999999999999999998888899999999999999999999999999999999999997554  89999999987533


Q ss_pred             cCC---CCCCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--
Q 019628          152 LHS---QPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--  225 (338)
Q Consensus       152 ~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  225 (338)
                      ...   ......|+..|+|||.+.... ..+.++|+||||+++|+|++|..||..............  ......++.  
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~  237 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--KRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc--cccCCcCCccc
Confidence            211   123456889999999987654 224448999999999999999999975443322222111  111222222  


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ...++..+.++|.+||..+|++|||+.++++|||+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            23568999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3e-46  Score=340.59  Aligned_cols=252  Identities=26%  Similarity=0.390  Sum_probs=191.8

Q ss_pred             eeeeccCCceEEEEEEEcC--CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeEEEEEeccCC
Q 019628            7 VKDIGSGNFGVAKLVRDKW--TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHLAIVMEYAAG   82 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~iv~e~~~~   82 (338)
                      ..+||+|+||+||+|....  ++..||+|.+.... ....+.+|+.+++.++||||+++++++..  +..+|++|||+. 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            3679999999999999653  56889999887543 33567899999999999999999999854  567899999996 


Q ss_pred             CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC--CCCcEEEeecCCCcccc
Q 019628           83 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--TAPRVKICDFGYSKSSV  151 (338)
Q Consensus        83 ~~L~~~i~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~--~~~~ikL~Dfg~a~~~~  151 (338)
                      ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+...  ..+.+||+|||+++...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence            5788877521         248899999999999999999999999999999999999432  23489999999997543


Q ss_pred             cCC----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh---------HHHHHHHhhHh-
Q 019628          152 LHS----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---------KNFRKTIGRIL-  217 (338)
Q Consensus       152 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~~~~~~~-  217 (338)
                      ...    ......||+.|+|||++.+....+.++||||+||++|+|+||++||......         ........... 
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF  243 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence            221    2234578999999999977554455599999999999999999999753321         11111100000 


Q ss_pred             -----------------------hcccc-------C-CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          218 -----------------------SVHYS-------F-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       218 -----------------------~~~~~-------~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                                             ...+.       . ......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                   00000       0 0011245668899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-46  Score=334.85  Aligned_cols=255  Identities=29%  Similarity=0.440  Sum_probs=210.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||.|+||.||++.+..++..+|+|.+.... ...+.+.+|+.++++++||||+++++++..+..+|+||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            58999999999999999999998899999999987543 23356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCC
Q 019628           81 AGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  158 (338)
                      ++++|..++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++  .++|+|||++...... .....
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC--CEEEccCccchhhcccccccce
Confidence            999999998763 4699999999999999999999999999999999999997554  8999999988643322 22334


Q ss_pred             ccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-ccCCCcccCCHH
Q 019628          159 TVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFPDYVRVSLE  232 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  232 (338)
                      ..||+.|+|||.+..     ..++ .++|+|||||++|+|++|++||...........    +.... ..+.....++.+
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~-~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCC-ccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCcccCCHH
Confidence            568999999999853     2233 348999999999999999999987544332222    22221 122222357899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +.++|.+||..+|.+|||+.++++||||...
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999999643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-45  Score=335.10  Aligned_cols=254  Identities=33%  Similarity=0.541  Sum_probs=211.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            479999999999999999999999999999999876432    2346778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||+++......   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~--~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC--CEEEeeCCCccccCcCcccc
Confidence            9999999999998888899999999999999999999999999999999999997554  89999999886321100   


Q ss_pred             -------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc
Q 019628          155 -------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY  221 (338)
Q Consensus       155 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  221 (338)
                                   ......|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||.+.....    ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~----~~~~~~~~~~  233 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEE----LFGQVISDDI  233 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccc
Confidence                         0112457889999999987777555 899999999999999999998654322    2222233222


Q ss_pred             cCCCc-ccCCHHHHHHHHHhcccCCCcCCC---hhHHhcCccccc
Q 019628          222 SFPDY-VRVSLECKHLLSRIFVANSEKRIT---IPEIKNHPWFLR  262 (338)
Q Consensus       222 ~~~~~-~~~~~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~  262 (338)
                      ..|.. ..++.++.++|.+||+.+|++|||   +.++++||||..
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            22321 257899999999999999999997   799999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=321.06  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=214.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +.+++..||.|+.|.|++++.+.+|...|||.+.+..  ...+++.+.+.++... .+|+||+.+++|..+..++|-||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            4567889999999999999999999999999998743  3346677777766555 489999999999999999999999


Q ss_pred             cCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           80 AAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |.. -+..+++ -.+++||..+-++...+++||.||..+ ||+|||+||+|||+|..+  ++||||||++.+.......+
T Consensus       173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G--niKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--NIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC--CEEeecccccceeecccccc
Confidence            953 3444443 356799999999999999999999865 999999999999998766  89999999999888887788


Q ss_pred             CccccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          158 STVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...|.+.|||||.+.-   ..|+-. +||||||++++||.||+.||.+.+.  .+..+-+.+....+.+|....+|++++
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln~ePP~L~~~~gFSp~F~  326 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLNEEPPLLPGHMGFSPDFQ  326 (391)
T ss_pred             cccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence            8889999999999853   456666 8999999999999999999987543  222222223344456666667999999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccCCCc
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRNLPI  266 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  266 (338)
                      +|+..||++|+.+||...++|+|||+......
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence            99999999999999999999999999866543

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-46  Score=342.09  Aligned_cols=290  Identities=29%  Similarity=0.400  Sum_probs=225.4

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-----eEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-----HLA   74 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~~   74 (338)
                      ||++.+.||.|++|.||+|.+..+++.||||++....   ...+.+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999999889999999987642   33467889999999999999999999988775     799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ++|||++ ++|.+.+.....+++..++.++.||+.||.|||++||+||||||.||+++.+  +.++|+|||++.......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~--~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN--CDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEcccCceEeecccc
Confidence            9999997 5899999887789999999999999999999999999999999999999765  489999999988554332


Q ss_pred             ----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc---------
Q 019628          155 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY---------  221 (338)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---------  221 (338)
                          ......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||...+....+............         
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                2344568999999999987733345599999999999999999999876654433332221100000         


Q ss_pred             ---------------cC-CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCC--CcccCCCCCCC
Q 019628          222 ---------------SF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGG--SWQSHDVNNPS  283 (338)
Q Consensus       222 ---------------~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~--~~~~~~~~~~~  283 (338)
                                     .+ .....++.++.+||.+||+.+|.+|||+.++++||||.+..........  .+....+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDE  317 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhh
Confidence                           00 0012367889999999999999999999999999999754432222221  21111244455


Q ss_pred             CCHHHHHHHhHh
Q 019628          284 QSLEEVLSLIHE  295 (338)
Q Consensus       284 ~~~~~~~~~~~~  295 (338)
                      -+.++..+++..
T Consensus       318 ~~~~~~~~~~~~  329 (330)
T cd07834         318 LTEEELKELIYE  329 (330)
T ss_pred             cCHHHHhHHhhc
Confidence            566666666653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.2e-46  Score=335.37  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=209.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            589999999999999999999998899999998865332   23567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~  157 (338)
                      |+++++|..+......+++..+..++.||+.||.|||+.|++||||+|+||+++.++  .++|+|||++...... ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--cEEEEeeeeeeeccCCccccC
Confidence            999988888877666799999999999999999999999999999999999997654  8999999998754332 2233


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc---------------ccc
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------HYS  222 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  222 (338)
                      ...++..|+|||++.+....+.++||||+||++|+|++|.+||......+............               ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            45688999999998764444455999999999999999999997655433322222110000               000


Q ss_pred             CC----------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          223 FP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       223 ~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+          ....++..+.+|+.+||..+|++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            11          122568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-45  Score=333.42  Aligned_cols=255  Identities=29%  Similarity=0.434  Sum_probs=209.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +.|++++.||.|+||.||++.+..+++.+|+|.+.... .....+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            46999999999999999999999999999999987643 23456788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCC
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  158 (338)
                      ++++|...+.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||++...... .....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceeccccccccce
Confidence            99999887754 45689999999999999999999999999999999999996544  8999999988643222 22344


Q ss_pred             ccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          159 TVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ..+++.|+|||.+.+     ..++ .++|+|||||++|+|++|..||...+......+..   .......+....++.++
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  245 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLSQPSKWSMEF  245 (292)
T ss_pred             ecCCccccCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---cCCCccCCCCcccCHHH
Confidence            568899999999853     2333 34899999999999999999997655332222211   11111222233678899


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .++|.+||..+|++||++.++++||||..
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            99999999999999999999999999953

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.1e-45  Score=326.33  Aligned_cols=249  Identities=31%  Similarity=0.475  Sum_probs=210.0

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||+|++|.||++.+..+++.|++|.+...   ......+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            589999999999999999999999999999998753   23345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           80 AAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        80 ~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      +++++|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.+.  .++|+|||+++...... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~--~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC--CEEEcccccceeccCccchh
Confidence            9999999999764  5689999999999999999999999999999999999997554  89999999987543322 22


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCCCcccCCHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLECKH  235 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (338)
                      ....|++.|+|||++.+..++.+ +|+|||||++|+|++|+.||..........    .+..... ..+.  .++..+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~  231 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALIL----KIIRGVFPPVSQ--MYSQQLAQ  231 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCcc--ccCHHHHH
Confidence            34568999999999988776555 899999999999999999998665322222    2222221 2222  57889999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCccc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ++.+||+.+|++||++.++++|||+
T Consensus       232 ~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         232 LIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-45  Score=333.12  Aligned_cols=260  Identities=29%  Similarity=0.438  Sum_probs=209.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      |++|++.+.||+|++|+||++.+..+|+.||+|.+....   .....+.+|+.++++++||||+++++++.....+|+||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            689999999999999999999999999999999986543   22356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-C
Q 019628           78 EYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~  154 (338)
                      ||++ ++|...+.....  +++..++.++.||+.||+|||++|++||||+|+||+++..+ +.+||+|||++...... .
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVR  158 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCcc
Confidence            9995 588888765443  57889999999999999999999999999999999997433 36999999998754322 2


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc--------------c
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------------H  220 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--------------~  220 (338)
                      ......+++.|+|||.+.+....+.++||||+||++|+|+||.+||..........+.+......              .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            22345678999999998765444455999999999999999999998765544443332211100              0


Q ss_pred             ccCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          221 YSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       221 ~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..++.         ...++..+.+++.+||..+|++|||+.++++||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence            00010         1246888999999999999999999999999999964

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.5e-46  Score=332.20  Aligned_cols=257  Identities=28%  Similarity=0.500  Sum_probs=213.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||.|+||.||++.+..+++.+|+|.+....  .....+.+|+.++++++||||+++++++...+.+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47899999999999999999999999999999987653  3345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           80 AAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      +++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++  .++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~-~~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSL-AK  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHH-hh
Confidence            9999999999875 789999999999999999999999 9999999999999997644  79999999987443222 22


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC-hHHHHHHHhhHhhc-cccCCCcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-PKNFRKTIGRILSV-HYSFPDYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  235 (338)
                      ...++..|+|||.+.+..++.+ +||||+||++|+|++|..||..... ........+.+... ....+.. .++.++.+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG-KFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh-hcCHHHHH
Confidence            2678899999999988776555 8999999999999999999976421 11122222222222 2222221 27889999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +|.+||..+|++|||+.+++.||||++.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-47  Score=300.78  Aligned_cols=259  Identities=27%  Similarity=0.485  Sum_probs=215.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      |.+|.-.++||+|.||+|+++++..+++.||+|.++...   .......+||-+++.++|.|||+++++...++.+-+|+
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            678889999999999999999999999999999998643   33467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CC
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~  155 (338)
                      |||. .+|..+... ++.+..+.++.++.|+++||.++|++++.||||||.|.||+  .+|.+||+|||+++..... ..
T Consensus        81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin--~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN--RNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec--cCCcEEecccchhhhcCCceEe
Confidence            9994 588877754 56799999999999999999999999999999999999995  4458999999999843322 22


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcc-ccCC------Ccc
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVH-YSFP------DYV  227 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~------~~~  227 (338)
                      ....+.|.+|++|.++.+...++...|+||-|||+.|+.. |++.|.+.+-.+++.+++..+.... -.+|      ++.
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            3456789999999999997766666899999999999986 7888888776666666554332211 1122      111


Q ss_pred             ----------------cCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          228 ----------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       228 ----------------~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                                      .++...++|++++|.-+|.+|+|++++++||||..
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence                            23455789999999999999999999999999964

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-46  Score=332.76  Aligned_cols=257  Identities=31%  Similarity=0.509  Sum_probs=210.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++.+.||+|+||.||++.+..+++.||+|+++..   ....+.+.+|+.+++.++|+||+++++++...+.++++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            5899999999999999999999999999999988653   2334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~  156 (338)
                      |++++.+..++.....+++..+..++.||+.||.|||++|++||||+|+||+++.+.  .+||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~--~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEEeeecccccCCCccccc
Confidence            999877776666666799999999999999999999999999999999999997644  89999999987654433  33


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc---------------cc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------HY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------------~~  221 (338)
                      ....++..|+|||++.+....+.++|+||+|+++|+|++|++||......+............               ..
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            456788999999999877333455999999999999999999998765443332221110000               00


Q ss_pred             cCCC----------c-ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          222 SFPD----------Y-VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       222 ~~~~----------~-~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .++.          + ..++.++++||++||..+|++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0000          0 1248889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.8e-46  Score=332.77  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=206.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEc------CCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLT------PTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~------~~~~~   74 (338)
                      .+|++.+.||.|+||.||++.+..+++.+|+|++.........+.+|+.+++++ +||||+++++++..      ...+|
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            468999999999999999999999999999999877655556788899999888 69999999999853      45789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      ++|||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++  .++|+|||++.....
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~--~~~l~dfg~~~~~~~  173 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCcchhhhhc
Confidence            999999999999998753  3588999999999999999999999999999999999997554  799999999874432


Q ss_pred             -CCCCCCccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCc
Q 019628          153 -HSQPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY  226 (338)
Q Consensus       153 -~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (338)
                       ........|++.|+|||.+..     ..++.+ +|+|||||++|+|++|..||...........    +..........
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~  248 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKS  248 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcc
Confidence             122345679999999999863     334444 8999999999999999999976543322211    11111111122


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ..++.++.+||++||+.+|.+|||+.|+++||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            3578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.5e-46  Score=332.05  Aligned_cols=255  Identities=28%  Similarity=0.458  Sum_probs=207.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      .|++++.||.|++|.||++.+..+++.||||.+.....   ....+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48999999999999999999999999999998875422   235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           80 AAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        80 ~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      +. ++|..++..  ...+++..++.++.|++.||.|||++|++||||+|+||+++.++  .+||+|||++...... ...
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~--~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEeeccchhhcccCcccc
Confidence            96 588888864  34689999999999999999999999999999999999997655  7999999998744322 122


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh--------------cccc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------------VHYS  222 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--------------~~~~  222 (338)
                      ....+++.|+|||.+.+....+.++|||||||++|+|+||+.||...+......+.......              ....
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            33457889999999877654455599999999999999999999876654443333221110              0011


Q ss_pred             CCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          223 FPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       223 ~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ++.         ...++.+++++|.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            111         12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-48  Score=338.19  Aligned_cols=257  Identities=30%  Similarity=0.472  Sum_probs=214.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC--C----CcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH--P----NIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h--~----~Iv~~~~~~~~~~~~~i   75 (338)
                      +||++++++|+|+||.|..+.+..++..||||+++.-.+..+...-|+++++++.+  |    -+|++.++|...++.||
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            58999999999999999999999999999999999877777888899999999942  3    38889999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC------------------
Q 019628           76 VMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST------------------  135 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~------------------  135 (338)
                      |+|.+ |.++++++..+.  +++-..++.+..|++.++++||+++++|.||||+|||+.++.                  
T Consensus       169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k  247 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK  247 (415)
T ss_pred             EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence            99999 779999998754  589999999999999999999999999999999999984211                  


Q ss_pred             CCcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhh
Q 019628          136 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR  215 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~  215 (338)
                      +..|+|+|||.|+...  ....+.+.|..|+|||++.+-+++.+ +||||+||||+|+.||...|...++.+.+ .++++
T Consensus       248 s~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMer  323 (415)
T KOG0671|consen  248 STAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMMER  323 (415)
T ss_pred             CcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHHH
Confidence            3478999999998543  33467789999999999999999877 99999999999999999999987765544 44444


Q ss_pred             Hhhc------------------cccCCCccc-----------------------CCHHHHHHHHHhcccCCCcCCChhHH
Q 019628          216 ILSV------------------HYSFPDYVR-----------------------VSLECKHLLSRIFVANSEKRITIPEI  254 (338)
Q Consensus       216 ~~~~------------------~~~~~~~~~-----------------------~~~~~~~li~~~L~~dp~~R~s~~el  254 (338)
                      +.+.                  ...+|+...                       --.++.|||++||.+||.+|+|+.|+
T Consensus       324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence            4331                  112221100                       11337799999999999999999999


Q ss_pred             hcCcccccC
Q 019628          255 KNHPWFLRN  263 (338)
Q Consensus       255 l~hp~~~~~  263 (338)
                      |.||||..-
T Consensus       404 L~HpFF~~~  412 (415)
T KOG0671|consen  404 LSHPFFARL  412 (415)
T ss_pred             hcCHHhhcC
Confidence            999999753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-46  Score=344.10  Aligned_cols=293  Identities=23%  Similarity=0.356  Sum_probs=229.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH------   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~------   72 (338)
                      ++|++.+.||+|++|.||++.+..+++.||+|++....   .....+.+|+.+++.+.||||+++++++...+.      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            58999999999999999999999999999999986532   233567789999999999999999998876554      


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+|+||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++  .++|+|||++.....
T Consensus        95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~~~~~~~  170 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLARHTDD  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEccccccccccc
Confidence            89999999 6799988865 5799999999999999999999999999999999999997654  899999999875432


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------  219 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (338)
                        ......++..|+|||.+.+....+.++|||||||++|+|++|+.||........+..........             
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             --cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence              24456789999999998664334455899999999999999999998765443333222111000             


Q ss_pred             -------cc----cCC-CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCCCCCHH
Q 019628          220 -------HY----SFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLE  287 (338)
Q Consensus       220 -------~~----~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (338)
                             ..    .++ .....+..+.+||.+||..+|++|||+.++++||||.+....+...........+.+....+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYDQSFESRDLTVD  328 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccccccCcchhhhhcCHH
Confidence                   00    000 012368899999999999999999999999999999876554333223333455666677888


Q ss_pred             HHHHHhHhhCCCC
Q 019628          288 EVLSLIHEATKPL  300 (338)
Q Consensus       288 ~~~~~~~~~~~~~  300 (338)
                      ++..+++.+...+
T Consensus       329 ~~~~~~~~~~~~~  341 (343)
T cd07851         329 EWKELVYKEIMNF  341 (343)
T ss_pred             HHHHHhHHHHHhc
Confidence            8888888776543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.3e-46  Score=328.60  Aligned_cols=246  Identities=33%  Similarity=0.583  Sum_probs=209.2

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ||.|+||.||++.+..+++.+|+|++.+..    ...+.+.+|+.+++.++||||+++++.+.++..+|++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999999999999999987643    2345788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcc
Q 019628           86 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY  165 (338)
Q Consensus        86 ~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y  165 (338)
                      .+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++  .++|+|||++.............|++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC--CEEEeeCCcccccCcccccccccCCcCc
Confidence            99998887899999999999999999999999999999999999997654  8999999998865443334456789999


Q ss_pred             cccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh--hccccCCCcccCCHHHHHHHHHhccc
Q 019628          166 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL--SVHYSFPDYVRVSLECKHLLSRIFVA  243 (338)
Q Consensus       166 ~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~  243 (338)
                      +|||.+.+..++.+ +|+||+|+++|+|++|..||.......  ......+.  .....+|.  ..+.+++++|.+||..
T Consensus       159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~  233 (262)
T cd05572         159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRR  233 (262)
T ss_pred             cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccC
Confidence            99999887777655 899999999999999999998765211  12222222  23334444  3588999999999999


Q ss_pred             CCCcCCC-----hhHHhcCccccc
Q 019628          244 NSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       244 dp~~R~s-----~~ell~hp~~~~  262 (338)
                      +|++|||     +.|+++||||..
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChhhhC
Confidence            9999999     999999999964

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.1e-46  Score=332.50  Aligned_cols=253  Identities=28%  Similarity=0.434  Sum_probs=205.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEE-----cCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLL-----TPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~-----~~~~~~i   75 (338)
                      ++|++++.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++.+ +||||+++++++.     ....+++
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            689999999999999999999999999999998876544456788899999999 6999999999874     3457999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           76 VMEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      ||||+++++|.+++..    ...+++..++.++.|++.||.|||+++++||||||+||+++.++  .++|+|||+++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~  175 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG--GVKLVDFGVSAQLT  175 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC--CEEEccCCceeecc
Confidence            9999999999988753    34689999999999999999999999999999999999997654  79999999987543


Q ss_pred             cCC-CCCCccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC
Q 019628          152 LHS-QPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD  225 (338)
Q Consensus       152 ~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (338)
                      ... ......|++.|+|||++..     ..++ .++||||+||++|+|++|+.||............   ..........
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~  251 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKI---PRNPPPTLHQ  251 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhcccccc-chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc---cccCCCcccC
Confidence            322 2334579999999999853     2243 4489999999999999999999865443222211   1111111112


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ...++..+.+||.+||+.+|++|||+.++++|+||
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            22467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.4e-46  Score=341.40  Aligned_cols=290  Identities=26%  Similarity=0.366  Sum_probs=225.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------e
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------H   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~   72 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+..   .....+.+|+.+++.++||||+++++++....      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            68999999999999999999999999999999986532   22346789999999999999999999987653      4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +++||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||++.....
T Consensus        95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~  170 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQTDS  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeccccccccc
Confidence            68999999 7789887764 5799999999999999999999999999999999999997544  799999999875422


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------  219 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (338)
                        ......+++.|+|||.+.+....+.++|+|||||++|+|++|..||........+..........             
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         171 --EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             --CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence              23345688999999998764434455899999999999999999998765433333222110000             


Q ss_pred             ---cccCC---------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCCCCCHH
Q 019628          220 ---HYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLE  287 (338)
Q Consensus       220 ---~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (338)
                         ....+         ....++.++.++|.+||..+|++|||+.+++.||||+.....+......-.........++.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLE  328 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCccccHHhhccchH
Confidence               00000         012577889999999999999999999999999999765443222222223344566778888


Q ss_pred             HHHHHhHhhC
Q 019628          288 EVLSLIHEAT  297 (338)
Q Consensus       288 ~~~~~~~~~~  297 (338)
                      |+.++-..+.
T Consensus       329 ~~~~~~~~~~  338 (343)
T cd07880         329 EWKRLTFTEI  338 (343)
T ss_pred             HHHHHHHHHH
Confidence            8888766554

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.3e-46  Score=334.76  Aligned_cols=256  Identities=28%  Similarity=0.446  Sum_probs=211.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .+|.+++.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            589999999999999999999999999999999876432 3356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      ++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++  .++|+|||++....... .....
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEECcCccceEccCCccCcCcc
Confidence            99999998865 4689999999999999999999999999999999999997554  89999999987543222 22345


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .+++.|+|||.+.+..++.+ +|+||+||++|+|++|..||...+.......   ..............++..+++|+.+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             cCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheee---eccCCCCCCCCccccCHHHHHHHHH
Confidence            78999999999987776544 8999999999999999999976543221111   1111111222223578889999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccCC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ||..+|++|||+.++++||||....
T Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         252 CLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HccCChhhCcCHHHHhcCchhcccc
Confidence            9999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.9e-45  Score=331.87  Aligned_cols=258  Identities=28%  Similarity=0.372  Sum_probs=206.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCe-----
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTH-----   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~-----   72 (338)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            589999999999999999999999999999998865422   2356788999999995 6999999999987665     


Q ss_pred             EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           73 LAIVMEYAAGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      .|++|||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++.+ ++.+||+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~-~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC-CCeEEEeecccc
Confidence            8999999975 888887642     357999999999999999999999999999999999999762 338999999998


Q ss_pred             cccccC-CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-cc---
Q 019628          148 KSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YS---  222 (338)
Q Consensus       148 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~---  222 (338)
                      ...... .......+++.|+|||++.+....+.++|+||+||++|+|++|..||...+...........+.... ..   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            754322 2223446788999999986644334559999999999999999999987665554444332211000 00   


Q ss_pred             ---------CCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          223 ---------FPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       223 ---------~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                               ++.         ...++..+.+||.+||..+|.+|||+.+++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                     010         124788899999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.8e-45  Score=330.41  Aligned_cols=256  Identities=26%  Similarity=0.398  Sum_probs=202.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++....  .....+.+|+.+++.++|+||+++++++..+...|+||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            57999999999999999999999999999999987543  2234677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCC
Q 019628           80 AAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~  157 (338)
                      +. ++|...+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++  .++|+|||+++..... ....
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC--cEEEeccccccccCCCCCCCC
Confidence            95 677776654 35688999999999999999999999999999999999997554  8999999998753222 2233


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHHhhH-----------hhcc----c
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF-RKTIGRI-----------LSVH----Y  221 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~-~~~~~~~-----------~~~~----~  221 (338)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|..||......... .......           ....    .
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            4567999999999876443334489999999999999999999865542211 1110000           0000    0


Q ss_pred             cC----C-------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          222 SF----P-------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       222 ~~----~-------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+    +       .....+..+.+++.+||..||++|||+.|++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00    0       001235788999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-45  Score=328.15  Aligned_cols=251  Identities=31%  Similarity=0.453  Sum_probs=205.7

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------KIDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHLA   74 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~   74 (338)
                      .|+..+.||+|+||.||++.+..+++.||+|++....      .....+.+|+.+++.++||||+++++++..  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6899999999999999999999999999999886432      123467889999999999999999998875  36789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-  153 (338)
                      ++|||+++++|.+.+.....+++..++.++.|++.||.|||+++|+||||||+||+++.+.  .++|+|||++...... 
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~--~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCCCcccccccc
Confidence            9999999999999998877899999999999999999999999999999999999997554  7999999998754221 


Q ss_pred             ---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          154 ---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       154 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                         .......++..|+|||.+.+..++.. +|+||+||++|+|++|+.||..............  ......+|.  .++
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~--~~~  235 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNPQLPS--HIS  235 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc--CCCCCCCch--hcC
Confidence               11223568899999999987776555 8999999999999999999987544333222111  111222332  467


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      +.+++++ +||..+|++|||++|+++||||+
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            8899999 56678999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-45  Score=328.24  Aligned_cols=248  Identities=30%  Similarity=0.502  Sum_probs=200.5

Q ss_pred             CCceEeeee--ccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhc-CCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDI--GSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRS-LKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~L--G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++.+.+  |+|+||.||++.++.++..+|+|.+.......    .|+..... .+||||++++++|..++.+|+|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            457777777  99999999999999999999999987643211    12222222 279999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |+++++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++ +.++|+|||+++...   ....
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~---~~~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIG---TPSC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecC---CCcc
Confidence            999999999998877899999999999999999999999999999999999997544 279999999887442   2234


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..|+..|+|||++.+..++.+ +|+||+||++|+|++|..||........ ........ ....  +.....++.+.+||
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~li  241 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKL--PFIKNVSKNANDFV  241 (267)
T ss_pred             CCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccC--CcccccCHHHHHHH
Confidence            578999999999988777655 8999999999999999999985443221 11222221 2222  22236899999999


Q ss_pred             HHhcccCCCcCCC-hhHHhcCcccc
Q 019628          238 SRIFVANSEKRIT-IPEIKNHPWFL  261 (338)
Q Consensus       238 ~~~L~~dp~~R~s-~~ell~hp~~~  261 (338)
                      .+||+.+|.+||+ ++++|+||||.
T Consensus       242 ~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        242 QSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHhccChhhCCchHHHHhcCCccc
Confidence            9999999999996 69999999995

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-45  Score=331.44  Aligned_cols=248  Identities=31%  Similarity=0.462  Sum_probs=198.2

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHH---hcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            9 DIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----DEHVQREIMNH---RSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         9 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l---~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .||+|+||.||++.+..+++.+|+|++.+....    .....+|..++   ....||||+.+++++..++.+++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998764321    12233444333   34479999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG  161 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  161 (338)
                      +++|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++  .++|+|||++...... ......|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~--~~~l~dfg~~~~~~~~-~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC--CEEEccCCcceecccc-CccCcCC
Confidence            999999998888899999999999999999999999999999999999997555  8999999998744322 2334579


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||.+.++...+.++|+||+||++|+|++|..||........ .............+|.  .++.++.++|++||
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l  234 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPD--SFSPELKSLLEGLL  234 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCcc--ccCHHHHHHHHHHh
Confidence            99999999986543333448999999999999999999976543221 1111111222233333  57899999999999


Q ss_pred             ccCCCcCC-----ChhHHhcCccccc
Q 019628          242 VANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      ..+|.+|+     |+.++++||||+.
T Consensus       235 ~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         235 QRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             cCCHHHhcCCCCCCHHHHHhCccccC
Confidence            99999999     6999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-46  Score=329.87  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=208.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC------eEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT------HLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~------~~~   74 (338)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|++.........+.+|+.+++++ .|+||+++++++....      .+|
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            689999999999999999999998999999999987666567889999999999 7999999999997644      589


Q ss_pred             EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc
Q 019628           75 IVMEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS  150 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~  150 (338)
                      +||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++...
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~  163 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCccceec
Confidence            99999999999998864    34789999999999999999999999999999999999997654  8999999988643


Q ss_pred             cc-CCCCCCccccCcccccccccCCc----cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC
Q 019628          151 VL-HSQPKSTVGTPAYIAPEVLTKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD  225 (338)
Q Consensus       151 ~~-~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (338)
                      .. ........|+..|+|||++....    ..+.++|||||||++|+|++|+.||..............   ........
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~  240 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTLKS  240 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCCCc
Confidence            32 22234566899999999985422    123348999999999999999999976543333222211   11112222


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ...++.++++||.+||..||++|||+.++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.9e-46  Score=333.65  Aligned_cols=256  Identities=31%  Similarity=0.444  Sum_probs=207.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~i   75 (338)
                      +++|++.+.||.|+||.||+|.+..+++.+|+|.++....   ....+.+|+.++++++||||+++++++...  ..+|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            3679999999999999999999999999999999975432   223567899999999999999999998877  88999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-
Q 019628           76 VMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-  153 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-  153 (338)
                      ||||+++ +|.+++.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++  .++|+|||++...... 
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG--ILKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--cEEEeecCceeeccCCc
Confidence            9999974 8988887543 589999999999999999999999999999999999997654  8999999998754433 


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------  218 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------  218 (338)
                      .......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||..........+.......               
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            22334568899999999876554345599999999999999999999876654444333221100               


Q ss_pred             --c----------cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          219 --V----------HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       219 --~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                        .          ...++. ..++..+.++|++||+.+|++|||+.|+++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              0          001111 0147889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.9e-45  Score=325.80  Aligned_cols=253  Identities=34%  Similarity=0.484  Sum_probs=207.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--Ce
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--TH   72 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~   72 (338)
                      +..|++.+.||+|+||.||++.+..+++.||||++....      ...+.+.+|+.+++++.||||+++++++.+.  ..
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            468999999999999999999999999999999886422      1224678899999999999999999998764  56


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      ++++|||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++  .++|+|||+++....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~Dfg~~~~~~~  158 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC--CEEECcCcccccccc
Confidence            899999999999999998877899999999999999999999999999999999999997554  899999999874322


Q ss_pred             C----CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          153 H----SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       153 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                      .    .......|+..|+|||.+.+..++.. +|+|||||++|+|++|+.||..............  .......|  ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~--~~  233 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPVLP--PH  233 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc--CCCCCCCc--hh
Confidence            1    12234568999999999987766544 8999999999999999999986544333222110  11111222  25


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      .+..+.++|++|+. +|++|||++++++|||+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            77889999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-45  Score=325.26  Aligned_cols=251  Identities=30%  Similarity=0.455  Sum_probs=211.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ||+..+.||+|+||.||++....+++.||+|.+....      ...+.+.+|+.+++.++|+||+++++++.....+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            6899999999999999999999899999999987643      1335688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||+++++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.+.  .+||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~--~~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG--VVKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccceeccccccc
Confidence            99999999999998887899999999999999999999999999999999999997554  8999999998765444334


Q ss_pred             CCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....|+..|+|||.+.... ++ .++|+||+||++|+|++|+.||..............  ......++.  .++..+.+
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~-~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~  233 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYG-LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPPIPD--HLSDEAKD  233 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCC-chhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCCcCC--CcCHHHHH
Confidence            5667899999999987665 54 448999999999999999999987653222222111  011112222  57899999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCccc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ++++||..+|++|||+.+++.|||+
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.6e-45  Score=326.57  Aligned_cols=256  Identities=30%  Similarity=0.487  Sum_probs=216.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||+|++|.||++.+..+++.||+|++.....  ....+.+|+..+++++|+||+++++++...+.++++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            479999999999999999999999999999999876542  346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC-C
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-K  157 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~-~  157 (338)
                      +++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++  .++|+|||++......... .
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~--~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC--CEEEccCccceecccCCCccc
Confidence            9999999999887889999999999999999999999 9999999999999997654  8999999998855433332 2


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCccc-CCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l  236 (338)
                      ...++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||...... ........+...... +.... ++..+.++
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  235 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPP-SLPAEEFSPEFRDF  235 (264)
T ss_pred             ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCCC-CCCcccCCHHHHHH
Confidence            4568899999999987766555 89999999999999999999876521 122233333322211 11123 78999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCccccc
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      |.+||..+|++|||+.++++|||+++
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-45  Score=338.36  Aligned_cols=260  Identities=29%  Similarity=0.452  Sum_probs=204.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~~   74 (338)
                      ++|++.+.||+|+||.||++.+..+|+.||+|++...  ......+.+|+.+++.++||||+++++++...     ..+|
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            5899999999999999999999999999999998642  22345677899999999999999999887654     3589


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +++||+. ++|...+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||++.......
T Consensus        85 lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          85 IVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC--DLKICDFGLARIADPEH  160 (336)
T ss_pred             EEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEECcccceeeccccc
Confidence            9999996 588887754 5799999999999999999999999999999999999997554  89999999987543222


Q ss_pred             C----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH-----------hh-
Q 019628          155 Q----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-----------LS-  218 (338)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~-----------~~-  218 (338)
                      .    .....||+.|+|||.+.+....+.++||||+||++|+|++|+.||................           .. 
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1    2335789999999987654433455899999999999999999997654322221111000           00 


Q ss_pred             --------cc--ccCC---CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          219 --------VH--YSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       219 --------~~--~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                              ..  ...+   .....++++.+||.+||+.+|++|||+.++++||||.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                    00  0000   01246788999999999999999999999999999986654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.5e-46  Score=340.16  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=208.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc----CCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT----PTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~   74 (338)
                      ++|++.+.||.|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++..    ...+|
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            47999999999999999999999999999999987642   234567789999999999999999998763    35789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEecccccceeecccC
Confidence            9999995 68999998777899999999999999999999999999999999999997554  89999999987543221


Q ss_pred             C-----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh------------
Q 019628          155 Q-----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL------------  217 (338)
Q Consensus       155 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~------------  217 (338)
                      .     .....|+..|+|||.+.+....+.++||||+||++|+|++|++||...+.............            
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            1     12457899999999987644345559999999999999999999977554332221111000            


Q ss_pred             -------h-cc--ccCC---CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          218 -------S-VH--YSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       218 -------~-~~--~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                             . ..  ...+   .....+.++.++|++||+.+|.+|||+.+++.||||.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                   0 00  0000   01246889999999999999999999999999999975443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-45  Score=335.36  Aligned_cols=257  Identities=28%  Similarity=0.372  Sum_probs=202.7

Q ss_pred             CceEeeeeccCCceEEEEEEEcC--CCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKW--TRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLA   74 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~   74 (338)
                      +|.+.++||+|+||.||+|.+..  +++.||+|.+....    .....+.+|+.+++.++||||+++++++...  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            69999999999999999999988  88999999987632    3346678899999999999999999999988  8899


Q ss_pred             EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC--CCCcEEEeecCCC
Q 019628           75 IVMEYAAGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--TAPRVKICDFGYS  147 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~--~~~~ikL~Dfg~a  147 (338)
                      +||||+++ +|.+.+...     ..+++..++.++.||+.||.|||+++|+||||||+||+++.+  ..+.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999965 777766422     268999999999999999999999999999999999999751  1448999999998


Q ss_pred             cccccCCC----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChH---------HHHHHHh
Q 019628          148 KSSVLHSQ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK---------NFRKTIG  214 (338)
Q Consensus       148 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---------~~~~~~~  214 (338)
                      ........    .....+|+.|+|||++.+....+.++|||||||++|+|++|++||.......         .....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            75433221    2345688999999998765443455999999999999999999997654321         1111110


Q ss_pred             hHh----------------------hccccCC---------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          215 RIL----------------------SVHYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       215 ~~~----------------------~~~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+.                      .....++         .+...+.++.+++.+||+.+|++|||+.|+++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            000                      0000011         111466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-45  Score=329.74  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=203.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHH-HhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMN-HRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++++.||+|+||.||++.+..+|+.||||+++....  ....+..|+.. ++.+.||||+++++++..++.+|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            579999999999999999999999999999999876432  23345556654 667799999999999999999999999


Q ss_pred             ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           79 YAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        79 ~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |++ ++|.+++..    ...+++..++.++.||+.||.|||++ +++||||||+||+++.++  .+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG--QVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecccccccccc
Confidence            996 588777753    23689999999999999999999998 999999999999997654  8999999998754333


Q ss_pred             CCCCCccccCcccccccccC----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          154 SQPKSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                      .......|+..|+|||.+.+    ..++ .++|+||+||++|+|++|+.||.......  .............++. ..+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~-~~~  233 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQVVEEPSPQLPA-EKF  233 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccC-ccccchhhHHHHHHHHhCCCCCCccccCH--HHHHHHHhcCCCCCCc-ccc
Confidence            33334568899999998865    2333 44899999999999999999997543221  1111112222223332 247


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |.++.+||.+||..+|.+|||+.++++||||.+.
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            8999999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=342.42  Aligned_cols=244  Identities=27%  Similarity=0.410  Sum_probs=209.9

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      +++++.||+|.||.||++... ....||+|.++......+.+.+|+.+|++|+|+|||++++++..++.+|||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            457889999999999999986 3347999999988777788999999999999999999999999988999999999999


Q ss_pred             ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CCCc
Q 019628           84 ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKST  159 (338)
Q Consensus        84 ~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~~~  159 (338)
                      +|.++|+.  ...+...+...++.||++|++||.++++|||||-..||||+++.  .+||+|||+|+.......  ....
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~--~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL--VVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc--eEEEcccccccccCCCceeecCCC
Confidence            99999986  45689999999999999999999999999999999999997666  899999999994332222  1222


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      -....|.|||.+..+.++.+ |||||+||+||||+| |+.||......+.+..     ....+++|....+|+.+-+++.
T Consensus       365 kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-----le~GyRlp~P~~CP~~vY~lM~  438 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-----LERGYRLPRPEGCPDEVYELMK  438 (468)
T ss_pred             CCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHH-----HhccCcCCCCCCCCHHHHHHHH
Confidence            34567999999999999877 899999999999999 9999998776444322     3345677777789999999999


Q ss_pred             HhcccCCCcCCChhHHhc
Q 019628          239 RIFVANSEKRITIPEIKN  256 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~  256 (338)
                      .|+..+|++|||.+.+..
T Consensus       439 ~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  439 SCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHhhCCcccCCCHHHHHH
Confidence            999999999999986653

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=350.19  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=213.6

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      |.=++.||.|+||.||.|++..+.+.||||++..+-+    .-..+..|+++|++++|||++.+.+||..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            4556789999999999999999999999999976432    225688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |- |+-.+++. ..+++.+.+|..|+.+.+.||.|||+.+.||||||..|||+.+.+  .|||+|||.|...   .+.++
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g--~VKLaDFGSAsi~---~PAns  181 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG--LVKLADFGSASIM---APANS  181 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC--eeeeccccchhhc---Cchhc
Confidence            95 56677665 456799999999999999999999999999999999999996554  8999999988743   45678


Q ss_pred             ccccCccccccccc---CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          159 TVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       159 ~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ++|||.|||||++.   .+.|+++ +||||||+++.||.-.++|+-..+.-..+..+.   .+..+.++. ..+|..++.
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIA---QNesPtLqs-~eWS~~F~~  256 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNESPTLQS-NEWSDYFRN  256 (948)
T ss_pred             ccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHH---hcCCCCCCC-chhHHHHHH
Confidence            99999999999985   4678888 899999999999999999987766544433322   233334432 368899999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccCCCc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRNLPI  266 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~~~~  266 (338)
                      |+..||++-|.+|||.+++|.|+|+.+..+.
T Consensus       257 Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  257 FVDSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             HHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            9999999999999999999999999876543

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3e-45  Score=323.80  Aligned_cols=250  Identities=30%  Similarity=0.504  Sum_probs=209.6

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||+|+||.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6999999999999999999999999999999987532   2335788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           80 AAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        80 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      +.+++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.+.  .++|+|||++....... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--TIKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEEeeccceeecCcchhhh
Confidence            99999999987543  579999999999999999999999999999999999997554  79999999987543222 12


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....|++.|+|||++.+..++.+ +|+||+||++|+|++|..||.............   .......+  ...+.++.++
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~l  232 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII---RGSYPPVS--SHYSYDLRNL  232 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh---cCCCCCCc--ccCCHHHHHH
Confidence            33568899999999987776555 899999999999999999998654433322221   11111222  3678899999


Q ss_pred             HHHhcccCCCcCCChhHHhcCccc
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      |.+||+.+|++||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4e-45  Score=331.82  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=201.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------   71 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------   71 (338)
                      +++|++.+.||+|+||.||+|.+..+++.||||++....   .....+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            468999999999999999999999999999999886532   22345678999999999999999999987653      


Q ss_pred             --eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           72 --HLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        72 --~~~iv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                        ..++||||+. ++|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++  .+||+|||++.
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~  167 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG--ILKLADFGLAR  167 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--cEEECcCCCcc
Confidence              4699999996 58888776543 689999999999999999999999999999999999997554  89999999987


Q ss_pred             ccccCCC-----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-c--
Q 019628          149 SSVLHSQ-----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-H--  220 (338)
Q Consensus       149 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~--  220 (338)
                      .......     .....++..|+|||.+.+....+.++||||+|+++|+|++|++||.......... .+..+... .  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGSITPE  246 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChh
Confidence            5433221     1234678899999998765433455899999999999999999998755432221 22221110 0  


Q ss_pred             -------------ccCCC-----------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          221 -------------YSFPD-----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       221 -------------~~~~~-----------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                                   ..++.           ....+..+.+||.+||..+|.+|||++++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                         00110           00135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.8e-45  Score=322.48  Aligned_cols=250  Identities=31%  Similarity=0.478  Sum_probs=211.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++++.||.|+||.||.+++..+++.+++|.+...   ......+.+|+.++++++|+||+++++++...+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            699999999999999999999999999999988653   23345678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           80 AAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        80 ~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      +++++|.+.+...  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+.  .+||+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~--~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC--CEEECcCcceEEcccccccc
Confidence            9999999999764  4589999999999999999999999999999999999997654  79999999987543322 23


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....|++.|+|||.+.+..++.+ +|+||+||++|+|++|..||...........    +....+.. ....++.++.++
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~  232 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVK----IVQGNYTP-VVSVYSSELISL  232 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCCC-CccccCHHHHHH
Confidence            45678999999999987766555 8999999999999999999987544332222    22222221 123578999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCccc
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +.+||..+|.+|||+.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-46  Score=358.68  Aligned_cols=258  Identities=24%  Similarity=0.398  Sum_probs=192.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC-cEEEEE------------------EeecCccccHHHHHHHHHHhcCCCCCcce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR-ELLAVK------------------FIERGQKIDEHVQREIMNHRSLKHPNIVR   62 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~   62 (338)
                      ++|++++.||+|+||+||+|..+... ...++|                  .+.........+.+|+.++++++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            58999999999999999998764322 222222                  11222223356789999999999999999


Q ss_pred             eEEEEEcCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC
Q 019628           63 FKEVLLTPTHLAIVMEYAAGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP  137 (338)
Q Consensus        63 ~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~  137 (338)
                      +++++...+..|++++++. ++|..++...     .......++.++.||+.||.|||++|||||||||+|||++.++  
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~--  304 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG--  304 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--
Confidence            9999999999999999994 5787776532     2244677889999999999999999999999999999996554  


Q ss_pred             cEEEeecCCCcccccCCC--CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCC-CCCCCC--hHHHHHH
Q 019628          138 RVKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPED--PKNFRKT  212 (338)
Q Consensus       138 ~ikL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~--~~~~~~~  212 (338)
                      .+||+|||+++.......  .....||+.|+|||++.+..++.+ +|||||||++|+|++|..+ |.....  ...+.+.
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            899999999975433222  234679999999999988877655 8999999999999998754 433221  1222222


Q ss_pred             HhhHhhccccCCC--------------------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          213 IGRILSVHYSFPD--------------------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       213 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +..+......+|.                          ...++.++.++|.+||++||.+|||+.|+|+||||...
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            2211111111111                          11356778899999999999999999999999999643

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-45  Score=337.41  Aligned_cols=291  Identities=26%  Similarity=0.398  Sum_probs=218.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC------Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~   72 (338)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+..   .....+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            68999999999999999999999899999999987532   2335678999999999999999999998754      35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+|+||+. .+|...+  ...+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||+++... 
T Consensus        95 ~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~-  168 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHAD-  168 (342)
T ss_pred             EEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCC-
Confidence            799999995 4776655  24689999999999999999999999999999999999997554  89999999987532 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH----------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI----------------  216 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~----------------  216 (338)
                       .......+++.|+|||.+.+....+.++|||||||++|+|++|+.||........+...+...                
T Consensus       169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         169 -AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             -CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence             223456788999999998764433455999999999999999999998755433332221100                


Q ss_pred             ---hhccccCC------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCCCCCHH
Q 019628          217 ---LSVHYSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLE  287 (338)
Q Consensus       217 ---~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (338)
                         .......+      .+...+.++.+||++||+.+|.+|||+.+++.||||....+.+......-............+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYDDSLENEKLSVD  327 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCcccchhhhhhCCHH
Confidence               00000000      012467889999999999999999999999999999765543322221111222233344567


Q ss_pred             HHHHHhHhhCCC
Q 019628          288 EVLSLIHEATKP  299 (338)
Q Consensus       288 ~~~~~~~~~~~~  299 (338)
                      ++..-|+++.+.
T Consensus       328 ~~~~~~~~~~~~  339 (342)
T cd07879         328 EWKKHIYKEVKS  339 (342)
T ss_pred             HHHHHhhhhhhc
Confidence            777777665443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.8e-45  Score=333.81  Aligned_cols=290  Identities=25%  Similarity=0.356  Sum_probs=218.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCC--CcEEEEEEeecCc---cccHHHHHHHHHHhcC-CCCCcceeEEEEEcC----Ce
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWT--RELLAVKFIERGQ---KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTP----TH   72 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~----~~   72 (338)
                      +|++.+.||+|+||.||++.+..+  +..||+|++....   ...+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            699999999999999999999887  8899999987532   2235677899999999 599999999875432    46


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|++++++. ++|...+.....+++..++.++.||+.||+|||++||+||||||+||+++.++  .+||+|||+++....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~--~~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC--ELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC--CEEeCcCCCceeccc
Confidence            889999985 69999998888899999999999999999999999999999999999997654  899999999875432


Q ss_pred             CC-----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh----------
Q 019628          153 HS-----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL----------  217 (338)
Q Consensus       153 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~----------  217 (338)
                      ..     ......||+.|+|||.+.+....+.++||||+||++|+|++|.+||........+...+....          
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            21     123357899999999886643334558999999999999999999987554333222211100          


Q ss_pred             -h------------c-cccCC-CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCC
Q 019628          218 -S------------V-HYSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNP  282 (338)
Q Consensus       218 -~------------~-~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~  282 (338)
                       .            . ...++ .....+..+.+|+.+||+.+|.+|||+.+++.|||+.+...........-..+..-..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES  317 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc
Confidence             0            0 00011 1123578899999999999999999999999999997554322222222222222334


Q ss_pred             CCCHHHHHHHhHh
Q 019628          283 SQSLEEVLSLIHE  295 (338)
Q Consensus       283 ~~~~~~~~~~~~~  295 (338)
                      ..++++++.+|.+
T Consensus       318 ~~~~~~~~~~~~~  330 (332)
T cd07857         318 EDSMEELRDMIIE  330 (332)
T ss_pred             cccHHHHHHHHhh
Confidence            4567777776654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.4e-45  Score=331.98  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=198.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC----------------CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCccee
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW----------------TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRF   63 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~   63 (338)
                      ++|++.+.||+|+||.||+|....                ++..||+|++....  .....+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            489999999999999999997532                34479999987642  223568899999999999999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCC
Q 019628           64 KEVLLTPTHLAIVMEYAAGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDL  124 (338)
Q Consensus        64 ~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~-------------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dl  124 (338)
                      ++++...+..++||||+++++|.+++....                   .++...+..++.||+.||.|||++||+||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            999999999999999999999999986432                   3677889999999999999999999999999


Q ss_pred             CCCcEEecCCCCCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc--CCCC
Q 019628          125 KLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYP  199 (338)
Q Consensus       125 kp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt--g~~p  199 (338)
                      ||+|||++.++  .+||+|||+++......   ......++..|+|||++.+..++.+ +|||||||++|+|++  +..|
T Consensus       165 kp~Nill~~~~--~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         165 ATRNCLVGENL--TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             chhheEEcCCc--cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCCC
Confidence            99999997554  89999999987543221   1223446788999999987777655 899999999999986  6688


Q ss_pred             CCCCCChHHHHHHHhhHhhc--cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          200 FEDPEDPKNFRKTIGRILSV--HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       200 f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      |...................  .........++..+.+|+.+||+.+|.+|||+.++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            88765433332222111111  1111112357889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-45  Score=329.18  Aligned_cols=238  Identities=21%  Similarity=0.229  Sum_probs=197.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcCCCCCcceeEEEEEc----CCeEEEEEec
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLKHPNIVRFKEVLLT----PTHLAIVMEY   79 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~iv~e~   79 (338)
                      ..||+|++|.||++..  +|+.||||.+++.....    +.+.+|+.++++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5789999999999998  68999999997654333    556799999999999999999999876    3578999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      +++|+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||++.++  .+||+|||+++....  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~--~~kl~dfg~~~~~~~--~~~~  179 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY--KLKIICHGLEKILSS--PPFK  179 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC--cEEEcccchHhhhcc--cccc
Confidence            99999999999888899999999999999999999985 999999999999997654  899999999875322  2334


Q ss_pred             ccccCcccccccccC--CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ..||+.|+|||++.+  ..++.+ +|||||||++|+|++|+.||...+....+..    +......++.....++.+++|
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~l~~l  254 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----IINKNNSLKLPLDCPLEIKCI  254 (283)
T ss_pred             ccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcCCCCCCCCcCcHHHHHH
Confidence            678999999999976  455444 8999999999999999999987654333322    222222222223578999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||+.||++|||+.++++
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-45  Score=335.40  Aligned_cols=258  Identities=25%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC------Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~   72 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+..   .....+.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            68999999999999999999999999999999987542   2235677899999999999999999988643      34


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|++++++ +++|...+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||+++... 
T Consensus        97 ~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~dfg~~~~~~-  171 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTD-  171 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC--CEEEeccccccccc-
Confidence            78899987 7799887764 4699999999999999999999999999999999999997654  79999999987532 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh---------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL---------------  217 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~---------------  217 (338)
                       .......++..|+|||.+.+....+.++||||+||++|+|++|+.||........+........               
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         172 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             -ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence             2334567899999999986633334458999999999999999999976554333322211100               


Q ss_pred             ----hccccCCC------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          218 ----SVHYSFPD------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       218 ----~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                          ......+.      ....++++.+||.+||+.+|.+|||+.++++||||++...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                00000010      1235788999999999999999999999999999986544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.3e-45  Score=326.51  Aligned_cols=258  Identities=30%  Similarity=0.471  Sum_probs=207.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~iv~   77 (338)
                      ++|+..+.||.|++|.||++.+..+++.+|+|.+.....  ....+.+|++++++++||||++++++|...  +.+|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            579999999999999999999999999999999876432  345788999999999999999999988654  4789999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           78 EYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.+.  .++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG--QVKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC--eEEEeecccccccccc
Confidence            99999999887653    34589999999999999999999999999999999999997654  7999999998744322


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh-HHHHHHHhhHhh-ccccCCC----cc
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILS-VHYSFPD----YV  227 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~----~~  227 (338)
                       ......++..|+|||.+.+..++.+ +|||||||++|+|++|..||...... .........+.. ....++.    ..
T Consensus       159 -~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         159 -LAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             -ccccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence             2234567889999999988777655 89999999999999999999865220 000111111121 1111111    12


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..++.+.+||.+||..+|++|||+.|++.||||++.
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            356789999999999999999999999999999643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.2e-45  Score=326.64  Aligned_cols=255  Identities=28%  Similarity=0.472  Sum_probs=207.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +|++.+.||.|++|.||++.+..+|..||||+++....  ....+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            59999999999999999999999999999999876432  3456778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           81 AGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        81 ~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      ++ +|.+++...   ..+++..+..++.|++.||.|||++|++||||||+||++++++  .++|+|||++...... ...
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--cEEEeecchhhhhcCCcccc
Confidence            75 888888654   3589999999999999999999999999999999999997554  7999999998744322 122


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh-----------h---cccc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-----------S---VHYS  222 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-----------~---~~~~  222 (338)
                      ....++..|++||++.+....+.++|+|||||++|+|++|+.||...+.............           .   ....
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            3456789999999986654445559999999999999999999987665444333322110           0   0001


Q ss_pred             CCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          223 FPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       223 ~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +|.         ....+..+++++.+||+.+|.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            110         01357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-45  Score=332.89  Aligned_cols=254  Identities=27%  Similarity=0.468  Sum_probs=209.7

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .|.....||+|+||.||++.+..++..||||.+.... ...+.+.+|+.+++.++||||+++++.+...+..|+||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            4556778999999999999999899999999986543 234568899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCcc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTV  160 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~  160 (338)
                      +++|..++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||++...... .......
T Consensus       103 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~  179 (292)
T cd06658         103 GGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG--RIKLSDFGFCAQVSKEVPKRKSLV  179 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEccCcchhhcccccccCceee
Confidence            9999988754 5689999999999999999999999999999999999997654  7999999998643222 2223457


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHh
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI  240 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (338)
                      |+..|+|||.+.+..++.+ +|+||+|+++|+|++|..||............ ..  ......+.....+..+.+++.+|
T Consensus       180 ~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~li~~~  255 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RD--NLPPRVKDSHKVSSVLRGFLDLM  255 (292)
T ss_pred             cCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hh--cCCCccccccccCHHHHHHHHHH
Confidence            8999999999987777555 89999999999999999999865543322221 11  11222233335788999999999


Q ss_pred             cccCCCcCCChhHHhcCcccccC
Q 019628          241 FVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       241 L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |..+|.+|||+.++++||||...
T Consensus       256 l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         256 LVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             ccCChhHCcCHHHHhhChhhhcc
Confidence            99999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.7e-45  Score=325.67  Aligned_cols=248  Identities=30%  Similarity=0.467  Sum_probs=200.0

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHH---HHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            9 DIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----DEHVQRE---IMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         9 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E---~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .||+|+||.||++.+..+++.||+|++.+....    ......|   +..++...||+|+++++++..++.+|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998764211    1122333   334455689999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG  161 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  161 (338)
                      |++|..++...+.+++..++.++.|++.||.|||+++|+||||||+||+++.++  .++|+|||++..... .......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~-~~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSK-KKPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCc-cCCcCcCC
Confidence            999999998888899999999999999999999999999999999999997554  799999999874432 22345679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      +..|+|||.+.++...+.++||||+||++|+|++|+.||........ .............+|.  ..+.++.+++.+||
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~~~~li~~~l  234 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPELRSLLEGLL  234 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCCC--cCCHHHHHHHHHHh
Confidence            99999999997553233448999999999999999999986533221 1111222223334443  46899999999999


Q ss_pred             ccCCCcCC-----ChhHHhcCccccc
Q 019628          242 VANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      ..+|.+||     ++.++++||||..
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccccC
Confidence            99999999     9999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.9e-45  Score=334.92  Aligned_cols=260  Identities=24%  Similarity=0.363  Sum_probs=209.1

Q ss_pred             CCceE-eeeeccCCceEEEEEEEcCCCcEEEEEEeecCcccc---------------HHHHHHHHHHhcCCCCCcceeEE
Q 019628            2 ERYEI-VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---------------EHVQREIMNHRSLKHPNIVRFKE   65 (338)
Q Consensus         2 ~~y~~-~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~E~~~l~~l~h~~Iv~~~~   65 (338)
                      +||.. .+.||.|+||+||++.+..+++.||||++.......               ..+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            57765 467999999999999999999999999987543221               24678999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecC
Q 019628           66 VLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG  145 (338)
Q Consensus        66 ~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg  145 (338)
                      ++...+.+|++|||+. ++|.+++.....+++..+..++.|++.||+|||++|++||||+|+||+++.++  .++|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~--~~kl~dfg  164 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG--ICKIADFG  164 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC--CEEECCcc
Confidence            9999999999999996 59999998878899999999999999999999999999999999999997554  89999999


Q ss_pred             CCccccc---------------CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHH
Q 019628          146 YSKSSVL---------------HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFR  210 (338)
Q Consensus       146 ~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~  210 (338)
                      ++.....               ........+++.|+|||.+.+....+.++|+|||||++|+|++|.+||...+......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9874331               1112234578899999998765544555999999999999999999998776544443


Q ss_pred             HHHhhHhhcc-ccCCC---------------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          211 KTIGRILSVH-YSFPD---------------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       211 ~~~~~~~~~~-~~~~~---------------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      .......... ..++.                     ....+.++.++|.+||+.+|++|||++++|.||||+...
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            3322211100 00000                     123578899999999999999999999999999997553

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.8e-45  Score=342.10  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=200.4

Q ss_pred             CCceEeeeeccCCceEEEEEEE-----cCCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRD-----KWTRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||.||+|..     ..++..||+|+++...  ...+.+.+|+.+++.+ .||||+++++++...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999974     3456789999986533  2335678999999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC------------------------------------------------------------
Q 019628           74 AIVMEYAAGGELFERICNAG------------------------------------------------------------   93 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~------------------------------------------------------------   93 (338)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999986432                                                            


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC---
Q 019628           94 ---------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---  155 (338)
Q Consensus        94 ---------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~---  155 (338)
                                     .+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++.......   
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCcccccc
Confidence                           367888999999999999999999999999999999997544  799999999875432221   


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||........+.+.+..    ..........+.++.
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~  347 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRMLSPECAPSEMY  347 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccCCCCCCCCHHHH
Confidence            112335667999999988777655 899999999999998 89999876544333333221    111122224678999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +|+.+||+.+|++|||+.++++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-45  Score=322.93  Aligned_cols=246  Identities=32%  Similarity=0.509  Sum_probs=200.4

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHH-HHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----DEHVQREIM-NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++.||.|+||.||+|.+..+++.||+|.+++....    ...+..|.. .....+|+||+++++++...+.+|++|||++
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            36799999999999999999999999998764321    122334443 3455689999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG  161 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  161 (338)
                      +++|..++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.+.  .++|+|||++.....   .....|
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEeecccceeccc---cccCCC
Confidence            999999998888899999999999999999999999999999999999997654  799999998874322   334568


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCCHHHHHHHHH
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHLLSR  239 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~  239 (338)
                      ++.|+|||.+.+..++ .++||||+|+++|+|++|..||........+.    .+......++  ....++..+.+++.+
T Consensus       156 ~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         156 TPDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD----NILSRRINWPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             CcCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcccCCCCcccccCCHHHHHHHHH
Confidence            8999999999877654 44899999999999999999998755433222    2222222222  222578999999999


Q ss_pred             hcccCCCcCCCh---hHHhcCccccc
Q 019628          240 IFVANSEKRITI---PEIKNHPWFLR  262 (338)
Q Consensus       240 ~L~~dp~~R~s~---~ell~hp~~~~  262 (338)
                      ||+.+|++|||+   .|++.||||..
T Consensus       231 ~l~~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         231 LLCMDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             HccCCHHHccCCCcHHHHHcChHhhc
Confidence            999999999955   79999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-44  Score=320.79  Aligned_cols=249  Identities=33%  Similarity=0.544  Sum_probs=208.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~iv~   77 (338)
                      +|++++.||.|+||.||++.+..++..+|+|.+....   ...+.+.+|+.+++.++||||+++++++..  ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            6999999999999999999999999999999987543   233567789999999999999999998764  45689999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhh-----hcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           78 EYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        78 e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH-----~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      ||+++++|.+++..    ..++++..++.++.||+.||.|||     +.+++|+||||+||++++++  .+||+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccccc
Confidence            99999999999865    357899999999999999999999     99999999999999997544  89999999988


Q ss_pred             ccccCCC-CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCCCc
Q 019628          149 SSVLHSQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDY  226 (338)
Q Consensus       149 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  226 (338)
                      ....... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||..... ..   ....+..... .++. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~-~~---~~~~~~~~~~~~~~~-  232 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQ-LQ---LASKIKEGKFRRIPY-  232 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCH-HH---HHHHHhcCCCCCCcc-
Confidence            6543332 345678999999999987776544 8999999999999999999987652 22   2222222222 2232 


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                       .++..+.+++.+||..+|++|||+.++++|||+
T Consensus       233 -~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 -RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence             678999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.4e-45  Score=342.28  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=199.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-----RELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||.||++.+...     +..||+|++....  .....+.+|+.+++.+ +|+||+++++++...+.+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4699999999999999999986443     3579999987543  2235678999999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-------------------------------------------------------------
Q 019628           74 AIVMEYAAGGELFERICNA-------------------------------------------------------------   92 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~-------------------------------------------------------------   92 (338)
                      |+||||+++|+|.+++...                                                             
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            9999999999999988542                                                             


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC---CCCcc
Q 019628           93 ---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTV  160 (338)
Q Consensus        93 ---------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~  160 (338)
                               .++++..++.++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++.......   .....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCCC
Confidence                     2378889999999999999999999999999999999997544  899999999875432211   11233


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      ++..|+|||++.+..++.+ +|||||||++|+|++ |+.||........+....    ......+.....++++.+++.+
T Consensus       276 ~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             CccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHHHHH
Confidence            5567999999987777655 899999999999997 999998755433332222    1122222222468999999999


Q ss_pred             hcccCCCcCCChhHHhc
Q 019628          240 IFVANSEKRITIPEIKN  256 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~  256 (338)
                      ||+.+|.+|||+.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-45  Score=326.43  Aligned_cols=254  Identities=29%  Similarity=0.458  Sum_probs=206.8

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      |++.+.||.|++|.||++.+..+|..||+|++....   .....+.+|+..++.++||||+++++++...+..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            788999999999999999999999999999987643   22356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCC
Q 019628           81 AGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPK  157 (338)
Q Consensus        81 ~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~  157 (338)
                      + ++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.+  +.++|+|||++...... ....
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE--GALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC--CcEEEeecccccccCCCccccC
Confidence            5 68999987665  68999999999999999999999999999999999999764  48999999998754322 2223


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh--------------hccccC
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL--------------SVHYSF  223 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~--------------~~~~~~  223 (338)
                      ...++..|+|||++.+......++|+|||||++|+|++|++||...+......+......              .....+
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            346788999999887654334559999999999999999999987655443333222110              000001


Q ss_pred             C---------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          224 P---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       224 ~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +         ....++..+.++|.+||+.+|.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            1         123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2e-45  Score=330.75  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=204.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|+..+.||+|+||.||++.+..+++.+|+|.+....  .....+.+|+.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            56788899999999999999999999999999987643  23356788999999996 9999999999999999999999


Q ss_pred             ccCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           79 YAAGGELFERI---C--NAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        79 ~~~~~~L~~~i---~--~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |+.. ++.++.   .  ....+++..+..++.|++.||+|||+. |++||||||+||+++.++  .++|+|||+++....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG--NIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC--cEEEeecchhHHhcc
Confidence            9854 554433   2  235799999999999999999999975 999999999999997554  799999999875544


Q ss_pred             CCCCCCccccCcccccccccCC---ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-ccccCC--Cc
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFP--DY  226 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~--~~  226 (338)
                      ........|++.|+|||++.+.   .++ .++||||+||++|+|++|+.||.....  .... +..... .....+  ..
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~--~~~~-~~~~~~~~~~~~~~~~~  236 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNS--VFDQ-LTQVVKGDPPILSNSEE  236 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCc-chhhhhHHHHHHHHHHhCCCCchhcch--HHHH-HhhhcCCCCCcCCCcCC
Confidence            4344455789999999999776   344 458999999999999999999976542  1122 222221 111221  12


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..++.++.+||.+||+.+|++|||+.+++.||||..
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            357899999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-47  Score=342.86  Aligned_cols=253  Identities=30%  Similarity=0.523  Sum_probs=228.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      .+.+++..||-|+||.|-++........+|+|++++..    +..+++..|-++|..+.+|+||++|..|.+..++|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            46788999999999999999987666679999998743    34467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |-|-||.|+..+..++.+.+...+.++..++.|++|||++|||+|||||+|++++..+  -+||.|||+|+....+..+.
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G--y~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG--YLKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC--ceEEeehhhHHHhccCCcee
Confidence            9999999999999999999999999999999999999999999999999999997655  79999999999988889999


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ++||||.|.|||++.+...+.. +|.||||+++|||++|.+||.+.+.-..++.+++.+..  +.||.  .++..+.+||
T Consensus       578 TFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--i~~Pr--~I~k~a~~Li  652 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--IEFPR--RITKTATDLI  652 (732)
T ss_pred             eecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--hhccc--ccchhHHHHH
Confidence            9999999999999999888766 89999999999999999999998877777766655443  34564  7899999999


Q ss_pred             HHhcccCCCcCCC-----hhHHhcCcccc
Q 019628          238 SRIFVANSEKRIT-----IPEIKNHPWFL  261 (338)
Q Consensus       238 ~~~L~~dp~~R~s-----~~ell~hp~~~  261 (338)
                      ++++..+|.+|..     +.+|..|.||.
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            9999999999985     89999999995

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-44  Score=325.85  Aligned_cols=257  Identities=31%  Similarity=0.551  Sum_probs=212.0

Q ss_pred             CceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ-----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|+++...     ...+.+.+|+.+++++ +|+||+++++++..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   478999999987532     2335678899999999 589999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+|||++.++  .+||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccc
Confidence            99999999999999998888899999999999999999999999999999999999997654  8999999998754332


Q ss_pred             C--CCCCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          154 S--QPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       154 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .  ......|+..|+|||.+.+.. ..+.++||||+|+++|+|++|..||...............+......+|.  .++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  236 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMS  236 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc--cCC
Confidence            2  223456899999999987532 22445899999999999999999997544333333443444433333443  578


Q ss_pred             HHHHHHHHHhcccCCCcCC-----ChhHHhcCcccccC
Q 019628          231 LECKHLLSRIFVANSEKRI-----TIPEIKNHPWFLRN  263 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~~  263 (338)
                      ..+.+++++||+.+|++||     ++.+++.||||.+.
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            8999999999999999997     89999999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.1e-45  Score=323.36  Aligned_cols=247  Identities=20%  Similarity=0.310  Sum_probs=201.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||.||++...   ..+..||+|.++...  .....+.+|+..++.++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            47999999999999999999764   456789999987643  2234678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.+.  .++++|||.+........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccccccch
Confidence            9999999999998764 4689999999999999999999999999999999999997554  899999998764322211


Q ss_pred             C--CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          156 P--KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      .  ....++..|+|||.+.+..++.+ +||||+||++|++++ |..||..........    .+... ...|....++..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~  236 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIK----AVEDG-FRLPAPRNCPNL  236 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHHCC-CCCCCCCCCCHH
Confidence            1  12335678999999988777655 899999999999775 999998765433222    22221 223334468899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         237 LHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-45  Score=325.03  Aligned_cols=253  Identities=27%  Similarity=0.466  Sum_probs=209.0

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCC---CCCcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLK---HPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      .|++++.||+|+||.||++.+..+++.||+|.+....  .....+.+|+.+++.+.   |||++++++++.....+|++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5889999999999999999999999999999986542  23356788999999986   999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      ||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++  .++|+|||++....... ..
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCcccc
Confidence            99999999998865 4799999999999999999999999999999999999997644  89999999987544332 23


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKH  235 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  235 (338)
                      ....|+..|+|||.+.++...+.++|+|||||++|+|++|..||..........    .+... ...++. ..++.++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~  233 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----LIPKSKPPRLED-NGYSKLLRE  233 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----ccccCCCCCCCc-ccCCHHHHH
Confidence            345789999999998765544455999999999999999999998654322211    11111 111222 137889999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ++.+||+.+|++|||+.+++.||||++.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            9999999999999999999999999653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.2e-44  Score=320.66  Aligned_cols=251  Identities=31%  Similarity=0.466  Sum_probs=203.2

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      ....||+|+||.||++.+..++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++..++.+++++||+++++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   91 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS   91 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence            45689999999999999998999999998876432 34578899999999999999999999999999999999999999


Q ss_pred             hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCcc
Q 019628           85 LFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKSTV  160 (338)
Q Consensus        85 L~~~i~~~-~~l--~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~~  160 (338)
                      |.+.+... ..+  ++..+..++.||+.||.|||++||+||||||+||+++... +.++|+|||++....... ......
T Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  170 (268)
T cd06624          92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTETFT  170 (268)
T ss_pred             HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCccccCC
Confidence            99999754 445  8889999999999999999999999999999999997532 379999999987543222 223456


Q ss_pred             ccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          161 GTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       161 gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      |++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||........... ..........+|.  .+++++++|+.+
T Consensus       171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~li~~  247 (268)
T cd06624         171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIPE--SLSAEAKNFILR  247 (268)
T ss_pred             CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCCCc--ccCHHHHHHHHH
Confidence            899999999986543 234458999999999999999999976543221111 1111122222333  578899999999


Q ss_pred             hcccCCCcCCChhHHhcCccc
Q 019628          240 IFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ||..+|++|||+.+++.||||
T Consensus       248 ~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         248 CFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=354.57  Aligned_cols=246  Identities=29%  Similarity=0.480  Sum_probs=206.8

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC-ccccHHHHHHHHHHhcCC-CCCcceeEEEE-EcC------CeE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG-QKIDEHVQREIMNHRSLK-HPNIVRFKEVL-LTP------THL   73 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~-~~~------~~~   73 (338)
                      ++++.+.|-+|||+.||+|.+...+..||+|++-.. +...+.+.+||.+|+.|+ |+|||.+++.. ...      -.+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            578999999999999999999988899999988654 334467889999999997 99999999943 211      247


Q ss_pred             EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           74 AIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      .|+||||.||.|-+++..  ...|+|.++.+|+.|+++||.+||...  |||||||-|||||+.++  +.||||||.|+.
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g--~~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG--NYKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC--CEEeCccccccc
Confidence            899999999999999974  345999999999999999999999997  99999999999996555  899999999873


Q ss_pred             cccCCCCC----------CccccCcccccccc---cCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH
Q 019628          150 SVLHSQPK----------STVGTPAYIAPEVL---TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI  216 (338)
Q Consensus       150 ~~~~~~~~----------~~~gt~~y~aPE~~---~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~  216 (338)
                      ........          ...-|+.|+|||++   .+...+.+ +|||+|||+||-|+....||+.....        +|
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~l--------aI  266 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGKL--------AI  266 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcce--------eE
Confidence            32221111          12378999999987   34555555 89999999999999999999976442        57


Q ss_pred             hhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                      .++.|.+|....++..+++||+.||+.+|++||++-|++.+-+
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            8899999999999999999999999999999999999987544

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.2e-45  Score=325.99  Aligned_cols=250  Identities=34%  Similarity=0.597  Sum_probs=213.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||.||++....+++.||+|++.+..    .....+.+|+.+++++. ||||+++++++...+.++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            58999999999999999999999999999999987632    22356788999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--  154 (338)
                      ||++++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++  .++|+|||++.......  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~--~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEecCCccccccCCcccc
Confidence            99999999999999888899999999999999999999999999999999999997544  89999999987433221  


Q ss_pred             -------------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhh
Q 019628          155 -------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR  215 (338)
Q Consensus       155 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~  215 (338)
                                         ......++..|+|||++....++.. +|+||||++++++++|+.||........+    ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~  233 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTF----QK  233 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHH----HH
Confidence                               1223457899999999887665444 89999999999999999999876543322    23


Q ss_pred             HhhccccCCCcccCCHHHHHHHHHhcccCCCcCCCh----hHHhcCccc
Q 019628          216 ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI----PEIKNHPWF  260 (338)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~ell~hp~~  260 (338)
                      +......+|.  .+++.+.+||.+||+.+|++|||+    .++++||||
T Consensus       234 ~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         234 ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            3344445554  578999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-44  Score=315.28  Aligned_cols=251  Identities=34%  Similarity=0.515  Sum_probs=212.6

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      +|.+.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+..++.++|+||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            58999999999999999999998999999999877543 45678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCcc
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV  160 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  160 (338)
                      +++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++  .++|+|||.+.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeecccccccccccccccee
Confidence            99999999775 5799999999999999999999999999999999999997644  89999999987654433244567


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHh
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI  240 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (338)
                      ++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.........   .......+....++..+.++|.+|
T Consensus       159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHHHHHHH
Confidence            8999999999987765544 899999999999999999998754332222211   122222333334588999999999


Q ss_pred             cccCCCcCCChhHHhcCcc
Q 019628          241 FVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       241 L~~dp~~R~s~~ell~hp~  259 (338)
                      |+.+|++|||+.++++|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=328.11  Aligned_cols=294  Identities=31%  Similarity=0.514  Sum_probs=236.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcccc----HHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      .+|.++..||+|+||.|.++..+.+.+.||||++++.-...    +--..|-++|... +-|.+++++.+|++-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46889999999999999999999999999999998753222    2233455555544 568999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~  155 (338)
                      |||++||+|...|++.+++.|..+..++..|+-||=+||++|||.||||..||++|..+  ++||+|||+++.... ...
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeecccccccccCCcc
Confidence            99999999999999999999999999999999999999999999999999999997554  999999999985433 344


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      +.++||||.|+|||++...+| ++++|+||+||+||||+.|++||.+.+..+.+    +.|......+|.  .+|.++.+
T Consensus       507 TkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF----~aI~ehnvsyPK--slSkEAv~  579 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----QAIMEHNVSYPK--SLSKEAVA  579 (683)
T ss_pred             eeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHHccCcCcc--cccHHHHH
Confidence            568999999999999988887 56689999999999999999999987664444    445556667777  79999999


Q ss_pred             HHHHhcccCCCcCCCh-----hHHhcCcccccCCCcccccCCCcccCCCCC--CCCCHHHHHHHhHhhCCCCCCCCc
Q 019628          236 LLSRIFVANSEKRITI-----PEIKNHPWFLRNLPIELTEGGSWQSHDVNN--PSQSLEEVLSLIHEATKPLEAPRV  305 (338)
Q Consensus       236 li~~~L~~dp~~R~s~-----~ell~hp~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  305 (338)
                      +...+|...|.+|...     .++.+||||++ .+++..+....+..--+.  -..+.+...+.+......+.+|..
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~-iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~  655 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRR-IDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDK  655 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhh-ccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchH
Confidence            9999999999999854     78999999964 344444444333221111  224555666666666555555543

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.3e-45  Score=326.56  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=204.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCC-----cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTR-----ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~   73 (338)
                      +++|++.+.||+|+||.||++.....+     ..+|+|.+....  .....+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            357999999999999999999976554     679999886543  2235678999999999999999999999998999


Q ss_pred             EEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC
Q 019628           74 AIVMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP  137 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~  137 (338)
                      |++|||+++++|.+++...                ..+++..+..++.||+.||.|||++|++||||||+||+++++.  
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~--  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL--  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC--
Confidence            9999999999999999764                4578899999999999999999999999999999999997554  


Q ss_pred             cEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHH
Q 019628          138 RVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTI  213 (338)
Q Consensus       138 ~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~  213 (338)
                      .++|+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||......+...   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~~---  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE---  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---
Confidence            79999999987543221   2234567889999999987777655 899999999999998 999998765433222   


Q ss_pred             hhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          214 GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                       .+.... ..+....++.++.+|+.+||+.+|.+|||+.+++++
T Consensus       238 -~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 -MIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             -HHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             222221 112223688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.4e-44  Score=323.60  Aligned_cols=254  Identities=29%  Similarity=0.493  Sum_probs=209.9

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      +|...+.||+|++|.||++.+..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4566789999999999999999899999999886543 223567899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCcc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKSTV  160 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~~  160 (338)
                      +++|.+++.. .++++..+..++.|++.||.|||++|++||||+|+||+++.++  .++|+|||++....... ......
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCccccccc
Confidence            9999999877 6799999999999999999999999999999999999997554  89999999876433221 223456


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-ccCCCcccCCHHHHHHHHH
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  239 (338)
                      |++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||..........    .+.... ........++..+.+|+.+
T Consensus       177 ~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMK----RIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             CCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHH----HHHhcCCCCCcccccCCHHHHHHHHH
Confidence            8999999999987776655 899999999999999999997644322222    222221 1222222478899999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccCC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ||..+|++|||+.++++||||.+..
T Consensus       252 ~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         252 MLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HcccChhhCcCHHHHccCcccccCC
Confidence            9999999999999999999997644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.7e-44  Score=316.96  Aligned_cols=250  Identities=35%  Similarity=0.511  Sum_probs=213.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~iv~   77 (338)
                      +|.+.+.||+|++|.||++.+..+++.+++|++....   ...+.+.+|+..+++++||||+++++.+...  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5899999999999999999999999999999987654   3356788999999999999999999999988  8999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--  155 (338)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccc
Confidence            9999999999998877899999999999999999999999999999999999997644  899999999876544432  


Q ss_pred             -CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh--hccccCCCcccCCHH
Q 019628          156 -PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL--SVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  232 (338)
                       .....++..|+|||.+.+...+.+ +|+||||+++|+|++|..||..........   ..+.  ......|.  ..+..
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~  232 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAAL---YKIGSSGEPPEIPE--HLSEE  232 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HhccccCCCcCCCc--ccCHH
Confidence             445678999999999987766555 899999999999999999998766322211   1122  11222333  56899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +.+||.+||..+|++|||+.+++.||||
T Consensus       233 l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         233 AKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.6e-45  Score=325.35  Aligned_cols=252  Identities=29%  Similarity=0.451  Sum_probs=209.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ..|+.++.||.|+||.||++.+..++..||+|++....  .....+.+|+.+++.+.||||+++++++.+++.+|+||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35888999999999999999999899999999987543  2345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  158 (338)
                      +++++|.+++.. .++++..+..++.|++.||.|||+++++|+||+|+||+++.++  .++|+|||++....... ....
T Consensus        84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC--CEEEcccccceeccCCcccccc
Confidence            999999998865 5789999999999999999999999999999999999997554  79999999987543322 2234


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  237 (338)
                      ..++..|+|||.+.+..++.+ +|+|||||++|+|++|..||..........    .+... ....+  ..++..+.+++
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li  233 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIPKNNPPTLT--GEFSKPFKEFI  233 (277)
T ss_pred             ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhhcCCCCCCc--hhhhHHHHHHH
Confidence            568889999999987776555 899999999999999999998654322211    11111 11111  24678899999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+||..+|++|||+.++++||||.+.
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhhc
Confidence            99999999999999999999999643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-44  Score=359.66  Aligned_cols=250  Identities=25%  Similarity=0.358  Sum_probs=202.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      |++|++++.||+|+||.||+|.+..+++.||+|++....    ...+++.+|+.++++++||||+++++++.+++..|++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            689999999999999999999999999999999987532    2235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecC
Q 019628           77 MEYAAGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG  145 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-----------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg  145 (338)
                      |||++|++|.+++...           ..++...+..++.||+.||+|||++||+||||||+||+++.++  .++|+|||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg--~vKLiDFG  158 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG--EVVILDWG  158 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC--CEEEEecC
Confidence            9999999999988641           2355677889999999999999999999999999999997554  79999999


Q ss_pred             CCcccccC-------------------CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh
Q 019628          146 YSKSSVLH-------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP  206 (338)
Q Consensus       146 ~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~  206 (338)
                      +++.....                   ......+||+.|+|||++.+..++.+ +||||+||++|+|+||..||......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            98754110                   01123469999999999988777555 89999999999999999999764432


Q ss_pred             HHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          207 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .....   ..............+++.+.+++.+||..+|++|++..+.+.
T Consensus       238 ki~~~---~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        238 KISYR---DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhh---hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            21111   111111222333468899999999999999999987666553

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-44  Score=323.42  Aligned_cols=254  Identities=29%  Similarity=0.473  Sum_probs=206.7

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEEEEe
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAIVME   78 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~iv~e   78 (338)
                      |++++.||.|+||.||++.+..+++.+|+|++....   .....+.+|+.+++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            789999999999999999999899999999998752   2335678899999999999999999999988  89999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--C
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--Q  155 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~  155 (338)
                      |+++ +|..++... ..+++..++.++.||+.||.|||+.|++|+||||+||++++++  .++|+|||++.......  .
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~--~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC--CEEEccccceeeccCCCccc
Confidence            9974 898888765 5799999999999999999999999999999999999997654  89999999987554332  1


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCC---------
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPD---------  225 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~---------  225 (338)
                      .....++..|+|||.+.+....+.++|||||||++|+|++|+.||................... ...++.         
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            2344678899999987664433455999999999999999999998766544433332211100 000111         


Q ss_pred             --------------ccc-CCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          226 --------------YVR-VSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       226 --------------~~~-~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                                    ... .+..+.+++++||..+|.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                          011 38889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-44  Score=318.38  Aligned_cols=245  Identities=26%  Similarity=0.410  Sum_probs=202.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||++... .+..+|+|.+.........+.+|+.++++++||||+++++++.....++++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            57999999999999999999876 45679999987665556788899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CCC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKS  158 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~~  158 (338)
                      +|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+.  .+||+|||.++.......  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCceeccCC
Confidence            99999998753 4689999999999999999999999999999999999997554  799999999875432221  122


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcc-ccCCCcccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVH-YSFPDYVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  236 (338)
                      ..++..|+|||.+.+..++.+ +|+||+|+++|+|++ |+.||...........    +.... ...|.  ..+..+.++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~~~~~~~~~~--~~~~~~~~l  233 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----ISRGFRLYRPK--LASMTVYEV  233 (256)
T ss_pred             CCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHCCCCCCCCC--CCCHHHHHH
Confidence            345568999999987776555 899999999999999 9999987654333322    22221 12222  467889999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||..+|++|||+.++++
T Consensus       234 i~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         234 MYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.9e-45  Score=329.60  Aligned_cols=249  Identities=23%  Similarity=0.322  Sum_probs=200.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcE--EEEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTREL--LAVKFIERG--QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++.+.||+|+||.||+|.+..++..  +|+|.++..  ......+.+|+.++.++ +||||+++++++...+.+|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            36899999999999999999998877754  577766542  22335678899999999 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcE
Q 019628           76 VMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV  139 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~i  139 (338)
                      ||||+++++|.+++....                .+++..++.++.||+.||+|||++|++||||||+|||++.+.  .+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~--~~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC--cE
Confidence            999999999999997542                478999999999999999999999999999999999997554  79


Q ss_pred             EEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhh
Q 019628          140 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS  218 (338)
Q Consensus       140 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  218 (338)
                      ||+|||++.............++..|+|||.+.+..++.+ +|||||||++|+|+| |.+||........+..    +. 
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~~-  237 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----LP-  237 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHHH----Hh-
Confidence            9999999864322222222334667999999877666544 899999999999998 9999976554332222    11 


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ..+..+.....++++.+|+.+||+.+|++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            112222233578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-44  Score=327.08  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=211.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            58999999999999999999998899999999986532 33456788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      ++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++....... .....
T Consensus        99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~--~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          99 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC--CEEEccCcceecccccccccccc
Confidence            999999998654 689999999999999999999999999999999999997554  79999999886443322 22345


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .|++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||...........   ........++....++..+.++|++
T Consensus       176 ~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             cCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhcCCCCCCCCccccCHHHHHHHHH
Confidence            68899999999987776554 8999999999999999999976543222111   1111222333334578889999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccCC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ||..+|++||++.+++.||||....
T Consensus       252 ~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         252 CLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.5e-44  Score=319.53  Aligned_cols=247  Identities=21%  Similarity=0.304  Sum_probs=204.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .+|.+.+.||+|+||.||++....+++.||+|++.........+.+|+.+++.++||||+++++++.....++++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            36889999999999999999999999999999987665555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC--C
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP--K  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~--~  157 (338)
                      +++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.+.  .+||+|||++.........  .
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--cEEeCCCccccccccceeeccC
Confidence            99999998753  3589999999999999999999999999999999999997554  8999999998754332211  1


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||.+.+..++.. +|||||||++|+|++ |..||........+...    .. .+..+....++.++.++
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EK-GYRMERPEGCPPKVYEL  237 (263)
T ss_pred             CCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HC-CCCCCCCCCCCHHHHHH
Confidence            2234567999999987777655 899999999999998 99999865443322222    11 11222223688999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||..+|++|||+.++++
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-44  Score=315.12  Aligned_cols=250  Identities=31%  Similarity=0.491  Sum_probs=213.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||+|++|.||++.+..+++.||+|.+.....   ....+.+|+.++++++|||++++++++...+.++++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            69999999999999999999998999999999977543   446788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-CCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-PKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-~~~  158 (338)
                      +++++|.+++.....+++..++.++.|++.||.+||++||+||||||+||+++.+  +.++|+|||++........ ...
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~--~~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD--GVVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC--CCEEEeccccceecCCCcccccc
Confidence            9999999999888889999999999999999999999999999999999999764  4899999999885543322 234


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      ..++..|+|||.+.+..++ .++|+||+|+++|+|++|..||............   .......++.  .++..+.+++.
T Consensus       159 ~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~i~  232 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI---VQDDHPPLPE--GISPELKDFLM  232 (254)
T ss_pred             cccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---hccCCCCCCC--CCCHHHHHHHH
Confidence            5689999999998776654 4489999999999999999999865532222221   1222223333  57899999999


Q ss_pred             HhcccCCCcCCChhHHhcCccc
Q 019628          239 RIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-46  Score=344.27  Aligned_cols=245  Identities=36%  Similarity=0.519  Sum_probs=208.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHH-hcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +.|++...+|.|+||+|..+.+..+++.+++|++.+.   .....+|+.++ +.-+||||+++++++.+..+.|+|||.+
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            5799999999999999999999999999999999876   23345666444 4458999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCcc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV  160 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  160 (338)
                      .|+.+.+.|.....+. .++..|++||+.|+.|||++|+|||||||+|||++ +..++++|+|||.++.....  ..+.+
T Consensus       399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~--~~tp~  474 (612)
T KOG0603|consen  399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS--CDTPA  474 (612)
T ss_pred             cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhCchh--hcccc
Confidence            9999999887765555 78889999999999999999999999999999996 34458999999998854333  45667


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHh
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI  240 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (338)
                      -|..|.|||++....|+.. +||||||++||+||+|+.||......   ..+.+++....+.    ..+|..+++||++|
T Consensus       475 ~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  475 LTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQQL  546 (612)
T ss_pred             hhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHHHh
Confidence            8899999999997777544 99999999999999999999876554   3444455544433    37999999999999


Q ss_pred             cccCCCcCCChhHHhcCcccc
Q 019628          241 FVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       241 L~~dp~~R~s~~ell~hp~~~  261 (338)
                      |+.||.+|+++.+++.||||.
T Consensus       547 L~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             ccCChhhCcChhhhccCcchh
Confidence            999999999999999999993

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.1e-45  Score=328.32  Aligned_cols=252  Identities=27%  Similarity=0.500  Sum_probs=208.4

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      |.....||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.+.||||+++++++..++.+|++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            455668999999999999999899999999986533 3345688999999999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCccc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~g  161 (338)
                      ++|...+.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||++...... .......|
T Consensus       103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC--cEEEeechhHhhcccccccccceec
Confidence            999887754 5789999999999999999999999999999999999997554  8999999998643322 12344679


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-ccCCCcccCCHHHHHHHHHh
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFPDYVRVSLECKHLLSRI  240 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  240 (338)
                      +..|+|||++.+..++.+ +||||+||++|+|++|+.||...........    +.... ........++..+.++|.+|
T Consensus       180 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         180 TPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             CccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhccCCCCccccCCCCHHHHHHHHHH
Confidence            999999999987776554 8999999999999999999986554333222    11111 11222335788999999999


Q ss_pred             cccCCCcCCChhHHhcCcccccC
Q 019628          241 FVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       241 L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |+.+|.+|||+.++++||||.+.
T Consensus       255 l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         255 LTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             hcCCcccCcCHHHHhhChhhccC
Confidence            99999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-44  Score=317.88  Aligned_cols=246  Identities=32%  Similarity=0.515  Sum_probs=205.9

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +|++.+.||+|+||.||++.+..+++.+|+|.++...  ...+.+.+|+.+++.++||||+++++.+...+.+|++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            6999999999999999999999999999999986532  33467788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCC
Q 019628           81 AGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPK  157 (338)
Q Consensus        81 ~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~  157 (338)
                      ++++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++  .++|+|||+++...... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG--KVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC--cEEEcccCcceeecccccccc
Confidence            999999988643  3589999999999999999999999999999999999997654  89999999987543222 233


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc-CCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  236 (338)
                      ...|++.|+|||++.+..++.+ +|+||+|+++|+|++|..||...+....    ...+...... .+  ..++..+.+|
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~l  231 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSYKPLP--SHYSYELRSL  231 (255)
T ss_pred             cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCCCCCC--cccCHHHHHH
Confidence            4678999999999987776555 8999999999999999999986443222    2222222222 23  2578899999


Q ss_pred             HHHhcccCCCcCCChhHHhcC
Q 019628          237 LSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~h  257 (338)
                      |.+||+.+|++|||+.++++-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-44  Score=320.58  Aligned_cols=245  Identities=36%  Similarity=0.585  Sum_probs=208.4

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ||.|+||.||++.+..+|+.+|+|++.....    ....+.+|+.++++++||||+++++.+......|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6999999999999998999999999876432    345688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---------CC
Q 019628           86 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---------QP  156 (338)
Q Consensus        86 ~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---------~~  156 (338)
                      .+++...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++  .++|+|||++.......         ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC--CEEEEecccchhcccCcccccccccccc
Confidence            99998877899999999999999999999999999999999999997655  89999999987543321         12


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....++..|+|||.+.....+.. +|+||||+++|+|++|..||........+    ..+......++....++..+.++
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCcCCCccccCCHHHHHH
Confidence            33568889999999987775444 89999999999999999999876543332    22333445555544468999999


Q ss_pred             HHHhcccCCCcCCCh---hHHhcCcccc
Q 019628          237 LSRIFVANSEKRITI---PEIKNHPWFL  261 (338)
Q Consensus       237 i~~~L~~dp~~R~s~---~ell~hp~~~  261 (338)
                      +.+||+.+|.+|||+   .++|+||||.
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~  261 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFK  261 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence            999999999999999   9999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.4e-44  Score=331.90  Aligned_cols=258  Identities=29%  Similarity=0.387  Sum_probs=204.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcC----------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTP----------   70 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~----------   70 (338)
                      .+|.+.+.||.|+||.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            589999999999999999999999999999999876543 335688999999999999999999876554          


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           71 ----THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        71 ----~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                          ..+|++|||++ ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++..+ +.++|+|||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~  161 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGL  161 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCccc
Confidence                35899999996 588888754 4799999999999999999999999999999999999996433 3689999999


Q ss_pred             CcccccCCC----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh-----
Q 019628          147 SKSSVLHSQ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-----  217 (338)
Q Consensus       147 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-----  217 (338)
                      ++.......    .....++..|+|||.+.+....+.++|||||||++|+|++|+.||.................     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            875422111    12346788999999876544445559999999999999999999987654433333221100     


Q ss_pred             ----------------hccccCC---CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          218 ----------------SVHYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       218 ----------------~~~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                                      ......+   ....++.++.+||.+||+.+|.+|||+.+++.||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                            0000000   01247788999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-44  Score=319.21  Aligned_cols=246  Identities=24%  Similarity=0.381  Sum_probs=204.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|+++++||+|+||.||++... ++..||+|.+.......+.+.+|+.+++.++|+||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            68999999999999999999975 56679999887655556788999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CC
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PK  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~  157 (338)
                      +++|.+++...  ..++...+..++.|++.||.|||+++++||||||+||+++.+.  .++|+|||+++.......  ..
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCCceeccC
Confidence            99999998653  4588999999999999999999999999999999999997554  899999999975432211  12


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...........    +.. ....+....++.++.++
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----LQR-GYRMPRMENCPDELYDI  236 (261)
T ss_pred             CCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHH
Confidence            2345678999999987776555 899999999999998 9999987554332222    221 22334444688999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||..+|++|||++++.+
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-44  Score=328.32  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=202.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcC-------
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTP-------   70 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-------   70 (338)
                      +++|++.+.||+|+||.||++.+..+++.+|+|++.....   ....+.+|+.+++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999999999999999865322   234677899999999999999999987543       


Q ss_pred             -CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           71 -THLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        71 -~~~~iv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                       ..+|++|||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||+++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG--ILKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECcCccch
Confidence             347999999964 67776654 44799999999999999999999999999999999999997654  89999999987


Q ss_pred             ccccCCC------------CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH
Q 019628          149 SSVLHSQ------------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI  216 (338)
Q Consensus       149 ~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~  216 (338)
                      .......            .....+++.|+|||.+.+....+.++||||+||++|+|++|++||................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            4332211            1234578899999998765433455899999999999999999998766554443332211


Q ss_pred             hhcc-cc------------------CC-----CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          217 LSVH-YS------------------FP-----DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       217 ~~~~-~~------------------~~-----~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .... ..                  .+     .....+..+.+||.+||+.+|.+|||+.++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            1000 00                  00     012355778999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-44  Score=317.58  Aligned_cols=251  Identities=34%  Similarity=0.508  Sum_probs=207.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~   73 (338)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+....      .....+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999875421      2234678899999999999999999998764  568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      +++|||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++  .++|+|||+++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECccccccccccc
Confidence            99999999999999998877899999999999999999999999999999999999997554  7999999998754221


Q ss_pred             ----CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          154 ----SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       154 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                          .......|+..|+|||.+.+..++.+ +|+|||||++|+|++|+.||.............  .......+|.  .+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~p~--~~  234 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA--TQPTKPMLPD--GV  234 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH--cCCCCCCCCc--cc
Confidence                11234568999999999988766544 899999999999999999998754433322211  1111223343  68


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ++.+.++|.+||+ +|.+|||+.+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            8999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-44  Score=326.38  Aligned_cols=257  Identities=30%  Similarity=0.476  Sum_probs=205.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------   71 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------   71 (338)
                      .++|++.+.||+|+||.||++.+..+++.||+|+++...   .....+.+|+.++++++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            368999999999999999999999999999999987542   22356778999999999999999999987654      


Q ss_pred             ----eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           72 ----HLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        72 ----~~~iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                          .+|++|||+++ ++...+... ..+++..++.++.|++.||.|||++||+||||||+||+++++.  .+||+|||+
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~kl~dfg~  162 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGL  162 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--cEEeCcccc
Confidence                79999999976 777777653 4689999999999999999999999999999999999997655  899999999


Q ss_pred             CcccccCCC--CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cC
Q 019628          147 SKSSVLHSQ--PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SF  223 (338)
Q Consensus       147 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~  223 (338)
                      +........  .....++..|+|||.+.+....+.++||||+||++|+|++|++||...+....+............ .+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            875433321  122356788999998866443345599999999999999999999876554433333221111000 00


Q ss_pred             -----------------------CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          224 -----------------------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       224 -----------------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                                             .....++..+.+++.+||..+|.+|||+.++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                   1122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-44  Score=318.17  Aligned_cols=251  Identities=33%  Similarity=0.526  Sum_probs=208.6

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||+|+||.||++.+..++..+|+|.+....   .....+.+|+.+++.++|+||+++++.+.....+|+++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            6999999999999999999999999999999987642   3345678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           80 AAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        80 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      +++++|.+++....  .+++..+..++.|++.||.|||+++++|+||||+||+++.++. .++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence            99999999987643  4799999999999999999999999999999999999975532 57999999887543222 12


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....|++.|+|||.+.+..++.+ +|+||+||++|+|++|..||..........    .+..... .+....++.++.++
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~  233 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVL----KICQGYF-APISPNFSRDLRSL  233 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHhcccC-CCCCCCCCHHHHHH
Confidence            33468999999999887776555 899999999999999999997654332222    2222211 12223578899999


Q ss_pred             HHHhcccCCCcCCChhHHhcCccc
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      |.+||..+|++|||+.+++.||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.6e-44  Score=319.76  Aligned_cols=252  Identities=27%  Similarity=0.394  Sum_probs=204.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++.+.||+|+||.||++++..+++.||||.+....    .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            478999999999999999999999999999999876532    2234578899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           77 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++  .++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~--~~~l~d~g~~~~~~~  158 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC--CEEECccccceeccc
Confidence            999999999988853    34589999999999999999999999999999999999997654  799999999875432


Q ss_pred             CC-CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          153 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       153 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      .. ......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||......  .......+....+........+.
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCH
Confidence            22 1234568899999999987776555 89999999999999999999654321  11222222222211111125778


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+.+++.+||..+|++|||+.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            89999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.5e-44  Score=325.84  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            479999999999999999999998999999999865322    2246788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      ||+. |+|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++  .++|+|||++....   ..
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~--~~kL~dfg~~~~~~---~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG--TVKLADFGSASLVS---PA  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC--CEEEeecCcceecC---CC
Confidence            9996 577776653 45689999999999999999999999999999999999997654  89999999987432   22


Q ss_pred             CCccccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          157 KSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ....+++.|+|||++.+   ..++ .++||||+|+++|+|++|+.||...+........   ........+ ...++..+
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~  243 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNDSPTLS-SNDWSDYF  243 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH---hcCCCCCCC-chhhCHHH
Confidence            34578899999999842   3344 4489999999999999999999765433222111   111111221 12467889


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .++|.+||..+|++|||+.+++.||||...
T Consensus       244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-46  Score=318.48  Aligned_cols=294  Identities=25%  Similarity=0.385  Sum_probs=233.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------e
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------H   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~   72 (338)
                      .||.-++.+|.|+. .|..+.+...++.||+|+....   ....++..+|...+..++|+||++++.+|....      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            48999999999999 7888999999999999998654   234477889999999999999999999997653      5


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+|||+| ..+|...+.  ..+..+.++.++.|++.|++|||+.||+||||||+||++....  .+||.|||+|+....
T Consensus        96 ~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~--~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC--TLKILDFGLARTEDT  170 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh--heeeccchhhcccCc
Confidence            79999999 569999887  4578999999999999999999999999999999999996555  899999999997766


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------  219 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (338)
                      .-..+.++.|..|+|||++.+..|... +||||+|||+.||++|...|.+....+++.+....+...             
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             ccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            667788999999999999999887655 899999999999999999999877666666554322111             


Q ss_pred             --------------cccCCCcc---------cCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccc-cCCC-c
Q 019628          220 --------------HYSFPDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELT-EGGS-W  274 (338)
Q Consensus       220 --------------~~~~~~~~---------~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~-~~~~-~  274 (338)
                                    ...||+..         .-+..+++++.+||..+|++|+|++++|+|||++-....... .+.. .
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~  329 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEI  329 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCch
Confidence                          11122211         124568999999999999999999999999999621111111 1111 1


Q ss_pred             ccCCCCCCCCCHHHHHHHhHhhCCCCCC
Q 019628          275 QSHDVNNPSQSLEEVLSLIHEATKPLEA  302 (338)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (338)
                      ......-..-+.+++++.|.++...+++
T Consensus       330 ~d~~~d~~~~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  330 YDKQLDEREHTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             hhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence            1122223334599999999998877665

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4e-44  Score=329.75  Aligned_cols=258  Identities=31%  Similarity=0.455  Sum_probs=205.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcC--CeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTP--THLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~--~~~~i   75 (338)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++...   ......+.+|+.+++++ +||||+++++++...  ..+|+
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            6899999999999999999999989999999988542   22234577899999999 999999999998654  46899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      ||||++ ++|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++....... 
T Consensus        87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~--~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC--RVKLADFGLARSLSELEE  162 (337)
T ss_pred             Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccchhccccccc
Confidence            999996 5999988765 789999999999999999999999999999999999997655  89999999987543322 


Q ss_pred             -----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH-------------
Q 019628          155 -----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-------------  216 (338)
Q Consensus       155 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~-------------  216 (338)
                           ......||..|+|||.+.+....+.++|+||+||++|+|++|+.||................             
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 22335689999999988665444455999999999999999999997655443322221110             


Q ss_pred             ----------hhccc-cC-CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          217 ----------LSVHY-SF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       217 ----------~~~~~-~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                ..... .. .....++.++.+||.+||+.+|++|||+.++++||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                      00000 00 0112368899999999999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-45  Score=339.44  Aligned_cols=253  Identities=33%  Similarity=0.521  Sum_probs=214.5

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      |..++.||-|+||.|.++....|+..||+|.+++....    ...++.|-.||..-..+-||++|..|.+.+++|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            67899999999999999999999999999999875432    34677888999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc--------
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV--------  151 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~--------  151 (338)
                      ++||++..+|.+.+.++|+.++.++..+.+|+++.|+.|+|||||||+|||||.++  +|||+||||++...        
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG--HIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC--ceeeeeccccccceeccccccc
Confidence            99999999999999999999999999999999999999999999999999997655  99999999986211        


Q ss_pred             -cCCCC----------------------------------CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcC
Q 019628          152 -LHSQP----------------------------------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG  196 (338)
Q Consensus       152 -~~~~~----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg  196 (338)
                       .+...                                  .+.+||+.|+|||++...+|+.. +|+||.|||||+|+.|
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLVG  867 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhhC
Confidence             00000                                  12359999999999999888655 9999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCC---ChhHHhcCccccc
Q 019628          197 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLR  262 (338)
Q Consensus       197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~  262 (338)
                      ++||...+......+++..  ...+.++....+|.++.++|.+++. +++.|.   .++++..||||+.
T Consensus       868 ~~pf~~~tp~~tq~kv~nw--~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINW--RNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             CCCccCCCCCcceeeeeeh--hhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence            9999877665444443332  2334566667899999999999864 788998   4678999999964

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.8e-44  Score=314.89  Aligned_cols=250  Identities=36%  Similarity=0.552  Sum_probs=211.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||.|+||.||++.+..+++.||+|++....   .....+.+|+++++.++|||++++++.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            6999999999999999999999999999999987643   3345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           80 AAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        80 ~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      +++++|...+...    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC--cEEECCccceeecccCcc
Confidence            9999999999764    6799999999999999999999999999999999999997544  89999999987543322 


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...+..........   ......|.  ..+..+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~  232 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILK---GQYPPIPS--QYSSELR  232 (258)
T ss_pred             eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc---CCCCCCCC--CCCHHHH
Confidence            2334578999999999887776555 8999999999999999999977653332222211   11112232  6789999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCccc
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +++.+||..+|++|||+.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.4e-45  Score=326.21  Aligned_cols=251  Identities=29%  Similarity=0.437  Sum_probs=208.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +.|++.+.||+|+||.||++.+..+++.||+|.+....  ...+.+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            35788899999999999999999899999999987532  2335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  158 (338)
                      +++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++....... ....
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC--CEEEccccccccccCcchhhhc
Confidence            999999998864 5789999999999999999999999999999999999997554  79999999987543322 1223


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  237 (338)
                      ..|+..|+|||.+.+..++.+ +|+||+||++|+|++|+.||..........    .+... ....+  ...+.++.++|
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li  233 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKNSPPTLE--GQYSKPFKEFV  233 (277)
T ss_pred             ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcCCCCCCC--cccCHHHHHHH
Confidence            468899999999988776555 899999999999999999997644322211    11111 11122  24678899999


Q ss_pred             HHhcccCCCcCCChhHHhcCccccc
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+||..+|++|||+.++++||||..
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         234 EACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             HHHccCCcccCcCHHHHHHhHHHHH
Confidence            9999999999999999999999964

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-46  Score=331.38  Aligned_cols=261  Identities=29%  Similarity=0.440  Sum_probs=221.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--------cccHHHHHHHHHHhcCCCCCcceeEEEEE-cCCe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--------KIDEHVQREIMNHRSLKHPNIVRFKEVLL-TPTH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~   72 (338)
                      +||-++.+||+|+|+.||+|.+...+++||+|+-....        ...+..-+|.++.+.|.||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            58999999999999999999999999999999864322        23356779999999999999999999996 4578


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc--CceecCCCCCcEEec-CCCCCcEEEeecCCCcc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QICHRDLKLENTLLD-GSTAPRVKICDFGYSKS  149 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~--~iiH~Dlkp~NIl~~-~~~~~~ikL~Dfg~a~~  149 (338)
                      +|.|+|||+|.+|..+++.++-+++.+++.|+.||+.||.||...  -|||.||||.|||+- .+..|.|||+|||+++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            999999999999999999999999999999999999999999976  699999999999984 44556899999999987


Q ss_pred             cccCCC--------CCCccccCcccccccccCCc---cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh
Q 019628          150 SVLHSQ--------PKSTVGTPAYIAPEVLTKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS  218 (338)
Q Consensus       150 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  218 (338)
                      +.....        +....||-||.+||.+.-+.   --+.++||||+|||+|+++.|+.||...............+..
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            554322        23467999999999875432   1234489999999999999999999875544444444444556


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ....||...-+++++++||++||++.-+.|..+.++-.||||..
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            67789988889999999999999999999999999999999975

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-46  Score=339.29  Aligned_cols=238  Identities=32%  Similarity=0.439  Sum_probs=208.0

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCChH
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELF   86 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~   86 (338)
                      ++-||.|+.|.||+++..  ++.||||+++.-      -+-+|+-|++|+||||+.|.++|...-.+|||||||..|.|+
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            456899999999999985  889999987532      235788899999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCccc
Q 019628           87 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI  166 (338)
Q Consensus        87 ~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~  166 (338)
                      ..|+....++......|..+|+.|+.|||.+.|||||||.-||||..+.  .|||+|||-++.........+++||..||
T Consensus       201 ~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d--~VKIsDFGTS~e~~~~STkMSFaGTVaWM  278 (904)
T KOG4721|consen  201 EVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD--VVKISDFGTSKELSDKSTKMSFAGTVAWM  278 (904)
T ss_pred             HHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc--eEEeccccchHhhhhhhhhhhhhhhHhhh
Confidence            9999999999999999999999999999999999999999999996554  79999999998666666677899999999


Q ss_pred             ccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCC
Q 019628          167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSE  246 (338)
Q Consensus       167 aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  246 (338)
                      |||++.+...+.+ +||||+||+|||||||..||..-+...    ++-.+....+.+|-...+++.++=||+.||.-.|.
T Consensus       279 APEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR  353 (904)
T KOG4721|consen  279 APEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR  353 (904)
T ss_pred             CHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchhe----eEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence            9999999888766 899999999999999999998754432    22223344455666568899999999999999999


Q ss_pred             cCCChhHHhcCcc
Q 019628          247 KRITIPEIKNHPW  259 (338)
Q Consensus       247 ~R~s~~ell~hp~  259 (338)
                      +|||+.++|.|-=
T Consensus       354 NRPSFrqil~Hld  366 (904)
T KOG4721|consen  354 NRPSFRQILLHLD  366 (904)
T ss_pred             CCccHHHHHHHHh
Confidence            9999999999843

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.1e-44  Score=317.07  Aligned_cols=247  Identities=24%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||+||++... .+..+|+|.+.........+.+|+.++++++||||+++++++.....++++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            57999999999999999999875 34569999987665555678999999999999999999999998889999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CCC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKS  158 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~~  158 (338)
                      +++|.+++... ..+++..+..++.||+.||.|||++|++|+||||.||+++.++  .+||+|||.++.......  ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCceeecCC
Confidence            99999999764 3689999999999999999999999999999999999997554  899999999875432221  112


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..++..|+|||.+.+..++.+ +|||||||++|+|++ |..||............    ..... .+.....+..+++++
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~li  234 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQGLR-LYRPHLASEKVYAIM  234 (256)
T ss_pred             CccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcCCC-CCCCCCCCHHHHHHH
Confidence            345677999999987776555 899999999999998 99999876543332222    22211 112224688999999


Q ss_pred             HHhcccCCCcCCChhHHhcC
Q 019628          238 SRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+||..+|.+|||+.+++.+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.6e-44  Score=321.93  Aligned_cols=247  Identities=24%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQKI--DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|.+.+.||+|+||.||++....     +++.||+|+++.....  .+.+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            578999999999999999998743     4678999998764332  467889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEE
Q 019628           75 IVMEYAAGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK  140 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~--------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ik  140 (338)
                      ++|||+++++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.+.  .++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--VVK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC--eEE
Confidence            9999999999999997542              378899999999999999999999999999999999997554  899


Q ss_pred             EeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhH
Q 019628          141 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI  216 (338)
Q Consensus       141 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  216 (338)
                      |+|||+++......   ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~----~~  237 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE----CI  237 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HH
Confidence            99999987432221   1233456788999999988877655 899999999999998 999997755433222    22


Q ss_pred             hhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .......+ ...++..+.+++.+||..+|++|||+.|+++
T Consensus       238 ~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            22222221 2358899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-44  Score=331.89  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=197.7

Q ss_pred             eeeeccC--CceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            7 VKDIGSG--NFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         7 ~~~LG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ...||+|  +||+||++.+..+|+.||+|++.....   ..+.+.+|+.+++.++||||++++++|..++.+++||||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3567777  999999999999999999999875432   23567889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC----
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ----  155 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~----  155 (338)
                      +++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++..+  .++++||+.+........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccCccccc
Confidence            99999998764  3589999999999999999999999999999999999997554  799999985432211111    


Q ss_pred             ----CCCccccCcccccccccCCcc-CCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh-------------
Q 019628          156 ----PKSTVGTPAYIAPEVLTKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-------------  217 (338)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------------  217 (338)
                          .....++..|+|||++.+... .+.++||||+||++|+|++|.+||.................             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                111235667999999976421 24458999999999999999999987554332222111000             


Q ss_pred             ----------------------------hccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          218 ----------------------------SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       218 ----------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                                  ......+.....+..+.+|+++||..||++|||+.|+|+||||.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                        0000111122356789999999999999999999999999999643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6e-44  Score=319.53  Aligned_cols=251  Identities=28%  Similarity=0.436  Sum_probs=208.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      =|++++.||+|+||.||++.+..+++.+|||++....  .....+.+|+.++++++||||+++++++..+..+|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3788999999999999999998899999999876543  22356888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      ++++|..++.. ..+++..+..++.|++.|+.+||++|++|+||||+||+++.++  .++|+|||++....... .....
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC--CEEEeecccceecccchhhhccc
Confidence            99999998864 4689999999999999999999999999999999999997554  79999999986543222 12345


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  238 (338)
                      .++..|+|||.+.+...+.+ +|+||+||++|+|++|..||..........    .+... ...++  ..++.++.+++.
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~i~  234 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLF----LIPKNNPPTLE--GNYSKPLKEFVE  234 (277)
T ss_pred             cCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHH----HHhcCCCCCCC--cccCHHHHHHHH
Confidence            68899999999987666545 899999999999999999997654322221    12111 11222  257889999999


Q ss_pred             HhcccCCCcCCChhHHhcCcccccC
Q 019628          239 RIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +||..+|.+||++.++++||||.+.
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHccCChhhCcCHHHHHhCHHHhhh
Confidence            9999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.6e-44  Score=320.60  Aligned_cols=249  Identities=20%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEc----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDK----WTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      |++|++.+.||+|+||+||++...    .++..+|+|.+.....  ....+.+|+.+++.++||||+++++++......|
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            468999999999999999999853    4567899999875332  2246788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC
Q 019628           75 IVMEYAAGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP  137 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~-----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~  137 (338)
                      ++|||+++++|.+++...                 ..+++..+..++.|++.||.|||++|++||||||+|||++.+.  
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~--  161 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL--  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC--
Confidence            999999999999998532                 2378899999999999999999999999999999999997654  


Q ss_pred             cEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHH
Q 019628          138 RVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTI  213 (338)
Q Consensus       138 ~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~  213 (338)
                      .+||+|||+++......   ......++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||......... .  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~~~-~--  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVI-E--  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-H--
Confidence            79999999997543221   2233456778999999987776555 899999999999998 99999775432221 1  


Q ss_pred             hhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          214 GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                       .+.. ....+....+++.+.+++.+||+.+|.+||++.+++++
T Consensus       238 -~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 -MVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             -HHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence             1111 11223333678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.3e-44  Score=321.83  Aligned_cols=255  Identities=30%  Similarity=0.494  Sum_probs=214.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      +.|++.+.||+|++|.||++.+..++..+|+|++.......+.+.+|+..++.++|+||+++++++......|+++||++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            46888999999999999999999889999999998765445678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           82 GGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        82 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      +++|.+++.... .++...+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++....... .....
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG--SVKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC--CEEECccchhhhhccchhhhccc
Confidence            999999998876 899999999999999999999999999999999999997554  89999999876433221 22344


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .+++.|+|||.+.+..++.+ +|+|||||++|+|++|..||............   ........+....++..+.+||.+
T Consensus       177 ~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLI---TTKGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             cCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCCCcchhhCCHHHHHHHHH
Confidence            58889999999987776555 89999999999999999999865433222211   111122223333478899999999


Q ss_pred             hcccCCCcCCChhHHhcCccccc
Q 019628          240 IFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ||+.+|.+|||+.++++||||.+
T Consensus       253 ~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         253 CLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HhccChhhCcCHHHHhhChHhhc
Confidence            99999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.6e-44  Score=323.03  Aligned_cols=249  Identities=24%  Similarity=0.316  Sum_probs=200.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCc--EEEEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRE--LLAVKFIERG--QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .++|++.+.||+|+||.||++....++.  .+++|.++..  ....+.+.+|+.+++++ +||||+++++++...+.+|+
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            3789999999999999999999877664  4688877642  22335688899999999 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcE
Q 019628           76 VMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV  139 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~i  139 (338)
                      +|||+++++|.+++....                .+++..++.++.|++.||+|||++||+||||||+|||++.+.  .+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~  158 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--AS  158 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC--eE
Confidence            999999999999997542                478899999999999999999999999999999999997654  79


Q ss_pred             EEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhh
Q 019628          140 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS  218 (338)
Q Consensus       140 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  218 (338)
                      ||+|||++..............+..|+|||.+.+..++.+ +|||||||++|+|++ |..||............    ..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~----~~  233 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL----PQ  233 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----hc
Confidence            9999999864322212222233557999999987776555 899999999999997 99999876543333222    21


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                       ....+....++..+.+|+.+||+.+|.+|||++++++.
T Consensus       234 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 -GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             11222223588999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.5e-44  Score=318.90  Aligned_cols=251  Identities=27%  Similarity=0.384  Sum_probs=205.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++.+.||+|+||.||++.+..+++.+|||.+....    .....+.+|+.+++.++||||+++++++..++.++++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            578999999999999999999999999999999886532    2235678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           77 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++  .++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~  158 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhcccc
Confidence            999999999998863    34589999999999999999999999999999999999997554  899999998875432


Q ss_pred             CC-CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          153 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       153 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      .. ......|+..|+|||.+.+..++.+ +|+||+|+++|+|++|..||......  .......+....+........+.
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccH
Confidence            22 1234578999999999987776555 89999999999999999999754321  12222233322222112235788


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhc
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-44  Score=321.00  Aligned_cols=254  Identities=30%  Similarity=0.475  Sum_probs=207.2

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEecc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      |++.+.||+|++|+||+|....+++.||||++.....  ......+|+..+++++ ||||+++++++..++..|+||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7899999999999999999998899999999865432  2234557899999999 999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           81 AGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                       +++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|.||+++.+.  .++|+|||++...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE--VVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--CEEEeecccceeccCCCCcCC
Confidence             789999887764  789999999999999999999999999999999999997654  899999999986554444455


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------ccccC
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VHYSF  223 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~  223 (338)
                      ..++..|+|||++.+....+.++|+||+|+++++|++|++||......+.+.+.......               ....+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            678999999999865443345599999999999999999999876654444333221100               00000


Q ss_pred             CC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          224 PD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       224 ~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +.         ....+.++.+||++||+.+|++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00         11236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.9e-44  Score=330.64  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=199.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcC-Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTP-TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-~~   72 (338)
                      +||++.+.||+|+||.||+|...     .+++.||+|++....  ...+.+.+|+.+++++ +|+||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            48999999999999999999753     345789999887532  2234677899999999 899999999988654 57


Q ss_pred             EEEEEeccCCCChHHHHHhc------------------------------------------------------------
Q 019628           73 LAIVMEYAAGGELFERICNA------------------------------------------------------------   92 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~------------------------------------------------------------   92 (338)
                      ++++|||+++++|.+++...                                                            
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            89999999999999988642                                                            


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---CCCCccccCccccc
Q 019628           93 -GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAP  168 (338)
Q Consensus        93 -~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  168 (338)
                       .++++..+..++.||+.||.|||++||+||||||+||+++.++  .++|+|||+++......   ......++..|+||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence             2578899999999999999999999999999999999997544  79999999997543221   12234466789999


Q ss_pred             ccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCc
Q 019628          169 EVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEK  247 (338)
Q Consensus       169 E~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  247 (338)
                      |++.+..++.+ +|||||||++|+|++ |..||........+...+...  .....|  ...++++.+++.+||+.+|++
T Consensus       245 E~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         245 ESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG--TRMRAP--EYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             HHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc--CCCCCC--ccCCHHHHHHHHHHccCChhh
Confidence            99988887666 899999999999998 999997654433333322211  111222  257889999999999999999


Q ss_pred             CCChhHHhcC
Q 019628          248 RITIPEIKNH  257 (338)
Q Consensus       248 R~s~~ell~h  257 (338)
                      |||+.|+++|
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=370.43  Aligned_cols=254  Identities=31%  Similarity=0.443  Sum_probs=216.9

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ||.-..+||.|.||.||.|.+..+|+..|+|-++..   .+..+.+.+|+.++..++|||+|++|++=.+.+.++|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            566778999999999999999999999999988754   33446688999999999999999999998888999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC----
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ----  155 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~----  155 (338)
                      |++|+|.+.+...+..+|...+.+..|++.|+.|||+.|||||||||+||+++.++  .+|++|||.|........    
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g--~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG--LIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC--cEEeecccceeEecCchhcCCH
Confidence            99999999998887889999999999999999999999999999999999998666  899999999986544321    


Q ss_pred             -CCCccccCcccccccccCCc--cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          156 -PKSTVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                       .....||+.|||||++.+..  -..-++|||||||++.||+||+.||...+.  .+.-+...-....+.+|.  .+|++
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy~V~~gh~Pq~P~--~ls~~ 1469 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMYHVAAGHKPQIPE--RLSSE 1469 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHhHHhccCCCCCch--hhhHh
Confidence             23467999999999998743  223458999999999999999999987664  233333333344556676  59999


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .++||.+||+.||++|.++.|+++|.|-+-
T Consensus      1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            999999999999999999999999998653

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.8e-44  Score=319.17  Aligned_cols=250  Identities=20%  Similarity=0.310  Sum_probs=202.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|.+.+.||+|+||.||+|.+..     ++..||+|.+....  .....+.+|+.+++.++|+||+++++++...+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            478999999999999999999976     67889999886432  22346788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCC
Q 019628           75 IVMEYAAGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGY  146 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~-------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~  146 (338)
                      ++|||+++++|.+++....       .+++..+..++.||+.||.|||+++++||||||+||+++.++ ...+||+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999997653       488999999999999999999999999999999999997543 23689999999


Q ss_pred             CcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcccc
Q 019628          147 SKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS  222 (338)
Q Consensus       147 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (338)
                      ++.......   ......+..|+|||++.+..++.+ +|||||||++|+|++ |..||......... ..+..  .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~--~~~~~  241 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFVTG--GGRLD  241 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHc--CCcCC
Confidence            875422211   112233567999999987777655 899999999999997 99999875543322 22111  11222


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +|  ..++..+.+++.+||+.+|++|||+.++++|
T Consensus       242 ~~--~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         242 PP--KGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            23  3678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-43  Score=318.67  Aligned_cols=249  Identities=29%  Similarity=0.414  Sum_probs=196.9

Q ss_pred             CCc-eEeeeeccCCceEEEEEE----EcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcC--Ce
Q 019628            2 ERY-EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTP--TH   72 (338)
Q Consensus         2 ~~y-~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~   72 (338)
                      +|| ++++.||+|+||+||++.    ...+++.||+|.++....  ....+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            577 999999999999998865    335678999999876432  345678999999999999999999987653  46


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      ++++|||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.+.  .++|+|||+++....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeecccccccCC
Confidence            89999999999999998764 699999999999999999999999999999999999997554  899999999875433


Q ss_pred             CCC----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH------------hhH
Q 019628          153 HSQ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI------------GRI  216 (338)
Q Consensus       153 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~------------~~~  216 (338)
                      ...    .....++..|+|||.+.+..++.+ +|||||||++|+|++|..||......  +....            ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh
Confidence            221    122345677999999987776555 89999999999999999998653321  11110            001


Q ss_pred             hhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .......+.....+..+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1111122223357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-45  Score=341.09  Aligned_cols=250  Identities=25%  Similarity=0.450  Sum_probs=208.8

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEee-----cCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe--EEEEE
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-----RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH--LAIVM   77 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~--~~iv~   77 (338)
                      ++...||+|+|-+||+|.+..+|..||--.++     +.....+++..|+.+|+.|+||||+++|++|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999999999988844332     233344789999999999999999999999988655  88999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |++.+|+|..++++.+.++...++.|++||++||.|||++.  |||||||.+||+|+.+ .|.|||+|+|+|+... ...
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl~r-~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATLLR-KSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHHhh-ccc
Confidence            99999999999999999999999999999999999999984  9999999999999754 4589999999998543 334


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-hhHhhccccCCCcccCCHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI-GRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ..+.+|||.|||||++. ..|+.. +||||||+++.||+|+..||.....+.+..+.+ ..+....+  ..  =-.++++
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl--~k--V~dPevr  274 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL--SK--VKDPEVR  274 (632)
T ss_pred             cceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh--hc--cCCHHHH
Confidence            55689999999999996 566555 899999999999999999998877765544332 22222211  11  1257899


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +||.+||.. .+.|+|+.|+|.||||..+
T Consensus       275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  275 EFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            999999999 9999999999999999765

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-43  Score=314.15  Aligned_cols=246  Identities=20%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|++|.||++.+. +++.||+|.++......+.+.+|+.++++++||||+++++++...+..|++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            57999999999999999999975 45689999987765556778899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC--C
Q 019628           82 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP--K  157 (338)
Q Consensus        82 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~--~  157 (338)
                      +++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||+++........  .
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN--ICKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC--CEEECCcceEEEccCCcccccC
Confidence            999999997654  689999999999999999999999999999999999997654  7999999998754322111  1


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....+..|+|||.+.+..++.+ +|+|||||++|+|++ |+.||...........    +.. .+..+.....+..+.++
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ----VDQ-GYRMPCPPGCPKELYDI  236 (261)
T ss_pred             CCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCCcCCHHHHHH
Confidence            1223457999999987776555 899999999999999 9999987554332222    211 12223333678999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||+.+|.+||++.++++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4e-44  Score=320.92  Aligned_cols=254  Identities=31%  Similarity=0.483  Sum_probs=207.2

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      |++.+.||.|++|.||++.+..+++.+|+|.+.....   ....+.+|+.++++++|+||+++++++..+..++++|||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            7889999999999999999999999999999876432   2457888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCC
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  158 (338)
                      ++ +|...+.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++  .++|+|||.+....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCcccccC
Confidence            75 88887765 35789999999999999999999999999999999999997544  79999999887543332 2234


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc---------------cccC
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------HYSF  223 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~  223 (338)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+..........               ...+
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            5688899999998776333455999999999999999999998766544433332221110               0011


Q ss_pred             CC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          224 PD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       224 ~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +.         ...++.++++||.+||..+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            11         12367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-43  Score=315.24  Aligned_cols=245  Identities=22%  Similarity=0.323  Sum_probs=200.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.++||+|+||.||++.+..+ ..||+|+++......+.+.+|+.+++.++||||+++++++. ....|+||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            5899999999999999999988755 45999999865555567899999999999999999999874 456899999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC--C
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP--K  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~--~  157 (338)
                      +++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.+.  .++|+|||.++........  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~--~~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC--cEEeccCCceeecccccccccc
Confidence            99999999753  3479999999999999999999999999999999999997544  7999999998754322211  2


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||.+.+..++.. +|||||||++|+|++ |..||...........    +.. ....+....++..+.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VER-GYRMPCPPECPESLHDL  235 (262)
T ss_pred             CCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----Hhc-CCCCCCccccCHHHHHH
Confidence            3346678999999887777555 899999999999999 8899987654332222    111 11223334688999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||+.+|++|||+.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-43  Score=313.77  Aligned_cols=250  Identities=29%  Similarity=0.437  Sum_probs=205.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      .++|++.+.||+|+||.||++.+..+|+.||+|.++...    .....+.+|+.++++++|+||+++++++...+..+++
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            368999999999999999999999999999999886422    2245788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           77 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||+++++|..++..    ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++  .++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~--~~~l~d~~~~~~~~~  158 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC--cEEEeccceeeeccC
Confidence            999999999998864    34589999999999999999999999999999999999997554  799999999875432


Q ss_pred             CC-CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCCCcccCC
Q 019628          153 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVS  230 (338)
Q Consensus       153 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  230 (338)
                      .. ......+++.|+|||.+.+..++.+ +|+||+||++|+|++|+.||.....  ........+..... ..| ...++
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~  234 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLP-ADHYS  234 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCC-hhhcC
Confidence            22 2234568999999999987777655 8999999999999999999965432  12222222222222 122 12577


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..+.++|.+||..+|++|||+.++++
T Consensus       235 ~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         235 EELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            89999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=317.55  Aligned_cols=253  Identities=30%  Similarity=0.447  Sum_probs=204.5

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcC---CCCCcceeEEEEEcCCe-----
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---DEHVQREIMNHRSL---KHPNIVRFKEVLLTPTH-----   72 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~~-----   72 (338)
                      |++.+.||+|+||.||++.+..+++.||+|.+......   ...+.+|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            78999999999999999999988999999998753221   23466777776655   69999999999988776     


Q ss_pred             EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc
Q 019628           73 LAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS  150 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~  150 (338)
                      ++++|||+.+ +|.+++....  .+++..++.++.|++.||.|||++|++|+||+|+||+++.+.  .++|+|||++...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceec
Confidence            9999999964 8988887643  489999999999999999999999999999999999997664  8999999998765


Q ss_pred             ccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCC-----
Q 019628          151 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFP-----  224 (338)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-----  224 (338)
                      ..........++..|+|||.+.+..++.+ +|+||+||++|+|++|.+||......+............ ...++     
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            44444445568899999999988777655 899999999999999999998766655544443321110 00000     


Q ss_pred             ------C---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          225 ------D---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       225 ------~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                            .         ...++..+.++|.+||..+|++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                  0         11356778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-43  Score=313.67  Aligned_cols=242  Identities=27%  Similarity=0.390  Sum_probs=203.3

Q ss_pred             eeeccCCceEEEEEEEcCC---CcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQKI--DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||++.+...   +..+|+|.+......  ...+.+|+..++.++|+||+++++++.....++++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   889999998775433  46788999999999999999999999999999999999999


Q ss_pred             CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           83 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        83 ~~L~~~i~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      ++|.+++...         ..+++..++.++.|++.||.|||++|++||||||+||+++.+.  .++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccccccccc
Confidence            9999999875         6799999999999999999999999999999999999997654  8999999999865433


Q ss_pred             ---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          154 ---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       154 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                         .......++..|+|||.+....++.+ +|||||||++|+|++ |..||..............   ......+  ..+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~--~~~  232 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---GYRLPKP--EYC  232 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCC--ccC
Confidence               22344568889999999987766555 899999999999999 6999988754333222211   1122223  357


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +.++.+++.+||..+|.+|||+.+++++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.2e-43  Score=319.49  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=201.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+|.+.+.||+|+||.||++...     .++..+|+|.+.... .....+.+|+.++++++||||+++++++...+.+++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            36899999999999999999852     345679999887643 334568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEe
Q 019628           76 VMEYAAGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC  142 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~-------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~  142 (338)
                      +|||+++++|.+++...+             .+++..+..++.||+.||+|||++|++||||||+||+++.++  .++|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--~~kl~  162 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIG  162 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEEec
Confidence            999999999999997543             389999999999999999999999999999999999997554  89999


Q ss_pred             ecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhh
Q 019628          143 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS  218 (338)
Q Consensus       143 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  218 (338)
                      |||+++......   ......++..|+|||.+.+..++.+ +|||||||++|+|++ |.+||.........    ..+..
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~----~~i~~  237 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----ECITQ  237 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHc
Confidence            999987543221   1223345778999999987776555 899999999999998 99999776543322    22222


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ... .+.....+.++.+|+.+||+.+|.+|||+.+++.
T Consensus       238 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            221 1122257889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-43  Score=317.65  Aligned_cols=247  Identities=19%  Similarity=0.282  Sum_probs=198.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++.+.||+|+||.||++.+.     .++..||+|++.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            57999999999999999999864     2356799998865322  2345788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           75 IVMEYAAGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~----------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                      +||||+++++|.+++....          .++...+..++.|++.||.|||++|++||||||+||+++.+.  .++|+||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--~~~l~df  163 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--CEEECCC
Confidence            9999999999999987532          257788999999999999999999999999999999997554  8999999


Q ss_pred             CCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcc
Q 019628          145 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVH  220 (338)
Q Consensus       145 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (338)
                      |+++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||..........    .+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~----~~~~~~  238 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----FVMEGG  238 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCC
Confidence            99874332211   122345778999999987777555 899999999999999 789998755432222    222221


Q ss_pred             -ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          221 -YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       221 -~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                       ...+  ...+..+.+++.+||+.+|++|||+.|++++
T Consensus       239 ~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             2223  2578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-43  Score=318.46  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=201.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQKI--DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++.+.||+|+||.||++..+.     .+..||+|.+......  ...+.+|+.+++.++||||+++++++...+..|
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            589999999999999999987642     3458999988654322  235678999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           75 IVMEYAAGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~----------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                      +||||+++|+|.+++...+          .++...++.++.|++.||.|||++||+||||||+||+++.+.  .++|+||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~Df  163 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIGDF  163 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEECcC
Confidence            9999999999999997532          245678899999999999999999999999999999997554  8999999


Q ss_pred             CCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhc-
Q 019628          145 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV-  219 (338)
Q Consensus       145 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~-  219 (338)
                      |+++.......   .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.........    ..+... 
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~~  238 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVMDGG  238 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC
Confidence            99874332211   122345678999999987777555 899999999999998 78999875443222    222222 


Q ss_pred             cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc------Ccccc
Q 019628          220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN------HPWFL  261 (338)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~------hp~~~  261 (338)
                      ....+.  ..++.+.+++.+||+.+|++|||+.++++      ||||.
T Consensus       239 ~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  284 (288)
T cd05061         239 YLDQPD--NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP  284 (288)
T ss_pred             CCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence            222232  56789999999999999999999999986      88885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-43  Score=319.56  Aligned_cols=257  Identities=32%  Similarity=0.551  Sum_probs=207.9

Q ss_pred             CceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ-----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      +|++.+.||+|+||.||++...   .+++.||+|++++..     .....+.+|+.+++++ +||||+++++++.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   467889999987532     2235677899999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+||||+++++|...+.....+++..++.++.|++.||.|||+.|++||||||.||+++.++  .++|+|||+++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccccccccc
Confidence            99999999999999998877899999999999999999999999999999999999997654  7999999998754332


Q ss_pred             CC--CCCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          154 SQ--PKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       154 ~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      ..  .....|+..|+|||.+.+.. ....++|+||||+++|+|++|..||...............+.......|.  .++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  236 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK--TMS  236 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc--ccC
Confidence            21  22346899999999987654 22345899999999999999999996533222222222333333333333  578


Q ss_pred             HHHHHHHHHhcccCCCcCCC---hhHHhcCcccccC
Q 019628          231 LECKHLLSRIFVANSEKRIT---IPEIKNHPWFLRN  263 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s---~~ell~hp~~~~~  263 (338)
                      ..+.++|.+||+.+|++|||   +.++|+||||+.-
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            89999999999999999998   5678999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9e-44  Score=313.73  Aligned_cols=241  Identities=26%  Similarity=0.399  Sum_probs=195.0

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      +.||+|+||.||++.+..+++.+|+|.+....  .....+.+|+.+++.++||||+++++++.....+++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999999999999999876432  2345788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC---Cccc
Q 019628           86 FERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVG  161 (338)
Q Consensus        86 ~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~---~~~g  161 (338)
                      .+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||++..........   ...+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC--cEEECccccCcccccccccccCCCCCC
Confidence            99997544 589999999999999999999999999999999999997544  79999999987533211111   1123


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHh
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI  240 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (338)
                      +..|+|||.+.+..++.+ +|||||||++|+|++ |..||........ ...+..  ......+  ...+..+.+|+.+|
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~~~~~--~~~~~~~--~~~~~~~~~li~~~  232 (252)
T cd05084         159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ--GVRLPCP--ELCPDAVYRLMERC  232 (252)
T ss_pred             ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHH-HHHHHc--CCCCCCc--ccCCHHHHHHHHHH
Confidence            456999999988777555 899999999999997 9999976543222 111111  1122222  35789999999999


Q ss_pred             cccCCCcCCChhHHhc
Q 019628          241 FVANSEKRITIPEIKN  256 (338)
Q Consensus       241 L~~dp~~R~s~~ell~  256 (338)
                      |+.+|++|||+.++++
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.7e-44  Score=325.37  Aligned_cols=247  Identities=21%  Similarity=0.350  Sum_probs=200.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc----EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+|++.+.||+|+||.||++....++.    .||+|+++...  .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            579999999999999999998766555    38999886532  3345788899999999999999999998764 5779


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +++|+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+.  .+||+|||+++......
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGADE  163 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC--cEEEccccccccccCCC
Confidence            999999999999998643 588999999999999999999999999999999999997554  79999999998544322


Q ss_pred             CC---CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 QP---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      ..   ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||....... ...    +......+|.....+
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~~~~~~  237 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGERLPQPPICT  237 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCCCCCCCCCCC
Confidence            21   22334678999999988777655 899999999999997 999998654322 222    222223334334578


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .++.+++.+||..+|.+|||+.+++.+
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.2e-44  Score=333.60  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-----RELLAVKFIERGQK--IDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++++.||+|+||.||++.+...     +..||||++.....  ..+.+.+|+.+++++. ||||+++++++.....+
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            5788999999999999999987432     34799999975432  2356889999999996 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-------------------------------------------------------------
Q 019628           74 AIVMEYAAGGELFERICNA-------------------------------------------------------------   92 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~-------------------------------------------------------------   92 (338)
                      |+|||||++|+|.++|..+                                                             
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999999999988642                                                             


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC
Q 019628           93 -----------------------------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP  137 (338)
Q Consensus        93 -----------------------------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~  137 (338)
                                                         ..+++..+..++.||+.||.|||++||+||||||+|||++.+.  
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~--  274 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--  274 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC--
Confidence                                               2377888899999999999999999999999999999997654  


Q ss_pred             cEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHH
Q 019628          138 RVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTI  213 (338)
Q Consensus       138 ~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~  213 (338)
                      .+||+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||........+...+
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence            79999999987543221   1223456788999999987777555 899999999999997 999998654333322221


Q ss_pred             hhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          214 GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                          ......+....++.++.+++.+||+.+|++|||+.++.+
T Consensus       354 ----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         354 ----KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ----hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                112223333468899999999999999999999988876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-43  Score=314.06  Aligned_cols=247  Identities=23%  Similarity=0.387  Sum_probs=202.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .+|++.+.||+|+||.||++.+. ++..+|+|++.+.......+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            46899999999999999999886 56689999987665555678889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC--CC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP--KS  158 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~--~~  158 (338)
                      +++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++  .+||+|||+++........  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN--VVKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC--cEEECCcccceecccccccccCC
Confidence            99999999753 4689999999999999999999999999999999999997654  7999999998754322111  11


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||...........    +.. ....+.....+..+.+++
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----VSA-GYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             CCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----HHc-CCcCCCCCCCCHHHHHHH
Confidence            223457999999988777655 899999999999999 8999976554332222    111 122222235789999999


Q ss_pred             HHhcccCCCcCCChhHHhcC
Q 019628          238 SRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+||..+|++|||+.++++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-43  Score=320.44  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=203.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCC----------------cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcce
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTR----------------ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVR   62 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~   62 (338)
                      +.+|++++.||+|+||.||++.+...+                ..||+|.+....  ...+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            368999999999999999999876544                458999887643  23457889999999999999999


Q ss_pred             eEEEEEcCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEe
Q 019628           63 FKEVLLTPTHLAIVMEYAAGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL  131 (338)
Q Consensus        63 ~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~-----------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~  131 (338)
                      +++++..+..++++||++++++|..++....           .+++..++.++.|++.||.|||++|++||||||+||++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili  163 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence            9999999999999999999999999997765           68999999999999999999999999999999999999


Q ss_pred             cCCCCCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc--CCCCCCCCCCh
Q 019628          132 DGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEDP  206 (338)
Q Consensus       132 ~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~~~~~~  206 (338)
                      +.+.  .++|+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++  |..||......
T Consensus       164 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         164 GKNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             cCCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            7654  89999999987543221   1233456788999999987776555 899999999999998  77888765544


Q ss_pred             HHHHHHHhhHh--hccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          207 KNFRKTIGRIL--SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       207 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..+........  ......+.....+.++.+++.+||+.+|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            33322221100  111112223356789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=311.58  Aligned_cols=242  Identities=40%  Similarity=0.647  Sum_probs=206.9

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ||.|+||.||++.+..+++.+|+|++.+...    ....+.+|+.+++.++||||+++++.+..+..+|++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            7999999999999998899999999876532    234688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCccccCc
Q 019628           86 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPA  164 (338)
Q Consensus        86 ~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~gt~~  164 (338)
                      .+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++  .++|+|||++...... .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG--HIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC--cEEEeecCcceecccCCCcccCCcCCcc
Confidence            99998887899999999999999999999999999999999999997654  7999999998754333 23445678999


Q ss_pred             ccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccC
Q 019628          165 YIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVAN  244 (338)
Q Consensus       165 y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  244 (338)
                      |+|||.+.+...+.+ +|+||||+++|+|++|..||......    .....+......+|.  ..+..+.+++.+||..+
T Consensus       159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPE--FLSPEARDLISGLLQKD  231 (250)
T ss_pred             ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCC
Confidence            999999987666444 89999999999999999999765432    222233334444444  56899999999999999


Q ss_pred             CCcCCCh---hHHhcCccc
Q 019628          245 SEKRITI---PEIKNHPWF  260 (338)
Q Consensus       245 p~~R~s~---~ell~hp~~  260 (338)
                      |++|||+   .++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-43  Score=312.54  Aligned_cols=248  Identities=33%  Similarity=0.495  Sum_probs=209.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....   .....+.+|+.+++.++|+||+++++++......|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            6999999999999999999999999999999987643   2234677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           80 AAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        80 ~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      +++++|..++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+.  .+||+|||++...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC-C
Confidence            999999998866    35689999999999999999999999999999999999997644  7999999998755433 3


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCCCcccCCHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLECK  234 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (338)
                      .....+++.|+|||.+.+..++.+ +|+||+|+++|+|++|+.||...+.... ..   .+....+ ..+  ...+.+++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~---~~~~~~~~~~~--~~~~~~~~  230 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDL-RY---KVQRGKYPPIP--PIYSQDLQ  230 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH---HHhcCCCCCCc--hhhCHHHH
Confidence            344678999999999987776555 8999999999999999999987654322 11   1222221 122  25788999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCccc
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +++.+||..+|++|||+.++++||++
T Consensus       231 ~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         231 NFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-43  Score=320.47  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=206.9

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      ...+||+|+||.||++....+++.||||++.... .....+.+|+.+++.++|+||+++++++...+..+++|||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3467999999999999999999999999886433 234568889999999999999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCccccC
Q 019628           85 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKSTVGTP  163 (338)
Q Consensus        85 L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~~gt~  163 (338)
                      |.+++. ...+++..++.++.|++.||+|||++|++||||+|+||+++.++  .++|+|||++....... ......|++
T Consensus       104 L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~  180 (292)
T cd06657         104 LTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSLVGTP  180 (292)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEcccccceecccccccccccccCc
Confidence            998775 44689999999999999999999999999999999999997554  79999999886443221 233457899


Q ss_pred             cccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhccc
Q 019628          164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA  243 (338)
Q Consensus       164 ~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  243 (338)
                      .|+|||.+.+..++.+ +|+||+|+++|+|++|..||.......... .+..  .....++....++..+.+++.+||..
T Consensus       181 ~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         181 YWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRD--NLPPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             cccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh--hCCcccCCcccCCHHHHHHHHHHHhC
Confidence            9999999877666544 899999999999999999998654332221 1111  11122223335788999999999999


Q ss_pred             CCCcCCChhHHhcCcccccCC
Q 019628          244 NSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       244 dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +|.+||++.++++||||....
T Consensus       257 ~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         257 DPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             CcccCcCHHHHhcChHHhccC
Confidence            999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-43  Score=319.09  Aligned_cols=257  Identities=27%  Similarity=0.392  Sum_probs=204.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +++|++.+.||+|+||.||++.+..+++.||||.+++...  ....+.+|+.++..+ .||||+++++++.....+|++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3689999999999999999999998899999999876432  224456677666566 5999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ||+. ++|...+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++  .+||+|||++........
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCCc
Confidence            9985 477776654 4568999999999999999999997 5999999999999997554  899999999875443333


Q ss_pred             CCCccccCcccccccccCCc----cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          156 PKSTVGTPAYIAPEVLTKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      .....++..|+|||.+.+..    ++. ++||||||+++|+|++|+.||......  ...............+....++.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDI-RADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCcccccc-chhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCCCCCCCCCCH
Confidence            34456888999999987543    444 489999999999999999999753322  11111112222233343335788


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ++.+|+.+||..+|.+|||+.++++||||...
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            99999999999999999999999999999743

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-43  Score=316.37  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=201.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWT-----RELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~   73 (338)
                      +++|++.+.||+|+||.||++.....     +..||+|.+.....  ....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            36899999999999999999988643     37899999865432  234677899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEee
Q 019628           74 AIVMEYAAGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD  143 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~----------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~D  143 (338)
                      |+||||+++++|.+++....          .+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~--~~kl~d  162 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL--TVKIGD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC--CEEECC
Confidence            99999999999999996432          367889999999999999999999999999999999997654  899999


Q ss_pred             cCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhc
Q 019628          144 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV  219 (338)
Q Consensus       144 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  219 (338)
                      ||+++......   ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||........ .+.+.  ...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~--~~~  238 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEV-LKFVI--DGG  238 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHH-HHHHh--cCC
Confidence            99987543222   2233456788999999977776555 899999999999998 9999986554332 22221  122


Q ss_pred             cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....|.  ..+..+.+++.+||..+|++|||+.++++
T Consensus       239 ~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLPE--NCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCC--CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            223343  56899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-43  Score=313.83  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=202.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC---CcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||+||+|....+   ...||+|.++...  .....+.+|+.+++.++||||+++++++...+.++++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5799999999999999999988644   4589999887543  2235678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.+.  .++|+|||+++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--CEEECccchhhccccccc
Confidence            9999999999999754 4689999999999999999999999999999999999997654  799999999986531111


Q ss_pred             ---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          156 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       156 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                         .....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.........    ..+.. ....+.....+.
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~  235 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI----KAVED-GYRLPPPMDCPS  235 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHH----HHHHc-CCCCCCCCCCCH
Confidence               112334678999999987777555 899999999999998 99999765543222    22222 122233346789


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+.+|+.+||+.+|++|||+.+++++
T Consensus       236 ~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         236 ALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=318.01  Aligned_cols=254  Identities=33%  Similarity=0.502  Sum_probs=208.2

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      |++.+.||+|++|.||++++..+++.||+|++...   ....+.+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            78899999999999999999999999999998864   333467788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCC
Q 019628           81 AGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  158 (338)
                      + ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++  .++|+|||+++...... ....
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC--CEEEecCCcccccCCCccccCc
Confidence            7 5899999876 5799999999999999999999999999999999999997644  89999999987543322 2334


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh--------------ccccCC
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------------VHYSFP  224 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~  224 (338)
                      ..++..|+|||.+.+....+.++|+|||||++|+|++|.+||........+.........              ....++
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            557788999999877633345589999999999999999999876654443333221100              011111


Q ss_pred             C---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          225 D---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       225 ~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .         ...++..+.++|.+||+.+|++||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            1         11347789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8e-44  Score=315.57  Aligned_cols=246  Identities=21%  Similarity=0.346  Sum_probs=205.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .+|++++.||.|+||.||++.+.. ++.+|+|++..... ....+.+|+.+++.++||||+++++++.....++++|||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            468999999999999999999986 88999999876544 4567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCC
Q 019628           81 AGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPK  157 (338)
Q Consensus        81 ~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~  157 (338)
                      ++++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++++.  .+||+|||++....... ...
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~--~~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL--VCKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc--eEEEccccchhhcCCcccccc
Confidence            999999999753  3589999999999999999999999999999999999997554  89999999987543221 122


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||.+.+..++.+ +|||||||++|+|++ |+.||........+...    .. .+..+.....+..+.++
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----TA-GYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             CCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----Hh-CCcCCCCCCCCHHHHHH
Confidence            3345678999999987776555 899999999999998 89999875543333322    21 22233334788999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||+.+|.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.8e-43  Score=313.45  Aligned_cols=245  Identities=22%  Similarity=0.357  Sum_probs=199.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||.||++... .+..+|+|.+.........+.+|+.++++++|+||+++++++. ....|++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            68999999999999999999876 5567999998876555567899999999999999999999875 456899999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CC
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PK  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~  157 (338)
                      +++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++++.  .++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCccccccc
Confidence            99999999753  3589999999999999999999999999999999999997554  899999999875432211  12


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||.+.+..++.+ +|+||||+++|+|++ |.+||...........    +.. ....+.....+..+.+|
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQ----VER-GYRMPCPQDCPISLHEL  235 (260)
T ss_pred             CCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCCcCCHHHHHH
Confidence            2335567999999877776545 899999999999999 8999987554332222    221 12223334678999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||..+|++|||+.++.+
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-43  Score=311.05  Aligned_cols=243  Identities=25%  Similarity=0.390  Sum_probs=202.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||.|+||.||++...  |+.||+|.+.......+++.+|+.+++.++|+||+++++++......++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            57999999999999999999875  8899999998765555678899999999999999999999998999999999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           82 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        82 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      +++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||.++.....  ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~--~~~l~d~g~~~~~~~~--~~~~  159 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL--VAKVSDFGLAKEASQG--QDSG  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC--CEEEcccccccccccc--cccC
Confidence            999999997665  689999999999999999999999999999999999997554  7999999998855222  2233


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      .++..|+|||.+.+..+..+ +|+|||||++|+|++ |..||........ ...+..  ......+  ...++.+.++|+
T Consensus       160 ~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~--~~~~~~~--~~~~~~~~~li~  233 (256)
T cd05039         160 KLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPHVEK--GYRMEAP--EGCPPEVYKVMK  233 (256)
T ss_pred             CCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhc--CCCCCCc--cCCCHHHHHHHH
Confidence            45667999999987776554 899999999999997 9999986543322 221111  1112222  357899999999


Q ss_pred             HhcccCCCcCCChhHHhc
Q 019628          239 RIFVANSEKRITIPEIKN  256 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~  256 (338)
                      +||..+|++|||+.++++
T Consensus       234 ~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         234 DCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.5e-43  Score=319.54  Aligned_cols=251  Identities=26%  Similarity=0.380  Sum_probs=204.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .|...+.||+|+||+||++++..+++.||+|++.....    ....+.+|+.+++.++|||++++++++.+....|+|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            46778899999999999999999999999999875322    22457789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |+. ++|...+.. ..++++..+..++.||+.||.|||++|++|+||+|+||+++.++  .++|+|||++...   ....
T Consensus       102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~--~~kL~dfg~~~~~---~~~~  175 (313)
T cd06633         102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASKS---SPAN  175 (313)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC--CEEEeecCCCccc---CCCC
Confidence            996 577777754 45689999999999999999999999999999999999997554  7999999988642   2234


Q ss_pred             CccccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          158 STVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...|+..|+|||++..   ..++ .++|||||||++|+|++|..||...+.........    ...........++..++
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~  250 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNDSPTLQSNEWTDSFR  250 (313)
T ss_pred             CccccccccChhhccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCccccCHHHH
Confidence            5678999999999842   3444 44899999999999999999998765433332221    11111111224678899


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +|+.+||+.+|.+|||+.+++.||||....
T Consensus       251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         251 GFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.1e-43  Score=311.89  Aligned_cols=245  Identities=23%  Similarity=0.365  Sum_probs=202.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|+++++||+|+||.||+|... +++.||+|.+.........+.+|+.++++++||||+++++++. .+.+|++|||+.
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            57999999999999999999865 5778999998876665678899999999999999999999874 467899999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CC
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PK  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~  157 (338)
                      +++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.+.  .++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL--CCKIADFGLARLIEDNEYTARE  161 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC--CEEEccCcceeecCCCCccccc
Confidence            99999998653  3589999999999999999999999999999999999997654  799999999875432221  12


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||.+.+..++.+ +||||||+++|+|++ |++||............    . .....+.....+.++.++
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         162 GAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL----E-RGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             CCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----H-cCCCCCCCCCCCHHHHHH
Confidence            3345678999999987776544 899999999999999 99999876544332221    1 122223334678899999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||..+|++|||++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.6e-43  Score=349.94  Aligned_cols=146  Identities=34%  Similarity=0.487  Sum_probs=134.1

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      |++|.++++||+|+||+||+|.+..+++.||||+++....    ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            5799999999999999999999999999999999976432    235678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      |||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCc
Confidence            99999999999998888899999999999999999999999999999999999997544  89999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.2e-43  Score=319.86  Aligned_cols=256  Identities=27%  Similarity=0.469  Sum_probs=204.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEc-CCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLT-PTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~iv~   77 (338)
                      ++|++++.||.|+||.||++.+..+++.||+|++.+.   ....+.+.+|+.+++.++||||++++++|.. ....|++|
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            5899999999999999999999999999999988643   2234678889999999999999999999876 56789999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||+ +++|...+.. ..+++..+..++.||+.||.|||++||+||||+|.||+++.++  .++|+|||++....  ....
T Consensus        90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~--~~~~  163 (328)
T cd07856          90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQD--PQMT  163 (328)
T ss_pred             ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccC--CCcC
Confidence            999 5688887754 4689999999999999999999999999999999999997554  89999999987432  2234


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH--------------------h
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI--------------------L  217 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~--------------------~  217 (338)
                      ...++..|+|||.+.+....+.++|+||+||++|+|++|+.||........+.......                    .
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            45688899999998664433455999999999999999999997654322211111000                    0


Q ss_pred             hc--cccCC---CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          218 SV--HYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       218 ~~--~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..  ....|   ....++..+.++|++||+.+|++|||+.+++.||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence            00  00011   012467889999999999999999999999999999654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-43  Score=318.78  Aligned_cols=248  Identities=19%  Similarity=0.309  Sum_probs=200.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      .+|++.+.||+|+||+||++....     .++.||+|++.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            578899999999999999998754     357899999875432  2356788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCc
Q 019628           75 IVMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR  138 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~  138 (338)
                      +++||+.+++|..++...                ..+++..+..++.|++.||.|||++||+||||||+||+++.+.  .
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL--N  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC--c
Confidence            999999999999998532                2478889999999999999999999999999999999997544  7


Q ss_pred             EEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHh
Q 019628          139 VKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIG  214 (338)
Q Consensus       139 ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~  214 (338)
                      +||+|||+++.......   .....+++.|+|||.+.+..++.. +|||||||++|+|++ |..||.........    .
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVI----E  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----H
Confidence            99999999875432221   223456788999999987777555 899999999999998 88899875543322    2


Q ss_pred             hHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          215 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+...... +....++..+.+|+.+||+.+|.+|||+.++++.
T Consensus       238 ~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            22222211 1223688999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.9e-43  Score=318.36  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=201.7

Q ss_pred             CCceEeeeeccCCceEEEEEEE-----cCCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRD-----KWTRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|.+.+.||+|+||.||++..     ..++..+|+|+++...  ...+.+.+|+.+++++ +||||+++++++...+.+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4789999999999999999975     2345689999887542  2235688999999999 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           74 AIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      |++|||+++++|.+++....  .+++..+..++.|++.||.|||++||+|+||||+||+++.+.  .++|+|||+++...
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~  192 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIM  192 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCccccccc
Confidence            99999999999999997543  389999999999999999999999999999999999997544  89999999987543


Q ss_pred             cCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcc
Q 019628          152 LHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV  227 (338)
Q Consensus       152 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (338)
                      ....   .....++..|+|||.+.+..++.+ +||||+||++|+|++ |..||........+.....    .....+...
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~  267 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRMAQPE  267 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcCCCCC
Confidence            2211   122346778999999988777555 899999999999998 9999987655444333222    112222223


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..+.++.+|+.+||..+|++|||+.++++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            57889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-43  Score=310.92  Aligned_cols=247  Identities=22%  Similarity=0.332  Sum_probs=204.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +++|++.+.||+|+||+||++.+. .++.+|||.+.......+.+.+|+.+++.++||||+++++++.....++++|||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            468999999999999999999976 5578999999876666678999999999999999999999999989999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CC
Q 019628           81 AGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QP  156 (338)
Q Consensus        81 ~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~  156 (338)
                      ++++|.+++....  .++...+..++.|++.||.|||++|++|+||||+||+++.+.  .++|+|||++.......  ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL--VCKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC--CEEECccccceeccchhhhhh
Confidence            9999999997643  689999999999999999999999999999999999997554  89999999987543211  11


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....++..|+|||.+.+..++.+ +|+||+||++|+|++ |+.||...........    +.. .+..+.....+.++.+
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~  235 (261)
T cd05034         162 EGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VER-GYRMPRPPNCPEELYD  235 (261)
T ss_pred             hccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHH
Confidence            22335568999999987766544 899999999999998 9999977554333322    221 1222333356889999


Q ss_pred             HHHHhcccCCCcCCChhHHhc
Q 019628          236 LLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++.+||..+|.+|||+.++++
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5e-43  Score=313.81  Aligned_cols=246  Identities=22%  Similarity=0.364  Sum_probs=198.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc----EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||+||+|....+++    .||+|++....  .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            579999999999999999999876665    48999886532  2345678899999999999999999998754 5789


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +++|+++|+|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||+++++  .+||+|||+++......
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~--~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN--HVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEEECCCCceeeccccc
Confidence            99999999999999764 4689999999999999999999999999999999999996544  79999999987543322


Q ss_pred             CC---CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 QP---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      ..   ....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||....... ....+   .. ....+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~---~~-~~~~~~~~~~~  237 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLL---EK-GERLPQPPICT  237 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH---HC-CCcCCCCccCC
Confidence            21   22335678999999988777655 899999999999998 999997654322 22221   11 12223334678


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .++.+++.+||..+|++|||+.+++.
T Consensus       238 ~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         238 IDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.1e-43  Score=310.03  Aligned_cols=239  Identities=26%  Similarity=0.368  Sum_probs=193.6

Q ss_pred             eeeccCCceEEEEEEE--cCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRD--KWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||++..  ..+++.+|+|+++....   ..+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            3699999999999864  45788999999865432   2356788999999999999999999875 4567899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC----CCC
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ----PKS  158 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~----~~~  158 (338)
                      ++|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.+.  .+||+|||+++.......    ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCC
Confidence            99999998878899999999999999999999999999999999999997654  899999999875433221    122


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  236 (338)
                      ..++..|+|||.+....++.+ +|+|||||++|+|++ |..||......... ..   +... ....|.  .+++++.++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~---i~~~~~~~~~~--~~~~~l~~l  230 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QM---IESGERMECPQ--RCPPEMYDL  230 (257)
T ss_pred             CCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH---HHCCCCCCCCC--CCCHHHHHH
Confidence            334578999999977666555 899999999999998 99999875543222 22   2222 223333  688999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      |.+||+.+|++|||+.+|..
T Consensus       231 i~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         231 MKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHhccCchhCcCHHHHHH
Confidence            99999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.7e-43  Score=313.49  Aligned_cols=248  Identities=31%  Similarity=0.485  Sum_probs=203.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ||.+.+.||+|+||.||++.+..++..+++|+++...      .....+.+|+.+++.++||||+++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            7999999999999999999998777777777765421      1223566789999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           77 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||+++++|...+..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.+   .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence            999999999988853    3468999999999999999999999999999999999999642   699999999875433


Q ss_pred             C-CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-ccccCCCcccCC
Q 019628          153 H-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDYVRVS  230 (338)
Q Consensus       153 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  230 (338)
                      . .......|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||.........    ..+.. ....++.  .++
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~--~~~  230 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVV----LRIVEGPTPSLPE--TYS  230 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCCCCCcc--hhc
Confidence            2 22334568899999999877666655 89999999999999999999754432222    22222 1222332  578


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .++.++|.+||..+|++||++.++++||||
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.1e-43  Score=309.64  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=199.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||++.+..+ ..+|+|.+.........+.+|+.+++.++|||++++++++. .+..+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            6899999999999999999988654 46999988766555567889999999999999999999875 456889999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CC
Q 019628           82 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PK  157 (338)
Q Consensus        82 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~  157 (338)
                      +++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.+.  .++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~--~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL--VCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--eEEECCCccceEccCCcccccC
Confidence            999999997543  478999999999999999999999999999999999997554  799999999875432221  12


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||.+.+..++.. +|||||||++|+|++ |..||............    .. .+..+.....+..+.++
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQV----ER-GYRMPCPQGCPESLHEL  235 (260)
T ss_pred             CCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCcccCHHHHHH
Confidence            2346678999999887776544 899999999999999 99999876544332221    11 12223233678999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +++||..+|++|||+.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-43  Score=312.18  Aligned_cols=245  Identities=21%  Similarity=0.328  Sum_probs=196.6

Q ss_pred             ceEeeeeccCCceEEEEEEEcCC---CcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe-----
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH-----   72 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-----   72 (338)
                      |++.+.||+|+||.||++....+   +..||+|.++....   ....+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67899999999999999987643   47899999875432   23467889999999999999999998866544     


Q ss_pred             -EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecC
Q 019628           73 -LAIVMEYAAGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG  145 (338)
Q Consensus        73 -~~iv~e~~~~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg  145 (338)
                       .+++|||+++++|..++...      ..+++..++.++.|++.||.|||++|++||||||+||+++.+.  .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCcc
Confidence             79999999999999988532      3589999999999999999999999999999999999997554  89999999


Q ss_pred             CCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhh-cc
Q 019628          146 YSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS-VH  220 (338)
Q Consensus       146 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~-~~  220 (338)
                      +++.......   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |.+||........+..    +.. ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~~  233 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----LRHGNR  233 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCC
Confidence            9875432221   122335678999999877766555 899999999999999 9999977554333222    222 12


Q ss_pred             ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          221 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ...|  ...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       234 ~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 LKQP--EDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCC--cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2223  3678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.6e-43  Score=314.35  Aligned_cols=247  Identities=24%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+|.+.++||+|+||.||++...     .++..+|+|.+.... .....+.+|+.+++.++|+||+++++++.....+++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            47899999999999999999742     356789999876543 334578899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEE
Q 019628           76 VMEYAAGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK  140 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~---------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ik  140 (338)
                      +|||+++++|.+++....               .+++..+..++.||+.||.|||++|++||||||+|||++++.  .+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CEE
Confidence            999999999999997643               478999999999999999999999999999999999997544  899


Q ss_pred             EeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhH
Q 019628          141 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI  216 (338)
Q Consensus       141 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  216 (338)
                      |+|||++.......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |.+||.............   
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---  238 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT---  238 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---
Confidence            99999987432221   1223345778999999988777655 899999999999998 999997655443332221   


Q ss_pred             hhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .......+  ..+++.+.+|+.+||..+|.+|||+.++++
T Consensus       239 ~~~~~~~~--~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGRELERP--RTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCccCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11122222  367899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.4e-43  Score=316.98  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-----RELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||.||++.....     ...+|+|.+....  .....+.+|+.+++.+ +||||+++++++...+.+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            5799999999999999999987643     3789999887532  2224578899999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC
Q 019628           74 AIVMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP  137 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~  137 (338)
                      +++|||+++++|..++...                ..+++..+..++.|++.||.|||++||+||||||+||+++.++  
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~--  169 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH--  169 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC--
Confidence            9999999999999999642                3588999999999999999999999999999999999997544  


Q ss_pred             cEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHH
Q 019628          138 RVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTI  213 (338)
Q Consensus       138 ~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~  213 (338)
                      .+||+|||+++.......   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||........+... 
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-  247 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-  247 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH-
Confidence            899999999885433221   122335677999999877777555 899999999999997 99999875543332222 


Q ss_pred             hhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          214 GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                         .. ....+.....+..+.+|+.+||..+|++|||+.+++++
T Consensus       248 ---~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         248 ---KE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             ---Hc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence               11 11222223578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.3e-43  Score=321.34  Aligned_cols=246  Identities=25%  Similarity=0.412  Sum_probs=191.9

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCChHHHHH
Q 019628           14 NFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERIC   90 (338)
Q Consensus        14 ~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~   90 (338)
                      ++|.||++++..+++.||+|++...   ......+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4456677777778999999998764   2334678899999999999999999999999999999999999999999997


Q ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--------CCCCcc
Q 019628           91 NA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--------QPKSTV  160 (338)
Q Consensus        91 ~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--------~~~~~~  160 (338)
                      ..  ..+++..++.++.|++.||+|||++||+||||||+||+++.++  .+||+|||.+.......        ......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~  169 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV  169 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC--ceEEecCccceeecccccccccccccccccc
Confidence            53  4589999999999999999999999999999999999997554  79999999886432211        123345


Q ss_pred             ccCcccccccccCC--ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-------------------
Q 019628          161 GTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------------  219 (338)
Q Consensus       161 gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------------  219 (338)
                      ++..|+|||++.+.  .++ .++|+||+||++|+|++|..||...................                   
T Consensus       170 ~~~~y~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         170 KNLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             ccccccCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            77889999998763  344 44899999999999999999998654433222111100000                   


Q ss_pred             ---------cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          220 ---------HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       220 ---------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                               ....+....++.++.+|+.+||..+|++|||+.++|+||||.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~  300 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ  300 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence                     0000001123567899999999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-43  Score=308.45  Aligned_cols=240  Identities=27%  Similarity=0.360  Sum_probs=195.3

Q ss_pred             eeeccCCceEEEEEEEcCCC---cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTR---ELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||+|.....+   ..+|+|.+.....  ..+.+.+|+.+++.++||||+++++++. ...++++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876554   7899999876543  4467889999999999999999999876 4568999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC----CC
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KS  158 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~----~~  158 (338)
                      ++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||+++........    ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~--~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC--cEEeccccccceeecCCcccccccC
Confidence            99999998887899999999999999999999999999999999999997654  8999999998754332211    11


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..++..|+|||.+.+..++.+ +|||||||++|+|++ |.+||........ ...   +.... ..+....++..++++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~-~~~---~~~~~-~~~~~~~~~~~l~~li  231 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEV-IAM---LESGE-RLPRPEECPQEIYSIM  231 (257)
T ss_pred             ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHH-HHH---HHcCC-cCCCCCCCCHHHHHHH
Confidence            223467999999987777555 899999999999998 9999987654322 222   22221 2233336789999999


Q ss_pred             HHhcccCCCcCCChhHHhc
Q 019628          238 SRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~  256 (338)
                      .+||..+|++|||+.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.9e-43  Score=315.39  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=200.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+|.+.+.||+|+||.||++...     .++..+++|.+..... ..+.+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46899999999999999999853     3456789998865432 23568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcE
Q 019628           76 VMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV  139 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~i  139 (338)
                      ||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+||+++.+.  .+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--LV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cE
Confidence            999999999999997542                378999999999999999999999999999999999997654  89


Q ss_pred             EEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhh
Q 019628          140 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGR  215 (338)
Q Consensus       140 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~  215 (338)
                      +|+|||+++......   ......++..|+|||.+.+..++.+ +|||||||++|+|+| |..||..........    .
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~----~  237 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----C  237 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----H
Confidence            999999987443221   1233456788999999988777555 899999999999998 999997655433222    2


Q ss_pred             HhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          216 ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +...... ......+..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            2222211 112246889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-43  Score=316.44  Aligned_cols=252  Identities=24%  Similarity=0.358  Sum_probs=198.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC--------------cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR--------------ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKE   65 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~   65 (338)
                      .+|++.+.||+|+||.||++.+..++              ..||+|.+....  .....+.+|+.++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            48999999999999999999875432              358999887532  22346889999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC
Q 019628           66 VLLTPTHLAIVMEYAAGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG  133 (338)
Q Consensus        66 ~~~~~~~~~iv~e~~~~~~L~~~i~~~~------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~  133 (338)
                      ++...+..++||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            9999999999999999999999986432            3688899999999999999999999999999999999975


Q ss_pred             CCCCcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc--CCCCCCCCCChHH
Q 019628          134 STAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEDPKN  208 (338)
Q Consensus       134 ~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~~  208 (338)
                      +.  .+||+|||++........   .....++..|+|||.+.+..++.+ +|+|||||++|+|++  |..||........
T Consensus       165 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         165 HY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             CC--cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            44  799999999875432221   122345678999999987777555 899999999999988  6788877554333


Q ss_pred             HHHHHhhHhh--ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          209 FRKTIGRILS--VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       209 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..........  ...........++.+.+|+.+||+.+|++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2222111111  11111122346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-42  Score=317.11  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=204.4

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .|+..+.||+|+||.||++++..++..+|+|++.....    ....+.+|+.+++.++|||++++++++..+...|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            47888999999999999999999999999999875422    22467889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++  .++|+|||++....   ...
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~---~~~  179 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIAS---PAN  179 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccC---Ccc
Confidence            9975 77776653 55689999999999999999999999999999999999996544  89999999886432   233


Q ss_pred             CccccCccccccccc---CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          158 STVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...|++.|+|||.+.   ...++ .++||||+||++|+|++|..||...........    +............++..++
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~  254 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEWSDYFR  254 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccCCCCCCccccHHHH
Confidence            457899999999974   23444 448999999999999999999976543322222    2222222222235788899


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +|+.+||+.+|.+|||+.++++|+|+....
T Consensus       255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         255 NFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            999999999999999999999999996543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.6e-43  Score=317.51  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=198.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-------CCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-------TRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      ++|.+.+.||+|+||.||++.+..       +...+|+|.+....  .....+.+|+.+++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            579999999999999999998643       23579999987542  2234677899999999 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      .+|+||||+++++|.+++....                .++...++.++.|++.||+|||++|++||||||+||+++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            9999999999999999997542                478899999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++.......   .....+++.|+|||.+.+..++.+ +|+|||||++|+|++ |..||..... .....
T Consensus       178 --~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~  253 (307)
T cd05098         178 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-EELFK  253 (307)
T ss_pred             --cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHH
Confidence              899999999875432211   122234568999999987776555 899999999999998 8899976443 22222


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .   +... ...+.....+.++.+|+.+||..+|.+|||+.+++++
T Consensus       254 ~---~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         254 L---LKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             H---HHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            2   2211 1222223678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.7e-43  Score=311.75  Aligned_cols=249  Identities=22%  Similarity=0.373  Sum_probs=204.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||.||+++.+.     +.+.+|+|.+.....  ....+.+|+.++++++||||+++++++......|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            579999999999999999999754     346799998865433  2457889999999999999999999999989999


Q ss_pred             EEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecC
Q 019628           75 IVMEYAAGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG  145 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg  145 (338)
                      +||||+++++|.+++....         .+++..+..++.||+.||+|||++||+||||||+||+++..+  .++|+|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR--EVKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC--cEEEcccc
Confidence            9999999999999998665         689999999999999999999999999999999999997654  79999999


Q ss_pred             CCcccccC--CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcccc
Q 019628          146 YSKSSVLH--SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS  222 (338)
Q Consensus       146 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (338)
                      ++......  .......++..|+|||.+.+..+.. ++||||||+++|+|++ |..||.........    ..+......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~----~~~~~~~~~  237 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFST-KSDVWSFGVLMWEVFTQGELPFYGLSDEEVL----NRLQAGKLE  237 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccchHHHH----HHHHcCCcC
Confidence            98643221  1223445678899999987776654 4899999999999998 88999765443222    223323333


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ++....++..+.+++.+||+.+|.+|||+.+++.+
T Consensus       238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            33334688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.2e-43  Score=308.14  Aligned_cols=243  Identities=23%  Similarity=0.378  Sum_probs=197.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEE-cCCeEEEEEec
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL-TPTHLAIVMEY   79 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~~iv~e~   79 (338)
                      +++|++.+.||+|+||.||++...  |..+|+|.++... ..+.+.+|+.++++++|+|++++++++. ..+.+|++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            468999999999999999999874  7889999886543 3457889999999999999999999754 55679999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           80 AAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      +++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||++......  ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~--~~  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST--QD  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC--cEEecCCccceecccc--CC
Confidence            99999999997644  378999999999999999999999999999999999997554  8999999998743322  23


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||++.+..++.+ +|||||||++|+|++ |+.||........    ...+... +.......+++.+.++
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~l  231 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV----VPRVEKG-YKMDAPDGCPPVVYDV  231 (256)
T ss_pred             CCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHhcC-CCCCCCCCCCHHHHHH
Confidence            3445678999999987776555 899999999999997 9999976543222    2222221 1112223678999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||..+|++|||+.++++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.2e-43  Score=314.88  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=198.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC----------------CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCccee
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW----------------TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRF   63 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~   63 (338)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|.+....  .....+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            489999999999999999986432                34578999887542  233568899999999999999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEec
Q 019628           64 KEVLLTPTHLAIVMEYAAGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD  132 (338)
Q Consensus        64 ~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~-----------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~  132 (338)
                      ++++...+.++++|||+++++|.+++....           .+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            999999999999999999999999987542           367788999999999999999999999999999999997


Q ss_pred             CCCCCcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc--CCCCCCCCCChH
Q 019628          133 GSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEDPK  207 (338)
Q Consensus       133 ~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt--g~~pf~~~~~~~  207 (338)
                      .+.  .++|+|||+++.......   .....+++.|+|||...+..++.+ +|+|||||++|+|++  |..||.......
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         165 KNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             CCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            544  899999999875432221   122344678999999877777555 899999999999998  789997655433


Q ss_pred             HHHHHHhhHhh--ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          208 NFRKTIGRILS--VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       208 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ...........  ....++....+++.+.+|+.+||+.+|++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33222111111  11122333457789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-42  Score=310.12  Aligned_cols=247  Identities=22%  Similarity=0.389  Sum_probs=201.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc---EEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE---LLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ..|++.+.||+|+||.||+|....+++   .||||++...  ......+..|+.+++.++||||+++++++.....+++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            579999999999999999999876664   6999998753  22345788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.+.  .++|+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence            9999999999998753 4589999999999999999999999999999999999997554  899999999874432221


Q ss_pred             CCC---cc---ccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          156 PKS---TV---GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       156 ~~~---~~---gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                      ...   ..   .+..|+|||.+.+..++.+ +||||+||++|+|++ |..||..........    .+. .....|....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~----~i~-~~~~~~~~~~  235 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIN----AIE-QDYRLPPPMD  235 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH----HHH-cCCcCCCccc
Confidence            111   11   2347999999987777555 899999999999886 999997655432222    221 1233344446


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++..+.+++.+||..+|.+||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.2e-43  Score=317.48  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=203.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|...+.||+|+||.||++++..++..+|+|.+....    .....+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            35778899999999999999999999999999986432    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      ||+. ++|...+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++  .++|+|||++....   ..
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~---~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMA---PA  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeec---Cc
Confidence            9996 578777653 45689999999999999999999999999999999999997544  89999999887432   23


Q ss_pred             CCccccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          157 KSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ....|++.|+|||.+.+   ..++ .++|||||||++|+|++|..||............    .............+..+
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  243 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYF  243 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCC-cccchHHHHHHHHHHHcCCCCCccccHHHHHHHH----hhcCCCCcCcccccHHH
Confidence            34578899999999753   3344 4489999999999999999999765433222211    11111111123578889


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+||++||..+|.+|||+.+++.|||+...
T Consensus       244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-43  Score=310.65  Aligned_cols=241  Identities=24%  Similarity=0.333  Sum_probs=193.3

Q ss_pred             eeeccCCceEEEEEEEcCCCc--EEEEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRE--LLAVKFIERG--QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||.||++....++.  .+|+|.++..  ......+.+|+.+++++ +||||+++++++...+.+|++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999987775  4688877642  23345788999999999 799999999999999999999999999


Q ss_pred             CChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           83 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        83 ~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                      ++|.+++....                .+++..+..++.|++.||+|||++|++||||||+||+++.+.  .+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEEECCCCC
Confidence            99999997543                378999999999999999999999999999999999997554  899999999


Q ss_pred             CcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCC
Q 019628          147 SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPD  225 (338)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (338)
                      +..............+..|+|||++.+..++.+ +|||||||++|+|++ |..||........+..    +.. .+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~-~~~~~~  232 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----LPQ-GYRLEK  232 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----HhC-CCCCCC
Confidence            864322222222334567999999977766545 899999999999997 9999976544332222    211 122222


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....+.++.+++.+||..+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-42  Score=309.29  Aligned_cols=247  Identities=23%  Similarity=0.380  Sum_probs=201.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC---cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR---ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      .+|++.+.||+|+||.||++.+..++   ..+|+|.++...  .....+.+|+.++++++||||+++++++..++.+|++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57999999999999999999886444   379999886542  2335788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+.  .++|+|||++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccccc
Confidence            9999999999999764 4589999999999999999999999999999999999997554  899999999875433221


Q ss_pred             ----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          156 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                          .....++..|+|||.+.+..++.+ +|+|||||++|++++ |..||...........    +... ...|.....+
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~  235 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IEEG-YRLPAPMDCP  235 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH----HhCC-CcCCCCCCCC
Confidence                111223567999999987776555 899999999999886 9999987554332222    2221 2334444678


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..+.+++.+||+.+|.+|||+.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHH
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.9e-42  Score=306.92  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=200.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +++|++.+.||+|+||.||++... .+..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            478999999999999999999865 45679999887665555678899999999999999999999887 7789999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--C
Q 019628           81 AGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--P  156 (338)
Q Consensus        81 ~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~  156 (338)
                      ++++|.+++...  ..++...+..++.|++.||.|||++|++||||||+||+++...  .+||+|||++........  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCcccc
Confidence            999999999753  3578889999999999999999999999999999999996544  899999998874432211  1


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....++..|+|||.+....++.+ +|+|||||++|+|++ |..||...+.......    +. ..+..+.....+.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LE-RGYRMPRPENCPEELYN  234 (260)
T ss_pred             cCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH----Hh-CCCCCCCcccCCHHHHH
Confidence            22345677999999987766545 899999999999998 9999987654332221    11 12233333468899999


Q ss_pred             HHHHhcccCCCcCCChhHHhc
Q 019628          236 LLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++.+||..+|++||++.++++
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-42  Score=310.38  Aligned_cols=246  Identities=22%  Similarity=0.342  Sum_probs=194.9

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCc--EEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcC------Ce
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRE--LLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------TH   72 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~--~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~   72 (338)
                      |.+.+.||+|+||.||++....++.  .+|+|.++..   ....+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578999999999999999877665  6899988654   22345678899999999999999999976432      24


Q ss_pred             EEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           73 LAIVMEYAAGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~------~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                      .+++|||+++|+|..++..      ...+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM--NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC--CEEECCCCc
Confidence            7899999999999988742      23489999999999999999999999999999999999997554  799999999


Q ss_pred             CcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcccc
Q 019628          147 SKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS  222 (338)
Q Consensus       147 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (338)
                      ++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |+.||..........    .+.... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~~~-~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYD----YLRQGN-R  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCC-C
Confidence            885433221   122346678999999988777555 899999999999999 899997654432222    222221 1


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+....++..+.++|.+||..+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22223678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.6e-44  Score=351.11  Aligned_cols=251  Identities=31%  Similarity=0.454  Sum_probs=200.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEc----------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLT----------   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----------   69 (338)
                      .+|+.++.||+||||.||+|+++-+|+.||||+|+..  .+...++.+|++.+.+|+|||||+++..|..          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            4688899999999999999999999999999999875  4455678999999999999999999876530          


Q ss_pred             --------------------------------------------------------------------------------
Q 019628           70 --------------------------------------------------------------------------------   69 (338)
Q Consensus        70 --------------------------------------------------------------------------------   69 (338)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ---------------------C--------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHhhhcCc
Q 019628           70 ---------------------P--------THLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQI  119 (338)
Q Consensus        70 ---------------------~--------~~~~iv~e~~~~~~L~~~i~~~~~l-~~~~~~~i~~qi~~al~~LH~~~i  119 (338)
                                           +        ..+||=||||+..+|.++|..+... ..+.++++++||+.||.|+|+.||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                 0        1368899999988888888766544 478899999999999999999999


Q ss_pred             eecCCCCCcEEecCCCCCcEEEeecCCCcccc-------------------cCCCCCCccccCcccccccccCCc---cC
Q 019628          120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLTKKE---YD  177 (338)
Q Consensus       120 iH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~  177 (338)
                      |||||||.||++++..  .|||+|||+|+...                   .....++.+||..|+|||++.+..   |+
T Consensus       719 IHRDLKP~NIFLd~~~--~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRN--SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeccCCcceeEEcCCC--CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            9999999999998665  89999999997411                   011235678999999999997755   65


Q ss_pred             CCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCCHHHHHHHHHhcccCCCcCCChhHHh
Q 019628          178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIK  255 (338)
Q Consensus       178 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~ell  255 (338)
                      .+ +||||||+|++||+   .||...-   .....+..+.++.+.+|.  +..--+.-..+|++||+.||++||||.|+|
T Consensus       797 ~K-iDmYSLGIVlFEM~---yPF~TsM---ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  797 SK-IDMYSLGIVLFEML---YPFGTSM---ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             ch-hhhHHHHHHHHHHh---ccCCchH---HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            55 89999999999998   4576432   223334444554444441  112234467899999999999999999999


Q ss_pred             cCcccc
Q 019628          256 NHPWFL  261 (338)
Q Consensus       256 ~hp~~~  261 (338)
                      ++.||.
T Consensus       870 ~s~llp  875 (1351)
T KOG1035|consen  870 NSELLP  875 (1351)
T ss_pred             hccCCC
Confidence            999996

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-42  Score=311.63  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=197.0

Q ss_pred             CCceEeeeeccCCceEEEEEEE----cCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRD----KWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~   74 (338)
                      ++|++++.||+|+||+||++..    ..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...  ..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4799999999999999999973    45788999999875432 235688999999999999999999987543  4689


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           75 IVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++  ++||+|||+++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC--eEEECCCcccccccCC
Confidence            999999999999999754 4589999999999999999999999999999999999997554  8999999998854332


Q ss_pred             CCC----CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChH-----------HHHHHHhhHhh
Q 019628          154 SQP----KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----------NFRKTIGRILS  218 (338)
Q Consensus       154 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-----------~~~~~~~~~~~  218 (338)
                      ...    ....++..|+|||.+.+..++.+ +|||||||++|+|++|..|+......-           .....+.....
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            211    11223456999999987776544 899999999999999877764322110           00001111222


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....++....++.++.+|+.+||..+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            22333444468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-42  Score=316.06  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=197.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-------CCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-------TRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      ++|++.+.||+|+||.||++.+..       .+..+|+|.+.....  ....+.+|+.+++.+ .||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            579999999999999999998632       345799998875322  234677899999999 6999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           72 HLAIVMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      .+|++|||+++++|.+++...                ..++...+..++.||+.||.|||++|++||||||+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            999999999999999999753                2478899999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++......   ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||........+. 
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-  247 (314)
T cd05099         172 --VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEELFK-  247 (314)
T ss_pred             --cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence              89999999997543211   1122234567999999987776555 899999999999999 899997654332222 


Q ss_pred             HHhhHhhc-cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          212 TIGRILSV-HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       212 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .   +... ....+  ..++.++++++.+||..+|++|||+.++++
T Consensus       248 ~---~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         248 L---LREGHRMDKP--SNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             H---HHcCCCCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2   2221 11222  357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2e-42  Score=310.17  Aligned_cols=246  Identities=21%  Similarity=0.314  Sum_probs=196.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc----EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||+||++....+++    .+++|.+....  .....+..|+..++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            579999999999999999999977776    46777765332  223456778888999999999999998754 56788


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.+.  .+||+|||+++......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccCCC
Confidence            9999999999999975 44689999999999999999999999999999999999997654  89999999997543222


Q ss_pred             C---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 Q---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||....... ....+   ... ...+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~---~~~-~~~~~~~~~~  237 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLL---EKG-ERLAQPQICT  237 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH---HCC-CcCCCCCCCC
Confidence            1   223456778999999988777655 899999999999998 999998654322 22221   111 1222222467


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .++.+++.+|+..+|++|||+.|+++
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            88999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.9e-43  Score=306.21  Aligned_cols=229  Identities=24%  Similarity=0.350  Sum_probs=190.2

Q ss_pred             CCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019628           13 GNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNA   92 (338)
Q Consensus        13 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~   92 (338)
                      |.+|.||+|.+..+++.||+|++.....    ..+|...+....||||+++++++...+.++++|||+++++|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            8999999999999999999999976532    334555555667999999999999999999999999999999999887


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCccccccccc
Q 019628           93 GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT  172 (338)
Q Consensus        93 ~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  172 (338)
                      ..+++..+..++.|++.||.|||++||+||||||+||+++.++  .++|+|||.+.....  ......++..|+|||.+.
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG--HIQLTYFSRWSEVED--SCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--CEEEecccchhcccc--ccccCCcCccccCCcccC
Confidence            7899999999999999999999999999999999999997654  799999998764322  233455678899999987


Q ss_pred             CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCCh-
Q 019628          173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITI-  251 (338)
Q Consensus       173 ~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-  251 (338)
                      +..++.+ +|+||+||++|+|++|..||.......      .  ......+|.  .+++.+++||.+||+.||++|||+ 
T Consensus       156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~~------~--~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         156 ISEETEA-CDWWSLGAILFELLTGKTLVECHPSGI------N--THTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCCCCch-hhHHHHHHHHHHHHHCcchhhcCchhc------c--cccccCCcc--cCCHHHHHHHHHHccCCHHHhcCCC
Confidence            7766554 899999999999999998876432110      0  011123343  478999999999999999999986 


Q ss_pred             ----hHHhcCccc
Q 019628          252 ----PEIKNHPWF  260 (338)
Q Consensus       252 ----~ell~hp~~  260 (338)
                          .++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.9e-43  Score=321.26  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=197.0

Q ss_pred             CCceEeeeeccCCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcC-Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRD-----KWTRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTP-TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-~~   72 (338)
                      ++|++.+.||+|+||+||+|.+     ..+++.||||+++....  ....+.+|+.++.++ .||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5899999999999999999984     34678999999875432  234678899999999 689999999987654 56


Q ss_pred             EEEEEeccCCCChHHHHHhc------------------------------------------------------------
Q 019628           73 LAIVMEYAAGGELFERICNA------------------------------------------------------------   92 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~------------------------------------------------------------   92 (338)
                      ++++|||+++|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            89999999999999998642                                                            


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC---CCCcccc
Q 019628           93 -------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGT  162 (338)
Q Consensus        93 -------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt  162 (338)
                             ..++...+..++.||+.||.|||++||+||||||+||+++.+.  .+||+|||++........   .....++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCCCC
Confidence                   1367778899999999999999999999999999999997554  899999999875422211   1223456


Q ss_pred             CcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      ..|+|||.+.+..++.+ +|||||||++|+|++ |..||............+..  ......|.  ..++++.+++.+||
T Consensus       245 ~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~cl  319 (343)
T cd05103         245 LKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--GTRMRAPD--YTTPEMYQTMLDCW  319 (343)
T ss_pred             cceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc--cCCCCCCC--CCCHHHHHHHHHHc
Confidence            77999999987777655 899999999999997 99999765433332222111  11122233  46788999999999


Q ss_pred             ccCCCcCCChhHHhcC
Q 019628          242 VANSEKRITIPEIKNH  257 (338)
Q Consensus       242 ~~dp~~R~s~~ell~h  257 (338)
                      ..+|++|||+.++++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-42  Score=305.47  Aligned_cols=245  Identities=29%  Similarity=0.394  Sum_probs=202.1

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCC----cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTR----ELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +++.+.||.|+||.||++.+...+    ..+|+|++.....  ..+.+.+|+..++.++|+||+++++++...+..|++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999998766    8999999976543  3567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           78 EYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ||+++++|.+++.....  +++..+..++.|++.||.+||++|++||||||+||++++++  .++|+|||++........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceecccccc
Confidence            99999999999976554  99999999999999999999999999999999999997655  899999999875443322


Q ss_pred             CC--CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          156 PK--STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ..  ...+++.|+|||.+.+..++.+ +|+|||||++|+|++ |.+||...........    +.... ..+.....+.+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~  232 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKGY-RLPKPENCPPE  232 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcCC-CCCCCCcCCHH
Confidence            11  2336789999999976666544 899999999999998 8899987544333222    22211 11222347899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+++.+||..+|++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.3e-42  Score=325.71  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=200.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQK--IDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|.+.+.||+|+||.||+|++.     .++..||+|+++....  ....+.+|+.++.++. ||||+++++++..++.+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46788899999999999999853     3556899999976432  2346788999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC------------------------------------------------------------
Q 019628           74 AIVMEYAAGGELFERICNAG------------------------------------------------------------   93 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~------------------------------------------------------------   93 (338)
                      ++||||+++|+|.+++...+                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999986432                                                            


Q ss_pred             --------------------------------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           94 --------------------------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        94 --------------------------------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                                                            .++...++.++.||+.||.|||+++++||||||+|||++.+.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                                  256677889999999999999999999999999999997544


Q ss_pred             CCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++......   ......+++.|+|||.+.+..++.+ +||||+||++|+|++ |..||...........
T Consensus       277 --~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         277 --LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             --EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence              89999999987532211   1223457888999999987776555 899999999999998 8999976554333222


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+.    .....+....++.++.+|+.+||..+|.+|||++++++.
T Consensus       354 ~~~----~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         354 AIK----RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHH----cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            221    122222233578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.4e-44  Score=295.38  Aligned_cols=254  Identities=23%  Similarity=0.435  Sum_probs=209.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeEEEEEcCC--eEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPT--HLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~--~~~iv~e   78 (338)
                      ++|++++++|+|.|+.|+.+.+..+++.++||+++.-.  .+.+.||+.+|+.|. ||||++++++..++.  ...+|+|
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            68999999999999999999999999999999987644  378999999999997 999999999998764  5789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |+++.+...+.   ..++...++.++.+++.||.|||++||.|||+||.|++||.... .++|+|+|+|....+...-+.
T Consensus       116 ~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eYnV  191 (338)
T KOG0668|consen  116 YVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNV  191 (338)
T ss_pred             hhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCceeee
Confidence            99887665543   45889999999999999999999999999999999999985543 799999999998877777777


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCC-CCChHHHHHHHhhHhh---------ccccC-----
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFED-PEDPKNFRKTIGRILS---------VHYSF-----  223 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~~~~~~~~---------~~~~~-----  223 (338)
                      .+.+..|--||.+..-+.+..+-|+|||||++..|++.+-||-. .++.+++.++.+.+..         -...+     
T Consensus       192 RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~  271 (338)
T KOG0668|consen  192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFE  271 (338)
T ss_pred             eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHh
Confidence            78889999999998765555557999999999999999988754 4444444443321111         00000     


Q ss_pred             ----------------CCcc-cCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          224 ----------------PDYV-RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       224 ----------------~~~~-~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                                      ++.. -.++++.||+.++|.+|..+|+||.|++.||||.
T Consensus       272 ~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  272 DILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             hHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence                            1111 1569999999999999999999999999999995

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-42  Score=313.71  Aligned_cols=248  Identities=22%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-------CCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-------WTRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      ++|.+.+.||+|+||.||++...       ..+..+|+|.+....  .....+.+|+.+++.+ +||||+++++++....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            57999999999999999999753       234579999886532  2335688999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           72 HLAIVMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      .+|++|||+++++|.+++...                ..++...+..++.||+.||.|||++|++||||||+||+++.++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            999999999999999999753                2467888999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++......   ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.......... 
T Consensus       175 --~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-  250 (304)
T cd05101         175 --VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-  250 (304)
T ss_pred             --cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-
Confidence              89999999987543221   1223346678999999987777655 899999999999998 888997654332222 


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                         .+... ........++..+.+|+.+||..+|++|||+.++++.
T Consensus       251 ---~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         251 ---LLKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ---HHHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence               22211 1222223678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-42  Score=312.00  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=197.4

Q ss_pred             ceEeeeeccCCceEEEEEEE----cCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEE
Q 019628            4 YEIVKDIGSGNFGVAKLVRD----KWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAI   75 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~i   75 (338)
                      |++++.||+|+||.||++..    ..++..||+|.++...  .....+.+|+.+++.++||||+++++++...  ..+++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            68999999999999999984    4578899999986542  2335788999999999999999999998775  56899


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ||||++|++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++  .++|+|||+++......
T Consensus        86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC--CEEECCCccccccccCc
Confidence            999999999999996543 589999999999999999999999999999999999997544  79999999987543322


Q ss_pred             C----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC-----------hHHHHHHHhhHhhc
Q 019628          155 Q----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-----------PKNFRKTIGRILSV  219 (338)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-----------~~~~~~~~~~~~~~  219 (338)
                      .    .....++..|+|||++.+..++.+ +|||||||++|+|+++..|+.....           ..........+. .
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  241 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE-E  241 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH-c
Confidence            1    223456778999999887776555 8999999999999998766532111           000111111111 1


Q ss_pred             cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ....+....++..+.+|+.+||+.+|++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            12233344688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.9e-42  Score=306.90  Aligned_cols=247  Identities=23%  Similarity=0.367  Sum_probs=201.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc---EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE---LLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|+..+.||+|+||.||++....++.   .+|+|++....  .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            468899999999999999999876554   79999887542  2335688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|..++... +.+++..+..++.|++.||.|||++|++||||||+||+++.+.  .+||+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceecccccc
Confidence            9999999999998753 5689999999999999999999999999999999999997544  799999999875432221


Q ss_pred             CC----CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          156 PK----STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       156 ~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      ..    ....+..|+|||++.+..++.+ +|||||||++|+|++ |..||......... .   .+.. ....|.....+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~-~---~i~~-~~~~~~~~~~~  236 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVM-K---AIND-GFRLPAPMDCP  236 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-H---HHhc-CCCCCCCCCCC
Confidence            11    1123457999999987777555 899999999999997 99999765543322 2   2222 12334444678


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .++.+++.+|+..+|++||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.9e-42  Score=303.87  Aligned_cols=247  Identities=24%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .+|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|+.++++++||||+++++++......|++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            47899999999999999999885 46789999987665555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CCC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKS  158 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~~  158 (338)
                      +++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||+++.......  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcccccCC
Confidence            99999998754 4589999999999999999999999999999999999997544  899999999874322211  122


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...........    +... .........+..+.+|+
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVET----INAG-FRLYKPRLASQSVYELM  234 (256)
T ss_pred             CccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH----HhCC-CCCCCCCCCCHHHHHHH
Confidence            335678999999987776544 899999999999998 9999986543322222    2211 11111224688999999


Q ss_pred             HHhcccCCCcCCChhHHhcC
Q 019628          238 SRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+||..+|++|||+.+++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-42  Score=311.26  Aligned_cols=246  Identities=22%  Similarity=0.343  Sum_probs=198.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +|++.+.||+|+||.||++.+..     ....+|+|.+.....  ....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998753     235688998765432  23568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEe
Q 019628           76 VMEYAAGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL  131 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~------------------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~  131 (338)
                      +|||+.+++|.+++...                        ..+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999988642                        247889999999999999999999999999999999999


Q ss_pred             cCCCCCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChH
Q 019628          132 DGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK  207 (338)
Q Consensus       132 ~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~  207 (338)
                      +++.  .+||+|||+++......   ......++..|+|||.+.+..++.. +|||||||++|+|++ |..||.......
T Consensus       161 ~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         161 AEGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             cCCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            7554  89999999987532221   1223345678999999877766544 899999999999998 999997654332


Q ss_pred             HHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      . ....    ......+....++.++.+++.+||+.+|++|||+.++++
T Consensus       238 ~-~~~~----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 L-FNLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             H-HHHH----hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            2 2221    112223333468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6e-43  Score=310.26  Aligned_cols=244  Identities=31%  Similarity=0.466  Sum_probs=193.7

Q ss_pred             eEeeeeccCCceEEEEEEEc----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            5 EIVKDIGSGNFGVAKLVRDK----WTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++.+.||.|+||.||+|...    ..+..|+||.++....  ....+.+|+..+++++||||+++++++...+.+++|||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            57899999999999999987    4567899999965322  34678899999999999999999999998888999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---
Q 019628           79 YAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---  153 (338)
Q Consensus        79 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---  153 (338)
                      |+++|+|.+++...  ..+++..+..++.||+.||.|||+++++|++|+|.||+++.+.  .+||+|||++......   
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccc
Confidence            99999999999886  6799999999999999999999999999999999999997655  8999999998754211   


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      .......+...|+|||.+....++.+ +||||||+++|||++ |+.||..........    .+... ...+....++..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~  233 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEIIE----KLKQG-QRLPIPDNCPKD  233 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH----HHHTT-EETTSBTTSBHH
T ss_pred             cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccc----ccccc-ccceeccchhHH
Confidence            12233457788999999988776544 999999999999999 789998764433222    22222 122223368899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +.++|.+||..+|.+|||+.++++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-42  Score=304.41  Aligned_cols=241  Identities=26%  Similarity=0.386  Sum_probs=197.4

Q ss_pred             eeeccCCceEEEEEEEcC-CCc--EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDKW-TRE--LLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|++|.||++.+.. .++  .||||.+.....  ..+.+.+|+..+++++||||+++++++.. ..++++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998865 333  689999877543  34678899999999999999999999988 889999999999


Q ss_pred             CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC----CC
Q 019628           83 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS----QP  156 (338)
Q Consensus        83 ~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~----~~  156 (338)
                      ++|.+.+....  .+++..++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||+++......    ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecc
Confidence            99999997754  689999999999999999999999999999999999997654  89999999987543321    11


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||............    .......+.....+..+.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  232 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEACPQDIYN  232 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccCCHHHHH
Confidence            23457788999999987777655 899999999999998 99999765543332222    2122222333357899999


Q ss_pred             HHHHhcccCCCcCCChhHHhc
Q 019628          236 LLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++.+||..+|++|||+.++++
T Consensus       233 li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.2e-43  Score=308.66  Aligned_cols=240  Identities=18%  Similarity=0.218  Sum_probs=191.4

Q ss_pred             eeeccCCceEEEEEEEcCCCc-------EEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            8 KDIGSGNFGVAKLVRDKWTRE-------LLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +.||+|+||.||++.+...+.       .+|+|.+.... ...+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999999865443       48888876543 2335678899999999999999999999998999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC------CcEEEeecCCCccccc
Q 019628           80 AAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA------PRVKICDFGYSKSSVL  152 (338)
Q Consensus        80 ~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~------~~ikL~Dfg~a~~~~~  152 (338)
                      +++|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.      +.++++|||++.... 
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~-  159 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL-  159 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC-
Confidence            99999999997644 5899999999999999999999999999999999999975542      137999999886432 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCC-CCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                        ......+++.|+|||++.+....+.++|||||||++|+|++|. .||........ ..    .......+|.  ..+.
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~----~~~~~~~~~~--~~~~  230 (258)
T cd05078         160 --PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ----FYEDRHQLPA--PKWT  230 (258)
T ss_pred             --CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH----HHHccccCCC--CCcH
Confidence              2234568889999999987543345589999999999999984 66655433221 11    1122233443  4568


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ++.+|+.+||+.+|++|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            89999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3e-42  Score=316.91  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=198.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-------CcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-------RELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      .+|++++.||+|+||.||+|.+...       +..+|+|.+....  .....+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            3799999999999999999986432       2368999877532  2335788999999999 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      .++++|||+++++|.+++....                .++...+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            9999999999999999997532                367788999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++.......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||........+..
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         172 --VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             --cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence              899999999875432211   122334567999999988777655 899999999999998 8899977543332222


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                          +.. ....+.....+.++.+|+.+||..+|.+|||+.+++++
T Consensus       249 ----~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         249 ----LKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             ----HHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                221 12222223678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.5e-42  Score=303.65  Aligned_cols=239  Identities=25%  Similarity=0.405  Sum_probs=190.5

Q ss_pred             eeccCCceEEEEEEEc--CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCC
Q 019628            9 DIGSGNFGVAKLVRDK--WTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         9 ~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      .||+|+||.||++...  ..+..||+|++.....  ..+.+.+|+.++++++||||+++++++. ...+++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999998764  4456799998876432  2356889999999999999999999875 457899999999999


Q ss_pred             hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC----CCCc
Q 019628           85 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ----PKST  159 (338)
Q Consensus        85 L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~----~~~~  159 (338)
                      |.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.+.  .+||+|||++........    ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC--cEEeccCCccccccCCccceeccCCC
Confidence            9999874 45689999999999999999999999999999999999997554  799999999874332211    1112


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      .++..|+|||.+.+..++.+ +|||||||++|+|++ |..||............ ..  ......|.  ..++++.+++.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~--~~~~~l~~li~  232 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQ--GKRLDCPA--ECPPEMYALMK  232 (257)
T ss_pred             CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HC--CCCCCCCC--CCCHHHHHHHH
Confidence            23578999999887776555 899999999999996 99999876543322211 11  11222333  57899999999


Q ss_pred             HhcccCCCcCCChhHHhc
Q 019628          239 RIFVANSEKRITIPEIKN  256 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~  256 (338)
                      +||..+|++||++.++++
T Consensus       233 ~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.8e-42  Score=305.31  Aligned_cols=243  Identities=24%  Similarity=0.330  Sum_probs=188.3

Q ss_pred             eeeccCCceEEEEEEEc--CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            8 KDIGSGNFGVAKLVRDK--WTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      +.||+|+||.||++...  .++..+|+|.++....  ....+.+|+.++++++||||+++++++.....+++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999754  3556799998876432  2246788999999999999999999999989999999999999


Q ss_pred             ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---C
Q 019628           84 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---Q  155 (338)
Q Consensus        84 ~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---~  155 (338)
                      +|.+++....     .+++..++.++.|++.||.|||++|++||||||+||+++.+.  ++||+|||+++......   .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeec
Confidence            9999996432     356778889999999999999999999999999999997654  89999999986432221   1


Q ss_pred             CCCccccCcccccccccCCc------cCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCC--C-
Q 019628          156 PKSTVGTPAYIAPEVLTKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFP--D-  225 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~-  225 (338)
                      .....++..|+|||++.+..      ..+.++||||+||++|+|++ |..||............   +.......+  . 
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VREQQLKLPKPRL  235 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---hhcccCCCCCCcc
Confidence            22345778899999986432      12345899999999999996 99999876543332221   111112222  1 


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....+..+.+++.+|+ .+|++|||+++++.
T Consensus       236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            1246788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=303.40  Aligned_cols=256  Identities=29%  Similarity=0.527  Sum_probs=215.1

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      |++|.++..||+|+|+.|.+++.+++.+.||+|++++.-    ....=++.|..+..+. +||++|.++.+|.++..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            578999999999999999999999999999999998732    1123355565555444 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc-ccCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~-~~~~  154 (338)
                      |.||++||+|.-.+++..++|++.++.+...|+.||.|||++|||.||||..|+|+|..+  ++||+|+|+++.. ....
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg--hikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC--ceeecccchhhcCCCCCc
Confidence            999999999999999889999999999999999999999999999999999999997655  9999999999843 3455


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCC--CChH--HHHHHHhhHhhccccCCCcccCC
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EDPK--NFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .+.++||||.|.|||++.+..|... +|+|+||++++||+.|+.||.--  .+++  .-.-.++.+.......|.  .+|
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--sls  483 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLS  483 (593)
T ss_pred             ccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eee
Confidence            6778999999999999999988555 89999999999999999999632  1111  111223445555666666  577


Q ss_pred             HHHHHHHHHhcccCCCcCC------ChhHHhcCcccc
Q 019628          231 LECKHLLSRIFVANSEKRI------TIPEIKNHPWFL  261 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~------s~~ell~hp~~~  261 (338)
                      -.+..+++..|.+||.+|.      ...++..|+||.
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr  520 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR  520 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence            7788999999999999997      468999999996

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.5e-42  Score=305.95  Aligned_cols=243  Identities=21%  Similarity=0.353  Sum_probs=187.0

Q ss_pred             eeeccCCceEEEEEEEcC--CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            8 KDIGSGNFGVAKLVRDKW--TRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      +.||+|+||.||++....  ....+|+|.+.....  ....+.+|+..++.++||||+++++.+.....+|+||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999996432  345788887754322  2345778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---C
Q 019628           84 ELFERICNAGR-----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---Q  155 (338)
Q Consensus        84 ~L~~~i~~~~~-----l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---~  155 (338)
                      +|.+++.....     .++..++.++.||+.||+|||++||+||||||+|||++.+.  .+||+|||++.......   .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL--SVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC--cEEEeccccccccccchheec
Confidence            99999976432     46788899999999999999999999999999999997655  89999999986432221   1


Q ss_pred             CCCccccCcccccccccCC------ccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCC---
Q 019628          156 PKSTVGTPAYIAPEVLTKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPD---  225 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  225 (338)
                      .....+++.|+|||++...      ...+.++|||||||++|+|++ |..||..............   .....++.   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR---EQDIKLPKPQL  235 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh---ccCccCCCCcc
Confidence            2233466789999997532      222455899999999999999 7889987654443333222   22222221   


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ...++..+.+++..|+ .||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2257888899999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-42  Score=308.15  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=201.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEc----CCCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK----WTRELLAVKFIERGQKI--DEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~   73 (338)
                      ++|++.+.||+|+||.||++...    .++..+|+|++......  ...+.+|+.+++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46889999999999999999864    34789999999866543  5678999999999999999999999887  5679


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           74 AIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +++|||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.+  +.++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~--~~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE--DLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC--CCEEEccccccccccc
Confidence            99999999999999997654 58999999999999999999999999999999999999765  4899999999885542


Q ss_pred             CCC----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHH----------HHHHHhhHhh
Q 019628          153 HSQ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN----------FRKTIGRILS  218 (338)
Q Consensus       153 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~----------~~~~~~~~~~  218 (338)
                      ...    .....++..|+|||.+.+..++.. +|||||||++|+|++|..||........          ....+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            211    112345567999999987776555 8999999999999999999865332110          0111112222


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .....+.....+.++.+|+.+||..+|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            23333433467789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.3e-42  Score=308.59  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=199.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++.+.||+|+||.||+|.+..     ++..+|+|++.....  ....+.+|+.+++.++||||+++++++.....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            579999999999999999998753     578899999875432  2356888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEec
Q 019628           75 IVMEYAAGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD  132 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~----------------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~  132 (338)
                      ++|||+++++|.+++....                      .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            9999999999999997432                      368888999999999999999999999999999999996


Q ss_pred             CCCCCcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHH
Q 019628          133 GSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKN  208 (338)
Q Consensus       133 ~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~  208 (338)
                      .+.  .++|+|||++........   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||........
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         165 ENM--VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             CCC--ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            544  899999999874332211   222345667999999988777655 899999999999997 8889976543322


Q ss_pred             HHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          209 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                          ...+..... ++.....+.++.+|+.+||+.+|++|||+.|+++
T Consensus       242 ----~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         242 ----IYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             ----HHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                222222221 1222257889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.5e-42  Score=306.27  Aligned_cols=247  Identities=20%  Similarity=0.264  Sum_probs=200.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC----CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEc-CCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW----TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLT-PTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~   74 (338)
                      ++|++.+.||+|+||.||++.+..    ++..||+|.+....  .....+.+|+.+++.++||||+++++++.. +...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            589999999999999999999875    35789999886532  224567889999999999999999998765 46789


Q ss_pred             EEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           75 IVMEYAAGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~--------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                      ++++|+++++|..++...        ..+++..+..++.|++.||.|||+++++||||||+||+++.+.  .+||+|||+
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~  163 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNAL  163 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCCC
Confidence            999999999999998653        3589999999999999999999999999999999999997554  899999999


Q ss_pred             CcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcccc
Q 019628          147 SKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS  222 (338)
Q Consensus       147 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (338)
                      ++.......   .....++..|+|||.+.+..++.+ +|||||||++|++++ |+.||....... ...   .+. ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---~~~-~~~~  237 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE-MAA---YLK-DGYR  237 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHH---HHH-cCCC
Confidence            975432221   123346678999999987776555 899999999999999 999998654322 211   111 1233


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++....+++++.+++.+||..+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3333457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=307.42  Aligned_cols=248  Identities=17%  Similarity=0.160  Sum_probs=188.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC---CcEEEEEEeecCcccc------------HHHHHHHHHHhcCCCCCcceeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQKID------------EHVQREIMNHRSLKHPNIVRFKEV   66 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~------------~~~~~E~~~l~~l~h~~Iv~~~~~   66 (338)
                      ++|++.+.||+|+||+||+|....+   +..+|+|+........            .....+...+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5899999999999999999998777   6677887654322110            112233445567799999999997


Q ss_pred             EEcCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEe
Q 019628           67 LLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC  142 (338)
Q Consensus        67 ~~~~~----~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~  142 (338)
                      +....    ..+++++++. .++.+.+......++..++.++.|++.||.|||+++|+||||||+|||++.+.  .++|+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~  168 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYII  168 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEE
Confidence            76543    4578888874 47777776655678999999999999999999999999999999999997554  79999


Q ss_pred             ecCCCcccccCC--------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHH---
Q 019628          143 DFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK---  211 (338)
Q Consensus       143 Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~---  211 (338)
                      |||+|+......        ......||+.|+|||++.+..++.+ +|||||||++|+|++|++||...........   
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            999997542211        1223469999999999988777555 8999999999999999999987643322211   


Q ss_pred             --HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          212 --TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       212 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                        ...++.......+   ..+..+.++++.|+..+|++||+..++++
T Consensus       248 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKIKIK---NANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              1233333333332   46788999999999999999999999875

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.8e-42  Score=303.98  Aligned_cols=240  Identities=19%  Similarity=0.231  Sum_probs=188.2

Q ss_pred             eeeccCCceEEEEEEEcC------------CCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            8 KDIGSGNFGVAKLVRDKW------------TRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      +.||+|+||.||++....            ....+|+|.+..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532            223588898765432 2346778899999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC-----CcEEEeecCCCc
Q 019628           75 IVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-----PRVKICDFGYSK  148 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~-----~~ikL~Dfg~a~  148 (338)
                      ++|||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.     +.++++|||++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            99999999999888865 356899999999999999999999999999999999999964431     138999999886


Q ss_pred             ccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHH-cCCCCCCCCCChHHHHHHHhhHhhccccCCCcc
Q 019628          149 SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV  227 (338)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (338)
                      ...   ......++..|+|||.+......+.++|||||||++|+|+ +|..||........ ..    ........  ..
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~----~~~~~~~~--~~  230 (262)
T cd05077         161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ER----FYEGQCML--VT  230 (262)
T ss_pred             ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HH----HHhcCccC--CC
Confidence            432   2234568889999999875443445599999999999998 58888876432221 11    11111111  22


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ..+.++.+||.+||+.||.+||++.+|+++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=326.66  Aligned_cols=243  Identities=27%  Similarity=0.422  Sum_probs=198.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++..+...||+|.||+||+++..  | .||||+++...   ...+.|++|+..+++-+|.||+-+.|++-.+.. .||..
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            34578899999999999999985  3 49999987643   345678999999999999999999999988877 99999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc---cccCC
Q 019628           79 YAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHS  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~---~~~~~  154 (338)
                      +|+|-+|+.+|.. ..++.....+.|++|+++|+.|||.++|||||||..|||+.++.  +|||+|||++..   .....
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC--cEEEecccceeeeeeecccc
Confidence            9999999999973 34688899999999999999999999999999999999997654  899999999862   23334


Q ss_pred             CCCCccccCcccccccccCC---ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC----cc
Q 019628          155 QPKSTVGTPAYIAPEVLTKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD----YV  227 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~  227 (338)
                      ......|...|||||++...   .| +..+||||+||++|||+||..||.. ...++   ++-.+..+ +..|+    ..
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi-~~~dq---IifmVGrG-~l~pd~s~~~s  619 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSI-QNRDQ---IIFMVGRG-YLMPDLSKIRS  619 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCC-CChhh---eEEEeccc-ccCccchhhhc
Confidence            45566789999999999753   44 4459999999999999999999983 33222   22222222 22222    23


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..+.++++|+..|+.+++++||+..+||.
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            46678999999999999999999999887

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-41  Score=303.73  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=198.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC---CcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|.+.+.||+|+||.||++.+...   ...+|||......  ...+.+.+|+.+++.++||||+++++++.. ...|+|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4789999999999999999987543   3568999886543  234578899999999999999999998875 457899


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++  .++|+|||+++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC--CeEEccCceeeecccccc
Confidence            99999999999997644 589999999999999999999999999999999999997554  899999999875433221


Q ss_pred             --CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          156 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                        .....++..|+|||.+....++.+ +|||||||++|+|++ |..||............    ... ...+....++..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~~~-~~~~~~~~~~~~  236 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----ENG-ERLPMPPNCPPT  236 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HcC-CcCCCCCCCCHH
Confidence              112234567999999877776555 899999999999986 99999876544333221    111 112223367899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +.+++.+|+..+|.+|||+.+++..
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.5e-42  Score=334.49  Aligned_cols=260  Identities=19%  Similarity=0.200  Sum_probs=178.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCC----CcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEE------EEcC
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWT----RELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEV------LLTP   70 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~------~~~~   70 (338)
                      .++|++.+.||+|+||.||+|.+..+    +..||+|++...... +....+  .++...+.+++.+...      ....
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            36899999999999999999999988    899999987643221 111111  1222223333332222      1345


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEE
Q 019628           71 THLAIVMEYAAGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL  130 (338)
Q Consensus        71 ~~~~iv~e~~~~~~L~~~i~~~~~--------------------l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl  130 (338)
                      ..+++||||+.+++|.+++.....                    ..+..++.++.||+.||.|||++||+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            679999999999999998864321                    123457789999999999999999999999999999


Q ss_pred             ecCCCCCcEEEeecCCCccccc--CCCCCCccccCcccccccccCCccC---------------------CCcchHHHHH
Q 019628          131 LDGSTAPRVKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLTKKEYD---------------------GKIADVWSCG  187 (338)
Q Consensus       131 ~~~~~~~~ikL~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DiwSlG  187 (338)
                      ++.. .+.+||+|||+|+....  .......++|+.|+|||.+......                     ..++||||+|
T Consensus       288 l~~~-~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEG-SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCC-CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9743 23799999999975332  2234567899999999976432211                     1235999999


Q ss_pred             HHHHHHHcCCCCCCCCCChHHHHHHHhhHh----------hccc------cCCCcccCCHHHHHHHHHhcccCCCcCCCh
Q 019628          188 VTLYVMLVGAYPFEDPEDPKNFRKTIGRIL----------SVHY------SFPDYVRVSLECKHLLSRIFVANSEKRITI  251 (338)
Q Consensus       188 ~il~~lltg~~pf~~~~~~~~~~~~~~~~~----------~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~  251 (338)
                      |++|+|+++..|+..  ....+...+....          ....      .+.........+.+||.+||++||.+|||+
T Consensus       367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            999999997665432  2222222211100          0000      000001123346699999999999999999


Q ss_pred             hHHhcCcccccCCCc
Q 019628          252 PEIKNHPWFLRNLPI  266 (338)
Q Consensus       252 ~ell~hp~~~~~~~~  266 (338)
                      .++|+||||.+....
T Consensus       445 ~e~L~Hpff~~~~~~  459 (566)
T PLN03225        445 KAALAHPYFDREGLL  459 (566)
T ss_pred             HHHhCCcCcCCCCcc
Confidence            999999999765443

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.3e-42  Score=305.78  Aligned_cols=239  Identities=20%  Similarity=0.244  Sum_probs=188.5

Q ss_pred             eeccCCceEEEEEEEcCC------------------------CcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCccee
Q 019628            9 DIGSGNFGVAKLVRDKWT------------------------RELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRF   63 (338)
Q Consensus         9 ~LG~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~   63 (338)
                      .||+|+||.||++....+                        ...||+|++..... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999875321                        23588888865432 23467788999999999999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-----CC
Q 019628           64 KEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-----AP  137 (338)
Q Consensus        64 ~~~~~~~~~~~iv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-----~~  137 (338)
                      ++++......++||||+++++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+     .+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999998865 45689999999999999999999999999999999999996432     22


Q ss_pred             cEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHH-cCCCCCCCCCChHHHHHHHhhH
Q 019628          138 RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRI  216 (338)
Q Consensus       138 ~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~  216 (338)
                      .+|++|||++.....   .....++..|+|||.+.+....+.++|||||||++|+|+ +|+.||........ ...    
T Consensus       162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~----  233 (274)
T cd05076         162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERF----  233 (274)
T ss_pred             eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHH----
Confidence            489999998763321   223457888999999876443345599999999999985 79999986544322 111    


Q ss_pred             hhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .......|.  ..++.+.++|.+||+.+|++|||+.+++++
T Consensus       234 ~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            112223333  356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.5e-44  Score=322.10  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=214.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC------CCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK------HPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~------h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .||.+....|+|-||+|..|.+...|..||||+|.+.+...+.=..|+++|++|+      --|+++++..|...+++|+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            4899999999999999999999999999999999998877777788999999995      3489999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           76 VMEYAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||-+ ..+|...+++.+   .|....++.|+.||+.||..|...||+|.||||.|||++.+.+ .+||||||.|.....
T Consensus       512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~e  589 (752)
T KOG0670|consen  512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASE  589 (752)
T ss_pred             Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccccc
Confidence            99988 569999998765   4889999999999999999999999999999999999987665 799999998875433


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhh--------Hhhcccc--
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR--------ILSVHYS--  222 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~--  222 (338)
                       ...+.+..+..|+|||++.+..|+.. .|+||+||+||||.||+..|.+.++...+.-.+.-        +..+.+.  
T Consensus       590 -neitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq  667 (752)
T KOG0670|consen  590 -NEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ  667 (752)
T ss_pred             -ccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence             34556778889999999999999887 79999999999999999999998875544333210        0000000  


Q ss_pred             -C------------------------------------------CC-cccCCHHHHHHHHHhcccCCCcCCChhHHhcCc
Q 019628          223 -F------------------------------------------PD-YVRVSLECKHLLSRIFVANSEKRITIPEIKNHP  258 (338)
Q Consensus       223 -~------------------------------------------~~-~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp  258 (338)
                       |                                          |. ...+-..+++||.+||..||++|+|+.|+|.||
T Consensus       668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence             0                                          00 000123478999999999999999999999999


Q ss_pred             cccc
Q 019628          259 WFLR  262 (338)
Q Consensus       259 ~~~~  262 (338)
                      ||+.
T Consensus       748 Fi~~  751 (752)
T KOG0670|consen  748 FITE  751 (752)
T ss_pred             cccC
Confidence            9963

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-41  Score=303.30  Aligned_cols=248  Identities=31%  Similarity=0.469  Sum_probs=200.6

Q ss_pred             CceEeeeeccCCceEEEEEEEcC-CCcEEEEEEeecCc-----------cccHHHHHHHHHHhc-CCCCCcceeEEEEEc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQ-----------KIDEHVQREIMNHRS-LKHPNIVRFKEVLLT   69 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~   69 (338)
                      .|++.+.||+|+||.||++.+.. +++.+|+|.+....           .....+.+|+.++++ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 67899999886421           112346678877764 799999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           70 PTHLAIVMEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                      .+..+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.+.  .++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~--~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD--KVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC--cEEEecc
Confidence            9999999999999999988743    3468999999999999999999996 6899999999999997554  8999999


Q ss_pred             CCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC
Q 019628          145 GYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP  224 (338)
Q Consensus       145 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  224 (338)
                      |++.............|+..|+|||.+.+..++.+ +|+||||+++|+|++|++||.........    ..+....+...
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~  233 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLA----TKIVEAVYEPL  233 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHH----HHHhhccCCcC
Confidence            99876544434445678999999999987776545 89999999999999999999765433222    22222222222


Q ss_pred             CcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ....++..+.++|.+||+.+|++|||+.|+.++
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            222578899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-41  Score=301.46  Aligned_cols=237  Identities=19%  Similarity=0.198  Sum_probs=190.9

Q ss_pred             eeeccCCceEEEEEEEcCCC----------cEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            8 KDIGSGNFGVAKLVRDKWTR----------ELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +.||+|+||.||++.+..++          ..+++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46999999999999998766          358888776654446778899999999999999999999888 7789999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC-----cEEEeecCCCcccc
Q 019628           78 EYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP-----RVKICDFGYSKSSV  151 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~-----~ikL~Dfg~a~~~~  151 (338)
                      ||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++.....     .+||+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            9999999999998765 78999999999999999999999999999999999999755422     69999999987543


Q ss_pred             cCCCCCCccccCcccccccccCC--ccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                      .   .....++..|+|||.+.+.  .+ +.++|||||||++|+|++ |..||...... .......    .....+.  .
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~-~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~----~~~~~~~--~  228 (259)
T cd05037         160 S---REERVERIPWIAPECIRNGQASL-TIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQ----DQHRLPM--P  228 (259)
T ss_pred             c---ccccccCCCccChhhhcCCCCCc-chhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHh----cCCCCCC--C
Confidence            2   2344577889999999776  44 445899999999999999 58888765422 1111111    1111121  2


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....+.+++.+||..+|.+|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            3378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-41  Score=300.86  Aligned_cols=241  Identities=25%  Similarity=0.369  Sum_probs=196.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||++..  +++.||+|.++... ....+.+|+.+++.++||||+++++++..+ ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5799999999999999999874  68889999886542 346788999999999999999999998664 5799999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           82 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        82 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      +++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++.....  .....
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~--~~~~~  157 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSM--GVDNS  157 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceeccc--cCCCC
Confidence            999999997643  479999999999999999999999999999999999997554  799999999874322  12233


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (338)
                      ..+..|+|||.+.+..++.+ +|+|||||++|+|++ |++||......... ..+   .. ....+....++..+.+++.
T Consensus       158 ~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~---~~-~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         158 KLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-ECV---EK-GYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             CCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHH---hC-CCCCCCCCcCCHHHHHHHH
Confidence            45678999999987776555 899999999999997 99999875543222 221   11 1222222367899999999


Q ss_pred             HhcccCCCcCCChhHHhc
Q 019628          239 RIFVANSEKRITIPEIKN  256 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~  256 (338)
                      +||..+|.+|||+.++++
T Consensus       232 ~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         232 SCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999976

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=316.14  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=196.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc-cHHHHHHHHHHhcCCCCCcceeEEEEEcCC-eEEEEEecc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSLKHPNIVRFKEVLLTPT-HLAIVMEYA   80 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-~~~iv~e~~   80 (338)
                      .|.-...||+|+||.||++.-. ++..||||++...... ...+.+|+.++.+++|||+|+++|+|.+.+ ..++|+||+
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym  154 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYM  154 (361)
T ss_pred             CCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEcc
Confidence            4555678999999999999986 4489999988765543 566999999999999999999999999988 599999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcC---ceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CC
Q 019628           81 AGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ---ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS  154 (338)
Q Consensus        81 ~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~---iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~  154 (338)
                      ++|+|.+.+....  ++++....+|+.++++||.|||...   ||||||||+|||+|.+.  ..||+|||+|+.... ..
T Consensus       155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~--~aKlsDFGLa~~~~~~~~  232 (361)
T KOG1187|consen  155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF--NAKLSDFGLAKLGPEGDT  232 (361)
T ss_pred             CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC--CEEccCccCcccCCcccc
Confidence            9999999998655  8999999999999999999999853   99999999999998766  789999999975543 32


Q ss_pred             CCCCc-cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCC--ChHHHHHHHh-hHhhccc---cCCCc-
Q 019628          155 QPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--DPKNFRKTIG-RILSVHY---SFPDY-  226 (338)
Q Consensus       155 ~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~--~~~~~~~~~~-~~~~~~~---~~~~~-  226 (338)
                      ..... .||.+|+|||.+..+..+.+ +||||+|+++.||+||+.|.....  ....+..... .+.....   .-|.. 
T Consensus       233 ~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~  311 (361)
T KOG1187|consen  233 SVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK  311 (361)
T ss_pred             ceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence            22233 89999999999988776555 999999999999999998887532  1111222111 1111111   01111 


Q ss_pred             -ccCC-----HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          227 -VRVS-----LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       227 -~~~~-----~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                       ...+     ..+..+..+|++.+|.+||++.|++.
T Consensus       312 ~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  312 EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence             1222     22567889999999999999999754

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=298.98  Aligned_cols=240  Identities=27%  Similarity=0.364  Sum_probs=195.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ++||.|+||.||++.+.. ++.||+|.+.....  ....+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999987 99999998876432  345788999999999999999999999999999999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC---CCccc
Q 019628           86 FERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVG  161 (338)
Q Consensus        86 ~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~---~~~~g  161 (338)
                      .+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++.........   ....+
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcceeccccCcc
Confidence            999965 34689999999999999999999999999999999999997554  8999999998754321111   12234


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHh
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI  240 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (338)
                      +..|+|||.+.+..++.. +|+|||||++|+|++ |..||...........    +.. ....+.....+..+.+++.+|
T Consensus       158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRER----IES-GYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHH----Hhc-CCCCCCCccCCHHHHHHHHHH
Confidence            567999999887776545 899999999999999 8999977654322221    111 122222336788999999999


Q ss_pred             cccCCCcCCChhHHhc
Q 019628          241 FVANSEKRITIPEIKN  256 (338)
Q Consensus       241 L~~dp~~R~s~~ell~  256 (338)
                      |..+|.+|||+.|+++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-41  Score=298.23  Aligned_cols=240  Identities=23%  Similarity=0.348  Sum_probs=193.7

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      +.||+|+||.||++... ++..+|+|.+....  .....+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46999999999999865 68899999886542  2234678899999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CCCcccc
Q 019628           86 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKSTVGT  162 (338)
Q Consensus        86 ~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~~~~gt  162 (338)
                      ..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+.  .++|+|||++........  .....++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC--eEEECCCccceeccccccccCCCCCCc
Confidence            9988653 4579999999999999999999999999999999999997554  799999999874332211  1122345


Q ss_pred             CcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      ..|+|||++.+..++.+ +||||||+++|+|++ |..||..........    .+... ........++..+.+++.+||
T Consensus       158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVEKG-YRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHHcC-CCCCCCCCCCHHHHHHHHHHc
Confidence            67999999987776555 899999999999998 999998654432221    22211 111222357899999999999


Q ss_pred             ccCCCcCCChhHHhc
Q 019628          242 VANSEKRITIPEIKN  256 (338)
Q Consensus       242 ~~dp~~R~s~~ell~  256 (338)
                      ..+|++|||+.++++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=303.29  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=199.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc----EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+|++.+.||+|+||.||++....+|.    .+|+|.+.....  ....+.+|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            579999999999999999999876654    589998765432  23567899999999999999999999887 78999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +|||+++|+|.+.+... ..+++..+..++.||+.||.|||++|++||||||+||+++.+.  .+||+|||+++......
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC--eEEECCCcccccccCcc
Confidence            99999999999999764 4689999999999999999999999999999999999997554  79999999997544322


Q ss_pred             CCC---CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 QPK---STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      ...   ...++..|+|||.+....++.+ +|+||+||++|++++ |..||........ ...   +... ..++.....+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~---~~~~-~~~~~~~~~~  237 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEI-PDL---LEKG-ERLPQPPICT  237 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHH---HhCC-CCCCCCCCCC
Confidence            211   1223567999999877776555 899999999999998 9999987543322 222   2221 1223323577


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .++.+++.+||..+|++|||+.++++
T Consensus       238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         238 IDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            88999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-42  Score=309.10  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=200.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----C---CCcceeEEEEEc----
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-----H---PNIVRFKEVLLT----   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-----h---~~Iv~~~~~~~~----   69 (338)
                      .||.+.++||+|.|++||+|.+..+.++||+|+.+..+.+.+....||++|++++     |   .+||++++.|..    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            4899999999999999999999999999999999988888888999999999983     3   369999999975    


Q ss_pred             CCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCC-----------
Q 019628           70 PTHLAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGST-----------  135 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~-----------  135 (338)
                      ..++|+|+|++ |.+|..+|..  .+.++...++.|++||+.||.|||.. ||||.||||+|||+-.+.           
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~  236 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAG  236 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhc
Confidence            35899999999 7899999974  45799999999999999999999975 999999999999972000           


Q ss_pred             --------------------------------------------------------------------------------
Q 019628          136 --------------------------------------------------------------------------------  135 (338)
Q Consensus       136 --------------------------------------------------------------------------------  135 (338)
                                                                                                      
T Consensus       237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v  316 (590)
T KOG1290|consen  237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV  316 (590)
T ss_pred             cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence                                                                                            


Q ss_pred             -------------------------------------------------------------------------CCcEEEe
Q 019628          136 -------------------------------------------------------------------------APRVKIC  142 (338)
Q Consensus       136 -------------------------------------------------------------------------~~~ikL~  142 (338)
                                                                                               .-++||+
T Consensus       317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa  396 (590)
T KOG1290|consen  317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA  396 (590)
T ss_pred             hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence                                                                                     0024555


Q ss_pred             ecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC------hHHHHHHHhhH
Q 019628          143 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED------PKNFRKTIGRI  216 (338)
Q Consensus       143 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~------~~~~~~~~~~~  216 (338)
                      |||-|...  ....+..+.|..|+|||++.+..|.+. +||||++|+++||+||...|.....      .+-+..++.-+
T Consensus       397 DlGNACW~--~khFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL  473 (590)
T KOG1290|consen  397 DLGNACWV--HKHFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL  473 (590)
T ss_pred             eccchhhh--hhhhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence            55555432  222344567889999999999999877 8999999999999999999965432      12222222111


Q ss_pred             h--------hcc------------------------------ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCc
Q 019628          217 L--------SVH------------------------------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHP  258 (338)
Q Consensus       217 ~--------~~~------------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp  258 (338)
                      .        .+.                              |.|+.  .-..++.+||.-||+++|++||||.++|+||
T Consensus       474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~--e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP  551 (590)
T KOG1290|consen  474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSE--EDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP  551 (590)
T ss_pred             hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCH--HHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence            0        111                              11111  1234577999999999999999999999999


Q ss_pred             ccccC
Q 019628          259 WFLRN  263 (338)
Q Consensus       259 ~~~~~  263 (338)
                      |+...
T Consensus       552 wLn~~  556 (590)
T KOG1290|consen  552 WLNPV  556 (590)
T ss_pred             cccCC
Confidence            99744

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-44  Score=299.42  Aligned_cols=259  Identities=25%  Similarity=0.375  Sum_probs=206.7

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeec---CccccHHHHHHHHHHhcCCCCCcceeEEEEEcC--------C
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--------T   71 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--------~   71 (338)
                      .|+-+.+||+|.||.|++|+.+.+|+.||+|++-.   ..-......+|+.+|..|+|+|++.++++|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            47778899999999999999999999999997654   223345678999999999999999998877542        3


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc
Q 019628           72 HLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS  150 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~  150 (338)
                      .+|+||.+|+. +|..++... .+++..+++.++.+++.||.|+|.+.|+|||+||+|+||+.+  |.+||+|||+++..
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d--gilklADFGlar~f  174 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD--GILKLADFGLARAF  174 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC--ceEEeeccccccce
Confidence            58999999965 899988765 579999999999999999999999999999999999999644  48999999999744


Q ss_pred             ccCC-----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc--ccC
Q 019628          151 VLHS-----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSF  223 (338)
Q Consensus       151 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~  223 (338)
                      ....     ..+..+.|.+|++||.+.+...++++.|||.-|||+.+|.||.+.+.+.+...++. .+..++...  -.+
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~-~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH-LISQLCGSITKEVW  253 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH-HHHHHhccCCcccC
Confidence            3322     12345679999999999998777787999999999999999999998766543332 222222110  011


Q ss_pred             CCcc----------------------------cCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          224 PDYV----------------------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       224 ~~~~----------------------------~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      |...                            .-.+++.+|+.+||..||.+|++++++++|.||...+.
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            1100                            01347889999999999999999999999999976543

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-43  Score=327.94  Aligned_cols=288  Identities=28%  Similarity=0.363  Sum_probs=216.8

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------eEEE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------HLAI   75 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~~~i   75 (338)
                      |...+.||+|+||.||+++++.+|+.||||.+++.  ....+..-+|+++|++++|||||+++++=.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            55678899999999999999999999999998763  234466789999999999999999998754433      4589


Q ss_pred             EEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC--cEEEeecCCCccc
Q 019628           76 VMEYAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP--RVKICDFGYSKSS  150 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~--~ikL~Dfg~a~~~  150 (338)
                      |||||+||+|...+.+   ...|++.+++.++..++.||.|||.+||+||||||.||++-.+..|  ..||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            9999999999999974   3469999999999999999999999999999999999999544433  4699999999988


Q ss_pred             ccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHh-------------
Q 019628          151 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIL-------------  217 (338)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------------  217 (338)
                      ..+....+..||+.|.+||++....+++..+|.||+||++|+++||..||.....+.....++-.+.             
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~  254 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE  254 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence            8888889999999999999998644445559999999999999999999987766643222221111             


Q ss_pred             --hc----cccCCCcccCCHH----HHHHHHHhcccCCCcCCC--h-------hHHhc----CcccccCCCcccccCCCc
Q 019628          218 --SV----HYSFPDYVRVSLE----CKHLLSRIFVANSEKRIT--I-------PEIKN----HPWFLRNLPIELTEGGSW  274 (338)
Q Consensus       218 --~~----~~~~~~~~~~~~~----~~~li~~~L~~dp~~R~s--~-------~ell~----hp~~~~~~~~~~~~~~~~  274 (338)
                        ++    ...+|.....++.    +-..+..+|..+|.+|-.  .       ++||+    |=|...         ...
T Consensus       255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhiFs~~---------~~~  325 (732)
T KOG4250|consen  255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHIFSMV---------QAT  325 (732)
T ss_pred             ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEEEeec---------cce
Confidence              11    1123333344444    345778889999999983  2       33333    222211         111


Q ss_pred             ccCCCCCCCCCHHHHHHHhHhhCCCC
Q 019628          275 QSHDVNNPSQSLEEVLSLIHEATKPL  300 (338)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (338)
                      .....-.+..++......|...+.-.
T Consensus       326 ~~~~~~~~~ntl~~~~~~I~~~Tgip  351 (732)
T KOG4250|consen  326 SHEYYVHADNTLHSLIERISKQTGIP  351 (732)
T ss_pred             EEEEecChhhhHHHHHHHHHHhhCCC
Confidence            11123345566777777787776443

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=321.09  Aligned_cols=246  Identities=28%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCc---E-EEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRE---L-LAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~---~-vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      -.+.++||+|+||.||++..+..+.   . ||+|..+.+    ......+.+|.++|++++|||||++||+......+++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3566899999999999998865422   3 899988742    2334578899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      |||+|+||+|.+++++++. ++..+...++.+.+.||+|||++++|||||-..|+|++.+.  .+||+|||+++......
T Consensus       239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~--~vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG--VVKISDFGLSRAGSQYV  316 (474)
T ss_pred             EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC--eEEeCccccccCCccee
Confidence            9999999999999998874 99999999999999999999999999999999999997554  68999999998554222


Q ss_pred             CCC-CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          155 QPK-STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       155 ~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ... ...-...|+|||.+....|+.+ +||||+||++||+++ |..||.+....    ...+.+....+..+.....+.+
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~~~p~~  391 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPSKTPKE  391 (474)
T ss_pred             eccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCCCCHHH
Confidence            222 2235578999999999887666 999999999999998 88999987654    3334454555555555578899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +..++.+|+..+|+.|||+.++.+
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999988865

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.3e-41  Score=306.84  Aligned_cols=247  Identities=21%  Similarity=0.364  Sum_probs=197.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc----EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++.+.||+|+||.||++.+..++.    .+|+|.+.....  ....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            578999999999999999999877775    468888765322  223577899999999999999999998764 4679


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||+++......
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~--~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDE  163 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC--ceEEccccccccccCcc
Confidence            999999999999987644 589999999999999999999999999999999999997554  79999999997543222


Q ss_pred             C---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 Q---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||..... ......+    .....++.....+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~~  237 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKGERLPQPPICT  237 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCCCCCCCCCCCC
Confidence            2   122345778999999987776555 899999999999997 9999976432 2222222    2222333334578


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .++.+++.+|+..+|++|||+.++++.
T Consensus       238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         238 IDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.6e-41  Score=302.09  Aligned_cols=243  Identities=23%  Similarity=0.356  Sum_probs=194.2

Q ss_pred             eeeccCCceEEEEEEEcCCC------cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            8 KDIGSGNFGVAKLVRDKWTR------ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +.||+|+||.||++......      ..+|+|.+.+..  .....+.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999986443      689999886543  2345788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC---CCcEEEeecCCCcc
Q 019628           80 AAGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST---APRVKICDFGYSKS  149 (338)
Q Consensus        80 ~~~~~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~---~~~ikL~Dfg~a~~  149 (338)
                      +++++|.+++...       ..+++..+..++.|++.||.|||+++++|+||||+||+++.+.   ...++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999999642       2378899999999999999999999999999999999997543   12699999999874


Q ss_pred             cccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCC
Q 019628          150 SVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPD  225 (338)
Q Consensus       150 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (338)
                      .....   ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||..........    .+.. ...+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~-~~~~~~  234 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----HVTA-GGRLQK  234 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHH----HHhc-CCccCC
Confidence            43221   1123345778999999988777544 899999999999998 999998655433221    1111 112222


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ...++..+.+||.+||..+|.+|||+.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2367899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-44  Score=299.56  Aligned_cols=251  Identities=27%  Similarity=0.423  Sum_probs=205.3

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHh-cCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHR-SLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      =+..||.|+||+|+++.++.+|+..|||.++...  +..+++..|..... .-+.||||++|+....++..|+-||+|. 
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence            3567999999999999999999999999998643  45567888886554 4479999999999999999999999994 


Q ss_pred             CChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           83 GELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        83 ~~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      .+|..+.+     +...++|+.+..|....+.||+||... .|||||+||+|||++..+  .+||||||.+.....+-..
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G--~vKLCDFGIcGqLv~SiAk  224 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG--DVKLCDFGICGQLVDSIAK  224 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC--CEeeecccchHhHHHHHHh
Confidence            46654432     345799999999999999999999865 999999999999997655  7999999999877666666


Q ss_pred             CCccccCcccccccccC--CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-c--CC-CcccCC
Q 019628          157 KSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-S--FP-DYVRVS  230 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~--~~-~~~~~~  230 (338)
                      +...|...|||||.+..  .+|+-. ||+||||++|||+.||..||....+  .+ ..+..+..+.+ .  ++ ....++
T Consensus       225 T~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s--vf-eql~~Vv~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  225 TVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS--VF-EQLCQVVIGDPPILLFDKECVHYS  300 (361)
T ss_pred             hhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH--HH-HHHHHHHcCCCCeecCcccccccC
Confidence            77789999999999854  346666 8999999999999999999987654  33 33333333332 2  12 224589


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..++.+|.-||.+|-+.||+..+++.+||++..
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            999999999999999999999999999999643

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.8e-41  Score=297.70  Aligned_cols=246  Identities=22%  Similarity=0.282  Sum_probs=186.9

Q ss_pred             eeeccCCceEEEEEEEcCC--CcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            8 KDIGSGNFGVAKLVRDKWT--RELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      ++||+|+||.||++.....  ...+++|.+....  ...+.+.+|+..++.++||||+++++.+.....+|+||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433  2356677665432  23457889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---CCC
Q 019628           84 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---SQP  156 (338)
Q Consensus        84 ~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---~~~  156 (338)
                      +|.+++...    ..+++..++.++.||+.||+|||+++++||||||+|||++.+.  .++|+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL--TVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc--cEEecccccccccCcchhhhcc
Confidence            999999753    2367778899999999999999999999999999999996554  7999999988643221   122


Q ss_pred             CCccccCcccccccccCCc------cCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          157 KSTVGTPAYIAPEVLTKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                      ....++..|+|||++....      ..+.++|||||||++|+|++ |..||........+...........+.......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3456889999999985321      11345899999999999997 5778876655444443332211111111112247


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++.+.+++..|+ .+|++|||+.++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            888999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.4e-41  Score=296.73  Aligned_cols=242  Identities=24%  Similarity=0.307  Sum_probs=188.0

Q ss_pred             eeeccCCceEEEEEEEcC---CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEE-cCCeEEEEEeccC
Q 019628            8 KDIGSGNFGVAKLVRDKW---TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLL-TPTHLAIVMEYAA   81 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~~iv~e~~~   81 (338)
                      +.||+|+||.||++....   .+..+|||.+....  .....+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998653   34679999885432  23356778999999999999999999775 4556899999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-----CC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-----SQ  155 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-----~~  155 (338)
                      +++|.+++... ..+++..+..++.|++.||.|||+++++||||||+|||++.+.  .+||+|||+++.....     ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF--TVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCccccccccCCcceeecc
Confidence            99999999754 3467888899999999999999999999999999999997654  7999999998743221     11


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....++..|+|||.+.+..++.+ +|||||||++|+|++ |.+||.........    ..+.... ..+.....+..+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~  232 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDIT----VYLLQGR-RLLQPEYCPDPLY  232 (262)
T ss_pred             cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHhcCC-CCCCCCcCCHHHH
Confidence            123346778999999987777555 899999999999999 56677654332221    1222211 1122225688999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +++.+||..+|++||++.+++..
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.2e-42  Score=328.94  Aligned_cols=245  Identities=27%  Similarity=0.393  Sum_probs=208.0

Q ss_pred             CceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +-+..+.||+|+||+||++.-.     .....||||.++....  ..+.|+||++++..++|||||+++|+|..++.+|+
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3467889999999999999864     2446899999987543  35689999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEE
Q 019628           76 VMEYAAGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKI  141 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~--------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL  141 (338)
                      |+|||..|||.++|....              +|+..+...|+.||+.|+.||-++.+|||||-..|+||.++.  .|||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l--~VKI  644 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL--VVKI  644 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce--EEEe
Confidence            999999999999997432              278889999999999999999999999999999999997666  8999


Q ss_pred             eecCCCcccccCCCCC---CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHh
Q 019628          142 CDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRIL  217 (338)
Q Consensus       142 ~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  217 (338)
                      +|||+++.....+..+   ...-...|||||.+..+.++++ |||||+||+|||+++ |..||.+..+.    +.++.+.
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~----EVIe~i~  719 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQ----EVIECIR  719 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchH----HHHHHHH
Confidence            9999998544333222   3345678999999999999887 899999999999998 99999987764    3444555


Q ss_pred             hccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHh
Q 019628          218 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK  255 (338)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell  255 (338)
                      .+.. ++.....|.++.+|+..|++..|.+|||+.||=
T Consensus       720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            5554 454458999999999999999999999999973

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=323.23  Aligned_cols=255  Identities=27%  Similarity=0.453  Sum_probs=220.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEc-----CCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLT-----PTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~-----~~~~~i   75 (338)
                      +.|+|.+.||.|.+|.||+++++.+++..|+|+........+.++.|.++++.. .|||++.+|++|..     ++.+|+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            468999999999999999999999999999999998888889999999999888 59999999999864     468999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-
Q 019628           76 VMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-  152 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-  152 (338)
                      |||||.||+..++++.-  ..+.|..+..|++.++.|+.+||.+.++|||||-.|||+..++  .+||+|||++..... 
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~--~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDST  176 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC--cEEEeeeeeeeeeecc
Confidence            99999999999999753  4689999999999999999999999999999999999996544  899999999875543 


Q ss_pred             CCCCCCccccCcccccccccCC-----ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcc
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV  227 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (338)
                      -....+.+|||+|||||++...     .|+.. +|+||||++..||.-|.+|+-++...   ..++....+.++.+..+.
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRNPPPKLKRPK  252 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchh---hhhccCCCCCCccccchh
Confidence            3345678899999999999653     34444 89999999999999999999876653   333444444555555566


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..+.++.+||..||..|-.+||+..++|.|||+++
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            78999999999999999999999999999999973

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.7e-41  Score=298.77  Aligned_cols=246  Identities=21%  Similarity=0.361  Sum_probs=193.9

Q ss_pred             ceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------
Q 019628            4 YEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------   71 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------   71 (338)
                      |++.+.||+|+||.||+|...   .+++.+|||++....   ...+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            788999999999999999864   357899999987532   22356788999999999999999999886542      


Q ss_pred             eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecC
Q 019628           72 HLAIVMEYAAGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG  145 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg  145 (338)
                      ..+++++|+.+|+|..++...      ..++...++.++.|++.||+|||++||+||||||+||+++.+.  .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC--CEEECccc
Confidence            247889999999998887432      1478999999999999999999999999999999999996544  79999999


Q ss_pred             CCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccc
Q 019628          146 YSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHY  221 (338)
Q Consensus       146 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (338)
                      +++......   ......+++.|++||.+.+..++.+ +|||||||++|+|++ |++||........+..    +.... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~-  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY----LIKGN-  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH----HHcCC-
Confidence            988543222   1223345678999999987776555 899999999999999 8999986554322222    11111 


Q ss_pred             cCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          222 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ..+.....+..+.+++.+||..+|++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            111223577899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.9e-40  Score=313.23  Aligned_cols=259  Identities=19%  Similarity=0.241  Sum_probs=189.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEc----------------CCCcEEEEEEeecCccc---------------cHHHHHHHH
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK----------------WTRELLAVKFIERGQKI---------------DEHVQREIM   50 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~---------------~~~~~~E~~   50 (338)
                      ++|++.++||+|+||+||++...                ..++.||||.+......               .+....|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            68999999999999999998642                24567999998653211               122334666


Q ss_pred             HHhcCCCCC-----cceeEEEEEc--------CCeEEEEEeccCCCChHHHHHhcC------------------------
Q 019628           51 NHRSLKHPN-----IVRFKEVLLT--------PTHLAIVMEYAAGGELFERICNAG------------------------   93 (338)
Q Consensus        51 ~l~~l~h~~-----Iv~~~~~~~~--------~~~~~iv~e~~~~~~L~~~i~~~~------------------------   93 (338)
                      ++.+++|.+     +++++++|..        .+..++||||+++++|.+++....                        
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            777776654     4667776653        356899999999999999886321                        


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC--ccccCcccccccc
Q 019628           94 RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVL  171 (338)
Q Consensus        94 ~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~~  171 (338)
                      .+++..++.++.|++.||.|||+++|+||||||+|||++.+.  .+||+|||++...........  ..+|+.|+|||.+
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG--QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC--cEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            235677899999999999999999999999999999997654  799999999875433222222  3358899999998


Q ss_pred             cCCcc--------------------C-CCcchHHHHHHHHHHHHcCCC-CCCCCCChHHH-------HHHHhhHhhcccc
Q 019628          172 TKKEY--------------------D-GKIADVWSCGVTLYVMLVGAY-PFEDPEDPKNF-------RKTIGRILSVHYS  222 (338)
Q Consensus       172 ~~~~~--------------------~-~~~~DiwSlG~il~~lltg~~-pf~~~~~~~~~-------~~~~~~~~~~~~~  222 (338)
                      .....                    . ....||||+||++|+|++|.. ||.........       ...........+.
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            64321                    1 112699999999999999875 77542211110       1111223334556


Q ss_pred             CCCcccCCHHHHHHHHHhcccCC---CcCCChhHHhcCccccc
Q 019628          223 FPDYVRVSLECKHLLSRIFVANS---EKRITIPEIKNHPWFLR  262 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp---~~R~s~~ell~hp~~~~  262 (338)
                      ++.+...++.+++|+.+||..+|   .+|+|+.|+|+||||.+
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            66666789999999999999876   68999999999999963

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-43  Score=295.40  Aligned_cols=253  Identities=26%  Similarity=0.402  Sum_probs=206.9

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-----eEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-----HLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~~iv~e   78 (338)
                      -+.||-|+||+||.+.+..+|+.||+|++..-.   ...+++.+|+.+|...+|.|++..+++....+     .+|++.|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            468999999999999999999999999987632   33478899999999999999999999876553     4789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC--CCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--SQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~--~~~  156 (338)
                      ++.. +|.+.|..-+.++.+.++-+++||++||+|||+.||.||||||.|+|++++.  .+||||||+++.....  ..+
T Consensus       138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC--vLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC--ILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc--eEEecccccccccchhhhhhh
Confidence            9964 8999999888999999999999999999999999999999999999996655  8999999999854433  234


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------------------hHh
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG-------------------RIL  217 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~-------------------~~~  217 (338)
                      +..+.|..|+|||++.+...++.+.||||+|||+.||+..+..|...+...++..+..                   .+.
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L  294 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL  294 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence            5678899999999999877667779999999999999999999987665544433221                   111


Q ss_pred             hccccCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          218 SVHYSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       218 ~~~~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .....-|+         ......+..+++.++|.+||++|++..+++.|+|.-+
T Consensus       295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            12222222         1123346789999999999999999999999999743

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=326.68  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=204.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCC-----cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTR-----ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .-++...||+|+||.||.+......     ..||||.+++..  .....+.+|..+|+.++|||||++++++.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            3467889999999999999876432     248999998753  344678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           76 VMEYAAGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      ++|||+||+|..+|++.       ..++......++.||++|++||+++++|||||-..|+|++..  ..+||+|||+|+
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~--r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER--RVVKIADFGLAR  850 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc--CcEEEcccchhH
Confidence            99999999999999865       248999999999999999999999999999999999999766  489999999999


Q ss_pred             ccccCCCCC---CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCC
Q 019628          149 SSVLHSQPK---STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFP  224 (338)
Q Consensus       149 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  224 (338)
                      .........   ...-...|||||.+..+.++++ +|||||||++||++| |..||....+.+.+..   ....+  +++
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~---~~~gg--RL~  924 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD---VLEGG--RLD  924 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHH---HHhCC--ccC
Confidence            433222211   1122357999999998888777 899999999999998 9999998765443322   22334  444


Q ss_pred             CcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....+++.+.+++..||+.+|++||+...|++
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            44479999999999999999999999999987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.5e-39  Score=279.90  Aligned_cols=241  Identities=43%  Similarity=0.674  Sum_probs=203.9

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019628           14 NFGVAKLVRDKWTRELLAVKFIERGQKI--DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN   91 (338)
Q Consensus        14 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~   91 (338)
                      +||.||++....+++.+|+|++......  .+.+.+|+..+++++|+||+++++++......++++|++++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            5899999999988999999998765433  47889999999999999999999999999999999999999999999987


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcccccccc
Q 019628           92 AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL  171 (338)
Q Consensus        92 ~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~  171 (338)
                      ...++...+..++.+++.++.+||+.+++|+||+|.||+++.+  +.++|+|||.+.............++..|++||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED--GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC--CcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            7668999999999999999999999999999999999999765  48999999998866554455667789999999999


Q ss_pred             cCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCccc-CCHHHHHHHHHhcccCCCcCCC
Q 019628          172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLECKHLLSRIFVANSEKRIT  250 (338)
Q Consensus       172 ~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s  250 (338)
                      .+..++. ++|+||+|+++|+|++|..||...........   .+............ ++.++.+++.+||..+|++||+
T Consensus       159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFK---KIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            8777765 48999999999999999999987443333222   22222222222112 7889999999999999999999


Q ss_pred             hhHHhcCccc
Q 019628          251 IPEIKNHPWF  260 (338)
Q Consensus       251 ~~ell~hp~~  260 (338)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=292.94  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=202.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +..++++||+|.||.|.+|.-. .+..||+|.++...  .....+.+|+++|.+|+|||||+++++|..++.+++|+||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            4578999999999999999875 35899999987643  22367999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC-
Q 019628           81 AGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-  157 (338)
Q Consensus        81 ~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~-  157 (338)
                      ++|+|.+++..+..  +.......|+.||+.|++||.+.++|||||.|.|+|++.+.  ++||+|||+++......... 
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~--~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF--TIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc--cEEecCcccccccccCCceee
Confidence            99999999987632  24455667999999999999999999999999999997655  89999999999654443322 


Q ss_pred             --CccccCcccccccccCCccCCCcchHHHHHHHHHHHH--cCCCCCCCCCChHHHHHHHhhHhhc--cccCCCcccCCH
Q 019628          158 --STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML--VGAYPFEDPEDPKNFRKTIGRILSV--HYSFPDYVRVSL  231 (338)
Q Consensus       158 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll--tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  231 (338)
                        ..+-...|||||.+..+++++. ||+|++|+++||++  +...||...++.......-.-....  ..-++...-++.
T Consensus       696 qgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence              2345678999999999999776 89999999999975  5889998877654443332211111  111222335788


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhc
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .+.+++.+|+..+..+|||.+++-.
T Consensus       775 ~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCHHHHHH
Confidence            8999999999999999999999854

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=306.37  Aligned_cols=242  Identities=30%  Similarity=0.408  Sum_probs=190.4

Q ss_pred             eeeeccCCce-EEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccCCCC
Q 019628            7 VKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         7 ~~~LG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      .+.+|.|+-| .||++..  .|+.||||.+-..  ....++||+..|+.- .|||||++|+.=.+.+..||..|+|. .+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS  588 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence            3568999998 5688887  5889999977543  335678999999888 69999999998888899999999994 69


Q ss_pred             hHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC---CCCCcEEEeecCCCcccccCCC--
Q 019628           85 LFERICNAG-R---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG---STAPRVKICDFGYSKSSVLHSQ--  155 (338)
Q Consensus        85 L~~~i~~~~-~---l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~---~~~~~ikL~Dfg~a~~~~~~~~--  155 (338)
                      |.+++.... .   ......+.++.|++.||.+||+.+||||||||.||||+.   .+..+++|+|||+++.......  
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence            999998631 1   122456889999999999999999999999999999965   3444789999999987654432  


Q ss_pred             --CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcC-CCCCCCCCChHHHHHHHhhHhhccccCCCccc-CCH
Q 019628          156 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSL  231 (338)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  231 (338)
                        ..+..||-+|+|||++...... +++||+||||++|+.++| .+||...-.      .-..|....+..-.... ...
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~------R~~NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLE------RQANILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             hcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHH------hhhhhhcCccceeeeccCchH
Confidence              3456799999999999887654 458999999999999885 999986322      11233444443221111 112


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      ++.+||.+||.++|..||||.++|.||+|
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlF  770 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLNHPLF  770 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence            89999999999999999999999999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-37  Score=319.99  Aligned_cols=242  Identities=19%  Similarity=0.214  Sum_probs=185.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      .|...+.||+|+||.||+|....++..||+|++.....   ....|+..+++++|||||++++++...+..|+||||+++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            35566789999999999999998999999998865432   223568889999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh---hcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH---~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      |+|.+++.   .+++..+..++.|++.||+|||   +.+|+||||||+||+++...  ..++. ||.+....   .....
T Consensus       768 g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~--~~~~~-~~~~~~~~---~~~~~  838 (968)
T PLN00113        768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLR-LSLPGLLC---TDTKC  838 (968)
T ss_pred             CcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC--ceEEE-eccccccc---cCCCc
Confidence            99999995   3789999999999999999999   67999999999999997665  34443 55543221   12234


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh-HHHHHHHhhHhh-c------cccCCC----cc
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILS-V------HYSFPD----YV  227 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~-~------~~~~~~----~~  227 (338)
                      .||+.|+|||++.+..++.+ +||||+||++|||+||+.||...... ............ .      ......    ..
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            78899999999988777655 89999999999999999999543211 111111110000 0      000000    00


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ....++.+++.+|++.+|++|||+.|+++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            122357789999999999999999999874

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=287.77  Aligned_cols=242  Identities=26%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             eEeeeeccCCceEEEEEEEcCC--C--cEEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWT--R--ELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~--~--~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .+.++||.|.||.||.+....-  |  --||||..+..  ....+.+..|..+|++++||||++++|++.. ...+||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            4567899999999999987532  2  35889988763  2335789999999999999999999999865 57899999


Q ss_pred             ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      +++.|.|..+++.++ .++......++.||+.||.|||+.++|||||-..|||+.+..  -+||+|||+++........+
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--eeeecccchhhhccccchhh
Confidence            999999999998655 589999999999999999999999999999999999997554  58999999999765544333


Q ss_pred             Ccc--ccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          158 STV--GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       158 ~~~--gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...  -...|||||-++-..+++. ||||-|||++||+++ |..||.+-.+.+.    +..+.++ .++|....+++.+.
T Consensus       549 aS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDV----I~~iEnG-eRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDV----IGHIENG-ERLPCPPNCPPALY  622 (974)
T ss_pred             ccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccce----EEEecCC-CCCCCCCCCChHHH
Confidence            333  3457999999988888655 999999999999876 9999998766443    2222222 23454458999999


Q ss_pred             HHHHHhcccCCCcCCChhHHh
Q 019628          235 HLLSRIFVANSEKRITIPEIK  255 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell  255 (338)
                      .|+.+|+.++|.+||...++.
T Consensus       623 slmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHH
Confidence            999999999999999987764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=287.86  Aligned_cols=198  Identities=30%  Similarity=0.482  Sum_probs=177.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcccc---------HHHHHHHHHHhcCC---CCCcceeEEEEEc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---------EHVQREIMNHRSLK---HPNIVRFKEVLLT   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~E~~~l~~l~---h~~Iv~~~~~~~~   69 (338)
                      ..|..++.||.|+||.|++|.++.++..|+||.|.+.+...         -.+-.||.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46999999999999999999999999999999998864322         23557999999997   9999999999999


Q ss_pred             CCeEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           70 PTHLAIVMEYA-AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        70 ~~~~~iv~e~~-~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      ++++|++||-- +|.+|+++|.....++|.++..|++|++.|+++||+.||||||||-+|+.++.++  -+||+|||.|.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g--~~klidfgsaa  718 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG--FVKLIDFGSAA  718 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC--eEEEeeccchh
Confidence            99999999965 4679999999988999999999999999999999999999999999999997665  89999999887


Q ss_pred             ccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCC
Q 019628          149 SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFED  202 (338)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~  202 (338)
                      .. .......++||..|.|||++.+..|-++.-|||+||+++|.+.....||..
T Consensus       719 ~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            43 344566789999999999999999999989999999999999999999863

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=296.87  Aligned_cols=258  Identities=30%  Similarity=0.420  Sum_probs=217.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|+++..+|.|+||.||+++++.+++..|+|+++... ...+.+++|+.+++.++|||||.+++.+...+.++|.||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            68999999999999999999999999999999998743 34467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~  159 (338)
                      .||+|.+.-.-.+++++.++.++++..+++|+|||+.|=+|||||-.|||+++.+  .+||+|||.+..... -...+++
T Consensus        95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g--DvklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen   95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG--DVKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC--ceeecccCchhhhhhhhhhhhcc
Confidence            9999999888888999999999999999999999999999999999999996555  899999998864332 3345788


Q ss_pred             cccCcccccccc---cCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          160 VGTPAYIAPEVL---TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       160 ~gt~~y~aPE~~---~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      +||+.|||||+-   +.+.|... +|||++|++..|+--.++|-.....-.. ..++.......+.+.+....++.+-+|
T Consensus       173 iGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~-l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRA-LFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHH-HHHhhccCCCCCcccCCccchHHHHHH
Confidence            999999999985   33556544 9999999999999988888654333221 122222222233444556788999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ++.+|..+|++|||++.+|+|||....
T Consensus       251 vK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHhcCCCccCCChhhheeceeeccc
Confidence            999999999999999999999998654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.2e-37  Score=277.05  Aligned_cols=255  Identities=27%  Similarity=0.407  Sum_probs=199.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC---CCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW---TRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +.|..+++||+|+|++||++.+..   .++.||+|.+..... ..++.+|++.|..+ .+.||+++.+++..++++.+|+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            468899999999999999999876   788999999876543 46789999999998 5889999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC----
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH----  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~----  153 (338)
                      ||++..+..++..   .++-..++.+++.++.||.++|.+|||||||||.|+|.+...+ +-.|+|||+|......    
T Consensus       115 p~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  115 PYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             cccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhhh
Confidence            9999888877775   4678999999999999999999999999999999999976554 6899999998610000    


Q ss_pred             ----------CC----------------C---------------CCccccCcccccccccCCccCCCcchHHHHHHHHHH
Q 019628          154 ----------SQ----------------P---------------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYV  192 (338)
Q Consensus       154 ----------~~----------------~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~  192 (338)
                                ..                +               ....||++|+|||++...+-.+.++||||.|+|+..
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                      00                0               112499999999999776555566999999999999


Q ss_pred             HHcCCCCCCCCCCh-HHHHHHH---------------hh---------------------H-----hhccc---cCCCc-
Q 019628          193 MLVGAYPFEDPEDP-KNFRKTI---------------GR---------------------I-----LSVHY---SFPDY-  226 (338)
Q Consensus       193 lltg~~pf~~~~~~-~~~~~~~---------------~~---------------------~-----~~~~~---~~~~~-  226 (338)
                      +++++.||-...+. .....+.               .+                     +     .+.+.   ....+ 
T Consensus       271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~  350 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS  350 (418)
T ss_pred             hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence            99999998543321 1111110               00                     0     00000   00001 


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      ...+..+.+|+.+||+.+|.+|+|++++|.||||.
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            12455789999999999999999999999999996

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=283.31  Aligned_cols=243  Identities=22%  Similarity=0.315  Sum_probs=208.9

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCC
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      .+..+||-|.||.||.+..++..-.||||.++......+.|..|..+|+.++|||+|+++++|..+.-+|||.|||..|+
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            45689999999999999999999999999998887778899999999999999999999999999999999999999999


Q ss_pred             hHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CCCcc
Q 019628           85 LFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKSTV  160 (338)
Q Consensus        85 L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~~~~  160 (338)
                      |.++++.  +..++.-.+.+++.||..|++||..+++|||||-..|+|+.++.  .+|++|||+++.+.....  .....
T Consensus       350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh--iVKvADFGLsRlMtgDTYTAHAGAK  427 (1157)
T KOG4278|consen  350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--IVKVADFGLSRLMTGDTYTAHAGAK  427 (1157)
T ss_pred             HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc--eEEeeccchhhhhcCCceecccCcc
Confidence            9999974  33477888899999999999999999999999999999996555  899999999996543322  22233


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      ..+.|.|||-+..+.++.+ +|||+|||+|||+.| |-.||.+.+-...+     .+....|.+.....+++.+..|++.
T Consensus       428 FPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSqVY-----~LLEkgyRM~~PeGCPpkVYeLMra  501 (1157)
T KOG4278|consen  428 FPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----GLLEKGYRMDGPEGCPPKVYELMRA  501 (1157)
T ss_pred             CcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHHHH-----HHHhccccccCCCCCCHHHHHHHHH
Confidence            4567999999988888777 899999999999998 88999886543322     2344456665556899999999999


Q ss_pred             hcccCCCcCCChhHHh
Q 019628          240 IFVANSEKRITIPEIK  255 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell  255 (338)
                      ||++.|..||+..|+-
T Consensus       502 CW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  502 CWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HhcCCcccCccHHHHH
Confidence            9999999999998873

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=286.83  Aligned_cols=249  Identities=25%  Similarity=0.370  Sum_probs=205.4

Q ss_pred             CceEeeeeccCCceEEEEEEEcC-CC--cEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKW-TR--ELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +.++.++||+|+||+|+++.... .|  ..||||+++....  ....|.+|+.+|.+|+|||++++|++..+ ..+.+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            45677899999999999997753 33  4689999976543  35689999999999999999999999887 6788999


Q ss_pred             eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           78 EYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |++++|+|.+.|.+  ...|....+..|+.||+.|+.||-++++|||||-..|+|+-.-.  .|||+|||+.+.....+.
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRALGENED  267 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceeccCCCCc
Confidence            99999999999986  33588899999999999999999999999999999999996433  899999999986554443


Q ss_pred             CCCc----cccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          156 PKST----VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       156 ~~~~----~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .-..    .-...|+|||.++...++.. +|+|++||++|||+| |.-||.+......+.+    +. ....++....++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----iD-~~erLpRPk~cs  341 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----ID-AGERLPRPKYCS  341 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----cc-ccccCCCCCCCh
Confidence            3222    23456999999999999766 899999999999998 8999998776544332    33 334455555899


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .++.+++.+||..+|.+|||+..|.+.-+.
T Consensus       342 edIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            999999999999999999999888654443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=248.41  Aligned_cols=198  Identities=28%  Similarity=0.429  Sum_probs=166.3

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEeec--CccccHHHHHHHHHHhc-CCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKIDEHVQREIMNHRS-LKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .-+..||+|+||.|-+.++..+|...|+|.+..  .....+++.+|+.+..+ ..+|++|.+|+.......++|.||.|.
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~  128 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD  128 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence            446789999999999999999999999999875  33445677788876544 479999999999999999999999994


Q ss_pred             CCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           82 GGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        82 ~~~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                       .+|..+-    +..+.++|..+-+|+..++.||.|||++ .+||||+||+||||+  ..|++|+||||.+.....+-..
T Consensus       129 -tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn--~~GqVKiCDFGIsG~L~dSiAk  205 (282)
T KOG0984|consen  129 -TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN--YDGQVKICDFGISGYLVDSIAK  205 (282)
T ss_pred             -hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc--cCCcEEEcccccceeehhhhHH
Confidence             4665543    4566799999999999999999999987 999999999999995  4459999999999876655555


Q ss_pred             CCccccCcccccccccC----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh
Q 019628          157 KSTVGTPAYIAPEVLTK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP  206 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~  206 (338)
                      +...|...|||||.+..    ..|+-+ |||||||++++||.+++.||.....+
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCH
Confidence            55778899999999853    456656 89999999999999999999876543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-37  Score=289.82  Aligned_cols=246  Identities=25%  Similarity=0.421  Sum_probs=208.7

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCC---cEEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTR---ELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      -+|.+.||.|.||.|++++.+..|   ..||||.++.+  ++....|..|..||-+++||||+++.++.....-+.||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            367899999999999999988666   47999999875  3444678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      ||++|+|..+|+.+ +.++..++--+++.|+.|++||.+.|+|||||-..|||++.+.  .+|++|||+++...... ..
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL--vCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce--EEEeccccceeecccCCCcc
Confidence            99999999999854 5689999999999999999999999999999999999998776  79999999998553332 12


Q ss_pred             CCcc-c--cCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          157 KSTV-G--TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       157 ~~~~-g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      .+.. |  ...|.|||.+...++++. |||||+|++|||.++ |..||-...+.+    .++. ....|.+|...+++..
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQd----VIka-Ie~gyRLPpPmDCP~a  862 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQD----VIKA-IEQGYRLPPPMDCPAA  862 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHH----HHHH-HHhccCCCCCCCCcHH
Confidence            2222 2  357999999998888655 999999999999765 999998877633    3333 3346788888899999


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +.+|+..|+++|-.+||...||+.+
T Consensus       863 L~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  863 LYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999998763

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=269.91  Aligned_cols=244  Identities=24%  Similarity=0.312  Sum_probs=184.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHH--hcCCCCCcceeEEEEEcCC----eEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH--RSLKHPNIVRFKEVLLTPT----HLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l--~~l~h~~Iv~~~~~~~~~~----~~~iv   76 (338)
                      -.++.+.||+|.||.||++...  ++.||||+++..++  +.++.|-.+.  -.++|+||+++++.-....    .+++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3456788999999999999984  79999999987655  4555555554  4568999999988755444    79999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh---------cCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------MQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~---------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ++|.+.|+|.++++.+ .++.....+++..|++||+|||+         ..|+|||||..|||+.++.  +..|+|||+|
T Consensus       287 t~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl--TccIaDFGLA  363 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL--TCCIADFGLA  363 (534)
T ss_pred             eeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC--cEEeecccee
Confidence            9999999999999876 68999999999999999999995         3699999999999996555  8999999999


Q ss_pred             cccccCC---CCCCccccCcccccccccCCcc-----CCCcchHHHHHHHHHHHHcCCC------------CCCC-CC--
Q 019628          148 KSSVLHS---QPKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAY------------PFED-PE--  204 (338)
Q Consensus       148 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~lltg~~------------pf~~-~~--  204 (338)
                      .+.....   .....+||..|||||++.+...     ..++.||||+|.++|||+++-.            ||.. -.  
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            8654332   2345789999999999976432     2345899999999999998632            3321 00  


Q ss_pred             -ChHHHHHHHhhHhhccccCCC-cc--cCCHHHHHHHHHhcccCCCcCCChhHH
Q 019628          205 -DPKNFRKTIGRILSVHYSFPD-YV--RVSLECKHLLSRIFVANSEKRITIPEI  254 (338)
Q Consensus       205 -~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~li~~~L~~dp~~R~s~~el  254 (338)
                       ..+..+..+- ..+.++.+|+ |.  .....+++.+..|+..||+.|+|+.=+
T Consensus       444 Pt~e~mq~~VV-~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  444 PTLEEMQELVV-RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCHHHHHHHHH-hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence             1112222111 1233344443 21  234558899999999999999998554

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=254.56  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=201.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeEEE-EEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEV-LLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~-~~~~~~~~iv~e~   79 (338)
                      +.|.|.+.||+|.||.+.+|.++.++..+++|.+++.......+.+|...--.|+ |.||+.-|++ |++.+.++++|||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            5799999999999999999999999999999999998888889999987665664 7899987664 6778899999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      ++.|+|...+... .+.|...+.++.|+++|+.|||++++||||||.+||||-.....++||||||+++.....  -.-.
T Consensus       104 aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~  180 (378)
T KOG1345|consen  104 APRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--VKYL  180 (378)
T ss_pred             CccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--ehhh
Confidence            9999999988664 689999999999999999999999999999999999995444448999999988743211  1112


Q ss_pred             cccCcccccccccCC---cc-CCCcchHHHHHHHHHHHHcCCCCCCCCCC-hHHHHHHHhhHhhccccCCC-cccCCHHH
Q 019628          160 VGTPAYIAPEVLTKK---EY-DGKIADVWSCGVTLYVMLVGAYPFEDPED-PKNFRKTIGRILSVHYSFPD-YVRVSLEC  233 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~---~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  233 (338)
                      --+..|.+||++...   .+ ..+.+|+|.||+++|.++||.+||..... ...+.+..+.........|. ...+++.+
T Consensus       181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a  260 (378)
T KOG1345|consen  181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKA  260 (378)
T ss_pred             hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHH
Confidence            235568999986432   21 23448999999999999999999984332 22334444444443344443 45689999


Q ss_pred             HHHHHHhcccCCCcC---CChhHHhcCccc
Q 019628          234 KHLLSRIFVANSEKR---ITIPEIKNHPWF  260 (338)
Q Consensus       234 ~~li~~~L~~dp~~R---~s~~ell~hp~~  260 (338)
                      ..+.++-|..+|++|   -+++.....-|.
T Consensus       261 ~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  261 LRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             HHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            999999999999999   455555555665

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.4e-33  Score=238.44  Aligned_cols=211  Identities=43%  Similarity=0.656  Sum_probs=183.1

Q ss_pred             eccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCChHH
Q 019628           10 IGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE   87 (338)
Q Consensus        10 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~   87 (338)
                      ||+|++|.||++....+++.+++|++.....  ....+.+|+..++.++|++|+++++++......+++||++.+++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999988899999999876544  24678999999999999999999999999999999999999899999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCccccCcc
Q 019628           88 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKSTVGTPAY  165 (338)
Q Consensus        88 ~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~~gt~~y  165 (338)
                      ++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++.. .+.++|+|||.+....... ......+...|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC-CCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            99765 478999999999999999999999999999999999999762 2389999999987543322 13345688899


Q ss_pred             cccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCC
Q 019628          166 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANS  245 (338)
Q Consensus       166 ~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp  245 (338)
                      ++||.+......+..+|+||+|+++++|                                     ..+.+++.+|+..+|
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCCc
Confidence            9999997762334448999999999998                                     457899999999999


Q ss_pred             CcCCChhHHhcCc
Q 019628          246 EKRITIPEIKNHP  258 (338)
Q Consensus       246 ~~R~s~~ell~hp  258 (338)
                      ++||++.+++.|+
T Consensus       203 ~~R~~~~~l~~~~  215 (215)
T cd00180         203 EKRPSAKEILEHL  215 (215)
T ss_pred             ccCcCHHHHhhCC
Confidence            9999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=257.42  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=188.7

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHh--cCCCCCcceeEEEEEcC----CeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR--SLKHPNIVRFKEVLLTP----THLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~--~l~h~~Iv~~~~~~~~~----~~~~iv   76 (338)
                      +-.+++.||+|-||.||++...  |+.||||++...+.  ....||.++.+  -|+|+||+.+++.-...    .++++|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            4578999999999999999985  99999999876543  55566666554  46999999998865433    369999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh--------cCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~--------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      .+|.+.|+|+++|.. ..++.+...+++..++.||.|||-        -.|.|||||..|||+..++  .+.|+|+|+|.
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~--~C~IADLGLAv  364 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAV  364 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC--cEEEeeceeeE
Confidence            999999999999987 579999999999999999999994        2599999999999996555  89999999997


Q ss_pred             ccccC-----CCCCCccccCcccccccccCCc----c-CCCcchHHHHHHHHHHHHcC----------CCCCCCCCChHH
Q 019628          149 SSVLH-----SQPKSTVGTPAYIAPEVLTKKE----Y-DGKIADVWSCGVTLYVMLVG----------AYPFEDPEDPKN  208 (338)
Q Consensus       149 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~-~~~~~DiwSlG~il~~lltg----------~~pf~~~~~~~~  208 (338)
                      .....     ...+..+||..|||||++....    + +.+.+||||+|.++||++..          ++||.+....+.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            54332     2345678999999999986432    1 23458999999999999853          688877655443


Q ss_pred             HHHHHhh-H--hhccccCCCcccCCH---HHHHHHHHhcccCCCcCCChhHHhc
Q 019628          209 FRKTIGR-I--LSVHYSFPDYVRVSL---ECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       209 ~~~~~~~-~--~~~~~~~~~~~~~~~---~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....+.. +  .+..+..|..-.-.+   .+..+++.|+..+|.-|.||-.+..
T Consensus       445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            3333322 2  233334443222223   3567899999999999999976654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=277.79  Aligned_cols=246  Identities=26%  Similarity=0.386  Sum_probs=198.3

Q ss_pred             ceEeeeeccCCceEEEEEEEc---C----CCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDK---W----TRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~---~----~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      .++.+.||+|+||.|+++.-.   .    ....||+|..+...  ...+.+..|+.+|+.+ +|+||+.+++++...+.+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            357779999999999998743   1    14579999887643  3346788999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC
Q 019628           74 AIVMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP  137 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~  137 (338)
                      ++|+||+..|+|..+++..+                .++......++.||+.|++||++.++|||||-..|||+..+.  
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~--  455 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK--  455 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC--
Confidence            99999999999999998765                388999999999999999999999999999999999997654  


Q ss_pred             cEEEeecCCCcccccCCCC--CCccc--cCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHH
Q 019628          138 RVKICDFGYSKSSVLHSQP--KSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKT  212 (338)
Q Consensus       138 ~ikL~Dfg~a~~~~~~~~~--~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~  212 (338)
                      .+||+|||+|+........  ....|  ...|||||.+....|+.+ +||||+|++|||++| |..||.+......+.+ 
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-  533 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-  533 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-
Confidence            8999999999854332222  11222  345999999999777666 899999999999998 8899987443333322 


Q ss_pred             HhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          213 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                        .+..+ ........++.++.++++.|+..+|++||+..++.+
T Consensus       534 --~l~~G-~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 --FLKEG-NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             --HHhcC-CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence              22222 233333367999999999999999999999999876

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-34  Score=269.90  Aligned_cols=243  Identities=24%  Similarity=0.368  Sum_probs=198.1

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCc----EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +..+.||.|+||+||++.....|+    +||||++....  +....+.+|+-+|.++.|||++++++++.... +-||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            456899999999999998876665    57888776533  33567899999999999999999999998765 889999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |+++|.|.++++.+ ..+.......|..||++|+.|||.+++|||||-..|||+..-.  ++|++|||+++........-
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN--HVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC--eEEEEecchhhccCcccccc
Confidence            99999999999854 4688999999999999999999999999999999999996444  89999999999765544332


Q ss_pred             Cc---cccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          158 ST---VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       158 ~~---~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ..   .-.+-|||-|.+....|..+ +||||+||++||++| |..|+.+....+     +..+.....+++.....+.++
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~geRLsqPpiCtiDV  929 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKGERLSQPPICTIDV  929 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhccccCCCCCCccHHH
Confidence            22   22456999999988888666 999999999999998 999998755422     122222223344445688999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .-++.+||-.|+..||+++++..
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999998864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-32  Score=235.64  Aligned_cols=196  Identities=45%  Similarity=0.725  Sum_probs=172.8

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.....  ..+.+.+|+..+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6789999999999999999998899999999987543  35678899999999999999999999999899999999999


Q ss_pred             CCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CCCC
Q 019628           82 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QPKS  158 (338)
Q Consensus        82 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~~~  158 (338)
                      +++|.+++..... +++..+..++.|++.++.+||+++++|+||+|.||+++.+  +.++|+|||.+.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~--~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD--GLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEeeCceeeEecCcccccccc
Confidence            9999999987766 8999999999999999999999999999999999999765  489999999987554332  3345


Q ss_pred             ccccCcccccccc-cCCccCCCcchHHHHHHHHHHHHcCCCCCCC
Q 019628          159 TVGTPAYIAPEVL-TKKEYDGKIADVWSCGVTLYVMLVGAYPFED  202 (338)
Q Consensus       159 ~~gt~~y~aPE~~-~~~~~~~~~~DiwSlG~il~~lltg~~pf~~  202 (338)
                      ..++..|++||.+ ....++. ++|+||||+++++|++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence            6788899999998 4455545 58999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=3.5e-34  Score=290.84  Aligned_cols=200  Identities=16%  Similarity=0.173  Sum_probs=148.4

Q ss_pred             cCCC-CCcceeEEEE-------EcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCC
Q 019628           54 SLKH-PNIVRFKEVL-------LTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDL  124 (338)
Q Consensus        54 ~l~h-~~Iv~~~~~~-------~~~~~~~iv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dl  124 (338)
                      .++| +||++++++|       .....++.+||++ +++|.++|.. ...+++.+++.+++||+.||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            4455 5788888877       2334678889988 6699999965 346999999999999999999999999999999


Q ss_pred             CCCcEEecC-----------------CCCCcEEEeecCCCcccccCC-----------------CCCCccccCccccccc
Q 019628          125 KLENTLLDG-----------------STAPRVKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEV  170 (338)
Q Consensus       125 kp~NIl~~~-----------------~~~~~ikL~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~  170 (338)
                      ||+|||++.                 +..+.+|++|||+++......                 ......||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999953                 223467888888876321100                 0112458999999999


Q ss_pred             ccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCC
Q 019628          171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRIT  250 (338)
Q Consensus       171 ~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s  250 (338)
                      +.+..++.+ +|||||||++|||++|.+|+.....  .........     ..+......+...+++.+||..+|.+|||
T Consensus       187 ~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        187 DNGSSSNCA-SDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-----LPPQILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             hccCCCCch-hhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-----cChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence            988887555 9999999999999999888753211  111111111     11111123456789999999999999999


Q ss_pred             hhHHhcCccccc
Q 019628          251 IPEIKNHPWFLR  262 (338)
Q Consensus       251 ~~ell~hp~~~~  262 (338)
                      +.|+++||||..
T Consensus       259 ~~eil~h~~~~~  270 (793)
T PLN00181        259 MSELLQSEFINE  270 (793)
T ss_pred             hHHHhhchhhhh
Confidence            999999999965

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=8e-31  Score=218.72  Aligned_cols=164  Identities=20%  Similarity=0.209  Sum_probs=125.9

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccc
Q 019628           83 GELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG  161 (338)
Q Consensus        83 ~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  161 (338)
                      |+|.+++..+ .++++..++.++.||+.||.|||+++      ||+|||++.+.  .+|+  ||++.....    ....|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~--~~~~--fG~~~~~~~----~~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG--LLKL--DGSVAFKTP----EQSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc--ceee--ccceEeecc----ccCCC
Confidence            6899999864 45999999999999999999999999      99999997554  7888  998875432    22368


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHHhhHhhcccc-CCCcccCCH--HHHHHH
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYS-FPDYVRVSL--ECKHLL  237 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~--~~~~li  237 (338)
                      |+.|||||++.+..++.+ +||||+||++|+|++|+.||........ +............. .+....++.  .+++++
T Consensus        67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            999999999988887655 8999999999999999999976543222 22222221111100 011112333  699999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccc
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      .+||..+|.+|||+.++++|+|+.
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHH
Confidence            999999999999999999999985

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.3e-32  Score=262.88  Aligned_cols=257  Identities=31%  Similarity=0.499  Sum_probs=201.7

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEee----cCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE----RGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~----~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      .....+|.|++|.|+.+......+.++.|...    ...   .....+..|+.+-..++|||++..+..+......+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988888887777767776543    211   11223667788888899999988777776666666669


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC----
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH----  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~----  153 (338)
                      |||++ +|+..+...+.++...+.-+++|++.||+|||+.||.|||+||+|+++..++  .+||+|||.+......    
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g--~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG--ILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC--ceEEeecCcceeeccCcchh
Confidence            99999 9999999888899999999999999999999999999999999999996555  8999999988633222    


Q ss_pred             -CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc---cCCCcccC
Q 019628          154 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY---SFPDYVRV  229 (338)
Q Consensus       154 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  229 (338)
                       ......+|+..|+|||++.+..|+....||||.|++++.|.+|+.||......++.............   ..+-+..+
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence             22345789999999999999999999999999999999999999999876554332111111000000   11123357


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +...+.+|.+||+.+|.+|+|+++|++.+||+...
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            88899999999999999999999999999997543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=1.2e-27  Score=216.36  Aligned_cols=255  Identities=35%  Similarity=0.569  Sum_probs=201.9

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCC-CcceeEEEEEcCCeEEEEEe
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHP-NIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~-~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....    ....+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999997   7889999876433    356788999999999988 79999999988888999999


Q ss_pred             ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           79 YAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      ++.++++...+....   .+++..+..++.|++.++.|+|+.+++|||+||+||+++.... .++++|||.++...... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence            999999997777664   7999999999999999999999999999999999999965432 58999999987433322 


Q ss_pred             ------CCCCccccCcccccccccCC--ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc-CC-
Q 019628          155 ------QPKSTVGTPAYIAPEVLTKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FP-  224 (338)
Q Consensus       155 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-  224 (338)
                            ......||..|+|||.+.+.  .......|+||+|++++++++|..||...............+...... .. 
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  24667899999999999873  344455899999999999999999987765410111121222222211 11 


Q ss_pred             -CcccC----CHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          225 -DYVRV----SLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       225 -~~~~~----~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                       .....    ...+.+++.+++..+|..|.+..+...++|...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence             11111    257899999999999999999999998877643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=6.4e-28  Score=220.39  Aligned_cols=252  Identities=24%  Similarity=0.206  Sum_probs=194.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCC-cEEEEEEeecCccc-cHHHHHHHHHHhcCC----CCCcceeEEEE-EcCCeEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTR-ELLAVKFIERGQKI-DEHVQREIMNHRSLK----HPNIVRFKEVL-LTPTHLAI   75 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~-~~~~~~E~~~l~~l~----h~~Iv~~~~~~-~~~~~~~i   75 (338)
                      +|++.+.||+|+||.||+|.+..++ ..+|+|+....... ...+..|+.++..+.    .+++..+++.+ ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999998764 67899987664322 226888998888886    36899999999 47788999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-C--CcEEEeecCCCc--
Q 019628           76 VMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-A--PRVKICDFGYSK--  148 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~--~~ikL~Dfg~a~--  148 (338)
                      ||+.+ |.+|.++....  +.++..++..++.|++.+|++||+.|++||||||+|+++.... .  ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99998 88999988543  4799999999999999999999999999999999999997543 1  379999999998  


Q ss_pred             ccccCC--------C-CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc
Q 019628          149 SSVLHS--------Q-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV  219 (338)
Q Consensus       149 ~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  219 (338)
                      ......        . .....||..|+++.+..+...... .|+||++.++.+++.|..||..........+........
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence            321111        1 223559999999999888777555 899999999999999999998766543333322221111


Q ss_pred             cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ... ......+..+..+...+-..+...+|....+...
T Consensus       257 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  257 LTD-RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccc-cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111 1122355778888888877899999988777553

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-29  Score=219.15  Aligned_cols=247  Identities=17%  Similarity=0.224  Sum_probs=193.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC-----cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcC-CeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR-----ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-THL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-~~~   73 (338)
                      +|+++.-.+-+|.||.||.+......     +.|-+|.++...  .....+..|-..+..+.|||+..+.++.... ...
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            46777888999999999999665322     234455554432  2235677899999999999999999987654 457


Q ss_pred             EEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecC
Q 019628           74 AIVMEYAAGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG  145 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg  145 (338)
                      .+++.++.-|+|..++..        .+.++..++-.++.|+..|++|||+.||||.||-..|++||+..  ++||+|=.
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDsa  441 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDSA  441 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccch
Confidence            788889988999999972        12377788889999999999999999999999999999998776  89999999


Q ss_pred             CCcccccCCCC---CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccc
Q 019628          146 YSKSSVLHSQP---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHY  221 (338)
Q Consensus       146 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (338)
                      +++...+.+..   ...-....||+||.+.+..|+.. +|+||||+++|||+| |+.|+..-+..+ ...    .....+
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfE-m~~----ylkdGy  515 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFE-MEH----YLKDGY  515 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHH-HHH----HHhccc
Confidence            98854433221   22334567999999999988766 899999999999998 899998755422 222    223344


Q ss_pred             cCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          222 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++....++++++..++..||...|++|||.+|+..
T Consensus       516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            55455589999999999999999999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=241.38  Aligned_cols=238  Identities=31%  Similarity=0.520  Sum_probs=201.1

Q ss_pred             eeccCCceEEEEEEE---cCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEeccC
Q 019628            9 DIGSGNFGVAKLVRD---KWTRELLAVKFIERGQK---IDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         9 ~LG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .+|+|+||.|+++..   ...+..+|+|+.++...   .......|..++..++ ||.+|+++..|..+..+++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999997764   34678899998876421   1224456667777776 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG  161 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  161 (338)
                      ||+|+..+.....+.+...+.+...++.|++++|+.+|+|||+|++||+++..+  ++++.|||+++........   ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G--hi~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG--HIKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC--ccccCCchhhhHhHhhhhc---cc
Confidence            999999998888899999999999999999999999999999999999997655  9999999999865444333   99


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |..|||||++++  . ..++|.||+|+++++|+||..||..        ....+|....+.+|.  .++..+++++..++
T Consensus       156 t~eymApEI~~g--h-~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  156 TYEYRAPEIING--H-LSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLF  222 (612)
T ss_pred             chhhhhhHhhhc--c-CCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHH
Confidence            999999999982  2 3447999999999999999999987        445566666666666  68899999999999


Q ss_pred             ccCCCcCCC-----hhHHhcCcccccCC
Q 019628          242 VANSEKRIT-----IPEIKNHPWFLRNL  264 (338)
Q Consensus       242 ~~dp~~R~s-----~~ell~hp~~~~~~  264 (338)
                      ..+|.+|.-     +.|+++|+||+...
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchheeee
Confidence            999999985     48999999997543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.2e-28  Score=223.81  Aligned_cols=160  Identities=16%  Similarity=0.131  Sum_probs=125.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcC-CCcEEEEEEeecC------ccccHHHHHHHHHHhcCCCCCcce-eEEEEEcCCe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERG------QKIDEHVQREIMNHRSLKHPNIVR-FKEVLLTPTH   72 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~-~~~~~~~~~~   72 (338)
                      +++|.+.+.||+|+||+||+|.+.. +++.+|||++...      ......+.+|+.++++++|+||+. +++.    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            4689999999999999999999876 6778899986532      112356889999999999999985 4432    45


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCC-CCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL-KLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dl-kp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      .|+||||++|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++  .+||+|||+|+...
T Consensus        93 ~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~  163 (365)
T PRK09188         93 DGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFR  163 (365)
T ss_pred             cEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceecc
Confidence            899999999999963 211   11   2568899999999999999999999 99999996543  79999999998443


Q ss_pred             cCC---------CCCCccccCcccccccccC
Q 019628          152 LHS---------QPKSTVGTPAYIAPEVLTK  173 (338)
Q Consensus       152 ~~~---------~~~~~~gt~~y~aPE~~~~  173 (338)
                      ...         ..+...+++.|+|||.+.-
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            221         1134568888999999853

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-27  Score=195.28  Aligned_cols=246  Identities=22%  Similarity=0.248  Sum_probs=192.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC-CCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-PNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .+|+++++||.|+||.+|++.+..+|..||||+-+.. .....+..|..+.+.|++ .+|..+..++....+-.+||+++
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            4799999999999999999999999999999975443 334567788888888875 67888888888888999999999


Q ss_pred             CCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccC-----
Q 019628           81 AGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH-----  153 (338)
Q Consensus        81 ~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~-----  153 (338)
                       |-+|.++.. ....++..++..++-|++.-++|+|.+++|||||||+|+|..-+. ...+-|+|||+|+.....     
T Consensus        94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence             789988875 345699999999999999999999999999999999999985332 226899999999853322     


Q ss_pred             ---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC---cc
Q 019628          154 ---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD---YV  227 (338)
Q Consensus       154 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~  227 (338)
                         ...+...||..|.+--...+...+.. .|+=|+|.++.++.-|..||.+.......++. ..|.....+.|.   ..
T Consensus       173 Ipyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-EkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-EKISEKKMSTPIEVLCK  250 (341)
T ss_pred             CccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHHHH-HHHHHhhcCCCHHHHhC
Confidence               22345679999999888777666555 79999999999999999999987765443322 233332222221   34


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCCh
Q 019628          228 RVSLECKHLLSRIFVANSEKRITI  251 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~  251 (338)
                      .+|.++.-.+.-|-..--++-|..
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcH
Confidence            678888888888877777777764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1e-26  Score=201.58  Aligned_cols=201  Identities=24%  Similarity=0.349  Sum_probs=170.8

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .|+++++||+|+||+.+.+++.-++++||||.-+. .....++..|.+..+.|. .++|...|.+.....+-.+|+|++ 
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            58999999999999999999999999999996554 344678889999888885 689999998888888889999999 


Q ss_pred             CCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC---CCCcEEEeecCCCccccc-----
Q 019628           82 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS---TAPRVKICDFGYSKSSVL-----  152 (338)
Q Consensus        82 ~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~---~~~~ikL~Dfg~a~~~~~-----  152 (338)
                      |-+|.++.. ....++...+..++.||+.-++|+|++++|.|||||+|+||..-   ....|.++|||+|+..-.     
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq  186 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ  186 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence            789988775 34479999999999999999999999999999999999999522   223689999999984322     


Q ss_pred             ---CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh
Q 019628          153 ---HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP  206 (338)
Q Consensus       153 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~  206 (338)
                         .+..++..||..||+-....+...+.. -|+=|||-++++.|-|..||.+....
T Consensus       187 HIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  187 HIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             cCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCc
Confidence               222356679999999988888777655 89999999999999999999886653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.95  E-value=1.2e-27  Score=233.71  Aligned_cols=218  Identities=33%  Similarity=0.549  Sum_probs=168.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .+|..+++|..|+||.||+++|+.+.+.+|+| +.++......      ++.....|.+|                    
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn------ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN------ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc------cccccCCccee--------------------
Confidence            47899999999999999999999999999995 5544321111      33333445544                    


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-------
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-------  154 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-------  154 (338)
                       |+-...++.-++++...        +.|++|||+.||+|||+||+|.+|..-  |++|++|||+++......       
T Consensus       136 -gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m--GhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 -GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM--GHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             -chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec--ccccccchhhhhhhhhhccchhhhc
Confidence             45566666666777655        889999999999999999999999644  499999999986322111       


Q ss_pred             ---------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC
Q 019628          155 ---------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD  225 (338)
Q Consensus       155 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (338)
                               ..+..+|||.|+|||++...+| ++.+|+|++|+|+|+.+-|..||.+.+..+.+-    ........+|+
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg----~visd~i~wpE  279 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG----QVISDDIEWPE  279 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHh----hhhhhhccccc
Confidence                     1234689999999999998888 455999999999999999999999876644443    34444445554


Q ss_pred             c-ccCCHHHHHHHHHhcccCCCcCC---ChhHHhcCccccc
Q 019628          226 Y-VRVSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLR  262 (338)
Q Consensus       226 ~-~~~~~~~~~li~~~L~~dp~~R~---s~~ell~hp~~~~  262 (338)
                      . ..++++++++|.++|+.+|..|.   .+-++.+|+||+.
T Consensus       280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            2 35789999999999999999996   6788999999953

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.5e-26  Score=201.42  Aligned_cols=191  Identities=28%  Similarity=0.401  Sum_probs=142.5

Q ss_pred             CCCCcceeEEEEEcC---------------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 019628           56 KHPNIVRFKEVLLTP---------------------------THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI  108 (338)
Q Consensus        56 ~h~~Iv~~~~~~~~~---------------------------~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~  108 (338)
                      +|||||++...|.+.                           ..+|+||..+. .+|..++..+ ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            599999999988642                           35799999884 5999999765 568888999999999


Q ss_pred             HHHHHhhhcCceecCCCCCcEEe--cCCCCCcEEEeecCCCcccccC-------CCCCCccccCcccccccccCCc----
Q 019628          109 SGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLH-------SQPKSTVGTPAYIAPEVLTKKE----  175 (338)
Q Consensus       109 ~al~~LH~~~iiH~Dlkp~NIl~--~~~~~~~ikL~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~----  175 (338)
                      +|+.|||++||.|||+|.+|||+  |++.-+.++|+|||.+-.....       ...-..-|...-||||+.....    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999999  4455568999999976422211       1112234778899999975421    


Q ss_pred             -cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChh
Q 019628          176 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIP  252 (338)
Q Consensus       176 -~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~  252 (338)
                       .+..++|.|+.|.+.||+++...||........-....  -...-+.+|+  .+++.+++++..+|+.||+||+|..
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y--qe~qLPalp~--~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY--QESQLPALPS--RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhh--hhhhCCCCcc--cCChHHHHHHHHHhcCCccccCCcc
Confidence             22334899999999999999999998743211000000  0111223344  6899999999999999999999864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=1.1e-25  Score=189.71  Aligned_cols=137  Identities=20%  Similarity=0.219  Sum_probs=110.4

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc----------c-----------------HHHHHHHHHHhcCCCCC
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----------D-----------------EHVQREIMNHRSLKHPN   59 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~-----------------~~~~~E~~~l~~l~h~~   59 (338)
                      .+.||+|+||.||+|.+. +|+.||||+++.....          .                 ....+|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999997 8999999999764211          0                 12235999999998888


Q ss_pred             cceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcCceecCCCCCcEEecCCCCCc
Q 019628           60 IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQICHRDLKLENTLLDGSTAPR  138 (338)
Q Consensus        60 Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~L-H~~~iiH~Dlkp~NIl~~~~~~~~  138 (338)
                      +.....+...  ..++||||++|+++...+....++++..+..++.|++.+|.+| |+.||+||||||+|||++.   +.
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~~  155 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---GK  155 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---Cc
Confidence            7554433222  2389999999887766554556899999999999999999999 7999999999999999973   37


Q ss_pred             EEEeecCCCcc
Q 019628          139 VKICDFGYSKS  149 (338)
Q Consensus       139 ikL~Dfg~a~~  149 (338)
                      ++|+|||+|..
T Consensus       156 v~LiDFG~a~~  166 (190)
T cd05147         156 LYIIDVSQSVE  166 (190)
T ss_pred             EEEEEcccccc
Confidence            99999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=1.4e-24  Score=183.50  Aligned_cols=139  Identities=20%  Similarity=0.178  Sum_probs=112.3

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---------------------------cHHHHHHHHHHhcCCCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---------------------------DEHVQREIMNHRSLKHP   58 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~   58 (338)
                      +.+.||+|++|.||+|.+. +|+.||||+++.....                           .....+|+..+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999998764210                           11235789999999999


Q ss_pred             CcceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCC
Q 019628           59 NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAP  137 (338)
Q Consensus        59 ~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~  137 (338)
                      +|.....+....  .|+||||++|+++.........+++..+..++.|++.++.+||+ +||+||||||+||+++   ++
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~---~~  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH---DG  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---CC
Confidence            886555544332  48999999987655443345678899999999999999999999 9999999999999997   34


Q ss_pred             cEEEeecCCCccc
Q 019628          138 RVKICDFGYSKSS  150 (338)
Q Consensus       138 ~ikL~Dfg~a~~~  150 (338)
                      .++|+|||+++..
T Consensus       155 ~~~liDFG~a~~~  167 (190)
T cd05145         155 KPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEcccceec
Confidence            7999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=3.9e-25  Score=189.04  Aligned_cols=168  Identities=14%  Similarity=0.173  Sum_probs=128.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccH----H------HHHHHHHHhcCCCCCcceeEEEEEcC-
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----H------VQREIMNHRSLKHPNIVRFKEVLLTP-   70 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~------~~~E~~~l~~l~h~~Iv~~~~~~~~~-   70 (338)
                      .+|++++.||.|+||.||++..  ++..+|||++.......+    +      +.+|+..+.++.|++|..+.+++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            4899999999999999999755  466899999865432222    2      57899999999999999999887643 


Q ss_pred             -------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEee
Q 019628           71 -------THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD  143 (338)
Q Consensus        71 -------~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~D  143 (338)
                             +..+++|||++|.+|.+..    .+++    ....+++.+|..||+.|++|||+||+||+++.+  + ++|+|
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~--g-i~liD  177 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN--G-LRIID  177 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC--C-EEEEE
Confidence                   3578999999999997763    2333    245699999999999999999999999999643  3 99999


Q ss_pred             cCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHH
Q 019628          144 FGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML  194 (338)
Q Consensus       144 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll  194 (338)
                      ||.+.........           ...+....+..+ +|+||||+++..+.
T Consensus       178 fg~~~~~~e~~a~-----------d~~vler~y~~~-~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAK-----------DRIDLERHYGIK-NEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhH-----------HHHHHHhHhccc-ccccceeEeehHHH
Confidence            9987643211110           113334456544 89999999997754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=1.7e-24  Score=190.46  Aligned_cols=230  Identities=22%  Similarity=0.245  Sum_probs=146.3

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCC----------CCcceeEEEEEc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKH----------PNIVRFKEVLLT   69 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h----------~~Iv~~~~~~~~   69 (338)
                      ++....||.|++|.||.+.+..+|+.+|+|++.....    ..+.+++|......+.+          -.++-.++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            5678899999999999999999999999999865332    22456666544444322          122222222221


Q ss_pred             ------------CC-----eEEEEEeccCCCChHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHhhhcCceecCCC
Q 019628           70 ------------PT-----HLAIVMEYAAGGELFERIC---NAGRF----SEDEARFFFQQLISGVSYCHSMQICHRDLK  125 (338)
Q Consensus        70 ------------~~-----~~~iv~e~~~~~~L~~~i~---~~~~l----~~~~~~~i~~qi~~al~~LH~~~iiH~Dlk  125 (338)
                                  ..     +.+++|+-+. ++|..++.   .....    .......+..|+++.+++||+.|++|+|||
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                        11     2367888884 58877764   22222    222334556899999999999999999999


Q ss_pred             CCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcccccccccCC-------ccCCCcchHHHHHHHHHHHHcCCC
Q 019628          126 LENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK-------EYDGKIADVWSCGVTLYVMLVGAY  198 (338)
Q Consensus       126 p~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~~lltg~~  198 (338)
                      |+|++++.++  .+.|+||+.........  .....+..|.+||.....       ...+.+.|.|+||+++|.|.||..
T Consensus       173 ~~nfll~~~G--~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDG--GVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS---EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCC--CEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999997654  89999998765332211  113455779999976442       112444799999999999999999


Q ss_pred             CCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcC
Q 019628          199 PFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKR  248 (338)
Q Consensus       199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  248 (338)
                      ||.......          .....|....++++.+++||+++|+++|.+|
T Consensus       249 Pf~~~~~~~----------~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEA----------DPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGS----------TSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccc----------cccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            998654321          1111444555789999999999999999998

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=4.5e-25  Score=216.13  Aligned_cols=237  Identities=22%  Similarity=0.376  Sum_probs=176.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccH---HHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDE---HVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~---~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      .|...+.||.+-|=+|.+|++. .| .|+||++-+..  ....   +...|++ ...+++||++.+..+-.....-|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            4678899999999999999986 34 48999986643  1122   3334444 56679999999988877778889999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      +|.. -+|++.|..+.-+..-+-+.|+.||+.||.-+|..||+|+|||.+||||.+=+  =+.|+||...+...... .+
T Consensus       101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCc
Confidence            9995 49999998887788899999999999999999999999999999999996333  58999998665332221 11


Q ss_pred             C-------CccccCcccccccccCCc---------c-CCCcchHHHHHHHHHHHHc-CCCCCCCCC-------ChHHHHH
Q 019628          157 K-------STVGTPAYIAPEVLTKKE---------Y-DGKIADVWSCGVTLYVMLV-GAYPFEDPE-------DPKNFRK  211 (338)
Q Consensus       157 ~-------~~~gt~~y~aPE~~~~~~---------~-~~~~~DiwSlG~il~~llt-g~~pf~~~~-------~~~~~~~  211 (338)
                      .       +...-.+|.|||.+....         . -.++.||||+||+++||++ |++||.-..       .....+.
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence            1       122445899999875421         1 2345899999999999988 799996310       0111111


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+..|            -+..++.+|..|++.||++|.||++.|+.
T Consensus       258 ~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            11111            12358899999999999999999999975

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.3e-23  Score=174.64  Aligned_cols=184  Identities=17%  Similarity=0.168  Sum_probs=136.4

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccH-----HHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEe
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE-----HVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      -....||+|+||+|+++..  .+..++.+.+.-..-...     .+.+|+++|++|. +++|++++++    +..|++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999997776  577788777665433222     5789999999995 4789999885    35699999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCC-CCCcEEecCCCCCcEEEeecCCCcccccCCCC-
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL-KLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dl-kp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~-  156 (338)
                      |+.|.+|...+..      . ...++.|++.+|+++|++||+|||| ||+|||++.+  +.++|+|||+|......... 
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~--g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED--GSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC--CCEEEEECCCceecCCcchHH
Confidence            9999888654321      1 2457889999999999999999999 7999999754  47999999999844322210 


Q ss_pred             ---C----------CccccCcccccccccCC-ccCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 019628          157 ---K----------STVGTPAYIAPEVLTKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDP  203 (338)
Q Consensus       157 ---~----------~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~  203 (338)
                         .          -...++.|++|+.-.-. ..+-...++++.|+-+|.++|+..|+-..
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence               0          01257778888754322 22223368899999999999999887543

>PRK10345 hypothetical protein; Provisional

Probab=99.90  E-value=3.7e-23  Score=176.15  Aligned_cols=136  Identities=18%  Similarity=0.220  Sum_probs=108.5

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcC-----CCCCcceeEEEEEcCC---eEE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSL-----KHPNIVRFKEVLLTPT---HLA   74 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l-----~h~~Iv~~~~~~~~~~---~~~   74 (338)
                      +.-.+.||+|+||.||.  +..++.. +||++.... ...+.+.+|+.+++.+     .||||+++++++.++.   .++
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34457899999999995  7666665 699887642 2346789999999999     5799999999999874   434


Q ss_pred             -EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHhhhcCceecCCCCCcEEecCC--CCCcEEEeecC
Q 019628           75 -IVMEY--AAGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQICHRDLKLENTLLDGS--TAPRVKICDFG  145 (338)
Q Consensus        75 -iv~e~--~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al-~~LH~~~iiH~Dlkp~NIl~~~~--~~~~ikL~Dfg  145 (338)
                       +||||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+++|+||||||+|||++..  +.+.++|+||+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence             78999  5579999999664 56666  36688888777 99999999999999999999643  23479999954

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=1.3e-24  Score=211.31  Aligned_cols=259  Identities=31%  Similarity=0.498  Sum_probs=209.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-CcEEEEEEeecCc---cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-RELLAVKFIERGQ---KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ..|.+.+.||+|+|+.|-++.+..+ ...+|.|.+....   ....+...|..+...++ |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4689999999999999988877543 4466777665542   33345566888888887 99999999999999999999


Q ss_pred             EeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHhh-hcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-
Q 019628           77 MEYAAGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i-~~~~-~l~~~~~~~i~~qi~~al~~LH-~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-  152 (338)
                      +++..|++++..+ .... ..+......++.|+..++.|+| ..++.||||||+|.+++.++. .++++|||+|..... 
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNK  178 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccccc
Confidence            9999999999999 5554 6788899999999999999999 999999999999999976654 799999999985443 


Q ss_pred             CC---CCCCccc-cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          153 HS---QPKSTVG-TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       153 ~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                      ..   .....+| ++.|+|||...+..+..+..|+||+|+++..+++|..||................ ........|..
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  257 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-KGRFTQLPWNS  257 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-ccccccCcccc
Confidence            21   2234678 9999999999987777777999999999999999999998765443221111111 12223445668


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ++....+++.++|..+|.+|.+.+++..+||+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8999999999999999999999999999999976

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.3e-22  Score=201.81  Aligned_cols=192  Identities=26%  Similarity=0.320  Sum_probs=155.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK---HPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +.|.|-+.||+|+||.||.|.+.. |+.||+|+-+......-  .--..++.+|+   -+.|..+..++...+.-++|+|
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf--YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e  774 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF--YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE  774 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee--eehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence            578999999999999999999986 99999998766543221  11122233343   2456666666666777889999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEec-----CCCCCcEEEeecCCCccccc-
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD-----GSTAPRVKICDFGYSKSSVL-  152 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~-----~~~~~~ikL~Dfg~a~~~~~-  152 (338)
                      |.+.|+|.+++...+.+++..+..+..||+..|++||..+|||+||||+|+||.     +....-++|+|||.+..+.. 
T Consensus       775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf  854 (974)
T KOG1166|consen  775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF  854 (974)
T ss_pred             ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence            999999999999888999999999999999999999999999999999999993     22233699999998864322 


Q ss_pred             --CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCC
Q 019628          153 --HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA  197 (338)
Q Consensus       153 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~  197 (338)
                        ....+..++|-.+-.+|+..+..++.. +|.|.|+.+++.||+|+
T Consensus       855 p~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGK  900 (974)
T ss_pred             CCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHH
Confidence              223455678999999999999999777 89999999999999995

>smart00090 RIO RIO-like kinase

Probab=99.88  E-value=2.2e-22  Score=175.24  Aligned_cols=139  Identities=19%  Similarity=0.128  Sum_probs=111.6

Q ss_pred             ceEeeeeccCCceEEEEEE-EcCCCcEEEEEEeecCccc-------------------------cHHHHHHHHHHhcCCC
Q 019628            4 YEIVKDIGSGNFGVAKLVR-DKWTRELLAVKFIERGQKI-------------------------DEHVQREIMNHRSLKH   57 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h   57 (338)
                      |.+.+.||+|+||.||+|. +..+|+.||+|+++.....                         ...+.+|+.+++++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7889999999999999999 7779999999998754210                         1235689999999976


Q ss_pred             CC--cceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC-ceecCCCCCcEEecCC
Q 019628           58 PN--IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-ICHRDLKLENTLLDGS  134 (338)
Q Consensus        58 ~~--Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~-iiH~Dlkp~NIl~~~~  134 (338)
                      .+  +.++++.    ...++||||++|.+|.........+....+..++.|++.+|.+||+.| |+||||||+||+++  
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~--  183 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH--  183 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE--
Confidence            33  3444432    235899999999888766544556677778899999999999999999 99999999999997  


Q ss_pred             CCCcEEEeecCCCcc
Q 019628          135 TAPRVKICDFGYSKS  149 (338)
Q Consensus       135 ~~~~ikL~Dfg~a~~  149 (338)
                       .+.++|+|||.+..
T Consensus       184 -~~~i~LiDFg~a~~  197 (237)
T smart00090      184 -DGKVVIIDVSQSVE  197 (237)
T ss_pred             -CCCEEEEEChhhhc
Confidence             33799999998763

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4.2e-22  Score=168.87  Aligned_cols=240  Identities=20%  Similarity=0.322  Sum_probs=186.6

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ..++-+|.+...|..|+++..  |..++.|++...+   .....+..|.-.|+..+||||+.+++.|..+.++.++..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            445667888899999999885  5556777765432   33456888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           81 AGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        81 ~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      +.|+|+..+.....  ....++.+++..+++|+.|||+..  |.---|....++||+....++..+|--++..      .
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------e  343 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------E  343 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------c
Confidence            99999999986554  567788999999999999999974  4455788899999887766666676544432      1


Q ss_pred             CCccccCcccccccccCCccC--CCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ....-.|.||+||.+...+.+  ..++|+||+++++|||-|...||.....-+.=.+  -.+.......|.  .++..+.
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk--ialeglrv~ipp--gis~hm~  419 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK--IALEGLRVHIPP--GISRHMN  419 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh--hhhccccccCCC--CccHHHH
Confidence            223346789999999876544  3458999999999999999999987665332222  123334444554  7899999


Q ss_pred             HHHHHhcccCCCcCCChhHHh
Q 019628          235 HLLSRIFVANSEKRITIPEIK  255 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell  255 (338)
                      .|+.-|...||.+||..+++.
T Consensus       420 klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999987654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=8.3e-23  Score=187.69  Aligned_cols=175  Identities=26%  Similarity=0.365  Sum_probs=134.6

Q ss_pred             eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           72 HLAIVMEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      ++||.|++|.-.+|.++|..+..   .+.-.+..++.|+..|++|   ++.+|||+||.||++..+.  .+||+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhhhee
Confidence            58999999999999999975433   5667899999999999999   9999999999999996554  79999999987


Q ss_pred             ccccCC-------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcc
Q 019628          149 SSVLHS-------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVH  220 (338)
Q Consensus       149 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (338)
                      ......       ..+...||.+||+||.+.+..|..+ +||||||+||+|++. -..+|..       ...+..+..+.
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g~  476 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDGI  476 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcCC
Confidence            554443       4456789999999999999998766 899999999999997 3333322       22233333333


Q ss_pred             ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          221 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      +. |....--++-..|+.+||...|.+||++.+.--|+|.
T Consensus       477 ip-~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  477 IP-PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CC-hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            22 1111222345689999999999999988777777764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.1e-20  Score=160.45  Aligned_cols=134  Identities=23%  Similarity=0.222  Sum_probs=112.7

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++.||+|++|.||++..  .|..+++|+......         ....+.+|+.++..+.|++|.....++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  677899997653211         1135778999999999999988877777778889999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      ||++|++|.+.+....   . ....++.+++.+|.+||+.|++|||++|.|||++   .+.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---CCCEEEEECCcccC
Confidence            9999999999886542   2 8889999999999999999999999999999997   33799999998874

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=7.6e-21  Score=177.62  Aligned_cols=203  Identities=23%  Similarity=0.317  Sum_probs=158.1

Q ss_pred             HhcCCCCCcceeEEEEEcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCc-eecCCCCCcE
Q 019628           52 HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQI-CHRDLKLENT  129 (338)
Q Consensus        52 l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~i-iH~Dlkp~NI  129 (338)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ...++......+++.|+.||.|||...| .|+.|+..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999986 4568888999999999999999998865 9999999999


Q ss_pred             EecCCCCCcEEEeecCCCccccc---CCCCCCccccCcccccccccCCcc------CCCcchHHHHHHHHHHHHcCCCCC
Q 019628          130 LLDGSTAPRVKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLTKKEY------DGKIADVWSCGVTLYVMLVGAYPF  200 (338)
Q Consensus       130 l~~~~~~~~ikL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlG~il~~lltg~~pf  200 (338)
                      ++|...  .+||+|||+......   ........-...|.|||.+.....      .++..||||+|++++|+++.+.||
T Consensus        81 lvd~~w--~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSRW--VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeeeE--EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999888  899999998775432   111122234556999999976421      244589999999999999999999


Q ss_pred             CCCCChHHHHHHHhhHhh-cc-ccCCC---cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          201 EDPEDPKNFRKTIGRILS-VH-YSFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~-~~-~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..........+.+..+.+ .. ...|.   .....+++..++.+|+..+|.+||+++++-.
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            874433322333333333 11 11222   1145667999999999999999999998854

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=5.2e-20  Score=156.64  Aligned_cols=129  Identities=20%  Similarity=0.182  Sum_probs=105.5

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecCc-c--------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            9 DIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-K--------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         9 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~--------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      .||+|+||.||++..  ++..+++|+..... .        ...++.+|+.+++.+.|+++.....++......+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  57889999854321 1        124567899999999988766665556666778999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      ++|++|.+.+.....       .++.|++.+|.+||+.|++|||++|.||+++   .+.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~---~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR---DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE---CCcEEEEECCCCcC
Confidence            999999988754321       8899999999999999999999999999997   34799999998874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=8.3e-20  Score=155.34  Aligned_cols=133  Identities=23%  Similarity=0.274  Sum_probs=105.5

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-----------------------ccHHHHHHHHHHhcCCCCC-
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-----------------------IDEHVQREIMNHRSLKHPN-   59 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~-   59 (338)
                      |.+.+.||+|+||.||++... +|+.||||+++....                       ......+|+.++..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 799999998765321                       0123567888888887774 


Q ss_pred             -cceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCc
Q 019628           60 -IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR  138 (338)
Q Consensus        60 -Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~  138 (338)
                       +...++    ....+++|||++|++|......      .....++.+++.++.++|+.||+||||||+||+++.+  +.
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~--~~  163 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD--EK  163 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC--Cc
Confidence             444443    2345899999999988665321      3467888999999999999999999999999999754  38


Q ss_pred             EEEeecCCCcc
Q 019628          139 VKICDFGYSKS  149 (338)
Q Consensus       139 ikL~Dfg~a~~  149 (338)
                      ++|+|||++..
T Consensus       164 ~~liDfg~~~~  174 (198)
T cd05144         164 IYIIDWPQMVS  174 (198)
T ss_pred             EEEEECCcccc
Confidence            99999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=3e-19  Score=173.95  Aligned_cols=133  Identities=21%  Similarity=0.155  Sum_probs=108.2

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEe-ecCc--------cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-ERGQ--------KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~-~~~~--------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      |...+.||+|+||+||++.....  .+++|+. .+..        ...+++.+|+.+++.++|++++....++......+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            45678999999999999987533  3444432 2111        11245789999999999999998877777777889


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      +||||++|++|.+.+.        ....++.|++.+|.+||+.|++||||||+|||++ +  +.++|+|||+++.
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~--~~~~liDFGla~~  476 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D--DRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C--CcEEEEeCccccc
Confidence            9999999999998885        3578999999999999999999999999999993 2  3799999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=1e-18  Score=147.07  Aligned_cols=134  Identities=22%  Similarity=0.303  Sum_probs=96.7

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHH-------------------------HHHHHHHHhcCCCCC-
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH-------------------------VQREIMNHRSLKHPN-   59 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------~~~E~~~l~~l~h~~-   59 (338)
                      +.+.||+|+||.||++.+. +++.||||++.........                         ...|...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 8899999998753211110                         134555555554433 


Q ss_pred             -cceeEEEEEcCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCC
Q 019628           60 -IVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTA  136 (338)
Q Consensus        60 -Iv~~~~~~~~~~~~~iv~e~~~~~~L~~-~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~  136 (338)
                       +.+.+.+    ...+++|||++++++.. .+... ... ..++.++.+++.++.++|+ .||+||||||+||+++   +
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~---~  150 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD---D  150 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---C
Confidence             4444443    24589999999854321 12111 111 6789999999999999999 9999999999999997   3


Q ss_pred             CcEEEeecCCCcc
Q 019628          137 PRVKICDFGYSKS  149 (338)
Q Consensus       137 ~~ikL~Dfg~a~~  149 (338)
                      +.++|+|||.+..
T Consensus       151 ~~~~liDfg~a~~  163 (187)
T cd05119         151 GKVYIIDVPQAVE  163 (187)
T ss_pred             CcEEEEECccccc
Confidence            4799999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.76  E-value=3.2e-18  Score=138.13  Aligned_cols=131  Identities=24%  Similarity=0.266  Sum_probs=111.6

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC--CCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH--PNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      +++.||.|.++.||++...  +..+++|....... ...+.+|+..++.+.+  .++++++.++...+..+++|||++|+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            5688999999999999985  37899998866543 4678899999999977  58999999888878899999999887


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc---CceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           84 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        84 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~---~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      .+...       +......++.+++.+|.+||..   +++|+|++|+||+++..  +.++++|||.++
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~--~~~~l~Df~~~~  137 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG--KILGIIDWEYAG  137 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC--cEEEEEeccccc
Confidence            77543       5667788899999999999985   79999999999999753  489999999876

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.76  E-value=1.5e-17  Score=145.27  Aligned_cols=133  Identities=19%  Similarity=0.234  Sum_probs=102.6

Q ss_pred             eeec-cCCceEEEEEEEcCCCcEEEEEEeecCc--------------cccHHHHHHHHHHhcCCCCCc--ceeEEEEEcC
Q 019628            8 KDIG-SGNFGVAKLVRDKWTRELLAVKFIERGQ--------------KIDEHVQREIMNHRSLKHPNI--VRFKEVLLTP   70 (338)
Q Consensus         8 ~~LG-~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~E~~~l~~l~h~~I--v~~~~~~~~~   70 (338)
                      ..|| .|+.|+||.+...  +..++||.+....              ....++.+|+.++.++.|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3577 7888889988874  7789999885421              122467889999999998875  6666664432


Q ss_pred             C-e---EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecC
Q 019628           71 T-H---LAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG  145 (338)
Q Consensus        71 ~-~---~~iv~e~~~~-~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg  145 (338)
                      . .   .++|||+++| .+|.+++.. ..+++..    +.|++.+|.+||++||+||||||+|||++.++  .++|+|||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg  187 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFD  187 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECC
Confidence            2 2   3599999997 688888754 4566543    57899999999999999999999999997544  79999999


Q ss_pred             CCcc
Q 019628          146 YSKS  149 (338)
Q Consensus       146 ~a~~  149 (338)
                      .+..
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8773

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=2.5e-18  Score=168.95  Aligned_cols=260  Identities=27%  Similarity=0.374  Sum_probs=200.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccH----HHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +.+.+.+.+-+|++|.+..+.-..+|...++|+.....+...    ...++-.++-...+|.+++....+......++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            567888999999999999999888888888887655433222    2222333333334577776655555667899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-----
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-----  152 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-----  152 (338)
                      +|+++++|...+...+..+++..+.++..++.++++||+..++|||++|.|+++..  .++.++++||.......     
T Consensus       884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~--~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY--DGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcc--cCCcccCccccccccccccCcC
Confidence            99999999999998888999999999999999999999999999999999999954  44899999984321000     


Q ss_pred             -C--------------------------CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCC
Q 019628          153 -H--------------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED  205 (338)
Q Consensus       153 -~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~  205 (338)
                       .                          .......||+.|.+||.+.+...... +|+|+.|+++++.++|.+||.....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcch
Confidence             0                          00122458999999999988776444 8999999999999999999998665


Q ss_pred             hHHHHHHHhhHhhccccCCCc-ccCCHHHHHHHHHhcccCCCcCCChh---HHhcCcccccCCCccc
Q 019628          206 PKNFRKTIGRILSVHYSFPDY-VRVSLECKHLLSRIFVANSEKRITIP---EIKNHPWFLRNLPIEL  268 (338)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s~~---ell~hp~~~~~~~~~~  268 (338)
                      ...+    ..+.+....+|.- ...+..+++++.++|..+|.+|..+.   ++..|+||+......+
T Consensus      1041 q~~f----~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1041 QQIF----ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred             hhhh----hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence            4443    4556666666642 35788899999999999999999887   9999999976544333

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=8.3e-17  Score=150.87  Aligned_cols=250  Identities=20%  Similarity=0.171  Sum_probs=190.3

Q ss_pred             CceEeeeecc--CCceEEEEEEE--cCCCcEEEEEEeecC---ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEE
Q 019628            3 RYEIVKDIGS--GNFGVAKLVRD--KWTRELLAVKFIERG---QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         3 ~y~~~~~LG~--G~~g~V~~~~~--~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+..   .....+-.+|+...+.+ .|+|.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4567788999  99999999988  888999999984332   12223445677766666 5999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           75 IVMEYAAGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~-l~~~~~~~i~~qi~~----al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      +-+|+| +.+|..+...... +++..++..+.+...    ||.++|+.+++|-|+||+||+...+. ..++++|||+...
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~  272 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSK  272 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEE
Confidence            999999 5688887765544 899999999999999    99999999999999999999996552 3789999999875


Q ss_pred             cccCCCCC------CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCC--CChHHHHHHHhhHhhccc
Q 019628          150 SVLHSQPK------STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EDPKNFRKTIGRILSVHY  221 (338)
Q Consensus       150 ~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~--~~~~~~~~~~~~~~~~~~  221 (338)
                      ........      ..-|...|++||...+..  +..+|++|+|.++.+..++..++...  ........       ...
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-------~~i  343 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-------GYI  343 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-------ccC
Confidence            54433221      224777899999986543  44589999999999999887666543  22221111       111


Q ss_pred             cCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          222 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ........+..+...+..|++.+|-.|+++..+++|+++...
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            111112456667779999999999999999999999998643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1e-15  Score=133.51  Aligned_cols=202  Identities=17%  Similarity=0.284  Sum_probs=140.8

Q ss_pred             HHHhcCCCCCcceeEEEEEcCC-----eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhc--C
Q 019628           50 MNHRSLKHPNIVRFKEVLLTPT-----HLAIVMEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSM--Q  118 (338)
Q Consensus        50 ~~l~~l~h~~Iv~~~~~~~~~~-----~~~iv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~--~  118 (338)
                      ..+-++-|.|||+++.++.+.+     ...++.|||+.|++..+|++.    ..++....++|+.||+.||.|||+.  -
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            4455667999999999987654     478999999999999999753    3589999999999999999999998  4


Q ss_pred             ceecCCCCCcEEecCCCCCcEEEeecCCCccccc-----CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHH
Q 019628          119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM  193 (338)
Q Consensus       119 iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l  193 (338)
                      |+|+++...-|++..++  -||++---.......     ........+-++|.+||.=......+. +|||++|....+|
T Consensus       199 iihgnlTc~tifiq~ng--LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlem  275 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNG--LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEM  275 (458)
T ss_pred             cccCCcchhheeecCCc--eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHH
Confidence            99999999999996443  566543211110000     001122346788999998655554455 8999999999999


Q ss_pred             HcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          194 LVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       194 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..|..--...+........+....   +...+     ..-++++.+||+-.|..||++.+++-||-+-+
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i---~~len-----~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVI---IGLEN-----GLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhe---eeccC-----ccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            887643222222111222221111   11111     11357899999999999999999999998643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=1.3e-15  Score=145.88  Aligned_cols=140  Identities=23%  Similarity=0.320  Sum_probs=93.9

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-----------------------------------ccHHHH-
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-----------------------------------IDEHVQ-   46 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------------------~~~~~~-   46 (338)
                      .|.. +.||.|++|.||+|+.+.+|+.||||+++++-.                                   ..+.+. 
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 789999999999999987899999999975310                                   011222 


Q ss_pred             -----HHHHHHhcC----CCCCcceeEEEEEc-CCeEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 019628           47 -----REIMNHRSL----KHPNIVRFKEVLLT-PTHLAIVMEYAAGGELFER--ICNAG----RFSEDEARFFFQQLISG  110 (338)
Q Consensus        47 -----~E~~~l~~l----~h~~Iv~~~~~~~~-~~~~~iv~e~~~~~~L~~~--i~~~~----~l~~~~~~~i~~qi~~a  110 (338)
                           +|...+.++    .+...+.+-.++.+ ....++||||+.|+.+.+.  +...+    .+.+..+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence                 333333332    23333333333322 3456799999999999764  33332    255555666666665  


Q ss_pred             HHHhhhcCceecCCCCCcEEecCCC--CCcEEEeecCCCccc
Q 019628          111 VSYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKSS  150 (338)
Q Consensus       111 l~~LH~~~iiH~Dlkp~NIl~~~~~--~~~ikL~Dfg~a~~~  150 (338)
                           ..|++|+|+||.||+++.++  .+.++++|||++...
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                 48999999999999996443  248999999998744

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.58  E-value=1.1e-14  Score=120.37  Aligned_cols=127  Identities=19%  Similarity=0.237  Sum_probs=96.7

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcc-eeEEEEEcCCeEEEEEeccCCCCh
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV-RFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv-~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ++.|+.|.++.||++...  +..|++|.............+|+.+++.+.+.+++ +++.+..  ..-++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            578999999999999875  77899998765543334567899999988665544 4554432  335799999999877


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCc-----eecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           86 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQI-----CHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        86 ~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~i-----iH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      ...        ......++.+++.+|..||+.++     +|+|++|.||+++ .  +.++++|||.+.
T Consensus        79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~--~~~~liDf~~a~  135 (170)
T cd05151          79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D--GRLWLIDWEYAG  135 (170)
T ss_pred             ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C--CeEEEEeccccc
Confidence            543        11124567899999999999985     9999999999997 2  369999999765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=5.1e-14  Score=118.07  Aligned_cols=136  Identities=15%  Similarity=0.167  Sum_probs=100.3

Q ss_pred             eeeeccCCceEEEEEEEcC------CCcEEEEEEeecC-------------c-c--------c-cHH----HHHHHHHHh
Q 019628            7 VKDIGSGNFGVAKLVRDKW------TRELLAVKFIERG-------------Q-K--------I-DEH----VQREIMNHR   53 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~------~~~~vaiK~~~~~-------------~-~--------~-~~~----~~~E~~~l~   53 (338)
                      ...||.|.-+.||.|....      .+..+|||+.+.+             . .        . .+.    .++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998753      3578999987531             0 0        0 112    238999998


Q ss_pred             cCCC--CCcceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcCceecCCCCCcEE
Q 019628           54 SLKH--PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQICHRDLKLENTL  130 (338)
Q Consensus        54 ~l~h--~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~L-H~~~iiH~Dlkp~NIl  130 (338)
                      ++..  -++.+++.+    ..-++||||+.+..+..-......+++..+..+..|++.+|..| |+.||||+||+|.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8853  456666654    45678999997654432222333566777888899999999998 8999999999999999


Q ss_pred             ecCCCCCcEEEeecCCCcc
Q 019628          131 LDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus       131 ~~~~~~~~ikL~Dfg~a~~  149 (338)
                      +++   +.+.|+|||.+..
T Consensus       158 ~~~---~~v~iIDF~qav~  173 (197)
T cd05146         158 WHD---GKVWFIDVSQSVE  173 (197)
T ss_pred             EEC---CcEEEEECCCcee
Confidence            963   3699999998763

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.56  E-value=1.1e-13  Score=131.31  Aligned_cols=167  Identities=17%  Similarity=0.263  Sum_probs=130.4

Q ss_pred             EEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHH
Q 019628           20 LVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSED   98 (338)
Q Consensus        20 ~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~   98 (338)
                      .+..+.++.+|.+.+.+.... ....+.+-+..|+.++||||+++++.+...+.+|+|+|.+.  .|..++++.   +..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~  104 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKE  104 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHH
Confidence            456677888999998876544 23457788899999999999999999999999999999984  777778654   488


Q ss_pred             HHHHHHHHHHHHHHHhh-hcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-CCCccccCcccccccccCCcc
Q 019628           99 EARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLTKKEY  176 (338)
Q Consensus        99 ~~~~i~~qi~~al~~LH-~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~  176 (338)
                      .+...+.||+.||.+|| +.+++|++|.-..|+++..+  ..||++|-++........ .....---.|..|+.+....+
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G--eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~  182 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG--EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW  182 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC--cEEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc
Confidence            88999999999999997 66999999999999996554  899999988764332221 122222334667776544332


Q ss_pred             CCCcchHHHHHHHHHHHHcC
Q 019628          177 DGKIADVWSCGVTLYVMLVG  196 (338)
Q Consensus       177 ~~~~~DiwSlG~il~~lltg  196 (338)
                        . .|.|-|||++++++.|
T Consensus       183 --s-~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 --S-IDSWGLGCLIEELFNG  199 (690)
T ss_pred             --c-hhhhhHHHHHHHHhCc
Confidence              2 6999999999999998

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=2.8e-14  Score=135.02  Aligned_cols=137  Identities=19%  Similarity=0.204  Sum_probs=92.6

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCccc-----------------------------------cH------HHH
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-----------------------------------DE------HVQ   46 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------~~------~~~   46 (338)
                      +.||.|++|.||+|+.+ +|+.||||+.+.+-..                                   ..      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999875 7899999998653100                                   00      123


Q ss_pred             HHHHHHhcC----CCCCcceeEEEE-EcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHhhhcCc
Q 019628           47 REIMNHRSL----KHPNIVRFKEVL-LTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQI  119 (338)
Q Consensus        47 ~E~~~l~~l----~h~~Iv~~~~~~-~~~~~~~iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~-al~~LH~~~i  119 (338)
                      +|...+.++    ++.+-+.+-.++ ......++||||++|++|.+..... ...   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            344444443    222222222222 2234568999999999998876432 122   23445666665 4678999999


Q ss_pred             eecCCCCCcEEecCCCCCcEEEeecCCCccc
Q 019628          120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSS  150 (338)
Q Consensus       120 iH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~  150 (338)
                      +|+|++|.||+++.+  ++++|+|||++...
T Consensus       279 ~H~D~hPgNilv~~~--g~i~liDfG~~~~l  307 (437)
T TIGR01982       279 FHADLHPGNIFVLKD--GKIIALDFGIVGRL  307 (437)
T ss_pred             eeCCCCcccEEECCC--CcEEEEeCCCeeEC
Confidence            999999999999654  48999999998744

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=7.7e-15  Score=137.74  Aligned_cols=249  Identities=21%  Similarity=0.206  Sum_probs=180.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-CCCcEEEEEEeecCccc---cHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-WTRELLAVKFIERGQKI---DEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      .+|..+..||.|.|+.|+.+... .++..|++|...+.-..   ...-..|+-+...+ .|.++++.+..|....+.|+=
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            46889999999999999987755 67889999987654211   11223455444444 689999998888888888899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      -|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++.+.+ +..++.|||..+.. ... .
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~-~~~-~  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL-AFS-S  421 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc-cee-c
Confidence            99999998887776666789999999999999999999999999999999999997543 46799999987641 111 1


Q ss_pred             CCccccCccc-ccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          157 KSTVGTPAYI-APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       157 ~~~~gt~~y~-aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....++.+++ ..|++........++|++|||..+++.+++...-.....   .    ..+..+.  .|.....+.++..
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~----~~i~~~~--~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---S----LTIRSGD--TPNLPGLKLQLQV  492 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---c----eeeeccc--ccCCCchHHhhhh
Confidence            1223334444 255554443344558999999999999998633222111   1    1122222  2222245578899


Q ss_pred             HHHHhcccCCCcCCChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +.+.+...++..|+++.++..|+-|.+
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhhh
Confidence            999999999999999999999887643

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.45  E-value=4.2e-12  Score=117.45  Aligned_cols=211  Identities=18%  Similarity=0.244  Sum_probs=150.8

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecCcccc-HHHHHHHHHHhcCCCCCcceeEEEEEc----CCeEEEEEeccCC-CChHHHH
Q 019628           16 GVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNIVRFKEVLLT----PTHLAIVMEYAAG-GELFERI   89 (338)
Q Consensus        16 g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~iv~e~~~~-~~L~~~i   89 (338)
                      .+.|++....+|..|++|.+.-.+... ...-.-+++++++.|+|||++.++|..    ...+++|++|+++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            578999999999999999994322111 122334678899999999999999984    3579999999986 6777765


Q ss_pred             Hh---------------cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           90 CN---------------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        90 ~~---------------~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      -.               +...+|+.+|.++.||..||.++|+.|+..+-|.|.+||++++.  +++|...|.........
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP  447 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC
Confidence            32               22478999999999999999999999999999999999997554  78888777655433221


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                            +       +-+.+.    ++-|.=.||.++..|.||..--...+.....  .+..+.         ..++.+++
T Consensus       448 ------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I~---------~~yS~D~r  499 (655)
T KOG3741|consen  448 ------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRIT---------TTYSTDLR  499 (655)
T ss_pred             ------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHhh---------hhhhHHHH
Confidence                  0       222221    2258889999999999995331111111111  011111         14788899


Q ss_pred             HHHHHhcccCCCcCCChhHHhcC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ++|.-+....+.. -++.+++.|
T Consensus       500 n~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  500 NVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHhcCccc-ccHHHHHHH
Confidence            9999998888876 677777764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=2.3e-12  Score=104.82  Aligned_cols=130  Identities=23%  Similarity=0.218  Sum_probs=97.9

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEe-ecC---ccc-----cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFI-ERG---QKI-----DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~-~~~---~~~-----~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ..+++|+-+.++.+...  |..+++|.- ++.   ...     ..+..+|.+++..+.--+|....-++.++....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46889999999998553  545666643 221   111     1346689999988876666666666677788889999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      |++|..|.+.+...       ...+++.+-..+.-||.+||+|+||.++||++.+.   .+.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~---~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG---RIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC---cEEEEECCcccc
Confidence            99998888888665       25566677777788999999999999999999543   499999999873

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.40  E-value=3.3e-12  Score=110.04  Aligned_cols=140  Identities=21%  Similarity=0.269  Sum_probs=106.3

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCC--CcceeEEEEEcC---CeEEEEEec
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHP--NIVRFKEVLLTP---THLAIVMEY   79 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~--~Iv~~~~~~~~~---~~~~iv~e~   79 (338)
                      ++.||.|..+.||++... +|+.+++|+......  ....+.+|..+++.+.+.  ++.+++.+....   +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            367899999999999874 357899998766543  346788999999999763  456777766553   267899999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------------
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------  116 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-------------------------------------------  116 (338)
                      ++|.++...+.. ..+++.....++.+++.+|..||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999888765432 356777777778888888888773                                           


Q ss_pred             -------------cCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          117 -------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       117 -------------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                                   ..++|+|+.|.||+++.+..+.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         24699999999999976423368999999776

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=3.9e-12  Score=103.15  Aligned_cols=142  Identities=16%  Similarity=0.101  Sum_probs=107.5

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---------ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---------QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      .+..|-+|+-+.|+++...  |+.+.||.-...         +....+..+|++.+.++.--+|.-..-+|.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            4678889999999998874  888888854321         12335677899999888765666666667777777899


Q ss_pred             EeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC-cEEEeecCCCcc
Q 019628           77 MEYAAG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKS  149 (338)
Q Consensus        77 ~e~~~~-~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~-~ikL~Dfg~a~~  149 (338)
                      |||++| .++.+++....  .........++++|-..+.-||.++|||+||..+||++...++. .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999977 47777776432  22333447899999999999999999999999999999655442 458999999863

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.22  E-value=4.8e-10  Score=99.17  Aligned_cols=129  Identities=14%  Similarity=0.052  Sum_probs=92.8

Q ss_pred             EEEEEEcCCCcEEEEEEeecCc------------cccHHHHHHHHHHhcCCCCCc--ceeEEEEEc-----CCeEEEEEe
Q 019628           18 AKLVRDKWTRELLAVKFIERGQ------------KIDEHVQREIMNHRSLKHPNI--VRFKEVLLT-----PTHLAIVME   78 (338)
Q Consensus        18 V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~E~~~l~~l~h~~I--v~~~~~~~~-----~~~~~iv~e   78 (338)
                      |.++..  .|+.|.||......            .....+.+|...+.+|..-+|  .....++..     ...-++|+|
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            445433  57789999664322            011147789988888743333  333444432     234689999


Q ss_pred             ccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC-----CCCCcEEEeecCCCc
Q 019628           79 YAAGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-----STAPRVKICDFGYSK  148 (338)
Q Consensus        79 ~~~~~-~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~-----~~~~~ikL~Dfg~a~  148 (338)
                      ++++. +|.+++..  ....++.....++.+++..+.-||+.||+|+|++|.|||++.     .+...+.|+||+.+.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99875 78888753  345667788899999999999999999999999999999974     234589999999775

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=7.9e-12  Score=119.36  Aligned_cols=153  Identities=17%  Similarity=0.274  Sum_probs=109.4

Q ss_pred             HHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC----------CCCCccccCcccccccccCC
Q 019628          106 QLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS----------QPKSTVGTPAYIAPEVLTKK  174 (338)
Q Consensus       106 qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~  174 (338)
                      +++.|+.|+|.. ++||++|.|++|.++.++  ..||+.|+++.......          ......-...|.|||.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~--~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG--DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc--ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344899999975 999999999999996555  89999999876432210          01112345679999999885


Q ss_pred             ccCCCcchHHHHHHHHHHHH-cCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhH
Q 019628          175 EYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE  253 (338)
Q Consensus       175 ~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~e  253 (338)
                      .. +.++|++|+||.+|.+. .|+..+........+..........  .+-....+++++++=+.++|..++..||++.+
T Consensus       185 ~~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~--~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  185 TN-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG--AFGYSNNLPSELRESLKKLLNGDSAVRPTLDL  261 (700)
T ss_pred             cc-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc--cccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence            54 44589999999999998 5666665544332222221111111  12222478999999999999999999999999


Q ss_pred             HhcCcccccC
Q 019628          254 IKNHPWFLRN  263 (338)
Q Consensus       254 ll~hp~~~~~  263 (338)
                      ++.-|||...
T Consensus       262 l~~~~ff~D~  271 (700)
T KOG2137|consen  262 LLSIPFFSDP  271 (700)
T ss_pred             hhcccccCCc
Confidence            9999999643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=1.9e-10  Score=96.15  Aligned_cols=122  Identities=27%  Similarity=0.340  Sum_probs=80.4

Q ss_pred             EEEEEEEcCCCcEEEEEEeecCc--------------c-------------ccHHHHHHHHHHhcCCCC--CcceeEEEE
Q 019628           17 VAKLVRDKWTRELLAVKFIERGQ--------------K-------------IDEHVQREIMNHRSLKHP--NIVRFKEVL   67 (338)
Q Consensus        17 ~V~~~~~~~~~~~vaiK~~~~~~--------------~-------------~~~~~~~E~~~l~~l~h~--~Iv~~~~~~   67 (338)
                      .||.|... .|..+|+|+.+.+.              .             ......+|.+.|.++..-  ++.+++.+ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            48888885 67799999875320              0             012467899999999765  46666654 


Q ss_pred             EcCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-hhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           68 LTPTHLAIVMEYAA--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        68 ~~~~~~~iv~e~~~--~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~-LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                       .  .-++||||++  |..+..+...  .++......++.+++..+.. +|+.||+|+||.+.||+++.+   .+.++||
T Consensus        79 -~--~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf  150 (188)
T PF01163_consen   79 -N--RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDF  150 (188)
T ss_dssp             -E--TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--G
T ss_pred             -e--CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEec
Confidence             2  2369999998  5555443322  22355677788888885555 579999999999999999654   6999999


Q ss_pred             CCCc
Q 019628          145 GYSK  148 (338)
Q Consensus       145 g~a~  148 (338)
                      |.+.
T Consensus       151 ~qav  154 (188)
T PF01163_consen  151 GQAV  154 (188)
T ss_dssp             TTEE
T ss_pred             Ccce
Confidence            9776

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.05  E-value=1.9e-09  Score=93.06  Aligned_cols=132  Identities=23%  Similarity=0.268  Sum_probs=99.0

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-----------------------cccHHHHHHHHHHhcCCCC--C
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----------------------KIDEHVQREIMNHRSLKHP--N   59 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~--~   59 (338)
                      .+..+||-|.-|.||.|.+. .|..+|||.-+.+.                       ......++|.++|.+|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            46789999999999999987 78889999754211                       0113467899999999755  6


Q ss_pred             cceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcE
Q 019628           60 IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV  139 (338)
Q Consensus        60 Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~i  139 (338)
                      |.+.+++    +.-.+|||+++|-.|...     +++.+....++..|+.-+..+-..||||+|+++-||++++++  .+
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg--~~  241 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG--DI  241 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC--CE
Confidence            6776553    566799999998766432     223555666666777766666689999999999999997654  79


Q ss_pred             EEeecCCCc
Q 019628          140 KICDFGYSK  148 (338)
Q Consensus       140 kL~Dfg~a~  148 (338)
                      .++||--+.
T Consensus       242 ~vIDwPQ~v  250 (304)
T COG0478         242 VVIDWPQAV  250 (304)
T ss_pred             EEEeCcccc
Confidence            999997554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.96  E-value=4.4e-11  Score=113.33  Aligned_cols=241  Identities=20%  Similarity=0.165  Sum_probs=169.8

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeEEEEEcCCeEEEEEeccCC
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN-IVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      |.....+++|+++.+++.+...+...+ .+++...    ....-++++|.+++||| .+..++-+..+...++.|+++.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            444566789999999999987766555 7766544    44566888999999999 78888877888899999999987


Q ss_pred             C-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCcc
Q 019628           83 G-ELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV  160 (338)
Q Consensus        83 ~-~L~~~i-~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  160 (338)
                      + +-.... ...-.+.+-+...+.+.-.++++++|+.-=+|||    ||+..++   ..++++|+...........++..
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~---~~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE---EVKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc---ccccccccCCcccCcccccccCC
Confidence            6 211111 1111244555666777788899999998778998    8888543   57999999887665555677889


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc--ccCCCcccCCHHH-HHHH
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSLEC-KHLL  237 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~li  237 (338)
                      +|+.++|||+...+.+... .|.||+|.-..+|.-|.+|-...-..      ...+....  +.+......+... .++.
T Consensus       392 ~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~~------~~~~g~~p~s~~L~~~~aw~~~~~~~~~  464 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPAV------LPMIGNGPNSPMLTDKSAWSPVFHRDFP  464 (829)
T ss_pred             CCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCccc------cCCCCCCCCccccchhhhcCcccccCCc
Confidence            9999999999999998877 69999999888887777665431100      00000000  0000000111111 2477


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..|+...|..|+..-.++-|.+|.+.
T Consensus       465 ~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  465 APCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             ccccCCCCCCCcchhhHHHHHHhccC
Confidence            89999999999999999999998654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=9.4e-09  Score=87.83  Aligned_cols=107  Identities=18%  Similarity=0.184  Sum_probs=83.6

Q ss_pred             cHHHHHHHHHHhcCCCCC--cceeEEEEEcC----CeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh
Q 019628           42 DEHVQREIMNHRSLKHPN--IVRFKEVLLTP----THLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYC  114 (338)
Q Consensus        42 ~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~----~~~~iv~e~~~~-~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~L  114 (338)
                      ..+..+|...+..|..-+  +.+.+.+....    ..-++|+|++++ .+|.+++.....++......++.++...+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            356788888887775333  34445554432    245899999987 47999888755577888899999999999999


Q ss_pred             hhcCceecCCCCCcEEecCCC-CCcEEEeecCCCc
Q 019628          115 HSMQICHRDLKLENTLLDGST-APRVKICDFGYSK  148 (338)
Q Consensus       115 H~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~  148 (338)
                      |.+||+|+|++|.|||++... ...+.|+||+-++
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            999999999999999997553 3479999999766

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.91  E-value=3.1e-08  Score=90.21  Aligned_cols=240  Identities=14%  Similarity=0.121  Sum_probs=147.8

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcce----eEEEE--EcC-CeEEEEEe
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVR----FKEVL--LTP-THLAIVME   78 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~----~~~~~--~~~-~~~~iv~e   78 (338)
                      ....||+|+-+.+|-.-...+   .+-|+.....-..+.-+.+ ++-..-.||-+..    .....  -+. ..+.++|.
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a-~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVA-ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecchhhc---hhheeecCCCchHHHHHHH-HhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            356799999999996655422   2456665433221111111 1112224554332    11100  112 23788899


Q ss_pred             ccCCCC-hHHHHH---hcC---CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           79 YAAGGE-LFERIC---NAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        79 ~~~~~~-L~~~i~---~~~---~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      .++|.. +..+..   .++   ...+....+..+.|+.|...||..|.+-+|++++|+|+++..  .+.|.|=..-....
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~--~V~LVdsDsfqi~~  168 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS--KVVLVDSDSFQINA  168 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc--eEEEEcccceeecc
Confidence            888742 222221   222   256778999999999999999999999999999999996444  78998865443334


Q ss_pred             cCCCCCCccccCcccccccccCC-----ccCCCcchHHHHHHHHHHHHcC-CCCCCCCC----ChHHHHHHHhh------
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKK-----EYDGKIADVWSCGVTLYVMLVG-AYPFEDPE----DPKNFRKTIGR------  215 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~~lltg-~~pf~~~~----~~~~~~~~~~~------  215 (338)
                      .+......+|...|.+||.-+-+     .-+.. .|.|.||+++++++.| ++||.+..    .+..+...+..      
T Consensus       169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya  247 (637)
T COG4248         169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA  247 (637)
T ss_pred             CCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence            44555667899999999986522     22233 7999999999999986 99996522    11111111110      


Q ss_pred             -Hhh-c---cccCCCcccCCHHHHHHHHHhcccC--CCcCCChh
Q 019628          216 -ILS-V---HYSFPDYVRVSLECKHLLSRIFVAN--SEKRITIP  252 (338)
Q Consensus       216 -~~~-~---~~~~~~~~~~~~~~~~li~~~L~~d--p~~R~s~~  252 (338)
                       -.. .   ...-+.+.-+++++..|+.+|+...  +.-|||++
T Consensus       248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence             000 0   0111223457889999999999864  46899874

>PRK09902 hypothetical protein; Provisional

Probab=98.88  E-value=5.4e-08  Score=82.08  Aligned_cols=136  Identities=13%  Similarity=0.113  Sum_probs=99.1

Q ss_pred             ccCCceEEEEEEEcCCCcEEEEEEeecC-------ccccHHHHHHHHHHhcCCCCC--cceeEE--EEEcC--CeEEEEE
Q 019628           11 GSGNFGVAKLVRDKWTRELLAVKFIERG-------QKIDEHVQREIMNHRSLKHPN--IVRFKE--VLLTP--THLAIVM   77 (338)
Q Consensus        11 G~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~E~~~l~~l~h~~--Iv~~~~--~~~~~--~~~~iv~   77 (338)
                      |+||.|.|+.....  |+.+-+|.....       .-....+.+|+..+++|..-+  +.+...  .-..+  -.-+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56899999988764  456888876521       123467999999998885332  344331  11111  2367899


Q ss_pred             eccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           78 EYAAG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        78 e~~~~-~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      |-++| .+|.+++...  .+.++.....++.++..++.-||+.|+.|+|+-+.||+++..+...++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97754 5888887552  34578888899999999999999999999999999999975543359999998665

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.86  E-value=4.5e-08  Score=98.95  Aligned_cols=205  Identities=21%  Similarity=0.244  Sum_probs=145.8

Q ss_pred             HHHHHHHHhcCCCCCcceeEEEEEcCCeE----EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCce
Q 019628           45 VQREIMNHRSLKHPNIVRFKEVLLTPTHL----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC  120 (338)
Q Consensus        45 ~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~----~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~ii  120 (338)
                      ..-|+..+..+.|+|++.++.+.......    .+..++++.-++...+.....++.+.++.+..++++||.|+|+....
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            44567778888999999999987765443    34457888899999999888999999999999999999999998666


Q ss_pred             ecCCCCCcEEec-CCCCCcEEEe--ecCCCcccccCCCCCCccccCcccccccccCCccCCC-cchHHHHHHHHHHHHcC
Q 019628          121 HRDLKLENTLLD-GSTAPRVKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK-IADVWSCGVTLYVMLVG  196 (338)
Q Consensus       121 H~Dlkp~NIl~~-~~~~~~ikL~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwSlG~il~~lltg  196 (338)
                      |.-|.-.-..-. ..+.+.+..+  ||+.+..............+..+.+||.......... ..|+|.+|..+..+..|
T Consensus       309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~  388 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG  388 (1351)
T ss_pred             eeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence            655544422111 1222345555  8888776655555555666777888988766554322 25999999999999988


Q ss_pred             CCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          197 AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ..+-.......       ....      .  .......+++.+|+.-++++|+++.+++.|+|.....
T Consensus       389 ~~i~~~~~~~~-------~~l~------~--~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  389 EDISEKSAVPV-------SLLD------V--LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             Ccccccccchh-------hhhc------c--ccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            65432211111       1111      0  0111577899999999999999999999999986443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.77  E-value=2.2e-07  Score=78.74  Aligned_cols=133  Identities=17%  Similarity=0.187  Sum_probs=86.0

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccH----------HHHHHHHHHhcCC---CCCcceeEEEEEc
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----------HVQREIMNHRSLK---HPNIVRFKEVLLT   69 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~E~~~l~~l~---h~~Iv~~~~~~~~   69 (338)
                      +|++++.+-.....-|.+..-  +|+.+++|..+......+          ...+++..+.++.   -...+.++-+...
T Consensus        32 ~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             CceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            577888888777777766554  578899997754321111          1223333333332   2233333333222


Q ss_pred             -----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           70 -----PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        70 -----~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                           ....+++|||++|..|.+...    +++    .+...+.+++.-||+.|++|+|..|.|+++.++   .+++.||
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~---~i~iID~  178 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN---GIRIIDT  178 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC---cEEEEEC
Confidence                 234568999999987765432    333    244567788999999999999999999999643   4999999


Q ss_pred             CCCc
Q 019628          145 GYSK  148 (338)
Q Consensus       145 g~a~  148 (338)
                      +..+
T Consensus       179 ~~k~  182 (229)
T PF06176_consen  179 QGKR  182 (229)
T ss_pred             cccc
Confidence            8544

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.70  E-value=2e-07  Score=79.85  Aligned_cols=135  Identities=16%  Similarity=0.145  Sum_probs=92.6

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcccc--------------------HH-----HHHHHHHHhcCC--CC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--------------------EH-----VQREIMNHRSLK--HP   58 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~-----~~~E~~~l~~l~--h~   58 (338)
                      +...|+.|.-+.||+|... ++..+|+|+.+......                    .+     ...|+..|+++.  +-
T Consensus        52 ~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            3457778888899999873 68899999986431110                    11     235777777774  34


Q ss_pred             CcceeEEEEEcCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCC
Q 019628           59 NIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTA  136 (338)
Q Consensus        59 ~Iv~~~~~~~~~~~~~iv~e~~~~~-~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~  136 (338)
                      .+.+.+.+.    .-.+||||+... .-.-.|+. -++..++...+..++++.+.-|-. .++||+||+.-|||+.   .
T Consensus       131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~---~  202 (268)
T COG1718         131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH---D  202 (268)
T ss_pred             CCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE---C
Confidence            455555543    356999999543 11112221 134444788888999999988876 8999999999999996   2


Q ss_pred             CcEEEeecCCCcc
Q 019628          137 PRVKICDFGYSKS  149 (338)
Q Consensus       137 ~~ikL~Dfg~a~~  149 (338)
                      +.+.++|||-|..
T Consensus       203 ~~p~iID~~QaV~  215 (268)
T COG1718         203 GEPYIIDVSQAVT  215 (268)
T ss_pred             CeEEEEECccccc
Confidence            3689999997763

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=3.8e-07  Score=79.00  Aligned_cols=72  Identities=17%  Similarity=0.189  Sum_probs=54.7

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeEEEEEcCCeEEEEEeccCCCC
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      .+||.|..+.||+.    .+..+++|...... ....+.+|.++++.+..-+  +.+.+.+....+..++|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984    24467889776532 3456789999999886443  4677777777788899999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.69  E-value=2e-07  Score=80.72  Aligned_cols=78  Identities=19%  Similarity=0.203  Sum_probs=56.9

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeEEEEEc---CCeEEEEEeccC
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFKEVLLT---PTHLAIVMEYAA   81 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~---~~~~~iv~e~~~   81 (338)
                      ++.|+.|..+.||++....  ..+++|..... .....+.+|..+++.+...+  +.+++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            5789999999999999864  58899987655 44567888888888885333  4566654432   345799999999


Q ss_pred             CCChHH
Q 019628           82 GGELFE   87 (338)
Q Consensus        82 ~~~L~~   87 (338)
                      |.++..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=3.1e-07  Score=88.11  Aligned_cols=137  Identities=19%  Similarity=0.210  Sum_probs=87.4

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc-----------------------------------cccHH------HH
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----------------------------------KIDEH------VQ   46 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------------------~~~~~------~~   46 (338)
                      ..|+.++-|-||+|+-+ +|+.||||+.+.+-                                   ...+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57889999999999997 59999999986420                                   00011      22


Q ss_pred             HHHHHHhcC-----CCCCcceeEEEEEcCCeEEEEEeccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHhhhcCc
Q 019628           47 REIMNHRSL-----KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQI  119 (338)
Q Consensus        47 ~E~~~l~~l-----~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i--~~~~~l~~~~~~~i~~qi~~al~~LH~~~i  119 (338)
                      +|...+.++     ..+++.-..-++.-.+.-.++|||++|..+.+..  +. ..++...+.....++.  ++.+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            344444333     1333322222233345667999999998887764  33 3455433333332222  122334899


Q ss_pred             eecCCCCCcEEecCCCCCcEEEeecCCCccc
Q 019628          120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSS  150 (338)
Q Consensus       120 iH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~  150 (338)
                      +|.|..|.||+++.+  |++.+.|||+....
T Consensus       287 fHaDpHpGNi~v~~~--g~i~~lDfGi~g~l  315 (517)
T COG0661         287 FHADPHPGNILVRSD--GRIVLLDFGIVGRL  315 (517)
T ss_pred             cccCCCccceEEecC--CcEEEEcCcceecC
Confidence            999999999999655  48999999987643

>PLN02876 acyl-CoA dehydrogenase

Probab=98.57  E-value=1e-06  Score=90.36  Aligned_cols=144  Identities=17%  Similarity=0.249  Sum_probs=91.6

Q ss_pred             EeeeeccCCceEEEEEEEcCCC--cEEEEEEeecCcc--ccHHHHHHHHHHhcCC-CCCc--ceeEEEEEcC---CeEEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTR--ELLAVKFIERGQK--IDEHVQREIMNHRSLK-HPNI--VRFKEVLLTP---THLAI   75 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~-h~~I--v~~~~~~~~~---~~~~i   75 (338)
                      -++.++.|.++.+|++.....+  ..+++|+.+....  ....+.+|+.+++.+. |++|  .+++.++.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3677899999999998765332  4678887665432  2346889999999995 6664  7777777654   46789


Q ss_pred             EEeccCCCChHH--------------------HHH---hcC----CC---------CHHHHHHHHHH-------------
Q 019628           76 VMEYAAGGELFE--------------------RIC---NAG----RF---------SEDEARFFFQQ-------------  106 (338)
Q Consensus        76 v~e~~~~~~L~~--------------------~i~---~~~----~l---------~~~~~~~i~~q-------------  106 (338)
                      ||||++|..+.+                    .+.   .-.    .+         ...++..|..+             
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998854321                    110   000    00         11233332222             


Q ss_pred             --HHHHHHHhhh-----------cCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628          107 --LISGVSYCHS-----------MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus       107 --i~~al~~LH~-----------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                        +...+.+|..           ..+||+|++|.||+++.......-|.||.++..
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence              2223455532           259999999999999754333457999998763

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.56  E-value=1.5e-06  Score=73.27  Aligned_cols=131  Identities=23%  Similarity=0.248  Sum_probs=95.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-----------------cccHHHHHHHHHHhcCC------CCCccee
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----------------KIDEHVQREIMNHRSLK------HPNIVRF   63 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~~Iv~~   63 (338)
                      ...||+|+.-.||.--+   ....+||+.....                 .......+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35789999998885443   4557899887654                 22355667777666665      7889999


Q ss_pred             EEEEEcCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC
Q 019628           64 KEVLLTPTHLAIVMEYAAG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP  137 (338)
Q Consensus        64 ~~~~~~~~~~~iv~e~~~~------~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~  137 (338)
                      +|+..++....+|+|.+.+      .+|.+++.. +.+++ .++.   .+-.-.+||-+++|+.+|++|.||++.....+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999997643      467777744 35666 3333   44455578889999999999999999655443


Q ss_pred             --cEEEee-cC
Q 019628          138 --RVKICD-FG  145 (338)
Q Consensus       138 --~ikL~D-fg  145 (338)
                        .+.|+| ||
T Consensus       158 ~~~lvlIDG~G  168 (199)
T PF10707_consen  158 EFRLVLIDGLG  168 (199)
T ss_pred             ceEEEEEeCCC
Confidence              477777 44

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.50  E-value=2.8e-06  Score=71.25  Aligned_cols=124  Identities=22%  Similarity=0.310  Sum_probs=89.0

Q ss_pred             CCceEeeeeccCCc-eEEEEEEEcCCCcEEEEEEeec---C------------c-------cccHHHHHHHHHHhcCC--
Q 019628            2 ERYEIVKDIGSGNF-GVAKLVRDKWTRELLAVKFIER---G------------Q-------KIDEHVQREIMNHRSLK--   56 (338)
Q Consensus         2 ~~y~~~~~LG~G~~-g~V~~~~~~~~~~~vaiK~~~~---~------------~-------~~~~~~~~E~~~l~~l~--   56 (338)
                      .+++.++.||.|.- |.||++..  .|+.||+|.+..   .            .       ....-+..|.+..-+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            36789999999999 99999998  488999999421   0            0       11123667777766664  


Q ss_pred             -CCCc--ceeEEEEEcC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh
Q 019628           57 -HPNI--VRFKEVLLTP------------------THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH  115 (338)
Q Consensus        57 -h~~I--v~~~~~~~~~------------------~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH  115 (338)
                       +.++  |+.+++..-.                  ....||.||++...         .++...    +.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence             4566  8999987422                  12468888876643         223333    456677777899


Q ss_pred             hcCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628          116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus       116 ~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ..||+-+|+++.|..   ++    +|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~G----~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---GG----KLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---CC----EEEecccC
Confidence            999999999999987   33    99999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.45  E-value=3.2e-06  Score=74.07  Aligned_cols=75  Identities=13%  Similarity=0.063  Sum_probs=53.8

Q ss_pred             eeccCCc-eEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEeccCCCChH
Q 019628            9 DIGSGNF-GVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELF   86 (338)
Q Consensus         9 ~LG~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~   86 (338)
                      .|-.|.. +.||++...  +..+.+|......  ...+.+|+.+++.+. +--+.+++.+....+..++||++++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555666 788999764  4678888776543  346778988888874 344667777777666788999999987765


Q ss_pred             H
Q 019628           87 E   87 (338)
Q Consensus        87 ~   87 (338)
                      .
T Consensus        81 ~   81 (244)
T cd05150          81 A   81 (244)
T ss_pred             H
Confidence            4

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=6.9e-06  Score=78.80  Aligned_cols=137  Identities=19%  Similarity=0.180  Sum_probs=87.1

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCc--------------------------------cccHHH------HHHH
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--------------------------------KIDEHV------QREI   49 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------------~~~~~~------~~E~   49 (338)
                      +.||.-+.|.||+|+-+. |+.||||+-+.+-                                ...+.+      .+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            678999999999999984 9999999975420                                001111      2232


Q ss_pred             HHH----hcCCCCC------cceeEEEEEcCCeEEEEEeccCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHHHhhhc
Q 019628           50 MNH----RSLKHPN------IVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSM  117 (338)
Q Consensus        50 ~~l----~~l~h~~------Iv~~~~~~~~~~~~~iv~e~~~~~~L~~--~i~~~~~l~~~~~~~i~~qi~~al~~LH~~  117 (338)
                      +..    +.++|-+      |.++|..+  ...-.++||||+|..+.+  .|.+. .++...+..-+.+...  +-|=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHhc
Confidence            222    2223444      44443332  245689999999976654  44443 4666644443333322  223357


Q ss_pred             CceecCCCCCcEEecCC--CCCcEEEeecCCCccc
Q 019628          118 QICHRDLKLENTLLDGS--TAPRVKICDFGYSKSS  150 (338)
Q Consensus       118 ~iiH~Dlkp~NIl~~~~--~~~~ikL~Dfg~a~~~  150 (338)
                      |++|+|-.|.||++..+  +++.+.+.|||+....
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            89999999999999753  3568999999997743

>PRK10593 hypothetical protein; Provisional

Probab=98.29  E-value=2e-05  Score=71.19  Aligned_cols=77  Identities=13%  Similarity=0.042  Sum_probs=56.2

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC---CCcceeEEEEEcC---CeEEEEEec
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH---PNIVRFKEVLLTP---THLAIVMEY   79 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h---~~Iv~~~~~~~~~---~~~~iv~e~   79 (338)
                      -.+.||.|..+.||..... ++ .+.+|.. +.......+..|...++.+..   -.+.++++++..+   +.-++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDS-QG-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcC-CC-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3568999999999999754 23 4667764 332234688899999988853   3678888777543   568999999


Q ss_pred             cCCCCh
Q 019628           80 AAGGEL   85 (338)
Q Consensus        80 ~~~~~L   85 (338)
                      ++|.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.26  E-value=7.1e-06  Score=71.53  Aligned_cols=74  Identities=11%  Similarity=0.012  Sum_probs=47.0

Q ss_pred             eeeeccCCce-EEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC---CcceeEEEEEcC---CeEEEEEec
Q 019628            7 VKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHP---NIVRFKEVLLTP---THLAIVMEY   79 (338)
Q Consensus         7 ~~~LG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~---~Iv~~~~~~~~~---~~~~iv~e~   79 (338)
                      ++.|+.|+.+ .||++.     ..+++|..+. ......+.+|..+++.+...   -+.+++......   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            4567877776 588762     3477886544 33345788999999887532   344444433322   234789999


Q ss_pred             cCCCChH
Q 019628           80 AAGGELF   86 (338)
Q Consensus        80 ~~~~~L~   86 (338)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9986663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.25  E-value=1.9e-05  Score=68.67  Aligned_cols=75  Identities=16%  Similarity=0.226  Sum_probs=49.9

Q ss_pred             eeeeccCCceEEEEEEEcC-CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeEEEEEcCCeEEEEEeccCCCC
Q 019628            7 VKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN-IVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      ++.|..|-...||++.... .++.|++|+........-...+|+.+++.+...+ ..+++..+.  +  .++|||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            4678888889999997643 2567889976544332234467888888885433 344444332  2  37999999876


Q ss_pred             h
Q 019628           85 L   85 (338)
Q Consensus        85 L   85 (338)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.23  E-value=1.7e-07  Score=97.02  Aligned_cols=206  Identities=15%  Similarity=0.077  Sum_probs=140.8

Q ss_pred             HHHHHHhcCCCCCcceeEEEEEcC--CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhc---
Q 019628           47 REIMNHRSLKHPNIVRFKEVLLTP--THLAIVMEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSM---  117 (338)
Q Consensus        47 ~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~iv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~---  117 (338)
                      .|...++...|+++...+.-....  ...|..++++.+|.++..|.+.    ..+.+..+.....+.+.+..-+|+.   
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            344455667899888766554433  3468899999999999998643    2344445555555657888887764   


Q ss_pred             --CceecCCCCCcEEecCCCCCcEEEeecCCCccc-ccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHH
Q 019628          118 --QICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML  194 (338)
Q Consensus       118 --~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll  194 (338)
                        -.+|++||+.|.+|..+-  +++++++|+.+.. ..........+++.|++|++.+.-.++.+ +|+|+.|+-+|...
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny--~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNY--NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRS 1434 (2724)
T ss_pred             CccchhhhhhhhccceecCC--cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHh
Confidence              278999999999996544  7999999999832 22233345678889999999887777555 89999999999998


Q ss_pred             cCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          195 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       195 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      -|..+|..     ..+...+.+....-.+....-.|.++......+|-..-..||.-...+.-+.|
T Consensus      1435 ~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1435 DGNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             cccHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            88777642     22233333322222221111234455556666666777899999888887776

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.16  E-value=2e-05  Score=64.25  Aligned_cols=126  Identities=18%  Similarity=0.173  Sum_probs=87.8

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcce-eEEEEEcCCeEEEEEeccCCCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVR-FKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~-~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      ..+.||+|++|.||++...  |..+|+|+-+ .......++.|.++|..++..++-. +|.+.    ...+.|||+.|-.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence            4578999999999999874  7789999654 4455678999999999998766644 44332    2235599999888


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCC--CcEEecCCCCCcEEEeecCCCc
Q 019628           85 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKL--ENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        85 L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp--~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      |.+.-...   ...+    +..++.+---|-..||-|..|.-  .||++...   .+.|+||..|+
T Consensus        99 L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~---~~~iIDFd~At  154 (201)
T COG2112          99 LGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR---DVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCC---cEEEEEccchh
Confidence            87655321   2222    33444444446677999998863  36666322   68999999776

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.06  E-value=2.4e-05  Score=70.64  Aligned_cols=136  Identities=18%  Similarity=0.151  Sum_probs=80.7

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeEEE------EEcCCeEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFKEV------LLTPTHLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~------~~~~~~~~iv~e   78 (338)
                      ++.|..|....+|++...  +..+++|+...  .....+..|+.++..+.+.+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            667888888899998653  45688998764  23456777888877774332  4444331      123456789999


Q ss_pred             ccCCCChHH-----------HH---Hh-cCCCCH--------HHHH------------HHHHHHHHHHHHhhh-------
Q 019628           79 YAAGGELFE-----------RI---CN-AGRFSE--------DEAR------------FFFQQLISGVSYCHS-------  116 (338)
Q Consensus        79 ~~~~~~L~~-----------~i---~~-~~~l~~--------~~~~------------~i~~qi~~al~~LH~-------  116 (338)
                      +++|..+..           .+   .. ...+..        .-..            .....+..++.++.+       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999866421           01   00 000000        0000            011112233444442       


Q ss_pred             cCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       117 ~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      .+++|+|+.|.||+++++.  .+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCc--eEEEeehhhhc
Confidence            4799999999999997532  45799998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.06  E-value=0.00019  Score=67.03  Aligned_cols=76  Identities=17%  Similarity=0.130  Sum_probs=54.5

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeec-----Cc---cccHHHHHHHHHHhcCC---CCCcceeEEEEEcCCeEEE
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIER-----GQ---KIDEHVQREIMNHRSLK---HPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+.||.|.++.||++.....++.++||.-..     ++   ....+...|.+.|+.+.   ..++.+++.+  ++...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            5689999999999999974446899997542     11   23356777888887763   3467777765  4466789


Q ss_pred             EEeccCCCC
Q 019628           76 VMEYAAGGE   84 (338)
Q Consensus        76 v~e~~~~~~   84 (338)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.05  E-value=3.2e-05  Score=68.30  Aligned_cols=131  Identities=14%  Similarity=0.090  Sum_probs=77.1

Q ss_pred             eeccCCceEEEEEEEcCCCcEEEEEEeecCcccc-HHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEEeccCCCChH
Q 019628            9 DIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVMEYAAGGELF   86 (338)
Q Consensus         9 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~e~~~~~~L~   86 (338)
                      .+..|-.+.+|++..  +++.+++|......... -...+|..+++.+...++ .+++...  .  -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence            456688889998873  56778899765433221 245789999988865444 3344332  2  26899999986543


Q ss_pred             HH----------H----H---hc----CCCCH-HHHHHHHHHH---------HHHHHHhhh--------cCceecCCCCC
Q 019628           87 ER----------I----C---NA----GRFSE-DEARFFFQQL---------ISGVSYCHS--------MQICHRDLKLE  127 (338)
Q Consensus        87 ~~----------i----~---~~----~~l~~-~~~~~i~~qi---------~~al~~LH~--------~~iiH~Dlkp~  127 (338)
                      ..          +    .   ..    .+++. ..+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            11          1    1   00    01111 2222322222         111222211        25899999999


Q ss_pred             cEEecCCCCCcEEEeecCCCc
Q 019628          128 NTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       128 NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      ||++++++   +.|+||..|.
T Consensus       157 Nil~~~~~---~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG---LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC---CEEEeccccC
Confidence            99997543   7899998776

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.99  E-value=4.7e-05  Score=69.05  Aligned_cols=136  Identities=20%  Similarity=0.252  Sum_probs=95.7

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----------------------ccccH-----HHHHHHHHHhcCCCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----------------------QKIDE-----HVQREIMNHRSLKHP   58 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~-----~~~~E~~~l~~l~h~   58 (338)
                      |-.+|..|.-+.||.|... +|..+|||+.+.+                      .....     =...|++.|.++...
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            5567889999999999876 7778999998642                      00111     135688888888765


Q ss_pred             CcceeEEEEEcCCeEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcCceecCCCCCcEEecCCCC
Q 019628           59 NIVRFKEVLLTPTHLAIVMEYAAGGEL-FERICNAGRFSEDEARFFFQQLISGVSYC-HSMQICHRDLKLENTLLDGSTA  136 (338)
Q Consensus        59 ~Iv~~~~~~~~~~~~~iv~e~~~~~~L-~~~i~~~~~l~~~~~~~i~~qi~~al~~L-H~~~iiH~Dlkp~NIl~~~~~~  136 (338)
                      +|.-.--+..  ..-.+||+++....- .-.| +...++...+..+-.|++.-+.-| |.+++||.||.--|+|+.   .
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh---d  300 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH---D  300 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE---C
Confidence            5433222222  234689999954222 2222 334688888999999999988887 466999999999999995   3


Q ss_pred             CcEEEeecCCCc
Q 019628          137 PRVKICDFGYSK  148 (338)
Q Consensus       137 ~~ikL~Dfg~a~  148 (338)
                      |.+.++|.+-+.
T Consensus       301 G~lyiIDVSQSV  312 (520)
T KOG2270|consen  301 GKLYIIDVSQSV  312 (520)
T ss_pred             CEEEEEEccccc
Confidence            379999998665

>PRK05231 homoserine kinase; Provisional

Probab=97.92  E-value=0.00012  Score=66.76  Aligned_cols=74  Identities=12%  Similarity=0.056  Sum_probs=45.0

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeEE------EEEcCCeEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFKE------VLLTPTHLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~------~~~~~~~~~iv~e   78 (338)
                      ++.|+.|....+|++...  +..+++|+...  ...+.+..|+.+++.|...+  +.+++.      +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            456777887899998764  33688998752  22344555666666653222  333332      1122456789999


Q ss_pred             ccCCCC
Q 019628           79 YAAGGE   84 (338)
Q Consensus        79 ~~~~~~   84 (338)
                      |++|..
T Consensus       103 ~l~G~~  108 (319)
T PRK05231        103 FLEGKW  108 (319)
T ss_pred             ecCCCC
Confidence            998864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.87  E-value=8.7e-06  Score=72.50  Aligned_cols=131  Identities=16%  Similarity=0.194  Sum_probs=91.9

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---------------------c--HHHHHHHHHHhcCCC-C-
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---------------------D--EHVQREIMNHRSLKH-P-   58 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------~--~~~~~E~~~l~~l~h-~-   58 (338)
                      |.++.+||-|.-+.||.+-+. .|+..++|.-+.+...                     .  -...+|...|+.|.. . 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            456789999999999999886 6788899965332110                     0  123567777777743 2 


Q ss_pred             CcceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCc
Q 019628           59 NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR  138 (338)
Q Consensus        59 ~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~  138 (338)
                      -|.+.+++    +.-++|||++.|-+|.+.-.      ...+..+...++.-+.-|..+|+||+|+.--||++++..  +
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~--~  240 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD--K  240 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC--C
Confidence            23444332    45689999999887755331      122345556666677778899999999999999997544  8


Q ss_pred             EEEeecCCC
Q 019628          139 VKICDFGYS  147 (338)
Q Consensus       139 ikL~Dfg~a  147 (338)
                      ++++||--+
T Consensus       241 i~vIDFPQm  249 (465)
T KOG2268|consen  241 IVVIDFPQM  249 (465)
T ss_pred             EEEeechHh
Confidence            999999643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.87  E-value=0.00014  Score=66.15  Aligned_cols=138  Identities=17%  Similarity=0.177  Sum_probs=79.7

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeEEEE------EcCCeEEEEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFKEVL------LTPTHLAIVM   77 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~------~~~~~~~iv~   77 (338)
                      .++.++.|....+|++...  +..+++|+..... ....+..|+.++..|...+  +.+++...      ...+..++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             eccccCCccccceEEEEeC--CCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            3667888888899998753  3357789765422 2345667777777774322  34443321      1235678999


Q ss_pred             eccCCCChH-----------HHH---Hh-cCCCC--------HHH-----HH----------HHHHHHHHHHHHhh----
Q 019628           78 EYAAGGELF-----------ERI---CN-AGRFS--------EDE-----AR----------FFFQQLISGVSYCH----  115 (338)
Q Consensus        78 e~~~~~~L~-----------~~i---~~-~~~l~--------~~~-----~~----------~i~~qi~~al~~LH----  115 (338)
                      +|++|.++.           ..+   .. ...++        ...     ..          .....+...++++.    
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885431           111   00 00110        000     00          00112233455553    


Q ss_pred             ---hcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          116 ---SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       116 ---~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                         ..+++|+|+.+.||+++.+.  ...|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDS--VKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence               26899999999999997543  46899999765

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.84  E-value=0.0002  Score=64.76  Aligned_cols=76  Identities=13%  Similarity=0.129  Sum_probs=51.0

Q ss_pred             eeeeccCCceEEEEEEEcC------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEEec
Q 019628            7 VKDIGSGNFGVAKLVRDKW------TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~e~   79 (338)
                      ++.|..|--..||++....      .++.+++|+............+|..+++.+...++ .+++.++. +   ..|++|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            4567777778999998643      25789999876554444567788888888864443 34555543 2   258999


Q ss_pred             cCCCChH
Q 019628           80 AAGGELF   86 (338)
Q Consensus        80 ~~~~~L~   86 (338)
                      ++|.++.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.71  E-value=0.00016  Score=60.69  Aligned_cols=97  Identities=14%  Similarity=0.093  Sum_probs=75.8

Q ss_pred             HHHHHHHhcCCC-CCcceeEEEEEcCCeEEEEEeccCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHhhh---cC
Q 019628           46 QREIMNHRSLKH-PNIVRFKEVLLTPTHLAIVMEYAAGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCHS---MQ  118 (338)
Q Consensus        46 ~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~---~i~~~~~l~~~~~~~i~~qi~~al~~LH~---~~  118 (338)
                      ..|..+++.+.+ +++.+++|+|-   . .++.||...+++..   .+......++....+|+.+++..+.+|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888876 69999999983   2 46889997665542   12222346899999999999999999987   35


Q ss_pred             ceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          119 ICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       119 iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      +.-.|++|+|+-+++++  ++|++|...+.
T Consensus        83 ~~lcDv~~~nfgv~~~~--~lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDG--RLKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCC--cEEEEechhcc
Confidence            88899999999997544  89999998664

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02236 choline kinase

Probab=97.51  E-value=0.0015  Score=60.26  Aligned_cols=137  Identities=16%  Similarity=0.194  Sum_probs=80.5

Q ss_pred             eeeeccCCceEEEEEEEcC----CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcc-eeEEEEEcCCeEEEEEeccC
Q 019628            7 VKDIGSGNFGVAKLVRDKW----TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV-RFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv-~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++.|-.|-...+|++....    .++.|++|+........-...+|..+++.+..-++. ++++.+.. .   .|.+|++
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            4556558888999986432    246889998765433322347788888888654443 45565533 2   4788888


Q ss_pred             CCChHHH----------H----H---hcC------CCCHHHHHHHHHHHH-----------------HHHHHh----h--
Q 019628           82 GGELFER----------I----C---NAG------RFSEDEARFFFQQLI-----------------SGVSYC----H--  115 (338)
Q Consensus        82 ~~~L~~~----------i----~---~~~------~l~~~~~~~i~~qi~-----------------~al~~L----H--  115 (338)
                      +.+|...          +    .   ...      ....+.+..+..++.                 ..+..|    .  
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665321          1    0   000      011233334432221                 111111    1  


Q ss_pred             --hcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          116 --SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       116 --~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                        ...++|+|+++.||++++.. +.+.++||..|.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence              23689999999999997432 369999998765

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.39  E-value=0.0017  Score=58.06  Aligned_cols=30  Identities=23%  Similarity=0.350  Sum_probs=23.7

Q ss_pred             CceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       118 ~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      .++|+|++|.||++++++ ...-|.||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~-~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDA-RVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCC-CEEEEECcHhcc
Confidence            489999999999997532 134699999776

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.34  E-value=0.0032  Score=57.78  Aligned_cols=75  Identities=15%  Similarity=0.153  Sum_probs=47.8

Q ss_pred             eeeeccCCceEEEEEEEcCC---CcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEEeccCC
Q 019628            7 VKDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      ++.|..|--..+|++.....   +..|++|+........-...+|..+++.+..-++ .++++++. ++   +|.+|++|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            45565577778998875422   2378899876543333344678888888875555 34555552 22   48888877


Q ss_pred             CCh
Q 019628           83 GEL   85 (338)
Q Consensus        83 ~~L   85 (338)
                      .+|
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            655

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.33  E-value=0.0023  Score=57.95  Aligned_cols=136  Identities=18%  Similarity=0.166  Sum_probs=80.8

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEeec-C--ccccHHHHHHHHHHhcCCCC--CcceeEEEEEcCC--eEEEEE
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-G--QKIDEHVQREIMNHRSLKHP--NIVRFKEVLLTPT--HLAIVM   77 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-~--~~~~~~~~~E~~~l~~l~h~--~Iv~~~~~~~~~~--~~~iv~   77 (338)
                      .+++.+..|.-..+|.....  ++.+++. .+. .  ........+|+.+++.+.--  -+...++++..+.  ..+.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            34555544444455666654  7788888 432 1  22335667888888777542  2334455555544  569999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHH-HHHHHHHHhhh----------------------------------------
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCHS----------------------------------------  116 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~-qi~~al~~LH~----------------------------------------  116 (338)
                      +|++|..+.....     +...-..++. .+...|.-||+                                        
T Consensus       105 ~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         105 EWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             EEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            9998843322111     0111112222 44444444443                                        


Q ss_pred             ------------------cCceecCCCCCcEEecCCCCCcEEEeecCCCccc
Q 019628          117 ------------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS  150 (338)
Q Consensus       117 ------------------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~  150 (338)
                                        ..++|+|+.+.||++++..  .+-+.||+++...
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~--~~gVlDwe~~~lG  229 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR--PTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC--eeEEEeccccccC
Confidence                              3589999999999997665  4889999988743

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.31  E-value=0.0049  Score=56.68  Aligned_cols=80  Identities=18%  Similarity=0.106  Sum_probs=52.0

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeec-----C---ccccHHHHHHHHHHhcCC--CC-CcceeEEEEEcCCeEEEE
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIER-----G---QKIDEHVQREIMNHRSLK--HP-NIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~---~~~~~~~~~E~~~l~~l~--h~-~Iv~~~~~~~~~~~~~iv   76 (338)
                      +.||.|....||++.+...++.++||.-..     +   .....+...|...|+...  .| .+.++|.  .++....+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence            358999999999999864446899997532     1   223356667777776663  24 4555544  355666799


Q ss_pred             EeccCCC-ChHHHH
Q 019628           77 MEYAAGG-ELFERI   89 (338)
Q Consensus        77 ~e~~~~~-~L~~~i   89 (338)
                      ||+++.. .|...+
T Consensus        79 MEdL~~~~ilR~~L   92 (370)
T TIGR01767        79 MEDLSHHKIARKGL   92 (370)
T ss_pred             HhhCccchHHHHHH
Confidence            9999653 333444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.30  E-value=0.00086  Score=63.50  Aligned_cols=165  Identities=16%  Similarity=0.194  Sum_probs=101.0

Q ss_pred             HHHHHHHHHHhcCCCCCcceeEEEEEcC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCcee
Q 019628           43 EHVQREIMNHRSLKHPNIVRFKEVLLTP-THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH  121 (338)
Q Consensus        43 ~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH  121 (338)
                      ..+......++.+.|+|...++++.... ....+|||++ +.+|.+.+..+. +-...       +.       .+|+.|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s-------~~-------~~~~~~   90 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDES-------LL-------AHGVLH   90 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhh-------hc-------ccccce
Confidence            4566677889999999999998876543 4588999999 569999887553 21111       11       122222


Q ss_pred             cCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCC
Q 019628          122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE  201 (338)
Q Consensus       122 ~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~  201 (338)
                      -     |         .++.+| -+++.      ..+.+|                 +++||||+|.++.++.-|...|.
T Consensus        91 ~-----~---------~~~~td-~~~t~------~~~~~~-----------------pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   91 L-----N---------IIYITD-HFLTK------YPSPIG-----------------PKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             e-----h---------hhhccc-ccccc------CCCCCC-----------------cchhhhhHHHHHHHHHHhhHHHH
Confidence            1     1         234444 11110      011111                 24899999999999999987776


Q ss_pred             CCCChHHHHHHHhhHhhccccC-------CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          202 DPEDPKNFRKTIGRILSVHYSF-------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .....+......+ ....+...       --...+....+++..+|+-..|..||...++..|+-|.+
T Consensus       133 ~~~~s~~l~~i~k-~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e  199 (725)
T KOG1093|consen  133 ELTESEYLEILLK-YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE  199 (725)
T ss_pred             HHHHHHHHHHHHH-hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence            5443333222211 00000000       001124556788999999999999999999999998854

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.27  E-value=0.0063  Score=56.97  Aligned_cols=80  Identities=19%  Similarity=0.162  Sum_probs=53.9

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeec-----Cc---cccHHHHHHHHHHhcCC---CCCcceeEEEEEcCCeEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-----GQ---KIDEHVQREIMNHRSLK---HPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~   74 (338)
                      -.+.||.|....||++.+.  +..++||.-..     +.   ....+...|...|+.+.   ..++.+++.++.  +.-+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3678999999999999874  45688997652     22   13345556677776653   247888887765  4466


Q ss_pred             EEEeccCC--CChHHHH
Q 019628           75 IVMEYAAG--GELFERI   89 (338)
Q Consensus        75 iv~e~~~~--~~L~~~i   89 (338)
                      ++||++++  ..+.+.+
T Consensus       112 lvME~L~~~~~ilr~~L  128 (418)
T PLN02756        112 IGMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEEeecCCcceehhhhh
Confidence            78999976  2444444

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.99  E-value=0.029  Score=50.86  Aligned_cols=29  Identities=34%  Similarity=0.665  Sum_probs=24.4

Q ss_pred             cCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       117 ~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      .+++|+|+.+.||+++. +  .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence            57999999999999975 2  58999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.97  E-value=0.011  Score=53.64  Aligned_cols=29  Identities=21%  Similarity=0.281  Sum_probs=24.9

Q ss_pred             CceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       118 ~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      +++|+|+.+.|+|++.++  .+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~--~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR--GGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC--CEEEEEhhhcc
Confidence            799999999999997554  68899998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.94  E-value=0.01  Score=55.28  Aligned_cols=81  Identities=19%  Similarity=0.122  Sum_probs=54.4

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeec----C---ccccHHHHHHHHHHhcCC--CC-CcceeEEEEEcCCeEEEE
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIER----G---QKIDEHVQREIMNHRSLK--HP-NIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~E~~~l~~l~--h~-~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++.||.|.-.-||++.+...++.++||.-..    +   .....+..-|...|+...  .| .+.++|.  .++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            6789999999999999854456799987532    1   123356777888877663  34 4566654  455667789


Q ss_pred             EeccCCC-ChHHHH
Q 019628           77 MEYAAGG-ELFERI   89 (338)
Q Consensus        77 ~e~~~~~-~L~~~i   89 (338)
                      ||+++.. .|...+
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            9999653 344443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.84  E-value=0.0042  Score=53.06  Aligned_cols=55  Identities=16%  Similarity=0.109  Sum_probs=33.7

Q ss_pred             CcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEEeccCCCCh
Q 019628           27 RELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus        27 ~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      ++.|++++........-....|..+++.++..++ .++++.+. ++   .|.+|++|.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~-~g---~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFE-NG---RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEET-TE---EEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcC-CC---cEEEEeccccc
Confidence            4678899887765555667788888888865454 44555443 22   45688876553

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.54  E-value=0.015  Score=52.21  Aligned_cols=75  Identities=11%  Similarity=0.069  Sum_probs=48.9

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeEEEEEcCCeEEEEEeccC
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK---HPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      +-.+.+|-|..+.+|++.  .+++.+.+|+-.  ......+..|..-|+.|.   .-.+.+++.+....+.-+++|||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            346778989999999988  467889999766  334467888888887773   4457788888877777799999997


Q ss_pred             CC
Q 019628           82 GG   83 (338)
Q Consensus        82 ~~   83 (338)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            65

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.46  E-value=0.013  Score=54.26  Aligned_cols=60  Identities=17%  Similarity=0.112  Sum_probs=45.0

Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh-hcCceecCCCCCcEEecC
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDG  133 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH-~~~iiH~Dlkp~NIl~~~  133 (338)
                      ..++-+|..|.++..+++.. ..++..++.++.-.+.|+--+- --+++|.|+.|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            45666788888988888654 4577777777777776665543 458999999999999953

>PRK06148 hypothetical protein; Provisional

Probab=96.45  E-value=0.071  Score=56.34  Aligned_cols=138  Identities=15%  Similarity=0.205  Sum_probs=76.3

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-------CCCcceeE-----EEEEc-CC--e
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-------HPNIVRFK-----EVLLT-PT--H   72 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-------h~~Iv~~~-----~~~~~-~~--~   72 (338)
                      +.|+ |..-.+|++... +|..+++|+.+... ....+..|...+..|.       -|.+++-.     ..... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTD-DGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeC-CCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            5565 456778888753 56689999887643 2334445555555442       23333311     11111 22  5


Q ss_pred             EEEEEeccCCCChHHH-------HHh--------------cC------CCC-----------------HHHHHHHHHHHH
Q 019628           73 LAIVMEYAAGGELFER-------ICN--------------AG------RFS-----------------EDEARFFFQQLI  108 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~-------i~~--------------~~------~l~-----------------~~~~~~i~~qi~  108 (338)
                      ++.+++|++|..+...       +..              ..      .+.                 ....+.++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            6788999998776541       100              00      000                 011223333343


Q ss_pred             HHHHH-----hh--hcCceecCCCCCcEEecCCCCCcEE-EeecCCCc
Q 019628          109 SGVSY-----CH--SMQICHRDLKLENTLLDGSTAPRVK-ICDFGYSK  148 (338)
Q Consensus       109 ~al~~-----LH--~~~iiH~Dlkp~NIl~~~~~~~~ik-L~Dfg~a~  148 (338)
                      ..+.-     +.  ..++||+|+.+.|||++.+..+++. |+|||-+.
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            33321     21  2479999999999999765433455 99999775

>PTZ00384 choline kinase; Provisional

Probab=96.40  E-value=0.065  Score=50.16  Aligned_cols=77  Identities=9%  Similarity=-0.000  Sum_probs=46.0

Q ss_pred             EeeeeccCCceEEEEEEEcCC-CcE-----EEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEEe
Q 019628            6 IVKDIGSGNFGVAKLVRDKWT-REL-----LAVKFIERGQKIDEHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~-~~~-----vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~e   78 (338)
                      -++.|..|--..+|++..... +..     |.++.........-...+|+.+++.+...++ .++++.|..    +++.|
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            445665688889999975432 122     4444322222222234678999999865544 455665532    58899


Q ss_pred             ccCCCChH
Q 019628           79 YAAGGELF   86 (338)
Q Consensus        79 ~~~~~~L~   86 (338)
                      |++|.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99886653

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.38  E-value=0.035  Score=50.73  Aligned_cols=131  Identities=18%  Similarity=0.180  Sum_probs=76.6

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC------cceeEE----EEEcCCeEEEEEeccCCC
Q 019628           14 NFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN------IVRFKE----VLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus        14 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~------Iv~~~~----~~~~~~~~~iv~e~~~~~   83 (338)
                      .-..||++... +|+ +++|+.... .....+..|+..++.|.-.+      +...=+    ....+...+-+++|++|.
T Consensus        37 ~eN~~f~~~~~-~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTE-DGR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEec-CCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            44568888875 333 489988877 66677888888888874222      122111    111113778899999987


Q ss_pred             ChHH-----HH----------H----hcC---C-----CCHH----H---------HHHHHHHHHHHHHHhhh-------
Q 019628           84 ELFE-----RI----------C----NAG---R-----FSED----E---------ARFFFQQLISGVSYCHS-------  116 (338)
Q Consensus        84 ~L~~-----~i----------~----~~~---~-----l~~~----~---------~~~i~~qi~~al~~LH~-------  116 (338)
                      .+..     .+          .    ...   +     ....    .         -.....++...++.+.+       
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7662     00          0    000   0     1111    0         01122334444444442       


Q ss_pred             c-C--ceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          117 M-Q--ICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       117 ~-~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      . +  +||+|+.|.||+++.... -+.+.|||-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence            3 3  999999999999976653 37899999665

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.38  E-value=0.09  Score=48.17  Aligned_cols=70  Identities=11%  Similarity=0.011  Sum_probs=43.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeE---E--EEEcCCeEEEEEeccCCCC
Q 019628           14 NFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFK---E--VLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus        14 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~---~--~~~~~~~~~iv~e~~~~~~   84 (338)
                      .-..||++... ++..+++|+.+.+......+..|+..+..|....  ++...   +  +...++..+.++++++|..
T Consensus        37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34568888753 4567899987654445566778888877764211  22211   1  1223456788999998754

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.27  E-value=0.031  Score=50.24  Aligned_cols=31  Identities=26%  Similarity=0.458  Sum_probs=25.5

Q ss_pred             CceecCCCCCcEEecCCCCC---cEEEeecCCCc
Q 019628          118 QICHRDLKLENTLLDGSTAP---RVKICDFGYSK  148 (338)
Q Consensus       118 ~iiH~Dlkp~NIl~~~~~~~---~ikL~Dfg~a~  148 (338)
                      -++|||+++.|||+..+..|   .+++.||.+++
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeecccccc
Confidence            38999999999999655443   68999998765

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.09  E-value=0.04  Score=50.52  Aligned_cols=122  Identities=21%  Similarity=0.218  Sum_probs=75.4

Q ss_pred             CCCCCcceeEEEEEc-CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEec
Q 019628           55 LKHPNIVRFKEVLLT-PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLD  132 (338)
Q Consensus        55 l~h~~Iv~~~~~~~~-~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~  132 (338)
                      ...++..+.+-+-.+ ..+.|++|++- |+++. .++   .-...++..++.+.+..+.-+..+ .+-|||+.-.||||+
T Consensus       282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId  356 (488)
T COG5072         282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID  356 (488)
T ss_pred             ccchhhhcceEEecCCceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence            334444444444322 34678888876 55553 222   235677888999999888888766 789999999999997


Q ss_pred             CCCCCcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHH
Q 019628          133 GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL  190 (338)
Q Consensus       133 ~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  190 (338)
                         .|+|.|+||-+++....+    ..+.....-.|-.+.|.. + ..-+||-+.-.+
T Consensus       357 ---~GnvtLIDfklsRl~~~q----~~isy~rldhp~lF~G~d-d-~QFeIYrlMr~l  405 (488)
T COG5072         357 ---EGNVTLIDFKLSRLSYSQ----GIISYNRLDHPDLFNGVD-D-YQFEIYRLMRRL  405 (488)
T ss_pred             ---cCceEEEEeeeeecccCC----ceeeccccCchhhhcCcc-c-eeeeHHHHHHHH
Confidence               347999999999832211    122222333455555433 2 225777654433

>PTZ00296 choline kinase; Provisional

Probab=95.53  E-value=0.24  Score=47.29  Aligned_cols=76  Identities=16%  Similarity=0.055  Sum_probs=47.7

Q ss_pred             EeeeeccCCceEEEEEEEcC--------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcc-eeEEEEEcCCeEEEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKW--------TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV-RFKEVLLTPTHLAIV   76 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv-~~~~~~~~~~~~~iv   76 (338)
                      -++.|..|---.+|++....        .++.|.+++...+....-...+|..+++.+..-+|- ++++.+. +   +.|
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I  184 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI  184 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence            45667667777889887542        146788998765443333456688888777654443 4555543 2   346


Q ss_pred             EeccCCCCh
Q 019628           77 MEYAAGGEL   85 (338)
Q Consensus        77 ~e~~~~~~L   85 (338)
                      .+|++|.+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            888887644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	338
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-144
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-144
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-143
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-143
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-140
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-139
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-55
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-50
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-50
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-50
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-50
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-50
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-50
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-49
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-49
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-49
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-49
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-48
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-48
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-47
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-47
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-46
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-46
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-46
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-42
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-42
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-42
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-41
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-41
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-41
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-41
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-41
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-41
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-41
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-41
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-41
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-41
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-41
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-41
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-40
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-39
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-39
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-39
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-39
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-39
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-39
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-39
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-39
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-38
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-38
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-38
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-38
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-38
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-38
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-38
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-38
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-38
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-38
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-38
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-38
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-38
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-38
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-38
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-38
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-38
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-38
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-38
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-38
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-38
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-38
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-38
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-38
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-38
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-38
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-38
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-38
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-37
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-37
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-37
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-37
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-37
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-37
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-37
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-37
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-37
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-37
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-37
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-37
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-37
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-37
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-37
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-37
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-37
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-37
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-37
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-37
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-37
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-37
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-37
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-37
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-37
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-37
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-37
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-37
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-37
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-37
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-37
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-37
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-37
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-37
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-37
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-37
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-37
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-37
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-37
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-36
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-36
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-36
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-36
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-36
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-36
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-36
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-36
3soa_A	444	Full-Length Human Camkii Length = 444		3e-36
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-36
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-36
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-36
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-36
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-35
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-35
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-35
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-35
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-35
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-34
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-34
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-33
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-33
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-33
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-33
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-33
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-33
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-32
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-32
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-32
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-32
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-32
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-32
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-32
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-32
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-32
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-32
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-32
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-32
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-32
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-32
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-32
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-32
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-32
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-32
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-32
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-32
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-32
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-32
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-32
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-32
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-32
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-32
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-32
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-32
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-32
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-32
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-32
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-32
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-32
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-32
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-32
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-32
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-32
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-32
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-32
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-32
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-32
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-32
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-31
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-31
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-31
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-31
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-31
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-31
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-31
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-31
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-31
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-31
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-31
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-31
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-31
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-31
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-31
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-31
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-31
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-31
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-31
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-31
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-31
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-31
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-31
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-31
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-31
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-31
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-31
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-31
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-31
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-31
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-31
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-31
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-31
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-31
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-31
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-31
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-31
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-31
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-31
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-31
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-31
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-31
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-31
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-30
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-30
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-30
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-30
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-30
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-30
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-30
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-30
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-29
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-29
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-29
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-29
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-29
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-29
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-29
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-29
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-29
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-29
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-28
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-28
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-28
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-28
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-28
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-28
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-28
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-28
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-28
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-28
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-28
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-28
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-28
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-27
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-27
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-27
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-27
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-27
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-27
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-27
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-27
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-27
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-27
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-27
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-27
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-27
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-27
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-27
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-27
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-27
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-26
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-26
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-26
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-26
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-26
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-26
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-26
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-26
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-26
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-26
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-26
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-26
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-26
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-25
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-25
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-24
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-24
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-24
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-24
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-24
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-24
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-24
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-24
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-24
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-23
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-23
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-23
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-23
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-23
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-23
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-23
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-23
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-23
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-23
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-22
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-22
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-22
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-22
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-22
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-22
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-22
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-22
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-22
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-22
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-22
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-22
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-22
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-22
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-22
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-22
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-22
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-22
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-22
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-22
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-22
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-22
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-22
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-22
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-22
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-22
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-22
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-22
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-22
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-22
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-22
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-22
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-22
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-22
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-22
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-21
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-21
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-21
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-21
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-21
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-21
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-21
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-21
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-21
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-21
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-21
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-21
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-21
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-21
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-21
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-21
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-21
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-21
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-21
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-21
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-21
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-20
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-20
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-20
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-20
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-20
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-20
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-20
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-20
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-20
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-20
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-20
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-20
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-20
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-20
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-20
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-20
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-19
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-19
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-19
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-19
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-19
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-19
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-19
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-19
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-18
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-18
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-18
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-18
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-18
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-18
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-18
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-18
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-18
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-18
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-18
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-18
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-18
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-18
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-18
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-18
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-18
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-17
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-17
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-16
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-15
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-13
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-13
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-11
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		7e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-11
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-11
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-11
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-11
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		9e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-11
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		8e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		8e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-07
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-07
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-07
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-07
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-07
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		8e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-06
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		4e-06
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		4e-06
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		4e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-05
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		1e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-05

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  508 bits (1309), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 239/315 (75%), Positives = 276/315 (87%), Gaps = 2/315 (0%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RYE+VKDIGSGNFGVA+L+RDK + EL+AVK+IERG+KIDE+V+REI+NHRSL+HPNIV
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 77
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 78  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 137
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGK+A
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 197
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIF
Sbjct: 198 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 257
Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKP 299
           VA+  KRI+IPEI+NH WFL+NLP +L    +   Q    + P QS+EE++ +I EAT P
Sbjct: 258 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQPGQSIEEIMQIIAEATVP 317
Query: 300 LEAPRVGGHLLGSSM 314
               +   H L  S+
Sbjct: 318 PAGTQNLNHYLTGSL 332

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  507 bits (1305), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 238/315 (75%), Positives = 276/315 (87%), Gaps = 2/315 (0%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RYE+VKDIGSGNFGVA+L+RDK + EL+AVK+IERG+KIDE+V+REI+NHRSL+HPNIV
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS APR+KIC FGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKP 299
           VA+  KRI+IPEI+NH WFL+NLP +L    +   Q  + + P QS+EE++ +I EAT P
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318
Query: 300 LEAPRVGGHLLGSSM 314
               +   H L  S+
Sbjct: 319 PAGTQNLNHYLTGSL 333

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  505 bits (1301), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 237/315 (75%), Positives = 275/315 (87%), Gaps = 2/315 (0%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RYE+VKDIGSGNFGVA+L+RDK + EL+AVK+IERG+KIDE+V+REI+NHRSL+HPNIV
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS APR+KIC FGYSKSSVLHSQPK TVGTPAYIAPEVL KKEYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKP 299
           VA+  KRI+IPEI+NH WFL+NLP +L    +   Q  + + P QS+EE++ +I EAT P
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318
Query: 300 LEAPRVGGHLLGSSM 314
               +   H L  S+
Sbjct: 319 PAGTQNLNHYLTGSL 333

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  504 bits (1299), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 237/315 (75%), Positives = 275/315 (87%), Gaps = 2/315 (0%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RYE+VKDIGSGNFGVA+L+RDK + EL+AVK+IERG+KI  +V+REI+NHRSL+HPNIV
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIV 78
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL KKEYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKP 299
           VA+  KRI+IPEI+NH WFL+NLP +L    +   Q  + + P QS+EE++ +I EAT P
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318
Query: 300 LEAPRVGGHLLGSSM 314
               +   H L  S+
Sbjct: 319 PAGTQNLNHYLTGSL 333

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  493 bits (1269), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 229/298 (76%), Positives = 266/298 (89%), Gaps = 2/298 (0%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RYE+VKDIG+GNFGVA+L+RDK   EL+AVK+IERG+KIDE+V+REI+NHRSL+HPNIV
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSY H+MQ+ H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAH 138
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS APR+KI DFGYSK+SVLHSQPKS VGTPAYIAPEVL KKEYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVA 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI RIL+V Y+ PDYV +S EC+HL+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 242 VANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEAT 297
           VA+  KRI+IPEI+NH WFL+NLP +L    +   Q  + + P QS+EE++ +I EAT
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEAT 316

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  491 bits (1265), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 232/301 (77%), Positives = 267/301 (88%), Gaps = 4/301 (1%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +RY+ VKDIGSGNFGVA+L+RDK T+EL+AVK+IERG  IDE+VQREI+NHRSL+HPNIV
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEARFFFQQL+SGVSYCHSMQICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
           RDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL ++EYDGKIA
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF 241
           DVWSCGVTLYVMLVGAYPFEDPE+P+++RKTI RILSV YS PD +R+S EC HL+SRIF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259
Query: 242 VANSEKRITIPEIKNHPWFLRNLPIEL---TEGGSWQSHDVNNPSQSLEEVLSLIHEATK 298
           VA+   RI+IPEIK H WFL+NLP +L   +  GS Q  +   P QSL+ ++ +I EAT 
Sbjct: 260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGS-QFQEPEQPMQSLDTIMQIISEATI 318
Query: 299 P 299
           P
Sbjct: 319 P 319

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  211 bits (537), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 121/266 (45%), Positives = 163/266 (61%), Gaps = 13/266 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG--QKIDEH--VQREIMNHRSLKHPN 59
           Y I + +G G+FG  KL     T++ +A+KFI R   +K D H  V+REI   + L+HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           I++  +V+ TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  +I
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            HRDLK EN LLD +    VKI DFG S      +  K++ G+P Y APEV+  K Y G 
Sbjct: 130 VHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             DVWSCG+ LYVMLVG  PF+D   P  F+K    + S  Y  PD+  +S   + L+ R
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLIRR 241
Query: 240 IFVANSEKRITIPEIKNHPWFLRNLP 265
           + VA+  +RITI EI+  PWF  NLP
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLP 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  194 bits (493), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 107/267 (40%), Positives = 150/267 (56%), Gaps = 14/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE-----HVQREIMNHRSLKHP 58
           Y +   +G G FG  K+   + T   +AVK + R QKI        ++REI N +  +HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           +I++  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S V YCH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           + HRDLK EN LLD       KI DFG S         +++ G+P Y APEV++ + Y G
Sbjct: 132 VVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 238
              D+WSCGV LY +L G  PF+D   P  F+K  G +  +    P+Y+  S+    LL 
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI----PEYLNRSVAT--LLM 243
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLP 265
            +   +  KR TI +I+ H WF ++LP
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLP 270

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  194 bits (493), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 106/260 (40%), Positives = 148/260 (56%), Gaps = 11/260 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T + +AVK I++ Q     +Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANSEKRITIPEIKNHPWF 260
            + N  KR T+ +I    W 
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  194 bits (493), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 106/260 (40%), Positives = 148/260 (56%), Gaps = 11/260 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T + +AVK I++ Q     +Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANSEKRITIPEIKNHPWF 260
            + N  KR T+ +I    W 
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  194 bits (492), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 106/259 (40%), Positives = 148/259 (57%), Gaps = 11/259 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T   +A+K I++ Q     +Q   RE+   + L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH  +I 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S    +  +  +  G+P Y APE+   K+YDG  
Sbjct: 134 HRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL R 
Sbjct: 192 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRF 245
Query: 241 FVANSEKRITIPEIKNHPW 259
            V N  KR T+ +I    W
Sbjct: 246 LVLNPIKRGTLEQIMKDRW 264

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  194 bits (492), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 107/267 (40%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE-----HVQREIMNHRSLKHP 58
           Y +   +G G FG  K+   + T   +AVK + R QKI        ++REI N +  +HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           +I++  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S V YCH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           + HRDLK EN LLD       KI DFG S         + + G+P Y APEV++ + Y G
Sbjct: 132 VVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAG 189
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 238
              D+WSCGV LY +L G  PF+D   P  F+K  G +  +    P+Y+  S+    LL 
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI----PEYLNRSVAT--LLM 243
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLP 265
            +   +  KR TI +I+ H WF ++LP
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLP 270

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  194 bits (492), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 106/260 (40%), Positives = 147/260 (56%), Gaps = 11/260 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T + +AVK I++ Q     +Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANSEKRITIPEIKNHPWF 260
            + N  KR T+ +I    W 
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 148/260 (56%), Gaps = 11/260 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T + +AV+ I++ Q     +Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANSEKRITIPEIKNHPWF 260
            + N  KR T+ +I    W 
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 106/259 (40%), Positives = 147/259 (56%), Gaps = 11/259 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T   +A+K I++ Q     +Q   RE+   + L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH  +I 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   K+YDG  
Sbjct: 137 HRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL R 
Sbjct: 195 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRF 248
Query: 241 FVANSEKRITIPEIKNHPW 259
            V N  KR T+ +I    W
Sbjct: 249 LVLNPIKRGTLEQIMKDRW 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 147/260 (56%), Gaps = 11/260 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T + +AV+ I++ Q     +Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S      ++     G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANSEKRITIPEIKNHPWF 260
            + N  KR T+ +I    W 
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  190 bits (483), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 147/260 (56%), Gaps = 11/260 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T + +AVK I++ Q     +Q   RE+   + L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L +VMEYA+GGE+F+ +   G   E EAR  F+Q++S V YCH   I 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 129 HRDLKAENLLLDADM--NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL + 
Sbjct: 187 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 240
Query: 241 FVANSEKRITIPEIKNHPWF 260
            + N  KR T+ +I    W 
Sbjct: 241 LILNPSKRGTLEQIMKDRWM 260

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 105/259 (40%), Positives = 145/259 (55%), Gaps = 11/259 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y ++K IG GNF   KL R   T + +AVK I++ Q     +Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L +V EYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADX--NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y   S +C++LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--XSTDCENLLKKF 247
Query: 241 FVANSEKRITIPEIKNHPW 259
            + N  KR T+ +I    W
Sbjct: 248 LILNPSKRGTLEQIXKDRW 266

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  189 bits (479), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 111/286 (38%), Positives = 161/286 (56%), Gaps = 17/286 (5%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE-----HVQREIMNHRSLKHPNIVRFK 64
           +G G FG  K+ + + T   +AVK + R QKI        ++REI N +  +HP+I++  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
           +V+ TP+ + +VMEY +GGELF+ IC  GR  E E+R  FQQ++SGV YCH   + HRDL
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVW 184
           K EN LLD       KI DFG S         + + G+P Y APEV++ + Y G   D+W
Sbjct: 143 KPENVLLDAHM--NAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIW 200
Query: 185 SCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVAN 244
           S GV LY +L G  PF+D   P  F+K    I    +  P Y+  S+    LL  +   +
Sbjct: 201 SSGVILYALLCGTLPFDDDHVPTLFKKICDGI----FYTPQYLNPSVIS--LLKHMLQVD 254
Query: 245 SEKRITIPEIKNHPWFLRNLPIEL-TEGGSWQSHDVNNPSQSLEEV 289
             KR TI +I+ H WF ++LP  L  E  S+ S  +++  ++L+EV
Sbjct: 255 PMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDD--EALKEV 298

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  184 bits (468), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 110/271 (40%), Positives = 151/271 (55%), Gaps = 13/271 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPN 59
           Y+IVK +G G+FG  KL     T + +A+K I +       +   ++REI   R L+HP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           I++  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            HRDLK EN LLD      VKI DFG S      +  K++ G+P Y APEV++ K Y G 
Sbjct: 135 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             DVWSCGV LYVML    PF+D   P  F+     +    Y+ P +  +S     L+ R
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 246
Query: 240 IFVANSEKRITIPEIKNHPWFLRNLPIELTE 270
           + + N   RI+I EI    WF  +LP  L E
Sbjct: 247 MLIVNPLNRISIHEIMQDDWFKVDLPEYLLE 277

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  184 bits (466), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 108/266 (40%), Positives = 149/266 (56%), Gaps = 13/266 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPN 59
           Y+IVK +G G+FG  KL     T + +A+K I +       +   ++REI   R L+HP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           I++  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            HRDLK EN LLD      VKI DFG S      +  K++ G+P Y APEV++ K Y G 
Sbjct: 134 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             DVWSCGV LYVML    PF+D   P  F+     +    Y+ P +  +S     L+ R
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 245
Query: 240 IFVANSEKRITIPEIKNHPWFLRNLP 265
           + + N   RI+I EI    WF  +LP
Sbjct: 246 MLIVNPLNRISIHEIMQDDWFKVDLP 271

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 108/266 (40%), Positives = 149/266 (56%), Gaps = 13/266 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPN 59
           Y+IVK +G G+FG  KL     T + +A+K I +       +   ++REI   R L+HP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           I++  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            HRDLK EN LLD      VKI DFG S      +  K++ G+P Y APEV++ K Y G 
Sbjct: 129 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             DVWSCGV LYVML    PF+D   P  F+     +    Y+ P +  +S     L+ R
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 240
Query: 240 IFVANSEKRITIPEIKNHPWFLRNLP 265
           + + N   RI+I EI    WF  +LP
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFKVDLP 266

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 108/266 (40%), Positives = 149/266 (56%), Gaps = 13/266 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPN 59
           Y+IVK +G G+FG  KL     T + +A+K I +       +   ++REI   R L+HP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           I++  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            HRDLK EN LLD      VKI DFG S      +  K++ G+P Y APEV++ K Y G 
Sbjct: 125 VHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             DVWSCGV LYVML    PF+D   P  F+     +    Y+ P +  +S     L+ R
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 236
Query: 240 IFVANSEKRITIPEIKNHPWFLRNLP 265
           + + N   RI+I EI    WF  +LP
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFKVDLP 262

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  180 bits (457), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 107/260 (41%), Positives = 149/260 (57%), Gaps = 11/260 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNI 60
           Y + K IG GNF   KL R   T   +AVK I++ Q     +Q   RE+   + L HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V+  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK EN LLDG     +KI DFG+S    + ++  +  G+P Y APE+   K+YDG  
Sbjct: 137 HRDLKAENLLLDGDM--NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
            DVWS GV LY ++ G+ PF    D +N ++   R+L   Y  P Y  +S +C++LL ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKL 248
Query: 241 FVANSEKRITIPEIKNHPWF 260
            V N  KR ++ +I    W 
Sbjct: 249 LVLNPIKRGSLEQIMKDRWM 268

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 103/268 (38%), Positives = 145/268 (54%), Gaps = 13/268 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKH 57
           +RY+ VK +GSG +G   L +DK T    A+K I++           +++     + L H
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG +Y H  
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 118 QICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            I HRDLK EN LL+  S    +KI DFG S    +  + K  +GT  YIAPEVL KK Y
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK-Y 182
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
           D K  DVWSCGV LY++L G  PF    D    ++ + R+    +SF  PD+ +VS E K
Sbjct: 183 DEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEAK 237
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLR 262
            L+  +      KRI+  E  NHPW ++
Sbjct: 238 QLVKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 103/268 (38%), Positives = 145/268 (54%), Gaps = 13/268 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKH 57
           +RY+ VK +GSG +G   L +DK T    A+K I++           +++     + L H
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG +Y H  
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 118 QICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            I HRDLK EN LL+  S    +KI DFG S    +  + K  +GT  YIAPEVL KK Y
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK-Y 199
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
           D K  DVWSCGV LY++L G  PF    D    ++ + R+    +SF  PD+ +VS E K
Sbjct: 200 DEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEAK 254
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLR 262
            L+  +      KRI+  E  NHPW ++
Sbjct: 255 QLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  167 bits (423), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 153/267 (57%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTPA++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 192 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 246
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 192 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 246
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 152/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSLK 56
           Y+  +++GSG F V K  R+K T    A KFI++ +          E ++RE+   + ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPN++   EV    T + ++ E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           +QI H DLK EN  LLD +   PR+KI DFG +      ++ K+  GTP ++APE++  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  + +V+Y F D  +   S  
Sbjct: 193 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + R+ V + +KR+TI +   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 141/264 (53%), Gaps = 12/264 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHP 58
           ERY IV  +G G+FG     +D+ T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NI++  E+L   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL +  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH 235
            K  DVWS GV LY++L G  PF      KN    + R+ +  Y+F  P +  +S + K 
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 236 LLSRIFVANSEKRITIPEIKNHPW 259
           L+ ++   +   RIT  +   HPW
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 134/261 (51%), Gaps = 10/261 (3%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIV 61
           +E  + +G+G F    L  +K T +L AVK I +   +  +  ++ EI   R +KH NIV
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
             +++  +P HL +VM+  +GGELF+RI   G ++E +A    +Q++  V Y H M I H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 122 RDLKLENTL-LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           RDLK EN L        ++ I DFG SK         +  GTP Y+APEVL +K Y  K 
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY-SKA 202
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLS 238
            D WS GV  Y++L G  PF D  D K F     +IL   Y F  P +  +S   K  + 
Sbjct: 203 VDCWSIGVIAYILLCGYPPFYDENDSKLFE----QILKAEYEFDSPYWDDISDSAKDFIR 258
Query: 239 RIFVANSEKRITIPEIKNHPW 259
            +   +  KR T  +   HPW
Sbjct: 259 NLMEKDPNKRYTCEQAARHPW 279

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 141/264 (53%), Gaps = 12/264 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHP 58
           ERY IV  +G G+FG     +D+ T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NI++  E+L   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL +  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH 235
            K  DVWS GV LY++L G  PF      KN    + R+ +  Y+F  P +  +S + K 
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 236 LLSRIFVANSEKRITIPEIKNHPW 259
           L+ ++   +   RIT  +   HPW
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 100/264 (37%), Positives = 141/264 (53%), Gaps = 12/264 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHP 58
           ERY IV  +G G+FG     +D+ T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NI++  E+L   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL +  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH 235
            K  DVWS GV LY++L G  PF      KN    + R+ +  Y+F  P +  +S + K 
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 236 LLSRIFVANSEKRITIPEIKNHPW 259
           L+ ++   +   RIT  +   HPW
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  GE+++ +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 132 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 241
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 145/262 (55%), Gaps = 14/262 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR-EIMNHRSLKHPNIVR 62
           +E+  ++G G   +    + K T++  A+K +++   +D+ + R EI     L HPNI++
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
            KE+  TPT +++V+E   GGELF+RI   G +SE +A    +Q++  V+Y H   I HR
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           DLK EN LL  + AP   +KI DFG SK        K+  GTP Y APE+L    Y G  
Sbjct: 173 DLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPE 230
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPE-DPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLL 237
            D+WS G+  Y++L G  PF D   D   FR    RIL+  Y F  P +  VSL  K L+
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQFMFR----RILNCEYYFISPWWDEVSLNAKDLV 286
Query: 238 SRIFVANSEKRITIPEIKNHPW 259
            ++ V + +KR+T  +   HPW
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPW 308

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 107/299 (35%), Positives = 149/299 (49%), Gaps = 49/299 (16%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID------------------ 42
           + +Y +  +IG G++GV KL  ++      A+K + + + I                   
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 43  ---------EHVQREIMNHRSLKHPNIVRFKEVLLTPT--HLAIVMEYAAGGELFERICN 91
                    E V +EI   + L HPN+V+  EVL  P   HL +V E    G + E +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 92  AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSK- 148
               SED+ARF+FQ LI G+ Y H  +I HRD+K  N L+  DG     +KI DFG S  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNE 186
Query: 149 ---SSVLHSQPKSTVGTPAYIAPEVL--TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 203
              S  L S   +TVGTPA++APE L  T+K + GK  DVW+ GVTLY  + G  PF D 
Sbjct: 187 FKGSDALLS---NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD- 242
Query: 204 EDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
              +       +I S    FPD   ++ + K L++R+   N E RI +PEIK HPW  R
Sbjct: 243 ---ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  GE+++ +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 132 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 241
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 140/271 (51%), Gaps = 14/271 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIV 61
           Y+    +G+G F    L  DK T++L+A+K I  E  +  +  ++ EI     +KHPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
              ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL +K Y  
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHL 236
           K  D WS GV  Y++L G  PF D  D K F     +IL   Y F  P +  +S   K  
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLPIE 267
           +  +   + EKR T  +   HPW   +  ++
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/271 (35%), Positives = 140/271 (51%), Gaps = 14/271 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIV 61
           Y+    +G+G F    L  DK T++L+A+K I +   +  +  ++ EI     +KHPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
              ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL +K Y  
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHL 236
           K  D WS GV  Y++L G  PF D  D K F     +IL   Y F  P +  +S   K  
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLPIE 267
           +  +   + EKR T  +   HPW   +  ++
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 140/271 (51%), Gaps = 14/271 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIV 61
           Y+    +G+G F    L  DK T++L+A+K I  E  +  +  ++ EI     +KHPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
              ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL +K Y  
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHL 236
           K  D WS GV  Y++L G  PF D  D K F     +IL   Y F  P +  +S   K  
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLPIE 267
           +  +   + EKR T  +   HPW   +  ++
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 140/271 (51%), Gaps = 14/271 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIV 61
           Y+    +G+G F    L  DK T++L+A+K I  E  +  +  ++ EI     +KHPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
              ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           RDLK EN L   LD  +  ++ I DFG SK     S   +  GTP Y+APEVL +K Y  
Sbjct: 140 RDLKPENLLYYSLDEDS--KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHL 236
           K  D WS GV  Y++L G  PF D  D K F     +IL   Y F  P +  +S   K  
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLPIE 267
           +  +   + EKR T  +   HPW   +  ++
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 148/267 (55%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLK 56
           Y+I +++GSG F + K  R+K T    A KFI++ Q          E ++RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
            +I H DLK EN  LLD +   P +K+ DFG +       + K+  GTP ++APE++   
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T+  I +V Y F +  + + S  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + ++ V  + KR+TI E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 150/269 (55%), Gaps = 16/269 (5%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRS 54
           + YE+ +++GSG F + +  R K T +  A KFI++ +          E ++RE+   R 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           ++HPNI+   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 115 HSMQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           HS +I H DLK EN  LLD +   PR+K+ DFG +      ++ K+  GTP ++APE++ 
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS 230
            +   G  AD+WS GV  Y++L GA PF      +  ++T+  I +V+Y F +  +   S
Sbjct: 185 YEPL-GLEADMWSIGVITYILLSGASPFLG----ETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPW 259
              K  + R+ V + ++R+TI +   H W
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 150/267 (56%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E ++I + +G G FG   L R++ ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL GS    +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 131 KRVIHRDIKPENLLL-GSNG-ELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGMPPFE----AHTYQETYRRISRVEFTFPDF--VTEGARDL 240
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N+ +R+T+ E+  HPW   N
Sbjct: 241 ISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 150/267 (56%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E ++I + +G G FG   L R++ ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL GS    +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 131 KRVIHRDIKPENLLL-GSNG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGMPPFE----AHTYQETYRRISRVEFTFPDF--VTEGARDL 240
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N+ +R+T+ E+  HPW   N
Sbjct: 241 ISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 153 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 209
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 210 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 262
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 127 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 236
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 130 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 186
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 131 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 240
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 241 ISRLLKHNPSQRPMLREVLEHPWITAN 267

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRS 54
           + YE+ +++GSG F + +  R K T +  A KFI++ +          E ++RE+   R 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           ++HPNI+   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 145
Query: 115 HSMQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           HS +I H DLK EN  LLD +   PR+K+ DFG +      ++ K+  GTP ++APE++ 
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 205
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS 230
            +   G  AD+WS GV  Y++L GA PF      +  ++T+  I +V+Y F +  +   S
Sbjct: 206 YEPL-GLEADMWSIGVITYILLSGASPFL----GETKQETLTNISAVNYDFDEEYFSNTS 260
Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPW 259
              K  + R+ V + ++R+ I +   H W
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 128 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMH 184
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 237
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 132 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 241
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 130 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 24  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 83
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 143
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 144 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 200
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 201 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 253
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 254 ISRLLKHNPSQRPMLREVLEHPWITAN 280

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 153 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMH 209
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 210 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 262
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 127 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 236
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 126 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 182
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 183 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 235
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 236 ISRLLKHNPSQRPMLREVLEHPWITAN 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 130 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 130 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 239
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S      S+  +  GT  Y+ PE++  + +
Sbjct: 128 KRVIHRDIKPENLLL--GSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 237
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE +  + +
Sbjct: 132 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEXIEGRXH 188
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 241
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPXLREVLEHPWITAN 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 127 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTELCGTLDYLPPEMIEGRMH 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 236
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 127 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 236
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 128 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 237
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRS 54
           + YE+ +++GSG F + +  R K T +  A KFI++ +          E ++RE+   R 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           ++HPNI+   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 131
Query: 115 HSMQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           HS +I H DLK EN  LLD +   PR+K+ DFG +      ++ K+  GTP ++APE++ 
Sbjct: 132 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 191
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS 230
            +   G  AD+WS GV  Y++L GA PF      +  ++T+  I +V+Y F +  +   S
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPFLG----ETKQETLTNISAVNYDFDEEYFSNTS 246
Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPW 259
              K  + R+ V + ++R+ I +   H W
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 127 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 236
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 127 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTXLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 236
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 132 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 241
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 141/264 (53%), Gaps = 12/264 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHP 58
           E Y+ VK +GSG +G   L RDK T    A+K I +       +  +  E+   + L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SGV+Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 119 ICHRDLKLENTLLDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HRDLK EN LL+       +KI DFG S       + K  +GT  YIAPEVL KK YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-YD 215
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH 235
            K  DVWS GV L+++L G  PF    D +  RK    +    Y+F  P++  VS   K 
Sbjct: 216 EK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEGAKD 270
Query: 236 LLSRIFVANSEKRITIPEIKNHPW 259
           L+ ++   +S++RI+  +   HPW
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPW 294

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 127 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 236
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 129 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 186 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 238
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+     GT  Y+ PE++  + +
Sbjct: 130 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 96/273 (35%), Positives = 139/273 (50%), Gaps = 19/273 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--------------KIDEHVQR 47
           E Y  V+ +GSG +G   L ++K      A+K I++ Q              K  E +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 48  EIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQL 107
           EI   +SL HPNI++  +V     +  +V E+  GGELFE+I N  +F E +A    +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGYSKSSVLHSQPKSTVGTPAYI 166
           +SG+ Y H   I HRD+K EN LL+   +   +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 226
           APEVL KK+Y+ K  DVWSCGV +Y++L G  PF    D    +K        ++ F D+
Sbjct: 216 APEVL-KKKYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--EKGKYYFDFNDW 271
Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
             +S E K L+  +   +  KR T  E  N  W
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K  + +LA+K + + Q     ++  ++RE+     L+
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 124 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 181 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 233
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 234 ISRLLKHNPSQRPMLREVLEHPWITAN 260

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 127 KKVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMH 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       ++ T  RI  V ++FPD+  V+   + L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQDTYKRISRVEFTFPDF--VTEGARDL 236
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 147/267 (55%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI +FG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 130 KRVIHRDIKPENLLL--GSAGELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDL 239
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL   +A  +KI +FG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 129 KRVIHRDIKPENLLL--GSAGELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 185
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+V      + L
Sbjct: 186 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEG--ARDL 238
Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 146/267 (54%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLK 56
           Y+I +++GSG F + K  R+K T    A KFI++ Q          E ++RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H N++   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
            +I H DLK EN  LLD +   P +K+ DFG +       + K+  GTP ++APE++  +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  I SV Y F +  +   S  
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + ++ V  + KR+TI E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 146/267 (54%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLK 56
           Y+I +++GSG F + K  R+K T    A KFI++ Q          E ++RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H N++   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
            +I H DLK EN  LLD +   P +K+ DFG +       + K+  GTP ++APE++  +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  I SV Y F +  +   S  
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + ++ V  + KR+TI E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D            +  Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKT--YLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 146/267 (54%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLK 56
           Y+I +++GSG F + K  R+K T    A KFI++ Q          E ++RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H N++   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
            +I H DLK EN  LLD +   P +K+ DFG +       + K+  GTP ++APE++  +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  I SV Y F +  +   S  
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + ++ V  + KR+TI E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 147/267 (55%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLK 56
           Y+I +++GSG F + K  R+K T    A KFI++ Q          E ++RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H N++   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
            +I H DLK EN  LLD +   P +K+ DFG +       + K+  GTP ++APE++  +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  I +V Y F +  + + S  
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + ++ V  + KR+TI E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 240
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 240
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 240
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 240
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 240
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 147/267 (55%), Gaps = 16/267 (5%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLK 56
           Y+I +++GSG F + K  R+K T    A KFI++ Q          E ++RE+   R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H N++   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
            +I H DLK EN  LLD +   P +K+ DFG +       + K+  GTP ++APE++  +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLE 232
              G  AD+WS GV  Y++L GA PF    D K  ++T+  I +V Y F +  + + S  
Sbjct: 194 PL-GLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPW 259
            K  + ++ V  + KR+TI E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 240
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 240
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 124 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 238
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKPL 267

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 137/264 (51%), Gaps = 12/264 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNI 60
           Y++ +++G G F V +        +  A K I   +   +  + ++RE    R LKHPNI
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VR  + +    H  ++ +   GGELFE I     +SE +A    QQ++  V +CH M + 
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 121 HRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTKKEYDG 178
           HRDLK EN LL        VK+ DFG +       Q      GTP Y++PEVL K  Y G
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-G 202
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHL 236
           K  D+W+CGV LY++LVG  PF D +  + +++    I +  Y F  P++  V+ E K L
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEAKDL 258
Query: 237 LSRIFVANSEKRITIPEIKNHPWF 260
           ++++   N  KRIT  E   HPW 
Sbjct: 259 INKMLTINPSKRITAAEALKHPWI 282

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 96/265 (36%), Positives = 138/265 (52%), Gaps = 12/265 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHP 58
           + Y++ +DIG G F V +      T    A K I   +   +  + ++RE    R LKH 
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +       +V +   GGELFE I     +SE +A    QQ++  V +CH M 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 119 ICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTKKEY 176
           + HRDLK EN LL        VK+ DFG +       Q      GTP Y++PEVL K+ Y
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
            GK  D+W+CGV LY++LVG  PF D +  K +++    I +  Y F  P++  V+ E K
Sbjct: 184 -GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQ----IKAGAYDFPSPEWDTVTPEAK 238
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
           +L++++   N  KRIT  E   HPW
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPW 263

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  +  L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 240
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNIVR 62
           Y +   IG G++G  K+   K TR   A K I +    D +  ++EI   +SL HPNI+R
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
             E     T + +VME   GGELFER+ +   F E +A    + ++S V+YCH + + HR
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 123 DLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           DLK EN L   D   +P +K+ DFG +         ++ VGTP Y++P+VL  +   G  
Sbjct: 148 DLKPENFLFLTDSPDSP-LKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPE 204
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHLLS 238
            D WS GV +YV+L G  PF  P D     + + +I    ++FP  D++ VS + + L+ 
Sbjct: 205 CDEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIR 260
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNL 264
           R+   + ++RIT  +   H WF + L
Sbjct: 261 RLLTKSPKQRITSLQALEHEWFEKQL 286

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNIVR 62
           Y +   IG G++G  K+   K TR   A K I +    D +  ++EI   +SL HPNI+R
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
             E     T + +VME   GGELFER+ +   F E +A    + ++S V+YCH + + HR
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 123 DLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           DLK EN L   D   +P +K+ DFG +         ++ VGTP Y++P+VL  +   G  
Sbjct: 131 DLKPENFLFLTDSPDSP-LKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPE 187
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHLLS 238
            D WS GV +YV+L G  PF  P D     + + +I    ++FP  D++ VS + + L+ 
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIR 243
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNL 264
           R+   + ++RIT  +   H WF + L
Sbjct: 244 RLLTKSPKQRITSLQALEHEWFEKQL 269

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 10/269 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G  G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E
Sbjct: 125 ITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWSCG+ L  ML G  P++ P D  + ++         Y  P + ++      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLA 239
Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNL 264
           LL +I V N   RITIP+IK   W+ + L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 141/265 (53%), Gaps = 13/265 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKID-EHVQREIMNHRSLKH 57
           +RY+  + +G G+FG   L +DK T +  AVK I +    QK D E + RE+   + L H
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 169
Query: 118 QICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 228
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
           D K  DVWS GV LY++L G  PF    +  N    + ++    Y+F  P + +VS   K
Sbjct: 229 DEK-CDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKGKYTFELPQWKKVSESAK 283
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
            L+ ++       RI+  +  +H W
Sbjct: 284 DLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 141/265 (53%), Gaps = 13/265 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKID-EHVQREIMNHRSLKH 57
           +RY+  + +G G+FG   L +DK T +  AVK I +    QK D E + RE+   + L H
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 168
Query: 118 QICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 227
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
           D K  DVWS GV LY++L G  PF    +  N    + ++    Y+F  P + +VS   K
Sbjct: 228 DEK-CDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKGKYTFELPQWKKVSESAK 282
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
            L+ ++       RI+  +  +H W
Sbjct: 283 DLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 141/265 (53%), Gaps = 13/265 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKID-EHVQREIMNHRSLKH 57
           +RY+  + +G G+FG   L +DK T +  AVK I +    QK D E + RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 118 QICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
           D K  DVWS GV LY++L G  PF    +  N    + ++    Y+F  P + +VS   K
Sbjct: 205 DEK-CDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
            L+ ++       RI+  +  +H W
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEW 284

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 95/268 (35%), Positives = 140/268 (52%), Gaps = 12/268 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +      T +  A K I   +   +  + ++RE    R LKHP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +       +V +   GGELFE I     +SE +A    QQ++  V++CH   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 119 ICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTKKEY 176
           I HRDLK EN LL   S    VK+ DFG +       Q      GTP Y++PEVL K  Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
            GK  D+W+CGV LY++LVG  PF D +  + +++    I +  Y F  P++  V+ E K
Sbjct: 184 -GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEAK 238
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLR 262
            L++++   N  KRIT  E   HPW  +
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 140/266 (52%), Gaps = 12/266 (4%)
Query: 2   ERYEIVKDIGSGNFGVAK-LVRDKWTRELLAVKFIERGQKIDEH--VQREIMNHRSLKHP 58
           E Y++ +++G G F V +  V+    +E  A+    +     +H  ++RE    R LKHP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +    H  ++ +   GGELFE I     +SE +A    QQ++  V +CH M 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 119 ICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTKKEY 176
           + HR+LK EN LL        VK+ DFG +       Q      GTP Y++PEVL K  Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
            GK  D+W+CGV LY++LVG  PF D +  + +++    I +  Y F  P++  V+ E K
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEAK 245
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWF 260
            L++++   N  KRIT  E   HPW 
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 95/268 (35%), Positives = 140/268 (52%), Gaps = 12/268 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +      T +  A K I   +   +  + ++RE    R LKHP
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +       +V +   GGELFE I     +SE +A    QQ++  V++CH   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 119 ICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTKKEY 176
           I HRDLK EN LL   S    VK+ DFG +       Q      GTP Y++PEVL K  Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
            GK  D+W+CGV LY++LVG  PF D +  + +++    I +  Y F  P++  V+ E K
Sbjct: 184 -GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEAK 238
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLR 262
            L++++   N  KRIT  E   HPW  +
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 136/261 (52%), Gaps = 10/261 (3%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSLKHPNIVRFKEVLL 68
           +GSG F    LV+ + T +L A+K I++     D  ++ EI   + +KH NIV  +++  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
           + TH  +VM+  +GGELF+RI   G ++E +A    QQ++S V Y H   I HRDLK EN
Sbjct: 77  STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 129 TL-LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCG 187
            L L      ++ I DFG SK    +    +  GTP Y+APEVL +K Y  K  D WS G
Sbjct: 137 LLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIG 194
Query: 188 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANS 245
           V  Y++L G  PF +  + K F K    I   +Y F  P +  +S   K  +  +   + 
Sbjct: 195 VITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDFICHLLEKDP 250
Query: 246 EKRITIPEIKNHPWFLRNLPI 266
            +R T  +  +HPW   N  +
Sbjct: 251 NERYTCEKALSHPWIDGNTAL 271

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 141/265 (53%), Gaps = 13/265 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKID-EHVQREIMNHRSLKH 57
           +RY+  + +G G+FG   L +DK T +  AVK I +    QK D E + RE+   + L H
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 151
Query: 118 QICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 210
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
           D K  DVWS GV LY++L G  PF    +  N    + ++    Y+F  P + +VS   K
Sbjct: 211 DEK-CDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKGKYTFELPQWKKVSESAK 265
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
            L+ ++       RI+  +  +H W
Sbjct: 266 DLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 139/265 (52%), Gaps = 13/265 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKID-EHVQREIMNHRSLKH 57
           +RY+  + +G G+FG   L +DK T +  AVK I +    QK D E + RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI +  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN 145
Query: 118 QICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HGTY 204
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
           D K  DVWS GV LY++L G  PF    +  N    + ++    Y+F  P + +VS   K
Sbjct: 205 DEK-CDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
            L+ +        RI+  +  +H W
Sbjct: 260 DLIRKXLTYVPSXRISARDALDHEW 284

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 134/263 (50%), Gaps = 7/263 (2%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +    K T    A K I   +   +  + ++RE    R L+HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +   +   +V +   GGELFE I     +SE +A    QQ++  ++YCHS  
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 119 ICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HR+LK EN LL   +    VK+ DFG +             GTP Y++PEVL K  Y 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 207
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K  D+W+CGV LY++LVG  PF D ED       I +  +  Y  P++  V+ E K L+
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLI 265
Query: 238 SRIFVANSEKRITIPEIKNHPWF 260
             +   N +KRIT  +    PW 
Sbjct: 266 DSMLTVNPKKRITADQALKVPWI 288

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 134/262 (51%), Gaps = 7/262 (2%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +    K T    A K I   +   +  + ++RE    R L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +   +   +V +   GGELFE I     +SE +A    QQ++  ++YCHS  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 119 ICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HR+LK EN LL   +    VK+ DFG +             GTP Y++PEVL K  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K  D+W+CGV LY++LVG  PF D ED       I +  +  Y  P++  V+ E K L+
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLI 242
Query: 238 SRIFVANSEKRITIPEIKNHPW 259
             +   N +KRIT  +    PW
Sbjct: 243 DSMLTVNPKKRITADQALKVPW 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 134/263 (50%), Gaps = 7/263 (2%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +    K T    A K I   +   +  + ++RE    R L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +   +   +V +   GGELFE I     +SE +A    QQ++  ++YCHS  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 119 ICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HR+LK EN LL   +    VK+ DFG +             GTP Y++PEVL K  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K  D+W+CGV LY++LVG  PF D ED       I +  +  Y  P++  V+ E K L+
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLI 242
Query: 238 SRIFVANSEKRITIPEIKNHPWF 260
             +   N +KRIT  +    PW 
Sbjct: 243 DSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 134/263 (50%), Gaps = 7/263 (2%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +    K T    A K I   +   +  + ++RE    R L+HP
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 64
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +   +   +V +   GGELFE I     +SE +A    QQ++  ++YCHS  
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 124
Query: 119 ICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HR+LK EN LL   +    VK+ DFG +             GTP Y++PEVL K  Y 
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 183
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K  D+W+CGV LY++LVG  PF D ED       I +  +  Y  P++  V+ E K L+
Sbjct: 184 SKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLI 241
Query: 238 SRIFVANSEKRITIPEIKNHPWF 260
             +   N +KRIT  +    PW 
Sbjct: 242 DSMLTVNPKKRITADQALKVPWI 264

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  144 bits (362), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 92/265 (34%), Positives = 137/265 (51%), Gaps = 12/265 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +    K   +  A K I   +   +  + ++RE    R LKHP
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +       +V +   GGELFE I     +SE +A     Q++  V++ H   
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD 150
Query: 119 ICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTKKEY 176
           I HRDLK EN LL        VK+ DFG +       Q      GTP Y++PEVL K  Y
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPY 210
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
            GK  D+W+CGV LY++LVG  PF D +  K +++    I +  Y F  P++  V+ E K
Sbjct: 211 -GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQ----IKAGAYDFPSPEWDTVTPEAK 265
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
           +L++++   N  KRIT  +   HPW
Sbjct: 266 NLINQMLTINPAKRITADQALKHPW 290

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLK 56
           ++ ++I++ +G+G+FG   L+R +      A+K +++      K  EH   E +    + 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y HS
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             I +RDLK EN LLD +    +KI DFG++K   +        GTP YIAPEV++ K Y
Sbjct: 125 KDIIYRDLKPENILLDKNG--HIKITDFGFAK--YVPDVTYXLCGTPDYIAPEVVSTKPY 180
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           +  I D WS G+ +Y ML G  PF D     N  KT  +IL+    FP +   + + K L
Sbjct: 181 NKSI-DWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPF--FNEDVKDL 233
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           LSR+   +  +R+        ++KNHPWF
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 144/270 (53%), Gaps = 20/270 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           ++ ++IV+ +G G FG   L R+K  + ++A+K + + Q     ++  ++REI     L+
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTK 173
            ++ HRD+K EN L+       +KI DFG+S    +H+   + +   GT  Y+ PE++  
Sbjct: 133 RKVIHRDIKPENLLM--GYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEG 186
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           K +D K+ D+W  GV  Y  LVG  PF+ P   +  R    RI++V   FP +  +S   
Sbjct: 187 KTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIVNVDLKFPPF--LSDGS 239
Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
           K L+S++   +  +R+ +  +  HPW   N
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 143/270 (52%), Gaps = 20/270 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           ++ ++I + +G G FG   L R+K  + ++A+K + + Q     ++  ++REI     L+
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTK 173
            ++ HRD+K EN L+       +KI DFG+S    +H+   + +   GT  Y+ PE++  
Sbjct: 134 RKVIHRDIKPENLLM--GYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           K +D K+ D+W  GV  Y  LVG  PF+ P   +  R    RI++V   FP +  +S   
Sbjct: 188 KTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIVNVDLKFPPF--LSDGS 240
Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
           K L+S++   +  +R+ +  +  HPW   N
Sbjct: 241 KDLISKLLRYHPPQRLPLKGVMEHPWVKAN 270

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 137/261 (52%), Gaps = 11/261 (4%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEV 66
           K +G G+F + +    K + +  AVK I +  +++ + Q+EI   +  + HPNIV+  EV
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 67  LLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKL 126
                H  +VME   GGELFERI     FSE EA +  ++L+S VS+ H + + HRDLK 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 127 ENTLL-DGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDGKIADVW 184
           EN L  D +    +KI DFG+++     +QP K+   T  Y APE+L +  YD +  D+W
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLW 193
Query: 185 SCGVTLYVMLVGAYPFEDPEDPKNFRKTI---GRILSVHYSFPD--YVRVSLECKHLLSR 239
           S GV LY ML G  PF+  +        +    +I    +SF    +  VS E K L+  
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253
Query: 240 IFVANSEKRITIPEIKNHPWF 260
           +   +  KR+ +  ++ + W 
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWL 274

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 126/255 (49%), Gaps = 9/255 (3%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           +G G FG      +  T   LA K I+ RG K  E V+ EI     L H N+++  +   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 69  TPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLE 127
           +   + +VMEY  GGELF+RI +     +E +   F +Q+  G+ + H M I H DLK E
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 128 NTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCG 187
           N L     A ++KI DFG ++      + K   GTP ++APEV+   ++     D+WS G
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN-YDFVSFPTDMWSVG 275
Query: 188 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANS 245
           V  Y++L G  PF    D     +T+  IL+  +   D  +  +S E K  +S++ +   
Sbjct: 276 VIAYMLLSGLSPFLGDNDA----ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 246 EKRITIPEIKNHPWF 260
             RI+  E   HPW 
Sbjct: 332 SWRISASEALKHPWL 346

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E ++ +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +V+EYA GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 142/268 (52%), Gaps = 18/268 (6%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---- 55
           +E +E+ K +G G+FG   L   K T +  A+K +++   + D+ V+  ++  R L    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           +HP +        T  +L  VMEY  GG+L   I +  +F    A F+  ++I G+ + H
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLTKK 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 137 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLEC 233
           +Y+  + D WS GV LY ML+G  PF   ++ + F        S+    P Y R +  E 
Sbjct: 195 KYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDNPFYPRWLEKEA 246
Query: 234 KHLLSRIFVANSEKRITI-PEIKNHPWF 260
           K LL ++FV   EKR+ +  +I+ HP F
Sbjct: 247 KDLLVKLFVREPEKRLGVRGDIRQHPLF 274

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 136/271 (50%), Gaps = 19/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  ++ +K +G G FG   LVR+K T    A+K + +   I  + V   +   R L   +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G+  D W  GV +Y M+ G  PF + +  + F      IL     FP    +S E K 
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFPR--TLSPEAKS 234
Query: 236 LLSRIFVANSEKRI-----TIPEIKNHPWFL 261
           LL+ +   + ++R+        E+  H +FL
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   E  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 181 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 289
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 136/271 (50%), Gaps = 19/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  ++ +K +G G FG   LVR+K T    A+K + +   I  + V   +   R L   +
Sbjct: 7   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 126
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 127 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G+  D W  GV +Y M+ G  PF + +  + F      IL     FP    +S E K 
Sbjct: 185 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFPR--TLSPEAKS 237
Query: 236 LLSRIFVANSEKRI-----TIPEIKNHPWFL 261
           LL+ +   + ++R+        E+  H +FL
Sbjct: 238 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 268

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 136/271 (50%), Gaps = 19/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  ++ +K +G G FG   LVR+K T    A+K + +   I  + V   +   R L   +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G+  D W  GV +Y M+ G  PF + +  + F      IL     FP    +S E K 
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFPR--TLSPEAKS 234
Query: 236 LLSRIFVANSEKRI-----TIPEIKNHPWFL 261
           LL+ +   + ++R+        E+  H +FL
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +     +  GTP Y+APE++  K Y
Sbjct: 181 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGY 236
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 289
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K IG+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 209 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 261
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 15/269 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLK 56
           +E +++   +G G+F          T   +A+K I++       + + VQ E+  H  LK
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 115
           HP+I+          ++ +V+E    GE+   + N  + FSE+EAR F  Q+I+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLTKK 174
           S  I HRDL L N LL  +    +KI DFG +    + H +  +  GTP YI+PE+ T+ 
Sbjct: 130 SHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            + G  +DVWS G   Y +L+G  PF    D    + T+ +++   Y  P +  +S+E K
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPF----DTDTVKNTLNKVVLADYEMPSF--LSIEAK 240
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRN 263
            L+ ++   N   R+++  + +HP+  RN
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN 269

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 135/271 (49%), Gaps = 19/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  ++ +K +G G FG   LVR+K T    A+K + +   I  + V   +   R L   +
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 128
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 129 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G+  D W  GV +Y M+ G  PF + +  + F      IL     FP    +S E K 
Sbjct: 187 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFPR--TLSPEAKS 239
Query: 236 LLSRIFVANSEKRI-----TIPEIKNHPWFL 261
           LL+ +   + ++R+        E+  H +FL
Sbjct: 240 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 270

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 135/271 (49%), Gaps = 19/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  ++ +K +G G FG   LVR+K T    A+K + +   I  + V   +   R L   +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G+  D W  GV +Y M+ G  PF + +  + F      IL     FP    +S E K 
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFPR--TLSPEAKS 234
Query: 236 LLSRIFVANSEKRI-----TIPEIKNHPWFL 261
           LL+ +   + ++R+        E+  H +FL
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 141/267 (52%), Gaps = 17/267 (6%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           YE+ +DIG G++ V K    K T    AVK I++ ++ D   + EI+  R  +HPNI+  
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEIL-LRYGQHPNIITL 81
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
           K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  + HRD
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 124 LKLENTL-LDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLTKKEYD 177
           LK  N L +D S  P  ++ICDFG++K   L ++    + TP Y    +APEVL ++ YD
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLERQGYD 198
Query: 178 GKIADVWSCGVTLYVMLVGAYPFED-PEDPKNFRKTIGRILSVHYSFPD--YVRVSLECK 234
               D+WS GV LY ML G  PF + P+D     + + RI S  +S     +  VS   K
Sbjct: 199 AA-CDIWSLGVLLYTMLTGYTPFANGPDDTP--EEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFL 261
            L+S++   +  +R+T   +  HPW +
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  134 bits (338), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 135/271 (49%), Gaps = 19/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  ++ +K +G G FG   LVR+K T    A+K + +   I  + V   +   R L   +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G+  D W  GV +Y M+ G  PF + +  + F      IL     FP    +S E K 
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFPR--TLSPEAKS 234
Query: 236 LLSRIFVANSEKRI-----TIPEIKNHPWFL 261
           LL+ +   + ++R+        E+  H +FL
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  134 bits (338), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 135/271 (49%), Gaps = 19/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  ++ +K +G G FG   LVR+K T    A+K + +   I  + V   +   R L   +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKKE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G+  D W  GV +Y M+ G  PF + +  + F      IL     FP    +S E K 
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFPR--TLSPEAKS 234
Query: 236 LLSRIFVANSEKRI-----TIPEIKNHPWFL 261
           LL+ +   + ++R+        E+  H +FL
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 147 LDLIYRDLKPENLLIDEQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 203 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 255
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 256 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 9/264 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPN 59
           ++ Y+I +++G+G FGV   V ++ T    A KF+    + D E V++EI     L+HP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 118
           +V   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G+ + H   
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
             H DLK EN +     +  +K+ DFG +         K T GT  + APEV   K   G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHL 236
              D+WS GV  Y++L G  PF    D +  R     + S  ++  D  +  +S + K  
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDF 390
Query: 237 LSRIFVANSEKRITIPEIKNHPWF 260
           + ++ +A+   R+TI +   HPW 
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWL 414

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 9/264 (3%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPN 59
           ++ Y+I +++G+G FGV   V ++ T    A KF+    + D E V++EI     L+HP 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 118
           +V   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G+ + H   
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
             H DLK EN +     +  +K+ DFG +         K T GT  + APEV   K   G
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 228
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHL 236
              D+WS GV  Y++L G  PF    D +  R     + S  ++  D  +  +S + K  
Sbjct: 229 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDF 284
Query: 237 LSRIFVANSEKRITIPEIKNHPWF 260
           + ++ +A+   R+TI +   HPW 
Sbjct: 285 IRKLLLADPNTRMTIHQALEHPWL 308

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 137/271 (50%), Gaps = 20/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  +E +K +G G FG   LV++K T    A+K +++   +  + V   +  +R L   +
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 117 MQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKK 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   
Sbjct: 267 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +Y G+  D W  GV +Y M+ G  PF + +  K F      IL     FP    +  E K
Sbjct: 325 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLGPEAK 377
Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            LLS +   + ++R+        EI  H +F
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLIIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K IG+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GG++F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLMIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 137/271 (50%), Gaps = 20/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  +E +K +G G FG   LV++K T    A+K +++   +  + V   +  +R L   +
Sbjct: 150 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 269
Query: 117 MQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKK 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   
Sbjct: 270 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +Y G+  D W  GV +Y M+ G  PF + +  K F      IL     FP    +  E K
Sbjct: 328 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLGPEAK 380
Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            LLS +   + ++R+        EI  H +F
Sbjct: 381 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 136/271 (50%), Gaps = 20/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  +E +K +G G FG   LV++K T    A+K +++   +  + V   +  +R L   +
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 126
Query: 117 MQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKK 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 127 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +Y G+  D W  GV +Y M+ G  PF + +  K F      IL     FP    +  E K
Sbjct: 185 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLGPEAK 237
Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            LLS +   + ++R+        EI  H +F
Sbjct: 238 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +  +  GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K IG+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GG++F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRF+E  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +  +  GTP Y+APE++  K Y
Sbjct: 146 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 202 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 254
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 255 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 136/271 (50%), Gaps = 20/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  +E +K +G G FG   LV++K T    A+K +++   +  + V   +  +R L   +
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 127
Query: 117 MQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKK 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 128 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +Y G+  D W  GV +Y M+ G  PF + +  K F      IL     FP    +  E K
Sbjct: 186 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLGPEAK 238
Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            LLS +   + ++R+        EI  H +F
Sbjct: 239 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 181 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 289
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 209 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 261
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 136/271 (50%), Gaps = 20/271 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---K 56
           M  +E +K +G G FG   LV++K T    A+K +++   +  + V   +  +R L   +
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 128
Query: 117 MQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLTKK 174
            + + +RDLKLEN +LD      +KI DFG  K  +   +  K   GTP Y+APEVL   
Sbjct: 129 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +Y G+  D W  GV +Y M+ G  PF + +  K F      IL     FP    +  E K
Sbjct: 187 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLGPEAK 239
Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            LLS +   + ++R+        EI  H +F
Sbjct: 240 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +K+ DFG +K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLMIDQQGY--IKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEYA GGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+ K T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +I NH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+AP ++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 155 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 210
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 211 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 263
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 264 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 95
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 96  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 155
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 156 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 213
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 214 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 273
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 274 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 304

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 87
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 88  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 147
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 148 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 205
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 206 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 265
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 266 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 296

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 141/268 (52%), Gaps = 18/268 (6%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---- 55
           +E + + K +G G+FG   L   K T +  A+K +++   + D+ V+  ++  R L    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           +HP +        T  +L  VMEY  GG+L   I +  +F    A F+  ++I G+ + H
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLTKK 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 136 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLEC 233
           +Y+  + D WS GV LY ML+G  PF   ++ + F        S+    P Y R +  E 
Sbjct: 194 KYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDNPFYPRWLEKEA 245
Query: 234 KHLLSRIFVANSEKRITI-PEIKNHPWF 260
           K LL ++FV   EKR+ +  +I+ HP F
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 131
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 132 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 191
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 192 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 249
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 250 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 309
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 310 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 340

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 186 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 243
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 244 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 303
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 304 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 80
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 81  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 140
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 141 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 198
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 199 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 258
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 259 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 289

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 79
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 80  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 139
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 140 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 197
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 198 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 257
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 258 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 288

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 142 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 199
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 200 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 259
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 260 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 290

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 86
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 87  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 146
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 147 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 204
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 205 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 264
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 265 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 295

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEK-----RITIPEIKNHPWF 260
           L  +   +  K     +  + +IKNH WF
Sbjct: 269 LRNLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 142 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 199
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 200 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 259
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 260 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 290

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 140/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 85
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 86  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 145
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 146 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 203
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 204 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 263
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 264 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 294

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +++ DFG +K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLMIDQQGY--IQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 146/272 (53%), Gaps = 25/272 (9%)
Query: 3   RYEIVKDIGSGNFGVAKLVRD---KWTRELLAVKFIERG-----QKIDEHVQREIMNHRS 54
           ++E++K +G G+FG   LV+       R+L A+K +++       ++   ++R+I+    
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 83
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + 
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTK 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV+ +
Sbjct: 144 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + +  + AD WS GV ++ ML G  PF+     K+ ++T+  IL      P +  +S E 
Sbjct: 202 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 254
Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           + LL  +F  N   R+      + EIK H +F
Sbjct: 255 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 146/272 (53%), Gaps = 25/272 (9%)
Query: 3   RYEIVKDIGSGNFGVAKLVRD---KWTRELLAVKFIERG-----QKIDEHVQREIMNHRS 54
           ++E++K +G G+FG   LV+       R+L A+K +++       ++   ++R+I+    
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTK 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV+ +
Sbjct: 143 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + +  + AD WS GV ++ ML G  PF+     K+ ++T+  IL      P +  +S E 
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           + LL  +F  N   R+      + EIK H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 139/271 (51%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 79
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 80  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 139
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+       TP Y+APEVL  ++YD K 
Sbjct: 140 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYD-KS 197
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 198 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 257
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 258 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 288

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 139/267 (52%), Gaps = 17/267 (6%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           YE+ +DIG G++ V K    K T    AVK I++ ++ D   + EI+  R  +HPNI+  
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKR-DPTEEIEIL-LRYGQHPNIITL 81
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
           K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  + HRD
Sbjct: 82  KDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 124 LKLENTL-LDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLTKKEYD 177
           LK  N L +D S  P  ++ICDFG++K   L ++    + TP Y    +APEVL ++ YD
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLXTPCYTANFVAPEVLERQGYD 198
Query: 178 GKIADVWSCGVTLYVMLVGAYPFED-PEDPKNFRKTIGRILSVHYSFPD--YVRVSLECK 234
               D+WS GV LY  L G  PF + P+D     + + RI S  +S     +  VS   K
Sbjct: 199 AA-CDIWSLGVLLYTXLTGYTPFANGPDDTP--EEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFL 261
            L+S+    +  +R+T   +  HPW +
Sbjct: 256 DLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 131/267 (49%), Gaps = 19/267 (7%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHP 58
           +  +K IG G+FG   L R K      AVK +++   + +  ++ IM+ R++     KHP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
            +V       T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYD 177
           I +RDLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL K+ YD
Sbjct: 160 IVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            +  D W  G  LY ML G  PF      + +   + + L +         ++   +HLL
Sbjct: 218 -RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK------PNITNSARHLL 270
Query: 238 SRIFVANSEKRI----TIPEIKNHPWF 260
             +   +  KR+       EIK+H +F
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 146/272 (53%), Gaps = 25/272 (9%)
Query: 3   RYEIVKDIGSGNFGVAKLVRD---KWTRELLAVKFIERG-----QKIDEHVQREIMNHRS 54
           ++E++K +G G+FG   LV+       R+L A+K +++       ++   ++R+I+    
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTK 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV+ +
Sbjct: 143 HSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + +  + AD WS GV ++ ML G  PF+     K+ ++T+  IL      P +  +S E 
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           + LL  +F  N   R+      + EIK H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  131 bits (330), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP  +APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 269
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++++E +K +G+G+FG   LV+   T    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           + K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268
Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 92/265 (34%), Positives = 140/265 (52%), Gaps = 17/265 (6%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y + + IG G++   K    K T    AVK I++ ++ D   + EI+  R  +HPNI+  
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR-DPSEEIEIL-LRYGQHPNIITL 86
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
           K+V     H+ +V E   GGEL ++I     FSE EA F    +   V Y HS  + HRD
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRD 146
Query: 124 LKLENTL-LDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLTKKEYD 177
           LK  N L +D S  P  ++ICDFG++K   L ++    + TP Y    +APEVL ++ YD
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQGYD 203
Query: 178 GKIADVWSCGVTLYVMLVGAYPFED-PEDPKNFRKTIGRILSVHYSFP--DYVRVSLECK 234
            +  D+WS G+ LY ML G  PF + P D     + + RI S  ++    ++  VS   K
Sbjct: 204 -EGCDIWSLGILLYTMLAGYTPFANGPSDTP--EEILTRIGSGKFTLSGGNWNTVSETAK 260
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
            L+S++   +  +R+T  ++  HPW
Sbjct: 261 DLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 92/265 (34%), Positives = 140/265 (52%), Gaps = 17/265 (6%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y + + IG G++   K    K T    AVK I++ ++ D   + EI+  R  +HPNI+  
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR-DPSEEIEIL-LRYGQHPNIITL 86
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
           K+V     H+ +V E   GGEL ++I     FSE EA F    +   V Y HS  + HRD
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRD 146
Query: 124 LKLENTL-LDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLTKKEYD 177
           LK  N L +D S  P  ++ICDFG++K   L ++    + TP Y    +APEVL ++ YD
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQGYD 203
Query: 178 GKIADVWSCGVTLYVMLVGAYPFED-PEDPKNFRKTIGRILSVHYSFP--DYVRVSLECK 234
            +  D+WS G+ LY ML G  PF + P D     + + RI S  ++    ++  VS   K
Sbjct: 204 -EGCDIWSLGILLYTMLAGYTPFANGPSDTP--EEILTRIGSGKFTLSGGNWNTVSETAK 260
Query: 235 HLLSRIFVANSEKRITIPEIKNHPW 259
            L+S++   +  +R+T  ++  HPW
Sbjct: 261 DLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/272 (31%), Positives = 146/272 (53%), Gaps = 27/272 (9%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTR----ELLAVKFIERG-----QKIDEHVQREIMNHRS 54
           +E++K +G G+FG   LVR K TR     L A+K +++       ++   ++R+I+    
Sbjct: 30  FELLKVLGQGSFGKVFLVR-KVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILA--D 86
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           + HP +V+      T   L +++++  GG+LF R+     F+E++ +F+  +L  G+ + 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTK 173
           HS+ I +RDLK EN LLD      +K+ DFG SK ++ H +   S  GT  Y+APEV+ +
Sbjct: 147 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + +    AD WS GV ++ ML G+ PF+     K+ ++T+  IL      P +  +S E 
Sbjct: 205 QGHSHS-ADWWSYGVLMFEMLTGSLPFQG----KDRKETMTLILKAKLGMPQF--LSTEA 257
Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           + LL  +F  N   R+        EIK H ++
Sbjct: 258 QSLLRALFKRNPANRLGSGPDGAEEIKRHVFY 289

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-------GQKIDE--HVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A+K I +        ++ D   +V+ EI   
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 172 TKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-PD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I S  Y+F P+ + 
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QITSGKYNFIPEVWA 251
Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-------GQKIDE--HVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A+K I +        ++ D   +V+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 172 TKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-PD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I S  Y+F P+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-------GQKIDE--HVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A+K I +        ++ D   +V+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 172 TKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-PD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I S  Y+F P+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-------GQKIDE--HVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A+K I +        ++ D   +V+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 172 TKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-PD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I S  Y+F P+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-------GQKIDE--HVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A+K I +        ++ D   +V+ EI   
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 172 TKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-PD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I S  Y+F P+ + 
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 244
Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  127 bits (319), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 20/270 (7%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           ++ +EI + +G G FG   L R+K +  ++A+K + + Q     ++  ++REI     L 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R          + +++EYA  GEL++ +  +  F E       ++L   + YCH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTK 173
            ++ HRD+K EN LL       +KI DFG+S    +H+   + K+  GT  Y+ PE++  
Sbjct: 142 KKVIHRDIKPENLLLGLKGE--LKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + ++ K+ D+W  GV  Y +LVG  PFE     + +R    RI+ V   FP    V    
Sbjct: 196 RMHNEKV-DLWCIGVLCYELLVGNPPFESASHNETYR----RIVKVDLKFP--ASVPTGA 248
Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
           + L+S++   N  +R+ + ++  HPW   N
Sbjct: 249 QDLISKLLRHNPSERLPLAQVSAHPWVRAN 278

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/207 (37%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL---- 55
           ++ +E ++ +G G+FG   L R K T +L AVK +++   + D+ V+  +   R L    
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            HP + +      TP  L  VME+  GG+L   I  + RF E  ARF+  ++IS + + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKK 174
              I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L + 
Sbjct: 142 DKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFE 201
            Y G   D W+ GV LY ML G  PFE
Sbjct: 200 LY-GPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/273 (32%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-------GQKIDE--HVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A++ I +        ++ D   +V+ EI   
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 172 TKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-PD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I S  Y+F P+ + 
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 384
Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/273 (32%), Positives = 135/273 (49%), Gaps = 18/273 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-------GQKIDE--HVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A++ I +        ++ D   +V+ EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 172 TKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-PD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I S  Y+F P+ + 
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 370
Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 127/261 (48%), Gaps = 9/261 (3%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH-VQREIMNHRSLKHPNIVR 62
           Y+I++++GSG FGV     +K T  +   KFI     +D++ V+ EI     L HP ++ 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICH 121
             +       + +++E+ +GGELF+RI     + SE E   + +Q   G+ + H   I H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIA 181
            D+K EN + +   A  VKI DFG +         K T  T  + APE++  +E  G   
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD-REPVGFYT 231
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLSR 239
           D+W+ GV  YV+L G  PF   +D     +T+  +    + F +  +  VS E K  +  
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 240 IFVANSEKRITIPEIKNHPWF 260
           +      KR+T+ +   HPW 
Sbjct: 288 LLQKEPRKRLTVHDALEHPWL 308

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 141/274 (51%), Gaps = 26/274 (9%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID------EHVQREIMNHRSLKH 57
           YE+ + IG G F V +   ++ T +  AVK ++  +         E ++RE      LKH
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL-FERICNAGR---FSEDEARFFFQQLISGVSY 113
           P+IV   E   +   L +V E+  G +L FE +  A     +SE  A  + +Q++  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 114 CHSMQICHRDLKLENTLLDG--STAPRVKICDFGYS----KSSVLHSQPKSTVGTPAYIA 167
           CH   I HRD+K EN LL    ++AP VK+ DFG +    +S ++       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAP-VKLGDFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DY 226
           PEV+ ++ Y GK  DVW CGV L+++L G  PF   ++    R   G I   +   P  +
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIKGKYKMNPRQW 256
Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             +S   K L+ R+ + +  +RIT+ E  NHPW 
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 96/275 (34%), Positives = 141/275 (51%), Gaps = 26/275 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH------VQREIMNHRSL 55
           E YE+VK IG G FG  +LVR K TR++ A+K + + + I          +R+IM   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN- 132
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
             P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H
Sbjct: 133 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIH 190
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVL 171
           SM   HRD+K +N LLD S    +K+ DFG     +K  ++     + VGTP YI+PEVL
Sbjct: 191 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVL 246
Query: 172 TKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
             +    Y G+  D WS GV LY MLVG  PF        + K +    S+  +FPD   
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--TFPDDND 304
Query: 229 VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
           +S E K+L+   F+ + E R+    + EIK H +F
Sbjct: 305 ISKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 135/271 (49%), Gaps = 17/271 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IV E   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 126 NLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHR 185
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +  H+   +   TP Y+APEVL  ++YD K 
Sbjct: 186 DVKPEN-LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 243
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D WS GV  Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 244 CDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIR 303
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R TI E  NHPW  ++  +  T
Sbjct: 304 NLLKTEPTQRXTITEFXNHPWIXQSTKVPQT 334

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/275 (34%), Positives = 141/275 (51%), Gaps = 26/275 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH------VQREIMNHRSL 55
           E YE+VK IG G FG  +LVR K TR++ A+K + + + I          +R+IM   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN- 132
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
             P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H
Sbjct: 133 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIH 190
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVL 171
           SM   HRD+K +N LLD S    +K+ DFG     +K  ++     + VGTP YI+PEVL
Sbjct: 191 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVL 246
Query: 172 TKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
             +    Y G+  D WS GV LY MLVG  PF        + K +    S+  +FPD   
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--TFPDDND 304
Query: 229 VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
           +S E K+L+   F+ + E R+    + EIK H +F
Sbjct: 305 ISKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 96/275 (34%), Positives = 141/275 (51%), Gaps = 26/275 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH------VQREIMNHRSL 55
           E YE+VK IG G FG  +LVR K TR++ A+K + + + I          +R+IM   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN- 127
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
             P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H
Sbjct: 128 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIH 185
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVL 171
           SM   HRD+K +N LLD S    +K+ DFG     +K  ++     + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVL 241
Query: 172 TKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
             +    Y G+  D WS GV LY MLVG  PF        + K +    S+  +FPD   
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--TFPDDND 299
Query: 229 VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
           +S E K+L+   F+ + E R+    + EIK H +F
Sbjct: 300 ISKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 333

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 130/265 (49%), Gaps = 14/265 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH----VQREIMNHRSLK 56
           M+RY   + +G G F     + D  T+E+ A K + +   +  H    +  EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +P++V F         + +V+E      L E        +E EAR+F +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKE 175
            ++ HRDLKL N  L+      VKI DFG +       + K T+ GTP YIAPEVL KK 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI    YS P ++        
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA-- 271
Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
           L+ R+  A+   R ++ E+    +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 132/277 (47%), Gaps = 24/277 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI----------ERGQKIDEHVQREIMN 51
           E YE  + +G G   V +    K T +  AVK I          E  Q++ E   +E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 52  HRSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
            R +  HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +S  GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 171 LTKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-- 223
           +     D     GK  D+WS GV +Y +L G+ PF   +     R     I+S +Y F  
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----MIMSGNYQFGS 250
Query: 224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           P++   S   K L+SR  V   +KR T  E   HP+F
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 135/267 (50%), Gaps = 26/267 (9%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIVRFKE 65
           + +GSG FG   LV ++ +     +K I  +R Q   E ++ EI   +SL HPNI++  E
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 66  VLLTPTHLAIVMEYAAGGELFERICNA---GR-FSEDEARFFFQQLISGVSYCHSMQICH 121
           V     ++ IVME   GGEL ERI +A   G+  SE       +Q+++ ++Y HS  + H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 122 RDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           +DLK EN L  D S    +KI DFG ++         +  GT  Y+APEV  K++   K 
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDVTFK- 205
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK------ 234
            D+WS GV +Y +L G  PF      +  +K         Y  P+Y   ++EC+      
Sbjct: 206 CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-------YKEPNY---AVECRPLTPQA 255
Query: 235 -HLLSRIFVANSEKRITIPEIKNHPWF 260
             LL ++   + E+R +  ++ +H WF
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 58/312 (18%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------KIDEHVQREIMNHRSL 55
           ++Y +   IG G++GV ++  +  TR + A+K + + +      K  E ++ E+   + L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFER--------------------ICNAGRF 95
            HPNI R  EV     ++ +VME   GG L ++                    IC     
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 96  SED----------EARFFFQ----------QLISGVSYCHSMQICHRDLKLENTLLDGST 135
           +E+          E+  F Q          Q+ S + Y H+  ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 136 APRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL-TKKEYDGKIADVWSCGVT 189
           +  +K+ DFG SK     ++  +    +  GTP ++APEVL T  E  G   D WS GV 
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 190 LYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSEK 247
           L+++L+GA PF    D      TI ++L+    F  P+Y  +S   + LLS +   N ++
Sbjct: 266 LHLLLMGAVPFPGVNDA----DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 248 RITIPEIKNHPW 259
           R        HPW
Sbjct: 322 RFDAMRALQHPW 333

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 129/265 (48%), Gaps = 14/265 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH----VQREIMNHRSLK 56
           M+RY   + +G G F     + D  T+E+ A K + +   +  H    +  EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +P++V F         + +V+E      L E        +E EAR+F +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
            ++ HRDLKL N  L+      VKI DFG  +K      + K   GTP YIAPEVL KK 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI    YS P ++        
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA-- 271
Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
           L+ R+  A+   R ++ E+    +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 129/265 (48%), Gaps = 14/265 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH----VQREIMNHRSLK 56
           M+RY   + +G G F     + D  T+E+ A K + +   +  H    +  EI  H+SL 
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +P++V F         + +V+E      L E        +E EAR+F +Q I GV Y H+
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
            ++ HRDLKL N  L+      VKI DFG  +K      + K   GTP YIAPEVL KK 
Sbjct: 145 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI    YS P ++        
Sbjct: 203 HSFEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA-- 255
Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
           L+ R+  A+   R ++ E+    +F
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 135/273 (49%), Gaps = 23/273 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRD---KWTRELLAVK-----FIERGQKIDEHVQREIMNHR 53
           E +E+++ +G G +G    VR      T ++ A+K      I R  K   H + E     
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
            +KHP IV       T   L +++EY +GGELF ++   G F ED A F+  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT 172
            H   I +RDLK EN +L+      VK+ DFG  K S+       T  GT  Y+APE+L 
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +  ++ +  D WS G  +Y ML GA PF      +N +KTI +IL    + P Y  ++ E
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LTQE 247
Query: 233 CKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            + LL ++   N+  R+        E++ HP+F
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 129/265 (48%), Gaps = 14/265 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH----VQREIMNHRSLK 56
           M+RY   + +G G F     + D  T+E+ A K + +   +  H    +  EI  H+SL 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +P++V F         + +V+E      L E        +E EAR+F +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKE 175
            ++ HRDLKL N  L+      VKI DFG +       + K  + GTP YIAPEVL KK 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI    YS P ++        
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA-- 271
Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
           L+ R+  A+   R ++ E+    +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 131/277 (47%), Gaps = 24/277 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI----------ERGQKIDEHVQREIMN 51
           E YE  + +G G   V +    K T +  AVK I          E  Q++ E   +E+  
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 52  HRSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
            R +  HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 171 LTKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-- 223
           +     D     GK  D+WS GV +Y +L G+ PF   +     R     I+S +Y F  
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----MIMSGNYQFGS 237
Query: 224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           P++   S   K L+SR  V   +KR T  E   HP+F
Sbjct: 238 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 131/277 (47%), Gaps = 24/277 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI----------ERGQKIDEHVQREIMN 51
           E YE  + +G G   V +    K T +  AVK I          E  Q++ E   +E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 52  HRSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
            R +  HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 171 LTKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-- 223
           +     D     GK  D+WS GV +Y +L G+ PF   +     R     I+S +Y F  
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----MIMSGNYQFGS 250
Query: 224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           P++   S   K L+SR  V   +KR T  E   HP+F
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 89/262 (33%), Positives = 131/262 (50%), Gaps = 20/262 (7%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHPNIVRFK 64
           +G G+FG   L   K T EL AVK +++   I D+ V+  ++  R L    K P + +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   GRF E  A F+  ++  G+ +  S  I +RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N +LD  +   +KI DFG  K ++      K   GTP YIAPE++  + Y GK  D 
Sbjct: 148 KLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDW 204
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           W+ GV LY ML G  PFE  ++ + F+     I+  + ++P    +S E   +   +   
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPK--SMSKEAVAICKGLMTK 258
Query: 244 NSEKRITI-PE----IKNHPWF 260
           +  KR+   PE    IK H +F
Sbjct: 259 HPGKRLGCGPEGERDIKEHAFF 280

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 126/257 (49%), Gaps = 16/257 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN-----HRSLKHPNIVRFK 64
           +G G F     + D  T+E+ A K + +   +  H QRE M+     HRSL H ++V F 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREKMSMEISIHRSLAHQHVVGFH 87
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
                   + +V+E      L E        +E EAR++ +Q++ G  Y H  ++ HRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADV 183
           KL N  L+      VKI DFG +       + K T+ GTP YIAPEVL+KK +  ++ DV
Sbjct: 148 KLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DV 204
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS G  +Y +LVG  PFE        ++T  RI    YS P ++        L+ ++   
Sbjct: 205 WSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPV--AASLIQKMLQT 258
Query: 244 NSEKRITIPEIKNHPWF 260
           +   R TI E+ N  +F
Sbjct: 259 DPTARPTINELLNDEFF 275

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 89/262 (33%), Positives = 131/262 (50%), Gaps = 20/262 (7%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHPNIVRFK 64
           +G G+FG   L   K T EL AVK +++   I D+ V+  ++  R L    K P + +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   GRF E  A F+  ++  G+ +  S  I +RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N +LD  +   +KI DFG  K ++      K   GTP YIAPE++  + Y GK  D 
Sbjct: 469 KLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDW 525
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           W+ GV LY ML G  PFE  ++ + F+     I+  + ++P    +S E   +   +   
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPK--SMSKEAVAICKGLMTK 579
Query: 244 NSEKRITI-PE----IKNHPWF 260
           +  KR+   PE    IK H +F
Sbjct: 580 HPGKRLGCGPEGERDIKEHAFF 601

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  120 bits (301), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-DEHVQREIMNHRSL----KHPNIVRFK 64
           +G G+FG   L   K T EL A+K +++   I D+ V+  ++  R L    K P + +  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   G+F E +A F+  ++  G+ + H   I +RDL
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDL 146
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLTKKEYDGKIADV 183
           KL+N +LD      +KI DFG  K  ++     +   GTP YIAPE++  + Y GK  D 
Sbjct: 147 KLDNVMLDSEG--HIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY-GKSVDW 203
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           W+ GV LY ML G  PF+  ++ + F+     I+  + S+P    +S E   +   +   
Sbjct: 204 WAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAVSICKGLMTK 257
Query: 244 NSEKRITI-PE----IKNHPWFLR 262
           +  KR+   PE    ++ H +F R
Sbjct: 258 HPAKRLGCGPEGERDVREHAFFRR 281

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 126/257 (49%), Gaps = 16/257 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN-----HRSLKHPNIVRFK 64
           +G G F     + D  T+E+ A K + +   +  H QRE M+     HRSL H ++V F 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREKMSMEISIHRSLAHQHVVGFH 83
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
                   + +V+E      L E        +E EAR++ +Q++ G  Y H  ++ HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADV 183
           KL N  L+      VKI DFG +       + K T+ GTP YIAPEVL+KK +  ++ DV
Sbjct: 144 KLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DV 200
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS G  +Y +LVG  PFE        ++T  RI    YS P ++        L+ ++   
Sbjct: 201 WSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPV--AASLIQKMLQT 254
Query: 244 NSEKRITIPEIKNHPWF 260
           +   R TI E+ N  +F
Sbjct: 255 DPTARPTINELLNDEFF 271

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 126/257 (49%), Gaps = 16/257 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN-----HRSLKHPNIVRFK 64
           +G G F     + D  T+E+ A K + +   +  H QRE M+     HRSL H ++V F 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREKMSMEISIHRSLAHQHVVGFH 83
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
                   + +V+E      L E        +E EAR++ +Q++ G  Y H  ++ HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADV 183
           KL N  L+      VKI DFG +       + K T+ GTP YIAPEVL+KK +  ++ DV
Sbjct: 144 KLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DV 200
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS G  +Y +LVG  PFE        ++T  RI    YS P ++        L+ ++   
Sbjct: 201 WSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPV--AASLIQKMLQT 254
Query: 244 NSEKRITIPEIKNHPWF 260
           +   R TI E+ N  +F
Sbjct: 255 DPTARPTINELLNDEFF 271

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 142/265 (53%), Gaps = 24/265 (9%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME+Y  ++ IG G+FG A LV+         +K I       K  E  +RE+    ++KH
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYC 114
           PNIV+++E       L IVM+Y  GG+LF+RI NA +   F ED+   +F Q+   + + 
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 115 HSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPE 169
           H  +I HRD+K +N  L  DG+    V++ DFG ++  VL+S     ++ +GTP Y++PE
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIAR--VLNSTVELARACIGTPYYLSPE 195
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 229
           +   K Y+ K +D+W+ G  LY +    + FE      + +  + +I+S  +  P  +  
Sbjct: 196 ICENKPYNNK-SDIWALGCVLYELCTLKHAFE----AGSMKNLVLKIISGSFP-PVSLHY 249
Query: 230 SLECKHLLSRIFVANSEKRITIPEI 254
           S + + L+S++F  N   R ++  I
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSI 274

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 134/273 (49%), Gaps = 23/273 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRD---KWTRELLAVK-----FIERGQKIDEHVQREIMNHR 53
           E +E+++ +G G +G    VR      T ++ A+K      I R  K   H + E     
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
            +KHP IV       T   L +++EY +GGELF ++   G F ED A F+  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLT 172
            H   I +RDLK EN +L+      VK+ DFG  K S+          GT  Y+APE+L 
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +  ++ +  D WS G  +Y ML GA PF      +N +KTI +IL    + P Y  ++ E
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LTQE 247
Query: 233 CKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            + LL ++   N+  R+        E++ HP+F
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 125/257 (48%), Gaps = 16/257 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN-----HRSLKHPNIVRFK 64
           +G G F     + D  T+E+ A K + +   +  H QRE M+     HRSL H ++V F 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREKMSMEISIHRSLAHQHVVGFH 107
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
                   + +V+E      L E        +E EAR++ +Q++ G  Y H  ++ HRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADV 183
           KL N  L+      VKI DFG +       + K  + GTP YIAPEVL+KK +  ++ DV
Sbjct: 168 KLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DV 224
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS G  +Y +LVG  PFE        ++T  RI    YS P ++        L+ ++   
Sbjct: 225 WSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPV--AASLIQKMLQT 278
Query: 244 NSEKRITIPEIKNHPWF 260
           +   R TI E+ N  +F
Sbjct: 279 DPTARPTINELLNDEFF 295

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 125/257 (48%), Gaps = 16/257 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN-----HRSLKHPNIVRFK 64
           +G G F     + D  T+E+ A K + +   +  H QRE M+     HRSL H ++V F 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREKMSMEISIHRSLAHQHVVGFH 105
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
                   + +V+E      L E        +E EAR++ +Q++ G  Y H  ++ HRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADV 183
           KL N  L+      VKI DFG +       + K  + GTP YIAPEVL+KK +  ++ DV
Sbjct: 166 KLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DV 222
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS G  +Y +LVG  PFE        ++T  RI    YS P ++        L+ ++   
Sbjct: 223 WSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPV--AASLIQKMLQT 276
Query: 244 NSEKRITIPEIKNHPWF 260
           +   R TI E+ N  +F
Sbjct: 277 DPTARPTINELLNDEFF 293

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 141/275 (51%), Gaps = 26/275 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH------VQREIMNHRSL 55
           E Y++VK IG G FG  +LVR K ++++ A+K + + + I          +R+IM   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN- 133
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
             P +V+         +L +VMEY  GG+L   + N     E  A+F+  +++  +   H
Sbjct: 134 -SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIH 191
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVL 171
           SM + HRD+K +N LLD      +K+ DFG      ++ ++H    + VGTP YI+PEVL
Sbjct: 192 SMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVHCD--TAVGTPDYISPEVL 247
Query: 172 TKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
             +    Y G+  D WS GV L+ MLVG  PF        + K +    S+   FP+   
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL--CFPEDAE 305
Query: 229 VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
           +S   K+L+   F+ + E R+    + EIK HP+F
Sbjct: 306 ISKHAKNLIC-AFLTDREVRLGRNGVEEIKQHPFF 339

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 125/257 (48%), Gaps = 16/257 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN-----HRSLKHPNIVRFK 64
           +G G F     + D  T+E+ A K + +   +  H QRE M+     HRSL H ++V F 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREKMSMEISIHRSLAHQHVVGFH 81
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
                   + +V+E      L E        +E EAR++ +Q++ G  Y H  ++ HRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKEYDGKIADV 183
           KL N  L+      VKI DFG +       + K  + GTP YIAPEVL+KK +  ++ DV
Sbjct: 142 KLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DV 198
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS G  +Y +LVG  PFE        ++T  RI    YS P ++        L+ ++   
Sbjct: 199 WSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPV--AASLIQKMLQT 252
Query: 244 NSEKRITIPEIKNHPWF 260
           +   R TI E+ N  +F
Sbjct: 253 DPTARPTINELLNDEFF 269

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE+LT
Sbjct: 153 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLT 208
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 209 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 261
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 262 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE+LT
Sbjct: 149 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLT 204
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 205 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 257
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 258 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 205
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 206 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 258
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANAFVGTAQYVSPELLT 205
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 206 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 258
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 207
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F K    I+ + Y FP+  +   +
Sbjct: 208 EKSAX-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK----IIKLEYDFPE--KFFPK 260
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 205
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 206 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 258
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 207
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 208 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 260
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 149 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 204
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 205 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 257
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 258 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 207
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 208 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 260
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 153 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 208
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 209 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 261
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 262 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 150 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 205
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 206 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 258
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 207
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 208 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 260
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 134 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 189
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 190 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 242
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 243 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 140/274 (51%), Gaps = 26/274 (9%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID------EHVQREIMNHRSLKH 57
           YE+ + IG G F V +   ++ T +  AVK ++  +         E ++RE      LKH
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL-FERI--CNAG-RFSEDEARFFFQQLISGVSY 113
           P+IV   E   +   L +V E+  G +L FE +   +AG  +SE  A  + +Q++  + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 114 CHSMQICHRDLKLENTLLDG--STAPRVKICDFGYS----KSSVLHSQPKSTVGTPAYIA 167
           CH   I HRD+K    LL    ++AP VK+  FG +    +S ++       VGTP ++A
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 203
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DY 226
           PEV+ ++ Y GK  DVW CGV L+++L G  PF   ++    R   G I   +   P  +
Sbjct: 204 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIKGKYKMNPRQW 258
Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             +S   K L+ R+ + +  +RIT+ E  NHPW 
Sbjct: 259 SHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 157 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 212
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 213 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 265
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 266 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 207
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F K    I+ + Y FP+  +   +
Sbjct: 208 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK----IIKLEYDFPE--KFFPK 260
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 127 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 182
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 183 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 235
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 236 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 129 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 184
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 185 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 237
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 238 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 128 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 183
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 184 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 236
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 130 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 185
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 186 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 238
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 239 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 138/274 (50%), Gaps = 26/274 (9%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID------EHVQREIMNHRSLKH 57
           YE+ + IG G F V +   ++ T +  AVK ++  +         E ++RE      LKH
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL-FERICNAGR---FSEDEARFFFQQLISGVSY 113
           P+IV   E   +   L +V E+  G +L FE +  A     +SE  A  + +Q++  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 114 CHSMQICHRDLKLENTLLDG--STAPRVKICDFGYS----KSSVLHSQPKSTVGTPAYIA 167
           CH   I HRD+K    LL    ++AP VK+  FG +    +S ++       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DY 226
           PEV+ ++ Y GK  DVW CGV L+++L G  PF   ++    R   G I   +   P  +
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIKGKYKMNPRQW 256
Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             +S   K L+ R+ + +  +RIT+ E  NHPW 
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 25/279 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---------RGQKIDEHVQREIMNH 52
           ++Y+    IG G   V +    + T    AVK +E         + +++ E  +RE    
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 53  RSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
           R +  HP+I+   +   + + + +V +    GELF+ +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           S+ H+  I HRDLK EN LLD +   ++++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 172 ------TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-- 223
                 T   Y GK  D+W+CGV L+ +L G+ PF         R     I+   Y F  
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS 326
Query: 224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
           P++   S   K L+SR+   + E R+T  +   HP+F R
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 142/279 (50%), Gaps = 25/279 (8%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRD---KWTRELLAVKFIERGQ-----KIDEHV--QREIM 50
           +E +E++K +G+G +G   LVR      T +L A+K +++       K  EH   +R+++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
            H   + P +V       T T L ++++Y  GGELF  +    RF+E E + +  +++  
Sbjct: 113 EHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAP 168
           + + H + I +RD+KLEN LLD +    V + DFG SK  V     ++    GT  Y+AP
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 169 EVLTKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG-RILSVHYSFPDY 226
           +++   +    K  D WS GV +Y +L GA PF   +  KN +  I  RIL     +P  
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRILKSEPPYPQ- 287
Query: 227 VRVSLECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
             +S   K L+ R+ + + +KR+        EIK H +F
Sbjct: 288 -EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 92/289 (31%), Positives = 135/289 (46%), Gaps = 24/289 (8%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH-PNIVRF 63
           K++G G F V +    K T +  A KF++   RGQ     +  EI      K  P ++  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQIC 120
            EV    + + +++EYAAGGE+F  +C    A   SE++     +Q++ GV Y H   I 
Sbjct: 95  HEVYENTSEIILILEYAAGGEIF-SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 121 HRDLKLENTLLDGSTAP--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD- 177
           H DLK +N LL  S  P   +KI DFG S+      + +  +GTP Y+APE+L    YD 
Sbjct: 154 HLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN---YDP 209
Query: 178 -GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
                D+W+ G+  Y++L    PF   ED +     I ++ +V YS   +  VS      
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVG-EDNQETYLNISQV-NVDYSEETFSSVSQLATDF 267
Query: 237 LSRIFVANSEKRITIPEIKNHPWF----LRNL--PIELTEGGSWQSHDV 279
           +  + V N EKR T     +H W       NL  P E +     Q H V
Sbjct: 268 IQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSV 316

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE+LT
Sbjct: 155 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 210
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP       +
Sbjct: 211 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFP--AAFFPK 263
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 264 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  G L + I   G F E   RF+  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLT 172
            I HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE+LT
Sbjct: 152 GIIHRDLKPENILLNEDM--HIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLT 207
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+  +   +
Sbjct: 208 EKS-ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 260
Query: 233 CKHLLSRIFVANSEKRITIPE------IKNHPWF 260
            + L+ ++ V ++ KR+   E      +K HP+F
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/240 (32%), Positives = 120/240 (50%), Gaps = 18/240 (7%)
Query: 39  QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH----LAIVMEYAAGGELFERICNAG- 93
           Q++D H Q       +   P+IV   +V     H    L I+ME   GGELF RI   G 
Sbjct: 70  QEVDHHWQ-------ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122
Query: 94  -RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV-KICDFGYSKSSV 151
             F+E EA    + + + + + HS  I HRD+K EN L        V K+ DFG++K + 
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK 211
            ++  ++   TP Y+APEVL  ++YD K  D+WS GV +Y++L G  PF           
Sbjct: 183 QNAL-QTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 240
Query: 212 TIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
              RI    Y FP+  +  VS + K L+  +   +  +R+TI +  NHPW  +++ +  T
Sbjct: 241 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 300

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/240 (32%), Positives = 120/240 (50%), Gaps = 18/240 (7%)
Query: 39  QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH----LAIVMEYAAGGELFERICNAG- 93
           Q++D H Q       +   P+IV   +V     H    L I+ME   GGELF RI   G 
Sbjct: 51  QEVDHHWQ-------ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 103
Query: 94  -RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV-KICDFGYSKSSV 151
             F+E EA    + + + + + HS  I HRD+K EN L        V K+ DFG++K + 
Sbjct: 104 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 163
Query: 152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK 211
            ++  ++   TP Y+APEVL  ++YD K  D+WS GV +Y++L G  PF           
Sbjct: 164 QNAL-QTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 221
Query: 212 TIGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
              RI    Y FP+  +  VS + K L+  +   +  +R+TI +  NHPW  +++ +  T
Sbjct: 222 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 281

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-----ERGQKIDEHVQREIMNHRSLK 56
           ERY+IV  +G G      L  D      +A+K I     E+ + + +  +RE+ N   L 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-KRFEREVHNSSQLS 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H NIV   +V        +VMEY  G  L E I + G  S D A  F  Q++ G+ + H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKK 174
           M+I HRD+K +N L+D +    +KI DFG +K  S    +Q    +GT  Y +PE   K 
Sbjct: 130 MRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKG 186
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPF 200
           E   +  D++S G+ LY MLVG  PF
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 147/312 (47%), Gaps = 46/312 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE------HVQREIMNHRSL 55
           E +EI+K IG G FG   +V+ K T  + A+K + + + +          +R+++ +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 114
           +   I           HL +VM+Y  GG+L   +     +  ED ARF+  +++  +   
Sbjct: 150 QW--ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           H +   HRD+K +N LLD      +++ DFG     +     Q    VGTP YI+PE+L 
Sbjct: 208 HQLHYVHRDIKPDNVLLD--VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 173 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDY 226
             E      G   D WS GV +Y ML G  PF      ++  +T G+I++    + FP +
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHEERFQFPSH 321
Query: 227 VR-VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLRNLPIELTEGGSWQS------ 276
           V  VS E K L+ R+ + + E+R+    I + K H +F         EG +W++      
Sbjct: 322 VTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFF---------EGLNWENIRNLEA 371
Query: 277 ---HDVNNPSQS 285
               DV++PS +
Sbjct: 372 PYIPDVSSPSDT 383

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 126/245 (51%), Gaps = 10/245 (4%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFI-ERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           +G G +G+    RD   +  +A+K I ER  +  + +  EI  H+ LKH NIV++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 69  TPTHLAIVMEYAAGGELFERI-CNAGRFSEDEAR--FFFQQLISGVSYCHSMQICHRDLK 125
               + I ME   GG L   +    G   ++E    F+ +Q++ G+ Y H  QI HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 126 LENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYD-GKIADV 183
            +N L++ + +  +KI DFG SK  + ++   ++  GT  Y+APE++ K     GK AD+
Sbjct: 136 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 194
Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS G T+  M  G  PF +  +P+     +G +  VH   P+   +S E K  + + F  
Sbjct: 195 WSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPE--SMSAEAKAFILKCFEP 251
Query: 244 NSEKR 248
           + +KR
Sbjct: 252 DPDKR 256

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 147/312 (47%), Gaps = 46/312 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE------HVQREIMNHRSL 55
           E +EI+K IG G FG   +V+ K T  + A+K + + + +          +R+++ +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 114
           +   I           HL +VM+Y  GG+L   +     +  ED ARF+  +++  +   
Sbjct: 134 QW--ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           H +   HRD+K +N LLD      +++ DFG     +     Q    VGTP YI+PE+L 
Sbjct: 192 HQLHYVHRDIKPDNVLLD--VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 173 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDY 226
             E      G   D WS GV +Y ML G  PF      ++  +T G+I++    + FP +
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHEERFQFPSH 305
Query: 227 VR-VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWFLRNLPIELTEGGSWQS------ 276
           V  VS E K L+ R+ + + E+R+    I + K H +F         EG +W++      
Sbjct: 306 VTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFF---------EGLNWENIRNLEA 355
Query: 277 ---HDVNNPSQS 285
               DV++PS +
Sbjct: 356 PYIPDVSSPSDT 367

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 8/262 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E+Y I +D+G G FG+     +  +++    KF++        V++EI      +H NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
              E   +   L ++ E+ +G ++FERI  +A   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           H D++ EN +     +  +KI +FG ++        +     P Y APEV  + +     
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-HQHDVVSTA 183
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS G  +YV+L G  PF    +    ++ I  I++  Y+F +  +  +S+E    + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 239 RIFVANSEKRITIPEIKNHPWF 260
           R+ V   + R+T  E   HPW 
Sbjct: 240 RLLVKERKSRMTASEALQHPWL 261

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/246 (31%), Positives = 129/246 (52%), Gaps = 12/246 (4%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFI-ERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           +G G +G+    RD   +  +A+K I ER  +  + +  EI  H+ LKH NIV++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 69  TPTHLAIVMEYAAGGELFERICNA-GRFSEDEAR--FFFQQLISGVSYCHSMQICHRDLK 125
               + I ME   GG L   + +  G   ++E    F+ +Q++ G+ Y H  QI HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 126 LENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK--KEYDGKIAD 182
            +N L++ + +  +KI DFG SK  + ++   ++  GT  Y+APE++ K  + Y GK AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 207
Query: 183 VWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV 242
           +WS G T+  M  G  PF +  +P+     +G +  VH   P+   +S E K  + + F 
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPE--SMSAEAKAFILKCFE 264
Query: 243 ANSEKR 248
            + +KR
Sbjct: 265 PDPDKR 270

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 139/287 (48%), Gaps = 23/287 (8%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-----GQKIDEHVQREIMNHRSL 55
           ++ +++++ IG G++    LVR K T  + A++ +++      + ID     + +  ++ 
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            HP +V       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKK 174
              I +RDLKL+N LLD  +   +K+ D+G  K  +      ST  GTP YIAPE+L  +
Sbjct: 171 ERGIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFE-----DPEDPKNFRKTIGRILSVHYSFPDYVRV 229
           +Y G   D W+ GV ++ M+ G  PF+     D  D          IL      P    +
Sbjct: 229 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSL 285
Query: 230 SLECKHLLSRIFVANSEKRI------TIPEIKNHPWFLRNLPIELTE 270
           S++   +L      + ++R+         +I+ HP+F RN+  ++ E
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMME 331

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 143/301 (47%), Gaps = 30/301 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A++ +  + Q   E +  EI+  R  K+PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYD 177
           HRD+K +N LL  DGS    VK+ DFG+          +ST VGTP ++APEV+T+K Y 
Sbjct: 139 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  ++S   +  L
Sbjct: 195 PKV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 250
Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEAT 297
           +R    + EKR +  E+  H  FL+                +  P  SL  +++   EAT
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQ-FLK----------------IAKPLSSLTPLIAAAKEAT 293
Query: 298 K 298
           K
Sbjct: 294 K 294

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 138/287 (48%), Gaps = 23/287 (8%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-----GQKIDEHVQREIMNHRSL 55
           ++ +++++ IG G++    LVR K T  + A+K +++      + ID     + +  ++ 
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            HP +V       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKK 174
              I +RDLKL+N LLD  +   +K+ D+G  K  +      S   GTP YIAPE+L  +
Sbjct: 124 ERGIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFE-----DPEDPKNFRKTIGRILSVHYSFPDYVRV 229
           +Y G   D W+ GV ++ M+ G  PF+     D  D          IL      P    +
Sbjct: 182 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSL 238
Query: 230 SLECKHLLSRIFVANSEKRI------TIPEIKNHPWFLRNLPIELTE 270
           S++   +L      + ++R+         +I+ HP+F RN+  ++ E
Sbjct: 239 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMME 284

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 138/287 (48%), Gaps = 23/287 (8%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-----GQKIDEHVQREIMNHRSL 55
           ++ +++++ IG G++    LVR K T  + A+K +++      + ID     + +  ++ 
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            HP +V       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKK 174
              I +RDLKL+N LLD  +   +K+ D+G  K  +      S   GTP YIAPE+L  +
Sbjct: 128 ERGIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFE-----DPEDPKNFRKTIGRILSVHYSFPDYVRV 229
           +Y G   D W+ GV ++ M+ G  PF+     D  D          IL      P    +
Sbjct: 186 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSL 242
Query: 230 SLECKHLLSRIFVANSEKRI------TIPEIKNHPWFLRNLPIELTE 270
           S++   +L      + ++R+         +I+ HP+F RN+  ++ E
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMME 288

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 138/287 (48%), Gaps = 23/287 (8%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-----GQKIDEHVQREIMNHRSL 55
           ++ +++++ IG G++    LVR K T  + A+K +++      + ID     + +  ++ 
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            HP +V       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKK 174
              I +RDLKL+N LLD  +   +K+ D+G  K  +      S   GTP YIAPE+L  +
Sbjct: 139 ERGIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFE-----DPEDPKNFRKTIGRILSVHYSFPDYVRV 229
           +Y G   D W+ GV ++ M+ G  PF+     D  D          IL      P    +
Sbjct: 197 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSM 253
Query: 230 SLECKHLLSRIFVANSEKRI------TIPEIKNHPWFLRNLPIELTE 270
           S++   +L      + ++R+         +I+ HP+F RN+  ++ E
Sbjct: 254 SVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF-RNVDWDMME 299

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 33/280 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
           E YE++  IG+G++G  + +R K   ++L  K ++ G   +   Q    E+   R LKHP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIVRFKEVLL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVS 112
           NIVR+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCHSMQ-----ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---SQPKSTVGTPA 164
            CH        + HRDLK  N  LDG     VK+ DFG ++  +L+   S  K+ VGTP 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDTSFAKTFVGTPY 181
Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEDPKNFRKTIGRILSVHY 221
           Y++PE + +  Y+ K +D+WS G  LY +     P   F   E     R+  G+   + Y
Sbjct: 182 YMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFRRIPY 238
Query: 222 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
            + D      E   +++R+       R ++ EI  +P  L
Sbjct: 239 RYSD------ELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 33/280 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
           E YE++  IG+G++G  + +R K   ++L  K ++ G   +   Q    E+   R LKHP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIVRFKEVLL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVS 112
           NIVR+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCHSMQ-----ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---SQPKSTVGTPA 164
            CH        + HRDLK  N  LDG     VK+ DFG ++  +L+   S  K+ VGTP 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDTSFAKAFVGTPY 181
Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEDPKNFRKTIGRILSVHY 221
           Y++PE + +  Y+ K +D+WS G  LY +     P   F   E     R+  G+   + Y
Sbjct: 182 YMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFRRIPY 238
Query: 222 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
            + D      E   +++R+       R ++ EI  +P  L
Sbjct: 239 RYSD------ELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 145/301 (48%), Gaps = 30/301 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A++ +  + Q   E +  EI+  R  K+PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 139
Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           HRD+K +N LL  DGS    VK+ DFG+ ++ +   S+    VGTP ++APEV+T+K Y 
Sbjct: 140 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 195
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  ++S   +  L
Sbjct: 196 PKV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 251
Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEAT 297
           +R    + EKR +  E+  H  FL+                +  P  SL  +++   EAT
Sbjct: 252 NRCLEMDVEKRGSAKELIQHQ-FLK----------------IAKPLSSLTPLIAAAKEAT 294
Query: 298 K 298
           K
Sbjct: 295 K 295

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 145/301 (48%), Gaps = 30/301 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A++ +  + Q   E +  EI+  R  K+PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           HRD+K +N LL  DGS    VK+ DFG+ ++ +   S+    VGTP ++APEV+T+K Y 
Sbjct: 139 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 194
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  ++S   +  L
Sbjct: 195 PKV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 250
Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEAT 297
           +R    + EKR +  E+  H  FL+                +  P  SL  +++   EAT
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQ-FLK----------------IAKPLSSLTPLIAAAKEAT 293
Query: 298 K 298
           K
Sbjct: 294 K 294

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 138/258 (53%), Gaps = 13/258 (5%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  L R+K +   +AVK ++ R Q+  E +  E++  R  +H N+V   +  L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L ++ME+  GG L + I +  R +E++     + ++  ++Y H+  + HRD+K ++
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 129 TL--LDGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            L  LDG    RVK+ DFG+ ++ S    + K  VGTP ++APEV+++  Y  ++ D+WS
Sbjct: 172 ILLTLDG----RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV-DIWS 226
Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANS 245
            G+ +  M+ G  P+   + P    K +    S      +  +VS   +  L R+ V + 
Sbjct: 227 LGIMVIEMVDGEPPYFS-DSPVQAMKRLRD--SPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 246 EKRITIPEIKNHPWFLRN 263
           ++R T  E+ +HP+ L+ 
Sbjct: 284 QERATAQELLDHPFLLQT 301

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 145/301 (48%), Gaps = 30/301 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A++ +  + Q   E +  EI+  R  K+PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           HRD+K +N LL  DGS    VK+ DFG+ ++ +   S+    VGTP ++APEV+T+K Y 
Sbjct: 139 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYG 194
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  ++S   +  L
Sbjct: 195 PKV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 250
Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEAT 297
           +R    + EKR +  E+  H  FL+                +  P  SL  +++   EAT
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQ-FLK----------------IAKPLSSLTPLIAAAKEAT 293
Query: 298 K 298
           K
Sbjct: 294 K 294

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 143/301 (47%), Gaps = 30/301 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A++ +  + Q   E +  EI+  R  K+PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 139
Query: 121 HRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYD 177
           HR++K +N LL  DGS    VK+ DFG+          +ST VGTP ++APEV+T+K Y 
Sbjct: 140 HRNIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 195
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K+ D+WS G+    M+ G  P+ + E+P      I    +     P+  ++S   +  L
Sbjct: 196 PKV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 251
Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEAT 297
           +R    + EKR +  E+  H  FL+                +  P  SL  +++   EAT
Sbjct: 252 NRCLEMDVEKRGSAKELIQHQ-FLK----------------IAKPLSSLTPLIAAAKEAT 294
Query: 298 K 298
           K
Sbjct: 295 K 295

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 129/271 (47%), Gaps = 38/271 (14%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVR----FK 64
           +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P+IVR    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 123 DLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           D+K EN LL  S  P   +K+ DFG++K +                     T ++YD K 
Sbjct: 142 DVKPEN-LLYTSKRPNAILKLTDFGFAKET---------------------TGEKYD-KS 178
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS GV +Y++L G  PF              RI    Y FP+  +  VS E K L+ 
Sbjct: 179 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 238
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
            +      +R+TI E  NHPW +++  +  T
Sbjct: 239 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 137/301 (45%), Gaps = 26/301 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE---------HVQREIMNH 52
           ++Y  +  +GSG FG      DK   + + VKFI++ + +++          V  EI   
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVME-YAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
             ++H NI++  ++        +VME + +G +LF  I    R  E  A + F+QL+S V
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
            Y     I HRD+K EN ++       +K+ DFG +          +  GT  Y APEVL
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
               Y G   ++WS GVTLY ++    PF + E+            ++H   P Y+ VS 
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--------AAIH---PPYL-VSK 249
Query: 232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLS 291
           E   L+S +     E+R T+ ++   PW  +  P+ L +    +   VN P   +    S
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ--PVNLADYTWEEVFRVNKPESGVLSAAS 307
Query: 292 L 292
           L
Sbjct: 308 L 308

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 20/221 (9%)
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYA-AGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           HP ++R  +   T     +V+E      +LF+ I   G   E  +R FF Q+++ + +CH
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKK 174
           S  + HRD+K EN L+D       K+ DFG    ++LH +P +   GT  Y  PE +++ 
Sbjct: 157 SRGVVHRDIKDENILIDLRRG-CAKLIDFG--SGALLHDEPYTDFDGTRVYSPPEWISRH 213
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +Y    A VWS G+ LY M+ G  PFE  ++          IL     FP +  VS +C 
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQE----------ILEAELHFPAH--VSPDCC 261
Query: 235 HLLSRIFVANSEKRITIPEIKNHPWF---LRNLPIELTEGG 272
            L+ R        R ++ EI   PW      ++P+  ++GG
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 31/279 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
           E YE++  IG+G++G  + +R K   ++L  K ++ G   +   Q    E+   R LKHP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIVRFKEVLL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVS 112
           NIVR+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCHSMQ-----ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKSTVGTPAY 165
            CH        + HRDLK  N  LDG     VK+ DFG ++  + H +   K  VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR-ILNHDEDFAKEFVGTPYY 182
Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEDPKNFRKTIGRILSVHYS 222
           ++PE + +  Y+ K +D+WS G  LY +     P   F   E     R+  G+   + Y 
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFRRIPYR 239
Query: 223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
           + D      E   +++R+       R ++ EI  +P  L
Sbjct: 240 YSD------ELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RVSXE 263
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RVSXE 262
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RVSXE 263
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 209
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSXE 257
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 258 CQHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSXE 249
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 250 CQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSXE 230
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSXE 250
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 251 CQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSXE 250
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 251 CQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSXE 277
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 278 CQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RVSSE 263
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 234
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSXE 282
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 283 CQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RVSSE 262
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RVSSE 263
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RVSSE 262
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 235
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 249
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 250 CQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RVSSE 230
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 277
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 278 CQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 250
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 251 CQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 221
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 269
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 270 CQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 135/265 (50%), Gaps = 23/265 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +   + + +L+AVK ++ R Q+  E +  E++  R  +H N+V      L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 142 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200
Query: 129 TLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            LL  DG    RVK+ DFG+ ++ S    + K  VGTP ++APE++++  Y G   D+WS
Sbjct: 201 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 255
Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTI-----GRILSVHYSFPDYVRVSLECKHLLSRI 240
            G+ +  M+ G  P+ + E P    K I      R+ ++H       +VS   K  L R+
Sbjct: 256 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLH-------KVSPSLKGFLDRL 307
Query: 241 FVANSEKRITIPEIKNHPWFLRNLP 265
            V +  +R T  E+  HP+  +  P
Sbjct: 308 LVRDPAQRATAAELLKHPFLAKAGP 332

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 234
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 262
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 135/265 (50%), Gaps = 23/265 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +   + + +L+AVK ++ R Q+  E +  E++  R  +H N+V      L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 99  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 157
Query: 129 TLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            LL  DG    RVK+ DFG+ ++ S    + K  VGTP ++APE++++  Y G   D+WS
Sbjct: 158 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 212
Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTI-----GRILSVHYSFPDYVRVSLECKHLLSRI 240
            G+ +  M+ G  P+ + E P    K I      R+ ++H       +VS   K  L R+
Sbjct: 213 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLH-------KVSPSLKGFLDRL 264
Query: 241 FVANSEKRITIPEIKNHPWFLRNLP 265
            V +  +R T  E+  HP+  +  P
Sbjct: 265 LVRDPAQRATAAELLKHPFLAKAGP 289

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 234
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 230
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 235
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 235
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 135/265 (50%), Gaps = 23/265 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +   + + +L+AVK ++ R Q+  E +  E++  R  +H N+V      L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 97  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 155
Query: 129 TLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            LL  DG    RVK+ DFG+ ++ S    + K  VGTP ++APE++++  Y G   D+WS
Sbjct: 156 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 210
Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTI-----GRILSVHYSFPDYVRVSLECKHLLSRI 240
            G+ +  M+ G  P+ + E P    K I      R+ ++H       +VS   K  L R+
Sbjct: 211 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLH-------KVSPSLKGFLDRL 262
Query: 241 FVANSEKRITIPEIKNHPWFLRNLP 265
            V +  +R T  E+  HP+  +  P
Sbjct: 263 LVRDPAQRATAAELLKHPFLAKAGP 287

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 134/278 (48%), Gaps = 26/278 (9%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI-----DEHVQREIMNHRSLKH 57
           +Y +   +G G++G  K V D  T    AVK +++ +       + +V++EI   R L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 58  PNIVRFKEVLLT--PTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSY 113
            N+++  +VL       + +VMEY   G  E+ + +    RF   +A  +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEY 124
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-----SQPKSTVGTPAYIAP 168
            HS  I H+D+K  N LL  +T   +KI   G +++  LH        +++ G+PA+  P
Sbjct: 125 LHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEA--LHPFAADDTCRTSQGSPAFQPP 180
Query: 169 EVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 227
           E+    + + G   D+WS GVTLY +  G YPFE      N  K    I    Y+ P   
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG----DNIYKLFENIGKGSYAIPGDC 236
Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
              L    LL  +      KR +I +I+ H WF +  P
Sbjct: 237 GPPLS--DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 135/265 (50%), Gaps = 23/265 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +   + + +L+AVK ++ R Q+  E +  E++  R  +H N+V      L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 146
Query: 129 TLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            LL  DG    RVK+ DFG+ ++ S    + K  VGTP ++APE++++  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTI-----GRILSVHYSFPDYVRVSLECKHLLSRI 240
            G+ +  M+ G  P+ + E P    K I      R+ ++H       +VS   K  L R+
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLH-------KVSPSLKGFLDRL 253
Query: 241 FVANSEKRITIPEIKNHPWFLRNLP 265
            V +  +R T  E+  HP+  +  P
Sbjct: 254 LVRDPAQRATAAELLKHPFLAKAGP 278

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 135/265 (50%), Gaps = 23/265 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +   + + +L+AVK ++ R Q+  E +  E++  R  +H N+V      L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 150
Query: 129 TLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            LL  DG    RVK+ DFG+ ++ S    + K  VGTP ++APE++++  Y G   D+WS
Sbjct: 151 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 205
Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTI-----GRILSVHYSFPDYVRVSLECKHLLSRI 240
            G+ +  M+ G  P+ + E P    K I      R+ ++H       +VS   K  L R+
Sbjct: 206 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLH-------KVSPSLKGFLDRL 257
Query: 241 FVANSEKRITIPEIKNHPWFLRNLP 265
            V +  +R T  E+  HP+  +  P
Sbjct: 258 LVRDPAQRATAAELLKHPFLAKAGP 282

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 135/265 (50%), Gaps = 23/265 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +   + + +L+AVK ++ R Q+  E +  E++  R  +H N+V      L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277
Query: 129 TLL--DGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWS 185
            LL  DG    RVK+ DFG+ ++ S    + K  VGTP ++APE++++  Y G   D+WS
Sbjct: 278 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 332
Query: 186 CGVTLYVMLVGAYPFEDPEDPKNFRKTI-----GRILSVHYSFPDYVRVSLECKHLLSRI 240
            G+ +  M+ G  P+ + E P    K I      R+ ++H       +VS   K  L R+
Sbjct: 333 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLH-------KVSPSLKGFLDRL 384
Query: 241 FVANSEKRITIPEIKNHPWFLRNLP 265
            V +  +R T  E+  HP+  +  P
Sbjct: 385 LVRDPAQRATAAELLKHPFLAKAGP 409

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREI--MNHR 53
           +Y++   +GSG FG             +A+K +E+ +  D         V  E+  +   
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVS 112
           S     ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE + 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 185
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 233
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
           C+HL+          R T  EI+NHPW 
Sbjct: 234 CQHLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 135/278 (48%), Gaps = 28/278 (10%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE------HVQREIMNHRSL 55
           E +EI+K IG G FG   +V+ K   ++ A+K + + + +          +R+++ +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 114
           K   I           +L +VM+Y  GG+L   +     R  E+ ARF+  +++  +   
Sbjct: 134 KW--ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLT 172
           H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L 
Sbjct: 192 HQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 173 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDY 226
             E      G   D WS GV +Y ML G  PF      ++  +T G+I++    + FP  
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHKERFQFPTQ 305
Query: 227 VR-VSLECKHLLSRIFVANSEKRI---TIPEIKNHPWF 260
           V  VS   K L+ R+ + + E R+    I + K HP+F
Sbjct: 306 VTDVSENAKDLIRRL-ICSREHRLGQNGIEDFKKHPFF 342

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 60  IVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH+  
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           + HRD+K EN L+D +    +K+ DFG S + +  +      GT  Y  PE +    Y G
Sbjct: 178 VLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHG 235
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 238
           + A VWS G+ LY M+ G  PFE  E+          I+     F    RVS EC+HL+ 
Sbjct: 236 RSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSECQHLIR 283
Query: 239 RIFVANSEKRITIPEIKNHPWF 260
                    R T  EI+NHPW 
Sbjct: 284 WCLALRPSDRPTFEEIQNHPWM 305

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 139/294 (47%), Gaps = 18/294 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-------SFPDYVRVSL 231
           + +D+WS G++L  M VG YP   P+  ++ R  +     + Y         P  V  SL
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV-FSL 240
Query: 232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPS 283
           E +  +++  + N  +R  + ++  H +  R+   E+   G W   +  +N PS
Sbjct: 241 EFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAG-WLCSTIGLNQPS 293

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 132/270 (48%), Gaps = 26/270 (9%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVR 62
           +EI+ ++G G FG     ++K T  L A K I+ + ++  E    EI    S  HPNIV+
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  ++Y H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVL---TKKE 175
           RDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV+   T K+
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 176 --YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RV 229
             YD K ADVWS G+TL  M        + E P +    +  +L +  S P  +    R 
Sbjct: 215 RPYDYK-ADVWSLGITLIEM-------AEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           S   K  L +    N + R T  ++  HP+
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 135/279 (48%), Gaps = 28/279 (10%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVR 62
           +EI+ ++G G FG     ++K T  L A K I+ + ++  E    EI    S  HPNIV+
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  ++Y H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVL---TKKE 175
           RDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV+   T K+
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 176 --YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RV 229
             YD K ADVWS G+TL  M        + E P +    +  +L +  S P  +    R 
Sbjct: 215 RPYDYK-ADVWSLGITLIEM-------AEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFL--RNLPI 266
           S   K  L +    N + R T  ++  HP+     N PI
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 305

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 129/257 (50%), Gaps = 17/257 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           IG G+ G+  +  +K T + +AVK ++ R Q+  E +  E++  R   H N+V      L
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +SY H+  + HRD+K ++
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 171
Query: 129 TLLDGSTAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCG 187
            LL  ++  R+K+ DFG+ ++ S    + K  VGTP ++APEV+++  Y G   D+WS G
Sbjct: 172 ILL--TSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIWSLG 228
Query: 188 VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP----DYVRVSLECKHLLSRIFVA 243
           + +  M+ G  P+ +    +  R+       +  S P    D  +VS   +  L  + V 
Sbjct: 229 IMVIEMIDGEPPYFNEPPLQAMRR-------IRDSLPPRVKDLHKVSSVLRGFLDLMLVR 281
Query: 244 NSEKRITIPEIKNHPWF 260
              +R T  E+  HP+ 
Sbjct: 282 EPSQRATAQELLGHPFL 298

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVR 62
           +EI+ ++G G FG     ++K T  L A K I+ + ++  E    EI    S  HPNIV+
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  ++Y H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL---TKKE 175
           RDLK  N L  LDG     +K+ DFG S  +    Q +   +GTP ++APEV+   T K+
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 176 --YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RV 229
             YD K ADVWS G+TL  M        + E P +    +  +L +  S P  +    R 
Sbjct: 215 RPYDYK-ADVWSLGITLIEM-------AEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           S   K  L +    N + R T  ++  HP+
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+ +     ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+ +     ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 31/286 (10%)
Query: 4   YEIVKDI-GSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREI-MNHRSLKHPNI 60
           Y++ +D+ G G     +   +  T +  AVK IE+    I   V RE+ M ++   H N+
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +   E         +V E   GG +   I     F+E EA    Q + S + + H+  I 
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 121 HRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQ--PKST------VGTPAYIAPEV 170
           HRDLK EN L +     +P VKICDFG      L+    P ST       G+  Y+APEV
Sbjct: 134 HRDLKPENILCEHPNQVSP-VKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 171 LTKKEYDGKI----ADVWSCGVTLYVMLVGAYPF-----------EDPEDPKNFRKTIGR 215
           +     +  I     D+WS GV LY++L G  PF                P         
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252
Query: 216 ILSVHYSFP--DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           I    Y FP  D+  +S   K L+S++ V ++++R++  ++  HPW
Sbjct: 253 IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+S+C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHV--DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 135/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+ +     +   +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  +   +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 30/288 (10%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           PNIV+  +V+ T   L +V E+     + F              + +  QL+ G+++CHS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKE 175
            ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L   +
Sbjct: 125 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY----------- 221
           Y     D+WS G     M+     F  D E  + FR  +T+G    V +           
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 222 SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 135/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+ +     +   +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTRELLAVKFIER----GQKIDEHVQREIMNHRSLKHPNIV 61
           I + IG+G+FG     R +W    +AVK +       ++++E + RE+   + L+HPNIV
Sbjct: 41  IKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNIV 97
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQ--QLISGVSYCHSMQ 118
            F   +  P +L+IV EY + G L+  +  +G R   DE R       +  G++Y H+  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 119 --ICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTK 173
             I HR+LK  N L+D      VK+CDFG S+   S+ L S  KS  GTP ++APEVL +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVL-R 212
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPF 200
            E   + +DV+S GV L+ +     P+
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 30/288 (10%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           PNIV+  +V+ T   L +V E+     + F              + +  QL+ G+++CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKE 175
            ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L   +
Sbjct: 121 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY----------- 221
           Y     D+WS G     M+     F  D E  + FR  +T+G    V +           
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 222 SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 126/286 (44%), Gaps = 31/286 (10%)
Query: 4   YEIVKDI-GSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREI-MNHRSLKHPNI 60
           Y++ +D+ G G     +   +  T +  AVK IE+    I   V RE+ M ++   H N+
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +   E         +V E   GG +   I     F+E EA    Q + S + + H+  I 
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 121 HRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQ--PKST------VGTPAYIAPEV 170
           HRDLK EN L +     +P VKICDF       L+    P ST       G+  Y+APEV
Sbjct: 134 HRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 171 LTKKEYDGKI----ADVWSCGVTLYVMLVGAYPF-----------EDPEDPKNFRKTIGR 215
           +     +  I     D+WS GV LY++L G  PF                P         
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252
Query: 216 ILSVHYSFP--DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           I    Y FP  D+  +S   K L+S++ V ++++R++  ++  HPW
Sbjct: 253 IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 32/275 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E +++++ +G G++G       K T +++A+K +     + E + +EI   +    P++V
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII-KEISIMQQCDSPHVV 87
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           ++       T L IVMEY   G + + I       +EDE     Q  + G+ Y H M+  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
           HRD+K  N LL+  T    K+ DFG + + +   ++    +GTP ++APEV+ +  Y+  
Sbjct: 148 HRDIKAGNILLN--TEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC- 204
Query: 180 IADVWSCGVTLYVMLVGAYPFED----------PED-PKNFRKTIGRILSVHYSFPDYVR 228
           +AD+WS G+T   M  G  P+ D          P + P  FRK    + S   +F D+V+
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP--ELWS--DNFTDFVK 260
Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
              +C        V + E+R T  ++  HP F+R+
Sbjct: 261 ---QC-------LVKSPEQRATATQLLQHP-FVRS 284

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 131/290 (45%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           M++YE ++ IG G +G     +++ T E++A+K + R    DE V     REI   + LK
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           H NIVR  +VL +   L +V E+     + +   CN G    +  + F  QL+ G+ +CH
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKK 174
           S  + HRDLK +N L++ +    +K+ DFG +++  +  +  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------HYSFPDY 226
           +      D+WS G     +   A P     D  +  K I R+L              PDY
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 227 V----------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                            +++   + LL  +   N  +RI+  E   HP+F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 20/207 (9%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTRELLAVKFIER----GQKIDEHVQREIMNHRSLKHPNIV 61
           I + IG+G+FG     R +W    +AVK +       ++++E + RE+   + L+HPNIV
Sbjct: 41  IKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNIV 97
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQ--QLISGVSYCHSMQ 118
            F   +  P +L+IV EY + G L+  +  +G R   DE R       +  G++Y H+  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 119 --ICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTK 173
             I HRDLK  N L+D      VK+CDFG S+   S  L S  K   GTP ++APEVL +
Sbjct: 158 PPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEVL-R 212
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPF 200
            E   + +DV+S GV L+ +     P+
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 135/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLA---VKFIERGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A   ++     + +     REI   + L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 135/290 (46%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLA---VKFIERGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A   ++     + +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYC 114
           PNIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTK 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY--------- 221
            +Y     D+WS G     M+     F  D E  + FR  +T+G    V +         
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 222 --SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 118/263 (44%), Gaps = 28/263 (10%)
Query: 31  AVKFIER-GQKIDEHVQREIMN-HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFER 88
           AVK IE+        V RE+   ++   + NI+   E     T   +V E   GG +   
Sbjct: 42  AVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAH 101
Query: 89  ICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYS 147
           I     F+E EA    + + + + + H+  I HRDLK EN L +       VKICDF   
Sbjct: 102 IQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLG 161
Query: 148 KSSVLH------SQPKSTV--GTPAYIAPEVL----TKKEYDGKIADVWSCGVTLYVMLV 195
               L+      + P+ T   G+  Y+APEV+     +  +  K  D+WS GV LY+ML 
Sbjct: 162 SGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLS 221
Query: 196 GAYPFED--PEDPKNFRKTIGRILSV---------HYSFP--DYVRVSLECKHLLSRIFV 242
           G  PF      D    R  + R+             Y FP  D+  +S E K L+S++ V
Sbjct: 222 GYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLV 281
Query: 243 ANSEKRITIPEIKNHPWFLRNLP 265
            ++++R++  ++  HPW     P
Sbjct: 282 RDAKQRLSAAQVLQHPWVQGQAP 304

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 135/289 (46%), Gaps = 34/289 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSLKHP 58
           E ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE---ARFFFQQLISGVSYCH 115
           NIV+  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++CH
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKK 174
           S ++ HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+L   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFE-DPEDPKNFR--KTIGRILSVHY---------- 221
           +Y     D+WS G     M+     F  D E  + FR  +T+G    V +          
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 222 -SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            SFP + R            + + LLS++   +  KRI+      HP+F
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 131/265 (49%), Gaps = 12/265 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH----VQREIMNHRSLKH 57
           + +EI++ IG G+FG   +V+   T+++ A+K++ + + ++ +    V +E+   + L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P +V           + +V++   GG+L   +     F E+  + F  +L+  + Y  + 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           +I HRD+K +N LLD      V I DF  +      +Q  +  GT  Y+APE+ + ++  
Sbjct: 135 RIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 178 GK--IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           G     D WS GVT Y +L G  P+       + ++ +    +   ++P     S E   
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYH-IRSSTSSKEIVHTFETTVVTYPS--AWSQEMVS 249
Query: 236 LLSRIFVANSEKRIT-IPEIKNHPW 259
           LL ++   N ++R + + +++N P+
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPY 274

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 126/292 (43%), Gaps = 37/292 (12%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAV-KFIERGQK--IDEHVQREIMNHRSLKH 57
           ME+YE +  IG G++GV    R++ T +++A+ KF+E      I +   REI   + LKH
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PN+V   EV      L +V EY     L E         E   +    Q +  V++CH  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLTK 173
              HRD+K EN L+   +   +K+CDFG+++   L + P       V T  Y +PE+L  
Sbjct: 122 NCIHRDVKPENILITKHSV--IKLCDFGFAR---LLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF---RKTIGRILSVHYS-------- 222
               G   DVW+ G     +L G   +    D       RKT+G ++  H          
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 223 ----FPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                PD          +  +S     LL      +  +R+T  ++ +HP+F
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 8/217 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V+ + +  ++A K I  E    I   + RE+        P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  A R  E+        ++ G++Y     Q
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y+APE L    Y  
Sbjct: 136 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMAPERLQGTHYSV 192
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR 215
           + +D+WS G++L  + VG YP   P D K      GR
Sbjct: 193 Q-SDIWSMGLSLVELAVGRYPIP-PPDAKELEAIFGR 227

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPN 59
           E +  +  IG G+FG      D  T+E++A+K I+    +   E +Q+EI        P 
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           I R+    L  T L I+MEY  GG   + +   G   E       ++++ G+ Y HS + 
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD 177
            HRD+K  N LL  S    VK+ DFG +   +  +Q K    VGTP ++APEV+ +  YD
Sbjct: 138 IHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 178 GKIADVWSCGVTLYVMLVGAYPFED 202
            K AD+WS G+T   +  G  P  D
Sbjct: 195 FK-ADIWSLGITAIELAKGEPPNSD 218

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 125/267 (46%), Gaps = 24/267 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPN 59
           E +  ++ IG G+FG      D  T++++A+K I+    +   E +Q+EI          
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           + ++    L  + L I+MEY  GG   + +  AG F E +     ++++ G+ Y HS + 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDG 178
            HRD+K  N LL  S    VK+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 142 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 199
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRILSVHYSFPDYVRVSL 231
           K AD+WS G+T   +  G  P  D          PKN   T+  +     SF +++   L
Sbjct: 200 K-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL--VGDFTKSFKEFIDACL 256
Query: 232 E--------CKHLLSRIFVANSEKRIT 250
                     K LL   F+  + K+ +
Sbjct: 257 NKDPSFRPTAKELLKHKFIVKNSKKTS 283

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-----EHVQREIMNHRSLKHPNIVRFK 64
           IG G FG  K+ R  W  + +AVK        D     E+V++E      LKHPNI+  +
Sbjct: 15  IGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---MQICH 121
            V L   +L +VME+A GG L  R+ +  R   D    +  Q+  G++Y H    + I H
Sbjct: 73  GVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 122 RDLKLENTLL-----DGSTAPRV-KICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLTKK 174
           RDLK  N L+     +G  + ++ KI DFG ++    H   K S  G  A++APEV+   
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAAGAYAWMAPEVIRAS 189
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPF 200
            +  K +DVWS GV L+ +L G  PF
Sbjct: 190 MFS-KGSDVWSYGVLLWELLTGEVPF 214

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 123/272 (45%), Gaps = 26/272 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPN 59
           E +  ++ IG G+FG      D  T++++A+K I+    +   E +Q+EI        P 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDG 178
            HRD+K  N LL  S    VK+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 146 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRILSVHYSFPDYVRVSL 231
           K AD+WS G+T   +  G  P  +          PKN   T    L  +YS P       
Sbjct: 204 K-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP------- 251
Query: 232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
             K  +          R T  E+  H + LRN
Sbjct: 252 -LKEFVEACLNKEPSFRPTAKELLKHKFILRN 282

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 7/206 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPE 204
           + +D+WS G++L  M VG YP   P+
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 124/273 (45%), Gaps = 28/273 (10%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPN 59
           E +  ++ IG G+FG      D  T++++A+K I+    +   E +Q+EI        P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD 177
            HRD+K  N LL  S    VK+ DFG +   +  +Q K    VGTP ++APEV+ +  YD
Sbjct: 141 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRILSVHYSFPDYVRVS 230
            K AD+WS G+T   +  G  P  +          PKN   T    L  +YS P      
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP------ 246
Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
              K  +          R T  E+  H + LRN
Sbjct: 247 --LKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 7/206 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPE 204
           + +D+WS G++L  M VG YP   P+
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 7/206 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 188 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 244
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPE 204
           + +D+WS G++L  M VG YP   P+
Sbjct: 245 Q-SDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 123/272 (45%), Gaps = 26/272 (9%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPN 59
           E +  ++ IG G+FG      D  T++++A+K I+    +   E +Q+EI        P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDG 178
            HRD+K  N LL  S    VK+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 183
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRILSVHYSFPDYVRVSL 231
           K AD+WS G+T   +  G  P  +          PKN   T    L  +YS P       
Sbjct: 184 K-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP------- 231
Query: 232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
             K  +          R T  E+  H + LRN
Sbjct: 232 -LKEFVEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 7/206 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPE 204
           + +D+WS G++L  M VG YP   P+
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 7/206 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPE 204
           + +D+WS G++L  M VG YP   P+
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 127/266 (47%), Gaps = 9/266 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 145 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 201
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLL 237
           + +D+WS G++L  M VG YP           + +  I++      P  V  SLE +  +
Sbjct: 202 Q-SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGV-FSLEFQDFV 259
Query: 238 SRIFVANSEKRITIPEIKNHPWFLRN 263
           ++  + N  +R  + ++  H +  R+
Sbjct: 260 NKCLIKNPAERADLKQLMVHAFIKRS 285

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 124/273 (45%), Gaps = 28/273 (10%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPN 59
           E +  ++ IG G+FG      D  T++++A+K I+    +   E +Q+EI        P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD 177
            HRD+K  N LL  S    VK+ DFG +   +  +Q K    VGTP ++APEV+ +  YD
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPED-------PKNFRKTIGRILSVHYSFPDYVRVS 230
            K AD+WS G+T   +  G  P  +          PKN   T    L  +YS P      
Sbjct: 183 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKP------ 231
Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
              K  +          R T  E+  H + LRN
Sbjct: 232 --LKEFVEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 7/206 (3%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 153 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSV 209
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPE 204
           + +D+WS G++L  M VG YP   P+
Sbjct: 210 Q-SDIWSMGLSLVEMAVGRYPIPPPD 234

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 34/290 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           M++YE ++ IG G +G     +++ T E++A+K + R    DE V     REI   + LK
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           H NIVR  +VL +   L +V E+     + +   CN G    +  + F  QL+ G+ +CH
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKK 174
           S  + HRDLK +N L++ +    +K+ +FG +++  +  +  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--------HYSFPDY 226
           +      D+WS G     +     P     D  +  K I R+L              PDY
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 227 V----------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                            +++   + LL  +   N  +RI+  E   HP+F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK-FIERG--QKIDEHVQREIMNHRSLKH 57
           ME+YE +  +G G++G+    R+K T  ++A+K F+E    + + +   REI   + L+H
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
            N+V   EV        +V E+     L   E   N   +   +   F  Q+I+G+ +CH
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF--QIINGIGFCH 141
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKK 174
           S  I HRD+K EN L+  S +  VK+CDFG++++     +     V T  Y APE+L   
Sbjct: 142 SHNIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPED 205
              GK  DVW+ G  +  M +G   F    D
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 16/223 (7%)
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 115
           IV       T T L +VM    GG++   I N       F E  A F+  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKK 174
              I +RDLK EN LLD      V+I D G + +     ++ K   GTP ++APE+L  +
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           EYD  + D ++ GVTLY M+    PF    +    ++   R+L    ++PD  + S   K
Sbjct: 365 EYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPASK 421
Query: 235 HLLSRIFVANSEKRITIPE-----IKNHPWFLRNLPIELTEGG 272
                +   + EKR+   +     ++ HP F R++     E G
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF-RDISWRQLEAG 463

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 16/223 (7%)
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 115
           IV       T T L +VM    GG++   I N       F E  A F+  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKK 174
              I +RDLK EN LLD      V+I D G + +     ++ K   GTP ++APE+L  +
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           EYD  + D ++ GVTLY M+    PF    +    ++   R+L    ++PD  + S   K
Sbjct: 365 EYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPASK 421
Query: 235 HLLSRIFVANSEKRITIPE-----IKNHPWFLRNLPIELTEGG 272
                +   + EKR+   +     ++ HP F R++     E G
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF-RDISWRQLEAG 463

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 16/223 (7%)
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 115
           IV       T T L +VM    GG++   I N       F E  A F+  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKK 174
              I +RDLK EN LLD      V+I D G + +     ++ K   GTP ++APE+L  +
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           EYD  + D ++ GVTLY M+    PF    +    ++   R+L    ++PD  + S   K
Sbjct: 365 EYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPASK 421
Query: 235 HLLSRIFVANSEKRITIPE-----IKNHPWFLRNLPIELTEGG 272
                +   + EKR+   +     ++ HP F R++     E G
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF-RDISWRQLEAG 463

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 16/223 (7%)
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 115
           IV       T T L +VM    GG++   I N       F E  A F+  Q++SG+ + H
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKK 174
              I +RDLK EN LLD      V+I D G + +     ++ K   GTP ++APE+L  +
Sbjct: 307 QRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           EYD  + D ++ GVTLY M+    PF    +    ++   R+L    ++PD  + S   K
Sbjct: 365 EYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPASK 421
Query: 235 HLLSRIFVANSEKRITIPE-----IKNHPWFLRNLPIELTEGG 272
                +   + EKR+   +     ++ HP F R++     E G
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF-RDISWRQLEAG 463

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 128/259 (49%), Gaps = 24/259 (9%)
Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
           E+ + +G G FGV  + + KW  + +A+K IE   +    +  E+     + HPNIV+  
Sbjct: 12  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 68
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQ--- 118
              L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV+Y HSMQ   
Sbjct: 69  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 119 ICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           + HRDLK  N LL  G T   +KICDFG   +  + +   +  G+ A++APEV     Y 
Sbjct: 127 LIHRDLKPPNLLLVAGGTV--LKICDFG--TACDIQTHMTNNKGSAAWMAPEVFEGSNYS 182
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH 235
            K  DV+S G+ L+ ++    PF++   P  FR     + +VH     P    +    + 
Sbjct: 183 EK-CDVFSWGIILWEVITRRKPFDEIGGPA-FRI----MWAVHNGTRPPLIKNLPKPIES 236
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++R +  +  +R ++ EI
Sbjct: 237 LMTRCWSKDPSQRPSMEEI 255

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 14/287 (4%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-Q 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++  +   +K+CDFG S   ++       VGT +Y++PE L    Y  
Sbjct: 129 IMHRDVKPSNILVN--SRGEIKLCDFGVS-GQLIDEMANEFVGTRSYMSPERLQGTHYSV 185
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 238
           + +D+WS G++L  M VG Y    P  P    + +  I++           SLE +  ++
Sbjct: 186 Q-SDIWSMGLSLVEMAVGRY----PRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVN 240
Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPS 283
           +  + N  +R  + ++  H +  R+   E+   G W   +  +N PS
Sbjct: 241 KCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAG-WLCSTIGLNQPS 286

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 128/259 (49%), Gaps = 24/259 (9%)
Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
           E+ + +G G FGV  + + KW  + +A+K IE   +    +  E+     + HPNIV+  
Sbjct: 11  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 67
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQ--- 118
              L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV+Y HSMQ   
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 119 ICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           + HRDLK  N LL  G T   +KICDFG   +  + +   +  G+ A++APEV     Y 
Sbjct: 126 LIHRDLKPPNLLLVAGGTV--LKICDFG--TACDIQTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH 235
            K  DV+S G+ L+ ++    PF++   P  FR     + +VH     P    +    + 
Sbjct: 182 EK-CDVFSWGIILWEVITRRKPFDEIGGPA-FRI----MWAVHNGTRPPLIKNLPKPIES 235
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++R +  +  +R ++ EI
Sbjct: 236 LMTRCWSKDPSQRPSMEEI 254

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 28/277 (10%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----- 55
           M  + + + IG G FG     R   T ++ A+K +++ +   +  +   +N R +     
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 56  --KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
               P IV       TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPE 169
            H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APE
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPE 360
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDYVR 228
           VL K       AD +S G  L+ +L G  PF   +     +  I R+ L++    PD   
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--S 416
Query: 229 VSLECKHLLSRIFVANSEKRITI-----PEIKNHPWF 260
            S E + LL  +   +  +R+        E+K  P+F
Sbjct: 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 28/277 (10%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----- 55
           M  + + + IG G FG     R   T ++ A+K +++ +   +  +   +N R +     
Sbjct: 187 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 246
Query: 56  --KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
               P IV       TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ +
Sbjct: 247 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 306
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPE 169
            H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APE
Sbjct: 307 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPE 359
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDYVR 228
           VL K       AD +S G  L+ +L G  PF   +     +  I R+ L++    PD   
Sbjct: 360 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--S 415
Query: 229 VSLECKHLLSRIFVANSEKRITI-----PEIKNHPWF 260
            S E + LL  +   +  +R+        E+K  P+F
Sbjct: 416 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 35/290 (12%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTR--ELLAVKFIERGQKIDEHVQREIMNHRSLKHP 58
           ME+Y+ ++ +G G +GV    +D   R   L  ++     + I     REI   + L HP
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 116
           NIV   +V+ +   L +V E+       +++ +  +    + + + +  QL+ GV++CH 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLTKKE 175
            +I HRDLK +N L++   A  +K+ DFG +++  +  +  +  V T  Y AP+VL   +
Sbjct: 138 HRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPF----EDPEDPKNFRKTIG----------------- 214
                 D+WS G     M+ G   F    +D + PK F   +G                 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF-SILGTPNPREWPQVQELPLWK 254
Query: 215 -RILSVHYSFPDYVRVSLECKH---LLSRIFVANSEKRITIPEIKNHPWF 260
            R   V    P    +   C+    LLS +   +  KRI+  +  NHP+F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 28/277 (10%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----- 55
           M  + + + IG G FG     R   T ++ A+K +++ +   +  +   +N R +     
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 56  --KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
               P IV       TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPE 169
            H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APE
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPE 360
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDYVR 228
           VL K       AD +S G  L+ +L G  PF   +     +  I R+ L++    PD   
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--S 416
Query: 229 VSLECKHLLSRIFVANSEKRITI-----PEIKNHPWF 260
            S E + LL  +   +  +R+        E+K  P+F
Sbjct: 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 28/277 (10%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----- 55
           M  + + + IG G FG     R   T ++ A+K +++ +   +  +   +N R +     
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 56  --KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
               P IV       TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPE 169
            H+  + +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APE
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPE 360
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDYVR 228
           VL K       AD +S G  L+ +L G  PF   +     +  I R+ L++    PD   
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--S 416
Query: 229 VSLECKHLLSRIFVANSEKRITI-----PEIKNHPWF 260
            S E + LL  +   +  +R+        E+K  P+F
Sbjct: 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 35/290 (12%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTR--ELLAVKFIERGQKIDEHVQREIMNHRSLKHP 58
           ME+Y+ ++ +G G +GV    +D   R   L  ++     + I     REI   + L HP
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 116
           NIV   +V+ +   L +V E+       +++ +  +    + + + +  QL+ GV++CH 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLTKKE 175
            +I HRDLK +N L++   A  +K+ DFG +++  +  +  +  V T  Y AP+VL   +
Sbjct: 138 HRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPF----EDPEDPKNFRKTIG----------------- 214
                 D+WS G     M+ G   F    +D + PK F   +G                 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF-SILGTPNPREWPQVQELPLWK 254
Query: 215 -RILSVHYSFPDYVRVSLECKH---LLSRIFVANSEKRITIPEIKNHPWF 260
            R   V    P    +   C+    LLS +   +  KRI+  +  NHP+F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           E +EIV ++G G FG     ++K T  L A K IE + ++  E    EI    +  HP I
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQI 119
           V+          L I++E+  GG +   +    R  +E + +   +Q++  +++ HS +I
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVL---TKKE 175
            HRDLK  N L+  +    +++ DFG S  ++   Q + S +GTP ++APEV+   T K+
Sbjct: 131 IHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 176 --YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RV 229
             YD K AD+WS G+TL  M          E P +    +  +L +  S P  +    + 
Sbjct: 189 TPYDYK-ADIWSLGITLIEM-------AQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 240
Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           S+E +  L      N E R +  ++  HP+
Sbjct: 241 SVEFRDFLKIALDKNPETRPSAAQLLEHPF 270

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           ME+Y  ++ IG G +GV    ++ +  E  A+K I R +K DE +     REI   + LK
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           H NIV+  +V+ T   L +V E+     +    +C  G      A+ F  QL++G++YCH
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKK 174
             ++ HRDLK +N L++      +KI DFG +++  +   +    V T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPF 200
           +      D+WS G     M+ GA  F
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGAPLF 201

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           E +EIV ++G G FG     ++K T  L A K IE + ++  E    EI    +  HP I
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQI 119
           V+          L I++E+  GG +   +    R  +E + +   +Q++  +++ HS +I
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVL---TKKE 175
            HRDLK  N L+  +    +++ DFG S  ++   Q + S +GTP ++APEV+   T K+
Sbjct: 139 IHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 176 --YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV----RV 229
             YD K AD+WS G+TL  M          E P +    +  +L +  S P  +    + 
Sbjct: 197 TPYDYK-ADIWSLGITLIEM-------AQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248
Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPW 259
           S+E +  L      N E R +  ++  HP+
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPF 278

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 102/192 (53%), Gaps = 17/192 (8%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQ---REIMNHRSLKHPNIVR 62
           +++IG G+FG     RD    E++A+K +   G++ +E  Q   +E+   + L+HPN ++
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 63  FKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           ++   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV---LTKKEYD 177
           HRD+K  N LL  S    VK+ DFG   S+ + +     VGTP ++APEV   + + +YD
Sbjct: 177 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 178 GKIADVWSCGVT 189
           GK+ DVWS G+T
Sbjct: 232 GKV-DVWSLGIT 242

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 102/192 (53%), Gaps = 17/192 (8%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQ---REIMNHRSLKHPNIVR 62
           +++IG G+FG     RD    E++A+K +   G++ +E  Q   +E+   + L+HPN ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 63  FKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           ++   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV---LTKKEYD 177
           HRD+K  N LL  S    VK+ DFG   S+ + +     VGTP ++APEV   + + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 178 GKIADVWSCGVT 189
           GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + YE+ + IGSG   V +       +E +A+K I  E+ Q   + + +EI       HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICN--------AGRFSEDEARFFFQQLISGV 111
           IV +    +    L +VM+  +GG + + I +        +G   E       ++++ G+
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 112 SYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSK-----SSVLHSQPKST-VGTP 163
            Y H     HRD+K  N LL  DGS    V+I DFG S        +  ++ + T VGTP
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 164 AYIAPEVLTK-KEYDGKIADVWSCGVTLYVMLVGAYPF 200
            ++APEV+ + + YD K AD+WS G+T   +  GA P+
Sbjct: 186 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPY 222

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + YE+ + IGSG   V +       +E +A+K I  E+ Q   + + +EI       HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICN--------AGRFSEDEARFFFQQLISGV 111
           IV +    +    L +VM+  +GG + + I +        +G   E       ++++ G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 112 SYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSK-----SSVLHSQPKST-VGTP 163
            Y H     HRD+K  N LL  DGS    V+I DFG S        +  ++ + T VGTP
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 164 AYIAPEVLTK-KEYDGKIADVWSCGVTLYVMLVGAYPF 200
            ++APEV+ + + YD K AD+WS G+T   +  GA P+
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPY 227

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           ME+Y  ++ IG G +GV    ++ +  E  A+K I R +K DE +     REI   + LK
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           H NIV+  +V+ T   L +V E+     +    +C  G      A+ F  QL++G++YCH
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKK 174
             ++ HRDLK +N L++      +KI DFG +++  +   +    V T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPF 200
           +      D+WS G     M+ G   F
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + +G+       RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVRL 78
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + +G+       RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVRL 78
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G+FG    ++DK T    AVK +    +++     E++    L  P IV     +  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H+ +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 130 LLDGSTAPRVKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLTKKEYDGKIADV 183
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  K  D K+ D+
Sbjct: 198 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 255
Query: 184 WSCGVTLYVMLVGAYPF 200
           WS    +  ML G +P+
Sbjct: 256 WSSCCMMLHMLNGCHPW 272

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           ME+Y  ++ IG G +GV    ++ +  E  A+K I R +K DE +     REI   + LK
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           H NIV+  +V+ T   L +V E+     +    +C  G      A+ F  QL++G++YCH
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKK 174
             ++ HRDLK +N L++      +KI DFG +++  +   +    + T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPF 200
           +      D+WS G     M+ G   F
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G+FG    ++DK T    AVK +    +++     E++    L  P IV     +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H+ +I H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 130 LLDGSTAPRVKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLTKKEYDGKIADV 183
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  K  D K+ D+
Sbjct: 182 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 239
Query: 184 WSCGVTLYVMLVGAYPF 200
           WS    +  ML G +P+
Sbjct: 240 WSSCCMMLHMLNGCHPW 256

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + +G+       RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVRL 78
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSED----EARFFFQQLISGVSY 113
           +    +        +L +V++Y     ++    +  R  +       + +  QL   ++Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE-VLT 172
            HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE +  
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 173 KKEYDGKIADVWSCGVTLYVMLVG 196
             +Y   I DVWS G  L  +L+G
Sbjct: 197 ATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G+FG    + DK T    AVK +    +++     E+M    L  P IV     +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 156
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + +   G   ED A ++  Q + G+ Y HS +I H D+K +N 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 130 LL--DGSTAPRVKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLTKKEYDGKIA 181
           LL  DGS A    +CDFG++         KS +      GT  ++APEV+  +  D K+ 
Sbjct: 217 LLSSDGSHA---ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV- 272
Query: 182 DVWSCGVTLYVMLVGAYPF 200
           DVWS    +  ML G +P+
Sbjct: 273 DVWSSCCMMLHMLNGCHPW 291

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E   ++K++GSG FGV KL   KW  +  +AVK I+ G   ++   +E      L HP +
Sbjct: 8   EEITLLKELGSGQFGVVKL--GKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL 65
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF-FFQQLISGVSYCHSMQI 119
           V+F  V      + IV EY + G L   + + G+  E          +  G+++  S Q 
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEY 176
            HRDL   N L+D      VK+ DFG ++  VL  Q  S+VGT     + APEV    +Y
Sbjct: 126 IHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFE 201
             K +DVW+ G+ ++ V  +G  P++
Sbjct: 183 SSK-SDVWAFGILMWEVFSLGKMPYD 207

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G+FG    ++DK T    AVK +    +++     E++    L  P IV     +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H+ +I H D+K +N 
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 130 LLDGSTAPRVKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLTKKEYDGKIADV 183
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  K  D K+ D+
Sbjct: 196 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 253
Query: 184 WSCGVTLYVMLVGAYPF 200
           WS    +  ML G +P+
Sbjct: 254 WSSCCMMLHMLNGCHPW 270

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 78
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 79
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 194
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 195 IFGATDYTSSI-DVWSAGCVLAELLLG 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 78
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 86
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 201
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 202 IFGATDYTSSI-DVWSAGCVLAELLLG 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 78
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 97
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 212
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 213 IFGATDYTSSI-DVWSAGCVLAELLLG 238

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 90
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 206 IFGATDYTSSI-DVWSAGCVLAELLLG 231

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 90
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 206 IFGATDYTSSI-DVWSAGCVLAELLLG 231

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 82
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 197
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 198 IFGATDYTSSI-DVWSAGCVLAELLLG 223

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 112
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 227
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 228 IFGATDYTSSI-DVWSAGCVLAELLLG 253

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 91
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 206
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 207 IFGATDYTSSI-DVWSAGCVLAELLLG 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 83
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 198
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 199 IFGATDYTSSI-DVWSAGCVLAELLLG 224

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 31/283 (10%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-MNHRSLKHPNIVR 62
           +E+V+ +G+G +G     R   T +L A+K ++     +E +++EI M  +   H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 63  FKEVLLTPT------HLAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 114
           +    +          L +VME+   G + + I N       E+   +  ++++ G+S+ 
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTK 173
           H  ++ HRD+K +N LL  +    VK+ DFG S         ++T +GTP ++APEV+  
Sbjct: 146 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 174 KE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF----RKTIGRILSVHYSFP 224
            E     YD K +D+WS G+T   M  GA P  D    +      R    R+ S  +   
Sbjct: 204 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW--- 259
Query: 225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIE 267
                S + +  +    V N  +R    ++  HP F+R+ P E
Sbjct: 260 -----SKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNE 296

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 78
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 157
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 272
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 273 IFGATDYTSSI-DVWSAGCVLAELLLG 298

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 112
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 228 IFGATDYTSSI-DVWSAGCVLAELLLG 253

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 106
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 221
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 222 IFGATDYTSSI-DVWSAGCVLAELLLG 247

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 114
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 229
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 230 IFGATDYTSSI-DVWSAGCVLAELLLG 255

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 116
Query: 64  KEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARFFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE- 169
           ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K  V      S + +  Y APE 
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 231
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVG 196
           +    +Y   I DVWS G  L  +L+G
Sbjct: 232 IFGATDYTSSI-DVWSAGCVLAELLLG 257

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 39/293 (13%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHP 58
           ME Y  +  +G G +      + K T  L+A+K I  E  +       RE+   + LKH 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSM 117
           NIV   +++ T   L +V EY    +L + + + G   +    + F  QL+ G++YCH  
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLT-KKE 175
           ++ HRDLK +N L++      +K+ DFG +++  + ++   + V T  Y  P++L    +
Sbjct: 120 KVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 176 YDGKIADVWSCGVTLYVMLVG--AYPFEDPEDPKNFRKTIGRILSV-------------- 219
           Y  +I D+W  G   Y M  G   +P    E+  +F   I RIL                
Sbjct: 178 YSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEE 233
Query: 220 --HYSFPDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
              Y++P Y          R+  +   LL+++       RI+  +   HP+FL
Sbjct: 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G+FG    + DK T    AVK +    +++     E+M    L  P IV     +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + +   G   ED A ++  Q + G+ Y HS +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 130 LL--DGSTAPRVKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLTKKEYDGKIA 181
           LL  DGS A    +CDFG++         K  +      GT  ++APEV+  +  D K+ 
Sbjct: 198 LLSSDGSHA---ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV- 253
Query: 182 DVWSCGVTLYVMLVGAYPF 200
           DVWS    +  ML G +P+
Sbjct: 254 DVWSSCCMMLHMLNGCHPW 272

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIV 61
           +E+ + +G+G FG       + T E +A+K    E   K  E    EI   + L HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 62  RFKEV-----LLTPTHLAIV-MEYAAGGEL------FERICNAGRFSEDEARFFFQQLIS 109
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 132
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRV-KICDFGYSKSSVLHSQPKSTVGTPAYIAP 168
            + Y H  +I HRDLK EN +L       + KI D GY+K           VGT  Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
           E+L +K+Y   + D WS G   +  + G  PF
Sbjct: 193 ELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIV 61
           +E+ + +G+G FG       + T E +A+K    E   K  E    EI   + L HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 62  RFKEV-----LLTPTHLAIV-MEYAAGGEL------FERICNAGRFSEDEARFFFQQLIS 109
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 133
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRV-KICDFGYSKSSVLHSQPKSTVGTPAYIAP 168
            + Y H  +I HRDLK EN +L       + KI D GY+K           VGT  Y+AP
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
           E+L +K+Y   + D WS G   +  + G  PF
Sbjct: 194 ELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 224

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 26/201 (12%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR----EIMNHRSLKHPNIVRFKE 65
           +G G FG A  V  + T E++ +K + R    DE  QR    E+   R L+HPN+++F  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 66  VLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDL 124
           VL     L  + EY  GG L   I +   ++   +   F + + SG++Y HSM I HRDL
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPK--------------STVGTPAYIAPE 169
              N L+  +    V + DFG ++  V   +QP+              + VG P ++APE
Sbjct: 135 NSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 170 VLTKKEYDGKIADVWSCGVTL 190
           ++  + YD K+ DV+S G+ L
Sbjct: 193 MINGRSYDEKV-DVFSFGIVL 212

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 251 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 310 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 345

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 147/334 (44%), Gaps = 48/334 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMXGXVATRWYRAPEIMLN 216
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 276
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR----- 262
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +     
Sbjct: 277 NYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335
Query: 263 NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
           + P+      S++S D+      S + +EV+S +
Sbjct: 336 DEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 369

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 275 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 334 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 369

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 251 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 310 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 345

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 274 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 333 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 368

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 150/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+   +  S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPQDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 261 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 320 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 355

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 204
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 264
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 265 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 323
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 324 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 359

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 147/334 (44%), Gaps = 48/334 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 192
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR----- 262
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +     
Sbjct: 253 NYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 263 NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
           + P+      S++S D+      S + +EV+S +
Sbjct: 312 DEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 345

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           ++RY  +  +G G +G      D  T E +A+K I R +  +E V     RE+   + L+
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQ 91
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H NI+  K V+     L ++ EYA   +L + +      S    + F  QLI+GV++CHS
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 117 MQICHRDLKLENTLL---DGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLT 172
            +  HRDLK +N LL   D S  P +KI DFG +++  +   Q    + T  Y  PE+L 
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210
Query: 173 KKEYDGKIADVWSCGVTLYVMLV 195
              +     D+WS       ML+
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLM 233

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 147/334 (44%), Gaps = 48/334 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR----- 262
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +     
Sbjct: 257 NYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315
Query: 263 NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
           + P+      S++S D+      S + +EV+S +
Sbjct: 316 DEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 150/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++  +   +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 320 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 355

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 150/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++  +   +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 316 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 351

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPRDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  IGSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 319 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 354

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 147/334 (44%), Gaps = 48/334 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR----- 262
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +     
Sbjct: 257 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315
Query: 263 NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
           + P+      S++S D+      S + +EV+S +
Sbjct: 316 DEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPTDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 147/334 (44%), Gaps = 48/334 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMTGXVATRWYRAPEIMLN 196
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR----- 262
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +     
Sbjct: 257 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315
Query: 263 NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
           + P+      S++S D+      S + +EV+S +
Sbjct: 316 DEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 132/295 (44%), Gaps = 44/295 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I  + + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++  +   +KI DFG  +    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDS--ELKILDFGLCR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 251 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 310 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 345

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 275 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 334 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 369

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 316 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 351

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 316 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 351

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 274 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 333 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 368

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 319 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 354

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 193
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 253
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 254 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 312
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 313 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 348

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 192
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 253 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 311
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 312 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 347

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 217
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 278 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 337 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 372

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 44/296 (14%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  ++ IG G +G+     D   +  +A+K I     Q   +   REI      +H N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +  +++L   T  A+   Y    +L E    ++  + + S D   +F  Q++ G+ Y HS
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQ-DLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N L++  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLIN--TTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 173 KKEYDGKIADVWSCGVTLYVML------------------VGAYPFEDPED--------P 206
             +   K  D+WS G  L  ML                  +G       ED         
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKA 280
Query: 207 KNFRKTIGRILSVHYS--FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           +N+ +++     V ++  FP     +L+   LL R+   N  KRIT+ E   HP+ 
Sbjct: 281 RNYLQSLPSKTKVAWAKLFPKSDSKALD---LLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 319 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 354

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDX--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 266 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 325 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 360

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 252 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 311 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 346

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 266 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 325 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 360

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 252 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 310
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 311 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 346

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 326 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 361

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 326 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 361

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 320 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 355

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 316 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 351

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 319 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 354

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 201
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 262 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 321 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 356

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 147/334 (44%), Gaps = 48/334 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR----- 262
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +     
Sbjct: 264 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322
Query: 263 NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
           + P+      S++S D+      S + +EV+S +
Sbjct: 323 DEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 356

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/334 (23%), Positives = 147/334 (44%), Gaps = 48/334 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--DDEMXGYVATRWYRAPEIMLN 219
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 279
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR----- 262
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +     
Sbjct: 280 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338
Query: 263 NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
           + P+      S++S D+      S + +EV+S +
Sbjct: 339 DEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 372

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 320 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 355

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F
Sbjct: 264 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++ +    +    V T  Y APE++  
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 174 KEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PEDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F
Sbjct: 264 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPFDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 112/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +A R    +   +  Q+  G+ Y 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 232

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 28/280 (10%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQREIMNHRSL 55
           + +EI+K IG G F    +V+ K T ++ A+K       ++RG+      +R+++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 114
           +   I +         +L +VMEY  GG+L   +   G R   + ARF+  +++  +   
Sbjct: 121 RW--ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLT 172
           H +   HRD+K +N LLD      +++ DFG           +S   VGTP Y++PE+L 
Sbjct: 179 HRLGYVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 173 KKEYDGKI------ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV--HYSFP 224
                          D W+ GV  Y M  G  PF       +  +T G+I+    H S P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY----ADSTAETYGKIVHYKEHLSLP 292
Query: 225 DYVR-VSLECKHLLSRIFVANSEK--RITIPEIKNHPWFL 261
                V  E +  + R+      +  R    + + HP+F 
Sbjct: 293 LVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 37/287 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           +E +  +G G FG     R+       A+K I   ++    +  E+M   SL H  +VR+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  KEVLL-------------TPTHLAIVMEYAAGGELFERICNAGRFSE-DEARFFFQQLIS 109
               L               + L I MEY   G L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-------VLHSQP------ 156
            +SY HS  I HRDLK  N  +D S    VKI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 157 --KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
              S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    +  N  K + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL- 241
Query: 215 RILSVHYSFPDYVRVSLECKHLLSRIFVANS-EKRITIPEIKNHPWF 260
           R +S+ +  PD+    ++ +  + R+ + +   KR     + N  W 
Sbjct: 242 RSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  +   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V    T L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK-----------TIGRILS-- 218
               +     D+WS G  +  +L G   F   +     ++            I R+ S  
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHE 283
Query: 219 -----------VHYSFPD-YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                         +F D ++  +     LL ++ V +++KRIT  E   HP+F
Sbjct: 284 ARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 24/218 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
           E+ EI + IG G FG  ++   +W  E+ A++ I+  +  ++ ++   RE+M +R  +H 
Sbjct: 33  EQLEIGELIGKGRFG--QVYHGRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARFFFQQLISGVSYCHSM 117
           N+V F    ++P HLAI+     G  L+  + +A    + ++ R   Q+++ G+ Y H+ 
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFG-YSKSSVLHS-----QPKSTVGTPAYIAPEVL 171
            I H+DLK +N   D     +V I DFG +S S VL +     + +   G   ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 172 TKKEYD--------GKIADVWSCGVTLYVMLVGAYPFE 201
            +   D         K +DV++ G   Y +    +PF+
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI D+G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDYGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/336 (23%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + +  +   H +R   E+   + +KH 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 326 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 361

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 120/250 (48%), Gaps = 22/250 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK ++      E  Q    E+   R  +H NI+ F   
Sbjct: 44  IGSGSFGT--VYKGKWHGDV-AVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG- 99
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
            +T  +LAIV ++  G  L++ +     +F   +     +Q   G+ Y H+  I HRD+K
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK 159
Query: 126 LENTLL-DGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYD--GK 179
             N  L +G T   VKI DFG +      S   Q +   G+  ++APEV+  ++ +    
Sbjct: 160 SNNIFLHEGLT---VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
            +DV+S G+ LY ++ G  P+    +       +GR     Y+ PD  ++   C   + R
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR----GYASPDLSKLYKNCPKAMKR 272
Query: 240 IFVANSEKRI 249
           + VA+  K++
Sbjct: 273 L-VADCVKKV 281

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+ G   +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 214 --GRILSVHYSF----PDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YSF    PD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           + YEI++ IG+G +GV    R + T + +A+K I     +  + +R   E+   +  KH 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 59  NIVRFKEVLLTPT-------HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
           NI+  K++L  PT        + +V++     +L + I ++   + +  R+F  QL+ G+
Sbjct: 114 NIIAIKDIL-RPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKST--VGTPAYI 166
            Y HS Q+ HRDLK  N L++ +    +KI DFG ++   +S    Q   T  V T  Y 
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 167 APEV-LTKKEYDGKIADVWSCGVTLYVMLV 195
           APE+ L+  EY   I D+WS G     ML 
Sbjct: 230 APELMLSLHEYTQAI-DLWSVGCIFGEMLA 258

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 122/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF----------- 223
            Y   + D+WS G  +  M+ G   F   +    + K I ++ +    F           
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 224 ----PDYVRVSLE---------------------CKHLLSRIFVANSEKRITIPEIKNHP 258
               P Y   S E                      + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+ G   +P  D                PE  K  + T+   
Sbjct: 202 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260
Query: 214 --GRILSVHYSF----PDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YSF    PD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320
Query: 259 WF 260
           + 
Sbjct: 321 YI 322

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/336 (23%), Positives = 148/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI DF  ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDFYLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  VRFKEVLLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT        ++ +  G +L+ ++      S D   +F  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLLN--TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           + YEI++ IG+G +GV    R + T + +A+K I     +  + +R   E+   +  KH 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 59  NIVRFKEVLLTPT-------HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
           NI+  K++L  PT        + +V++     +L + I ++   + +  R+F  QL+ G+
Sbjct: 115 NIIAIKDIL-RPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-------STVGTPA 164
            Y HS Q+ HRDLK  N L++ +    +KI DFG ++   L + P          V T  
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARG--LCTSPAEHQYFMTEYVATRW 228
Query: 165 YIAPEV-LTKKEYDGKIADVWSCGVTLYVMLV 195
           Y APE+ L+  EY   I D+WS G     ML 
Sbjct: 229 YRAPELMLSLHEYTQAI-DLWSVGCIFGEMLA 259

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           +R + ++ +GSG +G      D   R+ +AVK + R  +   H +R   E+   + LKH 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 59  NIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           N++   +V    T +     + +     G     I  +   S++  +F   QL+ G+ Y 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N  ++  +   ++I DFG ++ +    +    V T  Y APE++   
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDS--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 203
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDP-KNFRKTIG--------RILSVH--- 220
            +  +  D+WS G  +  +L G   +P  D  D  K   + +G        +I S H   
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 263
Query: 221 --YSFPDYVRVSLE---------CKHLLSRIFVANSEKRITIPEIKNHPWF 260
              S P   +  L             LL R+ V +S++R++  E   H +F
Sbjct: 264 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+ G   +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 214 --GRILSVHYSF----PDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YSF    PD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/336 (23%), Positives = 148/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI  FG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILGFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +AVK + R  +   H +R   E++  + + H
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 80
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C       D  R  +   Q++ G+ + 
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 140
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++  +      V T  Y APEV+   
Sbjct: 141 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI------------------ 216
            Y   + D+WS G  +  ++ G+  F+  +    + K I ++                  
Sbjct: 199 GYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNY 257
Query: 217 ---------LSVHYSFPDYVRVS---------LECKHLLSRIFVANSEKRITIPEIKNHP 258
                    ++    FPD++  S          + + LLS++ V + +KRI++ E   HP
Sbjct: 258 VENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHP 317
Query: 259 WF 260
           + 
Sbjct: 318 YI 319

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +AVK + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C       D  R  +   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++  +      V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI------------------ 216
            Y   + D+WS G  +  ++ G   F+  +    + K I ++                  
Sbjct: 201 GYAANV-DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNY 259
Query: 217 ---------LSVHYSFPDYVRVS---------LECKHLLSRIFVANSEKRITIPEIKNHP 258
                    +     FPD++  S          + + LLS++ V + +KRI++ E   HP
Sbjct: 260 VENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 36/291 (12%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           +R + ++ +GSG +G      D   R+ +AVK + R  +   H +R   E+   + LKH 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 59  NIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           N++   +V    T +     + +     G     I      S++  +F   QL+ G+ Y 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N  ++  +   ++I DFG ++ +    +    V T  Y APE++   
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDS--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 203
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDP-KNFRKTIG--------RILSVH--- 220
            +  +  D+WS G  +  +L G   +P  D  D  K   + +G        +I S H   
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 263
Query: 221 --YSFPDYVRVSLE---------CKHLLSRIFVANSEKRITIPEIKNHPWF 260
              S P   +  L             LL R+ V +S++R++  E   H +F
Sbjct: 264 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 229

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           +RYE+ + +G G      L RD      +AVK +      D       +RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           P IV   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 169
            H   I HRD+K  N L+  + A  VK+ DFG ++    S     Q  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANILISATNA--VKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 229

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 144
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 145 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM 202
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+ G   +P  D                PE  K  + T+   
Sbjct: 203 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 261
Query: 214 --GRILSVHYSF----PDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YSF    PD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 262 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 321
Query: 259 WF 260
           + 
Sbjct: 322 YI 323

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 88
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 149 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 206 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 247

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 101
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 162 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 219 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 260

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 76
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 137 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 194 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 235

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 232

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 68
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 129 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 186 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 227

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           +RYE+ + +G G      L RD      +AVK +      D       +RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           P IV   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  VK+ DFG ++    S    +Q  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 69
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 130 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 187 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++ME+   G L E +  +  R    +   +  Q+  G+ Y 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 232

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/336 (23%), Positives = 148/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDAGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 75
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 136 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 193 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 234

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 74
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 135 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 192 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 233

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           +RYE+ + +G G      L RD      +AVK +      D       +RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           P IV   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  VK+ DFG ++    S    +Q  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 88
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 149 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 206 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 247

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 77
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 138 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 195 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 236

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 112/261 (42%), Gaps = 22/261 (8%)
Query: 1   MERYEIVKDIGSGNFG---VAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLK 56
           +  + I K IG G F     A  + D     L  V+  +    K      +EI   + L 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVS 112
           HPN++++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIA 167
           + HS ++ HRD+K  N  +  +    VK+ D G      SK++  H    S VGTP Y++
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 204
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 227
           PE + +  Y+ K +D+WS G  LY M     PF    D  N      +I    Y      
Sbjct: 205 PERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSD 261
Query: 228 RVSLECKHLLSRIFVANSEKR 248
             S E + L++     + EKR
Sbjct: 262 HYSEELRQLVNMCINPDPEKR 282

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNI 60
           +++ ++ +G+G +       +K T   +A+K +  +  +       REI   + LKH NI
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 61  VRFKEVLLTPTHLAIVMEYAAGG---ELFER-ICNAGRFSE-DEARFFFQQLISGVSYCH 115
           VR  +V+ T   L +V E+        +  R + N  R  E +  ++F  QL+ G+++CH
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKK 174
             +I HRDLK +N L++     ++K+ DFG +++  +  +   S V T  Y AP+VL   
Sbjct: 126 ENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFR 210
                  D+WSCG  L  M+ G   F    D +  +
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK 219

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/336 (23%), Positives = 148/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDGGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           +RYE+ + +G G      L RD      +AVK +      D       +RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           P IV   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  VK+ DFG ++    S    +Q  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/336 (23%), Positives = 148/336 (44%), Gaps = 52/336 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +R   E+   + +KH 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIVRFKEVLLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      +KI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDC--ELKILDRGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVG--AYPFED------------------------PED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR--- 262
            +N+ +++ ++  ++++   ++  +     LL ++ V +S+KRIT  +   H +F +   
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 263 --NLPIELTEGGSWQSHDV---NNPSQSLEEVLSLI 293
             + P+      S++S D+      S + +EV+S +
Sbjct: 314 PDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 349

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS GV +  M+ G   +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 214 --GRILSVHYSF----PDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YSF    PD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           +RYE+ + +G G      L RD      +AVK +      D       +RE  N  +L H
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 88
Query: 58  PNIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           P IV   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  VK+ DFG ++    S    +Q  + +GT  Y++PE
Sbjct: 149 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 207 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 236

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 123/287 (42%), Gaps = 37/287 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           +E +  +G G FG     R+       A+K I   ++    +  E+M   SL H  +VR+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  KEVLL-------------TPTHLAIVMEYAAGGELFERICNAGRFSE-DEARFFFQQLIS 109
               L               + L I MEY     L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-------VLHSQP------ 156
            +SY HS  I HRDLK  N  +D S    VKI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 157 --KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
              S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    +  N  K + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL- 241
Query: 215 RILSVHYSFPDYVRVSLECKHLLSRIFVANS-EKRITIPEIKNHPWF 260
           R +S+ +  PD+    ++ +  + R+ + +   KR     + N  W 
Sbjct: 242 RSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK------IDEHVQREIMNHRSL 55
           +RYE +  +G G F      RDK T +++A+K I+ G +      I+    REI   + L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            HPNI+   +     +++++V ++           N+   +    + +    + G+ Y H
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKK 174
              I HRDLK  N LLD +    +K+ DFG +KS    +      V T  Y APE+L   
Sbjct: 130 QHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPF----EDPEDPKNFRKTIGRILSVHY----SFPDY 226
              G   D+W+ G  L  +L+   PF     D +      +T+G      +    S PDY
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246
Query: 227 V 227
           V
Sbjct: 247 V 247

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 36/291 (12%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHP 58
           +R + ++ +GSG +G      D   R+ +AVK + R  +   H +R   E+   + LKH 
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 79
Query: 59  NIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           N++   +V    T +     + +     G     I      S++  +F   QL+ G+ Y 
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N  ++      ++I DFG ++ +    +    V T  Y APE++   
Sbjct: 140 HSAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 195
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDP-KNFRKTIG--------RILSVH--- 220
            +  +  D+WS G  +  +L G   +P  D  D  K   + +G        +I S H   
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHART 255
Query: 221 --YSFPDYVRVSLE---------CKHLLSRIFVANSEKRITIPEIKNHPWF 260
              S P   +  L             LL R+ V +S++R++  E   H +F
Sbjct: 256 YIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           +RYE+ + +G G      L RD      +AVK +      D       +RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           P IV         T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  VK+ DFG ++    S    +Q  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS GV +  M+ G   +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 214 --GRILSVHYSF----PDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YSF    PD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLN--TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           M+R+++ +  G G FG  +L ++K T   +A+K + +  +      + + +   L HPNI
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 61  VRFKEVLLT-------PTHLAIVMEYAAGGELFERICNAGRFSEDEA------RFFFQQL 107
           V+ +    T         +L +VMEY    +   R C    +    A      + F  QL
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCR-NYYRRQVAPPPILIKVFLFQL 138
Query: 108 ISGVSYCH--SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY 165
           I  +   H  S+ +CHRD+K  N L++ +    +K+CDFG +K         + + +  Y
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVG 196
            APE++   ++     D+WS G     M++G
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 25/259 (9%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 32  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 89  STAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYD--GKI 180
             N  L       VKI DFG +      S   Q +   G+  ++APEV+  ++ +     
Sbjct: 148 SNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR-ILSVHYSFPDYVRVSLEC----KH 235
           +DV++ G+ LY ++ G  P+ +  +     + +GR  LS     PD  +V   C    K 
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS-----PDLSKVRSNCPKRMKR 260
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++       ++R + P I
Sbjct: 261 LMAECLKKKRDERPSFPRI 279

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 23/225 (10%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     RVKI DFG +K  +   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENEN--RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 229

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 25/259 (9%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 32  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 89  STKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYD--GKI 180
             N  L       VKI DFG +      S   Q +   G+  ++APEV+  ++ +     
Sbjct: 148 SNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR-ILSVHYSFPDYVRVSLEC----KH 235
           +DV++ G+ LY ++ G  P+ +  +     + +GR  LS     PD  +V   C    K 
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS-----PDLSKVRSNCPKRMKR 260
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++       ++R + P I
Sbjct: 261 LMAECLKKKRDERPSFPRI 279

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI    + +H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLN--TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIV 61
           +++   +G G +GV      K T E++A+K IE   K        REI   +  KH NI+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHSM 117
               +   P       E     EL +    R+ +    S+D  ++F  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQP-------KSTVGTPAYI 166
            + HRDLK  N L++ +    +K+CDFG ++    S+  +S+P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFED--------------PEDPKNFR 210
           APEV+       +  DVWSCG  L  + +    +P  D              P    + R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 211 -------KTIGRILSVHYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                  +   + L ++ + P    + RV+ +   LL R+ V +  KRIT  E   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIV 61
           +++   +G G +GV      K T E++A+K IE   K        REI   +  KH NI+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHSM 117
               +   P       E     EL +    R+ +    S+D  ++F  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKST-------VGTPAYI 166
            + HRDLK  N L++ +    +K+CDFG ++    S+  +S+P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFED--------------PEDPKNFR 210
           APEV+       +  DVWSCG  L  + +    +P  D              P    + R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 211 -------KTIGRILSVHYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                  +   + L ++ + P    + RV+ +   LL R+ V +  KRIT  E   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIV 61
           +++   +G G +GV      K T E++A+K IE   K        REI   +  KH NI+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHSM 117
               +   P       E     EL +    R+ +    S+D  ++F  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKST-------VGTPAYI 166
            + HRDLK  N L++ +    +K+CDFG ++    S+  +S+P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLV--GAYPFED--------------PEDPKNFR 210
           APEV+       +  DVWSCG  L  + +    +P  D              P    + R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 211 -------KTIGRILSVHYSFP---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                  +   + L ++ + P    + RV+ +   LL R+ V +  KRIT  E   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLN--TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 120/260 (46%), Gaps = 27/260 (10%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 20  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 77  STKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 135
Query: 126 LENTLLDGSTAPRVKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD--GK 179
             N  L       VKI DFG     S+ S  H Q +   G+  ++APEV+  ++ +    
Sbjct: 136 SNNIFLHEDNT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR-ILSVHYSFPDYVRVSLEC----K 234
            +DV++ G+ LY ++ G  P+ +  +     + +GR  LS     PD  +V   C    K
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS-----PDLSKVRSNCPKRMK 247
Query: 235 HLLSRIFVANSEKRITIPEI 254
            L++       ++R + P I
Sbjct: 248 RLMAECLKKKRDERPSFPRI 267

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI    + +H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 89  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 148 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 206 NSKGYTKSIDIWSVGCILAEML 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++      +  V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 214 --GRILSVHYS----FPDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YS    FPD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 21/224 (9%)
Query: 5   EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKH 57
           + ++ +G GNFG  ++ R       T E++AVK ++     +EH+   +REI   +SL+H
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 71
Query: 58  PNIVRFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYC 114
            NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAY-IAPEV 170
            + +  HR+L   N L++     RVKI DFG +K       + + K    +P +  APE 
Sbjct: 132 GTKRYIHRNLATRNILVENEN--RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
           LT+ ++    +DVWS GV LY +       + P  P  F + IG
Sbjct: 190 LTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIG 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 82  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 141 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 199 NSKGYTKSIDIWSVGCILAEML 220

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 6   IVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            V++IGSG FG+  L    W  ++ +A+K I  G   +E    E      L HP +V+  
Sbjct: 11  FVQEIGSGQFGLVHL--GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
            V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKI 180
           L   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV +   Y  K 
Sbjct: 129 LAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK- 184
Query: 181 ADVWSCGVTLY-VMLVGAYPFEDPEDPK-------NFRKTIGRILSVH 220
           +DVWS GV ++ V   G  P+E+  + +        FR    R+ S H
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 232

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 127/291 (43%), Gaps = 53/291 (18%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHPNIVRFKEV 66
           +GSG +G      DK + E +A+K + R    +   +   RE++  + ++H N++   +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 67  LLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
               + L       +VM +       ++I    +FSE++ ++   Q++ G+ Y HS  + 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDG 178
           HRDLK  N  ++      +KI DFG ++    H+  + T  V T  Y APEV+    +  
Sbjct: 149 HRDLKPGNLAVNEDC--ELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH------------------ 220
           +  D+WS G  +  ML G   F+     K++   + +IL V                   
Sbjct: 203 QTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258
Query: 221 --YSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
              S P          + R S +   LL ++   + +KR+T  +   HP+F
Sbjct: 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 82  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 141 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 199 NSKGYTKSIDIWSVGCILAEML 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLN--TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF----------- 223
            Y   + D+WS G  +  M+ G   F   +    + K I ++ +    F           
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 224 ----PDYVRVSLE---------------------CKHLLSRIFVANSEKRITIPEIKNHP 258
               P Y   S E                      + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 89  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 148 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 206 NSKGYTKSIDIWSVGCILAEML 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 90  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 149 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 207 NSKGYTKSIDIWSVGCILAEML 228

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 81  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 140 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 198 NSKGYTKSIDIWSVGCILAEML 219

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLN--TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 108/223 (48%), Gaps = 24/223 (10%)
Query: 7   VKDIGSGNFGVAKLV----RDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNI 60
           ++D+G G+FG   L      +  T E++AVK +  + G +     ++EI   R+L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 61  VRFKEVL--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHS 116
           +++K          L +VMEY   G L + +    R S   A+   F QQ+  G++Y H+
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLT 172
               HRDL   N LLD      VKI DFG +K+     +    +    +P +  APE L 
Sbjct: 153 QHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL- 209
Query: 173 KKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            KEY    A DVWS GVTLY +L      + P  P  F + IG
Sbjct: 210 -KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIG 249

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+ G   +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 214 --GRILSVHYSF----PDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YSF    PD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 87
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 147
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 205
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 206 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 264
Query: 214 --GRILSVHYS----FPDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YS    FPD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 265 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 324
Query: 259 WF 260
           + 
Sbjct: 325 YI 326

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            +K++G+G FGV K    KW  +  +A+K I+ G   ++    E     +L H  +V+  
Sbjct: 28  FLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 117
            V      + I+ EY A G      C      E   RF  QQL+         + Y  S 
Sbjct: 86  GVCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKK 174
           Q  HRDL   N L++      VK+ DFG S+  VL  +  S+VG+     +  PEVL   
Sbjct: 140 QFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYS 196
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  K +D+W+ GV ++ +  +G  P+E
Sbjct: 197 KFSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++      +  V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF----------- 223
            Y   + D+WS G  +  M+     F   +    + K I ++ +   +F           
Sbjct: 201 GYKENV-DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNY 259
Query: 224 ----PDYVRVSLE---------------------CKHLLSRIFVANSEKRITIPEIKNHP 258
               P Y   S E                      + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF----------- 223
            Y   + D+WS G  +  M+ G   F   +    + K I ++ +    F           
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 224 ----PDYVRVSLE---------------------CKHLLSRIFVANSEKRITIPEIKNHP 258
               P Y   S E                      + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 49/289 (16%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHPNIVRFKEV 66
           +GSG +G      DK + E +A+K + R    +   +   RE++  + ++H N++   +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 67  LLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
               + L       +VM +       ++I     FSE++ ++   Q++ G+ Y HS  + 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK  N  ++      +KI DFG ++ +   ++    V T  Y APEV+    +  + 
Sbjct: 167 HRDLKPGNLAVNEDC--ELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-------------------- 220
            D+WS G  +  ML G   F+     K++   + +IL V                     
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278
Query: 221 YSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            S P          + R S +   LL ++   + +KR+T  +   HP+F
Sbjct: 279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 195 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 253
Query: 214 --GRILSVHYS----FPDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHP 258
              R     YS    FPD +           + + + LLS++ V ++ KRI++ E   HP
Sbjct: 254 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 313
Query: 259 WF 260
           + 
Sbjct: 314 YI 315

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 117/301 (38%), Gaps = 46/301 (15%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVK-FIERGQKIDEHVQREIMNHRSLKHPNIV 61
           RY  +K +G G  G+     D    + +A+K  +    +  +H  REI   R L H NIV
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 62  RFKEVL-------------LTPTH-LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQL 107
           +  E+L             LT  + + IV EY         +   G   E+ AR F  QL
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQL 129
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG----TP 163
           + G+ Y HS  + HRDLK  N  ++      +KI DFG ++    H   K  +     T 
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDL-VLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS- 222
            Y +P +L       K  D+W+ G     ML G   F    + +  +  +  I  VH   
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 223 -------FPDYVR----------------VSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
                   P Y+R                +S E    L +I   +   R+T  E  +HP+
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308
Query: 260 F 260
Sbjct: 309 M 309

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 92  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 151 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 209 NSKGYTKSIDIWSVGCILAEML 230

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 19/268 (7%)
Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN----HRSLKHPNI 60
           E + ++G G +GV + +R   + +++AVK I R     +  +R +M+     R++  P  
Sbjct: 54  EPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFT 112
Query: 61  VRFKEVLLTPTHLAIVMEY--AAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHS- 116
           V F   L     + I ME    +  + ++++ + G+   ED        ++  + + HS 
Sbjct: 113 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 172
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV----LT 172
           + + HRD+K  N L++     +VK+CDFG S   V         G   Y+APE     L 
Sbjct: 173 LSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 230
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K Y  K +D+WS G+T+  + +  +P++    P  F++    +       P   + S E
Sbjct: 231 QKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLP-ADKFSAE 286
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
                S+    NS++R T PE+  HP+F
Sbjct: 287 FVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDE--------HVQREIMNHR 53
           E  K IG G FG+    +LV+DK    ++A+K +  G    E          QRE+    
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLIS-GVS 112
           +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +   +      I+ G+ 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 113 YCHSMQ--ICHRDLKLENTL---LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
           Y  +    I HRDL+  N     LD +     K+ DFG S+ SV HS     +G   ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-HSV-SGLLGNFQWMA 194
Query: 168 PEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFED 202
           PE +  +E  Y  K AD +S  + LY +L G  PF++
Sbjct: 195 PETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 19/268 (7%)
Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN----HRSLKHPNI 60
           E + ++G G +GV + +R   + +++AVK I R     +  +R +M+     R++  P  
Sbjct: 10  EPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 61  VRFKEVLLTPTHLAIVMEY--AAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHS- 116
           V F   L     + I ME    +  + ++++ + G+   ED        ++  + + HS 
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE----VLT 172
           + + HRD+K  N L++     +VK+CDFG S   V         G   Y+APE     L 
Sbjct: 129 LSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           +K Y  K +D+WS G+T+  + +  +P++    P  F++    +       P   + S E
Sbjct: 187 QKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLP-ADKFSAE 242
Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWF 260
                S+    NS++R T PE+  HP+F
Sbjct: 243 FVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 39/294 (13%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRD-KWTRELLAVKFI-----ERGQKIDEHVQREIMNH-RS 54
           ++YE V +IG G +G     RD K     +A+K +     E G  +    +  ++ H  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LKHPNIVRFKEVLLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQL 107
            +HPN+VR  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
           + G+ + HS ++ HRDLK +N L+  +++ ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDY 226
           PEVL +  Y   + D+WS G     M      F    D     K +  I L     +P  
Sbjct: 188 PEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 227 VRVSLECKH--------------------LLSRIFVANSEKRITIPEIKNHPWF 260
           V +  +  H                    LL +    N  KRI+     +HP+F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 39/294 (13%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRD-KWTRELLAVKFI-----ERGQKIDEHVQREIMNH-RS 54
           ++YE V +IG G +G     RD K     +A+K +     E G  +    +  ++ H  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LKHPNIVRFKEVLLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQL 107
            +HPN+VR  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
           + G+ + HS ++ HRDLK +N L+  +++ ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDY 226
           PEVL +  Y   + D+WS G     M      F    D     K +  I L     +P  
Sbjct: 188 PEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 227 VRVSLECKH--------------------LLSRIFVANSEKRITIPEIKNHPWF 260
           V +  +  H                    LL +    N  KRI+     +HP+F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF----------- 223
            Y   + D+WS G  +  M+ G   F   +    + K I ++ +    F           
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 224 ----PDYVRVSLE---------------------CKHLLSRIFVANSEKRITIPEIKNHP 258
               P Y   S E                      + LLS++ V ++ KRI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 39/294 (13%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRD-KWTRELLAVKFI-----ERGQKIDEHVQREIMNH-RS 54
           ++YE V +IG G +G     RD K     +A+K +     E G  +    +  ++ H  +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LKHPNIVRFKEVLLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQL 107
            +HPN+VR  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
           + G+ + HS ++ HRDLK +N L+  +++ ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-LSVHYSFPDY 226
           PEVL +  Y   + D+WS G     M      F    D     K +  I L     +P  
Sbjct: 188 PEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 227 VRVSLECKH--------------------LLSRIFVANSEKRITIPEIKNHPWF 260
           V +  +  H                    LL +    N  KRI+     +HP+F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDE--------HVQREIMNHR 53
           E  K IG G FG+    +LV+DK    ++A+K +  G    E          QRE+    
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLIS-GVS 112
           +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +   +      I+ G+ 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 113 YCHSMQ--ICHRDLKLENTL---LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
           Y  +    I HRDL+  N     LD +     K+ DFG S+ SV HS     +G   ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-HSV-SGLLGNFQWMA 194
Query: 168 PEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFED 202
           PE +  +E  Y  K AD +S  + LY +L G  PF++
Sbjct: 195 PETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 115/259 (44%), Gaps = 25/259 (9%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 16  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 73  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL---TKKEYDGK 179
             N  L       VKI DFG +      S   Q +   G+  ++APEV+    K  Y  +
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KH 235
            +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K 
Sbjct: 190 -SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMKR 244
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++       ++R   P+I
Sbjct: 245 LMAECLKKKRDERPLFPQI 263

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 6   IVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            V++IGSG FG+  L    W  ++ +A+K I  G   +E    E      L HP +V+  
Sbjct: 14  FVQEIGSGQFGLVHL--GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
            V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRD
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKI 180
           L   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV +   Y  K 
Sbjct: 132 LAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK- 187
Query: 181 ADVWSCGVTLY-VMLVGAYPFEDPEDPK-------NFRKTIGRILSVH 220
           +DVWS GV ++ V   G  P+E+  + +        FR    R+ S H
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 235

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            +K++G+G FGV K    KW  +  +A+K I+ G   ++    E     +L H  +V+  
Sbjct: 8   FLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 117
            V      + I+ EY A G      C      E   RF  QQL+         + Y  S 
Sbjct: 66  GVCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKK 174
           Q  HRDL   N L++      VK+ DFG S+  VL  +  S+VG+     +  PEVL   
Sbjct: 120 QFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  K +D+W+ GV ++ +  +G  P+E
Sbjct: 177 KFSSK-SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 115/259 (44%), Gaps = 25/259 (9%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 16  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 73  STAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL---TKKEYDGK 179
             N  L       VKI DFG +      S   Q +   G+  ++APEV+    K  Y  +
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KH 235
            +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K 
Sbjct: 190 -SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMKR 244
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++       ++R   P+I
Sbjct: 245 LMAECLKKKRDERPLFPQI 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 6   IVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            V++IGSG FG+  L    W  ++ +A+K I  G   +E    E      L HP +V+  
Sbjct: 9   FVQEIGSGQFGLVHL--GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
            V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRD
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKI 180
           L   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV +   Y  K 
Sbjct: 127 LAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK- 182
Query: 181 ADVWSCGVTLY-VMLVGAYPFEDPEDPK-------NFRKTIGRILSVH 220
           +DVWS GV ++ V   G  P+E+  + +        FR    R+ S H
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            +K++G+G FGV K    KW  +  +A+K I+ G   ++    E     +L H  +V+  
Sbjct: 13  FLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 117
            V      + I+ EY A G      C      E   RF  QQL+         + Y  S 
Sbjct: 71  GVCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKK 174
           Q  HRDL   N L++      VK+ DFG S+  VL  +  S+VG+     +  PEVL   
Sbjct: 125 QFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 181
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  K +D+W+ GV ++ +  +G  P+E
Sbjct: 182 KFSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            +K++G+G FGV K    KW  +  +A+K I+ G   ++    E     +L H  +V+  
Sbjct: 12  FLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 69
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 117
            V      + I+ EY A G      C      E   RF  QQL+         + Y  S 
Sbjct: 70  GVCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 123
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKK 174
           Q  HRDL   N L++      VK+ DFG S+  VL  +  S+VG+     +  PEVL   
Sbjct: 124 QFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 180
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  K +D+W+ GV ++ +  +G  P+E
Sbjct: 181 KFSSK-SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 23/258 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 36  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 93  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 151
Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYD--GKI 180
             N  L       VKI DFG +      S   Q +   G+  ++APEV+  ++ +     
Sbjct: 152 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KHL 236
           +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K L
Sbjct: 210 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMKRL 265
Query: 237 LSRIFVANSEKRITIPEI 254
           ++       ++R   P+I
Sbjct: 266 MAECLKKKRDERPLFPQI 283

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            +K++G+G FGV K    KW  +  +A+K I+ G   ++    E     +L H  +V+  
Sbjct: 28  FLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 117
            V      + I+ EY A G      C      E   RF  QQL+         + Y  S 
Sbjct: 86  GVCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKK 174
           Q  HRDL   N L++      VK+ DFG S+  VL  +  S+VG+     +  PEVL   
Sbjct: 140 QFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  K +D+W+ GV ++ +  +G  P+E
Sbjct: 197 KFSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A++ I     Q   +   REI      +H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 6   IVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            V++IGSG FG+  L    W  ++ +A+K I  G   +E    E      L HP +V+  
Sbjct: 11  FVQEIGSGQFGLVHL--GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
            V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKI 180
           L   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV +   Y  K 
Sbjct: 129 LAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK- 184
Query: 181 ADVWSCGVTLY-VMLVGAYPFEDPEDPK-------NFRKTIGRILSVH 220
           +DVWS GV ++ V   G  P+E+  + +        FR    R+ S H
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            +K++G+G FGV K    KW  +  +A+K I+ G   ++    E     +L H  +V+  
Sbjct: 19  FLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 76
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 117
            V      + I+ EY A G      C      E   RF  QQL+         + Y  S 
Sbjct: 77  GVCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 130
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKK 174
           Q  HRDL   N L++      VK+ DFG S+  VL  +  S+VG+     +  PEVL   
Sbjct: 131 QFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 187
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  K +D+W+ GV ++ +  +G  P+E
Sbjct: 188 KFSSK-SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 44/293 (15%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHPNI 60
           Y  ++ +GSG +G      D  T   +A+K + R    +   +   RE+   + ++H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 61  VRFKEVLLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           +   +V  TP       T   +VM +   G    ++    +  ED  +F   Q++ G+ Y
Sbjct: 87  IGLLDVF-TPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            H+  I HRDLK  N  ++      +KI DFG ++ +   S+    V T  Y APEV+  
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQA--DSEMXGXVVTRWYRAPEVILN 199
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE--------------------------DPEDPK 207
                +  D+WS G  +  M+ G   F+                            ++ K
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 208 NFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           N+ K +  +    ++       S    +LL ++ V ++E+R+T  E   HP+F
Sbjct: 260 NYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 23/258 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 44  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 101 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 159
Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYD--GKI 180
             N  L       VKI DFG +      S   Q +   G+  ++APEV+  ++ +     
Sbjct: 160 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KHL 236
           +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K L
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMKRL 273
Query: 237 LSRIFVANSEKRITIPEI 254
           ++       ++R   P+I
Sbjct: 274 MAECLKKKRDERPLFPQI 291

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 115/259 (44%), Gaps = 25/259 (9%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 16  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 73  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL---TKKEYDGK 179
             N  L       VKI DFG +      S   Q +   G+  ++APEV+    K  Y  +
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KH 235
            +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K 
Sbjct: 190 -SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMKR 244
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++       ++R   P+I
Sbjct: 245 LMAECLKKKRDERPLFPQI 263

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 117/260 (45%), Gaps = 27/260 (10%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 21  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 136
Query: 126 LENTLLDGSTAPRVKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVL---TKKEYDG 178
             N  L       VKI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 137 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----K 234
           + +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K
Sbjct: 194 Q-SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMK 248
Query: 235 HLLSRIFVANSEKRITIPEI 254
            L++       ++R   P+I
Sbjct: 249 RLMAECLKKKRDERPLFPQI 268

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 6   IVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            V++IGSG FG+  L    W  ++ +A+K I  G   +E    E      L HP +V+  
Sbjct: 12  FVQEIGSGQFGLVHL--GYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
            V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKI 180
           L   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV +   Y  K 
Sbjct: 130 LAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK- 185
Query: 181 ADVWSCGVTLY-VMLVGAYPFEDPEDPK-------NFRKTIGRILSVH 220
           +DVWS GV ++ V   G  P+E+  + +        FR    R+ S H
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 7   VKDIGSGNFGVAKLV----RDKWTRELLAVKFIER--GQKIDEHVQREIMNHRSLKHPNI 60
           ++D+G G+FG   L      +  T E++AVK ++   G +     ++EI   R+L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  VRFKEVL--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHS 116
           +++K          L +VMEY   G L + +    R S   A+   F QQ+  G++Y HS
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPEVLT 172
               HR+L   N LLD      VKI DFG +K+      + + +    +P +  APE L 
Sbjct: 136 QHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 173 KKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            KEY    A DVWS GVTLY +L      + P  P  F + IG
Sbjct: 193 -KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIG 232

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 115/259 (44%), Gaps = 25/259 (9%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 18  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 75  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 133
Query: 126 LENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL---TKKEYDGK 179
             N  L       VKI DFG +      S   Q +   G+  ++APEV+    K  Y  +
Sbjct: 134 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KH 235
            +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K 
Sbjct: 192 -SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMKR 246
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++       ++R   P+I
Sbjct: 247 LMAECLKKKRDERPLFPQI 265

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 117/260 (45%), Gaps = 27/260 (10%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 21  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 136
Query: 126 LENTLLDGSTAPRVKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVL---TKKEYDG 178
             N  L       VKI DFG     S+ S  H Q +   G+  ++APEV+    K  Y  
Sbjct: 137 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----K 234
           + +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K
Sbjct: 194 Q-SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMK 248
Query: 235 HLLSRIFVANSEKRITIPEI 254
            L++       ++R   P+I
Sbjct: 249 RLMAECLKKKRDERPLFPQI 268

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 25/259 (9%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 43  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 100 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 158
Query: 126 LENTLLDGSTAPRVKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD--GK 179
             N  L       VKI DFG     S+ S  H Q +   G+  ++APEV+  ++ +    
Sbjct: 159 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KH 235
            +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K 
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMKR 271
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++       ++R   P+I
Sbjct: 272 LMAECLKKKRDERPLFPQI 290

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 25/259 (9%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVRFKEV 66
           IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+ F   
Sbjct: 44  IGSGSFGT--VYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRDLK
Sbjct: 101 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 159
Query: 126 LENTLLDGSTAPRVKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD--GK 179
             N  L       VKI DFG     S+ S  H Q +   G+  ++APEV+  ++ +    
Sbjct: 160 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC----KH 235
            +DV++ G+ LY ++ G  P+ +  +       +GR     Y  PD  +V   C    K 
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDLSKVRSNCPKAMKR 272
Query: 236 LLSRIFVANSEKRITIPEI 254
           L++       ++R   P+I
Sbjct: 273 LMAECLKKKRDERPLFPQI 291

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 6   IVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            V++IGSG FG+  L    W  ++ +A+K I+ G   ++    E      L HP +V+  
Sbjct: 31  FVQEIGSGQFGLVHL--GYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICHRD 123
            V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRD
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 148
Query: 124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKI 180
           L   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV +   Y  K 
Sbjct: 149 LAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK- 204
Query: 181 ADVWSCGVTLY-VMLVGAYPFEDPEDPK-------NFRKTIGRILSVH 220
           +DVWS GV ++ V   G  P+E+  + +        FR    R+ S H
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 252

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 114/274 (41%), Gaps = 30/274 (10%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNI 60
           + Y  ++ +G G F    LV         A+K I   ++ D E  QRE   HR   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 61  VRFKEVLLT---PTHLA-IVMEYAAGGELF---ERICNAGRF-SEDEARFFFQQLISGVS 112
           +R     L      H A +++ +   G L+   ER+ + G F +ED+  +    +  G+ 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV----------GT 162
             H+    HRDLK  N LL     P   + D G    + +H +                T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 163 PAYIAPEVLTKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV- 219
            +Y APE+ + + +    +  DVWS G  LY M+ G  P++       F+K     L+V 
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALAVQ 261
Query: 220 -HYSFPDYVRVSLECKHLLSRIFVANSEKRITIP 252
              S P   R S     LL+ +   +  +R  IP
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 109/223 (48%), Gaps = 24/223 (10%)
Query: 7   VKDIGSGNFGVAKLV----RDKWTRELLAVKFIER--GQKIDEHVQREIMNHRSLKHPNI 60
           ++D+G G+FG   L      +  T E++AVK ++   G +     ++EI   R+L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  VRFKEVL--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHS 116
           +++K          L +VMEY   G L + +    R S   A+   F QQ+  G++Y H+
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPEVLT 172
               HR+L   N LLD      VKI DFG +K+      + + +    +P +  APE L 
Sbjct: 136 QHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 173 KKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            KEY    A DVWS GVTLY +L      + P  P  F + IG
Sbjct: 193 -KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIG 232

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 25/279 (8%)
Query: 1   MERYEIVKD-------IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR 53
           +ER  + K+       +G G FG     + + T ++ A K +E+ +      +   +N +
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 54  SLKHPNIVRFKEVLL----TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQL 107
            +      RF   L     T   L +V+    GG+L   I + G+  F E  A F+  ++
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI 295
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
             G+   H  +I +RDLK EN LLD      ++I D G +         K  VGT  Y+A
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDY 226
           PEV+  + Y     D W+ G  LY M+ G  PF+     K  R+ + R++  V   + + 
Sbjct: 354 PEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSE- 410
Query: 227 VRVSLECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            R S + + L S++   +  +R+     +  E+K HP F
Sbjct: 411 -RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 25/279 (8%)
Query: 1   MERYEIVKD-------IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR 53
           +ER  + K+       +G G FG     + + T ++ A K +E+ +      +   +N +
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 54  SLKHPNIVRFKEVLL----TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQL 107
            +      RF   L     T   L +V+    GG+L   I + G+  F E  A F+  ++
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI 295
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
             G+   H  +I +RDLK EN LLD      ++I D G +         K  VGT  Y+A
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDY 226
           PEV+  + Y     D W+ G  LY M+ G  PF+     K  R+ + R++  V   + + 
Sbjct: 354 PEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSE- 410
Query: 227 VRVSLECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            R S + + L S++   +  +R+     +  E+K HP F
Sbjct: 411 -RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 195 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 253
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 254 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 313
Query: 259 WF 260
           + 
Sbjct: 314 YI 315

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 259 WF 260
           + 
Sbjct: 313 YI 314

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDE--------HVQREIMNHR 53
           E  K IG G FG+    +LV+DK    ++A+K +  G    E          QRE+    
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLIS-GVS 112
           +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +   +      I+ G+ 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 113 YCHSMQ--ICHRDLKLENTL---LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIA 167
           Y  +    I HRDL+  N     LD +     K+ DF  S+ SV HS     +G   ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-HSV-SGLLGNFQWMA 194
Query: 168 PEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFED 202
           PE +  +E  Y  K AD +S  + LY +L G  PF++
Sbjct: 195 PETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 239 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 259 WF 260
           + 
Sbjct: 358 YI 359

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 81
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 141
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 142 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 199
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 200 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 258
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 259 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 318
Query: 259 WF 260
           + 
Sbjct: 319 YI 320

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 202 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 260
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 261 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 320
Query: 259 WF 260
           + 
Sbjct: 321 YI 322

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 195 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 253
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 254 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 313
Query: 259 WF 260
           + 
Sbjct: 314 YI 315

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 239 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 259 WF 260
           + 
Sbjct: 358 YI 359

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 202 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 260
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 261 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 320
Query: 259 WF 260
           + 
Sbjct: 321 YI 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 18/221 (8%)
Query: 7   VKDIGSGNFGVAKLVR----DKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNI 60
           ++D+G G+FG  +L R       T E +AVK +  E G      +++EI   R+L H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 61  VRFKEVLLTP--THLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 117
           V++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  S 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLTK 173
           Q  HRDL   N L++  +  +VKI DFG +K+     +    K    +P +  APE L +
Sbjct: 134 QYVHRDLAARNVLVE--SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            ++    +DVWS GVTL+ +L   Y   D      F K IG
Sbjct: 192 SKF-YIASDVWSFGVTLHELL--TYCDSDSSPMALFLKMIG 229

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 18/221 (8%)
Query: 7   VKDIGSGNFGVAKLVR----DKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNI 60
           ++D+G G+FG  +L R       T E +AVK +  E G      +++EI   R+L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 61  VRFKEVLLTP--THLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 117
           V++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  S 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLTK 173
           Q  HRDL   N L++  +  +VKI DFG +K+     +    K    +P +  APE L +
Sbjct: 146 QYVHRDLAARNVLVE--SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            ++    +DVWS GVTL+ +L   Y   D      F K IG
Sbjct: 204 SKF-YIASDVWSFGVTLHELL--TYCDSDSSPMALFLKMIG 241

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
            +K++G+G FGV K    KW  +  +A+K I+ G   ++    E     +L H  +V+  
Sbjct: 13  FLKELGTGQFGVVKY--GKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 117
            V      + I+ EY A G      C      E   RF  QQL+         + Y  S 
Sbjct: 71  GVCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKK 174
           Q  HRDL   N L++      VK+ DFG S+  VL  +  S+ G+     +  PEVL   
Sbjct: 125 QFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYS 181
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  K +D+W+ GV ++ +  +G  P+E
Sbjct: 182 KFSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 4   YEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           Y   K IG+G+FGV   AKLV      + +A+K + + ++      RE+   R +KHPN+
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVES----DEVAIKKVLQDKRFK---NRELQIMRIVKHPNV 94
Query: 61  VRFKEVLLT------PTHLAIVMEYAAGGELFERICNAGRFSEDEA--------RFFFQQ 106
           V  K    +         L +V+EY       E +  A R              + +  Q
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI 166
           L+  ++Y HS+ ICHRD+K +N LLD  +   +K+ DFG +K  +      S + +  Y 
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIAGEPNVSXICSRYYR 208
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVG 196
           APE++          D+WS G  +  ++ G
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 7   VKDIGSGNFGVAKLV----RDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNI 60
           ++D+G G+FG   L      +  T E++AVK ++ G   ++    QREI   R+L H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 61  VRFKEVL--LTPTHLAIVMEYAAGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           V++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 129
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPEVL 171
           +    HR L   N LLD      VKI DFG +K+      + + +    +P +  APE L
Sbjct: 130 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            + ++    +DVWS GVTLY +L      + P     F + IG
Sbjct: 188 KECKF-YYASDVWSFGVTLYELLTYCDSNQSPH--TKFTELIG 227

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 7   VKDIGSGNFGVAKLV----RDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNI 60
           ++D+G G+FG   L      +  T E++AVK ++ G   ++    QREI   R+L H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 61  VRFKEVL--LTPTHLAIVMEYAAGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           V++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 128
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPEVL 171
           +    HR L   N LLD      VKI DFG +K+      + + +    +P +  APE L
Sbjct: 129 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
            + ++    +DVWS GVTLY +L      + P     F + IG
Sbjct: 187 KECKF-YYASDVWSFGVTLYELLTYCDSNQSPH--TKFTELIG 226

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 96/242 (39%), Gaps = 28/242 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLK- 56
           + +YE+VK +G G +G+     D+ T E++AVK I    +     Q   REIM    L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H NIV    VL       + + +         +  A        ++   QLI  + Y HS
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL--------------------HSQP 156
             + HRD+K  N LL+      VK+ DFG S+S V                       QP
Sbjct: 128 GGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 157 KST--VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
             T  V T  Y APE+L       K  D+WS G  L  +L G   F          + IG
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 215 RI 216
            I
Sbjct: 246 VI 247

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 13/202 (6%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQKIDEHVQREIMNHRSLKHPNI 60
           RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +   +++  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLT 172
             + HRDLK  N LL+  T   +KI DFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLN--TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 KKEYDGKIADVWSCGVTLYVML 194
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 98/223 (43%), Gaps = 14/223 (6%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ-----REIMN-HRS 54
           M+RYEI   IG G+FG      D+  +E +A+K I+  +      Q      E+MN H +
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVS 112
                IV  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ + + 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 113 YCHS--MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +  +  + I H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEV
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEV 229
Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI 213
           L    YD  I D+WS G  L  M  G   F    +     K +
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 98/223 (43%), Gaps = 14/223 (6%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ-----REIMN-HRS 54
           M+RYEI   IG G+FG      D+  +E +A+K I+  +      Q      E+MN H +
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 93
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVS 112
                IV  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ + + 
Sbjct: 94  EMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTALL 152
Query: 113 YCHS--MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +  +  + I H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEV
Sbjct: 153 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEV 210
Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI 213
           L    YD  I D+WS G  L  M  G   F    +     K +
Sbjct: 211 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 252

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 41/282 (14%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWT-RELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNI 60
           R  + + +  G F      +D  + RE    + +   ++ +  + +E+   + L  HPNI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 61  VRF--------KEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISG 110
           V+F        +E         ++ E   G   E  +++ + G  S D     F Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 111 VSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-------SQPKSTV- 160
           V + H  +  I HRDLK+EN LL  S    +K+CDFG S +++ H       +Q ++ V 
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLCDFG-SATTISHYPDYSWSAQRRALVE 205
Query: 161 ------GTPAYIAPEV--LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT 212
                  TP Y  PE+  L      G+  D+W+ G  LY++    +PFED          
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 213 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 254
             RI++  YS P +         L+  +   N E+R++I E+
Sbjct: 260 --RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 98/223 (43%), Gaps = 14/223 (6%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-----MN-HRS 54
           M+RYEI   IG G+FG      D+  +E +A+K I+  +      Q E+     MN H +
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVS 112
                IV  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ + + 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 113 YCHS--MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +  +  + I H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEV
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEV 229
Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI 213
           L    YD  I D+WS G  L  M  G   F    +     K +
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 4   YEIVKDIGSG--NFGVAKLVRDKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKHP 58
           YE++  IG G  +     L R K T E + V+ I      +E V   Q E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHS 116
           NIV ++   +    L +V  + A G   + IC       +E    +  Q ++  + Y H 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 117 MQICHRDLKLENTLL--DGS---TAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEV 170
           M   HR +K  + L+  DG    +  R  +    +  +  V+H  PK +V    +++PEV
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 190
Query: 171 LTK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 202
           L +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 191 LQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 223

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 4   YEIVKDIGSG--NFGVAKLVRDKWTRELLAVKFIERGQKIDEHV---QREIMNHRSLKHP 58
           YE++  IG G  +     L R K T E + V+ I      +E V   Q E+   +   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHS 116
           NIV ++   +    L +V  + A G   + IC       +E    +  Q ++  + Y H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 117 MQICHRDLKLENTLL--DGS---TAPRVKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEV 170
           M   HR +K  + L+  DG    +  R  +    +  +  V+H  PK +V    +++PEV
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 171 LTK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 202
           L +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 207 LQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 5   EIVKDIGSGNFG--VAKLVRDKWTREL-LAVKFIERG----QKIDEHVQREIMNHRSLKH 57
           +I K IG G FG   +  ++    RE+ +A+K ++ G    Q+ D   +  IM      H
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ--FDH 89
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+  + V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y  
Sbjct: 90  PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLS 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPE 169
            M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE
Sbjct: 149 DMSAVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPE 204
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 205 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 237

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 5   EIVKDIGSGNFG--VAKLVRDKWTREL-LAVKFIERG----QKIDEHVQREIMNHRSLKH 57
           +I K IG G FG   +  ++    RE+ +A+K ++ G    Q+ D   +  IM      H
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ--FDH 74
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+  + V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y  
Sbjct: 75  PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLS 133
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPE 169
            M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE
Sbjct: 134 DMSYVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPE 189
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 190 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 222

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 5   EIVKDIGSGNFG--VAKLVRDKWTREL-LAVKFIERG----QKIDEHVQREIMNHRSLKH 57
           +I K IG G FG   +  ++    RE+ +A+K ++ G    Q+ D   +  IM      H
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ--FDH 68
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+  + V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y  
Sbjct: 69  PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLS 127
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPE 169
            M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE
Sbjct: 128 DMSYVHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPE 183
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 184 AIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTR----------ELLAVKFIERGQKIDEHVQREIMNHRSL 55
           +++ +G G+FGV +  R +W            + L    + + + +D+ + RE+    SL
Sbjct: 12  LLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 68
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 114
            H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-------SVLHSQPKSTVGTPAYIA 167
            S +  HRDL   N LL  +T   VKI DFG  ++        V+    K      A+ A
Sbjct: 128 ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF---AWCA 182
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
           PE L  + +    +D W  GVTL+ M   G  P+
Sbjct: 183 PESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTR----------ELLAVKFIERGQKIDEHVQREIMNHRSL 55
           +++ +G G+FGV +  R +W            + L    + + + +D+ + RE+    SL
Sbjct: 22  LLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 78
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 114
            H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-------SVLHSQPKSTVGTPAYIA 167
            S +  HRDL   N LL  +T   VKI DFG  ++        V+    K      A+ A
Sbjct: 138 ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF---AWCA 192
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
           PE L  + +    +D W  GVTL+ M   G  P+
Sbjct: 193 PESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNI 60
           E + ++GSG  G    +R + T  ++AVK + R    +E+ +R +M+     +S   P I
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYI 86
Query: 61  VRFKEVLLTPTHLAIVMEYAAG----------GELFERICNAGRFSEDEARFFFQQLISG 110
           V+     +T T + I ME              G + ERI      +  +A ++ ++    
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---- 142
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
                   + HRD+K  N LLD     ++K+CDFG S   V       + G  AY+APE 
Sbjct: 143 -----KHGVIHRDVKPSNILLD--ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPER 195
Query: 171 L-----TKKEYDGKIADVWSCGVTLYVMLVGAYPFED 202
           +     TK +YD + ADVWS G++L  +  G +P+++
Sbjct: 196 IDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKN 231

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/292 (21%), Positives = 126/292 (43%), Gaps = 41/292 (14%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-PNIVR 62
           Y++V+ +G G +       +    E + VK ++  +K    ++REI    +L+  PNI+ 
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGPNIIT 96
Query: 63  FKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
             +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCHSM I 
Sbjct: 97  LADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIM 153
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +     
Sbjct: 154 HRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 212
Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL------- 231
            D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L       
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 272
Query: 232 ---------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                          E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 273 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 122/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTR----------ELLAVKFIERGQKIDEHVQREIMNHRSL 55
           +++ +G G+FGV +  R +W            + L    + + + +D+ + RE+    SL
Sbjct: 16  LLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 72
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 114
            H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-------SVLHSQPKSTVGTPAYIA 167
            S +  HRDL   N LL  +T   VKI DFG  ++        V+    K      A+ A
Sbjct: 132 ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCA 186
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
           PE L  + +    +D W  GVTL+ M   G  P+
Sbjct: 187 PESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTR----------ELLAVKFIERGQKIDEHVQREIMNHRSL 55
           +++ +G G+FGV +  R +W            + L    + + + +D+ + RE+    SL
Sbjct: 22  LLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 78
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 114
            H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-------SVLHSQPKSTVGTPAYIA 167
            S +  HRDL   N LL  +T   VKI DFG  ++        V+    K      A+ A
Sbjct: 138 ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCA 192
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
           PE L  + +    +D W  GVTL+ M   G  P+
Sbjct: 193 PESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 122/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 135
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 259 WF 260
           + 
Sbjct: 313 YI 314

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTR----------ELLAVKFIERGQKIDEHVQREIMNHRSL 55
           +++ +G G+FGV +  R +W            + L    + + + +D+ + RE+    SL
Sbjct: 12  LLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 68
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 114
            H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-------SVLHSQPKSTVGTPAYIA 167
            S +  HRDL   N LL  +T   VKI DFG  ++        V+    K      A+ A
Sbjct: 128 ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCA 182
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
           PE L  + +    +D W  GVTL+ M   G  P+
Sbjct: 183 PESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 122/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTR----------ELLAVKFIERGQKIDEHVQREIMNHRSL 55
           +++ +G G+FGV +  R +W            + L    + + + +D+ + RE+    SL
Sbjct: 12  LLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 68
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 114
            H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-------SVLHSQPKSTVGTPAYIA 167
            S +  HRDL   N LL  +T   VKI DFG  ++        V+    K      A+ A
Sbjct: 128 ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCA 182
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
           PE L  + +    +D W  GVTL+ M   G  P+
Sbjct: 183 PESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 22  RDKWTRELLAVKF---IERGQKIDEHVQREIMNHRSLKHPNIVRF--KEVLLTPTHLAIV 76
           R K T +L A+K    I   + +D  + RE    + L H NIV+    E   T  H  ++
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87
Query: 77  MEYAAGGELF---ERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-- 131
           ME+   G L+   E   NA    E E     + ++ G+++     I HR++K  N +   
Sbjct: 88  MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147
Query: 132 --DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK--------KEYDGKIA 181
             DG +    K+ DFG ++      Q  S  GT  Y+ P++  +        K+Y G   
Sbjct: 148 GEDGQSV--YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATV 204
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           D+WS GVT Y    G+ PF   E P+  ++ + +I++
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 122/302 (40%), Gaps = 45/302 (14%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +R   E++  + + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYC 114
            NI+    V      L    +     EL +  +    +   D  R  +   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFED----------------PEDPKNFRKTI--- 213
            Y   + D+WS G  +  M+     +P  D                PE  K  + T+   
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 214 --GRILSVHYSFPDYVRVSL-------------ECKHLLSRIFVANSEKRITIPEIKNHP 258
              R      +FP     SL             + + LLS++ V +  KRI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-----ERGQKIDEHVQREIMNHRSLK- 56
           RYE V +IG G +G     RD  +   +A+K +     E G  I     RE+   R L+ 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLRRLEA 62
Query: 57  --HPNIVRFKEVLLTP-THLAIVMEYAAGGELFERICNAGRFSEDEA----------RFF 103
             HPN+VR  +V  T  T   I +       +FE +    R   D+A          +  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTL-----VFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP 163
            +Q + G+ + H+  I HRDLK EN L+  ++   VK+ DFG ++           V T 
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALDPVVVTL 175
Query: 164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVML 194
            Y APEVL +  Y   + D+WS G     M 
Sbjct: 176 WYRAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-----ERGQKIDEHVQREIMNHRSLK- 56
           RYE V +IG G +G     RD  +   +A+K +     E G  I     RE+   R L+ 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLRRLEA 62
Query: 57  --HPNIVRFKEVLLTP-THLAIVMEYAAGGELFERICNAGRFSEDEA----------RFF 103
             HPN+VR  +V  T  T   I +       +FE +    R   D+A          +  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTL-----VFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP 163
            +Q + G+ + H+  I HRDLK EN L+  ++   VK+ DFG ++           V T 
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALAPVVVTL 175
Query: 164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVML 194
            Y APEVL +  Y   + D+WS G     M 
Sbjct: 176 WYRAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTR----------ELLAVKFIERGQKIDEHVQREIMNHRSL 55
           +++ +G G+FGV +  R +W            + L    + + + +D+ + RE+    SL
Sbjct: 16  LLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 72
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYC 114
            H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-------SVLHSQPKSTVGTPAYIA 167
            S +  HRDL   N LL  +T   VKI DFG  ++        V+    K      A+ A
Sbjct: 132 ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCA 186
Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPF 200
           PE L  + +    +D W  GVTL+ M   G  P+
Sbjct: 187 PESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----- 57
           RYE++K IG G+FG      D    + +A+K +   ++       EI   R L+H     
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEHLRKQD 154
Query: 58  ----PNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGV 111
                N++   E      H+ +  E  +    EL ++    G FS    R F   ++  +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCL 213
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
              H  +I H DLK EN LL       +K+ DFG   S   H +  + + +  Y APEV+
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVI 271
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 205
               Y G   D+WS G  L  +L G YP    ED
Sbjct: 272 LGARY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----- 57
           RYE++K IG G+FG      D    + +A+K +   ++       EI   R L+H     
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEHLRKQD 154
Query: 58  ----PNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGV 111
                N++   E      H+ +  E  +    EL ++    G FS    R F   ++  +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCL 213
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
              H  +I H DLK EN LL       +K+ DFG   S   H +  + + +  Y APEV+
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVI 271
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 205
               Y G   D+WS G  L  +L G YP    ED
Sbjct: 272 LGARY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 7   VKDIGSGNFGVAKLVR----DKWTRELLAVKFIER-GQKIDEHVQREIMNHRSLKHPNIV 61
           +  +G GNFG  +L R       T  L+AVK ++  G       QREI   ++L    IV
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 62  RFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           +++ V   P    L +VMEY   G L + +  +  R        +  Q+  G+ Y  S +
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLTK 173
             HRDL   N L++      VKI DFG +K   L  +    V  P      + APE L+ 
Sbjct: 132 CVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDXXVVREPGQSPIFWYAPESLSD 188
Query: 174 KEYDGKIADVWSCGVTLYVMLV 195
             +  + +DVWS GV LY +  
Sbjct: 189 NIF-SRQSDVWSFGVVLYELFT 209

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 8   KDIGSGNFG---VAKLVRDKWTREL-LAVKFIERG----QKIDEHVQREIMNHRSLKHPN 59
           K IG+G FG      L      +E+ +A+K ++ G    Q++D   +  IM   S  H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHN 107
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 118
           I+R + V+     + I+ EY   G L + +    G FS  +     + + +G+ Y  +M 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLT 172
             HRDL   N L++ +     K+ DFG S+  VL   P++T  T        + APE ++
Sbjct: 168 YVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            +++    +DVWS G+ ++ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSFGIVMWEVMTYGERPY 251

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 37/250 (14%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF 63
           +E +  +G G FG     R+       A+K I   ++    +  E+    SL H  +VR+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 64  KEVLL-------------TPTHLAIVMEYAAGGELFERICNAGRFSE-DEARFFFQQLIS 109
               L               + L I  EY     L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-------VLHSQP------ 156
            +SY HS  I HR+LK  N  +D S    VKI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 157 --KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
              S +GT  Y+A EVL    +  +  D +S G+  +  +   YPF    +  N  K   
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILK--- 239
Query: 215 RILSVHYSFP 224
           ++ SV   FP
Sbjct: 240 KLRSVSIEFP 249

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-----ERGQKIDEHVQREIMNHRSLK- 56
           RYE V +IG G +G     RD  +   +A+K +     E G  I     RE+   R L+ 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLRRLEA 62
Query: 57  --HPNIVRFKEVLLTP-THLAIVMEYAAGGELFERICNAGRFSEDEA----------RFF 103
             HPN+VR  +V  T  T   I +       +FE +    R   D+A          +  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTL-----VFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP 163
            +Q + G+ + H+  I HRDLK EN L+  ++   VK+ DFG ++           V T 
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALFPVVVTL 175
Query: 164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVML 194
            Y APEVL +  Y   + D+WS G     M 
Sbjct: 176 WYRAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 47/237 (19%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           ++Y + K +G+G+FG+   V D  + +  A+K + +  +   +  RE+   + L H NI+
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNII 63
Query: 62  RF-----------------------------------KEVLLTPT---HLAIVMEYAAGG 83
           +                                    K V++ P+   +L ++MEY    
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 84  --ELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK 140
             ++ +    +GR    +    +  QL   V + HS+ ICHRD+K +N L++ S    +K
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTLK 182
Query: 141 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVG 196
           +CDFG +K  +      + + +  Y APE+ L   EY   I D+WS G     +++G
Sbjct: 183 LCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 7   VKDIGSGNFGVAKLVR----DKWTRELLAVKFIER-GQKIDEHVQREIMNHRSLKHPNIV 61
           +  +G GNFG  +L R       T  L+AVK ++  G       QREI   ++L    IV
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 75
Query: 62  RFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           +++ V   P    L +VMEY   G L + +  +  R        +  Q+  G+ Y  S +
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLTK 173
             HRDL   N L++      VKI DFG +K   L  +    V  P      + APE L+ 
Sbjct: 136 CVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSD 192
Query: 174 KEYDGKIADVWSCGVTLYVMLV 195
             +  + +DVWS GV LY +  
Sbjct: 193 NIFS-RQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 7   VKDIGSGNFGVAKLVR----DKWTRELLAVKFIER-GQKIDEHVQREIMNHRSLKHPNIV 61
           +  +G GNFG  +L R       T  L+AVK ++  G       QREI   ++L    IV
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 62  RFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           +++ V   P    L +VMEY   G L + +  +  R        +  Q+  G+ Y  S +
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLTK 173
             HRDL   N L++      VKI DFG +K   L  +    V  P      + APE L+ 
Sbjct: 148 CVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSD 204
Query: 174 KEYDGKIADVWSCGVTLYVMLV 195
             +  + +DVWS GV LY +  
Sbjct: 205 NIFS-RQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 7   VKDIGSGNFGVAKLVR----DKWTRELLAVKFIER-GQKIDEHVQREIMNHRSLKHPNIV 61
           +  +G GNFG  +L R       T  L+AVK ++  G       QREI   ++L    IV
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 62  RFKEVLLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           +++ V   P    L +VMEY   G L + +  +  R        +  Q+  G+ Y  S +
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLTK 173
             HRDL   N L++      VKI DFG +K   L  +    V  P      + APE L+ 
Sbjct: 135 CVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSD 191
Query: 174 KEYDGKIADVWSCGVTLYVMLV 195
             +  + +DVWS GV LY +  
Sbjct: 192 NIF-SRQSDVWSFGVVLYELFT 212

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 166 MGFVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 107/242 (44%), Gaps = 24/242 (9%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHPNIVRFK 64
           IG G+FGV    + +     R   A+K + R  ++   E   RE +  R L HPN++   
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 65  EVLLTPTHLA-IVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            ++L P  L  +++ Y   G+L + I +  R  +  +   F  Q+  G+ Y    +  HR
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLTKK 174
           DL   N +LD S    VK+ DFG ++        S   H   +  V    + A E L   
Sbjct: 149 DLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPV---KWTALESLQTY 203
Query: 175 EYDGKIADVWSCGVTLYVMLV-GAYPFE--DPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
            +  K +DVWS GV L+ +L  GA P+   DP D  +F     R+    Y      +V  
Sbjct: 204 RFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQ 262
Query: 232 EC 233
           +C
Sbjct: 263 QC 264

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 21/269 (7%)
Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIM-----NHRSLKHPN 59
           E + ++G G +GV +  R   + ++ AVK I     ++   Q+ ++     + R++  P 
Sbjct: 37  EPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR--ATVNSQEQKRLLXDLDISXRTVDCPF 94
Query: 60  IVRFKEVLLTPTHLAIVMEY--AAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHS 116
            V F   L     + I  E    +  + ++++ + G+   ED        ++  + + HS
Sbjct: 95  TVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 154
Query: 117 -MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPE----VL 171
            + + HRD+K  N L++     +VK CDFG S   V         G   Y APE     L
Sbjct: 155 KLSVIHRDVKPSNVLINA--LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPEL 212
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
            +K Y  K +D+WS G+T   + +  +P++    P  F++    +       P   + S 
Sbjct: 213 NQKGYSVK-SDIWSLGITXIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLP-ADKFSA 268
Query: 232 ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           E     S+    NS++R T PE+  HP+F
Sbjct: 269 EFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 22  RDKWTRELLAVKF---IERGQKIDEHVQREIMNHRSLKHPNIVRF--KEVLLTPTHLAIV 76
           R K T +L A+K    I   + +D  + RE    + L H NIV+    E   T  H  ++
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87
Query: 77  MEYAAGGELF---ERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL-- 131
           ME+   G L+   E   NA    E E     + ++ G+++     I HR++K  N +   
Sbjct: 88  MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147
Query: 132 --DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK--------KEYDGKIA 181
             DG +    K+ DFG ++      Q     GT  Y+ P++  +        K+Y G   
Sbjct: 148 GEDGQSV--YKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKY-GATV 204
Query: 182 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           D+WS GVT Y    G+ PF   E P+  ++ + +I++
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 119/262 (45%), Gaps = 18/262 (6%)
Query: 9   DIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEH--VQREIMNHRSLKHPNIVRFKE 65
           +IG G+F  V K +  + T E+   +  +R     E    + E    + L+HPNIVRF +
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 66  VLLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--I 119
              +       + +V E    G L   +           R + +Q++ G+ + H+    I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            HRDLK +N  + G T   VKI D G + +    S  K+ +GTP + APE   +K YD  
Sbjct: 153 IHRDLKCDNIFITGPTGS-VKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YDES 209
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL-ECKHLLS 238
           + DV++ G          YP+ + ++       I R ++       + +V++ E K ++ 
Sbjct: 210 V-DVYAFGXCXLEXATSEYPYSECQNAAQ----IYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 239 RIFVANSEKRITIPEIKNHPWF 260
                N ++R +I ++ NH +F
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFF 286

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 166 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 166 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----- 57
           RYE++K IG G FG      D    + +A+K +   ++       EI   R L+H     
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEHLRKQD 154
Query: 58  ----PNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGV 111
                N++   E      H+ +  E  +    EL ++    G FS    R F   ++  +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCL 213
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
              H  +I H DLK EN LL       +K+ DFG   S   H +    + +  Y APEV+
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVI 271
Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 205
               Y G   D+WS G  L  +L G YP    ED
Sbjct: 272 LGARY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 9   DIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-----RSLKHPNIVRF 63
           +IG G +G    +  K + +++AVK I     +DE  Q++++       RS   P IV+F
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 114
              L       I ME  +    F++         D+     ++++  ++           
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDV--IPEEILGKITLATVKALNHLK 142
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL--- 171
            +++I HRD+K  N LLD S    +K+CDFG S   V         G   Y+APE +   
Sbjct: 143 ENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 172 -TKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
            +++ YD + +DVWS G+TLY +  G +P+
Sbjct: 201 ASRQGYDVR-SDVWSLGITLYELATGRFPY 229

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 166 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 37  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 94
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 153
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 154 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 209
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 210 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 239

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 166 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 132/304 (43%), Gaps = 57/304 (18%)
Query: 4   YEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREI--MNHRSLK 56
           Y I+K IGSG    V +++ +K  +++ A+K++       Q +D + + EI  +N     
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQH 114
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
              I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 117 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAP 168
             I H DLK  N L+ DG     +K+ DFG +       QP +T       VGT  Y+ P
Sbjct: 174 HGIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPP 225
Query: 169 EV---LTKKEYDGKIA-------DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           E    ++    +GK         DVWS G  LY M  G  PF+         + I +I  
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISK 276
Query: 219 VH--------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF-LRNLPIELT 269
           +H          FPD     L+   +L      + ++RI+IPE+  HP+  ++  P+   
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334
Query: 270 EGGS 273
             G+
Sbjct: 335 AKGT 338

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 47  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 104
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 163
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 164 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 219
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 220 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 249

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 132/304 (43%), Gaps = 57/304 (18%)
Query: 4   YEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREI--MNHRSLK 56
           Y I+K IGSG    V +++ +K  +++ A+K++       Q +D + + EI  +N     
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQH 70
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
              I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 71  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 117 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAP 168
             I H DLK  N L+ DG     +K+ DFG +       QP +T       VGT  Y+ P
Sbjct: 130 HGIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPP 181
Query: 169 EV---LTKKEYDGKIA-------DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           E    ++    +GK         DVWS G  LY M  G  PF+         + I +I  
Sbjct: 182 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISK 232
Query: 219 VH--------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF-LRNLPIELT 269
           +H          FPD     L+   +L      + ++RI+IPE+  HP+  ++  P+   
Sbjct: 233 LHAIIDPNHEIEFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 290
Query: 270 EGGS 273
             G+
Sbjct: 291 AKGT 294

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 132/304 (43%), Gaps = 57/304 (18%)
Query: 4   YEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREI--MNHRSLK 56
           Y I+K IGSG    V +++ +K  +++ A+K++       Q +D + + EI  +N     
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQH 86
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
              I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 117 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAP 168
             I H DLK  N L+ DG     +K+ DFG +       QP +T       VGT  Y+ P
Sbjct: 146 HGIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPP 197
Query: 169 EV---LTKKEYDGKIA-------DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           E    ++    +GK         DVWS G  LY M  G  PF+         + I +I  
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISK 248
Query: 219 VH--------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF-LRNLPIELT 269
           +H          FPD     L+   +L      + ++RI+IPE+  HP+  ++  P+   
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 306
Query: 270 EGGS 273
             G+
Sbjct: 307 AKGT 310

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 77
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 136
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 137 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 193 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKID-EHVQREIMNHRSLKHP 58
           + Y I   IG G++G   L  DK T + +A+K + R     ID + + REI     LK  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 59  NIVRFKEV-----LLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
            I+R  ++     LL    L IV+E  A  +L +        +E+  +     L+ G ++
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-----------------------S 150
            H   I HRDLK  N LL+   +  VK+CDFG +++                        
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 151 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 194
            L  Q  S V T  Y APE++  +E   K  D+WS G     +L
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 132/304 (43%), Gaps = 57/304 (18%)
Query: 4   YEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREI--MNHRSLK 56
           Y I+K IGSG    V +++ +K  +++ A+K++       Q +D + + EI  +N     
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQH 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
              I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 117 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAP 168
             I H DLK  N L+ DG     +K+ DFG +       QP +T       VGT  Y+ P
Sbjct: 127 HGIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPP 178
Query: 169 EV---LTKKEYDGKIA-------DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           E    ++    +GK         DVWS G  LY M  G  PF+         + I +I  
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISK 229
Query: 219 VH--------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF-LRNLPIELT 269
           +H          FPD     L+   +L      + ++RI+IPE+  HP+  ++  P+   
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 287
Query: 270 EGGS 273
             G+
Sbjct: 288 AKGT 291

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 132/304 (43%), Gaps = 57/304 (18%)
Query: 4   YEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREI--MNHRSLK 56
           Y I+K IGSG    V +++ +K  +++ A+K++       Q +D + + EI  +N     
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQH 66
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
              I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 67  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 117 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAP 168
             I H DLK  N L+ DG     +K+ DFG +       QP +T       VGT  Y+ P
Sbjct: 126 HGIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPP 177
Query: 169 EV---LTKKEYDGKIA-------DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           E    ++    +GK         DVWS G  LY M  G  PF+         + I +I  
Sbjct: 178 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISK 228
Query: 219 VH--------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF-LRNLPIELT 269
           +H          FPD     L+   +L      + ++RI+IPE+  HP+  ++  P+   
Sbjct: 229 LHAIIDPNHEIEFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 286
Query: 270 EGGS 273
             G+
Sbjct: 287 AKGT 290

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 105 QQLISGVSYCHSMQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP 163
           + +++  SY H+ + ICHRD+K  N L+D +   RVK+ DFG S+  V   + K + GT 
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMV-DKKIKGSRGTY 214
Query: 164 AYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPF 200
            ++ PE  + +  Y+G   D+WS G+ LYVM     PF
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 132/304 (43%), Gaps = 57/304 (18%)
Query: 4   YEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREI--MNHRSLK 56
           Y I+K IGSG    V +++ +K  +++ A+K++       Q +D + + EI  +N     
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQH 114
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
              I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 117 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAP 168
             I H DLK  N L+ DG     +K+ DFG +       QP +T       VGT  Y+ P
Sbjct: 174 HGIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPP 225
Query: 169 EV---LTKKEYDGKIA-------DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           E    ++    +GK         DVWS G  LY M  G  PF+         + I +I  
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISK 276
Query: 219 VH--------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF-LRNLPIELT 269
           +H          FPD     L+   +L      + ++RI+IPE+  HP+  ++  P+   
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334
Query: 270 EGGS 273
             G+
Sbjct: 335 AKGT 338

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 10  IGSGNFG---VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----KHPNIVR 62
           IG+G FG     +L         +A+K ++ G    E  +RE ++  S+    +HPNI+R
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 81
Query: 63  FKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
            + V+     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLTKK 174
           HRDL   N L++ +     K+ DFG S+    +S   +   +        + APE +  +
Sbjct: 141 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           ++    +D WS G+ ++ VM  G  P+ D
Sbjct: 199 KFTSA-SDAWSYGIVMWEVMSFGERPYWD 226

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 10  IGSGNFG---VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL----KHPNIVR 62
           IG+G FG     +L         +A+K ++ G    E  +RE ++  S+    +HPNI+R
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 79
Query: 63  FKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
            + V+     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLTKK 174
           HRDL   N L++ +     K+ DFG S+    +S   +   +        + APE +  +
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           ++    +D WS G+ ++ VM  G  P+ D
Sbjct: 197 KFTSA-SDAWSYGIVMWEVMSFGERPYWD 224

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG ++  VL   P++   T        + +PE 
Sbjct: 166 MGYVHRDLAARNILINSNLV--CKVSDFGLAR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE------RGQKIDEHVQREIMNHRSLK 56
           RYE V +IG G +G     RD  +   +A+K +        G  +     RE+   R L+
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 57  ---HPNIVRFKEVLLTP-THLAIVMEYAAGGELFERICNAGRFSEDEA----------RF 102
              HPN+VR  +V  T  T   I +       +FE +    R   D+A          + 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTL-----VFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT 162
             +Q + G+ + H+  I HRDLK EN L+  ++   VK+ DFG ++           V T
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALTPVVVT 182
Query: 163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 194
             Y APEVL +  Y   + D+WS G     M 
Sbjct: 183 LWYRAPEVLLQSTYATPV-DMWSVGCIFAEMF 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 3   RYEIVKDIGSGNFG--VAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSL---- 55
           R  I K IGSG+ G      +R    R++ +A+K ++ G    E  +R+ ++  S+    
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQF 107
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSY 113
            HPNI+R + V+       IV EY   G L  F R  + G+F+  +     + + +G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRY 166
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIA 167
              +   HRDL   N L+D +     K+ DFG S+  VL   P +   T        + A
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAXTTTGGKIPIRWTA 222
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           PE +  + +    +DVWS GV ++ V+  G  P+
Sbjct: 223 PEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 4   YEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREI--MNHRSLK 56
           Y I+K IGSG    V +++ +K  +++ A+K++       Q +D + + EI  +N     
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQH 86
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
              I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 117 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPK-------STVGTPAYIAP 168
             I H DLK  N L+ DG     +K+ DFG +       QP        S VGT  Y+ P
Sbjct: 146 HGIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDXXXVVKDSQVGTVNYMPP 197
Query: 169 EV---LTKKEYDGKIA-------DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           E    ++    +GK         DVWS G  LY M  G  PF+         + I +I  
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISK 248
Query: 219 VH--------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF-LRNLPIELT 269
           +H          FPD     L+   +L      + ++RI+IPE+  HP+  ++  P+   
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 306
Query: 270 EGGS 273
             G+
Sbjct: 307 AKGT 310

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 3   RYEIVKDIGSGNFG--VAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSL---- 55
           R  I K IGSG+ G      +R    R++ +A+K ++ G    E  +R+ ++  S+    
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQF 107
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSY 113
            HPNI+R + V+       IV EY   G L  F R  + G+F+  +     + + +G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRY 166
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIA 167
              +   HRDL   N L+D +     K+ DFG S+  VL   P +   T        + A
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAYTTTGGKIPIRWTA 222
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           PE +  + +    +DVWS GV ++ V+  G  P+
Sbjct: 223 PEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG  +  VL   P++   T        + +PE 
Sbjct: 166 MGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKID-EHVQREIMNHRSLKHP 58
           +RYEI   IG+G++G      DK  + ++A+K I R     ID + + REI     L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 59  NIVRFKEVLLTPT-----HLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVS 112
           ++V+  ++++         L +V+E A     F+++     + +E   +     L+ GV 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK------------------------ 148
           Y HS  I HRDLK  N L++   +  VK+CDFG ++                        
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 149 ----SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 194
               +  L  Q    V T  Y APE++  +E   +  DVWS G     +L
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I + IG+G FG     R K    REL +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 83
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 117
           NI+  + V+     + IV EY   G L   +  N G+F+  +     + + +G+ Y   M
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVL 171
              HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE +
Sbjct: 144 GYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 172 TKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             +++    +DVWS G+ ++ V+  G  P+
Sbjct: 200 AFRKFTSA-SDVWSYGIVMWEVVSYGERPY 228

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKID-EHVQREIMNHRSLKHP 58
           + YEI   IG G++G   L  DK   + +A+K + R     ID + + REI     LK  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 59  NIVRFKEV-----LLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
            I+R  ++     LL    L IV+E  A  +L +        +E   +     L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS------------------------ 149
            H   I HRDLK  N LL+   +  VKICDFG +++                        
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCS--VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 150 --SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 194
               L  Q  S V T  Y APE++  +E      D+WS G     +L
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 4   YEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIE----RGQKIDEHVQREI--MNHRSLK 56
           Y I+K IGSG    V +++ +K  +++ A+K++       Q +D + + EI  +N     
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQH 114
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
              I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 117 MQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKST-------VGTPAYIAP 168
             I H DLK  N L+ DG     +K+ DFG +       QP +T       VG   Y+ P
Sbjct: 174 HGIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGAVNYMPP 225
Query: 169 EV---LTKKEYDGKIA-------DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS 218
           E    ++    +GK         DVWS G  LY M  G  PF+         + I +I  
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISK 276
Query: 219 VH--------YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF-LRNLPIELT 269
           +H          FPD     L+   +L      + ++RI+IPE+  HP+  ++  P+   
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQ--DVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334
Query: 270 EGGS 273
             G+
Sbjct: 335 AKGT 338

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N L+D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV E    G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 166 MGAVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV E    G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 165
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 166 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 222 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 117/290 (40%), Gaps = 58/290 (20%)
Query: 31  AVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT--HLAIVMEYAAGGEL--- 85
           A+K IE G  I     REI   R LKHPN++  ++V L+     + ++ +YA        
Sbjct: 52  ALKQIE-GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 110
Query: 86  -FERICNAGR----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL--DGSTAPR 138
            F R   A +          +    Q++ G+ Y H+  + HRDLK  N L+  +G    R
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170
Query: 139 VKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML 194
           VKI D G+++      +P +     V T  Y APE+L    +  K  D+W+ G     +L
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
Query: 195 -----------------------------VGAYP----FED----PEDP---KNFRK-TI 213
                                        V  +P    +ED    PE     K+FR+ T 
Sbjct: 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 290
Query: 214 GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
                + Y     V+   +  HLL ++   +  KRIT  +    P+FL +
Sbjct: 291 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 5   EIVKDIGSGNFG--VAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSL----KH 57
           +I + IG+G FG   +  ++    RE+ +A+K ++ G    E  +R+ ++  S+     H
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDH 93
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PN++  + V+   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y  
Sbjct: 94  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLA 152
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA--------YIA 167
            M   HRDL   N L++ +     K+ DFG S+   L         T A        + A
Sbjct: 153 DMNYVHRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           PE +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 209 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 243

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 272
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 273 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 6   IVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERGQKIDEHVQREIMNHRSL----KHP 58
           I K +G+G FG     R K    +E+ +A+K ++ G    E  +R+ +   S+     HP
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 77
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI+R + V+     + IV E    G L  F R  +A +F+  +     + + SG+ Y   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSD 136
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEV 170
           M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE 
Sbjct: 137 MGYVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +  +++    +DVWS G+ L+ VM  G  P+
Sbjct: 193 IAYRKFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G FG  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 8   MERTDITMKHKLGGGQFG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 65
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 126 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPE 180
Query: 170 VLTKKEYDGKIADVWSCGVTLYVML---VGAYPFEDP 203
            L   ++  K +DVW+ GV L+ +    +  YP  DP
Sbjct: 181 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDP 216

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 58  PNIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           SM I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSL-- 231
                 D+WS G  L  M+    PF    D  +    I ++L     Y + D   + L  
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 232 --------------------ECKHLLS--------RIFVANSEKRITIPEIKNHPWF 260
                               E +HL+S        ++   + + R+T  E   HP+F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 8   MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 65
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I++E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 126 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPE 180
Query: 170 VLTKKEYDGKIADVWSCGVTLYVML---VGAYPFEDP 203
            L   ++  K +DVW+ GV L+ +    +  YP  DP
Sbjct: 181 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDP 216

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 128/323 (39%), Gaps = 70/323 (21%)
Query: 3   RYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREI--MNHRSLKHPN 59
           RYEIV  +G G FG V + +  K     +AVK ++   +  E  + EI  + H +   PN
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 60  ----IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSY 113
                V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V++
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 114 CHSMQICHRDLKLENTLL---DGSTA--------------PRVKICDFGYSKSSVLHSQP 156
            HS ++ H DLK EN L    D + A              P +K+ DFG   S+    + 
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDEH 190
Query: 157 KST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTL--YVMLVGAYPFEDPED-------- 205
            ST V T  Y APEV+    +  +  DVWS G  L  Y +    +P  D ++        
Sbjct: 191 HSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 206 ----PKNFRKTIGRILSVHYSFPDYVR-------VSLECK-----------------HLL 237
               PK+  +   +    H+   D+         VS  CK                  L+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 238 SRIFVANSEKRITIPEIKNHPWF 260
            ++   +  KRIT+ E   HP+F
Sbjct: 310 QKMLEYDPAKRITLREALKHPFF 332

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 24/224 (10%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFKE 65
           + IG GNFG     R +    L+AVK        D   +  +E    +   HPNIVR   
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 118
           V      + IVME   GG+    +   G      AR   + L+       +G+ Y  S  
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLTKKE 175
             HRDL   N L+       +KI DFG S+     +++        P  + APE L    
Sbjct: 234 CIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFED--PEDPKNFRKTIGRI 216
           Y  + +DVWS G+ L+    +GA P+ +   +  + F +  GR+
Sbjct: 292 YSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL 334

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 9   DIGSGNFGVAK--LVRDKWTRELLAVKFIERG-QKID-EHVQREIMNHRSLKHPNIVRFK 64
           ++G GNFG  +  + R +  +  +A+K +++G +K D E + RE      L +P IVR  
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARFFFQQLISGVSYCHSMQICH 121
            V      L +VME A GG L + +   G+  E           Q+  G+ Y       H
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGTP-AYIAPEVLTKKEYD 177
           RDL   N LL        KI DFG SK+      +   +S    P  + APE +  +++ 
Sbjct: 134 RDLAARNVLL--VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 178 GKIADVWSCGVTLYVML-VGAYPFEDPEDPK 207
            + +DVWS GVT++  L  G  P++  + P+
Sbjct: 192 SR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 14/209 (6%)
Query: 1   MERYEIVKD--IGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 11  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 68
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 69  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLT 172
                 HRDL   N L+  +    VK+ DFG S+  +   ++ P        + APE L 
Sbjct: 129 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 186
Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             ++  K +DVW+ GV L+ +   G  P+
Sbjct: 187 YNKFSIK-SDVWAFGVLLWEIATYGMSPY 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 14/209 (6%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 12  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLT 172
                 HRDL   N L+  +    VK+ DFG S+  +   ++ P        + APE L 
Sbjct: 130 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 187
Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             ++  K +DVW+ GV L+ +   G  P+
Sbjct: 188 YNKFSIK-SDVWAFGVLLWEIATYGMSPY 215

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 43/232 (18%)
Query: 54  SLKHPNIVRF--KEVLLTPTHLAIVMEYAAGGELFER--ICNAGRFSEDEARFFFQQLIS 109
           S +HPN++R+   E      ++AI +  A   E  E+    + G     E     QQ  S
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL----EPITLLQQTTS 129
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAP---RVKICDFGYSKSSVL----HSQPKSTVGT 162
           G+++ HS+ I HRDLK  N L+    A    +  I DFG  K   +     S+     GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 163 PAYIAPEVLTK--KEYDGKIADVWSCG-VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             +IAPE+L++  KE      D++S G V  YV+  G++PF      K+ ++    +L  
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-----GKSLQRQANILLGA 244
Query: 220 HYSFPDYVRVSLECKH-----------LLSRIFVANSEKRITIPEIKNHPWF 260
                     SL+C H           L+ ++   + +KR +   +  HP+F
Sbjct: 245 ---------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 5   EIVKDIGSGNFGVAKLVRDKW--TREL-LAVKFIERG----QKIDEHVQREIMNHRSLKH 57
           +I + IG+G FG     R K    R++ +A+K ++ G    Q+ D   +  IM      H
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQ--FDH 103
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PN+V  + V+     + IV+E+   G L  F R  + G+F+  +     + + +G+ Y  
Sbjct: 104 PNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRK-HDGQFTVIQLVGMLRGIAAGMRYLA 162
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA------YIAPE 169
            M   HRDL   N L++ +     K+ DFG S+  V+   P++   T        + APE
Sbjct: 163 DMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VIEDDPEAVYTTTGGKIPVRWTAPE 218
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 219 AIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 251

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 10  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I++E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 182
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 183 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 10  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I++E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 182
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 183 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 213

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 24/224 (10%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFKE 65
           + IG GNFG     R +    L+AVK        D   +  +E    +   HPNIVR   
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 66  VLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 118
           V      + IVME   GG+    +   G      AR   + L+       +G+ Y  S  
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLTKKE 175
             HRDL   N L+       +KI DFG S+     + +        P  + APE L    
Sbjct: 234 CIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFED--PEDPKNFRKTIGRI 216
           Y  + +DVWS G+ L+    +GA P+ +   +  + F +  GR+
Sbjct: 292 YSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL 334

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 16/210 (7%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHP 58
           MER +I     +G G +G   +   K     +AVK ++      E   +E    + +KHP
Sbjct: 29  MERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP 88
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHS 116
           N+V+   V        IV EY   G L +  R CN    +     +   Q+ S + Y   
Sbjct: 89  NLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK 148
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL 171
               HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE L
Sbjct: 149 KNFIHRDLAARNCLVGENHV--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 203
Query: 172 TKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
               +  K +DVW+ GV L+ +   G  P+
Sbjct: 204 AYNTFSIK-SDVWAFGVLLWEIATYGMSPY 232

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 8   MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 65
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 126 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTFTAHAGAKFPI---KWTAPE 180
Query: 170 VLTKKEYDGKIADVWSCGVTLYVML---VGAYPFEDP 203
            L   ++  K +DVW+ GV L+ +    +  YP  DP
Sbjct: 181 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDP 216

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF------ 63
           IGSG FG     + +   +   +K ++     +E  +RE+     L H NIV +      
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 64  ---------KEVLLTPTH-LAIVMEYAAGGELFERI--CNAGRFSEDEARFFFQQLISGV 111
                    K    + T  L I ME+   G L + I      +  +  A   F+Q+  GV
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
            Y HS ++ +RDLK  N  L      +VKI DFG   S     +   + GT  Y++PE +
Sbjct: 136 DYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 172 TKKEYDGKIADVWSCGVTLYVML 194
           + ++Y GK  D+++ G+ L  +L
Sbjct: 194 SSQDY-GKEVDLYALGLILAELL 215

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSL-KHPNIVR 62
           ++ IGSG FG       +    + A+K  ++   G   +++  RE+  H  L +H ++VR
Sbjct: 12  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 71
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQ 118
           +        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y HSM 
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 131
Query: 119 ICHRDLKLENTLLDGSTAPRV-----------------KICDFGYSKSSVLHSQPKSTVG 161
           + H D+K  N  +  ++ P                   KI D G+       S P+   G
Sbjct: 132 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEG 188
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
              ++A EVL +       AD+++  +T+ V   GA P 
Sbjct: 189 DSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPL 226

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 15  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 133 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 187
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 188 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 218

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSL-KHPNIVR 62
           ++ IGSG FG       +    + A+K  ++   G   +++  RE+  H  L +H ++VR
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQ 118
           +        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y HSM 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 119 ICHRDLKLENTLLDGSTAPRV-----------------KICDFGYSKSSVLHSQPKSTVG 161
           + H D+K  N  +  ++ P                   KI D G+       S P+   G
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEG 190
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
              ++A EVL +       AD+++  +T+ V   GA P 
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL 228

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 10  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 182
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 183 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 11  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 68
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I++E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 69  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 129 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPE 183
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 184 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 214

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 10  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 182
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 183 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 213

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSL-KHPNIVR 62
           ++ IGSG FG       +    + A+K  ++   G   +++  RE+  H  L +H ++VR
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQ 118
           +        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y HSM 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 119 ICHRDLKLENTLLDGSTAPRV-----------------KICDFGYSKSSVLHSQPKSTVG 161
           + H D+K  N  +  ++ P                   KI D G+       S P+   G
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEG 190
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
              ++A EVL +       AD+++  +T+ V   GA P 
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL 228

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSL-KHPNIVR 62
           ++ IGSG FG       +    + A+K  ++   G   +++  RE+  H  L +H ++VR
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQ 118
           +        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y HSM 
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 119 ICHRDLKLENTLLDGSTAPRV-----------------KICDFGYSKSSVLHSQPKSTVG 161
           + H D+K  N  +  ++ P                   KI D G+       S P+   G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEG 192
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
              ++A EVL +       AD+++  +T+ V   GA P 
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL 230

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 15  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I++E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 73  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 133 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 187
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 188 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 218

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 5   EIVKDIGSGNFG--VAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSL----KH 57
           +I + IG+G FG   +  ++    RE+ +A+K ++ G    E  +R+ ++  S+     H
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDH 67
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PN++  + V+   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y  
Sbjct: 68  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLA 126
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA--------YIA 167
            M   HR L   N L++ +     K+ DFG S+   L         T A        + A
Sbjct: 127 DMNYVHRALAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           PE +  +++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 183 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 217

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 15  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 133 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPE 187
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 188 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 218

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKH 57
           + +YE +  IG G FG     R + T + +A+K +      +       REI   + LKH
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 58  PNIVRFKEVLLTPTH--------LAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLI 108
            N+V   E+  T           + +V ++    +L   + N   +F+  E +   Q L+
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 109 SGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVL--HSQPK---STVG 161
           +G+ Y H  +I HRD+K  N L+  DG     +K+ DFG +++  L  +SQP    + V 
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 193
           T  Y  PE+L  +   G   D+W  G  +  M
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKH 57
           + +YE +  IG G FG     R + T + +A+K +      +       REI   + LKH
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 58  PNIVRFKEVLLTPTH--------LAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLI 108
            N+V   E+  T           + +V ++    +L   + N   +F+  E +   Q L+
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 109 SGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVL--HSQPK---STVG 161
           +G+ Y H  +I HRD+K  N L+  DG     +K+ DFG +++  L  +SQP    + V 
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 193
           T  Y  PE+L  +   G   D+W  G  +  M
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKH 57
           + +YE +  IG G FG     R + T + +A+K +      +       REI   + LKH
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 58  PNIVRFKEVLLTPTH--------LAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLI 108
            N+V   E+  T           + +V ++    +L   + N   +F+  E +   Q L+
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 109 SGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVL--HSQPK---STVG 161
           +G+ Y H  +I HRD+K  N L+  DG     +K+ DFG +++  L  +SQP    + V 
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 193
           T  Y  PE+L  +   G   D+W  G  +  M
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKH 57
           + +YE +  IG G FG     R + T + +A+K +      +       REI   + LKH
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 58  PNIVRFKEVLLTPTH--------LAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLI 108
            N+V   E+  T           + +V ++    +L   + N   +F+  E +   Q L+
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 109 SGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVL--HSQPK---STVG 161
           +G+ Y H  +I HRD+K  N L+  DG     +K+ DFG +++  L  +SQP    + V 
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVM 193
           T  Y  PE+L  +   G   D+W  G  +  M
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 217 MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 274
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    S     +   Q+ S + Y 
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HR+L   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 389
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 390 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 420

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 9   DIGSGNFGVAK--LVRDKWTRELLAVKFIERG-QKID-EHVQREIMNHRSLKHPNIVRFK 64
           ++G GNFG  +  + R +  +  +A+K +++G +K D E + RE      L +P IVR  
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARFFFQQLISGVSYCHSMQICH 121
            V      L +VME A GG L + +   G+  E           Q+  G+ Y       H
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKS---SVLHSQPKSTVGTP-AYIAPEVLTKKEYD 177
           R+L   N LL        KI DFG SK+      +   +S    P  + APE +  +++ 
Sbjct: 460 RNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 178 GKIADVWSCGVTLYVML-VGAYPFEDPEDPK 207
            + +DVWS GVT++  L  G  P++  + P+
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 127/323 (39%), Gaps = 70/323 (21%)
Query: 3   RYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREI--MNHRSLKHPN 59
           RYEIV  +G G FG V + +  K     +AVK ++   +  E  + EI  + H +   PN
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 60  ----IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSY 113
                V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V++
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 114 CHSMQICHRDLKLENTLL---DGSTA--------------PRVKICDFGYSKSSVLHSQP 156
            HS ++ H DLK EN L    D + A              P +K+ DFG   S+    + 
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDEH 190
Query: 157 KST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTL--YVMLVGAYPFEDPED-------- 205
            ST V    Y APEV+    +  +  DVWS G  L  Y +    +P  D ++        
Sbjct: 191 HSTLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 206 ----PKNFRKTIGRILSVHYSFPDYVR-------VSLECK-----------------HLL 237
               PK+  +   +    H+   D+         VS  CK                  L+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 238 SRIFVANSEKRITIPEIKNHPWF 260
            ++   +  KRIT+ E   HP+F
Sbjct: 310 QKMLEYDPAKRITLREALKHPFF 332

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/236 (21%), Positives = 101/236 (42%), Gaps = 38/236 (16%)
Query: 59  NIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI++  + +  P     A+V EY    + F+++      ++ + RF+  +L+  + YCHS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 155
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   + 
Sbjct: 156 KGIMHRDVKPHNVMIDHQQK-KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 214
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------H 220
                D+WS G  L  M+    PF   +D  +    I ++L                  H
Sbjct: 215 YDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPH 274
Query: 221 YS----------FPDYVR------VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           ++          + +++       VS E   LL ++   + ++R+T  E   HP+F
Sbjct: 275 FNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 15  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 133 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 187
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 188 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 14  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 71
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 131
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 132 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 186
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 187 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 217

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/236 (21%), Positives = 101/236 (42%), Gaps = 38/236 (16%)
Query: 59  NIVRFKEVLLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NI++  + +  P     A+V EY    + F+++      ++ + RF+  +L+  + YCHS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 150
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   + 
Sbjct: 151 KGIMHRDVKPHNVMIDHQQK-KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 209
Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV----------------H 220
                D+WS G  L  M+    PF   +D  +    I ++L                  H
Sbjct: 210 YDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPH 269
Query: 221 YS----------FPDYVR------VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           ++          + +++       VS E   LL ++   + ++R+T  E   HP+F
Sbjct: 270 FNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 10  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 182
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 183 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 213

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 12  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 130 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 184
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 185 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 10  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 67
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 182
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 183 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 18/257 (7%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++VK +G+G FG V     +  T+  +AVK ++ G    +    E    ++L+H  +
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 70
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+     + I+ EY A G L  F +    G+    +   F  Q+  G++Y     
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 130
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  S +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 131 YIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +  K +DVWS G+ LY ++  G  P+     P      +   LS  Y  P       E  
Sbjct: 188 FTIK-SDVWSFGILLYEIVTYGKIPY-----PGRTNADVMTALSQGYRMPRVENCPDELY 241
Query: 235 HLLSRIFVANSEKRITI 251
            ++   +   +E+R T 
Sbjct: 242 DIMKMCWKEKAEERPTF 258

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 15  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 72
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 133 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 187
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 188 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 12  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 69
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 130 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 184
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 185 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 215

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 23  MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 80
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 81  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 140
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HRDL   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 141 EKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 195
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 196 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 226

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/323 (22%), Positives = 125/323 (38%), Gaps = 57/323 (17%)
Query: 4   YEIVKDIGSGNFG-----------------VAKLVRDKWTRELLAVKFIERGQKIDEHVQ 46
           Y + + I SG++G                 V   V D  T  +L+  F+ +       V 
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK------RVL 77
Query: 47  REIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL---FERICNAGRF--SEDEAR 101
           REI       HPNI+  +++ +     A+   Y     +     ++ +  R   S    +
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ 137
Query: 102 FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG 161
           +F   ++ G+   H   + HRDL   N LL  +    + ICDF  ++     +     V 
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICDFNLAREDTADANKTHYVT 195
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--- 218
              Y APE++ + +   K+ D+WS G  +  M      F          K +  + +   
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 219 ---VHYSFP---DYVRVSLE-----------------CKHLLSRIFVANSEKRITIPEIK 255
              V +S P   DY+R SL                     L++++   N ++RI+  +  
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 256 NHPWFLRNL-PIELTEGGSWQSH 277
            HP+F     P++LTEG S + H
Sbjct: 316 RHPYFESLFDPLDLTEGLSERFH 338

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/323 (22%), Positives = 125/323 (38%), Gaps = 57/323 (17%)
Query: 4   YEIVKDIGSGNFG-----------------VAKLVRDKWTRELLAVKFIERGQKIDEHVQ 46
           Y + + I SG++G                 V   V D  T  +L+  F+ +       V 
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK------RVL 77
Query: 47  REIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL---FERICNAGRF--SEDEAR 101
           REI       HPNI+  +++ +     A+   Y     +     ++ +  R   S    +
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ 137
Query: 102 FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG 161
           +F   ++ G+   H   + HRDL   N LL  +    + ICDF  ++     +     V 
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICDFNLAREDTADANKTHYVT 195
Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--- 218
              Y APE++ + +   K+ D+WS G  +  M      F          K +  + +   
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 219 ---VHYSFP---DYVRVSLE-----------------CKHLLSRIFVANSEKRITIPEIK 255
              V +S P   DY+R SL                     L++++   N ++RI+  +  
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 256 NHPWFLRNL-PIELTEGGSWQSH 277
            HP+F     P++LTEG S + H
Sbjct: 316 RHPYFESLFDPLDLTEGLSERFH 338

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIV 61
           +E ++ +G G FGV    ++K      A+K I    +    E V RE+     L+HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 62  RFKEVLLTPT------------HLAIVMEYAAGGELFERICNAGRFSEDEARF---FFQQ 106
           R+    L               +L I M+      L + +       E E       F Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY--------SKSSVLHSQP-- 156
           +   V + HS  + HRDLK  N          VK+ DFG          + +VL   P  
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 157 ---KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF 200
                 VGT  Y++PE +    Y  K+ D++S G+ L+ +L   YPF
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELL---YPF 227

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-----RGQKIDEHVQREIMNHRSLKHPNIVRFK 64
           +G G FGV  + +       +AVK +        +++ +   +EI      +H N+V   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHSMQICH 121
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKEYDG 178
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE L + E   
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-RGEITP 213
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPK 207
           K +D++S GV L  ++ G    ++  +P+
Sbjct: 214 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-----RGQKIDEHVQREIMNHRSLKHPNIVRFK 64
           +G G FGV  + +       +AVK +        +++ +   +EI      +H N+V   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHSMQICH 121
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKEYDG 178
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE L + E   
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEITP 213
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPK 207
           K +D++S GV L  ++ G    ++  +P+
Sbjct: 214 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-----RGQKIDEHVQREIMNHRSLKHPNIVRFK 64
           +G G FGV  + +       +AVK +        +++ +   +EI      +H N+V   
Sbjct: 33  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 65  EVLLTPTHLAIVMEYAAGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHSMQICH 121
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 150
Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDG 178
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE L + E   
Sbjct: 151 RDIKSANILLD--EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGEITP 207
Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPK 207
           K +D++S GV L  ++ G    ++  +P+
Sbjct: 208 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 1   MERYEIV--KDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQREIMNHRSLK 56
           MER +I     +G G +G  ++    W +  L  AVK ++      E   +E    + +K
Sbjct: 256 MERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 313
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V+   V        I+ E+   G L +  R CN    +     +   Q+ S + Y 
Sbjct: 314 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 373
Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPE 169
                 HR+L   N L+  +    VK+ DFG S+     +   H+  K  +    + APE
Sbjct: 374 EKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 428
Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L   ++  K +DVW+ GV L+ +   G  P+
Sbjct: 429 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPY 459

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-----MNHRSL 55
           ERYEIV  +G G FG V + V  +     +A+K I+  +K  E  + EI     +N +  
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDP 92
Query: 56  KHPNI-VRFKEVLLTPTHLAIVMEYAAGGEL-FERICNAGRFSEDEARFFFQQLISGVSY 113
            + N+ V+  +      H+ I  E        F +  N   +   + R    QL   V +
Sbjct: 93  DNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKF 152
Query: 114 CHSMQICHRDLKLENTLLDGS-----------------TAPRVKICDFGYSKSSVLHSQP 156
            H  ++ H DLK EN L   S                  +  V++ DFG   ++  H   
Sbjct: 153 LHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG--SATFDHEHH 210
Query: 157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI 216
            + V T  Y APEV+ +  +  +  DVWS G  ++   VG   F+   D +     + RI
Sbjct: 211 STIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGFTLFQ-THDNREHLAMMERI 268
Query: 217 L 217
           L
Sbjct: 269 L 269

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 11  GSGNFGVAKLVRDKWTRELLAVKFIE-----RGQKIDEHVQREIMNHRSLKHPNIVRFKE 65
           G G FGV  + +       +AVK +        +++ +   +EI      +H N+V    
Sbjct: 31  GEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 66  VLLTPTHLAIVMEYAAGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHSMQICHR 122
                  L +V  Y   G L +R+ C  G    S        Q   +G+++ H     HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGK 179
           D+K  N LLD   A   KI DFG +++S   +Q       VGT AY APE L + E   K
Sbjct: 149 DIKSANILLD--EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-RGEITPK 205
Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPK 207
            +D++S GV L  ++ G    ++  +P+
Sbjct: 206 -SDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 63/124 (50%), Gaps = 5/124 (4%)
Query: 73  LAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL 130
           L I ME+   G L + I      +  +  A   F+Q+  GV Y HS ++ HRDLK  N  
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 131 LDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTL 190
           L      +VKI DFG   S     +   + GT  Y++PE ++ ++Y GK  D+++ G+ L
Sbjct: 169 L--VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLIL 225
Query: 191 YVML 194
             +L
Sbjct: 226 AELL 229

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 48/290 (16%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH--RALMSELKIL 86
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF----SEDEARFFFQ 105
                H N+V        P   L +++E+   G L   +      F     ED  + F  
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLT 146
Query: 106 ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 156
                    Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   +   P
Sbjct: 147 LEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILL--SEKNVVKICDFGLARD--IXKDP 202
Query: 157 KSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFR 210
                  A     ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F 
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 211 KTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 114/262 (43%), Gaps = 29/262 (11%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++ K +G+G FG V     +K T+  +AVK ++ G    E    E    ++L+H  +
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 239
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQ 118
           V+   V+ T   + I+ E+ A G L + + +     +   +   F  Q+  G+++     
Sbjct: 240 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 298
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  S     KI DFG ++           VG      + APE +    
Sbjct: 299 YIHRDLRAANILVSASLV--CKIADFGLAR-----------VGAKFPIKWTAPEAINFGS 345
Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +  K +DVWS G+ L  ++  G  P+    +P+     + R L   Y  P       E  
Sbjct: 346 FTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELY 399
Query: 235 HLLSRIFVANSEKRITIPEIKN 256
           +++ R +    E+R T   I++
Sbjct: 400 NIMMRCWKNRPEERPTFEYIQS 421

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 38/237 (16%)
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--------FFQQLI 108
           HPN++R+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 109 SGVSYCHSMQICHRDLKLENTLLD-----------GSTAPRVKICDFGYSK-----SSVL 152
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K      S  
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 153 HSQPKSTVGTPAYIAPEVL-------TKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 204
            +   +  GT  + APE+L       TK+     I D++S G   Y +L  G +PF D  
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKY 244
Query: 205 DPKNFRKTIGRILSVHYSFPDYVRVSL-ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             ++    I  I S+      + R  + E   L+S++   +  KR T  ++  HP F
Sbjct: 245 SRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 117/262 (44%), Gaps = 19/262 (7%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++ K +G+G FG V     +K T+  +AVK ++ G    E    E    ++L+H  +
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 72
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQ 118
           V+   V+ T   + I+ E+ A G L + + +     +   +   F  Q+  G+++     
Sbjct: 73  VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 132 YIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +  K +DVWS G+ L  ++  G  P+    +P+     + R L   Y  P       E  
Sbjct: 189 FTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELY 242
Query: 235 HLLSRIFVANSEKRITIPEIKN 256
           +++ R +    E+R T   I++
Sbjct: 243 NIMMRCWKNRPEERPTFEYIQS 264

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 112/257 (43%), Gaps = 18/257 (7%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++VK +G+G FG V     +  T+  +AVK ++ G    +    E    ++L+H  +
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 69
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+     + I+ E+ A G L  F +    G+    +   F  Q+  G++Y     
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  S +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 130 YIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGC 186
Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +  K ++VWS G+ LY ++  G  P+     P      +   LS  Y  P       E  
Sbjct: 187 FTIK-SNVWSFGILLYEIVTYGKIPY-----PGRTNADVMSALSQGYRMPRMENCPDELY 240
Query: 235 HLLSRIFVANSEKRITI 251
            ++   +   +E+R T 
Sbjct: 241 DIMKMCWKEKAEERPTF 257

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 1   MERYEIV--KDIGSGNFGVAKLV--------RDKWTRELLAVKFIERGQKIDEHVQREIM 50
           ++R+ IV  +++G G FG   L         +DK    +  +K      + D H + E++
Sbjct: 10  IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 69
Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-------------RFSE 97
              +L+H +IV+F  V +    L +V EY   G+L + +   G               ++
Sbjct: 70  T--NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQ 127
Query: 98  DEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHS 154
            +     QQ+ +G+ Y  S    HRDL   N L+  +    VKI DFG S+   S+  + 
Sbjct: 128 SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYR 185
Query: 155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
               T+    ++ PE +  +++  + +DVWS GV L+ +   G  P+
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 231

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 47/294 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           ++ ++VK IG G +G  ++   KW  E +AVK     ++     + EI     ++H NI+
Sbjct: 37  KQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL 94
Query: 62  RFKEVLL----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
            F    +    + T L ++ +Y   G L++ + +    ++   +  +   +SG+ + H+ 
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTE 153
Query: 118 --------QICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPA 164
                    I HRDLK +N L+  +      I D G      S ++ +   P + VGT  
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 165 YIAPEV----LTKKEYDGKI-ADVWSCGVTLYVM--------LVGAY--PFED--PEDP- 206
           Y+ PEV    L +  +   I AD++S G+ L+ +        +V  Y  P+ D  P DP 
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 207 -KNFRKTIGRILSVHYSFPDYVRVSLEC----KHLLSRIFVANSEKRITIPEIK 255
            ++ R+ +  I  +  SFP+    S EC      L++  +  N   R+T   +K
Sbjct: 272 YEDMREIVC-IKKLRPSFPNRWS-SDECLRQMGKLMTECWAHNPASRLTALRVK 323

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 117/262 (44%), Gaps = 19/262 (7%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++ K +G+G FG V     +K T+  +AVK ++ G    E    E    ++L+H  +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 245
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQ 118
           V+   V+ T   + I+ E+ A G L + + +     +   +   F  Q+  G+++     
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 305 YIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +  K +DVWS G+ L  ++  G  P+    +P+     + R L   Y  P       E  
Sbjct: 362 FTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELY 415
Query: 235 HLLSRIFVANSEKRITIPEIKN 256
           +++ R +    E+R T   I++
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQS 437

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 121/292 (41%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 84
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF------SEDEARFF 103
                H N+V        P   L +++E+   G L   +      F       ED  + F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++ 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYK 200
Query: 155 QPKSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P       A     ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--------FFQQLI 108
           HPN++R+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 109 SGVSYCHSMQICHRDLKLENTLLD-----------GSTAPRVKICDFGYSK-----SSVL 152
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 153 HSQPKSTVGTPAYIAPEVL---TKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKN 208
                +  GT  + APE+L   TK+     I D++S G   Y +L  G +PF D    ++
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 209 FRKTIGRILSVHYSFPDYVRVSL-ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
               I  I S+      + R  + E   L+S++   +  KR T  ++  HP F
Sbjct: 263 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R  + K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH--RALMSELKIL 84
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF--SEDEARFFFQ-- 105
                H N+V        P   L +++E+   G L   +      F   +D  + F    
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLE 144
Query: 106 -------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-- 156
                  Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++  P  
Sbjct: 145 HLICYSFQVAKGMEFLASRKXIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDY 200
Query: 157 --KSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKT 212
             K     P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F + 
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 259
Query: 213 I---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 300

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--------FFQQLI 108
           HPN++R+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 109 SGVSYCHSMQICHRDLKLENTLLD-----------GSTAPRVKICDFGYSK-----SSVL 152
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 153 HSQPKSTVGTPAYIAPEVL---TKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKN 208
                +  GT  + APE+L   TK+     I D++S G   Y +L  G +PF D    ++
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 209 FRKTIGRILSVHYSFPDYVRVSL-ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
               I  I S+      + R  + E   L+S++   +  KR T  ++  HP F
Sbjct: 263 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 97  EDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP 156
           ED   + FQ +  G+ +  S +  HRDL   N LL  +    VKICDFG ++   ++  P
Sbjct: 199 EDLISYSFQ-VARGMEFLSSRKCIHRDLAARNILLSENNV--VKICDFGLARD--IYKNP 253
Query: 157 ----KSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFR 210
               K     P  ++APE +  K Y  K +DVWS GV L+ +  +G  P+   +  ++F 
Sbjct: 254 DYVRKGDTRLPLKWMAPESIFDKIYSTK-SDVWSYGVLLWEIFSLGGSPYPGVQMDEDFC 312
Query: 211 KTIG---RILSVHYSFPDYVRVSLECKH 235
             +    R+ +  YS P+  ++ L+C H
Sbjct: 313 SRLREGMRMRAPEYSTPEIYQIMLDCWH 340

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 84
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF------SEDEARFF 103
                H N+V        P   L +++E+   G L   +      F       ED  + F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++ 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYK 200
Query: 155 QP----KSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P    K     P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 121
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF------SEDEARFF 103
                H N+V        P   L +++E+   G L   +      F       ED  + F
Sbjct: 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 181
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++ 
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYK 237
Query: 155 QP----KSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P    K     P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 238 DPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 296
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 341

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 86
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERICNA-------GRFSEDEARFF 103
                H N+V        P   L +++E+   G L   + +            ED  + F
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF 146
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++ 
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYK 202
Query: 155 QP----KSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P    K     P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 203 DPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 261
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 262 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 306

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 49/291 (16%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R  + K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 85
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERICNAG------RFSEDEARFFF 104
                H N+V        P   L +++E+   G L   + +        +  ED  + F 
Sbjct: 86  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFL 145
Query: 105 Q---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 155
                     Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   +   
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IXKD 201
Query: 156 PKSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNF 209
           P       A     ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 210 RKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 41/223 (18%)
Query: 5   EIVKDIGSGNFGVAKLVR-------DKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSL 55
           E V+DIG G FG     R       + +T  ++AVK +  E    +    QRE       
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----------------------RICNAG 93
            +PNIV+   V      + ++ EY A G+L E                      R+ + G
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 94  --RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-- 149
               S  E     +Q+ +G++Y    +  HRDL   N L+  +    VKI DFG S++  
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIY 225
Query: 150 SVLHSQPKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY 191
           S  + +       P  ++ PE +    Y  + +DVW+ GV L+
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 267

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 175
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 176 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 233
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 234 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 292
Query: 235 H 235
           H
Sbjct: 293 H 293

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFT 214
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 215 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 273
Query: 235 H 235
           H
Sbjct: 274 H 274

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 75
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF------SEDEARFF 103
                H N+V        P   L ++ E+   G L   +      F       ED  + F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++ 
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYK 191
Query: 155 QP----KSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P    K     P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 250
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 295

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 75
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF------SEDEARFF 103
                H N+V        P   L ++ E+   G L   +      F       ED  + F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++ 
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYK 191
Query: 155 QP----KSTVGTP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P    K     P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 250
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 295

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 84
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF------SEDEARFF 103
                H N+V        P   L +++E+   G L   +      F       ED  + F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   +  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IXK 200
Query: 155 QPKSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P       A     ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 7   VKDIGSGNFGVAKLVRDKW------TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHP 58
           VK +GSG FG   + +  W       +  +A+K +      K ++ +  E      +  P
Sbjct: 22  VKVLGSGAFGT--VYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 79
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 117
            + R   + LT T + +V +    G L + +  N GR    +   +  Q+  G+SY   +
Sbjct: 80  YVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLTKK 174
           ++ HRDL   N L+   +   VKI DFG ++   +        G      ++A E + ++
Sbjct: 139 RLVHRDLAARNVLV--KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            +  + +DVWS GVT++ +M  GA P++
Sbjct: 197 RFTHQ-SDVWSYGVTVWELMTFGAKPYD 223

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 149
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 150 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 207
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 208 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 266
Query: 235 H 235
           H
Sbjct: 267 H 267

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 75
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF------SEDEARFF 103
                H N+V        P   L +++E+   G L   +      F       ED  + F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   +  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IXK 191
Query: 155 QPKSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P       A     ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 250
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 295

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 216 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 274
Query: 235 H 235
           H
Sbjct: 275 H 275

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 176
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 177 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 234
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 235 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 293
Query: 235 H 235
           H
Sbjct: 294 H 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 154
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 155 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 213 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 271
Query: 235 H 235
           H
Sbjct: 272 H 272

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRE------LLAVKFIER--GQKIDEHVQREIMNHRSLKHP 58
           VK +GSG FG   + +  W  E       +A+K +    G K +     E +   S+ HP
Sbjct: 43  VKVLGSGAFGT--VYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 100
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 117
           ++VR   V L+PT + +V +    G L E +  +           +  Q+  G+ Y    
Sbjct: 101 HLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 159
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLTKK 174
           ++ HRDL   N L+       VKI DFG ++      +  +  G      ++A E +  +
Sbjct: 160 RLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  + +DVWS GVT++ +M  G  P++
Sbjct: 218 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 244

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 216 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 274
Query: 235 H 235
           H
Sbjct: 275 H 275

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 155
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 213
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 214 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 272
Query: 235 H 235
           H
Sbjct: 273 H 273

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 152
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 153 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 211 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 269
Query: 235 H 235
           H
Sbjct: 270 H 270

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 18/241 (7%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPA-YIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++            K+    P  ++A E L  +++ 
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 214
Query: 178 GKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C 
Sbjct: 215 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 273
Query: 235 H 235
           H
Sbjct: 274 H 274

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRE------LLAVKFIER--GQKIDEHVQREIMNHRSLKHP 58
           VK +GSG FG   + +  W  E       +A+K +    G K +     E +   S+ HP
Sbjct: 20  VKVLGSGAFGT--VYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 77
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 117
           ++VR   V L+PT + +V +    G L E +  +           +  Q+  G+ Y    
Sbjct: 78  HLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 136
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLTKK 174
           ++ HRDL   N L+       VKI DFG ++      +  +  G      ++A E +  +
Sbjct: 137 RLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFE 201
           ++  + +DVWS GVT++ +M  G  P++
Sbjct: 195 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 221

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 113/290 (38%), Gaps = 46/290 (15%)
Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           E  E  K +GSG FG      A  +        +AVK ++  +K D   +  +M+   + 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALMSELKMM 102
Query: 56  ----KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARF-------- 102
                H NIV           + ++ EY   G+L   +     +FSEDE  +        
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 103 --------------FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 148
                         F  Q+  G+ +       HRDL   N L+  +    VKICDFG ++
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGKVVKICDFGLAR 220
Query: 149 SSVLHSQ--PKSTVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPE 204
             +  S    +     P  ++APE L +  Y  K +DVWS G+ L+ +  +G  P+    
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 205 DPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 254
              NF K I     +   F      + E   ++   +  +S KR + P +
Sbjct: 280 VDANFYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNL 325

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--------FFQQLI 108
           HPN++R+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 109 SGVSYCHSMQICHRDLKLENTLLD-----------GSTAPRVKICDFGYSK-----SSVL 152
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 153 HSQPKSTVGTPAYIAPEVL-------TKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 204
                +  GT  + APE+L       TK+     I D++S G   Y +L  G +PF D  
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKY 244
Query: 205 DPKNFRKTIGRILSVHYSFPDYVRVSL-ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             ++    I  I S+      + R  + E   L+S++   +  KR T  ++  HP F
Sbjct: 245 SRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 2   ERYEIVKDIGSGNFGV-----AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL- 55
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH  R +M+   + 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKIL 75
Query: 56  ----KHPNIVRFKEVLLTPTH-LAIVMEYAAGGELFERI-CNAGRF------SEDEARFF 103
                H N+V        P   L ++ E+   G L   +      F       ED  + F
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 135
Query: 104 FQ---------QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
                      Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   +  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IXK 191
Query: 155 QPKSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKN 208
            P       A     ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + 
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEE 250
Query: 209 FRKTI---GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
           F + +    R+ +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 295

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 53  RSLKHPNIVRFKEVLLTPT--HLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLI 108
           R   HPN++       +P   H  ++  +   G L+  +     F  D+++   F   + 
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 109 SGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI 166
            G+++ H+++  I    L   + ++D     R+ + D  +S       Q    +  PA++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS------FQSPGRMYAPAWV 175
Query: 167 APEVLTKKEYDG--KIADVWSCGVTLYVMLVGAYPFED 202
           APE L KK  D   + AD+WS  V L+ ++    PF D
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 28/229 (12%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           ERYEIV ++G G FG V + +     +  +A+K I    K  E  + EI   + +K  + 
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 61  V-RFKEVLLTP-----THLAIVMEYAAGGEL-FERICNAGRFSEDEARFFFQQLISGVSY 113
             +F  VL++       H+ I  E        F +  N   +     R    QL   + +
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 114 CHSMQICHRDLKLENTLLDGS-----------------TAPRVKICDFGYSKSSVLHSQP 156
            H  Q+ H DLK EN L   S                     +++ DFG   ++  H   
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 196
Query: 157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 205
            + V T  Y  PEV+ +  +  +  DVWS G  L+    G   F+  E+
Sbjct: 197 TTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHEN 244

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 28/229 (12%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           ERYEIV ++G G FG V + +     +  +A+K I    K  E  + EI   + +K  + 
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 110
Query: 61  V-RFKEVLLTP-----THLAIVMEYAAGGEL-FERICNAGRFSEDEARFFFQQLISGVSY 113
             +F  VL++       H+ I  E        F +  N   +     R    QL   + +
Sbjct: 111 ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 170
Query: 114 CHSMQICHRDLKLENTLLDGS-----------------TAPRVKICDFGYSKSSVLHSQP 156
            H  Q+ H DLK EN L   S                     +++ DFG   ++  H   
Sbjct: 171 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 228
Query: 157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 205
            + V T  Y  PEV+ +  +  +  DVWS G  L+    G   F+  E+
Sbjct: 229 TTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHEN 276

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 106/243 (43%), Gaps = 47/243 (19%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G +G  ++ R  W  E +AVK      +     + E+ N   L+H NI+ F    +T
Sbjct: 16  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 70  PTH----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SM 117
             H    L ++  Y   G L++ +      +    R     + SG+++ H          
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL-SIASGLAHLHIEIFGTQGKP 132
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--------VGTPAYIAPE 169
            I HRDLK +N L+  +   +  I D G    +V+HSQ  +         VGT  Y+APE
Sbjct: 133 AIAHRDLKSKNILVKKN--GQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 170 VLTKKE----YDG-KIADVWSCGVTLYVM--------LVGAY--PFED--PEDP--KNFR 210
           VL +      +D  K  D+W+ G+ L+ +        +V  Y  PF D  P DP  ++ R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 211 KTI 213
           K +
Sbjct: 248 KVV 250

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 20/242 (8%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKSSV------LHSQPKSTVGTPAYIAPEVLTKKEY 176
           DL   N +LD      VK+ DFG ++  +      +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
             K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C
Sbjct: 216 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 274
Query: 234 KH 235
            H
Sbjct: 275 WH 276

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 28/229 (12%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           ERYEIV ++G G FG V + +     +  +A+K I    K  E  + EI   + +K  + 
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 87
Query: 61  V-RFKEVLLTP-----THLAIVMEYAAGGEL-FERICNAGRFSEDEARFFFQQLISGVSY 113
             +F  VL++       H+ I  E        F +  N   +     R    QL   + +
Sbjct: 88  ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 147
Query: 114 CHSMQICHRDLKLENTLLDGS-----------------TAPRVKICDFGYSKSSVLHSQP 156
            H  Q+ H DLK EN L   S                     +++ DFG   ++  H   
Sbjct: 148 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEHH 205
Query: 157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 205
            + V T  Y  PEV+ +  +  +  DVWS G  L+    G   F+  E+
Sbjct: 206 TTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHEN 253

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTRELLAVKFIE------RGQKIDEHVQREIMNHRSLKHPN 59
           +++ +G G FG   L +    ++  AVK +       R  KI+  + ++I  +  + + N
Sbjct: 39  VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI-QNDDINNNN 97
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSM 117
           IV++    +   H+ ++ E   G  L+E I   N   F  ++ + +  +++  ++Y   M
Sbjct: 98  IVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 118 QICHRDLKLENTLLDG-----------------------STAPRVKICDFGYSK-SSVLH 153
            + H DLK EN LLD                        + +  +K+ DFG +   S  H
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH 216
Query: 154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 204
               S + T  Y APEV+    +D   +D+WS G  L  +  G+  F   E
Sbjct: 217 G---SIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 114/261 (43%), Gaps = 52/261 (19%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI------DE--HVQR------- 47
           RY +V+ +G G+F    L +D      +A+K + RG K+      DE   +QR       
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 48  -----------EIMNHRSLKHPNIVRFKEV--LLTPTHLAIVMEYAAGGELFERICNAGR 94
                      ++++H + K PN V    V  +L    LA++ +Y   G     +    +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 95  FSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAP----RVKICDFGYSKS 149
                      QL+ G+ Y H    I H D+K EN L++   +P    ++KI D G   +
Sbjct: 139 -----------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 150 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF 209
                   +++ T  Y +PEVL    + G  AD+WS    ++ ++ G + FE P++  ++
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE-PDEGHSY 243
Query: 210 RKT---IGRILSVHYSFPDYV 227
            K    I +I+ +    P Y+
Sbjct: 244 TKDDDHIAQIIELLGELPSYL 264

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 106/243 (43%), Gaps = 47/243 (19%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G +G  ++ R  W  E +AVK      +     + E+ N   L+H NI+ F    +T
Sbjct: 16  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 70  PTH----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SM 117
             H    L ++  Y   G L++ +      +    R     + SG+++ H          
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL-SIASGLAHLHIEIFGTQGKP 132
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--------VGTPAYIAPE 169
            I HRDLK +N L+  +   +  I D G    +V+HSQ  +         VGT  Y+APE
Sbjct: 133 AIAHRDLKSKNILVKKN--GQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 170 VLTKKE----YDG-KIADVWSCGVTLYVM--------LVGAY--PFED--PEDP--KNFR 210
           VL +      +D  K  D+W+ G+ L+ +        +V  Y  PF D  P DP  ++ R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 211 KTI 213
           K +
Sbjct: 248 KVV 250

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 114/261 (43%), Gaps = 52/261 (19%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI------DE--HVQR------- 47
           RY +V+ +G G+F    L +D      +A+K + RG K+      DE   +QR       
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 48  -----------EIMNHRSLKHPNIVRFKEV--LLTPTHLAIVMEYAAGGELFERICNAGR 94
                      ++++H + K PN V    V  +L    LA++ +Y   G     +    +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 95  FSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAP----RVKICDFGYSKS 149
                      QL+ G+ Y H    I H D+K EN L++   +P    ++KI D G   +
Sbjct: 139 -----------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 150 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF 209
                   +++ T  Y +PEVL    + G  AD+WS    ++ ++ G + FE P++  ++
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE-PDEGHSY 243
Query: 210 RKT---IGRILSVHYSFPDYV 227
            K    I +I+ +    P Y+
Sbjct: 244 TKDDDHIAQIIELLGELPSYL 264

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 106/243 (43%), Gaps = 47/243 (19%)
Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G +G  ++ R  W  E +AVK      +     + E+ N   L+H NI+ F    +T
Sbjct: 45  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 70  PTH----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SM 117
             H    L ++  Y   G L++ +      +    R     + SG+++ H          
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL-SIASGLAHLHIEIFGTQGKP 161
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--------VGTPAYIAPE 169
            I HRDLK +N L+  +   +  I D G    +V+HSQ  +         VGT  Y+APE
Sbjct: 162 AIAHRDLKSKNILVKKN--GQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 170 VLTKKE----YDG-KIADVWSCGVTLYVM--------LVGAY--PFED--PEDP--KNFR 210
           VL +      +D  K  D+W+ G+ L+ +        +V  Y  PF D  P DP  ++ R
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 276
Query: 211 KTI 213
           K +
Sbjct: 277 KVV 279

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 20/242 (8%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           DL   N +LD      VK+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 217 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 273
Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
             K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C
Sbjct: 274 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 332
Query: 234 KH 235
            H
Sbjct: 333 WH 334

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 20/242 (8%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           DL   N +LD      VK+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
             K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 273
Query: 234 KH 235
            H
Sbjct: 274 WH 275

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 20/242 (8%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           DL   N +LD      VK+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
             K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C
Sbjct: 216 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 274
Query: 234 KH 235
            H
Sbjct: 275 WH 276

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF---- 63
           + IG G FG  ++ R KW  E +AVK     ++     + EI     L+H NI+ F    
Sbjct: 48  ESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-------- 115
            +   T T L +V +Y   G LF+ +       E   +       SG+++ H        
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQG 164
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 170
              I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEV
Sbjct: 165 KPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 171 L----TKKEYDG-KIADVWSCGVTLY 191
           L      K ++  K AD+++ G+  +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 69/175 (39%), Gaps = 31/175 (17%)
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N++  K       H+ I M Y    E F  I N+  F E   R +   L   +   H   
Sbjct: 81  NVMGVKYCFRKNDHVVIAMPYLEH-ESFLDILNSLSFQE--VREYMLNLFKALKRIHQFG 137
Query: 119 ICHRDLKLENTLLD---------------GSTAPRVKICDFGYSKSSVLH-SQPKSTV-- 160
           I HRD+K  N L +               G+   ++++  F  S++     SQ K ++  
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 161 ----------GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED 205
                     GTP + APEVLTK        D+WS GV    +L G YPF    D
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 20/242 (8%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 162
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           DL   N +LD      VK+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 163 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 219
Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
             K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C
Sbjct: 220 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 278
Query: 234 KH 235
            H
Sbjct: 279 WH 280

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 20/242 (8%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           DL   N +LD      VK+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
             K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 273
Query: 234 KH 235
            H
Sbjct: 274 WH 275

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDXXKKT 216
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF---- 63
           + IG G FG  ++ R KW  E +AVK     ++     + EI     L+H NI+ F    
Sbjct: 9   ESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-------- 115
            +   T T L +V +Y   G LF+ +       E   +       SG+++ H        
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQG 125
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 170
              I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEV
Sbjct: 126 KPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 171 L----TKKEYDG-KIADVWSCGVTLY 191
           L      K ++  K AD+++ G+  +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF---- 63
           + IG G FG  ++ R KW  E +AVK     ++     + EI     L+H NI+ F    
Sbjct: 10  ESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-------- 115
            +   T T L +V +Y   G LF+ +       E   +       SG+++ H        
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQG 126
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 170
              I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEV
Sbjct: 127 KPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 171 L----TKKEYDG-KIADVWSCGVTLY 191
           L      K ++  K AD+++ G+  +
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 47/288 (16%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF---- 63
           + IG G FG  ++ R KW  E +AVK     ++     + EI     L+H NI+ F    
Sbjct: 12  ESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-------- 115
            +   T T L +V +Y   G LF+ +       E   +       SG+++ H        
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQG 128
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 170
              I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEV
Sbjct: 129 KPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 171 L----TKKEYDG-KIADVWSCGVTLYVML----VGA------YPFED--PEDP--KNFRK 211
           L      K ++  K AD+++ G+  + +     +G        P+ D  P DP  +  RK
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 246
Query: 212 TIGRILSVHYSFPDYVRVSLECKHLLSRI----FVANSEKRITIPEIK 255
            +     +  + P+  + S E   ++++I    + AN   R+T   IK
Sbjct: 247 VVCE-QKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIK 292

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 47/288 (16%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF---- 63
           + IG G FG  ++ R KW  E +AVK     ++     + EI     L+H NI+ F    
Sbjct: 15  ESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-------- 115
            +   T T L +V +Y   G LF+ +       E   +       SG+++ H        
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQG 131
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 170
              I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEV
Sbjct: 132 KPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 171 L----TKKEYDG-KIADVWSCGVTLYVML----VGA------YPFED--PEDP--KNFRK 211
           L      K ++  K AD+++ G+  + +     +G        P+ D  P DP  +  RK
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 249
Query: 212 TIGRILSVHYSFPDYVRVSLECKHLLSRI----FVANSEKRITIPEIK 255
            +     +  + P+  + S E   ++++I    + AN   R+T   IK
Sbjct: 250 VVCE-QKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIK 295

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 20/242 (8%)
Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--REIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E  Q   E +  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVLL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 155
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           DL   N +LD      VK+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 212
Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFEDPE--DPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
             K +DVWS GV L+ +M  GA P+ D    D   +     R+L   Y       V L+C
Sbjct: 213 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 271
Query: 234 KH 235
            H
Sbjct: 272 WH 273

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 8   KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF---- 63
           + IG G FG  ++ R KW  E +AVK     ++     + EI     L+H NI+ F    
Sbjct: 35  ESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 64  KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-------- 115
            +   T T L +V +Y   G LF+ +       E   +       SG+++ H        
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQG 151
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 170
              I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEV
Sbjct: 152 KPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 171 L----TKKEYDG-KIADVWSCGVTLY 191
           L      K ++  K AD+++ G+  +
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-----------CNAGRFSEDEARF-- 102
           KH NI+           L +++EYA+ G L E +            +  R  E++  F  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 103 ---FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
                 QL  G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDXXKKT 216
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 161
           Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++  P    K    
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDAR 256
Query: 162 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTI---GRI 216
            P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F + +    R+
Sbjct: 257 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315
Query: 217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 316 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 349

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 161
           Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++  P    K    
Sbjct: 208 QVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDAR 263
Query: 162 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTI---GRI 216
            P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F + +    R+
Sbjct: 264 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 322
Query: 217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 323 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 356

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 161
           Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++  P    K    
Sbjct: 206 QVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDAR 261
Query: 162 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTI---GRI 216
            P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F + +    R+
Sbjct: 262 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 320
Query: 217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 321 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 354

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP----KSTVG 161
           Q+  G+ +  S +  HRDL   N LL  S    VKICDFG ++   ++  P    K    
Sbjct: 199 QVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDAR 254
Query: 162 TP-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTI---GRI 216
            P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F + +    R+
Sbjct: 255 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 313
Query: 217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            +  Y+ P+  +  L+C H           +R T  E+  H
Sbjct: 314 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 347

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 2   ERYEIVKDIGSGNFG---VAKLV---RDKWTREL-LAVKFIERG---QKIDEHVQREIMN 51
           ++  + K +G G FG   +A+ V   +DK    + +AVK ++     + + + V    M 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARF 102
               KH NI+           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 QPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             K+T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 151 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKT 208
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKT 216
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 146 LVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNV--MKIADFGLARDINNIDYYKKT 203
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 247

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKT 262
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 148 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKT 205
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 249

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKT 216
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 12/195 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSL-KH 57
           + ++ +  +G G++G    VR K    L AVK      RG K       E+ +H  + +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCH 115
           P  VR ++       L +  E    G   ++ C A   S  EA+   + +  +  +++ H
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           S  + H D+K  N  L      R K+ DFG           +   G P Y+APE+L +  
Sbjct: 175 SQGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231
Query: 176 YDGKIADVWSCGVTL 190
           Y G  ADV+S G+T+
Sbjct: 232 Y-GTAADVFSLGLTI 245

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 107 PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 160
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 161 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 220 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 18  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 76  DNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKG 130
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 131 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 189 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 140
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPK 157
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++ + +  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKNT 216
Query: 158 STVGTPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +    P  ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++EYA+ G L E    R      +S D     E +  F+ 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    ++I DFG ++  + +    K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MRIADFGLARDINNIDYYKKT 216
Query: 159 TVGT--PAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 140
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 80/168 (47%), Gaps = 14/168 (8%)
Query: 58  PNIVRFKEVLL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           PNIV+  +++      TP+   ++ EY    + F+ +      ++ + R++  +L+  + 
Sbjct: 88  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 141
Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           YCHS  I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L 
Sbjct: 142 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 173 K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
             ++YD  + D+WS G     M+    PF    D  +    I ++L  
Sbjct: 201 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 10  IGSGNFG--VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHPNIVR 62
           IG GNFG  +   ++    R   A+K ++     D+H  R+      +      HPNI+ 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 80
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFE--------------RICN--AGRFSEDEARFFFQQ 106
                    +L + +EYA  G L +               I N  A   S  +   F   
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG-TPA- 164
           +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 141 VARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYV--KKTMGRLPVR 196
Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 197 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 232

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 85/355 (23%), Positives = 131/355 (36%), Gaps = 75/355 (21%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----- 57
           RY +++ +G G+F    L  D   +  +A+K ++  Q   E    EI   + ++      
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 58  PN-------IVRFKEVLLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARFFFQQLI 108
           PN       I  FK   +   H+ +V E   G  L + I   N         +   +Q++
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFE-VLGHHLLKWIIKSNYQGLPVRCVKSIIRQVL 150
Query: 109 SGVSYCHS-MQICHRDLKLENTLL---DG-------------------------STAP-- 137
            G+ Y HS  +I H D+K EN L+   D                          STAP  
Sbjct: 151 QGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAA 210
Query: 138 ---------------RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIAD 182
                          RVKI D G   +  +H      + T  Y + EVL    Y    AD
Sbjct: 211 DLLVNPLDPRNADKIRVKIADLG--NACWVHKHFTEDIQTRQYRSIEVLIGAGYSTP-AD 267
Query: 183 VWSCGVTLYVMLVGAYPFE--DPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           +WS     + +  G Y FE    ED       I  I+ +  S P +  +S +     SR 
Sbjct: 268 IWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGK----YSRE 323
Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHE 295
           F     +   I ++K  PW L ++   L E   W   D    +  L  +L ++ E
Sbjct: 324 FFNRRGELRHITKLK--PWSLFDV---LVEKYGWPHEDAAQFTDFLIPMLEMVPE 373

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 10  IGSGNFG--VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHPNIVR 62
           IG GNFG  +   ++    R   A+K ++     D+H  R+      +      HPNI+ 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 90
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFE--------------RICN--AGRFSEDEARFFFQQ 106
                    +L + +EYA  G L +               I N  A   S  +   F   
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG-TPA- 164
           +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYV--KKTMGRLPVR 206
Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 207 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 242

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRE------LLAVKFIE--RGQKIDEHVQREIMNHRSLKHP 58
           +K +GSG FG     +  W  E       + +K IE   G++  + V   ++   SL H 
Sbjct: 36  LKVLGSGVFGTVH--KGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 93
Query: 59  NIVRFKEVLLTP-THLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 116
           +IVR   + L P + L +V +Y   G L + +  + G         +  Q+  G+ Y   
Sbjct: 94  HIVRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 151
Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEV 170
             + HR+L   N LL   +  +V++ DFG +         +L+S+ K+ +    ++A E 
Sbjct: 152 HGMVHRNLAARNVLLKSPS--QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALES 206
Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +   +Y  + +DVWS GVT++ +M  GA P+
Sbjct: 207 IHFGKYTHQ-SDVWSYGVTVWELMTFGAEPY 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 7   VKDIGSGNFGVAKLVRDKWTRE------LLAVKFIE--RGQKIDEHVQREIMNHRSLKHP 58
           +K +GSG FG     +  W  E       + +K IE   G++  + V   ++   SL H 
Sbjct: 18  LKVLGSGVFGTVH--KGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 117
           +IVR    L   + L +V +Y   G L + +  + G         +  Q+  G+ Y    
Sbjct: 76  HIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 171
            + HR+L   N LL   +  +V++ DFG +         +L+S+ K+ +    ++A E +
Sbjct: 135 GMVHRNLAARNVLLKSPS--QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESI 189
Query: 172 TKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              +Y  + +DVWS GVT++ +M  GA P+
Sbjct: 190 HFGKYTHQ-SDVWSYGVTVWELMTFGAEPY 218

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 20  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 78  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 132
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 133 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 21  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 79  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 133
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 134 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 192 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 19  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 131
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 132 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 17  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 75  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 129
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 18  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 76  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 130
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 131 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 189 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 19  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 131
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 132 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 19  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 77  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 131
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 132 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 21  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 79  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 133
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 134 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 192 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++ YA+ G L E    R      +S D     E +  F+ 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKT 216
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 10  IGSGNFGVAKLVRDKWTR-ELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIVRFKEV 66
           +G G FG  K+ + +     L+AVK +  ER Q  +   Q E+       H N++R +  
Sbjct: 46  LGRGGFG--KVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGF 103
Query: 67  LLTPTHLAIVMEYAAGGE----LFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QI 119
            +TPT   +V  Y A G     L ER  +       + +        G++Y H     +I
Sbjct: 104 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 163
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLTKKEYD 177
            HRD+K  N LLD        + DFG +K           +  GT  +IAPE L+  +  
Sbjct: 164 IHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSS 221
Query: 178 GKIADVWSCGVTLYVMLVGAYPFE 201
            K  DV+  GV L  ++ G   F+
Sbjct: 222 EK-TDVFGYGVMLLELITGQRAFD 244

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYI 166
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK      Q        GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVML 194
            PE   K     K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYI 166
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK      Q        GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVML 194
            PE   K     K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTREL-LAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  +++K +G+G FG  ++    W     +A+K ++ G    E    E    + LKH  +
Sbjct: 9   ESLQLIKRLGNGQFG--EVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKL 66
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GR-FSEDEARFFFQQLISGVSYCHSMQ 118
           V+   V+ +   + IV EY   G L + + +  GR            Q+ +G++Y   M 
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+        KI DFG ++  +  ++  +  G      + APE      
Sbjct: 126 YIHRDLRSANILVGNGLI--CKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGR 182
Query: 176 YDGKIADVWSCGVTLYVMLV-GAYPF 200
           +  K +DVWS G+ L  ++  G  P+
Sbjct: 183 FTIK-SDVWSFGILLTELVTKGRVPY 207

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 91  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 150 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 206
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 207 SK-SDVWSFGVLMW 219

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 152 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 208
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 209 SK-SDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 152 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 208
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 209 SK-SDVWSFGVLMW 221

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 35/230 (15%)
Query: 1   MERYEIV--KDIGSGNFGVAKLV--------RDKWTRELLAVKFIERGQKIDEHVQREIM 50
           ++R +IV  +++G G FG   L         +DK    + A+K      + D   QRE  
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAE 69
Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICN--------------AGR 94
              +L+H +IV+F  V      L +V EY   G+L  F R                  G 
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 95  FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSV 151
               +      Q+ SG+ Y  S    HRDL   N L+  +    VKI DFG S+   S+ 
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTD 187
Query: 152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            +     T+    ++ PE +  +++  + +DVWS GV L+ +   G  P+
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 236

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 136 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 192
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 193 SK-SDVWSFGVLMW 205

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEARFFFQQ 106
               KH NI+           L +++EYA+ G L E +  A R     FS + +    +Q
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEFSFNPSHNPEEQ 146
Query: 107 LIS------------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH 153
           L S            G+ Y  S +  HRDL   N L+       +KI DFG ++    + 
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHID 204
Query: 154 SQPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 136 DLAARNVLL--VTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY-APECINYYKFS 192
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 193 SK-SDVWSFGVLMW 205

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 142 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 198
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 199 SK-SDVWSFGVLMW 211

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARFFFQQ 106
           KH NI+           L +++ YA+ G L E    R      +S D     E +  F+ 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKS 158
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +    K+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKT 216
Query: 159 TVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           T G     ++APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 132 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 188
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 189 SK-SDVWSFGVLMW 201

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 10  IGSGNFG--VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-----KHPNIVR 62
           IG GNFG  +   ++    R   A+K ++     D+H  R+      +      HPNI+ 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 87
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFE--------------RICN--AGRFSEDEARFFFQQ 106
                    +L + +EYA  G L +               I N  A   S  +   F   
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG-TPA- 164
           +  G+ Y    Q  HR+L   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 148 VARGMDYLSQKQFIHRNLAARNILVGENYV--AKIADFGLSRGQEVYV--KKTMGRLPVR 203
Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           ++A E L    Y    +DVWS GV L+ ++ +G  P+
Sbjct: 204 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 239

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 79
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 80  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 139 YIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGT 195
Query: 176 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
           +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 196 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 227

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V  +E  +       +EI++      S+
Sbjct: 51  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 109 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 163
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 164 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 222 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 255

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 72
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 73  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 132 YIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 176 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
           +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 189 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 220

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----PN 59
           + + K IG GNFG  +L ++ +T E +A+K +E  +     +  E   ++ L      P 
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           +  F        + A+V+E       +LF+ +C+   FS         QLIS + Y HS 
Sbjct: 70  VYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSK 124
Query: 118 QICHRDLKLENTLL---DGSTAPRVKICDFGY--------SKSSVLHSQPKSTVGTPAYI 166
            + +RD+K EN L+      T   + I DFG         +K  + + + KS  GT  Y+
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
           +      KE   +  D+ + G      L G+ P++
Sbjct: 185 SINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 71  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 130 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 186
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 187 SK-SDVWSFGVLMW 199

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 176 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
           +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 176 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
           +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 71
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 72  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 131 YIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 176 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
           +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 188 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 78
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 79  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 138 YIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 176 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
           +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 195 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 226

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKE 175
             HRDL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 136 YIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 176 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
           +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 193 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 435 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 493
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 494 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 550
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 551 SK-SDVWSFGVLMW 563

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 12/212 (5%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 65
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 66  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             HRDL+  N L+  + +   KI DFG ++      ++  +       + APE +    +
Sbjct: 125 YIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 182
Query: 177 DGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
             K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 183 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 213

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 17  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKG 129
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKHPNIVR 62
           K++GSGNFG V K               I + +  D  ++ E++      + L +P IVR
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 436 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 494
Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N LL   T    KI DFG SK+     +   +Q         Y APE +   ++ 
Sbjct: 495 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 551
Query: 178 GKIADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 552 SK-SDVWSFGVLMW 564

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 51/241 (21%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKE 65
           +V+ +G G +G  ++ R  W  E +AVK      +     + EI N   L+H NI+ F  
Sbjct: 12  LVECVGKGRYG--EVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 66  VLLT----PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLIS---GVSYCH--- 115
             +T     T L ++  Y   G L++ +    +    E     +  +S   G+++ H   
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEI 125
Query: 116 -----SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS--------TVGT 162
                   I HRD K  N L+  +   +  I D G    +V+HSQ            VGT
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNL--QCCIADLGL---AVMHSQGSDYLDIGNNPRVGT 180
Query: 163 PAYIAPEVLTKKEYDG-----KIADVWSCGVTLYVM--------LVGAY--PFED--PED 205
             Y+APEVL ++         K  D+W+ G+ L+ +        +V  Y  PF D  P D
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPND 240
Query: 206 P 206
           P
Sbjct: 241 P 241

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 12/212 (5%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             HRDL+  N L+  + +   KI DFG ++      ++  +       + APE +    +
Sbjct: 136 YIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 193
Query: 177 DGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
             K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 194 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 12/212 (5%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 75
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 76  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             HRDL+  N L+  + +   KI DFG ++      ++  +       + APE +    +
Sbjct: 135 YIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 192
Query: 177 DGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
             K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 193 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 223

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 1   MERYEIVK--DIGSGNFGVAKLVR-----DKWTRELLAVKFI-ERGQKIDEHVQREIMNH 52
           ++R +IV   ++G G FG   L        +  + L+AVK + E  +   +  QRE    
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA------ 100
             L+H +IVRF  V      L +V EY   G+L   + + G         ED A      
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 101 ---RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHS 154
                   Q+ +G+ Y   +   HRDL   N L+       VKI DFG S+   S+  + 
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYR 215
Query: 155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
               T+    ++ PE +  +++  + +DVWS GV L+ +   G  P+
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 1   MERYEIVK--DIGSGNFGVAKLVR-----DKWTRELLAVKFI-ERGQKIDEHVQREIMNH 52
           ++R +IV   ++G G FG   L        +  + L+AVK + E  +   +  QRE    
Sbjct: 15  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 74
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA------ 100
             L+H +IVRF  V      L +V EY   G+L   + + G         ED A      
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 101 ---RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHS 154
                   Q+ +G+ Y   +   HRDL   N L+       VKI DFG S+   S+  + 
Sbjct: 135 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYR 192
Query: 155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
               T+    ++ PE +  +++  + +DVWS GV L+ +   G  P+
Sbjct: 193 VGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 238

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 12/212 (5%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 80
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 81  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             HRDL+  N L+  + +   KI DFG ++      ++  +       + APE +    +
Sbjct: 140 YIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 197
Query: 177 DGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
             K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 198 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 228

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 12/212 (5%)
Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++V+ +G+G FG V     +  T+  +AVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             HRDL+  N L+  + +   KI DFG ++      ++  +       + APE +    +
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 177 DGKIADVWSCGVTLYVMLV-GAYPFEDPEDPK 207
             K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 188 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/196 (21%), Positives = 76/196 (38%), Gaps = 17/196 (8%)
Query: 18  AKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT--H 72
            +L + +W    + VK +   +   +       E    R   HPN++       +P   H
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 73  LAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQ--ICHRDLKLEN 128
             ++  +   G L+  +     F  D+++   F      G ++ H+++  I    L   +
Sbjct: 84  PTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRS 143
Query: 129 TLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG--KIADVWSC 186
             +D     R+   D  +S       Q       PA++APE L KK  D   + AD WS 
Sbjct: 144 VXIDEDXTARISXADVKFS------FQSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSF 197
Query: 187 GVTLYVMLVGAYPFED 202
            V L+ ++    PF D
Sbjct: 198 AVLLWELVTREVPFAD 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 1   MERYEIVK--DIGSGNFGVAKLVR-----DKWTRELLAVKFI-ERGQKIDEHVQREIMNH 52
           ++R +IV   ++G G FG   L        +  + L+AVK + E  +   +  QRE    
Sbjct: 9   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 68
Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA------ 100
             L+H +IVRF  V      L +V EY   G+L   + + G         ED A      
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 101 ---RFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHS 154
                   Q+ +G+ Y   +   HRDL   N L+       VKI DFG S+   S+  + 
Sbjct: 129 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYR 186
Query: 155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
               T+    ++ PE +  +++  + +DVWS GV L+ +   G  P+
Sbjct: 187 VGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 232

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 23  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 81  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 135
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 136 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 194 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 20  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 132
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 133 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 20  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 132
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 133 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K + SG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 24  FKKIKVLSSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G
Sbjct: 82  DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 136
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 137 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 195 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 19  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 77  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 131
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 132 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 20  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 78  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 132
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 133 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 24  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 136
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 137 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 195 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 17  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 129
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 27  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 85  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 139
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 140 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 198 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 231

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 42  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 100 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 154
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 155 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 213 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 246

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEARFFFQQ 106
               KH NI+           L +++EYA+ G L E +  A R     +S + +    +Q
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 135
Query: 107 LIS------------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH 153
           L S            G+ Y  S +  HRDL   N L+       +KI DFG ++    + 
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHID 193
Query: 154 SQPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 242

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 10  IGSGNFGVAKLVRDKWTR-ELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPNIVRFKEV 66
           +G G FG  K+ + +     L+AVK +  ER Q  +   Q E+       H N++R +  
Sbjct: 38  LGRGGFG--KVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 67  LLTPTHLAIVMEYAAGGE----LFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QI 119
            +TPT   +V  Y A G     L ER  +       + +        G++Y H     +I
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLTKKEYD 177
            HRD+K  N LLD        + DFG +K           +  G   +IAPE L+  +  
Sbjct: 156 IHRDVKAANILLDEEF--EAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSS 213
Query: 178 GKIADVWSCGVTLYVMLVGAYPFE 201
            K  DV+  GV L  ++ G   F+
Sbjct: 214 EK-TDVFGYGVMLLELITGQRAFD 236

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 14  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 72  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAEG 126
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 127 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 185 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 218

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEARFFFQQ 106
               KH NI+           L +++EYA+ G L E +  A R     +S + +    +Q
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 138
Query: 107 LIS------------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH 153
           L S            G+ Y  S +  HRDL   N L+       +KI DFG ++    + 
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHID 196
Query: 154 SQPKSTVGT--PAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 245

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 19  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 77  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 131
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 132 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 17  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 129
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEARFFFQQ 106
               KH NI+           L +++EYA+ G L E +  A R     +S + +    +Q
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 187
Query: 107 LIS------------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH 153
           L S            G+ Y  S +  HRDL   N L+       +KI DFG ++    + 
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHID 245
Query: 154 SQPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 294

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----------------- 94
               KH NI+           L +++EYA+ G L E +  A R                 
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEEQ 146
Query: 95  FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH 153
            S  +      Q+  G+ Y  S +  HRDL   N L+       +KI DFG ++    + 
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHID 204
Query: 154 SQPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEARFFFQQ 106
               KH NI+           L +++EYA+ G L E +  A R     +S + +    +Q
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 139
Query: 107 LIS------------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH 153
           L S            G+ Y  S +  HRDL   N L+       +KI DFG ++    + 
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHID 197
Query: 154 SQPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 246

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 11  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 69  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 123
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 124 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 182 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----------------- 94
               KH NI+           L +++EYA+ G L E +  A R                 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEEQ 131
Query: 95  FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH 153
            S  +      Q+  G+ Y  S +  HRDL   N L+       +KI DFG ++    + 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHID 189
Query: 154 SQPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 238

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 24  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 136
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 137 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 195 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEARFFFQQ 106
               KH NI+           L +++EYA+ G L E +  A R     +S + +    +Q
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 146
Query: 107 LIS------------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLH 153
           L S            G+ Y  S +  HRDL   N L+       +KI DFG ++    + 
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHID 204
Query: 154 SQPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 66/261 (25%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH--PN- 59
           RY +++ +G G+F    L  D   ++ +A+K ++  +   E    EI   +S+++  PN 
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 60  ---------IVRFKEVLLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARFFFQQLI 108
                    +  FK   +  TH+ +V E   G  L + I   N         +   QQ++
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 140
Query: 109 SGVSYCHS-MQICHRDLKLENTLLD----------------------------GSTAP-- 137
            G+ Y H+  +I H D+K EN LL                              STAP  
Sbjct: 141 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 200
Query: 138 -----------------RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
                            +VKI D G   +  +H      + T  Y + EVL    Y+   
Sbjct: 201 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 257
Query: 181 ADVWSCGVTLYVMLVGAYPFE 201
           AD+WS     + +  G Y FE
Sbjct: 258 ADIWSTACMAFELATGDYLFE 278

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K +GSG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 17  FKKIKVLGSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 129
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 2   ERYEIVKDIGSGNFGVAKLV------RDKWTR-ELLAVKFIERG---QKIDEHVQREIMN 51
           +R  + K +G G FG   L       +DK  R   +AVK ++     + + + +    M 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARFFFQQL 107
               KH NI+           L +++EYA+ G L E    R      +S + +    +QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 108 IS------------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHS 154
            S            G+ Y  S +  HRDL   N L+       +KI DFG ++    +  
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDY 205
Query: 155 QPKSTVG--TPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             K+T G     ++APE L  + Y  + +DVWS GV L+ +  +G  P+
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 66/261 (25%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH--PN- 59
           RY +++ +G G+F    L  D   ++ +A+K ++  +   E    EI   +S+++  PN 
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 60  ---------IVRFKEVLLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARFFFQQLI 108
                    +  FK   +  TH+ +V E   G  L + I   N         +   QQ++
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 109 SGVSYCHS-MQICHRDLKLENTLLD----------------------------GSTAP-- 137
            G+ Y H+  +I H D+K EN LL                              STAP  
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 138 -----------------RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
                            +VKI D G   +  +H      + T  Y + EVL    Y+   
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 273
Query: 181 ADVWSCGVTLYVMLVGAYPFE 201
           AD+WS     + +  G Y FE
Sbjct: 274 ADIWSTACMAFELATGDYLFE 294

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----PN 59
           + + K IG GNFG  +L ++ +T E +A+K +E  +     +  E   ++ L      P 
Sbjct: 32  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 90
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           +  F        + A+V+E       +LF+ +C+   FS         QLIS + Y HS 
Sbjct: 91  VYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSK 145
Query: 118 QICHRDLKLENTLL---DGSTAPRVKICDFGY--------SKSSVLHSQPKSTVGTPAYI 166
            + +RD+K EN L+      T   + I DF          +K  + + + KS  GT  Y+
Sbjct: 146 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 205
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
           +      KE   +  D+ + G      L G+ P++
Sbjct: 206 SINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 239

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH----PN 59
           + + K IG GNFG  +L ++ +T E +A+K +E  +     +  E   ++ L      P 
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           +  F        + A+V+E       +LF+ +C+   FS         QLIS + Y HS 
Sbjct: 70  VYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSK 124
Query: 118 QICHRDLKLENTLL---DGSTAPRVKICDFGY--------SKSSVLHSQPKSTVGTPAYI 166
            + +RD+K EN L+      T   + I DF          +K  + + + KS  GT  Y+
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
           +      KE   +  D+ + G      L G+ P++
Sbjct: 185 SINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH------ 57
           + + K IG GNFG  +L ++ +T E +A+K     + I     +  + +R  K       
Sbjct: 6   FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPIKSRAPQLHLEYRFYKQLSATEG 61
Query: 58  -PNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYC 114
            P +  F        + A+V+E       +LF+ +C+   F+         QLI+ + Y 
Sbjct: 62  VPQVYYFGP---XGKYNAMVLELLGPSLEDLFD-LCDR-TFTLKTVLMIAIQLITRMEYV 116
Query: 115 HSMQICHRDLKLENTLLDGSTAPR---VKICDFGY--------SKSSVLHSQPKSTVGTP 163
           H+  + +RD+K EN L+      R   + I DFG         +K  + + + KS  GT 
Sbjct: 117 HTKSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTA 176
Query: 164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
            Y++      KE   +  D+ + G      L G+ P++
Sbjct: 177 RYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 213

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 84/186 (45%), Gaps = 15/186 (8%)
Query: 30  LAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FE 87
           +AVK +++G    +    E    + L+H  +VR   V+ T   + I+ EY   G L  F 
Sbjct: 40  VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL 98
Query: 88  RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS 147
           +  +  + + ++      Q+  G+++       HRDL+  N L+  + +   KI DFG +
Sbjct: 99  KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLA 156
Query: 148 KSSVLHSQPKSTVGTPA-----YIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFE 201
           +   L    + T    A     + APE +    +  K +DVWS G+ L  ++  G  P+ 
Sbjct: 157 R---LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYP 212
Query: 202 DPEDPK 207
              +P+
Sbjct: 213 GMTNPE 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 23/178 (12%)
Query: 43  EHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED 98
           E  + E M    L+HPN+V    V+     L+++  Y + G+L E    R  ++   S D
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 99  EAR------------FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 146
           + R                Q+ +G+ Y  S  + H+DL   N L+       VKI D G 
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL--NVKISDLGL 191
Query: 147 SKSSVLHSQPK---STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            +        K   +++    ++APE +   ++    +D+WS GV L+ V   G  P+
Sbjct: 192 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 248

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 23/178 (12%)
Query: 43  EHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE----RICNAGRFSED 98
           E  + E M    L+HPN+V    V+     L+++  Y + G+L E    R  ++   S D
Sbjct: 57  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 99  EAR------------FFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 146
           + R                Q+ +G+ Y  S  + H+DL   N L+       VKI D G 
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL--NVKISDLGL 174
Query: 147 SKSSVLHSQPK---STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            +        K   +++    ++APE +   ++    +D+WS GV L+ V   G  P+
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRE----LLAVKFIERGQKIDEH----VQREIMNHRSLKHP 58
           K +G+G FG V +       +E     +AVK ++     DE      + +IM+H   +H 
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-QHE 110
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--------------FF 104
           NIV           + ++ EY   G+L   +    R  E +  F              F 
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 105 QQLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQ--PKSTVG 161
            Q+  G+++  S    HRD+   N LL +G  A   KI DFG ++  +  S    K    
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMNDSNYIVKGNAR 227
Query: 162 TPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            P  ++APE +    Y  + +DVWS G+ L+ +  +G  P+
Sbjct: 228 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPY 267

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 8   KDIGSGNFG-VAKLVRDKWTRE----LLAVKFIERGQKIDEH----VQREIMNHRSLKHP 58
           K +G+G FG V +       +E     +AVK ++     DE      + +IM+H   +H 
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-QHE 110
Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARF--------------FF 104
           NIV           + ++ EY   G+L   +    R  E +  F              F 
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 105 QQLISGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQ--PKSTVG 161
            Q+  G+++  S    HRD+   N LL +G  A   KI DFG ++  +  S    K    
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMNDSNYIVKGNAR 227
Query: 162 TPA-YIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            P  ++APE +    Y  + +DVWS G+ L+ +  +G  P+
Sbjct: 228 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPY 267

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 10  IGSGNFGVAKLVRDKW---TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEV 66
           +G G FG  ++    W   TR  +A+K ++ G    E   +E    + L+H  +V+   V
Sbjct: 16  LGQGCFG--EVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARFFFQQLISGVSYCHSMQICHRDL 124
           + +   + IV EY + G L + +    G++    +      Q+ SG++Y   M   HRDL
Sbjct: 72  V-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 130
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKIA 181
           +  N L+  +     K+ DFG ++  +  ++  +  G      + APE      +  K +
Sbjct: 131 RAANILVGENLV--CKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK-S 186
Query: 182 DVWSCGVTL 190
           DVWS G+ L
Sbjct: 187 DVWSFGILL 195

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 15/188 (7%)
Query: 10  IGSGNFGVAKLVRDKW---TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEV 66
           +G G FG  ++    W   TR  +A+K ++ G    E   +E    + L+H  +V+   V
Sbjct: 26  LGQGCFG--EVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARFFFQQLISGVSYCHSMQICHRDL 124
           + +   + IVMEY + G L + +    G++    +      Q+ SG++Y   M   HRDL
Sbjct: 82  V-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 125 KLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIAD 182
           +  N L+  +     K+ DFG ++      ++  +       + APE      +  K +D
Sbjct: 141 RAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 197
Query: 183 VWSCGVTL 190
           VWS G+ L
Sbjct: 198 VWSFGILL 205

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 17/189 (8%)
Query: 10  IGSGNFGVAKLVRDKW---TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEV 66
           +G G FG  ++    W   TR  +A+K ++ G    E   +E    + L+H  +V+   V
Sbjct: 26  LGQGCFG--EVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 67  LLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARFFFQQLISGVSYCHSMQICHRDL 124
           + +   + IV+EY + G L + +    G++    +      Q+ SG++Y   M   HRDL
Sbjct: 82  V-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLTKKEYDGKIA 181
           +  N L+  +     K+ DFG ++  +  ++  +  G      + APE      +  K +
Sbjct: 141 RAANILVGENLV--CKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 182 DVWSCGVTL 190
           DVWS G+ L
Sbjct: 197 DVWSFGILL 205

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 6   IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-------- 57
           + K IG GNFG  +L ++ +T E +A+K     + I     +  + +R  K         
Sbjct: 4   VGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPIKSRAPQLHLEYRFYKQLGSAGEGL 59
Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           P +  F        + A+V+E       +LF+ +C+   F+         QL+S + Y H
Sbjct: 60  PQVYYFGP---XGKYNAMVLELLGPSLEDLFD-LCDR-TFTLKTVLMIAIQLLSRMEYVH 114
Query: 116 SMQICHRDLKLENTLLDGSTAPR---VKICDFGY--------SKSSVLHSQPKSTVGTPA 164
           S  + +RD+K EN L+      +   + I DFG         +K  + + + KS  GT  
Sbjct: 115 SKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTAR 174
Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
           Y++      KE   +  D+ + G      L G+ P++
Sbjct: 175 YMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 210

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K + SG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 17  FKKIKVLSSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 129
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 188 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 23/174 (13%)
Query: 57  HPNIVR-FKEVLLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
           HP+IV+ F  V  T  H      IVMEY  GG+  +R     +    EA  +  +++  +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR-SKGQKLPVAEAIAYLLEILPAL 195
Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           SY HS+ + + DLK EN +L   T  ++K+ D G    S ++S      GTP + APE++
Sbjct: 196 SYLHSIGLVYNDLKPENIML---TEEQLKLIDLG--AVSRINSF-GYLYGTPGFQAPEIV 249
Query: 172 TKKEYDGKIADVWSCGVTLYVMLV------GAYPFEDPEDPKNFR--KTIGRIL 217
             +       D+++ G TL  + +      G Y    PED    +   + GR+L
Sbjct: 250 --RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKF-IERGQKIDEHVQREI--MNHRSLKHPN 59
           RY + + IGSG+FG   L  D    E +A+K    + +    H++ +I  M    +  P 
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 117
           I   +       +  +VME    G   E + N  + +FS         Q+IS + Y HS 
Sbjct: 70  I---RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 118 QICHRDLKLENTLLD-GSTAPRVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAP 168
              HRD+K +N L+  G     V I DFG +K          + + + K+  GT  Y + 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
                 E   +  D+ S G  L    +G+ P++
Sbjct: 185 NTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQ 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERGQKIDEHVQREIMNHR----SL 55
           ++ +K + SG FG   + +  W  E     + V   E  +       +EI++      S+
Sbjct: 24  FKKIKVLSSGAFGT--VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARFFFQ---QLISG 110
            +P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G
Sbjct: 82  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKG 136
Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA---YIA 167
           ++Y    ++ HRDL   N L+   T   VKI DFG +K      +     G      ++A
Sbjct: 137 MNYLEDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 201
            E +  + Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 195 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	338
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	0.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-146
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-143
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-114
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-112
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-112
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-111
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-111
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-110
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-110
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-109
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-108
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-108
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-107
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-106
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-103
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-102
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-101
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-92
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-91
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-91
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-91
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-90
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-90
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-90
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-90
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-89
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-89
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-89
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-88
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-88
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-88
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-88
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-88
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-88
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-87
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-87
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-87
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-87
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-87
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-86
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-86
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-86
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-85
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-85
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-85
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-85
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-85
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-85
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-84
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-82
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-82
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-81
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-81
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-80
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-80
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-78
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-76
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-73
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-73
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-72
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-70
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-69
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-69
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-66
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-64
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-64
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-63
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-63
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-63
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-62
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-62
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-62
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-61
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-61
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-61
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-61
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-61
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-61
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-61
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-60
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-60
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-59
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-59
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-59
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-59
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-58
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-58
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-56
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-55
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-55
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-53
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-52
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-49
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-48
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-47
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-47
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-47
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-46
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-46
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-46
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-46
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-46
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-45
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-43
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-43
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-42
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-42
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-41
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-41
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-40
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-39
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-39
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-38
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-38
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-38
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-38
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-37
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-37
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-36
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-36
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-36
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-36
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-36
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-36
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-35
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-35
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-35
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-34
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-33
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-33
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-32
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-32
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-32
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-32
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-32
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-31
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-31
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-31
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-30
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-29
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-29
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-28
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-28
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-27
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-26
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  528 bits (1363), Expect = 0.0
 Identities = 242/343 (70%), Positives = 284/343 (82%), Gaps = 5/343 (1%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
            +RY+ VKDIGSGNFGVA+L+RDK T+EL+AVK+IERG  IDE+VQREI+NHRSL+HPNI
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VRFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEARFFFQQL+SGVSYCHSMQIC
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLKLENTLLDGS APR+KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL ++EYDGKI
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDPE+P+++RKTI RILSV YS PD +R+S EC HL+SRI
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258

Query: 241 FVANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATK 298
           FVA+   RI+IPEIK H WFL+NLP +L    +   Q  +   P QSL+ ++ +I EAT 
Sbjct: 259 FVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATI 318

Query: 299 PLEAPRVGGHLLGSSMELDDLDADADLE---DTETSGDFVCPL 338
           P    R     +  +++LDD   D D E   D ++SG+ V  L
Sbjct: 319 PAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGEIVYAL 361

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  414 bits (1066), Expect = e-146
 Identities = 93/312 (29%), Positives = 155/312 (49%), Gaps = 12/312 (3%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++        GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +  +  DVWSCG+ L  ML G  P++ P D  + +                + ++     
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPWKKIDSAPL 239

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIH 294
            LL +I V N   RITIP+IK   W+ + L                +PS   + + S + 
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLD 299

Query: 295 EATKPLEAPRVG 306
            +     +   G
Sbjct: 300 FSPVNSASRTPG 311

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  404 bits (1040), Expect = e-143
 Identities = 89/274 (32%), Positives = 145/274 (52%), Gaps = 12/274 (4%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQREIMNHRSLKHP 58
           +E +++V+ +G G +G  +L  ++ T E +AVK ++  + +D  E++++EI  ++ L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N+V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTKKE 175
           I HRD+K EN LLD      +KI DFG +     +++        GT  Y+APE+L ++E
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +  +  DVWSCG+ L  ML G  P++ P D  + +                + ++     
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPWKKIDSAPL 239

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRNLPIEL 268
            LL +I V N   RITIP+IK   W+ + L    
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  330 bits (849), Expect = e-114
 Identities = 103/269 (38%), Positives = 148/269 (55%), Gaps = 12/269 (4%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +  Y +   +G G FG  K+   + T   +AVK + R +     +   ++REI N +  +
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP+I++  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S V YCH 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             + HRDLK EN LLD       KI DFG S         +++ G+P Y APEV++ + Y
Sbjct: 130 HMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
            G   D+WSCGV LY +L G  PF+D   P  F+K    I    +  P+Y  ++     L
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATL 241

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           L  +   +  KR TI +I+ H WF ++LP
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQDLP 270

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  326 bits (839), Expect = e-112
 Identities = 101/267 (37%), Positives = 146/267 (54%), Gaps = 13/267 (4%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLKHP 58
            Y ++K IG GNF   KL R   T   +A+K I++  +++    + + RE+   + L HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIV+  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH  +
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   K+YDG
Sbjct: 135 IVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 238
              DVWS GV LY ++ G+ PF+     +   +    +L   Y  P Y  +S +C++LL 
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFY--MSTDCENLLK 246

Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLP 265
           R  V N  KR T+ +I    W      
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHE 273

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  324 bits (834), Expect = e-111
 Identities = 86/274 (31%), Positives = 128/274 (46%), Gaps = 15/274 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
             RY   + +G G F     + D  T+E+ A K + +         E +  EI  HRSL 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H ++V F         + +V+E      L E        +E EAR++ +Q++ G  Y H 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKE 175
            ++ HRDLKL N  L+      VKI DFG +       + K  + GTP YIAPEVL+KK 
Sbjct: 134 NRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWS G  +Y +LVG  PFE        ++T  RI    YS P +  ++     
Sbjct: 192 HSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKH--INPVAAS 244

Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRN-LPIEL 268
           L+ ++   +   R TI E+ N  +F    +P  L
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  325 bits (835), Expect = e-111
 Identities = 120/296 (40%), Positives = 169/296 (57%), Gaps = 15/296 (5%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHP 58
            Y I + +G G+FG  KL     T++ +A+KFI R       +   V+REI   + L+HP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           +I++  +V+ TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  +
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRDLK EN LLD +    VKI DFG S      +  K++ G+P Y APEV+  K Y G
Sbjct: 129 IVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 238
              DVWSCG+ LYVMLVG  PF+D   P  F+K    + S  Y  PD+  +S   + L+ 
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLIR 240

Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIH 294
           R+ VA+  +RITI EI+  PWF  NLP  L      Q    ++  + + ++   + 
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADS--RIVSKLGEAMG 294

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  329 bits (846), Expect = e-110
 Identities = 109/299 (36%), Positives = 158/299 (52%), Gaps = 15/299 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-----EHVQREIMNHRSL 55
           +  Y +   +G G FG  K+ + + T   +AVK + R QKI        ++REI N +  
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLF 73

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           +HP+I++  +V+ TP+ + +VMEY +GGELF+ IC  GR  E E+R  FQQ++SGV YCH
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
              + HRDLK EN LLD       KI DFG S         +++ G+P Y APEV++ + 
Sbjct: 134 RHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 191

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y G   D+WS GV LY +L G  PF+D   P  F+K    I    +  P Y  ++     
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQY--LNPSVIS 245

Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIH 294
           LL  +   +  KR TI +I+ H WF ++LP  L       S  + +    L+EV     
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEA-LKEVCEKFE 303

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  323 bits (831), Expect = e-110
 Identities = 86/274 (31%), Positives = 128/274 (46%), Gaps = 15/274 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
             RY   + +G G F     + D  T+E+ A K + +         E +  EI  HRSL 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H ++V F         + +V+E      L E        +E EAR++ +Q++ G  Y H 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKKE 175
            ++ HRDLKL N  L+      VKI DFG +       + K  + GTP YIAPEVL+KK 
Sbjct: 160 NRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           +  +  DVWS G  +Y +LVG  PFE        ++T  RI    YS P +  ++     
Sbjct: 218 HSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKH--INPVAAS 270

Query: 236 LLSRIFVANSEKRITIPEIKNHPWFLRN-LPIEL 268
           L+ ++   +   R TI E+ N  +F    +P  L
Sbjct: 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  317 bits (816), Expect = e-109
 Identities = 82/278 (29%), Positives = 141/278 (50%), Gaps = 15/278 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +++   +G G+F          T   +A+K I++       + + VQ E+  H  LK
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCH 115
           HP+I+          ++ +V+E    GE+   + N    FSE+EAR F  Q+I+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKK 174
           S  I HRDL L N LL  +    +KI DFG +    +  +   T+ GTP YI+PE+ T+ 
Sbjct: 130 SHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            +  + +DVWS G   Y +L+G  PF+        + T+ +++   Y  P +  +S+E K
Sbjct: 188 AHGLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLADYEMPSF--LSIEAK 240

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGG 272
            L+ ++   N   R+++  + +HP+  RN   +  + G
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  317 bits (814), Expect = e-108
 Identities = 80/269 (29%), Positives = 141/269 (52%), Gaps = 14/269 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           ++ ++I + +G G FG   L R+K  + ++A+K + + Q     ++  ++REI     L+
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN L+       +KI DFG+S  +    + ++  GT  Y+ PE++  K +
Sbjct: 133 RKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K  D+W  GV  Y  LVG  PF+ P   +  R+    I++V   FP +  +S   K L
Sbjct: 190 DEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPF--LSDGSKDL 242

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           +S++   +  +R+ +  +  HPW   N  
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR 271

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  316 bits (811), Expect = e-108
 Identities = 88/309 (28%), Positives = 140/309 (45%), Gaps = 24/309 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----KIDEHVQREIMNHRSLKH 57
           +Y +   +G G++G  K V D  T    AVK +++ +       + +V++EI   R L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 58  PNIVRFKEVLL--TPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARFFFQQLISGVSY 113
            N+++  +VL       + +VMEY   G  E+ + +    RF   +A  +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEV 170
            HS  I H+D+K  N LL       +KI   G +++    +     +++ G+PA+  PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 171 LT-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV 229
                 + G   D+WS GVTLY +  G YPFE     K F      I    Y+ P     
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----IGKGSYAIPGD--C 236

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEV 289
                 LL  +      KR +I +I+ H WF +  P          S D  +  +S+  V
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVV 296

Query: 290 LSL--IHEA 296
             L  +H A
Sbjct: 297 PYLEDLHGA 305

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  314 bits (807), Expect = e-107
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 14/269 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q     ++  ++RE+     L+
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL  +    +KI DFG+S      S+     GT  Y+ PE++  + +
Sbjct: 128 KRVIHRDIKPENLLLGSAG--ELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 184

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K  D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 185 DEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDL 237

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           +SR+   N  +R  + E+  HPW   N  
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSS 266

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  313 bits (803), Expect = e-106
 Identities = 104/296 (35%), Positives = 145/296 (48%), Gaps = 47/296 (15%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------------------- 42
           +Y +  +IG G++GV KL  ++      A+K + + + I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 43  -------EHVQREIMNHRSLKHPNIVRFKEVLLTPT--HLAIVMEYAAGGELFERICNAG 93
                  E V +EI   + L HPN+V+  EVL  P   HL +V E    G + E +    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 94  RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS-----K 148
             SED+ARF+FQ LI G+ Y H  +I HRD+K  N L+       +KI DFG S      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGS 190

Query: 149 SSVLHSQPKSTVGTPAYIAPEVL--TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP 206
            ++L     +TVGTPA++APE L  T+K + GK  DVW+ GVTLY  + G  PF D    
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 207 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
               K    I S    FPD   ++ + K L++R+   N E RI +PEIK HPW  R
Sbjct: 247 CLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  306 bits (786), Expect = e-103
 Identities = 83/312 (26%), Positives = 127/312 (40%), Gaps = 26/312 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---------KIDEHVQREIMN 51
            ++Y  +  +GSG FG      DK   + + VKFI++ +              V  EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARFFFQQLISG 110
              ++H NI++  ++        +VME    G +LF  I    R  E  A + F+QL+S 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           V Y     I HRD+K EN ++       +K+ DFG +          +  GT  Y APEV
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 230
           L    Y G   ++WS GVTLY ++    PF + E            +      P    VS
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE----------ETVEAAIHPPYL--VS 248

Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVL 290
            E   L+S +     E+R T+ ++   PW     P+ L +    +   VN P   +    
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWV--TQPVNLADYTWEEVFRVNKPESGVLSAA 306

Query: 291 SLIHEATKPLEA 302
           SL        + 
Sbjct: 307 SLEMGNRSLSDV 318

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  301 bits (773), Expect = e-102
 Identities = 82/283 (28%), Positives = 124/283 (43%), Gaps = 33/283 (11%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH--------VQREIMNHRS 54
           +Y++   +GSG FG             +A+K +E+  +I +         V  E++  + 
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 102

Query: 55  LKH--PNIVRFKEVLLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGV 111
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS---KSSVLHSQPKSTVGTPAYIAP 168
            +CH+  + HRD+K EN L+D +    +K+ DFG     K +V         GT  Y  P
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSPP 217

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
           E +    Y G+ A VWS G+ LY M+ G  PFE  E           I+     F     
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQR-- 265

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR-NLPIELTE 270
           VS EC+HL+          R T  EI+NHPW     LP E  E
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  300 bits (770), Expect = e-101
 Identities = 73/279 (26%), Positives = 109/279 (39%), Gaps = 34/279 (12%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE--------HVQREI----M 50
            Y +   +G G FG          R  +A+K I R  ++              E+     
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLWK 90

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARFFFQQLIS 109
                 HP ++R  +   T     +V+E      +LF+ I   G   E  +R FF Q+++
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS---KSSVLHSQPKSTVGTPAYI 166
            + +CHS  + HRD+K EN L+D       K+ DFG                  GT  Y 
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVYS 205

Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 226
            PE +++ +Y    A VWS G+ LY M+ G  PFE  +           IL     FP +
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELHFPAH 255

Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
             VS +C  L+ R        R ++ EI   PW      
Sbjct: 256 --VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  290 bits (744), Expect = 5e-97
 Identities = 61/318 (19%), Positives = 110/318 (34%), Gaps = 59/318 (18%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------------------KID 42
           +  Y I++ +  G F    L       +  A+K  E+                       
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 43  EHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG--------R 94
           +  + E+     +K+   +  + ++     + I+ EY     + +               
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 95  FSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SS 150
                 +   + +++  SY H+   ICHRD+K  N L+D +   RVK+ DFG S+     
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMVDK 205

Query: 151 VLHSQPKSTVGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF 209
            +      + GT  ++ PE  + +  Y+G   D+WS G+ LYVM     PF       + 
Sbjct: 206 KIK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SL 258

Query: 210 RKTIGRILSVHYSFPDYVR-----------------VSLECKHLLSRIFVANSEKRITIP 252
            +    I + +  +P                     +S E    L      N  +RIT  
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 253 EIKNHPWFLRNLPIELTE 270
           +   H W       +L E
Sbjct: 319 DALKHEWLADTNIEDLRE 336

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  279 bits (716), Expect = 8e-94
 Identities = 93/268 (34%), Positives = 140/268 (52%), Gaps = 10/268 (3%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNI 60
           + Y +   IG G++G  K+   K TR   A K I +    D +  ++EI   +SL HPNI
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +R  E     T + +VME   GGELFER+ +   F E +A    + ++S V+YCH + + 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 121 HRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
           HRDLK EN L    S    +K+ DFG +         ++ VGTP Y++P+VL +  Y G 
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY-GP 186

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLL 237
             D WS GV +YV+L G  PF  P D +   K    I    ++F   D++ VS + + L+
Sbjct: 187 ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESLI 242

Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLP 265
            R+   + ++RIT  +   H WF + L 
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEKQLS 270

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  277 bits (711), Expect = 2e-92
 Identities = 87/274 (31%), Positives = 128/274 (46%), Gaps = 20/274 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---------GQKIDEHVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A+K I +               +V+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 172 TKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYV- 227
                    +  D WS GV L++ L G  PF +     +   +    I S  Y+F   V 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEVW 244

Query: 228 -RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  274 bits (703), Expect = 1e-91
 Identities = 89/265 (33%), Positives = 135/265 (50%), Gaps = 11/265 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +    K T    A K I       +  + ++RE    R L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +   +   +V +   GGELFE I     +SE +A    QQ++  ++YCHS  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 119 ICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HR+LK EN LL   +    VK+ DFG +             GTP Y++PEVL K  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH 235
            K  D+W+CGV LY++LVG  PF D +  + + +    I +  Y +  P++  V+ E K 
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS 240

Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
           L+  +   N +KRIT  +    PW 
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWI 265

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  273 bits (700), Expect = 2e-91
 Identities = 76/267 (28%), Positives = 130/267 (48%), Gaps = 14/267 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEH-VQREIMNHRSLKHPN 59
           + +   + +GSG FG   LV ++ +     +K I + + ++    ++ EI   +SL HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCH 115
           I++  EV     ++ IVME   GGEL ERI          SE       +Q+++ ++Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 116 SMQICHRDLKLENTLLDGSTA-PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           S  + H+DLK EN L   ++    +KI DFG ++         +  GT  Y+APEV  K+
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KR 200

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-VSLEC 233
           +   K  D+WS GV +Y +L G  PF      +  +K          ++    R ++ + 
Sbjct: 201 DVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQA 255

Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWF 260
             LL ++   + E+R +  ++ +H WF
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWF 282

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  273 bits (700), Expect = 5e-91
 Identities = 89/264 (33%), Positives = 138/264 (52%), Gaps = 12/264 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH-VQREIMNHRSLKHPNI 60
           + +  ++ +GSG F    LV+ + T +L A+K I++     +  ++ EI   + +KH NI
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V  +++  + TH  +VM+  +GGELF+RI   G ++E +A    QQ++S V Y H   I 
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 121 HRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKEYDG 178
           HRDLK EN L        ++ I DFG SK  +  +    +  GTP Y+APEVL +K Y  
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY-S 185

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHL 236
           K  D WS GV  Y++L G  PF +  + K F K    I   +Y F  P +  +S   K  
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDF 241

Query: 237 LSRIFVANSEKRITIPEIKNHPWF 260
           +  +   +  +R T  +  +HPW 
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWI 265

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  276 bits (709), Expect = 7e-91
 Identities = 85/273 (31%), Positives = 129/273 (47%), Gaps = 18/273 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---------GQKIDEHVQREIMNH 52
           + Y + K +GSG  G  KL  ++ T + +A++ I +               +V+ EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 172 TKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYV 227
                    +  D WS GV L++ L G  PF +     + +    +I S  Y+F    + 
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QITSGKYNFIPEVWA 370

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            VS +   L+ ++ V + + R T  E   HPW 
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  270 bits (694), Expect = 2e-90
 Identities = 87/272 (31%), Positives = 142/272 (52%), Gaps = 20/272 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-------ERGQKIDEHVQRE--IMNH 52
           + YE+ +++GSG F + +  R K T +  A KFI        R     E ++RE  I+  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
             ++HPNI+   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ GV 
Sbjct: 65  --IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122

Query: 113 YCHSMQICHRDLKLENTLLDGSTAP--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           Y HS +I H DLK EN +L     P  R+K+ DFG +      ++ K+  GTP ++APE+
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVR 228
           +  +   G  AD+WS GV  Y++L GA PF      +        I +V+Y F +  +  
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSN 237

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            S   K  + R+ V + ++R+TI +   H W 
Sbjct: 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  271 bits (695), Expect = 4e-90
 Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 41/305 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPN 59
             + +   +G G        R K T +L A+K        +  +   RE    + L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IVRFKEVL--LTPTHLAIVMEYAAGGELFERIC---NAGRFSEDEARFFFQQLISGVSYC 114
           IV+   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+++ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 115 HSMQICHRDLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
               I HR++K  N +       +   K+ DFG ++      Q  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 173 K--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP 224
           +        K+Y     D+WS GVT Y    G+ PF   E P+  ++ + +I++   S  
Sbjct: 189 RAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 225 DYVR-----------------------VSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
                                      + +    +L+ I  A+ EK     +       +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 262 RNLPI 266
            +   
Sbjct: 308 LHRGN 312

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  269 bits (691), Expect = 9e-90
 Identities = 74/290 (25%), Positives = 114/290 (39%), Gaps = 39/290 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
             +E +  +G G FG     R+       A+K I   ++    +  E+M   SL H  +V
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65

Query: 62  RFKEV-------------LLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARFFFQQL 107
           R+                +   + L I MEY   G L++ I +       DE    F+Q+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS---------------SVL 152
           +  +SY HS  I HRDLK  N  +D S    VKI DFG +K+                  
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT 212
                S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    +  N  K 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK- 239

Query: 213 IGRILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             ++ SV   FP           K ++  +   +  KR     + N  W 
Sbjct: 240 --KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  271 bits (695), Expect = 9e-90
 Identities = 82/317 (25%), Positives = 133/317 (41%), Gaps = 60/317 (18%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID------EHVQREIMNHRSL 55
           ++Y +   IG G++GV ++  +  TR + A+K + + +         E ++ E+   + L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--------------------- 94
            HPNI R  EV     ++ +VME   GG L +++                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 95  -------------------FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST 135
                                E       +Q+ S + Y H+  ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 136 APRVKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVL--TKKEYDGKIADVWSCGV 188
           +  +K+ DFG SK     +        +  GTP ++APEVL  T + Y G   D WS GV
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGV 264

Query: 189 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLSRIFVANSE 246
            L+++L+GA PF    D     +    +L+    F  P+Y  +S   + LLS +   N +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320

Query: 247 KRITIPEIKNHPWFLRN 263
           +R        HPW  + 
Sbjct: 321 ERFDAMRALQHPWISQF 337

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  269 bits (691), Expect = 1e-89
 Identities = 91/285 (31%), Positives = 135/285 (47%), Gaps = 24/285 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI----------ERGQKIDEHVQREIMN 51
           E YE  + +G G   V +    K T +  AVK I          E  Q++ E   +E+  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 52  HRSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
            R +  HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 171 LTKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-- 223
           +     D     GK  D+WS GV +Y +L G+ PF   +     R     I+S +Y F  
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFGS 250

Query: 224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIEL 268
           P++   S   K L+SR  V   +KR T  E   HP+F + +  E+
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  269 bits (691), Expect = 2e-89
 Identities = 93/272 (34%), Positives = 144/272 (52%), Gaps = 20/272 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-------ERGQKIDEHVQRE--IMNH 52
           + Y+  +++GSG F V K  R+K T    A KFI        R     E ++RE  I+  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
             ++HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV 
Sbjct: 71  --IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128

Query: 113 YCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           Y HS+QI H DLK EN +L       PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVR 228
           +  +   G  AD+WS GV  Y++L GA PF      +        + +V+Y F D  +  
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSN 243

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            S   K  + R+ V + +KR+TI +   HPW 
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  268 bits (688), Expect = 4e-89
 Identities = 61/278 (21%), Positives = 112/278 (40%), Gaps = 26/278 (9%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKH 57
              Y I+K IGSG       V ++  +++ A+K++   +  +   +  + EI     L+ 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 58  PN--IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            +  I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLT 172
              I H DLK  N L+       +K+ DFG +             S VGT  Y+ PE + 
Sbjct: 145 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 173 KKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS 222
                             +DVWS G  LY M  G  PF+   +       +  I+  ++ 
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHE 258

Query: 223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                    + + +L      + ++RI+IPE+  HP+ 
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  267 bits (685), Expect = 5e-89
 Identities = 97/269 (36%), Positives = 141/269 (52%), Gaps = 14/269 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHP 58
           ERY IV  +G G+FG     +D+ T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NI++  E+L   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 119 ICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           I HRDLK EN LL+        +KI DFG S     +++ K  +GT  YIAPEVL +  Y
Sbjct: 142 IVHRDLKPENILLESKEKDCD-IKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK 234
           D K  DVWS GV LY++L G  PF    +    ++    + +  Y+F  P +  +S + K
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRN 263
            L+ ++   +   RIT  +   HPW  + 
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  268 bits (688), Expect = 6e-89
 Identities = 88/272 (32%), Positives = 138/272 (50%), Gaps = 20/272 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-------ERGQKIDEHVQRE--IMNH 52
           + Y+I +++GSG F + K  R+K T    A KFI        R     E ++RE  I+  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
             + H N++   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+
Sbjct: 72  --VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129

Query: 113 YCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           Y H+ +I H DLK EN +L       P +K+ DFG +       + K+  GTP ++APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVR 228
           +  +   G  AD+WS GV  Y++L GA PF      +        I SV Y F +  +  
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSH 244

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            S   K  + ++ V  + KR+TI E   HPW 
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  269 bits (690), Expect = 1e-88
 Identities = 90/265 (33%), Positives = 136/265 (51%), Gaps = 11/265 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KID-EHVQREIMNHRSLKHP 58
           + Y++ +++G G F V +    K T    A K I   +    D + ++RE    R L+HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +   +   +V +   GGELFE I     +SE +A    QQ++  ++YCHS  
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148

Query: 119 ICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HR+LK EN LL   +    VK+ DFG +             GTP Y++PEVL K  Y 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 207

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH 235
            K  D+W+CGV LY++LVG  PF D +  + + +    I +  Y +  P++  V+ E K 
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS 263

Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
           L+  +   N +KRIT  +    PW 
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWI 288

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  269 bits (689), Expect = 1e-88
 Identities = 80/276 (28%), Positives = 127/276 (46%), Gaps = 23/276 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---------GQKIDEHVQREIMNH 52
           ++Y+    IG G   V +    + T    AVK +E           +++ E  +RE    
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 53  RSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
           R +  HP+I+   +   + + + +V +    GELF+ +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           S+ H+  I HRDLK EN LLD +    +++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

Query: 172 TKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 226
                +     GK  D+W+CGV L+ +L G+ PF         R     I+   Y F   
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSP 327

Query: 227 V--RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                S   K L+SR+   + E R+T  +   HP+F
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  268 bits (687), Expect = 2e-88
 Identities = 89/272 (32%), Positives = 140/272 (51%), Gaps = 20/272 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-------ERGQKIDEHVQRE--IMNH 52
           + Y+I +++GSG F + K  R+K T    A KFI        R     E ++RE  I+  
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
             + HPNI+   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+
Sbjct: 72  --VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129

Query: 113 YCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           Y H+ +I H DLK EN +L       P +K+ DFG +       + K+  GTP ++APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVR 228
           +  +   G  AD+WS GV  Y++L GA PF      +        I +V Y F +  + +
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQ 244

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            S   K  + ++ V  + KR+TI E   HPW 
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  266 bits (682), Expect = 5e-88
 Identities = 68/264 (25%), Positives = 121/264 (45%), Gaps = 12/264 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQRE--IMNHRSLKHPN 59
           E+Y I +D+G G FG+     +  +++    KF++        V++E  I+N    +H N
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNI--ARHRN 62

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ 118
           I+   E   +   L ++ E+ +G ++FERI  +    +E E   +  Q+   + + HS  
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I H D++ EN +     +  +KI +FG ++        +     P Y APEV        
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-S 181

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHL 236
              D+WS G  +YV+L G  PF    + +        I++  Y+F +  +  +S+E    
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDF 237

Query: 237 LSRIFVANSEKRITIPEIKNHPWF 260
           + R+ V   + R+T  E   HPW 
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWL 261

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  266 bits (683), Expect = 6e-88
 Identities = 88/266 (33%), Positives = 128/266 (48%), Gaps = 13/266 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQRE--IMNHRSLKHPN 59
           + YE+ +DIG G++ V K    K T    AVK I+   K       E  I+  R  +HPN
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTEEIEIL-LRYGQHPN 77

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           I+  K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  +
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 120 CHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEY 176
            HRDLK  N L   +      ++ICDFG++K     +    T   T  ++APEVL ++ Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECK 234
           D    D+WS GV LY ML G  PF +  D     + + RI S  +S        VS   K
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAK 255

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWF 260
            L+S++   +  +R+T   +  HPW 
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWI 281

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  266 bits (682), Expect = 8e-88
 Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 26/277 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKHP 58
             Y I+K IGSG       V ++  +++ A+K++   +  +   +  + EI     L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 59  N--IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           +  I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTK 173
             I H DLK  N L+       +K+ DFG +             S VGT  Y+ PE +  
Sbjct: 127 HGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 174 KEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF 223
                            +DVWS G  LY M  G  PF+   +  +    +  I+  ++  
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI 240

Query: 224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                   + + +L      + ++RI+IPE+  HP+ 
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  269 bits (689), Expect = 5e-87
 Identities = 105/329 (31%), Positives = 155/329 (47%), Gaps = 28/329 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHP 58
           E Y+ VK +GSG +G   L RDK T    A+K I +       +  +  E+   + L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SGV+Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 119 ICHRDLKLENTLLDGSTAP--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           I HRDLK EN LL+ S      +KI DFG S       + K  +GT  YIAPEVL +K+Y
Sbjct: 157 IVHRDLKPENLLLE-SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKY 214

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECK 234
           D K  DVWS GV L+++L G  PF    D +  RK    +    Y+F       VS   K
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEGAK 269

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIH 294
            L+ ++   +S++RI+  +   HPW                  +      SL   +  + 
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIKEMC----------SKKESGIELPSLANAIENMR 319

Query: 295 E--ATKPL--EAPRVGGHLLGSSMELDDL 319
           +   ++ L   A       L S  E  +L
Sbjct: 320 KFQNSQKLAQAALLYMASKLTSQEETKEL 348

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  269 bits (689), Expect = 5e-87
 Identities = 97/269 (36%), Positives = 140/269 (52%), Gaps = 14/269 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHP 58
           ERY IV  +G G+FG     +D+ T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NI++  E+L   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 119 ICHRDLKLENTLLDGSTAP--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           I HRDLK EN LL+ S      +KI DFG S     +++ K  +GT  YIAPEVL +  Y
Sbjct: 142 IVHRDLKPENILLE-SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLECK 234
           D K  DVWS GV LY++L G  PF    +    ++    + +  Y+F       +S + K
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRN 263
            L+ ++   +   RIT  +   HPW  + 
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  264 bits (676), Expect = 8e-87
 Identities = 93/263 (35%), Positives = 141/263 (53%), Gaps = 10/263 (3%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           + +E+  ++G G   +    + K T++  A+K +++     + V+ EI     L HPNI+
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNII 111

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
           + KE+  TPT +++V+E   GGELF+RI   G +SE +A    +Q++  V+Y H   I H
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171

Query: 122 RDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           RDLK EN L    +    +KI DFG SK        K+  GTP Y APE+L    Y G  
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPE 230

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYSF--PDYVRVSLECKHLL 237
            D+WS G+  Y++L G  PF D    +  FR+    IL+  Y F  P +  VSL  K L+
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQFMFRR----ILNCEYYFISPWWDEVSLNAKDLV 286

Query: 238 SRIFVANSEKRITIPEIKNHPWF 260
            ++ V + +KR+T  +   HPW 
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWV 309

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  268 bits (687), Expect = 8e-87
 Identities = 96/267 (35%), Positives = 139/267 (52%), Gaps = 15/267 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKID-EHVQREIMNHRSLKH 57
           +RY+  + +G G+FG   L +DK T +  AVK I +    QK D E + RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 118 QICHRDLKLENTLLDGSTAP--RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           +I HRDLK EN LL+ S +    ++I DFG S       + K  +GT  YIAPEVL    
Sbjct: 146 KIVHRDLKPENLLLE-SKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGT 203

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLEC 233
           YD K  DVWS GV LY++L G  PF    +    +K    +    Y+F      +VS   
Sbjct: 204 YDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKK----VEKGKYTFELPQWKKVSESA 258

Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWF 260
           K L+ ++       RI+  +  +H W 
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWI 285

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  263 bits (674), Expect = 8e-87
 Identities = 90/270 (33%), Positives = 139/270 (51%), Gaps = 14/270 (5%)

Query: 2   ERYEI---VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-H 57
           + Y++    K +G G+F + +    K + +  AVK I +  +++ + Q+EI   +  + H
Sbjct: 8   QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGH 65

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PNIV+  EV     H  +VME   GGELFERI     FSE EA +  ++L+S VS+ H +
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 118 QICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKE 175
            + HRDLK EN L  D +    +KI DFG+++     +QP  T   T  Y APE+L +  
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG---RILSVHYSFPDYV--RVS 230
           YD +  D+WS GV LY ML G  PF+  +        +    +I    +SF       VS
Sbjct: 186 YD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244

Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            E K L+  +   +  KR+ +  ++ + W 
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  265 bits (678), Expect = 1e-86
 Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 26/283 (9%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKH 57
              Y I+K IGSG       V ++  +++ A+K++   +  +   +  + EI     L+ 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 58  PN--IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            +  I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLT 172
              I H DLK  N L+       +K+ DFG +      +      S VG   Y+ PE + 
Sbjct: 173 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 173 KKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS 222
                             +DVWS G  LY M  G  PF+   +  +    I    +    
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIE 288

Query: 223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           FPD      + + +L      + ++RI+IPE+  HP+      
Sbjct: 289 FPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  265 bits (678), Expect = 1e-86
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 13/265 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQRE--IMNHRSLKHP 58
           + Y+I++++GSG FGV     +K T  +   KFI     +D   V+ E  IMN   L HP
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ--LHHP 108

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSM 117
            ++   +       + +++E+ +GGELF+RI     + SE E   + +Q   G+ + H  
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
            I H D+K EN + +   A  VKI DFG +         K T  T  + APE++ ++   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV- 227

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKH 235
           G   D+W+ GV  YV+L G  PF   +D +  +     +    + F +  +  VS E K 
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKD 283

Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
            +  +      KR+T+ +   HPW 
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEHPWL 308

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  262 bits (672), Expect = 7e-86
 Identities = 85/267 (31%), Positives = 129/267 (48%), Gaps = 15/267 (5%)

Query: 2   ERYEIVK--DIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQRE--IMNHRSLK 56
             Y + K   +G G FG      +  T   LA K I+ RG K  E V+ E  +MN   L 
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ--LD 144

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCH 115
           H N+++  +   +   + +VMEY  GGELF+RI +     +E +   F +Q+  G+ + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
            M I H DLK EN L     A ++KI DFG ++      + K   GTP ++APEV+   +
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYD 263

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLEC 233
           +     D+WS GV  Y++L G  PF    D +        IL+  +   D  +  +S E 
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN----ILACRWDLEDEEFQDISEEA 319

Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWF 260
           K  +S++ +     RI+  E   HPW 
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWL 346

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  268 bits (686), Expect = 1e-85
 Identities = 79/265 (29%), Positives = 132/265 (49%), Gaps = 13/265 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQRE--IMNHRSLKHP 58
           + Y+I +++G+G FGV   V ++ T    A KF+    + D E V++E   M+   L+HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV--LRHP 214

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM 117
            +V   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G+ + H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
              H DLK EN +     +  +K+ DFG +         K T GT  + APEV   K   
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV- 333

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKH 235
           G   D+WS GV  Y++L G  PF    D +  R     + S  ++  D  +  +S + K 
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKD 389

Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
            + ++ +A+   R+TI +   HPW 
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWL 414

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  264 bits (677), Expect = 1e-85
 Identities = 93/267 (34%), Positives = 137/267 (51%), Gaps = 14/267 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKHP 58
           E Y++ +++G G F V +        +  A   I   +      + ++RE    R LKHP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NIVR  + +    H  ++ +   GGELFE I     +SE +A    QQ++  V +CH M 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 119 ICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKE 175
           + HR+LK EN LL      A  VK+ DFG +       Q      GTP Y++PEVL K  
Sbjct: 131 VVHRNLKPENLLLASKLKGAA-VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLEC 233
           Y GK  D+W+CGV LY++LVG  PF D +  + +++    I +  Y F  P++  V+ E 
Sbjct: 190 Y-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEA 244

Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWF 260
           K L++++   N  KRIT  E   HPW 
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWI 271

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  262 bits (672), Expect = 1e-85
 Identities = 62/305 (20%), Positives = 113/305 (37%), Gaps = 41/305 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPN 59
             + +   +G G        R K T +L A+K        +  +   RE    + L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IVRFKEVL--LTPTHLAIVMEYAAGGELFERIC---NAGRFSEDEARFFFQQLISGVSYC 114
           IV+   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+++ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 115 HSMQICHRDLKLENTLLDGSTAPR--VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
               I HR++K  N +       +   K+ DFG ++      Q  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 173 K--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP 224
           +        K+Y     D+WS GVT Y    G+ PF   E P+  ++ + +I++   S  
Sbjct: 189 RAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 225 DYVR-----------------------VSLECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
                                      + +    +L+ I  A+ EK     +       +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 262 RNLPI 266
            +  +
Sbjct: 308 LHRMV 312

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  259 bits (665), Expect = 2e-85
 Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 19/271 (7%)

Query: 2   ERYEIV-KDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQRE--IMNHRSL 55
             Y +  K++G G F V +    K T +  A KF++   RGQ     +  E  ++     
Sbjct: 28  NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL--A 85

Query: 56  KH-PNIVRFKEVLLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVS 112
           K  P ++   EV    + + +++EYAAGGE+F       A   SE++     +Q++ GV 
Sbjct: 86  KSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145

Query: 113 YCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y H   I H DLK +N LL        +KI DFG S+      + +  +GTP Y+APE+L
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL 205

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRV 229
                     D+W+ G+  Y++L    PF   ++ + +      I  V+  + +  +  V
Sbjct: 206 NYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSV 260

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           S      +  + V N EKR T     +H W 
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  265 bits (678), Expect = 3e-85
 Identities = 95/277 (34%), Positives = 139/277 (50%), Gaps = 25/277 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--------------GQKIDEHVQR 47
           E Y  V+ +GSG +G   L ++K      A+K I++               +K  E +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 48  EIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQL 107
           EI   +SL HPNI++  +V     +  +V E+  GGELFE+I N  +F E +A    +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAP--RVKICDFGYSKSSVLHSQPKSTVGTPAY 165
           +SG+ Y H   I HRD+K EN LL+ +      +KI DFG S       + +  +GT  Y
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLE-NKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214

Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD 225
           IAPEVL KK+Y+ K  DVWSCGV +Y++L G  PF      +N +  I ++    Y F  
Sbjct: 215 IAPEVL-KKKYNEK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKYYFDF 268

Query: 226 YV--RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                +S E K L+  +   +  KR T  E  N  W 
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  269 bits (689), Expect = 4e-85
 Identities = 75/288 (26%), Positives = 114/288 (39%), Gaps = 31/288 (10%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKIDEHVQREIMNHRSLKHPNI 60
            +E+ + +G+G FG       + T E +A+K   +    K  E    EI   + L HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 61  VRFKEVLLTPTHLA------IVMEYAAGGELFERIC---NAGRFSEDEARFFFQQLISGV 111
           V  +EV      LA      + MEY  GG+L + +    N     E   R     + S +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 112 SYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
            Y H  +I HRDLK EN +L         KI D GY+K           VGT  Y+APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI----------GRILSVH 220
           L +K+Y     D WS G   +  + G  PF     P  +   +             L+  
Sbjct: 195 LEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253

Query: 221 YSFPDYVRV--------SLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             F   +          + + +  L  + + +  +R T P+  N   F
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  258 bits (661), Expect = 1e-84
 Identities = 84/274 (30%), Positives = 129/274 (47%), Gaps = 22/274 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE------RGQKIDEHVQREIMNHRSL 55
           + YE+ + IG G F V +   ++ T +  AVK ++            E ++RE      L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGV 111
           KHP+IV   E   +   L +V E+  G +L   I         +SE  A  + +Q++  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 112 SYCHSMQICHRDLKLENTLLDG--STAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAP 168
            YCH   I HRD+K    LL    ++AP VK+  FG +             VGTP ++AP
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDY 226
           EV+ ++ Y GK  DVW CGV L+++L G  PF      + F      I+   Y      +
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYG-TKERLFEG----IIKGKYKMNPRQW 256

Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             +S   K L+ R+ + +  +RIT+ E  NHPW 
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  250 bits (640), Expect = 7e-82
 Identities = 78/294 (26%), Positives = 122/294 (41%), Gaps = 31/294 (10%)

Query: 2   ERYEIVKD-IGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLK-HP 58
           + Y++ +D +G G     +   +  T +  AVK IE+        V RE+      + H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           N++   E         +V E   GG +   I     F+E EA    Q + S + + H+  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 119 ICHRDLKLENTLLD--GSTAPRVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAP 168
           I HRDLK EN L +     +P VKICDF            S +   +  +  G+  Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 169 EVLTKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG---------- 214
           EV+     +     K  D+WS GV LY++L G  PF                        
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250

Query: 215 -RILSVHYSFPDYV--RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
             I    Y FPD     +S   K L+S++ V ++++R++  ++  HPW     P
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  253 bits (647), Expect = 7e-82
 Identities = 92/271 (33%), Positives = 137/271 (50%), Gaps = 18/271 (6%)

Query: 2   ERYEIV-KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-MNHRSLKHPN 59
           + Y++  + +G G  G    + +K T+E  A+K ++   K     +RE+ ++ R+ + P+
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPH 116

Query: 60  IVRFKEV----LLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSY 113
           IVR  +V          L IVME   GGELF RI + G   F+E EA    + +   + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 114 CHSMQICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
            HS+ I HRD+K EN L       A  +K+ DFG++K +  H+   +   TP Y+APEVL
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAI-LKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RV 229
             ++YD K  D+WS GV +Y++L G  PF              RI    Y FP+     V
Sbjct: 236 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           S E K L+  +      +R+TI E  NHPW 
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  250 bits (641), Expect = 1e-81
 Identities = 83/271 (30%), Positives = 128/271 (47%), Gaps = 19/271 (7%)

Query: 2   ERYEIVKD-IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPN 59
           + Y++ K  +G G  G       + T +  A+K +    K     ++E+ +H ++   P+
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPH 83

Query: 60  IVRFKEVLLTPTHLA----IVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSY 113
           IV   +V     H      I+ME   GGELF RI   G   F+E EA    + + + + +
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 114 CHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL 171
            HS  I HRD+K EN L         +K+ DFG++K         ++   TP Y+APEVL
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVL 201

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RV 229
             ++YD K  D+WS GV +Y++L G  PF              RI    Y FP+     V
Sbjct: 202 GPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           S + K L+  +   +  +R+TI +  NHPW 
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  248 bits (635), Expect = 5e-81
 Identities = 65/283 (22%), Positives = 107/283 (37%), Gaps = 26/283 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNI 60
           + Y  ++ +G G F    LV         A+K I   ++ D E  QRE   HR   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 61  VRFKEVLLTPT----HLAIVMEYAAGGELFERI----CNAGRFSEDEARFFFQQLISGVS 112
           +R     L          +++ +   G L+  I          +ED+  +    +  G+ 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----------VGT 162
             H+    HRDLK  N LL      +  + D G    + +H +                T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 163 PAYIAPEVLTKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH 220
            +Y APE+ + + +    +  DVWS G  LY M+ G  P++      +        +   
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA---LAVQNQ 263

Query: 221 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
            S P   R S     LL+ +   +  +R  IP + +    L+ 
Sbjct: 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  247 bits (633), Expect = 2e-80
 Identities = 78/276 (28%), Positives = 138/276 (50%), Gaps = 14/276 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKH 57
           ME+Y  ++ IG G+FG A LV+         +K I   +      E  +RE+    ++KH
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCH 115
           PNIV+++E       L IVM+Y  GG+LF+RI       F ED+   +F Q+   + + H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKK 174
             +I HRD+K +N  L       V++ DFG ++  +      ++ +GTP Y++PE+   K
Sbjct: 143 DRKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            Y+ K +D+W+ G  LY +    + FE      + +  + +I+S  +  P  +  S + +
Sbjct: 201 PYNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFP-PVSLHYSYDLR 254

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTE 270
            L+S++F  N   R ++  I    +  + +   L+ 
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  244 bits (625), Expect = 4e-80
 Identities = 83/279 (29%), Positives = 132/279 (47%), Gaps = 23/279 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKH 57
            E YE++  IG+G++G  + +R K   ++L  K ++ G   +   + +  E+   R LKH
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 58  PNIVRFKE--VLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGV 111
           PNIVR+ +  +  T T L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 112 SYCHSM-----QICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAY 165
             CH        + HRDLK  N  LDG     VK+ DFG ++  +   S  K+ VGTP Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 166 IAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD 225
           ++PE + +  Y+ K +D+WS G  LY +     PF       + ++  G+I    +    
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFR-RI 236

Query: 226 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 264
             R S E   +++R+       R ++ EI  +P  L + 
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  239 bits (611), Expect = 6e-78
 Identities = 66/283 (23%), Positives = 111/283 (39%), Gaps = 34/283 (12%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
              ++ ++ IGSG FG     + +   +   +K ++     +E  +RE+     L H NI
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAEREVKALAKLDHVNI 66

Query: 61  VRFKE----------------VLLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARF 102
           V +                         L I ME+   G L + I      +  +  A  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT 162
            F+Q+  GV Y HS ++ +RDLK  N  L  +   +VKI DFG   S     +   + GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS 222
             Y++PE ++ ++Y  +  D+++ G+ L  +L         E  K F      I+S  + 
Sbjct: 185 LRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTA--FETSKFFTDLRDGIISDIFD 241

Query: 223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
                    + K LL ++     E R    EI       +  P
Sbjct: 242 K--------KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  237 bits (607), Expect = 1e-76
 Identities = 69/292 (23%), Positives = 115/292 (39%), Gaps = 39/292 (13%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLK-HPNI 60
           R  + + +  G F      +D  +    A+K +   ++     + +E+   + L  HPNI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 61  VRF-------KEVLLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARFFFQQLISG 110
           V+F       KE   T     +++     G+L E +      G  S D     F Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 111 VSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--------- 159
           V + H  +  I HRDLK+EN LL       +K+CDFG + +   +     +         
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 160 ----VGTPAYIAPEV--LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI 213
                 TP Y  PE+  L      G+  D+W+ G  LY++    +PFED           
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AK 258

Query: 214 GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
            RI++  YS P +         L+  +   N E+R++I E+ +    +    
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  228 bits (583), Expect = 2e-73
 Identities = 82/271 (30%), Positives = 119/271 (43%), Gaps = 34/271 (12%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +     + +G G  G    + +K T+E  A+K ++   K    V+  +   R+ + P+IV
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE--LH-WRASQCPHIV 74

Query: 62  RFKEV----LLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCH 115
           R  +V          L IVME   GGELF RI + G   F+E EA    + +   + Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 116 SMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           S+ I HRD+K EN L         +K+ DFG                     A E   +K
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETTGEK 174

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV--RVSLE 232
            YD K  D+WS GV +Y++L G  PF              RI    Y FP+     VS E
Sbjct: 175 -YD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 232

Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
            K L+  +      +R+TI E  NHPW +++
Sbjct: 233 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  227 bits (582), Expect = 3e-73
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 14/274 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN----HRSLK 56
           +  + I K IG G F              +A+K ++    +D   + + +      + L 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVS 112
           HPN++++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVL 171
           + HS ++ HRD+K  N  +  +    VK+ D G  +  S   +   S VGTP Y++PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
            +  Y+ K +D+WS G  LY M     PF    D  N      +I    Y        S 
Sbjct: 209 HENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           E + L++     + EKR  +  + +    +    
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  225 bits (576), Expect = 2e-72
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 17/265 (6%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSL-K 56
            + ++ +  +G G++G    VR K    L AVK      RG K       E+ +H  + +
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCH 115
           HP  VR ++       L +  E   G  L +     G    E +   + +  +  +++ H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           S  + H D+K  N  L      R K+ DFG           +   G P Y+APE+L    
Sbjct: 175 SQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS- 231

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y    ADV+S G+T+  +          E  +  R+       +   F     +S E + 
Sbjct: 232 YGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGY-----LPPEFTAG--LSSELRS 283

Query: 236 LLSRIFVANSEKRITIPEIKNHPWF 260
           +L  +   + + R T   +   P  
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVL 308

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  221 bits (565), Expect = 1e-70
 Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 28/273 (10%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVK-----FIERGQKIDEHVQRE--IMNHRSLK 56
           ++  K +G G+F    L R+  T    A+K      I +  K+  +V RE  +M+   L 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV-PYVTRERDVMS--RLD 88

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLTK 173
             I HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+LT+
Sbjct: 149 KGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           K    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ + Y FP+      + 
Sbjct: 207 KSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPEK--FFPKA 259

Query: 234 KHLLSRIFVANSEKRITIP------EIKNHPWF 260
           + L+ ++ V ++ KR+          +K HP+F
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  217 bits (556), Expect = 2e-69
 Identities = 63/290 (21%), Positives = 109/290 (37%), Gaps = 40/290 (13%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHP 58
           +  +E ++ +G G FGV    ++K      A+K I     +   E V RE+     L+HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 59  NIVRFKEVLLT------------PTHLAIVMEYAAGGELFERI---CNAGRFSEDEARFF 103
            IVR+    L               +L I M+      L + +   C             
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-------------SS 150
           F Q+   V + HS  + HRDLK  N          VK+ DFG                  
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 151 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFR 210
             +++    VGT  Y++PE +    Y  K  D++S G+ L+ +L   YPF    +     
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV--- 234

Query: 211 KTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           +T+  + ++ +  P + +       ++  +   +  +R     I  +  F
Sbjct: 235 RTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  221 bits (566), Expect = 2e-69
 Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 46/295 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMN-HRSLKHPNI 60
                 K +G G+ G     +  +    +AVK +       +    EI     S  HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSED-------EARFFFQQLISGVSY 113
           +R+     T   L I +E      L + + +     E+             +Q+ SGV++
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 114 CHSMQICHRDLKLENTLLDGSTAP-----------RVKICDFGYSK-----SSVLHSQPK 157
            HS++I HRDLK +N L+  S+             R+ I DFG  K      S   +   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 158 STVGTPAYIAPEVLTKKEYD------GKIADVWSCGVTLYVMLVGAY-PFEDPEDPKNFR 210
           +  GT  + APE+L +           +  D++S G   Y +L     PF D        
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245

Query: 211 KTIGRILSVHYSFPDYVR-----VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                I+   +S  +        +  E   L+S++   +  KR T  ++  HP F
Sbjct: 246 -RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  214 bits (547), Expect = 2e-66
 Identities = 59/271 (21%), Positives = 99/271 (36%), Gaps = 21/271 (7%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIV 61
            +     +G G  G     R  +    +AVK I    +      RE+   R   +HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQIC 120
           R+           I +E      L E +          E     QQ  SG+++ HS+ I 
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 121 HRDLKLENTLL---DGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL-- 171
           HRDLK  N L+   +     +  I DFG  K         S+     GT  +IAPE+L  
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 172 -TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR-V 229
             K+       D++S G   Y ++            +     +G             +  
Sbjct: 201 DCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA---CSLDCLHPEKHE 256

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            +  + L+ ++   + +KR +   +  HP+F
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  207 bits (529), Expect = 2e-64
 Identities = 37/305 (12%), Positives = 75/305 (24%), Gaps = 62/305 (20%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK-- 56
                  +G  +        D+ T E   V      ++      + ++ E++  R L+  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 57  -----------------------HPNIVRFKEVLLTPTHLAIVMEYAA--------GGEL 85
                                     ++R +        L+    Y          G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 86  FERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG 145
                               Q+I  ++  H   + H  L+  + +LD      V +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFLTGFE 251

Query: 146 YSKSSVLHSQPKSTVGTPAYIAPEVLT----------KKEYDGKIADVWSCGVTLYVMLV 195
                V       +  +  +  PE+            ++       D W+ G+ +Y +  
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 196 GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 255
              P                I     + P         + LL        E R+   +  
Sbjct: 309 ADLPITKDAALGGSEW----IFRSCKNIPQ------PVRALLEGFLRYPKEDRLLPLQAM 358

Query: 256 NHPWF 260
             P +
Sbjct: 359 ETPEY 363

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  207 bits (529), Expect = 2e-64
 Identities = 69/271 (25%), Positives = 131/271 (48%), Gaps = 20/271 (7%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQRE--IMNHRS 54
            + +EI++ IG G+FG   +V+   T+++ A+K++ + + ++     +V +E  IM    
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG-- 71

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           L+HP +V           + +V++   GG+L   +     F E+  + F  +L+  + Y 
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131

Query: 115 HSMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
            + +I HRD+K +N LLD  G     V I DF  +      +Q  +  GT  Y+APE+ +
Sbjct: 132 QNQRIIHRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187

Query: 173 KKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 230
            ++  G     D WS GVT Y +L G  P+       + ++ +    +   ++P     S
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI-RSSTSSKEIVHTFETTVVTYPSA--WS 244

Query: 231 LECKHLLSRIFVANSEKRI-TIPEIKNHPWF 260
            E   LL ++   N ++R   + +++N P+ 
Sbjct: 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  204 bits (522), Expect = 1e-63
 Identities = 84/269 (31%), Positives = 142/269 (52%), Gaps = 20/269 (7%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K   +  +  +  GTP  +APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGY 215

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
             K  D W+ GV +Y M  G  PF   +  + + K    I+S    FP +   S + K L
Sbjct: 216 -NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKDL 268

Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  203 bits (518), Expect = 2e-63
 Identities = 88/271 (32%), Positives = 140/271 (51%), Gaps = 24/271 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++ ++I++ +G+G+FG   L+R +      A+K +++   +     EH   E +    + 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y HS
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 117 MQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
             I +RDLK EN LLD  G     +KI DFG++K   +     +  GTP YIAPEV++ K
Sbjct: 125 KDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTK 178

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            Y  K  D WS G+ +Y ML G  PF D  +     KT  +IL+    FP +   + + K
Sbjct: 179 PY-NKSIDWWSFGILIYEMLAGYTPFYD-SNTM---KTYEKILNAELRFPPF--FNEDVK 231

Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            LLSR+   +  +R+        ++KNHPWF
Sbjct: 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  202 bits (516), Expect = 4e-63
 Identities = 84/275 (30%), Positives = 141/275 (51%), Gaps = 27/275 (9%)

Query: 1   MERYEIVKDIGSGNFGVAKLVR---DKWTRELLAVKFIERGQKIDEHVQREIMNHR---- 53
             ++E++K +G G+FG   LV+       R+L A+K + +   +    +      R    
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILV 81

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
            + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   + +
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 114 CHSMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 170
            HS+ I +RDLK EN LLD  G     +K+ DFG SK S+ H +   +  GT  Y+APEV
Sbjct: 142 LHSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 230
           + ++ +  + AD WS GV ++ ML G  PF+     K+ ++T+  IL      P +  +S
Sbjct: 198 VNRRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LS 250

Query: 231 LECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            E + LL  +F  N   R+      + EIK H +F
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  201 bits (514), Expect = 3e-62
 Identities = 89/272 (32%), Positives = 131/272 (48%), Gaps = 23/272 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR-----SL 55
              +  +K IG G+FG   L R K      AVK +++   + +  ++ IM+ R     ++
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           KHP +V       T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y H
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156

Query: 116 SMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLT 172
           S+ I +RDLK EN LLD  G     + + DFG  K ++ H+   ST  GTP Y+APEVL 
Sbjct: 157 SLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           K+ Y  +  D W  G  LY ML G  PF      +N  +    IL+          ++  
Sbjct: 213 KQPY-DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKPN--ITNS 265

Query: 233 CKHLLSRIFVANSEKRITIP----EIKNHPWF 260
            +HLL  +   +  KR+       EIK+H +F
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  200 bits (511), Expect = 5e-62
 Identities = 89/270 (32%), Positives = 137/270 (50%), Gaps = 22/270 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQRE--IMNHRS 54
           +E + + K +G G+FG   L   K T +  A+K +++   +     E    E  +++  +
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS-LA 74

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
            +HP +        T  +L  VMEY  GG+L   I +  +F    A F+  ++I G+ + 
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134

Query: 115 HSMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 171
           HS  I +RDLKL+N LLD  G     +KI DFG  K ++L     +T  GTP YIAPE+L
Sbjct: 135 HSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 190

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
             ++Y     D WS GV LY ML+G  PF   ++ + F      I   +  +P +  +  
Sbjct: 191 LGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW--LEK 243

Query: 232 ECKHLLSRIFVANSEKRI-TIPEIKNHPWF 260
           E K LL ++FV   EKR+    +I+ HP F
Sbjct: 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  201 bits (511), Expect = 6e-62
 Identities = 43/300 (14%), Positives = 85/300 (28%), Gaps = 44/300 (14%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLKHP 58
           + ++V+ +  G+  V  LVRD    E  A+K    G +      E +         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 59  NIVRFKEVL--------------------------LTPTHLAIVMEYAAG------GELF 86
           +    ++                                +  ++M  A+         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 87  ERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY 146
                 G            QLI   +   S  + H     +N  +      R+ + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG--RLMLGDVSA 240

Query: 147 SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPED 205
                + ++  ++     Y   E L           + W  G+++Y +     PF     
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 206 PKNF---RKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
                  R ++    +   +F     +    K L+ R    +  +R+   E    P FL+
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  199 bits (508), Expect = 2e-61
 Identities = 48/300 (16%), Positives = 99/300 (33%), Gaps = 43/300 (14%)

Query: 2   ERYEIVKDIGSGNFGVAKLVR-----DKWTRELLAVKFIERGQKIDEHVQREIMN-HRSL 55
           +   +   +G G F            D   ++   +K  +     + ++  ++M   +  
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-----NAGRFSEDEARFFFQQLISG 110
                ++F    L      +V E  + G L   I            +     F  +++  
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPR---------VKICDFGYSKSSVLHSQPKSTV- 160
           +   H  +I H D+K +N +L      +         + + D G S    +   PK T+ 
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGTIF 242

Query: 161 ----GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR- 215
                T  +   E+L+ K ++ +I D +    T+Y ML G Y     E  +   + + R 
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

Query: 216 ---------ILSVHYSFPDYVRVSL--ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 264
                       V  + PD   +      +  L ++F  +   +I       +   +  L
Sbjct: 302 LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI---RALRNRLIVLLL 358

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  198 bits (506), Expect = 2e-61
 Identities = 89/272 (32%), Positives = 132/272 (48%), Gaps = 23/272 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQREIMNHRS 54
           M  ++ +K +G G FG   LVR+K T    A+K       I + +    H   E    ++
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV--AHTVTESRVLQN 61

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
            +HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTK 173
           HS  + +RD+KLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
            +Y G+  D W  GV +Y M+ G  PF + +  + F      IL     FP    +S E 
Sbjct: 180 NDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--LSPEA 232

Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           K LL+ +   + ++R+        E+  H +F
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  198 bits (505), Expect = 2e-61
 Identities = 89/278 (32%), Positives = 137/278 (49%), Gaps = 31/278 (11%)

Query: 1   MERYEIVKDIGSGNFGVAKLVR---DKWTRELLAVK-----FIERGQKIDEHVQ--REIM 50
            E +E+++ +G G +G    VR      T ++ A+K      I R  K   H +  R I+
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
               +KHP IV       T   L +++EY +GGELF ++   G F ED A F+  ++   
Sbjct: 76  E--EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133

Query: 111 VSYCHSMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIA 167
           + + H   I +RDLK EN +L+  G     VK+ DFG  K S+       T  GT  Y+A
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

Query: 168 PEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 227
           PE+L +  +  +  D WS G  +Y ML GA PF      +N +KTI +IL    + P Y 
Sbjct: 190 PEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY- 243

Query: 228 RVSLECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            ++ E + LL ++   N+  R+        E++ HP+F
Sbjct: 244 -LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  199 bits (509), Expect = 5e-61
 Identities = 93/273 (34%), Positives = 135/273 (49%), Gaps = 26/273 (9%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQ--REIMNHRSLKH 57
           YE+VK IG G FG  +LVR K TR++ A+K + + + I           R+IM       
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF--ANS 128

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P +V+         +L +VMEY  GG+L   + +     E  ARF+  +++  +   HSM
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSM 187

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKE 175
              HRD+K +N LLD S    +K+ DFG           +    VGTP YI+PEVL  + 
Sbjct: 188 GFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245

Query: 176 YD---GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPDYVRVS 230
            D   G+  D WS GV LY MLVG  PF       +   T  +I++     +FPD   +S
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDNDIS 301

Query: 231 LECKHLLSRIFVANSEKRIT---IPEIKNHPWF 260
            E K+L+   F+ + E R+    + EIK H +F
Sbjct: 302 KEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  195 bits (498), Expect = 7e-61
 Identities = 63/287 (21%), Positives = 105/287 (36%), Gaps = 38/287 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE---RGQKIDEHVQREIMNHRSL-KH 57
             +  ++ IGSG FG       +    + A+K  +    G   +++  RE+  H  L +H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVSY 113
            ++VR+        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 114 CHSMQICHRDLKLENTLLD-----------------GSTAPRVKICDFGYSKSSVLHSQP 156
            HSM + H D+K  N  +                   S     KI D G+       S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSP 187

Query: 157 KSTVGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR 215
           +   G   ++A EVL     +  K AD+++  +T+           + +     R+    
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP 246

Query: 216 ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
            +            S E   LL  +   + E+R +   +  H   L 
Sbjct: 247 RIPQVL--------SQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  197 bits (504), Expect = 7e-61
 Identities = 87/273 (31%), Positives = 130/273 (47%), Gaps = 23/273 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQRE--IMNHRS 54
           ++ +E ++ +G G+FG   L R K T +L AVK +++   +     E    E  I++  +
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL-A 80

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
             HP + +      TP  L  VME+  GG+L   I  + RF E  ARF+  ++IS + + 
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTK 173
           H   I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L +
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
             Y G   D W+ GV LY ML G  PFE   +   F      IL+    +P +  +  + 
Sbjct: 199 MLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTW--LHEDA 251

Query: 234 KHLLSRIFVANSEKRI------TIPEIKNHPWF 260
             +L      N   R+          I  HP+F
Sbjct: 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  197 bits (503), Expect = 7e-61
 Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 24/278 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQRE--IMNHRS 54
           ++ +++++ IG G++    LVR K T  + A+K +++    D    + VQ E  +    +
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ-A 66

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
             HP +V       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y 
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTK 173
           H   I +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L  
Sbjct: 127 HERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPF-----EDPEDPKNFRKTIGRILSVHYSFPDYVR 228
           ++Y G   D W+ GV ++ M+ G  PF      D  D          IL      P    
Sbjct: 185 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-- 241

Query: 229 VSLECKHLLSRIFVANSEKRI------TIPEIKNHPWF 260
           +S++   +L      + ++R+         +I+ HP+F
Sbjct: 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  196 bits (501), Expect = 2e-60
 Identities = 84/272 (30%), Positives = 126/272 (46%), Gaps = 22/272 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQRE--IMNHRS 54
           +  +  +  +G G+FG   L   K T EL AVK +++   I     E    E  ++    
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LP 77

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
            K P + +      T   L  VMEY  GG+L   I   GRF E  A F+  ++  G+ + 
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTK 173
            S  I +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE++  
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 195

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + Y GK  D W+ GV LY ML G  PFE     ++  +    I+  + ++P    +S E 
Sbjct: 196 QPY-GKSVDWWAFGVLLYEMLAGQAPFEG----EDEDELFQSIMEHNVAYPKS--MSKEA 248

Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
             +   +   +  KR+        +IK H +F
Sbjct: 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  196 bits (499), Expect = 9e-60
 Identities = 77/278 (27%), Positives = 132/278 (47%), Gaps = 24/278 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQRE--IMNHRS 54
           ++ +++++ IG G++    LVR K T  + A++ +++    D    + VQ E  +   ++
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE-QA 109

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
             HP +V       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y 
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTK 173
           H   I +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L  
Sbjct: 170 HERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPF-----EDPEDPKNFRKTIGRILSVHYSFPDYVR 228
           ++Y G   D W+ GV ++ M+ G  PF      D  D          IL      P    
Sbjct: 228 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-- 284

Query: 229 VSLECKHLLSRIFVANSEKRI------TIPEIKNHPWF 260
           +S++   +L      + ++R+         +I+ HP+F
Sbjct: 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  194 bits (496), Expect = 1e-59
 Identities = 85/280 (30%), Positives = 139/280 (49%), Gaps = 27/280 (9%)

Query: 1   MERYEIVKDIGSGNFGVAKLVR---DKWTRELLAVK-----FIERGQKIDEHVQ--REIM 50
           +E +E++K +G+G +G   LVR      T +L A+K      I +  K  EH +  R+++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
            H   + P +V       T T L ++++Y  GGELF  +    RF+E E + +  +++  
Sbjct: 113 EHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171

Query: 111 VSYCHSMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYI 166
           + + H + I +RD+KLEN LLD  G     V + DFG SK  V     ++    GT  Y+
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 167 APEVLTKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD 225
           AP+++   +    K  D WS GV +Y +L GA PF    +  +  +   RIL     +P 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287

Query: 226 YVRVSLECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
              +S   K L+ R+ + + +KR+        EIK H +F
Sbjct: 288 E--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  196 bits (501), Expect = 1e-59
 Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 28/279 (10%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQ--REIMNHRS 54
            E +EI+K IG G FG   +V+ K   ++ A+K + + + +        +  R+++ +  
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-- 130

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSY 113
                I           +L +VM+Y  GG+L   +     R  E+ ARF+  +++  +  
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 171
            H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 172 TKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFPD 225
              E      G   D WS GV +Y ML G  PF      ++  +T G+I++    + FP 
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPT 304

Query: 226 YV-RVSLECKHLLSRIFVANSEKRIT---IPEIKNHPWF 260
            V  VS   K L+ R+  +  E R+    I + K HP+F
Sbjct: 305 QVTDVSENAKDLIRRLICSR-EHRLGQNGIEDFKKHPFF 342

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  195 bits (498), Expect = 2e-59
 Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 34/280 (12%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVK------FIERGQKIDEHVQ--REIMNHRSL 55
           +EI+K IG G F    +V+ K T ++ A+K       ++RG+      +  R+++ +   
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV--SCFREERDVLVN--G 118

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 114
               I +         +L +VMEY  GG+L   +   G R   + ARF+  +++  +   
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLT 172
           H +   HRD+K +N LLD      +++ DFG           +S   VGTP Y++PE+L 
Sbjct: 179 HRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 173 KKEYD------GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFP 224
                      G   D W+ GV  Y M  G  PF       +  +T G+I+    H S P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLSLP 292

Query: 225 DY-VRVSLECKHLLSRIFVANSEKRIT---IPEIKNHPWF 260
                V  E +  + R  +   E R+      + + HP+F
Sbjct: 293 LVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  196 bits (500), Expect = 2e-59
 Identities = 91/271 (33%), Positives = 132/271 (48%), Gaps = 20/271 (7%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR----SLK 56
           M  +E +K +G G FG   LV++K T    A+K +++   + +      +       + +
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266

Query: 117 MQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTKK 174
            + + +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL   
Sbjct: 267 EKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +Y G+  D W  GV +Y M+ G  PF + +  K F      IL     FP    +  E K
Sbjct: 325 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAK 377

Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            LLS +   + ++R+        EI  H +F
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  199 bits (507), Expect = 2e-58
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 18/272 (6%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR------- 53
           M  + + + IG G FG     R   T ++ A+K +++ +   +  +   +N R       
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           +   P IV       TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            H+  + +RDLK  N LLD      V+I D G +       +P ++VGT  Y+APEVL K
Sbjct: 308 MHNRFVVYRDLKPANILLDEHG--HVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQK 364

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
                  AD +S G  L+ +L G  PF      K+  +     L++    PD    S E 
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPEL 421

Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           + LL  +   +  +R+        E+K  P+F
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  197 bits (501), Expect = 8e-58
 Identities = 84/272 (30%), Positives = 127/272 (46%), Gaps = 22/272 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQRE--IMNHRS 54
           +  +  +  +G G+FG   L   K T EL AVK +++   I     E    E  ++    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LP 398

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
            K P + +      T   L  VMEY  GG+L   I   GRF E  A F+  ++  G+ + 
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLTK 173
            S  I +RDLKL+N +LD  +   +KI DFG  K ++       T  GTP YIAPE++  
Sbjct: 459 QSKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + Y GK  D W+ GV LY ML G  PFE     ++  +    I+  + ++P    +S E 
Sbjct: 517 QPY-GKSVDWWAFGVLLYEMLAGQAPFEG----EDEDELFQSIMEHNVAYPKS--MSKEA 569

Query: 234 KHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
             +   +   +  KR+        +IK H +F
Sbjct: 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  190 bits (484), Expect = 5e-56
 Identities = 66/271 (24%), Positives = 115/271 (42%), Gaps = 16/271 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRS----LK 56
              +   + +G G FG     + + T ++ A K +E+ +      +   +N +     + 
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYC 114
              +V       T   L +V+    GG+L   I + G+  F E  A F+  ++  G+   
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
           H  +I +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+  +
Sbjct: 303 HRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            Y     D W+ G  LY M+ G  PF+  +      +    +  V   + +    S + +
Sbjct: 361 RY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQAR 417

Query: 235 HLLSRIFVANSEKRI-----TIPEIKNHPWF 260
            L S++   +  +R+     +  E+K HP F
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  189 bits (481), Expect = 1e-55
 Identities = 73/274 (26%), Positives = 115/274 (41%), Gaps = 19/274 (6%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR----SLK 56
            + +   + +G G FG     + K T +L A K + + +       +  M  +     + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVS 112
              IV       T T L +VM    GG++   I N       F E  A F+  Q++SG+ 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 171
           + H   I +RDLK EN LLD      V+I D G +              GTP ++APE+L
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
             +EY     D ++ GVTLY M+    PF    +    ++   R+L    ++PD    S 
Sbjct: 362 LGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSP 418

Query: 232 ECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
             K     +   + EKR+     +   ++ HP F
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  182 bits (464), Expect = 3e-55
 Identities = 65/265 (24%), Positives = 100/265 (37%), Gaps = 15/265 (5%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT 69
           +G G+FG    ++DK T    AVK +     ++     E++    L  P IV     +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRIVPLYGAVRE 121

Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H+ +I H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181

Query: 130 LLDGSTAPRVKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADV 183
           LL  S   R  +CDFG++                   GT  ++APEV+  K  D K  D+
Sbjct: 182 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDI 239

Query: 184 WSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
           WS    +  ML G +P+          K I          P     +      +      
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP--SCAPLTAQAIQEGLRK 296

Query: 244 NSEKRITIPEIKNHPWFLRNLPIEL 268
               R +  E++            L
Sbjct: 297 EPVHRASAMELRRKVGKALQEVGGL 321

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  179 bits (454), Expect = 4e-53
 Identities = 39/296 (13%), Positives = 78/296 (26%), Gaps = 55/296 (18%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSL---------- 55
           +G  +        D+ T E   V      ++      + ++ E++  R L          
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 56  ------------KHPNIVRFKEVLLTPTHLAIVMEYAA-----------GGELFERICNA 92
                       K P   +   V L    + ++  +             G  L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 93  GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS--S 150
                        Q+I  ++  H   + H  L+  + +LD      V +  F +     +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFEHLVRDGA 263

Query: 151 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKI----ADVWSCGVTLYVMLVGAYPFEDPEDP 206
              S        P   A  +L   ++   +     D W+ G+ +Y +     P  D    
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323

Query: 207 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
                           F     +    + LL        E R+   +    P + +
Sbjct: 324 GGSEWI----------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  173 bits (440), Expect = 4e-52
 Identities = 75/259 (28%), Positives = 125/259 (48%), Gaps = 16/259 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNIVRFKEVLL 68
           +G G +G+    RD   +  +A+K I  R  +  + +  EI  H+ LKH NIV++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 69  TPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLK 125
               + I ME   GG    L        + +E    F+ +Q++ G+ Y H  QI HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 126 LENTLLDGSTAPRVKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLTKKE--YDGKIAD 182
            +N L++  +   +KI DFG SK  + ++   ++  GT  Y+APE++ K    Y    AD
Sbjct: 150 GDNVLINTYSG-VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207

Query: 183 VWSCGVTLYVMLVGAYPFEDPEDPKN--FRKTIGRILSVHYSFPDYVRVSLECKHLLSRI 240
           +WS G T+  M  G  PF +  +P+   F+  +G    VH   P+   +S E K  + + 
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFK--VGM-FKVHPEIPE--SMSAEAKAFILKC 262

Query: 241 FVANSEKRITIPEIKNHPW 259
           F  + +KR    ++    +
Sbjct: 263 FEPDPDKRACANDLLVDEF 281

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  166 bits (422), Expect = 8e-49
 Identities = 76/303 (25%), Positives = 122/303 (40%), Gaps = 45/303 (14%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH--VQREIMNHRSLKHP 58
            + +E + ++G+GN GV   V  K +  ++A K I    K      + RE+        P
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-M 117
            IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y     
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           +I HRD+K  N L+  ++   +K+CDFG S   +  S   S VGT +Y++PE L    Y 
Sbjct: 152 KIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYS 208

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH-- 235
            + +D+WS G++L  M VG YP   P+  +       ++       P   R      +  
Sbjct: 209 VQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 236 ------------LLSRI-------------------FVA-----NSEKRITIPEIKNHPW 259
                       LL  I                   FV      N  +R  + ++  H +
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327

Query: 260 FLR 262
             R
Sbjct: 328 IKR 330

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  164 bits (417), Expect = 2e-48
 Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 26/277 (9%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREI-MNHRSLKH 57
           +   E + ++GSG  G    +R + T  ++AVK +     ++ ++ +  ++ +  +S   
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 116
           P IV+     +T T + I ME         +    G   E         ++  + Y    
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL---- 171
             + HRD+K  N LLD     ++K+CDFG S   V   + K    G  AY+APE +    
Sbjct: 144 HGVIHRDVKPSNILLD--ERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPD 200

Query: 172 -TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHY---SFPD 225
            TK +YD + ADVWS G++L  +  G +P+++        KT   +L+  +       P 
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKNC-------KTDFEVLTKVLQEEPPLLPG 252

Query: 226 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
           ++  S + +  +      +  KR    ++  H +  R
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  161 bits (409), Expect = 1e-47
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 23/276 (8%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH--VQREI-MNHRSLKH 57
            +  E + ++G G +GV + +R   + +++AVK I       E   +  ++ ++ R++  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICN-AGRFSEDEARFFFQQLISGVSYC 114
           P  V F   L     + I ME       + ++++ +      ED        ++  + + 
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 115 HS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV-- 170
           HS + + HRD+K  N L++     +VK+CDFG S   V     K    G   Y+APE   
Sbjct: 126 HSKLSVIHRDVKPSNVLIN--ALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERIN 182

Query: 171 --LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DY 226
             L +K Y  K +D+WS G+T+  + +  +P++    P    K +     V    P    
Sbjct: 183 PELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-----VEEPSPQLPA 236

Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
            + S E     S+    NS++R T PE+  HP+F  
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  161 bits (409), Expect = 2e-47
 Identities = 80/274 (29%), Positives = 124/274 (45%), Gaps = 30/274 (10%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           E +  ++ IG G+FG      D  T++++A+K I  E  +   E +Q+EI        P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDG 178
            HRD+K  N LL  S    VK+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 141 IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI-------LSVHYS--FPDYVRV 229
           K AD+WS G+T   +  G  P  +   P    K +  I       L  +YS    ++V  
Sbjct: 199 K-ADIWSLGITAIELARGEPPHSE-LHP---MKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
            L                R T  E+  H + LRN
Sbjct: 254 CL----------NKEPSFRPTAKELLKHKFILRN 277

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  160 bits (407), Expect = 6e-47
 Identities = 74/272 (27%), Positives = 133/272 (48%), Gaps = 26/272 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
              +    IG G+ G+  L R+K +   +AVK ++ R Q+  E +  E++  R  +H N+
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V   +  L    L ++ME+  GG L + I +  R +E++     + ++  ++Y H+  + 
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
           HRD+K ++ LL  +   RVK+ DFG+  + S    + KS VGTP ++APEV+++  Y  +
Sbjct: 164 HRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             D+WS G+ +  M+ G  P+   + P          +       D     L+  H +S 
Sbjct: 222 -VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHKVSP 269

Query: 240 IF--------VANSEKRITIPEIKNHPWFLRN 263
           +         V + ++R T  E+ +HP FL  
Sbjct: 270 VLRDFLERMLVRDPQERATAQELLDHP-FLLQ 300

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  158 bits (402), Expect = 2e-46
 Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 26/272 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE-RGQKIDEHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A++ +  + Q   E +  EI+  R  K+PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
           HRD+K +N LL       VK+ DFG+  + +   S+  + VGTP ++APEV+T+K Y  K
Sbjct: 139 HRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             D+WS G+    M+ G  P+ + E+P          L   Y         L+    LS 
Sbjct: 197 -VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQNPEKLSA 244

Query: 240 IF--------VANSEKRITIPEIKNHPWFLRN 263
           IF          + EKR +  E+  H  FL+ 
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKI 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  159 bits (403), Expect = 2e-46
 Identities = 73/272 (26%), Positives = 127/272 (46%), Gaps = 26/272 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E +++++ +G G++G       K T +++A+K +     + E + +EI   +    P++V
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHVV 87

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           ++       T L IVMEY   G + + I       +EDE     Q  + G+ Y H M+  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
           HRD+K  N LL  +T    K+ DFG + + +   ++  + +GTP ++APEV+ +  Y+  
Sbjct: 148 HRDIKAGNILL--NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCV 205

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
            AD+WS G+T   M  G  P+ D   P          +   +  P     +     L S 
Sbjct: 206 -ADIWSLGITAIEMAEGKPPYAD-IHP----------MRAIFMIPTNPPPTFRKPELWSD 253

Query: 240 IF--------VANSEKRITIPEIKNHPWFLRN 263
            F        V + E+R T  ++  HP F+R+
Sbjct: 254 NFTDFVKQCLVKSPEQRATATQLLQHP-FVRS 284

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  158 bits (401), Expect = 2e-46
 Identities = 67/261 (25%), Positives = 116/261 (44%), Gaps = 18/261 (6%)

Query: 10  IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR---EIMNHRSLKHPNIVRF--- 63
           IG G+F       D  T   +A   ++  +      QR   E    + L+HPNIVRF   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 64  -KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--IC 120
            +  +     + +V E    G L   +           R + +Q++ G+ + H+    I 
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           HRDLK +N  + G T   VKI D G +      S  K+ +GTP ++APE+  +++YD   
Sbjct: 154 HRDLKCDNIFITGPTG-SVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMY-EEKYDES- 209

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKN-FRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
            DV++ G+ +  M    YP+ + ++    +R+    +     SF        E K ++  
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDK--VAIPEVKEIIEG 265

Query: 240 IFVANSEKRITIPEIKNHPWF 260
               N ++R +I ++ NH +F
Sbjct: 266 CIRQNKDERYSIKDLLNHAFF 286

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  157 bits (399), Expect = 9e-46
 Identities = 48/278 (17%), Positives = 95/278 (34%), Gaps = 30/278 (10%)

Query: 6   IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIVR 62
           IV+   +      +  +++     L  +  +        +     +I         N V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
             +      +L I M+      L + +   C+            F Q+   V + HS  +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-------------VGTPAYI 166
            HRDLK  N          VK+ DFG   +     + ++              VGT  Y+
Sbjct: 186 MHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 226
           +PE +    Y  K  D++S G+ L+ +L   Y F          + I  + ++ +    +
Sbjct: 244 SPEQIHGNNYSHK-VDIFSLGLILFELL---YSFSTQM---ERVRIITDVRNLKFP-LLF 295

Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 264
            +   +   ++  +   +  +R    +I  +  F  NL
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF-ENL 332

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  156 bits (397), Expect = 2e-45
 Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 29/281 (10%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREI-MNHRSLKH 57
            E  + + +IG G +G    +  K + +++AVK I     +K  + +  ++ +  RS   
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGG--ELFERICNA--GRFSEDEARFFFQQLISGVSY 113
           P IV+F   L       I ME  +    + ++ + +       E+         +  +++
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 114 CHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL- 171
               ++I HRD+K  N LLD   +  +K+CDFG S   V         G   Y+APE + 
Sbjct: 141 LKENLKIIHRDIKPSNILLD--RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198

Query: 172 ---TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VHYSFP-- 224
              +++ YD + +DVWS G+TLY +  G +P+           ++   L+  V    P  
Sbjct: 199 PSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWN-------SVFDQLTQVVKGDPPQL 250

Query: 225 ---DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
              +    S    + ++     +  KR    E+  HP+ L 
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  154 bits (392), Expect = 7e-45
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 15/208 (7%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
           E+ + +G G FG   + + KW  + +A+K I   +   +    E+     + HPNIV+  
Sbjct: 11  EVEEVVGRGAFG--VVCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLY 67

Query: 65  EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHSMQ--- 118
              L P  + +VMEYA GG L+  +  A       A       +    GV+Y HSMQ   
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           + HRDLK  N LL  +    +KICDFG +    + +   +  G+ A++APEV     Y  
Sbjct: 126 LIHRDLKPPNLLLV-AGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDP 206
           K  DV+S G+ L+ ++    PF++   P
Sbjct: 183 K-CDVFSWGIILWEVITRRKPFDEIGGP 209

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  149 bits (377), Expect = 9e-43
 Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 27/292 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + YE+ + IGSG   V +       +E +A+K I  E+ Q   + + +EI       HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELF--------ERICNAGRFSEDEARFFFQQLISGV 111
           IV +    +    L +VM+  +GG +         +    +G   E       ++++ G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS------KSSVLHSQPKSTVGTPAY 165
            Y H     HRD+K  N LL    +  V+I DFG S           +   K+ VGTP +
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 166 IAPEVLTK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----KNFRKTIGRILSV 219
           +APEV+ + + YD K AD+WS G+T   +  GA P+     P        +     + + 
Sbjct: 193 MAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLETG 250

Query: 220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIE-LTE 270
                   +     + ++S     + EKR T  E+  H +F +    E L E
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  149 bits (377), Expect = 9e-43
 Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 32/283 (11%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           E +EIV ++G G FG     ++K T  L A K I  +  +++++    EI    +  HP 
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHPY 77

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 118
           IV+          L I++E+  GG +   +       +E + +   +Q++  +++ HS +
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLT----- 172
           I HRDLK  N L+  +    +++ DFG S K+     +  S +GTP ++APEV+      
Sbjct: 138 IIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              YD K AD+WS G+TL  M     P  +  +P          + V          +L 
Sbjct: 196 DTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP----------MRVLLKIAKSDPPTLL 243

Query: 233 CKHLLSRIF--------VANSEKRITIPEIKNHPWFLRNLPIE 267
                S  F          N E R +  ++  HP+       +
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  148 bits (376), Expect = 1e-42
 Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 18/209 (8%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIV 61
            I + IG+G+FG   + R +W    +AVK +       E V    RE+   + L+HPNIV
Sbjct: 40  NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM- 117
            F   +  P +L+IV EY + G L+  +  +G      E         +  G++Y H+  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 118 -QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLTK 173
             I HR+LK  N L+D      VK+CDFG S+  +  S     KS  GTP ++APEVL  
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFED 202
           +  + K +DV+S GV L+ +     P+ +
Sbjct: 214 EPSNEK-SDVYSFGVILWELATLQQPWGN 241

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  145 bits (369), Expect = 7e-42
 Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 19/212 (8%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-----EHVQREIMNHRSLKHPN 59
            + + IG G FG  K+ R  W  + +AVK        D     E+V++E      LKHPN
Sbjct: 10  TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 117
           I+  + V L   +L +VME+A GG L   +    R   D    +  Q+  G++Y H    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 118 -QICHRDLKLENTLLDGSTAPR------VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
             I HRDLK  N L+             +KI DFG ++     +   S  G  A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFED 202
           +    +    +DVWS GV L+ +L G  PF  
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  147 bits (372), Expect = 8e-42
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 18/216 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNI 60
             +E+V+ +G+G +G     R   T +L A+K ++     +E +++EI   +    H NI
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 83

Query: 61  VRF------KEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVS 112
             +      K        L +VME+   G + +  +        E+   +  ++++ G+S
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 171
           + H  ++ HRD+K +N LL  +    VK+ DFG S         ++T +GTP ++APEV+
Sbjct: 144 HLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 172 TKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 202
              E     YD K +D+WS G+T   M  GA P  D
Sbjct: 202 ACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  147 bits (372), Expect = 1e-41
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 13/208 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI----ERGQKIDEHVQREIMNHRSLKH 57
           + +  +++IG G+FG     RD    E++A+K +    ++  +  + + +E+   + L+H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PN ++++   L      +VMEY  G        +     E E        + G++Y HS 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV---LTKK 174
            + HRD+K  N LL  S    VK+ DFG +      +   S VGTP ++APEV   + + 
Sbjct: 174 NMIHRDVKAGNILL--SEPGLVKLGDFGSASI---MAPANSFVGTPYWMAPEVILAMDEG 228

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFED 202
           +YDGK  DVWS G+T   +     P  +
Sbjct: 229 QYDGK-VDVWSLGITCIELAERKPPLFN 255

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  147 bits (372), Expect = 6e-41
 Identities = 83/313 (26%), Positives = 128/313 (40%), Gaps = 56/313 (17%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
             Y   K IG+G+FGV    +   + EL+A+K      K+ +  +   RE+   R L H 
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDHC 107

Query: 59  NIVRFKEVLLTPT------HLAIVMEYAAGGELFERI----CNAGRFSEDEARFFFQQLI 108
           NIVR +    +        +L +V++Y     ++                  + +  QL 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYI 166
             ++Y HS  ICHRD+K +N LLD  TA  +K+CDFG +K   L     +   + +  Y 
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVSYICSRYYR 223

Query: 167 APEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED-----------PKNFRKT 212
           APE+     +Y   I DVWS G  L  +L+G   +P +   D           P   R+ 
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQ 280

Query: 213 IGRILS--VHYSFPDYVRVSL----------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           I  +      + FP                 E   L SR+       R+T  E   H +F
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

Query: 261 --LRNLPIELTEG 271
             LR+  ++L  G
Sbjct: 341 DELRDPNVKLPNG 353

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  146 bits (369), Expect = 8e-41
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 20/218 (9%)

Query: 2   ERYEIVKDIGSG--NFGVAKLVRDKWTRELLAVKFI--ERGQKID-EHVQREIMNHRSLK 56
             YE++  IG G  +     L R K T E + V+ I  E         +Q E+   +   
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYC 114
           HPNIV ++   +    L +V  + A G   + IC       +E    +  Q ++  + Y 
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYS--------KSSVLHSQPKSTVGTPAYI 166
           H M   HR +K  + L+       V +     +        +  V+H  PK +V    ++
Sbjct: 145 HHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 167 APEVLT--KKEYDGKIADVWSCGVTLYVMLVGAYPFED 202
           +PEVL    + YD K +D++S G+T   +  G  PF+D
Sbjct: 203 SPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  144 bits (365), Expect = 9e-41
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIV 61
           EI + IG G FG  ++   +W  E+ A++ I+  +  ++ ++   RE+M +R  +H N+V
Sbjct: 36  EIGELIGKGRFG--QVYHGRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQIC 120
            F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G+ Y H+  I 
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL--- 171
           H+DLK +N   D      V I DFG         +     + +   G   ++APE++   
Sbjct: 153 HKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 172 ------TKKEYDGKIADVWSCGVTLYVMLVGAYPFED 202
                  K  +    +DV++ G   Y +    +PF+ 
Sbjct: 210 SPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  140 bits (356), Expect = 5e-40
 Identities = 43/209 (20%), Positives = 82/209 (39%), Gaps = 19/209 (9%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIV 61
             +  +   + G  +L + +W    + VK ++         +    E    R   HPN++
Sbjct: 13  NFLTKLNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 62  RFKEVLLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 117
                  +P   H  ++  +   G L+  +     F  D+++   F   +  G+++ H++
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 118 Q--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKE 175
           +  I    L   + ++D       +I       S     Q    +  PA++APE L KK 
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184

Query: 176 YDGKI--ADVWSCGVTLYVMLVGAYPFED 202
            D     AD+WS  V L+ ++    PF D
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  139 bits (352), Expect = 3e-39
 Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 28/275 (10%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHPNIV 61
            + + IGSG+FG   + + KW  ++ AVK +       + +Q    E+   R  +H NI+
Sbjct: 27  TVGQRIGSGSFG--TVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
            F     T   LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+  I 
Sbjct: 84  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKKE-- 175
           HRDLK  N  L       VKI DFG +          Q +   G+  ++APEV+  ++  
Sbjct: 143 HRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 176 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC- 233
            Y  + +DV++ G+ LY ++ G  P+ +  +     + +GR        PD  +V   C 
Sbjct: 201 PYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----GSLSPDLSKVRSNCP 255

Query: 234 ---KHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
              K L++       ++R + P I      +  L 
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAE---IEELA 287

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  139 bits (353), Expect = 7e-39
 Identities = 80/306 (26%), Positives = 131/306 (42%), Gaps = 49/306 (16%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           ++RY  +  +G G +G      D  T E +A+K I R +  +E V     RE+   + L+
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQ 91

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           H NI+  K V+     L ++ EYA   +L + +      S    + F  QLI+GV++CHS
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150

Query: 117 MQICHRDLKLENTLLDGSTAPR---VKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT 172
            +  HRDLK +N LL  S A     +KI DFG +++  +  +  +  + T  Y  PE+L 
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210

Query: 173 -KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV---------- 219
             + Y   + D+WS       ML+    +P +   D       + +I  V          
Sbjct: 211 GSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEID------QLFKIFEVLGLPDDTTWP 263

Query: 220 --------HYSFPDYVRVSL----------ECKHLLSRIFVANSEKRITIPEIKNHPWFL 261
                     SFP +   +L          E   LL+ +   +  KRI+      HP+F 
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF- 322

Query: 262 RNLPIE 267
            +   +
Sbjct: 323 SHNDFD 328

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  137 bits (348), Expect = 1e-38
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 21/214 (9%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHV--------QREIMNHRSLK 56
           E  K IG G FG+    R    + ++A+K +  G    E          QRE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 115
           HPNIV+   ++  P    +VME+   G+L+ R+ +                +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 116 SM--QICHRDLKLENTLLDGSTAPR---VKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +    I HRDL+  N  L           K+ DFG S+           +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197

Query: 171 LT--KKEYDGKIADVWSCGVTLYVMLVGAYPFED 202
           +   ++ Y  K AD +S  + LY +L G  PF++
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  139 bits (353), Expect = 2e-38
 Identities = 78/312 (25%), Positives = 127/312 (40%), Gaps = 53/312 (16%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
              Y   K IG+G+FGV    +   + E+ A+K + + ++      RE+   R +KHPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFK---NRELQIMRIVKHPNV 94

Query: 61  VRFKEVLLTPTH------LAIVMEYAAGGELFERIC-----NAGRFSEDEARFFFQQLIS 109
           V  K    +         L +V+EY    E   R                 + +  QL+ 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIA 167
            ++Y HS+ ICHRD+K +N LLD  +   +K+ DFG +K  +L +   +   + +  Y A
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRA 209

Query: 168 PEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED-----------PKNFRKTI 213
           PE+      Y   I D+WS G  +  ++ G   +P E   D           P   R+ I
Sbjct: 210 PELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS--REQI 266

Query: 214 GRILS--VHYSFPDYVRVSL----------ECKHLLSRIFVANSEKRITIPEIKNHPWF- 260
             +    + + FP                 +   L+SR+       R+T  E   HP+F 
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326

Query: 261 -LRNLPIELTEG 271
            LR     +  G
Sbjct: 327 ELRTGEARMPNG 338

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  136 bits (344), Expect = 5e-38
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 51/303 (16%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           M++YE ++ IG G +G     +++ T E++A+K + R    DE V     REI   + LK
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           H NIVR  +VL +   L +V E+      + F+     G    +  + F  QL+ G+ +C
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT- 172
           HS  + HRDLK +N L++ +    +K+ +FG +++  +  +  S  V T  Y  P+VL  
Sbjct: 118 HSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPF---EDPEDPKNFRKTIGRILSV---------- 219
            K Y   I D+WS G     +     P     D +D       + RI  +          
Sbjct: 176 AKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDD------QLKRIFRLLGTPTEEQWP 228

Query: 220 -HYSFPDYV----------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR 262
                PDY                 +++   + LL  +   N  +RI+  E   HP+F  
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-S 287

Query: 263 NLP 265
           +  
Sbjct: 288 DFC 290

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  136 bits (345), Expect = 6e-38
 Identities = 76/301 (25%), Positives = 126/301 (41%), Gaps = 46/301 (15%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           ME+YE +  IG G++GV    R++ T +++A+K      + D  ++    REI   + LK
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLK 60

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           HPN+V   EV      L +V EY         +R        E   +    Q +  V++C
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVL 171
           H     HRD+K EN L+   +   +K+CDFG+++   L          V T  Y +PE+L
Sbjct: 119 HKHNCIHRDVKPENILITKHS--VIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELL 174

Query: 172 TK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--PKNFRKTIG----RILSVHYS 222
               +Y   + DVW+ G     +L G   +P +   D      + T+G    R   V  +
Sbjct: 175 VGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK-TLGDLIPRHQQVFST 232

Query: 223 FPDYVRVSL------------------ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 264
              +  V +                      LL      +  +R+T  ++ +HP+F  N+
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF-ENI 291

Query: 265 P 265
            
Sbjct: 292 R 292

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  134 bits (340), Expect = 2e-37
 Identities = 81/297 (27%), Positives = 131/297 (44%), Gaps = 50/297 (16%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           ME+Y  ++ IG G +GV    ++    E  A+K I R +K DE +     REI   + LK
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           H NIV+  +V+ T   L +V E+      +L +     G      A+ F  QL++G++YC
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYC 116

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT- 172
           H  ++ HRDLK +N L++      +KI DFG +++  +  +  +  + T  Y AP+VL  
Sbjct: 117 HDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV----------- 219
            K+Y   I D+WS G     M+ G   +P     D       + RI  +           
Sbjct: 175 SKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEAD------QLMRIFRILGTPNSKNWPN 227

Query: 220 -------HYSFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                    +F  Y  +               LLS++   +  +RIT  +   H +F
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  135 bits (342), Expect = 2e-37
 Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 41/302 (13%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHP 58
             +++ ++ +G+G +       +K T   +A+K ++   +        REI   + LKH 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63

Query: 59  NIVRFKEVLLTPTHLAIVMEY-----AAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           NIVR  +V+ T   L +V E+         +             +  ++F  QL+ G+++
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT 172
           CH  +I HRDLK +N L++     ++K+ DFG +++  +     S+ V T  Y AP+VL 
Sbjct: 124 CHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181

Query: 173 -KKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFED--------P 203
             + Y   I D+WSCG  L  M+ G                      P E         P
Sbjct: 182 GSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240

Query: 204 EDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN 263
           +   N ++   R L           +       L  +   N + R++  +  +HPWF   
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF-AE 299

Query: 264 LP 265
             
Sbjct: 300 YY 301

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  135 bits (342), Expect = 3e-37
 Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 41/294 (13%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHV----QREIMNHRSLK 56
           ME+YE +  +G G++G+    R+K T  ++A+K        D+ V     REI   + L+
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLR 82

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           H N+V   EV        +V E+      +  E   N         + +  Q+I+G+ +C
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFC 140

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT- 172
           HS  I HRD+K EN L+  S    VK+CDFG++++     +     V T  Y APE+L  
Sbjct: 141 HSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--PKNFRKTIG----RILSVHYSFP 224
             +Y   + DVW+ G  +  M +G   +P +   D         +G    R   +    P
Sbjct: 199 DVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM-CLGNLIPRHQELFNKNP 256

Query: 225 DYVRVSL------------------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            +  V L                      L  +    + +KR    E+ +H +F
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  133 bits (337), Expect = 6e-37
 Identities = 64/297 (21%), Positives = 107/297 (36%), Gaps = 59/297 (19%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF- 63
            +++ +G G +G  ++ R  W  E +AVK      +     + E+ N   L+H NI+ F 
Sbjct: 11  TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 64  ---KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 118
                   + T L ++  Y   G L++ +                 + SG+++ H     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 119 ------ICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 167
                 I HRDLK +N L+  +   +  I D G +      ++ L       VGT  Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 168 PEVL------TKKEYDGKIADVWSCGVTLYVMLVGAY----------PFED--PEDP--- 206
           PEVL         +   +  D+W+ G+ L+ +               PF D  P DP   
Sbjct: 186 PEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 207 --------KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 255
                      R  I        +     ++  EC +        N   R+T   IK
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRIK 294

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  133 bits (338), Expect = 1e-36
 Identities = 73/319 (22%), Positives = 128/319 (40%), Gaps = 57/319 (17%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ------REIMNHRS 54
           M+R+++ +  G G FG  +L ++K T   +A+K      K+ +  +      + + +   
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------KVIQDPRFRNRELQIMQDLAV 75

Query: 55  LKHPNIVRFKEVLLTPTH-------LAIVMEYAAGGELFERICNAGR----FSEDEARFF 103
           L HPNIV+ +    T          L +VMEY     L     N  R          + F
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 104 FQQLISGVSYCH--SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG 161
             QLI  +   H  S+ +CHRD+K  N L++ +    +K+CDFG +K         + + 
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVAYIC 193

Query: 162 TPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------- 205
           +  Y APE+    + Y   + D+WS G     M++G   +  ++                
Sbjct: 194 SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252

Query: 206 --------PKNFRKTIGRILSVHYS--FPDYV-RVSLECKHLLSRIFVANSEKRITIPEI 254
                   P +    +     + +S  F D+  + + E   LLS +     E+R+   E 
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312

Query: 255 KNHPWF--LRNLPIELTEG 271
             HP+F  L +   +L   
Sbjct: 313 LCHPYFDELHDPATKLPNN 331

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  131 bits (332), Expect = 4e-36
 Identities = 77/306 (25%), Positives = 138/306 (45%), Gaps = 52/306 (16%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ----REIMNHRSLK 56
           ME+Y+ ++ +G G +GV    +D     ++A+K I R    DE +     REI   + L 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPSTAIREISLLKELH 77

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           HPNIV   +V+ +   L +V E+      ++ +   N     + + + +  QL+ GV++C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT- 172
           H  +I HRDLK +N L++      +K+ DFG +++  +  +  +  V T  Y AP+VL  
Sbjct: 136 HQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV----------- 219
            K+Y   + D+WS G     M+ G   +P    +D       + +I S+           
Sbjct: 194 SKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDD------QLPKIFSILGTPNPREWPQ 246

Query: 220 --------HYSFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKNHPWFLR 262
                     +F  + +                LLS +   +  KRI+  +  NHP+F +
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-K 305

Query: 263 NLPIEL 268
           +L  ++
Sbjct: 306 DLDPQI 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  132 bits (333), Expect = 5e-36
 Identities = 65/300 (21%), Positives = 123/300 (41%), Gaps = 51/300 (17%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLK-H 57
            + Y++V+ +G G +       +    E + VK +   + +KI    +REI    +L+  
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI----KREIKILENLRGG 90

Query: 58  PNIVRFKEVLLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+   +++  P     A+V E+    +  +        ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 147

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL-T 172
           SM I HRD+K  N ++D     ++++ D+G ++    H   +    V +  +  PE+L  
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVD 204

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPF---EDPED-------------PKNFRKTIGRI 216
            + YD  + D+WS G  L  M+    PF    D  D               ++       
Sbjct: 205 YQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263

Query: 217 LSVHY--SFPDYVR--------------VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           L   +      + R              VS E    L ++   + + R+T  E   HP+F
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  130 bits (330), Expect = 7e-36
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 30/221 (13%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQRE------IMNHRSLKHP 58
              + +G G FG A  V  + T E++ +K +    + DE  QR       +M  R L+HP
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKEL---IRFDEETQRTFLKEVKVM--RCLEHP 67

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 117
           N+++F  VL     L  + EY  GG L   I +    +   +   F + + SG++Y HSM
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK---------------SSVLHSQPKSTVGT 162
            I HRDL   N L+  +    V + DFG ++                     +  + VG 
Sbjct: 128 NIIHRDLNSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 163 PAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 203
           P ++APE++  + YD K  DV+S G+ L  ++       D 
Sbjct: 186 PYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDY 225

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  131 bits (331), Expect = 8e-36
 Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 48/301 (15%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHP 58
           ME Y  +  +G G +      + K T  L+A+K I  E  +       RE+   + LKH 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           NIV   +++ T   L +V EY      +  +        +    + F  QL+ G++YCH 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLT-KK 174
            ++ HRDLK +N L++      +K+ DFG +++  + ++     V T  Y  P++L    
Sbjct: 119 QKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176

Query: 175 EYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV------------- 219
           +Y  +I D+W  G   Y M  G   +P    E+       +  I  +             
Sbjct: 177 DYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEE------QLHFIFRILGTPTEETWPGIL 229

Query: 220 ------HYSFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKNHPWFLRNL 264
                  Y++P Y   +L             LL+++       RI+  +   HP+F  +L
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF-LSL 288

Query: 265 P 265
            
Sbjct: 289 G 289

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  130 bits (329), Expect = 4e-35
 Identities = 75/358 (20%), Positives = 123/358 (34%), Gaps = 82/358 (22%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKH 57
            ++Y + K +G+G+FG+   V D  + +  A+K      K+ +  +   RE+   + L H
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK------KVLQDPRYKNRELDIMKVLDH 59

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG------------------------ 93
            NI++  +   T                     N G                        
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 94  -----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA 136
                                +    +  QL   V + HS+ ICHRD+K +N L++    
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 137 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLV 195
             +K+CDFG +K  +      + + +  Y APE+ L   EY   I D+WS G     +++
Sbjct: 180 -TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELIL 237

Query: 196 GA--YPFEDPED-----------PKNFRKTIGRILSVH--YSFPDYVRVSL--------- 231
           G   +  E   D           P   ++ + R+   +    FP                
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295

Query: 232 -ECKHLLSRIFVANSEKRITIPEIKNHPWF--LRNLPIELTEGGSWQSHDVNNPSQSL 286
                LL +I     + RI   E   HP+F  LRN      +  S   H VN     L
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQL 353

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  129 bits (326), Expect = 4e-35
 Identities = 72/304 (23%), Positives = 107/304 (35%), Gaps = 50/304 (16%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNI 60
            RY  +K +G G  G+     D    + +A+K I        +H  REI   R L H NI
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 61  VRFKEVLLTPTHLAIVMEYAAGG--------ELFE----RICNAGRFSEDEARFFFQQLI 108
           V+  E+L            +           E  E     +   G   E+ AR F  QL+
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPA 164
            G+ Y HS  + HRDLK  N  ++ +    +KI DFG ++    H   K      + T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 165 YIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------------DPED 205
           Y +P + L+   Y   I D+W+ G     ML G   F                     ED
Sbjct: 190 YRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 206 PKNFRKTIGRILSVHYSFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKN 256
            +     I   +    +        L              L +I   +   R+T  E  +
Sbjct: 249 RQELLSVIPVYIR---NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305

Query: 257 HPWF 260
           HP+ 
Sbjct: 306 HPYM 309

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  129 bits (326), Expect = 5e-35
 Identities = 71/298 (23%), Positives = 112/298 (37%), Gaps = 59/298 (19%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF- 63
            + + IG G FG  ++ R KW  E +AVK     ++     + EI     L+H NI+ F 
Sbjct: 45  VLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 64  ---KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---- 116
               +   T T L +V +Y   G LF+ + N    + +          SG+++ H     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 117 ----MQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G +      +  +   P   VGT  Y+A
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 168 PEVL------TKKEYDGKIADVWSCGVTLYVMLVG----------AYPFED--PEDP--- 206
           PEVL         E   + AD+++ G+  + +               P+ D  P DP   
Sbjct: 220 PEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 207 --------KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN 256
                   +  R  I        +     ++  EC +       AN   R+T   IK 
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY-------ANGAARLTALRIKK 329

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  128 bits (324), Expect = 5e-35
 Identities = 69/311 (22%), Positives = 111/311 (35%), Gaps = 59/311 (18%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ------REIMNHRS 54
             RYE V +IG G +G     RD  +   +A+K +                 RE+   R 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 55  LK---HPNIVRFKEVLLTPTH-----LAIVMEYAAG--GELFERICNAGRFSEDEARFFF 104
           L+   HPN+VR  +V  T        + +V E+         ++         +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK---STVG 161
           +Q + G+ + H+  I HRDLK EN L+       VK+ DFG ++    +S        V 
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLARI---YSYQMALTPVVV 181

Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV 219
           T  Y APEVL +  Y   + D+WS G     M      +      D       +G+I  +
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEAD------QLGKIFDL 234

Query: 220 ----------------HYSFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEI 254
                             +FP      ++            LL  +   N  KRI+    
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294

Query: 255 KNHPWFLRNLP 265
             H +  ++  
Sbjct: 295 LQHSYLHKDEG 305

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  129 bits (326), Expect = 8e-35
 Identities = 73/305 (23%), Positives = 123/305 (40%), Gaps = 54/305 (17%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ-------REIMNHR 53
            +RYE +  +G G F      RDK T +++A+K I +     E          REI   +
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQ 67

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQQLISGV 111
            L HPNI+   +     +++++V ++       + +   N+   +    + +    + G+
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGL 125

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 170
            Y H   I HRDLK  N LLD +    +K+ DFG +KS    ++  +  V T  Y APE+
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 171 LT-KKEYDGKIADVWSCGVTLYVMLVGAYPF---EDPEDPKNFRKTIGRILSV------- 219
           L   + Y   + D+W+ G  L  +L+   PF   +   D       + RI          
Sbjct: 184 LFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLD------QLTRIFETLGTPTEE 235

Query: 220 ---------HY-SFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKNHPWF 260
                     Y +F  +  + L             L+  +F+ N   RIT  +     +F
Sbjct: 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

Query: 261 LRNLP 265
             N P
Sbjct: 296 -SNRP 299

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (320), Expect = 2e-34
 Identities = 71/208 (34%), Positives = 99/208 (47%), Gaps = 13/208 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHV----QREIMNHRSLKH 57
           ERY+IV  +G G      L  D      +A+K I    +  E      +RE+ N   L H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
            NIV   +V        +VMEY  G  L E I + G  S D A  F  Q++ G+ + H M
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 118 QICHRDLKLENTLL--DGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTK 173
           +I HRD+K +N L+  +      +KI DFG +K  S    +Q    +GT  Y +PE    
Sbjct: 131 RIVHRDIKPQNILIDSNK----TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFE 201
           +  D    D++S G+ LY MLVG  PF 
Sbjct: 187 EATDEC-TDIYSIGIVLYEMLVGEPPFN 213

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  127 bits (321), Expect = 3e-34
 Identities = 65/297 (21%), Positives = 111/297 (37%), Gaps = 59/297 (19%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF- 63
           ++VK IG G +G  ++   KW  E +AVK     ++     + EI     ++H NI+ F 
Sbjct: 40  QMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 64  ---KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 118
               +   + T L ++ +Y   G L++ + +                +SG+ + H+    
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 119 ------ICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G +      ++ +   P + VGT  Y+ 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 168 PEVL------TKKEYDGKIADVWSCGVTLYVMLVG----------AYPFED--PEDP--- 206
           PEVL         +     AD++S G+ L+ +               P+ D  P DP   
Sbjct: 215 PEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

Query: 207 --------KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 255
                   K  R +     S         ++  EC          N   R+T   +K
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA-------HNPASRLTALRVK 323

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  124 bits (314), Expect = 5e-33
 Identities = 76/296 (25%), Positives = 124/296 (41%), Gaps = 46/296 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +   RE+   + +KH 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 59  NIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           N++   +V      L       +V     G +L   I    + ++D  +F   Q++ G+ 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      +KI DFG ++     +  + T  V T  Y APE+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARH----TADEMTGYVATRWYRAPEI 200

Query: 171 -LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PKNFRKTIGR 215
            L    Y+  + D+WS G  +  +L G   +P  D  D                 K I  
Sbjct: 201 MLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 216 ILSVHY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             + +Y  S     +++              LL ++ V +S+KRIT  +   H +F
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  124 bits (313), Expect = 6e-33
 Identities = 71/296 (23%), Positives = 129/296 (43%), Gaps = 47/296 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
           + Y     +GSG +G      DK + E +A+K + R  + +   +   RE++  + ++H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 59  NIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           N++   +V    + L       +VM +    +L + +    +FSE++ ++   Q++ G+ 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGLK 140

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 170
           Y HS  + HRDLK  N  ++      +KI DFG ++     +  + T  V T  Y APEV
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARH----ADAEMTGYVVTRWYRAPEV 194

Query: 171 -LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PKNFRKTIGR 215
            L+   Y+  + D+WS G  +  ML G   +  +D  D               F + +  
Sbjct: 195 ILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253

Query: 216 ILSVHY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             +  Y  S P   R            +   LL ++   + +KR+T  +   HP+F
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  123 bits (312), Expect = 1e-32
 Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 46/296 (15%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKID-EHVQREIMNHRSLKHP 58
             Y  ++ +GSG +G      D  T   +A+K + R    ++  +   RE+   + ++H 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 59  NIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           N++   +V      L       +VM +  G +L  ++    +  ED  +F   Q++ G+ 
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGLR 142

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 170
           Y H+  I HRDLK  N  ++      +KI DFG ++     +  + T  V T  Y APEV
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ----ADSEMTGYVVTRWYRAPEV 196

Query: 171 -LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PKNFRKTIGR 215
            L    Y   + D+WS G  +  M+ G   +   D  D            P  F + +  
Sbjct: 197 ILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255

Query: 216 ILSVHY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
             + +Y    P+  +               +LL ++ V ++E+R+T  E   HP+F
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  123 bits (310), Expect = 2e-32
 Identities = 80/310 (25%), Positives = 123/310 (39%), Gaps = 62/310 (20%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQ------REIMNHR 53
             +++   +G G +GV      K T E++A+K      KI+  +         REI   +
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKILK 64

Query: 54  SLKHPNIVRFKEVLLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLI 108
             KH NI+    +    +        I+ E     +L  R+ +    S+D  ++F  Q +
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTL 122

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQPKST----- 159
             V   H   + HRDLK  N L++ +    +K+CDFG      +S+  +S+P        
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 160 --VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED--------- 205
             V T  Y APEV LT  +Y   + DVWSCG  L  + +    +P  D            
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239

Query: 206 ----PKNFRKTIGRILSVHY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRIT 250
                 N  + I    +  Y  S P Y    L         +   LL R+ V +  KRIT
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299

Query: 251 IPEIKNHPWF 260
             E   HP+ 
Sbjct: 300 AKEALEHPYL 309

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  122 bits (309), Expect = 2e-32
 Identities = 78/302 (25%), Positives = 119/302 (39%), Gaps = 54/302 (17%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID--EHVQ------REIMNHR 53
            RY  +  IG G +G+     D   +  +A+K      KI   EH        REI    
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILL 80

Query: 54  SLKHPNIVRFKEVLLTPTH-----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI 108
             +H NI+   +++  PT      + IV +     +L  ++      S D   +F  Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQIL 138

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST----VGTPA 164
            G+ Y HS  + HRDLK  N LL+ +    +KICDFG ++ +             V T  
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 165 YIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED------------PKNF 209
           Y APE+ L  K Y   I D+WS G  L  ML     +P +   D             +  
Sbjct: 197 YRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255

Query: 210 RKTIGRILSVHY--SFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKNHP 258
              I  + + +Y  S P   +V               LL ++   N  KRI + +   HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315

Query: 259 WF 260
           + 
Sbjct: 316 YL 317

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  122 bits (308), Expect = 3e-32
 Identities = 73/330 (22%), Positives = 123/330 (37%), Gaps = 63/330 (19%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHV----QREIMNHRSLK 56
           + +YE +  IG G FG     R + T + +A+K +   +   E       REI   + LK
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLK 74

Query: 57  HPNIVRFKEVLLTPTHLA--------IVMEYA----AGGELFERICNAGRFSEDEARFFF 104
           H N+V   E+  T             +V ++     AG  L   +    +F+  E +   
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVM 130

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG----YSKSSVLHSQP-KST 159
           Q L++G+ Y H  +I HRD+K  N L+       +K+ DFG    +S +         + 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 160 VGTPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVMLVGA--------------------Y 198
           V T  Y  PE+L  +++Y   I D+W  G  +  M   +                     
Sbjct: 189 VVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247

Query: 199 PFED--PE-------DPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRI 249
              +  P        +     K   R +        YVR       L+ ++ V +  +RI
Sbjct: 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDR--LKAYVR-DPYALDLIDKLLVLDPAQRI 304

Query: 250 TIPEIKNHPWFLRN-LPIELTEGGSWQSHD 278
              +  NH +F  + +P +L    S     
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTS 334

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (306), Expect = 3e-32
 Identities = 66/247 (26%), Positives = 95/247 (38%), Gaps = 47/247 (19%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVK-----------FIERGQKIDEHVQREIM 50
           +RYE+ + +G G      L RD      +AVK           F  R        +RE  
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-------FRREAQ 64

Query: 51  NHRSLKHPNIVR---FKEVLLTPTHLA-IVMEYAAGGELFERICNAGRFSEDEARFFFQQ 106
           N  +L HP IV      E       L  IVMEY  G  L + +   G  +   A      
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 107 LISGVSYCHSMQICHRDLKLENTLL--DGSTAPRVKICDFG----YSKSSVLHSQPKSTV 160
               +++ H   I HRD+K  N ++         VK+ DFG     + S    +Q  + +
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATN----AVKVMDFGIARAIADSGNSVTQTAAVI 180

Query: 161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------EDPEDP 206
           GT  Y++PE       D + +DV+S G  LY +L G  PF              EDP  P
Sbjct: 181 GTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239

Query: 207 KNFRKTI 213
               + +
Sbjct: 240 SARHEGL 246

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (305), Expect = 3e-32
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 23/212 (10%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVK-----------FIERGQKIDEHVQREIMN 51
            Y + + +G G  G      D     ++A+K           F  R       +QRE   
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-------MQREART 87

Query: 52  HRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
              L+ P++V   +       L + M    G +L   +   G  +   A    +Q+ S +
Sbjct: 88  AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG--YSKSSVLHSQPKSTVGTPAYIAPE 169
              H+    HRD+K EN L+         + DFG   + +    +Q  +TVGT  Y+APE
Sbjct: 148 DAAHAAGATHRDVKPENILVSAD--DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205

Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
             ++     + AD+++    LY  L G+ P++
Sbjct: 206 RFSESHATYR-ADIYALTCVLYECLTGSPPYQ 236

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  121 bits (306), Expect = 4e-32
 Identities = 79/309 (25%), Positives = 124/309 (40%), Gaps = 58/309 (18%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRD-KWTRELLAVKFIERGQKIDEHVQ----REIMNHRSL 55
            ++YE V +IG G +G     RD K     +A+K + R Q  +E +     RE+   R L
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHL 68

Query: 56  K---HPNIVRFKEVLLTP-----THLAIVMEYAAG--GELFERICNAGRFSEDEARFFFQ 105
           +   HPN+VR  +V         T L +V E+         ++         +  +    
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMF 127

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTP 163
           QL+ G+ + HS ++ HRDLK +N L+  S   ++K+ DFG ++      Q   T  V T 
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARI--YSFQMALTSVVVTL 183

Query: 164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEDPKNFRKTIGRILSV-- 219
            Y APEVL +  Y   + D+WS G     M      +      D       +G+IL V  
Sbjct: 184 WYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKILDVIG 236

Query: 220 --------------HYSFPDYVRVSLECK---------HLLSRIFVANSEKRITIPEIKN 256
                           +F       +E            LL +    N  KRI+     +
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296

Query: 257 HPWFLRNLP 265
           HP+F ++L 
Sbjct: 297 HPYF-QDLE 304

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  121 bits (305), Expect = 8e-32
 Identities = 58/306 (18%), Positives = 106/306 (34%), Gaps = 54/306 (17%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ------------REI 49
             Y + + I SG++G      D      +A+K +         V             REI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 50  MNHRSLKHPNIVRFKEVLLTPTH-----LAIVMEYAAGGELFERI-CNAGRFSEDEARFF 103
                  HPNI+  +++ +         L +V E     +L + I       S    ++F
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP 163
              ++ G+   H   + HRDL   N LL  +    + ICDF  ++     +     V   
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICDFNLAREDTADANKTHYVTHR 197

Query: 164 AYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPED-----------PKNF 209
            Y APE+ +  K +   + D+WS G  +  M      +      +           PK  
Sbjct: 198 WYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK-- 254

Query: 210 RKTIGRILS------VHYSFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEI 254
            + +    S      +  S  +    +              L++++   N ++RI+  + 
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314

Query: 255 KNHPWF 260
             HP+F
Sbjct: 315 LRHPYF 320

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  121 bits (306), Expect = 1e-31
 Identities = 71/326 (21%), Positives = 112/326 (34%), Gaps = 66/326 (20%)

Query: 2   ERYEIVKD-IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH 57
           + +E     +G G +G    AK  +D    +  A+K IE    I     REI   R LKH
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77

Query: 58  PNIVRFKEVLLTPTHLAI--VMEYA--------AGGELFERICNAGRFSEDEARFFFQQL 107
           PN++  ++V L+     +  + +YA              +      +      +    Q+
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSTAPR--VKICDFG----YSKSSVLHSQPKSTVG 161
           + G+ Y H+  + HRDLK  N L+ G    R  VKI D G    ++      +     V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 162 TPAYIAPEVLT-KKEYDGKIADVWSCGVTLYVML-------------------------- 194
           T  Y APE+L   + Y   I D+W+ G     +L                          
Sbjct: 198 TFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256

Query: 195 ---------------VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
                          +   P          R T      + Y     V+   +  HLL +
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316

Query: 240 IFVANSEKRITIPEIKNHPWFLRNLP 265
           +   +  KRIT  +    P+F    P
Sbjct: 317 LLTMDPIKRITSEQAMQDPYF-LEDP 341

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (310), Expect = 3e-31
 Identities = 48/215 (22%), Positives = 78/215 (36%), Gaps = 34/215 (15%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDK--WTRELLAVK---------FIERGQKIDEHVQREIMN 51
           +YE+   I  G  G   L  D+    R +  +K                       E   
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAM-------AMAERQF 132

Query: 52  HRSLKHPNIVR---FKEVLLTPTHLA--IVMEYAAGGELFERICNAGRFSEDEARFFFQQ 106
              + HP+IV+   F E           IVMEY  G  L        +    EA  +  +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLE 190

Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI 166
           ++  +SY HS+ + + DLK EN +L      ++K+ D G        +      GTP + 
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQ 244

Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFE 201
           APE++          D+++ G TL  + +      
Sbjct: 245 APEIVRTGPTVA--TDIYTVGRTLAALTLDLPTRN 277

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  119 bits (301), Expect = 4e-31
 Identities = 65/331 (19%), Positives = 112/331 (33%), Gaps = 72/331 (21%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-----------MN 51
           RY +V+ +G G+F    L +D      +A+K +   +   E  + EI             
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 52  HRSLKHPNIVRFKEVL----LTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQ 105
             S+   +I++  +          H+ +V E   G  L    +            +   +
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 106 QLISGVSYCHSM-QICHRDLKLENTLLDGSTAPR----VKICDFGYSKSSVLHSQPKSTV 160
           QL+ G+ Y H    I H D+K EN L++   +P     +KI D G   +        +++
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSI 196

Query: 161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED--------------- 205
            T  Y +PEVL    +     D+WS    ++ ++ G + FE  E                
Sbjct: 197 QTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 206 -----PKNF------------------------RKTIGRILSVHYSFPDYVRVSLECKHL 236
                P                              +  +L+  Y F      + E    
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK--DEAKEISDF 313

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLPIE 267
           LS +   +  KR     + NHPW    L +E
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  119 bits (300), Expect = 5e-31
 Identities = 77/345 (22%), Positives = 132/345 (38%), Gaps = 59/345 (17%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R  +   H +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 58  PNIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
            NI+    V      L       IVME      L  ++        +   +   Q++ G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
            + HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------------DPEDPKNFRKTI 213
               Y   + D+WS G  +  M+ G   F                    PE  K  + T+
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257

Query: 214 GRILSVHYSFPDYVRVSL---------------------ECKHLLSRIFVANSEKRITIP 252
              +    + P Y   S                      + + LLS++ V ++ KRI++ 
Sbjct: 258 RTYVE---NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 253 EIKNHPWF--LRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHE 295
           E   HP+     +               ++    ++EE   LI++
Sbjct: 315 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYK 359

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  120 bits (302), Expect = 5e-31
 Identities = 77/329 (23%), Positives = 110/329 (33%), Gaps = 75/329 (22%)

Query: 3   RYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH---- 57
           RYE++K IG G+FG V K   D    + +A+K +   ++       EI   R L+H    
Sbjct: 98  RYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEHLRKQ 153

Query: 58  -----PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISG 110
                 N++   E      H+ +  E      L+E I       FS    R F   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 169
           +   H  +I H DLK EN LL       +K+ DFG   SS    Q   T + +  Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFYRAPE 269

Query: 170 VLTKKEYDGKIADVWSCGVTLY---------------------VMLVGAYP--------- 199
           V+    Y   I D+WS G  L                      + L+G            
Sbjct: 270 VILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328

Query: 200 ----FEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC-------------------KHL 236
                     P+    T     SV  +     R  L                        
Sbjct: 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           L +    +   R+T  +   HPW  R LP
Sbjct: 389 LKQCLEWDPAVRMTPGQALRHPWLRRRLP 417

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  116 bits (291), Expect = 4e-30
 Identities = 59/293 (20%), Positives = 102/293 (34%), Gaps = 53/293 (18%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF- 63
           ++++ IG G +G   + +       +AVK      + +   ++ I     ++H NI RF 
Sbjct: 16  KLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFI 73

Query: 64  ----KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 117
               +          +VMEY   G L + + +        +      +  G++Y H+   
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132

Query: 118 -------QICHRDLKLENTLLDGSTAPRVKICDFGYSK---------SSVLHSQPKSTVG 161
                   I HRDL   N L+         I DFG S               +   S VG
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 162 TPAYIAPEVL------TKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEDPKNFRKT 212
           T  Y+APEVL         E   K  D+++ G+  + +       +P E   +       
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE------- 243

Query: 213 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPE-IKNHPWFLRNL 264
                   Y       V         ++ V+  ++R   PE  K +   +R+L
Sbjct: 244 --------YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  116 bits (292), Expect = 2e-29
 Identities = 70/309 (22%), Positives = 119/309 (38%), Gaps = 61/309 (19%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKID-EHVQREIMNHRSLKHP 58
           +RY+ +K IGSG  G+     D      +A+K + R    +   +   RE++  + + H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 59  NIVRFKEVLLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           NI+    V      L       +VME      L + I        +   +   Q++ G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGIK 178

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 170
           + HS  I HRDLK  N ++       +KI DFG +++    +    T  V T  Y APEV
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 234

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------------DPEDPKNFRKT 212
           +    Y   + D+WS G  +  M+     F                    PE  K  + T
Sbjct: 235 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293

Query: 213 IGRILSVHYSFPDYVRVSL---------------------ECKHLLSRIFVANSEKRITI 251
           +   +    + P Y  ++                      + + LLS++ V +  KRI++
Sbjct: 294 VRNYVE---NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 252 PEIKNHPWF 260
            +   HP+ 
Sbjct: 351 DDALQHPYI 359

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  113 bits (285), Expect = 6e-29
 Identities = 75/333 (22%), Positives = 113/333 (33%), Gaps = 74/333 (22%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHP--- 58
           +RYEI   IG G+FG      D+  +E +A+K I+  +      Q E+     +      
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 59  ---NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSY 113
               IV  K   +   HL +V E      L++ + N      S +  R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 114 CHS--MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 170
             +  + I H DLK EN LL       +KI DFG   SS    Q     + +  Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVG---------------------------------- 196
           L    YD  I D+WS G  L  M  G                                  
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

Query: 197 ----------AYPFEDPEDPKN-----FRKTIGRILSVHYSFPDYVRVSLECK------- 234
                      +  +  +D K        + +  IL V    P   R             
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348

Query: 235 --HLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
              L+ R+   + + RI       H +F +   
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  114 bits (286), Expect = 1e-28
 Identities = 76/344 (22%), Positives = 121/344 (35%), Gaps = 89/344 (25%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKID-EHVQREIMNHRSLKHP 58
           + Y I   IG G++G   L  DK T + +A+K + R     ID + + REI     LK  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 59  NIVRFKEVLLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
            I+R  ++++    L      IV+E A   +L +        +E+  +     L+ G ++
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA--------- 164
            H   I HRDLK  N LL+      VK+CDFG +++                        
Sbjct: 145 IHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 165 --------------YIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVG------------- 196
                         Y APE+ L ++ Y   I D+WS G     +L               
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNRFP 261

Query: 197 -----------AYPFEDPEDPKNFRKTIGRILSV------------------HY--SFPD 225
                                K+ R  +  I ++                   Y   FP 
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH 321

Query: 226 YVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
              ++L         +  +LL  +   N  KRITI +  +HP+ 
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  110 bits (278), Expect = 3e-28
 Identities = 62/297 (20%), Positives = 107/297 (36%), Gaps = 59/297 (19%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRF- 63
           ++++    G FG   + + +   E +AVK      K     + E+ +   +KH NI++F 
Sbjct: 27  QLLEVKARGRFG--CVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFI 84

Query: 64  ---KEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 118
              K        L ++  +   G L + +  A   S +E     + +  G++Y H     
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHEDIPG 143

Query: 119 --------ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST---VGTPAYIA 167
                   I HRD+K +N LL  +      I DFG +           T   VGT  Y+A
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201

Query: 168 PEVL-----TKKEYDGKIADVWSCGVTL---------YVMLVGAY--PFED--PEDP--- 206
           PEVL      +++   +  D+++ G+ L             V  Y  PFE+   + P   
Sbjct: 202 PEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260

Query: 207 --------KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 255
                   K  R  +      H           EC          ++E R++   + 
Sbjct: 261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD-------HDAEARLSAGCVG 310

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  112 bits (283), Expect = 3e-28
 Identities = 81/352 (23%), Positives = 124/352 (35%), Gaps = 97/352 (27%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKID-EHVQREIMNHRSLKHP 58
           +RYEI   IG+G++G      DK  + ++A+K I R     ID + + REI     L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 59  NIVRFKEVLLTPT-----HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           ++V+  ++++         L +V+E A   +  +        +E   +     L+ GV Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPA--------- 164
            HS  I HRDLK  N L++      VK+CDFG +++        S +             
Sbjct: 172 VHSAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229

Query: 165 -------------------YIAPEV-LTKKEYDGKIADVWSCG----------------- 187
                              Y APE+ L ++ Y   I DVWS G                 
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAELLNMIKENVAYH 288

Query: 188 ----------VTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV------------------ 219
                         +        +     +  R  +  I ++                  
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348

Query: 220 HY--SFPDYVRVSL---------ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
            Y   FP      L         +  HLL R+ V N  KRITI E   HP+F
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  108 bits (272), Expect = 5e-27
 Identities = 78/329 (23%), Positives = 117/329 (35%), Gaps = 75/329 (22%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER--GQKID-EHVQREIMNHRSLK-H 57
            +YE+VK +G G +G+     D+ T E++AVK I        D +   REIM    L  H
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 58  PNIVRFKEVLLTPT--HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
            NIV    VL       + +V +Y    +L   +  A        ++   QLI  + Y H
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST---------------- 159
           S  + HRD+K  N LL+      VK+ DFG S+S V   +  +                 
Sbjct: 127 SGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 160 ------VGTPAYIAPEV-LTKKEYDGKIADVWSCGVTLYVMLVG---------------- 196
                 V T  Y APE+ L   +Y   I D+WS G  L  +L G                
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

Query: 197 -------------------------AYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL 231
                                    +   +      N R    +  ++          + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303

Query: 232 ECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           E   LL ++   N  KRI+  +   HP+ 
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFV 332

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  105 bits (265), Expect = 3e-26
 Identities = 74/348 (21%), Positives = 115/348 (33%), Gaps = 76/348 (21%)

Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHP-- 58
           ERYEIV ++G G FG V + +     +  +A+K I    K  E  + EI   + +K    
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78

Query: 59  ----NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVS 112
                 V   +      H+ I  E   G   FE +       +     R    QL   + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 113 YCHSMQICHRDLKLENTLLDGSTA-----------------PRVKICDFGYSKSSVLHSQ 155
           + H  Q+ H DLK EN L   S                     +++ DFG   S+    +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194

Query: 156 PKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA--YPFED---------- 202
             +T V T  Y  PEV+ +  +     DVWS G  L+    G   +   +          
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 203 --------------------------PEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
                                      E+  + R        +           ++   L
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQ 284
           + R+   +  +RIT+ E   HP+F    P E         H   NPS+
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEER------SFHTSRNPSR 355

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  104 bits (261), Expect = 2e-25
 Identities = 57/336 (16%), Positives = 108/336 (32%), Gaps = 88/336 (26%)

Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-----MNHRSL 55
             + +++ +G G FG V    +    ++  AVK +   +K     + E      + +  +
Sbjct: 35  NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSY 113
            + NIV++    +   H+ ++ E   G  L+E I       F  ++ + +  +++  ++Y
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 114 CHSMQICHRDLKLENTLLDGSTA-----------------------PRVKICDFGYSKSS 150
              M + H DLK EN LLD                             +K+ DFG    +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209

Query: 151 VLHSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG------------- 196
              S    + + T  Y APEV+    +D    D+WS G  L  +  G             
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHMEHL 268

Query: 197 --------------------------------AYPFEDPEDPKNFRKTIGRILSVHYSFP 224
                                              + +     N  K + + L ++    
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328

Query: 225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                       L  I   +   R +  E+  H + 
Sbjct: 329 H-----ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  100 bits (251), Expect = 3e-24
 Identities = 78/327 (23%), Positives = 117/327 (35%), Gaps = 76/327 (23%)

Query: 2   ERYEIVKDIGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH--- 57
            RYEIV  +G G FG V + +  K     +AVK ++   +  E  + EI   + L+H   
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI---QVLEHLNT 70

Query: 58  ------PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLIS 109
                    V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+  
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTA-----------------PRVKICDFGYSKSSVL 152
            V++ HS ++ H DLK EN L   S                   P +K+ DFG   S+  
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATY 186

Query: 153 HSQPKST-VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLY-------------------- 191
             +  ST V T  Y APEV+    +     DVWS G  L                     
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245

Query: 192 -VMLVGAYP------------FEDPEDPKNFRKTIGR-ILSVHYSFPDYVRVS----LEC 233
              ++G  P            F       +   + GR +        +++          
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305

Query: 234 KHLLSRIFVANSEKRITIPEIKNHPWF 260
             L+ ++   +  KRIT+ E   HP+F
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFF 332

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 99.0 bits (247), Expect = 4e-24
 Identities = 33/210 (15%), Positives = 58/210 (27%), Gaps = 39/210 (18%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH----VQREIMNHRSLKHP 58
           RY ++   G           D      +A+ F++    + +          +    +  P
Sbjct: 32  RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
            + R  +V+ T     +V E+  GG L E        S   A    Q L +     H   
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 119 ICHRDLKLENTLL--DGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           +           +  DG     V                    +  PA +          
Sbjct: 150 VALSIDHPSRVRVSIDG----DVV-------------------LAYPATMPDA------- 179

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDP 206
                D+   G +LY +LV  +P  +    
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVR 208

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 97.7 bits (244), Expect = 1e-23
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 25/228 (10%)

Query: 5   EIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFI-ERGQKIDEHVQRE--IMNHRSLK 56
           + ++ +G GNFG         ++D  T E++AVK +    ++     +RE  I+  +SL+
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEIL--KSLQ 69

Query: 57  HPNIVRFKEVLLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 113
           H NIV++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G+ Y
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 168
             + +  HRDL   N L+      RVKI DFG +K  +   +    V  P        AP
Sbjct: 130 LGTKRYIHRDLATRNILV--ENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAP 186

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI 216
           E LT+ ++    +DVWS GV LY +    Y  +    P  F + IG  
Sbjct: 187 ESLTESKFSVA-SDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGND 231

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 25/228 (10%)

Query: 5   EIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFI-ERGQKIDEHVQRE--IMNHRSLK 56
           + ++ +G GNFG         ++D  T E++AVK +    ++     +RE  I+  +SL+
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEIL--KSLQ 100

Query: 57  HPNIVRFKEVLLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 113
           H NIV++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G+ Y
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 168
             + +  HRDL   N L+      RVKI DFG +K  +   +    V  P        AP
Sbjct: 161 LGTKRYIHRDLATRNILV--ENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAP 217

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI 216
           E LT+ ++    +DVWS GV LY +    Y  +    P  F + IG  
Sbjct: 218 ESLTESKFSVA-SDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGND 262

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 26/234 (11%)

Query: 5   EIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFI-ERGQKIDEHVQRE--IMNHRSLK 56
           + +  +G GNFG         + D  T  L+AVK +   G       QRE  I+  ++L 
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDN-TGALVAVKQLQHSGPDQQRDFQREIQIL--KALH 82

Query: 57  HPNIVRFKEVLLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 113
              IV+++ V   P    L +VMEY   G L + +  +  R        +  Q+  G+ Y
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYI-----A 167
             S +  HRDL   N L+   +   VKI DFG +K  +L        V  P        A
Sbjct: 143 LGSRRCVHRDLAARNILV--ESEAHVKIADFGLAK--LLPLDKDYYVVREPGQSPIFWYA 198

Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTIGRILSVH 220
           PE L+   +  + +DVWS GV LY +            +          + ++ 
Sbjct: 199 PESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 58/209 (27%), Positives = 83/209 (39%), Gaps = 18/209 (8%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ--RE--IMNHRSLKHPNI 60
            + + IG GNFG     R +    L+AVK        D   +  +E  I+  +   HPNI
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL--KQYSHPNI 174

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           VR   V      + IVME   GG+    +     R              +G+ Y  S   
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLTKK 174
            HRDL   N L+       +KI DFG S+         +  G    +     APE L   
Sbjct: 235 IHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYG 290

Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            Y  + +DVWS G+ L+    +GA P+ +
Sbjct: 291 RYSSE-SDVWSFGILLWETFSLGASPYPN 318

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 93.1 bits (232), Expect = 5e-22
 Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 21/213 (9%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH----RSLKH 57
            +++ +G G+FGV    +          +AVK ++           + +       SL H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 116
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEV 170
            +  HRDL   N LL  +T   VKI DFG  +   L                    APE 
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           L  + +    +D W  GVTL+ +   G  P+  
Sbjct: 196 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 92.8 bits (231), Expect = 8e-22
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
              + ++D+G G+FG           D  T E +AVK ++     +     ++E  I+  
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEIL-- 77

Query: 53  RSLKHPNIVRFKEVLLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLIS 109
           R+L H NIV++K +        + ++ME+   G L E +  N  + +  +   +  Q+  
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYI-- 166
           G+ Y  S Q  HRDL   N L++     +VKI DFG +K   + +  +  TV        
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTK--AIETDKEYYTVKDDRDSPV 193

Query: 167 ---APEVLTKKEYDGKIADVWSCGVTLY 191
              APE L + ++    +DVWS GVTL+
Sbjct: 194 FWYAPECLMQSKFYIA-SDVWSFGVTLH 220

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 94.2 bits (234), Expect = 8e-22
 Identities = 72/365 (19%), Positives = 115/365 (31%), Gaps = 112/365 (30%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREI-----MNHRSLK 56
            RY +++ +G G+F    L  D   ++ +A+K ++  +   E    EI     + +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 57  HPN---IVR----FKEVLLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARFFFQQL 107
            PN   +V+    FK   +  TH+ +V E   G  L + I   N         +   QQ+
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 108 ISGVSYCHS-MQICHRDLKLENTLLD---------------------------------- 132
           + G+ Y H+  +I H D+K EN LL                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 133 -------------GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
                         +   +VKI D G   +  +H      + T  Y + EVL    Y+  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273

Query: 180 IADVWSCGVTLYVMLVGAYPFE--------DPED------------PKNFRK-------- 211
            AD+WS     + +  G Y FE          ED            P+            
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 212 ----------------TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 255
                            +  +L   Y +      +      L  +     EKR T  E  
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQ--EEAAGFTDFLLPMLELIPEKRATAAECL 390

Query: 256 NHPWF 260
            HPW 
Sbjct: 391 RHPWL 395

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 19/211 (9%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELL-AVKFIERGQKIDEHVQREIMNH----RSLK 56
           + +K +GSG FG       + +    ++  A+K +           +EI++      S+ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 115
           +P++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y  
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLT 172
             ++ HRDL   N L+   T   VKI DFG +K      +     G   P  ++A E + 
Sbjct: 135 DRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            + Y  + +DVWS GVT++ +M  G+ P++ 
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFI--ERGQKIDEHVQRE--IMNH 52
              + ++D+G G+FG           D  T E++AVK +  + G +     ++E  I+  
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDG-TGEMVAVKALKADAGPQHRSGWKQEIDIL-- 87

Query: 53  RSLKHPNIVRFKEVLLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
           R+L H +I+++K          L +VMEY   G L + +         +   F QQ+  G
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEG 146

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---- 166
           ++Y H+    HRDL   N LL       VKI DFG +K+ V        V          
Sbjct: 147 MAYLHAQHYIHRDLAARNVLL--DNDRLVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFW 203

Query: 167 -APEVLTKKEYDGKIADVWSCGVTLY 191
            APE L + ++    +DVWS GVTLY
Sbjct: 204 YAPECLKEYKFYYA-SDVWSFGVTLY 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 16/210 (7%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQRE--IMNHRSLKH 57
               +   +G G +G   +    W +  L  AVK ++      E   +E  +M  + +KH
Sbjct: 220 TDITMKHKLGGGQYGE--VYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM--KEIKH 275

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PN+V+   V        I+ E+   G L  + R CN    S     +   Q+ S + Y  
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLTK 173
                HR+L   N L+  +    VK+ DFG S+     +              APE L  
Sbjct: 336 KKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            ++  K +DVW+ GV L+ +   G  P+  
Sbjct: 394 NKFSIK-SDVWAFGVLLWEIATYGMSPYPG 422

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 8   KDIGSGNFG-VAK-LVRDKWTRELLAVKFIERG---QKIDEHVQRE--IMNHRSLKHPNI 60
           K++GSGNFG V K   + K   + +AVK ++       + + +  E  +M  + L +P I
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM--QQLDNPYI 80

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           VR   +    + + +VME A  G L + +       +        Q+  G+ Y       
Sbjct: 81  VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLTKK 174
           HRDL   N LL   T    KI DFG SK   L +     K+      P  + APE +   
Sbjct: 140 HRDLAARNVLL--VTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYY 195

Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           ++  K +DVWS GV ++     G  P+  
Sbjct: 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 87.7 bits (218), Expect = 5e-20
 Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 18/211 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKIDEHVQRE--IMNHRSLKH 57
               +   +G G +G   +    W +  L  AVK ++      E   +E  +M  + +KH
Sbjct: 13  TDITMKHKLGGGQYGE--VYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM--KEIKH 68

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PN+V+   V        I+ E+   G L  + R CN    S     +   Q+ S + Y  
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLT 172
                HRDL   N L+  +    VK+ DFG S+  +      +  G   P  + APE L 
Sbjct: 129 KKNFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 185

Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
             ++  K +DVW+ GV L+ +   G  P+  
Sbjct: 186 YNKFSIK-SDVWAFGVLLWEIATYGMSPYPG 215

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 86.5 bits (215), Expect = 8e-20
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 18/210 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELL-AVKFIERGQKIDEHVQRE--IMNHRSLKHP 58
                V++IGSG FG   +    W  +   A+K I  G   +E    E  +M    L HP
Sbjct: 8   SELTFVQEIGSGQFG--LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVM--MKLSHP 63

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            +V+   V L    + +V E+   G L  + R    G F+ +        +  G++Y   
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTK 173
             + HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT   +   +PEV + 
Sbjct: 123 ACVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSF 179

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
             Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 180 SRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 20/212 (9%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--RE--IMNHRSLKH 57
            I K IGSG+ G     +L         +A+K ++ G    +      E  IM      H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM--GQFDH 109

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 115
           PNI+R + V+       IV EY   G L  F R  + G+F+  +     + + +G+ Y  
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVL 171
            +   HRDL   N L+D +     K+ DFG S+          +T G    I   APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 172 TKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
             + +    +DVWS GV ++ V+  G  P+ +
Sbjct: 227 AFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 12/207 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELL-AVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E   +   +G G FG   +    W      A+K ++ G    E   +E    + L+H  +
Sbjct: 184 ESLRLEVKLGQGCFGE--VWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL 241

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           V+   V+ +   + IV EY + G L  F +          +      Q+ SG++Y   M 
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLTKKEY 176
             HRDL+  N L+  +     K+ DFG ++    +               APE      +
Sbjct: 301 YVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358

Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS G+ L  +   G  P+  
Sbjct: 359 TIK-SDVWSFGILLTELTTKGRVPYPG 384

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 19/211 (9%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELL-AVKFIERGQKIDEHVQREIMNH----RSLK 56
           + +K +GSG FG       + +    ++  A+K +           +EI++      S+ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 115
           +P++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y  
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLT 172
             ++ HRDL   N L+   T   VKI DFG +K      +     G   P  ++A E + 
Sbjct: 135 DRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 173 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            + Y  + +DVWS GVT++ +M  G+ P++ 
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 30/223 (13%)

Query: 2   ERYEIVKD--------IGSGNFG-VAK-LVRDKWTRELLAVKFIERGQKIDEHVQ--RE- 48
           ++  + +D        +G GNFG V + + R +  +  +A+K +++G +  +  +  RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 49  -IMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQ 106
            IM    L +P IVR   V      + +VME A GG L + +                 Q
Sbjct: 62  QIM--HQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGT- 162
           +  G+ Y       HRDL   N LL        KI DFG SK   L +      +     
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLL--VNRHYAKISDFGLSK--ALGADDSYYTARSAGK 174

Query: 163 -P-AYIAPEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            P  + APE +  +++  + +DVWS GVT++  +  G  P++ 
Sbjct: 175 WPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 12/207 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELL-AVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E   +   +G G FG   +    W      A+K ++ G    E   +E    + L+H  +
Sbjct: 267 ESLRLEVKLGQGCFGE--VWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL 324

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           V+   V+ +   + IV EY + G L  F +          +      Q+ SG++Y   M 
Sbjct: 325 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLTKKEY 176
             HRDL+  N L+  +     K+ DFG ++    +               APE      +
Sbjct: 384 YVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441

Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS G+ L  +   G  P+  
Sbjct: 442 TIK-SDVWSFGILLTELTTKGRVPYPG 467

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 20/209 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR-EIMNHRSLKHPNI 60
           +  ++++ IG G FG   ++   +    +AVK I+        +    +M    L+H N+
Sbjct: 21  KELKLLQTIGKGEFG--DVMLGDYRGNKVAVKCIKNDATAQAFLAEASVM--TQLRHSNL 76

Query: 61  VRFKEV-LLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           V+   V +     L IV EY A G L  + R         D    F   +   + Y    
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKK 174
              HRDL   N L+        K+ DFG +K +       +       +   APE L +K
Sbjct: 137 NFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 189

Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           ++  K +DVWS G+ L+ +   G  P+  
Sbjct: 190 KFSTK-SDVWSFGILLWEIYSFGRVPYPR 217

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 85.3 bits (212), Expect = 2e-19
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELL-AVKFIERGQKIDEHVQRE--IMNHRSLKHP 58
           E   ++K++GSG FGV  +   KW  +   AVK I+ G   ++   +E   M    L HP
Sbjct: 8   EEITLLKELGSGQFGV--VKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTM--MKLSHP 63

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            +V+F  V      + IV EY + G L  + R  +       +       +  G+++  S
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTK 173
            Q  HRDL   N L+D      VK+ DFG ++  VL  Q  S+VGT   +   APEV   
Sbjct: 123 HQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHY 179

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +Y  K +DVW+ G+ ++ V  +G  P++ 
Sbjct: 180 FKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 20/209 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQR-EIMNHRSLKHPNI 60
           +  ++++ IG G FG   ++   +    +AVK I+        +    +M    L+H N+
Sbjct: 193 KELKLLQTIGKGEFG--DVMLGDYRGNKVAVKCIKNDATAQAFLAEASVM--TQLRHSNL 248

Query: 61  VRFKEV-LLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           V+   V +     L IV EY A G L  + R         D    F   +   + Y    
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKK 174
              HRDL   N L+        K+ DFG +K +       +       +   APE L +K
Sbjct: 309 NFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 361

Query: 175 EYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           ++  K +DVWS G+ L+ +   G  P+  
Sbjct: 362 KFSTK-SDVWSFGILLWEIYSFGRVPYPR 389

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 23/213 (10%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELL-AVKFI--ERGQKIDEHVQRE--IMNHRSLK 56
             +K +GSG FG       + +  + ++   +K I  + G++  + V      +   SL 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI--GSLD 73

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 115
           H +IVR   +    + L +V +Y   G L + +  + G         +  Q+  G+ Y  
Sbjct: 74  HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEV 170
              + HR+L   N LL   +  +V++ DFG +   +L    K  + + A       A E 
Sbjct: 133 EHGMVHRNLAARNVLL--KSPSQVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALES 188

Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           +   +Y  + +DVWS GVT++ +M  GA P+  
Sbjct: 189 IHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 5e-19
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELL-AVKFIERGQKIDEHVQRE--IMNHRSLKHP 58
           E  ++V+ +G+G FG   +    +      AVK +++G    +    E  +M  + L+H 
Sbjct: 13  ETLKLVERLGAGQFGE--VWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM--KQLQHQ 68

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            +VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++   
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTK 173
               HRDL+  N L+  + +   KI DFG ++  +  ++  +  G    I   APE +  
Sbjct: 128 RNYIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 174 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
             +  K +DVWS G+ L  ++  G  P+  
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPG 213

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 85.5 bits (212), Expect = 7e-19
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRS 54
               I K +G+G FG     +L         +A+K ++ G    Q+ D   +  IM    
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM--GQ 102

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVS 112
             HPNI+R + V+     + IV EY   G L  F R  +  +F+  +     + + SG+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 166
           Y   M   HRDL   N L++ +     K+ DFG  +  VL   P    +T G    I   
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217

Query: 167 APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           +PE +  +++    +DVWS G+ L+ VM  G  P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 83.8 bits (208), Expect = 9e-19
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELL-AVKFIERGQKIDEHVQRE--IMNHRSLKHPNIV 61
             +K++G+G FGV  +   KW  +   A+K I+ G   ++    E  +M   +L H  +V
Sbjct: 27  TFLKELGTGQFGV--VKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVM--MNLSHEKLV 82

Query: 62  RFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           +   V      + I+ EY A G L  + R     RF   +     + +   + Y  S Q 
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKEY 176
            HRDL   N L++      VK+ DFG S+  VL  +  S+VG+   +    PEVL   ++
Sbjct: 142 LHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198

Query: 177 DGKIADVWSCGVTLY-VMLVGAYPFED 202
             K +D+W+ GV ++ +  +G  P+E 
Sbjct: 199 SSK-SDIWAFGVLMWEIYSLGKMPYER 224

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 84.7 bits (210), Expect = 9e-19
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 21/216 (9%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELL-AVKFIERGQKIDEHV--QRE--IMNHR 53
                 K IG+G FG      L      +E+  A+K ++ G    + V    E  IM   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM--G 101

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGV 111
              H NI+R + V+     + I+ EY   G L  F R    G FS  +     + + +G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 160

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYI---A 167
            Y  +M   HRDL   N L++ +     K+ DFG S+      +   +T G    I   A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218

Query: 168 PEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           PE ++ +++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 219 PEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 24/208 (11%)

Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERG--QKIDEHVQRE--IMNHRSLKHPNIVR 62
           +G GNFG          K   ++ A+K +++G  +   E + RE  IM    L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIM--HQLDNPYIVR 400

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
              V      + +VME A GG L + +                 Q+  G+ Y       H
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459

Query: 122 RDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLTKKE 175
           R+L   N LL        KI DFG SK   L +      +       +   APE +  ++
Sbjct: 460 RNLAARNVLL--VNRHYAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFED 202
           +  + +DVWS GVT++  +  G  P++ 
Sbjct: 516 FSSR-SDVWSYGVTMWEALSYGQKPYKK 542

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 49/228 (21%), Positives = 89/228 (39%), Gaps = 39/228 (17%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQR-----EIMNHR 53
           +++ + + +G G FG    A+L ++  +   +AVK ++        ++        M  +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM--K 80

Query: 54  SLKHPNIVRF------KEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQ 105
              HP++ +                  +++ +   G+L  F     A R  E+      Q
Sbjct: 81  EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137

Query: 106 QLI-------SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS 158
            L+        G+ Y  S    HRDL   N +L       V + DFG S+   ++S    
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193

Query: 159 TVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
             G  + +     A E L    Y    +DVW+ GVT++ +M  G  P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELL-AVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           E  ++ K +G+G FG   +    + +    AVK ++ G    E    E    ++L+H  +
Sbjct: 188 ESLKLEKKLGAGQFGE--VWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 245

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           V+   V+ T   + I+ E+ A G L  F +     +    +   F  Q+  G+++     
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLTKKE 175
             HRDL+  N L+  S     KI DFG ++  +  ++  +  G    I   APE +    
Sbjct: 305 YIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS 361

Query: 176 YDGKIADVWSCGVTLY-VMLVGAYPFED 202
           +  K +DVWS G+ L  ++  G  P+  
Sbjct: 362 FTIK-SDVWSFGILLMEIVTYGRIPYPG 388

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 51/222 (22%), Positives = 82/222 (36%), Gaps = 28/222 (12%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
           +   +++ +G G FG         + +  +   +AVK +       + +    E  I++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI---- 108
               H NIVR   V L      I+ME  AGG+L   +          +      L+    
Sbjct: 90  --FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 109 ---SGVSYCHSMQICHRDLKLENTLLDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPA 164
               G  Y       HRD+   N LL      R  KI DFG ++   ++       G  A
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCA 205

Query: 165 YI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            +      PE   +  +  K  D WS GV L+ +  +G  P+
Sbjct: 206 MLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 28/222 (12%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNH 52
           +   +++ +G G FG         + +  +   +AVK +        ++D  ++  I++ 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS- 129

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI---- 108
               H NIVR   V L      I++E  AGG+L   +          +      L+    
Sbjct: 130 -KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 109 ---SGVSYCHSMQICHRDLKLENTLLDGSTAPR-VKICDFGYSKSSVLHSQPKSTVGTPA 164
               G  Y       HRD+   N LL      R  KI DFG ++   ++       G  A
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCA 246

Query: 165 YI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            +      PE   +  +  K  D WS GV L+ +  +G  P+
Sbjct: 247 MLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 51/227 (22%), Positives = 85/227 (37%), Gaps = 38/227 (16%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ---RE--IMNHR 53
               + K +G G FG      L ++  T   +AVK ++        ++    E   M  +
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM--K 91

Query: 54  SLKHPNIVR-----FKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQ 106
              HPN++R      +          +++ +   G+L  +       R          Q 
Sbjct: 92  DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQT 148

Query: 107 LI-------SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST 159
           L+        G+ Y  +    HRDL   N +L       V + DFG SK   ++S     
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYR 204

Query: 160 VGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            G  A +     A E L  + Y  K +DVW+ GVT++ +   G  P+
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 19/213 (8%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--RE--IMNHRS 54
           E   + + +G G FG          K  +  +AVK  ++   +D   +   E  IM  ++
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM--KN 69

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 113
           L HP+IV+   ++       I+ME    GEL   +  N           +  Q+   ++Y
Sbjct: 70  LDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI---APEV 170
             S+   HRD+ + N L+  ++   VK+ DFG S+  +          T   I   +PE 
Sbjct: 129 LESINCVHRDIAVRNILV--ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 185

Query: 171 LTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
           +  + +    +DVW   V ++ ++  G  PF  
Sbjct: 186 INFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 78.8 bits (195), Expect = 5e-17
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 21/214 (9%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--RE--IMNHRS 54
           ER E+ + IG G FG       +  +     +A+K  +         +  +E   M  R 
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM--RQ 72

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVS 112
             HP+IV+   V+       I+ME    GEL  F +              +  QL + ++
Sbjct: 73  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALA 130

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPE 169
           Y  S +  HRD+   N L+  S+   VK+ DFG S+  +  S          P  ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE 187

Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +  + +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 188 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 21/214 (9%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNHRS 54
           ER E+ + IG G FG       +  +     +A+K  +            +E   M  R 
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM--RQ 447

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 113
             HP+IV+   V+       I+ME    GEL   +              +  QL + ++Y
Sbjct: 448 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPE 169
             S +  HRD+   N L+  S+   VK+ DFG S+   +      K++ G  P  ++APE
Sbjct: 507 LESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPE 562

Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 202
            +  + +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 563 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 595

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 39/221 (17%), Positives = 77/221 (34%), Gaps = 33/221 (14%)

Query: 5   EIVKDIGSGNFG-----VAKLVRDKWTRELL--AVKFIERG-QKIDEHVQRE--IMNHRS 54
              + +G G F      V + V D          +K +++  +   E       +M    
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM--SK 68

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVS 112
           L H ++V    V +      +V E+   G L  + +  N    +        +QL + + 
Sbjct: 69  LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMH 127

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPR------VKICDFGYSKSSVLHSQPKSTVGTPAYI 166
           +     + H ++  +N LL      +      +K+ D G S + +     +  +    ++
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWV 184

Query: 167 APEVLTKKEYDGKI----ADVWSCGVTLY-VMLVGAYPFED 202
            PE +     + K      D WS G TL+ +   G  P   
Sbjct: 185 PPECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--RE--IMNHRSLKH 57
              + IG G+FG      L+ +   +   AVK + R   I E  Q   E  IM  +   H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM--KDFSH 85

Query: 58  PNIVRFKEVLLTPTH-LAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 114
           PN++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ Y 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGT-PA-YIAPE 169
            S +  HRDL   N +LD      VK+ DFG ++       +S    T    P  ++A E
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L  +++  K +DVWS GV L+ +M  GA P+
Sbjct: 203 SLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 22/212 (10%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--RE--IMNHRSLKH 57
              + IG G+FG      L+ +   +   AVK + R   I E  Q   E  IM  +   H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM--KDFSH 149

Query: 58  PNIVRFKEVLLTPTH-LAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 114
           PN++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ + 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFL 208

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYI-----APE 169
            S +  HRDL   N +LD      VK+ DFG ++             T A +     A E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 170 VLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            L  +++  K +DVWS GV L+ +M  GA P+
Sbjct: 267 SLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 75.7 bits (187), Expect = 8e-16
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 38/220 (17%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDE-HVQRE--IMNHR 53
               + +++G G FG         +     + L+AVK ++          QRE  ++   
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL--T 72

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE---------RICNAGRFSEDEARFFF 104
           +L+H +IV+F  V      L +V EY   G+L +          I   G+  + +     
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 105 QQLI-------SGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQP 156
            Q++       SG+ Y  S    HRDL   N L+        VKI DFG S+   ++S  
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDFGMSR--DVYSTD 187

Query: 157 KSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY 191
              VG    +      PE +  +++  + +DVWS GV L+
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.7 bits (187), Expect = 9e-16
 Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 39/231 (16%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
            R    K +G+G FG      A  +        +AVK ++    + E      E  ++++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL-----------FERICNAGRFSEDEAR 101
               H NIV             ++ EY   G+L                +     +DE  
Sbjct: 83  LG-NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 102 FFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
              + L+S       G+++  S    HRDL   N LL        KICDFG ++   + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKN 197

Query: 155 QPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYP 199
                V   A +     APE +    Y  + +DVWS G+ L+ +  +G+ P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 56/227 (24%), Positives = 86/227 (37%), Gaps = 39/227 (17%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNHRS 54
              +    IG GNFG    A++ +D    +  A+K ++     D+H     E  ++    
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLG 83

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARFFFQ 105
             HPNI+          +L + +EYA  G L          E        +   +    Q
Sbjct: 84  -HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 106 QLI-------SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS 158
           QL+        G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++     
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVY----- 195

Query: 159 TVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYP 199
              T   +     A E L    Y    +DVWS GV L+ ++ +G  P
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 36/228 (15%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHR 53
               +  ++G G FG         +  +  + L+AVK ++      + D   + E++   
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM- 99

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE--------RICNAGRFSEDEARFFFQ 105
            L+H +IVRF  V      L +V EY   G+L              AG            
Sbjct: 100 -LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 106 QLI-------SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS 158
           QL+       +G+ Y   +   HRDL   N L+       VKI DFG S+   ++S    
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSR--DIYSTDYY 214

Query: 159 TVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
            VG    +      PE +  +++  + +DVWS GV L+ +   G  P+
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 47/224 (20%), Positives = 89/224 (39%), Gaps = 32/224 (14%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
           E+  + +++G G+FG     VAK V        +A+K +     + E +    E  +M  
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM-- 82

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEAR--------F 102
           +     ++VR   V+       ++ME    G+L  + R       +              
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT 162
              ++  G++Y ++ +  HRDL   N ++       VKI DFG ++   ++       G 
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTR--DIYETDYYRKGG 198

Query: 163 PAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              +     +PE L    +    +DVWS GV L+ +  +   P+
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 39/231 (16%)

Query: 2   ERYEIVKDIGSGNFG------VAKLVRDKWTRELL-AVKFIERGQKIDEHV--QRE--IM 50
           ++  + K +G G FG         + +DK    +  AVK ++      +      E  +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEAR 101
                KH NI+           L +++EYA+ G L              +       E +
Sbjct: 95  KMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153

Query: 102 FFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
             F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINN 209

Query: 155 QPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYP 199
                  T   +     APE L  + Y  + +DVWS GV ++ +  +G  P
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 57/239 (23%), Positives = 90/239 (37%), Gaps = 48/239 (20%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
              E V+DIG G FG      A  +       ++AVK ++     D     QRE  +M  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL-----------------FERICNAGRF 95
               +PNIV+   V      + ++ EY A G+L                  +    A   
Sbjct: 107 --FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 96  SEDEARFFFQQLI-------SGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYS 147
           S         + +       +G++Y    +  HRDL   N L+ +      VKI DFG S
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLS 221

Query: 148 KSSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           ++  ++S           I      PE +    Y  + +DVW+ GV L+ +   G  P+
Sbjct: 222 RN--IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 72.6 bits (179), Expect = 8e-15
 Identities = 42/231 (18%), Positives = 86/231 (37%), Gaps = 40/231 (17%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
                ++++G   FG                + +A+K ++   +       + E  +   
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR-- 66

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARFF 103
             L+HPN+V    V+     L+++  Y + G+L            + +       ++   
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 104 FQQLI-------SGVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQ 155
               +       +G+ Y  S  + H+DL   N L+ D      VKI D G  +   +++ 
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLFR--EVYAA 181

Query: 156 PKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
               +   + +     APE +   ++    +D+WS GV L+ V   G  P+
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 41/233 (17%)

Query: 2   ERYEIVKDIGSGNFG------VAKLVRDKWTRELL-AVKFIERGQKIDEHV--QRE--IM 50
           ++  + K +G G FG         + +DK    +  AVK ++      +      E  +M
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEAR 101
                KH NI+           L +++EYA+ G L              +       E +
Sbjct: 141 KMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199

Query: 102 FFFQQLIS-------GVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLH 153
             F+ L+S       G+ Y  S +  HRDL   N L+ + +    +KI DFG ++   ++
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLAR--DIN 254

Query: 154 SQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           +       T   +     APE L  + Y  + +DVWS GV ++ +  +G  P+
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 38/222 (17%)

Query: 2   ERYEIVKDIGSGNFG------VAKLVRDKWTRELL-AVKFIERGQKIDEHV--QRE--IM 50
           +R  + K +G G FG         L +DK  R    AVK ++      +      E  +M
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 51  NHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEAR 101
                KH NI+           L +++EYA+ G L              +       E +
Sbjct: 129 KMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187

Query: 102 FFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS 154
              + L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++   +H 
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLAR--DIHH 243

Query: 155 QPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY 191
                  T   +     APE L  + Y  + +DVWS GV L+
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 38/231 (16%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
           +R ++ K +G G FG      A  +    T   +AVK ++ G    EH     E  I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 53  RSLKHPNIVRFKEV-LLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARF 102
               H N+V            L +++E+   G L                      +   
Sbjct: 87  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 155
             + LI        G+ +  S +  HRDL   N LL       VKICDFG ++   ++  
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLAR--DIYKD 201

Query: 156 PKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           P       A +     APE +  + Y  + +DVWS GV L+ +  +GA P+
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 5   EIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDEHVQ--RE--IMNHRSLKH 57
              + IG G+FGV    + +     R   A+K + R  ++ +     RE  +M  R L H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM--RGLNH 81

Query: 58  PNIVRFKEVLLT--PTHLAIVMEYAAGGEL--FERICNAGRFSEDEARFFFQQLISGVSY 113
           PN++    ++L        +++ Y   G+L  F R       +  +   F  Q+  G+ Y
Sbjct: 82  PNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEY 139

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGT-PA-YIAP 168
               +  HRDL   N +LD S    VK+ DFG ++       +S  +      P  + A 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 169 EVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
           E L    +  K +DVWS GV L+ ++  GA P+
Sbjct: 198 ESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 37/228 (16%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
              +  K +G+G FG      A  +  +     +AVK ++     DE      E  IM+H
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE-------RICNAGRFSEDEARFFFQ 105
              +H NIV           + ++ EY   G+L          +     F+   +    +
Sbjct: 106 LG-QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 106 QLIS-------GVSYCHSMQICHRDLKLENTLL-DGSTAPRVKICDFGYSKSSVLHSQPK 157
            L+        G+++  S    HRD+   N LL +G      KI DFG ++   + +   
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV---AKIGDFGLARD--IMNDSN 219

Query: 158 STVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYP 199
             V   A +     APE +    Y  + +DVWS G+ L+ +  +G  P
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNP 266

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 70.5 bits (173), Expect = 5e-14
 Identities = 39/179 (21%), Positives = 73/179 (40%), Gaps = 19/179 (10%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-PNI 60
             Y++ + IG G+FGV     +    + +A+KF E  +     ++ E   ++ L     I
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 61  VRFKEVLLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
                      H  +V++   G    +L   +C   +FS        +Q+++ V   H  
Sbjct: 69  PNVYYFGQEGLHNVLVIDL-LGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 118 QICHRDLKLENTLL---DGSTAPRVKICDFGYSK-----SSVLH---SQPKSTVGTPAY 165
            + +RD+K +N L+   +   A  + + DFG  K      +  H    + K+  GT  Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 70.3 bits (173), Expect = 6e-14
 Identities = 53/238 (22%), Positives = 91/238 (38%), Gaps = 46/238 (19%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
           +   + K +G G FG      A  ++ +     +AVK ++      E      E  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL-----------------FERICNAGRF 95
             + HP++++          L +++EYA  G L                      ++   
Sbjct: 83  --VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 96  SEDEARFFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 148
             DE       LIS       G+ Y   M++ HRDL   N L+       +KI DFG S+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSR 198

Query: 149 SSVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPF 200
              ++ +      +   I     A E L    Y  + +DVWS GV L+ ++ +G  P+
Sbjct: 199 D--VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 17/177 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNI 60
            ++ + + IGSG+FG   L  +  T E +A+K  E  +     +  E   +R L+    I
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 61  VRFKEVLLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
              +   +   +  +VM+   G    +LF   C+  + S         Q+I+ V + HS 
Sbjct: 66  PNVRWFGVEGDYNVLVMDL-LGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSK 122

Query: 118 QICHRDLKLENTLLD-GSTAPRVKICDFGYSK-----SSVLH---SQPKSTVGTPAY 165
              HRD+K +N L+  G  A +V I DFG +K     S+  H    + K+  GT  Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 58/236 (24%), Positives = 83/236 (35%), Gaps = 44/236 (18%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERGQKIDEHV--QRE--IMNH 52
           E  E  K +GSG FG      A  +        +AVK ++      E      E  +M  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 53  RSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGEL----------------FERICNAGRFS 96
               H NIV           + ++ EY   G+L                           
Sbjct: 105 LG-SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163

Query: 97  EDEARFFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS 149
           ED     F+ L+        G+ +       HRDL   N L+       VKICDFG ++ 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD 221

Query: 150 SVLHSQPKSTVGTPAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYP 199
             + S     V   A +     APE L +  Y  K +DVWS G+ L+ +  +G  P
Sbjct: 222 --IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 49/179 (27%), Positives = 77/179 (43%), Gaps = 21/179 (11%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-PNIV 61
            + + K IG GNFG  +L ++ +T E +A+K  E  +     +  E   ++ L     I 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 62  RFKEVLLTPTHLAIVMEYAAGG----ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           +         + A+V+E    G    +LF  +C+   FS         QLIS + Y HS 
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 118 QICHRDLKLENTLL---DGSTAPRVKICDFGYSK-----SSVLH---SQPKSTVGTPAY 165
            + +RD+K EN L+      T   + I DF  +K      +  H    + KS  GT  Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 17/177 (9%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-PNI 60
            RY + + IGSG+FG   L  D    E +A+K  E  +     +  E   ++ ++    I
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 61  VRFKEVLLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
              +       +  +VME   G    +LF   C+  +FS         Q+IS + Y HS 
Sbjct: 68  PTIRWCGAEGDYNVMVMEL-LGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSK 124

Query: 118 QICHRDLKLENTLL-DGSTAPRVKICDFGYSK-----SSVLH---SQPKSTVGTPAY 165
              HRD+K +N L+  G     V I DFG +K      +  H    + K+  GT  Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 2e-11
 Identities = 39/198 (19%), Positives = 61/198 (30%), Gaps = 54/198 (27%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---------ERGQKIDEHVQREIMNH 52
           E+ +  + IG G FG             +A+K I            QK  E +  EI+  
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 53  RSL---------KHPNIVRFKEV------------------------------LLTPTHL 73
           + L         +    +    V                                    L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 74  AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLD 132
            IV+E+  GG   E++      S   A+    QL + ++    S++  HRDL   N LL 
Sbjct: 138 FIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 133 GSTAPRVKICDFGYSKSS 150
            +     K+      KSS
Sbjct: 197 KT--SLKKLHYTLNGKSS 212

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 13/105 (12%)

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-SSVLHSQPKST--VGTPAYI 166
           G+++ H     HRD+K  N LLD +     KI DFG ++ S        ++  VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202

Query: 167 APEVLTKKEYDGKI---ADVWSCGVTLYVMLVGAYPFEDPEDPKN 208
           APE L      G+I   +D++S GV L  ++ G    ++  +P+ 
Sbjct: 203 APEALR-----GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 32/165 (19%), Positives = 61/165 (36%), Gaps = 20/165 (12%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVR 62
           ++ + K IGSG FG+  L       E  A   ++   + +  +  E+  ++ +   + ++
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 63  FKEVLLTPTHLAI-------------------VMEYAAGGELFERICNAGRFSEDEARFF 103
                    +L I                   VME   G +L +     G F +      
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQL 156

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 148
             +++  + Y H  +  H D+K  N LL      +V + D+G S 
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 52/215 (24%)

Query: 10  IGSGNFG-VAK-LVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKE 65
           IG G FG V K ++RD      +A+K       Q I+E  + EI      +HP++V    
Sbjct: 47  IGHGVFGKVYKGVLRDG---AKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLVS--- 99

Query: 66  VLL----TPTHLAIVMEYAAGGELFERICNAGRFSE------------DEARFFFQQLIS 109
            L+        + ++ +Y   G L   +  +   +               AR        
Sbjct: 100 -LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------- 150

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK-STV--GTPAYI 166
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK      Q   STV  GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208

Query: 167 APE-----VLTKKEYDGKIADVWSCGVTLYVMLVG 196
            PE      LT+K      +DV+S GV L+ +L  
Sbjct: 209 DPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 55.7 bits (135), Expect = 5e-09
 Identities = 60/215 (27%), Positives = 80/215 (37%), Gaps = 61/215 (28%)

Query: 10  IGSGNFGV---AKLVRDKWTRELLAVK--FIERGQKIDEHVQREIMNHRSLKHPNIVRFK 64
           +G G FG     +L        L+AVK    ER Q  +   Q E+       H N++R  
Sbjct: 38  LGRGGFGKVYKGRL----ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR-- 91

Query: 65  EVLL----TPTHLAIVMEYAAGG----ELFERICNAGRFS--------EDEARFFFQQLI 108
             L     TPT   +V  Y A G     L ER  +                AR       
Sbjct: 92  --LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR------- 142

Query: 109 SGVSYCH---SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV----- 160
            G++Y H     +I HRD+K  N LLD        + DFG +K   L     + V     
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVR 196

Query: 161 GTPAYIAPE-----VLTKKEYDGKIADVWSCGVTL 190
           GT  +IAPE       ++K       DV+  GV L
Sbjct: 197 GTIGHIAPEYLSTGKSSEK------TDVFGYGVML 225

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 26/200 (13%), Positives = 62/200 (31%), Gaps = 41/200 (20%)

Query: 2   ERYEIVKDIGSGNFGV--------AKLVRDKWTRELLAVKF-IERGQKIDEHVQREIMNH 52
            ++++       N G+                 ++  ++K   + G+  +E         
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQN----FFQ 97

Query: 53  RSLKHPNIVRFKEVLLTPT---------------HLAIVMEYAAG---GELFERICNAGR 94
           R+ K   + ++K++  TP                +  +V+    G       +       
Sbjct: 98  RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV-SPKHV 155

Query: 95  FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSV 151
            SE        +L+  + + H  +  H ++  EN  +D     +V +  +G++     S 
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 152 LH-----SQPKSTVGTPAYI 166
            H            G   +I
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 11/117 (9%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGT 162
           +  Q+  G+ +  S +  HRDL   N LL       VKICDFG ++   ++  P      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253

Query: 163 PAYI-----APEVLTKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEDPKNFRKTI 213
            A +     APE +  + Y  + +DVWS GV L+ +  +GA P+   +  + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 39.9 bits (93), Expect = 7e-04
 Identities = 28/143 (19%), Positives = 51/143 (35%), Gaps = 15/143 (10%)

Query: 2   ERYEIVKDIGSGNFG-----VAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNH 52
           +R ++ K +G G FG      A  +    T   +AVK ++ G    +      + +I+ H
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 53  RSLKHPNIVRFK-EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
               H N+V            L +++E+   G L   + +  R      +    +   G 
Sbjct: 82  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKTKGARFRQGK 139

Query: 112 SYCHSMQICHRDLKLENTLLDGS 134
            Y   +     DLK     +  S
Sbjct: 140 DY---VGAIPVDLKRRLDSITSS 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 30/170 (17%), Positives = 62/170 (36%), Gaps = 27/170 (15%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELL-----AVKF--IERGQKIDE----------HV 45
            +++   IG G FG   L     +  +       VK    + G    E            
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 46  QREIMNHRSLKHPNIVRFK----EVLLTPTHLAIVMEYAAG---GELFERICNAGRFSED 98
            ++ +  R LK+  + ++           ++  ++M+   G    +++E      RFS  
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NA-KRFSRK 152

Query: 99  EARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK 148
                  +++  + Y H  +  H D+K  N LL+     +V + D+G + 
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 5e-05
 Identities = 54/371 (14%), Positives = 113/371 (30%), Gaps = 96/371 (25%)

Query: 12  SGNFGVAKLVRD------KWTRELLAVKFIERGQKIDEHV-QREIM---NHRSLKHPNIV 61
                V K V +      K+    +  +  +       ++ QR+ +   N    K+ N+ 
Sbjct: 74  KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-NVS 132

Query: 62  RFKEVL--------LTPTHLAIVMEYAAGGE----LFERICNAGRFSEDEARFFFQQL-I 108
           R +  L        L P    ++      G     +   +C + +    + +  F+   +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLI--DGVLGSGKTWVALDVCLSYKV---QCKMDFKIFWL 187

Query: 109 SGVSYCHS-------MQ-ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST- 159
           + +  C+S       +Q + ++      +  D S+  +++I         +L S+P    
Sbjct: 188 N-LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246

Query: 160 ------VGTPAYIAP-----EVL--TKKEYDGKIADVWSCGVTLYVMLV----GAYPFE- 201
                 V             ++L  T+     ++ D  S   T ++ L        P E 
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILLTTR---FKQVTDFLSAATTTHISLDHHSMTLTPDEV 303

Query: 202 ----------DPED-PKNFRKT-------IGRILSVHYSFPDYVRVSLECKHLLSRIFVA 243
                      P+D P+    T       I   +    +  D  +  + C  L + I   
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK-HVNCDKLTTII--E 360

Query: 244 NSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAP 303
           +S   +   E +        L +             + P+     +LSLI       +  
Sbjct: 361 SSLNVLEPAEYRKM---FDRLSV-FPP-------SAHIPTI----LLSLIWFDVIKSDVM 405

Query: 304 RVGGHLLGSSM 314
            V   L   S+
Sbjct: 406 VVVNKLHKYSL 416

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	338
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.9
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.81
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.55
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.25
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.0
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.87
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.77
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.67
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.58
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.51
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.34
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.08
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.97
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.76
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.72
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.69
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.66
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.62
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.62
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.6
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.46
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.28
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.17
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.65
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.56
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.23
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.06

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-70  Score=485.19  Aligned_cols=256  Identities=42%  Similarity=0.707  Sum_probs=213.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||+|+||+||+|.++.+|+.||||++.+..    .....+.+|+.++++++|||||+++++|.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999997643    2345789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||| +|+|.+++.+++++++..++.+++||+.||+|||++||+||||||+|||++.++  ++||+|||+|+........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC--CEEECCSSCC---------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC--CEEEeecCCCeecCCCCcc
Confidence            9999 679999999999999999999999999999999999999999999999997554  8999999999876555566


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      .+.+||+.|||||++.+..|++.++|||||||++|+|+||++||...+.    ......+....+.+|.  .+|+++++|
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l  242 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLFKNISNGVYTLPK--FLSPGAAGL  242 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TSCHHHHHH
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence            7789999999999999888877779999999999999999999987543    3344556666677776  689999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      |++||+.||++|||+.|+++||||+.+.+
T Consensus       243 i~~~L~~dP~~R~s~~eil~hpw~k~~~p  271 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQDDWFKVDLP  271 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred             HHHHccCChhHCcCHHHHHcCcccccCCC
Confidence            99999999999999999999999986654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.8e-70  Score=488.33  Aligned_cols=252  Identities=31%  Similarity=0.546  Sum_probs=224.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999999999999999999864    233467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---S  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---~  154 (338)
                      |||+||+|.++|.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.....   .
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g--~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECCTTTTCC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC--CEEEEEcCCceecCCCCCcc
Confidence            9999999999999989999999999999999999999999999999999999997554  8999999999865322   2


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...+.+||+.|||||++.+..|+. ++|||||||++|+|+||++||...+..    ..+..+....+.+|.  .+|++++
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~  262 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKIIKLEYDFPE--KFFPKAR  262 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCT--TCCHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCc--ccCHHHH
Confidence            345679999999999998888754 499999999999999999999875543    344556667777876  6899999


Q ss_pred             HHHHHhcccCCCcCCChhH------HhcCccccc
Q 019628          235 HLLSRIFVANSEKRITIPE------IKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~e------ll~hp~~~~  262 (338)
                      +||++||+.||++|||+.|      +++||||+.
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            9999999999999999988      589999964

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-68  Score=486.24  Aligned_cols=256  Identities=27%  Similarity=0.469  Sum_probs=223.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+|+.++|||||+++++|.+++.+|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999999999999999997643 33456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  159 (338)
                      +||+|.+++.. +++++..++.|+.||+.||+|||++|||||||||+|||++.++  ++||+|||+|+..... ....+.
T Consensus       154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC--CEEEecCcCceecCCCCCccccc
Confidence            99999998875 5799999999999999999999999999999999999997554  8999999999865433 345678


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-ccccCCCcccCCHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  238 (338)
                      +||+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+....+..    +.. ....++.+..+|+++++||.
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~----i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM----IRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCCCCCCccccCCHHHHHHHH
Confidence            99999999999988888655 9999999999999999999987654433332    222 23344556679999999999


Q ss_pred             HhcccCCCcCCChhHHhcCcccccCCC
Q 019628          239 RIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      +||+.||++|||+.|+|+||||++..+
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            999999999999999999999986543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.9e-69  Score=489.38  Aligned_cols=256  Identities=30%  Similarity=0.523  Sum_probs=215.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      |++|++++.||+|+||+||+|+++.+|+.||||++.+..   ...+.+.+|+.++++|+|||||+++++|.+++.+|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            789999999999999999999999999999999998653   23457889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-C
Q 019628           78 EYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~  154 (338)
                      |||+||+|.++|...+  .+++..++.|+.||+.||+|||++|||||||||+|||++.++  ++||+|||+|+..... .
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--TVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC--CEEECSTTEESCCCHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--CEEEcccccceeecCCcc
Confidence            9999999999997543  479999999999999999999999999999999999997554  8999999999865332 2


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...+.+||+.|||||++.+..|+.+ +|||||||++|+|+||++||...+....+    ..+....+. +....+|++++
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~~-~~~~~~s~~~~  254 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLV----LKIISGSFP-PVSLHYSYDLR  254 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCC-CCCTTSCHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHcCCCC-CCCccCCHHHH
Confidence            2345689999999999998888655 99999999999999999999876544333    334443332 23347899999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +||.+||+.||++|||+.|+|+||||++..
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            999999999999999999999999997643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-66  Score=486.28  Aligned_cols=255  Identities=27%  Similarity=0.461  Sum_probs=222.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46999999999999999999999999999999997643 33456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  159 (338)
                      +||+|.+++.. +.+++..++.|++||+.||+|||++|||||||||+|||++.++  ++||+|||+|+..... ....+.
T Consensus       231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC--CEEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEecCccceECCCCCcccccc
Confidence            99999999865 5799999999999999999999999999999999999997554  8999999999865433 345678


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-ccccCCCcccCCHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDYVRVSLECKHLLS  238 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  238 (338)
                      +||+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+....+..    +.. ....++.+..+|+++++||.
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~----i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM----IRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCCCCCcccccCCHHHHHHHH
Confidence            99999999999998888655 9999999999999999999987654433322    222 22344555679999999999


Q ss_pred             HhcccCCCcCCChhHHhcCcccccCC
Q 019628          239 RIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      +||+.||++|||+.|+|+||||++..
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999998654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-67  Score=474.13  Aligned_cols=252  Identities=33%  Similarity=0.565  Sum_probs=215.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||+||+|++.   .+++.||||++++..   .....+.+|+.++++++|||||+++++|.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999984   467899999997643   233468899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~  154 (338)
                      |||||+||+|.++|.+.+.+++..++.+++||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.... ..
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS--CEEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC--CEEecccccceeccCCCc
Confidence            999999999999999999999999999999999999999999999999999999997554  899999999985433 34


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...+.+||+.|||||++.+..|+.+ +|||||||++|+|+||++||.+.+..    ..+..+....+.+|.  .+|++++
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~  254 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRK----ETMTMILKAKLGMPQ--FLSPEAQ  254 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHH----HHHHHHHcCCCCCCC--cCCHHHH
Confidence            4567899999999999998888655 99999999999999999999875543    334445566666776  6899999


Q ss_pred             HHHHHhcccCCCcCCCh-----hHHhcCccccc
Q 019628          235 HLLSRIFVANSEKRITI-----PEIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~-----~ell~hp~~~~  262 (338)
                      +||++||+.||++|||+     +|+++||||+.
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            99999999999999984     79999999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-66  Score=463.32  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=212.9

Q ss_pred             Cc-eEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc----CCeEE
Q 019628            3 RY-EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT----PTHLA   74 (338)
Q Consensus         3 ~y-~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~   74 (338)
                      || ++.++||+|+||+||+|.+..+++.||+|++....   ...+.+.+|+.++++++|||||+++++|.+    ++.+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            44 78889999999999999999999999999997643   233568899999999999999999999875    35689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+|||++.. ++.+||+|||+|+.. .
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~-~g~vKl~DFGla~~~-~  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLK-R  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST-TSCEEECCTTGGGGC-C
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC-CCCEEEEeCcCCEeC-C
Confidence            99999999999999999889999999999999999999999998  9999999999999632 348999999999743 2


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      .....+.+||+.|||||++.+ .|+. ++|||||||++|+|+||++||...........   .+.............+++
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~-~y~~-~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~  258 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHH
T ss_pred             CCccCCcccCccccCHHHcCC-CCCc-HHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH---HHHcCCCCCCCCccCCHH
Confidence            334456789999999999865 5654 49999999999999999999987665444333   233322211122357899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +++||.+||+.||++|||+.|+|+||||++
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.9e-66  Score=467.50  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=214.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++....    ..+|+.+++.++|||||+++++|.+++.+|+|||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            468999999999999999999999999999999986533    2479999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC------
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ------  155 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~------  155 (338)
                      ||+|.++|+..+.+++..++.|+.||+.||+|||++|||||||||+|||++.++. ++||+|||+|+.......      
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceec
Confidence            9999999999889999999999999999999999999999999999999975432 699999999985433221      


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC-CcccCCHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DYVRVSLECK  234 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  234 (338)
                      ....+||+.|||||++.+..|+.+ +|||||||++|+|+||++||........+..+.    .....++ .+..+|++++
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA----SEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH----HSCCGGGGSCTTSCHHHH
T ss_pred             CCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH----cCCCCchhcCccCCHHHH
Confidence            234579999999999998888655 999999999999999999998766554443332    2222211 1236899999


Q ss_pred             HHHHHhcccCCCcCCChhHH-------------hcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIPEI-------------KNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~el-------------l~hp~~~~~  263 (338)
                      +||.+||+.||.+|||+.|+             |+|||+.+.
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            99999999999999999997             579998643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-65  Score=474.05  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=220.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEc------CCe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLT------PTH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~~   72 (338)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++...   ..+.+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            589999999999999999999999999999999976432   23567899999999999999999999764      367


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+|||||+ |+|.+++...+++++..++.+++||+.||.|||++|||||||||+|||++.++  .+||+|||+|+....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~--~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC--ELKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCC--
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC--CEEEeecceeeeccc
Confidence            999999995 68999999888999999999999999999999999999999999999997554  899999999985432


Q ss_pred             -----CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc------
Q 019628          153 -----HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY------  221 (338)
Q Consensus       153 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~------  221 (338)
                           .....+.+||+.|||||++.+..+++.++||||+||++|+|++|++||.+.+....+..+.........      
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence                 223456799999999999988777677799999999999999999999987766665554432211110      


Q ss_pred             ----------cCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          222 ----------SFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       222 ----------~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                                .+|.         +..+++++++||++||++||++|||+.|+|+||||++...
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                      1111         1247899999999999999999999999999999986543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-64  Score=467.27  Aligned_cols=337  Identities=71%  Similarity=1.167  Sum_probs=244.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||+||++++..+++.||||++.......+.+.+|+.+++.++||||+++++++..++.+|+||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            68999999999999999999999999999999998877777889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG  161 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  161 (338)
                      +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+..+++||+|||+++...........+|
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g  179 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  179 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcC
Confidence            99999999888899999999999999999999999999999999999999877666799999999986555555567789


Q ss_pred             cCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhc
Q 019628          162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIF  241 (338)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (338)
                      |+.|+|||++.+..++++++|||||||++|+|++|+.||........+...+..+....+.+|....+++++++||++||
T Consensus       180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  259 (361)
T 3uc3_A          180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF  259 (361)
T ss_dssp             -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHS
T ss_pred             CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHc
Confidence            99999999998888877768999999999999999999998777667777777778888888887789999999999999


Q ss_pred             ccCCCcCCChhHHhcCcccccCCCcccccCCCc--ccCCCCCCCCCHHHHHHHhHhhCCCCCCCCcCCcccCCCCCCCcc
Q 019628          242 VANSEKRITIPEIKNHPWFLRNLPIELTEGGSW--QSHDVNNPSQSLEEVLSLIHEATKPLEAPRVGGHLLGSSMELDDL  319 (338)
Q Consensus       242 ~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (338)
                      +.+|.+|||+.|+++||||.+..+.........  ......++.++++++.+.+.+...+....+...+......+.|++
T Consensus       260 ~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~  339 (361)
T 3uc3_A          260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDD  339 (361)
T ss_dssp             CSCTTTSCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHHHHHHTCC--------------------
T ss_pred             cCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCcccccccchhccccccccccc
Confidence            999999999999999999987765544322211  122234566888999999988776654333333322223332222


Q ss_pred             c---cccccccccCCCcccccC
Q 019628          320 D---ADADLEDTETSGDFVCPL  338 (338)
Q Consensus       320 ~---~d~~~~~~~~~~~~~~~~  338 (338)
                      +   |++++.|.|.+++++||+
T Consensus       340 ~~~~d~~~~~d~d~~g~~~~~~  361 (361)
T 3uc3_A          340 MDDFDSESEIDIDSSGEIVYAL  361 (361)
T ss_dssp             ----------------------
T ss_pred             cccccchhhhccCCCCcEEecC
Confidence            2   234467888899999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.3e-63  Score=480.25  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=220.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHH---HHHHHHhcCCCCCcceeEEEEEcCCeE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQ---REIMNHRSLKHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~---~E~~~l~~l~h~~Iv~~~~~~~~~~~~   73 (338)
                      |++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.   +++.+++.++|||||+++++|.+++.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            578999999999999999999999999999999997642    1122333   346677888999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+|||||+||+|..+|.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.++  ++||+|||+|+... .
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G--~vKL~DFGlA~~~~-~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFS-K  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS-S
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC--CEEecccceeeecC-C
Confidence            99999999999999999999999999999999999999999999999999999999997554  89999999998543 3


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ....+.+||+.|||||++.++..++.++|||||||++|+|++|++||....... ...+...+....+.+|.  .+|+++
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~a  421 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPEL  421 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHHH
Confidence            345678999999999999765433555999999999999999999997644322 23445556666677776  689999


Q ss_pred             HHHHHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      ++||.+||+.||.+|++     +.|+++||||+.
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999999999999998     799999999964

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.6e-63  Score=455.96  Aligned_cols=256  Identities=26%  Similarity=0.393  Sum_probs=207.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|+++++||+|+||+||+|+++   .+++.||||++.+.. ...++.+|+.+++.+ +|||||+++++|.+++++|+||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            57999999999999999999875   467899999987643 345788999999988 6999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC----
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH----  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~----  153 (338)
                      |||+||+|.+++.   .+++.+++.+++||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+.....    
T Consensus       100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A          100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGG
T ss_pred             eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccc
Confidence            9999999999883   599999999999999999999999999999999999997542 48999999999743211    


Q ss_pred             -------------------------CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHH
Q 019628          154 -------------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN  208 (338)
Q Consensus       154 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~  208 (338)
                                               ....+.+||+.|||||++.+..+++.++||||+||++|+|+||++||....+...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~  255 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT  255 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence                                     1123467999999999998876556669999999999999999999976554322


Q ss_pred             HHHHHhhHh-----------------------------------hcc--------------ccCCCcccCCHHHHHHHHH
Q 019628          209 FRKTIGRIL-----------------------------------SVH--------------YSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       209 ~~~~~~~~~-----------------------------------~~~--------------~~~~~~~~~~~~~~~li~~  239 (338)
                      ....+..+.                                   ...              ...+.+..+|++++|||++
T Consensus       256 ~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~  335 (361)
T 4f9c_A          256 ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDK  335 (361)
T ss_dssp             HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHH
Confidence            211111110                                   000              0112345689999999999


Q ss_pred             hcccCCCcCCChhHHhcCccccc
Q 019628          240 IFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ||++||++|||++|+|+||||++
T Consensus       336 lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          336 LLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HCcCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999964

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.2e-63  Score=445.31  Aligned_cols=250  Identities=25%  Similarity=0.377  Sum_probs=198.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCC--------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPT--------   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--------   71 (338)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++....  ..+.+.+|+.+|++++|||||+++++|...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999976432  3357889999999999999999999997543        


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           72 ----HLAIVMEYAAGGELFERICNAGRF---SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        72 ----~~~iv~e~~~~~~L~~~i~~~~~l---~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                          .+|+|||||+||+|.+++.....+   ++..++.++.||+.||+|||++|||||||||+|||++.++  .+||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~--~vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC--cEEEccC
Confidence                479999999999999999876554   4567899999999999999999999999999999997554  8999999


Q ss_pred             CCCcccccCC-------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHH
Q 019628          145 GYSKSSVLHS-------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK  211 (338)
Q Consensus       145 g~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~  211 (338)
                      |+|+......             ..++.+||+.|||||++.+..|+.+ +|||||||++|||++   ||...   .....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~---~~~~~  235 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQ---MERVR  235 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSH---HHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCc---cHHHH
Confidence            9998543321             1234689999999999998888655 999999999999996   77642   12222


Q ss_pred             HHhhHhhccccCC-CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          212 TIGRILSVHYSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       212 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+..+....  +| .+...++.+.+||++||+.||++|||+.|+|+||||+.
T Consensus       236 ~~~~~~~~~--~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          236 TLTDVRNLK--FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHHTTC--CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHHhcCC--CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            223333222  22 22346778899999999999999999999999999964

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.4e-62  Score=477.68  Aligned_cols=258  Identities=29%  Similarity=0.563  Sum_probs=227.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      |++|++++.||+|+||+||+|.++.+|+.||||++.+... ..+.+.+|+.+|+.++|||||+++++|.+++.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            4789999999999999999999999999999999976543 346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |+||+|.++|.. .+.+++..++.+++||+.||+|||++||+||||||+|||++....+.+||+|||+|+..........
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~  315 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  315 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence            999999999964 4579999999999999999999999999999999999999866556899999999987665555667


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  236 (338)
                      .+||+.|||||++.+..|+.. +|||||||++|+|++|++||.+.+....    +..+....+.++  .+..+|+++++|
T Consensus       316 ~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDET----LRNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             eEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHHHHhCCCCCCcccccCCCHHHHHH
Confidence            789999999999998888544 8999999999999999999987665433    334455554443  345789999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |++||+.||.+|||+.|+|+||||+..
T Consensus       391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          391 IRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-60  Score=428.65  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=207.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++.+.||+|+||+||+|...     .++..||||+++... ...+.+.+|+.+|++++|||||+++++|.+++.+|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            47999999999999999999864     357899999997643 334678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEe
Q 019628           76 VMEYAAGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC  142 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~-------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~  142 (338)
                      |||||++|+|.++|...             ..+++..+..++.||+.||.|||+++||||||||+|||++.+.  .+||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~--~~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC--cEEEC
Confidence            99999999999999764             3599999999999999999999999999999999999997655  89999


Q ss_pred             ecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhh
Q 019628          143 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS  218 (338)
Q Consensus       143 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  218 (338)
                      |||+|+......   ......||+.|||||++.+..|+.+ +|||||||++|||+| |+.||...+.....    ..+..
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~----~~i~~  245 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----ECITQ  245 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----HHHHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHc
Confidence            999997543322   2234579999999999998888655 999999999999998 89999886654332    23333


Q ss_pred             cc-ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          219 VH-YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       219 ~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      .. ...|.  .+|+++.+|+.+||+.||++|||+.++.  +|+.
T Consensus       246 ~~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~  285 (299)
T 4asz_A          246 GRVLQRPR--TCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ  285 (299)
T ss_dssp             TCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred             CCCCCCCc--cchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence            22 23343  6899999999999999999999999994  4553

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-60  Score=425.44  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=199.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +++++.++||+|+||+||+|+..   ..||||+++...   ...+.+.+|+.++++++|||||++++++.. +.+|+|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            57889999999999999999864   359999987543   233578899999999999999999998754 56899999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---C
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---S  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---~  154 (338)
                      ||+||+|.++|... .++++..+..|+.||+.||.|||+++||||||||+|||++.+.  ++||+|||+|+.....   .
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL--TVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE--EEEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC--cEEEeeccCceecccCCcce
Confidence            99999999999754 5799999999999999999999999999999999999997655  8999999999854322   2


Q ss_pred             CCCCccccCcccccccccCC---ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC-CcccCC
Q 019628          155 QPKSTVGTPAYIAPEVLTKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DYVRVS  230 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  230 (338)
                      .....+||+.|||||++.+.   .|+ .++|||||||++|||+||+.||...+........+..-.. ....+ ....++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~-~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~  267 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFS-FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-SPDLSKLYKNCP  267 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-CCCSTTSCTTSC
T ss_pred             eecccccCCCccCHHHhhccCCCCCC-cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-CCCcccccccch
Confidence            34567899999999999643   354 4599999999999999999999887665444433322111 11111 234688


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +++.+|+.+||+.||++|||+.|++++
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-59  Score=428.12  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|.+.++||+|+||+||+|...     .+++.||||+++... ...+.+.+|+.+|++++|||||+++++|.+++.+|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46889999999999999999864     468899999997643 334678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEE
Q 019628           76 VMEYAAGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK  140 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~---------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ik  140 (338)
                      |||||++|+|.+++...               .++++..+..|+.||+.||.|||+++||||||||+|||++.+.  .+|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~--~~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL--VVK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC--cEE
Confidence            99999999999999753               3589999999999999999999999999999999999997655  899


Q ss_pred             EeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhH
Q 019628          141 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRI  216 (338)
Q Consensus       141 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  216 (338)
                      |+|||+|+......   .....+||+.|||||++.+..|+.+ +|||||||++|||+| |+.||...+......    .+
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~----~i  273 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAID----CI  273 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH----HH
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHH----HH
Confidence            99999998543322   2345679999999999998888655 999999999999999 899998866543332    22


Q ss_pred             hh-ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          217 LS-VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       217 ~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .. .....|.  .+++++.+|+.+||+.||++|||+.|++++
T Consensus       274 ~~g~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQGRELERPR--ACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHTCCCCCCT--TCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCCCCCcc--cccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            22 2333444  689999999999999999999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.5e-59  Score=422.54  Aligned_cols=248  Identities=20%  Similarity=0.323  Sum_probs=207.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      .+++++++||+|+||+||+|...     .+++.||||+++...  ...+.+.+|+.++++++|||||++++++..++.+|
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            46889999999999999999853     467899999997542  33467999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCc
Q 019628           75 IVMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPR  138 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~  138 (338)
                      +|||||++|+|.++|...                ..+++..+..++.||+.||.|||+++||||||||+|||++.+.  +
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~--~  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL--N  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--C
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC--C
Confidence            999999999999999643                3589999999999999999999999999999999999997655  8


Q ss_pred             EEEeecCCCcccccC---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHh
Q 019628          139 VKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIG  214 (338)
Q Consensus       139 ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~  214 (338)
                      +||+|||+|+.....   ......+||+.|||||++.+..|+.+ +|||||||++|||+| |..||.+.+.....    .
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~----~  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVV----E  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHH----H
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHH----H
Confidence            999999999854332   23445689999999999998888655 999999999999998 89999887654332    2


Q ss_pred             hHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          215 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+.... ..|....+++++.+|+.+||+.||++|||+.||+++
T Consensus       259 ~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            233222 223334789999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.9e-58  Score=419.31  Aligned_cols=256  Identities=40%  Similarity=0.687  Sum_probs=227.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +.+|++++.||+|+||.||+|.+..+|+.||||++.+..   ...+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            368999999999999999999999999999999997643   23356789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.........
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTCCGGGSSSCGGG
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC--CEEEeeccCceecCCCCccc
Confidence            9999999999999888999999999999999999999999999999999999997554  89999999998665555566


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+..    .....+....+.+|.  .+++++.+||
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~li  245 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRERVLRGKYRIPF--YMSTDCENLL  245 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHHHHH
Confidence            7789999999999998888767799999999999999999999875543    333445556666665  5899999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccCC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ++||+.||.+|||+.|+++||||....
T Consensus       246 ~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999997644

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.6e-58  Score=423.07  Aligned_cols=249  Identities=23%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecCcc--ccHHHHHHHHHHhcCCC-CCcceeEEEEEcC-Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-----RELLAVKFIERGQK--IDEHVQREIMNHRSLKH-PNIVRFKEVLLTP-TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~-~~   72 (338)
                      ++|++++.||+|+||+||+|....+     ++.||||++.....  ..+.+.+|+.+|++++| ||||+++++|..+ +.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            5899999999999999999997643     46899999876432  23568899999999976 8999999998764 57


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC
Q 019628           73 LAIVMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA  136 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~  136 (338)
                      +|+|||||++|+|.++|+..                ..+++..+..++.||+.||.|||+++||||||||+|||++.+. 
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~-  222 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-  222 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC-
Confidence            99999999999999999753                3489999999999999999999999999999999999997655 


Q ss_pred             CcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHH
Q 019628          137 PRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKT  212 (338)
Q Consensus       137 ~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~  212 (338)
                       .+||+|||+|+......   .....+||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+......+...
T Consensus       223 -~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          223 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             -CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             -CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             89999999998543322   2235679999999999998888655 999999999999998 99999887655444433


Q ss_pred             HhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          213 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +..  ......|.  .+++++.+|+.+||+.||++|||+.|+++|
T Consensus       301 i~~--g~~~~~p~--~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 LKE--GTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHH--TCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHc--CCCCCCCc--cCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            322  22333444  689999999999999999999999999997

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.1e-56  Score=407.30  Aligned_cols=253  Identities=34%  Similarity=0.604  Sum_probs=223.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||+|+||.||+|.++.+|+.||||++++.    ......+.+|+.+++.++||||++++++|...+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999999763    23346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~~  155 (338)
                      |||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++... ....
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhcccCCCc
Confidence            99999999999999888999999999999999999999999999999999999997554  89999999998533 2334


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+......+|.  .+++++++
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~  234 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFPR--TLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHH
Confidence            456789999999999988887655 899999999999999999998755432    33344455566665  68999999


Q ss_pred             HHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      ||.+||+.||.+||     ++.|+++||||..
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            99999999999999     9999999999964

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-56  Score=414.82  Aligned_cols=256  Identities=34%  Similarity=0.628  Sum_probs=224.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+...       ..+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            579999999999999999999999999999999986432       2367899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC--CcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~--~~ikL~Dfg~a~~~~~  152 (338)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  ..+||+|||++.....
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            99999999999999988888999999999999999999999999999999999999975442  2799999999986655


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCC
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS  230 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (338)
                      .......+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+......    ...+....+.++.  +..++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          172 GVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQET----LANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTSC
T ss_pred             CCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCCCCchhccCCC
Confidence            555667789999999999988777544 9999999999999999999987654333    3334444454442  34689


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +++++||.+||..||.+|||+.|+|+||||..
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            99999999999999999999999999999974

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-56  Score=411.19  Aligned_cols=256  Identities=45%  Similarity=0.784  Sum_probs=224.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +.+|++++.||+|+||.||+|.+..+++.||+|++.+.    ......+.+|+.+++.++||||+++++++..++.+|+|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36899999999999999999999999999999998753    23346789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.........
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC--CEEECCSSCTBTTTTSBTT
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC--CEEEEEeccceeccCCccc
Confidence            9999 789999998888999999999999999999999999999999999999997554  8999999999876666666


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.......    ....+....+.+|.  .+++++.+|
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~l  238 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----LFKKVNSCVYVMPD--FLSPGAQSL  238 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----CBCCCCSSCCCCCT--TSCHHHHHH
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----HHHHHHcCCCCCcc--cCCHHHHHH
Confidence            778899999999999988876667999999999999999999998654322    12223333444554  589999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      |++||+.||.+|||+.|+++||||+...+
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence            99999999999999999999999986654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-56  Score=413.62  Aligned_cols=253  Identities=33%  Similarity=0.546  Sum_probs=217.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++++.||+|+||+||+|+++.+++.||||++++.    ......+.+|..+++.+ +||||++++++|.+.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            47899999999999999999999999999999999764    23345678899999988 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~  154 (338)
                      ||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+... ...
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g--~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCC---
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC--CEEEccccceeecccCCc
Confidence            999999999999999888999999999999999999999999999999999999997554  89999999998533 233


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|++||...+...    ....+......+|.  .++.++.
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~  252 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILNDEVVYPT--WLHEDAT  252 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHH
Confidence            4456789999999999988777554 999999999999999999998765433    34445566666776  5899999


Q ss_pred             HHHHHhcccCCCcCCCh------hHHhcCccccc
Q 019628          235 HLLSRIFVANSEKRITI------PEIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~------~ell~hp~~~~  262 (338)
                      +||++||+.+|.+||++      .++++||||..
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            99999999999999999      89999999965

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3e-56  Score=416.55  Aligned_cols=257  Identities=28%  Similarity=0.513  Sum_probs=221.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++++.||+|+||+||+|+++.+++.||+|++++..    .....+.+|..+++++ +||||++++++|.+++.+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999999999999999998643    2234678899998876 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccc-ccCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS-VLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~-~~~~  154 (338)
                      ||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+.. ....
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC--CEEEeecceeeecccCCC
Confidence            999999999999999888999999999999999999999999999999999999997554  8999999999853 3334


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHHHhhHhhccccCCCcccC
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----NFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                      .....+||+.|+|||++.+..++.. +|||||||++|+|++|++||.......     ........+......+|.  .+
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~  285 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL  285 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TS
T ss_pred             ccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cC
Confidence            4567889999999999998887555 899999999999999999997543211     122334455666667776  68


Q ss_pred             CHHHHHHHHHhcccCCCcCCCh------hHHhcCccccc
Q 019628          230 SLECKHLLSRIFVANSEKRITI------PEIKNHPWFLR  262 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~------~ell~hp~~~~  262 (338)
                      +.++++||++||+.||.+||++      .|+++||||..
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            9999999999999999999995      79999999964

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-57  Score=410.33  Aligned_cols=258  Identities=26%  Similarity=0.513  Sum_probs=224.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      .++|++++.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.++||||+++++++.+.+.+|+||||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            37899999999999999999999999999999999876655667889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           81 AGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      +|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+++...........
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            9999999997653 699999999999999999999999999999999999998654568999999999865544444556


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCCHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLL  237 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li  237 (338)
                      .||+.|+|||++.+..++ .++|||||||++|+|++|..||........    ...+....+.++.  +..++.++.+||
T Consensus       164 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQI----IENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHH----HHHHHcCCCCCChhhhccCCHHHHHHH
Confidence            799999999999887665 449999999999999999999987654333    3334444444432  346899999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+||..||.+|||+.|+|+||||++.
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-55  Score=401.12  Aligned_cols=251  Identities=34%  Similarity=0.637  Sum_probs=222.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||+|+||.||+|++..+|+.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997642    3346778999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...  ...
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~~--~~~  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceecC--Ccc
Confidence            99999999999999888999999999999999999999999999999999999997554  89999999997542  234


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|.  .+++++++|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~l  233 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKT----YEKILNAELRFPP--FFNEDVKDL  233 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHH
T ss_pred             ccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHH
Confidence            56789999999999988887655 8999999999999999999987654333    3344555566665  689999999


Q ss_pred             HHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          237 LSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      |++||..||.+||     +++++++||||+.
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            9999999999999     9999999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.4e-56  Score=407.02  Aligned_cols=254  Identities=34%  Similarity=0.560  Sum_probs=221.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++++.||+|+||.||+|+++.+|+.||||++++..    .....+.+|..+++.+ +||||++++++|.+.+.+|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999998642    3345677889888876 99999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~  154 (338)
                      ||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.... ..
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhhcccCCC
Confidence            999999999999999888999999999999999999999999999999999999997554  899999999985432 23


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....+||+.|+|||++.+..++.. +|||||||++|+|++|..||...+...    ....+......+|.  .++++++
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  246 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYPR--WLEKEAK  246 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHhCCCCCCc--ccCHHHH
Confidence            4456789999999999988877554 899999999999999999998765433    33344555556665  5899999


Q ss_pred             HHHHHhcccCCCcCCChh-HHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIP-EIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~-ell~hp~~~~~  263 (338)
                      +||.+||..||.+|||+. ++++||||...
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            999999999999999998 99999999643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.5e-55  Score=404.16  Aligned_cols=257  Identities=28%  Similarity=0.515  Sum_probs=220.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++++.||+|+||.||+|+++.+++.||+|++.+...    ....+.+|+.+++++ +||||++++++|.+.+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            4689999999999999999999999999999999986532    234578899999887 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~  154 (338)
                      ||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++... ...
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBCSCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEeccccccccCCCC
Confidence            999999999999999888999999999999999999999999999999999999997554  89999999998532 233


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh-----HHHHHHHhhHhhccccCCCcccC
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----KNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......     .........+......+|.  .+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~  242 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL  242 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TS
T ss_pred             cccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CC
Confidence            4456789999999999988877544 99999999999999999999753221     1122333445555666665  68


Q ss_pred             CHHHHHHHHHhcccCCCcCCCh------hHHhcCccccc
Q 019628          230 SLECKHLLSRIFVANSEKRITI------PEIKNHPWFLR  262 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~------~ell~hp~~~~  262 (338)
                      +.++++||.+||+.||.+|||+      .++++||||..
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            9999999999999999999996      79999999964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1e-55  Score=403.30  Aligned_cols=260  Identities=34%  Similarity=0.608  Sum_probs=220.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4799999999999999999999999999999999875432  23568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---CC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---SQ  155 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---~~  155 (338)
                      |+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....   ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEECC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC--CEEEEEeeccceeccCCcccc
Confidence            999999999998888899999999999999999999999999999999999997554  8999999999743221   22


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...........   .........+.+..+++.+.+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHHH
Confidence            34578999999999998877766669999999999999999999987655322222   122223334445678999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      ||.+||+.||.+|||+.|+++||||++...
T Consensus       241 li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            999999999999999999999999976543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-54  Score=400.64  Aligned_cols=251  Identities=33%  Similarity=0.596  Sum_probs=222.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||+|+||.||+|.+..+|+.||||++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999999999999999997642    2346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...  ...
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFg~a~~~~--~~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCB
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC--CEEEcccccceecc--CCc
Confidence            99999999999999888999999999999999999999999999999999999997554  89999999998543  234


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||...+...    ....+......+|.  .+++++.+|
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  268 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSGKVRFPS--HFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TCCHHHHHH
T ss_pred             ccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHH
Confidence            56789999999999988877654 999999999999999999998755433    33445555666665  689999999


Q ss_pred             HHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          237 LSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      |.+||+.||.+||+     +.++++||||..
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            99999999999998     999999999963

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.8e-55  Score=391.82  Aligned_cols=260  Identities=27%  Similarity=0.449  Sum_probs=212.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      |++|++++.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++.+++.+|+||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            6899999999999999999999999999999999976432   2367889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCC
Q 019628           78 EYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~  155 (338)
                      ||+++ +|...+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... ...
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCSCCSC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecCCcccc
Confidence            99976 5555554 467899999999999999999999999999999999999997554  899999999975432 233


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--cC----------
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SF----------  223 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~----------  223 (338)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|..||............+........  .+          
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            455689999999999987764456699999999999999988885544443332222222111000  00          


Q ss_pred             ------------CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          224 ------------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       224 ------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                  .....+++++++||++||+.||++|||+.|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                        0112478899999999999999999999999999999754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.1e-55  Score=408.31  Aligned_cols=256  Identities=26%  Similarity=0.494  Sum_probs=223.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997642    3346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||+.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++........
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTCCB
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC--CEEEeccceeeeccCCCce
Confidence            99999999999999888999999999999999999999999999999999999997554  8999999999866555566


Q ss_pred             CCccccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          157 KSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ...+||+.|+|||++.+   ..++ .++|||||||++|+|++|+.||....... .......+......+|.  .++.++
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p~--~~s~~~  247 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYPS--AWSQEM  247 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred             eccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCCC--cCCHHH
Confidence            77899999999999974   2354 44899999999999999999997644322 23334444555555665  689999


Q ss_pred             HHHHHHhcccCCCcCCC-hhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRIT-IPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s-~~ell~hp~~~~  262 (338)
                      .+||.+||+.+|.+||+ +.++++||||..
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            99999999999999998 899999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2e-55  Score=407.38  Aligned_cols=256  Identities=34%  Similarity=0.611  Sum_probs=223.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            479999999999999999999999999999999976432   23568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |++||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||++..........
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~  188 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  188 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence            999999999998888899999999999999999999999999999999999997553 3469999999998665555556


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (338)
                      ..+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||...+....    ...+....+.+  +.+..+++++++
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~  263 (362)
T 2bdw_A          189 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRL----YAQIKAGAYDYPSPEWDTVTPEAKS  263 (362)
T ss_dssp             CSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred             cCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCCcccccCCCHHHHH
Confidence            6789999999999988777554 9999999999999999999987654332    33344444443  345678999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ||.+||+.||.+|||+.++|+||||..
T Consensus       264 li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          264 LIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-55  Score=401.07  Aligned_cols=257  Identities=35%  Similarity=0.647  Sum_probs=221.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.+...       ..+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            479999999999999999999999999999999976432       2467889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC--CCcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~--~~~ikL~Dfg~a~~~~~  152 (338)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ...+||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            9999999999999998888899999999999999999999999999999999999996543  23799999999986655


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCC
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS  230 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (338)
                      ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+....+.++.  +..++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHHTCCCCCHHHHTTSC
T ss_pred             CCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHH----HHHhcCCCcCccccccCC
Confidence            555566789999999999987777555 899999999999999999998765433332    23333333332  24688


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..+.+||++||+.||.+|||+.|+|+||||+..
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            999999999999999999999999999999743

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7e-55  Score=402.10  Aligned_cols=253  Identities=32%  Similarity=0.530  Sum_probs=221.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++++.||+|+||.||+|.++.+++.||||++.+..    .....+.+|..++..+ .||||++++++|.+.+.+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            478999999999999999999999999999999997642    3345678899999888 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~  154 (338)
                      ||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++... ...
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccccccCCc
Confidence            999999999999999888999999999999999999999999999999999999997554  89999999998533 233


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....+||+.|+|||++.+..++.. +|||||||++|+|++|++||...+...    ....+......+|.  .++++++
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  249 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYPK--SMSKEAV  249 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHH
T ss_pred             ccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHH
Confidence            4456789999999999988887544 899999999999999999998755433    33445555666665  6899999


Q ss_pred             HHHHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          235 HLLSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      +||.+||..||.+||+     +.++++||||..
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            9999999999999995     699999999964

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.4e-55  Score=415.64  Aligned_cols=256  Identities=35%  Similarity=0.621  Sum_probs=220.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            579999999999999999999999999999999976542   23568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCcccccCC-CC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHS-QP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~~~-~~  156 (338)
                      |++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||+++...... ..
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~  170 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW  170 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence            99999999999998899999999999999999999999999999999999999743 34589999999997554332 23


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCcccCCHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECK  234 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  234 (338)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||........+    ..+....+.+  +.+..++++++
T Consensus       171 ~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          171 FGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLY----QQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             ecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHhCCCCCCccccccCCHHHH
Confidence            45789999999999988877655 99999999999999999999876543333    3344444433  44567899999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +||.+||+.||.+|||+.|+|+||||..
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            9999999999999999999999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.3e-55  Score=392.98  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=218.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++..... ..+.+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            589999999999999999999999999999999876433 3466889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  159 (338)
                      ++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++....... .....
T Consensus       100 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC--CEEEeeCCCceecCCcccccCCc
Confidence            999999999764 699999999999999999999999999999999999997554  89999999987544332 33456


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .||+.|+|||++.+..++.+ +|||||||++|+|++|..||.............   ......++....++..+.+||.+
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~  252 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNR  252 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSCGGGSCHHHHHHHHH
T ss_pred             cCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCCCccccCHHHHHHHHH
Confidence            89999999999988887655 999999999999999999998765443332221   22222333344789999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||+.||.+|||+.|+++||||+..
T Consensus       253 ~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          253 CLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HccCChhHCcCHHHHhhChhhccc
Confidence            999999999999999999999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-55  Score=419.70  Aligned_cols=292  Identities=25%  Similarity=0.377  Sum_probs=221.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC------Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~   72 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..   ...+++.+|+.+++.++||||++++++|...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            68999999999999999999999999999999997642   3346788999999999999999999999754      46


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+||||+++ +|...+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+....
T Consensus       142 ~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCCC-----
T ss_pred             EEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC--CEEEEEEEeeeecCC
Confidence            8999999965 57777743  599999999999999999999999999999999999997554  899999999987655


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH------------  220 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~------------  220 (338)
                      .......+||+.|+|||++.+..|+.+ +|||||||++|+|++|++||.+.+....+..++..+....            
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            555677899999999999998887655 8999999999999999999998776655555443221100            


Q ss_pred             -----------cc----CCCcc---------cCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccC--CCc
Q 019628          221 -----------YS----FPDYV---------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEG--GSW  274 (338)
Q Consensus       221 -----------~~----~~~~~---------~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~--~~~  274 (338)
                                 ..    +|...         ..++++++||.+||+.||++|||++|+|+||||.........+.  ...
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~  375 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQI  375 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC---
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCCCCcc
Confidence                       00    01000         01567999999999999999999999999999975443222111  111


Q ss_pred             ccCCCCCCCCCHHHHHHHhHhhCCC
Q 019628          275 QSHDVNNPSQSLEEVLSLIHEATKP  299 (338)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~  299 (338)
                      ..........+.+++++.+.++...
T Consensus       376 ~~~~~~~~~~~~~~~~~~~~~e~~~  400 (464)
T 3ttj_A          376 YDKQLDEREHTIEEWKELIYKEVMN  400 (464)
T ss_dssp             --------CCCHHHHHHHHHHHHHC
T ss_pred             CCcchhhccCCHHHHHHHHHHHHHH
Confidence            2223344556788888887765443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.3e-56  Score=400.12  Aligned_cols=251  Identities=24%  Similarity=0.283  Sum_probs=192.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC----eEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT----HLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~iv~   77 (338)
                      ++|.+.++||+|+||+||+|+.  +|+.||||++..........++|+..+.+++|||||++++++..++    .+|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4799999999999999999987  5899999999765543344556777778899999999999998653    689999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc--------CceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      |||++|+|.+++... ++++..+..++.|++.||.|||++        +||||||||+|||++.++  ++||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC--CEEEEeCCCCcc
Confidence            999999999999764 799999999999999999999987        999999999999997655  899999999975


Q ss_pred             cccCC-----CCCCccccCcccccccccCCcc-----CCCcchHHHHHHHHHHHHcCCCCCCCCCC----------h-HH
Q 019628          150 SVLHS-----QPKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPED----------P-KN  208 (338)
Q Consensus       150 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~lltg~~pf~~~~~----------~-~~  208 (338)
                      .....     .....+||+.|||||++.+...     .+.++|||||||++|||+||.+||.....          . ..
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            43322     2234679999999999975421     23458999999999999999877643221          0 11


Q ss_pred             HHHHHhhHhhcc--ccCCCcc---cCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          209 FRKTIGRILSVH--YSFPDYV---RVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       209 ~~~~~~~~~~~~--~~~~~~~---~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .......+....  +.+|...   ..+..+.+|+.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            122222222222  2233321   233568899999999999999999999873

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-54  Score=407.17  Aligned_cols=255  Identities=35%  Similarity=0.528  Sum_probs=219.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+.    ......+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999999763    223356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--Q  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~  155 (338)
                      ||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+......  .
T Consensus       149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSEEE
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC--CEEEeccceeEeeccCCccc
Confidence            99999999999875 4799999999999999999999999999999999999997555  89999999997543332  2


Q ss_pred             CCCccccCcccccccccCCc----cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          156 PKSTVGTPAYIAPEVLTKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      ..+.+||+.|+|||++.+..    + +.++|||||||++|+|++|++||...+....+..+....  ..+.+|....++.
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~  302 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYY-GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISK  302 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEE-ETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCCCH
T ss_pred             ccCCcCCccccCHHHhhccCCCcCC-CCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccccH
Confidence            34678999999999997654    4 345999999999999999999998766554444443321  2345676668999


Q ss_pred             HHHHHHHHhcccCCCc--CCChhHHhcCccccc
Q 019628          232 ECKHLLSRIFVANSEK--RITIPEIKNHPWFLR  262 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~  262 (338)
                      ++++||++||..+|.+  |+++.|+++||||+.
T Consensus       303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             HHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            9999999999999988  999999999999974

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.7e-55  Score=406.73  Aligned_cols=293  Identities=28%  Similarity=0.351  Sum_probs=216.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCC--eEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPT--HLA   74 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~--~~~   74 (338)
                      +++|++++.||+|+||+||+|.+..+|+.||||++.+..   .....+.+|+.+++.+. ||||+++++++..++  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            368999999999999999999999999999999986532   33456789999999997 999999999997654  799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc--
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL--  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~--  152 (338)
                      +||||++ ++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC--CEEecCCcccccccccc
Confidence            9999997 589998876 4799999999999999999999999999999999999997554  899999999974322  


Q ss_pred             --------------------CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHH
Q 019628          153 --------------------HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT  212 (338)
Q Consensus       153 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~  212 (338)
                                          .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                112344689999999999987544456699999999999999999999987765555544


Q ss_pred             HhhHhhccc-----------------------------------------cCCCcccCCHHHHHHHHHhcccCCCcCCCh
Q 019628          213 IGRILSVHY-----------------------------------------SFPDYVRVSLECKHLLSRIFVANSEKRITI  251 (338)
Q Consensus       213 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~  251 (338)
                      +..+.....                                         .......+++++.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            422111000                                         000112578999999999999999999999


Q ss_pred             hHHhcCcccccCCCccccc--CCCcccCCCCCCCCCHHHHHHHhHhhC
Q 019628          252 PEIKNHPWFLRNLPIELTE--GGSWQSHDVNNPSQSLEEVLSLIHEAT  297 (338)
Q Consensus       252 ~ell~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (338)
                      .|+|+||||..........  ...+..........+.+++.+.+.++.
T Consensus       324 ~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (388)
T 3oz6_A          324 NDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEI  371 (388)
T ss_dssp             HHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHH
T ss_pred             HHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHH
Confidence            9999999997543322111  111111111233457788877776654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-55  Score=406.23  Aligned_cols=257  Identities=29%  Similarity=0.537  Sum_probs=221.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            579999999999999999999999999999999976532 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           81 AGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      +|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+++...........
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~  210 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  210 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeee
Confidence            9999999997553 699999999999999999999999999999999999998655568999999999865544444556


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCCHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHLL  237 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li  237 (338)
                      +||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+....+.++  .+..+++++++||
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li  285 (387)
T 1kob_A          211 TATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQ----NVKRCDWEFDEDAFSSVSPEAKDFI  285 (387)
T ss_dssp             CSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             ccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCccccccCCHHHHHHH
Confidence            89999999999988777544 899999999999999999998765433332    2333333332  3446899999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+||..||.+|||+.|+|+||||...
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          286 KNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHcCCChhHCcCHHHHhhCccccCC
Confidence            99999999999999999999999754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-55  Score=404.08  Aligned_cols=303  Identities=23%  Similarity=0.355  Sum_probs=225.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------e
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------H   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~   72 (338)
                      ++|++++.||+|+||.||+|.+..+|+.||||++....   ...+.+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            58999999999999999999999999999999986532   23456889999999999999999999998763      4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++... 
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~-  179 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQAD-  179 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECC-
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--CEEEEeeecccccc-
Confidence            69999999 7899999876 5799999999999999999999999999999999999997554  89999999998543 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH------------  220 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~------------  220 (338)
                       ......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+...........            
T Consensus       180 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          180 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             -SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             -cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence             2345678999999999998743334559999999999999999999998766555444432211100            


Q ss_pred             ------------ccCC-CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCCCCCHH
Q 019628          221 ------------YSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLE  287 (338)
Q Consensus       221 ------------~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (338)
                                  ..+. .....++++.+||.+||+.||.+|||+.|+|+||||........................+.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLD  338 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCCCCC-----CCHH
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCCCCCChhhhcCCHH
Confidence                        0000 113578999999999999999999999999999999765433322211112223344456788


Q ss_pred             HHHHHhHhhCCCCCCCCcCCccc
Q 019628          288 EVLSLIHEATKPLEAPRVGGHLL  310 (338)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~  310 (338)
                      ++.+.+.++...+.++..-+.+.
T Consensus       339 ~~~~~~~~~~~~~~~~~~l~~~~  361 (367)
T 1cm8_A          339 EWKRVTYKEVLSFKPPRQLGARV  361 (367)
T ss_dssp             HHHHHHHHHHHTCCC--------
T ss_pred             HHHHHHHHHHHHhccccccchhc
Confidence            99999998887777665544443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.1e-55  Score=417.31  Aligned_cols=256  Identities=39%  Similarity=0.735  Sum_probs=226.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.+..    .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999997642    23467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.........
T Consensus        96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~--~vkL~DFG~a~~~~~~~~~~  173 (476)
T 2y94_A           96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLR  173 (476)
T ss_dssp             ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC--CEEECCCSSCEECCTTCCBC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC--CeEEEeccchhhcccccccc
Confidence            9999999999998888899999999999999999999999999999999999997554  89999999998665555556


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||........+.    .+....+..|.  .+++++.+||
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~s~~~~~Li  247 (476)
T 2y94_A          174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIFYTPQ--YLNPSVISLL  247 (476)
T ss_dssp             CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----HHHTTCCCCCT--TCCHHHHHHH
T ss_pred             ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----HHhcCCcCCCc--cCCHHHHHHH
Confidence            77899999999999988776677999999999999999999998766544333    34444455554  5889999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      ++||+.||.+|||+.|+++||||++..+
T Consensus       248 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             HHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            9999999999999999999999986543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-54  Score=388.86  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=210.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      |++|++++.||+|+||+||+|.+ .+++.||+|++....   .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            68999999999999999999999 578999999987543   23467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCC
Q 019628           78 EYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~  155 (338)
                      ||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... ...
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEeECccccccCccccc
Confidence            99975 999988754 5799999999999999999999999999999999999997554  899999999875432 223


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--------------
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--------------  221 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--------------  221 (338)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|+.||.....................              
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            345679999999999976554455699999999999999999999887665554444332211100              


Q ss_pred             cCC---------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          222 SFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       222 ~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .++         ....+++++.+||.+||+.||++|||+.|+++||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            000         01247899999999999999999999999999999974

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-54  Score=412.45  Aligned_cols=298  Identities=26%  Similarity=0.352  Sum_probs=213.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~   73 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..   ...+++.+|+.+++.++||||+++++++...     ..+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            68999999999999999999999999999999997632   2346788999999999999999999999543     579


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+||||+ +++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCTTSC
T ss_pred             EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC--CEeecccccchhccCc
Confidence            9999998 579999999888899999999999999999999999999999999999997554  8999999999854321


Q ss_pred             ----------------------------CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc----------
Q 019628          154 ----------------------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV----------  195 (338)
Q Consensus       154 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt----------  195 (338)
                                                  ......+||++|+|||++......+.++|||||||++|+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence                                        123456789999999987554434555999999999999999          


Q ss_pred             -CCCCCCCCCC--------------------hHHHHHHHhhHhhc----------------cccC---------CCcccC
Q 019628          196 -GAYPFEDPED--------------------PKNFRKTIGRILSV----------------HYSF---------PDYVRV  229 (338)
Q Consensus       196 -g~~pf~~~~~--------------------~~~~~~~~~~~~~~----------------~~~~---------~~~~~~  229 (338)
                       |.++|.+...                    ...+..++..+...                ...+         ..+...
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6777765431                    11111111100000                0000         112346


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCC-cccCCC-CCCCCCHHHHHHHhHhhCCCCCC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGS-WQSHDV-NNPSQSLEEVLSLIHEATKPLEA  302 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  302 (338)
                      ++++.+||++||+.||.+|||+.|+|+||||............. .....+ .....+.+++...+.++...+.+
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  444 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHP  444 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCT
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCc
Confidence            89999999999999999999999999999997654332211111 000111 12346788888888887766554

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-54  Score=392.03  Aligned_cols=259  Identities=28%  Similarity=0.462  Sum_probs=211.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +++|++++.||+|+||+||+|.+. +++.||+|++.....   ....+.+|+.++++++||||+++++++.+++.+|+||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            479999999999999999999996 589999999875432   2356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CC
Q 019628           78 EYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~  155 (338)
                      ||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ..
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEETTSCCC-
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC--CEEEccCcCceecCCCccc
Confidence            99975 888887654 3599999999999999999999999999999999999997554  8999999999754322 33


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCC----------
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFP----------  224 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~----------  224 (338)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|+.||..................... .++          
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            345679999999999977554455699999999999999999999887776665555433221110 000          


Q ss_pred             -------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          225 -------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       225 -------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                   ....+++++.+||.+||+.||++|||+.|+|+||||+.-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                         012467899999999999999999999999999999753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=390.73  Aligned_cols=254  Identities=38%  Similarity=0.630  Sum_probs=212.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------------------------ccHHHHHHHHHHh
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------------------------IDEHVQREIMNHR   53 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~E~~~l~   53 (338)
                      +++|++.+.||+|+||.||+|.+..+++.||||++.+...                           ..+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999976431                           1246889999999


Q ss_pred             cCCCCCcceeEEEEEc--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEe
Q 019628           54 SLKHPNIVRFKEVLLT--PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL  131 (338)
Q Consensus        54 ~l~h~~Iv~~~~~~~~--~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~  131 (338)
                      +++||||+++++++..  ...+|+||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999987  56899999999999998765 34579999999999999999999999999999999999999


Q ss_pred             cCCCCCcEEEeecCCCcccccCC-CCCCccccCcccccccccCCcc--CCCcchHHHHHHHHHHHHcCCCCCCCCCChHH
Q 019628          132 DGSTAPRVKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLTKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN  208 (338)
Q Consensus       132 ~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~  208 (338)
                      +.++  .+||+|||+++...... ......||+.|+|||++.+...  .+.++|||||||++|+|++|+.||......  
T Consensus       171 ~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--  246 (298)
T 2zv2_A          171 GEDG--HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM--  246 (298)
T ss_dssp             CTTS--CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             CCCC--CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH--
Confidence            7554  89999999997543322 2345679999999999976542  355589999999999999999999875432  


Q ss_pred             HHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          209 FRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                        .....+......+|....+++++.+||.+||+.||++|||+.|+++||||+
T Consensus       247 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 --CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             --HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             --HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence              223334445556666667999999999999999999999999999999995

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.2e-54  Score=401.53  Aligned_cols=253  Identities=34%  Similarity=0.555  Sum_probs=212.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHH-HhcCCCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMN-HRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++++.||+|+||.||+|+++.+++.||||++.+...    ....+.+|..+ ++.++||||++++++|.+.+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3689999999999999999999999999999999987532    22445666665 577899999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~  154 (338)
                      ||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++... ...
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCBCGGGBCCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEeeCccccccccCCC
Confidence            999999999999999888999999999999999999999999999999999999997554  89999999998532 233


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....+||+.|+|||++.+..++.. +|||||||++|+|++|..||...+....    ...+......++.  .++.+++
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~  267 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEM----YDNILNKPLQLKP--NITNSAR  267 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHH----HHHHHHSCCCCCS--SSCHHHH
T ss_pred             ccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHhcccCCCC--CCCHHHH
Confidence            4566789999999999988877554 9999999999999999999987554333    3344455555554  6899999


Q ss_pred             HHHHHhcccCCCcCCCh----hHHhcCccccc
Q 019628          235 HLLSRIFVANSEKRITI----PEIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~----~ell~hp~~~~  262 (338)
                      +||++||+.||.+||++    .++++||||..
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            99999999999999987    69999999964

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.5e-54  Score=397.22  Aligned_cols=257  Identities=35%  Similarity=0.601  Sum_probs=205.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.... ..+.+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            46999999999999999999999999999999997653 34567899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC-CCCCcEEEeecCCCcccccCCCCCCcc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKSTV  160 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~-~~~~~ikL~Dfg~a~~~~~~~~~~~~~  160 (338)
                      +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ..++.+||+|||+++...........+
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC  211 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence            9999999988888999999999999999999999999999999999999974 234589999999998655444455678


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCcccCCHHHHHHHH
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLLS  238 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~  238 (338)
                      ||+.|+|||++.+..++.+ +|||||||++|+|++|..||.........   ...+....+.+  +.+..++.++.+||+
T Consensus       212 gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~li~  287 (349)
T 2w4o_A          212 GTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNAKDLVR  287 (349)
T ss_dssp             -CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             CCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence            9999999999988777554 99999999999999999999876554322   22333333332  334578999999999


Q ss_pred             HhcccCCCcCCChhHHhcCcccccC
Q 019628          239 RIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       239 ~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +||..||++|||+.|+|+||||...
T Consensus       288 ~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          288 KLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             HHccCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.1e-54  Score=390.87  Aligned_cols=261  Identities=25%  Similarity=0.425  Sum_probs=202.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++....  .....+.+|+.++++++||||+++++++..++.+|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            368999999999999999999999999999999997643  334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           79 YAAGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        79 ~~~~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |++ ++|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC--CEEECcCccceecCC
Confidence            997 5999988754      3589999999999999999999999999999999999997554  899999999975432


Q ss_pred             C-CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-------cCC
Q 019628          153 H-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-------SFP  224 (338)
Q Consensus       153 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~  224 (338)
                      . .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.....................       ..+
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            2 23445689999999999977544455599999999999999999999987765554444332111000       000


Q ss_pred             ---------------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          225 ---------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       225 ---------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                                           ....++.++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                                 0124788999999999999999999999999999997644

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.3e-54  Score=407.70  Aligned_cols=257  Identities=28%  Similarity=0.514  Sum_probs=218.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+..    .....+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997632    22334788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      ||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+....... 
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSCE
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC--CEEEcchhhhhhcccCCCc
Confidence            99999999999987 56799999999999999999999999999999999999997555  899999999975433222 


Q ss_pred             -CCCccccCccccccccc-----CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCc-cc
Q 019628          156 -PKSTVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY-VR  228 (338)
Q Consensus       156 -~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  228 (338)
                       ....+||+.|+|||++.     ...++ .++|||||||++|+|++|++||...+....+..++...  ..+.+|.. ..
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~  308 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPTQVTD  308 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCSSCCC
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCC-CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--ccccCCccccc
Confidence             34468999999999986     34454 45999999999999999999999866555554443322  23344543 46


Q ss_pred             CCHHHHHHHHHhcccCCCc--CCChhHHhcCcccccC
Q 019628          229 VSLECKHLLSRIFVANSEK--RITIPEIKNHPWFLRN  263 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~--R~s~~ell~hp~~~~~  263 (338)
                      +++++++||++||..+|++  |++++|+++||||...
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            8999999999999998888  9999999999999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-54  Score=402.30  Aligned_cols=297  Identities=23%  Similarity=0.371  Sum_probs=218.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC------Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~   72 (338)
                      ++|++++.||+|+||.||+|.+..+|+.||||++....   ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            58999999999999999999999999999999987542   2345678999999999999999999999764      56


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|++||++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++... 
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~-  183 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTA-  183 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC---------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--CEEEeecccccccc-
Confidence            89999999 7899998865 5799999999999999999999999999999999999997554  89999999998543 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH------------  220 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~------------  220 (338)
                       .......||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..+...+....            
T Consensus       184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          184 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             -ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence             2345678999999999998744345559999999999999999999988776555444433211100            


Q ss_pred             -------ccCCC------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCCCCCHH
Q 019628          221 -------YSFPD------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLE  287 (338)
Q Consensus       221 -------~~~~~------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (338)
                             ...+.      ....++++.+||++||+.||.+|||+.|+|+||||..........................+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSLESRDLLID  342 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCCCCGGGSSCCCCHH
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCCCCcchhhccCCHH
Confidence                   00000      12468899999999999999999999999999999865443322211112223344566789


Q ss_pred             HHHHHhHhhCCCCCCCC
Q 019628          288 EVLSLIHEATKPLEAPR  304 (338)
Q Consensus       288 ~~~~~~~~~~~~~~~~~  304 (338)
                      ++.+++.++...+.++.
T Consensus       343 ~~~~~~~~e~~~~~~~~  359 (367)
T 2fst_X          343 EWKSLTYDEVISFVPPP  359 (367)
T ss_dssp             HHHHHHHHHHHHCCCCC
T ss_pred             HHHHHHHHHHHHhccCc
Confidence            99999988877665554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.6e-54  Score=415.03  Aligned_cols=257  Identities=37%  Similarity=0.628  Sum_probs=221.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+.   ......+.+|+.++++++||||+++++++...+.+|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            5799999999999999999999999999999998753   2334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++.........
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  181 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence            99999999999888899999999999999999999999999999999999999643 33479999999998665555566


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc--ccCCCcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YSFPDYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  235 (338)
                      ..+||+.|+|||++.+ .++ .++|||||||++|+|++|.+||........+.    .+....  +..|.+..+|+++++
T Consensus       182 ~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          182 DRIGTAYYIAPEVLRG-TYD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILK----RVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             CCTTGGGGCCGGGGGS-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCcCCCCCCCHHHhCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCCcccCCCCHHHHH
Confidence            7789999999999976 454 55999999999999999999998765543332    333333  334566789999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ||.+||+.+|.+|||+.|+|+||||++..
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999997543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3e-54  Score=418.27  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=223.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.+..    .....+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57999999999999999999999999999999997632    23456789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           78 EYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ||++||+|..++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTCC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceecccCcc
Confidence            99999999999986543  99999999999999999999999999999999999997554  899999999986554444


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....+||+.|+|||++.+..++.. +|||||||++|+|++|++||...............+......+|.  .+++++++
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~--~~s~~~~d  418 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE--RFSPQARS  418 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred             ccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc--cCCHHHHH
Confidence            456789999999999988877655 899999999999999999998765433333444445555555664  68999999


Q ss_pred             HHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      ||++||..||.+||     |+.|+++||||+.
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            99999999999999     8999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-53  Score=386.67  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=213.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCC---CCCcceeEEEEEcCC-
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------KIDEHVQREIMNHRSLK---HPNIVRFKEVLLTPT-   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~-   71 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++....      .....+.+|+.+++.++   ||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            68999999999999999999999999999999987432      22356778888877775   999999999998765 


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecC
Q 019628           72 ----HLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFG  145 (338)
Q Consensus        72 ----~~~iv~e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg  145 (338)
                          .+++||||+. ++|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg  165 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFG  165 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS--CEEECSCS
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEEeeCc
Confidence                5899999996 599999987654  99999999999999999999999999999999999997554  89999999


Q ss_pred             CCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-ccCC
Q 019628          146 YSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFP  224 (338)
Q Consensus       146 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  224 (338)
                      +++............||+.|+|||++.+..++.+ +|||||||++|+|++|++||.................... ..++
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            9986655555566789999999999988887655 8999999999999999999988776655555443321110 0011


Q ss_pred             C--------------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          225 D--------------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       225 ~--------------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .                    ...+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            0                    12478999999999999999999999999999999754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-54  Score=409.85  Aligned_cols=253  Identities=36%  Similarity=0.599  Sum_probs=211.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||+|+||.||+|.+..+|+.||||++.+.    ......+.+|+.+++.++||||++++++|...+.+|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999999753    22335677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHS  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~  154 (338)
                      |||+++|+|..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++  .+||+|||+|+... ...
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--CEEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--CEEEccCCCceeccCCCc
Confidence            9999999999999988899999999999999999999998 8999999999999997554  89999999998532 233


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......    ....+......+|.  .+++++.
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~  377 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIRFPR--TLGPEAK  377 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHH
T ss_pred             ccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHH
Confidence            4456789999999999988877555 999999999999999999998765433    23334445556665  6899999


Q ss_pred             HHHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          235 HLLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      +||.+||+.||.+||     |+.|+++||||..
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            999999999999999     9999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.6e-54  Score=391.49  Aligned_cols=252  Identities=32%  Similarity=0.546  Sum_probs=210.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ-----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++++.||+|+||.||+|++.   .+++.||+|++++..     .....+.+|+.+++.++||||+++++++...+.+
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            68999999999999999999985   689999999997642     2335577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-  152 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-  152 (338)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... 
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSCC------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCcccccccC
Confidence            99999999999999999888899999999999999999999999999999999999997554  899999999875332 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      .......+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.........    ..+......+|.  .++.+
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~  247 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRSGHNR-AVDWWSLGALMYDMLTGAPPFTGENRKKTI----DKILKCKLNLPP--YLTQE  247 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCCT--TSCHH
T ss_pred             CccccccCCCcCccCHhhCcCCCCCC-cccchhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCC--CCCHH
Confidence            23345678999999999998877754 499999999999999999999876543333    334444555555  68999


Q ss_pred             HHHHHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      +++||.+||..+|.+||     ++.|+++||||..
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            99999999999999999     8899999999964

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-54  Score=397.82  Aligned_cols=255  Identities=31%  Similarity=0.568  Sum_probs=215.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc------cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ------KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++.+.||+|+||+||+|.+..+++.||||++....      ...+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            47999999999999999999999999999999986532      134678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCccc
Q 019628           76 VMEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSS  150 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~  150 (338)
                      ||||++|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+|||+++..
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998887643    2589999999999999999999999999999999999997543 235999999999755


Q ss_pred             ccCCC-CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--Ccc
Q 019628          151 VLHSQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYV  227 (338)
Q Consensus       151 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  227 (338)
                      ..... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||....  .   .....+....+.++  .+.
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~--~---~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK--E---RLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH--H---HHHHHHHHTCCCCCHHHHT
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH--H---HHHHHHHcCCCCCCccccc
Confidence            43322 345689999999999988877554 999999999999999999998642  1   22333333333332  234


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .++.++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            68999999999999999999999999999999964

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.7e-54  Score=405.47  Aligned_cols=300  Identities=26%  Similarity=0.305  Sum_probs=224.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~   73 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..   ...+++.+|+.+++.++||||+++++++...     ..+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            68999999999999999999999999999999997642   2336788999999999999999999999776     579


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+||||++ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEEC---
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC--CEEEccCCCccccccc
Confidence            99999995 59999999888899999999999999999999999999999999999997554  8999999999854322


Q ss_pred             C-----------------------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcC-----------CCC
Q 019628          154 S-----------------------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-----------AYP  199 (338)
Q Consensus       154 ~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg-----------~~p  199 (338)
                      .                       .....+||++|+|||++......+.++|||||||++|+|++|           .++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            1                       235678999999999975544445669999999999999984           444


Q ss_pred             CCCCCC-----------------hHHHHHHHhhH--------------------hhccccCC-----CcccCCHHHHHHH
Q 019628          200 FEDPED-----------------PKNFRKTIGRI--------------------LSVHYSFP-----DYVRVSLECKHLL  237 (338)
Q Consensus       200 f~~~~~-----------------~~~~~~~~~~~--------------------~~~~~~~~-----~~~~~~~~~~~li  237 (338)
                      |.+...                 ...+..++..+                    .......+     .+..+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            443321                 11111111100                    00000101     1135899999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccCCCcccccC--CCcccCCCCCCCCCHHHHHHHhHhhCCCCCCCC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEG--GSWQSHDVNNPSQSLEEVLSLIHEATKPLEAPR  304 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (338)
                      ++||+.||.+|||+.|+|+||||...........  .............+.+++...+.++...+.+..
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  411 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPEL  411 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCccc
Confidence            9999999999999999999999976543222111  111111111245678888888888776555433

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6e-54  Score=413.25  Aligned_cols=255  Identities=36%  Similarity=0.612  Sum_probs=218.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++++.||+|+||+||+|.+..++..||+|++.+..   .....+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            37999999999999999999999999999999997642   335678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||++|+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++.........
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~  196 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK  196 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence            999999999999888999999999999999999999999999999999999997543 3469999999998665555566


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc--CCCcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS--FPDYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  235 (338)
                      ..+||+.|+|||++.+ .++. ++|||||||++|+|++|.+||........+    ..+....+.  .+.+..+++.+++
T Consensus       197 ~~~gt~~y~aPE~l~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          197 ERLGTAYYIAPEVLRK-KYDE-KCDVWSIGVILFILLAGYPPFGGQTDQEIL----RKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             CCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             ccCCCcCeeCHHHHcc-cCCC-chhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCchhcccCCHHHHH
Confidence            7789999999999864 4654 499999999999999999999876654333    333333333  3445679999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ||++||+.+|.+|||+.|+|+||||++
T Consensus       271 li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          271 LIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHHCCCChhhCccHHHHhcCccccc
Confidence            999999999999999999999999965

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.5e-54  Score=393.22  Aligned_cols=262  Identities=28%  Similarity=0.424  Sum_probs=210.1

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +++|++++.||+|+||+||+|.+..+++.||||++.....   ....+.+|+.++++++||||+++++++..++.+|+||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            4789999999999999999999999999999999975432   2345779999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC---CCCcEEEeecCCCccccc-C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS---TAPRVKICDFGYSKSSVL-H  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~---~~~~ikL~Dfg~a~~~~~-~  153 (338)
                      ||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+   ..+.+||+|||+++.... .
T Consensus       113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            9997 5999999988899999999999999999999999999999999999999532   233699999999875432 2


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-ccCC------Cc
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFP------DY  226 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~------~~  226 (338)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.................... ..++      .+
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW  271 (329)
T ss_dssp             --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence            3344567899999999998765445569999999999999999999988776555554443321110 0011      00


Q ss_pred             -----------------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          227 -----------------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       227 -----------------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                       ..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                             0167899999999999999999999999999999753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-53  Score=385.78  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=212.1

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +++|++++.||+|+||+||+|.+..+|+.||+|++......   .+.+.+|+.++++++||||+++++++...+.+++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            68999999999999999999999999999999998664332   356778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~  156 (338)
                      ||+++++|..++.....+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||++..... ....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhccCccccc
Confidence            9999999999988888899999999999999999999999999999999999997554  899999999975432 2233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc---------------cc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV---------------HY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------------~~  221 (338)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|.+||...................               ..
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV  239 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred             CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence            456899999999999774444556999999999999999999998876655443332221110               00


Q ss_pred             cCCC----------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          222 SFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       222 ~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..+.          ...++.++.+||.+||..||.+|||+.|+++||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence            1111          13578899999999999999999999999999999753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-53  Score=401.13  Aligned_cols=256  Identities=27%  Similarity=0.464  Sum_probs=215.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+..    .....+.+|..++..++||||++++++|.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997632    22345788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           78 EYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      ||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++....... 
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g--~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSCE
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC--CEEEeechhheeccCCCcc
Confidence            9999999999998754 799999999999999999999999999999999999997554  899999999975443322 


Q ss_pred             -CCCccccCcccccccccC-------CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC-c
Q 019628          156 -PKSTVGTPAYIAPEVLTK-------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-Y  226 (338)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~  226 (338)
                       ....+||+.|+|||++..       ..++ .++|||||||++|+|++|++||...+....+.++....  ....+|. .
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~  295 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLPLVD  295 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC---
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCCccc
Confidence             335689999999999873       3454 45999999999999999999998866554444433221  1233442 2


Q ss_pred             ccCCHHHHHHHHHhcccCCCcC---CChhHHhcCcccccC
Q 019628          227 VRVSLECKHLLSRIFVANSEKR---ITIPEIKNHPWFLRN  263 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R---~s~~ell~hp~~~~~  263 (338)
                      ..+|+++++||++||. +|.+|   ++++|+++||||...
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            3689999999999999 99998   599999999999753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-53  Score=380.69  Aligned_cols=257  Identities=34%  Similarity=0.605  Sum_probs=222.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++...+..|+|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            689999999999999999999999999999999876432   23567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+.+||+|||++..........
T Consensus        86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (284)
T 3kk8_A           86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  165 (284)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence            999999999999888899999999999999999999999999999999999997544 2359999999997665555555


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--cCCCcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SFPDYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  235 (338)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +.....  ..+.+..+++++.+
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          166 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             CSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHH----HHhccccCCchhhcccCHHHHH
Confidence            6789999999999988877555 8999999999999999999987654433322    233333  33444578999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||.+||+.+|++|||+.|+++||||.+.
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCC
Confidence            9999999999999999999999999754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.9e-54  Score=395.70  Aligned_cols=256  Identities=33%  Similarity=0.556  Sum_probs=217.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+...   ...+|+.++.++ +||||+++++++.+.+.+|+||||+
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            479999999999999999999999999999999987543   234688888777 7999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC--CcEEEeecCCCcccccC-CCCC
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVLH-SQPK  157 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~--~~ikL~Dfg~a~~~~~~-~~~~  157 (338)
                      +||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+.....  +.+||+|||+++..... ....
T Consensus        99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  178 (342)
T 2qr7_A           99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM  178 (342)
T ss_dssp             CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCcee
Confidence            99999999998888999999999999999999999999999999999999853322  35999999999854332 3345


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (338)
                      ..+||+.|+|||++.+..++. ++|||||||++|+|++|..||..... .........+....+.++  .+..+++++++
T Consensus       179 ~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  256 (342)
T 2qr7_A          179 TPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKD  256 (342)
T ss_dssp             CSSCCSSCCCHHHHHHHHHHH-HHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHH
T ss_pred             ccCCCccccCHHHhcCCCCCC-ccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHHH
Confidence            678999999999998776654 48999999999999999999986432 222344445555555544  34578999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ||++||..||.+|||+.++++||||..
T Consensus       257 li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          257 LVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            999999999999999999999999964

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.3e-54  Score=413.63  Aligned_cols=257  Identities=37%  Similarity=0.616  Sum_probs=220.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--------------cccHHHHHHHHHHhcCCCCCcceeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--------------KIDEHVQREIMNHRSLKHPNIVRFKEVL   67 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   67 (338)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+..              ...+.+.+|+.++++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            58999999999999999999999999999999997643              2345788999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC-CcEEEeecCC
Q 019628           68 LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGY  146 (338)
Q Consensus        68 ~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~-~~ikL~Dfg~  146 (338)
                      .+...+|+|||||+||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  195 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL  195 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence            999999999999999999999998889999999999999999999999999999999999999975542 3699999999


Q ss_pred             CcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--C
Q 019628          147 SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--P  224 (338)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~  224 (338)
                      ++...........+||+.|+|||++.+ .++. ++|||||||++|+|++|.+||........    ...+....+.+  +
T Consensus       196 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          196 SSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQDI----IKKVEKGKYYFDFN  269 (504)
T ss_dssp             CEECCTTSCBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCHH
T ss_pred             CEEcCCCCccccccCCcCCCCHHHhcc-CCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCcc
Confidence            986655555667789999999999874 4554 49999999999999999999988655433    33344444433  3


Q ss_pred             CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      .+..+|+++++||++||+.||.+|||+.|+|+||||++..
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            4567899999999999999999999999999999997543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-53  Score=381.96  Aligned_cols=255  Identities=29%  Similarity=0.520  Sum_probs=209.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||+|+||+||+|.+..++..+|+|++....  ...+.+.+|+.++++++||||+++++++...+.+|+||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            47999999999999999999999999999999987653  2346789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCcccccCC
Q 019628           80 AAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        80 ~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +++++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+||+++.. ..+.+||+|||++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            999999998854    3679999999999999999999999999999999999999643 34579999999998655555


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC-CcccCCHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DYVRVSLEC  233 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  233 (338)
                      ......||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||...........    .......++ ....+++++
T Consensus       182 ~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  255 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQA  255 (285)
T ss_dssp             -----CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCC--CCCCHHH
T ss_pred             cCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh----hccCCcccccccCcCCHHH
Confidence            5566789999999999864 44 4559999999999999999999987654332222    222222221 223578999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+||.+||+.||++|||+.|+|+||||++
T Consensus       256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            99999999999999999999999999974

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.7e-54  Score=403.96  Aligned_cols=257  Identities=35%  Similarity=0.596  Sum_probs=206.8

Q ss_pred             CCceEe-eeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHH-hcCCCCCcceeEEEEEc----CCeEEE
Q 019628            2 ERYEIV-KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVRFKEVLLT----PTHLAI   75 (338)
Q Consensus         2 ~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~----~~~~~i   75 (338)
                      ++|.+. +.||+|+||+||++.+..+|+.||||++...    ..+.+|+.++ +..+||||++++++|..    ...+|+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            578887 7899999999999999999999999998643    5677888876 55689999999999875    567999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCccccc
Q 019628           76 VMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVL  152 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~  152 (338)
                      ||||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++... ++.+||+|||+++....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999999998653  599999999999999999999999999999999999997532 45899999999986554


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCcccCC
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVS  230 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  230 (338)
                      .......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............+....+.+  +.+..++
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  295 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  295 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred             CCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence            445567789999999999988777655 8999999999999999999976543221111122233333433  3456799


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .++++||++||..||.+|||+.|+++||||.+.
T Consensus       296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.9e-54  Score=389.51  Aligned_cols=256  Identities=34%  Similarity=0.614  Sum_probs=220.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.....       ..+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            479999999999999999999999999999999976432       2467899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC--CcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~--~~ikL~Dfg~a~~~~~  152 (338)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  ..+||+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            99999999999999998888999999999999999999999999999999999999975542  2699999999986555


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCC
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS  230 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (338)
                      ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+....+.++.  +..++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          172 GVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL----ANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTCC
T ss_pred             cccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcccccChhhhcccC
Confidence            545566789999999999988777544 89999999999999999999876543333    233333333332  23688


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..+.+||.+||..||.+|||+.|+++||||..
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            99999999999999999999999999999964

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.1e-54  Score=415.43  Aligned_cols=256  Identities=36%  Similarity=0.599  Sum_probs=222.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++.+..    .....+.+|+.++++++||||+++++++...+.+|+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999999999997642    33467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCcccccCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      ||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++........
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  185 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM  185 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence            999999999999988899999999999999999999999999999999999999542 3458999999998765444444


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--cCCCcccCCHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SFPDYVRVSLECK  234 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  234 (338)
                      ...+||+.|+|||++.+ .++ .++|||||||++|+|++|.+||..........    .+....+  ..|.+..+|++++
T Consensus       186 ~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          186 KDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILK----KVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             HHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCSGGGGGSCHHHH
T ss_pred             ccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCCCCCcccccCCHHHH
Confidence            55689999999999976 454 45999999999999999999998866543333    3333333  3455678999999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +||++||+.+|.+|||+.|+|+||||+..
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.9e-54  Score=391.46  Aligned_cols=259  Identities=34%  Similarity=0.602  Sum_probs=200.7

Q ss_pred             CCceEe---eeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIV---KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~---~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.   +.||+|+||+||+|.+..+++.||||++.+.  ....+.+|+.+++.+. ||||+++++++.+...+|+||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            467775   7899999999999999999999999999754  3467789999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccC-CC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH-SQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~-~~  155 (338)
                      ||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||+++..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999999999999988999999999999999999999999999999999999996543 237999999999754332 23


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhhHhhccccCCC--cccCC
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---KNFRKTIGRILSVHYSFPD--YVRVS  230 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~  230 (338)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......   .........+....+.++.  +..++
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             ------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             ccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            456679999999999988777544 89999999999999999999864431   1123344455555554443  34689


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +++++||.+||..||.+|||+.|+++||||+..
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999999999999999754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-53  Score=412.06  Aligned_cols=256  Identities=30%  Similarity=0.431  Sum_probs=221.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+..    .....+.+|+.++++++||||++++++|.+.+.+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997642    23457889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           78 EYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        78 e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      ||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g--~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC--CEEEeecceeeeccCC
Confidence            999999999999763    3699999999999999999999999999999999999997554  8999999999865433


Q ss_pred             CC-CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          154 SQ-PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       154 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      .. ....+||+.|+|||++.+..++.+ +|||||||++|+|++|++||...............+......+|.  .++++
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~  419 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPA  419 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCHH
T ss_pred             CcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCHH
Confidence            32 344689999999999988877655 899999999999999999998765433334445555566666665  68999


Q ss_pred             HHHHHHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      +++||++||+.||.+||+     +.++++||||+.
T Consensus       420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            999999999999999996     589999999974

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=389.75  Aligned_cols=260  Identities=25%  Similarity=0.447  Sum_probs=207.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc--cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI--DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      |++|++++.||+|+||+||+|.+..+++.||+|++......  ...+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            68999999999999999999999999999999998754321  1245579999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           79 YAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      |++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ...
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC--CEEECSSSEEECC-------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC--CEEEccCcccccccCCcccc
Confidence            997 58988887644 589999999999999999999999999999999999997554  8999999998754322 233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-ccCC-----------
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFP-----------  224 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-----------  224 (338)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|+.||.................... ..++           
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            4567899999999998755445569999999999999999999998766554444333221110 0011           


Q ss_pred             ---C---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          225 ---D---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       225 ---~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                         .         ...+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence               0         12478899999999999999999999999999999643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.9e-54  Score=394.06  Aligned_cols=249  Identities=31%  Similarity=0.475  Sum_probs=216.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~   72 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.....         ....+.+|+.++++++||||++++++|...+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            479999999999999999999999999999999986532         22356789999999999999999999999999


Q ss_pred             EEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           73 LAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        73 ~~iv~e~~~~~-~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      +++||||+.+| +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECC
Confidence            99999998766 9999999888999999999999999999999999999999999999997554  89999999998665


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      ........+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.....          ........|.  .+++
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~~--~~~~  249 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPY--LVSK  249 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCSS--CCCH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCCc--ccCH
Confidence            555555678999999999998888766668999999999999999999975321          1222222232  5899


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ++.+||.+||+.+|.+|||+.++++||||++..
T Consensus       250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            999999999999999999999999999997543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.1e-53  Score=397.47  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=211.7

Q ss_pred             CCceEeeeeccC--CceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSG--NFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++++.||+|  +||+||+|.+..+|+.||||++....   ...+.+.+|+.+++.++||||++++++|..++.+|+|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            589999999999  99999999999999999999997653   2235678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc--
Q 019628           77 MEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL--  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~--  152 (338)
                      |||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||.+.....  
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEECEETT
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccceeecccc
Confidence            9999999999999875  6799999999999999999999999999999999999997554  899999998753211  


Q ss_pred             ------CCCCCCccccCcccccccccC--CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh------
Q 019628          153 ------HSQPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS------  218 (338)
Q Consensus       153 ------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~------  218 (338)
                            .......+||+.|+|||++.+  ..++ .++|||||||++|+|++|+.||..................      
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence                  122334579999999999987  4554 4599999999999999999999876654443322211100      


Q ss_pred             ----------------------------------ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          219 ----------------------------------VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       219 ----------------------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                                        .....+....+++++.+||++||+.||++|||+.|+|+||||++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                                              000111223578999999999999999999999999999999753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-53  Score=379.45  Aligned_cols=257  Identities=35%  Similarity=0.607  Sum_probs=221.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||.||++.+..++..+|+|++.... ...+.+.+|+.++++++||||+++++++...+.+|+||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            47999999999999999999999999999999997643 33467899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC-CCCCcEEEeecCCCcccccCCCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~-~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      ++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||++.. +..+.+||+|||++............
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~  168 (277)
T 3f3z_A           89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK  168 (277)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence            99999999998888999999999999999999999999999999999999932 22348999999999866555555677


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCCHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLL  237 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li  237 (338)
                      .||+.|+|||++.+. ++. ++|||||||++|+|++|+.||..........    .+......++.  +..+++.+.+||
T Consensus       169 ~~t~~y~aPE~~~~~-~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li  242 (277)
T 3f3z_A          169 VGTPYYVSPQVLEGL-YGP-ECDEWSAGVMMYVLLCGYPPFSAPTDSEVML----KIREGTFTFPEKDWLNVSPQAESLI  242 (277)
T ss_dssp             CSCTTTCCHHHHTTC-BCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred             CCCCCccChHHhccc-CCc-hhhehhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCchhhhcCCHHHHHHH
Confidence            899999999998654 544 4899999999999999999998765543332    33334444443  236899999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccCC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      .+||+.+|.+|||+.++|+||||++..
T Consensus       243 ~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          243 RRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999997543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.8e-53  Score=379.98  Aligned_cols=254  Identities=34%  Similarity=0.636  Sum_probs=217.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++++.||+|+||.||+|.+..++..||+|++.+..    .....+.+|+.++++++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            478999999999999999999999999999999986532    2345688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||++.... ....
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~Dfg~~~~~~-~~~~  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAP-SSRR  164 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS--CEEECSCCEESCC------
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC--CEEEEeccccccCC-cccc
Confidence            99999999999999888999999999999999999999999999999999999997554  89999999886432 2234


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......    ....+......+|.  .+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~l  237 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRVEFTFPD--FVTEGARDL  237 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCT--TSCHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHH----HHHHHHhCCCCCCC--cCCHHHHHH
Confidence            55689999999999988776555 899999999999999999998755433    23334444555555  588999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      |.+||+.+|.+|||+.|+++||||+...
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCc
Confidence            9999999999999999999999997543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=397.34  Aligned_cols=252  Identities=31%  Similarity=0.536  Sum_probs=211.6

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCCCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      ..+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++...+.+|+||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3678999999999999999999999999998653 334678899999999999999999999999999999999999999


Q ss_pred             hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccC
Q 019628           85 LFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTP  163 (338)
Q Consensus        85 L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~  163 (338)
                      |.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+.....+.+||+|||+++...........+||+
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  252 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP  252 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCC
Confidence            99988654 46999999999999999999999999999999999999954444589999999998665555556678999


Q ss_pred             cccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCCHHHHHHHHHhc
Q 019628          164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHLLSRIF  241 (338)
Q Consensus       164 ~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L  241 (338)
                      .|+|||++.+..++. ++|||||||++|+|++|..||........+...    ....+.++  .+..+++++++||.+||
T Consensus       253 ~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~~~~~li~~~L  327 (373)
T 2x4f_A          253 EFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI----LACRWDLEDEEFQDISEEAKEFISKLL  327 (373)
T ss_dssp             TTCCHHHHTTCBCCH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTCCCSCSGGGTTSCHHHHHHHHTTS
T ss_pred             cEeChhhccCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhccCCCChhhhccCCHHHHHHHHHHc
Confidence            999999998776654 489999999999999999999887654444333    33333332  23468999999999999


Q ss_pred             ccCCCcCCChhHHhcCccccc
Q 019628          242 VANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       242 ~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +.||.+|||+.|+|+||||..
T Consensus       328 ~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          328 IKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHC
T ss_pred             CCChhhCCCHHHHhcCcCcCC
Confidence            999999999999999999964

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.6e-53  Score=376.41  Aligned_cols=256  Identities=39%  Similarity=0.728  Sum_probs=213.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||.||++.+..+|+.||||++....    .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            68999999999999999999999999999999987532    23457889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++..........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~  168 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLR  168 (276)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS--CEEECCCCGGGCCCC-----
T ss_pred             eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC--CEEEeecccccccCCCccee
Confidence            9999999999999888899999999999999999999999999999999999997554  89999999988655444445


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ...||+.|+|||++.+..+.+.++||||||+++|+|++|+.||........    ...+......+|.  .++..+.+||
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~l~~li  242 (276)
T 2h6d_A          169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL----FKKIRGGVFYIPE--YLNRSVATLL  242 (276)
T ss_dssp             --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred             cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCcccCch--hcCHHHHHHH
Confidence            678999999999998876655669999999999999999999987544322    2333444444454  5789999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      .+||+.||.+|||+.++++||||++..+
T Consensus       243 ~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHccCChhhCCCHHHHHhChhhccCch
Confidence            9999999999999999999999986543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.7e-53  Score=384.44  Aligned_cols=261  Identities=30%  Similarity=0.507  Sum_probs=213.1

Q ss_pred             CCceEe-eeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIV-KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++. +.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++++ +||||+++++++..++.+|+|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            579996 78999999999999999999999999997654 3346788999999885 79999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC-CcEEEeecCCCcccccCC---
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~-~~ikL~Dfg~a~~~~~~~---  154 (338)
                      |+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++.......   
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            9999999999998888999999999999999999999999999999999999975542 349999999987543211   


Q ss_pred             -----CCCCccccCcccccccccC-----CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChH-----------HHHHHH
Q 019628          155 -----QPKSTVGTPAYIAPEVLTK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK-----------NFRKTI  213 (338)
Q Consensus       155 -----~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-----------~~~~~~  213 (338)
                           .....+||+.|+|||++.+     ..++. ++|||||||++|+|++|+.||.......           ......
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK-RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHHTT-THHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhcccccccCCCc-ccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                 1234569999999999865     34544 4899999999999999999998654311           122333


Q ss_pred             hhHhhccccCCC--cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          214 GRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       214 ~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..+....+.+|.  +..++.++++||++||..||.+|||+.|+++||||+..
T Consensus       251 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            444555555553  24689999999999999999999999999999999754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.8e-53  Score=392.34  Aligned_cols=256  Identities=23%  Similarity=0.406  Sum_probs=213.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----CCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-----HPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-----h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++...........+|+.+++.+.     ||||+++++++...+.+|+|
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            6899999999999999999999999999999999876655677888999999986     99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC---------------------
Q 019628           77 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG---------------------  133 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~---------------------  133 (338)
                      |||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.                     
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            9999 899999998654  4999999999999999999999999999999999999975                     


Q ss_pred             --CCCCcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHH
Q 019628          134 --STAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK  211 (338)
Q Consensus       134 --~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~  211 (338)
                        ...+.+||+|||+++..  ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........
T Consensus       194 ~~~~~~~~kl~DFG~a~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~  270 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAM  270 (360)
T ss_dssp             EEESCCCEEECCCTTCEET--TSCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccCCCCEEEEeccCceec--CCCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence              12458999999999743  233456789999999999998887655 8999999999999999999987665444333


Q ss_pred             HHhhHhhc----------------------cccCCCcc------------------cCCHHHHHHHHHhcccCCCcCCCh
Q 019628          212 TIGRILSV----------------------HYSFPDYV------------------RVSLECKHLLSRIFVANSEKRITI  251 (338)
Q Consensus       212 ~~~~~~~~----------------------~~~~~~~~------------------~~~~~~~~li~~~L~~dp~~R~s~  251 (338)
                      ........                      ...+|...                  ..++.+.+||.+||+.||.+|||+
T Consensus       271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta  350 (360)
T 3llt_A          271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP  350 (360)
T ss_dssp             HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence            22111000                      00111110                  124678899999999999999999


Q ss_pred             hHHhcCcccc
Q 019628          252 PEIKNHPWFL  261 (338)
Q Consensus       252 ~ell~hp~~~  261 (338)
                      .|+|+||||+
T Consensus       351 ~elL~hp~f~  360 (360)
T 3llt_A          351 AELLKHKFLE  360 (360)
T ss_dssp             HHHTTSGGGC
T ss_pred             HHHhcCcccC
Confidence            9999999994

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-53  Score=394.14  Aligned_cols=290  Identities=26%  Similarity=0.388  Sum_probs=219.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------e
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------H   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~   72 (338)
                      ++|++++.||+|+||.||+|.+..+++.||||++....   .....+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            68999999999999999999999999999999997643   23356789999999999999999999998765      7


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+||||+++ +|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       105 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCC------
T ss_pred             eEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEEEeeccccccc
Confidence            8999999964 7888885  4589999999999999999999999999999999999997554  899999999986554


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh--------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--------------  218 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--------------  218 (338)
                      .......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+...+.....              
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            444556789999999999988877655 89999999999999999999987665554444332110              


Q ss_pred             ----cccc--------------CCCc----ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCccccc--CCCc
Q 019628          219 ----VHYS--------------FPDY----VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTE--GGSW  274 (338)
Q Consensus       219 ----~~~~--------------~~~~----~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~--~~~~  274 (338)
                          ....              +|..    ...++++++||++||+.||.+|||+.|+|+||||..........  ....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~  338 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKI  338 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCC
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCCC
Confidence                0000              0000    01256799999999999999999999999999997544322211  1122


Q ss_pred             ccCCCCCCCCCHHHHHHHhHhhC
Q 019628          275 QSHDVNNPSQSLEEVLSLIHEAT  297 (338)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~  297 (338)
                      ............+++.+++....
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~  361 (371)
T 2xrw_A          339 PDKQLDEREHTIEEWKELIYKEV  361 (371)
T ss_dssp             CTTTTCCCCCCHHHHHHHHHHHH
T ss_pred             CChhhccccCcHHHHHHHHHHHH
Confidence            23334455678888888887654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.5e-53  Score=419.09  Aligned_cols=253  Identities=32%  Similarity=0.535  Sum_probs=223.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++++.||+|+||.||+|.+..+++.||||++++.    ......+.+|..++..+ +||+|++++++|.+.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999763    23446778899999887 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc-cCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV-LHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~-~~~  154 (338)
                      ||||++||+|..++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+... ...
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS--CEEECCCTTCEECCCTTC
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC--cEEEeecceeeccccCCc
Confidence            999999999999999888999999999999999999999999999999999999997554  89999999998532 233


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|++||...+..    .....+......+|.  .++++++
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~  570 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYPK--SMSKEAV  570 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHSSCCCCCT--TSCHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHH----HHHHHHHhCCCCCCc--cCCHHHH
Confidence            4556789999999999988888555 99999999999999999999876543    334445566667776  6899999


Q ss_pred             HHHHHhcccCCCcCCCh-----hHHhcCccccc
Q 019628          235 HLLSRIFVANSEKRITI-----PEIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~-----~ell~hp~~~~  262 (338)
                      +||++||+.||.+||++     +||++||||..
T Consensus       571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            99999999999999998     99999999964

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.8e-53  Score=392.89  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=211.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc------------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT------------   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------------   69 (338)
                      ++|++++.||+|+||+||+|.+..+|+.||||++......   ..+|+.+++.++||||++++++|..            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            6899999999999999999999999999999998765332   3479999999999999999999844            


Q ss_pred             --------------------------CCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhcCc
Q 019628           70 --------------------------PTHLAIVMEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQI  119 (338)
Q Consensus        70 --------------------------~~~~~iv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~LH~~~i  119 (338)
                                                ...+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                      3458999999974 7776664    45679999999999999999999999999


Q ss_pred             eecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCC
Q 019628          120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYP  199 (338)
Q Consensus       120 iH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~p  199 (338)
                      +||||||+|||++.. ++.+||+|||+|+............||+.|+|||++.+....+.++||||+||++|+|++|++|
T Consensus       163 ~H~Dikp~Nil~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSK-DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             ECSCCCGGGEEEETT-TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCccCHHHEEEcCC-CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            999999999999732 2389999999998766666667788999999999988765445569999999999999999999


Q ss_pred             CCCCCChHHHHHHHhhHhhc-------------cccCCC----------cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          200 FEDPEDPKNFRKTIGRILSV-------------HYSFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       200 f~~~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      |......+.+...+......             ...+|.          ....++++.+||.+||+.+|.+|||+.|+|+
T Consensus       242 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            99877666555554321110             111111          1147889999999999999999999999999


Q ss_pred             Cccccc
Q 019628          257 HPWFLR  262 (338)
Q Consensus       257 hp~~~~  262 (338)
                      ||||..
T Consensus       322 hp~f~~  327 (383)
T 3eb0_A          322 HPFFDH  327 (383)
T ss_dssp             SGGGHH
T ss_pred             CHHHHH
Confidence            999964

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-52  Score=387.80  Aligned_cols=297  Identities=25%  Similarity=0.386  Sum_probs=230.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~~   74 (338)
                      ++|++++.||+|+||.||+|.+..+++.||||++....  .....+.+|+.++++++||||+++++++...     ..+|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            48999999999999999999999999999999997533  2336788999999999999999999999765     4689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus       107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGG
T ss_pred             EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC--CEEEEeCcceEecCCCC
Confidence            9999996 599998865 4799999999999999999999999999999999999997554  89999999997543222


Q ss_pred             ----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc----------
Q 019628          155 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH----------  220 (338)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~----------  220 (338)
                          .....+||+.|+|||++.+....+.++|||||||++|+|++|++||....................          
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                134568999999999976655445569999999999999999999988776665554433211100          


Q ss_pred             ------ccCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCC-cccCCCCCCCC
Q 019628          221 ------YSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGS-WQSHDVNNPSQ  284 (338)
Q Consensus       221 ------~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~-~~~~~~~~~~~  284 (338)
                            ...+.         ...+++++.+||.+||+.||++|||+.|+|+||||.+........... ...........
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDL  342 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC-----C
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCcccccccC
Confidence                  00110         124789999999999999999999999999999998764332211111 11112223344


Q ss_pred             CHHHHHHHhHhhCCCCCC
Q 019628          285 SLEEVLSLIHEATKPLEA  302 (338)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~  302 (338)
                      ..+++.+++.++...+.+
T Consensus       343 ~~~~~~~~~~~e~~~~~~  360 (364)
T 3qyz_A          343 PKEKLKELIFEETARFQP  360 (364)
T ss_dssp             CHHHHHHHHHHHTGGGCC
T ss_pred             CHHHHHHHHHHHHHHhhh
Confidence            577888888887766554

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-53  Score=402.24  Aligned_cols=256  Identities=34%  Similarity=0.570  Sum_probs=206.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~   72 (338)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.+...         ....+.+|+.++++++||||+++++++.. +.
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            589999999999999999999999999999999876421         11247899999999999999999999864 56


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSV  151 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~  151 (338)
                      +|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++...
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  293 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  293 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence            899999999999999998888999999999999999999999999999999999999996543 3369999999998765


Q ss_pred             cCCCCCCccccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--Cc
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DY  226 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  226 (338)
                      ........+||+.|+|||++.+   ..+ +.++|||||||++|+|++|++||............+   ....+.++  .+
T Consensus       294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i---~~~~~~~~~~~~  369 (419)
T 3i6u_A          294 ETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNFIPEVW  369 (419)
T ss_dssp             -----------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH---HTTCCCCCHHHH
T ss_pred             CCccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH---hcCCCCCCchhh
Confidence            5555567789999999999864   333 445899999999999999999998755443333322   22222222  23


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            468999999999999999999999999999999964

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-52  Score=387.17  Aligned_cols=261  Identities=24%  Similarity=0.359  Sum_probs=211.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc--------
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT--------   69 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--------   69 (338)
                      +++|++++.||+|+||+||+|.+..+|+.||||++....   .....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            368999999999999999999999999999999986543   234578899999999999999999999987        


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           70 PTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      .+.+|+||||+++ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--CEEEccchhcc
Confidence            3468999999975 777777643 5799999999999999999999999999999999999997554  89999999997


Q ss_pred             cccc-----CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc-
Q 019628          149 SSVL-----HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-  222 (338)
Q Consensus       149 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  222 (338)
                      ....     ........||+.|+|||++.+....+.++|||||||++|+|++|.+||...................... 
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            5431     2223456789999999999775544556999999999999999999999866554444333222211111 


Q ss_pred             CCCcc-------------------------cCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          223 FPDYV-------------------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       223 ~~~~~-------------------------~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ++...                         ..++.+.+||.+||+.||.+|||+.|+|+||||....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            11110                         0267899999999999999999999999999997543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-52  Score=374.81  Aligned_cols=253  Identities=32%  Similarity=0.640  Sum_probs=220.0

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999987532    2346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++..... ...
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~-~~~  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAPS-LRR  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC--CEEECCCTTCEECSS-SCB
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC--CEEEecccccccCcc-ccc
Confidence            99999999999999888899999999999999999999999999999999999997554  899999999864432 233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+......+|.  .++.++++|
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~l  242 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFPP--FLSDGSKDL  242 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCCT--TSCHHHHHH
T ss_pred             ccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHH----HHHhccccCCCC--cCCHHHHHH
Confidence            45679999999999988777655 89999999999999999999876543332    233444445554  688999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |.+||..+|.+|||+.++++||||+..
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            999999999999999999999999743

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.2e-53  Score=398.32  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=213.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC------CCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL------KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l------~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+|++++.||+|+||+||+|.+..+++.||||++.........+.+|+.+++.+      +|+||+++++++...+.+|+
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            579999999999999999999999999999999987665556778888888776      57799999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           76 VMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      ||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||+++..  .
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~--~  253 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--H  253 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET--T
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec--C
Confidence            999995 69999997654  499999999999999999999999999999999999998666445999999999743  2


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc------------
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY------------  221 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~------------  221 (338)
                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||........+..++........            
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  332 (429)
T 3kvw_A          254 QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF  332 (429)
T ss_dssp             CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHH
T ss_pred             CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhc
Confidence            33456789999999999988887555 99999999999999999999887765554444322110000            


Q ss_pred             ----cCCC-------------------------------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          222 ----SFPD-------------------------------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       222 ----~~~~-------------------------------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                          .+|.                                     ....++++.+||++||+.||++|||+.|+|+||||
T Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~  412 (429)
T 3kvw_A          333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL  412 (429)
T ss_dssp             BCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred             cCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhh
Confidence                0000                                     01237889999999999999999999999999999


Q ss_pred             ccCCC
Q 019628          261 LRNLP  265 (338)
Q Consensus       261 ~~~~~  265 (338)
                      ++..+
T Consensus       413 ~~~~~  417 (429)
T 3kvw_A          413 RRRLP  417 (429)
T ss_dssp             C----
T ss_pred             ccCCC
Confidence            86543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.8e-53  Score=374.12  Aligned_cols=258  Identities=34%  Similarity=0.612  Sum_probs=219.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            58999999999999999999999999999999987543  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---CCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---SQP  156 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---~~~  156 (338)
                      +++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++......   ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC--CEEEeeCCCccccCCCcchhcc
Confidence            99999999998777899999999999999999999999999999999999997554  8999999998743222   223


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||+.|+|||++.+..+.+.++|||||||++|+|++|..||............   ........+.+..+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHHHHH
Confidence            45679999999999988776566699999999999999999999876543222221   222222334445789999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      |.+||..||.+|||+.|+++||||++..
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChh
Confidence            9999999999999999999999997543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.1e-53  Score=376.16  Aligned_cols=256  Identities=33%  Similarity=0.632  Sum_probs=215.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++.....       ..+.+.+|+.++++++||||+++++++...+.++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            479999999999999999999999999999999876421       2467899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC--CCcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST--APRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~--~~~ikL~Dfg~a~~~~~  152 (338)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+.+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999997543  23799999999986544


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCC
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVS  230 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  230 (338)
                      ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+......++  ....++
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLT----NISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTTCCCCCHHHHTTCC
T ss_pred             CCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHH----HhHhcccCCcchhcccCC
Confidence            444556679999999999988777554 899999999999999999998765433322    2223333222  123678


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..+.+||.+||..||.+|||+.++++||||+.
T Consensus       240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999999964

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=374.58  Aligned_cols=254  Identities=31%  Similarity=0.567  Sum_probs=195.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++.+.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.++++++||||+++++++...+..|+|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            468999999999999999999999999999999997542    2236788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-C
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-S  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~  154 (338)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++...... .
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC--CEEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEEeecceeeccCCCC
Confidence            9999999999999865 5699999999999999999999999999999999999997554  8999999998754322 2


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........    .+....+..|.  .++.++.
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~  240 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLADYEMPS--FLSIEAK  240 (278)
T ss_dssp             ------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCCT--TSCHHHH
T ss_pred             cceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhhcccCCcc--ccCHHHH
Confidence            2345679999999999987776555 899999999999999999998755433222    22223333443  5889999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +||.+||+.||++|||+.++++||||.+.
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            99999999999999999999999999754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.4e-52  Score=378.28  Aligned_cols=253  Identities=27%  Similarity=0.495  Sum_probs=215.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .|...+.||+|+||.||+|.+..+|+.||||++..... ..+.+.+|+.+++.++||||+++++++...+.+|+||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            37888999999999999999999999999999976443 34668899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCcc
Q 019628           82 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKSTV  160 (338)
Q Consensus        82 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~  160 (338)
                      +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++...... .......
T Consensus       126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--cEEEeeeeeeeecccCcccccccc
Confidence            9999998864 5799999999999999999999999999999999999997554  8999999998754332 2334568


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHHHHH
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  239 (338)
                      ||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........    .+... ...+.....+++.+.+||.+
T Consensus       203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~  277 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMK----RLRDSPPPKLKNSHKVSPVLRDFLER  277 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred             CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCCCcCccccCCHHHHHHHHH
Confidence            9999999999988777655 899999999999999999998755433322    22222 22233344689999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||+.||++|||+.++++||||.+.
T Consensus       278 ~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          278 MLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HccCChhhCcCHHHHhcChhhccC
Confidence            999999999999999999999754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-53  Score=389.36  Aligned_cols=259  Identities=31%  Similarity=0.560  Sum_probs=213.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC------ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG------QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+.      ....+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            4799999999999999999999999999999998753      2334678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHhh
Q 019628           76 VMEYAAGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYCH  115 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~----------------------------------------~~~l~~~~~~~i~~qi~~al~~LH  115 (338)
                      ||||++||+|.+++..                                        ...+++..++.++.||+.||.|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998842                                        112467889999999999999999


Q ss_pred             hcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-----CCCCccccCcccccccccC--CccCCCcchHHHHHH
Q 019628          116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGV  188 (338)
Q Consensus       116 ~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~  188 (338)
                      ++||+||||||+|||++.++...+||+|||+++......     ......||+.|+|||++.+  ..+ +.++|||||||
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~  264 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGV  264 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC-CTHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC-CcHHHHHHHHH
Confidence            999999999999999976655589999999997543211     2345679999999999975  344 45599999999


Q ss_pred             HHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          189 TLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       189 il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ++|+|++|+.||...............  ...+..+.+..+++++.+||.+||+.+|.+|||+.++|+||||++.
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNK--KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhc--ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            999999999999887665444333222  1122233444689999999999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.4e-52  Score=374.10  Aligned_cols=257  Identities=34%  Similarity=0.537  Sum_probs=219.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----------cccHHHHHHHHHHhcCC-CCCcceeEEEEEc
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----------KIDEHVQREIMNHRSLK-HPNIVRFKEVLLT   69 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~   69 (338)
                      +++|++.+.||+|+||.||+|.+..+++.||||++....          ...+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            478999999999999999999999999999999997542          12345778999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           70 PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      .+.+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC--cEEEecccchhh
Confidence            999999999999999999999888899999999999999999999999999999999999997554  899999999986


Q ss_pred             cccCCCCCCccccCccccccccc------CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc-
Q 019628          150 SVLHSQPKSTVGTPAYIAPEVLT------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-  222 (338)
Q Consensus       150 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  222 (338)
                      ...........||+.|+|||++.      ...+ +.++|||||||++|+|++|..||..........    .+....+. 
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~  248 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----MIMSGNYQF  248 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCC
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHH----HHhcCCccc
Confidence            55555556678999999999985      2334 445899999999999999999998765433222    23333333 


Q ss_pred             -CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          223 -FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       223 -~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                       .+.+..++..+.+||.+||..||.+|||+.|+++||||++..
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence             334457899999999999999999999999999999997543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-52  Score=385.47  Aligned_cols=260  Identities=26%  Similarity=0.400  Sum_probs=211.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.....      ....+.+|+.+++.++||||+++++++...+.+++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            689999999999999999999999999999999875321      23467899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-C
Q 019628           76 VMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-H  153 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~  153 (338)
                      ||||+++ +|...+.... .+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++.... .
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC--CEEEEecccceeccCCc
Confidence            9999975 8888887543 589999999999999999999999999999999999997554  899999999985432 2


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-ccCCC-------
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-YSFPD-------  225 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~-------  225 (338)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||........+........... ..++.       
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            3345578999999999997655445669999999999999999999988776555555443322111 11111       


Q ss_pred             --------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          226 --------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       226 --------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                                    ...++.++++||.+||+.||.+|||+.|+|+||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                          134678999999999999999999999999999997654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-52  Score=378.34  Aligned_cols=256  Identities=35%  Similarity=0.611  Sum_probs=216.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            479999999999999999999999999999999986532 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC-CCCCcEEEeecCCCcccccCCCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~-~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      ++++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||++.. +..+.+||+|||++..... ......
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~  167 (304)
T 2jam_A           89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTA  167 (304)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHHH
T ss_pred             CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Cccccc
Confidence            99999999988888999999999999999999999999999999999999932 2334899999999874322 223345


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCcccCCHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHLL  237 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li  237 (338)
                      .||+.|+|||++.+..++ .++|||||||++|+|++|..||..........    .+....+.+  +.+..+++++.+||
T Consensus       168 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~~li  242 (304)
T 2jam_A          168 CGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFE----KIKEGYYEFESPFWDDISESAKDFI  242 (304)
T ss_dssp             HSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred             cCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCCCCccccccCCHHHHHHH
Confidence            799999999999887765 44999999999999999999998765433322    233333332  23346899999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+||..||.+|||+.|+++||||...
T Consensus       243 ~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          243 CHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHcCCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.2e-52  Score=379.76  Aligned_cols=256  Identities=22%  Similarity=0.403  Sum_probs=211.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeEEEEEc--CCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEVLLT--PTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~--~~~~~iv~e   78 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++....  .+.+.+|+.++++++ ||||+++++++..  ....++|||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            58999999999999999999999999999999987543  467899999999997 9999999999988  567999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |+++++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+++..........
T Consensus       114 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~~~~~  189 (330)
T 3nsz_A          114 HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFYHPGQEYNV  189 (330)
T ss_dssp             CCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-TEEEECCCTTCEECCTTCCCCS
T ss_pred             ccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC-CEEEEEeCCCceEcCCCCcccc
Confidence            999999998874   489999999999999999999999999999999999997443 2799999999986655555667


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH----------hhcccc------
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI----------LSVHYS------  222 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~----------~~~~~~------  222 (338)
                      ..||+.|+|||++.+....+.++|||||||++|+|++|..||............+...          ......      
T Consensus       190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (330)
T 3nsz_A          190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN  269 (330)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred             ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence            7899999999999874444556999999999999999999996544432221111110          000000      


Q ss_pred             ----------------CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          223 ----------------FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       223 ----------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                      ......+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence                            01112378999999999999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-52  Score=387.65  Aligned_cols=254  Identities=32%  Similarity=0.560  Sum_probs=217.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++.....         ..+.+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            469999999999999999999999999999999876431         134677899999999 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           72 HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      ..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++  .+||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~--~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEecCcccccC
Confidence            9999999999999999999888899999999999999999999999999999999999997554  89999999998665


Q ss_pred             cCCCCCCccccCcccccccccCC------ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--  223 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--  223 (338)
                      ........+||+.|+|||++.+.      .++ .++|||||||++|+|++|..||.........    ..+....+.+  
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~~~~~  326 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYG-KEVDLWACGVILFTLLAGSPPFWHRRQILML----RMIMEGQYQFSS  326 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCH
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCC-chhhHHhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCC
Confidence            55555667899999999998632      344 4489999999999999999999875543322    2233333332  


Q ss_pred             CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      |.+...+..+.+||.+||..||.+|||+.++++||||++
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            334578999999999999999999999999999999963

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-52  Score=383.92  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=213.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++......   .+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            57999999999999999999999999999999998664322   345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~  156 (338)
                      ||+++++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... ....
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC----------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCcccc
Confidence            9999999988888778899999999999999999999999999999999999997554  899999999975433 2234


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh---------------ccc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS---------------VHY  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (338)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|+.||..................               ...
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            45679999999999987644456699999999999999999999887765554443322111               001


Q ss_pred             cCCC----------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          222 SFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       222 ~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..+.          ...+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            1111          1247899999999999999999999999999999964

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.5e-52  Score=394.06  Aligned_cols=256  Identities=29%  Similarity=0.433  Sum_probs=210.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcC------CeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------THLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~~~iv   76 (338)
                      +|++++.||+|+||+||+|.+..+|+.||||++.....   ...+|+.+++.++||||++++++|...      ..+++|
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            69999999999999999999999999999999876533   234799999999999999999998542      247899


Q ss_pred             EeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           77 MEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||+++ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+. +.+||+|||+++....
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCT
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC-CeEEeccchhhhhccc
Confidence            999975 6666654    356799999999999999999999999999999999999997443 3689999999986655


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-------------c
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------V  219 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------------~  219 (338)
                      .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+....+.+...+..+..             .
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            555667889999999999977543455599999999999999999999987766655555432211             1


Q ss_pred             cccCCCc----------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          220 HYSFPDY----------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       220 ~~~~~~~----------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+.+|..          ..+++++++||++||+.||.+|||+.|+++||||...
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            1122221          2468999999999999999999999999999999653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.6e-53  Score=383.58  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=203.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC--------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT--------   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--------   71 (338)
                      ++|++++.||+|+||.||+|.+..+|+.||||++....  ...+.+.+|+.++++++||||++++++|....        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            58999999999999999999999999999999997543  33467899999999999999999999986543        


Q ss_pred             -------------------------------------------------eEEEEEeccCCCChHHHHHhcCC---CCHHH
Q 019628           72 -------------------------------------------------HLAIVMEYAAGGELFERICNAGR---FSEDE   99 (338)
Q Consensus        72 -------------------------------------------------~~~iv~e~~~~~~L~~~i~~~~~---l~~~~   99 (338)
                                                                       .+++||||+++++|.+++.....   .++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999987554   46667


Q ss_pred             HHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-------------CCCCCccccCccc
Q 019628          100 ARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-------------SQPKSTVGTPAYI  166 (338)
Q Consensus       100 ~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-------------~~~~~~~gt~~y~  166 (338)
                      ++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....             ......+||+.|+
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            999999999999999999999999999999997554  8999999999754432             1234467999999


Q ss_pred             ccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC-CcccCCHHHHHHHHHhcccCC
Q 019628          167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DYVRVSLECKHLLSRIFVANS  245 (338)
Q Consensus       167 aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp  245 (338)
                      |||++.+..++.+ +|||||||++|+|++|..|+..      ...........  .+| .....++++.+||.+||+.||
T Consensus       244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p  314 (332)
T 3qd2_B          244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQME------RVRIITDVRNL--KFPLLFTQKYPQEHMMVQDMLSPSP  314 (332)
T ss_dssp             CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred             ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhcc--CCCcccccCChhHHHHHHHHccCCC
Confidence            9999988777555 8999999999999998776532      11222222222  122 123467889999999999999


Q ss_pred             CcCCChhHHhcCccccc
Q 019628          246 EKRITIPEIKNHPWFLR  262 (338)
Q Consensus       246 ~~R~s~~ell~hp~~~~  262 (338)
                      .+|||+.|+++||||++
T Consensus       315 ~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          315 TERPEATDIIENAIFEN  331 (332)
T ss_dssp             GGSCCHHHHHHSTTCCC
T ss_pred             CcCCCHHHHhhchhhhc
Confidence            99999999999999963

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-52  Score=388.21  Aligned_cols=257  Identities=32%  Similarity=0.560  Sum_probs=217.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ-----KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~   72 (338)
                      ++|++++.||+|+||.||++++.   .+++.||||++++..     .....+.+|+.+++.+ .||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            68999999999999999999984   588999999987532     2335677899999999 69999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECCG
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--cEEEeeCCCCeeccc
Confidence            999999999999999999888999999999999999999999999999999999999997554  899999999874322


Q ss_pred             C--CCCCCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          153 H--SQPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       153 ~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                      .  ......+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...............+......+|.  .+
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~  289 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM  289 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TS
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc--cc
Confidence            2  2234567999999999998632 23455899999999999999999998655444444444445554444554  68


Q ss_pred             CHHHHHHHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          230 SLECKHLLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      +..+.+||.+||..||.+||     |+.|+++||||..
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            99999999999999999999     9999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.1e-52  Score=390.25  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=207.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------eEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------HLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~~~i   75 (338)
                      .+|++++.||+|+||+||+|++..+++ +|+|++......   ..+|+.+++.++||||++++++|...+      .+|+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            379999999999999999999987666 888887654332   237999999999999999999996543      4899


Q ss_pred             EEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           76 VMEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        76 v~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      ||||+++ ++...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||+|+...
T Consensus       116 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCCTTCEECC
T ss_pred             EeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC-CCCcEEEeeCCCccccc
Confidence            9999976 4444433    3567999999999999999999999999999999999999972 23389999999998766


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-------------
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------  218 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------------  218 (338)
                      .........||+.|+|||++.+....+.++|||||||++|+|++|++||.+......+...+.....             
T Consensus       194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  273 (394)
T 4e7w_A          194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY  273 (394)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred             CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            6666677889999999999977654455699999999999999999999987766555554432111             


Q ss_pred             ccccCCC----------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          219 VHYSFPD----------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       219 ~~~~~~~----------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ....+|.          ...+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            0011111          11378999999999999999999999999999999754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.5e-52  Score=381.40  Aligned_cols=258  Identities=29%  Similarity=0.494  Sum_probs=213.2

Q ss_pred             CceEe-eeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIV-KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +|.+. +.||+|+||+||+|.+..+++.||+|++....   .....+.+|+.+++.+. ||||+++++++...+.+|+||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            57887 89999999999999999999999999997643   23467889999999995 699999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccCC
Q 019628           78 EYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++......
T Consensus       109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            999999999988543  5799999999999999999999999999999999999997521 4589999999998655444


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............  ...+..+.+..+++.+.
T Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~  265 (327)
T 3lm5_A          189 ELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQLAT  265 (327)
T ss_dssp             -----CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHH
T ss_pred             ccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHHHH
Confidence            4556789999999999988777555 89999999999999999999876654443332221  12223333457899999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +||.+||+.||.+|||+.++|+||||++.
T Consensus       266 ~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          266 DFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            99999999999999999999999999753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.4e-52  Score=383.52  Aligned_cols=292  Identities=20%  Similarity=0.310  Sum_probs=218.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc------------ccHHHHHHHHHHhcCCCCCcceeEEEEEc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK------------IDEHVQREIMNHRSLKHPNIVRFKEVLLT   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~   69 (338)
                      ++|++++.||+|+||.||++.+.. |+.||||++.....            ..+.+.+|+.++++++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            689999999999999999999864 89999999865321            12678899999999999999999999853


Q ss_pred             -----CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEee
Q 019628           70 -----PTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD  143 (338)
Q Consensus        70 -----~~~~~iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~D  143 (338)
                           ...+|+||||++ |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~D  177 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN--DITICD  177 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC--CEEEEe
Confidence                 347899999997 5888888654 3699999999999999999999999999999999999997554  899999


Q ss_pred             cCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc---
Q 019628          144 FGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---  220 (338)
Q Consensus       144 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~---  220 (338)
                      ||+++............||+.|+|||++.+....+.++|||||||++|+|++|+.||....................   
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            99998655555556678999999999998744445569999999999999999999998765554444432211100   


Q ss_pred             -----------------ccCCC------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccC
Q 019628          221 -----------------YSFPD------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSH  277 (338)
Q Consensus       221 -----------------~~~~~------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~  277 (338)
                                       ...+.      ....++.+.+||.+||+.||.+|||+.|+++||||+................
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~  337 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERF  337 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTCCCCC
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccccccc
Confidence                             00000      1246888999999999999999999999999999987654433333322333


Q ss_pred             CCCCCCCCHHHHHHHhHhhC
Q 019628          278 DVNNPSQSLEEVLSLIHEAT  297 (338)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~  297 (338)
                      ..........++.+.+..+.
T Consensus       338 ~~~~~~~~~~~~~~~~~~e~  357 (362)
T 3pg1_A          338 HFDESVTDVYDMHKIFTAEV  357 (362)
T ss_dssp             CCCTTCCCHHHHHHHHHHHH
T ss_pred             ChhhhhhhHHHHHHHHHHHH
Confidence            44445566777777766553

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.8e-52  Score=384.97  Aligned_cols=291  Identities=24%  Similarity=0.354  Sum_probs=223.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE-----
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL-----   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~-----   73 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....   .....+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            58999999999999999999999999999999997643   2346788999999999999999999999887654     


Q ss_pred             -EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           74 -AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        74 -~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                       |+||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++... 
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~-  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHAD-  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECSTTCC-----
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC--CEEEEecCcccccc-
Confidence             99999996 58888773  3599999999999999999999999999999999999997554  89999999997542 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH------------  220 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~------------  220 (338)
                       ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||...+....+...........            
T Consensus       196 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          196 -AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             -cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence             2345578999999999998743334559999999999999999999988765554444332111000            


Q ss_pred             -------ccCC------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccc-cCCCcccCCCCCCCCCH
Q 019628          221 -------YSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELT-EGGSWQSHDVNNPSQSL  286 (338)
Q Consensus       221 -------~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  286 (338)
                             ...+      ....+++++.+||.+||+.||.+|||+.|+|+||||......... ...............+.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTV  354 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTSSCCCCH
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcchhhcccch
Confidence                   0000      012468999999999999999999999999999999754332221 11111122233444567


Q ss_pred             HHHHHHhHhhCCC
Q 019628          287 EEVLSLIHEATKP  299 (338)
Q Consensus       287 ~~~~~~~~~~~~~  299 (338)
                      +++.+.+.++...
T Consensus       355 ~~~~~~~~~~~~~  367 (371)
T 4exu_A          355 DEWKQHIYKEIVN  367 (371)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHh
Confidence            8888887776543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-51  Score=371.23  Aligned_cols=254  Identities=33%  Similarity=0.521  Sum_probs=220.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            58999999999999999999999999999999987643    23356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      ||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++...... ...
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC--CEEEEeccCceecccCcccc
Confidence            9999999999998888899999999999999999999999999999999999997554  8999999999754322 233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........    ..+......+|.  .+++.+.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~l  245 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIPK--HINPVAASL  245 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCCT--TSCHHHHHH
T ss_pred             ccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhhccCCCcc--ccCHHHHHH
Confidence            45679999999999988777545 89999999999999999999876543332    233344444554  688999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      |.+||+.+|++|||+.++++||||....
T Consensus       246 i~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          246 IQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHcccChhhCcCHHHHhhChheecCC
Confidence            9999999999999999999999997553

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-51  Score=378.11  Aligned_cols=254  Identities=33%  Similarity=0.521  Sum_probs=220.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999987643    23356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      ||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ...
T Consensus       121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC--CEEEeeccCceecccCcccc
Confidence            9999999999998888899999999999999999999999999999999999997554  8999999999754322 233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........+    ..+....+.+|.  .++..+.+|
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~l  271 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIPK--HINPVAASL  271 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCT--TSCHHHHHH
T ss_pred             cccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHhcCCCCCCc--cCCHHHHHH
Confidence            45679999999999988777544 89999999999999999999875543332    233444455554  688999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      |.+||+.||++|||+.|+++||||....
T Consensus       272 i~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          272 IQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHccCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999997543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.1e-52  Score=385.10  Aligned_cols=262  Identities=25%  Similarity=0.395  Sum_probs=204.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-------eE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-------HL   73 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-------~~   73 (338)
                      +++|++.+.||+|+||+||+|.+..+|+.||||++...........+++..++.++||||++++++|...+       .+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            47899999999999999999999999999999999776666667788888899999999999999996533       38


Q ss_pred             EEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhh--hcCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           74 AIVMEYAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCH--SMQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~LH--~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ++||||+++ +|...+.    ....+++..++.++.||+.||.|||  ++||+||||||+|||++.. ++.+||+|||++
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA-DGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT-TTEEEECCCTTC
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC-CCcEEEeeCCCc
Confidence            999999976 5554443    4567899999999999999999999  9999999999999999742 338999999999


Q ss_pred             cccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-------
Q 019628          148 KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-------  220 (338)
Q Consensus       148 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-------  220 (338)
                      +............||+.|+|||++.+....+.++|||||||++|+|++|+.||........+...........       
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            8766555666778999999999997766445669999999999999999999998766555544433211100       


Q ss_pred             ------cc------------CC-CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          221 ------YS------------FP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       221 ------~~------------~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                            ..            ++ .....++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence                  00            00 0112567899999999999999999999999999997643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.5e-52  Score=386.11  Aligned_cols=258  Identities=28%  Similarity=0.449  Sum_probs=214.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||+||++.+..+++.||+|++....  .....+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            58999999999999999999999999999999997642  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      +++++|.+++...+.+++..++.++.|++.||.|||+. ||+||||||+|||++.++  .+||+|||++..... .....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~-~~~~~  189 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SMANS  189 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHHH-HC---
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC--CEEEEECCCCccccc-ccccC
Confidence            99999999999888999999999999999999999996 999999999999997554  899999999864322 23445


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHH----------------------------
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFR----------------------------  210 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~----------------------------  210 (338)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........                            
T Consensus       190 ~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (360)
T 3eqc_A          190 FVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG  268 (360)
T ss_dssp             -CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred             CCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence            689999999999988777544 899999999999999999998654322111                            


Q ss_pred             ----------HHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          211 ----------KTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       211 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                .....+............++.++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                      11111111111111123478899999999999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.6e-52  Score=372.44  Aligned_cols=256  Identities=38%  Similarity=0.631  Sum_probs=220.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....   .....+.+|+.++++++||||+++++++...+.+|+|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            47999999999999999999999999999999987643   334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+.+||+|||++..........
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~  181 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence            999999999998888899999999999999999999999999999999999997543 3479999999988655444455


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--cCCCcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SFPDYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  235 (338)
                      ...||+.|+|||++.+. ++ .++|||||||++|+|++|..||.........    ..+....+  ..+.+..+++++.+
T Consensus       182 ~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          182 DRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CHHHHHTTCCHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             cccCcccccChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCchhhhhcCHHHHH
Confidence            66799999999998764 54 4589999999999999999999876543322    23333333  33445578999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||.+||..+|.+|||+.|+++||||++.
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-52  Score=376.53  Aligned_cols=249  Identities=22%  Similarity=0.264  Sum_probs=199.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhc-CCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---DEHVQREIMNHRS-LKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|+++++||+|+||+||+|.+..+|+.||||++......   .....+|+..+.. .+||||++++++|...+.+|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            4699999999999999999999999999999998654322   2234445544444 49999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           78 EYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      ||+ +++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG--CEEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEccceeeeecccCCCC
Confidence            999 679988887544 599999999999999999999999999999999999996554  8999999999865555555


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ....||+.|+|||++.+ .++ .++|||||||++|+|++|..||...   ......    ............+++++.+|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~el~~g~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHGG---EGWQQL----RQGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCS-THHHHHHHHHHHHHHHHTCCCCSSH---HHHHHH----TTTCCCHHHHTTSCHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCc---cHHHHH----hccCCCcccccCCCHHHHHH
Confidence            66779999999999876 554 4599999999999999997766542   222221    11111111123588999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCccccc
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      |.+||+.||++|||+.|+|+||||++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999964

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-51  Score=369.07  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=211.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc----CCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT----PTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~   74 (338)
                      ..|++.+.||+|+||+||+|.+..++..||+|++....   ...+.+.+|+.+++.++||||+++++++..    ...+|
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            35899999999999999999999999999999987643   233568899999999999999999999875    46799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++|  |+||||||+|||++. ..+.+||+|||++.... 
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~kl~Dfg~~~~~~-  183 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCEEECCTTGGGGCC-
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-CCCCEEEeeCCCccccc-
Confidence            99999999999999998888999999999999999999999999  999999999999962 23389999999986432 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ........||+.|+|||++.+ .++ .++|||||||++|+|++|+.||.............   .............+++
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---TSGVKPASFDKVAIPE  258 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---TTTCCCGGGGGCCCHH
T ss_pred             ccccccccCCcCcCCHHHHhc-cCC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH---hccCCccccCCCCCHH
Confidence            223345679999999999864 454 45999999999999999999998766554433332   2221111112356789


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +.+||.+||+.+|.+|||+.++++||||++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999999974

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-52  Score=377.01  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=211.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC--eEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT--HLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~iv~   77 (338)
                      ++|++.+.||+|+||+||+|.+..+++.||||++....  ...+.+.+|+.++++++||||+++++++....  .+|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            47999999999999999999999999999999997643  23466789999999999999999999998765  789999


Q ss_pred             eccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEec--CCCCCcEEEeecCCCccccc
Q 019628           78 EYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~--~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      ||+++++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+.  .+..+.+||+|||+++....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence            99999999999986443   99999999999999999999999999999999999981  12333799999999986655


Q ss_pred             CCCCCCccccCccccccccc--------CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc---
Q 019628          153 HSQPKSTVGTPAYIAPEVLT--------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY---  221 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---  221 (338)
                      ........||+.|+|||++.        +..++ .++|||||||++|+|++|+.||............+..+.....   
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred             CCceeecccCCCccCHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence            55556678999999999986        34554 4489999999999999999999866554444444444433221   


Q ss_pred             ----------------cCCCc----ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          222 ----------------SFPDY----VRVSLECKHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       222 ----------------~~~~~----~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                                      .++..    ..++..+.+||++||+.||++|||+.|+|+||=
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                            11111    124567889999999999999999999999974

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-51  Score=369.00  Aligned_cols=250  Identities=23%  Similarity=0.345  Sum_probs=207.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++....   .....+.+|+..+..+ +||||+++++++..++.+++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            47999999999999999999999999999999998642   2345678899999998 9999999999999999999999


Q ss_pred             eccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-----------------CC
Q 019628           78 EYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-----------------TA  136 (338)
Q Consensus        78 e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-----------------~~  136 (338)
                      ||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+                 ..
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999999764    679999999999999999999999999999999999999743                 23


Q ss_pred             CcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH
Q 019628          137 PRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI  216 (338)
Q Consensus       137 ~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~  216 (338)
                      ..+||+|||++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+....   .......  
T Consensus       171 ~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~--  242 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQ--  242 (289)
T ss_dssp             CCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHT--
T ss_pred             eEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHc--
Confidence            3799999999875432   3345699999999999876444456999999999999999998775432   2222111  


Q ss_pred             hhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                       .....+|.  .+++++.+||.+||..||.+|||+.++++||||..
T Consensus       243 -~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          243 -GRLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             -TCCCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             -CCCCCCCc--ccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence             11122333  68999999999999999999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-52  Score=380.02  Aligned_cols=256  Identities=34%  Similarity=0.569  Sum_probs=209.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~   72 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.....         ....+.+|+.+++.++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            479999999999999999999999999999999875321         1235789999999999999999999987665 


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSV  151 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~  151 (338)
                      +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            899999999999999998888999999999999999999999999999999999999997543 2359999999997543


Q ss_pred             cCCCCCCccccCccccccccc---CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--Cc
Q 019628          152 LHSQPKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DY  226 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  226 (338)
                      .........||+.|+|||++.   ...+ +.++|||||||++|+|++|..||............+   ....+.+.  .+
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~  244 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNFIPEVW  244 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH---HHTCCCCCHHHH
T ss_pred             cccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH---HhCccccCchhh
Confidence            322223457999999999974   3344 455999999999999999999998655433332222   22222221  12


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..++..+.+||.+||..||.+|||+.++++||||..
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            358899999999999999999999999999999964

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.7e-52  Score=370.59  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=195.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++......   ...+.++...++.++||||+++++++..++..|+|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            6899999999999999999999999999999998764322   1234445556888999999999999999999999999


Q ss_pred             ccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           79 YAAGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        79 ~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+++ +|.+++.    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++  .+||+|||+++.....
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC---------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccccc
Confidence            9974 8877665    356799999999999999999999998 999999999999997554  8999999999865555


Q ss_pred             CCCCCccccCcccccccc----cCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          154 SQPKSTVGTPAYIAPEVL----TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                      .......||+.|+|||++    .+..+ +.++|||||||++|+|++|+.||.........  ....+.......+ ...+
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~-~~~~  239 (290)
T 3fme_A          164 VAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVVEEPSPQLP-ADKF  239 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHHHHHSCCCCCC-TTTS
T ss_pred             ccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHHHhccCCCCcc-cccC
Confidence            455556899999999997    33344 45599999999999999999999865443222  1122222222222 2368


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ++++.+||.+||+.+|++|||+.|+++||||+.
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            999999999999999999999999999999964

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-51  Score=379.15  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=210.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +|++++.||+|+||+||+|.+..+++.||||++.....    ..+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            58999999999999999999999999999999976432    22467899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           79 YAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      |+. |+|.+.+. ....+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++...   ...
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~---~~~  208 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMA---PAN  208 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSS---SBC
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecC---CCC
Confidence            997 58888775 456799999999999999999999999999999999999997554  89999999997543   234


Q ss_pred             CccccCccccccccc---CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          158 STVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...||+.|+|||++.   ...++. ++|||||||++|+|++|..||............    ............+++.+.
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCCCCCCTTSCHHHH
T ss_pred             cccCCcceeCHhhhccccCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCCCCCCCCHHHH
Confidence            568999999999985   345544 489999999999999999999876544333322    222222222236789999


Q ss_pred             HHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          235 HLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +||.+||+.+|++|||+.++++||||.+.
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            99999999999999999999999999754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=378.08  Aligned_cols=251  Identities=25%  Similarity=0.419  Sum_probs=204.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCC--CCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKH--PNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++++.||+|+||.||++.+. +++.||||++.....   ....+.+|+.+++.++|  |||+++++++...+.+|+|
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            47999999999999999999985 688999999876432   23567899999999987  9999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--  154 (338)
                      ||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+++   +.+||+|||+++......  
T Consensus        88 ~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~---~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             ECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCCC------
T ss_pred             EeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC---CcEEEeecccccccCccccc
Confidence            995 57899999999889999999999999999999999999999999999999963   379999999998543322  


Q ss_pred             -CCCCccccCcccccccccC-----------CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh--cc
Q 019628          155 -QPKSTVGTPAYIAPEVLTK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS--VH  220 (338)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--~~  220 (338)
                       .....+||+.|+|||++.+           ..+ +.++|||||||++|+|++|+.||.........   ...+..  ..
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~  239 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHE  239 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHHCTTSC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHHH---HHHHhcCCcc
Confidence             2335679999999999864           334 45589999999999999999999875443211   112222  22


Q ss_pred             ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          221 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..+|.  ..+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       240 ~~~~~--~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          240 IEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cCCcc--cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            23333  567889999999999999999999999999999754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-52  Score=378.59  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=207.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCC----eE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPT----HL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~   73 (338)
                      ++|++++.||+|+||.||+|.+..+++.||||++.....    ....+.+|+.++++++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            689999999999999999999999999999999976432    2346789999999999999999999987654    35


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS--CEEECCCSCC------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC--CEEEeeccCccccccc
Confidence            99999999999999999888999999999999999999999999999999999999997554  8999999999754322


Q ss_pred             C----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--Ccc
Q 019628          154 S----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYV  227 (338)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  227 (338)
                      .    ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..............    .....+  ...
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~  244 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR----EDPIPPSARHE  244 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----CCCCCHHHHST
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc----CCCCCcccccC
Confidence            1    2234569999999999988777544 8999999999999999999987654433322221    111111  123


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .++.++.+||.+||+.||.+||++.+++.|+|+..
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            58999999999999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.8e-51  Score=376.02  Aligned_cols=292  Identities=23%  Similarity=0.360  Sum_probs=225.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH------   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~------   72 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....   .....+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            58999999999999999999999999999999987643   223567899999999999999999999987654      


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++... 
T Consensus       104 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~-  177 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHAD-  177 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--CEEECSTTCTTC---
T ss_pred             EEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--cEEEeecccccCCC-
Confidence            599999996 58887774  3599999999999999999999999999999999999997554  89999999998543 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------  219 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (338)
                       .......||+.|+|||++.+....+.++|||||||++|+|++|+.||...+....+..........             
T Consensus       178 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          178 -AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             -CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence             224456899999999999874333455999999999999999999998866544443332211000             


Q ss_pred             -----------cccCC-CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccc-cCCCcccCCCCCCCCCH
Q 019628          220 -----------HYSFP-DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELT-EGGSWQSHDVNNPSQSL  286 (338)
Q Consensus       220 -----------~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  286 (338)
                                 ...++ ....+++++.+||.+||..||.+|||+.++++||||......+.. ...............+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTV  336 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTTTTCCCCH
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCCccchhhccCCH
Confidence                       00111 123578999999999999999999999999999999765433221 11212223334456678


Q ss_pred             HHHHHHhHhhCCCC
Q 019628          287 EEVLSLIHEATKPL  300 (338)
Q Consensus       287 ~~~~~~~~~~~~~~  300 (338)
                      +++.+.+.++...+
T Consensus       337 ~~~~~~~~~~~~~~  350 (353)
T 3coi_A          337 DEWKQHIYKEIVNF  350 (353)
T ss_dssp             HHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHHHhh
Confidence            88888888765443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-51  Score=383.25  Aligned_cols=259  Identities=28%  Similarity=0.379  Sum_probs=211.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CC-----CcceeEEEEEcCCeEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HP-----NIVRFKEVLLTPTHLA   74 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~-----~Iv~~~~~~~~~~~~~   74 (338)
                      +++|++.+.||+|+||+||+|.+..+++.||||+++........+.+|+.+++.++ |+     +|+++++++...+.+|
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            46899999999999999999999999999999999876555567788888888875 44     4999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhh--hcCceecCCCCCcEEecCCCCCcEEEeecCCCccc
Q 019628           75 IVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSS  150 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH--~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~  150 (338)
                      +||||++ ++|.+++...  ..+++..++.++.||+.||.|||  +.||+||||||+|||++.+..+.+||+|||+++..
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            9999996 5999999765  45999999999999999999999  57999999999999997555568999999999754


Q ss_pred             ccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc---------
Q 019628          151 VLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY---------  221 (338)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---------  221 (338)
                      .  .......||+.|+|||++.+..++.+ +|||||||++|+|++|++||........+............         
T Consensus       212 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  288 (382)
T 2vx3_A          212 G--QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA  288 (382)
T ss_dssp             T--CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred             c--cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence            2  33456789999999999988877655 99999999999999999999987665555444332110000         


Q ss_pred             -----cCC-------------------Cccc-------------------------CCHHHHHHHHHhcccCCCcCCChh
Q 019628          222 -----SFP-------------------DYVR-------------------------VSLECKHLLSRIFVANSEKRITIP  252 (338)
Q Consensus       222 -----~~~-------------------~~~~-------------------------~~~~~~~li~~~L~~dp~~R~s~~  252 (338)
                           ..|                   ....                         .++++++||.+||+.||++|||+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~  368 (382)
T 2vx3_A          289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY  368 (382)
T ss_dssp             HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence                 000                   0000                         013789999999999999999999


Q ss_pred             HHhcCcccccC
Q 019628          253 EIKNHPWFLRN  263 (338)
Q Consensus       253 ell~hp~~~~~  263 (338)
                      |+|+||||++.
T Consensus       369 e~L~hp~f~~~  379 (382)
T 2vx3_A          369 YALQHSFFKKT  379 (382)
T ss_dssp             HHTTSGGGCC-
T ss_pred             HHhcCcccccC
Confidence            99999999754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=387.07  Aligned_cols=260  Identities=26%  Similarity=0.386  Sum_probs=192.9

Q ss_pred             CceE-eeeeccCCceEEEEEEEc--CCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeEEEEE
Q 019628            3 RYEI-VKDIGSGNFGVAKLVRDK--WTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHLAIVM   77 (338)
Q Consensus         3 ~y~~-~~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~iv~   77 (338)
                      +|++ .++||+|+||+||+|.+.  .+++.||||++.... ....+.+|+.+++.++||||++++++|..  ...+|+||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            4676 457999999999999966  578899999987543 34678899999999999999999999954  67899999


Q ss_pred             eccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC--CCCCcEEEeecCC
Q 019628           78 EYAAGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG--STAPRVKICDFGY  146 (338)
Q Consensus        78 e~~~~~~L~~~i~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~--~~~~~ikL~Dfg~  146 (338)
                      ||+. ++|.+.+...         ..+++..++.++.||+.||.|||++||+||||||+|||+..  ...+.+||+|||+
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            9996 5888887532         24999999999999999999999999999999999999942  2334899999999


Q ss_pred             CcccccC----CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh---------HHHHHHH
Q 019628          147 SKSSVLH----SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---------KNFRKTI  213 (338)
Q Consensus       147 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~~~  213 (338)
                      |+.....    ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||......         ..+..++
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            9854322    22345689999999999987664566699999999999999999999765431         2222222


Q ss_pred             hhHhhccc-cCC-------------------------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          214 GRILSVHY-SFP-------------------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       214 ~~~~~~~~-~~~-------------------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      ..+..... .++                               .....++.+.+||.+||+.||.+|||+.|+|+||||.
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~  338 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL  338 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence            21110000 000                               0012377899999999999999999999999999998


Q ss_pred             cCC
Q 019628          262 RNL  264 (338)
Q Consensus       262 ~~~  264 (338)
                      ...
T Consensus       339 ~~~  341 (405)
T 3rgf_A          339 EDP  341 (405)
T ss_dssp             SSS
T ss_pred             cCC
Confidence            654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-50  Score=373.13  Aligned_cols=291  Identities=26%  Similarity=0.385  Sum_probs=223.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~~   74 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....  .....+.+|+.+++.++||||+++++++...     ...|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            58999999999999999999999999999999996533  2335678999999999999999999988754     6799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus        91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECC---
T ss_pred             EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC--cEEEEeccccccccccc
Confidence            9999996 589998876 5799999999999999999999999999999999999997554  89999999997543211


Q ss_pred             -----------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc---
Q 019628          155 -----------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH---  220 (338)
Q Consensus       155 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~---  220 (338)
                                 .....+||+.|+|||++.+....+.++|||||||++|+|++|++||....................   
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence                       122357899999999987644445669999999999999999999988665444333322111000   


Q ss_pred             -----------------ccCC------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCccccc-CC----
Q 019628          221 -----------------YSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTE-GG----  272 (338)
Q Consensus       221 -----------------~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~-~~----  272 (338)
                                       ...+      ....+++++.+||.+||..||++|||+.|+++||||+......... ..    
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~  326 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPP  326 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCG
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCc
Confidence                             0000      0125789999999999999999999999999999997644322111 11    


Q ss_pred             CcccCCCCCCCCCHHHHHHHhHhh
Q 019628          273 SWQSHDVNNPSQSLEEVLSLIHEA  296 (338)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~  296 (338)
                      ............+.+++.+++.++
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~  350 (353)
T 2b9h_A          327 SFFEFDHYKEALTTKDLKKLIWNE  350 (353)
T ss_dssp             GGGGGGCCSSCCCHHHHHHHHHHH
T ss_pred             ceeeecchhhcCCHHHHHHHHHHH
Confidence            112222334455677777777654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.4e-51  Score=383.74  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=206.4

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCC--CCCcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLK--HPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +|++++.||+|+||+||++.+.. ++.||||++.....   ....+.+|+.+++.++  ||||+++++++...+.+|+||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            59999999999999999999875 88999999976432   3356889999999997  599999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      | +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+++   +.+||+|||+++......   
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS---SCEEECCCSSSCCC-------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC---CeEEEEecCccccccCCCccc
Confidence            9 558899999998889999999999999999999999999999999999999953   379999999998653322   


Q ss_pred             CCCCccccCcccccccccCC----------ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc--cc
Q 019628          155 QPKSTVGTPAYIAPEVLTKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--YS  222 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--~~  222 (338)
                      .....+||+.|+|||++.+.          ...+.++|||||||++|+|++|+.||........   .+..+....  ..
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~~~~~~~~~~~  288 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE  288 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHCTTSCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH---HHHHHhCccccCC
Confidence            23456899999999998652          1234559999999999999999999986544221   122223222  23


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +|.  ..+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       289 ~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          289 FPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCc--cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            343  457899999999999999999999999999999754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.5e-51  Score=375.01  Aligned_cols=256  Identities=29%  Similarity=0.402  Sum_probs=211.4

Q ss_pred             CCceEeeeeccCCceEEEEEEE-cCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC------CcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRD-KWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHP------NIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~------~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||+||+|.+ ..+++.||+|+++........+.+|+.+++.++|+      +|+++++++...+.+|
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            6899999999999999999998 56889999999987665567788999999888665      4999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-----------------
Q 019628           75 IVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-----------------  135 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-----------------  135 (338)
                      +||||+ +++|.+++....  ++++..++.++.||+.||.|||++||+||||||+|||++...                 
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            999999 889999998765  689999999999999999999999999999999999997643                 


Q ss_pred             CCcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhh
Q 019628          136 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR  215 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~  215 (338)
                      .+.+||+|||+++...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+......... .
T Consensus       173 ~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~-~  248 (339)
T 1z57_A          173 NPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME-R  248 (339)
T ss_dssp             CCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH-H
T ss_pred             CCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-H
Confidence            4579999999987532  33456789999999999988777655 899999999999999999998766544332221 1


Q ss_pred             Hhhc-c-----------------ccCC---------------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          216 ILSV-H-----------------YSFP---------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       216 ~~~~-~-----------------~~~~---------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +... .                 ..++                     .....++++.+||.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            1110 0                 0000                     01123567899999999999999999999999


Q ss_pred             Cccccc
Q 019628          257 HPWFLR  262 (338)
Q Consensus       257 hp~~~~  262 (338)
                      ||||+.
T Consensus       329 hp~f~~  334 (339)
T 1z57_A          329 HPFFDL  334 (339)
T ss_dssp             SGGGGG
T ss_pred             CHHHHH
Confidence            999964

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.2e-51  Score=368.54  Aligned_cols=253  Identities=30%  Similarity=0.396  Sum_probs=207.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||.||++.+..+++.||+|++....    ...+.+.+|+.++++++||||+++++++...+.+|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            58999999999999999999999999999999986533    22356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--Q  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~  155 (338)
                      ||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++......  .
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCSSSTTC-------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEEeCCCccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999997554  89999999998543322  2


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCcccCCHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLEC  233 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  233 (338)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............+..   .....  .....+++.+
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD---SVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS---CCCCHHHHSCTTSCHHH
T ss_pred             cCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc---cCCCcchhcccCCCHHH
Confidence            334679999999999988777555 89999999999999999999876654433332221   11111  1123688999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .++|.+||..||.+||+..+.+.+.|.
T Consensus       245 ~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            999999999999999966666666654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-51  Score=370.95  Aligned_cols=255  Identities=26%  Similarity=0.421  Sum_probs=208.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEc------CCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLT------PTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~------~~~~~   74 (338)
                      ++|++++.||+|+||.||+|.+..+++.||||++.........+.+|+.+++++ +||||+++++++..      .+.+|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            589999999999999999999999999999999987766678899999999998 79999999999987      46899


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.....
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCTTTC----
T ss_pred             EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC--CEEEeeCcCceecCc
Confidence            999999999999999764  4699999999999999999999999999999999999997554  899999999875432


Q ss_pred             C-CCCCCccccCccccccccc-----CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCc
Q 019628          153 H-SQPKSTVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY  226 (338)
Q Consensus       153 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (338)
                      . .......||+.|+|||++.     +..++ .++|||||||++|+|++|..||...........    +..........
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~  256 (326)
T 2x7f_A          182 TVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKS  256 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------CC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSC
T ss_pred             CccccccccCCccccChhhhccccccCcCCC-ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCccccCCc
Confidence            2 2234567999999999986     34454 448999999999999999999987654333222    22222222223


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..++..+.+||.+||..||.+|||+.++++||||...
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            4688999999999999999999999999999999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=366.17  Aligned_cols=255  Identities=26%  Similarity=0.423  Sum_probs=212.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||.||++.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++...+.+|+||||++
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            57999999999999999999999999999999997653 35778999999999999999999999999999999999999


Q ss_pred             CCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCc
Q 019628           82 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKST  159 (338)
Q Consensus        82 ~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  159 (338)
                      +++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||+++.++  .+||+|||++...... ......
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECBTTBSCBCCC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC--CEEEeecccchhhhhhccccCcc
Confidence            999999997 456799999999999999999999999999999999999997554  8999999999754332 223456


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      .||+.|+|||++.+..++.+ +|||||||++|+|++|..||............   .......+.....++..+.+||.+
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~  261 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFVKQ  261 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred             CCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHHHHH
Confidence            79999999999988877655 89999999999999999999876543322211   112222233334578999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||..||.+|||+.++++||||...
T Consensus       262 ~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          262 CLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HccCChhhCcCHHHHHhCHHHhcC
Confidence            999999999999999999999754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-51  Score=377.49  Aligned_cols=253  Identities=24%  Similarity=0.417  Sum_probs=214.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc----c--------------HHHHHHHHHHhcCCCCCccee
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----D--------------EHVQREIMNHRSLKHPNIVRF   63 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~--------------~~~~~E~~~l~~l~h~~Iv~~   63 (338)
                      ++|++++.||+|+||.||+|.+  +++.||||++......    .              ..+.+|+.++++++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            6899999999999999999999  8999999999763211    1              788999999999999999999


Q ss_pred             EEEEEcCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCC
Q 019628           64 KEVLLTPTHLAIVMEYAAGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGS  134 (338)
Q Consensus        64 ~~~~~~~~~~~iv~e~~~~~~L~~~------i~~--~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~  134 (338)
                      ++++...+.+|+||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+||+++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            9999999999999999999999998      655  5679999999999999999999999 999999999999999755


Q ss_pred             CCCcEEEeecCCCcccccCCCCCCccccCcccccccccCC-ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Q 019628          135 TAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI  213 (338)
Q Consensus       135 ~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~  213 (338)
                      +  .+||+|||++...... ......||+.|+|||++.+. .++..++|||||||++|+|++|..||..........   
T Consensus       189 ~--~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---  262 (348)
T 2pml_X          189 G--RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF---  262 (348)
T ss_dssp             S--CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH---
T ss_pred             C--cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---
Confidence            4  8999999999754322 34556799999999999877 554535999999999999999999998766533222   


Q ss_pred             hhHhhccccCCCc-----------------ccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          214 GRILSVHYSFPDY-----------------VRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       214 ~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..+......+|..                 ..++.++.+||.+||..||.+|||+.|+++||||..
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            2333333444421                 468999999999999999999999999999999964

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-51  Score=383.84  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=206.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC--------CCCcceeEEEEE----c
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK--------HPNIVRFKEVLL----T   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~--------h~~Iv~~~~~~~----~   69 (338)
                      ++|++++.||+|+||+||+|++..+++.||||++.........+.+|+.+++.++        |+||++++++|.    .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            5899999999999999999999999999999999876666678889999999885        788999999998    5


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCC-----------
Q 019628           70 PTHLAIVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGST-----------  135 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~-----------  135 (338)
                      ...+|+||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++           
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            56899999999 56777777654  4699999999999999999999998 999999999999997542           


Q ss_pred             ------------------------------------CCcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCC
Q 019628          136 ------------------------------------APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK  179 (338)
Q Consensus       136 ------------------------------------~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  179 (338)
                                                          ...+||+|||+++...  ......+||+.|+|||++.+..++.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~  273 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSGYNTP  273 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--BCSCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--ccCccCCCCCcccCChhhcCCCCCcH
Confidence                                                1269999999997543  23455689999999999988877655


Q ss_pred             cchHHHHHHHHHHHHcCCCCCCCCCCh------HHHHHHHhhHhh--------cccc-----------------------
Q 019628          180 IADVWSCGVTLYVMLVGAYPFEDPEDP------KNFRKTIGRILS--------VHYS-----------------------  222 (338)
Q Consensus       180 ~~DiwSlG~il~~lltg~~pf~~~~~~------~~~~~~~~~~~~--------~~~~-----------------------  222 (338)
                       +|||||||++|+|++|+.||......      ............        ..+.                       
T Consensus       274 -~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (397)
T 1wak_A          274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE  352 (397)
T ss_dssp             -HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred             -HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence             89999999999999999999865431      111111111100        0000                       


Q ss_pred             -----CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          223 -----FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       223 -----~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                           +......+..+.+||.+||+.||.+|||+.|+|+||||+
T Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                 000112346788999999999999999999999999995

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.9e-51  Score=367.53  Aligned_cols=256  Identities=31%  Similarity=0.530  Sum_probs=211.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeEEEEE--cCCeE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----KIDEHVQREIMNHRSLKHPNIVRFKEVLL--TPTHL   73 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--~~~~~   73 (338)
                      +++|++++.||+|+||.||++.+..+++.||+|++....     .....+.+|+.+++.++||||+++++++.  ..+.+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999999999999999997642     23467889999999999999999999984  44679


Q ss_pred             EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           74 AIVMEYAAGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      |+||||++++ |.+.+..  ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC--cEEeeccccccccC
Confidence            9999999875 7777764  45699999999999999999999999999999999999997554  89999999987543


Q ss_pred             cC---CCCCCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcc
Q 019628          152 LH---SQPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV  227 (338)
Q Consensus       152 ~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (338)
                      ..   .......||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.......    ....+....+.++.  
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~~~~~~~--  234 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFENIGKGSYAIPG--  234 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHCCCCCCS--
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHHhcCCCCCCC--
Confidence            21   2223557999999999987643 23455899999999999999999998754332    33334444455554  


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP  265 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~  265 (338)
                      .+++.+.+||.+||..||.+|||+.|+++||||++..+
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            68999999999999999999999999999999976543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-51  Score=371.35  Aligned_cols=260  Identities=27%  Similarity=0.389  Sum_probs=193.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||+|+||.||++.+..+++.||||++....  .....+.+|+.++++++||||+++++++...+..++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            68999999999999999999999899999999886542  3345678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           80 AAGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        80 ~~~~~L~~~i~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      +++++|.+++..        ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++....
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSAFLA  172 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCHHHHHCC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC--CEEEEeccchheec
Confidence            999999999974        45699999999999999999999999999999999999997554  89999999886432


Q ss_pred             cC------CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc----c
Q 019628          152 LH------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH----Y  221 (338)
Q Consensus       152 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~----~  221 (338)
                      ..      .......||+.|+|||++.+....+.++|||||||++|+|++|+.||....................    .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  252 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ  252 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence            21      1223457999999999987633334559999999999999999999988665544433322111100    0


Q ss_pred             cCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          222 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .......++.++.+||.+||..||.+|||+.++++||||++.
T Consensus       253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            011123578999999999999999999999999999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.8e-51  Score=375.00  Aligned_cols=258  Identities=31%  Similarity=0.510  Sum_probs=185.1

Q ss_pred             CCceEee-eeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc----CCeEEEE
Q 019628            2 ERYEIVK-DIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT----PTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~-~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~iv   76 (338)
                      ++|++++ .||+|+||+||+|.+..+++.||||++.....   ...+....++.++||||+++++++..    ...+++|
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            5899966 59999999999999999999999999876432   22222334677899999999999876    4568999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccccC
Q 019628           77 MEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSVLH  153 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~~~  153 (338)
                      |||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+.+||+|||+++... .
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~-~  183 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-Q  183 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc-c
Confidence            99999999999998654  699999999999999999999999999999999999997543 3469999999997543 2


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--cCCCcccCCH
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--SFPDYVRVSL  231 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (338)
                      .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............+.....  ..+.+..+++
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (336)
T 3fhr_A          184 NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE  262 (336)
T ss_dssp             --------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred             cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence            33445678999999999987777544 89999999999999999999765543322222222222222  3344567899


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            999999999999999999999999999997643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-50  Score=364.83  Aligned_cols=253  Identities=28%  Similarity=0.427  Sum_probs=203.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc------------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT------------   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------------   69 (338)
                      ++|++++.||+|+||.||+|.+..+++.||||++.........+.+|+.+++.++||||+++++++..            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            47999999999999999999999999999999997765556778899999999999999999998865            


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           70 -PTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        70 -~~~~~iv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                       ...+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC--CEEEeeCcch
Confidence             357899999999999999998543 578999999999999999999999999999999999997554  8999999998


Q ss_pred             cccccC---------------CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHH
Q 019628          148 KSSVLH---------------SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT  212 (338)
Q Consensus       148 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~  212 (338)
                      ......               .......||+.|+|||++.+....+.++|||||||++|+|++   ||.....   ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---~~~~  237 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---RVNI  237 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---HHHH
Confidence            754321               123456799999999999865434555999999999999998   5543222   2223


Q ss_pred             HhhHhhccccCCC--cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          213 IGRILSVHYSFPD--YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       213 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ...+......+|.  ....+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            3333333333332  2356788999999999999999999999999999964

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.6e-51  Score=366.08  Aligned_cols=255  Identities=28%  Similarity=0.409  Sum_probs=208.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            58999999999999999999999999999999987643 33467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCCCCC
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~~~~  158 (338)
                      ++++|..++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++  .+||+|||++..... ......
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  176 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDS  176 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS--CEEECCCHHHHHHHHHHHC---
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC--CEEEEECCCCcccccccccccc
Confidence            99999998875 45799999999999999999999999999999999999997554  899999998753211 122345


Q ss_pred             ccccCccccccccc-----CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          159 TVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       159 ~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ..||+.|+|||++.     +..+ +.++|||||||++|+|++|..||..............   ...........++..+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l  252 (302)
T 2j7t_A          177 FIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKWSVEF  252 (302)
T ss_dssp             --CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSCHHH
T ss_pred             ccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCccccCHHH
Confidence            67999999999984     4444 4459999999999999999999987654433322211   1122222334688999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+||.+||..+|.+|||+.++++||||..
T Consensus       253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          253 RDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             HHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence            99999999999999999999999999964

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.7e-50  Score=365.42  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=211.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-CCCcEEEEEEeecCc---cccHHHHHHHHHHhcC---CCCCcceeEEEEE-----c
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-WTRELLAVKFIERGQ---KIDEHVQREIMNHRSL---KHPNIVRFKEVLL-----T   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~-----~   69 (338)
                      ++|++++.||+|+||.||+|.+. .+++.||+|++....   .....+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            58999999999999999999995 678999999987532   2234566787777666   8999999999987     5


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           70 PTHLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ...+++||||++ ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~--~~kl~Dfg~~  167 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA  167 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC--CEEEecCccc
Confidence            578999999997 59999998653  499999999999999999999999999999999999997554  8999999999


Q ss_pred             cccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCC--
Q 019628          148 KSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFP--  224 (338)
Q Consensus       148 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~--  224 (338)
                      +............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||................... ...++  
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            86544444556789999999999988777555 899999999999999999999877655554443322110 00010  


Q ss_pred             ------------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          225 ------------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       225 ------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                        ....++..+++||.+||..||.+|||+.++++||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                              113578999999999999999999999999999999753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.3e-50  Score=362.28  Aligned_cols=252  Identities=29%  Similarity=0.450  Sum_probs=215.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||.||++.+..+++.||||++....  ...+.+.+|+.+++.++||||+++++++.....+|+||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            57999999999999999999999999999999997643  3346789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-CCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-QPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  158 (338)
                      +++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++....... ....
T Consensus       102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECBTTBCCBCC
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC--CEEEeecccceecCccccccCc
Confidence            999999998864 5799999999999999999999999999999999999997554  89999999997543322 2345


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  237 (338)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +... ...++  ..++..+.+||
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~~~~l~~li  251 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFL----IPKNNPPTLE--GNYSKPLKEFV  251 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCC--SSCCHHHHHHH
T ss_pred             cCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----hhcCCCCCCc--cccCHHHHHHH
Confidence            679999999999988777655 8999999999999999999987554332221    1211 12222  36889999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+||..+|.+|||+.++++||||.+.
T Consensus       252 ~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          252 EACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHhhChhhhcC
Confidence            99999999999999999999999754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3e-52  Score=388.19  Aligned_cols=244  Identities=14%  Similarity=0.129  Sum_probs=197.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHH---HHHhcCCCCCcceeE-------EEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREI---MNHRSLKHPNIVRFK-------EVL   67 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~---~~l~~l~h~~Iv~~~-------~~~   67 (338)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....    ...+.+.+|+   ..++.++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            47999999999999999999999899999999997532    2346788999   555666899999998       777


Q ss_pred             EcCC-----------------eEEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHhhhcCceecC
Q 019628           68 LTPT-----------------HLAIVMEYAAGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQICHRD  123 (338)
Q Consensus        68 ~~~~-----------------~~~iv~e~~~~~~L~~~i~~~~~l~~-------~~~~~i~~qi~~al~~LH~~~iiH~D  123 (338)
                      ..++                 ..|+||||+ +|+|.+++...+.+++       ..+..++.||+.||.|||++||+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            6654                 289999999 6799999987655655       88888999999999999999999999


Q ss_pred             CCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcccccccccCC-----------ccCCCcchHHHHHHHHHH
Q 019628          124 LKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK-----------EYDGKIADVWSCGVTLYV  192 (338)
Q Consensus       124 lkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwSlG~il~~  192 (338)
                      |||+|||++.++  .+||+|||+|+..  .......+| +.|+|||++.+.           .++ .++|||||||++|+
T Consensus       232 ikp~NIll~~~~--~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~e  305 (377)
T 3byv_A          232 LRPVDIVLDQRG--GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVIYW  305 (377)
T ss_dssp             CCGGGEEECTTC--CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCC--CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHHHH
Confidence            999999997554  8999999999843  223345677 999999999876           564 55999999999999


Q ss_pred             HHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          193 MLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       193 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      |++|+.||.........    ..      .......+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       306 lltg~~Pf~~~~~~~~~----~~------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          306 IWCADLPITKDAALGGS----EW------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHSSCCC------CCS----GG------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHCCCCCcccccccch----hh------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999764432111    11      11223468999999999999999999999999999999963

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=367.23  Aligned_cols=259  Identities=28%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEE------------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLL------------   68 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~------------   68 (338)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            58999999999999999999999999999999987643 33467889999999999999999999874            


Q ss_pred             --cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           69 --TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        69 --~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                        ....+|+||||++ |+|.+++.. +++++..++.++.||+.||.|||++||+||||||+||+++... +.+||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~  167 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGL  167 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCcc
Confidence              3468999999997 599998864 5799999999999999999999999999999999999996332 3899999999


Q ss_pred             CcccccC----CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh----
Q 019628          147 SKSSVLH----SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS----  218 (338)
Q Consensus       147 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----  218 (338)
                      ++.....    .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||..................    
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            9854321    22334568999999999876444456699999999999999999999887654444333321100    


Q ss_pred             --------------ccccCC------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          219 --------------VHYSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       219 --------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                    .....+      ....++.++++||.+||+.||.+|||+.|+++||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence                          000000      012578999999999999999999999999999999743

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.8e-50  Score=362.95  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=201.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++.+.||+|+||+||++.+  +|+.||+|++.....   ..+.+.+|+.++++++||||+++++++...+.+++|||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            5899999999999999999987  588999999876432   23467899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           79 YAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+++++|.+++.....   +++..++.++.||+.||.|||++|  |+||||||+|||++.++  .+||+|||+++.....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRLKAST  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC--CEEECCCC--------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC--cEEECCCCCCcccccc
Confidence            9999999999986553   999999999999999999999999  99999999999997554  8999999999743322


Q ss_pred             -CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          154 -SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       154 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                       .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.............  .......+|.  .++++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~  267 (309)
T 3p86_A          193 FLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--FKCKRLEIPR--NLNPQ  267 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--HSCCCCCCCT--TSCHH
T ss_pred             ccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCc--cCCHH
Confidence             22345679999999999988877555 899999999999999999998765433322211  1122233333  68999


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhc--Ccccc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKN--HPWFL  261 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~--hp~~~  261 (338)
                      +.+||.+||+.+|.+|||+.++++  ++++.
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            999999999999999999999988  45554

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=364.73  Aligned_cols=248  Identities=27%  Similarity=0.388  Sum_probs=205.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC-ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG-QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||+||++.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            6899999999999999999999999999999988653 334467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC---
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP---  156 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~---  156 (338)
                      ++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++........   
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK--NVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS--CEEECCCTTCEECC--------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC--CEEEeecccceecccccccccc
Confidence            99999999987 56799999999999999999999999999999999999997554  8999999999754322211   


Q ss_pred             ------------CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHHhhHhhccccC
Q 019628          157 ------------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF-RKTIGRILSVHYSF  223 (338)
Q Consensus       157 ------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~  223 (338)
                                  ...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||......... ........  ....
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~  244 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DRYC  244 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--HHTC
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--cccC
Confidence                        14679999999999988777655 99999999999999999998754321110 00000000  0112


Q ss_pred             CCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +  ..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       245 ~--~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          245 P--PNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             C--TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C--CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2  257889999999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.9e-50  Score=371.71  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=209.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC-cEEEEEEeecCccccHHHHHHHHHHhcCCCCC------cceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR-ELLAVKFIERGQKIDEHVQREIMNHRSLKHPN------IVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~------Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||+||+|.+..++ +.||+|+++........+.+|+.+++.++|++      ++.+++++...+.+|
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            68999999999999999999998776 68999999876666677889999999987665      999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-----------------C
Q 019628           75 IVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-----------------T  135 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-----------------~  135 (338)
                      +||||+ +++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+|||++..                 .
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            999999 667878776543  69999999999999999999999999999999999999432                 2


Q ss_pred             CCcEEEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhh
Q 019628          136 APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGR  215 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~  215 (338)
                      .+.+||+|||+++..  ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............
T Consensus       178 ~~~~kl~Dfg~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (355)
T 2eu9_A          178 NTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI  254 (355)
T ss_dssp             CCCEEECCCTTCEET--TSCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCcEEEeecCccccc--cccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            458999999999753  233456789999999999988777655 89999999999999999999876654433322211


Q ss_pred             Hhhcc-----------------ccC---------------------CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          216 ILSVH-----------------YSF---------------------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       216 ~~~~~-----------------~~~---------------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .....                 ..+                     ......+.++.+||.+||+.||.+|||+.|+|+|
T Consensus       255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11000                 000                     0011124578899999999999999999999999


Q ss_pred             cccccC
Q 019628          258 PWFLRN  263 (338)
Q Consensus       258 p~~~~~  263 (338)
                      |||...
T Consensus       335 p~f~~~  340 (355)
T 2eu9_A          335 PFFAGL  340 (355)
T ss_dssp             GGGGGC
T ss_pred             hhhcCC
Confidence            999754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-50  Score=369.26  Aligned_cols=249  Identities=31%  Similarity=0.514  Sum_probs=212.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCC--CCCcceeEEEEEcCCe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLK--HPNIVRFKEVLLTPTH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~   72 (338)
                      ++|++++.||+|+||.||+|.+..+++.||||++.....       ....+.+|+.++++++  ||||+++++++..++.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            589999999999999999999999999999999976432       2245678999999996  5999999999999999


Q ss_pred             EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           73 LAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        73 ~~iv~e~~~~-~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      +++|||++.+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+++...
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLK  201 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TTEEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC-CCCEEEeeCccccccc
Confidence            9999999976 8999999988899999999999999999999999999999999999999732 2389999999987543


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      . .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||....          .+......++.  .+++
T Consensus       202 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~~~~~~~~~~--~~~~  268 (320)
T 3a99_A          202 D-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--RVSS  268 (320)
T ss_dssp             S-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCSS--CCCH
T ss_pred             c-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hhhcccccccc--cCCH
Confidence            2 334456799999999999877766666899999999999999999997521          11222223333  6899


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ++.+||.+||..||.+|||+.++++||||+...
T Consensus       269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            999999999999999999999999999997543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.9e-52  Score=384.13  Aligned_cols=253  Identities=17%  Similarity=0.207  Sum_probs=190.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHH---HHHhcCCCCCcceeE-------EEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREI---MNHRSLKHPNIVRFK-------EVLL   68 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~---~~l~~l~h~~Iv~~~-------~~~~   68 (338)
                      +|++.+.||+|+||+||+|.+..+|+.||||++.....    ..+.+.+|+   ..++. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            59999999999999999999999999999999987532    234566774   55555 799988755       5554


Q ss_pred             cC-----------------CeEEEEEeccCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHhhhcCceecCC
Q 019628           69 TP-----------------THLAIVMEYAAGGELFERICNAG-RFSEDEA------RFFFQQLISGVSYCHSMQICHRDL  124 (338)
Q Consensus        69 ~~-----------------~~~~iv~e~~~~~~L~~~i~~~~-~l~~~~~------~~i~~qi~~al~~LH~~~iiH~Dl  124 (338)
                      .+                 ..+|+||||++ ++|.+++.... .+++...      ..++.||+.||.|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 34899999998 89999998632 3444445      577799999999999999999999


Q ss_pred             CCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcccccccccC--CccCCCcchHHHHHHHHHHHHcCCCCCCC
Q 019628          125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFED  202 (338)
Q Consensus       125 kp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~  202 (338)
                      ||+|||++.++  .+||+|||+|+....  ......+|+.|+|||++.+  ..++ .++|||||||++|+|++|+.||..
T Consensus       221 kp~NIll~~~~--~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          221 TPDNLFIMPDG--RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             SGGGEEECTTS--CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CHHHEEECCCC--CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999997554  899999999985422  2225567899999999976  4554 559999999999999999999987


Q ss_pred             CCChHH--HHH-HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          203 PEDPKN--FRK-TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       203 ~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ......  +.. .........+.++....+++.+.+||.+||+.||++|||+.++|+||||++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            532110  000 001112234445555678999999999999999999999999999999964

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.8e-50  Score=374.93  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=207.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----------CCCcceeEEEEEcC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-----------HPNIVRFKEVLLTP   70 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-----------h~~Iv~~~~~~~~~   70 (338)
                      ++|++++.||+|+||+||+|.+..+++.||||++.........+.+|+.++++++           ||||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            5899999999999999999999999999999999876655677889999998886           89999999999865


Q ss_pred             C----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCC----CCCcE
Q 019628           71 T----HLAIVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGS----TAPRV  139 (338)
Q Consensus        71 ~----~~~iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~----~~~~i  139 (338)
                      +    .++++||++ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++..    ..+.+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence            4    799999999 88999999763  4599999999999999999999998 99999999999999532    22379


Q ss_pred             EEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh------HHHHHHH
Q 019628          140 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP------KNFRKTI  213 (338)
Q Consensus       140 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~------~~~~~~~  213 (338)
                      ||+|||+++...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......      .......
T Consensus       178 kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (373)
T 1q8y_A          178 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  254 (373)
T ss_dssp             EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             EEcccccccccC--CCCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence            999999997543  23455689999999999988877544 99999999999999999999865421      1111211


Q ss_pred             hhHhh--------------------------------------ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHh
Q 019628          214 GRILS--------------------------------------VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK  255 (338)
Q Consensus       214 ~~~~~--------------------------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell  255 (338)
                      ..+..                                      ..+.++  ...+.++.+||.+||+.||.+|||+.|+|
T Consensus       255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            11100                                      001111  13467789999999999999999999999


Q ss_pred             cCcccccCC
Q 019628          256 NHPWFLRNL  264 (338)
Q Consensus       256 ~hp~~~~~~  264 (338)
                      +||||++..
T Consensus       333 ~hp~f~~~~  341 (373)
T 1q8y_A          333 NHPWLKDTL  341 (373)
T ss_dssp             TCGGGTTCT
T ss_pred             hChhhhccc
Confidence            999998654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-50  Score=355.42  Aligned_cols=247  Identities=22%  Similarity=0.391  Sum_probs=209.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||.||++.+. +++.||+|++.......+.+.+|+.++++++||||+++++++.+.+.+|+||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            58999999999999999999987 57789999998877667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC--CCCCC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--SQPKS  158 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~--~~~~~  158 (338)
                      +++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||+++.....  .....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC--CEEeccccccccccccccccccC
Confidence            99999999654 4589999999999999999999999999999999999996554  8999999998744322  12344


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+|+.|+|||++.+..++. ++|||||||++|+|++ |..||............    ... .........++.+.+|+
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI----STG-FRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTT-CCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCHHHhcCCCCCc-hhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----hcC-ccCCCCCcCCHHHHHHH
Confidence            56788899999998777654 4899999999999999 99999876554333222    221 12222235789999999


Q ss_pred             HHhcccCCCcCCChhHHhcC
Q 019628          238 SRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+||+.+|.+|||+.++++|
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHH
Confidence            99999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=357.83  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=208.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      +|.....||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.++||||+++++++...+.+++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555569999999999999999999999999987653 334678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCC
Q 019628           82 GGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPK  157 (338)
Q Consensus        82 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~  157 (338)
                      +++|.+++....   .+++..++.++.||+.||.|||++||+||||||+||+++.. ++.+||+|||++...... ....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TCCEEECCTTTCEESCC-----C
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC-CCCEEEeecccccccCCCCCccc
Confidence            999999997652   46799999999999999999999999999999999999752 238999999998754332 2234


Q ss_pred             CccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||............ .........++.  .++.++.+|
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~l  258 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPE--SMSAEAKAF  258 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCCCCCT--TSCHHHHHH
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccccccc--cCCHHHHHH
Confidence            567999999999987643 2345599999999999999999999765443321111 111222223333  689999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |.+||..||++|||+.++++||||+..
T Consensus       259 i~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          259 ILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHccCChhhCCCHHHHhcChhhhhc
Confidence            999999999999999999999999743

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.1e-50  Score=366.35  Aligned_cols=255  Identities=24%  Similarity=0.362  Sum_probs=187.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc--ccHHHHHHHH-HHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK--IDEHVQREIM-NHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      .++|++++.||+|+||.||++.+..+|+.||||++.....  ....+.+|+. +++.++||||+++++++..++..|+||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            3689999999999999999999999999999999976432  2234555655 778889999999999999999999999


Q ss_pred             eccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           78 EYAAGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        78 e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      ||+++ +|.+++..     ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++  .+||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT--EEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC--CEEEccCCCceecc
Confidence            99975 88887763     56799999999999999999999999 999999999999997554  89999999998654


Q ss_pred             cCCCCCCccccCccccccccc----CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCC--
Q 019628          152 LHSQPKSTVGTPAYIAPEVLT----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFP--  224 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~--  224 (338)
                      .........||+.|+|||++.    +..++ .++|||||||++|+|++|+.||.......   .....+... ...++  
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             ----------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCC
T ss_pred             cccccccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCCc
Confidence            444444568999999999983    44454 45999999999999999999998644321   111222221 11222  


Q ss_pred             CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ....+++.+.+||.+||..||.+|||+.++++||||..
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            22358999999999999999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.4e-49  Score=352.52  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=209.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||.||++.+. ++..||+|++.........+.+|+.++++++||||+++++++...+.+++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            68999999999999999999886 56789999998876667789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CCCC
Q 019628           82 GGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QPKS  158 (338)
Q Consensus        82 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~~~  158 (338)
                      +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.......  ....
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC--CEEECCTTCEEECCTTCEEECCS
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC--CEEEccCccceecchhhhhcccC
Confidence            999999997654 599999999999999999999999999999999999997554  89999999987443221  1234


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||..............   ......|  ...++.+.+||
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~l~~li  238 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ---GHRLYRP--HLASDTIYQIM  238 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---TCCCCCC--TTSCHHHHHHH
T ss_pred             CCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc---CCCCCCC--CcChHHHHHHH
Confidence            456778999999988777655 899999999999999 9999987665433322211   1122222  35789999999


Q ss_pred             HHhcccCCCcCCChhHHhcC
Q 019628          238 SRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+||+.+|.+|||+.++++|
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.1e-50  Score=364.05  Aligned_cols=255  Identities=21%  Similarity=0.351  Sum_probs=192.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc---EEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE--
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE---LLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL--   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~--   73 (338)
                      ++|++++.||+|+||+||+|.+..++.   .||||++...   ....+.+.+|+.++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            579999999999999999999887765   8999998764   23346788999999999999999999999887655  


Q ss_pred             ----EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEee
Q 019628           74 ----AIVMEYAAGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD  143 (338)
Q Consensus        74 ----~iv~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~D  143 (338)
                          ++||||+++++|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~D  180 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVAD  180 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEee
Confidence                99999999999999996533      589999999999999999999999999999999999997554  899999


Q ss_pred             cCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhc
Q 019628          144 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV  219 (338)
Q Consensus       144 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  219 (338)
                      ||+++.......   .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||..............   ..
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~~  256 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG---GN  256 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TC
T ss_pred             ccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc---CC
Confidence            999975433222   2234577889999999887765 44999999999999999 9999988776554433322   11


Q ss_pred             cccCCCcccCCHHHHHHHHHhcccCCCcCCC-------hhHHhcCcccccCC
Q 019628          220 HYSFPDYVRVSLECKHLLSRIFVANSEKRIT-------IPEIKNHPWFLRNL  264 (338)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-------~~ell~hp~~~~~~  264 (338)
                      ..  +....+++++.+||.+||+.||.+|||       ++++++|||+....
T Consensus       257 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          257 RL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            22  223368899999999999999999999       77889999997543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-50  Score=359.86  Aligned_cols=254  Identities=32%  Similarity=0.531  Sum_probs=209.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~i   75 (338)
                      +++|++++.||+|+||.||++.+..+++.||+|++....   ...+.+.+|+.++++++||||+++++++..  ...+|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            368999999999999999999999999999999997643   233568899999999999999999998854  578999


Q ss_pred             EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcC-----ceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           76 VMEYAAGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----ICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~LH~~~-----iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                      ||||+++++|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+||+++.++  .+||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~--~~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS--CEEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC--CEEEecCch
Confidence            99999999999999753    34999999999999999999999999     99999999999997554  899999999


Q ss_pred             CcccccCC-CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCC
Q 019628          147 SKSSVLHS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFP  224 (338)
Q Consensus       147 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  224 (338)
                      ++...... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||.........    ..+..... .++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~i~~~~~~~~~  237 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKFRRIP  237 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCC
T ss_pred             heeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHH----HHHhhcccccCC
Confidence            87432211 11235689999999999887765 4489999999999999999999876543222    22233222 233


Q ss_pred             CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .  .++.++.+||.+||+.+|.+|||+.|+++|+|+...
T Consensus       238 ~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          238 Y--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             T--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             c--ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            3  688999999999999999999999999999999754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.8e-50  Score=364.28  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=205.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc---EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE---LLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||.||++.+..+++   .||||+++...  ...+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            579999999999999999999986554   59999997642  3345788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC----
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccCcc
Confidence            9999999999999754 5799999999999999999999999999999999999997554  899999999975433221


Q ss_pred             ----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          156 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                          .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||............    .. ....+....++
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~  280 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV----EE-GYRLPAPMGCP  280 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH----HT-TCCCCCCTTCC
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----Hc-CCCCCCCCCcC
Confidence                223346778999999987777554 899999999999999 99999876654333222    21 12333444789


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+.+||.+||..||.+|||+.++++
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=365.85  Aligned_cols=248  Identities=29%  Similarity=0.489  Sum_probs=205.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcC----CCCCcceeEEEEEcC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSL----KHPNIVRFKEVLLTP   70 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l----~h~~Iv~~~~~~~~~   70 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.....       ....+.+|+.+++++    +||||+++++++...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            579999999999999999999999999999999976432       123355788888888    899999999999999


Q ss_pred             CeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           71 THLAIVMEY-AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        71 ~~~~iv~e~-~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      +..++|||+ +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.. ++.+||+|||++..
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~kl~dfg~~~~  189 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR-RGCAKLIDFGSGAL  189 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETT-TTEEEECCCSSCEE
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCC-CCeEEEEEcchhhh
Confidence            999999999 7889999999988889999999999999999999999999999999999999722 33899999999875


Q ss_pred             cccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          150 SVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       150 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                      ... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||....          .+......++.  .+
T Consensus       190 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~~~~~~~~~~--~~  256 (312)
T 2iwi_A          190 LHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELHFPA--HV  256 (312)
T ss_dssp             CCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHTCCCCCT--TS
T ss_pred             ccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------HHhhhccCCcc--cC
Confidence            433 334556799999999999877766656999999999999999999997521          12223334444  68


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +..+.+||.+||..+|++|||+.|+++||||+..
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            9999999999999999999999999999999754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-49  Score=368.87  Aligned_cols=248  Identities=22%  Similarity=0.319  Sum_probs=205.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-------CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-------WTRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      ++|++++.||+|+||.||+|.+.       .++..||||+++....  ....+.+|+.+++.+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            58999999999999999999874       3456799999976432  335688999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      .+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            9999999999999999998653                479999999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||........+..
T Consensus       241 --~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~~~~  317 (370)
T 2psq_A          241 --VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  317 (370)
T ss_dssp             --CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             --CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              89999999997543222   2334567889999999988777544 999999999999999 9999987655433322


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .    ... ...+....++.++.+||.+||+.+|.+|||+.|++++
T Consensus       318 ~----~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          318 L----KEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             H----HTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H----hcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2    111 1122223688999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.7e-49  Score=354.73  Aligned_cols=247  Identities=22%  Similarity=0.368  Sum_probs=206.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||+||++.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++...+.+|+||||++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            58999999999999999999886 67789999998876667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC--CCCCC
Q 019628           82 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--SQPKS  158 (338)
Q Consensus        82 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~--~~~~~  158 (338)
                      +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++.....  .....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS--CEEECSTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC--CEEEccccccccccccccccccC
Confidence            9999999976 55799999999999999999999999999999999999997554  8999999998744322  12334


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||...............   .....|  ...++.+.+||
T Consensus       181 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~l~~li  254 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRP--HLASEKVYTIM  254 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCC--TTCCHHHHHHH
T ss_pred             CccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc---cCCCCC--CcCCHHHHHHH
Confidence            5578889999999877765 44899999999999998 99999886654433332211   112222  35789999999


Q ss_pred             HHhcccCCCcCCChhHHhcC
Q 019628          238 SRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+||+.+|.+|||+.++++|
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=359.14  Aligned_cols=256  Identities=24%  Similarity=0.357  Sum_probs=193.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcccc---HHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      +++|++++.||+|+||.||+|.+..+|+.||||++.......   ..+.++..+++.++||||+++++++..++.+|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            468999999999999999999999999999999997653221   23444556788889999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhc-CceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           78 EYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~-~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  .+||+|||++........
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS--CEEECCCTTC--------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC--CEEEEECCCchhccCCcc
Confidence            999 5555555543 46799999999999999999999995 999999999999997554  899999999976544444


Q ss_pred             CCCccccCccccccccc-----CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          156 PKSTVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .....||+.|+|||++.     ...+ +.++|||||||++|+|++|+.||...........  .........++....++
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  257 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLT--KVLQEEPPLLPGHMGFS  257 (318)
T ss_dssp             ------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH--HHHHSCCCCCCSSSCCC
T ss_pred             ccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH--HHhccCCCCCCccCCCC
Confidence            55668999999999995     3344 4458999999999999999999987544322221  11222333455555789


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .++.+||.+||..||.+|||+.++++||||++
T Consensus       258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            99999999999999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=372.81  Aligned_cols=255  Identities=19%  Similarity=0.273  Sum_probs=209.1

Q ss_pred             CCceEeeeeccCCceEEEEEE-----EcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVR-----DKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||+||+|.     +..+++.||||+++...  .....+.+|+.++++++||||+++++++......|
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            579999999999999999999     55678899999987532  23356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCC
Q 019628           75 IVMEYAAGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGY  146 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~-------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~  146 (338)
                      +||||+++|+|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            9999999999999998653       489999999999999999999999999999999999997443 23699999999


Q ss_pred             Cccccc---CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcccc
Q 019628          147 SKSSVL---HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS  222 (338)
Q Consensus       147 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (338)
                      ++....   ........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||...........    +.... .
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~~----i~~~~-~  304 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF----VTSGG-R  304 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHTTC-C
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCC-C
Confidence            874322   123344668999999999987777544 999999999999998 9999987654333222    22221 1


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+....++..+.+||.+||+.+|.+|||+.++++|.++..
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            2222368899999999999999999999999999988753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.7e-49  Score=350.58  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc--------cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI--------DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++......        .+.+.+|+.++++++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6899999999999999999999999999999998653321        167889999999999999999999987665  


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCC---CcEEEeecCCC
Q 019628           74 AIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTA---PRVKICDFGYS  147 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~---~~ikL~Dfg~a  147 (338)
                      ++||||+++++|.+.+... ..+++..++.++.|++.||.|||++|  |+||||||+|||++.++.   ..+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            6899999999999888654 46999999999999999999999999  999999999999965441   13999999998


Q ss_pred             cccccCCCCCCccccCcccccccccC--CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC
Q 019628          148 KSSVLHSQPKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD  225 (338)
Q Consensus       148 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (338)
                      +...  .......||+.|+|||++..  ..+ +.++|||||||++|+|++|+.||..........  ...+.......+.
T Consensus       177 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~  251 (287)
T 4f0f_A          177 QQSV--HSVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLRPTI  251 (287)
T ss_dssp             BCCS--SCEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCCCCC
T ss_pred             cccc--ccccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCCCCC
Confidence            7432  23445679999999999843  334 445899999999999999999998765543211  1122222222222


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ...+++.+.+||.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3368999999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.4e-50  Score=368.65  Aligned_cols=249  Identities=23%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             CCceEeeeeccCCceEEEEEE-----EcCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC-e
Q 019628            2 ERYEIVKDIGSGNFGVAKLVR-----DKWTRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT-H   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~-~   72 (338)
                      ++|++++.||+|+||.||+|.     +..+++.||||+++....  ..+.+.+|+.+++++ +||||+++++++...+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            689999999999999999999     556778999999976432  235688999999999 7899999999998765 4


Q ss_pred             EEEEEeccCCCChHHHHHhcCC----------------------------------------------------------
Q 019628           73 LAIVMEYAAGGELFERICNAGR----------------------------------------------------------   94 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~----------------------------------------------------------   94 (338)
                      +++||||+++|+|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            9999999999999999976543                                                          


Q ss_pred             --------CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---CCCCccccC
Q 019628           95 --------FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTP  163 (338)
Q Consensus        95 --------l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~  163 (338)
                              +++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......   ......||+
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--cEEEEeccceeeecccccchhccccCCCc
Confidence                    89999999999999999999999999999999999997554  89999999997543222   233466899


Q ss_pred             cccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcc
Q 019628          164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFV  242 (338)
Q Consensus       164 ~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (338)
                      .|+|||++.+..++. ++|||||||++|+|++ |..||............+..  ......|  ..+++++.++|.+||.
T Consensus       260 ~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          260 KWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--GTRMRAP--DYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             GGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH--TCCCCCC--TTCCHHHHHHHHHHTC
T ss_pred             eeEChhhhcCCCCCc-hhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc--CCCCCCC--CCCCHHHHHHHHHHcc
Confidence            999999998777754 4999999999999998 99999887655444333322  1122233  3688999999999999


Q ss_pred             cCCCcCCChhHHhcC
Q 019628          243 ANSEKRITIPEIKNH  257 (338)
Q Consensus       243 ~dp~~R~s~~ell~h  257 (338)
                      .+|.+|||+.|+++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.4e-49  Score=349.78  Aligned_cols=248  Identities=28%  Similarity=0.397  Sum_probs=197.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++.+.||+|+||.||++.+.  ++.||+|++....     ...+.+.+|+.+++.++||||+++++++..++.+|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            478999999999999999999985  8899999987642     223678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC---ceecCCCCCcEEecCC------CCCcEEEeecCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---ICHRDLKLENTLLDGS------TAPRVKICDFGY  146 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~---iiH~Dlkp~NIl~~~~------~~~~ikL~Dfg~  146 (338)
                      ||||+++++|.+++. .+.+++..++.++.|++.||.|||++|   |+||||||+||+++..      ..+.+||+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999998885 457999999999999999999999999   9999999999999752      245799999999


Q ss_pred             CcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCc
Q 019628          147 SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY  226 (338)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (338)
                      ++..... ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........    +.......+..
T Consensus       163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~  236 (271)
T 3dtc_A          163 AREWHRT-TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG----VAMNKLALPIP  236 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----HHTSCCCCCCC
T ss_pred             ccccccc-cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh----hhcCCCCCCCC
Confidence            9754322 23456799999999999877765 448999999999999999999987654333222    22223333333


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ..+++.+.+||.+||+.+|.+|||+.|+++|
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            4789999999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-48  Score=354.62  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=199.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++.+.||+|+||.||++.+..+++.||+|++......    .+.+.+|+.++++++||||+++++++..++.+|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            47899999999999999999999999999999998764322    35688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--  154 (338)
                      |||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.......  
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccc
Confidence            99999999999999888899999999999999999999999999999999999997554  89999999987543322  


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cCCCcccCCHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLEC  233 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (338)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .....   +..... .......+++++
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAH---INQAIPRPSTVRPGIPVAF  265 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHH---HHSCCCCGGGTSTTCCTHH
T ss_pred             cccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHH---hccCCCCccccCCCCCHHH
Confidence            2235679999999999988777655 89999999999999999999864432 21111   111111 111223688999


Q ss_pred             HHHHHHhcccCCCcCC-ChhHHhc
Q 019628          234 KHLLSRIFVANSEKRI-TIPEIKN  256 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~-s~~ell~  256 (338)
                      .+||.+||..+|++|| |+.++++
T Consensus       266 ~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999999 7887775

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.2e-49  Score=361.10  Aligned_cols=251  Identities=22%  Similarity=0.248  Sum_probs=205.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++...+..|+||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            579999999999999999999999999999999876533 35688999999999 9999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC---CcEEEeecCCCcccccCCC-
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA---PRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~---~~ikL~Dfg~a~~~~~~~~-  155 (338)
                       +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   ..+||+|||+++....... 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence             8999999986 467999999999999999999999999999999999999975541   1299999999975432221 


Q ss_pred             -------CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--c
Q 019628          156 -------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--Y  226 (338)
Q Consensus       156 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~  226 (338)
                             .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||........ ......+.......+.  .
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~  244 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPIEVL  244 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCHHHH
Confidence                   2467899999999999887775 448999999999999999999987543222 2222223222222221  1


Q ss_pred             ccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          227 VRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       227 ~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....+++.+|+.+||..+|.+||++.++++
T Consensus       245 ~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          245 CENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            112238999999999999999999988876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.8e-49  Score=354.70  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=201.2

Q ss_pred             CCceEeeeeccCCceEEEEEE----EcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~   74 (338)
                      ++|++++.||+|+||+||+|.    +..+++.||||++.... ...+.+.+|+.++++++||||+++++++...  ..++
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            589999999999999999998    56789999999987643 2335788999999999999999999998654  5689


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           75 IVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      +||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.....
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCSCC-----
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC--eEEEccCcccccccCC
Confidence            9999999999999997654 499999999999999999999999999999999999997554  8999999999854332


Q ss_pred             C----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh------------HHHHHHHhhHh
Q 019628          154 S----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP------------KNFRKTIGRIL  217 (338)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~------------~~~~~~~~~~~  217 (338)
                      .    ......+|+.|+|||++.+..++. ++|||||||++|+|++|..||......            ......... .
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  245 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-L  245 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH-H
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCCh-HHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH-H
Confidence            2    223345778899999998877754 499999999999999999998642110            000111111 1


Q ss_pred             hccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          218 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ......+....+++++.+||.+||..+|++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            222233444478999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.3e-49  Score=356.87  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=203.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCC--CCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLK--HPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++++.||+|+||.||++.+. +++.||+|++....   .....+.+|+.++++++  ||||+++++++...+.+|+|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            47999999999999999999986 58899999997543   23356889999999997  59999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--  154 (338)
                      || +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+++   +.+||+|||+++......  
T Consensus       107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC-------
T ss_pred             Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcccc
Confidence            99 557899999998889999999999999999999999999999999999999963   489999999998543322  


Q ss_pred             -CCCCccccCcccccccccCC----------ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC
Q 019628          155 -QPKSTVGTPAYIAPEVLTKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF  223 (338)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (338)
                       ......||+.|+|||++.+.          ...+.++|||||||++|+|++|..||.........   ...+.......
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~  259 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHEI  259 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHHCTTSCC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH---HHHHHhccccc
Confidence             12345799999999998652          22345599999999999999999999875543221   11222222222


Q ss_pred             CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +.....+.++.+||.+||..||.+|||+.|+++||||+..
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            2222468899999999999999999999999999999754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.3e-49  Score=360.96  Aligned_cols=250  Identities=21%  Similarity=0.274  Sum_probs=198.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC----eEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT----HLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~iv~   77 (338)
                      ++|++++.||+|+||+||++.+.  ++.||||++...........+|+.++++++||||+++++++....    .+|+||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            58999999999999999999885  899999999876655566778999999999999999999998743    479999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc----------CceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ||+++|+|.+++... .+++..++.++.||+.||.|||+.          ||+||||||+|||++.+.  .+||+|||++
T Consensus       102 e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~kL~DFg~a  178 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGLA  178 (322)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEEECCCTTC
T ss_pred             ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEEEccCCcc
Confidence            999999999999764 699999999999999999999999          999999999999997554  8999999999


Q ss_pred             cccccCC---CCCCccccCcccccccccCCcc----CCCcchHHHHHHHHHHHHcCCCCCCCCCChH------------H
Q 019628          148 KSSVLHS---QPKSTVGTPAYIAPEVLTKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEDPK------------N  208 (338)
Q Consensus       148 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~------------~  208 (338)
                      +......   ......||+.|+|||++.+...    .+.++|||||||++|+|+||+.||.......            .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            7543322   2334679999999999976322    2234799999999999999999997643211            1


Q ss_pred             HHHHHhhHhhccc--cCCCc---ccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          209 FRKTIGRILSVHY--SFPDY---VRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       209 ~~~~~~~~~~~~~--~~~~~---~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .......+.....  .++..   ...++++.+||.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1111111111111  11110   112455999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4e-49  Score=359.90  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=205.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEE--EEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELL--AVKFIERG--QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~v--aiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||.||+|.+..++..+  |+|.+...  ......+.+|+.+++++ +||||+++++++...+.+|+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999998888865  99988753  23345788999999999 899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEE
Q 019628           77 MEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVK  140 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ik  140 (338)
                      |||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+|
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~k  182 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK  182 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC--eEE
Confidence            99999999999997654                699999999999999999999999999999999999996554  899


Q ss_pred             EeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhc
Q 019628          141 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV  219 (338)
Q Consensus       141 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  219 (338)
                      |+|||+++............+|+.|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+...
T Consensus       183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~~~~  257 (327)
T 1fvr_A          183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLPQG  257 (327)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HGGGT
T ss_pred             EcccCcCccccccccccCCCCCccccChhhhccccCCc-hhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH----HhhcC
Confidence            99999987544444445566889999999998777654 4899999999999998 999998765433222    22221


Q ss_pred             cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                       ...+....+++++.+||.+||..+|.+|||+.+++++
T Consensus       258 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             2222334688999999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.1e-49  Score=355.22  Aligned_cols=248  Identities=22%  Similarity=0.329  Sum_probs=206.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            58999999999999999999983     456899999987643  23357889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEE
Q 019628           75 IVMEYAAGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL  130 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~------------------------l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl  130 (338)
                      +||||+++++|.+++.....                        +++..++.++.||+.||.|||++||+||||||+||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            99999999999999986543                        899999999999999999999999999999999999


Q ss_pred             ecCCCCCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCCh
Q 019628          131 LDGSTAPRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDP  206 (338)
Q Consensus       131 ~~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~  206 (338)
                      ++.++  .+||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||......
T Consensus       183 i~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          183 VAEGR--KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             EETTT--EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EcCCC--CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            97554  89999999987543222   2234567889999999987776544 899999999999999 99999876654


Q ss_pred             HHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          207 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ......    ... ...+....+++++.+||.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~~----~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          260 RLFNLL----KTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GHHHHH----HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHh----hcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            333222    111 1222233689999999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.7e-48  Score=350.47  Aligned_cols=251  Identities=20%  Similarity=0.230  Sum_probs=206.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +|+|++++++++......++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            57999999999999999999999999999999987543 335688899999999 7999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC---CCcEEEeecCCCcccccCC--
Q 019628           81 AGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST---APRVKICDFGYSKSSVLHS--  154 (338)
Q Consensus        81 ~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~---~~~ikL~Dfg~a~~~~~~~--  154 (338)
                       +++|.+++.... ++++..++.++.||+.||.|||++||+||||||+|||++.++   .+.+||+|||+++......  
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence             999999998654 599999999999999999999999999999999999996543   2249999999997543321  


Q ss_pred             ------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC---C
Q 019628          155 ------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP---D  225 (338)
Q Consensus       155 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~  225 (338)
                            ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......... ....+.......+   .
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  245 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQSTPLREL  245 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHHHSCHHHH
T ss_pred             ccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhhccCccHHHH
Confidence                  23456799999999999887775 45999999999999999999998754322211 1111111111111   1


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ...+++++.+|+.+||+.+|++|||+.++++
T Consensus       246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1258899999999999999999999999976

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.6e-49  Score=353.55  Aligned_cols=246  Identities=16%  Similarity=0.191  Sum_probs=202.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC-------cEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR-------ELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||+||++.+..++       ..||+|++.... ...+.+.+|+.++++++||||+++++++..++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            68999999999999999999998777       469999987643 3446789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC------CcEEEeecCC
Q 019628           74 AIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA------PRVKICDFGY  146 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~------~~ikL~Dfg~  146 (338)
                      ++||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.      +.+||+|||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~  167 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI  167 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence            999999999999999987654 999999999999999999999999999999999999975542      1299999999


Q ss_pred             CcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCC-CCCCCCCChHHHHHHHhhHhhccccCCC
Q 019628          147 SKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEDPKNFRKTIGRILSVHYSFPD  225 (338)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (338)
                      +....   ......||+.|+|||++.+....+.++|||||||++|+|++|. +||..... ......    ......++.
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~----~~~~~~~~~  239 (289)
T 4fvq_A          168 SITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQF----YEDRHQLPA  239 (289)
T ss_dssp             CTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHH----HHTTCCCCC
T ss_pred             ccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHH----hhccCCCCC
Confidence            87432   2234568999999999987444456699999999999999954 55544332 222221    122233333


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                        ..+.++.+||.+||+.||.+|||+.++++|
T Consensus       240 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          240 --PKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             --CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              467889999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=363.78  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=206.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-------CCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-------TRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      ++|++.+.||+|+||+||+|.+..       .+..||+|++.....  ....+.+|+.+++++ +||||+++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            589999999999999999999753       335799999876432  235688999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      .+|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence            9999999999999999998654                499999999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccC---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++.....   .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.......... 
T Consensus       229 --~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~~~~-  304 (382)
T 3tt0_A          229 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-  304 (382)
T ss_dssp             --CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-
T ss_pred             --cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence              8999999999854332   22344567889999999988776544 899999999999999 999998765433222 


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                         .+... ...+....+++++.+||.+||+.+|++|||+.|++++
T Consensus       305 ---~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          305 ---LLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ---HHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               22221 1222234689999999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-49  Score=360.67  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=208.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERG--QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||.||+|.+.     .++..||+|++...  ......+.+|+.+++++ +||||+++++++...+.+
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            57999999999999999999973     45678999999753  23456789999999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEE
Q 019628           74 AIVMEYAAGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL  130 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~-----------------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl  130 (338)
                      |+||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            99999999999999997643                       2799999999999999999999999999999999999


Q ss_pred             ecCCCCCcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCCh
Q 019628          131 LDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDP  206 (338)
Q Consensus       131 ~~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~  206 (338)
                      ++.++  .+||+|||++........   .....||+.|+|||++.+..++ .++|||||||++|+|+| |..||......
T Consensus       205 l~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          205 VTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            97554  899999999975433222   2345678899999999877765 44899999999999998 99999887655


Q ss_pred             HHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          207 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                      ..+...+..    ....+....+++++.+||.+||..||.+|||+.++++|..
T Consensus       282 ~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          282 ANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             HHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            544443322    2222333468999999999999999999999999998743

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.4e-49  Score=352.23  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=211.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||+||++.+..++..||+|++.......+.+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            57999999999999999999999999999999998776666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CCC
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QPK  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~~  157 (338)
                      +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.......  ...
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG--CEEECCCCGGGTSCSSSSEEET
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC--CEEEccCccceeccCCcccccc
Confidence            99999999863  3489999999999999999999999999999999999996554  89999999987543322  123


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+|+.|+|||++.+..++. ++|||||||++|+|++ |..||.............     .....+....+++.+.+|
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~l  244 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----KDYRMERPEGCPEKVYEL  244 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-----TTCCCCCCTTCCHHHHHH
T ss_pred             CCccccCcCChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----ccCCCCCCCCCCHHHHHH
Confidence            345788999999998777654 4899999999999999 999998766544332221     122223334689999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      |.+||..+|.+|||+.++++
T Consensus       245 i~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          245 MRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=370.79  Aligned_cols=297  Identities=22%  Similarity=0.310  Sum_probs=222.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC--eEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT--HLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~iv~   77 (338)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++....  .....+.+|+.++++++||||+++++++...+  .+|+||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            47999999999999999999999999999999997643  23466789999999999999999999998765  789999


Q ss_pred             eccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEec--CCCCCcEEEeecCCCccccc
Q 019628           78 EYAAGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~--~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      ||+++|+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+.  .+..+.+||+|||+++....
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            99999999999975433   99999999999999999999999999999999999981  22333799999999986655


Q ss_pred             CCCCCCccccCcccccccccC--------CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc---
Q 019628          153 HSQPKSTVGTPAYIAPEVLTK--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY---  221 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---  221 (338)
                      ........||+.|+|||++.+        ..+ +.++|||||||++|+|++|+.||............+..+.....   
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (396)
T 4eut_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (396)
T ss_dssp             GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred             CCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence            555566789999999999864        334 34589999999999999999999765443333333333332221   


Q ss_pred             ----------------cCCCc----ccCCHHHHHHHHHhcccCCCcCCChhHHhcCcc--cccCCCcccccCCCc-ccCC
Q 019628          222 ----------------SFPDY----VRVSLECKHLLSRIFVANSEKRITIPEIKNHPW--FLRNLPIELTEGGSW-QSHD  278 (338)
Q Consensus       222 ----------------~~~~~----~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~--~~~~~~~~~~~~~~~-~~~~  278 (338)
                                      .++..    ..++..+.+||++||+.||++|||+.+++++-.  +.+... ........ ....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~~-~~~~~~~~~~~~~  326 (396)
T 4eut_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVI-HVFSLQQMTAHKI  326 (396)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEEE-EEEETTTTEEEEE
T ss_pred             chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceEE-EEEEeccceEEEE
Confidence                            11111    124467889999999999999999999865321  110000 00001111 1111


Q ss_pred             CCCCCCCHHHHHHHhHhhCCCC
Q 019628          279 VNNPSQSLEEVLSLIHEATKPL  300 (338)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~  300 (338)
                      ...+..+..++.+.+.+.+...
T Consensus       327 ~~~~~~~~~~~~~~~~~~t~i~  348 (396)
T 4eut_A          327 YIHSYNTATIFHELVYKQTKII  348 (396)
T ss_dssp             EECTTCBHHHHHHHHHHHHCCC
T ss_pred             EcCchhHHHHHHHHHHHhcCCC
Confidence            2345567788888888776543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.2e-49  Score=354.71  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=209.3

Q ss_pred             CCceEeeeeccCCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRD-----KWTRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||.||++.+     ..+++.||+|++.....  ..+.+.+|+.+++++ +||||+++++++..++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     45778999999976532  336788999999999 999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           74 AIVMEYAAGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~------------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      ++||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            99999999999999997654                  489999999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||++........   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||...........
T Consensus       183 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  259 (313)
T 1t46_A          183 --ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (313)
T ss_dssp             --EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             --CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence              899999999875433322   2345678899999999877765 44999999999999999 9999988765554444


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ....    ....+....++..+.+||.+||..||.+|||+.+++++
T Consensus       260 ~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          260 MIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            3322    22222334689999999999999999999999999974

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.7e-48  Score=345.43  Aligned_cols=244  Identities=19%  Similarity=0.271  Sum_probs=204.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~i   75 (338)
                      +++|++.+.||+|+||+||++.+.  ++.||+|++....   ...+.+.+|+.++++++||||+++++++...  ..+++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            368999999999999999999985  8899999997643   2335688999999999999999999999887  78999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           76 VMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      ||||+++|+|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+||+++.++  .++|+|||++..  
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~--~~~l~~~~~~~~--  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM--TARISMADVKFS--  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS--CEEEEGGGSCCT--
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc--ceeEEeccceee--
Confidence            999999999999998765  4899999999999999999999999  99999999999997554  788988887653  


Q ss_pred             cCCCCCCccccCcccccccccCCccCCC--cchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGK--IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                        .......||+.|+|||++.+..+...  ++|||||||++|+|++|+.||............    .......+....+
T Consensus       163 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~  236 (271)
T 3kmu_A          163 --FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV----ALEGLRPTIPPGI  236 (271)
T ss_dssp             --TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH----HHSCCCCCCCTTC
T ss_pred             --ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH----HhcCCCCCCCCCC
Confidence              22345678999999999987655442  589999999999999999999876654333222    2222222223368


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++++.+||.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-49  Score=361.44  Aligned_cols=247  Identities=22%  Similarity=0.324  Sum_probs=200.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcE----EEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTREL----LAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||+||+|.+..+++.    ||+|.+....  .....+.+|+.+++.++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            6899999999999999999999888876    6777664432  23356778999999999999999999886 456899


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS--QVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS--CEEECSCSGGGGSCCCT
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC--eEEECCCCcccccCccc
Confidence            99999999999999764 5799999999999999999999999999999999999997554  89999999998543322


Q ss_pred             ---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                         ......||+.|+|||++.+..++. ++|||||||++|+|++ |..||............ ..  ......|.  .++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~--~~~~~~~~--~~~  243 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTH-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EK--GERLAQPQ--ICT  243 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-HT--TCBCCCCT--TBC
T ss_pred             ccccccCCCCcccccChHHhccCCCCh-hhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-Hc--CCCCCCCC--cCc
Confidence               223456888999999998777754 4999999999999999 99999876654332221 11  11222233  577


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .++.+||.+||..+|.+|||+.++++|
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            889999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.7e-49  Score=367.32  Aligned_cols=247  Identities=25%  Similarity=0.341  Sum_probs=205.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||+|+||.||++.+..+++.||||+++...  .....+.+|+.++++++||||+++++++...+.+|+||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            57999999999999999999999999999999987542  2224577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---C
Q 019628           80 AAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---Q  155 (338)
Q Consensus        80 ~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---~  155 (338)
                      +++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......   .
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC--cEEECcCCCceecCCCceeec
Confidence            99999999997654 599999999999999999999999999999999999997554  89999999987432211   1


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......... ..   +.. ....+....+++++.
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~-~~---~~~-~~~~~~~~~~~~~l~  345 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTR-EF---VEK-GGRLPCPELCPDAVF  345 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-HH---HHT-TCCCCCCTTCCHHHH
T ss_pred             CCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH---HHc-CCCCCCCCCCCHHHH
Confidence            122346778999999987777544 899999999999998 99999876543322 21   111 222333336889999


Q ss_pred             HHHHHhcccCCCcCCChhHHhc
Q 019628          235 HLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +||.+||+.+|++|||+.++++
T Consensus       346 ~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          346 RLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999976

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7e-49  Score=360.10  Aligned_cols=247  Identities=25%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||.||++.+.     .+++.||||+++...  .....+.+|+.+++.++||||+++++++...+.+|
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            58999999999999999999997     355899999997643  23457889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEE
Q 019628           75 IVMEYAAGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL  130 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~------------------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl  130 (338)
                      +||||+++++|.+++...                        ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            999999999999999763                        56899999999999999999999999999999999999


Q ss_pred             ecCCCCCcEEEeecCCCcccccC---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCCh
Q 019628          131 LDGSTAPRVKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDP  206 (338)
Q Consensus       131 ~~~~~~~~ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~  206 (338)
                      ++.++  .+||+|||+++.....   .......||+.|+|||++.+..++. ++|||||||++|+|++ |..||......
T Consensus       207 ~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~  283 (343)
T 1luf_A          207 VGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAHE  283 (343)
T ss_dssp             ECGGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ECCCC--eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc-ccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence            97554  8999999998743222   2233456899999999998777654 4999999999999999 99999876543


Q ss_pred             HHHHHHHhhHhhcc-ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          207 KNFRKTIGRILSVH-YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       207 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ....    .+.... ...|.  .++.++.+||.+||..+|.+|||+.+++++
T Consensus       284 ~~~~----~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          284 EVIY----YVRDGNILACPE--NCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHH----HHHTTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHH----HHhCCCcCCCCC--CCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            3222    222222 22333  688999999999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.9e-49  Score=362.81  Aligned_cols=253  Identities=20%  Similarity=0.231  Sum_probs=199.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC---CCcEEEEEEeecCcc------------ccHHHHHHHHHHhcCCCCCcceeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW---TRELLAVKFIERGQK------------IDEHVQREIMNHRSLKHPNIVRFKEV   66 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~------------~~~~~~~E~~~l~~l~h~~Iv~~~~~   66 (338)
                      ++|++.+.||+|+||+||+|.+..   ++..+|+|++.....            ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999987   788999999876432            12346678889999999999999999


Q ss_pred             EEc----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEe
Q 019628           67 LLT----PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKIC  142 (338)
Q Consensus        67 ~~~----~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~  142 (338)
                      +..    ...+|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+.+||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            988    78899999999 9999999988778999999999999999999999999999999999999986665589999


Q ss_pred             ecCCCcccccCCC--------CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHH
Q 019628          143 DFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-DPKNFRKTI  213 (338)
Q Consensus       143 Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~~~  213 (338)
                      |||+++.......        .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.... .........
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            9999975432211        1345799999999999887765 44999999999999999999996432 222222222


Q ss_pred             hhHhhccc----cCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          214 GRILSVHY----SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       214 ~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ........    .......+++++.+||.+||..+|++|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            22111100    00111268899999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3e-48  Score=349.74  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=203.5

Q ss_pred             CCceEeeeeccCCceEEEEEE----EcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcC--CeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTP--THL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~   73 (338)
                      ++|++++.||+|+||.||+|.    +..+++.||+|++....  .....+.+|+.+++.++||||+++++++...  ..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            469999999999999999999    57789999999987543  3346789999999999999999999999877  679


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           74 AIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccccccccC
Confidence            999999999999999954 45699999999999999999999999999999999999997554  899999999975433


Q ss_pred             CC----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCC-----------ChHHHHHHHhhHh
Q 019628          153 HS----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-----------DPKNFRKTIGRIL  217 (338)
Q Consensus       153 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-----------~~~~~~~~~~~~~  217 (338)
                      ..    ......||..|+|||++.+..++.+ +|||||||++|+|++|..|+....           ...........+.
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            32    2344568889999999988777544 899999999999999999864311           1111122222222


Q ss_pred             hccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          218 SVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                       .....+....+++++.+||.+||+.||.+|||+.++++
T Consensus       258 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          258 -EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             -ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence             22233334478999999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-48  Score=349.50  Aligned_cols=247  Identities=23%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC---CcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||.||+|.+..+   +..||+|++....  ...+.+.+|+.++++++||||+++++++. .+..|+|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            5899999999999999999998654   4579999887532  23456889999999999999999999984 5678999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCcccc
Confidence            99999999999998654 699999999999999999999999999999999999997554  899999999975433222


Q ss_pred             --CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          156 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                        .....+|+.|+|||++.+..++. ++|||||||++|+|++ |..||............    .... ..+....+++.
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~~~-~~~~~~~~~~~  245 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGE-RLPMPPNCPPT  245 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTC-CCCCCTTCCHH
T ss_pred             cccccCCCcccccChhhcccCCCCC-ccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----HcCC-CCCCCCCCCHH
Confidence              23345778999999998777654 4899999999999997 99999877655443322    2211 12223368999


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +.+||.+||..+|.+|||+.+++++
T Consensus       246 l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-48  Score=345.27  Aligned_cols=247  Identities=23%  Similarity=0.393  Sum_probs=208.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||.||++.+. +++.||+|++.......+.+.+|+.+++.++||||+++++++...+.+|+||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            58999999999999999999987 67889999998876666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC--CCCCC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--SQPKS  158 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~--~~~~~  158 (338)
                      +++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||++......  .....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG--CEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC--CEEEccccccccccccccccccc
Confidence            99999999765 4689999999999999999999999999999999999996554  8999999998754221  12334


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||...........    +... .........+..+.+|+
T Consensus       165 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----i~~~-~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTG-FRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTT-CCCCCCTTSCHHHHHHH
T ss_pred             ccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH----HhcC-CcCCCCccCcHHHHHHH
Confidence            5678899999999877765 45999999999999999 8999987654333222    2222 11122235789999999


Q ss_pred             HHhcccCCCcCCChhHHhcC
Q 019628          238 SRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~h  257 (338)
                      .+||..+|.+|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.6e-48  Score=346.83  Aligned_cols=245  Identities=25%  Similarity=0.358  Sum_probs=208.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc------------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT------------   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------------   69 (338)
                      .+|++++.||+|+||.||++.+..+++.||+|++....   ..+.+|+.+++.++||||+++++++..            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            47999999999999999999999999999999987653   456789999999999999999998864            


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEee
Q 019628           70 ----PTHLAIVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICD  143 (338)
Q Consensus        70 ----~~~~~iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~D  143 (338)
                          ...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~D  165 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGD  165 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC--CEEECc
Confidence                45589999999999999999754  5799999999999999999999999999999999999997554  899999


Q ss_pred             cCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC
Q 019628          144 FGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF  223 (338)
Q Consensus       144 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (338)
                      ||++.............||+.|+|||++.+..++.+ +|||||||++|+|++|..||...      ......+...  ..
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~--~~  236 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET------SKFFTDLRDG--II  236 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTT--CC
T ss_pred             chhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhcc--cc
Confidence            999986655555566789999999999988777554 89999999999999999887531      1112222221  12


Q ss_pred             CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +.  .++..+.+||.+||..||.+|||+.|+++|.+..+
T Consensus       237 ~~--~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          237 SD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cc--cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            22  57899999999999999999999999999988754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-48  Score=351.81  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=192.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhc--CCCCCcceeEEEEEc----CCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRS--LKHPNIVRFKEVLLT----PTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~----~~~~~i   75 (338)
                      ++|++++.||+|+||+||++.+  +++.||||++.....  ....+|.+++..  ++||||+++++++..    ...+|+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc--hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            5899999999999999999988  689999999876533  444555555554  899999999998654    356899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh--------hcCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ||||+++|+|.+++.. ..+++..+..++.||+.||.|||        ++||+||||||+|||++.++  .+||+|||++
T Consensus        84 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a  160 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA  160 (301)
T ss_dssp             EECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTC
T ss_pred             ehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--CEEEeeCCCe
Confidence            9999999999999954 57999999999999999999999        99999999999999997554  8999999998


Q ss_pred             cccccCC-----CCCCccccCcccccccccCCccC-----CCcchHHHHHHHHHHHHcC----------CCCCCCCCChH
Q 019628          148 KSSVLHS-----QPKSTVGTPAYIAPEVLTKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDPEDPK  207 (338)
Q Consensus       148 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~~lltg----------~~pf~~~~~~~  207 (338)
                      +......     ......||+.|+|||++.+....     +.++|||||||++|+|++|          ..||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            6433222     12345899999999999876322     2358999999999999999          88986543322


Q ss_pred             HHHHHHhhHhh---ccccCCC---cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          208 NFRKTIGRILS---VHYSFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       208 ~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ...........   .....|.   ....+.++.+||.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            11111111111   1112221   1124577999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.2e-48  Score=360.37  Aligned_cols=252  Identities=16%  Similarity=0.220  Sum_probs=198.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-----CcEEEEEEeecCcc------------ccHHHHHHHHHHhcCCCCCcceeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-----RELLAVKFIERGQK------------IDEHVQREIMNHRSLKHPNIVRFK   64 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~------------~~~~~~~E~~~l~~l~h~~Iv~~~   64 (338)
                      ++|++++.||+|+||+||+|.+..+     ++.||||++.....            ......+|+..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4899999999999999999998764     57899999876431            112344566677888999999999


Q ss_pred             EEEEcC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcE
Q 019628           65 EVLLTP----THLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV  139 (338)
Q Consensus        65 ~~~~~~----~~~~iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~i  139 (338)
                      +++...    ..+|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            998764    5689999999 99999999865 57999999999999999999999999999999999999984455689


Q ss_pred             EEeecCCCcccccCCC--------CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHH
Q 019628          140 KICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK  211 (338)
Q Consensus       140 kL~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~  211 (338)
                      ||+|||+++.......        .....||+.|+|||++.+..++ .++|||||||++|+|+||+.||...........
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            9999999975432211        1345599999999999887775 449999999999999999999986433322222


Q ss_pred             HHhhHhhccc------cCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          212 TIGRILSVHY------SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       212 ~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..........      .++ ...++.++.+|+.+||..+|.+|||+.++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2111110000      111 1367899999999999999999999999876

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6e-48  Score=349.31  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=196.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      +++|++.+.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            368999999999999999999999999999999987532    2335688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           77 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence            999999999999864    45699999999999999999999999999999999999997554  899999999875433


Q ss_pred             CC-CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          153 HS-QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       153 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                      .. ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||......  .......+....+.......++.
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCH
Confidence            22 2334679999999999988776544 89999999999999999999764322  12222233333222222246889


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ++.+||.+||..||.+|||+.+++++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999873

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.7e-48  Score=366.09  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=203.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-eEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-HLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-~~~iv~e~~   80 (338)
                      ++|++++.||+|+||.||++...  ++.||||+++... ..+.+.+|+.++++++||||+++++++.... .+|+||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            57999999999999999999985  7899999997654 4578999999999999999999999987665 799999999


Q ss_pred             CCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           81 AGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      ++|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....  ....
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~--~~~~  345 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS--TQDT  345 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS--CEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC--CEEEeeCCCcccccc--cccC
Confidence            99999999987554  79999999999999999999999999999999999997554  899999999984322  2233


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+++.|+|||++.+..++.+ +|||||||++|+|++ |..||............    .. ....+....+++++.+||
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~-~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EK-GYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----HT-TCCCCCCTTCCHHHHHHH
T ss_pred             CCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCcCCHHHHHHH
Confidence            467889999999988877655 999999999999998 99999876654433322    11 122233347899999999


Q ss_pred             HHhcccCCCcCCChhHHhc
Q 019628          238 SRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~  256 (338)
                      .+||..||.+|||+.++++
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-48  Score=355.85  Aligned_cols=247  Identities=20%  Similarity=0.336  Sum_probs=197.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEE----EEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELL----AVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~v----aiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||+||+|.+..+++.+    |+|.+....  ...+.+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            58999999999999999999998777654    777765432  34467899999999999999999999998765 788


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +++++.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTHHHHHTTTC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC--CEEEccCcceeEccCCc
Confidence            9999999999999976 45699999999999999999999999999999999999997554  89999999987543322


Q ss_pred             C---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 Q---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .   .....||+.|+|||++.+..++. ++|||||||++|+|++ |..||......... ..+.    .....+.....+
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~----~~~~~~~~~~~~  245 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE----KGERLPQPPICT  245 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHH----TTCCCCCCTTBC
T ss_pred             ccccccCCCccccccChHHhccCCCCc-hhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHH----cCCCCCCCccCC
Confidence            2   22345688999999998877754 4999999999999999 99999876654332 2221    112223334688


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .++.+|+.+||+.+|.+|||+.+++++
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          246 IDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-48  Score=349.89  Aligned_cols=238  Identities=34%  Similarity=0.594  Sum_probs=192.0

Q ss_pred             CCCceEe-eeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHH-hcCCCCCcceeEEEEEc----CCeEE
Q 019628            1 MERYEIV-KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHPNIVRFKEVLLT----PTHLA   74 (338)
Q Consensus         1 ~~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~----~~~~~   74 (338)
                      +++|.++ +.||+|+||.||++.+..+++.||+|++...    ....+|+.++ +.++||||+++++++..    ...+|
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3678888 7899999999999999999999999998653    5677888887 66799999999999987    67899


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccc
Q 019628           75 IVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSV  151 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~  151 (338)
                      +||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            9999999999999998754  699999999999999999999999999999999999997632 4589999999886321


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccC
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRV  229 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  229 (338)
                                           +..++ .++|||||||++|+|++|+.||...............+......++  .+..+
T Consensus       172 ---------------------~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (299)
T 3m2w_A          172 ---------------------GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  229 (299)
T ss_dssp             ---------------------TCGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred             ---------------------cccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence                                 12343 4489999999999999999999765432221111122222222232  12468


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ++++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus       230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            99999999999999999999999999999997543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-48  Score=374.00  Aligned_cols=247  Identities=21%  Similarity=0.306  Sum_probs=211.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||++.+..++..||||+++......+.+.+|+.++++++||||+++++++.....+|+||||++
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            46899999999999999999999889999999998776667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CCC
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QPK  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~~  157 (338)
                      +|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++......  ...
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEECCTTCCEECCT
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC--cEEEeecccceeccCCceeecC
Confidence            99999999863  4589999999999999999999999999999999999996554  89999999998543221  223


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+++.|+|||++.+..++.+ +|||||||++|+|++ |..||............     ...+..+....+++.+.+|
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKDYRMERPEGCPEKVYEL  451 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----HTTCCCCCCTTCCHHHHHH
T ss_pred             CCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCCCCHHHHHH
Confidence            4456788999999988777555 899999999999999 99999886654333222     1122333334789999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      |.+||+.+|.+|||+.++++
T Consensus       452 i~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=360.26  Aligned_cols=249  Identities=14%  Similarity=0.182  Sum_probs=203.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC--------CcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcce-----------
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT--------RELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVR-----------   62 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~-----------   62 (338)
                      ++|++.+.||+|+||.||+|.+..+        ++.||+|++...    ..+.+|+.++++++||||++           
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            5899999999999999999999874        889999998765    46789999999999999887           


Q ss_pred             ----eEEEEEc-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           63 ----FKEVLLT-PTHLAIVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        63 ----~~~~~~~-~~~~~iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                          +++++.. .+.+|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence                6777765 68899999999 99999999875  6899999999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccCC--------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCC-Ch
Q 019628          136 APRVKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-DP  206 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~  206 (338)
                      ...+||+|||+++......        ......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.... ..
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~  275 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR-RSDLQSLGYCMLKWLYGFLPWTNCLPNT  275 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence            3379999999997543221        123457999999999998877654 4999999999999999999998764 33


Q ss_pred             HHHHHHHhhHhhccccCC----CcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          207 KNFRKTIGRILSVHYSFP----DYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ................++    .+..+++++.+||.+||..||.+|||+.++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            333333333332222221    22357999999999999999999999999987

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-48  Score=354.09  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=194.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHh--cCCCCCcceeEEEEEcC----CeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR--SLKHPNIVRFKEVLLTP----THLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~--~l~h~~Iv~~~~~~~~~----~~~~i   75 (338)
                      ++|++++.||+|+||.||++.+.  ++.||||++.....  ....+|.+++.  .++||||+++++++...    ..+|+
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            47999999999999999999985  89999999876543  33444444444  45999999999999887    78999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc--------CceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ||||+++|+|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||++.++  .+||+|||++
T Consensus       113 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~a  189 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLA  189 (337)
T ss_dssp             EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTC
T ss_pred             EEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--CEEEEeCCCc
Confidence            99999999999999654 799999999999999999999998        999999999999997554  8999999999


Q ss_pred             cccccCCC-----CCCccccCcccccccccCCccCCC-----cchHHHHHHHHHHHHcC----------CCCCCCCCChH
Q 019628          148 KSSVLHSQ-----PKSTVGTPAYIAPEVLTKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDPEDPK  207 (338)
Q Consensus       148 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwSlG~il~~lltg----------~~pf~~~~~~~  207 (338)
                      +.......     .....||+.|+|||++.+..+...     ++|||||||++|+|++|          +.||.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            64432221     235679999999999987665433     37999999999999999          77776543222


Q ss_pred             HHHHHHhh-H--hhccccCCC---cccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          208 NFRKTIGR-I--LSVHYSFPD---YVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       208 ~~~~~~~~-~--~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ........ .  ......+|.   ...+++++.+||.+||+.||.+|||+.++++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            11111111 1  111222222   11456779999999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.9e-49  Score=358.40  Aligned_cols=254  Identities=21%  Similarity=0.229  Sum_probs=203.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||+||++.+. +++.||||++.... ...+.+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            68999999999999999999975 68899999887643 33467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---
Q 019628           81 AGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---  153 (338)
Q Consensus        81 ~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---  153 (338)
                      ++++|.+++....    .+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++.....   
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSSSSCC
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccccccc
Confidence            9999999886543    589999999999999999999999999999999999997554  8999999998753322   


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHH--HHH-HhhHhhccc------cC-
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNF--RKT-IGRILSVHY------SF-  223 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~--~~~-~~~~~~~~~------~~-  223 (338)
                      .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........  ... .........      .. 
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             ccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence            12234569999999999987777555 89999999999999999999764432111  110 000011100      00 


Q ss_pred             -CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          224 -PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       224 -~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                       ......+..+.+++.+||+.||++|||+.|+++|..
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence             011234567899999999999999999999998643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.1e-48  Score=368.16  Aligned_cols=245  Identities=23%  Similarity=0.370  Sum_probs=206.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||++... ++..||||+++......+.+.+|+.++++++||||+++++++. .+.+|+||||++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            57999999999999999999986 4678999999877666788999999999999999999999986 567899999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC--CCCC
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--SQPK  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~--~~~~  157 (338)
                      +|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++.....  ....
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCCHHHHTTC
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCCCceeccC
Confidence            99999999754  3689999999999999999999999999999999999997554  8999999999854321  1223


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+|+.|+|||++....++. ++|||||||++|+|+| |+.||............    .. .+..+....+++++.+|
T Consensus       344 ~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~-~~~~~~~~~~~~~l~~l  417 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ER-GYRMPRPENCPEELYNI  417 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HH-TCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHHHhccCCCCc-HHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCHHHHHH
Confidence            445778899999998777754 4999999999999999 99999876654333222    21 23344444789999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      |.+||..||++|||+.++++
T Consensus       418 i~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          418 MMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHH
Confidence            99999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.2e-48  Score=367.47  Aligned_cols=249  Identities=27%  Similarity=0.344  Sum_probs=191.8

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      .|.+.+.||+|+||+||.+ ...+|+.||||++....  ...+.+|+.+++.+ +||||+++++++.+.+.+|+||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            4667789999999999875 44579999999987543  35678899999876 89999999999999999999999995


Q ss_pred             CCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-----------CCCcEEEee
Q 019628           82 GGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-----------TAPRVKICD  143 (338)
Q Consensus        82 ~~~L~~~i~~~~~l-------~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-----------~~~~ikL~D  143 (338)
                       |+|.+++......       ++..+..++.||+.||.|||++||+||||||+|||++..           ....+||+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence             6999999865433       233457899999999999999999999999999999643           234799999


Q ss_pred             cCCCcccccCC-----CCCCccccCcccccccccC-------CccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHH
Q 019628          144 FGYSKSSVLHS-----QPKSTVGTPAYIAPEVLTK-------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFR  210 (338)
Q Consensus       144 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~  210 (338)
                      ||+++......     .....+||+.|+|||++.+       ..+ +.++|||||||++|+|++ |..||.......  .
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~  248 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--S  248 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--H
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhhHhHHHHHHHHHhCCCCCCCCchhhH--H
Confidence            99998543322     1234579999999999965       334 455999999999999999 999997654322  1


Q ss_pred             HHHhhHhhccccCCC-----cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          211 KTIGRILSVHYSFPD-----YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       211 ~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .    +......++.     ...+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       249 ~----i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          249 N----IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             H----HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             H----HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            1    2222222222     1234678999999999999999999999999999953

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=368.91  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=194.0

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      +|.+.+.||+|+||+|+. ....+++.||||++.....  ..+.+|+.+++.+ +|||||++++++.+.+.+|+||||+.
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            589999999999999763 4455889999999875432  3456899999999 79999999999999999999999996


Q ss_pred             CCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC---CCCCcEEEeecCCCcccccC----
Q 019628           82 GGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG---STAPRVKICDFGYSKSSVLH----  153 (338)
Q Consensus        82 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~---~~~~~ikL~Dfg~a~~~~~~----  153 (338)
                       |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.   .+...+||+|||+|+.....    
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~  180 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF  180 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence             59999997654 4566678899999999999999999999999999999953   22336889999999754432    


Q ss_pred             CCCCCccccCcccccccccC---CccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcccc-CCCccc
Q 019628          154 SQPKSTVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS-FPDYVR  228 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  228 (338)
                      ......+||+.|+|||++.+   ..+ +.++|||||||++|+|++ |..||....... .....   ...... ......
T Consensus       181 ~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~---~~~~~~~~~~~~~  255 (432)
T 3p23_A          181 SRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILL---GACSLDCLHPEKH  255 (432)
T ss_dssp             -----CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHT---TCCCCTTSCTTCH
T ss_pred             eeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHh---ccCCccccCcccc
Confidence            22345679999999999974   333 445899999999999999 999997544322 11111   111111 111123


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            4566899999999999999999999999999953

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=352.54  Aligned_cols=250  Identities=25%  Similarity=0.401  Sum_probs=200.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEE----cCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLL----TPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~----~~~~~~iv   76 (338)
                      ++|++++.||+|+||.||++.+..+++.||||++.... ...+.+.+|+.+++.++||||+++++++.    .....|+|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            57999999999999999999999999999999986543 33467889999999999999999999987    34578999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           77 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACI  186 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCSSCEESCE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--CEEEEecCcchhccc
Confidence            999999999999975    46799999999999999999999999999999999999996554  899999998874321


Q ss_pred             CCCC----------CCccccCcccccccccCCcc--CCCcchHHHHHHHHHHHHcCCCCCCCCCCh-HHHHHHHhhHhhc
Q 019628          153 HSQP----------KSTVGTPAYIAPEVLTKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEDP-KNFRKTIGRILSV  219 (338)
Q Consensus       153 ~~~~----------~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~  219 (338)
                      ....          ....||+.|+|||++.+...  .+.++|||||||++|+|++|+.||...... .....    ....
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~  262 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AVQN  262 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HHHC
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----Hhhc
Confidence            1111          12357999999999875431  234599999999999999999999531100 01111    1122


Q ss_pred             cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ...+|....++.++.+||.+||+.||.+|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            33445555789999999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.1e-48  Score=353.99  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=205.5

Q ss_pred             CCceEeeeeccCCceEEEEEE----EcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEE--cCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLL--TPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--~~~~~~   74 (338)
                      ++|++++.||+|+||.||+|.    +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.  ....+|
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            589999999999999999999    56789999999987653 23356889999999999999999999987  456799


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           75 IVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      +||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCGGGCEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC--CEEEcccccceecccC
Confidence            99999999999999976 44699999999999999999999999999999999999997554  8999999999754322


Q ss_pred             C----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh-----------HHHHHHHhhHhh
Q 019628          154 S----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----------KNFRKTIGRILS  218 (338)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-----------~~~~~~~~~~~~  218 (338)
                      .    ......||+.|+|||++.+..++. ++|||||||++|+|++|..||......           ......... ..
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  258 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSR-QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL-LE  258 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH-HH
T ss_pred             CccceeeccCCccccccCHHHhccCCCCh-HHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH-hh
Confidence            2    233456888999999998777654 489999999999999999998643211           011111111 12


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      .....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222333344789999999999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.6e-48  Score=345.87  Aligned_cols=247  Identities=25%  Similarity=0.393  Sum_probs=191.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++.+.||+|+||+||++.+.   ..+|+|+++....   ..+.+.+|+.++++++||||+++++++ ....+++|||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            58999999999999999999864   3599999875432   235688999999999999999999965 5567899999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc---CC
Q 019628           79 YAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---HS  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~---~~  154 (338)
                      |+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++....   ..
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC------------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccccccccccc
Confidence            9999999999964 45699999999999999999999999999999999999997654  899999999874332   22


Q ss_pred             CCCCccccCccccccccc---CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC-CcccCC
Q 019628          155 QPKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP-DYVRVS  230 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  230 (338)
                      ......||+.|+|||++.   +..+ +.++|||||||++|+|++|+.||.................. ...++ ....++
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  255 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL-SPDLSKVRSNCP  255 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC-CCCTTSSCTTSC
T ss_pred             cccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc-CcchhhccccCC
Confidence            234467999999999986   3344 34589999999999999999999887765554444332111 11111 123678


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+.+||.+||..+|.+|||+.++++
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-47  Score=342.02  Aligned_cols=245  Identities=22%  Similarity=0.349  Sum_probs=204.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||.||++.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++.. +..++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            58999999999999999999976 56789999998776666789999999999999999999998864 56899999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CCC
Q 019628           82 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QPK  157 (338)
Q Consensus        82 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~~  157 (338)
                      +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.+.  .+||+|||++.......  ...
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNEYTARE  168 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSCEECCT
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC--CEEECCCcccccccCccccccc
Confidence            999999997543  699999999999999999999999999999999999997554  89999999997543322  223


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||............    ... ...+....++.++.+|
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~l~~l  242 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERG-YRMVRPDNCPEELYQL  242 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTT-CCCCCCTTCCHHHHHH
T ss_pred             CCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH----hcc-cCCCCcccccHHHHHH
Confidence            4557889999999987776544 899999999999999 99999876654333222    211 2222233689999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+||..+|++|||+.++++
T Consensus       243 i~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          243 MRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHH
Confidence            99999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3e-48  Score=351.80  Aligned_cols=249  Identities=23%  Similarity=0.377  Sum_probs=205.8

Q ss_pred             CCceEeeeeccCCceEEEEEEE-----cCCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC-e
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRD-----KWTRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT-H   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~-~   72 (338)
                      ++|++++.||+|+||+||+|.+     ..+++.||||++.....  ....+.+|+.+++++ +||||+++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     45678999999976432  235688999999999 6899999999987754 5


Q ss_pred             EEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC
Q 019628           73 LAIVMEYAAGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA  136 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~----------------l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~  136 (338)
                      +++||||+++++|.+++.....                +++..++.++.||+.||.|||++||+||||||+||+++.++ 
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-  185 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-  185 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-
Confidence            9999999999999999987554                89999999999999999999999999999999999996544 


Q ss_pred             CcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHH
Q 019628          137 PRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKT  212 (338)
Q Consensus       137 ~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~  212 (338)
                       .+||+|||+++.......   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||............
T Consensus       186 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  263 (316)
T 2xir_A          186 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  263 (316)
T ss_dssp             -CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             -CEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence             899999999875433221   2345688899999999877765 44999999999999998 99999876654443333


Q ss_pred             HhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          213 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +..  ......+  ..+++.+.++|.+||..+|.+|||+.++++|
T Consensus       264 ~~~--~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          264 LKE--GTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHH--TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcc--CccCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222  1122233  3588999999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.5e-48  Score=352.23  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-------CCCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-------WTRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      ++|++.+.||+|+||.||+|.+.       .++..||+|++....  .....+.+|+.+++++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            68999999999999999999985       456789999987643  2335688999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      .+|+||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            9999999999999999998654                389999999999999999999999999999999999997554


Q ss_pred             CCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.......... 
T Consensus       195 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~-  270 (334)
T 2pvf_A          195 --VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-  270 (334)
T ss_dssp             --CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-
T ss_pred             --CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH-
Confidence              89999999997543322   2334567889999999987776544 899999999999999 999998765433222 


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                         .+.... ..+....++.++.+||.+||..+|.+|||+.+++++
T Consensus       271 ---~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          271 ---LLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             ---HHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               222211 122223689999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.4e-48  Score=354.80  Aligned_cols=255  Identities=19%  Similarity=0.270  Sum_probs=205.2

Q ss_pred             CCceEeeeeccCCceEEEEEE-----EcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVR-----DKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||.||++.     +..+++.||||++....  .....+.+|+.++++++||||+++++++......|
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            589999999999999999999     55678899999986532  33456889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCC
Q 019628           75 IVMEYAAGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGY  146 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~-------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~  146 (338)
                      +||||+++++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            9999999999999998653       489999999999999999999999999999999999997433 33699999998


Q ss_pred             CcccccC---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcccc
Q 019628          147 SKSSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYS  222 (338)
Q Consensus       147 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (338)
                      +......   .......||+.|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+.... .
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~~-~  263 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTSGG-R  263 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTTC-C
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH----HHhcCC-C
Confidence            8643222   2223456889999999998777654 4999999999999998 999998765433222    222221 1


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      .+....++..+.+||.+||..+|.+|||+.++++|.|+..
T Consensus       264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            1222368899999999999999999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.4e-48  Score=360.25  Aligned_cols=247  Identities=22%  Similarity=0.363  Sum_probs=195.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||.||++.+.   .++..||||+++...  .....+.+|+.++++++||||+++++++...+.+|+|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47999999999999999999986   467789999987643  2345688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++.......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--VCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC--CEEECcCccccccccCCc
Confidence            99999999999997654 699999999999999999999999999999999999997554  899999999975433221


Q ss_pred             ----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          156 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                          .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||...........    +. .....+....++
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~----i~-~~~~~~~~~~~~  276 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA----VD-EGYRLPPPMDCP  276 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH----HH-TTEECCCCTTCB
T ss_pred             cceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCcccc
Confidence                122345778999999987777544 899999999999998 9999987654332222    22 223334444788


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..+.+|+.+||+.+|.+|||+.++++
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            99999999999999999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.6e-48  Score=352.99  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=207.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc-----EEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE-----LLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||.||+|.+..+++     .||+|++....  .....+.+|+.+++.+ +||||+++++++...+.+
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            579999999999999999999976654     79999987643  2345688999999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcE
Q 019628           74 AIVMEYAAGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV  139 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~--------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~i  139 (338)
                      |+||||+++|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~  203 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--VA  203 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--EE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--eE
Confidence            9999999999999999753              3589999999999999999999999999999999999997554  89


Q ss_pred             EEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhh
Q 019628          140 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGR  215 (338)
Q Consensus       140 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~  215 (338)
                      ||+|||+++.......   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||...............
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  282 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD  282 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence            9999999975433221   2345678899999999877765 44999999999999998 99999876655444433322


Q ss_pred             HhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          216 ILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                          ....+.....+..+.+||.+||+.+|.+|||+.+++++
T Consensus       283 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          283 ----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence                22223333578999999999999999999999999873

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=343.64  Aligned_cols=249  Identities=25%  Similarity=0.384  Sum_probs=204.3

Q ss_pred             CCceEee-eeccCCceEEEEEEEc--CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVK-DIGSGNFGVAKLVRDK--WTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~-~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|.+.+ .||+|+||.||++.+.  .++..||+|++....  ...+.+.+|+.+++.++||||+++++++ ..+.+++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            5688887 9999999999999864  467889999997643  3346788999999999999999999999 45669999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++....... 
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeeeccCcc
Confidence            9999999999999643 4699999999999999999999999999999999999997554  89999999997543221 


Q ss_pred             ---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                         ......||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||..............   .....+|  ..++
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---~~~~~~~--~~~~  239 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECP--PECP  239 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TCCCCCC--TTCC
T ss_pred             eeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---CCcCCCC--CCcC
Confidence               1233457889999999987776544 899999999999998 9999988765443322211   1122233  3689


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                      +++.+||.+||..+|.+|||+.++++|.+
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99999999999999999999999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.2e-48  Score=350.95  Aligned_cols=248  Identities=19%  Similarity=0.282  Sum_probs=205.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            57999999999999999999876     3578899999876432  2346889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           75 IVMEYAAGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                      +||||+++++|.+++...          ..+++..+..++.||+.||.|||++||+||||||+||+++.++  .+||+||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~kl~Df  182 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  182 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC--eEEECcC
Confidence            999999999999999753          3579999999999999999999999999999999999997554  8999999


Q ss_pred             CCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcc
Q 019628          145 GYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVH  220 (338)
Q Consensus       145 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (338)
                      |+++......   ......||+.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +....
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~  257 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEGG  257 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTTC
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccCCCCc-hhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH----HHcCC
Confidence            9997543322   123446788999999998777654 4899999999999999 8999987654333222    22221


Q ss_pred             ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          221 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      . .+....++..+.+||.+||..+|.+|||+.++++|
T Consensus       258 ~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1 12223689999999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-47  Score=343.87  Aligned_cols=245  Identities=23%  Similarity=0.330  Sum_probs=200.8

Q ss_pred             CCceEee-eeccCCceEEEEEE--EcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVK-DIGSGNFGVAKLVR--DKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~-~LG~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++.+ .||+|+||+||++.  +..+++.||||++.....   ..+.+.+|+.+++.++||||+++++++ ..+.+|+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4799998 99999999999994  456788999999876432   245788999999999999999999998 5667899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++........
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCS
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceeeccCCC
Confidence            999999999999999888899999999999999999999999999999999999997554  899999999875432221


Q ss_pred             ----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccC
Q 019628          156 ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRV  229 (338)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  229 (338)
                          .....+|+.|+|||++.+..++. ++|||||||++|+|++ |+.||...........    +... ....+  ..+
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~  245 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----LEKGERMGCP--AGC  245 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTTCCCCCC--TTC
T ss_pred             cccccccCCCCceeeChHHhccCCCCh-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCCCCC--CCC
Confidence                22344678899999998777654 4899999999999999 9999987654332222    2221 22233  368


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++.+.++|.+||..||.+|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-47  Score=342.89  Aligned_cols=248  Identities=22%  Similarity=0.240  Sum_probs=201.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEE-EcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVL-LTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||.||++.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            689999999999999999999999999999999876543 35688999999999988866655544 6677899999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC-CCCCcEEEeecCCCcccccCCC---
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQ---  155 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~-~~~~~ikL~Dfg~a~~~~~~~~---  155 (338)
                       +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ...+.+||+|||+++.......   
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence             8999999973 457999999999999999999999999999999999999941 1233799999999975433222   


Q ss_pred             -----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhhHhhccccCC---
Q 019628          156 -----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP---KNFRKTIGRILSVHYSFP---  224 (338)
Q Consensus       156 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~---  224 (338)
                           .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||......   ..+......    ....+   
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~  241 (296)
T 3uzp_A          167 IPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KMSTPIEV  241 (296)
T ss_dssp             CCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HHHSCHHH
T ss_pred             cccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----ccCCchHH
Confidence                 2456799999999999887765 4499999999999999999999864432   222222221    11111   


Q ss_pred             CcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          225 DYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....+++++.+|+.+||+.+|.+|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            11358899999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.7e-49  Score=384.01  Aligned_cols=301  Identities=25%  Similarity=0.311  Sum_probs=227.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEc------CCe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLT------PTH   72 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~~   72 (338)
                      +++|++.+.||+|+||+||++.+..+|+.||||++....  .....+.+|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999999999999999987542  234568899999999999999999998765      677


Q ss_pred             EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC-CcEEEeecCCCc
Q 019628           73 LAIVMEYAAGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA-PRVKICDFGYSK  148 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~-~~ikL~Dfg~a~  148 (338)
                      .|+||||++|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+||+++.++. ..+||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999999998654   5899999999999999999999999999999999999975542 248999999998


Q ss_pred             ccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH----------hhHhh
Q 019628          149 SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI----------GRILS  218 (338)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~----------~~~~~  218 (338)
                      ............||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+....          .....
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             ccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            7665555667789999999999988877655 899999999999999999997643221110000          00011


Q ss_pred             ccccCCC--------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCC---cc----cccCCCcccCCCCCCC
Q 019628          219 VHYSFPD--------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP---IE----LTEGGSWQSHDVNNPS  283 (338)
Q Consensus       219 ~~~~~~~--------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~---~~----~~~~~~~~~~~~~~~~  283 (338)
                      ....++.        ...+++.+.+||.+||..||.+|||+.++++||||..-..   ..    +.............+.
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~kil~~f~~~~~~~~~~~i~~~  331 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTEN  331 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCEEECCCSSSSCCCEEECCTT
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccccccccccccccceeecCCC
Confidence            1111111        1135688999999999999999999999999999954211   00    0001111111223477


Q ss_pred             CCHHHHHHHhHhhCCCCCC
Q 019628          284 QSLEEVLSLIHEATKPLEA  302 (338)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~  302 (338)
                      .++..+..++.+.+.-.+.
T Consensus       332 ~tl~~l~~~i~~~T~i~~~  350 (676)
T 3qa8_A          332 ENLQNLKSWLQQDTGIPEE  350 (676)
T ss_dssp             CCHHHHHHHHHTTSCCCST
T ss_pred             ccHHHHHHHHHHHhCCCHH
Confidence            8899999999988765443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=347.81  Aligned_cols=246  Identities=20%  Similarity=0.335  Sum_probs=197.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEE----EEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELL----AVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||+||+|.+..+++.+    |+|.+...  ......+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            68999999999999999999998888765    66655432  234467899999999999999999999998765 788


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +++++.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTC--------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC--CEEEccCcceeEccCcc
Confidence            9999999999999976 45699999999999999999999999999999999999997554  89999999997543322


Q ss_pred             C---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 Q---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .   .....+|+.|+|||++.+..++. ++|||||||++|+|++ |..||........... +.    .....+....++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~----~~~~~~~~~~~~  245 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LE----KGERLPQPPICT  245 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HH----TTCCCCCCTTBC
T ss_pred             ccccccCCCccccccCHHHHcCCCCCh-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HH----cCCCCCCCccCC
Confidence            2   22345678899999998877754 4999999999999999 9999987665443222 11    122233334688


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .++.+||.+||..+|.+|||+.|+++
T Consensus       246 ~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          246 IDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.1e-47  Score=342.91  Aligned_cols=249  Identities=23%  Similarity=0.237  Sum_probs=198.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEE-EcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVL-LTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-~~~~~~~iv~e~~   80 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            589999999999999999999999999999998765432 34578899999999988877665554 6678899999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEe---cCCCCCcEEEeecCCCcccccCC--
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLL---DGSTAPRVKICDFGYSKSSVLHS--  154 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~---~~~~~~~ikL~Dfg~a~~~~~~~--  154 (338)
                       +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.+  +.+||+|||+++......  
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~--~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG--NLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT--TCEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC--CeEEEecCccceeccCcccC
Confidence             8999999974 4579999999999999999999999999999999999999   433  379999999997543322  


Q ss_pred             ------CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC---
Q 019628          155 ------QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD---  225 (338)
Q Consensus       155 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  225 (338)
                            ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......... ....+.......+.   
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  242 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMSTPIEVL  242 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHHHSCHHHH
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhh-hhhhhhcccccchhhhh
Confidence                  22356799999999999887765 44899999999999999999998654321111 11111111112221   


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ...+++++.+||.+||+.+|++|||+.++++
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            1357899999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.5e-47  Score=345.76  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=195.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC---CCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCC----
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW---TRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPT----   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----   71 (338)
                      ++|++.+.||+|+||.||+|....   ++..||+|++.....   ....+.+|+.++++++||||+++++++....    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            579999999999999999998765   456899999875432   2356889999999999999999999998765    


Q ss_pred             -eEEEEEeccCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           72 -HLAIVMEYAAGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        72 -~~~iv~e~~~~~~L~~~i~------~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                       ..++||||+++++|.+++.      ....+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kl~Df  191 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--TVCVADF  191 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS--CEEECSC
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEEeec
Confidence             3599999999999999984      335699999999999999999999999999999999999997554  8999999


Q ss_pred             CCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhcc
Q 019628          145 GYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVH  220 (338)
Q Consensus       145 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (338)
                      |+++......   ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..............   ...
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---~~~  267 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH---GHR  267 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCC
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc---CCC
Confidence            9997543322   2234457889999999988776544 899999999999999 9999987765544333221   112


Q ss_pred             ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          221 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ...  ...+++.+.+||.+||..+|.+|||+.+++++
T Consensus       268 ~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 LKQ--PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCC--BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCC--CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222  23688999999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-47  Score=340.96  Aligned_cols=243  Identities=23%  Similarity=0.368  Sum_probs=195.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcC-CeEEEEEec
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP-THLAIVMEY   79 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-~~~~iv~e~   79 (338)
                      +++|++++.||+|+||+||++.+.  |+.||+|++.... ..+.+.+|+.++++++||||+++++++... +.+|+||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            368999999999999999999884  8899999987543 456788999999999999999999987654 478999999


Q ss_pred             cCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           80 AAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      +++++|.+++.....  +++..+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||++.....  ...
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~--~~~  172 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS--TQD  172 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeeccccccccc--ccc
Confidence            999999999976543  89999999999999999999999999999999999997554  899999999874332  233


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+++.|+|||++.+..++. ++|||||||++|+|++ |..||............    ... ...+....+++.+.++
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKG-YKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----TTT-CCCCCCTTCCHHHHHH
T ss_pred             CCCccccccCHHHhCCCCCCc-hhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hcC-CCCCCcccCCHHHHHH
Confidence            456889999999998777654 4899999999999998 99999876554333222    111 1222234689999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      |.+||..+|.+|||+.++++
T Consensus       247 i~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-47  Score=341.47  Aligned_cols=247  Identities=21%  Similarity=0.259  Sum_probs=200.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC---CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW---TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||+||++.+..   ++..||+|++....  ...+.+.+|+.+++.++||||+++++++..+ ..|+|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence            589999999999999999998653   34569999987642  2346788999999999999999999998654 56899


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           77 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      |||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++  .+||+|||++....... 
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC-----
T ss_pred             EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCcccccccc
Confidence            99999999999997654 599999999999999999999999999999999999997554  89999999987543322 


Q ss_pred             -CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          155 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                       ......+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||............    ... ...+....+++.
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~  242 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL----EKG-DRLPKPDLCPPV  242 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH----HHT-CCCCCCTTCCHH
T ss_pred             cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH----hcC-CCCCCCCCCCHH
Confidence             22345578899999999877765 44899999999999998 99999876554433222    111 122233368899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +.+||.+||..+|++|||+.+++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-47  Score=348.37  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC----cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR----ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+|++.+.||+|+||.||+|.+..++    ..||+|++....  .....+.+|+.++++++||||+++++++...+.+++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            57999999999999999999986543    459999987643  223468899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC--------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhcccc
Confidence            99999999999999764 5799999999999999999999999999999999999997554  89999999997543221


Q ss_pred             C----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          155 Q----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                      .    .....+|+.|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+.. ....+....+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~~~-~~~~~~~~~~  275 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AIND-GFRLPTPMDC  275 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHT-TCCCCCCTTC
T ss_pred             ccccccCCCCccccccCchhcccCCCCc-hhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHHC-CCcCCCcccC
Confidence            1    12234678899999998777754 4899999999999999 999998765433222    2222 1233334478


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +..+.+||.+||+.+|.+|||+.+++++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-47  Score=343.92  Aligned_cols=244  Identities=28%  Similarity=0.452  Sum_probs=194.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||+||++.+.  ++.||+|++... ...+.+.+|+.++++++||||+++++++.+  ..|+||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            58999999999999999999985  788999998653 334678899999999999999999998764  4789999999


Q ss_pred             CCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhh---cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           82 GGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS---MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        82 ~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~LH~---~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      +++|.+++.....   +++..+..++.|++.||.|||+   +||+||||||+|||++.++. .+||+|||++.....  .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~--~  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT--H  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC---------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc--c
Confidence            9999999986553   7899999999999999999999   89999999999999975542 489999999874322  2


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  ........ ....+....++..+.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHN-GTRPPLIKNLPKPIES  235 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHT-TCCCCCBTTCCHHHHH
T ss_pred             cccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhc-CCCCCcccccCHHHHH
Confidence            344579999999999988777555 8999999999999999999986544321  11111111 1122223468999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcC
Q 019628          236 LLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ||.+||+.+|.+|||+.+++++
T Consensus       236 li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999873

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=348.86  Aligned_cols=246  Identities=26%  Similarity=0.423  Sum_probs=184.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCC-CCCcceeEEEEE--------cCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLK-HPNIVRFKEVLL--------TPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~--------~~~   71 (338)
                      .+|++.+.||+|+||.||++.+..+++.||||++.... .....+.+|+.+++++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            37999999999999999999999999999999886543 33456889999999996 999999999984        345


Q ss_pred             eEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           72 HLAIVMEYAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                      .++++|||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++  .+||+|||+
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS--CEEBCCCTT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC--CEEEecCcc
Confidence            6899999995 689888864   456999999999999999999999999  99999999999997554  899999999


Q ss_pred             CcccccCCC-------------CCCccccCccccccccc---CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHH
Q 019628          147 SKSSVLHSQ-------------PKSTVGTPAYIAPEVLT---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFR  210 (338)
Q Consensus       147 a~~~~~~~~-------------~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~  210 (338)
                      ++.......             .....||+.|+|||++.   +..+ +.++|||||||++|+|++|+.||.......   
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~---  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR---  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence            975433211             12456999999999983   4444 445999999999999999999997643321   


Q ss_pred             HHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          211 KTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                           +.......+.....+..+.+||.+||+.+|.+|||+.|+++|-+
T Consensus       261 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          261 -----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             -----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                 22223334444567888999999999999999999999999754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-47  Score=339.19  Aligned_cols=247  Identities=24%  Similarity=0.325  Sum_probs=199.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCc---EEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeE-EEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRE---LLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHL-AIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~-~iv   76 (338)
                      +|++.+.||+|+||+||+|.+..+++   .+|+|++.....  ..+.+.+|+.+++.++||||+++++++...+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46778999999999999999765544   799999876432  335688999999999999999999999876655 999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc---
Q 019628           77 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL---  152 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~---  152 (338)
                      |||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||+++....   
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--TVKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEeCcCCCcccccCCcc
Confidence            999999999999976 45689999999999999999999999999999999999997554  899999999974322   


Q ss_pred             --CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          153 --HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       153 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                        ........+|+.|+|||.+.+..++. ++|||||||++|+|++|..||............+..    ....+....++
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  254 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTT-KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----GRRLPQPEYCP  254 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT----TCCCCCCTTCC
T ss_pred             cccccCcCCCCCccccChhhhccCCCCh-hhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc----CCCCCCCccch
Confidence              12234567889999999998877754 489999999999999955454333333333332222    11223334688


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +.+.+|+.+||..+|.+|||+.++++
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.6e-47  Score=346.75  Aligned_cols=250  Identities=28%  Similarity=0.408  Sum_probs=200.7

Q ss_pred             Cc-eEeeeeccCCceEEEEEE----EcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeE
Q 019628            3 RY-EIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHL   73 (338)
Q Consensus         3 ~y-~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~   73 (338)
                      +| ++++.||+|+||+||++.    +..+++.||||++....  .....+.+|+.++++++||||+++++++..  ...+
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            55 999999999999998775    34578999999997653  234568899999999999999999999987  4689


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      ++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.+.  .+||+|||++......
T Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECCTT
T ss_pred             EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC--CEEECCcccccccccc
Confidence            9999999999999999764 599999999999999999999999999999999999997554  8999999999754332


Q ss_pred             C----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh----------HHHHHHHhhHhhc
Q 019628          154 S----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP----------KNFRKTIGRILSV  219 (338)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----------~~~~~~~~~~~~~  219 (338)
                      .    ......||+.|+|||++.+..++. ++|||||||++|+|++|..||......          .............
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYY-ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            2    233456888999999998877754 489999999999999999999753211          0001111122222


Q ss_pred             cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ....+....++.++.+||.+||+.+|.+|||+.++++
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2333444578999999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-47  Score=349.92  Aligned_cols=254  Identities=22%  Similarity=0.249  Sum_probs=201.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++.+.||+|+||.||++.+. +++.||||++....  .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            68999999999999999999864 68899999987643  2234788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhc---CceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           80 AAGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        80 ~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~LH~~---~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +++++|.+++....    .+++..++.++.|++.||.|||++   ||+||||||+|||++.+.  .+||+|||+++....
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDY  186 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC--CEEECCCSSCEECCS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC--CEEeccCccccccCc
Confidence            99999999997643    399999999999999999999999   999999999999997554  899999999975432


Q ss_pred             CC--CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCC----CCChHHHHHHHhhHhhcc------
Q 019628          153 HS--QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFED----PEDPKNFRKTIGRILSVH------  220 (338)
Q Consensus       153 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~----~~~~~~~~~~~~~~~~~~------  220 (338)
                      ..  ......||+.|+|||++.+..++. ++|||||||++|+|++|..||..    ..................      
T Consensus       187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 3uim_A          187 KDTHVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV  265 (326)
T ss_dssp             SSSCEECCCCSCGGGCCHHHHHHSEECH-HHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred             ccccccccccCCcCccCHHHhccCCCCc-cccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence            22  233456999999999998777754 48999999999999999999952    111111111111111110      


Q ss_pred             ---ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          221 ---YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       221 ---~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                         .........+..+.+|+.+||+.+|.+|||+.|+++|-.
T Consensus       266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence               000001123467999999999999999999999999754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.1e-47  Score=362.49  Aligned_cols=245  Identities=22%  Similarity=0.322  Sum_probs=201.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||++.+.. +..||||+++......+.+.+|+.++++++||||+++++++.. +.+|+||||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            579999999999999999999874 4679999998766556789999999999999999999999876 67899999999


Q ss_pred             CCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CCC
Q 019628           82 GGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QPK  157 (338)
Q Consensus        82 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~~  157 (338)
                      +|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++......  ...
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC-----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC--CEEECCCccceecCCCceeccc
Confidence            9999999974  34699999999999999999999999999999999999997544  89999999998543222  122


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||...........    +.. ....+....+++.+.+|
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VER-GYRMPCPPECPESLHDL  413 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHT-TCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHH
Confidence            3457788999999987777544 999999999999999 9999987665433322    221 22333334789999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      |.+||+.+|++|||+.++++
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=353.79  Aligned_cols=243  Identities=16%  Similarity=0.171  Sum_probs=195.7

Q ss_pred             CCceEeeeeccCCceEEEEE-----EEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLV-----RDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK---HPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||+||+|     .+..+++.||||++....  ...+.+|+.+++.++   |+||+++++++...+..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            57999999999999999999     467789999999987643  456778888888887   89999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC---------CCCCcE
Q 019628           74 AIVMEYAAGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG---------STAPRV  139 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~---------~~~~~i  139 (338)
                      |+||||+++|+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.         ...+.+
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence            999999999999999973     456999999999999999999999999999999999999965         114589


Q ss_pred             EEeecCCCcccc---cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhH
Q 019628          140 KICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRI  216 (338)
Q Consensus       140 kL~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~  216 (338)
                      ||+|||+|+...   ........+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.......         
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~---------  292 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGE---------  292 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTE---------
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCc---------
Confidence            999999996432   2223456789999999999998887655 999999999999999999996532210         


Q ss_pred             hhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          217 LSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ......++.. ..++.+.+++.+||..+|.+|++..+.+.+
T Consensus       293 ~~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 CKPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             EEECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             eeechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            0011111211 346778999999999999999766555543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=349.35  Aligned_cols=256  Identities=22%  Similarity=0.286  Sum_probs=191.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc-----CCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT-----PTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-----~~~~~i   75 (338)
                      +++|++++.||+|+||+||+++.  +++.||||++............|+..+..++||||+++++.+..     ...+|+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            57999999999999999999977  68999999997654333333445555566899999999985542     346899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc---------CceecCCCCCcEEecCCCCCcEEEeecCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QICHRDLKLENTLLDGSTAPRVKICDFGY  146 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~  146 (338)
                      ||||+++|+|.+++... ..++..+..++.||+.||.|||++         ||+||||||+|||++.++  .+||+|||+
T Consensus        90 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~  166 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGL  166 (336)
T ss_dssp             EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTT
T ss_pred             EEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeeccc
Confidence            99999999999999765 569999999999999999999999         999999999999997554  899999999


Q ss_pred             CcccccC---------CCCCCccccCcccccccccCC-------ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHH--
Q 019628          147 SKSSVLH---------SQPKSTVGTPAYIAPEVLTKK-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKN--  208 (338)
Q Consensus       147 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~--  208 (338)
                      ++.....         .......||+.|+|||++.+.       .+ +.++|||||||++|+|++|..||........  
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9754321         122345799999999999763       23 3458999999999999999777643222110  


Q ss_pred             ------------HHHHHhhH--hhccccCCC----cccCCHHHHHHHHHhcccCCCcCCChhHHh------cCccccc
Q 019628          209 ------------FRKTIGRI--LSVHYSFPD----YVRVSLECKHLLSRIFVANSEKRITIPEIK------NHPWFLR  262 (338)
Q Consensus       209 ------------~~~~~~~~--~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~s~~ell------~hp~~~~  262 (338)
                                  ........  ......+|.    ....++++.+||.+||+.||++|||+.|++      .++|-++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence                        00000000  111122222    122455799999999999999999999994      4666543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=343.57  Aligned_cols=252  Identities=26%  Similarity=0.396  Sum_probs=202.3

Q ss_pred             CCceEeeeeccCCceEEEEEE----EcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC--eEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVR----DKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT--HLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~   74 (338)
                      ++|++++.||+|+||.||++.    +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...+  .++
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            479999999999999999998    46689999999987643 23457889999999999999999999987654  789


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           75 IVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      +||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++.....
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCSS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcchhhcccc
Confidence            999999999999999875 4599999999999999999999999999999999999997554  8999999999754332


Q ss_pred             CC----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCCh-----------HHHHHHHhhHhh
Q 019628          154 SQ----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----------KNFRKTIGRILS  218 (338)
Q Consensus       154 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-----------~~~~~~~~~~~~  218 (338)
                      ..    .....+|..|+|||++.+..++. ++|||||||++|+|++|..||......           ......+.....
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  277 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCc-hhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence            21    23345778899999998777654 489999999999999999998642100           001111111122


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .....+....++.++.+||.+||..+|++|||+.++++
T Consensus       278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22223334478999999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.7e-47  Score=341.57  Aligned_cols=248  Identities=25%  Similarity=0.405  Sum_probs=195.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-CCc--EEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-TRE--LLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||+||++.+.. +++  .||+|+++...    ...+.+.+|+.++++++||||+++++++..+. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            589999999999999999998643 333  68999887532    23467889999999999999999999998765 88


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           75 IVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      +||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++  .+||+|||++......
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEcccccccccccc
Confidence            999999999999999764 5699999999999999999999999999999999999997554  8999999998754332


Q ss_pred             C----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          154 S----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                      .    ......+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.........    ..+......++....
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~  249 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPRPED  249 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTSCCCCCCCTT
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHH----HHHHccCCCCCCCcC
Confidence            2    12345678889999999877765 44899999999999999 99999876543332    233333334444457


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ++.++.++|.+||..+|.+|||+.+++++
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            89999999999999999999999999973

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1e-46  Score=339.22  Aligned_cols=246  Identities=22%  Similarity=0.281  Sum_probs=197.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCC---CcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEE-cCCeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLL-TPTHLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~~iv   76 (338)
                      +|++.+.||+|+||+||+|.+..+   +..+|+|.+....  ...+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            699999999999999999997543   3468999887533  23356889999999999999999999854 55688999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC--
Q 019628           77 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--  153 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~--  153 (338)
                      |||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++.....  
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGGG
T ss_pred             EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccccch
Confidence            999999999999975 34589999999999999999999999999999999999996554  8999999999754322  


Q ss_pred             ---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          154 ---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       154 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                         .......||+.|+|||++.+..++. ++|||||||++|+|++ |.+||..............   ......|  ..+
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~  257 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRRLLQP--EYC  257 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT---TCCCCCC--TTC
T ss_pred             hccccccCCCCCccccChHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc---CCCCCCC--ccC
Confidence               1233456788999999998777654 4899999999999999 6677776555443322221   1112222  357


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++.+.+++.+||..+|.+|||+.++++
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.6e-47  Score=341.89  Aligned_cols=248  Identities=24%  Similarity=0.315  Sum_probs=198.9

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      |...+.||+|+||+||++..  +++.||+|++....     ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            45568999999999999987  58899999986532     234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           79 YAAGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      |+++++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+++...... 
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccccc
Confidence            9999999999973   34699999999999999999999999999999999999997554  89999999987543221 


Q ss_pred             --CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--------cCC
Q 019628          155 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--------SFP  224 (338)
Q Consensus       155 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~  224 (338)
                        ......||+.|+|||++.+ .++ .++|||||||++|+|++|..||...............+.....        .++
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~-~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG-EIT-PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT-EEC-THHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccCCCcCcCChHHhcC-CCC-ccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence              1234579999999999865 354 4489999999999999999999876543322222222211111        011


Q ss_pred             -CcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          225 -DYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       225 -~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                       .....+..+.+++.+||..+|.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             112345678999999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-46  Score=342.89  Aligned_cols=249  Identities=24%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhc--CCCCCcceeEEEEEcCC----eEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRS--LKHPNIVRFKEVLLTPT----HLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~~----~~~i   75 (338)
                      ++|++.+.||+|+||.||++.+  +++.||||++....  ...+.+|+.+++.  ++||||+++++++....    .+|+
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            4799999999999999999998  48999999986543  3567788888877  79999999999998876    8999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh--------hcCceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ||||+++|+|.+++.. ..+++..++.++.||+.||.|||        ++||+||||||+|||++.++  .+||+|||++
T Consensus       118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~  194 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLA  194 (342)
T ss_dssp             EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS--CEEECCCTTC
T ss_pred             EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC--CEEEEECCCc
Confidence            9999999999999976 47999999999999999999999        89999999999999997554  8999999999


Q ss_pred             cccccCC-----CCCCccccCcccccccccCCccC-----CCcchHHHHHHHHHHHHcC----------CCCCCCCCChH
Q 019628          148 KSSVLHS-----QPKSTVGTPAYIAPEVLTKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDPEDPK  207 (338)
Q Consensus       148 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~~lltg----------~~pf~~~~~~~  207 (338)
                      .......     ......||+.|+|||++.+....     +.++|||||||++|+|++|          ..||.......
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            7543332     23456799999999999765322     1458999999999999999          78987643221


Q ss_pred             -HHHHHHhhHhhc--cccCCCc---ccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          208 -NFRKTIGRILSV--HYSFPDY---VRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       208 -~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                       ........+...  ...++..   ...+..+.+||.+||+.+|++|||+.++++|
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence             112222222221  1222221   1334678999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=364.95  Aligned_cols=245  Identities=22%  Similarity=0.323  Sum_probs=205.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||++.+.. +..||||+++......+.+.+|+.++++++||||+++++++.. +.+|+||||++
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            579999999999999999999874 4679999998766566789999999999999999999999876 67899999999


Q ss_pred             CCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC--CCCC
Q 019628           82 GGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH--SQPK  157 (338)
Q Consensus        82 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~--~~~~  157 (338)
                      +|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++.....  ....
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCTTSTTTCCCHHHHTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC--cEEEcccccceecCCCceeccc
Confidence            9999999974  34699999999999999999999999999999999999996544  8999999999854321  1223


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...++..|+|||++.+..++.+ +|||||||++|+|++ |+.||...........    +.. .+..+....++..+.+|
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~l  496 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VER-GYRMPCPPECPESLHDL  496 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----HHT-TCCCCCCTTCCHHHHHH
T ss_pred             CCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHH
Confidence            4457788999999987777544 999999999999999 9999987655433322    221 22333334789999999


Q ss_pred             HHHhcccCCCcCCChhHHhc
Q 019628          237 LSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~  256 (338)
                      |.+||+.+|++|||+.++++
T Consensus       497 i~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          497 MCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=350.02  Aligned_cols=247  Identities=22%  Similarity=0.270  Sum_probs=192.3

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCC---cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEc-CCeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTR---ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLT-PTHLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~iv   76 (338)
                      +|++.+.||+|+||+||++....++   ..||+|.+....  ...+.+.+|+.++++++||||+++++++.. ++..|+|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4788999999999999999875432   468999886533  234678899999999999999999998654 5678999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           77 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      |||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++...... 
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeecccccccccccc
Confidence            99999999999997643 589999999999999999999999999999999999997554  89999999997543221 


Q ss_pred             ----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccC
Q 019628          155 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRV  229 (338)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (338)
                          ......+|+.|+|||++.+..++. ++|||||||++|+|++ |.+||..............   ......|  ..+
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---~~~~~~p--~~~  321 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRRLLQP--EYC  321 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT---TCCCCCC--TTC
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCc-HHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc---CCCCCCC--CCC
Confidence                123345788999999998777754 4999999999999999 7888877655443322211   1122223  368


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +..+.+++.+||..+|.+|||+.+++++
T Consensus       322 ~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          322 PDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.9e-46  Score=354.83  Aligned_cols=251  Identities=22%  Similarity=0.241  Sum_probs=201.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC-CCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-PNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||.||++.+..+++.||||++..... ...+.+|+.+++.++| ++|..+..++...+..++||||+
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            689999999999999999999999999999998776443 3457889999999987 55666667777788999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCcccccCCC---
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHSQ---  155 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~~~~---  155 (338)
                       +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++.......   
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH  164 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence             8999999974 5579999999999999999999999999999999999999411 233899999999975433221   


Q ss_pred             -----CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC---Ccc
Q 019628          156 -----PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP---DYV  227 (338)
Q Consensus       156 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~  227 (338)
                           .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............ ..+.......+   ...
T Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~~l~~  242 (483)
T 3sv0_A          165 IPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVATSIEALCR  242 (483)
T ss_dssp             CCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH-HHHHHHHHHSCHHHHHT
T ss_pred             cccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHH-HHHhhccccccHHHHhc
Confidence                 235679999999999988877544 89999999999999999999876543222111 11111111100   112


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .++.++.+||.+||..+|.+||++.+|++
T Consensus       243 ~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          243 GYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             TSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            57899999999999999999999988754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=340.89  Aligned_cols=246  Identities=25%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      .++|++.+.||+|+||.||++.+..   .+|+|++....   ...+.+.+|+.++++++||||+++++++...+.+++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            3789999999999999999999853   49999987542   23356778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc----
Q 019628           78 EYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL----  152 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~----  152 (338)
                      ||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++++   +.+||+|||+++....    
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~---~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC--------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC---CCEEEeecCCcccccccccc
Confidence            9999999999997654 6999999999999999999999999999999999999972   3799999999864321    


Q ss_pred             --CCCCCCccccCcccccccccCC--------ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc
Q 019628          153 --HSQPKSTVGTPAYIAPEVLTKK--------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS  222 (338)
Q Consensus       153 --~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (338)
                        ........||+.|+|||++.+.        ...+.++|||||||++|+|++|..||...........    +......
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~  261 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ----MGTGMKP  261 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH----HHTTCCC
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hccCCCC
Confidence              1222345699999999998752        2234558999999999999999999987654333222    2222222


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ......++.++.+||.+||..+|.+|||+.++++
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            2222357889999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.3e-46  Score=367.12  Aligned_cols=240  Identities=24%  Similarity=0.342  Sum_probs=196.0

Q ss_pred             eeeccCCceEEEEEEE--cCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRD--KWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      +.||+|+||+||++..  ..+++.||||+++...   ...+.+.+|+.++++++|||||++++++.. +.+++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954  4567899999997643   234678999999999999999999999865 458899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC----CCCC
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS----QPKS  158 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~----~~~~  158 (338)
                      |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++......    ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccccccccC
Confidence            99999999888899999999999999999999999999999999999997555  89999999987543222    1233


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||............. .  ......|  ..++.++.+||
T Consensus       532 ~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~--~~~~~~p--~~~~~~l~~li  605 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-K--GERMGCP--AGCPREMYDLM  605 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-T--TCCCCCC--TTCCHHHHHHH
T ss_pred             CCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c--CCCCCCC--CCCCHHHHHHH
Confidence            457788999999987777554 999999999999998 999998866543322221 1  1122233  36899999999


Q ss_pred             HHhcccCCCcCCChhHHhc
Q 019628          238 SRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~  256 (338)
                      .+||..||++|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=363.43  Aligned_cols=245  Identities=25%  Similarity=0.387  Sum_probs=197.4

Q ss_pred             CceEee-eeccCCceEEEEEEEc--CCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            3 RYEIVK-DIGSGNFGVAKLVRDK--WTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         3 ~y~~~~-~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++.+.+ .||+|+||.||++...  .++..||||+++...  ...+.+.+|+.++++++|||||++++++.. +.+|+||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            445555 8999999999999875  356679999997643  344678999999999999999999999976 5699999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           78 EYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        78 e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      ||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....... 
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC-----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCCCce
Confidence            999999999999754 4599999999999999999999999999999999999997554  899999999985432221 


Q ss_pred             ---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          156 ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       156 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                         .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||..............   ......|  ..+++
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~~~~~p--~~~~~  566 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECP--PECPP  566 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT---TCCCCCC--TTCCH
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCC--CcCCH
Confidence               122346689999999987777554 899999999999998 9999998776543322211   1122333  36899


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhc
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ++.+||.+||..+|.+|||+.++++
T Consensus       567 ~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          567 ELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999854

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.9e-48  Score=355.66  Aligned_cols=243  Identities=19%  Similarity=0.240  Sum_probs=189.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCC---------CCCccee
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------IDEHVQREIMNHRSLK---------HPNIVRF   63 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~E~~~l~~l~---------h~~Iv~~   63 (338)
                      ++|++++.||+|+||+||+|++  +|+.||||++.....         ..+.+.+|+.+++.++         ||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  689999999986431         2267889999988885         7777777


Q ss_pred             EEEEE------------------------------cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 019628           64 KEVLL------------------------------TPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY  113 (338)
Q Consensus        64 ~~~~~------------------------------~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~  113 (338)
                      .+++.                              ..+.+|+||||+++|++.+.+.. +.+++..++.++.||+.||.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            76643                              26789999999999977776644 578999999999999999999


Q ss_pred             hh-hcCceecCCCCCcEEecCCC------------------CCcEEEeecCCCcccccCCCCCCccccCcccccccccCC
Q 019628          114 CH-SMQICHRDLKLENTLLDGST------------------APRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK  174 (338)
Q Consensus       114 LH-~~~iiH~Dlkp~NIl~~~~~------------------~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  174 (338)
                      || ++||+||||||+|||++.++                  ...+||+|||+|+....    ...+||+.|+|||++.+.
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC
Confidence            99 99999999999999997553                  12799999999985432    245899999999999866


Q ss_pred             ccCCCcchHHHHHHH-HHHHHcCCCCCCCCCChHHHHHHHhhHhh-cccc----CCCcccCCHHHHHHHHHhcccCCCcC
Q 019628          175 EYDGKIADVWSCGVT-LYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYS----FPDYVRVSLECKHLLSRIFVANSEKR  248 (338)
Q Consensus       175 ~~~~~~~DiwSlG~i-l~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~li~~~L~~dp~~R  248 (338)
                      .  +.++||||+|++ .+++++|..||.....   .......+.. ....    .+.+..+++++++||++||++|    
T Consensus       253 ~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          253 G--DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             S--SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             C--ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            5  455999998777 7788999999853110   0111111111 1111    1112357889999999999976    


Q ss_pred             CChhHHh-cCcccc
Q 019628          249 ITIPEIK-NHPWFL  261 (338)
Q Consensus       249 ~s~~ell-~hp~~~  261 (338)
                       |+.|+| +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999994

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-46  Score=352.23  Aligned_cols=243  Identities=15%  Similarity=0.129  Sum_probs=189.5

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCC-CCc---------ce------
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKH-PNI---------VR------   62 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h-~~I---------v~------   62 (338)
                      +|++.+.||+|+||+||+|.+..+|+.||||++...    ....+.+.+|+.+++.+.| +|.         +.      
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            478899999999999999999999999999998743    2335678999999999987 221         11      


Q ss_pred             ------eEEEEEc-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCC
Q 019628           63 ------FKEVLLT-----PTHLAIVMEYAAGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQICHRDL  124 (338)
Q Consensus        63 ------~~~~~~~-----~~~~~iv~e~~~~~~L~~~i~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dl  124 (338)
                            +..++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||.|||++||+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                  1111111     12467888877 6799998841       234788899999999999999999999999999


Q ss_pred             CCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcccccccc----------cCCccCCCcchHHHHHHHHHHHH
Q 019628          125 KLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----------TKKEYDGKIADVWSCGVTLYVML  194 (338)
Q Consensus       125 kp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwSlG~il~~ll  194 (338)
                      ||+|||++.++  .+||+|||+++.....  ....+| +.|+|||++          .+..++ .++|||||||++|+|+
T Consensus       238 Kp~NILl~~~~--~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          238 RPVDIVLDQRG--GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CGGGEEECTTC--CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCC--eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCC-chhhHHHHHHHHHHHH
Confidence            99999997655  7999999998754322  445678 999999999          444454 4599999999999999


Q ss_pred             cCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          195 VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       195 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +|+.||........          ....++....+++++.+||.+||+.||++|||+.++++||||.+
T Consensus       312 tg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          312 CADLPNTDDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HSSCCCCTTGGGSC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HCCCCCCCcchhhh----------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            99999986543211          11223344468999999999999999999999999999999953

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.8e-45  Score=360.95  Aligned_cols=245  Identities=23%  Similarity=0.369  Sum_probs=199.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC---CcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT---RELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||.||+|.+..+   +..||+|++....  ...+.+.+|+.++++++||||+++++++. .+.+|+|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            5799999999999999999998643   4579999887532  23367889999999999999999999985 4668999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      |||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.......
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCCcc
Confidence            99999999999998654 689999999999999999999999999999999999997554  899999999985433222


Q ss_pred             --CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCH
Q 019628          156 --PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSL  231 (338)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  231 (338)
                        .....+|+.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +... ....|  ..+++
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~----i~~~~~~~~~--~~~~~  619 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGERLPMP--PNCPP  619 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHHTCCCCCC--TTCCH
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCc-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcCCCCCCC--ccccH
Confidence              22345778999999998777654 4899999999999997 9999987655433222    2222 22233  36899


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhc
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .+.+||.+||..||.+|||+.++++
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-45  Score=365.16  Aligned_cols=237  Identities=22%  Similarity=0.261  Sum_probs=195.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCe-----E
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTH-----L   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-----~   73 (338)
                      ++|++++.||+|+||+||++.+.. +++.||||++....  .....+.+|+.++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999976 78999999986543  233567899999999999999999999987654     7


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+||||++|++|.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.+   .+||+|||+++.... 
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~-  233 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS-  233 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC-
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc-
Confidence            999999999999988754  79999999999999999999999999999999999999753   799999999975432 


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                        .....||+.|+|||++.+..  +.++|||||||++|+|++|.+||.......        +    .........++.+
T Consensus       234 --~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~----~~~~~~~~~~~~l  297 (681)
T 2pzi_A          234 --FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------L----PEDDPVLKTYDSY  297 (681)
T ss_dssp             --CSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------C----CTTCHHHHHCHHH
T ss_pred             --CCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccc--------c----cccccccccCHHH
Confidence              25567999999999986643  455999999999999999999987521100        0    0001111346789


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+||.+||+.||.+||+..+.+.|+|+
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            999999999999999999999999987

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-44  Score=323.06  Aligned_cols=223  Identities=15%  Similarity=0.125  Sum_probs=181.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc----cHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI----DEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++.+.||+|+||.||+|.+..+++.||||++......    ...+.+|+..+++++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            5899999999999999999999999999999999865433    267889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      ||++|++|.+++...  ..+..+..++.||+.||+|||++||+||||||+|||++.++  .+||+++|            
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g--~~kl~~~~------------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG--DVVLAYPA------------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS--CEEECSCC------------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC--CEEEEecc------------
Confidence            999999999999543  46667899999999999999999999999999999997554  78988543            


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCCHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKH  235 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (338)
                             |++|       + +.++|||||||++|+|+||+.||...+...........+ ......+  ....+++++.+
T Consensus       175 -------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 -------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             -------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCHHHHCTTSCHHHHH
T ss_pred             -------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCChhhcccCCCHHHHH
Confidence                   3332       3 455899999999999999999998755432110000000 1111110  12358899999


Q ss_pred             HHHHhcccCCCcCCChhHHhcC
Q 019628          236 LLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ||.+||+.||.+| |+.|+++.
T Consensus       239 li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHcccCCccC-CHHHHHHH
Confidence            9999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.9e-37  Score=300.76  Aligned_cols=185  Identities=15%  Similarity=0.072  Sum_probs=135.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-----------cccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEE
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----------KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ....+.|++|.+..++....|+.||+|++.+..           ...+.+.+|+.+|+++ .|+||+++++++.+++.+|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            345678888888888888889999999997631           2234688999999999 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-  153 (338)
                      |||||++|++|.+.|...+++++.   .|+.||+.||+|||++|||||||||+|||++.++  ++||+|||+|+..... 
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg--~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ--HARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS--CEEECCCTTEESCC---
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC--CEEEeecccCeeCCCCC
Confidence            999999999999999998888875   4789999999999999999999999999997554  8999999999854332 


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCC
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAY  198 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~  198 (338)
                      ....+.+||+.|||||++.+. +... +|+||+|+++++|.++..
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~-~~~~-~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAEN-KSWN-GFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             ccccCceechhhccHHHhCCC-CCCc-ccccccccchhhhccccc
Confidence            334557899999999999764 3334 899999999988766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=2.5e-31  Score=257.62  Aligned_cols=181  Identities=19%  Similarity=0.111  Sum_probs=140.8

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ..+.||+|+||.||++..  .++.+|+|+......         ..+++.+|+.++++++||||+++..++...+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            456899999999999944  578899998654211         123578999999999999999665555667778999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC-
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ-  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~-  155 (338)
                      |||++|++|.+++..        +..++.||+.||+|||++||+||||||+|||++.    ++||+|||+|+....... 
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence            999999999999865        6789999999999999999999999999999975    799999999985433211 


Q ss_pred             -------CCCccccCcccccccccC--CccCCCcchHHHHHHHHHHHHcCCCCCC
Q 019628          156 -------PKSTVGTPAYIAPEVLTK--KEYDGKIADVWSCGVTLYVMLVGAYPFE  201 (338)
Q Consensus       156 -------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~lltg~~pf~  201 (338)
                             ..+.+||+.|||||++..  ..|... +|+||.++-..+...++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence                   135679999999999976  455444 799999998888877776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=9.6e-28  Score=214.04  Aligned_cols=142  Identities=20%  Similarity=0.165  Sum_probs=115.3

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------------------ccHHHHHHHHHHhcCCCCCcceeE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------------------IDEHVQREIMNHRSLKHPNIVRFK   64 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~~Iv~~~   64 (338)
                      |.+.+.||+|+||.||+|.+ .+|+.||||+++....                   ....+.+|+.++++++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55669999999999999999 7899999999865321                   2345789999999999  4 5665


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           65 EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        65 ~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                      +++.. +..|+||||++|++|.+ +.      ......++.|++.||.|||++||+||||||+|||++   ++.+||+||
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~---~~~vkl~DF  236 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---EEGIWIIDF  236 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---TTEEEECCC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE---CCcEEEEEC
Confidence            55543 55699999999999987 42      133567999999999999999999999999999997   448999999


Q ss_pred             CCCcccccCCCCCCccccCccccccccc
Q 019628          145 GYSKSSVLHSQPKSTVGTPAYIAPEVLT  172 (338)
Q Consensus       145 g~a~~~~~~~~~~~~~gt~~y~aPE~~~  172 (338)
                      |+|+            .+..++|||.+.
T Consensus       237 G~a~------------~~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSV------------EVGEEGWREILE  252 (282)
T ss_dssp             TTCE------------ETTSTTHHHHHH
T ss_pred             CCCe------------ECCCCCHHHHHH
Confidence            9986            334578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.90  E-value=6.7e-24  Score=186.79  Aligned_cols=135  Identities=16%  Similarity=0.152  Sum_probs=107.3

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcE--EEEEEeecCccc-------------------------cHHHHHHHHHHhcCC
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTREL--LAVKFIERGQKI-------------------------DEHVQREIMNHRSLK   56 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-------------------------~~~~~~E~~~l~~l~   56 (338)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++.....                         ...+.+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78899999999999999999778988  999987543211                         125788999999998


Q ss_pred             CCCc--ceeEEEEEcCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh-hcCceecCCCCCc
Q 019628           57 HPNI--VRFKEVLLTPTHLAIVMEYAAG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLEN  128 (338)
Q Consensus        57 h~~I--v~~~~~~~~~~~~~iv~e~~~~-~----~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH-~~~iiH~Dlkp~N  128 (338)
                      |+++  ..++..    +..++||||+.+ |    +|.+....   .++..+..++.||+.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8764  344432    356899999942 3    66665432   345678899999999999999 9999999999999


Q ss_pred             EEecCCCCCcEEEeecCCCcc
Q 019628          129 TLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus       129 Il~~~~~~~~ikL~Dfg~a~~  149 (338)
                      ||++.    .++|+|||+|..
T Consensus       202 ILl~~----~~~liDFG~a~~  218 (258)
T 1zth_A          202 IMYID----KVYFIDMGQAVT  218 (258)
T ss_dssp             EEESS----SEEECCCTTCEE
T ss_pred             EEEcC----cEEEEECccccc
Confidence            99965    699999999873

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.81  E-value=2.8e-20  Score=170.91  Aligned_cols=136  Identities=16%  Similarity=0.145  Sum_probs=98.9

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccc---------------cH--------HHHHHHHHHhcCCCCCc
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKI---------------DE--------HVQREIMNHRSLKHPNI   60 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------~~--------~~~~E~~~l~~l~h~~I   60 (338)
                      |.+.++||.|+||.||+|.+. +|+.||||+++.....               ..        ...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6899999987542110               00        12356777777755444


Q ss_pred             ceeEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCC---
Q 019628           61 VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAP---  137 (338)
Q Consensus        61 v~~~~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~---  137 (338)
                      .-..-+...  ..++||||++|++|..+.      .......++.||+.+|.+||++|||||||||.|||++.++.+   
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            322211122  237999999998885432      223456789999999999999999999999999999755422   


Q ss_pred             -----cEEEeecCCCc
Q 019628          138 -----RVKICDFGYSK  148 (338)
Q Consensus       138 -----~ikL~Dfg~a~  148 (338)
                           .+.|+||+-+.
T Consensus       248 ~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TSEEEEEEECCCTTCE
T ss_pred             cccccceEEEEeCCcc
Confidence                 37899998654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.55  E-value=2.8e-14  Score=125.15  Aligned_cols=138  Identities=19%  Similarity=0.139  Sum_probs=110.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +.|++...+|.|+.+.||++...  +..+++|+..... .....+.+|+.+++.+. +..+.++++++...+..|+|||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            57999999999999999999854  6789999887532 22346889999998884 67788999999888899999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------------
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------  116 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-------------------------------------------  116 (338)
                      ++|.+|...+.     +......++.++..+|..||+                                           
T Consensus        92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            99999876531     223345788999999999998                                           


Q ss_pred             ----------------cCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          117 ----------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       117 ----------------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                                      ..++|+|++|.||+++++.  .+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence                            4589999999999996432  45699998664

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.42  E-value=5.5e-13  Score=116.32  Aligned_cols=134  Identities=14%  Similarity=0.112  Sum_probs=98.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ..|.+....+.|..+.||++.. .+|..+++|+....  ....+.+|+.+++.+.+.+  +.+++.++...+..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3566655445666799999965 46778999987654  2356788999988886544  56688888888889999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-----------------------------------------  118 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----------------------------------------  118 (338)
                      ++|.+|.  ..   ..+   ...++.++..+|..||+..                                         
T Consensus        97 i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           97 VPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             CSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             cCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            9998873  21   122   2356777788888888643                                         


Q ss_pred             -----------------ceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          119 -----------------ICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       119 -----------------iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                                       ++|+|++|.||+++++.  .+.|+|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence                             99999999999996432  45699999765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.35  E-value=2.3e-12  Score=118.20  Aligned_cols=141  Identities=13%  Similarity=0.212  Sum_probs=106.7

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEee--cCc--cccHHHHHHHHHHhcCC--CCCcceeEEEEEcC---CeEEE
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIE--RGQ--KIDEHVQREIMNHRSLK--HPNIVRFKEVLLTP---THLAI   75 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~---~~~~i   75 (338)
                      .-++.|+.|.++.||++...  +..+++|+..  ...  .....+.+|+.+++.+.  +..+.+++.++.+.   +..|+
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            35678999999999999864  4678899876  432  22356888999999887  45578888888766   45889


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------  116 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~---------------------------------------  116 (338)
                      ||||++|..+.+..  ...+++.....++.+++.+|..||+                                       
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999987774321  2347888899999999999999997                                       


Q ss_pred             -------------------cCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628          117 -------------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus       117 -------------------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                                         .+++|+|++|.||+++.++...+.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               369999999999999755433468999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.25  E-value=5.1e-12  Score=113.25  Aligned_cols=183  Identities=17%  Similarity=0.155  Sum_probs=120.6

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCC--cceeEEEEEcCC---eEEEEEecc
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPN--IVRFKEVLLTPT---HLAIVMEYA   80 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~--Iv~~~~~~~~~~---~~~iv~e~~   80 (338)
                      ++.++.|..+.||++.     ..+++|+.... .....+.+|..+++.+. +..  +.+++......+   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999864     45889975433 33467889999998873 333  445554433333   348899999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh--------------------------------------------
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------------------------------------------  116 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~--------------------------------------------  116 (338)
                      +|.+|.....  ..++..+...++.|++..|..||+                                            
T Consensus        99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9988875443  247888888899999999999886                                            


Q ss_pred             --------------cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCccccCcc---cccccccC--CccC
Q 019628          117 --------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAY---IAPEVLTK--KEYD  177 (338)
Q Consensus       117 --------------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y---~aPE~~~~--~~~~  177 (338)
                                    ..++|+|++|.||+++.+..+.+.|+||+.+........   ......+   ..|+....  ..|.
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHHHcC
Confidence                          137999999999999764233578999998763221100   0000000   12221110  0111


Q ss_pred             CC-----------cchHHHHHHHHHHHHcCCCCC
Q 019628          178 GK-----------IADVWSCGVTLYVMLVGAYPF  200 (338)
Q Consensus       178 ~~-----------~~DiwSlG~il~~lltg~~pf  200 (338)
                      ..           -.+.|++|.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11           158999999999999998766

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.87  E-value=3e-08  Score=88.74  Aligned_cols=135  Identities=20%  Similarity=0.167  Sum_probs=94.7

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC---CcceeEEEEE-cCCeEEEEEeccCC
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHP---NIVRFKEVLL-TPTHLAIVMEYAAG   82 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~---~Iv~~~~~~~-~~~~~~iv~e~~~~   82 (338)
                      ++.++.|....||++     +..+++|+. ........+.+|..+++.+.+.   .+.+.+.+.. ..+..++||++++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            467888999999988     456888974 3333346788999999998753   3566666664 44567899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------------------------------------------  117 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------------------  117 (338)
                      .++....-  ..++......++.|+...|..||+.                                             
T Consensus        98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            88866322  2345555666666666666666632                                             


Q ss_pred             ---------------CceecCCCCCcEEecCC-CCCc-EEEeecCCCcc
Q 019628          118 ---------------QICHRDLKLENTLLDGS-TAPR-VKICDFGYSKS  149 (338)
Q Consensus       118 ---------------~iiH~Dlkp~NIl~~~~-~~~~-ikL~Dfg~a~~  149 (338)
                                     .++|+|++|.||+++.+ ..+. +.|+||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           35999999999999751 1124 48999998763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.77  E-value=9.1e-08  Score=83.71  Aligned_cols=131  Identities=18%  Similarity=0.193  Sum_probs=96.2

Q ss_pred             eccCCce-EEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEeccCCCChHH
Q 019628           10 IGSGNFG-VAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFE   87 (338)
Q Consensus        10 LG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e~~~~~~L~~   87 (338)
                      +..|..| .||+......+..+++|+-+..  ....+.+|...|+.+. +--+.+++.++.+.+..++|||+++|.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            4445544 7999988777888999986644  2356788999888874 2336778888888899999999999988877


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------------------
Q 019628           88 RICNAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------------------  116 (338)
Q Consensus        88 ~i~~~~~l~~~~~~~i~~qi~~al~~LH~---------------------------------------------------  116 (338)
                      .....    ......+..++...|..||+                                                   
T Consensus       110 ~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  185 (272)
T 4gkh_A          110 VLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK  185 (272)
T ss_dssp             HHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred             cccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence            65431    22344566677777777774                                                   


Q ss_pred             -------cCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          117 -------MQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       117 -------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                             ..++|+|+.|.||++++..  .+-|+||+.+.
T Consensus       186 ~~~~~~~~~l~HGDl~~~Nil~~~~~--~~~viDwe~a~  222 (272)
T 4gkh_A          186 LLPFSPDSVVTHGDFSLDNLIFDEGK--LIGCIDVGRVG  222 (272)
T ss_dssp             TCCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             cccccCCcEEEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence                   1278999999999997532  45699999765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.58  E-value=2.4e-07  Score=85.90  Aligned_cols=76  Identities=17%  Similarity=0.067  Sum_probs=50.4

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--------cccHHHHHHHHHHhcCCC--C-CcceeEEEEEcCCeEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--------KIDEHVQREIMNHRSLKH--P-NIVRFKEVLLTPTHLA   74 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~E~~~l~~l~h--~-~Iv~~~~~~~~~~~~~   74 (338)
                      -++.||.|..+.||++....+++.+++|......        ....++.+|..+++.+..  | .+.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3678999999999999766567889999764321        123466788888887742  3 34455543  344567


Q ss_pred             EEEeccCCC
Q 019628           75 IVMEYAAGG   83 (338)
Q Consensus        75 iv~e~~~~~   83 (338)
                      +|||+++|.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=3.1e-07  Score=83.76  Aligned_cols=80  Identities=11%  Similarity=0.182  Sum_probs=55.7

Q ss_pred             Eeeee-ccCCceEEEEEEEcC------CCcEEEEEEeecCc---c-ccHHHHHHHHHHhcCCC---CCcceeEEEEEcC-
Q 019628            6 IVKDI-GSGNFGVAKLVRDKW------TRELLAVKFIERGQ---K-IDEHVQREIMNHRSLKH---PNIVRFKEVLLTP-   70 (338)
Q Consensus         6 ~~~~L-G~G~~g~V~~~~~~~------~~~~vaiK~~~~~~---~-~~~~~~~E~~~l~~l~h---~~Iv~~~~~~~~~-   70 (338)
                      .++.| +.|..+.+|++....      ++..+++|+.....   . ....+.+|+.+++.+..   -.+.+++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            35677 889899999887530      15678999765533   1 13567888888887742   3577788776654 


Q ss_pred             --CeEEEEEeccCCCCh
Q 019628           71 --THLAIVMEYAAGGEL   85 (338)
Q Consensus        71 --~~~~iv~e~~~~~~L   85 (338)
                        +..++|||+++|.++
T Consensus       104 ~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTSSCEEEEECCCCBCC
T ss_pred             ccCCceEEEEecCCCCh
Confidence              356899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.34  E-value=4.5e-06  Score=75.19  Aligned_cols=74  Identities=18%  Similarity=0.227  Sum_probs=42.8

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----CCCcceeE-E--EEEcCCeEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-----HPNIVRFK-E--VLLTPTHLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-----h~~Iv~~~-~--~~~~~~~~~iv~e   78 (338)
                      ++.|+.|..+.||++...  +..+++|+.....   ..+..|..+++.|.     .|.++... +  +....+..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            456776788999999864  3458999887532   34445555555543     24443310 0  1124567899999


Q ss_pred             ccCCCCh
Q 019628           79 YAAGGEL   85 (338)
Q Consensus        79 ~~~~~~L   85 (338)
                      |++|.++
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.08  E-value=9.3e-06  Score=72.12  Aligned_cols=74  Identities=14%  Similarity=0.127  Sum_probs=46.6

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEEecc-C
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVMEYA-A   81 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~e~~-~   81 (338)
                      +.-++.|+.|....+|++      ..+++|+........-...+|+.+++.+...++ .+++..  .++.-++++||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence            444788999999999999      458899876542222234568877777643333 355544  333346899999 6


Q ss_pred             CCCh
Q 019628           82 GGEL   85 (338)
Q Consensus        82 ~~~L   85 (338)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.03  E-value=2e-05  Score=73.40  Aligned_cols=73  Identities=18%  Similarity=0.254  Sum_probs=45.0

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeec-----Ccc-----ccHHHHHHHHHHh-cCCCCCcceeEEEEEcCCeEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIER-----GQK-----IDEHVQREIMNHR-SLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~-----~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      -++.||.|..+.||++..  +++.++||....     ...     ....++.|+..+. ......+.+++.+.  .+..+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            467899999999999964  467899994321     111     1122333333222 12234566777664  45678


Q ss_pred             EEEecc-CC
Q 019628           75 IVMEYA-AG   82 (338)
Q Consensus        75 iv~e~~-~~   82 (338)
                      +|||++ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 76

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.97  E-value=8.2e-05  Score=66.42  Aligned_cols=76  Identities=17%  Similarity=0.105  Sum_probs=60.3

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK---HPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      -++.|+.|....+|++..  .+..+++|+....  ....+.+|...|+.|.   ...+.+++.+....+..++|||+++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            357799999999999985  4677889987643  2456888988888873   35688888888888889999999998


Q ss_pred             CCh
Q 019628           83 GEL   85 (338)
Q Consensus        83 ~~L   85 (338)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.76  E-value=0.00015  Score=64.86  Aligned_cols=75  Identities=13%  Similarity=0.098  Sum_probs=48.4

Q ss_pred             eeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeEEE-----EEcCCeEEEEEecc
Q 019628            8 KDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFKEV-----LLTPTHLAIVMEYA   80 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~-----~~~~~~~~iv~e~~   80 (338)
                      ..|+ |....||++... +|+.+++|+..........+..|..+++.+...+  +++++..     ....+..+++|+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4567 778899987653 4667899988644334456777888877764222  3444332     12245678899999


Q ss_pred             CCCC
Q 019628           81 AGGE   84 (338)
Q Consensus        81 ~~~~   84 (338)
                      +|.+
T Consensus       110 ~G~~  113 (328)
T 1zyl_A          110 GGRQ  113 (328)
T ss_dssp             CCEE
T ss_pred             CCCC
Confidence            8744

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.72  E-value=6.3e-05  Score=67.17  Aligned_cols=137  Identities=16%  Similarity=0.120  Sum_probs=74.8

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC--cceeEEE------EEcCCeEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN--IVRFKEV------LLTPTHLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~------~~~~~~~~iv~e   78 (338)
                      ++.|+.|....||++... +| .+++|+.... .....+..|+.+++.+...+  +.+++..      ....+..+++|+
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            567788888999999764 33 6889987653 12345667777776663212  2333211      122356789999


Q ss_pred             ccCCCChH-----------H---HHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHhhh----
Q 019628           79 YAAGGELF-----------E---RICNA-GRF--------SEDEARFF---------------FQQLISGVSYCHS----  116 (338)
Q Consensus        79 ~~~~~~L~-----------~---~i~~~-~~l--------~~~~~~~i---------------~~qi~~al~~LH~----  116 (338)
                      +++|..+.           .   .+... ..+        ........               ...+...++.+..    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            99885431           0   01110 010        10100000               0113334455542    


Q ss_pred             ---cCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          117 ---MQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       117 ---~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                         .+++|+|+.|.||+++.+.  .+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence               4799999999999997532  34799998665

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.69  E-value=0.00071  Score=56.48  Aligned_cols=122  Identities=16%  Similarity=0.061  Sum_probs=75.0

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhh-hcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCcc
Q 019628           83 GELFERICN-AGRFSEDEARFFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTV  160 (338)
Q Consensus        83 ~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH-~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  160 (338)
                      -+|.+.|.. ..+++|+++|.++.|.+.+|.-+- .+.-..+=+.|..|++..++  +|.+.+ +.+.           .
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG--~V~f~~-~~s~-----------~   98 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG--AVTLAP-AADD-----------A   98 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS--CEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC--ceeccc-cccc-----------c
Confidence            378888874 568999999999999999988762 12222344557888885444  666553 2111           1


Q ss_pred             ccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHHh
Q 019628          161 GTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRI  240 (338)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (338)
                      ....+.|||....  ..+.+.=|||||+++|..+-=..|    .                   .....+|+.+.+||..|
T Consensus        99 ~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~----e-------------------~eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           99 GEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLK----E-------------------NEERELSPPLEQLIDHM  153 (229)
T ss_dssp             --------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCC----T-------------------TEEECCCHHHHHHHHHH
T ss_pred             cccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCC----c-------------------ccchhhCHHHHHHHHHH
Confidence            2234668888632  223346899999999998731111    0                   01236899999999999


Q ss_pred             ccc
Q 019628          241 FVA  243 (338)
Q Consensus       241 L~~  243 (338)
                      ..-
T Consensus       154 t~~  156 (229)
T 2yle_A          154 ANT  156 (229)
T ss_dssp             TTC
T ss_pred             Hhc
Confidence            866

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.66  E-value=0.00011  Score=67.18  Aligned_cols=74  Identities=15%  Similarity=0.035  Sum_probs=45.2

Q ss_pred             eeeeccCCceEEEEEEEcC--------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeEEEEEcCCeEEEEE
Q 019628            7 VKDIGSGNFGVAKLVRDKW--------TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN-IVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++.|+.|....+|++....        .+..+++|+.............|..+++.+...+ +.+++..+  ++  ++||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            5678888888999998643        1267889987554322223467888887775334 44666554  22  5799


Q ss_pred             eccCCCC
Q 019628           78 EYAAGGE   84 (338)
Q Consensus        78 e~~~~~~   84 (338)
                      +|++|.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.62  E-value=0.00019  Score=67.07  Aligned_cols=74  Identities=12%  Similarity=0.115  Sum_probs=50.3

Q ss_pred             EeeeeccCCceEEEEEEEcC-------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKW-------TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~   77 (338)
                      -++.|+.|....||++....       .++.+++|+.... .....+.+|..+++.+...++ .++++.+.  +  .+|+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            35678889889999998652       2578899987432 111556689988888854344 56666553  2  2899


Q ss_pred             eccCCCC
Q 019628           78 EYAAGGE   84 (338)
Q Consensus        78 e~~~~~~   84 (338)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.62  E-value=0.00012  Score=67.16  Aligned_cols=138  Identities=15%  Similarity=0.121  Sum_probs=81.5

Q ss_pred             eeeeccCCceEEEEEEEcC-------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeEEEEEcCCeEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDKW-------TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN-IVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++.|..|....+|++....       +++.+++|+..........+.+|..+++.+...+ ..++++++..    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            3567668788899988642       3578999986443233456778999988875323 3556665543    28999


Q ss_pred             ccCCCChHH----------HH----H---hc-----CCC--CHHHHHHHHHHHHH-------------------HHHHhh
Q 019628           79 YAAGGELFE----------RI----C---NA-----GRF--SEDEARFFFQQLIS-------------------GVSYCH  115 (338)
Q Consensus        79 ~~~~~~L~~----------~i----~---~~-----~~l--~~~~~~~i~~qi~~-------------------al~~LH  115 (338)
                      |++|.+|..          .+    .   ..     +..  -...+..+..++-.                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999855421          11    1   11     011  13566666655532                   223332


Q ss_pred             ----h----cCceecCCCCCcEEecCC--CCCcEEEeecCCCc
Q 019628          116 ----S----MQICHRDLKLENTLLDGS--TAPRVKICDFGYSK  148 (338)
Q Consensus       116 ----~----~~iiH~Dlkp~NIl~~~~--~~~~ikL~Dfg~a~  148 (338)
                          .    ..++|+|+.+.||+++.+  ..+.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                1    359999999999999755  12478999998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.60  E-value=0.00045  Score=60.67  Aligned_cols=77  Identities=14%  Similarity=0.065  Sum_probs=54.0

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCCC---CCcceeEEEEEcCCeEEEEEec
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLKH---PNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h---~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ..-++.+|.|..+.||++... +|+.|++|+.+... .....+.+|...|+.|..   -.+.+++.+  ..  -++|||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            345788999999999999864 78899999865443 223467889998888742   234555553  22  3688999


Q ss_pred             cCCCCh
Q 019628           80 AAGGEL   85 (338)
Q Consensus        80 ~~~~~L   85 (338)
                      +.++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.46  E-value=0.0014  Score=58.77  Aligned_cols=137  Identities=15%  Similarity=0.088  Sum_probs=70.6

Q ss_pred             eeeeccCCceE-EEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC--CCcceeEEEEEcCCeEEEEEeccCCC
Q 019628            7 VKDIGSGNFGV-AKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH--PNIVRFKEVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus         7 ~~~LG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~~~iv~e~~~~~   83 (338)
                      ++.|+.|+... +|++.. .++..+++|.......  ..+..|+.+++.+..  -.+.+++.+....+  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            45566565544 666653 2356777886554321  234456666666532  23556666533333  6899999776


Q ss_pred             ChHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHh---
Q 019628           84 ELFERICNA--------------------------GRFSEDEAR-------F-FF------------QQLISGVSYC---  114 (338)
Q Consensus        84 ~L~~~i~~~--------------------------~~l~~~~~~-------~-i~------------~qi~~al~~L---  114 (338)
                      ++...+...                          ..+......       . +.            ..+..++..+   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            665443211                          012221111       0 00            0111222233   


Q ss_pred             ---hhcCceecCCCCCcEEecCCC--CCcEEEeecCCCc
Q 019628          115 ---HSMQICHRDLKLENTLLDGST--APRVKICDFGYSK  148 (338)
Q Consensus       115 ---H~~~iiH~Dlkp~NIl~~~~~--~~~ikL~Dfg~a~  148 (338)
                         +...++|+|+.|.||+++.+.  .+.+.|+||+.+.
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence               234799999999999997531  1368999999876

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.28  E-value=0.0036  Score=58.84  Aligned_cols=76  Identities=16%  Similarity=0.088  Sum_probs=49.6

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEEeccCCCC
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVMEYAAGGE   84 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~e~~~~~~   84 (338)
                      -++.|+.|....+|++.....+..+++|+........-...+|..+++.|...++ .++++++.  +.  .||||++|.+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~  187 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA  187 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence            3567888988999999876435788899875432222223688888888875554 56777662  32  4999998744


Q ss_pred             h
Q 019628           85 L   85 (338)
Q Consensus        85 L   85 (338)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.17  E-value=0.0027  Score=57.20  Aligned_cols=68  Identities=10%  Similarity=0.003  Sum_probs=41.9

Q ss_pred             ccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC---CCCcceeEEE------EEcCCeEEEEEeccC
Q 019628           11 GSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK---HPNIVRFKEV------LLTPTHLAIVMEYAA   81 (338)
Q Consensus        11 G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~------~~~~~~~~iv~e~~~   81 (338)
                      |.|....||++... +| .+++|+......     .+|+..++.|.   -|++++++..      ....+..+++|+|++
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            34446799999854 34 899998765442     34555555542   2224444332      123467899999999


Q ss_pred             CCCh
Q 019628           82 GGEL   85 (338)
Q Consensus        82 ~~~L   85 (338)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.65  E-value=0.0058  Score=56.74  Aligned_cols=76  Identities=18%  Similarity=0.078  Sum_probs=49.6

Q ss_pred             EeeeeccCCceEEEEEEEcCC-------CcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeEEEEEcCCeEEEEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWT-------RELLAVKFIERGQKIDEHVQREIMNHRSLKHPN-IVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~iv~   77 (338)
                      -++.|..|....+|++.....       ++.|++|+........-...+|..+++.+...+ ..++++.+  .+  +.||
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~  149 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE  149 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence            356777788889999987521       578999986554322233567888888775323 44555533  22  6789


Q ss_pred             eccCCCCh
Q 019628           78 EYAAGGEL   85 (338)
Q Consensus        78 e~~~~~~L   85 (338)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998553

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.23  E-value=0.068  Score=49.08  Aligned_cols=31  Identities=35%  Similarity=0.561  Sum_probs=24.6

Q ss_pred             CceecCCCCCcEEecC----CCCCcEEEeecCCCc
Q 019628          118 QICHRDLKLENTLLDG----STAPRVKICDFGYSK  148 (338)
Q Consensus       118 ~iiH~Dlkp~NIl~~~----~~~~~ikL~Dfg~a~  148 (338)
                      .++|+|+.+.|||+..    +....+.++||..|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            3679999999999943    223479999998876

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.06  E-value=0.059  Score=50.55  Aligned_cols=60  Identities=8%  Similarity=0.035  Sum_probs=17.4

Q ss_pred             EeeeeccCCceEEEEEEEcCCCcEEEE------EEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEE
Q 019628            6 IVKDIGSGNFGVAKLVRDKWTRELLAV------KFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLL   68 (338)
Q Consensus         6 ~~~~LG~G~~g~V~~~~~~~~~~~vai------K~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   68 (338)
                      +.+.||   ||.||++........||+      |..+...   .....+.+|..+++.++|||+++.+.+-.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345676   999999988655567888      6544322   22245677888888999999999887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	338
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-82
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-81
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-80
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-79
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-78
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-75
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-74
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-74
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-74
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-73
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-72
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-72
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-69
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-67
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-66
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-66
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-65
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-62
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-60
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-60
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-60
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-60
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-60
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-60
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-59
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-58
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-58
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-57
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-56
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-55
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-53
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-51
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-49
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-42
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-41
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (632), Expect = 7e-82
 Identities = 89/269 (33%), Positives = 141/269 (52%), Gaps = 10/269 (3%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           E +++V+ +G G +G  +L  ++ T E +AVK +  +R     E++++EI  ++ L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           +V+F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + I
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLTKKEY 176
            HRD+K EN LLD      +KI DFG +     +++ +      GT  Y+APE+L ++E+
Sbjct: 125 THRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
             +  DVWSCG+ L  ML G  P++ P D                    + ++      L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLAL 239

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           L +I V N   RITIP+IK   W+ + L 
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLK 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  249 bits (636), Expect = 2e-81
 Identities = 82/307 (26%), Positives = 137/307 (44%), Gaps = 19/307 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEH-VQREIMNHRSLKHPNI 60
           + Y+I++++GSG FGV     +K T  +   KFI     +D++ V+ EI     L HP +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQI 119
           +   +       + +++E+ +GGELF+RI     + SE E   + +Q   G+ + H   I
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGK 179
            H D+K EN + +   A  VKI DFG +         K T  T  + APE++ ++     
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLL 237
             D+W+ GV  YV+L G  PF   +D +  +     +    + F +  +  VS E K  +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFI 263

Query: 238 SRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEEVLSLIHEAT 297
             +      KR+T+ +   HPW            G   +     PS    ++   I E  
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLK----------GDHSNLTSRIPSSRYNKIRQKIKEKY 313

Query: 298 KPLEAPR 304
               AP+
Sbjct: 314 ADWPAPQ 320

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (624), Expect = 1e-80
 Identities = 87/267 (32%), Positives = 143/267 (53%), Gaps = 14/267 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +E +EI + +G G FG   L R+K ++ +LA+K + + Q         ++RE+     L+
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
            ++ HRD+K EN LL  +    +KI DFG+S  +   S+  +  GT  Y+ PE++  + +
Sbjct: 125 KRVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           D K  D+WS GV  Y  LVG  PFE       +++T  RI  V ++FPD+  V+   + L
Sbjct: 182 DEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDL 234

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRN 263
           +SR+   N  +R  + E+  HPW   N
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITAN 261

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  244 bits (625), Expect = 1e-79
 Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 9/264 (3%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPN 59
           ++ Y+I +++G+G FGV   V ++ T    A KF+    + D E V++EI     L+HP 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 118
           +V   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G+ + H   
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
             H DLK EN +     +  +K+ DFG +         K T GT  + APEV   K    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHL 236
              D+WS GV  Y++L G  PF    D +  R     + S  ++  D  +  +S + K  
Sbjct: 205 Y-TDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDF 259

Query: 237 LSRIFVANSEKRITIPEIKNHPWF 260
           + ++ +A+   R+TI +   HPW 
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWL 283

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 1e-78
 Identities = 69/267 (25%), Positives = 124/267 (46%), Gaps = 8/267 (2%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E+Y I +D+G G FG+     +  +++    KF++        V++EI      +H NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
              E   +   L ++ E+ +G ++FERI  +A   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKI 180
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183

Query: 181 ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLLS 238
            D+WS G  +YV+L G  PF      +  ++ I  I++  Y+F +  +  +S+E    + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 239 RIFVANSEKRITIPEIKNHPWFLRNLP 265
           R+ V   + R+T  E   HPW  + + 
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIE 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  234 bits (599), Expect = 3e-76
 Identities = 91/271 (33%), Positives = 137/271 (50%), Gaps = 10/271 (3%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLKHPN 59
           + Y+    +G+G F    L  DK T++L+A+K I +   +  +  ++ EI     +KHPN
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           IV   ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 120 CHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
            HRDLK EN L        ++ I DFG SK     S   +  GTP Y+APEVL +K Y  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYVRVSLECKHL 236
              D WS GV  Y++L G  PF D    +N  K   +IL   Y F  P +  +S   K  
Sbjct: 189 A-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243

Query: 237 LSRIFVANSEKRITIPEIKNHPWFLRNLPIE 267
           +  +   + EKR T  +   HPW   +  ++
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 2e-75
 Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 9/267 (3%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNI 60
           ++Y   + IG G  G      D  T + +A++ +   Q+   E +  EI+  R  K+PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           V + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDGK 179
           HRD+K +N LL       VK+ DFG+          +ST VGTP ++APEV+T+K Y  K
Sbjct: 139 HRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 180 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR 239
             D+WS G+    M+ G  P+ +    +          +      +  ++S   +  L+R
Sbjct: 197 -VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLNR 252

Query: 240 IFVANSEKRITIPEIKNHPWFLRNLPI 266
               + EKR +  E+  H +     P+
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPL 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 2e-74
 Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 22/272 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDE----HVQREIMNHRSLKH 57
           E ++  K +G G+F    L R+  T    A+K +E+   I E    +V RE      L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLTKK 174
            I HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+LT+K
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
                 +D+W+ G  +Y ++ G  PF       N      +I+ + Y FP+  +   + +
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238

Query: 235 HLLSRIFVANSEKRITI------PEIKNHPWF 260
            L+ ++ V ++ KR+          +K HP+F
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 3e-74
 Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 45/303 (14%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
           + +E + ++G+GN GV   V  K +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 60  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 118
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y      
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           I HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPED--------------------------------- 205
           + +D+WS G++L  M VG YP   P+                                  
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 206 -----PKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                P    + +  I++           SLE +  +++  + N  +R  + ++  H + 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 261 LRN 263
            R+
Sbjct: 302 KRS 304

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  229 bits (585), Expect = 3e-74
 Identities = 69/271 (25%), Positives = 115/271 (42%), Gaps = 17/271 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLKH 57
           + +  +++IG G+FG     RD    E++A+K +    K      + + +E+   + L+H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           PN ++++   L      +VMEY  G        +     E E        + G++Y HS 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---TKK 174
            + HRD+K  N LL       VK+ DFG +    + +   S VGTP ++APEV+    + 
Sbjct: 135 NMIHRDVKAGNILLSEPG--LVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEG 189

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +YDGK  DVWS G+T   +     P  +     N    +  I             S   +
Sbjct: 190 QYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYFR 244

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
           + +        + R T   +  H + LR  P
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (581), Expect = 7e-74
 Identities = 74/266 (27%), Positives = 120/266 (45%), Gaps = 12/266 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-EHVQREIMNHRSLKHPNI 60
           + +EI+ ++G G FG     ++K T  L A K I+   + + E    EI    S  HPNI
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 71

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQI 119
           V+  +      +L I++E+ AGG +   +    R  +E + +   +Q +  ++Y H  +I
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEYDG 178
            HRDLK  N L        +K+ DFG S  +    Q + + +GTP ++APEV+  +    
Sbjct: 132 IHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 179 KI----ADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +     ADVWS G+TL  M     P  +    +   K      S   +     R S   K
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNFK 246

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWF 260
             L +    N + R T  ++  HP+ 
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  227 bits (579), Expect = 1e-73
 Identities = 89/277 (32%), Positives = 131/277 (47%), Gaps = 24/277 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI----------ERGQKIDEHVQREIMN 51
           E YE  + +G G   V +    K T +  AVK I          E  Q++ E   +E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 52  HRSLK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISG 110
            R +  HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 111 VSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 171 LTKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-- 223
           +     D     GK  D+WS GV +Y +L G+ PF      +     +  I+S +Y F  
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLMLRMIMSGNYQFGS 236

Query: 224 PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           P++   S   K L+SR  V   +KR T  E   HP+F
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 1e-72
 Identities = 92/280 (32%), Positives = 140/280 (50%), Gaps = 16/280 (5%)

Query: 1   MERYEIVKD-IGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNH-RSLKHP 58
           ++ Y++    +G G  G    + +K T+E  A+K ++   K     +RE+  H R+ + P
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQCP 65

Query: 59  NIVRFKEVLLTP----THLAIVMEYAAGGELFERICNAG--RFSEDEARFFFQQLISGVS 112
           +IVR  +V          L IVME   GGELF RI + G   F+E EA    + +   + 
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 113 YCHSMQICHRDLKLENTLLDGSTAP-RVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
           Y HS+ I HRD+K EN L         +K+ DFG++K +  H+   +   TP Y+APEVL
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRV 229
             ++YD    D+WS GV +Y++L G  PF              RI    Y FP+  +  V
Sbjct: 186 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELT 269
           S E K L+  +      +R+TI E  NHPW +++  +  T
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 284

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 2e-72
 Identities = 92/270 (34%), Positives = 146/270 (54%), Gaps = 16/270 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI-------ERGQKIDEHVQREIMNHRS 54
           + Y+  +++GSG F V K  R+K T    A KFI        R     E ++RE+   + 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYC 114
           ++HPN++   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 115 HSMQICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           HS+QI H DLK EN +L       PR+KI DFG +      ++ K+  GTP ++APE++ 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS 230
            +      AD+WS GV  Y++L GA PF         ++T+  + +V+Y F D  +   S
Sbjct: 190 YEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 231 LECKHLLSRIFVANSEKRITIPEIKNHPWF 260
              K  + R+ V + +KR+TI +   HPW 
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 2e-69
 Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 23/273 (8%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKHP 58
           E YE++  IG+G++G  + +R K   ++L  K ++ G   +   + +  E+   R LKHP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 59  NIVRFKEVLL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARFFFQQLISGVS 112
           NIVR+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 113 YCH-----SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVG-TPAYI 166
            CH        + HRDLK  N  LDG     VK+ DFG ++     +        TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 167 APEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDY 226
           +PE + +  Y+ K +D+WS G  LY +     PF       + ++  G+I    +    Y
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 236

Query: 227 VRVSLECKHLLSRIFVANSEKRITIPEIKNHPW 259
            R S E   +++R+       R ++ EI  +P 
Sbjct: 237 -RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 6e-68
 Identities = 87/267 (32%), Positives = 135/267 (50%), Gaps = 16/267 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREI-MNHRSL 55
           +E + + K +G G+FG   L   K T +  A+K +++   +     E    E  +   + 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           +HP +        T  +L  VMEY  GG+L   I +  +F    A F+  ++I G+ + H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKK 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+L  +
Sbjct: 121 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
           +Y+    D WS GV LY ML+G  PF      ++  +    I   +  +P +  +  E K
Sbjct: 179 KYNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPRW--LEKEAK 231

Query: 235 HLLSRIFVANSEKRITIP-EIKNHPWF 260
            LL ++FV   EKR+ +  +I+ HP F
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 3e-67
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 16/266 (6%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID---EHVQREIMNHRSLKHPNI 60
            +   +IG G+F       D  T   +A   ++  +      +  + E    + L+HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 61  VRFKEVLLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           VRF +   +       + +V E    G L   +           R + +Q++ G+ + H+
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 117 M--QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKK 174
               I HRDLK +N  + G T   VKI D G +      S  K+ +GTP ++APE+  +K
Sbjct: 131 RTPPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEK 188

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            YD    DV++ G+ +  M    YP+ + ++     +   R+ S             E K
Sbjct: 189 -YDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVK 243

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWF 260
            ++      N ++R +I ++ NH +F
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 5e-66
 Identities = 81/280 (28%), Positives = 126/280 (45%), Gaps = 27/280 (9%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID-------EHVQREIMNHRSL 55
           +Y++   +GSG FG             +A+K +E+ +  D         V  E++  + +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 56  K--HPNIVRFKEVLLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARFFFQQLISGVS 112
                 ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           +CH+  + HRD+K EN L+D +    +K+ DFG     +  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIR 182

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+     F    RVS E
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 230

Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWFLRN--LPIELTE 270
           C+HL+          R T  EI+NHPW  ++  LP E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM-QDVLLPQETAE 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  208 bits (529), Expect = 9e-66
 Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 20/269 (7%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           ++ ++I++ +G+G+FG   L+R +      A+K +++   +     EH   E +    + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y HS
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
             I +RDLK EN LLD +    +KI DFG++K   +     +  GTP YIAPEV++ K Y
Sbjct: 123 KDIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           +    D WS G+ +Y ML G  PF D     N  KT  +IL+    FP +   + + K L
Sbjct: 179 NKS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPF--FNEDVKDL 231

Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           LSR+   +  +R+        ++KNHPWF
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  208 bits (531), Expect = 2e-65
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 18/272 (6%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR------- 53
           M  + + + IG G FG     R   T ++ A+K +++ +   +  +   +N R       
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 54  SLKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           +   P IV       TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ +
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            H+  + +RDLK  N LLD      V+I D G +       +P ++VGT  Y+APEVL K
Sbjct: 123 MHNRFVVYRDLKPANILLDEH--GHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQK 179

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
                  AD +S G  L+ +L G  PF      K+  +     L++    PD    S E 
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDS--FSPEL 236

Query: 234 KHLLSRIFVANSEKRITIP-----EIKNHPWF 260
           + LL  +   +  +R+        E+K  P+F
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 3e-62
 Identities = 87/270 (32%), Positives = 131/270 (48%), Gaps = 19/270 (7%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           M  ++ +K +G G FG   LVR+K T    A+K + +   I      H   E    ++ +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLTKKE 175
             + +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH 235
           Y     D W  GV +Y M+ G  PF +    ++  +    IL     FP    +S E K 
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPRT--LSPEAKS 234

Query: 236 LLSRIFVANSEKRI-----TIPEIKNHPWF 260
           LL+ +   + ++R+        E+  H +F
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  193 bits (491), Expect = 1e-60
 Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 17/261 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI----ERGQKIDEHVQREIMNHRSLKH 57
           +RYE+ + +G G      L RD      +AVK +     R        +RE  N  +L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 58  PNIVRFKEVLLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           P IV   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVL 171
            H   I HRD+K  N ++  + A +V         + S    +Q  + +GT  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR--V 229
                D + +DV+S G  LY +L G  PF          +     +      P      +
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----HVREDPIPPSARHEGL 241

Query: 230 SLECKHLLSRIFVANSEKRIT 250
           S +   ++ +    N E R  
Sbjct: 242 SADLDAVVLKALAKNPENRYQ 262

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (497), Expect = 1e-60
 Identities = 82/269 (30%), Positives = 139/269 (51%), Gaps = 20/269 (7%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRSLK 56
           +++++ +K +G+G+FG   LV+ K +    A+K +++ + +     EH   E    +++ 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
            P +V+ +      ++L +VMEY AGGE+F  +   GRFSE  ARF+  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEY 176
           + + +RDLK EN L+D      +++ DFG++K      +  +  GTP  +APE++  K Y
Sbjct: 160 LDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGY 215

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL 236
           +    D W+ GV +Y M  G  PF          +   +I+S    FP +   S + K L
Sbjct: 216 NKA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPSH--FSSDLKDL 268

Query: 237 LSRIFVANSEKRI-----TIPEIKNHPWF 260
           L  +   +  KR       + +IKNH WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 2e-60
 Identities = 70/290 (24%), Positives = 113/290 (38%), Gaps = 32/290 (11%)

Query: 5   EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG------QKIDEHVQREIMNHRSLKHP 58
           E +  +G G F      RDK T +++A+K I+ G        I+    REI   + L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 118
           NI+   +     +++++V ++           N+   +    + +    + G+ Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 119 ICHRDLKLENTLLDGSTAPRVKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           I HRDLK  N LLD +    +K+ DFG +KS    +      V T  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------HYSFPDYV--- 227
           G   D+W+ G  L  +L+         D     +    + +          S PDYV   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 228 ------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLP 265
                           +   L+  +F+ N   RIT  +     +F  N P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRP 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  193 bits (492), Expect = 4e-60
 Identities = 60/295 (20%), Positives = 120/295 (40%), Gaps = 41/295 (13%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPN 59
            + Y++V+ +G G +       +    E + VK ++  +K  + ++REI    +L+  PN
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 91

Query: 60  IVRFKEVLLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           I+   +++  P     A+V E+    +  +        ++ + RF+  +++  + YCHSM
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
            I HRD+K  N ++D     ++++ D+G ++      +    V +  +  PE+L   +  
Sbjct: 149 GIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-------------- 223
               D+WS G  L  M+    PF    D  +    I ++L     +              
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

Query: 224 ------------------PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                              +   VS E    L ++   + + R+T  E   HP+F
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 6e-60
 Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 16/274 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
            +  + + IGSG+FG     +       +AVK +       + +Q    E+   R  +H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 59  NIVRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSM 117
           NI+ F     T   LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+ 
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKK 174
            I HRDLK  N  L       VKI DFG +          Q +   G+  ++APEV+  +
Sbjct: 124 SIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 175 EYD--GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE 232
           + +     +DV++ G+ LY ++ G  P+ +  +       +GR                 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241

Query: 233 CKHLLSRIFVANSEKRITIPEIKNHPWFL-RNLP 265
            K L++       ++R   P+I      L R+LP
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 7e-60
 Identities = 78/303 (25%), Positives = 119/303 (39%), Gaps = 38/303 (12%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVR 62
            Y   K IG+G+FGV    +   + EL+A+K + + ++      RE+   R L H NIVR
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVR 77

Query: 63  FKEVLLTP------THLAIVMEYAAGG---ELFERICNAGRFSEDEARFFFQQLISGVSY 113
            +    +        +L +V++Y                        + +  QL   ++Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  ICHRD+K +N LLD  TA   K+CDFG +K  V      S + +  Y APE++  
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPED-----------------------PKNFR 210
                   DVWS G  L  +L+G   F                            P    
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 211 KTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF--LRNLPIEL 268
               +I +  ++     R   E   L SR+       R+T  E   H +F  LR+  ++L
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

Query: 269 TEG 271
             G
Sbjct: 317 PNG 319

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 8e-59
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 30/288 (10%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKH 57
           ME ++ V+ IG G +GV    R+K T E++A+K I      + +     REI   + L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 116
           PNIV+  +V+ T   L +V E+     + F              + +  QL+ G+++CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 117 MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKE 175
            ++ HRDLK +N L++      +K+ DFG +++  +  +  +  V T  Y APE+L   +
Sbjct: 121 HRVLHRDLKPQNLLINTE--GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI-------GRILSVHYSFPDYV- 227
           Y     D+WS G     M+     F    +     +           +     S PDY  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 228 ---------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                           +  + + LLS++   +  KRI+      HP+F
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-58
 Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 30/288 (10%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKH 57
           M++YE ++ IG G +G     +++ T E++A+K +   +  + +     REI   + LKH
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
            NIVR  +VL +   L +V E+             G    +  + F  QL+ G+ +CHS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLTKKEY 176
            + HRDLK +N L++ +    +K+ +FG +++  +  +  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--------YSFPDYV- 227
                D+WS G     +     P     D  +  K I R+L              PDY  
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 228 ---------------RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                          +++   + LL  +   N  +RI+  E   HP+F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-58
 Identities = 75/330 (22%), Positives = 124/330 (37%), Gaps = 39/330 (11%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI--ERGQKIDEHVQREIMNHRSLKHPN 59
            RY  +  IG G +G+     D   +  +A+K I     Q   +   REI      +H N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 60  IVRFKEVLLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 115
           I+   +++  PT        ++ +  G +L++ +      S D   +F  Q++ G+ Y H
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 171
           S  + HRDLK  N LL+ +    +KICDFG ++               V T  Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG----------------R 215
              +   K  D+WS G  L  ML     F            +G                +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 216 ILSVHYSFPDYVR---------VSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL-P 265
             +   S P   +            +   LL ++   N  KRI + +   HP+  +   P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

Query: 266 IELTEGGSWQSHDVNNPSQSLEEVLSLIHE 295
            +     +    D+       E++  LI E
Sbjct: 305 SDEPIAEAPFKFDMELDDLPKEKLKELIFE 334

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  187 bits (476), Expect = 3e-58
 Identities = 71/287 (24%), Positives = 120/287 (41%), Gaps = 30/287 (10%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKH 57
           ME+Y  ++ IG G +GV    ++    E  A+K I   +  + I     REI   + LKH
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
            NIV+  +V+ T   L +V E+             G      A+ F  QL++G++YCH  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLTKKEY 176
           ++ HRDLK +N L++      +KI DFG +++  +  +  +  + T  Y AP+VL   + 
Sbjct: 120 RVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 177 DGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRK--------------TIGRILSVHYS 222
                D+WS G     M+ G   F    +     +               +  +     +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 223 FPDYVR---------VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
           F  Y           +      LLS++   +  +RIT  +   H +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 6e-58
 Identities = 63/315 (20%), Positives = 115/315 (36%), Gaps = 53/315 (16%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLKH 57
           + +YE +  IG G FG     R + T + +A+K +      +       REI   + LKH
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 58  PNIVRFKEVLLTPT--------HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLIS 109
            N+V   E+  T           + +V ++              +F+  E +   Q L++
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPA 164
           G+ Y H  +I HRD+K  N L+       +K+ DFG ++      +   ++  + V T  
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 165 YIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP 224
           Y  PE+L  +   G   D+W  G  +  M   +   +        +  +  I  +  S  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALISQLCGSIT 242

Query: 225 DYVR------------------------------VSLECKHLLSRIFVANSEKRITIPEI 254
             V                                      L+ ++ V +  +RI   + 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 255 KNHPWFLRN-LPIEL 268
            NH +F  + +P +L
Sbjct: 303 LNHDFFWSDPMPSDL 317

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 7e-57
 Identities = 58/260 (22%), Positives = 101/260 (38%), Gaps = 15/260 (5%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI 60
           M+  ++++ IG G FG   L    +    +AVK I +     +    E      L+H N+
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNL 62

Query: 61  VRFKEVLL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 117
           V+   V++     L IV EY A G L + + + GR     D    F   +   + Y    
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
              HRDL   N L+        K+ DFG +K     S   +      + APE L +K++ 
Sbjct: 123 NFVHRDLAARNVLVSEDN--VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFS 178

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K +DVWS G+ L+ +             K+    + +        PD          ++
Sbjct: 179 TK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYKMDAPDG--CPPAVYEVM 233

Query: 238 SRIFVANSEKRITIPEIKNH 257
              +  ++  R +  +++  
Sbjct: 234 KNCWHLDAAMRPSFLQLREQ 253

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-56
 Identities = 75/330 (22%), Positives = 136/330 (41%), Gaps = 44/330 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKHP 58
             Y  ++ +GSG +G      D  T   +A+K + R    +   +   RE+   + ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 59  NIVRFKEV------LLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVS 112
           N++   +V      L   T   +VM +   G    ++    +  ED  +F   Q++ G+ 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 113 YCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLT 172
           Y H+  I HRDLK  N  ++      +KI DFG ++     S+    V T  Y APEV+ 
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPED--------------PKNFRKTIGRILS 218
                 +  D+WS G  +  M+ G   F+  +               P  F + +    +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 219 VHY--SFPDYVR---------VSLECKHLLSRIFVANSEKRITIPEIKNHPWF--LRNLP 265
            +Y    P+  +          S    +LL ++ V ++E+R+T  E   HP+F  L +  
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311

Query: 266 IELTEGGSWQSHDVNNPSQSLEEVLSLIHE 295
            E        S D  +  ++L+E   + ++
Sbjct: 312 DEPQVQKYDDSFD--DVDRTLDEWKRVTYK 339

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-55
 Identities = 78/277 (28%), Positives = 134/277 (48%), Gaps = 21/277 (7%)

Query: 1   MERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQ-----KIDEHVQREIMNH 52
           +E +E++K +G+G +G     + +    T +L A+K +++       K  EH + E    
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 53  RSLKH-PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
             ++  P +V       T T L ++++Y  GGELF  +    RF+E E + +  +++  +
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPE 169
            + H + I +RD+KLEN LLD +    V + DFG SK   +    +     GT  Y+AP+
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 170 VL-TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
           ++        K  D WS GV +Y +L GA PF    +  +  +   RIL     +P    
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--E 258

Query: 229 VSLECKHLLSRIFVANSEKRI-----TIPEIKNHPWF 260
           +S   K L+ R+ + + +KR+        EIK H +F
Sbjct: 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-55
 Identities = 57/260 (21%), Positives = 110/260 (42%), Gaps = 13/260 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           +    +K++G+G FGV K  + +  +  +A+K I+ G   ++    E     +L H  +V
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +   V      + I+ EY A G L   +     RF   +     + +   + Y  S Q  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYDG 178
           HRDL   N L++      VK+ DFG S+  +      S        +  PEVL   ++  
Sbjct: 123 HRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 179 KIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
           K +D+W+ GV ++ +  +G  P+E         +T   I      +  ++  S +   ++
Sbjct: 181 K-SDIWAFGVLMWEIYSLGKMPYER----FTNSETAEHIAQGLRLYRPHL-ASEKVYTIM 234

Query: 238 SRIFVANSEKRITIPEIKNH 257
              +   +++R T   + ++
Sbjct: 235 YSCWHEKADERPTFKILLSN 254

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 74/293 (25%), Positives = 113/293 (38%), Gaps = 37/293 (12%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRD-KWTRELLAVKFI---ERGQKIDEHVQREIMNHRSLK- 56
           ++YE V +IG G +G     RD K     +A+K +      + +     RE+   R L+ 
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 57  --HPNIVRFKEVLLTP-----THLAIVMEYAAGGEL-FERICNAGRFSEDEARFFFQQLI 108
             HPN+VR  +V         T L +V E+       +           +  +    QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAP 168
            G+ + HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDYV 227
           EVL +  Y     D+WS G     M      F    D     K +  I       +P  V
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 228 R--------------------VSLECKHLLSRIFVANSEKRITIPEIKNHPWF 260
                                +    K LL +    N  KRI+     +HP+F
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 4e-54
 Identities = 55/270 (20%), Positives = 100/270 (37%), Gaps = 15/270 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E   +   +G G FG   +     T  + A+K ++ G    E   +E    + L+H  +V
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           +   V+ +   + IV EY + G L +  +          +      Q+ SG++Y   M  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 135 VHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K +DVWS G+ L  +             +     + R     Y  P           L+
Sbjct: 193 IK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLM 247

Query: 238 SRIFVANSEKRITIPEIKN--HPWFLRNLP 265
            + +    E+R T   ++     +F    P
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-53
 Identities = 54/259 (20%), Positives = 97/259 (37%), Gaps = 11/259 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
                V++IGSG FG+  L      ++ +A+K I  G   +E    E      L HP +V
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
           +   V L    + +V E+   G L +      G F+ +        +  G++Y     + 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 121 HRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           HRDL   N L+  +    +K+ DFG ++      ++    T     + +PEV +   Y  
Sbjct: 124 HRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 179 KIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLS 238
           K +DVWS GV ++ +        +        + I       +        S     +++
Sbjct: 182 K-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYKPRLASTHVYQIMN 236

Query: 239 RIFVANSEKRITIPEIKNH 257
             +    E R     +   
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  175 bits (445), Expect = 1e-53
 Identities = 55/257 (21%), Positives = 93/257 (36%), Gaps = 11/257 (4%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
               +   +G G +G       K     +AVK ++      E   +E    + +KHPN+V
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQI 119
           +   V        I+ E+   G L + +    R   S     +   Q+ S + Y      
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
            HRDL   N L+  +    VK+ DFG S+  +   ++          + APE L   ++ 
Sbjct: 137 IHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K +DVW+ GV L+ +           D     +    +L   Y          +   L+
Sbjct: 195 IK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKDYRMERPEGCPEKVYELM 249

Query: 238 SRIFVANSEKRITIPEI 254
              +  N   R +  EI
Sbjct: 250 RACWQWNPSDRPSFAEI 266

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (448), Expect = 2e-53
 Identities = 71/339 (20%), Positives = 128/339 (37%), Gaps = 46/339 (13%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQ---REIMNHRSLKHP 58
           ERY+ +  +GSG +G      D  T   +AVK + R  +   H +   RE+   + +KH 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 59  NIVRFKEVLLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSY 113
           N++   +V      L       ++ +  G      I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTK 173
            HS  I HRDLK  N  ++      +KI DFG ++      +    V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 192

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD-------- 225
             +  +  D+WS G  +  +L G   F   +     +     IL +  +           
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL----ILRLVGTPGAELLKKISS 248

Query: 226 ---------------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL 264
                                ++  +     LL ++ V +S+KRIT  +   H +F +  
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

Query: 265 PIELTEGGSWQSHDVNNPSQSLEEVLSLIHEATKPLEAP 303
             +             +    ++E  SL ++       P
Sbjct: 309 DPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPP 347

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 6e-52
 Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 21/269 (7%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERGQKID----EHVQREIMNHRS 54
           +   +++ +G G+FGV    +          +AVK ++          +   RE+    S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSY 113
           L H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 114 CHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 169
             S +  HRDL   N LL       VKI DFG  +    +   +   +      A+ APE
Sbjct: 127 LESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR 228
            L  + +    +D W  GVTL+ M   G  P+       N  + + +I       P    
Sbjct: 185 SLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPED 239

Query: 229 VSLECKHLLSRIFVANSEKRITIPEIKNH 257
              +  +++ + +    E R T   +++ 
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 8e-52
 Identities = 53/265 (20%), Positives = 102/265 (38%), Gaps = 15/265 (5%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
           E  ++V+ +G+G FG   +         +AVK +++G    +    E    + L+H  +V
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQI 119
           R   V+ T   + I+ EY   G L + +   +  + + ++      Q+  G+++      
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130

Query: 120 CHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTKKEYD 177
            HRDL+  N L+  +     KI DFG ++    +             + APE +    + 
Sbjct: 131 IHRDLRAANILVSDT--LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K +DVWS G+ L  ++                + + R     Y          E   L+
Sbjct: 189 IK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQLM 243

Query: 238 SRIFVANSEKRITIPEIKN--HPWF 260
              +    E R T   +++    +F
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFF 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (431), Expect = 2e-51
 Identities = 59/281 (20%), Positives = 104/281 (37%), Gaps = 19/281 (6%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN-IV 61
           RY + + IGSG+FG   L  D    E +A+K +E  +     +  E   ++ ++    I 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 62  RFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
             +       +  +VME             + +FS         Q+IS + Y HS    H
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 122 RDLKLENTLL-DGSTAPRVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLT 172
           RD+K +N L+  G     V I DFG +K          + + + K+  GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 173 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV---RV 229
             E   +  D+ S G  L    +G+ P++  +     +K   RI     S P  V     
Sbjct: 187 GIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTPIEVLCKGY 244

Query: 230 SLECKHLLSRIFVANSEKRITIPEIKN---HPWFLRNLPIE 267
             E    L+       + +     ++    + +  +    +
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 3e-51
 Identities = 61/291 (20%), Positives = 105/291 (36%), Gaps = 42/291 (14%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTREL-----LAVKFI--ERGQKIDEHVQREIMNHRS 54
           E  E  K +GSG FG           +      +AVK +  +      E +  E+     
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 55  L-KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI-----------------------C 90
           L  H NIV           + ++ EY   G+L   +                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 91  NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-- 148
           +    + ++   F  Q+  G+ +       HRDL   N L+       VKICDFG ++  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLARDI 214

Query: 149 -SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDP 206
            S   +    +      ++APE L +  Y  K +DVWS G+ L+ +  +G  P+      
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 207 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            NF K    ++   +        + E   ++   +  +S KR + P + + 
Sbjct: 274 ANFYK----LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (430), Expect = 3e-51
 Identities = 56/270 (20%), Positives = 106/270 (39%), Gaps = 21/270 (7%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRE---LLAVKFIERG--QKIDEHVQREIMNHRSL 55
           +   +I + IG+G FG       K   +    +A+K ++ G  +K       E       
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARFFFQQLISGVSYC 114
            HPN++  + V+   T + I+ E+   G L      N G+F+  +     + + +G+ Y 
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK------SSVLHSQPKSTVGTPAYIAP 168
             M   HRDL   N L++ +     K+ DFG S+      S   ++          + AP
Sbjct: 145 ADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 169 EVLTKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYV 227
           E +  +++    +DVWS G+ ++ ++  G  P+ D  +           +   Y  P  +
Sbjct: 203 EAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-----IEQDYRLPPPM 256

Query: 228 RVSLECKHLLSRIFVANSEKRITIPEIKNH 257
                   L+   +  +   R    +I N 
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 6e-51
 Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 16/264 (6%)

Query: 2   ERYEIVKDIGSGNFGV---AKLVRDKWTRELLAVKFIERG--QKIDEHVQREIMNHRSLK 56
           ER E+ + IG G FG       +  +     +A+K  +      + E   +E +  R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCH 115
           HP+IV+   V +T   + I+ME    GEL   +              +  QL + ++Y  
Sbjct: 67  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLTK 173
           S +  HRD+   N L+  +    VK+ DFG S+     +  K++       ++APE +  
Sbjct: 126 SKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 174 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC 233
           + +    +DVW  GV ++ +L+       P         IGRI +     P         
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPPTL 238

Query: 234 KHLLSRIFVANSEKRITIPEIKNH 257
             L+++ +  +  +R    E+K  
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-50
 Identities = 53/291 (18%), Positives = 105/291 (36%), Gaps = 16/291 (5%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFI------ERGQKIDEHVQREIMNHRSLKH 57
           ++ +K +GSG FG           E + +             K ++ +  E     S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 58  PNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 117
           P++ R   + LT T   I      G  L     +           +  Q+  G++Y    
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 118 QICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLTKK 174
           ++ HRDL   N L+       VKI DFG +K   +       +       ++A E +  +
Sbjct: 131 RLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 175 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK 234
            Y  + +DVWS GVT++ ++       D             IL      P     +++  
Sbjct: 189 IYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGERLPQPPICTIDVY 243

Query: 235 HLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQS 285
            ++ + ++ +++ R    E+      +   P         +   + +P+ S
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 3e-50
 Identities = 58/267 (21%), Positives = 100/267 (37%), Gaps = 24/267 (8%)

Query: 8   KDIGSGNFGVAKLV--RDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVR 62
           K++GSGNFG  K    + K   + +AVK ++       + + +  E    + L +P IVR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 63  FKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLTKKEYDG 178
           DL   N LL        KI DFG SK+       +           + APE +   ++  
Sbjct: 132 DLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 179 KIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRVSLECKHL 236
           K +DVWS GV ++     G  P+          +    +        P       E   L
Sbjct: 190 K-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLEKGERMGCPAG--CPREMYDL 242

Query: 237 LSRIFVANSEKRITIPEIK---NHPWF 260
           ++  +  + E R     ++    + ++
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYY 269

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 4e-50
 Identities = 63/274 (22%), Positives = 106/274 (38%), Gaps = 25/274 (9%)

Query: 2   ERYEIVK-DIGSGNFGVAKLVRDKWTRE--LLAVKFIERG--QKIDEHVQREIMNHRSLK 56
           +   I   ++G GNFG  +    +  ++   +A+K +++G  +   E + RE      L 
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67

Query: 57  HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 115
           +P IVR   V      L +VME A GG L + +                 Q+  G+ Y  
Sbjct: 68  NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126

Query: 116 SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 171
                HRDL   N LL        KI DFG SK        ++   +      + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 172 TKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEDPKNFRKTIGRILSVHY-SFPDYVRV 229
             +++  + +DVWS GVT++  L  G  P++         + +  I        P     
Sbjct: 185 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFIEQGKRMECPPE--C 237

Query: 230 SLECKHLLSRIFVANSEKRITIPEIK---NHPWF 260
             E   L+S  ++   E R     ++      ++
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  163 bits (414), Expect = 7e-49
 Identities = 45/270 (16%), Positives = 92/270 (34%), Gaps = 18/270 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-PNI 60
             Y++ + IG G+FGV     +    + +A+KF  R +     ++ E   ++ L     I
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 61  VRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQIC 120
                      H  +V++               +FS        +Q+++ V   H   + 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 121 HRDLKLENTLLDGSTAP---RVKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 169
           +RD+K +N L+    +     + + DFG  K          + + + K+  GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 170 VLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR- 228
               +E   +  D+ + G      L G+ P+         ++   RI     S P     
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 229 --VSLECKHLLSRIFVANSEKRITIPEIKN 256
                E    +        +       ++ 
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 8e-49
 Identities = 57/278 (20%), Positives = 94/278 (33%), Gaps = 28/278 (10%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELL--AVKFIERGQKID--EHVQREIMNHRSL- 55
               +    IG GNFG     R K     +  A+K ++     D       E+     L 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDE 99
            HPNI+          +L + +EYA  G L + +                  A   S  +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 100 ARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST 159
              F   +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++ +    
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMG 186

Query: 160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV 219
                ++A E L    Y    +DVWS GV L+ ++                + + +    
Sbjct: 187 RLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---- 241

Query: 220 HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            Y     +    E   L+ + +     +R +  +I   
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 8e-49
 Identities = 66/305 (21%), Positives = 113/305 (37%), Gaps = 51/305 (16%)

Query: 1   MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIER---GQKIDEHVQREIMNHRSLKH 57
           ++RY+ +K IGSG  G+     D      +A+K + R    Q   +   RE++  + + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIVRFKEVLLTP------THLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGV 111
            NI+    V            + +VME                   +   +   Q++ G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGI 132

Query: 112 SYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 171
            + HS  I HRDLK  N ++       +KI DFG ++++         V T  Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 172 TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI------------------ 213
               Y   + D+WS G  +  M+     F   +    + K I                  
Sbjct: 191 LGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 214 -----GRILSVHYSFPDYVR-------------VSLECKHLLSRIFVANSEKRITIPEIK 255
                 R      +FP                  + + + LLS++ V +  KRI++ +  
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 256 NHPWF 260
            HP+ 
Sbjct: 310 QHPYI 314

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 63/288 (21%), Positives = 105/288 (36%), Gaps = 43/288 (14%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFI--ERGQKIDEHVQREIMNHRS 54
              E V+DIG G FG     R           ++AVK +  E    +    QRE      
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGR-------------------- 94
             +PNIV+   V      + ++ EY A G+L E + +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 95  ----FSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK-- 148
                S  E     +Q+ +G++Y    +  HRDL   N L+  +    VKI DFG S+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190

Query: 149 -SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK 207
            S+  +    +      ++ PE +    Y  + +DVW+ GV L+ +         P    
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGM 246

Query: 208 NFRKTIGRILSVHY-SFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 254
              + I  +   +  + P+     LE  +L+   +      R +   I
Sbjct: 247 AHEEVIYYVRDGNILACPEN--CPLELYNLMRLCWSKLPADRPSFCSI 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 9e-46
 Identities = 53/264 (20%), Positives = 97/264 (36%), Gaps = 18/264 (6%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERG--QKIDEHVQREIMNHRSL 55
                 K IG+G FG       K +       +A+K ++ G  +K       E       
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 56  KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 114
            H NI+R + V+     + I+ EY   G L + +    G FS  +     + + +G+ Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 115 HSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEV 170
            +M   HRDL   N L++ +     K+ DFG S+                    + APE 
Sbjct: 127 ANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 171 LTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS 230
           ++ +++    +DVWS G+ ++ ++                K I       +  P  +   
Sbjct: 185 ISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCP 239

Query: 231 LECKHLLSRIFVANSEKRITIPEI 254
                L+ + +     +R    +I
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADI 263

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-45
 Identities = 54/282 (19%), Positives = 93/282 (32%), Gaps = 35/282 (12%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQKID--EHVQREIMNHRS 54
            R    K +G+G FG                  +AVK ++    +   E +  E+     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 55  LK-HPNIVRFKEVLLTPTHLAIVMEYAAGGELFERIC------------------NAGRF 95
           L  H NIV             ++ EY   G+L   +                   +    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 96  SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ 155
             ++   F  Q+  G+++  S    HRDL   N LL        KICDFG ++     S 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKNDSN 200

Query: 156 PKST---VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKT 212
                       ++APE +    Y  + +DVWS G+ L+ +              +    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS---K 256

Query: 213 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 254
             +++   +          E   ++   + A+  KR T  +I
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-45
 Identities = 52/260 (20%), Positives = 97/260 (37%), Gaps = 19/260 (7%)

Query: 10  IGSGNFGV---AKLVRDKWTRELLAVKFIERGQKIDE--HVQREIMNHRSLKHPNIVRFK 64
           IG G+FG      L+ +   +   AVK + R   I E      E +  +   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94

Query: 65  EVLL-TPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L           +  +   F  Q+  G+ +  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154

Query: 123 DLKLENTLLDGSTAPRVKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLTKKEYD 177
           DL   N +LD      VK+ DFG ++                     ++A E L  +++ 
Sbjct: 155 DLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212

Query: 178 GKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL 237
            K +DVWS GV L+ ++    P     +  +    + +                    ++
Sbjct: 213 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GRRLLQPEYCPDPLYEVM 267

Query: 238 SRIFVANSEKRITIPEIKNH 257
            + +   +E R +  E+ + 
Sbjct: 268 LKCWHPKAEMRPSFSELVSR 287

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-43
 Identities = 66/292 (22%), Positives = 106/292 (36%), Gaps = 43/292 (14%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIV 61
               + + IG G FG  ++ R KW  E +AVK     ++     + EI     L+H NI+
Sbjct: 3   RTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 62  RFKEVL----LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 116
            F         T T L +V +Y   G LF+ + N    + +          SG+++ H  
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 119

Query: 117 -------MQICHRDLKLENTLLDGSTAPRVKICDFG-----YSKSSVLHSQPKSTVGTPA 164
                    I HRDLK +N L+  +      I D G      S +  +   P   VGT  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 165 YIAPEVL-----TKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI------ 213
           Y+APEVL      K     K AD+++ G+  + +          ED +     +      
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 214 ----------GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIK 255
                      ++     +             ++   + AN   R+T   IK
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-42
 Identities = 51/280 (18%), Positives = 97/280 (34%), Gaps = 32/280 (11%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTRE-------LLAVKFI--ERGQKIDEHVQREIMNH 52
           +R  + K +G G FG   L       +        +AVK +  +  +K    +  E+   
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 53  RSL-KHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERI----------------CNAGRF 95
           + + KH NI+           L +++EYA+ G L E +                    + 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 96  SEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV-KICDFGYSKSSVLHS 154
           S  +      Q+  G+ Y  S +  HRDL   N L+      ++              + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIG 214
           +  +      ++APE L  + Y  + +DVWS GV L+ +             +   K + 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 215 RILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEI 254
                 +        + E   ++   + A   +R T  ++
Sbjct: 252 E----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (370), Expect = 9e-42
 Identities = 59/326 (18%), Positives = 108/326 (33%), Gaps = 62/326 (19%)

Query: 3   RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVR 62
           RY +V+ +G G+F    L +D      +A+K +   +   E  + EI   + +   +  +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 63  ---------------FKEVLLTPTHLAIVMEYAAGGEL-FERICNAGRFSEDEARFFFQQ 106
                          F        H+ +V E      L   +            +   +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 107 LISGVSYCHSMQ-ICHRDLKLENTLLD--GSTAPRVKICDFGYSKSSVLHSQPKSTVGTP 163
           L+ G+ Y H    I H D+K EN L++   S    ++I       +        +++ T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 164 AYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEDPKNFRKTIGRILSVHY 221
            Y +PEVL    +    AD+WS    ++ ++ G + F  ++          I +I+ +  
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 222 SFPDYV----------------------------------------RVSLECKHLLSRIF 241
             P Y+                                          + E    LS + 
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 242 VANSEKRITIPEIKNHPWFLRNLPIE 267
             +  KR     + NHPW    L +E
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGME 338

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 56/284 (19%), Positives = 98/284 (34%), Gaps = 34/284 (11%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTREL-----LAVKFIERGQKIDEH---VQREIMNHR 53
           +R ++ K +G G FG           +      +AVK ++ G    EH   +    +   
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 54  SLKHPNIVRFKEVLLTP-THLAIVMEYAAGGELFERICNAGR----------------FS 96
              H N+V        P   L +++E+   G L   + +                    +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 97  EDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLH 153
            +    +  Q+  G+ +  S +  HRDL   N LL       VKICDFG ++       +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDY 190

Query: 154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI 213
            +         ++APE +  + Y  + +DVWS GV L+ +         P       +  
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDEEF 246

Query: 214 GRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH 257
            R L            + E    +   +     +R T  E+  H
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-41
 Identities = 51/285 (17%), Positives = 101/285 (35%), Gaps = 33/285 (11%)

Query: 2   ERYEIVKDIGSGNFGVAKLVRDKWTR-----ELLAVKFIERGQKIDE--HVQREIMNHRS 54
           E+  + +++G G+FG+      K          +A+K +     + E      E    + 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 55  LKHPNIVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRF----------SEDEARFFF 104
               ++VR   V+       ++ME    G+L   + +              S  +     
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK---SSVLHSQPKSTVG 161
            ++  G++Y ++ +  HRDL   N ++       VKI DFG ++    +  + +    + 
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 162 TPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY 221
              +++PE L    +     DVWS GV L+ +   A         +   + +        
Sbjct: 198 PVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--GGLL 254

Query: 222 SFPDYVRVSLECKHLLSRIFVANSEKRITIPEI------KNHPWF 260
             PD          L+   +  N + R +  EI      +  P F
Sbjct: 255 DKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.1 bits (176), Expect = 1e-15
 Identities = 31/202 (15%), Positives = 56/202 (27%), Gaps = 39/202 (19%)

Query: 4   YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-----------KIDEHVQREIMNH 52
             I K +G G          +   E   VKF + G              D H     +  
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 53  RSLKHPNIVRFKEVLLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLI 108
              +   + + + + +   +     A++ME               R   +        ++
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKSTVGTPAYIAP 168
             V+  +   I H DL   N L+       + I DF     SV   +          +  
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEEGW----REILER 163

Query: 169 EVLT-----KKEYDGKIADVWS 185
           +V        + Y     D+ S
Sbjct: 164 DVRNIITYFSRTY-RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	338
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.78
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.32
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.57
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.55
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.12

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-68  Score=469.20  Aligned_cols=259  Identities=34%  Similarity=0.612  Sum_probs=222.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +++|++++.||+|+||+||+|.++.+|+.||||++.+..  ...+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            478999999999999999999999999999999997643  233568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---CC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---SQ  155 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---~~  155 (338)
                      ||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.....   ..
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~--~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC--CEEEccchhheeeccCCcccc
Confidence            999999999998888899999999999999999999999999999999999997554  8999999999854322   23


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....+||+.|||||++.+..+++.++|||||||++|+|+||++||............   ........+.+..+|+++++
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHH
Confidence            456789999999999988888777799999999999999999999876543332222   22223334445678999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      ||++||+.||++|||++|+|+||||++..
T Consensus       239 li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            99999999999999999999999997654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-67  Score=463.03  Aligned_cols=253  Identities=34%  Similarity=0.636  Sum_probs=224.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      |++|++++.||+|+||+||+|.++.+++.||+|++.+.    ......+.+|+.++++++|||||++++++.+++.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999999753    23346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      ||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.... ...
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~~kl~DFG~a~~~~~-~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAPS-SRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCSCSCCCC-CCC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC--CEeecccceeeecCC-Ccc
Confidence            99999999999999888999999999999999999999999999999999999997554  899999999975432 334


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+||+.|||||++.+..++.+ +|||||||++|+|++|+.||...+..    .....+....+.+|.  .+|+++++|
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l  234 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPD--FVTEGARDL  234 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCT--TSCHHHHHH
T ss_pred             cccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCc--cCCHHHHHH
Confidence            56789999999999998887655 89999999999999999999875433    334445566666776  689999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |.+||+.||++|||++|+|+||||+.+
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            999999999999999999999999643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-65  Score=458.36  Aligned_cols=255  Identities=28%  Similarity=0.443  Sum_probs=221.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||+||+|.++.+|+.||||++..... ..+.+.+|+.++++++|||||+++++|.+++.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            479999999999999999999999999999999976543 3467899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCCc
Q 019628           81 AGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  159 (338)
                      +||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+..... ......
T Consensus       100 ~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC--cEeeccchhheeecccccccccc
Confidence            99999998765 4799999999999999999999999999999999999997554  8999999999865433 334567


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLLSR  239 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (338)
                      +||+.|+|||++.+..++.+ +|||||||++|+|+||++||.+.+........   .....+.++....+|+++++||.+
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             ccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHH---HhCCCCCCCCcccCCHHHHHHHHH
Confidence            89999999999998888655 99999999999999999999876544333222   223333444455789999999999


Q ss_pred             hcccCCCcCCChhHHhcCcccccC
Q 019628          240 IFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       240 ~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||+.||++|||+.|+|+||||+..
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999743

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-66  Score=464.51  Aligned_cols=257  Identities=35%  Similarity=0.620  Sum_probs=207.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+|+.++++++|||||+++++|.+++.+|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            46999999999999999999999999999999997643  2335678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecC-CCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDG-STAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~-~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+.. ..++.+||+|||+|+.........+
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  168 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST  168 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence            999999999998889999999999999999999999999999999999999964 2345899999999987665556667


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc--CCCcccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS--FPDYVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  236 (338)
                      .+||+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.......    ..+....+.  .+.+..+|+++++|
T Consensus       169 ~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~l  243 (307)
T d1a06a_         169 ACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSAKDF  243 (307)
T ss_dssp             ----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             eeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHhccCCCCCCccccCCCHHHHHH
Confidence            889999999999998887655 99999999999999999999876544333    333443333  33445799999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |.+||+.||++|||+.|+|+||||++.
T Consensus       244 i~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         244 IRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.3e-65  Score=467.29  Aligned_cols=258  Identities=29%  Similarity=0.567  Sum_probs=225.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      |++|++++.||+|+||+||+|.++.+|+.||||++.+... ..+.+.+|+.++++++|||||+++++|.+++.+|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5799999999999999999999999999999999976543 345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      |+||+|.+++. ..+.+++..++.++.||+.||+|||++|||||||||+|||++.+.++.+||+|||+|+.........+
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            99999999995 44579999999999999999999999999999999999999765556899999999987655555566


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  236 (338)
                      ..||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+....+    ..+....+.++.  +..+|+++++|
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             ecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCcccccCCCHHHHHH
Confidence            889999999999998887644 99999999999999999999876543333    334444444432  34689999999


Q ss_pred             HHHhcccCCCcCCChhHHhcCcccccC
Q 019628          237 LSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      |++||+.||++|||++|+|+||||+..
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-64  Score=460.93  Aligned_cols=253  Identities=34%  Similarity=0.605  Sum_probs=226.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      |++|++++.||+|+||+||+|+++.+|+.||||++++.    ....+.+.+|+.+|++++||||++++++|.+++.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            68999999999999999999999999999999999864    23346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~~  155 (338)
                      ||||+||+|..++...+.+++..++.+++||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.... ...
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccccCCcc
Confidence            99999999999999999999999999999999999999999999999999999997654  899999999986543 334


Q ss_pred             CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          156 PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      ....+||+.|+|||++.+..|+.+ +|||||||++|+|++|++||...+..    .....+....+.+|.  .+|+++++
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~d  234 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFPR--TLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHH----HHHHHHhcCCCCCCc--cCCHHHHH
Confidence            556889999999999999888655 99999999999999999999876543    334455666677776  68999999


Q ss_pred             HHHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          236 LLSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       236 li~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      ||++||++||.+|++     +.|+++||||..
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            999999999999994     899999999965

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-65  Score=455.21  Aligned_cols=252  Identities=31%  Similarity=0.542  Sum_probs=219.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+.    ....+.+.+|+.++++++||||++++++|.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999999753    233467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---C
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---S  154 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---~  154 (338)
                      |||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.....   .
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~--~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc--eEEecccccceecccCCccc
Confidence            9999999999999999999999999999999999999999999999999999997554  8999999999854322   2


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      ...+.+||+.|+|||++.+..++. ++|||||||++|+|++|++||...+...    ....+....+.+|.  .++++++
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  238 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFPE--KFFPKAR  238 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTTCCCCCT--TCCHHHH
T ss_pred             ccccccCCccccCceeeccCCCCc-ccceehhhHHHHHHhhCCCCCCCcCHHH----HHHHHHcCCCCCCc--cCCHHHH
Confidence            334568999999999998888754 5999999999999999999998765433    33445566677776  6899999


Q ss_pred             HHHHHhcccCCCcCCChhH------HhcCccccc
Q 019628          235 HLLSRIFVANSEKRITIPE------IKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~e------ll~hp~~~~  262 (338)
                      +||++||+.||++|||++|      +++||||..
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            9999999999999999998      578999853

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-64  Score=464.05  Aligned_cols=257  Identities=29%  Similarity=0.534  Sum_probs=225.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.+... ....+.+|+.++++++|||||+++++|.+++.+|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            679999999999999999999999999999999977542 3356789999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           81 AGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      +||+|.+.+.... ++++..++.++.||+.||+|||++||+||||||+|||++....+.+||+|||+|+...........
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~  188 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  188 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence            9999998876544 699999999999999999999999999999999999998666679999999999876666556677


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC--CcccCCHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP--DYVRVSLECKHLL  237 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li  237 (338)
                      .||+.|+|||++.+..++.+ +|||||||++|+|+||++||.+.+....+    ..+....+.++  .+..+|+++++||
T Consensus       189 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li  263 (352)
T d1koba_         189 TATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDAFSSVSPEAKDFI  263 (352)
T ss_dssp             CSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             cCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCcccccCCCHHHHHHH
Confidence            89999999999998888655 89999999999999999999876654433    33444444444  3357899999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ++||+.||.+|||+.|+|+||||+..
T Consensus       264 ~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         264 KNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-65  Score=462.54  Aligned_cols=257  Identities=29%  Similarity=0.457  Sum_probs=215.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++++..  .....+.+|+.+|++++|||||+++++|.+++.+|+||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            68999999999999999999999999999999997643  3346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      ++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++  ++||+|||+|+.... ....+
T Consensus        86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~-~~~~~  162 (322)
T d1s9ja_          86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SMANS  162 (322)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHHH-HTC--
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC--CEEEeeCCCccccCC-Ccccc
Confidence            9999999999988899999999999999999999997 5999999999999997554  899999999985432 33456


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------------------------
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTI-------------------------  213 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~-------------------------  213 (338)
                      .+||+.|||||++.+..|+.+ +||||+||++|+|++|+.||...+.........                         
T Consensus       163 ~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG  241 (322)
T ss_dssp             -CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred             ccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence            799999999999999888665 899999999999999999997755322111000                         


Q ss_pred             -------------hhHhhcc-ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          214 -------------GRILSVH-YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       214 -------------~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                                   ..+.... ...+ ...+|.++++||.+||+.||.+|||++|+|+||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         242 MDSRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ----CCCCHHHHHHHHHTSCCCCCC-BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccchhHHHHHhhhhccCCccCc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                         0001110 0111 12368899999999999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-64  Score=453.16  Aligned_cols=257  Identities=35%  Similarity=0.646  Sum_probs=224.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-------cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-------KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..       ...+.+.+|+.++++++|||||+++++|.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57999999999999999999999999999999997532       12467899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC--CcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA--PRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~--~~ikL~Dfg~a~~~~~  152 (338)
                      +|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  ..+||+|||+|+....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            99999999999999998889999999999999999999999999999999999999975542  3699999999987666


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCC
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVS  230 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (338)
                      .....+..||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+....+    ..+....+.++.  ...+|
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTSC
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHH----HHHHhcCCCCCchhcCCCC
Confidence            666677889999999999988777655 99999999999999999999876543333    334444444432  24689


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      +++++||++||+.||++|||++|+|+||||+..
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-64  Score=451.12  Aligned_cols=255  Identities=29%  Similarity=0.428  Sum_probs=217.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC-ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG-QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +.|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.++++++|||||++++++.+++.+|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4699999999999999999999999999999999764 344467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCCC
Q 019628           81 AGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPKS  158 (338)
Q Consensus        81 ~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  158 (338)
                      +||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|+..... ....+
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~--~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECHHHHHHHTC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC--CEEEEechhhhccCCCcccccc
Confidence            99999998765 45699999999999999999999999999999999999997554  8999999999743322 22346


Q ss_pred             ccccCccccccccc-----CCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          159 TVGTPAYIAPEVLT-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       159 ~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      .+||+.|+|||++.     +..| +.++|||||||++|+|+||++||...+....+.....   .....++....+|+++
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH---SCCCCCSSGGGSCHHH
T ss_pred             cccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---CCCCCCCccccCCHHH
Confidence            78999999999984     2334 4459999999999999999999988766554433221   2222334445789999


Q ss_pred             HHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ++||++||+.||++|||+.|+|+||||+.
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999964

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-65  Score=459.67  Aligned_cols=258  Identities=26%  Similarity=0.514  Sum_probs=228.5

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEecc
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++||++++.||+|+||+||+|.++.+|+.||||++++.......+.+|+.+|+.++|||||+++++|.+++.+|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            58999999999999999999999999999999999877655567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCCc
Q 019628           81 AGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKST  159 (338)
Q Consensus        81 ~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  159 (338)
                      +||+|.++|...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+....+||+|||+++...........
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~  163 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence            9999999998665 699999999999999999999999999999999999998666668999999999866555555567


Q ss_pred             cccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccCCHHHHHHH
Q 019628          160 VGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRVSLECKHLL  237 (338)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li  237 (338)
                      .||+.|+|||.+.+..++. ++|||||||++|+|++|.+||...+...    ....+....+.++.  +..+|+++++||
T Consensus       164 ~~t~~y~ape~~~~~~~~~-~~DiWSlGvily~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         164 FTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccccchhccCCCCCc-hhhcccHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence            8999999999998888765 4999999999999999999998765433    33445555555543  346899999999


Q ss_pred             HHhcccCCCcCCChhHHhcCcccccC
Q 019628          238 SRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+||+.||++|||+.|+|+||||++.
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-64  Score=451.78  Aligned_cols=251  Identities=26%  Similarity=0.381  Sum_probs=216.2

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +|+++++||+|+||+||+|++..+|+.||||++.+...    ..+.+.+|+.++++++|||||+++++|.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            59999999999999999999999999999999976532    22468899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      ||.+|+|..++...+++++..++.++.||+.||.|||++|||||||||+|||++.++  ++||+|||+|+...   ....
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~~Kl~DFG~a~~~~---~~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMA---PANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSS---SBCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC--CEEEeecccccccC---CCCc
Confidence            999999988888888999999999999999999999999999999999999997554  89999999998543   2345


Q ss_pred             ccccCcccccccccC---CccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHH
Q 019628          159 TVGTPAYIAPEVLTK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKH  235 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (338)
                      .+||+.|||||++.+   ..|+. ++|||||||++|+|++|..||........+.    .+.......+....+|+++++
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~-~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSCTTSCHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCc-hhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCCCCCCCHHHHH
Confidence            789999999999864   33544 4899999999999999999998765443332    233333333333468999999


Q ss_pred             HHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          236 LLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       236 li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ||.+||+.||.+|||++|+|+||||.+.
T Consensus       246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            9999999999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-63  Score=440.25  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=211.8

Q ss_pred             Cc-eEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc----CCeEE
Q 019628            3 RY-EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT----PTHLA   74 (338)
Q Consensus         3 ~y-~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~   74 (338)
                      || ++.++||+|+||+||+|.+..+++.||+|++....   ...+.+.+|++++++++|||||+++++|..    +..+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            45 78889999999999999999999999999987643   233568899999999999999999999865    45789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~--iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +||||+++|+|.+++.+...+++..++.++.||+.||+|||++|  |+||||||+|||++.. ++.+||+|||+|+... 
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~-~~~~Kl~DFGla~~~~-  166 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR-  166 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST-TSCEEECCTTGGGGCC-
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC-CCCEEEeecCcceecc-
Confidence            99999999999999998889999999999999999999999998  9999999999999632 3379999999997432 


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      .....+.+||+.|||||++.+ .++ .++|||||||++|+|++|+.||............   +.............+++
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCCCGGGGGCCCHH
T ss_pred             CCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH---HHcCCCCcccCccCCHH
Confidence            233456789999999999865 465 4599999999999999999999876654443332   33222211122357899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcCcccc
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNHPWFL  261 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~hp~~~  261 (338)
                      +++||.+||+.||++|||+.|+|+||||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999999995

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-63  Score=450.07  Aligned_cols=251  Identities=35%  Similarity=0.640  Sum_probs=223.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      |++|++++.||+|+||+||+|+++.+|+.||||++++.    ....+.+.+|+.++++++|||||++++++.+++.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            57899999999999999999999999999999999753    23346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      ||||+||+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|+...  ...
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--~vkL~DFG~a~~~~--~~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC--CEEEecCccceEec--ccc
Confidence            99999999999999999999999999999999999999999999999999999997554  89999999998543  334


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      .+.+||+.|||||++.+..|+.+ +|||||||++|+|+||+.||...+...    ....+......+|.  .++++++++
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~l  231 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNAELRFPP--FFNEDVKDL  231 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred             ccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHH----HHHHHHcCCCCCCC--CCCHHHHHH
Confidence            56789999999999988888655 899999999999999999998755433    33445556666665  689999999


Q ss_pred             HHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          237 LSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      |.+||+.||.+|+     |++++|+||||+.
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            9999999999996     9999999999964

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.3e-63  Score=440.12  Aligned_cols=257  Identities=33%  Similarity=0.510  Sum_probs=222.6

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----------ccHHHHHHHHHHhcCC-CCCcceeEEEEEc
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----------IDEHVQREIMNHRSLK-HPNIVRFKEVLLT   69 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~   69 (338)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++...          ..+.+.+|+.++++++ ||||++++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            3799999999999999999999999999999999976431          1235789999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           70 PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      ++.+|+|||||+||+|.++|..++++++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~  159 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQ  159 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC--CeEEccchheeE
Confidence            999999999999999999999999999999999999999999999999999999999999997554  899999999987


Q ss_pred             cccCCCCCCccccCcccccccccCC-----ccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc--c
Q 019628          150 SVLHSQPKSTVGTPAYIAPEVLTKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY--S  222 (338)
Q Consensus       150 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~  222 (338)
                      ..........+||+.|+|||++.+.     ...+.++||||+||++|+|++|+.||.+.+......    .+....+  .
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~----~i~~~~~~~~  235 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----MIMSGNYQFG  235 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCC
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH----HHHhCCCCCC
Confidence            6655556678899999999998632     222455999999999999999999999866543332    3333333  3


Q ss_pred             CCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          223 FPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      .+....+|+++++||.+||+.+|++|||++|+|+||||++.
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            44556799999999999999999999999999999999753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-62  Score=449.14  Aligned_cols=251  Identities=33%  Similarity=0.596  Sum_probs=222.9

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      |++|++++.||+|+||+||+|.++.+|+.||||++.+..    ...+.+.+|+.+|+.++|||||+++++|.....+|+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            589999999999999999999999999999999997532    3346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCC
Q 019628           77 MEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQP  156 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~  156 (338)
                      |||+.||+|...+...+.+++..++.++.||+.||.|||++|||||||||+|||++.++  ++||+|||+|+...  ...
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~--~~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCB
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeecc--ccc
Confidence            99999999999999988999999999999999999999999999999999999997554  89999999998643  334


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      .+.+||+.|||||++.+..++.+ +|||||||++|+|+||++||.+.+..    .....+....+.+|.  .+++++.+|
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l  268 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIVSGKVRFPS--HFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TCCHHHHHH
T ss_pred             ccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHH----HHHHHHhcCCCCCCc--cCCHHHHHH
Confidence            56789999999999998888655 99999999999999999999875433    334445555666665  689999999


Q ss_pred             HHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          237 LSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       237 i~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      |++||+.||.+|+     |++++++||||+.
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            9999999999995     9999999999964

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-63  Score=440.37  Aligned_cols=250  Identities=32%  Similarity=0.534  Sum_probs=203.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEc--CCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLT--PTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~iv   76 (338)
                      |+|++++.||+|+||+||+|+++.+|+.||||++.....   ..+.+.+|+.++++++|||||++++++.+  ++.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            789999999999999999999999999999999976532   23568899999999999999999999865  4568999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcC-----ceecCCCCCcEEecCCCCCcEEEeecCCC
Q 019628           77 MEYAAGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----ICHRDLKLENTLLDGSTAPRVKICDFGYS  147 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~LH~~~-----iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a  147 (338)
                      ||||+||+|.+++..    ...+++..++.++.||+.||+|||++|     |+||||||+|||++.++  .+||+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~--~vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS--CEEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC--cEEEeeccce
Confidence            999999999999863    457999999999999999999999976     99999999999997554  8999999999


Q ss_pred             cccccC-CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcccc-CCC
Q 019628          148 KSSVLH-SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYS-FPD  225 (338)
Q Consensus       148 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  225 (338)
                      +..... ......+||+.|||||++.+..++. ++|||||||++|+|+||+.||...+...    ....+....+. .| 
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~~~~~~~~~-  235 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFRRIP-  235 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCCCCC-
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCCh-HHHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCCCCC-
Confidence            864432 2345678999999999998888764 4999999999999999999998755433    23333433332 33 


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                       ..+|+++++||++||+.||++|||+.|+|+|||+
T Consensus       236 -~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 -YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence             3689999999999999999999999999999995

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.1e-63  Score=453.88  Aligned_cols=256  Identities=28%  Similarity=0.452  Sum_probs=217.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHH---HHHHHHhcCCCCCcceeEEEEEcCCeE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQ---REIMNHRSLKHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~---~E~~~l~~l~h~~Iv~~~~~~~~~~~~   73 (338)
                      |++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.   +++.+++.++|||||+++++|.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            689999999999999999999999999999999997532    1122233   447778888999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+|||||+||+|.++|.....+++..++.++.||+.||.|||++|||||||||+|||++.++  .+||+|||+|+.... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g--~iKl~DFGla~~~~~-  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSK-  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS--CEEECCCTTCEECSS-
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC--cEEEeeeceeeecCC-
Confidence            99999999999999999988999999999999999999999999999999999999997554  899999999985433 


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHH
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLEC  233 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
                      ......+||+.|+|||++.++..++.++|||||||++|+|+||+.||........ ......+......+|.  .+|+++
T Consensus       160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~~  236 (364)
T d1omwa3         160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPEL  236 (364)
T ss_dssp             SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCCCCCS--SSCHHH
T ss_pred             CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCCCCCC--CCCHHH
Confidence            3455678999999999997655445559999999999999999999987554332 2333334444444554  689999


Q ss_pred             HHHHHHhcccCCCcCCC-----hhHHhcCccccc
Q 019628          234 KHLLSRIFVANSEKRIT-----IPEIKNHPWFLR  262 (338)
Q Consensus       234 ~~li~~~L~~dp~~R~s-----~~ell~hp~~~~  262 (338)
                      ++||.+||+.||.+|||     |+|+++||||+.
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            99999999999999999     799999999964

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-63  Score=453.62  Aligned_cols=259  Identities=34%  Similarity=0.573  Sum_probs=219.3

Q ss_pred             CCCceEee-eeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHh-cCCCCCcceeEEEEEc----CCeEE
Q 019628            1 MERYEIVK-DIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHR-SLKHPNIVRFKEVLLT----PTHLA   74 (338)
Q Consensus         1 ~~~y~~~~-~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~----~~~~~   74 (338)
                      +++|++++ .||+|+||+||+|.+..+++.||||++++.    ..+.+|+.++. .++|||||+++++|.+    ...+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            46899886 599999999999999999999999999754    56788998865 4589999999999975    46799


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC-CCcEEEeecCCCcccc
Q 019628           75 IVMEYAAGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST-APRVKICDFGYSKSSV  151 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~-~~~ikL~Dfg~a~~~~  151 (338)
                      +|||||+||+|.++|...  ..+++.+++.++.||+.||+|||++||+||||||+|||++... .+.+||+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            999999999999999864  3699999999999999999999999999999999999997543 4579999999998766


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCC--cccC
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPD--YVRV  229 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  229 (338)
                      ........+||+.|||||++.+..|+.+ +|||||||++|+|+||++||.+.+...........+....+.+|.  +..+
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  244 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred             CCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence            6666777899999999999988888655 999999999999999999998766555555555555555655553  3468


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                      |+++++||++||+.||++|||+.|+|+||||.+..
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            99999999999999999999999999999997543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-62  Score=443.39  Aligned_cols=253  Identities=34%  Similarity=0.571  Sum_probs=220.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc----cccHHHHHHHHHHh-cCCCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ----KIDEHVQREIMNHR-SLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      |++|++++.||+|+||+||+|+++.+|+.||||++++..    ...+.+.+|..++. .++|||||++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            689999999999999999999999999999999997632    23345667776654 7899999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CC
Q 019628           76 VMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~  154 (338)
                      |||||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.... ..
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--ceeccccchhhhcccccc
Confidence            999999999999999999999999999999999999999999999999999999997554  899999999985443 33


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECK  234 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...    ....+....+.+|.  .+|++++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  231 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYPR--WLEKEAK  231 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCc--cCCHHHH
Confidence            3445789999999999999888654 899999999999999999998755433    33445556666665  6899999


Q ss_pred             HHHHHhcccCCCcCCChh-HHhcCccccc
Q 019628          235 HLLSRIFVANSEKRITIP-EIKNHPWFLR  262 (338)
Q Consensus       235 ~li~~~L~~dp~~R~s~~-ell~hp~~~~  262 (338)
                      +||++||+.||.+|||+. ++++||||++
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            999999999999999995 8999999964

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-62  Score=433.63  Aligned_cols=248  Identities=31%  Similarity=0.518  Sum_probs=215.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------ccHHHHHHHHHHhcCC--CCCcceeEEEEEcCCe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------IDEHVQREIMNHRSLK--HPNIVRFKEVLLTPTH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~   72 (338)
                      +||++.+.||+|+||+||+|++..+|+.||||++.+...       ...++.+|+.++++++  |||||+++++|.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            589999999999999999999999999999999976421       1234678999999987  8999999999999999


Q ss_pred             EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           73 LAIVMEYAAG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        73 ~~iv~e~~~~-~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      +|+||||+.+ +++..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceecc
Confidence            9999999976 68888998888999999999999999999999999999999999999997442 389999999997543


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCH
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSL  231 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
                       .....+..||+.|+|||++.+..+++.++|||||||++|+|+||+.||...+          .+......++.  .+|+
T Consensus       163 -~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~~--~~s~  229 (273)
T d1xwsa_         163 -DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--RVSS  229 (273)
T ss_dssp             -SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCSS--CCCH
T ss_pred             -cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCCCC--CCCH
Confidence             3344567899999999999887777777899999999999999999997521          23344445555  6899


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ++++||++||+.||++|||++|+|+||||++.
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-61  Score=436.00  Aligned_cols=258  Identities=25%  Similarity=0.355  Sum_probs=212.9

Q ss_pred             eEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc------ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK------IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      +.++.||+|+||+||+|+++.+|+.||||+++....      ..+.+.+|+.++++++|||||+++++|..++++|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            457899999999999999999999999999975432      23568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQPK  157 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~~  157 (338)
                      |+.++++..++.....+++..++.+++||+.||+|||++||+||||||+|||++..+  .+||+|||+|+..... ....
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~--~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC--ccccccCccccccCCCccccc
Confidence            999887777776677899999999999999999999999999999999999997554  8999999999754333 3345


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc-cC-------------
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY-SF-------------  223 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~-------------  223 (338)
                      ..+||+.|+|||++.+...++.++||||+||++|+|+||.+||...+..+.+..+......... .+             
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            6789999999999987665566699999999999999999999987766555544432211000 00             


Q ss_pred             --CC------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          224 --PD------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       224 --~~------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                        +.      ...+++++++||.+||+.||++|||+.|+|+||||++.+
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence              00      124688999999999999999999999999999997543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-61  Score=432.43  Aligned_cols=259  Identities=28%  Similarity=0.451  Sum_probs=214.8

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ||+|++++.||+|+||+||+|.+..+|+.||||+++...   .....+.+|+.++++++|||||+++++|.+++.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            799999999999999999999999999999999996543   23578899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc-CC
Q 019628           78 EYAAGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL-HS  154 (338)
Q Consensus        78 e~~~~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~-~~  154 (338)
                      ||+.+ .+...+.  ....+++..++.++.||+.||+|||++|||||||||+|||++.++  .+||+|||+|+.... ..
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~--~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTHHHHHCCCSB
T ss_pred             eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC--cceeccCCcceeccCCcc
Confidence            99965 4444443  345699999999999999999999999999999999999997554  899999999975433 33


Q ss_pred             CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc--------------
Q 019628          155 QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--------------  220 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--------------  220 (338)
                      ......||+.|+|||++....+.+.++||||+||++|+|++|+.||...+................              
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            445678999999999988888777779999999999999999999987665554444432211100              


Q ss_pred             ccCCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          221 YSFPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       221 ~~~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      ..++.         ...+|.++++||++||++||++|||+.|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence            01111         1246789999999999999999999999999999964

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-60  Score=425.21  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=214.2

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      ||||+++++||+|+||+||+|+++ +|+.||||++....   ...+.+.+|+.++++++|||||+++++|..++..|++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            799999999999999999999996 78999999997642   33578999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      |++.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++  .+||+|||+|...... ...
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC-----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC--CEEecccccceecccCcccc
Confidence            9998877777777788899999999999999999999999999999999999997654  8999999998754332 233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc--------------cc
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH--------------YS  222 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--------------~~  222 (338)
                      ....|++.|+|||.+.+..+.+.++|||||||++|+|++|++||...+..+.+.+.........              ..
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            4567999999999998877666779999999999999999999988766555444432211100              00


Q ss_pred             CC---------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          223 FP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       223 ~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                      +.         ....+++++++||++||+.||++|||+.|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            00         01247889999999999999999999999999999963

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-60  Score=436.54  Aligned_cols=294  Identities=23%  Similarity=0.358  Sum_probs=222.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC------e
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT------H   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~   72 (338)
                      ++|+++++||+|+||+||+|.++.+|+.||||++++..   ...+.+.+|+.+|+.++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            68999999999999999999999999999999997643   23457889999999999999999999998764      5


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCccccc
Q 019628           73 LAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVL  152 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~  152 (338)
                      +|+||||+ +.+|...++ +..+++..++.+++||+.||+|||++||+||||||+|||++.++  .+||+|||+|+..  
T Consensus        98 ~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~--~~kl~Dfg~a~~~--  171 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQA--  171 (346)
T ss_dssp             CEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEEC--
T ss_pred             EEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc--ccccccccceecc--
Confidence            79999999 567776664 56899999999999999999999999999999999999997555  8999999999854  


Q ss_pred             CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-------------
Q 019628          153 HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------  219 (338)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (338)
                      ....+..+||+.|+|||++.+..+.+.++||||+||++|+|++|++||...+....+..........             
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence            3345667899999999999876665666999999999999999999998876544433332211000             


Q ss_pred             --------cc---cC-CCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCCCCCHH
Q 019628          220 --------HY---SF-PDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLE  287 (338)
Q Consensus       220 --------~~---~~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (338)
                              ..   .+ .....+++++++||++||+.||++|||+.|+|+||||+.....+......-..........+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLD  331 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCCCCC-----CCHH
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCCCCCchhhhhcCHH
Confidence                    00   00 0113578999999999999999999999999999999764332221111112223445567889


Q ss_pred             HHHHHhHhhCCCCC
Q 019628          288 EVLSLIHEATKPLE  301 (338)
Q Consensus       288 ~~~~~~~~~~~~~~  301 (338)
                      ++++++.++...+.
T Consensus       332 e~k~~~~~e~~~~~  345 (346)
T d1cm8a_         332 EWKRVTYKEVLSFK  345 (346)
T ss_dssp             HHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHhhcCC
Confidence            99999888765543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=423.57  Aligned_cols=258  Identities=28%  Similarity=0.386  Sum_probs=210.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-CcEEEEEEeecCc---cccHHHHHHHHHHhcC---CCCCcceeEEEEEc-----
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-RELLAVKFIERGQ---KIDEHVQREIMNHRSL---KHPNIVRFKEVLLT-----   69 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~-----   69 (338)
                      ++|++++.||+|+||+||+|++..+ ++.||||+++...   .....+.+|+.+++.|   +||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            5899999999999999999999765 6789999987532   2334567788777666   79999999999863     


Q ss_pred             CCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628           70 PTHLAIVMEYAAGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                      ...+|++||++.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++..+  .+||+|||+++
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~--~~kl~dfg~~~  164 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC--Ceeecchhhhh
Confidence            357899999998876654443 345699999999999999999999999999999999999997555  89999999998


Q ss_pred             ccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-cccCC---
Q 019628          149 SSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-HYSFP---  224 (338)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~---  224 (338)
                      ...........+||+.|+|||++.+..|+.+ +||||+||++|+|++|++||.+.+..+.+.......... ...++   
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            7666666677899999999999998888655 999999999999999999999877655555443322110 00000   


Q ss_pred             -----------------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          225 -----------------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       225 -----------------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                                       ....+++.+++||++||++||++|||+.|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence                             12257899999999999999999999999999999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-59  Score=415.53  Aligned_cols=262  Identities=26%  Similarity=0.412  Sum_probs=220.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVM   77 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~   77 (338)
                      |+||++++.||+|+||+||+|++..+++.||||+++...   ....++.+|+.+++.++||||++++++|.....+++++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            799999999999999999999999999999999997643   33467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC-CCC
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH-SQP  156 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~-~~~  156 (338)
                      +++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++...  .+||+|||.|+..... ...
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~--~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSCCSCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC--ceeeeecchhhcccCCCccc
Confidence            9999999999998888999999999999999999999999999999999999997554  8999999999865433 233


Q ss_pred             CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccc---------------
Q 019628          157 KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHY---------------  221 (338)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---------------  221 (338)
                      ....+++.|+|||++.+..+.+.++||||+||++|+|++|+.||....+.......+........               
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence            45568889999999988776666699999999999999999997665554443333222211100               


Q ss_pred             ---------cCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCC
Q 019628          222 ---------SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNL  264 (338)
Q Consensus       222 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~  264 (338)
                               .......+++.+++||++||+.||.+||||+|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                     0001224688999999999999999999999999999997543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-59  Score=430.99  Aligned_cols=297  Identities=23%  Similarity=0.357  Sum_probs=231.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcC-----CeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTP-----THL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~   73 (338)
                      +||+++++||+|+||+||+|++..+|+.||||++++...   ..+++.+|+.++++++|||||+++++|...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            689999999999999999999999999999999976432   235678999999999999999999999643     234


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      +++|+++.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++  .+|++|||++...  .
T Consensus        98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~--~~kl~dfg~a~~~--~  172 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHT--D  172 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCC----CC--T
T ss_pred             EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc--cccccccchhccc--C
Confidence            556667779999998854 5799999999999999999999999999999999999997554  8999999998743  2


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhcc-------------
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVH-------------  220 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-------------  220 (338)
                      ....+..||+.|+|||++.+..+.+.++|||||||++|+|++|++||.+.+................             
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence            3345678999999999988877666669999999999999999999988765544444332211100             


Q ss_pred             ------ccCC------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCcccccCCCcccCCCCCCCCCHHH
Q 019628          221 ------YSFP------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTEGGSWQSHDVNNPSQSLEE  288 (338)
Q Consensus       221 ------~~~~------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (338)
                            ...+      ....+++++++||++||+.||.+|||+.|+|+||||++........................++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDE  332 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCCCGGGGCCCCHHH
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCCCcccchhcCHHH
Confidence                  0001      0235789999999999999999999999999999998654332222122222334456678899


Q ss_pred             HHHHhHhhCCCCCCC
Q 019628          289 VLSLIHEATKPLEAP  303 (338)
Q Consensus       289 ~~~~~~~~~~~~~~~  303 (338)
                      +++++.++...+.+|
T Consensus       333 ~k~~~~~e~~~~~p~  347 (348)
T d2gfsa1         333 WKSLTYDEVISFVPP  347 (348)
T ss_dssp             HHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHhhccCCC
Confidence            999998887776655

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.3e-59  Score=423.67  Aligned_cols=255  Identities=23%  Similarity=0.428  Sum_probs=213.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-CCCcceeEEEEEcC--CeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-HPNIVRFKEVLLTP--THLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~--~~~~iv~e   78 (338)
                      ++|+++++||+|+||+||+|+++.+|+.||||++++..  .+++.+|+.+|+.++ ||||++++++|...  ..+|+|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            68999999999999999999999999999999997643  467889999999995 99999999999754  56999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCCC
Q 019628           79 YAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPKS  158 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~~  158 (338)
                      ||++++|....   +.+++..++.+++||+.||+|||++||+||||||+|||++.++ +.+||+|||+|+..........
T Consensus       113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~-~~vkl~DFG~a~~~~~~~~~~~  188 (328)
T d3bqca1         113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFYHPGQEYNV  188 (328)
T ss_dssp             CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-TEEEECCGGGCEECCTTCCCCS
T ss_pred             ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC-CeeeecccccceeccCCCcccc
Confidence            99999987653   4699999999999999999999999999999999999997543 2699999999987666666777


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-------------------
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-------------------  219 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------------  219 (338)
                      .+||+.|+|||++.+....+.++||||+||++|+|++|+.||....+.......+..+...                   
T Consensus       189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  268 (328)
T d3bqca1         189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN  268 (328)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred             cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence            8899999999998876655566999999999999999999998766544332222211110                   


Q ss_pred             -------------cccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCccccc
Q 019628          220 -------------HYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLR  262 (338)
Q Consensus       220 -------------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~  262 (338)
                                   ....+....+++++++||++||++||.+|||++|+|+||||+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                         0011122347899999999999999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=424.76  Aligned_cols=257  Identities=29%  Similarity=0.408  Sum_probs=210.8

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcC------CeEEEE
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTP------THLAIV   76 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~~~iv   76 (338)
                      +|+.++.||+|+||+||+|++..+|+.||||++.+....   ..+|+.+|++++||||++++++|...      .++|+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            699999999999999999999999999999999875433   34799999999999999999998543      358999


Q ss_pred             EeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           77 MEYAAGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        77 ~e~~~~~~L~~~---i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      ||||+++.+..+   ......+++..++.+++||+.||+|||++||+||||||+|||++.++. .+||+|||+++.....
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence            999976533222   234567999999999999999999999999999999999999975432 7999999999876666


Q ss_pred             CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-------------cc
Q 019628          154 SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------VH  220 (338)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------------~~  220 (338)
                      ....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||...+..+.+.........             ..
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence            66777899999999999877655556699999999999999999999887765555444322110             01


Q ss_pred             ccCC----------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          221 YSFP----------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       221 ~~~~----------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..++          .....++++.+||.+||++||++|||+.|+|+||||++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            1111          122478999999999999999999999999999999753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=418.86  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=209.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecC---ccccHHHHHHHHHHhcCCCCCcceeEEEEEc--------
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERG---QKIDEHVQREIMNHRSLKHPNIVRFKEVLLT--------   69 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--------   69 (338)
                      ++||+++++||+|+||+||+|++..+|+.||||++...   +.....+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36999999999999999999999999999999998654   2344678899999999999999999999865        


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           70 PTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      ++.+|++|||+.++.+.........+++..++.+++||+.||.|||++||+||||||+|||++.++  .+||+|||+++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~--~~kl~dfg~~~~  166 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARA  166 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC--cEEeeecceeee
Confidence            346899999998876666666667899999999999999999999999999999999999997554  899999999964


Q ss_pred             ccc-----CCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC-
Q 019628          150 SVL-----HSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF-  223 (338)
Q Consensus       150 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-  223 (338)
                      ...     .....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+................... 
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            332     12234567999999999998765445569999999999999999999987665444433322221111000 


Q ss_pred             CC-------------------------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccC
Q 019628          224 PD-------------------------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRN  263 (338)
Q Consensus       224 ~~-------------------------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~  263 (338)
                      ..                         ....++++++||.+||++||++|||++|+|+||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            00                         00136788999999999999999999999999999754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-58  Score=422.96  Aligned_cols=296  Identities=26%  Similarity=0.388  Sum_probs=221.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCC-----eEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT-----HLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~~   74 (338)
                      +||++++.||+|+||+||+|.+..+|+.||||++.+..  ...+.+.+|+.+|+.++||||+++++++..+.     .+|
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            58999999999999999999999999999999997643  23457889999999999999999999997653     355


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           75 IVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ++| ++.+|+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++  .+||+|||+|+......
T Consensus        88 l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          88 LVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGG
T ss_pred             EEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCceeeccCCC
Confidence            555 55689999999754 799999999999999999999999999999999999997554  89999999997543322


Q ss_pred             ----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhc-----------
Q 019628          155 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSV-----------  219 (338)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-----------  219 (338)
                          .....+||+.|+|||++.....++.++||||+||++|+|++|++||......+............           
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence                23456799999999999776665666999999999999999999998766544433332211000           


Q ss_pred             -----cccCC---------CcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCccccc-CCCcccCCCCCCCC
Q 019628          220 -----HYSFP---------DYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTE-GGSWQSHDVNNPSQ  284 (338)
Q Consensus       220 -----~~~~~---------~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~-~~~~~~~~~~~~~~  284 (338)
                           ....+         ....+++++++||.+||+.||.+|||+.|+|+||||++........ .......+......
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDL  323 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC--------C
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCChhhhhC
Confidence                 00011         1225788999999999999999999999999999998654432211 11111222333445


Q ss_pred             CHHHHHHHhHhhCCCCC
Q 019628          285 SLEEVLSLIHEATKPLE  301 (338)
Q Consensus       285 ~~~~~~~~~~~~~~~~~  301 (338)
                      +.+++.+++.++.+...
T Consensus       324 ~~~~l~~l~~~e~~~~~  340 (345)
T d1pmea_         324 PKEKLKELIFEETARFQ  340 (345)
T ss_dssp             CHHHHHHHHHHHSGGGS
T ss_pred             CHHHHHHHHHHHHHhcC
Confidence            67777777777765443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-59  Score=415.56  Aligned_cols=248  Identities=21%  Similarity=0.265  Sum_probs=211.6

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||+||+|.+..+++.||||+++......+.+.+|+.++++++|||||+++++|.+++.+|+|||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            57899999999999999999999999999999998877667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CC
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PK  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~  157 (338)
                      +|+|..++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.......  ..
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCCTTTCCSSSSEEET
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC--cEEEccccceeecCCCCceeec
Confidence            99999999754  4689999999999999999999999999999999999997654  899999999985433222  23


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ...||+.|+|||++.+..++. ++||||+||++|||++|..||............+.    ..+..+....+++++.+||
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~-k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~----~~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KDYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----TTCCCCCCTTCCHHHHHHH
T ss_pred             cccccccccChHHHcCCCCCc-hhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh----cCCCCCCCccchHHHHHHH
Confidence            345899999999998888764 49999999999999997766655444444333322    2233333347899999999


Q ss_pred             HHhcccCCCcCCChhHHhc
Q 019628          238 SRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~  256 (338)
                      .+||+.||++|||+.|+++
T Consensus       250 ~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         250 RACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999976

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.9e-59  Score=414.03  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=203.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc----ccHHHHHHHHHHhcCCCCCcceeEEEEEcCC----eE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK----IDEHVQREIMNHRSLKHPNIVRFKEVLLTPT----HL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~   73 (338)
                      +||++.+.||+|+||+||+|.+..+|+.||||++++...    ....+.+|+.+++.++|||||++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            689999999999999999999999999999999976432    2346889999999999999999999997643    48


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           74 AIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      |+||||++|++|..++...+++++..++.++.||+.||+|||++||+||||||+|||++.++  .++|+|||.+......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~--~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS--CEEECCCTTCEECC--
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc--cceeehhhhhhhhccc
Confidence            99999999999999999988999999999999999999999999999999999999997655  7999999988643222


Q ss_pred             ----CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccC--CCcc
Q 019628          154 ----SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSF--PDYV  227 (338)
Q Consensus       154 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  227 (338)
                          ....+.+||+.|+|||++.+..++.+ +|||||||++|+|+||++||...+....+...    .......  ....
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~  239 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----VREDPIPPSARHE  239 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHCCCCCGGGTSS
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHH----HhcCCCCCchhcc
Confidence                23445689999999999988877655 99999999999999999999876554433332    2222222  2234


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChhHHhcCccc
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIPEIKNHPWF  260 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~  260 (338)
                      .+|+++.+||++||+.||.+||+..+.+.|+|.
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            689999999999999999999955455556665

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=424.86  Aligned_cols=291  Identities=25%  Similarity=0.370  Sum_probs=216.1

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEc------CC
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLT------PT   71 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~   71 (338)
                      +++|+++++||+|+||+||+|.++.+|+.||||++++..   ....++.+|+.++++++|||||+++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            478999999999999999999999999999999998653   223468899999999999999999999964      36


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           72 HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      ++|+|||||.+ ++...+.  ..+++..++.+++||+.||.|||++||+||||||+|||++.++  .+|++|||+++...
T Consensus        96 ~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~--~~kl~df~~~~~~~  170 (355)
T d2b1pa1          96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC-----
T ss_pred             eeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc--ceeeechhhhhccc
Confidence            89999999965 5555553  4689999999999999999999999999999999999997554  79999999998766


Q ss_pred             cCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-------------
Q 019628          152 LHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-------------  218 (338)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------------  218 (338)
                      ........+||+.|+|||++.+..++.+ +||||+||++|+|++|++||.+.+........+.....             
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            6666677889999999999988877655 89999999999999999999877655444443322111             


Q ss_pred             -----cccc---------CCC---------cccCCHHHHHHHHHhcccCCCcCCChhHHhcCcccccCCCccccc--CCC
Q 019628          219 -----VHYS---------FPD---------YVRVSLECKHLLSRIFVANSEKRITIPEIKNHPWFLRNLPIELTE--GGS  273 (338)
Q Consensus       219 -----~~~~---------~~~---------~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~~~~~~~~~~~~--~~~  273 (338)
                           ....         ++.         ....++++++||++||..||++||||+|+|+||||+........+  ...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~  329 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQ  329 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCC
Confidence                 0000         000         012467899999999999999999999999999998754432222  222


Q ss_pred             cccCCCCCCCCCHHHHHHHhHhhC
Q 019628          274 WQSHDVNNPSQSLEEVLSLIHEAT  297 (338)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~  297 (338)
                      .......+...++++++++|..+.
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~  353 (355)
T d2b1pa1         330 IYDKQLDEREHTIEEWKELIYKEV  353 (355)
T ss_dssp             ------CCCCCCHHHHHHHHHHHH
T ss_pred             CCCcchhhhhcCHHHHHHHHHHHh
Confidence            233344556778899988887653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=418.83  Aligned_cols=258  Identities=32%  Similarity=0.564  Sum_probs=221.3

Q ss_pred             CCCceEeeeeccCCceEEEEEEEc---CCCcEEEEEEeecCc-----cccHHHHHHHHHHhcCCC-CCcceeEEEEEcCC
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDK---WTRELLAVKFIERGQ-----KIDEHVQREIMNHRSLKH-PNIVRFKEVLLTPT   71 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~   71 (338)
                      |++|++++.||+|+||+||+|.+.   .+|+.||||++++..     ...+.+.+|+.++++++| |||+++++++.++.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            578999999999999999999974   468999999986532     234568899999999977 89999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccc
Q 019628           72 HLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSV  151 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~  151 (338)
                      .++++|||+.+|+|...+...+.+++..++.+++||+.||+|||++||+||||||+|||++.++  .+||+|||+|+...
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECC
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeeccchhhhc
Confidence            9999999999999999999999999999999999999999999999999999999999997654  89999999987543


Q ss_pred             c--CCCCCCccccCcccccccccCCc-cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          152 L--HSQPKSTVGTPAYIAPEVLTKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       152 ~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                      .  .....+..||+.|+|||.+.+.. +.+.++|||||||++|+|++|+.||......................+|.  .
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~  258 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--E  258 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--T
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--c
Confidence            2  22345678999999999997654 33555999999999999999999998877666655555555555555554  6


Q ss_pred             CCHHHHHHHHHhcccCCCcCC-----ChhHHhcCccccc
Q 019628          229 VSLECKHLLSRIFVANSEKRI-----TIPEIKNHPWFLR  262 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~-----s~~ell~hp~~~~  262 (338)
                      +|+++++||.+||++||.+||     |++|+++||||++
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            899999999999999999999     5899999999964

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-58  Score=403.91  Aligned_cols=246  Identities=23%  Similarity=0.393  Sum_probs=199.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||+||+|.+. +++.||||+++......+.+.+|+.++++++|||||++++++..++.+|+||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            58999999999999999999986 56789999998877667889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CCC
Q 019628           82 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKS  158 (338)
Q Consensus        82 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~~  158 (338)
                      +|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+.  .+||+|||+|+.......  ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG--CEEECSCC---------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC--CeEecccchheeccCCCceeecc
Confidence            99999988754 4689999999999999999999999999999999999997655  899999999985543322  234


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHcC-CCCCCCCCChHHHHHHHhhHhhc-cccCCCcccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  236 (338)
                      ..||+.|+|||++.+..++.+ +||||+||++|||+|+ .+||..... .....   .+... ....|  ...++++.+|
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~---~i~~~~~~~~p--~~~~~~l~~l  234 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSN-SEVVE---DISTGFRLYKP--RLASTHVYQI  234 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHH---HHHHTCCCCCC--TTSCHHHHHH
T ss_pred             eecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCH-HHHHH---HHHhcCCCCCc--cccCHHHHHH
Confidence            679999999999998887655 9999999999999994 666655433 22222   22222 22233  3678999999


Q ss_pred             HHHhcccCCCcCCChhHHhcC
Q 019628          237 LSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~h  257 (338)
                      +.+||+.||++|||++|+++|
T Consensus       235 i~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         235 MNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=408.98  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=200.3

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc---cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEe
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ---KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e   78 (338)
                      ++|++.+.||+|+||+||+|+..   ..||||+++...   ...+.+.+|+.++++++|||||++++++.. +.+|+|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            57999999999999999999753   459999987542   334678899999999999999999998654 56899999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC---C
Q 019628           79 YAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH---S  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~---~  154 (338)
                      ||++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.+.  ++||+|||+|+.....   .
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~--~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS--SEEECCCCCSCC--------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC--CEEEccccceeeccccCCcc
Confidence            99999999999754 5699999999999999999999999999999999999997655  8999999999754322   2


Q ss_pred             CCCCccccCcccccccccCCc--cCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          155 QPKSTVGTPAYIAPEVLTKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                      ...+..||+.|||||++.+..  ..+.++|||||||++|||+||+.||............+..-............++++
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            334568999999999986532  224558999999999999999999988766554443332211111111122368899


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +.+||.+||+.||++|||+.|++++
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-58  Score=417.18  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=208.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc-----EEEEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE-----LLAVKFIERG--QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++++.||+|+||+||+|++..+++     .||+|.+...  ......+.+|+.+++++ +|||||++++++.+++.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            579999999999999999999875543     6899988653  33446788999999988 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEE
Q 019628           74 AIVMEYAAGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL  130 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~-----------------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl  130 (338)
                      |+|||||++|+|.++|....                       .+++..++.++.||+.||+|||++|||||||||+|||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            99999999999999997542                       4899999999999999999999999999999999999


Q ss_pred             ecCCCCCcEEEeecCCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCCh
Q 019628          131 LDGSTAPRVKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDP  206 (338)
Q Consensus       131 ~~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~  206 (338)
                      ++.++  ++||+|||+|+.......   ..+..||+.|||||++.+..++.+ +|||||||++|||+| |++||.+....
T Consensus       197 l~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         197 VTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccCC--eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            97655  899999999986544332   234568999999999988887654 999999999999998 89999886665


Q ss_pred             HHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          207 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ..+.+.+    ...+.++....+|+++++||.+||+.||++|||++||++|
T Consensus       274 ~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHH----hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5444433    2333344444789999999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-58  Score=406.41  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=207.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++++.||+|+||+||+|.+. +++.||||+++......+.+.+|+.++++++|||||++++++.+ +.+|+||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            58999999999999999999986 67889999998877667889999999999999999999998754 56799999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CCC
Q 019628           82 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QPK  157 (338)
Q Consensus        82 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~~  157 (338)
                      +|+|.+++...  .++++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+|+......  ...
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~--~~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSCEECCT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc--ceeeccccceEEccCCcccccc
Confidence            99999977543  3599999999999999999999999999999999999997654  89999999998654322  334


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCC-CCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...||+.|+|||++.+..++.+ +|||||||++|||+||. +||..... .....   .+... ...+....+++++.+|
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~---~i~~~-~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQ---NLERG-YRMVRPDNCPEELYQL  242 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHH---HHHTT-CCCCCCTTCCHHHHHH
T ss_pred             ccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHH---HHHhc-CCCCCcccChHHHHHH
Confidence            5679999999999988777644 99999999999999965 45554333 22222   22222 2222233789999999


Q ss_pred             HHHhcccCCCcCCChhHHhc--Ccccc
Q 019628          237 LSRIFVANSEKRITIPEIKN--HPWFL  261 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~--hp~~~  261 (338)
                      +.+||+.||++|||+.++++  |+||.
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            99999999999999999998  78885

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=400.48  Aligned_cols=247  Identities=22%  Similarity=0.362  Sum_probs=213.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|+++++||+|+||+||+++++ +++.||||++++.....+.+.+|+.++++++||||+++++++.+++.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            58999999999999999999985 78899999999877777889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC--CCC
Q 019628           82 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ--PKS  158 (338)
Q Consensus        82 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~--~~~  158 (338)
                      +|+|..++.. ...+++..+..++.||++||+|||++||+||||||+|||++.+.  .+||+|||+++.......  ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC--CEEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC--cEEECcchhheeccCCCceeecc
Confidence            9999998764 45689999999999999999999999999999999999997654  899999999975443322  334


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ..||+.|+|||++.+..++.+ +||||+||++|||+| |+.||...+..+....    +... ...+.....++++.+||
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~----i~~~-~~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQG-LRLYRPHLASEKVYTIM  234 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HHTT-CCCCCCTTCCHHHHHHH
T ss_pred             cCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHHHH----HHhC-CCCCCcccccHHHHHHH
Confidence            679999999999998887654 999999999999998 8999988765443322    2222 22233347889999999


Q ss_pred             HHhcccCCCcCCChhHHhcC
Q 019628          238 SRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~h  257 (338)
                      ++||+.||++|||+.++++|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-57  Score=408.10  Aligned_cols=248  Identities=22%  Similarity=0.373  Sum_probs=197.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc---EEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE---LLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++.+.||+|+||+||+|.++.+++   .||||++....  ...+.+.+|+.+|++++|||||++++++..++.+|+|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            579999999999999999999986664   58899886542  2345789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCC
Q 019628           77 MEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQ  155 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~  155 (338)
                      ||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+.......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC--cEEECCcccceEccCCCC
Confidence            9999999999988764 4699999999999999999999999999999999999997655  899999999985433222


Q ss_pred             C------CCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          156 P------KSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       156 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                      .      ....||+.|||||++.+..++.+ +|||||||++|||+| |++||..........    .+.. ....|....
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~----~i~~-~~~~~~~~~  257 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVIN----AIEQ-DYRLPPPMD  257 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHT-TCCCCCCTT
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCcc
Confidence            1      22457899999999988877655 899999999999998 899998766543322    2222 233344457


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +++++.+|+.+||+.||++|||+.|++++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999998874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=404.91  Aligned_cols=243  Identities=23%  Similarity=0.349  Sum_probs=198.6

Q ss_pred             eeeccCCceEEEEEEEc--CCCcEEEEEEeecCcc---ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccCC
Q 019628            8 KDIGSGNFGVAKLVRDK--WTRELLAVKFIERGQK---IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAAG   82 (338)
Q Consensus         8 ~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~~   82 (338)
                      ++||+|+||+||+|...  .+++.||||+++....   ..+.+.+|+.++++++|||||++++++..+ .+|+|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999764  4567899999975432   235788999999999999999999998654 57899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC----CCCC
Q 019628           83 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS----QPKS  158 (338)
Q Consensus        83 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~----~~~~  158 (338)
                      |+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+......    ....
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~--~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC--cccccchhhhhhccccccccccccc
Confidence            99999999988999999999999999999999999999999999999997555  89999999997543222    2234


Q ss_pred             ccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhh-ccccCCCcccCCHHHHHH
Q 019628          159 TVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILS-VHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  236 (338)
                      ..||+.|||||++.+..++.+ +|||||||++|||+| |++||.+.......    ..+.. .....|  ..+|+++.+|
T Consensus       170 ~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~----~~i~~~~~~~~p--~~~~~~~~~l  242 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----AMLEKGERMGCP--AGCPREMYDL  242 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHTTCCCCCC--TTCCHHHHHH
T ss_pred             cCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHH----HHHHcCCCCCCC--cccCHHHHHH
Confidence            568999999999988877655 999999999999998 89999876543322    22222 223334  3789999999


Q ss_pred             HHHhcccCCCcCCChhHH---hcCccc
Q 019628          237 LSRIFVANSEKRITIPEI---KNHPWF  260 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~el---l~hp~~  260 (338)
                      |.+||+.||++|||+.++   |+|+|+
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999998   456664

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-57  Score=400.89  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=206.3

Q ss_pred             CCceEeee-eccCCceEEEEEEEcC--CCcEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKD-IGSGNFGVAKLVRDKW--TRELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~-LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||+++...  ...+.+.+|+.++++++|||||++++++.. +.+|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            46788884 9999999999998754  44579999997643  234678899999999999999999999875 468999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           77 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      ||||++|+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+...... 
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC--ceeeccchhhhccccccc
Confidence            999999999998764 45799999999999999999999999999999999999997655  89999999998543322 


Q ss_pred             ---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhc-cccCCCcccC
Q 019628          155 ---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSV-HYSFPDYVRV  229 (338)
Q Consensus       155 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  229 (338)
                         ......||+.|+|||++.+..++.+ +||||+||++|||+| |+.||......+...    .+..+ ....|.  .+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~~~~~~~p~--~~  237 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGKRMECPP--EC  237 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHTTCCCCCCT--TC
T ss_pred             ccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCCCC--cC
Confidence               2234568999999999988877655 999999999999998 999999876543322    22222 233443  68


Q ss_pred             CHHHHHHHHHhcccCCCcCCChhHH---hcCcccc
Q 019628          230 SLECKHLLSRIFVANSEKRITIPEI---KNHPWFL  261 (338)
Q Consensus       230 ~~~~~~li~~~L~~dp~~R~s~~el---l~hp~~~  261 (338)
                      |+++.+||.+||+.+|++|||+.++   |+|+|+.
T Consensus       238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999888   6788873

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=397.59  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=204.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEEEeccC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIVMEYAA   81 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv~e~~~   81 (338)
                      ++|++.+.||+|+||.||+|++..+ +.||||+++......+.+.+|+.++++++|||||++++++.+ +.+++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            6899999999999999999999754 579999998777667889999999999999999999999854 56789999999


Q ss_pred             CCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC--CCC
Q 019628           82 GGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS--QPK  157 (338)
Q Consensus        82 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~--~~~  157 (338)
                      +|+|..++..  .+.+++..+..++.||+.||+|||++||+||||||+|||++.+.  ++||+|||+|+......  ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~--~~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC-----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC--cEEEcccchhhhccCCCceeec
Confidence            9999988854  35699999999999999999999999999999999999997554  89999999998543322  233


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHLL  237 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (338)
                      ...||+.|+|||++....++. ++||||+||++|||+||..||............+   .. ....+....+++++++||
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~-ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---~~-~~~~~~~~~~~~~l~~li  247 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ER-GYRMPCPPECPESLHDLM  247 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT-TCCCCCCTTSCHHHHHHH
T ss_pred             cccccccccChHHHhCCCCCc-HHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hh-cCCCCCCcccCHHHHHHH
Confidence            467999999999998888765 4999999999999999655554444333333222   22 122333447899999999


Q ss_pred             HHhcccCCCcCCChhHHhc--CcccccC
Q 019628          238 SRIFVANSEKRITIPEIKN--HPWFLRN  263 (338)
Q Consensus       238 ~~~L~~dp~~R~s~~ell~--hp~~~~~  263 (338)
                      .+||+.||++|||++++++  |+||...
T Consensus       248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         248 CQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999999999988  8888643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-56  Score=393.34  Aligned_cols=247  Identities=23%  Similarity=0.353  Sum_probs=195.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC---cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR---ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAIV   76 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~iv   76 (338)
                      ++|++++.||+|+||+||+|.+..++   ..||||.++...  ...+.+.+|+.++++++|||||++++++. ++.+|+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            68999999999999999999987543   468899886533  23356889999999999999999999986 4678999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC-
Q 019628           77 MEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS-  154 (338)
Q Consensus        77 ~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~-  154 (338)
                      |||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||+|+...... 
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~--~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC--cEEEccchhheeccCCcc
Confidence            999999999998764 44699999999999999999999999999999999999997655  89999999998643322 


Q ss_pred             -CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHH
Q 019628          155 -QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLE  232 (338)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
                       ......||+.|+|||++.+..++. ++|||||||++|||+| |.+||............    .... ..+....+|++
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~-~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~~~-~~~~~~~~~~~  237 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGE-RLPMPPNCPPT  237 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTC-CCCCCTTCCHH
T ss_pred             eeccceecCcccchhhHhccCCCCC-ccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCC-CCCCCCCCCHH
Confidence             234456899999999998877755 4999999999999998 89999887665443332    2221 22333478999


Q ss_pred             HHHHHHHhcccCCCcCCChhHHhcC
Q 019628          233 CKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       233 ~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +.+||.+||..||++|||+.|+++|
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999886

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-55  Score=389.14  Aligned_cols=248  Identities=21%  Similarity=0.294  Sum_probs=197.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC----cEEEEEEeecCc--cccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR----ELLAVKFIERGQ--KIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +.|++.+.||+|+||+||+|....++    ..||||++....  .....+.+|+.++++++|||||++++++...+.+++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            46999999999999999999987554    479999987543  223468899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      ||||+.++++...+... ..+++..+..++.||+.||+|||++||+||||||+|||++.+.  .+||+|||+|+......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC--eEEEcccchhhcccCCC
Confidence            99999999999887654 5699999999999999999999999999999999999997655  89999999998543322


Q ss_pred             ----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                          ......||+.|||||++.+..++.+ +|||||||++|||++|..||............   +.. ....+....++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~---i~~-~~~~~~~~~~~  239 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---IND-GFRLPTPMDCP  239 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHT-TCCCCCCTTCB
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHH---Hhc-cCCCCCchhhH
Confidence                1223568999999999988887655 99999999999999965555443333332222   222 22333344789


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ..+.+||.+||+.+|++|||+.|+++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=394.13  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=205.4

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcE--EEEEEeecC--ccccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeEEE
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTREL--LAVKFIERG--QKIDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      +++|++.+.||+|+||+||+|.++.+|..  ||||++...  ....+.+.+|+.+++++ +|||||++++++..++.+|+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            36899999999999999999999888764  677777543  22345789999999999 69999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcE
Q 019628           76 VMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRV  139 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~i  139 (338)
                      ||||+++|+|.++|...                ..+++..+..++.||+.||.|||++||+||||||+|||++...  .+
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~--~~  166 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA  166 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CE
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC--ce
Confidence            99999999999999754                4699999999999999999999999999999999999997655  89


Q ss_pred             EEeecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCC-CCCCCCCChHHHHHHHhhHhh
Q 019628          140 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEDPKNFRKTIGRILS  218 (338)
Q Consensus       140 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~  218 (338)
                      ||+|||+|+............||+.|+|||.+.+..++.+ +|||||||++|||++|. +||...+.....    ..+..
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~~~----~~i~~  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLPQ  241 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHGGG
T ss_pred             EEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHHHH----HHHHh
Confidence            9999999986655555556779999999999988888655 99999999999999965 567665433322    22222


Q ss_pred             ccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          219 VHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      . ..++....+++++++||.+||+.||++|||+.|+++|
T Consensus       242 ~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 G-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             T-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2 2233334789999999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-55  Score=393.52  Aligned_cols=248  Identities=20%  Similarity=0.325  Sum_probs=200.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCc----EEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRE----LLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~i   75 (338)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|+++..  ....+.+.+|+.++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            479999999999999999999988776    5788887653  23456789999999999999999999999875 5677


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC
Q 019628           76 VMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS  154 (338)
Q Consensus        76 v~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~  154 (338)
                      +++++.+|+|.+.+.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++  ++||+|||+|+......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~--~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC--CeEeeccccceeccccc
Confidence            8899999999988765 45799999999999999999999999999999999999997655  89999999998543322


Q ss_pred             C---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCC
Q 019628          155 Q---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVS  230 (338)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (338)
                      .   .....||+.|+|||++.+..++. ++|||||||++|||+| |.+||......... ..+   .. ....+....++
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i---~~-~~~~~~p~~~~  239 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL---EK-GERLPQPPICT  239 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHH---HH-TCCCCCCTTBC
T ss_pred             ccccccccccCccccChHHHhcCCCCh-hhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHH---Hc-CCCCCCCcccC
Confidence            2   23346899999999998887754 4999999999999998 89999876654332 222   22 12223334689


Q ss_pred             HHHHHHHHHhcccCCCcCCChhHHhcCc
Q 019628          231 LECKHLLSRIFVANSEKRITIPEIKNHP  258 (338)
Q Consensus       231 ~~~~~li~~~L~~dp~~R~s~~ell~hp  258 (338)
                      +++.+|+.+||..||.+|||+.|+++|.
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999999984

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-55  Score=384.73  Aligned_cols=244  Identities=23%  Similarity=0.388  Sum_probs=197.7

Q ss_pred             CCCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEc-CCeEEEEEec
Q 019628            1 MERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLT-PTHLAIVMEY   79 (338)
Q Consensus         1 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~iv~e~   79 (338)
                      +++|++++.||+|+||.||+|..+  |+.||||++++.. ..+.+.+|+.++++++||||+++++++.+ ++.+|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            578999999999999999999984  7889999997643 45779999999999999999999999865 4678999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCCCCC
Q 019628           80 AAGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHSQPK  157 (338)
Q Consensus        80 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~~~~  157 (338)
                      +++|+|.+++....  .+++..++.++.||+.||.|||+++|+||||||+|||++.++  .+||+|||+++...  ....
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~s~~~~--~~~~  158 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEAS--STQD  158 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC--CEeecccccceecC--CCCc
Confidence            99999999996543  489999999999999999999999999999999999997655  89999999998532  2344


Q ss_pred             CccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCcccCCHHHHHH
Q 019628          158 STVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVRVSLECKHL  236 (338)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (338)
                      ...+|+.|+|||++.+..++ .++|||||||++|||+| |++||............ ..  ...+.+|.  .+++++.+|
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~--~~~~~~~~--~~~~~~~~l  232 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EK--GYKMDAPD--GCPPAVYEV  232 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TT--TCCCCCCT--TCCHHHHHH
T ss_pred             cccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-Hc--CCCCCCCc--cCCHHHHHH
Confidence            56789999999999887775 45999999999999998 78888876554433332 11  22333444  688999999


Q ss_pred             HHHhcccCCCcCCChhHHhcC
Q 019628          237 LSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       237 i~~~L~~dp~~R~s~~ell~h  257 (338)
                      |++||..||.+|||+.+++++
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=392.45  Aligned_cols=249  Identities=23%  Similarity=0.351  Sum_probs=194.9

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCc--cccHHHHHHHHHHhcC-CCCCcceeEEEEEcC-Ce
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQ--KIDEHVQREIMNHRSL-KHPNIVRFKEVLLTP-TH   72 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-~~   72 (338)
                      ++|++++.||+|+||.||+|.+..     +++.||||+++...  ...+.+.+|...+.++ .|+||+.+++++..+ ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            679999999999999999999754     45689999987543  2234567777777666 689999999987654 56


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCC
Q 019628           73 LAIVMEYAAGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTA  136 (338)
Q Consensus        73 ~~iv~e~~~~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~  136 (338)
                      +++|||||++|+|.+++...                ..+++..+..++.||+.||.|||++|||||||||+|||++.++ 
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~-  171 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-  171 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC-
Confidence            89999999999999999753                2489999999999999999999999999999999999997554 


Q ss_pred             CcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcC-CCCCCCCCChHHHHHH
Q 019628          137 PRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKT  212 (338)
Q Consensus       137 ~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~~  212 (338)
                       ++||+|||+|+......   ......||+.|+|||++.+..++. ++||||+||++|||+|| .+||........+...
T Consensus       172 -~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         172 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             -CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             -cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc-ccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             89999999997543322   234567999999999998877754 49999999999999986 5788776655544443


Q ss_pred             HhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          213 IGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      +..  ...+..|  ..+++++++||.+||+.||++|||+.|+++|
T Consensus       250 ~~~--~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKE--GTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHH--TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhc--CCCCCCC--ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            322  1222333  3689999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-55  Score=385.84  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=196.5

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCC-C--cEEEEEEeecC----ccccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWT-R--ELLAVKFIERG----QKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||.||+|+.... +  ..||||++.+.    ....+.+.+|+.++++++|||||++++++.+ ..++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5799999999999999999986433 3  36899998753    2233578999999999999999999999976 4678


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccC
Q 019628           75 IVMEYAAGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLH  153 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~  153 (338)
                      +||||+++|++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++.....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc--ceeeccchhhhhcccC
Confidence            99999999999987764 45699999999999999999999999999999999999997655  8999999999854332


Q ss_pred             C----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHHHHhhHhhccccCCCccc
Q 019628          154 S----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRKTIGRILSVHYSFPDYVR  228 (338)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (338)
                      .    ......||..|+|||++.+..++.+ +|||||||++|||+| |.+||.+.+.....    ..+......++....
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~  239 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPRPED  239 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTSCCCCCCCTT
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHH----HHHHhCCCCCCCccc
Confidence            2    1234567889999999988777544 899999999999998 89999876654433    334444445555567


Q ss_pred             CCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          229 VSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       229 ~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +|+++.+||.+||..||++|||+.|+++
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8999999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-54  Score=384.68  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCC-------cEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCC
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTR-------ELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPT   71 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~   71 (338)
                      ++|++++.||+|+||.||+|++..++       ..||||++++...  ....+.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            68999999999999999999986554       4799999976543  335677888888887 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        72 ~~~iv~e~~~~~~L~~~i~~~~----------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      .+++||||+++|+|.++|....                .+++..+..++.||+.||+|||++|||||||||+|||++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            9999999999999999997543                489999999999999999999999999999999999997655


Q ss_pred             CCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++......   ......||+.|+|||.+.++.|+.+ +|||||||++|+|++ |.+||........+  
T Consensus       173 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~--  247 (299)
T d1fgka_         173 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF--  247 (299)
T ss_dssp             --CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred             --CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHHHH--
Confidence              89999999998554332   2344679999999999988887655 899999999999998 78999875543322  


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                        ..+.. ...++....+++++++||.+||+.||++|||+.|+++
T Consensus       248 --~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 --KLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             --HHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence              22222 2233333478999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-54  Score=385.92  Aligned_cols=247  Identities=24%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||+||+|+.+     .+++.||||+++....  ..+.+.+|+.++++++||||+++++++...+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            57999999999999999999975     3567899999876432  3457899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEE
Q 019628           75 IVMEYAAGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTL  130 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~~------------------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl  130 (338)
                      ++|||+++|+|.+++....                        .+++..+..++.||+.||+|||++|||||||||+|||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            9999999999999996532                        3889999999999999999999999999999999999


Q ss_pred             ecCCCCCcEEEeecCCCcccccC---CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCC-CCCCCCCCh
Q 019628          131 LDGSTAPRVKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEDP  206 (338)
Q Consensus       131 ~~~~~~~~ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~  206 (338)
                      ++.+.  .+||+|||+|+.....   ....+..||+.|+|||++.+..++. ++|||||||++|||++|. +||......
T Consensus       173 ld~~~--~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~-ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         173 VGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             ECGGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ECCCC--cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh-hhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            97554  8999999999744322   2234567999999999999888764 499999999999999985 678776554


Q ss_pred             HHHHHHHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          207 KNFRKTIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      +....    +.... ..+....+++++.+||.+||+.+|++|||+.|+++
T Consensus       250 e~~~~----v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         250 EVIYY----VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHH----HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHH----HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            33322    33322 12223378999999999999999999999999965

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=381.17  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=206.7

Q ss_pred             CCceEeeeeccCCceEEEEEEEc-----CCCcEEEEEEeecCcc--ccHHHHHHHHHHhcC-CCCCcceeEEEEEcCCeE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDK-----WTRELLAVKFIERGQK--IDEHVQREIMNHRSL-KHPNIVRFKEVLLTPTHL   73 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~   73 (338)
                      ++|++.+.||+|+||.||+|+..     .+++.||||+++....  ....+.+|+.+++.+ +|||||++++++.+++.+
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            58999999999999999999863     4667999999976432  334688999999999 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCC
Q 019628           74 AIVMEYAAGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGST  135 (338)
Q Consensus        74 ~iv~e~~~~~~L~~~i~~~~------------------~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~  135 (338)
                      |+|||||++|+|..++....                  .+++..+..++.||+.||+|||++|++||||||+||+++.+.
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            99999999999999997543                  589999999999999999999999999999999999997655


Q ss_pred             CCcEEEeecCCCcccccCC---CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHc-CCCCCCCCCChHHHHH
Q 019628          136 APRVKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEDPKNFRK  211 (338)
Q Consensus       136 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~  211 (338)
                        .+||+|||+++......   .....+||+.|+|||++.+..++.+ +|||||||++|||+| |.+||........+.+
T Consensus       183 --~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         183 --ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             --EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             --cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence              89999999998544322   2244679999999999987777544 999999999999998 6777766655554444


Q ss_pred             HHhhHhhccccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          212 TIGRILSVHYSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      .+..    ....+....+++++.+||.+||+.||++|||+.|+++
T Consensus       260 ~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4322    2222333368999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=381.10  Aligned_cols=247  Identities=19%  Similarity=0.268  Sum_probs=205.2

Q ss_pred             CCceEeeeeccCCceEEEEEEEcC-----CCcEEEEEEeecCcc--ccHHHHHHHHHHhcCCCCCcceeEEEEEcCCeEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKW-----TRELLAVKFIERGQK--IDEHVQREIMNHRSLKHPNIVRFKEVLLTPTHLA   74 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~   74 (338)
                      ++|++++.||+|+||+||+|.+..     +++.||||++++...  ....+.+|+.++++++|||||++++++..++.++
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            689999999999999999998752     357899999976432  2245789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           75 IVMEYAAGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        75 iv~e~~~~~~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                      +||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.+.  ++||+||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~--~~Kl~DF  177 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  177 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc--eEEEeec
Confidence            999999999999988643          2478999999999999999999999999999999999997555  8999999


Q ss_pred             CCCcccccCCC---CCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcC-CCCCCCCCChHHHHHHHhhHhhcc
Q 019628          145 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEDPKNFRKTIGRILSVH  220 (338)
Q Consensus       145 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~  220 (338)
                      |+|+.......   .....||+.|+|||.+.+..++.+ +||||+||++|||+|| .+||...+....+..    +.+..
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~----i~~~~  252 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEGG  252 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTTC
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhCC
Confidence            99985433222   334578999999999988877644 8999999999999998 578877655433332    22222


Q ss_pred             ccCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          221 YSFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                       ..+....+++.+.+||.+||+.+|++|||+.++++
T Consensus       253 -~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         253 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             22223468899999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.9e-53  Score=377.30  Aligned_cols=258  Identities=22%  Similarity=0.215  Sum_probs=201.1

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCC-cceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPN-IVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      +||++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|+| |+.+..++...+..++||||+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            589999999999999999999999999999998876533 346788999999998776 555566677888999999999


Q ss_pred             CCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC-CCCcEEEeecCCCcccccCC----
Q 019628           81 AGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-TAPRVKICDFGYSKSSVLHS----  154 (338)
Q Consensus        81 ~~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~-~~~~ikL~Dfg~a~~~~~~~----  154 (338)
                      . ++|...+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.. .+..+||+|||+|+......    
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             C-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            4 56666554 45679999999999999999999999999999999999998533 23479999999998543222    


Q ss_pred             ----CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC---Ccc
Q 019628          155 ----QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP---DYV  227 (338)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~  227 (338)
                          .....+||+.|||||++.+..++. ++|||||||++|+|+||+.||.............. ........|   ...
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  242 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-ISEKKMSTPIEVLCK  242 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBCCCH-HHHHHHHHHHHHHHHHSSCTTCCCC-------HHH-HHHHHHHSCHHHHTT
T ss_pred             eeccccCCcCCCccccCHHHHhCCCCCC-hhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH-hhcccCCCChhHhcc
Confidence                234567999999999998887754 49999999999999999999987655433322211 111111111   123


Q ss_pred             cCCHHHHHHHHHhcccCCCcCCChh---HHhcCcccccC
Q 019628          228 RVSLECKHLLSRIFVANSEKRITIP---EIKNHPWFLRN  263 (338)
Q Consensus       228 ~~~~~~~~li~~~L~~dp~~R~s~~---ell~hp~~~~~  263 (338)
                      .+|+++.+||.+||+.+|++||++.   ++|+|+|....
T Consensus       243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            6889999999999999999999986   45778876543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=371.82  Aligned_cols=245  Identities=22%  Similarity=0.275  Sum_probs=195.9

Q ss_pred             eEeeeeccCCceEEEEEEEcCCC---cEEEEEEeecC--ccccHHHHHHHHHHhcCCCCCcceeEEEEEc-CCeEEEEEe
Q 019628            5 EIVKDIGSGNFGVAKLVRDKWTR---ELLAVKFIERG--QKIDEHVQREIMNHRSLKHPNIVRFKEVLLT-PTHLAIVME   78 (338)
Q Consensus         5 ~~~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~iv~e   78 (338)
                      .+.+.||+|+||+||+|....++   ..||||++++.  ....+++.+|+.++++++|||||++++++.. ++.+++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            34678999999999999986543   36899998753  2334678999999999999999999999765 568999999


Q ss_pred             ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeecCCCcccccCC---
Q 019628           79 YAAGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDFGYSKSSVLHS---  154 (338)
Q Consensus        79 ~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~~~~~~---  154 (338)
                      ||++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++++.  .+||+|||+++......   
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~--~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSSGGGCCTTTTTCCC
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC--CEEEecccchhhcccccccc
Confidence            999999999887544 477889999999999999999999999999999999997655  89999999998543322   


Q ss_pred             --CCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhh-ccccCCCcccCCH
Q 019628          155 --QPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILS-VHYSFPDYVRVSL  231 (338)
Q Consensus       155 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  231 (338)
                        ......||+.|+|||.+.+..++.+ +|||||||++|||+||..||...........   .+.. .....|.  .+++
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g~~~~~p~--~~~~  261 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRLLQPE--YCPD  261 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTTCCCCCCT--TCCH
T ss_pred             ceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCCCCCCcc--cCcH
Confidence              2233568999999999988777545 8999999999999998877765433222222   2222 2233333  6889


Q ss_pred             HHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          232 ECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       232 ~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ++.+||.+||+.||++|||+.|+++|
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-51  Score=366.20  Aligned_cols=251  Identities=20%  Similarity=0.236  Sum_probs=204.0

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC-CCcceeEEEEEcCCeEEEEEecc
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH-PNIVRFKEVLLTPTHLAIVMEYA   80 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~iv~e~~   80 (338)
                      ++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+|++.++.++| +||+.+++++......|+||||+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            58999999999999999999999999999999886543 23567889999999976 89999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCC---CCCcEEEeecCCCcccccC---
Q 019628           81 AGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGS---TAPRVKICDFGYSKSSVLH---  153 (338)
Q Consensus        81 ~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~---~~~~ikL~Dfg~a~~~~~~---  153 (338)
                       +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++..   ..+.+||+|||+|+.....   
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  162 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence             789999887654 69999999999999999999999999999999999999642   3457999999999753321   


Q ss_pred             -----CCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhhHhhccccCC---C
Q 019628          154 -----SQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRILSVHYSFP---D  225 (338)
Q Consensus       154 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~  225 (338)
                           ....+.+||+.|||||++.+..++.+ +|||||||++|+|+||..||............ ..+.......+   -
T Consensus       163 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~~l  240 (293)
T d1csna_         163 QHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPLREL  240 (293)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHSCHHHH
T ss_pred             cceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCCChHHh
Confidence                 12345679999999999988777544 99999999999999999999865543332211 11111111111   1


Q ss_pred             cccCCHHHHHHHHHhcccCCCcCCChhHHhc
Q 019628          226 YVRVSLECKHLLSRIFVANSEKRITIPEIKN  256 (338)
Q Consensus       226 ~~~~~~~~~~li~~~L~~dp~~R~s~~ell~  256 (338)
                      ...+|+++.+++..|+..+|++||+.+.+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1358899999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=368.41  Aligned_cols=251  Identities=24%  Similarity=0.281  Sum_probs=191.8

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCcceeEEEEEcCC----eEEEEE
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNIVRFKEVLLTPT----HLAIVM   77 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~iv~   77 (338)
                      ++|.+.+.||+|+||.||+|+.  +|+.||||+++.........++|+..++.++|||||++++++..++    .+|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4799999999999999999987  5899999999765443334455666677889999999999998653    689999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh--------cCceecCCCCCcEEecCCCCCcEEEeecCCCcc
Q 019628           78 EYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQICHRDLKLENTLLDGSTAPRVKICDFGYSKS  149 (338)
Q Consensus        78 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~--------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~~  149 (338)
                      |||++|+|.+++++. ++++..+..++.|++.||.|||+        +|||||||||+|||++.++  ++||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--CeEEEecCcccc
Confidence            999999999999764 69999999999999999999996        5999999999999997554  899999999985


Q ss_pred             cccCC-----CCCCccccCcccccccccCCcc-----CCCcchHHHHHHHHHHHHcCCCCCCCCCCh-----------HH
Q 019628          150 SVLHS-----QPKSTVGTPAYIAPEVLTKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEDP-----------KN  208 (338)
Q Consensus       150 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~lltg~~pf~~~~~~-----------~~  208 (338)
                      .....     ......||+.|+|||++.....     .+.++|||||||++|||+||..||......           ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            43322     2345679999999999875421     133489999999999999998887432210           01


Q ss_pred             HHHHHhhHhhcc--ccCCCc---ccCCHHHHHHHHHhcccCCCcCCChhHHhcC
Q 019628          209 FRKTIGRILSVH--YSFPDY---VRVSLECKHLLSRIFVANSEKRITIPEIKNH  257 (338)
Q Consensus       209 ~~~~~~~~~~~~--~~~~~~---~~~~~~~~~li~~~L~~dp~~R~s~~ell~h  257 (338)
                      ............  ..+|..   ...+..+.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            111111111111  122221   1223458899999999999999999999873

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-50  Score=370.03  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=197.1

Q ss_pred             CceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCC-----------CCCcceeEEEEEc--
Q 019628            3 RYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLK-----------HPNIVRFKEVLLT--   69 (338)
Q Consensus         3 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-----------h~~Iv~~~~~~~~--   69 (338)
                      ||+++++||+|+||+||+|+++.+|+.||||++++.....+.+.+|+.+++.+.           |+||+++++++..  
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            799999999999999999999999999999999877655677888999888875           5789999998864  


Q ss_pred             CCeEEEEEeccCCCChHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHhhh-cCceecCCCCCcEEecCCCC----CcEEE
Q 019628           70 PTHLAIVMEYAAGGELFER-I--CNAGRFSEDEARFFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSTA----PRVKI  141 (338)
Q Consensus        70 ~~~~~iv~e~~~~~~L~~~-i--~~~~~l~~~~~~~i~~qi~~al~~LH~-~~iiH~Dlkp~NIl~~~~~~----~~ikL  141 (338)
                      ....+++|.++..+..... .  .....+++..++.++.||+.||.|||+ .||+||||||+|||++..+.    ..+++
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence            3566677776655433222 2  234568999999999999999999998 89999999999999964432    24899


Q ss_pred             eecCCCcccccCCCCCCccccCcccccccccCCccCCCcchHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhh
Q 019628          142 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLTKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPK------NFRKTIGR  215 (338)
Q Consensus       142 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~------~~~~~~~~  215 (338)
                      +|||.|....  ......+||+.|+|||++.+..++.+ +||||+||++++|++|+.||.......      .....+..
T Consensus       174 ~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~  250 (362)
T d1q8ya_         174 ADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  250 (362)
T ss_dssp             CCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             eecccccccc--cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence            9999987432  34456789999999999998888655 899999999999999999997543211      11111110


Q ss_pred             Hhh--------cc------------c----------------cCCCcccCCHHHHHHHHHhcccCCCcCCChhHHhcCcc
Q 019628          216 ILS--------VH------------Y----------------SFPDYVRVSLECKHLLSRIFVANSEKRITIPEIKNHPW  259 (338)
Q Consensus       216 ~~~--------~~------------~----------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ell~hp~  259 (338)
                      +..        ..            .                ........++++++||.+||.+||.+|||++|+|+|||
T Consensus       251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~  330 (362)
T d1q8ya_         251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW  330 (362)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred             hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            000        00            0                00001124677999999999999999999999999999


Q ss_pred             cccCC
Q 019628          260 FLRNL  264 (338)
Q Consensus       260 ~~~~~  264 (338)
                      |++..
T Consensus       331 f~~~~  335 (362)
T d1q8ya_         331 LKDTL  335 (362)
T ss_dssp             GTTCT
T ss_pred             cCCCC
Confidence            98543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.7e-27  Score=198.35  Aligned_cols=131  Identities=21%  Similarity=0.182  Sum_probs=106.3

Q ss_pred             ceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCcc-------------------ccHHHHHHHHHHhcCCCCCcceeE
Q 019628            4 YEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQK-------------------IDEHVQREIMNHRSLKHPNIVRFK   64 (338)
Q Consensus         4 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~~Iv~~~   64 (338)
                      |.+.++||+|+||+||+|.+. +|+.||||+++.+..                   ......+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999985 789999998753210                   012345788899999999999988


Q ss_pred             EEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCceecCCCCCcEEecCCCCCcEEEeec
Q 019628           65 EVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSTAPRVKICDF  144 (338)
Q Consensus        65 ~~~~~~~~~~iv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~~~iiH~Dlkp~NIl~~~~~~~~ikL~Df  144 (338)
                      ++..    .+++|||+++..+.       .++...+..++.|++.||.|||++||+||||||+|||++++   .++|+||
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~---~~~liDF  146 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE---GIWIIDF  146 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT---EEEECCC
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC---CEEEEEC
Confidence            7532    26999999876542       35666778999999999999999999999999999999743   5899999


Q ss_pred             CCCcc
Q 019628          145 GYSKS  149 (338)
Q Consensus       145 g~a~~  149 (338)
                      |+|..
T Consensus       147 G~a~~  151 (191)
T d1zara2         147 PQSVE  151 (191)
T ss_dssp             TTCEE
T ss_pred             CCccc
Confidence            99874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.78  E-value=1.6e-08  Score=86.00  Aligned_cols=138  Identities=18%  Similarity=0.132  Sum_probs=94.4

Q ss_pred             CCceEeeeeccCCceEEEEEEEcCCCcEEEEEEeecCc-cccHHHHHHHHHHhcCC-CCCcceeEEEEEcCCeEEEEEec
Q 019628            2 ERYEIVKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQ-KIDEHVQREIMNHRSLK-HPNIVRFKEVLLTPTHLAIVMEY   79 (338)
Q Consensus         2 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~iv~e~   79 (338)
                      +.|++++..+-++.+.||++..  .++.+++|+..... .....+.+|...++.+. +--+.+++.+...++..++||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            5788888766666789998864  46667888876543 23345778888887764 33367778888888899999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------------
Q 019628           80 AAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------  116 (338)
Q Consensus        80 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~LH~-------------------------------------------  116 (338)
                      ++|.++.......     .....++.++...+..||+                                           
T Consensus        92 l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          92 ADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            9998775543211     1122334444445555552                                           


Q ss_pred             ----------------cCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          117 ----------------MQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       117 ----------------~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                                      ..++|+|+.|.||+++++.  .+-|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~--~~~lIDwe~a~  212 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc--eEEEeechhcc
Confidence                            2389999999999997432  44699998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.38  E-value=1.2e-06  Score=78.95  Aligned_cols=77  Identities=18%  Similarity=0.127  Sum_probs=50.1

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeec-----Cc---cccHHHHHHHHHHhcCC-C--CCcceeEEEEEcCCeEEE
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIER-----GQ---KIDEHVQREIMNHRSLK-H--PNIVRFKEVLLTPTHLAI   75 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~E~~~l~~l~-h--~~Iv~~~~~~~~~~~~~i   75 (338)
                      .+.||.|....||++.+..+++.+++|.-..     ++   ....+...|...++.+. +  ..+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5679999999999999887788999996532     11   12345667888877663 2  345556543  4445578


Q ss_pred             EEeccCCCCh
Q 019628           76 VMEYAAGGEL   85 (338)
Q Consensus        76 v~e~~~~~~L   85 (338)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.32  E-value=9.8e-07  Score=74.16  Aligned_cols=74  Identities=16%  Similarity=0.081  Sum_probs=52.3

Q ss_pred             eeccCCc-eEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCC--CCcceeEEEEEcCCeEEEEEeccCCCCh
Q 019628            9 DIGSGNF-GVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKH--PNIVRFKEVLLTPTHLAIVMEYAAGGEL   85 (338)
Q Consensus         9 ~LG~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~~~iv~e~~~~~~L   85 (338)
                      .+..|.. +.||++... .+..+++|..+...  ...+.+|...++.+..  -.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455553 688988864 56668889765443  2456778887776643  3367778888888889999999988665

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.57  E-value=0.00014  Score=63.05  Aligned_cols=67  Identities=15%  Similarity=0.121  Sum_probs=45.3

Q ss_pred             eEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc--ceeE-----EEEEcCCeEEEEEeccCCC
Q 019628           16 GVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI--VRFK-----EVLLTPTHLAIVMEYAAGG   83 (338)
Q Consensus        16 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I--v~~~-----~~~~~~~~~~iv~e~~~~~   83 (338)
                      -.||++... +|..|++|+.+.+....+.+..|+..+..|...+|  +...     ..+...+..+.++++++|.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            579998874 67889999887765566778889888877742221  1111     1223456788999999763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.55  E-value=0.00015  Score=64.65  Aligned_cols=74  Identities=14%  Similarity=0.150  Sum_probs=50.6

Q ss_pred             eeeeccCCceEEEEEEEcC-------CCcEEEEEEeecCccccHHHHHHHHHHhcCCCCCc-ceeEEEEEcCCeEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDKW-------TRELLAVKFIERGQKIDEHVQREIMNHRSLKHPNI-VRFKEVLLTPTHLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~iv~e   78 (338)
                      ++.|+.|---.+|++....       ..+.|.+++... ....-...+|..+++.+.-.++ .++++++..    ..|+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            5678888888999998753       345677777653 3333456789988888854444 467776642    57899


Q ss_pred             ccCCCCh
Q 019628           79 YAAGGEL   85 (338)
Q Consensus        79 ~~~~~~L   85 (338)
                      |++|.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.12  E-value=0.00067  Score=58.16  Aligned_cols=137  Identities=16%  Similarity=0.071  Sum_probs=70.7

Q ss_pred             eeeeccCCceEEEEEEEcCCCcEEEEEEeecCccccHHHHHHHHHHhcCCCC-----CcceeE---EEEEcCCeEEEEEe
Q 019628            7 VKDIGSGNFGVAKLVRDKWTRELLAVKFIERGQKIDEHVQREIMNHRSLKHP-----NIVRFK---EVLLTPTHLAIVME   78 (338)
Q Consensus         7 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~-----~Iv~~~---~~~~~~~~~~iv~e   78 (338)
                      ++.|..|.--+.|++... +| .|++|+.... .....+..|+.++..|...     ..+...   .+.........++.
T Consensus        23 ~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~   99 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS   99 (316)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeee
Confidence            455667777889998865 34 5899988654 2345666777777776422     222110   00112345566666


Q ss_pred             ccCCCChHH--------------HHHhc---C------CC------------------CHHHHHHHHHHHHHHHHHhh--
Q 019628           79 YAAGGELFE--------------RICNA---G------RF------------------SEDEARFFFQQLISGVSYCH--  115 (338)
Q Consensus        79 ~~~~~~L~~--------------~i~~~---~------~l------------------~~~~~~~i~~qi~~al~~LH--  115 (338)
                      +..|.....              .+...   .      ..                  ........+..+...+.-.+  
T Consensus       100 ~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  179 (316)
T d2ppqa1         100 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  179 (316)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             ecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcc
Confidence            665532210              00000   0      00                  01112222333333333333  


Q ss_pred             --hcCceecCCCCCcEEecCCCCCcEEEeecCCCc
Q 019628          116 --SMQICHRDLKLENTLLDGSTAPRVKICDFGYSK  148 (338)
Q Consensus       116 --~~~iiH~Dlkp~NIl~~~~~~~~ikL~Dfg~a~  148 (338)
                        ..|+||+|+.+.||+++.+.  ..-+.||+.+.
T Consensus       180 ~L~~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~  212 (316)
T d2ppqa1         180 DLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  212 (316)
T ss_dssp             SSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             ccccccccCCcchhhhhccccc--ceeEecccccc
Confidence              25899999999999997543  45799999765